PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Domanskyi, A; Geissler, C; Vinnikov, IA; Alter, H; Schober, A; Vogt, MA; Gass, P; Parlato, R; Schutz, G				Domanskyi, Andrii; Geissler, Christin; Vinnikov, Ilya A.; Alter, Heike; Schober, Andreas; Vogt, Miriam A.; Gass, Peter; Parlato, Rosanna; Schuetz, Guenther			Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models	FASEB JOURNAL			English	Article						neurodegeneration; mTOR; mouse	TUMOR-SUPPRESSOR GENE; NIGROSTRIATAL SYSTEM; NUCLEOLAR DISRUPTION; MAMMALIAN TARGET; CRE RECOMBINASE; MOTOR DEFICITS; ANIMAL-MODELS; CELL-DEATH; MICE; BRAIN	Parkinson's disease (PD) is a progressive age-related movement disorder that results primarily from the selective loss of midbrain dopaminergic (DA) neurons. Symptoms of PD can be induced by genetic mutations or by DA neuron-specific toxins. A specific ablation of an essential factor controlling ribosomal RNA transcription, TifIa, in adult mouse DA neurons represses mTOR signaling and leads to progressive neurodegeneration and PD-like phenotype. Using an inducible Cre system in adult mice, we show here that the specific ablation of Pten in adult mouse DA neurons leads to activation of mTOR pathway and is neuroprotective in genetic (TifIa deletion) and neurotoxin-induced (MPTP or 6OHDA) mouse models of PD. Adult mice with DA neuron-specific Pten deletion exhibit elevated expression of tyrosine hydroxylase, a rate-limiting enzyme in the dopamine biosynthesis pathway, associated with increased striatal dopamine content, and increased mRNA levels of Foxa2, Pitx3, En1, Nurr1, and Lmx1b-the essential factors for maintaining physiological functions of adult DA neurons. Pten deletion attenuates the loss of tyrosine hydroxylase-positive cells after 6OHDA treatment, restores striatal dopamine in TifIa-knockout and MPTP-treated mice, and rescues locomotor impairments caused by TifIa loss. Inhibition of Pten-dependent functions in adult DA neurons may represent a promising PD therapy.-Domanskyi, A., Geissler, C., Vinnikov, I. A., Alter, H., Schober, A., Vogt, M. A., Gass, P., Parlato, R., Schutz, G. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J. 25, 2898-2910 (2011). www.fasebj.org	[Domanskyi, Andrii; Geissler, Christin; Vinnikov, Ilya A.; Alter, Heike; Parlato, Rosanna; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Schober, Andreas] Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol 2, Freiburg, Germany; [Vogt, Miriam A.; Gass, Peter] Univ Heidelberg, Cent Inst Mental Hlth, RG Anim Models Psychiat, D-6800 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Schutz, G (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 1, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.schuetz@dkfz.de	Parlato, Rosanna/G-8768-2015; Parlato, Rosanna/AAH-4429-2020; Domanskyi, Andrii/H-3437-2012	Parlato, Rosanna/0000-0001-6682-9645; Domanskyi, Andrii/0000-0002-4755-5981; Vinnikov, Ilya/0000-0003-0488-8484; Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche Forschungsgemeinschaft [SFB 488, SFB 636]; Fonds der Chemischen Industrie; European Union [LSHM-CT-2005-018652 (CRESCENDO)]; Bundesministerium fur Bildung und Forschung [FZK 01GS08153, 01GS08142, 0313074C (HepatoSys)]; Helmholtz Gemeinschaft Deutscher Forschungszentren, through Initiative CoReNe and Alliance HelMA; Deutsche Krebshilfe [108567]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Gemeinschaft Deutscher Forschungszentren, through Initiative CoReNe and Alliance HelMA(Helmholtz Association); Deutsche Krebshilfe(Deutsche Krebshilfe)	The authors thank R. Hertel for HPLC-ED. This work was supported by the Deutsche Forschungsgemeinschaft, through Collaborative Research Centers SFB 488 and SFB 636; the Fonds der Chemischen Industrie; the European Union, through grant LSHM-CT-2005-018652 (CRESCENDO); the Bundesministerium fur Bildung und Forschung, through NGFNplus grants FZK 01GS08153 and 01GS08142 and project 0313074C (HepatoSys); the Helmholtz Gemeinschaft Deutscher Forschungszentren, through Initiative CoReNe and Alliance HelMA; and the Deutsche Krebshilfe, through project 108567.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Burke RE, 2004, CELL TISSUE RES, V318, P63, DOI 10.1007/s00441-004-0908-4; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Diaz-Ruiz O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007027; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Lin W, 2009, DEV BIOL, V333, P386, DOI 10.1016/j.ydbio.2009.07.006; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; OTTO D, 1990, J NEUROSCI, V10, P1912; Parkitna Jan Rodriguez, 2009, V530, P325, DOI 10.1007/978-1-59745-471-1_17; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Schober A, 2007, NEUROBIOL DIS, V25, P378, DOI 10.1016/j.nbd.2006.10.005; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Xu PY, 2002, NEUROLOGY, V58, P881, DOI 10.1212/WNL.58.6.881; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zaborszky L, 2001, BEHAV GENET, V31, P47, DOI 10.1023/A:1010257808945; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zheng KN, 2003, ARCH NEUROL-CHICAGO, V60, P722, DOI 10.1001/archneur.60.5.722; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	64	90	94	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2898	2910		10.1096/fj.11-181958	http://dx.doi.org/10.1096/fj.11-181958			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21593433	Bronze			2022-12-25	WOS:000294435200006
J	Chung, YSA; Kocks, C				Chung, Yoon-Suk Alexander; Kocks, Christine			Recognition of Pathogenic Microbes by the Drosophila Phagocytic Pattern Recognition Receptor Eater	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; MACROPHAGE SCAVENGER RECEPTORS; INNATE IMMUNE-SYSTEM; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; TEICHOIC-ACIDS; PEPTIDOGLYCAN; PROTEIN; RESISTANCE; BACTERIA	Non-opsonic phagocytosis is a primordial form of pathogen recognition that is mediated by the direct interaction of phagocytic receptors with microbial surfaces. In the fruit fly Drosophila melanogaster, the EGF-like repeat containing scavenger receptor Eater is expressed by phagocytes and is required to survive infections with Gram-positive and Gram-negative bacteria. However, the mechanisms by which this receptor recognizes different types of bacteria are poorly understood. To address this problem, we generated a soluble, Fc-tagged receptor variant of Eater comprising the N-terminal 199 amino acids including four EGF-like repeats. We first established that Eater-Fc displayed specific binding to broad yet distinct classes of heat- or ethanol-inactivated microbes and behaved similarly to the membrane-bound, full-length Eater receptor. We then used Eater-Fc as a tool to probe Eater binding to the surface of live bacteria. Eater-Fc bound equally well to naive or inactivated Staphylococcus aureus or Enterococcus faecalis, suggesting that in vivo, Eater directly targets live Gram-positive bacteria, enabling their phagocytic clearance and destruction. By contrast, Eater-Fc was unable to interact with live, naive Gram-negative bacteria (Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa). For these bacteria, Eater-Fc binding required membrane-disrupting treatments. Furthermore, we found that cecropin A, a cationic, membrane-disrupting antimicrobial peptide, could promote Eater-Fc binding to live E. coli, even at sublethal concentrations. These results suggest a previously unrecognized mechanism by which antimicrobial peptides cooperate with phagocytic receptors to extend the range of microbes that can be targeted by a single, germline-encoded receptor.	[Kocks, Christine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kocks, C (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, 185 Cambridge St,CPZN 7-250, Boston, MA 02114 USA.	kocks@molbio.mgh.harvard.edu			National Institutes of Health [P01 AI44220]; National Institutes of Health Center for the Study of Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center for the Study of Inflammatory Bowel Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AI44220.; We thank Bol-Luel Lee for the gift of a baculovirus expression plasmid, Janice Lee for synthesizing dsRNAs, Joseph Garlick, Ji-Joon Song, and Robert E. Kingston for help with baculovirus expression, Dominique Ferrandon, Frederick M. Ausubel, and Iain Fraser for microbial strains, David McLaughlin, Lizabeth A. Perkins, and the members of the Ausubel laboratory for support, advice, suggestions, or comments on the manuscript, in particular Brent Cezairliyan, Mark Rosenzweig, and Fred Ausubel. EM was performed by Mary McKee in the Microscopy Core of the Center for Systems Biology/Program in Membrane Biology, which is partially supported by a National Institutes of Health Center for the Study of Inflammatory Bowel Disease Grant DK43351 and a Boston Area Diabetes and Endocrinology Research Center Award DK57521.	Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Ju JS, 2006, J IMMUNOL, V177, P1838, DOI 10.4049/jimmunol.177.3.1838; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Metchnikoff I. I., 1908, ILYA MECHNIKOV NOBEL; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nehme NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014743; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Peiser L, 2006, INFECT IMMUN, V74, P5191, DOI 10.1128/IAI.00124-06; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pluddemann A, 2009, J INNATE IMMUN, V1, P153, DOI 10.1159/000155227; POWELL DA, 1975, BIOCHEM J, V151, P387, DOI 10.1042/bj1510387; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rizki T.M., 1984, P579; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Roux S, 2008, J PEPT SCI, V14, P354, DOI 10.1002/psc.951; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Speert D P, 1993, Trends Microbiol, V1, P217, DOI 10.1016/0966-842X(93)90135-E; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; van Oss CJ, 1984, MOL IMMUNOL, P91; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; WRIGHT AE, 1989, REV INFECT DIS, V11, P827	67	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26524	26532		10.1074/jbc.M110.214007	http://dx.doi.org/10.1074/jbc.M110.214007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613218	Green Published, hybrid			2022-12-25	WOS:000293078200031
J	Guan, WX; Huang, QF; Cheng, F; Qiu, JM				Guan, Wuxiang; Huang, Qinfeng; Cheng, Fang; Qiu, Jianming			Internal Polyadenylation of the Parvovirus B19 Precursor mRNA Is Regulated by Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID PROGENITOR CELLS; HUMAN-BONE MARROW; VIRUS TYPE-5 RNA; TRANSCRIPTION PROFILE; POLY(A) SITE; INFECTIOUS CLONE; UNIQUE FEATURES; REPLICATION; PROTEIN; PROMOTER	Alternative processing of parvovirus B19 (B19V) pre-mRNA is critical to generating appropriate levels of B19V mRNA transcripts encoding capsid proteins and small nonstructural proteins. Polyadenylation of the B19V pre-mRNA at the proximal polyadenylation site ((pA)p), which prevents generation of full-length capsid proteins encoding mRNA transcripts, has been suggested as a step that blocks B19V permissiveness. We report here that efficient splicing of the B19V pre-mRNA within the first intron (upstream of the (pA) p site) stimulated the polyadenylation; in contrast, splicing of the B19V pre-mRNA within the second intron (in which the (pA) p site resides) interfered with the polyadenylation, leading to the generation of a sufficient number of B19V mRNA transcripts polyadenylated at the distal polyadenylation site ((pA)d). We also found that splicing within the second intron and polyadenylation at the (pA) p site compete during processing of the B19V pre-mRNA. Furthermore, we discovered that the U1 RNA that binds to the 5' splice donor site of the second intron is fully responsible for inhibiting polyadenylation at the (pA) p site, whereas actual splicing, and perhaps assembly of the functional spliceosome, is not required. Finally, we demonstrated that inhibition of B19V pre-mRNA splicing within the second intron by targeting an intronic splicing enhancer using a Morpholino antisense oligonucleotide prevented B19V mRNA transcripts polyadenylated at the (pA) d site during B19V infection of human erythroid progenitors. Thus, our study reveals the mechanism by which alternative splicing coordinates alternative polyadenylation to generate full-length B19V mRNA transcripts at levels sufficient to support productive B19V infection.	[Guan, Wuxiang; Huang, Qinfeng; Cheng, Fang; Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Qiu, JM (corresponding author), Mail Stop 3029,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jqiu@kumc.edu	Huang, Qinfeng/AAJ-7454-2021		National Institutes of Health USPHS from NIAID [R01 AI070723]; National Center for Research Resources Centers of Biomedical Research [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070723] Funding Source: NIH RePORTER	National Institutes of Health USPHS from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources Centers of Biomedical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health USPHS Grant R01 AI070723 from NIAID and Grant P20 RR016443 from the National Center for Research Resources Centers of Biomedical Research Excellence Program.	ASHE MP, 1995, GENE DEV, V9, P3008, DOI 10.1101/gad.9.23.3008; BARKSDALE SK, 1995, J VIROL, V69, P6553, DOI 10.1128/JVI.69.10.6553-6556.1995; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Cotmore SF, 2005, PARVOVIRUSES, P73; deJong L, 1996, CRIT REV EUKAR GENE, V6, P215, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.60; Fauquet C. M., 2004, VIRUS TAXONOMY, P277; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Gilmartin GM, 1996, J VIROL, V70, P1775, DOI 10.1128/JVI.70.3.1775-1783.1996; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guan WX, 2011, J VIROL, V85, P2463, DOI 10.1128/JVI.01708-10; Guan WX, 2009, J VIROL, V83, P9541, DOI 10.1128/JVI.00702-09; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; LIU JM, 1992, J VIROL, V66, P4686, DOI 10.1128/JVI.66.8.4686-4692.1992; Liu ZW, 2004, J VIROL, V78, P12929, DOI 10.1128/JVI.78.23.12929-12939.2004; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; OZAWA K, 1986, SCIENCE, V233, P883, DOI 10.1126/science.3738514; OZAWA K, 1987, J VIROL, V61, P2395, DOI 10.1128/JVI.61.8.2395-2406.1987; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Qiu JM, 2006, J VIROL, V80, P654, DOI 10.1128/JVI.80.2.654-662.2006; Qiu JM, 2004, J BIOL CHEM, V279, P14889, DOI 10.1074/jbc.M312734200; Qiu JM, 2004, J VIROL, V78, P83, DOI 10.1128/JVI.78.1.83-93.2004; SCHOBORG RV, 1991, VIROLOGY, V181, P22, DOI 10.1016/0042-6822(91)90466-O; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; STAMAND J, 1991, VIROLOGY, V183, P133, DOI 10.1016/0042-6822(91)90126-V; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Vagner S, 2000, GENE DEV, V14, P403; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Yoto Y, 2006, J VIROL, V80, P1604, DOI 10.1128/JVI.80.3.1604-1609.2006; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zhi N, 2004, VIROLOGY, V318, P142, DOI 10.1016/j.virol.2003.09.011; Zhi N, 2006, J VIROL, V80, P5941, DOI 10.1128/JVI.02430-05; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	39	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24793	24805		10.1074/jbc.M111.227439	http://dx.doi.org/10.1074/jbc.M111.227439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622561	Green Published, hybrid			2022-12-25	WOS:000292547900030
J	Brown, HC; Gangadharan, B; Doering, CB				Brown, Harrison C.; Gangadharan, Bagirath; Doering, Christopher B.			Enhanced Biosynthesis of Coagulation Factor VIII through Diminished Engagement of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HIGH-LEVEL EXPRESSION; PORCINE FACTOR-VIII; GLUCOSE-REGULATED PROTEINS; HEMATOPOIETIC STEM-CELLS; HEMOPHILIA-A; GENE-THERAPY; SECRETION; TRANSGENE; IMMUNITY	Human and porcine coagulation factor VIII (fVIII) display a biosynthetic efficiency differential that is being exploited for the development of new protein and gene transfer-based therapies for hemophilia A. The cellular and/or molecular mechanism(s) responsible for this phenomenon have yet to be uncovered, although it has been temporally localized to post-translational biosynthetic steps. The unfolded protein response (UPR) is a cellular adaptation to structurally distinct (e.g. misfolded) or excess protein in the endoplasmic reticulum and is known to be induced by heterologous expression of recombinant human fVIII. Therefore, it is plausible that the biosynthetic differential between human and porcine fVIII results from differential UPR activation. In the current study, UPR induction was examined in the context of ongoing fVIII expression. UPR activation was greater during human fVIII expression when compared with porcine fVIII expression as determined by ER response element (ERSE)-luciferase reporter activity, X-box-binding protein 1 (XBP1) splicing, and immunoglobulin-binding protein (BiP) up-regulation. Immunofluorescence microscopy of fVIII expressing cells revealed that human fVIII was notably absent in the Golgi apparatus, confirming that endoplasmic reticulum to Golgi transport is rate-limiting. In contrast, a significant proportion of porcine fVIII was localized to the Golgi indicating efficient transit through the secretory pathway. Overexpression of BiP, an integral UPR protein, reduced the secretion of human fVIII by 50%, but had no effect on porcine fVIII biosynthesis. In contrast, expression of BiP shRNA increased human fVIII expression levels. The current data support the model of differential engagement of UPR by human and porcine fVIII as a non-traditional mechanism for regulation of gene product biosynthesis.	[Doering, Christopher B.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Blood Disorders Serv, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	Doering, CB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, 2015 Uppergate Dr,Room 418, Atlanta, GA 30322 USA.	cdoerin@emory.edu	Doering, Christopher/W-2064-2019		National Institutes of Health from the NHLBI [HL 092179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092179] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 092179 from the NHLBI (to C. B. D.).	Bohn RL, 1998, THROMB HAEMOSTASIS, V79, P932; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Doering CB, 2007, MOL THER, V15, P1093, DOI 10.1038/sj.mt.6300146; Doering CB, 2009, EXPERT REV HEMATOL, V2, P673, DOI 10.1586/EHM.09.63; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Dooriss KL, 2009, HUM GENE THER, V20, P465, DOI 10.1089/hum.2008.150; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gangadharan B, 2006, BLOOD, V107, P3859, DOI 10.1182/blood-2005-12-4961; Goodeve AC, 2010, HAEMOPHILIA, V16, P79, DOI 10.1111/j.1365-2516.2010.02303.x; Ide LM, 2007, BLOOD, V110, P2855, DOI 10.1182/blood-2007-04-082602; Ide LM, 2010, J GENE MED, V12, P333, DOI 10.1002/jgm.1442; Kaufman RJ, 1997, BLOOD COAGUL FIBRIN, V8, pS3; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Spencer HT, 2011, MOL THER, V19, P302, DOI 10.1038/mt.2010.239; Spreafico M, 2009, SEMIN THROMB HEMOST, V35, P390, DOI 10.1055/s-0029-1225761; Swaroop M, 1997, J BIOL CHEM, V272, P24121, DOI 10.1074/jbc.272.39.24121; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800	27	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24451	24457		10.1074/jbc.M111.238758	http://dx.doi.org/10.1074/jbc.M111.238758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606503	Green Published, hybrid			2022-12-25	WOS:000292294900085
J	Glebov, K; Schutze, S; Walter, J				Glebov, Konstantin; Schuetze, Sebastian; Walter, Jochen			Functional Relevance of a Novel SlyX Motif in Non-conventional Secretion of Insulin-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL PROTEIN SECRETION; AMYLOID BETA-PROTEIN; SUBSTRATE RECOGNITION; LOCALIZATION; BRAIN; DEGRADATION; REMOVES; PATHWAY; DISEASE; DOMAIN	Insulin-degrading enzyme (IDE) is a Zn2+ metalloprotease with a characteristic inverted catalytic motif. IDE is ubiquitously expressed and degrades peptide substrates including insulin, endorphin, and the amyloid-beta peptide. Although IDE is mainly expressed in the cytosol, it can also be found on the cell surface and in secreted form in extracellular fluids. As IDE lacks a characteristic signal sequence that targets the protein to the classical secretory pathway, release of the enzyme involves non-conventional mechanisms. However, functional domains of IDE involved in its secretion remain elusive. By bioinformatical, biochemical, and cell biological methods, we identified a novel amino acid motif ((EKPPHY858)-E-853) close to the C terminus of IDE and characterized its function in the non-conventional secretion of the protein. Because of its close homology to an amino acid sequence found in bacterial proteins belonging to the SlyX family, we propose to call it the SlyX motif. Mutagenesis revealed that deletion of this motif strongly decreased the release of IDE, whereas deletion of a potential microbody-targeting signal at the extreme C terminus had little effect on secretion. The combined data indicate that the non-conventional secretion of IDE is regulated by the newly identified SlyX motif.	[Glebov, Konstantin; Schuetze, Sebastian; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft [SFB645, KFO177]; Federal Ministry for Education and Research (BMBF) [01GI0708]; BONFOR Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BONFOR Program	This work was supported in part by the Deutsche Forschungsgemeinschaft (Grants SFB645 and KFO177), the Federal Ministry for Education and Research (BMBF) (Grant 01GI0708), and the BONFOR Program.	AKIYAMA H, 1988, BIOCHEM BIOPH RES CO, V155, P914, DOI 10.1016/S0006-291X(88)80583-7; Behl Mamta, 2009, Cerebrospinal Fluid Res, V6, P11, DOI 10.1186/1743-8454-6-11; Bernstein HG, 1999, NEUROSCI LETT, V263, P161, DOI 10.1016/S0304-3940(99)00135-4; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chesneau V, 1997, ENDOCRINOLOGY, V138, P3444, DOI 10.1210/en.138.8.3444; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leal MC, 2006, J NEUROPATH EXP NEUR, V65, P976, DOI 10.1097/01.jnen.0000235853.70092.ba; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	24	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22711	22715		10.1074/jbc.C110.217893	http://dx.doi.org/10.1074/jbc.C110.217893			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21576244	Green Published, hybrid			2022-12-25	WOS:000292025000005
J	Gruber, J; Ng, LF; Fong, S; Wong, YT; Koh, SA; Chen, CB; Shui, GH; Cheong, WF; Schaffer, S; Wenk, MR; Halliwell, B				Gruber, Jan; Ng, Li Fang; Fong, Sheng; Wong, Yee Ting; Koh, Soon Ann; Chen, Ce-Belle; Shui, Guanghou; Cheong, Wei Fun; Schaffer, Sebastian; Wenk, Markus R.; Halliwell, Barry			Mitochondrial Changes in Ageing Caenorhabditis elegans - What Do We Learn from Superoxide Dismutase Knockouts?	PLOS ONE			English	Article							OXIDATIVE DAMAGE THEORY; LIFE-SPAN; UNCOUPLING PROTEINS; REDOX REGULATION; CYTOCHROME-C; NO LONGER; OXYGEN; STRESS; OVEREXPRESSION; METABOLISM	One of the most popular damage accumulation theories of ageing is the mitochondrial free radical theory of ageing (mFRTA). The mFRTA proposes that ageing is due to the accumulation of unrepaired oxidative damage, in particular damage to mitochondrial DNA (mtDNA). Within the mFRTA, the "vicious cycle" theory further proposes that reactive oxygen species (ROS) promote mtDNA mutations, which then lead to a further increase in ROS production. Recently, data have been published on Caenorhabditis elegans mutants deficient in one or both forms of mitochondrial superoxide dismutase (SOD). Surprisingly, even double mutants, lacking both mitochondrial forms of SOD, show no reduction in lifespan. This has been interpreted as evidence against the mFRTA because it is assumed that these mutants suffer from significantly elevated oxidative damage to their mitochondria. Here, using a novel mtDNA damage assay in conjunction with related, well established damage and metabolic markers, we first investigate the age-dependent mitochondrial decline in a cohort of ageing wild-type nematodes, in particular testing the plausibility of the "vicious cycle" theory. We then apply the methods and insights gained from this investigation to a mutant strain for C. elegans that lacks both forms of mitochondrial SOD. While we show a clear age-dependent, linear increase in oxidative damage in WT nematodes, we find no evidence for autocatalytic damage amplification as proposed by the "vicious cycle" theory. Comparing the SOD mutants with wild-type animals, we further show that oxidative damage levels in the mtDNA of SOD mutants are not significantly different from those in wild-type animals, i.e. even the total loss of mitochondrial SOD did not significantly increase oxidative damage to mtDNA. Possible reasons for this unexpected result and some implications for the mFRTA are discussed.	[Gruber, Jan; Ng, Li Fang; Fong, Sheng; Wong, Yee Ting; Koh, Soon Ann; Chen, Ce-Belle; Schaffer, Sebastian; Wenk, Markus R.; Halliwell, Barry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou; Cheong, Wei Fun; Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Gruber, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	jan_gruber@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; Fong, Sheng/I-3061-2012; Halliwell, Barry/C-8318-2009	Fong, Sheng/0000-0001-5381-8955; Shui, Guanghou/0000-0002-1621-9643; Halliwell, Barry/0000-0002-3560-7123	Biomedical Research Council of Singapore [BMRC 07/1/21/19/524]; Singapore National Research Foundation [2007-04]; National Institutes of Health National Centre for Research Resources	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore); National Institutes of Health National Centre for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would also like to gratefully acknowledge the Biomedical Research Council of Singapore (Grant number: BMRC 07/1/21/19/524) for support of this study (http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). Work in the authors' laboratory is supported by grants from the Singapore National Research Foundation under CRP Award No. 2007-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Takao Inoue for his helpful comments during the writing of this manuscript and Dr. Alfredo Amiel Leonardia for his help and support during the design and troubleshooting of the PCR assays. We thank the Caenorhabditis Genetics Centre, which is funded by the National Institutes of Health National Centre for Research Resources, for the provision of worm strains.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Brys K, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-91; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Gardner R, 2006, J THEOR BIOL, V242, P798, DOI 10.1016/j.jtbi.2006.04.007; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Gems David, 2009, SEB Exp Biol Ser, V62, P31; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halliwell B., 2007, FREE RADICALS BIOL M; Hanak P, 2001, FEBS LETT, V495, P137, DOI 10.1016/S0014-5793(01)02338-9; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Headlam HA, 2004, FREE RADICAL BIO MED, V36, P1175, DOI 10.1016/j.freeradbiomed.2004.02.017; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Iser WB, 2005, MECH AGEING DEV, V126, P1090, DOI 10.1016/j.mad.2005.04.002; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kowald A, 2006, J THEOR BIOL, V238, P828, DOI 10.1016/j.jtbi.2005.06.034; Kowald A, 1996, MUTAT RES-DNAGING G, V316, P209, DOI 10.1016/S0921-8734(96)90005-3; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liochev SI, 2002, FREE RADICAL BIO MED, V33, P137, DOI 10.1016/S0891-5849(02)00864-X; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; SCHAFFER S, 2010, BIOGERONTOLOGY; Shahrestani Parvin, 2009, Curr Aging Sci, V2, P3; Shoyama T, 2007, MECH AGEING DEV, V128, P529, DOI 10.1016/j.mad.2007.07.003; Shoyama T, 2009, EXP GERONTOL, V44, P784, DOI 10.1016/j.exger.2009.09.006; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Stiernagle Theresa, 2006, WormBook, P1; Suda H, 2005, BIOCHEM BIOPH RES CO, V330, P839, DOI 10.1016/j.bbrc.2005.03.050; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yanase S, 2009, J GERONTOL A-BIOL, V64, P530, DOI 10.1093/gerona/glp020; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; Yasuda K, 2011, BIOCHEM BIOPH RES CO, V404, P751, DOI 10.1016/j.bbrc.2010.12.017	79	66	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19444	10.1371/journal.pone.0019444	http://dx.doi.org/10.1371/journal.pone.0019444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611128	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200006
J	Danner, R; Chaudhari, SN; Rosenberger, J; Surls, J; Richie, TL; Brumeanu, TD; Casares, S				Danner, Rebecca; Chaudhari, Snehal N.; Rosenberger, John; Surls, Jacqueline; Richie, Thomas L.; Brumeanu, Teodor-Doru; Casares, Sofia			Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; SEVERE COMBINED IMMUNODEFICIENCY; SCID IL2R-GAMMA(NULL) MICE; FLOW-CYTOMETRIC ANALYSIS; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; HIV-INFECTION; HOST-DISEASE; BONE-MARROW	Background: Humanized mice able to reconstitute a surrogate human immune system (HIS) can be used for studies on human immunology and may provide a predictive preclinical model for human vaccines prior to clinical trials. However, current humanized mouse models show sub-optimal human T cell reconstitution and limited ability to support immunoglobulin class switching by human B cells. This limitation has been attributed to the lack of expression of Human Leukocyte Antigens (HLA) molecules in mouse lymphoid organs. Recently, humanized mice expressing HLA class I molecules have been generated but showed little improvement in human T cell reconstitution and function of T and B cells. Methods: We have generated NOD.Rag1KO.IL2RccKO mice expressing HLA class II (HLA-DR4) molecules under the I-E-d promoter that were infused as adults with HLA-DR-matched human hematopoietic stem cells (HSC). Littermates lacking expression of HLA-DR4 molecules were used as control. Results: HSC-infused HLA-DR4.NOD.Rag1KO.IL-2RccKO mice developed a very high reconstitution rate (>90%) with long-lived and functional human T and B cells. Unlike previous humanized mouse models reported in the literature and our control mice, the HLA-DR4 expressing mice reconstituted serum levels (natural antibodies) of human IgM, IgG (all four subclasses), IgA, and IgE comparable to humans, and elicited high titers of specific human IgG antibodies upon tetanus toxoid vaccination. Conclusions: Our study demonstrates the critical role of HLA class II molecules for development of functional human T cells able to support immunoglobulin class switching and efficiently respond to vaccination.	[Danner, Rebecca; Chaudhari, Snehal N.; Rosenberger, John; Richie, Thomas L.; Casares, Sofia] USN, US Mil Malaria Vaccine Program, Med Res Ctr, Walter Reed Army Inst Res, Silver Spring, MD USA; [Surls, Jacqueline; Brumeanu, Teodor-Doru; Casares, Sofia] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; United States Navy; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA	Danner, R (corresponding author), USN, US Mil Malaria Vaccine Program, Med Res Ctr, Walter Reed Army Inst Res, Silver Spring, MD USA.	sofia.casares@med.navy.mil	Brumeanu, Teodor/AAB-1965-2020	Richie, Thomas/0000-0002-2946-5456	NIH/NIDDK; Juvenile Diabetes Research Foundation; USUHS; USAID; Military Infectious Diseases Research Program;  [6000.RAD1.F]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); USUHS; USAID(United States Agency for International Development (USAID)); Military Infectious Diseases Research Program; 	This work was supported by grants from NIH/NIDDK, Juvenile Diabetes Research Foundation, Military Infectious Diseases Research Program, and USAID to SC and a USUHS grant to TBD. This work was supported by work unit number 6000.RAD1.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; Casares S, 1997, J EXP MED, V186, P1481, DOI 10.1084/jem.186.9.1481; Chung A, 2008, CURR HIV RES, V6, P515, DOI 10.2174/157016208786501472; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Colovai AI, 2004, MODERN PATHOL, V17, P918, DOI 10.1038/modpathol.3800141; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; GREINIX HT, 1991, BLOOD, V78, P2131; GREINIX HT, 1992, BLOOD, V80, P1950; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; HUPPES W, 1992, EUR J IMMUNOL, V22, P197, DOI 10.1002/eji.1830220129; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; KYOIZUMI S, 1992, BLOOD, V79, P1704; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Mamoni RL, 2006, CYTOKINE, V35, P207, DOI 10.1016/j.cyto.2006.08.005; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Nazarov-Stoica C, 2009, J IMMUNOL, V182, P102, DOI 10.4049/jimmunol.182.1.102; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; PFLUMIO F, 1993, INT IMMUNOL, V5, P1509, DOI 10.1093/intimm/5.12.1509; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Takahama Y, 2010, SEMIN IMMUNOL, V22, P287, DOI 10.1016/j.smim.2010.04.012; TORBETT BE, 1991, IMMUNOL REV, V124, P139, DOI 10.1111/j.1600-065X.1991.tb00620.x; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Velasquez-Lopera MM, 2008, CLIN EXP IMMUNOL, V154, P107, DOI 10.1111/j.1365-2249.2008.03734.x; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; WORTIS HH, 1971, CLIN EXP IMMUNOL, V8, P305; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204	51	135	145	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19826	10.1371/journal.pone.0019826	http://dx.doi.org/10.1371/journal.pone.0019826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611197	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500025
J	Alho, JS; Leinonen, T; Merila, J				Alho, Jussi S.; Leinonen, Tuomas; Merila, Juha			Inheritance of Vertebral Number in the Three-Spined Stickleback (Gasterosteus aculeatus)	PLOS ONE			English	Article							MERISTIC VARIATION; LATITUDINAL VARIATION; GENETIC CORRELATION; NATURAL-SELECTION; LATERAL PLATES; LIFE-HISTORY; EVOLUTION; HERITABILITY; TRAITS; MEDAKA	Intraspecific variation in the number of vertebrae is taxonomically widespread, and both genetic and environmental factors are known to contribute to this variation. However, the relative importance of genetic versus environmental influences on variation in vertebral number has seldom been investigated with study designs that minimize bias due to non-additive genetic and maternal influences. We used a paternal half-sib design and animal model analysis to estimate heritability and causal components of variance in vertebral number in three-spined sticklebacks (Gasterosteus aculeatus). We found that both the number of vertebrae (h(2) = 0.36) and body size (h(2) = 0.42) were moderately heritable, whereas the influence of maternal effects was estimated to be negligible. While the number of vertebrae had a positive effect on body size, no evidence for a genetic correlation between body size and vertebral number was detected. However, there was a significant positive environmental correlation between these two traits. Our results support the generalization-in accordance with results from a review of heritability estimates for vertebral number in fish, reptiles and mammals-that the number of vertebrae appears to be moderately to highly heritable in a wide array of species. In the case of the three-spined stickleback, independent evolution of body size and number of vertebrae should be possible given the low genetic correlation between the two traits.	[Alho, Jussi S.; Leinonen, Tuomas; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Alho, JS (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072; Alho, Jussi/0000-0002-7765-2096	Academy of Finland	Academy of Finland(Academy of Finland)	This research was supported by the Academy of Finland (www.aka.fi) with grants to J.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MY, 1974, CAN J ZOOL, V52, P959, DOI 10.1139/z74-128; ANDO D, 1996, FISH GENET BREED SCI, V23, P59; Ando D, 2008, FISHERIES SCI, V74, P293, DOI 10.1111/j.1444-2906.2008.01531.x; Arnold S.J., 1988, P619; Barrett RDH, 2010, J FISH BIOL, V77, P311, DOI 10.1111/j.1095-8649.2010.02640.x; Belk MC, 2002, AM NAT, V160, P803, DOI 10.1086/343880; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BERGE S, 1948, J ANIM SCI, V7, P233, DOI 10.2527/jas1948.72233x; Billerbeck JN, 1997, CAN J FISH AQUAT SCI, V54, P1796, DOI 10.1139/cjfas-54-8-1796; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Falconer D. S, 1996, INTRO QUANTITATIVE G; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HAGEN DW, 1973, HEREDITY, V30, P303, DOI 10.1038/hdy.1973.40; Hermida M, 2002, CAN J ZOOL, V80, P532, DOI 10.1139/Z02-022; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; JORDAN DS, 1982, P US NAT MUS, V14, P107; Kirpichnikov V.S, 1981, GENETIC BASIS FISH S; LEARY RF, 1985, EVOLUTION, V39, P308, DOI [10.2307/2408364, 10.1111/j.1558-5646.1985.tb05668.x]; Leinonen T, 2011, HEREDITY, V106, P218, DOI 10.1038/hdy.2010.104; Leinonen T, 2011, J EVOLUTION BIOL, V24, P206, DOI 10.1111/j.1420-9101.2010.02161.x; Lindell LE, 1996, BIOL J LINN SOC, V59, P69, DOI 10.1111/j.1095-8312.1996.tb01453.x; Lindsey C.C., 1988, P197; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P1237, DOI 10.1139/z62-100; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P271, DOI 10.1139/z62-028; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; McDowall RM, 2003, ENVIRON BIOL FISH, V66, P361, DOI 10.1023/A:1023902922843; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Nakajima Masamichi, 1996, Tohoku Journal of Agricultural Research, V47, P29; NENASHEV G. A., 1966, IZV GOS NAUCH ISSLED INST OZER RECHN RYB KHOZ, V61, P125; ORSKA I, 1963, ZOOL POL, V12, P309; OSTLUNDNILSSON S, 2007, BIOL THREESPINE STIC; Sasaki K, 2009, CONSERV BIOL, V23, P93, DOI 10.1111/j.1523-1739.2008.01067.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SHIKANO T, 2007, AQUAC RES, V18, P1248; SNYDER RJ, 1991, COPEIA, P526; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SWAIN DP, 1984, CAN J FISH AQUAT SCI, V41, P1231, DOI 10.1139/f84-146; SWAIN DP, 1992, EVOLUTION, V46, P987, DOI 10.1111/j.1558-5646.1992.tb00614.x; TAVE D, 1984, COPEIA, P794; Wootton RJ, 2009, J FISH BIOL, V75, P1919, DOI 10.1111/j.1095-8649.2009.02412.x; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Yamahira K, 2009, BIOL J LINN SOC, V96, P856, DOI 10.1111/j.1095-8312.2008.01150.x; Yamahira K, 2009, BIOL J LINN SOC, V96, P867, DOI 10.1111/j.1095-8312.2008.01181.x; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	46	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19579	10.1371/journal.pone.0019579	http://dx.doi.org/10.1371/journal.pone.0019579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603609	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300013
J	Nakamura, H; Wang, YW; Kurita, T; Adomat, H; Cunha, GR; Wang, YZ				Nakamura, Hisae; Wang, Yuwei; Kurita, Takeshi; Adomat, Hans; Cunha, Gerald R.; Wang, Yuzhuo			Genistein Increases Epidermal Growth Factor Receptor Signaling and Promotes Tumor Progression in Advanced Human Prostate Cancer	PLOS ONE			English	Article							CELL-CYCLE ARREST; SOY ISOFLAVONES; DIETARY GENISTEIN; ORTHOTOPIC MODEL; PROTEIN-KINASES; UP-REGULATION; SCID MICE; PHYTOESTROGENS; METASTASIS; APOPTOSIS	Genistein is an isoflavone found in soy, and its chemo-preventive and -therapeutic effects have been well established from in vitro studies. Recently, however, its therapeutic actions in vivo have been questioned due to contradictory reports from animal studies, which rely on rodent models or implantation of cell lines into animals. To clarify in vivo effects of genistein in advanced prostate cancer patients, we developed a patient-derived prostate cancer xenograft model, in which a clinical prostatectomy sample was grafted into immune deficient mice. Our results showed an increased lymph node (LN) and secondary organ metastases in genistein-treated mice compared to untreated controls. Interestingly, invasive malignant cells aggregated to form islands/micrometastasis only in the secondary organs of the genistein-treated groups, not in the untreated control group. To understand the underlying mechanism for metastatic progression, we examined cell proliferation and apoptosis on paraffin-sections. Immunohistological data show that tumors of genistein-treated groups have more proliferating and fewer apoptotic cancer cells than those of the untreated group. Our immunoblotting data suggest that increased proliferation and metastasis are linked to enhanced activities of tyrosine kinases, EGFR and its downstream Src, in genistein-treated groups. Despite the chemopreventive effects proposed by earlier in vitro studies, the cancer promoting effect of genistein observed here suggests the need for careful selection of patients and safer planning of clinical trials.	[Nakamura, Hisae; Wang, Yuwei; Wang, Yuzhuo] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Nakamura, Hisae; Adomat, Hans; Wang, Yuzhuo] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Wang, Yuzhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Kurita, Takeshi] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Anat & Urol, San Francisco, CA 94143 USA	British Columbia Cancer Agency; University of British Columbia; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco	Nakamura, H (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada.	ywang@bccrc.ca	Kurita, Takeshi/A-2236-2013	Kurita, Takeshi/0000-0003-4281-5884; Wang, Yuzhuo/0000-0002-9749-8591	Canadian Institute of Health Research [MOP-86730]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institute of Health Research (MOP-86730: YZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.2307/3432518; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alhasan SA, 1999, NUTR CANCER, V34, P12, DOI 10.1207/S15327914NC340102; Aronson WJ, 1999, NUTR CANCER, V35, P130, DOI 10.1207/S15327914NC352_6; Balabhadrapathruni S, 2000, NUTR CANC, V7, P3; Cohen LA, 2003, PROSTATE, V54, P169, DOI 10.1002/pros.10127; Davis JN, 1998, NUTR CANCER, V32, P123, DOI 10.1080/01635589809514730; El Touny LH, 2009, CANCER RES, V69, P3695, DOI 10.1158/0008-5472.CAN-08-2958; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fischer L, 2004, NUTR CANCER, V48, P160, DOI 10.1207/s15327914nc4802_5; Gallagher Richard P., 1997, Can J Urol, V4, P22; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Hillman GG, 2004, MOL CANCER THER, V3, P1271; Hillman GG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-4; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Ishikawa H, 2000, EMBO J, V19, P5406; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knight DC, 1996, OBSTET GYNECOL, V87, P897; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; LACROIX H, 1989, ONCOGENE, V4, P145; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; LEE HP, 1991, LANCET, V337, P1197, DOI 10.1016/0140-6736(91)92867-2; Lee K, 2009, BIOORGAN MED CHEM, V17, P3152, DOI 10.1016/j.bmc.2009.02.054; Li YW, 1999, INT J ONCOL, V15, P525; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Lian FR, 1998, NUTR CANCER, V31, P184, DOI 10.1080/01635589809514701; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; MARKIEWICZ L, 1993, J STEROID BIOCHEM, V45, P399, DOI 10.1016/0960-0760(93)90009-L; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; MAYR U, 1992, TOXICOLOGY, V74, P135, DOI 10.1016/0300-483X(92)90134-Z; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Ohno S, 2003, LIFE SCI, V74, P733, DOI 10.1016/j.lfs.2003.04.006; Pendleton JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-132; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Raffoul JJ, 2007, INT J CANCER, V120, P2491, DOI 10.1002/ijc.22548; Ryan CJ, 2005, J CLIN ONCOL, V23, P8225, DOI 10.1200/JCO.2005.03.5311; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; SPINOZZI F, 1994, LEUKEMIA RES, V18, P431, DOI 10.1016/0145-2126(94)90079-5; Takimoto CH, 2003, CANCER EPIDEM BIOMAR, V12, P1213; Tan M, 1997, CANCER RES, V57, P1199; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang XY, 2006, J NUTR BIOCHEM, V17, P204, DOI 10.1016/j.jnutbio.2005.07.005; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; YU DH, 1994, CANCER RES, V54, P3260; YU DH, 1995, ONCOGENE, V11, P1383; Zava DT, 1998, P SOC EXP BIOL MED, V217, P369	56	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20034	10.1371/journal.pone.0020034	http://dx.doi.org/10.1371/journal.pone.0020034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603581	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300049
J	Panopoulos, AD; Ruiz, S; Yi, F; Herrerias, A; Batchelder, EM; Carlos, J; Belmonte, I				Panopoulos, Athanasia D.; Ruiz, Sergio; Yi, Fei; Herrerias, Aida; Batchelder, Erika M.; Carlos, Juan; Belmonte, Izpisua			Rapid and Highly Efficient Generation of Induced Pluripotent Stem Cells from Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							INDUCTION; CULTURE; BANKING; OCT4	The ability to induce somatic cells to pluripotency by ectopic expression of defined transcription factors (e. g. KLF-4, OCT4, SOX2, c-MYC, or KOSM) has transformed the future of regenerative medicine. Here we report somatic cell reprogramming of human umbilical vein endothelial cells (HUVECs), yielding induced pluripotent stem (iPS) cells with the fastest kinetics, and one of the highest reprogramming efficiencies for a human somatic cell to date. HUVEC-derived iPS (Huv-iPS) cell colonies appeared as early as 6 days after a single KOSM infection, and were generated with a 2.5-3% reprogramming efficiency. Furthermore, when HUVEC reprogramming was performed under hypoxic conditions in the presence of a TGF-beta family signaling inhibitor, colony formation increased an additional similar to 2.5-fold over standard conditions. Huv-iPS cells were indistinguishable from human embryonic stem (ES) cells with regards to morphology, pluripotent marker expression, and their ability to generate all embryonic germ layers in vitro and in vivo. The high efficiency and rapid kinetics of Huv-iPS cell formation, coupled with the ease by which HUVECs can be collected, expanded and stored, make these cells an attractive somatic source for therapeutic application, and for studying the reprogramming process.	[Panopoulos, Athanasia D.; Ruiz, Sergio; Yi, Fei; Batchelder, Erika M.; Carlos, Juan; Belmonte, Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Herrerias, Aida; Belmonte, Izpisua] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Panopoulos, AD (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	; Ruiz, Sergio/G-1561-2016	Panopoulos, Athanasia/0000-0002-9610-2604; Ruiz, Sergio/0000-0002-0177-6965	NIH [T32 CA009370]; Instituto de Salud Carlos III [CGCV-1335/07-3]; Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN); NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ADP was partially supported by NIH training grant T32 CA009370. SR was partially supported by the Instituto de Salud Carlos III (CGCV-1335/07-3). Work in this manuscript was supported by grants from Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER), Terapia Celular (TERCEL), and Ministerio de Ciencia e Innovacion (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Ho PJ, 2010, ARTERIOSCL THROM VAS, V30, P1905, DOI 10.1161/ATVBAHA.110.206540; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	27	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19743	10.1371/journal.pone.0019743	http://dx.doi.org/10.1371/journal.pone.0019743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603572	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300023
J	Rodriguez-Suarez, C; Atienza, SG; Piston, F				Rodriguez-Suarez, Cristina; Atienza, Sergio G.; Piston, Fernando			Allelic Variation, Alternative Splicing and Expression Analysis of Psy1 Gene in Hordeum chilense Roem. et Schult	PLOS ONE			English	Article							PHYTOENE-SYNTHASE GENE; PERFORMANCE LIQUID-CHROMATOGRAPHY; YELLOW PIGMENT CONTENT; DURUM-WHEAT; CAROTENOID BIOSYNTHESIS; COMMON WHEAT; ACCUMULATION; IDENTIFICATION; ASSOCIATION; TRITORDEUM	Background: The wild barley Hordeum chilense Roem. et Schult. is a valuable source of genes for increasing carotenoid content in wheat. Tritordeums, the amphiploids derived from durum or common wheat and H. chilense, systematically show higher values of yellow pigment colour and carotenoid content than durum wheat. Phytoene synthase 1 gene (Psy1) is considered a key step limiting the carotenoid biosynthesis, and the correlation of Psy1 transcripts accumulation and endosperm carotenoid content has been demonstrated in the main grass species. Methodology/Principal findings: We analyze the variability of Psy1 alleles in three lines of H. chilense (H1, H7 and H16) representing the three ecotypes described in this species. Moreover, we analyze Psy1 expression in leaves and in two seed developing stages of H1 and H7, showing mRNA accumulation patterns similar to those of wheat. Finally, we identify thirty-six different transcripts forms originated by alternative splicing of the 59 UTR and/or exons 1 to 5 of Psy1 gene. Transcripts function is tested in a heterologous complementation assay, revealing that from the sixteen different predicted proteins only four types (those of 432, 370, 364 and 271 amino acids), are functional in the bacterial system. Conclusions/Significance: The large number of transcripts originated by alternative splicing of Psy1, and the coexistence of functional and non functional forms, suggest a fine regulation of PSY activity in H. chilense. This work is the first analysis of H. chilense Psy1 gene and the results reported here are the bases for its potential use in carotenoid enhancement in durum wheat.	[Rodriguez-Suarez, Cristina; Atienza, Sergio G.; Piston, Fernando] IAS CSIC, Consejo Super Invest Sci, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Rodriguez-Suarez, C (corresponding author), IAS CSIC, Consejo Super Invest Sci, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	crodriguez@ias.csic.es	Rodríguez-Suárez, Cristina/M-2304-2014; Atienza, Sergio G/K-1080-2014; Piston, Fernando/AAD-6975-2020	Rodríguez-Suárez, Cristina/0000-0002-5409-1839; Atienza, Sergio G/0000-0001-5175-8303; Piston, Fernando/0000-0002-5496-0205	Spanish Ministry of Science and Innovation (MSI) [AGL2008-03720, 200840I137]; CSIC; FEDER; MSI; FSE	Spanish Ministry of Science and Innovation (MSI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; FEDER(European Commission); MSI; FSE(European Social Fund (ESF))	This work was supported by grants (to SGA) AGL2008-03720 and 200840I137 from the Spanish Ministry of Science and Innovation (MSI), CSIC and FEDER. FP acknowledges financial support from the MSI Juan de la Cierva program. CR-S and FP acknowledge financial support from JAE-Doc program (CSIC, co-funded by FSE) and the Ramon y Cajal program (Spanish Ministry of Science and Innovation) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; Alvarez JB, 1999, PLANT BREEDING, V118, P187, DOI 10.1046/j.1439-0523.1999.118002187.x; Alvarez JB, 1998, PLANT BREEDING, V117, P287, DOI 10.1111/j.1439-0523.1998.tb01942.x; Atienza SG, 2007, AUST J AGR RES, V58, P767, DOI 10.1071/AR06338; Atienza SG, 2007, J AGR FOOD CHEM, V55, P4244, DOI 10.1021/jf070342p; Atienza SG, 2005, AUST J AGR RES, V56, P85, DOI 10.1071/AR04154; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Borrelli GM, 2003, CEREAL CHEM, V80, P225, DOI 10.1094/CCHEM.2003.80.2.225; Britton George, 2008, V4, P189, DOI 10.1007/978-3-7643-7499-0_10; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Castillo A, 2010, ANN APPL BIOL, V156, P347, DOI 10.1111/j.1744-7348.2010.00391.x; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cenci A, 2004, GENOME, V47, P911, DOI 10.1139/G04-033; Cong L, 2009, J AGR FOOD CHEM, V57, P8652, DOI 10.1021/jf9012218; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Digesu AM, 2009, J CEREAL SCI, V50, P210, DOI 10.1016/j.jcs.2009.05.002; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fu ZY, 2010, THEOR APPL GENET, V120, P709, DOI 10.1007/s00122-009-1188-x; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; He XY, 2008, THEOR APPL GENET, V116, P213, DOI 10.1007/s00122-007-0660-8; He XY, 2009, MOL BREEDING, V23, P553, DOI 10.1007/s11032-009-9255-1; He XY, 2009, CROP SCI, V49, P2058, DOI 10.2135/cropsci2008.11.0651; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kim IJ, 2003, J MICROBIOL, V41, P212; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Martin A, 1998, TRITICEAE III, P377; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; MISAWA N, 1994, J BIOCHEM-TOKYO, V116, P980, DOI 10.1093/oxfordjournals.jbchem.a124656; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Panfili G, 2004, J AGR FOOD CHEM, V52, P6373, DOI 10.1021/jf0402025; Patto MCV, 2001, CAN J BOT, V79, P204, DOI 10.1139/cjb-79-2-204; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reimer S, 2008, GENOME, V51, P1016, DOI 10.1139/G08-083; Rodriguez-Suarez C, 2010, CROP PASTURE SCI, V61, P743, DOI 10.1071/CP10025; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x; Singh A, 2009, THEOR APPL GENET, V118, P1539, DOI 10.1007/s00122-009-1001-x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Wang JW, 2009, HEREDITAS, V146, P208, DOI 10.1111/j.1601-5223.2009.02132.x; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhang YL, 2009, EUPHYTICA, V165, P435, DOI 10.1007/s10681-008-9744-z	57	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19885	10.1371/journal.pone.0019885	http://dx.doi.org/10.1371/journal.pone.0019885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603624	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300035
J	Schooling, CM; Jiang, CQ; Lam, TH; Zhang, WS; Cheng, KK; Leung, GM				Schooling, C. Mary; Jiang, ChaoQiang; Lam, Tai Hing; Zhang, WeiSen; Cheng, Kar Keung; Leung, Gabriel M.			Parental Death during Childhood and Adult Cardiovascular Risk in a Developing Country: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EARLY-LIFE STRESS; BLOOD-CELL COUNT; METABOLIC SYNDROME; TRUNK LENGTH; EXPERIENCES; PUBERTY; OBESITY; HEALTH; CIRCUMSTANCES	Background: In observational studies from western countries childhood emotional adversity is usually associated with adult cardiovascular disease. These findings are open to contextual biases making evidence from other settings valuable. We examined the association of a potential marker of childhood emotional adversity with cardiovascular disease risk factors in a developing country. Methods: We used multivariable regression in cross-sectional analysis of older (>= 50 years) men (n = 7,885) and women (n = 20,886) from the Guangzhou Biobank Cohort Study (2003-8) to examine the adjusted association of early life (<18 years) parental death (none, one or two deaths) with blood pressure, fasting glucose, LDL-cholesterol, HDL-cholesterol, triglycerides, body mass index (BMI), waist-hip ratio (WHR) and white blood cell count (WBC). We used seated height and delayed 10-word recall to assess content validity of parental death as a measure of childhood emotional adversity. We also examined whether associations varied by sex. Results: Early life parental death was associated with shorter age-and sex-adjusted seated height. It was also associated with lower 10-word recall score adjusted for age, sex, socio-economic position, leg length and lifestyle. Similarly, adjusted early life parental death was not associated with blood pressure, fasting glucose, LDL-cholesterol or HDL-cholesterol but was associated with lower BMI (-0.40, 95% confidence interval (CI) -0.62 to -0.19 for 2 compared with no early life parental deaths) and triglycerides. Associations varied by sex for WHR and WBC. Among men only, early life parental death was associated with lower WHR (-0.008, 95% CI -0.015 to -0.001) and WBC (-0.35 10(9)/L, 95% CI -0.56 to -0.13). Conclusions: In a non-western population from a developing country, childhood emotional adversity was negatively associated with some cardiovascular risk factors, particularly among men. Our study suggests that some of the observed associations in western populations may be socially rather than biologically based or may be population specific.	[Schooling, C. Mary; Lam, Tai Hing; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Jiang, ChaoQiang; Zhang, WeiSen] Guangzhou 12 Hosp, Guangzhou Occupat Dis Prevent & Treatment Ctr, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	The study was funded by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China, and The University of Birmingham, UK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Cerel J, 2006, J AM ACAD CHILD PSY, V45, P681, DOI 10.1097/01.chi.0000215327.58799.05; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Fimmel S, 2005, Aging Male, V8, P166, DOI 10.1080/13685530500233847; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Harrell FE, 2001, REGRESSION MODELING; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Hope S, 1998, ADDICTION, V93, P505, DOI 10.1046/j.1360-0443.1998.9345056.x; Ikeda A, 2008, INT J EPIDEMIOL, V37, P1395, DOI 10.1093/ije/dyn124; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Kavikondala S, 2009, INT J EPIDEMIOL, V38, P72, DOI 10.1093/ije/dyn221; KESSLER RC, 1980, AM SOCIOL REV, V45, P463, DOI 10.2307/2095178; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Little R.J.A., 2002, STAT ANAL MISSING DA; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Luecken LJ, 1998, PSYCHOSOM MED, V60, P765, DOI 10.1097/00006842-199811000-00021; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Nielsen NR, 2006, EPIDEMIOLOGY, V17, P391, DOI 10.1097/01.ede.0000220556.86419.76; O'Rand AM, 2005, J GERONTOL B-PSYCHOL, V60, P117, DOI 10.1093/geronb/60.Special_Issue_2.S117; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Roemmich JN, 1999, AM J HUM BIOL, V11, P209, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;209::AID-AJHB9&gt;3.0.CO;2-G; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; Sumanen M, 2005, J PSYCHOSOM RES, V59, P331, DOI 10.1016/j.jpsychores.2005.04.005; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Taylor SE, 2006, BIOL PSYCHIAT, V60, P819, DOI 10.1016/j.biopsych.2006.03.016; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Yamamoto K, 1996, CHILD PSYCHIAT HUM D, V26, P139, DOI 10.1007/BF02353355	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19675	10.1371/journal.pone.0019675	http://dx.doi.org/10.1371/journal.pone.0019675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603607	Green Published, gold			2022-12-25	WOS:000290656300017
J	Vaddepalli, P; Fulton, L; Batoux, M; Yadav, RK; Schneitz, K				Vaddepalli, Prasad; Fulton, Lynette; Batoux, Martine; Yadav, Ram Kishor; Schneitz, Kay			Structure-Function Analysis of STRUBBELIG, an Arabidopsis Atypical Receptor-Like Kinase Involved in Tissue Morphogenesis	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; RETICULUM-ASSOCIATED DEGRADATION; DEFECTIVE BRASSINOSTEROID RECEPTOR; STEM-CELL SPECIFICATION; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; PROTEIN-KINASES; ORGAN DEVELOPMENT; OVULE DEVELOPMENT; FLORAL DEVELOPMENT	Tissue morphogenesis in plants requires the coordination of cellular behavior across clonally distinct histogenic layers. The underlying signaling mechanisms are presently being unraveled and are known to include the cell surface leucine-rich repeat receptor-like kinase STRUBBELIG in Arabidopsis. To understand better its mode of action an extensive structure-function analysis of STRUBBELIG was performed. The phenotypes of 20 EMS and T-DNA-induced strubbelig alleles were assessed and homology modeling was applied to rationalize their possible effects on STRUBBELIG protein structure. The analysis was complemented by phenotypic, cell biological, and pharmacological investigations of a strubbelig null allele carrying genomic rescue constructs encoding fusions between various mutated STRUBBELIG proteins and GFP. The results indicate that STRUBBELIG accepts quite some sequence variation, reveal the biological importance for the STRUBBELIG N-capping domain, and reinforce the notion that kinase activity is not essential for its function in vivo. Furthermore, individual protein domains of STRUBBELIG cannot be related to specific STRUBBELIG-dependent biological processes suggesting that process specificity is mediated by factors acting together with or downstream of STRUBBELIG. In addition, the evidence indicates that biogenesis of a functional STRUBBELIG receptor is subject to endoplasmic reticulum-mediated quality control, and that an MG132-sensitive process regulates its stability. Finally, STRUBBELIG and the receptor-like kinase gene ERECTA interact synergistically in the control of internode length. The data provide genetic and molecular insight into how STRUBBELIG regulates intercellular communication in tissue morphogenesis.	[Vaddepalli, Prasad; Fulton, Lynette; Batoux, Martine; Yadav, Ram Kishor; Schneitz, Kay] Tech Univ Munich, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Vaddepalli, P (corresponding author), Tech Univ Munich, D-8050 Freising Weihenstephan, Germany.	schneitz@wzw.tum.de	Yadav, Ram Kishor/C-7133-2011; Vaddepalli, Prasad/AAS-9487-2020; Vaddepalli, Prasad/ABG-6642-2021	Vaddepalli, Prasad/0000-0002-9236-6063; Fulton, Lynette/0000-0002-9640-5840; Schneitz, Kay/0000-0001-6688-0539	German Research Council (DFG) [SCHN 723/1-3, SCHN 723/6-1]; Free State of Bavaria	German Research Council (DFG)(German Research Foundation (DFG)); Free State of Bavaria	This work was funded through grants SCHN 723/1-3 and SCHN 723/6-1 from the German Research Council (DFG) to KS and by the Free State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Calderon-Villalobos LIA, 2006, PLANT PHYSIOL, V141, P3, DOI 10.1104/pp.106.078097; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; EVANS MJ, 1989, GENE, V84, P135, DOI 10.1016/0378-1119(89)90147-9; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fulton L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000355; Fulton L, 2010, BIOCHEM SOC T, V38, P583, DOI 10.1042/BST0380583; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Gifford ML, 2005, PLANT CELL, V17, P1154, DOI 10.1105/tpc.104.029975; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ingram GC, 2006, CURR OPIN PLANT BIOL, V9, P12, DOI 10.1016/j.pbi.2005.11.007; Jenik PD, 2000, DEVELOPMENT, V127, P1267; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kolade OO, 2006, BBA-PROTEINS PROTEOM, V1764, P1043, DOI 10.1016/j.bbapap.2006.03.014; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Lease KA, 2001, NEW PHYTOL, V151, P133, DOI 10.1046/j.1469-8137.2001.00150.x; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillitteri LJ, 2007, DEVELOPMENT, V134, P3099, DOI 10.1242/dev.004788; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sambrook J, 1989, MOL CLONING; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Schneitz K, 1997, DEVELOPMENT, V124, P1367; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Watanabe M, 2004, PLANT J, V39, P298, DOI 10.1111/j.1365-313X.2004.02132.x; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yadav RK, 2008, DEV BIOL, V323, P261, DOI 10.1016/j.ydbio.2008.08.010; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	98	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19730	10.1371/journal.pone.0019730	http://dx.doi.org/10.1371/journal.pone.0019730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603601	Green Submitted, Green Published, gold			2022-12-25	WOS:000290656300021
J	Deng, W; Yang, DS; Zhao, BT; Ouyang, Z; Song, J; Fan, NN; Liu, ZM; Zhao, Y; Wu, QH; Nashun, B; Tang, JJ; Wu, ZF; Gu, WW; Lai, LX				Deng, Wei; Yang, Dongshan; Zhao, Bentian; Ouyang, Zhen; Song, Jun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Wu, Qinghong; Nashun, Bayaer; Tang, Jiangjing; Wu, Zhenfang; Gu, Weiwang; Lai, Liangxue			Use of the 2A Peptide for Generation of Multi-Transgenic Pigs through a Single Round of Nuclear Transfer	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; DECAY-ACCELERATING FACTOR; EXPRESSING HUMAN CD59; IN-VIVO; RETROVIRAL VECTOR; STEM-CELLS; GENE-EXPRESSION; COEXPRESSION; HOXB4; MODEL	Multiple genetic modifications in pigs can essentially benefit research on agriculture, human disease and xenotransplantation. Most multi-transgenic pigs have been produced by complex and time-consuming breeding programs using multiple single-transgenic pigs. This study explored the feasibility of producing multi-transgenic pigs using the viral 2A peptide in the light of previous research indicating that it can be utilized for multi-gene transfer in gene therapy and somatic cell reprogramming. A 2A peptide-based double-promoter expression vector that mediated the expression of four fluorescent proteins was constructed and transfected into primary porcine fetal fibroblasts. Cell colonies (54.3%) formed under G418 selection co-expressed the four fluorescent proteins at uniformly high levels. The reconstructed embryos, which were obtained by somatic cell nuclear transfer and confirmed to express the four fluorescent proteins evenly, were transplanted into seven recipient gilts. Eleven piglets were delivered by two gilts, and seven of them co-expressed the four fluorescent proteins at equivalently high levels in various tissues. The fluorescence intensities were directly observed at the nose, hoof and tongue using goggles. The results suggest that the strategy of combining the 2A peptide and double promoters efficiently mediates the co-expression of the four fluorescent proteins in pigs and is hence a promising methodology to generate multi-transgenic pigs by a single nuclear transfer.	[Deng, Wei; Yang, Dongshan; Zhao, Bentian; Ouyang, Zhen; Song, Jun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Tang, Jiangjing; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wu, Qinghong; Nashun, Bayaer; Gu, Weiwang] So Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Wu, Qinghong; Nashun, Bayaer; Gu, Weiwang] So Med Univ, Ctr Lab Anim, Guangzhou, Guangdong, Peoples R China; [Wu, Zhenfang] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Southern Medical University - China; Southern Medical University - China; South China Agricultural University	Deng, W (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.	guww100@163.com; Lai_liangxue@gibh.ac.cn	Lai, Liangxue/H-4545-2011; Yang, Dongshan/N-3333-2014; Song, Jun/A-3487-2013	Yang, Dongshan/0000-0003-2449-8651; Song, Jun/0000-0002-6128-6378; Wu, Zhenfang/0000-0002-5586-6771	National High Technology Research and Development Program of China [2006AA02A103]; Chinese Academy of Sciences [A0858]; National 973 Program of China [2009CB941001]; Natural Science Foundation of Guangdong Province, China [9251066302000001, 8451066302001811]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National 973 Program of China(National Basic Research Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work supported by grants from the National High Technology Research and Development Program of China (2006AA02A103), the Hundred Talents Projects of the Chinese Academy of Sciences (A0858), the National 973 Program of China (2009CB941001), and the Natural Science Foundation of Guangdong Province, China (9251066302000001, 8451066302001811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Asano Takako, 2005, Journal of Medical and Dental Sciences, V52, P129; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen RH, 1999, XENOTRANSPLANTATION, V6, P194, DOI 10.1034/j.1399-3089.1999.00017.x; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; de Cicco RL, 2007, MOL CARCINOGEN, V46, P654, DOI 10.1002/mc.20331; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; GALIMBERTI D, INT J CLIN EXP HYP, V3, P129; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Klump H, 2001, GENE THER, V8, P811, DOI 10.1038/sj.gt.3301447; Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127; Lai Liangxue, 2003, Reprod Biol Endocrinol, V1, P82, DOI 10.1186/1477-7827-1-82; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Menoret S, 2004, TRANSPLANTATION, V77, P1468, DOI 10.1097/01.TP.0000111758.35048.EA; Milsom MD, 2004, MOL THER, V10, P862, DOI 10.1016/j.ymthe.2004.07.019; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Sachs DH, 2009, CURR OPIN ORGAN TRAN, V14, P148, DOI 10.1097/MOT.0b013e3283292549; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun M, 2003, HUM GENE THER, V14, P415, DOI 10.1089/104303403321467180; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Webster NL, 2005, MOL REPROD DEV, V72, P68, DOI 10.1002/mrd.20316; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Wu ZF, 2008, MOL REPROD DEV, V75, P26, DOI 10.1002/mrd.20778; Xu K, 2005, WORLD J GASTROENTERO, V11, P2885, DOI 10.3748/wjg.v11.i19.2885; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou CY, 2005, XENOTRANSPLANTATION, V12, P142, DOI 10.1111/j.1399-3089.2005.00209.x; Zhou CY, 2002, XENOTRANSPLANTATION, V9, P183, DOI 10.1034/j.1399-3089.2002.01034.x; Zhou Y, 1998, HUM GENE THER, V9, P287, DOI 10.1089/hum.1998.9.3-287	41	57	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19986	10.1371/journal.pone.0019986	http://dx.doi.org/10.1371/journal.pone.0019986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603633	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500040
J	Parbery-Clark, A; Strait, DL; Anderson, S; Hittner, E; Kraus, N				Parbery-Clark, Alexandra; Strait, Dana L.; Anderson, Samira; Hittner, Emily; Kraus, Nina			Musical Experience and the Aging Auditory System: Implications for Cognitive Abilities and Hearing Speech in Noise	PLOS ONE			English	Article							WORKING-MEMORY; OLDER-ADULTS; LANGUAGE IMPAIRMENTS; PITCH DISCRIMINATION; CORTICAL PLASTICITY; COMPETING SPEECH; BACKGROUND-NOISE; AGE-DIFFERENCES; VERBAL MEMORY; IN-NOISE	Much of our daily communication occurs in the presence of background noise, compromising our ability to hear. While understanding speech in noise is a challenge for everyone, it becomes increasingly difficult as we age. Although aging is generally accompanied by hearing loss, this perceptual decline cannot fully account for the difficulties experienced by older adults for hearing in noise. Decreased cognitive skills concurrent with reduced perceptual acuity are thought to contribute to the difficulty older adults experience understanding speech in noise. Given that musical experience positively impacts speech perception in noise in young adults (ages 18-30), we asked whether musical experience benefits an older cohort of musicians (ages 45-65), potentially offsetting the age-related decline in speech-in-noise perceptual abilities and associated cognitive function (i.e., working memory). Consistent with performance in young adults, older musicians demonstrated enhanced speech-in-noise perception relative to nonmusicians along with greater auditory, but not visual, working memory capacity. By demonstrating that speech-in-noise perception and related cognitive function are enhanced in older musicians, our results imply that musical training may reduce the impact of age-related auditory decline.	[Parbery-Clark, Alexandra; Strait, Dana L.; Anderson, Samira; Hittner, Emily; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Strait, Dana L.; Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Parbery-Clark, A (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu	Parbery-Clark, Alexandra/G-2966-2012	Parbery-Clark, Alexandra/0000-0002-9485-4095; Strait, Dana/0000-0002-1279-6240	National Science Foundation [0842376]; Division Of Behavioral and Cognitive Sci [1057556] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	National Science Foundation: Small Grants for Exploratory Research No. 0842376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; DANAHER EM, 1973, J SPEECH HEAR RES, V16, P439, DOI 10.1044/jshr.1603.439; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; Davis H. R., 1998, COLORADO ASSESSMENT; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Espinoza-Varas B, 2006, EXP AGING RES, V32, P209, DOI 10.1080/03610730600554008; Fitzgibbons PJ, 2010, SPRINGER HANDB AUDIT, V34, P111, DOI 10.1007/978-1-4419-0993-0_5; FITZGIBBONS PJ, 1994, J SPEECH HEAR RES, V37, P662, DOI 10.1044/jshr.3703.662; Forgeard Marie, 2008, PLoS One, V3, pe3566, DOI 10.1371/journal.pone.0003566; Francis AL, 2010, ATTEN PERCEPT PSYCHO, V72, P501, DOI 10.3758/APP.72.2.501; Franklin MS, 2008, PSYCHOL MUSIC, V36, P353, DOI 10.1177/0305735607086044; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gehr SE, 1999, J ACOUST SOC AM, V106, P2793, DOI 10.1121/1.428104; GELFAND SA, 1986, J ACOUST SOC AM, V80, P1589, DOI 10.1121/1.394323; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; Harris KC, 2010, HEARING RES, V264, P21, DOI 10.1016/j.heares.2009.09.017; Hartley DEH, 2003, INT J PEDIATR OTORHI, V67, pS137, DOI 10.1016/j.ijporl.2003.08.012; Hartley DEH, 2002, J ACOUST SOC AM, V112, P2962, DOI 10.1121/1.1512701; Heinrich A, 2008, Q J EXP PSYCHOL, V61, P735, DOI 10.1080/17470210701402372; Helfer KS, 2009, J AM ACAD AUDIOL, V20, P264, DOI 10.3766/jaaa.20.4.6; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Humes L E, 1996, J Am Acad Audiol, V7, P161; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; JEON J. Y., 1997, PSYCHOL MUSIC, V25, P70, DOI [10.1177/0305735697251006, DOI 10.1177/0305735697251006]; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Killion MC, 2000, HEAR J, V53, P46, DOI DOI 10.1097/00025572-200003000-00006; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2009, HUM BRAIN MAPP, V30, P859, DOI 10.1002/hbm.20550; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Lee YS, 2007, LEARN INSTR, V17, P336, DOI 10.1016/j.learninstruc.2007.02.010; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Munzer S., 2002, PSYCHOL BEITR, V44, P187; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newson RS, 2005, J GERONTOL B-PSYCHOL, V60, pP113, DOI 10.1093/geronb/60.3.P113; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peretz Isabelle, 2003, COGNITIVE NEUROSCIEN; Pichora-Fuller M. K., 2006, HEARING CARE ADULTS, P71; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS26; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Rammsayer T. H., 2003, PSYCHOL MUSIC, V31, P123, DOI [DOI 10.1177/0305735603031002290, 10.1177/0305735603031002290]; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Salthouse T.A., 1985, HDB PSYCHOL AGING, V2nd, P400; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Schellenberg EG, 2008, EMPIR MUSICOL REV, V3, P205, DOI 10.18061/1811/35991; Schellenberg EG, 2009, MUSIC PERCEPT, V27, P139, DOI 10.1525/MP.2009.27.2.139; Schellenberg EG, 2006, EXPOSURE MUSIC TRUTH; Schneider Bruce A., 2001, Seminars in Hearing, V22, P227, DOI 10.1055/s-2001-15628; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Shahin A, 2004, NEUROREPORT, V15, P1917, DOI 10.1097/00001756-200408260-00017; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Sommers MS, 1996, PSYCHOL AGING, V11, P333, DOI 10.1037/0882-7974.11.2.333; Souza PE, 2007, J AM ACAD AUDIOL, V18, P54, DOI 10.3766/jaaa.18.1.5; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Strouse A, 1998, J ACOUST SOC AM, V104, P2385, DOI 10.1121/1.423748; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Trainor LJ, 2003, ANN NY ACAD SCI, V999, P506, DOI 10.1196/annals.1284.061; Tremblay KL, 2003, CLIN NEUROPHYSIOL, V114, P1332, DOI 10.1016/S1388-2457(03)00114-7; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Tun PA, 1999, J GERONTOL B-PSYCHOL, V54, pP317, DOI 10.1093/geronb/54B.5.P317; WALTERS GS, 2005, MEMORY, V13, P403; Wechsler D., 1999, WECHSLER ABBREVIATED; WILSON RH, 1993, J REHABIL RES DEV, V30, P342; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Wingfield A, 2007, J AM ACAD AUDIOL, V18, P548, DOI 10.3766/jaaa.18.7.3; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; WRIGHT BA, 1998, PSYCHOPHYSICAL PHYSL, P604; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9	94	188	191	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18082	10.1371/journal.pone.0018082	http://dx.doi.org/10.1371/journal.pone.0018082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589653	gold, Green Published			2022-12-25	WOS:000290483600001
J	Sun, M; Lo, EYY				Sun, Mei; Lo, Eugenia Y. Y.			Genomic Markers Reveal Introgressive Hybridization in the Indo-West Pacific Mangroves: A Case Study	PLOS ONE			English	Article							BAYESIAN-INFERENCE; EVOLUTION; HYBRIDS; BRUGUIERA; PROGRAM; MRBAYES; ORIGIN	Biodiversity of mangrove ecosystems is difficult to assess, at least partly due to lack of genetic verification of morphology-based documentation of species. Natural hybridization, on the one hand, plays an important role in evolution as a source of novel gene combinations and a mechanism of speciation. However, on the other hand, recurrent introgression allows gene flow between species and could reverse the process of genetic differentiation among populations required for speciation. To understand the dynamic evolutionary consequences of hybridization, this study examines genomic structure of hybrids and parental species at the population level. In the Indo-West Pacific, Bruguiera is one of the dominant mangrove genera and species ranges overlap extensively with one another. Morphological intermediates between sympatric Bruguiera gymnorrhiza and Bruguiera sexangula have been reported as a variety of B. sexangula or a new hybrid species, B. x rhynchopetala. However, the direction of hybridization and extent of introgression are unclear. A large number of species-specific inter-simple sequence repeat (ISSR) markers were found in B. gymnorrhiza and B. sexangula, and the additive ISSR profiling of B. x rhynchopetala ascertained its hybrid status and identified its parental origin. The varying degree of scatterness among hybrid individuals in Principal Coordinate Analysis and results from NewHybrids analysis indicate that B. x rhynchopetala comprises different generations of introgressants in addition to F(1)s. High genetic relatedness between B. x rhynchopetala and B. gymnorrhiza based on nuclear and chloroplast sequences suggests preferential hybrid backcrosses to B. gymnorrhiza. We conclude that B. x rhynchopetala has not evolved into an incipient hybrid species, and its persistence can be explained by recurrent hybridization and introgression. Genomic data provide insights into the hybridization dynamics of mangrove plants. Such information can assist in biodiversity assessment by helping detect novel taxa and/or define species boundaries.	[Sun, Mei] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sun, Mei] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lo, Eugenia Y. Y.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Harvard University; University of Hong Kong; Yale University	Sun, M (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	meisun@oeb.harvard.edu	Sun, Mei/D-3124-2009		HKRGC [HKU7261/00M]	HKRGC(Hong Kong Research Grants Council)	This research was funded by a HKRGC GRF grant (HKU7261/00M) to M. Sun. (URL:http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Abeysinghe PD, 1999, HYDROBIOLOGIA, V413, P11, DOI 10.1023/A:1003899028558; Allen James A., 2000, Pacific Science, V54, P331; ANDERSON EC, USERS GUIDE PROGRAM; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Archibald JK, 2004, AM J BOT, V91, P1333, DOI 10.3732/ajb.91.9.1333; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Baumel A, 2003, PLANT SYST EVOL, V237, P87, DOI 10.1007/s00606-002-0251-8; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRAWFORD DJ, 1993, AM J BOT, V80, P89, DOI 10.2307/2445124; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DUKE NC, 1984, AUST J BOT, V32, P87, DOI 10.1071/BT9840087; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; GE XJ, 2001, THESIS U HONG KONG; Grant V., 1981, PLANT SPECIATION, Vsecond; Gross BL, 2003, AM J BOT, V90, P1708, DOI 10.3732/ajb.90.12.1708; Hawkins JA, 1998, PLANT SYST EVOL, V213, P43, DOI 10.1007/BF00988907; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ioos R, 2007, MOL ECOL NOTES, V7, P133, DOI 10.1111/j.1471-8286.2006.01554.x; Kathiresan K., 1995, ENV ECOL, V13, P240; Kathiresan K, 2005, BIODIVERSITY MANGROV; Ko WC., 1978, ACTA PHYTOTAXONOMICA, V16, P109; Kovach W. L., 2005, MVSP MULTIVARIATE ST; LEGENDRE L, 1983, DEV ENV MODELING; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Manly B.F.J., 1985, STAT NATURAL SELECTI; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2003, TRACER; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; RIESEBERG LH, 1990, EVOLUTION, V44, P1498, DOI 10.1111/j.1558-5646.1990.tb03841.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Swofford DL, 2002, PHYLOGENETIC ANAL US; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tyagi AP, 1998, SEX PLANT REPROD, V11, P60, DOI 10.1007/s004970050121; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112; Zhou RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-149	49	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19671	10.1371/journal.pone.0019671	http://dx.doi.org/10.1371/journal.pone.0019671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589927	Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600020
J	Zuo, YF; Wu, JX; Xu, ZM; Yang, SP; Yan, HJ; Tan, L; Meng, XQ; Ying, XF; Liu, RY; Kang, TB; Huang, WL				Zuo, Yufang; Wu, Jiangxue; Xu, Zumin; Yang, Shiping; Yan, Haijiao; Tan, Li; Meng, Xiangqi; Ying, Xiaofang; Liu, Ranyi; Kang, Tiebang; Huang, Wenlin			Minicircle-oriP-IFN gamma: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPISOMAL TRANSGENE EXPRESSION; IN-VIVO; NUCLEAR ANTIGEN-1; DNA; VECTOR; INFECTION; PROTEINS; GROWTH; CANCER	Background: Nonviral vectors are attractively used for gene therapy owing to their distinctive advantages. Our previous study has demonstrated that transfer of human IFN gamma gene into nasopharyngeal carcinoma (NPC) by using a novel nonviral vector, minicircle (mc), under the control of cytomegalovirus (CMV) promoter was effective to inhibit tumor growth. However, therapies based on CMV promoter cannot express the targeted genes in cancer tissues. Previous studies indicated that the development of human NPC was closely associated with Epstein-Barr virus (EBV) and demonstrated the transcriptional enhancer function of oriP when bound by EBV protein. Therefore, the present study is to explore the targeted gene expression and the anti-tumor effect of a novel tumor-specific gene therapeutic system (mc-oriP-IFN gamma) in which the transgene expression was under the transcriptional regulation of oriP promoter. Methodology/Principal Findings: Dual-luciferase reporter assay and ELISA were used to assess the expression of luciferase and IFN gamma. WST assay was used to assess the cell proliferation. RT-PCR was used to detect the mRNA level of EBNA1. RNAi was used to knockdown the expression of EBNA1. NPC xenograft models in nude mice were used to investigate the targeted antitumor efficacy of mc-oriP-IFN gamma. Immunohistochemistry was used to detect the expression and the activity of the IFN gamma in tumor sections. Our results demonstrated that mc-oriP vectors mediated comparable gene expression and anti-proliferative effect in the EBV-positive NPC cell line C666-1 compared to mc-CMV vectors. Furthermore, mc-oriP vectors exhibited much lower killing effects on EBV-negative cell lines compared to mc-CMV vectors. The targeted expression of mc-oriP vectors was inhibited by EBNA1-siRNA in C666-1. This selective expression was corroborated in EBV-positive and -negative tumor models. Conclusions/Significance: This study demonstrates the feasibility of mc-oriP-IFN gamma as a safe and highly effective targeted gene therapeutic system for the treatment of EBV positive NPC.	[Zuo, Yufang; Wu, Jiangxue; Xu, Zumin; Yang, Shiping; Yan, Haijiao; Tan, Li; Meng, Xiangqi; Ying, Xiaofang; Liu, Ranyi; Kang, Tiebang; Huang, Wenlin] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Xu, Zumin] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Sun Yat Sen University	Zuo, YF (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	hwenl@mail.sysu.edu.cn	zuo, yufang/AAH-7155-2021; Liu, Ran-yi/F-8680-2011; Liu, Ran-yi/L-1008-2019; huang, wen/GXW-0661-2022	Meng, Xiangqi/0000-0002-6407-6122	National Basic Research Program of China (973 Program) [2010CB529904, 2010CB912201]; National Natural Science Foundation of China [30801360, 30973448]; Chinese Ministry of Education [109124]; Cancer Center of Sun Yat-Sen University; Sun Yat-Sen University [2009267]; Chinese Academy of Sciences [KSCX1-YW-10]; Creative Research Groups	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Cancer Center of Sun Yat-Sen University; Sun Yat-Sen University; Chinese Academy of Sciences(Chinese Academy of Sciences); Creative Research Groups	Funding was provided by the National Basic Research Program of China (973 Program, Nos. 2010CB529904 and 2010CB912201), the National Natural Science Foundation of China (Nos. 30801360 and 30973448), the Key Project of Chinese Ministry of Education (No. 109124), the Science Fund for Young Scholar of Cancer Center of Sun Yat-Sen University, the Science Fund for Young Teacher of Sun Yat-Sen University (2009267), a grant from Chinese Academy of Sciences KSCX1-YW-10, and by support from the Guangdong Recruitment Program of Creative Research Groups. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Chang CW, 2008, J CONTROL RELEASE, V125, P155, DOI 10.1016/j.jconrel.2007.10.014; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chen XJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009397; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chia MC, 2004, MOL THER, V9, P804, DOI 10.1016/j.ymthe.2004.03.016; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Fauvet R, 2003, VIRCHOWS ARCH, V443, P38, DOI 10.1007/s00428-003-0813-3; Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192; Friboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590; Glasgow JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008355; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judde JG, 1996, HUM GENE THER, V7, P647, DOI 10.1089/hum.1996.7.5-647; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Li JH, 2003, MOL THER, V8, P964, DOI 10.1016/j.ymthe.2003.08.018; Li JH, 2002, CANCER RES, V62, P171; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Liu TF, 2007, CLIN CANCER RES, V13, P3960, DOI 10.1158/1078-0432.CCR-07-0089; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Niedobitek G, 1996, SEMIN CANCER BIOL, V7, P165, DOI 10.1006/scbi.1996.0023; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Teng ZP, 1996, VIRUS GENES, V13, P53, DOI 10.1007/BF00576978; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Wu JX, 2006, CLIN CANCER RES, V12, P4702, DOI 10.1158/1078-0432.CCR-06-0520; Wu JX, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-55; Wu LL, 2003, TRENDS MOL MED, V9, P421, DOI 10.1016/j.molmed.2003.08.005; Yin QY, 2006, VIROLOGY, V346, P385, DOI 10.1016/j.virol.2005.11.021; Yip KW, 2004, MOL THER, V10, P533, DOI 10.1016/j.ymthe.2004.05.026; Zhang C, 2010, BIOMATERIALS, V31, P6075, DOI 10.1016/j.biomaterials.2010.04.042; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zhu YL, 2006, INT J ONCOL, V28, P67	43	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19407	10.1371/journal.pone.0019407	http://dx.doi.org/10.1371/journal.pone.0019407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573215	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400009
J	Momke, S; Kerkmann, A; Wohlke, A; Ostmeier, M; Hewicker-Trautwein, M; Ganter, M; Kijas, J; Distl, O				Moemke, Stefanie; Kerkmann, Andrea; Woehlke, Anne; Ostmeier, Miriam; Hewicker-Trautwein, Marion; Ganter, Martin; Kijas, James; Distl, Ottmar		Int Sheep Consortium	A Frameshift Mutation within LAMC2 Is Responsible for Herlitz Type Junctional Epidermolysis Bullosa (HJEB) in Black Headed Mutton Sheep	PLOS ONE			English	Article							MECHANOBULLOUS DISEASE; LAMININ-5; GENE; ASSOCIATION	Junctional epidermolysis bullosa (JEB) is a hereditary mechanobullous skin disease in humans and animals. A Herlitz type JEB was identified in German Black Headed Mutton (BHM) sheep and affected lambs were reproduced in a breeding trial. Affected lambs showed skin and mucous membranes blistering and all affected lambs died within the first weeks of life. The pedigree data were consistent with a monogenic autosomal recessive inheritance. Immunofluorescence showed a reduced expression of laminin 5 protein which consists of 3 subunits encoded by the genes LAMA3, LAMB3 and LAMC2. We screened these genes for polymorphisms. Linkage and genome-wide association analyses identified LAMC2 as the most likely candidate for HJEB. A two base pair deletion within exon 18 of the LAMC2 gene (FM872310:c.2746delCA) causes a frameshift mutation resulting in a premature stop codon (p.A928*) 13 triplets downstream of this mutation and in addition, introduces an alternative splicing of exon 18 LAMC2. This deletion showed a perfect co-segregation with HJEB in all 740 analysed BHM sheep. Identification of the LAMC2 deletion means an animal model for HJEB is now available to develop therapeutic approaches of relevance to the human form of this disease.	[Moemke, Stefanie; Kerkmann, Andrea; Woehlke, Anne] Univ Vet Med, Inst Genet & Anim Breeding, Hannover, Germany; [Kerkmann, Andrea; Ganter, Martin; Distl, Ottmar] Univ Vet Med, Forens Med & Ambulatory Serv, Clin Swine & Small Ruminants, Hannover, Germany; [Ostmeier, Miriam; Hewicker-Trautwein, Marion] Univ Vet Med, Inst Pathol, Hannover, Germany; [Kijas, James] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Momke, S (corresponding author), Univ Vet Med, Inst Genet & Anim Breeding, Hannover, Germany.	ottmar.distl@tiho-hannover.de	Kijas, James W/A-4656-2011	Kijas, James W/0000-0002-1417-8278	FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main	FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main	A. Kerkmann was supported by the FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alhaidari Z, 2005, VET DERMATOL, V16, P69, DOI 10.1111/j.1365-3164.2005.00420.x; Alley M R, 1974, N Z Vet J, V22, P55, DOI 10.1080/00480169.1974.34133; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bruckner-Tuderman L, 1992, Exp Dermatol, V1, P115, DOI 10.1111/j.1600-0625.1992.tb00001.x; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P452, DOI 10.1111/1523-1747.ep12470130; Capt A, 2005, J INVEST DERMATOL, V124, P530, DOI 10.1111/j.0022-202X.2004.23584.x; Castiglia D, 2001, J INVEST DERMATOL, V117, P731, DOI 10.1046/j.0022-202x.2001.01453.x; DUNSTAN RW, 1988, AM J DERMATOPATH, V10, P442; Graves KT, 2009, ANIM GENET, V40, P35, DOI 10.1111/j.1365-2052.2008.01795.x; Guaguere E, 2003, B ACAD VET FRANCE, V157, P47; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Kerkmann A, 2010, BERL MUNCH TIERARZTL, V123, P413, DOI 10.2376/0005-9366-123-413; Masunaga T, 1996, J HISTOCHEM CYTOCHEM, V44, P1223, DOI 10.1177/44.11.8918896; Milenkovic D, 2003, GENET SEL EVOL, V35, P249, DOI [10.1051/gse:2003007, 10.1186/1297-9686-35-2-249]; Nagata M, 1997, BRIT J DERMATOL, V137, P445, DOI 10.1111/j.1365-2133.1997.tb03756.x; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; PEREZ V, 2005, P 23 M EUR SOC VET P, P173; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Schneider H, 2007, EUR J CELL BIOL, V86, P701, DOI 10.1016/j.ejcb.2006.07.004; Spirito F, 2002, J INVEST DERMATOL, V119, P684, DOI 10.1046/j.1523-1747.2002.01852.x; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003	24	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18943	10.1371/journal.pone.0018943	http://dx.doi.org/10.1371/journal.pone.0018943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573221	Green Submitted, gold, Green Published			2022-12-25	WOS:000290224800007
J	Liu, RY; Dong, Z; Liu, J; Yin, JY; Zhou, L; Wu, X; Yang, Y; Mo, W; Huang, W; Khoo, SK; Chen, J; Petillo, D; Teh, BT; Qian, CN; Zhang, JT				Liu, R-Y; Dong, Z.; Liu, J.; Yin, J-Y; Zhou, L.; Wu, X.; Yang, Y.; Mo, W.; Huang, W.; Khoo, S. K.; Chen, J.; Petillo, D.; Teh, B. T.; Qian, C-N; Zhang, J-T			Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma	ONCOGENE			English	Article						cisplatin sensitivity; eIF3a; nasopharyngeal carcinoma; nucleotide excision repair; translational control	RIBONUCLEOTIDE REDUCTASE M2; INITIATION-FACTOR EIF3; BREAST-CANCER CELLS; DNA-DAMAGE; DRUG-RESISTANCE; OVEREXPRESSION; IDENTIFICATION; EXPRESSION; P150; CHEMORADIOTHERAPY	Translational control at the initiation step has been recognized as a major and important regulatory mechanism of gene expression. Eukaryotic initiation factor-3a (eIF3a), a putative subunit of the eIF3 complex, has recently been shown to have an important role in regulating the translation of a subset of mRNAs and is found to correlate with the prognosis of cancers. In this study, using nasopharyngeal carcinoma (NPC) cells as a model system, we tested the hypothesis that eIF3a negatively regulates the synthesis of nucleotide excision repair (NER) proteins, and, in turn, cellular response to treatments with DNA-damaging agents such as cisplatin (cis-dichlorodiammine platinum(II) (CDDP)). We found that a CDDP-sensitive sub-clone S16 isolated through limited dilution from an NPC cell line CNE-2 has increased eIF3a expression. Knocking down its expression in S16 cells increased cellular resistance to CDDP, NER activity and synthesis of the NER proteins XPA, XPC, RAD23B and RPA32. Altering eIF3a expression also changed the cellular response to CDDP and UV treatment in other NPC cell lines. Taken together, we conclude that eIF3a has an important role in the CDDP response and in NER activity of NPCs by suppressing the synthesis of NER proteins. Oncogene (2011) 30, 4814-4823; doi: 10.1038/onc.2011.189; published online 30 May 2011	[Zhang, J-T] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Liu, R-Y; Zhou, L.; Huang, W.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Khoo, S. K.] Van Andel Res Inst, Lab Microarray Technol, Grand Rapids, MI USA; [Chen, J.; Petillo, D.; Teh, B. T.] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Petillo, D.; Teh, B. T.; Qian, C-N] Van Andel Res Inst, Lab Genome Biol, Grand Rapids, MI USA; [Teh, B. T.; Qian, C-N] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore, Singapore; [Qian, C-N] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	Indiana University System; Indiana University Bloomington; Sun Yat Sen University; Van Andel Institute; Van Andel Institute; Van Andel Institute; National Cancer Centre Singapore (NCCS); Sun Yat Sen University	Zhang, JT (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, IU Simon Canc Ctr, 980 W Walnut St,R3-510, Indianapolis, IN 46202 USA.	jianzhan@iupui.edu	Liu, Ran-yi/L-1008-2019; Zhang, Jian-Ting/L-8334-2015; huang, wen/GXW-0661-2022; Yin, Ji-Ye/AAE-6794-2020; mo, wei/N-5636-2014	Yin, Ji-Ye/0000-0002-1244-5045; Teh, Bin Tean/0000-0003-1514-1124	National Institutes of Health [CA94961]; Showalter Trust; National Natural Science Foundation of China [81071822]; NATIONAL CANCER INSTITUTE [R01CA094961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Trust; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The CDDP-sensitive clone S16 was established and characterized at Van Andel Research Institute. The stable CNE-2 cells with eIF3a overexpression and the SUNE-1 cell line were studied at Sun Yat-sen University Cancer Center. All other studies were performed at the Indiana University School of Medicine. The VARI team dedicate this paper to the memory of a friend and co-worker, Dr Han-Mo Koo. This work was supported in part by the National Institutes of Health Grant CA94961 (JTZ), the Showalter Trust Fund (ZD) and the National Natural Science Foundation of China (no. 81071822) (RYL).	Afqir S, 2009, J CANCER RES THER, V5, P3, DOI 10.4103/0973-1482.48763; Agulnik M, 2005, BRIT J CANCER, V92, P799, DOI 10.1038/sj.bjc.6602449; Bachmann F, 1997, CANCER RES, V57, P988; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Chaudhuri J, 1997, J BIOL CHEM, V272, P30975, DOI 10.1074/jbc.272.49.30975; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2005, NUCLEIC ACIDS RES, V33, P2715, DOI 10.1093/nar/gki569; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Furuta T, 2002, CANCER RES, V62, P4899; Koo HM, 1999, JNCI-J NATL CANCER I, V91, P236, DOI 10.1093/jnci/91.3.236; Li Zhaomin, 2010, BMC Cancer, V10, P598, DOI 10.1186/1471-2407-10-598; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Neher TM, 2010, ACS CHEM BIOL, V5, P953, DOI 10.1021/cb1000444; Neher TM, 2010, BIOCHEMISTRY-US, V49, P669, DOI 10.1021/bi901575h; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; OLDROYD NJ, 1995, ELECTROPHORESIS, V16, P334, DOI 10.1002/elps.1150160155; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Thephamongkhol K, 2004, J CLIN ONCOL, V22, p493S; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Xiao WW, 2009, INT J RADIAT ONCOL, V74, P1070, DOI 10.1016/j.ijrobp.2008.09.008; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Yin JY, 2011, CLIN CANC R IN PRESS; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	39	60	65	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	48					4814	4823		10.1038/onc.2011.189	http://dx.doi.org/10.1038/onc.2011.189			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21625209	Green Accepted			2022-12-25	WOS:000298134700005
J	Krishnamurthy, N; Ngam, CR; Berdis, AJ; Montano, MM				Krishnamurthy, N.; Ngam, C. R.; Berdis, A. J.; Montano, M. M.			The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites	ONCOGENE			English	Article						EpRE; hPMC2; quninone reductase; tamoxifen	QUINONE REDUCTASE GENE; DNA-BINDING; RECEPTOR; BREAST; TAMOXIFEN; MECHANISM; IDENTIFICATION; ACTIVATION; CANCER; RNA	We have previously reported that the expression of antioxidative stress enzymes is upregulated by trans-hydroxytamoxifen (TOT) in breast epithelial cell lines providing protection against estrogen-induced DNA damage. This regulation involves Estrogen Receptor beta (ER beta) recruitment to the Electrophile Response Element (EpRE) and a novel protein, human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2). We have also demonstrated that ER beta and hPMC2 are required for TOT-dependent recruitment of poly (ADP-ribose) polymerase 1 (PARP-1) and Topoisomerase II beta (Topo II beta) to the EpRE. Sequence analysis reveals that the C-terminus of hPMC2 encodes a putative exonuclease domain. Using in vitro kinetic assays, we found that hPMC2 is a 3'-5' non-processive exonuclease that degrades both single-stranded and double-stranded substrates. Mutation of two conserved carboxylate residues drastically reduced the exonuclease activity of hPMC2, indicating the relative importance of the catalytic residues. Western blot analysis of breast cancer cell lines for Quinone Reductase (QR) levels revealed that the intrinsic exonuclease activity of hPMC2 was required for TOT-induced QR upregulation. Chromatin immunoprecipitation (ChIP) assays also indicated that hPMC2 was involved in the formation of strand breaks observed with TOT treatment and is specific for the EpRE-containing region of the QR gene. We also determined that the transcription factor NF-E2-related factor-2 (Nrf2) is involved in the specificity of hPMC2 for the EpRE. In addition, we determined that the catalytic activity of hPMC2 is required for repair of abasic sites that result from estrogen-induced DNA damage. Thus, our study provides a mechanistic basis for transcriptional regulation by hPMC2 and provides novel insights into its role in cancer prevention. Oncogene (2011) 30, 4731-4739; doi:10.1038/onc.2011.186; published online 23 May 2011	[Montano, M. M.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Montano, MM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, HG Wood Bldg W305,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mxm126@case.edu			Department of Defense [BC087610]; NIH [CA92240]; NATIONAL CANCER INSTITUTE [R01CA092240, R01CA092440] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Breast Cancer Postdoctoral award (BC087610) to NK and NIH Grant (CA92240) to MMM.	Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Berdis AJ, 2001, BIOCHEMISTRY-US, V40, P7180, DOI 10.1021/bi0101594; Bianco NR, 2003, MOL ENDOCRINOL, V17, P1344, DOI 10.1210/me.2002-0382; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gaikwad NW, 2007, FREE RADICAL BIO MED, V43, P1289, DOI 10.1016/j.freeradbiomed.2007.07.021; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang P, 1998, ONCOGENE, V17, P261, DOI 10.1038/sj.onc.1201946; Jordan VC, 1998, J NATL CANCER I, V90, P967, DOI 10.1093/jnci/90.13.967; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Montano MM, 2007, ONCOGENE, V26, P3587, DOI 10.1038/sj.onc.1210144; Montano MM, 2000, J BIOL CHEM, V275, P34306, DOI 10.1074/jbc.M003880200; Montano MM, 1997, P NATL ACAD SCI USA, V94, P2581, DOI 10.1073/pnas.94.6.2581; Montano MM, 2004, ONCOGENE, V23, P2442, DOI 10.1038/sj.onc.1207358; Montano MM, 1998, J BIOL CHEM, V273, P25443, DOI 10.1074/jbc.273.39.25443; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Skalski V, 2000, ONCOGENE, V19, P3321, DOI 10.1038/sj.onc.1203649; Sripathy SP, 2008, ONCOGENE, V27, P6376, DOI 10.1038/onc.2008.235; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	33	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	47					4731	4739		10.1038/onc.2011.186	http://dx.doi.org/10.1038/onc.2011.186			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21602889	Green Accepted, Green Submitted			2022-12-25	WOS:000298033700005
J	Chan, SL; Cipolla, MJ				Chan, Siu-Lung; Cipolla, Marilyn J.			Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-gamma	FASEB JOURNAL			English	Article						hypertrophy; middle cerebral arteries; myogenic reactivity	PPAR-GAMMA; MYOGENIC REACTIVITY; CEREBRAL ARTERIOLES; RENAL VASODILATION; CEREBROVASCULAR RESISTANCE; VASCULAR DYSFUNCTION; PREGNANCY; RATS; MICE; HYPERFILTRATION	Brain parenchymal arterioles (PAs), but not pial arteries, undergo hypotrophic outward remodeling during pregnancy that involves peroxisome proliferator-activated receptor-gamma (PPAR gamma) activation. Relaxin, a peptide hormone produced during pregnancy, is involved in systemic and renal artery remodeling and activates PPAR gamma in vitro. Thus, we hypothesized that relaxin is involved in the selective outward remodeling of PAs through a PPAR gamma-dependent mechanism. Nonpregnant rats were treated with relaxin (4 mu g/h, osmotic minipump), relaxin plus PPAR gamma inhibitor GW9662 (10 mg/kg/d), or vehicle for 10 d. Vascular function and structure were compared in isolated and pressurized middle cerebral arteries (MCAs) and PAs taken from the same animals. Relaxin treatment increased serum relaxin to the level of pregnancy (54 ng/ml) and increased passive wall thickness (hypertrophy; 70 +/- 5 vs. 54 +/- 4 mu m in vehicle; P<0.05) and inner diameter (outward remodeling; 10.6 +/- 0.5 vs. 8.0 +/- 0.6 mu m in vehicle; P<0.05) in PAs, but not in MCAs. This hypertrophic outward remodeling was prevented by GW9662 that had diameters (57 +/- 3 mu m) and wall thickness (8.6 +/- 1.0 mu m) similar to vehicle. GW9662 also prevented relaxin-induced changes in PPAR gamma target gene expression. These results suggest that relaxin produced during pregnancy may be partly responsible for selective remodeling of PAs during pregnancy through a mechanism involving PPAR gamma.-Chan, S.-L., Cipolla, M. J. Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-gamma. FASEB J. 25, 3229-3239 (2011). www.fasebj.org	[Chan, Siu-Lung; Cipolla, Marilyn J.] Univ Vermont, Dept Neurol, Burlington, VT 05401 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05401 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Pharmacol, Burlington, VT 05401 USA	University of Vermont; University of Vermont; University of Vermont	Cipolla, MJ (corresponding author), Univ Vermont, Dept Neurol, 89 Beaumont Ave,C454 Given, Burlington, VT 05401 USA.	marilyn.cipolla@uvm.edu	Chan, Siu-Lung/I-3023-2019	Chan, Siu-Lung/0000-0001-7564-3287	U.S. National Institutes of Health [NS045940]; American Recovery and Reinvestment Act supplement [NS045940-05S1]; American Heart Association [0540081N]; Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act supplement; American Heart Association(American Heart Association); Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Dennis Stewart (Corthera, Inc., San Carlos, CA, USA) and Novartis Pharmaceuticals (Basel, Switzerland) for providing recombinant human relaxin-2. The authors thank Mr. Timothy Hunter, Ms. Mary Lou Shane, and the Vermont Cancer Center DNA analysis facility at the University of Vermont for their technical expertise and help with PCR. The authors also thank Ms. Julie Sweet for technical expertise with the PA experiments. The authors gratefully acknowledge the continued support from the U.S. National Institutes of Health (NS045940), the American Recovery and Reinvestment Act supplement (NS045940-05S1), the American Heart Association Established Investigator Award (0540081N), and the Totman Medical Research Trust. Recombinant human relaxin-2 was a gift from Corthera Inc. and Novartis Pharmaceuticals.	Arck P, 2010, BIOL REPROD, V83, P168, DOI 10.1095/biolreprod.110.083550; BANI D, 2008, HLTH RISK MANAG, V4, P515; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Baumbach Gary L., 2000, Journal of Hypertension, V18, pS7; Baumbach GL, 1996, HYPERTENSION, V27, P159, DOI 10.1161/01.HYP.27.2.159; BAUMBACH GL, 1989, J PHYSIOL-LONDON, V416, P123, DOI 10.1113/jphysiol.1989.sp017753; Baumbach GL, 2004, CIRC RES, V95, P822, DOI 10.1161/01.RES.0000146279.11923.14; Baumbach GL, 2003, HYPERTENSION, V41, P50, DOI 10.1161/01.HYP.0000042427.05390.5C; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; CHAN SL, 2010, FRONT VASC PHYSL, V1, P12; Chillon JM, 1999, HYPERTENSION, V33, P856, DOI 10.1161/01.HYP.33.3.856; Cipolla MJ, 2008, MICROCIRCULATION, V15, P495, DOI 10.1080/10739680801986742; Cipolla MJ, 2008, REPROD SCI, V15, p288A; Cipolla MJ, 2008, FASEB J, V22; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Cipolla MJ, 2009, REPROD SCI, V16, p91A; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; Cipolla MJ, 2004, J CARDIOVASC PHARM, V44, P1, DOI 10.1097/00005344-200407000-00001; CIPOLLA MJ, 2010, FASEB J, V24; Conrad KP, 2004, AM J PHYSIOL-REG I, V287, pR250, DOI 10.1152/ajpregu.00672.2003; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Debrah DO, 2006, ENDOCRINOLOGY, V147, P5126, DOI 10.1210/en.2006-0567; Debrah DO, 2005, J APPL PHYSIOL, V98, P1013, DOI 10.1152/japplphysiol.01083.2004; Dello Russo C, 2003, J BIOL CHEM, V278, P5828, DOI 10.1074/jbc.M208132200; DESAN PH, 1988, PHARMACOL BIOCHEM BE, V30, P563, DOI 10.1016/0091-3057(88)90066-4; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Fournier T, 2008, CURR MED CHEM, V15, P3011, DOI 10.2174/092986708786848677; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; Inoue I, 2001, METABOLISM, V50, P3, DOI 10.1053/meta.2001.19415; Jeyabalan A, 2003, CIRC RES, V93, P1249, DOI 10.1161/01.RES.0000104086.43830.6C; Jeyabalan A, 2006, J APPL PHYSIOL, V100, P1955, DOI 10.1152/japplphysiol.01330.2005; Jeyabalan A, 2007, ENDOCRINOLOGY, V148, P189, DOI 10.1210/en.2006-0989; Li Y, 2005, REGUL PEPTIDES, V132, P41, DOI 10.1016/j.regpep.2005.09.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Novak J, 2002, AM J PHYSIOL-REG I, V283, pR349, DOI 10.1152/ajpregu.00635.2001; Pohl U, 2000, ACTA PHYSIOL SCAND, V168, P505, DOI 10.1046/j.1365-201x.2000.00702.x; Samuel CS, 2006, KIDNEY INT, V69, P1498, DOI 10.1038/sj.ki.5000264; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; SHERWOOD OD, 1994, PHYSL REPRODUCTION, V1, P861; Singh S, 2010, MOL CELL ENDOCRINOL, V315, P239, DOI 10.1016/j.mce.2009.08.014; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Toth B, 2007, AM J REPROD IMMUNOL, V58, P289, DOI 10.1111/j.1600-0897.2007.00514.x; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Unemori E, 2009, ANN NY ACAD SCI, V1160, P381, DOI 10.1111/j.1749-6632.2009.03838.x; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; Wieser F, 2008, PPAR RES, V2008, DOI 10.1155/2008/527048; Williams KP, 1998, AM J OBSTET GYNECOL, V179, P1200, DOI 10.1016/S0002-9378(98)70131-0	52	40	40	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3229	3239		10.1096/fj.10-175471	http://dx.doi.org/10.1096/fj.10-175471			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21602449	Green Published			2022-12-25	WOS:000294435200035
J	Hellriegel, C; Caiolfa, VR; Corti, V; Sidenius, N; Zamai, M				Hellriegel, Christian; Caiolfa, Valeria R.; Corti, Valeria; Sidenius, Nicolai; Zamai, Moreno			Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane	FASEB JOURNAL			English	Article						fluorescence microscopy; GPI-anchored proteins; ligand binding; receptor dimerization	RECEPTOR-RELATED-PROTEIN; FLUORESCENCE CORRELATION SPECTROSCOPY; PHOTON-COUNTING HISTOGRAM; EPIDERMAL-GROWTH-FACTOR; UROKINASE RECEPTOR; PLASMINOGEN-ACTIVATOR; LIVING CELLS; IN-VIVO; BINDING; COMPLEX	We studied the molecular forms of the GPI-anchored urokinase plasminogen activator receptor (uPAR-mEGFP) in the human embryo kidney (HEK293) cell membrane and demonstrated that the binding of the amino-terminal fragment (ATF) of urokinase plasminogen activator is sufficient to induce the dimerization of the receptor. We followed the association kinetics and determined precisely the dimeric stoichiometry of uPAR-mEGFP complexes by applying number and brightness (N&B) image analysis. N&B is a novel fluctuation-based approach for measuring the molecular brightness of fluorophores in an image time sequence in live cells. Because N&B is very sensitive to long-term temporal fluctuations and photobleaching, we have introduced a filtering protocol that corrects for these important sources of error. Critical experimental parameters in N&B analysis are illustrated and analyzed by simulation studies. Control experiments are based on mEGFP-GPI, mEGFP-mEGFP-GPI, and mCherry-GPI, expressed in HEK293. This work provides a first direct demonstration of the dimerization of uPAR in live cells. We also provide the first methodological guide on N&B to discern minor changes in molecular composition such as those due to dimerization events, which are involved in fundamental cell signaling mechanisms.-Hellriegel, C., Caiolfa, V. R., Corti, V., Sidenius, N., Zamai, M. Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane. FASEB J. 25, 2883-2897 (2011). www.fasebj.org	[Hellriegel, Christian; Caiolfa, Valeria R.; Zamai, Moreno] Natl Ctr Cardiovasc Res CNIC, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Caiolfa, Valeria R.; Corti, Valeria; Zamai, Moreno] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy; [Caiolfa, Valeria R.; Zamai, Moreno] Ist Sci San Raffaele, Italian Inst Technol Network Res, Unit Mol Neurosci, I-20132 Milan, Italy; [Sidenius, Nicolai] Italian Canc Res Fdn FIRX, Inst Mol Oncol IFOM, Milan, Italy	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IFOM - FIRC Institute of Molecular Oncology	Zamai, M (corresponding author), Natl Ctr Cardiovasc Res, Microscopy & Dynam Imaging Unit, Melchor Fernandez Almagro 3, ES-28029 Madrid, Spain.	valeria.caiolfa@hsr.it; mzamai@cnic.es	Zamai, Moreno/H-5923-2015; Hellriegel, Christian/B-8263-2014; Sidenius, Nicolai/M-9643-2015; Caiolfa, Valeria R./H-2769-2015	Zamai, Moreno/0000-0002-2222-6815; Sidenius, Nicolai/0000-0002-7825-7629; Caiolfa, Valeria R./0000-0003-4814-6490	Cariplo Foundation; Italian Association for Cancer Research (AIRC); Spanish Ministry of Science and Innovation; Pro-CNIC Foundation; National Center for Research Resources of the U.S. National Institutes of Health [PHS 5 P41-RR003155]; UCI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER	Cariplo Foundation(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; National Center for Research Resources of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors are grateful to Elvira Arza for technical help. The authors thank Enrico Gratton for the valuable discussion. The authors acknowledge the financial support from the Cariplo Foundation (V. R. C. and N.S.) and the Italian Association for Cancer Research (AIRC; N.S.). CNIC is supported by the Spanish Ministry of Science and Innovation and by the Pro-CNIC Foundation. Raw data in Figs. 4 and 5 were acquired at the Laboratory for Fluorescence Dynamics (LFD) at the University of California, Irvine (UCI; Irvine, CA, USA). The LFD is supported jointly by the National Center for Research Resources of the U.S. National Institutes of Health (PHS 5 P41-RR003155) and UCI.	APPELLA E, 1987, ANN NY ACAD SCI, V511, P192, DOI 10.1111/j.1749-6632.1987.tb36247.x; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hellriegel C, 2009, J R SOC INTERFACE, V6, pS3, DOI 10.1098/rsif.2008.0313.focus; Huang MD, 2005, ACTA CRYSTALLOGR D, V61, P697, DOI 10.1107/S0907444905014174; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P567, DOI 10.1111/j.1432-1033.1994.00567.x; LINDEMANN B, 1969, MED BIOL ENG, V7, P239, DOI 10.1007/BF02474182; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; Maupas-Schwalm F, 2009, CELL SIGNAL, V21, P1925, DOI 10.1016/j.cellsig.2009.08.010; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Perroud TD, 2005, CHEMPHYSCHEM, V6, P905, DOI 10.1002/cphc.200400547; PLOUG M, 1991, J BIOL CHEM, V266, P1926; QIAN H, 1990, P NATL ACAD SCI USA, V87, P5479, DOI 10.1073/pnas.87.14.5479; Sahores M, 2008, BBA-BIOMEMBRANES, V1778, P250, DOI 10.1016/j.bbamem.2007.09.030; Sanchez-Andres A, 2005, BIOPHYS J, V89, P3531, DOI 10.1529/biophysj.105.067082; Schriebl K, 2006, PROTEIN EXPRES PURIF, V49, P265, DOI 10.1016/j.pep.2006.05.018; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shliom O, 2000, J BIOL CHEM, V275, P24304, DOI 10.1074/jbc.M002024200; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; Zacharias DA, 2006, METHOD BIOCHEM ANAL, V47, P83	43	32	33	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					2883	2897		10.1096/fj.11-181537	http://dx.doi.org/10.1096/fj.11-181537			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21602447	Green Published			2022-12-25	WOS:000294435200005
J	Reilly, MC; Aoki, K; Wang, ZA; Skowyra, ML; Williams, M; Tiemeyer, M; Doering, TL				Reilly, Morgann C.; Aoki, Kazuhiro; Wang, Zhuo A.; Skowyra, Michael L.; Williams, Matthew; Tiemeyer, Michael; Doering, Tamara L.			A Xylosylphosphotransferase of Cryptococcus neoformans Acts in Protein O-Glycan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; MUTANT STRAINS; YEAST; FAMILY; GENE; BETA-1,2-XYLOSYLTRANSFERASE; GALACTOXYLOMANNAN; GLYCOSYLATION; BIOSYNTHESIS; DIVERSITY	Cryptococcal meningoencephalitis is an AIDS-defining illness caused by the opportunistic pathogen Cryptococcus neoformans. This organism possesses an elaborate polysaccharide capsule that is unique among pathogenic fungi, and the glycobiology of C. neoformans has been a focus of research in the field. The capsule and other cellular glycans and glycoconjugates have been described, but the machinery responsible for their synthesis remains largely unexplored. We recently discovered Xpt1p, an enzyme with the unexpected activity of generating a xylose-phosphate-mannose linkage. We now demonstrate that this novel activity is conserved throughout the C. neoformans species complex, localized to the Golgi apparatus, and functions in the O-glycosylation of proteins. We also present the first survey of O-glycans from C. neoformans.	[Reilly, Morgann C.; Wang, Zhuo A.; Skowyra, Michael L.; Williams, Matthew; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Washington University (WUSTL); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu	Skowyra, Michal Leszek/AAS-4850-2020; Wang, Zhuo/L-6912-2019; Aoki, Kazuhiro/H-8283-2014	Skowyra, Michal Leszek/0000-0002-1365-034X; Wang, Zhuo/0000-0002-4707-036X; Reilly, Morgann/0000-0002-5526-8245; Aoki, Kazuhiro/0000-0003-0029-4291	National Institutes of Health [R01 GM071007, R21 AI076737]; National Institutes of Health (National Center for Research Resources) [P01 GM085354, P41 RR018502]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071007 and R21 AI076737 (to T. L. D.) and P01 GM085354 and P41 RR018502 (National Center for Research Resources) (to M. T.).	ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; ECKERT TF, 1987, INFECT IMMUN, V55, P1895, DOI 10.1128/IAI.55.8.1895-1899.1987; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Franzot SP, 1999, BIOCHEM J, V340, P25, DOI 10.1042/0264-6021:3400025; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gallagher Sean R, 2006, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1002as75; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JARS MU, 1995, J BIOL CHEM, V270, P24810, DOI 10.1074/jbc.270.42.24810; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P1869, DOI 10.1128/IAI.60.5.1869-1874.1992; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; McQuiston T, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P373; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Netski D, 2002, INFECT IMMUN, V70, P2812, DOI 10.1128/IAI.70.6.2812-2819.2002; NISHIKAWA S, 1994, MOL BIOL CELL, V5, P1129, DOI 10.1091/mbc.5.10.1129; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; SPIROPULU C, 1989, INFECT IMMUN, V57, P3240, DOI 10.1128/IAI.57.10.3240-3242.1989; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Warren RL, 2005, BIOTECHNIQUES, V38, P715, DOI 10.2144/05385ST01; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	44	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26888	26899		10.1074/jbc.M111.262162	http://dx.doi.org/10.1074/jbc.M111.262162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21606487	Green Published, hybrid			2022-12-25	WOS:000293078200063
J	Shirakawa, J; Amo, K; Ohminami, H; Orime, K; Togashi, Y; Ito, Y; Tajima, K; Koganei, M; Sasaki, H; Takeda, E; Terauchi, Y				Shirakawa, Jun; Amo, Kikuko; Ohminami, Hirokazu; Orime, Kazuki; Togashi, Yu; Ito, Yuzuru; Tajima, Kazuki; Koganei, Megumi; Sasaki, Hajime; Takeda, Eiji; Terauchi, Yasuo			Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased beta Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLASMA-INSULIN CONCENTRATION; OIL-ENRICHED DIET; GLUCOSE-TOLERANCE; E-CADHERIN; ER STRESS; INTESTINAL CONTENT; KEY ROLE; ACTIVATION; MASS	Chronic exposure to high glucose and fatty acid levels caused by dietary sugar and fat intake induces beta cell apoptosis, leading to the exacerbation of type 2 diabetes. Oleic acid and linoleic acid are two major dietary fatty acids, but their effects in diabetes are unclear. We challenged beta cell-specific glucokinase haploinsufficient (Gck(+/-)) mice with a diet containing sucrose and oleic acid (SO) or sucrose and linoleic acid (SL) and analyzed beta cell apoptosis. In Gck(+/-) but not wild-type mice, SL significantly decreased the beta cell mass and beta cell proportion in islet cells arising from increased apoptosis to a greater degree than did SO. The mRNA expression of SREBP-1c was significantly higher, and that of E-cadherin was significantly lower in the islets of Gck(+/-) mice fed SL compared with mice fed SO. We next evaluated monotherapy with desfluorositagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in these mouse groups. DPP-4 inhibitor protected against beta cell apoptosis, restored the beta cell mass, and normalized islet morphology in Gck(+/-) mice fed SL. DPP-4 inhibition normalized the changes in the islet expression of SREBP-1c and E-cadherin mRNA induced by the SL diet. Furthermore, linoleic acid induced beta cell apoptosis to a greater degree in the presence of high glucose levels than in the presence of low glucose levels in vitro in islets and MIN6 cells, whereas a GLP-1 receptor agonist prevented apoptosis. In conclusion, SL exacerbated beta cell apoptosis in diabetic Gck(+/-) mice but not in euglycemic wild-type mice, and DPP-4 inhibition protected against these effects.	[Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Amo, Kikuko; Ohminami, Hirokazu; Takeda, Eiji] Univ Tokushima, Inst Hlth Biosci, Dept Clin Nutr, Tokushima 7708503, Japan; [Koganei, Megumi; Sasaki, Hajime] Meiji Dairies Corp, Div Res & Dev, Inst Food Sci, Odawara, Kanagawa 2500862, Japan	Yokohama City University; Tokushima University; Meiji Holdings Co., Ltd.	Terauchi, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	terauchi-tky@umin.ac.jp	Terauchi, Yasuo/AAO-4347-2020	Shirakawa, Jun/0000-0002-0822-8750	Ministry of Education, Culture, Sports, Science and Technology of Japan [19390251, 21390282]; Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (B) 19390251 and (B) 21390282 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a medical award from the Japan Medical Association, a grant-in-aid from the Japan Diabetes Foundation, a grant-in-aid from the Suzuken Memorial Foundation, a grant-in-aid from the Naito Foundation, a grant-in-aid from the Uehara Memorial Foundation (to Y. T.), and a grant-in-aid for Japan Society for the Promotion of Science fellows (to J. S.).	Ahren B, 2004, HORM METAB RES, V36, P842, DOI 10.1055/s-2004-826173; Andrikopoulos S, 2000, DIABETES, V49, P2056, DOI 10.2337/diabetes.49.12.2056; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cancelas J, 2006, HORM METAB RES, V38, P98, DOI 10.1055/s-2006-925126; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Grundy SM, 2002, AM J MED, V113, P25, DOI 10.1016/S0002-9343(01)00988-3; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Natalicchio A, 2010, ENDOCRINOLOGY, V151, P2019, DOI 10.1210/en.2009-1166; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; Prieto PG, 2005, ENDOCRINE, V26, P107, DOI 10.1385/ENDO:26:2:107; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Sato K, 2007, J NUTR, V137, P1908, DOI 10.1093/jn/137.8.1908; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tsunekawa S, 2007, J ENDOCRINOL, V193, P65, DOI 10.1677/JOE-06-0148; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	44	44	47	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25467	25476		10.1074/jbc.M110.217216	http://dx.doi.org/10.1074/jbc.M110.217216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613229	Green Published, hybrid			2022-12-25	WOS:000293073000009
J	Vetting, MW; Hegde, SS; Wang, MH; Jacoby, GA; Hooper, DC; Blanchard, JS				Vetting, Matthew W.; Hegde, Subray S.; Wang, Minghua; Jacoby, George A.; Hooper, David C.; Blanchard, John S.			Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTAPEPTIDE REPEAT PROTEINS; QUINOLONE-RESISTANCE; CRYSTAL-STRUCTURE; INTRINSIC RESISTANCE; MICROCIN B17; DNA CLEAVAGE; GENE; GYRASE; CRYSTALLIZATION; RECOGNITION	QnrB1 is a plasmid-encoded pentapeptide repeat protein (PRP) that confers a moderate degree of resistance to fluoroquinolones. Its gene was cloned into an expression vector with an N-terminal polyhistidine tag, and the protein was purified by nickel affinity chromatography. The structure of QnrB1 was determined by a combination of trypsinolysis, surface mutagenesis, and single anomalous dispersion phasing. QnrB1 folds as a right-handed quadrilateral beta-helix with a highly asymmetric dimeric structure typical of PRP-topoisomerase poison resistance factors. The threading of pentapeptides into the beta-helical fold is interrupted by two noncanonical PRP sequences that produce outward projecting loops that interrupt the regularity of the PRP surface. Deletion of the larger upper loop eliminated the protective effect of QnrB1 on DNA gyrase toward inhibition by quinolones, whereas deletion of the smaller lower loop drastically reduced the protective effect. These loops are conserved among all plasmid-based Qnr variants (QnrA, QnrC, QnrD, and QnrS) and some chromosomally encoded Qnr varieties. A mechanism in which PRP-topoisomerase poison resistance factors bind to and disrupt the quinolone-DNA-gyrase interaction is proposed.	[Vetting, Matthew W.; Hegde, Subray S.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wang, Minghua; Hooper, David C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Jacoby, George A.] Lahey Clin Fdn, Burlington, MA 01805 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts General Hospital; Lahey Hospital & Medical Center	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	blanchar@aecom.yu.edu	Jacoby, George A/G-2604-2011		National Institutes of Health [R01AI033696, R01AI057576]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033696, R01AI057576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI033696 (to J. S. B.) and R01AI057576 (to D. C. H. and G. A. J.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; Buchko GW, 2008, J STRUCT BIOL, V162, P184, DOI 10.1016/j.jsb.2007.11.008; Buchko GW, 2006, PROTEIN SCI, V15, P2579, DOI 10.1110/ps.062407506; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chandler LE, 2003, BIOCHEMISTRY-US, V42, P5508, DOI 10.1021/bi027113a; Da Re S, 2009, EMBO REP, V10, P929, DOI 10.1038/embor.2009.99; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; GARRIDO MD, 1988, EMBO J, V7, P1853, DOI 10.1002/j.1460-2075.1988.tb03018.x; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hashimi SM, 2007, ANTIMICROB AGENTS CH, V51, P181, DOI 10.1128/AAC.00918-06; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; Hegde SS, 2011, ANTIMICROB AGENTS CH, V55, P110, DOI 10.1128/AAC.01158-10; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Jacoby GA, 2009, ANTIMICROB AGENTS CH, V53, P1665, DOI 10.1128/AAC.01447-08; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Merens A, 2009, J BACTERIOL, V191, P1587, DOI 10.1128/JB.01205-08; Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001; Ni SS, 2009, J STRUCT BIOL, V165, P47, DOI 10.1016/j.jsb.2008.09.010; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P3050, DOI 10.1128/AAC.49.7.3050-3052.2005; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Vetting MW, 2007, PROTEIN SCI, V16, P755, DOI 10.1110/ps.062637707; Vetting MW, 2011, ACTA CRYSTALLOGR F, V67, P296, DOI 10.1107/S1744309110053315; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P821, DOI 10.1128/AAC.00132-08; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Xiong XL, 2011, NUCLEIC ACIDS RES, V39, P3917, DOI 10.1093/nar/gkq1296	55	56	59	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25265	25273		10.1074/jbc.M111.226936	http://dx.doi.org/10.1074/jbc.M111.226936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21597116	Green Published, hybrid			2022-12-25	WOS:000292547900072
J	Suhadev, M; Thomas, BE; Sakthivel, MR; Murugesan, P; Chandrasekaran, V; Charles, N; Durga, R; Auxilia, M; Mathew, TA; Wares, F				Suhadev, Mohanarani; Thomas, Beena E.; Sakthivel, Raja M.; Murugesan, P.; Chandrasekaran, V; Charles, Niruparani; Durga, R.; Auxilia, M.; Mathew, Trini A.; Wares, Fraser			Alcohol Use Disorders (AUD) among Tuberculosis Patients: A Study from Chennai, South India	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; RISK-FACTORS; INDUSTRIAL-WORKERS; HAZARDOUS DRINKING; DEATH; GOA	Background: Alcohol Use Disorders (AUDs) among tuberculosis (TB) patients are associated with nonadherence and poor treatment outcomes. Studies from Tuberculosis Research Centre (TRC), Chennai have reported that alcoholism has been one of the major reasons for default and mortality in under the DOTS programme in South India. Hence, it is planned to conduct a study to estimate prevalence of alcohol use and AUDs among TB patients attending the corporation health centres in Chennai, India. Methodology: This is a cross-sectional cohort study covering 10 corporation zones at Chennai and it included situational assessment followed by screening of TB patients by a WHO developed Alcohol Use Disorders Identification Test AUDIT scale. Four zones were randomly selected and all TB patients treated during July to September 2009 were screened with AUDIT scale for alcohol consumption. Results: Out of 490 patients, 66% were males, 66% were 35 years and above, 57% were married, 58% were from the low monthly income group of <Rs 5000 per month. No females reported alcohol use. Overall, out of 490 TB pts, 29% (141) were found to consume alcohol. Among 141 current drinkers 52% (73) had an AUDIT score of >8. Age (>35 years), education (less educated), income (<Rs 5000 per month), marital status (separated/divorced) and treatment category (Category 2) were statistically significant for TB patients with alcohol use than those TB patients without alcohol use. Conclusions: AUD among TB patients needs to be addressed urgently and the findings suggest the importance of integrating alcohol treatment into TB care.	[Suhadev, Mohanarani; Thomas, Beena E.; Sakthivel, Raja M.; Murugesan, P.; Chandrasekaran, V; Charles, Niruparani; Durga, R.; Auxilia, M.] TB Res Ctr, Madras, Tamilnadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India; [Mathew, Trini A.] Univ Mississipi, Med Ctr, Div Infect Dis, Jackson, MS USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; University of Mississippi Medical Center	Suhadev, M (corresponding author), TB Res Ctr, Madras, Tamilnadu, India.	mohanasuhadev@yahoo.com			WHO; United States Agency for International Development	WHO(World Health Organization); United States Agency for International Development(United States Agency for International Development (USAID))	The study was supported by WHO, with financial assistance provided by the United States Agency for International Development under the Model DOTS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1993, ADDICTION, V88, P1493, DOI 10.1111/j.1360-0443.1993.tb03135.x; [Anonymous], 2003, J SUBST USE, DOI DOI 10.1080/1465989031000109798; [Anonymous], 2001, AUDIT ALCOHOL USE DI; Benegal V, 2005, ADDICTION, V100, P1051, DOI 10.1111/j.1360-0443.2005.01176.x; D'Costa G, 2007, ALCOHOL ALCOHOLISM, V42, P131, DOI 10.1093/alcal/agl103; DEMENESESGAYA C, 2009, PSYCHOL NEUROSCI, V2; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; DORSCHNER J, 1983, J STUD ALCOHOL, V44, P538, DOI 10.15288/jsa.1983.44.538; Edwards G., 1994, ALCOHOL POLICY PUBLI; FLEMING MF, 1991, INT J ADDICT, V26, P1173, DOI 10.3109/10826089109062153; Gaunekar G, 2005, SOC PSYCH PSYCH EPID, V40, P267, DOI 10.1007/s00127-005-0886-1; GAUNEKAR G, 2004, DRINKING PATTERNS HA, P125; GREENFIELD, 2010, ALCOHOLISM CLIN EXPT; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; Mohan D, 2002, INDIAN J MED RES, V116, P150; Mohan D, 2002, INDIAN J MED RES, V115, P128; MUNIYANDI M, 2009, 1 INT C ALC HIV IND; MUNIYANDI M, IJT; NAYAK MB, 2009, ALCOHOLISM CLIN EXPT, V33, P1; PRAKASH R, 2009, 1 INT C ALC HIV IND; RAY R, EXTANT PATTERN TREND; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Saunders J. B., 1987, WHO COLLABORATIVE PR; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Silva MC, 2003, ALCOHOL ALCOHOLISM, V38, P79, DOI 10.1093/alcalc/agg016; Sivaram S, 2008, DRUG ALCOHOL DEPEN, V94, P133, DOI 10.1016/j.drugalcdep.2007.11.016; SIVARAM S, 2007, J URBAN HEALTH, V84, P4; *TB IND, 2009, RNTCP STAT REP, P10011; *WHO, 1980, WHO TECH REP SER, V650; World Health Organization, 2009, GLOB TB REP; XU L, 2001, INT J TUBERC LUNG D, V14; 2009, ALCOHOLISM CLIN EXPT	35	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19485	10.1371/journal.pone.0019485	http://dx.doi.org/10.1371/journal.pone.0019485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611189	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500005
J	Ott, E; Norio, P; Ritzi, M; Schildkraut, C; Schepers, A				Ott, Elisabeth; Norio, Paolo; Ritzi, Marion; Schildkraut, Carl; Schepers, Aloys			The Dyad Symmetry Element of Epstein-Barr Virus Is a Dominant but Dispensable Replication Origin	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; HUMAN-CELLS; RECOGNITION COMPLEX; NUCLEAR ANTIGEN-1; LATENT ORIGIN; AUTONOMOUS REPLICATION; CHROMATIN ASSOCIATION; SEQUENCE REQUIREMENTS; STABLE REPLICATION; VIRAL GENOMES	OriP, the latent origin of Epstein-Barr virus (EBV), consists of two essential elements: the dyad symmetry (DS) and the family of repeats (FR). The function of these elements has been predominantly analyzed in plasmids transfected into transformed cells. Here, we examined the molecular functions of DS in its native genomic context and at an ectopic position in the mini-EBV episome. Mini-EBV plasmids contain 41% of the EBV genome including all information required for the proliferation of human B cells. Both FR and DS function independently of their genomic context. We show that DS is the most active origin of replication present in the mini-EBV genome regardless of its location, and it is characterized by the binding of the origin recognition complex (ORC) allowing subsequent replication initiation. Surprisingly, the integrity of oriP is not required for the formation of the pre-replicative complex (pre-RC) at or near DS. In addition we show that initiation events occurring at sites other than the DS are also limited to once per cell cycle and that they are ORC-dependent. The deletion of DS increases initiation from alternative origins, which are normally used very infrequently in the mini-EBV genome. The sequence-independent distribution of ORC-binding, pre-RC-assembly, and initiation patterns indicates that a large number of silent origins are present in the mini-EBV genome. We conclude that, in mini-EBV genomes lacking the DS element, the absence of a strong ORC binding site results in an increase of ORC binding at dispersed sites.	[Ott, Elisabeth; Ritzi, Marion; Schepers, Aloys] Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany; [Norio, Paolo; Schildkraut, Carl] Albert Einstein Coll Med, Dept Cell Biol CH 416, New York, NY USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Yeshiva University	Ott, E (corresponding author), Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany.	schildkr@aecom.yu.edu; schepers@helmholtz-muenchen.de		Schepers, Aloys/0000-0002-5442-5608	Deutsche Forschungsgemeinschaft [SFB/TR05, SFB646]; National Institutes of Health (NIH) [GM45751]; NIH/National Cancer Institute [P30CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045751] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported from Institutional grants, the Deutsche Forschungsgemeinschaft (SFB/TR05 and SFB646 to A. S.), the National Institutes of Health (NIH) grants GM45751 (C. L. S.) and by the Cancer Center Support Grant NIH/National Cancer Institute P30CA13330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; BULLOCK PA, 1995, MOL CELL BIOL, V15, P173, DOI 10.1128/MCB.15.1.173; CADDLE MS, 1992, NUCLEIC ACIDS RES, V20, P5971, DOI 10.1093/nar/20.22.5971; Chau CM, 2004, J VIROL, V78, P12308, DOI 10.1128/JVI.78.22.12308-12319.2004; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Deutsch MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Dimitrova DS, 2002, J CELL SCI, V115, P51; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HAASE SB, 1991, NUCLEIC ACIDS RES, V19, P5053; HARRISON S, 1994, J VIROL, V68, P1913, DOI 10.1128/JVI.68.3.1913-1925.1994; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Julien MD, 2004, VIROLOGY, V326, P317, DOI 10.1016/j.virol.2004.05.026; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kirchmaier AL, 1998, J VIROL, V72, P4657, DOI 10.1128/JVI.72.6.4657-4666.1998; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; KRYSAN PJ, 1993, MOL CELL BIOL, V13, P2688, DOI 10.1128/MCB.13.5.2688; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mesner LD, 2003, MOL CELL BIOL, V23, P804, DOI 10.1128/MCB.23.3.804-814.2003; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Norio P, 2000, J VIROL, V74, P8563, DOI 10.1128/JVI.74.18.8563-8574.2000; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Schepers A, 2010, CHROMOSOME RES, V18, P63, DOI 10.1007/s10577-009-9087-1; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Sivaprasad Umasundari, 2006, V47, P63; STERNAS L, 1990, J VIROL, V64, P2407; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wang CY, 2008, P NATL ACAD SCI USA, V105, P9639, DOI 10.1073/pnas.0801378105; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e18609	10.1371/journal.pone.0018609	http://dx.doi.org/10.1371/journal.pone.0018609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603652	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300001
J	Catalano, RD; Wilson, MR; Boddy, SC; McKinlay, ATM; Sales, KJ; Jabbour, HN				Catalano, Rob D.; Wilson, Martin R.; Boddy, Sheila C.; McKinlay, Andrew T. M.; Sales, Kurt J.; Jabbour, Henry N.			Hypoxia and Prostaglandin E Receptor 4 Signalling Pathways Synergise to Promote Endometrial Adenocarcinoma Cell Proliferation and Tumour Growth	PLOS ONE			English	Article							AUTOCRINE/PARACRINE REGULATION; PROSTANOID RECEPTORS; CANCER-CELLS; EXPRESSION; EP4; CYCLOOXYGENASE-2; COX-2; E-2; ANGIOGENESIS; INVOLVEMENT	The prostaglandin endoperoxide synthase (PTGS) pathway is a potent driver of tumour development in humans by enhancing the biosynthesis and signalling of prostaglandin (PG) E-2. PTGS2 expression and PGE(2) biosynthesis is elevated in endometrial adenocarcinoma, however the mechanism whereby PTGS and PGE2 regulate endometrial tumour growth is unknown. Here we investigated (a) the expression profile of the PGE synthase enzymes (PTGES, PTGES-2, PTGES-3) and PGE receptors (PTGER1-4) in endometrial adenocarcinomas compared with normal endometrium and (b) the role of PTGER4 in endometrial tumorigenesis in vivo. We found elevated expression of PTGES2 and PTGER4 and suppression of PTGER1 and PTGER3 in endometrial adenocarcinomas compared with normal endometrium. Using WT Ishikawa endometrial adenocarcinoma cells and Ishikawa cells stably transfected with the full length PTGER4 cDNA (PTGER4 cells) xenografted in the dorsal flanks of nude mice, we show that PTGER4 rapidly and significantly enhances tumour growth rate. Coincident with enhanced PTGER4-mediated tumour growth we found elevated expression of PTGS2 in PTGER4 xenografts compared with WT xenografts. Furthermore we found that the augmented growth rate of the PTGER4 xenografts was not due to enhanced angiogenesis, but regulated by an increased proliferation index and hypoxia. In vitro, we found that PGE2 and hypoxia independently induce expression of PTGER4 indicating two independent pathways regulating prostanoid receptor expression. Finally we have shown that PGE2 and hypoxia synergise to promote cellular proliferation of endometrial adenocarcinoma cells.	[Catalano, Rob D.; Wilson, Martin R.; Boddy, Sheila C.; McKinlay, Andrew T. M.; Sales, Kurt J.; Jabbour, Henry N.] Univ Edinburgh, Med Res Council, Human Reprod Sci Unit, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Catalano, RD (corresponding author), Univ Edinburgh, Med Res Council, Human Reprod Sci Unit, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	h.jabbour@hrsu.mrc.ac.uk	McKinlay, Andrew T. M./B-3613-2010	McKinlay, Andrew T. M./0000-0002-5639-3267; Sales, Kurt/0000-0002-9880-5143	Medical Research Council [U.1276.00.004.00002.01]; MRC [MC_U127684438] Funding Source: UKRI; Medical Research Council [MC_U127684438] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Medical Research Council core funding (U.1276.00.004.00002.01) awarded to H.N.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera AB, 2010, CELL SIGNAL, V22, P71, DOI 10.1016/j.cellsig.2009.09.012; Catalano RD, 2011, MOL HUM REPROD, V17, P182, DOI 10.1093/molehr/gaq094; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Cherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004; Chiarugi V, 1998, INT J MOL MED, V2, P715; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; DuBois RN, 1996, CANCER RES, V56, P733; Fujino H, 2003, TRENDS PHARMACOL SCI, V24, P335, DOI 10.1016/S0165-6147(03)00162-7; Fukuda R, 2003, CANCER RES, V63, P2330; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; George RJ, 2007, PROSTAG OTH LIPID M, V83, P112, DOI 10.1016/j.prostaglandins.2006.10.005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirani N, 2001, MOL MED, V7, P685, DOI 10.1007/BF03401959; Horree N, 2008, J CLIN PATHOL, V61, P36, DOI 10.1136/jcp.2006.043794; Horree N, 2007, HUM PATHOL, V38, P1232, DOI 10.1016/j.humpath.2007.01.008; IMTIYAZ HZ, 2010, CURR TOP MICROBIOL I, V810, P105; Iniguez MA, 2003, TRENDS MOL MED, V9, P73, DOI 10.1016/S1471-4914(02)00011-4; Jabbour HN, 2001, BRIT J CANCER, V85, P1023; Jabbour HN, 2004, TRENDS ENDOCRIN MET, V15, P398, DOI 10.1016/j.tem.2004.08.006; Jain RK, 2003, J CLIN INVEST, V112, P1134, DOI 10.1172/JCI200320087; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Pijnenborg JMA, 2007, INT J GYNECOL CANCER, V17, P897, DOI 10.1111/j.1525-1438.2007.00893.x; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Robertson Fredika M, 2008, J Exp Ther Oncol, V7, P299; Sales KJ, 2002, CANCER RES, V62, P424; Sales KJ, 2004, J CLIN ENDOCR METAB, V89, P6112, DOI 10.1210/jc.2004-0892; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; St-Germain ME, 2004, INT J ONCOL, V24, P1311; Tong BJ, 2000, NEOPLASIA, V2, P483, DOI 10.1038/sj.neo.7900119; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Weinberg E, 2009, J CELL BIOCHEM, V108, P207, DOI 10.1002/jcb.22242; Zheng Y, 2009, CANCER RES, V69, P896, DOI 10.1158/0008-5472.CAN-08-2677	45	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19209	10.1371/journal.pone.0019209	http://dx.doi.org/10.1371/journal.pone.0019209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589857	Green Published, gold, Green Submitted			2022-12-25	WOS:000290531100006
J	Giffard, M; Ferte, N; Ragot, F; El Hajji, M; Castro, B; Bonnete, F				Giffard, Marion; Ferte, Natalie; Ragot, Francois; El Hajji, Mohamed; Castro, Bertrand; Bonnete, Francoise			Urate Oxidase Purification by Salting-in Crystallization: Towards an Alternative to Chromatography	PLOS ONE			English	Article							X-RAY-SCATTERING; RELATIVE EFFECTIVENESS; PROTEIN SOLUTIONS; SOLUBILITY; LYSOZYME; AMYLASE; UREASE; GROWTH; PH	Background: Rasburicase (Fasturtec (R) or Elitek (R), Sanofi-Aventis), the recombinant form of urate oxidase from Aspergillus flavus, is a therapeutic enzyme used to prevent or decrease the high levels of uric acid in blood that can occur as a result of chemotherapy. It is produced by Sanofi-Aventis and currently purified via several standard steps of chromatography. This work explores the feasibility of replacing one or more chromatography steps in the downstream process by a crystallization step. It compares the efficacy of two crystallization techniques that have proven successful on pure urate oxidase, testing them on impure urate oxidase solutions. Methodology/Principal Findings: Here we investigate the possibility of purifying urate oxidase directly by crystallization from the fermentation broth. Based on attractive interaction potentials which are known to drive urate oxidase crystallization, two crystallization routes are compared: a) by increased polymer concentration, which induces a depletion attraction and b) by decreased salt concentration, which induces attractive interactions via a salting-in effect. We observe that adding polymer, a very efficient way to crystallize pure urate oxidase through the depletion effect, is not an efficient way to grow crystals from impure solution. On the other hand, we show that dialysis, which decreases salt concentration through its strong salting-in effect, makes purification of urate oxidase from the fermentation broth possible. Conclusions: The aim of this study is to compare purification efficacy of two crystallization methods. Our findings show that crystallization of urate oxidase from the fermentation broth provides purity comparable to what can be achieved with one chromatography step. This suggests that, in the case of urate oxidase, crystallization could be implemented not only for polishing or concentration during the last steps of purification, but also as an initial capture step, with minimal changes to the current process.	[Giffard, Marion; Ferte, Natalie; Bonnete, Francoise] Aix Marseille Univ, CNRS, UPR3118, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France; [Ragot, Francois] Sanofi Aventis, Dept Biotechnol, Aramon, France; [El Hajji, Mohamed; Castro, Bertrand] Sanofi Aventis Res & Dev, Dept Analyt Sci, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Giffard, M (corresponding author), Aix Marseille Univ, CNRS, UPR3118, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France.	bonnete@cinam.univ-mrs.fr	Bonneté, Francoise/AAL-6725-2020; bonnete, francoise/Q-2143-2015	bonnete, francoise/0000-0002-1690-1757	Sanofi-Aventis (France) [006978]	Sanofi-Aventis (France)(Sanofi-Aventis)	Sanofi-Aventis (France) supported this work with contract no 006978 (2006-2009) for a PhD thesis. Francois Ragot, Mohamed El Hajji and Bertrand Castro are employees of Sanofi-Aventis, which supplied the protein for the study, organized regular meetings and reports during the three PhD thesis years, validated study design, data collection and analysis. They accepted the decision to publish and participated in the writing of the manuscript.	ALDERTON G, 1946, J BIOL CHEM, V146, P1; ALEMAN C, 1998, Patent No. 5811096; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARAKAWA T, 1985, METHOD ENZYMOL, V114, P49; Bayol A, 2002, BIOTECHNOL APPL BIOC, V36, P21, DOI 10.1042/BA20010083; Bonnete F, 2001, J CRYST GROWTH, V232, P330, DOI 10.1016/S0022-0248(01)01054-5; Bonnete F, 1999, J CRYST GROWTH, V196, P403, DOI 10.1016/S0022-0248(98)00826-4; Budayova M, 1999, J CRYST GROWTH, V196, P210, DOI 10.1016/S0022-0248(98)00844-6; Cammalleri Lisa, 2007, Int J Med Sci, V4, P83; CARBONNAUX C, 1995, PROTEIN SCI, V4, P2123, DOI 10.1002/pro.5560041018; Faber C, 2007, J CHEM ENG DATA, V52, P707, DOI 10.1021/je0603123; Finet S, 2004, CURR OPIN COLLOID IN, V9, P112, DOI 10.1016/j.cocis.2004.05.014; Finet S, 2003, METHOD ENZYMOL, V368, P105, DOI 10.1016/S0076-6879(03)68007-9; Fraisse L, 2002, ANAL BIOCHEM, V309, P173, DOI 10.1016/S0003-2697(02)00293-2; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Giffard M, 2008, CRYST GROWTH DES, V8, P4220, DOI 10.1021/cg800679v; Giffard M, 2009, CRYST GROWTH DES, V9, P4199, DOI 10.1021/cg900473n; Jacobsen C, 1998, BIOTECHNOL BIOENG, V57, P666, DOI 10.1002/(SICI)1097-0290(19980320)57:6<666::AID-BIT4>3.0.CO;2-J; JOHAL S, 1982, Patent No. [04334024, 4334024]; JUDGE RA, 1995, BIOTECHNOL BIOENG, V48, P316, DOI 10.1002/bit.260480404; Lawlis V. B., 1991, US Pat., Patent No. [5041377, 5,041,377]; Malfois M, 1996, J CHEM PHYS, V105, P3290, DOI 10.1063/1.471843; NIELSEN N, 1998, Patent No. 5837513; Retailleau P, 1997, BIOPHYS J, V73, P2156, DOI 10.1016/S0006-3495(97)78246-8; RIESKAUTT MM, 1989, J BIOL CHEM, V264, P745; Roberts B.M., 1997, U.S. Pat., Patent No. [US5597893 A, 5597893]; SCHMOLKA IR, 1977, J AM OIL CHEM SOC, V54, P110, DOI 10.1007/BF02894385; Sumner JB, 1926, J BIOL CHEM, V69, P435; Tardieu A, 1999, J CRYST GROWTH, V196, P193, DOI 10.1016/S0022-0248(98)00828-8; VISURI K, 1972, EUR J BIOCHEM, V28, P555, DOI 10.1111/j.1432-1033.1972.tb01944.x; VISURI K, 2006, Patent No. 7087719; Vivares D, 2006, CRYST GROWTH DES, V6, P287, DOI 10.1021/cg0500223; Vivares D, 2004, J PHYS CHEM B, V108, P6498, DOI 10.1021/jp037502u; Vivares D, 2002, EUR PHYS J E, V9, P15, DOI 10.1140/epje/i2002-10047-7; Vivares D, 2002, ACTA CRYSTALLOGR D, V58, P472, DOI 10.1107/S0907444902000124; Wagner O., 1973, US Patent, Patent No. 3773624; Walsh G., 2005, DIRECTORY THERAPEUTI; Weber M, 2008, CRYST GROWTH DES, V8, P711, DOI 10.1021/cg070070i; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	39	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19013	10.1371/journal.pone.0019013	http://dx.doi.org/10.1371/journal.pone.0019013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589929	gold, Green Published, Green Submitted			2022-12-25	WOS:000290483600005
J	Johnson, CJ; Bennett, JP; Biro, SM; Duque-Velasquez, JC; Rodriguez, CM; Bessen, RA; Rocke, TE				Johnson, Christopher J.; Bennett, James P.; Biro, Steven M.; Camilo Duque-Velasquez, Juan; Rodriguez, Cynthia M.; Bessen, Richard A.; Rocke, Tonie E.			Degradation of the Disease-Associated Prion Protein by a Serine Protease from Lichens	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; CHRONIC WASTING DISEASE; ANTIMICROBIAL ACTIVITY; SCRAPIE PRION; MULE DEER; IN-VITRO; AGENT; PRPSC; SOIL; INACTIVATION	The disease-associated prion protein (PrPTSE), the probable etiological agent of the transmissible spongiform encephalopathies (TSEs), is resistant to degradation and can persist in the environment. Lichens, mutualistic symbioses containing fungi, algae, bacteria and occasionally cyanobacteria, are ubiquitous in the environment and have evolved unique biological activities allowing their survival in challenging ecological niches. We investigated PrPTSE inactivation by lichens and found acetone extracts of three lichen species (Parmelia sulcata, Cladonia rangiferina and Lobaria pulmonaria) have the ability to degrade prion protein (PrP) from TSE-infected hamsters, mice and deer. Immunoblots measuring PrP levels and protein misfolding cyclic amplification indicated at least two logs of reductions in PrPTSE. Degradative activity was not found in closely related lichen species or in algae or a cyanobacterium that inhabit lichens. Degradation was blocked by Pefabloc SC, a serine protease inhibitor, but not inhibitors of other proteases or enzymes. Additionally, we found that PrP levels in PrPTSE-enriched preps or infected brain homogenates are also reduced following exposure to freshly-collected P. sulcata or an aqueous extract of the lichen. Our findings indicate that these lichen extracts efficiently degrade PrPTSE and suggest that some lichens could have potential to inactivate TSE infectivity on the landscape or be a source for agents to degrade prions. Further work to clone and characterize the protease, assess its effect on TSE infectivity and determine which organism or organisms present in lichens produce or influence the protease activity is warranted.	[Johnson, Christopher J.; Bennett, James P.; Biro, Steven M.; Rodriguez, Cynthia M.; Rocke, Tonie E.] US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA; [Johnson, Christopher J.; Bessen, Richard A.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Bennett, James P.] Univ Wisconsin, Inst Environm Studies, Madison, WI 53706 USA; [Biro, Steven M.; Rodriguez, Cynthia M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Camilo Duque-Velasquez, Juan] Univ Antioquia, Fac Ciencias Agr, Grp Invest CENTAURO, Medellin, Antioquia, Colombia	United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidad de Antioquia	Johnson, CJ (corresponding author), US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA.	cjjohnson@usgs.gov	Johnson, Christopher/B-1436-2009	Johnson, Christopher/0000-0003-4539-2581; Rocke, Tonie/0000-0003-3933-1563	United States Geological Survey	United States Geological Survey(United States Geological Survey)	This work was funded by the United States Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi A, 2004, COMPOST SCI UTIL, V12, P185; AVALOS A, 1986, LICHEN PHYSL BIOCH, V1, P77; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Beckett RP, 2007, PHYSIOL PLANTARUM, V129, P588, DOI 10.1111/j.1399-3054.2006.00846.x; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Candan M, 2007, Z NATURFORSCH C, V62, P619; Chen J, 2000, CATENA, V39, P121, DOI 10.1016/S0341-8162(99)00085-5; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cook WE, 2007, J WILDLIFE DIS, V43, P498, DOI 10.7589/0090-3558-43.3.498; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DAWSON HJ, 1984, SOIL SCI, V138, P40, DOI 10.1097/00010694-198407000-00007; Dickinson J, 2009, J HOSP INFECT, V72, P65, DOI 10.1016/j.jhin.2008.12.007; EASTON RM, 1994, GEOSCI CAN, V21, P59; FAHSELT D, 1994, SYMBIOSIS, V17, P127; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hinckley GT, 2008, ENVIRON SCI TECHNOL, V42, P5254, DOI 10.1021/es703186e; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hui Z, 2004, BIOCHEM BIOPH RES CO, V321, P45, DOI 10.1016/j.bbrc.2004.06.100; Huneck S, 1996, IDENTIFICATION LICHE; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Kranner I, 2008, BRYOLOGIST, V111, P576, DOI 10.1639/0007-2745-111.4.576; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Laufer Z, 2009, BRYOLOGIST, V112, P418, DOI 10.1639/0007-2745-112.2.418; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Lorenzo M, 2005, CHEMOSPHERE, V60, P1124, DOI 10.1016/j.chemosphere.2004.12.051; Madamombe IT, 2003, PHARM BIOL, V41, P199, DOI 10.1076/phbi.41.3.199.15089; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Meade-White KD, 2009, EMERG INFECT DIS, V15, P207, DOI 10.3201/eid1502.081173; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; NEARY K, 1991, J VIROL, V65, P1031, DOI 10.1128/JVI.65.2.1031-1034.1991; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Palsson P. A., 1979, Slow transmissible diseases of the nervous system. Volume 1., P357; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pilon JL, 2009, J VIROL METHODS, V161, P168, DOI 10.1016/j.jviromet.2009.04.040; Purvis OW, 1996, LICHENOLOGIST, V28, P571; Purvis W., 2000, LICHENS; Radeka M, 2007, J EUR CERAM SOC, V27, P1763, DOI 10.1016/j.jeurceramsoc.2006.05.001; Rankovic B, 2007, BRIT J BIOMED SCI, V64, P143, DOI 10.1080/09674845.2007.11732776; Rankovic B, 2007, Mikrobiologiia, V76, P817; Rapp D, 2006, ENVIRON SCI TECHNOL, V40, P6324, DOI 10.1021/es060943h; Russo F, 2009, J GEN VIROL, V90, P275, DOI 10.1099/vir.0.003251-0; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; SHAPIRO IA, 1979, SOV J ECOL+, V10, P565; Tay T, 2004, Z NATURFORSCH C, V59, P384; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Thomas DN, 2005, TRENDS MICROBIOL, V13, P87, DOI 10.1016/j.tim.2004.11.002; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Weissman L, 2005, APPL ENVIRON MICROB, V71, P6508, DOI 10.1128/AEM.71.11.6508-6514.2005; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Yoshioka M, 2007, BIOSCI BIOTECH BIOCH, V71, P2565, DOI 10.1271/bbb.70257; Zavarzina A G, 2006, Mikrobiologiia, V75, P630	67	22	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19836	10.1371/journal.pone.0019836	http://dx.doi.org/10.1371/journal.pone.0019836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589935	gold, Green Submitted, Green Published			2022-12-25	WOS:000290483600032
J	Huang, ST; Yang, RC; Wu, HT; Wang, CN; Pang, JHS				Huang, Sheng-Teng; Yang, Rong-Chi; Wu, Hsiao-Ting; Wang, Chao-Nin; Pang, Jong-Hwei S.			Zinc-Chelation Contributes to the Anti-Angiogenic Effect of Ellagic Acid on Inhibiting MMP-2 Activity, Cell Migration and Tube Formation	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; ACTIVATION; RECK; METASTASIS; PROTEIN; GROWTH; ROLES	Background: Ellagic acid (EA), a dietary polyphenolic compound, has been demonstrated to exert anti-angiogenic effect but the detailed mechanism is not yet fully understood. The aim of this study was to investigate whether the zinc chelating activity of EA contributed to its anti-angiogenic effect. Methods and Principal Findings: The matrix metalloproteinases-2 (MMP-2) activity, a zinc-required reaction, was directly inhibited by EA as examined by gelatin zymography, which was reversed dose-dependently by adding zinc chloride. In addition, EA was demonstrated to inhibit the secretion of MMP-2 from human umbilical vein endothelial cells (HUVECs) as analyzed by Western blot method, which was also reversed by the addition of zinc chloride. Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), known to down-regulate the MMP-2 activity, was induced by EA at both the mRNA and protein levels which was correlated well with the inhibition of MMP-2 activity. Interestingly, zinc chloride could also abolish the increase of EA-induced RECK expression. The anti-angiogenic effect of EA was further confirmed to inhibit matrix-induced tube formation of endothelial cells. The migration of endothelial cells as analyzed by transwell filter assay was suppressed markedly by EA dose-dependently as well. Zinc chloride could reverse these two effects of EA also in a dose-dependent manner. Since magnesium chloride or calcium chloride could not reverse the inhibitory effect of EA, zinc was found to be involved in tube formation and migration of vascular endothelial cells. Conclusions/Significance: Together these results demonstrated that the zinc chelation of EA is involved in its anti-angiogenic effects by inhibiting MMP-2 activity, tube formation and cell migration of vascular endothelial cells. The role of zinc was confirmed to be important in the process of angiogenesis.	[Huang, Sheng-Teng; Wu, Hsiao-Ting] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Chinese Med, Kaohsiung, Taiwan; [Wang, Chao-Nin] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Pang, Jong-Hwei S.] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, ST (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Chinese Med, Kaohsiung, Taiwan.	jonghwei@mail.cgu.edu.tw		PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital [CMRPG880811, CMRPG371623]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Memorial Hospital with CMRPG880811 and CMRPG371623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2001, J NUTR, V131, P2837, DOI 10.1093/jn/131.11.2837; BOCK PE, 1981, BIOCHEMISTRY-US, V20, P7258, DOI 10.1021/bi00528a032; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Chakraborty S, 2004, J ENVIRON PATHOL TOX, V23, P215, DOI 10.1615/JEnvPathToxOncol.v23.i3.50; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Festa F, 2001, ANTICANCER RES, V21, P3903; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; FORKMAN J, 1992, SEMIN CANCER BIOL, V3, P65; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Hannum SM, 2004, CRIT REV FOOD SCI, V44, P1, DOI 10.1080/10408690490263756; Herrera MC, 2004, ANAL BIOANAL CHEM, V379, P1106, DOI 10.1007/s00216-004-2684-0; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803; Innocenti A, 2010, BIOORGAN MED CHEM, V18, P2159, DOI 10.1016/j.bmc.2010.01.076; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Itoh T, 1998, CANCER RES, V58, P1048; Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024; Lassen U, 2010, BRIT J CANCER, V103, P12, DOI 10.1038/sj.bjc.6605726; Liu LT, 2003, CANCER RES, V63, P3069; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Mertens-Talcott SU, 2003, J NUTR, V133, P2669, DOI 10.1093/jn/133.8.2669; Narayanan BA, 2002, LIFE SCI, V70, P1821, DOI 10.1016/S0024-3205(02)01481-9; Narayanan BA, 2001, ANTICANCER RES, V21, P359; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; Rumjahn SM, 2007, BRIT J CANCER, V97, P1372, DOI 10.1038/sj.bjc.6604019; Saleem A, 2002, J ETHNOPHARMACOL, V81, P327, DOI 10.1016/S0378-8741(02)00099-5; Seftor REB, 2001, CANCER RES, V61, P6322; Span PN, 2003, CANCER, V97, P2710, DOI 10.1002/cncr.11395; Talbot DC, 1996, EUR J CANCER, V32A, P2528; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128	37	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18986	10.1371/journal.pone.0018986	http://dx.doi.org/10.1371/journal.pone.0018986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573219	gold, Green Published, Green Submitted			2022-12-25	WOS:000290224800012
J	Cherkasova, E; Malinzak, E; Rao, S; Takahashi, Y; Senchenko, VN; Kudryavtseva, AV; Nickerson, ML; Merino, M; Hong, JA; Schrump, DS; Srinivasan, R; Linehan, WM; Tian, X; Lerman, MI; Childs, RW				Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Senchenko, V. N.; Kudryavtseva, A. V.; Nickerson, M. L.; Merino, M.; Hong, J. A.; Schrump, D. S.; Srinivasan, R.; Linehan, W. M.; Tian, X.; Lerman, M. I.; Childs, R. W.			Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer	ONCOGENE			English	Article						renal cell carcinoma; endogenous retrovirus; VHL; HIF; DNA methylation	RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTORS; HERV-K18 SUPERANTIGEN; BREAST-CANCER; MESSENGER-RNA; B-CELLS; GENE; METHYLATION; TRANSPLANTATION; PROTEIN	A human endogenous retrovirus type E (HERV-E) was recently found to be selectively expressed in most renal cell carcinomas (RCCs). Importantly, antigens derived from this provirus are immunogenic, stimulating cytotoxic T cells that kill RCC cells in vitro and in vivo. Here, we show HERV-E expression is restricted to the clear cell subtype of RCC (ccRCC) characterized by an inactivation of the von Hippel-Lindau (VHL) tumor-suppressor gene with subsequent stabilization of hypoxia-inducible transcription factors (HIFs)-1 alpha and -2 alpha. HERV-E expression in ccRCC linearly correlated with HIF-2 alpha levels and could be silenced in tumor cells by either transfection of normal VHL or small interfering RNA inhibition of HIF-2 alpha. Using chromatin immunoprecipitation, we demonstrated that HIF-2 alpha can serve as transcriptional factor for HERV-E by binding with HIF response element (HRE) localized in the proviral 5' long terminal repeat (LTR). Remarkably, the LTR was found to be hypomethylated only in HERV-E-expressing ccRCC while other tumors and normal tissues possessed a hypermethylated LTR preventing proviral expression. Taken altogether, these findings provide the first evidence that inactivation of a tumor suppressor gene can result in aberrant proviral expression in a human tumor and give insights needed for translational research aimed at boosting human immunity against antigenic components of this HERV-E. Oncogene (2011) 30, 4697-4706; doi:10.1038/onc.2011.179; published online 23 May 2011	[Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Lerman, M. I.; Childs, R. W.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Senchenko, V. N.; Kudryavtseva, A. V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Nickerson, M. L.] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Merino, M.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Hong, J. A.; Schrump, D. S.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Srinivasan, R.; Linehan, W. M.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Tian, X.] NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Childs, RW (corresponding author), NHLBI, Hematol Branch, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	childsr@mail.nih.gov	Senchenko, Vera N/C-8992-2014; Takahashi, Yoshiyuki/I-1929-2012; Kudryavtseva, Anna V/C-9032-2014	Senchenko, Vera N/0000-0002-3119-515X; Kudryavtseva, Anna V/0000-0002-3722-8207; Cherkasova, Elena/0000-0002-7269-6516	NIH, National Heart, Lung, and Blood Institute, Hematology Branch; ACKC (Action to Cure Kidney Cancer); Dean R O'Neill Memorial Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011028, ZIABC011038, ZIDBC011092, ZIABC011043, ZIDBC011089, ZIABC010696, ZIABC011405] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345] Funding Source: NIH RePORTER	NIH, National Heart, Lung, and Blood Institute, Hematology Branch; ACKC (Action to Cure Kidney Cancer); Dean R O'Neill Memorial Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the intramural research program of NIH, National Heart, Lung, and Blood Institute, Hematology Branch. We wish to acknowledge ACKC (Action to Cure Kidney Cancer) for their support of the ACKC fellow who conducted this research and the Dean R O'Neill Memorial Fellowship for generous contributions supporting this research. We also thank Bill and Giuliana Rancic for their contributions supporting kidney cancer research. We thank Robert Worrell for his assistance in providing tissue samples.	Bregni M, 2002, BLOOD, V99, P4234, DOI 10.1182/blood.V99.11.4234; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Ghosh AK, 2009, BLOOD, V113, P5568, DOI 10.1182/blood-2008-10-185686; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Hahn S, 2008, AIDS RES HUM RETROV, V24, P717, DOI 10.1089/aid.2007.0286; Hsiao FC, 2006, J IMMUNOL, V177, P2056, DOI 10.4049/jimmunol.177.4.2056; Hsiao FC, 2009, VIROLOGY, V385, P261, DOI 10.1016/j.virol.2008.11.025; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kim CM, 2006, J UROLOGY, V175, P1908, DOI 10.1016/S0022-5347(05)00890-6; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Rao S, 2008, P 99 ANN M AM ASS CA; Rini BI, 2002, J CLIN ONCOL, V20, P2017, DOI 10.1200/JCO.2002.08.068; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Sandlund J, 2009, ACTA ONCOL, V48, P909, DOI 10.1080/02841860902824891; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Turner KJ, 2002, CANCER RES, V62, P2957; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Wright TM, 2010, J BIOL CHEM, V285, P12916, DOI 10.1074/jbc.M109.073924	30	41	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	47					4697	4706		10.1038/onc.2011.179	http://dx.doi.org/10.1038/onc.2011.179			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21602888	Green Accepted			2022-12-25	WOS:000298033700002
J	Chen, JC; Chuang, JG; Su, YY; Chiang, BL; Lin, YS; Chow, LP				Chen, Jui-Chieh; Chuang, Jiing-Guang; Su, Yu-Yi; Chiang, Bor-Luen; Lin, You-Shuei; Chow, Lu-Ping			The Protease Allergen Pen c 13 Induces Allergic Airway Inflammation and Changes in Epithelial Barrier Integrity and Function in a Murine Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITE ALLERGEN; SERINE-PROTEASE; BRONCHIAL HYPERRESPONSIVENESS; PROTEOLYTIC ACTIVITY; ASTHMA INSIGHTS; MOLECULAR-BASIS; TIGHT JUNCTION; ALPHA-CATENIN; LUNG INJURY; EXPRESSION	Fungal allergens are associated with the development of asthma, and some have been characterized as proteases. Here, we established an animal model of allergic airway inflammation in response to continuous exposure to proteolytically active Pen c 13, a major allergen secreted by Penicillium citrinum. In functional analyses, Pen c 13 exposure led to increased airway hyperresponsiveness, significant inflammatory cell infiltration, mucus overproduction, and collagen deposition in the lung, dramatically elevated serum levels of total IgE and Pen c 13-specific IgE and IgG1, and increased production of the Th2 cytokines IL-4, IL-5, and IL-13 by splenocytes stimulated in vitro with Pen c 13. To examine the mechanisms involved in the regulation of allergenicity by Pen c 13, we performed two-dimensional fluorescence difference gel electrophoresis analysis combined with nano-LC-MS/MS, followed by bioinformatics analysis to identify potential targets that associated with allergic inflammation, which suggested that galectin-3 and laminin might be involved in novel pathogenic mechanisms. Finally, we focused on junctional proteins between cells, because, in addition to opening of the epithelial barrier by environmental proteases possibly being the initial step in the development of asthma, these proteins are also associated with actin rearrangement. Taken together, our findings indicate that Pen c 13 exposure causes junctional structure alterations and actin cytoskeletal rearrangements, resulting in increased permeability and airway structural changes. These effects probably change the lung microenvironment and foster the development of allergic sensitization.	[Chen, Jui-Chieh; Chuang, Jiing-Guang; Su, Yu-Yi; Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; [Lin, You-Shuei] Taipei Med Univ, Dept Physiol, Taipei 110, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chow, LP (corresponding author), 1,Sec 1,Jen Ai Rd, Taipei 100, Taiwan.	chowip@ntu.edu.tw	é, çå/HCH-5712-2022	CHIANG, BOR-LUEN/0000-0002-6705-0286; Lin, You Shuei/0000-0003-1364-0245; Chen, Jui-Chieh/0000-0002-8854-9801; CHOW, LU-PING/0000-0002-4420-211X	Ministry of Education; Republic of China National Science Council [99-2320-B-002-012]	Ministry of Education; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by the Program for Excellence Research Teams from the Ministry of Education and Republic of China National Science Council Grant NSC 99-2320-B-002-012.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Bisht V, 2004, FEMS IMMUNOL MED MIC, V42, P205, DOI 10.1016/j.femsim.2004.05.003; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chen CL, 2003, J IMMUNOL, V170, P528, DOI 10.4049/jimmunol.170.1.528; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Fattouh R, 2005, AM J RESP CRIT CARE, V172, P314, DOI 10.1164/rccm.200502-198OC; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Folli C, 2008, CURR OPIN ALLERGY CL, V8, P367, DOI 10.1097/ACI.0b013e32830a7086; Furmonaviciene R, 2005, BIOINFORMATICS, V21, P4201, DOI 10.1093/bioinformatics/bti700; Furmonaviciene R, 2001, J CLIN PATHOL-MOL PA, V54, P155, DOI 10.1136/mp.54.3.155; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P728, DOI 10.1046/j.1365-2222.2002.01374.x; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hashimoto S, 2008, AM J PHYSIOL-LUNG C, V295, pL566, DOI 10.1152/ajplung.90250.2008; Inoue K, 2009, INT IMMUNOPHARMACOL, V9, P1281, DOI 10.1016/j.intimp.2009.07.010; Jensen LB, 2008, J IMMUNOL METHODS, V335, P116, DOI 10.1016/j.jim.2008.02.012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kurup VP, 2002, INT ARCH ALLERGY IMM, V129, P129, DOI 10.1159/000065882; Lai CH, 2005, BRAIN RES REV, V50, P7, DOI 10.1016/j.brainresrev.2005.03.007; Lai CKW, 2003, J ALLERGY CLIN IMMUN, V111, P263, DOI 10.1067/mai.2003.30; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Matsuwaki Y, 2009, J IMMUNOL, V183, P6708, DOI 10.4049/jimmunol.0901220; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rudiger M, 1998, BIOESSAYS, V20, P733; Ryan TP, 1997, FREE RADICAL BIO MED, V22, P901, DOI 10.1016/S0891-5849(96)00483-2; Saegusa J, 2009, AM J PATHOL, V174, P922, DOI 10.2353/ajpath.2009.080500; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Shen HD, 2007, CURR ALLERGY ASTHM R, V7, P351, DOI 10.1007/s11882-007-0053-8; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Smith PK, 2006, ALLERGY, V61, P1441, DOI 10.1111/j.1398-9995.2006.01233.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Su NY, 1999, EUR J BIOCHEM, V261, P115, DOI 10.1046/j.1432-1327.1999.00242.x; Sudha VT, 2008, ALLERGY, V63, P768, DOI 10.1111/j.1398-9995.2007.01602.x; Sudha VT, 2009, EUR J CLIN INVEST, V39, P507, DOI 10.1111/j.1365-2362.2009.02112.x; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Tai HY, 2006, ALLERGY, V61, P382, DOI 10.1111/j.1398-9995.2005.00958.x; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; YOUNG CL, 1994, J BIOL CHEM, V269, P13997; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Yu CK, 1999, J ALLERGY CLIN IMMUN, V104, P228, DOI 10.1016/S0091-6749(99)70140-5; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	75	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26667	26679		10.1074/jbc.M110.193987	http://dx.doi.org/10.1074/jbc.M110.193987			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613216	Green Published, hybrid			2022-12-25	WOS:000293078200044
J	Doherty, JT; Lenhart, KC; Cameron, MV; Mack, CP; Conlon, FL; Taylor, JM				Doherty, Jason T.; Lenhart, Kaitlin C.; Cameron, Morgan V.; Mack, Christopher P.; Conlon, Frank L.; Taylor, Joan M.			Skeletal Muscle Differentiation and Fusion Are Regulated by the BAR-containing Rho-GTPase-activating Protein (Rho-GAP), GRAF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MYOBLAST FUSION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; MUSCULAR-DYSTROPHY; ACTIN CYTOSKELETON; DNA-BINDING; XENOPUS; CELLS; DOMAIN	Although RhoA activity is necessary for promoting myogenic mesenchymal stem cell fates, recent studies in cultured cells suggest that down-regulation of RhoA activity in specified myoblasts is required for subsequent differentiation and myotube formation. However, whether this phenomenon occurs in vivo and which Rho modifiers control these later events remain unclear. We found that expression of the Rho-GTPase-activating protein, GRAF1, was transiently up-regulated during myogenesis, and studies in C2C12 cells revealed that GRAF1 is necessary and sufficient for mediating RhoA down-regulation and inducing muscle differentiation. Moreover, forced expression of GRAF1 in pre-differentiated myoblasts drives robust muscle fusion by a process that requires GTPase-activating protein-dependent actin remodeling and BAR-dependent membrane binding or sculpting. Moreover, morpholino-based knockdown studies in Xenopus laevis determined that GRAF1 expression is critical for muscle development. GRAF1-depleted embryos exhibited elevated RhoA activity and defective myofibrillogenesis that resulted in progressive muscle degeneration, defective motility, and embryonic lethality. Our results are the first to identify a GTPase-activating protein that regulates muscle maturation and to highlight the functional importance of BAR domains in myotube formation.	[Taylor, Joan M.] Univ N Carolina, CB7525, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Conlon, Frank L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Mack, Christopher P.; Conlon, Frank L.; Taylor, Joan M.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Taylor, JM (corresponding author), Univ N Carolina, CB7525, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	jmt3x@med.unc.edu		Taylor, Joan/0000-0002-8794-5167	National Institutes of Health from NHLBI [HL-081844, HL-071054, HL-070953, HL-089641]; NIDCR [DE-018825]; American Heart Association [0355776U, 0555476U]; National Institutes of Health [T32HL69768, T32 HD046369-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070953, R01HL081844, R01HL071054, R01HL089641, R01HL102446, T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-081844 and HL-071054 (to J. M. T.), HL-070953 (to C. P. M.), and HL-089641 (to F. L. C.) from NHLBI and by Grant DE-018825 (to F. L. C.) from NIDCR. This work was also supported by American Heart Association Grants 0355776U (to J. M. T.) and 0555476U (to C. P. M.).; Trainee in the Integrative Vascular Biology Program supported by National Institutes of Health Grant T32HL69768.; Trainee in the Developmental Biology Program supported by National Institutes of Health Grant T32 HD046369-05.	Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1985, ADV EXP MED BIOL, V182, P231; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Chanturiya A, 2002, BIOPHYS J, V82, P3072, DOI 10.1016/S0006-3495(02)75648-8; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chong SW, 2005, TRENDS CELL BIOL, V15, P453, DOI 10.1016/j.tcb.2005.07.008; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Goetz SC, 2006, DEVELOPMENT, V133, P2575, DOI 10.1242/dev.02420; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henry CA, 2001, DEV BIOL, V240, P474, DOI 10.1006/dbio.2001.0467; Hidalgo M, 2009, DEV DYNAM, V238, P1332, DOI 10.1002/dvdy.21814; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jacoby AS, 2009, DEVELOPMENT, V136, P3367, DOI 10.1242/dev.034561; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Keller R, 2000, CURR TOP DEV BIOL, V47, P183; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kragtorp KA, 2007, DEV DYNAM, V236, P2713, DOI 10.1002/dvdy.21280; Liu KJ, 2003, DEV BIOL, V264, P339, DOI 10.1016/j.ydbio.2003.08.017; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Marrink SJ, 2003, J AM CHEM SOC, V125, P11144, DOI 10.1021/ja036138+; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Peckham M, 2008, J MICROSC-OXFORD, V231, P486, DOI 10.1111/j.1365-2818.2008.02061.x; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Swailes NT, 2004, J ANAT, V205, P381, DOI 10.1111/j.0021-8782.2004.00341.x; Taylor JM, 1999, J CELL SCI, V112, P231; Taylor JM, 1998, J BIOL CHEM, V273, P8063, DOI 10.1074/jbc.273.14.8063; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; WILSON L, 1995, J CELL SCI, V108, P2381; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06	55	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25903	25921		10.1074/jbc.M111.243030	http://dx.doi.org/10.1074/jbc.M111.243030			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622574	Green Published, hybrid			2022-12-25	WOS:000293073000051
J	Albaugh, BN; Arnold, KM; Lee, S; Denu, JM				Albaugh, Brittany N.; Arnold, Kevin M.; Lee, Susan; Denu, John M.			Autoacetylation of the Histone Acetyltransferase Rtt109	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; COVALENT MODIFICATIONS; H3K56 ACETYLATION; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; LYSINE-56 ACETYLATION; CHAPERONE COMPLEX; GENOME INTEGRITY; H3	Rtt109 is a yeast histone acetyltransferase (HAT) that associates with histone chaperones Asf1 and Vps75 to acetylate H3K56, H3K9, and H3K27 and is important in DNA replication and maintaining genomic integrity. Recently, mass spectrometry and structural studies of Rtt109 have shown that active site residue Lys-290 is acetylated. However, the functional role of this modification and how the acetyl group is added to Lys-290 was unclear. Here, we examined the mechanism of Lys-290 acetylation and found that Rtt109 catalyzes intramolecular autoacetylation of Lys-290 similar to 200-times slower than H3 acetylation. Deacetylated Rtt109 was prepared by reacting with a sirtuin protein deacetylase, producing an enzyme with negligible HAT activity. Autoacetylation of Rtt109 restored full HAT activity, indicating that autoacetylation is necessary for HAT activity and is a fully reversible process. To dissect the mechanism of activation, biochemical, and kinetic analyses were performed with Lys-290 variants of the Rtt109-Vps75 complex. We found that autoacetylation of Lys-290 increases the binding affinity for acetyl-CoA and enhances the rate of acetyl-transfer onto histone substrates. This study represents the first detailed investigation of a HAT enzyme regulated by single-site intramolecular autoacetylation.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Albaugh, Brittany N.; Arnold, Kevin M.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), 2140 Wisconsin Inst Discovery, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu			National Institutes of Health [GM059785]; Wisconsin Partnership Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059785 (to J. M. D.).; We thank all members in the research group of Dr. John Denu for helpful discussions, especially Dr. Erin Kolonko. We also thank Dr. Julie Mitchell (University of Wisconsin-Madison) for performing molecular simulations with the available Rtt109 structures, which has been useful in thinking about this study. We also appreciate the generosity of Dr. Deane Mosher (University of Wisconsin-Madison), who allowed us to use the Flouromax-3 instrument. We would also like to thank Dr. Paul Kaufman and Jessica Lopes da Rosa (University of Massachusetts Medical School). We acknowledge the University of Wisconsin-Madison Human Proteomics Program, funded by the Wisconsin Partnership Fund.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Antczak AJ, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-26; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Scholes DT, 2001, GENETICS, V159, P1449; Smith CM, 2005, METHODS, V36, P395, DOI 10.1016/j.ymeth.2005.03.007; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Sundin BA, 2004, YEAST, V21, P793, DOI 10.1002/yea.1133; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200	58	51	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24694	24701		10.1074/jbc.M111.251579	http://dx.doi.org/10.1074/jbc.M111.251579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606491	hybrid, Green Published			2022-12-25	WOS:000292547900020
J	Joe, Y; Kim, HJ; Kim, S; Chung, J; Ko, MS; Lee, WH; Chang, KC; Park, JW; Chung, HT				Joe, Yeonsoo; Kim, Hyo Jeong; Kim, Sena; Chung, Jiwha; Ko, Myoung Seok; Lee, Won Hyeok; Chang, Ki Churl; Park, Jeong Woo; Chung, Hun Taeg			Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; ACETYLCHOLINE-RECEPTOR ALPHA-7; MESSENGER-RNA DECAY; PROTEIN-KINASE P38; HYPER-IGE SYNDROME; GENE-EXPRESSION; VAGUS NERVE; POSTTRANSCRIPTIONAL REGULATION; INFLAMMATORY RESPONSE	Nicotine inhibits the release of TNF-alpha from macrophage through activation of STAT3. Tristetraprolin (TTP) is known to destabilize pro-inflammatory transcripts containing AU-rich elements (ARE) in 3'-untranslated region (3'-UTR). Here we show that in LPS-stimulated human macrophages the anti-inflammatory action of nicotine is mediated by TTP. Nicotine induced activation of STAT3 enhanced STAT3 binding to the TTP promoter, increased TTP promoter activity, and increased TTP expression resulting in the suppression of LPS-stimulated TNF-alpha production. Overexpression of a dominant negative mutant of STAT3 (R382W) or down-regulation of STAT3 by siRNA abolished nicotine-induced TTP expression and suppression of LPS-stimulated TNF-alpha production. Nicotine enhanced the decay of TNF-alpha mRNA and decreased luciferase expression of a TNF-alpha 3'-UTR reporter plasmid in U937 cells. However, siRNA to TTP abrogated these effects of nicotine. In this experiment, we are reporting for the first time the involvement of TTP in the cholinergic anti-inflammatory cascade consisting of nicotine-STAT3-TTP-dampening inflammation.	[Joe, Yeonsoo; Kim, Hyo Jeong; Kim, Sena; Chung, Jiwha; Ko, Myoung Seok; Lee, Won Hyeok; Park, Jeong Woo; Chung, Hun Taeg] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Chang, Ki Churl] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju 660751, South Korea; [Chang, Ki Churl] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju 660751, South Korea	University of Ulsan; Gyeongsang National University; Gyeongsang National University	Park, JW (corresponding author), Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr; chung@ulsan.ac.kr		Kim, Sena/0000-0002-6930-2416	Korean government (MOEHRD) [BRL-2009-0087350]	Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Research Foundation funded by the Korean government (MOEHRD) (BRL-2009-0087350).	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; HARANAKA K, 1986, P NATL ACAD SCI USA, V83, P3949, DOI 10.1073/pnas.83.11.3949; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sugano N, 1998, BIOCHEM BIOPH RES CO, V252, P25, DOI 10.1006/bbrc.1998.9599; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588	41	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24735	24742		10.1074/jbc.M110.204859	http://dx.doi.org/10.1074/jbc.M110.204859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606497	hybrid, Green Published			2022-12-25	WOS:000292547900024
J	Guo, F; Carter, DE; Leask, A				Guo, Fen; Carter, David E.; Leask, Andrew			Mechanical Tension Increases CCN2/CTGF Expression and Proliferation in Gingival Fibroblasts via a TGF beta-Dependent Mechanism	PLOS ONE			English	Article							ORTHODONTIC TOOTH MOVEMENT; TISSUE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; TYROSINE KINASE; TGF-BETA-1; FIBROSIS; COLLAGEN; FAMILY; MYOFIBROBLAST; ENDOTHELIN-1	Unlike skin, oral gingival do not scar in response to tissue injury. Fibroblasts, the cell type responsible for connective tissue repair and scarring, are exposed to mechanical tension during normal and pathological conditions including wound healing and fibrogenesis. Understanding how human gingival fibroblasts respond to mechanical tension is likely to yield valuable insights not only into gingival function but also into the molecular basis of scarless repair. CCN2/connective tissue growth factor is potently induced in fibroblasts during tissue repair and fibrogenesis. We subjected gingival fibroblasts to cyclical strain (up to 72 hours) using the Flexercell system and showed that CCN2 mRNA and protein was induced by strain. Strain caused the rapid activation of latent TGF beta, in a fashion that was reduced by blebbistatin and FAK/src inhibition, and the induction of endothelin (ET-1) mRNA and protein expression. Strain did not cause induction of alpha-smooth muscle actin or collagen type I mRNAs (proteins promoting scarring); but induced a cohort of pro-proliferative mRNAs and cell proliferation. Compared to dermal fibroblasts, gingival fibroblasts showed reduced ability to respond to TGF beta by inducing fibrogenic mRNAs; addition of ET-1 rescued this phenotype. Pharmacological inhibition of the TGF beta type I (ALK5) receptor, the endothelin A/B receptors and FAK/src significantly reduced the induction of CCN2 and pro-proliferative mRNAs and cell proliferation. Controlling TGF beta, ET-1 and FAK/src activity may be useful in controlling responses to mechanical strain in the gingiva and may be of value in controlling fibroproliferative conditions such as gingival hyperplasia; controlling ET-1 may be of benefit in controlling scarring in response to injury in the skin.	[Guo, Fen; Leask, Andrew] Univ Western Ontario, Dept Dent, London, ON, Canada; [Carter, David E.] Robarts Res Inst, London Reg Genom Ctr Microarray Facil, London, ON N6A 5C1, Canada; [Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Guo, F (corresponding author), Univ Western Ontario, Dept Dent, London, ON, Canada.	andrew.leask@schulich.uwo.ca	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institute of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, J BIOL CHEM, V278, P47707, DOI 10.1074/jbc.M306228200; Abraham David J, 2007, Curr Rheumatol Rep, V9, P136, DOI 10.1007/s11926-007-0008-z; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dang C, 2003, CLIN PLAST SURG, V30, P13, DOI 10.1016/S0094-1298(02)00067-6; DOHERTY AM, 1991, J CARDIOVASC PHARM, V17, pS59, DOI 10.1097/00005344-199100177-00016; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Henneman S, 2008, EUR J ORTHODONT, V30, P299, DOI 10.1093/ejo/cjn020; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Hong HH, 1999, LAB INVEST, V79, P1655; Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Ohuchi N, 2010, FUND CLIN PHARMACOL, V24, P501, DOI 10.1111/j.1472-8206.2009.00786.x; Pang CY, 2003, J BIOL CHEM, V278, P47707; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Schor S L, 1996, Oral Dis, V2, P155; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008	38	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19756	10.1371/journal.pone.0019756	http://dx.doi.org/10.1371/journal.pone.0019756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611193	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500018
J	Alborzinia, H; Can, S; Holenya, P; Scholl, C; Lederer, E; Kitanovic, I; Wolfl, S				Alborzinia, Hamed; Can, Suzan; Holenya, Pavlo; Scholl, Catharina; Lederer, Elke; Kitanovic, Igor; Woelfl, Stefan			Real-Time Monitoring of Cisplatin-Induced Cell Death	PLOS ONE			English	Article							INDUCED APOPTOSIS; ERK ACTIVATION; DNA; INHIBITION; PLATINUM; P53; COMPLEXES; CANCER; ARRAYS; LISTS	Since the discovery of cisplatin more than 40 years ago and its clinical introduction in the 1970s an enormous amount of research has gone into elucidating the mechanism of action of cisplatin on tumor cells. With a novel cell biosensor chip system allowing continuous monitoring of respiration, glycolysis, and impedance we followed cisplatin treatment of different cancer cell lines in real-time. Our measurements reveal a first effect on respiration, in all cisplatin treated cell lines, followed with a significant delay by interference with glycolysis in HT-29, HCT-116, HepG2, and MCF-7 cells but not in the cisplatin-resistant cell line MDA-MB-231. Most strikingly, cell death started in all cisplatin-sensitive cell lines within 8 to 11 h of treatment, indicating a clear time frame from exposure, first response to cisplatin lesions, to cell fate decision. The time points of most significant changes were selected for more detailed analysis of cisplatin response in the breast cancer cell line MCF-7. Phosphorylation of selected signal transduction mediators connected with cellular proliferation, as well as changes in gene expression, were analyzed in samples obtained directly from sensor chips at the time points when changes in glycolysis and impedance occurred. Our online cell biosensor measurements reveal for the first time the time scale of metabolic response until onset of cell death under cisplatin treatment, which is in good agreement with models of p53-mediated cell fate decision.	[Alborzinia, Hamed; Can, Suzan; Holenya, Pavlo; Scholl, Catharina; Lederer, Elke; Kitanovic, Igor; Woelfl, Stefan] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Alborzinia, H (corresponding author), Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wolfl@uni-hd.de		Alborzinia, Hamed/0000-0001-6903-3001	German Research foundation [DFG-FOR630]; BMBF [01EA0509]	German Research foundation(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research foundation collaborative research project DFG-FOR630 (SW). The BIONAS2500 bisosensorchip system was financed by BMBF research grant 01EA0509 (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Ehret R, 2001, FRESEN J ANAL CHEM, V369, P30, DOI 10.1007/s002160000628; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Harlos M, 2008, J MED CHEM, V51, P3924, DOI 10.1021/jm800173s; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Holenya P, 2011, PROTEOMICS, V11, P2129, DOI 10.1002/pmic.201000690; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Kim HS, 2008, J BIOL CHEM, V283, P3731, DOI 10.1074/jbc.M704432200; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kroll TC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e50; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Panka DJ, 2008, J BIOL CHEM, V283, P726, DOI 10.1074/jbc.M705343200; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rubbiani R, 2010, J MED CHEM, V53, P8608, DOI 10.1021/jm100801e; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; WILTSHAW E, 1976, CANCER TREAT REP, V60, P55; Wolfl S, 2005, PROTEIN MICROARRAYS, P159; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200	27	75	77	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19714	10.1371/journal.pone.0019714	http://dx.doi.org/10.1371/journal.pone.0019714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603599	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300019
J	Sharma, NS; Nagrath, D; Yarmush, ML				Sharma, Nripen S.; Nagrath, Deepak; Yarmush, Martin L.			Metabolic Profiling Based Quantitative Evaluation of Hepatocellular Metabolism in Presence of Adipocyte Derived Extracellular Matrix	PLOS ONE			English	Article							CULTURED RAT HEPATOCYTES; CELL-CELL INTERACTIONS; AMINO-ACIDS; SANDWICH CONFIGURATION; BASEMENT-MEMBRANE; PROTEIN-SYNTHESIS; COLLAGEN GEL; IN-VITRO; MEDIATED ENHANCEMENT; BIOLOGICAL-ACTIVITY	The elucidation of the effect of extracellular matrices on hepatocellular metabolism is critical to understand the mechanism of functional upregulation. We have developed a system using natural extracellular matrices [Adipogel] for enhanced albumin synthesis of rat hepatocyte cultures for a period of 10 days as compared to collagen sandwich cultures. Primary rat hepatocytes isolated from livers of female Lewis rats recover within 4 days of culture from isolation induced injury while function is stabilized at 7 days post-isolation. Thus, the culture period can be classified into three distinct stages viz. recovery stage [day 0-4], pre-stable stage [day 5-7] and the stable stage [day 8-10]. A Metabolic Flux Analysis of primary rat hepatocytes cultured in Adipogel was performed to identify the key metabolic pathways modulated as compared to collagen sandwich cultures. In the recovery stage [day 4], the collagen-soluble Adipogel cultures shows an increase in TriCarboxylic Acid [TCA] cycle fluxes; in the pre-stable stage [day 7], there is an increase in PPP and TCA cycle fluxes while in the stable stage [day 10], there is a significant increase in TCA cycle, urea cycle fluxes and amino acid uptake rates concomitant with increased albumin synthesis rate as compared to collagen sandwich cultures throughout the culture period. Metabolic analysis of the collagen-soluble Adipogel condition reveals significantly higher transamination reaction fluxes, amino acid uptake and albumin synthesis rates for the stable vs. recovery stages of culture. The identification of metabolic pathways modulated for hepatocyte cultures in presence of Adipogel will be a useful step to develop an optimization algorithm to further improve hepatocyte function for Bioartificial Liver Devices. The development of this framework for upregulating hepatocyte function in Bioartificial Liver Devices will facilitate the utilization of an integrated experimental and computational approach for broader applications of Adipogel in tissue e engineering and regenerative medicine.	[Sharma, Nripen S.; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med Surg Serv, Boston, MA 02115 USA; [Sharma, Nripen S.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA USA; [Nagrath, Deepak] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Rice University	Sharma, NS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med Surg Serv, Boston, MA 02115 USA.	ireis@sbi.org		Yarmush, Martin/0000-0003-4986-8444; Nagrath, Deepak/0000-0002-8999-2282	NIH [R01 DK059766, R01 AI063795]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 DK059766 and R01 AI063795, and grants from the Shriners Hospitals for Children. Resources were provided by the BioMEMS Resource Center (P41 EB-002503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Banta S, 2005, J SURG RES, V127, P93, DOI 10.1016/j.jss.2005.01.001; Berthiaume F, 2003, METAB ENG, V5, P108, DOI 10.1016/S1096-7176(03)00010-7; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chan C, 2003, BIOTECHNOL PROGR, V19, P580, DOI 10.1021/bp025660h; Chan C, 2002, BIOTECHNOL BIOENG, V78, P753, DOI 10.1002/bit.10275; Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013; Cho CH, 2008, BIOTECHNOL BIOENG, V101, P345, DOI 10.1002/bit.21911; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; DUNN JCY, 1993, BIOTECHNOL BIOENG, V41, P593, DOI 10.1002/bit.260410512; EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505; Hoshiba T, 2007, BIOCHEM BIOPH RES CO, V359, P151, DOI 10.1016/j.bbrc.2007.05.079; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022; Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934; Jones CN, 2009, BIOMATERIALS, V30, P3733, DOI 10.1016/j.biomaterials.2009.03.039; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; Kang YH, 2004, EXP CELL RES, V293, P239, DOI 10.1016/j.yexcr.2003.10.011; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; LEE J, 1993, FASEB J, V7, P586, DOI 10.1096/fasebj.7.6.8472895; LEE JW, 1992, BIOTECHNOL BIOENG, V40, P298, DOI 10.1002/bit.260400214; Lee K, 2003, METAB ENG, V5, P221, DOI 10.1016/S1096-7176(03)00042-9; Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P77, DOI 10.1007/BF01606580; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5; MUSAT AI, 1993, HEPATOLOGY, V18, P198, DOI 10.1002/hep.1840180129; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Nagrath D, 2010, METAB ENG, V12, P429, DOI 10.1016/j.ymben.2010.05.003; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Novik EI, 2008, BIOTECHNOL PROGR, V24, P1132, DOI 10.1002/btpr.41; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; RINKES IHMB, 1992, CRYOBIOLOGY, V29, P443, DOI 10.1016/0011-2240(92)90047-6; ROTEM A, 1992, BIOTECHNOL BIOENG, V40, P1286, DOI 10.1002/bit.260401020; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; SEGLEN PO, 1978, BIOCHIM BIOPHYS ACTA, V520, P630, DOI 10.1016/0005-2787(78)90148-X; SEGLEN PO, 1978, EUR J BIOCHEM, V85, P15, DOI 10.1111/j.1432-1033.1978.tb12208.x; Sharma NS, 2006, BIOTECHNOL BIOENG, V94, P1053, DOI 10.1002/bit.20936; Sharma Nripen, 2008, Critical Reviews in Biomedical Engineering, V36, P413; Sharma NS, 2010, FASEB J, V24, P2364, DOI 10.1096/fj.09-135095; Sharma NS, 2009, TISSUE ENG PART C-ME, V15, P297, DOI 10.1089/ten.tec.2008.0303; Sharma NS, 2005, BIOTECHNOL BIOENG, V92, P321, DOI 10.1002/bit.20586; Tilles Arno W, 2002, J Hepatobiliary Pancreat Surg, V9, P686, DOI 10.1007/s005340200095; Van Poll D, 2006, TISSUE ENG, V12, P2965; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Washizu J, 2000, J SURG RES, V93, P237, DOI 10.1006/jsre.2000.5986; Washizu J, 2001, TISSUE ENG, V7, P691, DOI 10.1089/107632701753337654; Zeisberg M, 2006, MOL CELL BIOCHEM, V283, P181, DOI 10.1007/s11010-006-2677-8	62	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20137	10.1371/journal.pone.0020137	http://dx.doi.org/10.1371/journal.pone.0020137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603575	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300052
J	Eisenberg, ML; Hsieh, MH; Walters, RC; Krasnow, R; Lipshultz, LI				Eisenberg, Michael L.; Hsieh, Michael H.; Walters, Rustin Chanc; Krasnow, Ross; Lipshultz, Larry I.			The Relationship between Anogenital Distance, Fatherhood, and Fertility in Adult Men	PLOS ONE			English	Article							TESTICULAR DEVELOPMENTAL PROBLEMS; PROGRAMMING WINDOW; WHISTLE BLOWERS; NEWBORN-INFANTS; ANDROGEN ACTION; CANCER TRENDS; RAT; POPULATIONS; COUNTRIES; EXPOSURE	Background: Anogenital distance (AGD), a sexually dimorphic measure of genital development, is a marker for endocrine disruption in animal studies and may be shorter in infant males with genital anomalies. Given the correlation between anogenital distance and genital development, we sought to determine if anogenital distance varied in fertile compared to infertile adult men. Methods: A cross sectional study of consecutive men being evaluated for infertility and men with proven fertility was recruited from an andrology clinic. Anogenital distance (the distance from the posterior aspect of the scrotum to the anal verge) and penile length (PL) were measured using digital calipers. ANOVA and linear regression were used to determine correlations between AGD, fatherhood status, and semen analysis parameters (sperm density, motility, and total motile sperm count). Findings: A total of 117 infertile men (mean age: 35.3 +/- 17.4) and 56 fertile men (mean age: 44.8 +/- 9.7) were recruited. The infertile men possessed significantly shorter mean AGD and PL compared to the fertile controls (AGD: 31.8 vs 44.6 mm, PL: 107.1 vs 119.5 mm, p<0.01). The difference in AGD persisted even after accounting for ethnic and anthropomorphic differences. In addition to fatherhood, on both unadjusted and adjusted linear regression, AGD was significantly correlated with sperm density and total motile sperm count. After adjusting for demographic and reproductive variables, for each 1 cm increase in a man's AGD, the sperm density increases by 4.3 million sperm per mL (95% CI 0.53, 8.09, p = 0.03) and the total motile sperm count increases by 6.0 million sperm (95% CI 1.34, 10.58, p = 0.01). On adjusted analyses, no correlation was seen between penile length and semen parameters. Conclusion: A longer anogenital distance is associated with fatherhood and may predict normal male reproductive potential. Thus, AGD may provide a novel metric to assess reproductive potential in men.	[Eisenberg, Michael L.; Walters, Rustin Chanc; Krasnow, Ross; Lipshultz, Larry I.] Baylor Coll Med, Scott Dept Urol, Div Male Reprod Med & Surg, Houston, TX 77030 USA; [Hsieh, Michael H.] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA	Baylor College of Medicine; Stanford University	Eisenberg, ML (corresponding author), Baylor Coll Med, Scott Dept Urol, Div Male Reprod Med & Surg, Houston, TX 77030 USA.	eisenberg@stanford.edu		Krasnow, Ross/0000-0001-9773-9431; Eisenberg, Michael/0000-0001-5482-0141				CALLEGARI C, 1987, J PEDIATR-US, V111, P240, DOI 10.1016/S0022-3476(87)80075-6; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Carpenter DO, 2008, ANN NY ACAD SCI, V1140, P155, DOI 10.1196/annals.1454.004; Christiansen S, 2008, INT J ANDROL, V31, P241, DOI 10.1111/j.1365-2605.2008.00866.x; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; GREENHAM L W, 1977, Laboratory Animals (London), V11, P181, DOI 10.1258/002367777780936620; Grigor KM, 2007, INT J ANDROL, V30, P204; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Larsen WJ, 1997, HUMAN EMBRYOLOGY, P261; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Marois G., 1968, Biologie Medicale, V57, P44; Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8; Sathyanarayana S, 2010, INT J ANDROL, V33, P317, DOI 10.1111/j.1365-2605.2009.01044.x; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; Velde ET, 2010, HUM REPROD, V25, P1348, DOI 10.1093/humrep/deq085; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x	21	155	158	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18973	10.1371/journal.pone.0018973	http://dx.doi.org/10.1371/journal.pone.0018973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589916	Green Submitted, gold, Green Published			2022-12-25	WOS:000290483600004
J	Mandili, G; Marini, C; Carta, F; Zanini, C; Prato, M; Khadjavi, A; Turrini, F; Giribaldi, G				Mandili, Giorgia; Marini, Cristina; Carta, Franco; Zanini, Cristina; Prato, Mauro; Khadjavi, Amina; Turrini, Franco; Giribaldi, Giuliana			Identification of Phosphoproteins as Possible Differentiation Markers in All-Trans-Retinoic Acid-Treated Neuroblastoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN HEPATOCARCINOMA CELLS; GLUCOSE-REGULATED PROTEIN; NEURONAL DIFFERENTIATION; CANCER-CELLS; NEURITE OUTGROWTH; PROGNOSTIC MARKER; EWINGS-SARCOMA; SH-SY5Y CELLS; KINASE-C	Background: Neuroblastic tumors account for 9-10% of pediatric tumors and neuroblastoma (NB) is the first cause of death in pre-school age children. NB is classified in four stages, depending on the extent of spreading. A fifth type of NB, so-called stage 4S (S for special), includes patients with metastatic tumors but with an overall survival that approximates 75% at five years. In most of these cases, the tumor regresses spontaneously and regression is probably associated with delayed neuroblast cell differentiation. Methodology/Principal Findings: In order to identify new early markers to follow and predict this process for diagnostic and therapeutics intents, we mimicked the differentiation process treating NB cell line SJ-NK-P with all-trans-retinoic acid (ATRA) at different times; therefore the cell proteomic pattern by mass spectrometry and the phosphoproteomic pattern by a 2-DE approach coupled with anti-phosphoserine and anti-phosphotyrosine western blotting were studied. Conclusions/Significance: Proteomic analysis identified only two proteins whose expression was significantly different in treated cells versus control cells: nucleoside diphosphate kinase A (NDKA) and reticulocalbin-1 (RCN1), which were both downregulated after 9 days of ATRA treatment. However, phosphoproteomic analysis identified 8 proteins that were differentially serine-phosphorylated and 3 that were differentially tyrosine-phosphorylated after ATRA treatment. All proteins were significantly regulated (at least 0.5-fold down-regulated). Our results suggest that differentially phosphorylated proteins could be considered as more promising markers of differentiation for NB than differentially expressed proteins.	[Mandili, Giorgia; Marini, Cristina; Zanini, Cristina; Prato, Mauro; Khadjavi, Amina; Turrini, Franco; Giribaldi, Giuliana] Univ Turin, Dipartimento Genet Biol Biochim, Turin, Italy; [Carta, Franco] Nurex SRL, Sassari, Italy	University of Turin	Mandili, G (corresponding author), Univ Turin, Dipartimento Genet Biol Biochim, Turin, Italy.	giuliana.giribaldi@unito.it	Giribaldi, Giuliana/I-8115-2018	Giribaldi, Giuliana/0000-0003-1374-1919; carta, franco/0000-0001-7776-8243; Zanini, Cristina/0000-0002-6554-2113	Compagnia di San Paolo/FIRMS; 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy)	Compagnia di San Paolo/FIRMS(Compagnia di San Paolo); 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy)(Regione Piemonte)	This work was supported by the 'Oncology Special Project', Compagnia di San Paolo/FIRMS and by the 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Dott. Franco Carta and Nurex S.R.L. for the free of charge mass spectrometry analyses. As Franco Carta is employed by Nurex S.R.L., Nurex did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Amendola R, 2001, MED PEDIATR ONCOL, V36, P93, DOI 10.1002/1096-911X(20010101)36:1<93::AID-MPO1021>3.0.CO;2-3; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; CARLINO A, 1994, BIOCHEM BIOPH RES CO, V201, P1548, DOI 10.1006/bbrc.1994.1880; Chlapek P, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-45; CICCARONE V, 1989, CANCER RES, V49, P219; Cimmino F, 2007, J PROTEOME RES, V6, P2550, DOI 10.1021/pr060701g; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; FREYRIA AM, 1995, BIOCHEM J, V305, P391, DOI 10.1042/bj3050391; Futami H, 2010, CANCER LETT, V297, P220, DOI 10.1016/j.canlet.2010.05.014; Gu L, 2003, CELL MOTIL CYTOSKEL, V54, P286, DOI 10.1002/cm.10099; Haque N, 2004, MOL BRAIN RES, V129, P163, DOI 10.1016/j.molbrainres.2004.07.001; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Hsu WM, 2005, INT J CANCER, V113, P920, DOI 10.1002/ijc.20693; HUNTER T, 1991, METHODS ENZYMOL, V200, P3; Inberg A, 2007, PROTEOMICS, V7, P910, DOI 10.1002/pmic.200600547; Isoardo G, 2005, J NEUROIMMUNOL, V161, P78, DOI 10.1016/j.jneuroim.2004.12.005; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Kim JE, 2005, J PROTEOME RES, V4, P1339, DOI 10.1021/pr050048h; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lim YP, 2005, CLIN CANCER RES, V11, P3163, DOI 10.1158/1078-0432.CCR-04-2243; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; Miloso M, 2004, J NEUROSCI RES, V75, P241, DOI 10.1002/jnr.10848; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Navakauskiene R, 2004, PROTEOMICS, V4, P1029, DOI 10.1002/pmic.200300671; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHTA Y, 1987, FEBS LETT, V222, P305, DOI 10.1016/0014-5793(87)80391-5; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; RETTIG WJ, 1987, CANCER RES, V47, P1383; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salih E, 2005, MASS SPECTROM REV, V24, P828, DOI 10.1002/mas.20042; Sanli UA, 2003, ONCOL REP, V10, P2083; SCHWAB M, 2000, PATHOLOGY GENETICS T; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; THIELE CJ, 1991, CANCER METAST REV, V10, P311, DOI 10.1007/BF00554793; Tonini GP, 2006, CURR PHARM DESIGN, V12, P2303, DOI 10.2174/138161206777585193; Ueda Koichiro, 2001, Kurume Medical Journal, V48, P159; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Xu YY, 2007, J CELL BIOCHEM, V100, P773, DOI 10.1002/jcb.21088; Xu YY, 2010, J CELL BIOCHEM, V109, P468, DOI 10.1002/jcb.22423; Yu YM, 2003, NEUROREPORT, V14, P941, DOI 10.1097/01.wnr.0000074341.81633.b8; Zanini C, 2008, VIRCHOWS ARCH, V452, P157, DOI 10.1007/s00428-007-0549-6; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x	65	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e18254	10.1371/journal.pone.0018254	http://dx.doi.org/10.1371/journal.pone.0018254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573212	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400002
J	Thomas, JD; Hatcher, CP; Satterfield, DA; Theodore, MJ; Bach, MC; Linscott, KB; Zhao, X; Wang, X; Mair, R; Schmink, S; Arnold, KE; Stephens, DS; Harrison, LH; Hollick, RA; Andrade, AL; Lamaro-Cardoso, J; de Lemos, APS; Gritzfeld, J; Gordon, S; Soysal, A; Bakir, M; Sharma, D; Jain, S; Satola, SW; Messonnier, NE; Mayer, LW				Thomas, Jennifer Dolan; Hatcher, Cynthia P.; Satterfield, Dara A.; Theodore, M. Jordan; Bach, Michelle C.; Linscott, Kristin B.; Zhao, Xin; Wang, Xin; Mair, Raydel; Schmink, Susanna; Arnold, Kathryn E.; Stephens, David S.; Harrison, Lee H.; Hollick, Rosemary A.; Andrade, Ana Lucia; Lamaro-Cardoso, Juliana; de Lemos, Ana Paula S.; Gritzfeld, Jenna; Gordon, Stephen; Soysal, Ahmet; Bakir, Mustafa; Sharma, Dolly; Jain, Shabnam; Satola, Sarah W.; Messonnier, Nancy E.; Mayer, Leonard W.			sodC-Based Real-Time PCR for Detection of Neisseria meningitidis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; STREPTOCOCCUS-PNEUMONIAE; CEREBROSPINAL-FLUID; HAEMOPHILUS-INFLUENZAE; BACTERIAL-MENINGITIS; IDENTIFICATION; SEQUENCE; DIAGNOSIS; GENES; RESISTANCE	Real-time PCR (rt-PCR) is a widely used molecular method for detection of Neisseria meningitidis (Nm). Several rt-PCR assays for Nm target the capsule transport gene, ctrA. However, over 16% of meningococcal carriage isolates lack ctrA, rendering this target gene ineffective at identification of this sub-population of meningococcal isolates. The Cu-Zn superoxide dismutase gene, sodC, is found in Nm but not in other Neisseria species. To better identify Nm, regardless of capsule genotype or expression status, a sodC-based TaqMan rt-PCR assay was developed and validated. Standard curves revealed an average lower limit of detection of 73 genomes per reaction at cycle threshold (C-t) value of 35, with 100% average reaction efficiency and an average R-2 of 0.9925. 99.7% (624/626) of Nm isolates tested were sodC-positive, with a range of average C-t values from 13.0 to 29.5. The mean sodC C-t value of these Nm isolates was 17.6 +/- 2.2 (+/- SD). Of the 626 Nm tested, 178 were nongroupable (NG) ctrA-negative Nm isolates, and 98.9% (176/178) of these were detected by sodC rt-PCR. The assay was 100% specific, with all 244 non-Nm isolates testing negative. Of 157 clinical specimens tested, sodC detected 25/157 Nm or 4 additional specimens compared to ctrA and 24 more than culture. Among 582 carriage specimens, sodC detected Nm in 1 more than ctrA and in 4 more than culture. This sodC rt-PCR assay is a highly sensitive and specific method for detection of Nm, especially in carriage studies where many meningococcal isolates lack capsule genes.	[Thomas, Jennifer Dolan; Hatcher, Cynthia P.; Satterfield, Dara A.; Theodore, M. Jordan; Bach, Michelle C.; Linscott, Kristin B.; Zhao, Xin; Wang, Xin; Mair, Raydel; Schmink, Susanna; Messonnier, Nancy E.; Mayer, Leonard W.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Arnold, Kathryn E.] Georgia Dept Community Hlth, Div Publ Hlth, Atlanta, GA USA; [Stephens, David S.; Sharma, Dolly; Jain, Shabnam; Satola, Sarah W.] Emory Univ, Sch Med, Atlanta, GA USA; [Arnold, Kathryn E.; Stephens, David S.; Satola, Sarah W.] Georgia Emerging Infect Program, Atlanta, GA USA; [Stephens, David S.; Satola, Sarah W.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Sharma, Dolly; Jain, Shabnam] Childrens Healthcare Atlanta, Atlanta, GA USA; [Satterfield, Dara A.; Bach, Michelle C.] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Harrison, Lee H.; Hollick, Rosemary A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Andrade, Ana Lucia; Lamaro-Cardoso, Juliana] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [de Lemos, Ana Paula S.] Adolfo Lutz Inst, Sao Paulo, Brazil; [Gritzfeld, Jenna; Gordon, Stephen] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Soysal, Ahmet; Bakir, Mustafa] Marmara Univ, Sch Med, Div Pediat Infect Dis, Istanbul, Turkey	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Children's Healthcare of Atlanta (CHOA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Goias; Instituto Adolfo Lutz; Liverpool School of Tropical Medicine; University of Liverpool; Marmara University	Thomas, JD (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	fsu8@cdc.gov	Iats, Inct/K-2300-2013; Satterfield, Dara/N-4484-2017; Lemos, Ana Paula/ABE-6240-2021; Stephens, David S/A-8788-2012; Andrade, Ana Lucia/L-5751-2013	Satterfield, Dara/0000-0003-3036-5580; Gordon, Stephen/0000-0001-6576-1116; Bach, Michelle/0000-0002-2342-5242	Brazilian National Council for Scientific and Technological Development (CNPq) [309196/2007-8]; National Institute of Science and Technology for Health Technology Assessment/IATS; National Institutes of Health [5D43TW006592]; FOGARTY INTERNATIONAL CENTER [D43TW006592] Funding Source: NIH RePORTER	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health Technology Assessment/IATS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	ALA was supported by the Brazilian National Council for Scientific and Technological Development (CNPq grant # 309196/2007-8) (http://www.cnpq.br/english/cnpq/index.htm) and was supported by the National Institute of Science and Technology for Health Technology Assessment/IATS (http://www.iats.com.br/eng/instituto.php?id_cms_menu = 1). APS de Lemos was supported by the Fogarty International Center Global Infectious Diseases Research Training Program grant from the National Institutes of Health (5D43TW006592) (http://www.fic.nih.gov/). JG and SG thank the NIHR Biomedical Research Centre in Microbial Diseases (http://www.rlbuht.nhs.uk/NIHR_BRC/Introduction.asp) and the Northwest Regional Development Agency (http://www.nwda.co.uk/) for infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cavrini F, 2010, J CLIN MICROBIOL, V48, P3016, DOI 10.1128/JCM.00103-10; Chiba N, 2009, J INFECT CHEMOTHER, V15, P92, DOI 10.1007/s10156-009-0670-3; CLARK TA, 2008, 16 INT PATH NEISS C; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Deutch S, 2008, SCAND J INFECT DIS, V40, P607, DOI 10.1080/00365540801914833; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Fung WWM, 2006, J CLIN MICROBIOL, V44, P4222, DOI 10.1128/JCM.01376-06; Gurley ES, 2009, AM J TROP MED HYG, V81, P475, DOI 10.4269/ajtmh.2009.81.475; Hedberg ST, 2009, APMIS, V117, P856, DOI 10.1111/j.1600-0463.2009.02539.x; Janda WM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P601; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Jordens JZ, 2002, J CLIN MICROBIOL, V40, P75, DOI 10.1128/JCM.40.1.75-79.2002; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Katz LS, 2009, NUCLEIC ACIDS RES, V37, pW606, DOI 10.1093/nar/gkp288; Kellerman SE, 2002, J INFECT DIS, V186, P40, DOI 10.1086/341067; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; LANGFORD PR, 1992, J GEN MICROBIOL, V138, P517, DOI 10.1099/00221287-138-3-517; LASCOLEA LJ, 1984, J CLIN MICROBIOL, V19, P187, DOI 10.1128/JCM.19.2.187-190.1984; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCrea KW, 2010, J CLIN MICROBIOL, V48, P714, DOI 10.1128/JCM.01416-09; Mhlanga B., 2009, Morbidity and Mortality Weekly Report, V58, P493; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; POPOVIC T, 1999, LAB MANUAL DIAGNOSIS; Sadler F, 2003, EPIDEMIOL INFECT, V130, P59, DOI 10.1017/S0950268802007987; Sharma D, 2010, 7 INT S PNEUM PNEUM; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Staquet P, 2007, INTENS CARE MED, V33, P1168, DOI 10.1007/s00134-007-0667-2; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Van Gastel E, 2007, EUR J CLIN MICROBIOL, V26, P651, DOI 10.1007/s10096-007-0350-0; VANDERENDE A, 1995, J CLIN MICROBIOL, V33, P3326, DOI 10.1128/JCM.33.12.3326-3327.1995; WANG X, 2011, INT J MED M IN PRESS; Wilks KE, 1998, INFECT IMMUN, V66, P213, DOI 10.1128/IAI.66.1.213-217.1998; Zhu Bing-Qing, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P360	45	65	67	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19361	10.1371/journal.pone.0019361	http://dx.doi.org/10.1371/journal.pone.0019361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573213	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000290256400007
J	Luchtefeld, M; Preuss, C; Ruhle, F; Bogalle, EP; Sietmann, A; Figura, S; Muller, W; Grote, K; Schieffer, B; Stoll, M				Luchtefeld, Maren; Preuss, Christoph; Ruehle, Frank; Bogalle, Eskindir P.; Sietmann, Anika; Figura, Stefanie; Mueller, Werner; Grote, Karsten; Schieffer, Bernhard; Stoll, Monika			Gp130-Dependent Release of Acute Phase Proteins Is Linked to the Activation of Innate Immune Signaling Pathways	PLOS ONE			English	Article							INSULIN-RESISTANCE; ATHEROSCLEROSIS; MICE; INFLAMMATION; DISEASE; LIPOCALIN-2; EXPRESSION; RESPONSES; MACROPHAGES; OBESITY	Background: Elevated levels of acute phase proteins (APP) are often found in patients with cardiovascular diseases. In a previous study, we demonstrated the importance of the IL-6-gp130 axis -as a key regulator of inflammatory acute phase signaling in hepatocytes-for the development of atherosclerosis. Background/Principal Findings: Gp130-dependent gene expression was analyzed in a previously established hepatocyte-specific gp130 knockout mouse model. We performed whole transcriptome analysis in isolated hepatocytes to measure tissue specific responses after proinflammatory stimulus with IL-6 across different time points. Our analyses revealed an unexpected small gene cluster that requires IL-6 stimulus for early activation. Several of the genes in this cluster are involved in different cell defense mechanisms. Thus, stressors that trigger both general stress and inflammatory responses lead to activation of a stereotypic innate cellular defense response. Furthermore, we identified a potential biomarker Lipocalin (LCN) 2 for the gp130 dependent early inflammatory response. Conclusions/Significance: Our findings suggest a complex network of tightly linked genes involved in the early activation of different parts of the innate immune response including acute phase proteins, complement and coagulation cascade.	[Luchtefeld, Maren; Bogalle, Eskindir P.; Grote, Karsten; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Preuss, Christoph; Ruehle, Frank; Sietmann, Anika; Figura, Stefanie; Stoll, Monika] Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Hannover Medical School; University of Manchester	Luchtefeld, M (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	Schieffer.Bernhard@MH-Hannover.de	Witten, Anika/C-5297-2019; Muller, Werner/B-9044-2008	Muller, Werner/0000-0002-1297-9725; Grote, Karsten/0000-0001-7914-3159; Ruhle, Frank/0000-0001-7688-2394	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) [SFB 566/b9]	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich)(German Research Foundation (DFG))	Drs. Schieffer and Grote are supported by funding from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) SFB 566/b9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Castillo L, 2010, J INTERF CYTOK RES, V30, P339, DOI 10.1089/jir.2009.0045; Danesh J, 1999, EUR HEART J, V20, P954, DOI 10.1053/euhj.1998.1309; Dittrich AM, 2010, CLIN EXP ALLERGY, V40, P1689, DOI 10.1111/j.1365-2222.2010.03508.x; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Kastl SP, 2008, ARTERIOSCL THROM VAS, V28, P498, DOI 10.1161/ATVBAHA.107.160580; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KORDULA T, 1992, FEBS LETT, V313, P143, DOI 10.1016/0014-5793(92)81431-K; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020; Luchtefeld M, 2007, J EXP MED, V204, P1935, DOI 10.1084/jem.20070120; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	23	13	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19427	10.1371/journal.pone.0019427	http://dx.doi.org/10.1371/journal.pone.0019427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573245	Green Submitted, Green Published, gold			2022-12-25	WOS:000290224800029
J	Tayo, BO; Teil, M; Tong, LP; Qin, HZ; Khitrov, G; Zhang, WJ; Song, QB; Gottesman, O; Zhu, XF; Pereira, AC; Cooper, RS; Bottinger, EP				Tayo, Bamidele O.; Teil, Marie; Tong, Liping; Qin, Huaizhen; Khitrov, Gregory; Zhang, Weijia; Song, Quinbin; Gottesman, Omri; Zhu, Xiaofeng; Pereira, Alexandre C.; Cooper, Richard S.; Bottinger, Erwin P.			Genetic Background of Patients from a University Medical Center in Manhattan: Implications for Personalized Medicine	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-DERIVED POPULATIONS; CORONARY-ARTERY-DISEASE; PRAVASTATIN PHARMACOKINETICS; GENOTYPING ALGORITHM; SUSCEPTIBILITY LOCI; WEST AFRICANS; HAPLOTYPE MAP; AMERICANS; GWAS	Background: The rapid progress currently being made in genomic science has created interest in potential clinical applications; however, formal translational research has been limited thus far. Studies of population genetics have demonstrated substantial variation in allele frequencies and haplotype structure at loci of medical relevance and the genetic background of patient cohorts may often be complex. Methods and Findings: To describe the heterogeneity in an unselected clinical sample we used the Affymetrix 6.0 gene array chip to genotype self-identified European Americans (N = 326), African Americans (N = 324) and Hispanics (N = 327) from the medical practice of Mount Sinai Medical Center in Manhattan, NY. Additional data from US minority groups and Brazil were used for external comparison. Substantial variation in ancestral origin was observed for both African Americans and Hispanics; data from the latter group overlapped with both Mexican Americans and Brazilians in the external data sets. A pooled analysis of the African Americans and Hispanics from NY demonstrated a broad continuum of ancestral origin making classification by race/ethnicity uninformative. Selected loci harboring variants associated with medical traits and drug response confirmed substantial within-and between-group heterogeneity. Conclusion: As a consequence of these complementary levels of heterogeneity group labels offered no guidance at the individual level. These findings demonstrate the complexity involved in clinical translation of the results from genome-wide association studies and suggest that in the genomic era conventional racial/ethnic labels are of little value.	[Tayo, Bamidele O.; Tong, Liping; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA; [Teil, Marie; Khitrov, Gregory; Zhang, Weijia; Song, Quinbin; Gottesman, Omri; Bottinger, Erwin P.] Mt Sinai Sch Med, Charles R Bronfman Inst Personalized Med, New York, NY USA; [Qin, Huaizhen; Zhu, Xiaofeng] Case Western Univ, Dept Biostat & Epidemiol, Cleveland, OH USA; [Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Loyola University Chicago; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Universidade de Sao Paulo	Tayo, BO (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA.	btayo@lumc.edu; erwin.bottinger@mssm.edu	Pereira, Alexandre/HHN-1038-2022; Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	National Heart Lung and Blood Institute [RO1 HL53353]; Andrea and Charles Bronfman Philantropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053353] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Andrea and Charles Bronfman Philantropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Andrea and Charles Bronfman Philantropies (to EPB); NIH grant National Heart Lung and Blood Institute RO1 HL53353 (to RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Adeyemo A, 2010, DIABETES, V59, P1549, DOI 10.2337/db09-1252; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chierici M, 2010, PHARMACOGENOMICS J, V10, P355, DOI 10.1038/tpj.2010.47; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Falush D, 2003, GENETICS, V164, P1567; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Hawken SJ, 2010, HUM GENET, V128, P89, DOI 10.1007/s00439-010-0828-1; Hong H, 2010, PHARMACOGENOMICS J, V10, P364, DOI 10.1038/tpj.2010.24; Hong HX, 2010, J GENET, V89, P55, DOI 10.1007/s12041-010-0011-4; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kivisto KT, 2007, PHARM RES-DORDR, V24, P239, DOI 10.1007/s11095-006-9159-2; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P324, DOI 10.1038/tpj.2010.46; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P336, DOI 10.1038/tpj.2010.36; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; *NEW YORK CIT DEP, 2004, NEW NEW YORK 2000 IM; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; QIN H, 2010, BIOINFORMATICS; Qin HZ, 2010, BIOINFORMATICS, V26, P2961, DOI 10.1093/bioinformatics/btq560; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenwaike I., 1972, POPULATION HIST NEW; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Urban TJ, 2010, MT SINAI J MED, V77, P133, DOI 10.1002/msj.20168; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weiss KM, 2010, EVOL ANTHROPOL, V19, P92, DOI 10.1002/evan.20261; Zhang L, 2010, PHARMACOGENOMICS J, V10, P347, DOI 10.1038/tpj.2010.27	56	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19166	10.1371/journal.pone.0019166	http://dx.doi.org/10.1371/journal.pone.0019166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573225	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800016
J	Weckworth, BV; Dawson, NG; Talbot, SL; Flamme, MJ; Cook, JA				Weckworth, Byron V.; Dawson, Natalie G.; Talbot, Sandra L.; Flamme, Melanie J.; Cook, Joseph A.			Going Coastal: Shared Evolutionary History between Coastal British Columbia and Southeast Alaska Wolves (Canis lupus)	PLOS ONE			English	Article							SQUIRRELS GLAUCOMYS-SABRINUS; MARTEN MARTES-AMERICANA; PACIFIC-NORTHWEST; ALEXANDER ARCHIPELAGO; GENETIC-STRUCTURE; MEXICAN WOLVES; WOLF; POPULATION; PHYLOGEOGRAPHY; DIFFERENTIATION	Background: Many coastal species occupying the temperate rainforests of the Pacific Northwest in North America comprise endemic populations genetically and ecologically distinct from interior continental conspecifics. Morphological variation previously identified among wolf populations resulted in recognition of multiple subspecies of wolves in the Pacific Northwest. Recently, separate genetic studies have identified diverged populations of wolves in coastal British Columbia and coastal Southeast Alaska, providing support for hypotheses of distinct coastal subspecies. These two regions are geographically and ecologically contiguous, however, there is no comprehensive analysis across all wolf populations in this coastal rainforest. Methodology/Principal Findings: By combining mitochondrial DNA datasets from throughout the Pacific Northwest, we examined the genetic relationship between coastal British Columbia and Southeast Alaska wolf populations and compared them with adjacent continental populations. Phylogenetic analysis indicates complete overlap in the genetic diversity of coastal British Columbia and Southeast Alaska wolves, but these populations are distinct from interior continental wolves. Analyses of molecular variation support the separation of all coastal wolves in a group divergent from continental populations, as predicted based on hypothesized subspecies designations. Two novel haplotypes also were uncovered in a newly assayed continental population of interior Alaska wolves. Conclusions/Significance: We found evidence that coastal wolves endemic to these temperate rainforests are diverged from neighbouring, interior continental wolves; a finding that necessitates new international strategies associated with the management of this species.	[Weckworth, Byron V.] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Dawson, Natalie G.; Cook, Joseph A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Dawson, Natalie G.; Cook, Joseph A.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA; [Talbot, Sandra L.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Flamme, Melanie J.] Yukon Charley Rivers Natl Preserve, Natl Pk Serv, Fairbanks, AK USA	University of Calgary; University of New Mexico; University of New Mexico; United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Weckworth, BV (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	byweck@gmail.com	Talbot, Sandra L/C-9433-2011	Cook, Joseph/0000-0003-3985-0670	U.S. Geological Survey Alaska Science Center; Yukon-Charley Rivers National Reserve; U.S. Fish & Wildlife Service; United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory; National Science Foundation [NSF DEB 0196095, 0415668]	U.S. Geological Survey Alaska Science Center(United States Geological Survey); Yukon-Charley Rivers National Reserve; U.S. Fish & Wildlife Service(US Fish & Wildlife Service); United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF))	Funding was provided by the U.S. Geological Survey Alaska Science Center, Yukon-Charley Rivers National Reserve, U.S. Fish & Wildlife Service, United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory, and National Science Foundation (NSF DEB 0196095 and 0415668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Andrew JM, 2002, WATERBIRDS, V25, P122; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bidlack AL, 2002, CONSERV GENET, V3, P247, DOI 10.1023/A:1019966032259; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; BOERTJE RD, 2003, 343 AL DEP FISH GAM; Burch J., 2002, NPSARNRTR200141; BURCH JW, 2009, NPSCAKNNRTR2009228; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Cook JA, 2006, BIOL CONSERV, V133, P1, DOI 10.1016/j.biocon.2006.05.026; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; Dawson N. G., 2008, THESIS U NEW MEXICO; Demboski JR, 1999, EVOLUTION, V53, P2008, DOI 10.1111/j.1558-5646.1999.tb04584.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goldman E.A., 1944, WOLVES N AM, P389; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Hall E., 1959, MAMMALS N AM, V2; Hall E.R., 1981, MAMMALS N AM, V2; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hilton-Taylor C., 2000, IUCN RED LIST THREAT; HOGAN KM, 1993, J MAMMAL, V74, P819, DOI 10.2307/1382420; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; KIESTER AR, 1994, REV WILDLIFE MANAGEM; Latch EK, 2008, ANIM CONSERV, V11, P234, DOI 10.1111/j.1469-1795.2008.00174.x; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; LUIKART G, 1997, THESIS U MONTANA MIS; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; National Park Service, 2006, NAT PARK SERV MAN PO; Nowak Ronald M., 1995, Canadian Circumpolar Institute Occasional Publication, V35, P375; Person D. K., 2001, THESIS U ALASKA FAIR; Person DK, 2008, J WILDLIFE MANAGE, V72, P1540, DOI 10.2193/2007-520; PERSON DK, 1996, PNWGTR384 USDA FOR S, P1; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Small MP, 2003, MOL ECOL, V12, P89, DOI 10.1046/j.1365-294X.2003.01720.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Stone KD, 2002, MOL PHYLOGENET EVOL, V24, P169, DOI 10.1016/S1055-7903(02)00229-4; Stone KD, 2002, MOL ECOL, V11, P2049, DOI 10.1046/j.1365-294X.2002.01596.x; Stone KD, 2000, CAN J ZOOL, V78, P1218, DOI 10.1139/cjz-78-7-1218; SURING LH, 1993, STRATEGY MAINTAINING; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; Tanaka Y, 2007, ECOL RES, V22, P929, DOI 10.1007/s11284-007-0384-x; *US DEP INT ENV CA, 2001, CONS BORD SPEC PARTN; Weckworth BV, 2005, MOL ECOL, V14, P917, DOI 10.1111/j.1365-294X.2005.02461.x; Weckworth BV, 2010, J MAMMAL, V91, P363, DOI 10.1644/09-MAMM-A-036.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; West E. W., 1991, STATUS REPORTS SELEC; Wooding S, 1997, MOL BIOL EVOL, V14, P1096, DOI 10.1093/oxfordjournals.molbev.a025719	61	16	17	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19582	10.1371/journal.pone.0019582	http://dx.doi.org/10.1371/journal.pone.0019582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573241	Green Published, Green Submitted, gold			2022-12-25	WOS:000290224800036
J	Braconi, C; Kogure, T; Valeri, N; Huang, N; Nuovo, G; Costinean, S; Negrini, M; Miotto, E; Croce, CM; Patel, T				Braconi, C.; Kogure, T.; Valeri, N.; Huang, N.; Nuovo, G.; Costinean, S.; Negrini, M.; Miotto, E.; Croce, C. M.; Patel, T.			microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer	ONCOGENE			English	Article						MEG3; methylation; HCC; non-coding RNA	ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR GENE; LIVER-CANCER; CARCINOMA; CELLS; HYPERMETHYLATION; METHYLATION; TUMORIGENICITY; ACTIVATION; APOPTOSIS	The human genome is replete with long non-coding RNAs (lncRNA), many of which are transcribed and likely to have a functional role. Microarray analysis of 423 000 lncRNAs revealed downregulation of 712 (similar to 3%) lncRNA in malignant hepatocytes, among which maternally expressed gene 3 (MEG3) was downregulated by 210-fold relative to expression in non-malignant hepatocytes. MEG3 expression was markedly reduced in four human hepatocellular cancer (HCC) cell lines compared with normal hepatocytes by real-time PCR. RNA in situ hybridization showed intense cytoplasmic expression of MEG3 in non-neoplastic liver with absent or very weak expression in HCC tissues. Enforced expression of MEG3 in HCC cells significantly decreased both anchorage-dependent and -independent cell growth, and induced apoptosis. MEG3 promoter hypermethylation was identified by methylation-specific PCR and MEG3 expression was increased with inhibition of methylation with either 5-Aza-2-Deoxycytidine, or siRNA to DNA Methyltransferase (DNMT) 1 and 3b in HCC cells. MiRNA-dependent regulation of MEG3 expression was studied by evaluating the involvement of miR-29, which can modulate DNMT 1 and 3. Overexpression of mir-29a increased expression of MEG3. GTL2, the murine homolog of MEG3, was reduced in liver tissues from hepatocyte-specific miR-29a/b1 knock-out mice compared with wild-type controls. These data show that methylation-dependent tissue-specific regulation of the lncRNA MEG3 by miR-29a may contribute to HCC growth and highlight the inter-relationship between two classes of non-coding RNA, miRNAs and lncRNAs, and epigenetic regulation of gene expression. Oncogene (2011) 30, 4750-4756; doi:10.1038/onc.2011.193; published online 30 May 2011	[Patel, T.] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA; [Braconi, C.; Kogure, T.; Valeri, N.; Huang, N.; Costinean, S.; Croce, C. M.; Patel, T.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Braconi, C.; Kogure, T.; Valeri, N.; Huang, N.; Costinean, S.; Croce, C. M.; Patel, T.] Ohio State Univ, Ohio State Univ Comprehens Canc Ctr, Columbus, OH 43210 USA; [Nuovo, G.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Negrini, M.; Miotto, E.] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	Mayo Clinic; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Ferrara	Patel, T (corresponding author), Mayo Clin, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	patel.tushar@mayo.edu	patel, tushar/J-3976-2013; Young, Richard A/F-6495-2012; Kogure, Takayuki/AAI-3946-2021; Negrini, Massimo/J-2377-2016	patel, tushar/0000-0001-7021-9532; Young, Richard A/0000-0001-8855-8647; Negrini, Massimo/0000-0002-0007-1920; braconi, chiara/0000-0003-4835-1259; valeri, nicola/0000-0002-5426-5683	NCI NIH HHS [P30 CA016058] Funding Source: Medline; NIDDK NIH HHS [R01 DK069370] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Benetatos L, 2008, CLIN LYMPHOMA MYELOM, V8, P171, DOI 10.3816/CLM.2008.n.021; Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Cazals-Hatem D, 2004, J HEPATOL, V41, P292, DOI 10.1016/j.jhep.2004.04.030; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Lujambio A, 2010, ONCOGENE, V29, P6390, DOI 10.1038/onc.2010.361; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oliva J, 2009, EXP MOL PATHOL, V87, P12, DOI 10.1016/j.yexmp.2009.03.006; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wojcik SE, 2010, CARCINOGENESIS, V31, P208, DOI 10.1093/carcin/bgp209; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	36	521	581	1	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	47					4750	4756		10.1038/onc.2011.193	http://dx.doi.org/10.1038/onc.2011.193			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21625215	Green Published, Green Accepted			2022-12-25	WOS:000298033700007
J	Goyal, A; Pal, N; Concannon, M; Paul, M; Doran, M; Poluzzi, C; Sekiguchi, K; Whitelock, JM; Neill, T; Iozzo, RV				Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Sekiguchi, Kiyotoshi; Whitelock, John M.; Neill, Thomas; Iozzo, Renato V.			Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the alpha 2 beta 1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) A DUAL RECEPTOR ANTAGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; PROTEIN-TYROSINE-PHOSPHATASE; MUSCLE-CELL PROLIFERATION; BASEMENT-MEMBRANE PROTEOGLYCANS; COLON-CARCINOMA-CELLS; TUMOR-GROWTH; IN-VIVO; ALPHA(2)BETA(1) INTEGRINS; EXTRACELLULAR MATRICES; INTIMAL HYPERPLASIA	Endorepellin, the C-terminal module of perlecan, negatively regulates angiogenesis counter to its proangiogenic parental molecule. Endorepellin (the C-terminal domain V of perlecan) binds the alpha 2 beta 1 integrin on endothelial cells and triggers a signaling cascade that leads to disruption of the actin cytoskeleton. Here, we show that both perlecan and endorepellin bind directly and with high affinity to both VEGF receptors 1 and 2, in a region that differs from VEGFA-binding site. In both human and porcine endothelial cells, this interaction evokes a physical down-regulation of both the alpha 2 beta 1 integrin and VEGFR2, with concurrent activation of the tyrosine phosphatase SHP-1 and downstream attenuation of VEGFA transcription. We demonstrate that endorepellin requires both the alpha 2 beta 1 integrin and VEGFR2 for its angiostatic activity. Endothelial cells that express alpha 2 beta 1 integrin but lack VEGFR2, do not respond to endorepellin treatment. Thus, we provide a new paradigm for the activity of an antiangiogenic protein and mechanistically explain the specificity of endorepellin for endothelial cells, the only cells that simultaneously express both receptors. We hypothesize that a mechanism such as dual receptor antagonism could operate for other angiostatic fragments.	[Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Neill, Thomas; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Neill, Thomas; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Sekiguchi, Kiyotoshi] Osaka Univ, Lab Extracellular Matrix Biochem, Inst Prot Res, Suita, Osaka 5650871, Japan; [Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia	Jefferson University; Jefferson University; Osaka University; University of New South Wales Sydney	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	iozzo@KimmelCancerCenter.org	Concannon, Matthew/ABG-5026-2021; Iozzo, Renato/AAS-1980-2020; Poluzzi, Chiara/T-3376-2019	Concannon, Matthew/0000-0001-8777-4786; Pal, Nutan/0000-0002-5948-3508; Paul, Matthew/0000-0002-3020-7729; Whitelock, John/0000-0003-1835-802X; Iozzo, Renato/0000-0002-5908-5112; Doran, Michael/0000-0001-5876-4757	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975]; Mizutani Foundation for Glycoscience; National Research Service [T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481, R01CA120975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience; National Research Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975. This work was also supported by a grant from the Mizutani Foundation for Glycoscience (to R. V. I.).; Supported by National Research Service Award Training Grant T32 AA07463.	Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Borza CM, 2010, J BIOL CHEM, V285, P40114, DOI 10.1074/jbc.M110.156729; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; DODGE GR, 1990, J BIOL CHEM, V265, P18023; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gluzman-Poltorak Z, 2001, J BIOL CHEM, V276, P18688, DOI 10.1074/jbc.M006909200; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; Ito N, 1999, Angiogenesis, V3, P159, DOI 10.1023/A:1009008926710; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kendrew J, 2011, MOL CANCER THER, V10, P770, DOI 10.1158/1535-7163.MCT-10-0876; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lee SJ, 2010, LAB INVEST, V90, P374, DOI 10.1038/labinvest.2009.136; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Mathiak M, 1997, CANCER RES, V57, P2130; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Muthusamy A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-43; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; PARK JE, 1994, J BIOL CHEM, V269, P25646; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhang ZH, 2008, BLOOD, V111, P1980, DOI 10.1182/blood-2007-06-094680; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	111	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25947	25962		10.1074/jbc.M111.243626	http://dx.doi.org/10.1074/jbc.M111.243626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596751	hybrid, Green Published			2022-12-25	WOS:000293073000054
J	Lee, K; Kerner, J; Hoppel, CL				Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.			Mitochondrial Carnitine Palmitoyltransferase 1a (CPT1a) Is Part of an Outer Membrane Fatty Acid Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; RAT-LIVER MITOCHONDRIA; MALONYL-COA BINDING; CONTACT SITES; OXIDATIVE-PHOSPHORYLATION; PROTEIN COMPLEXES; STRIATED-MUSCLES; TRANSLOCASE; POLYANION; PURIFICATION	CPT1a (carnitine palmitoyltransferase 1a) in the liver mitochondrial outer membrane (MOM) catalyzes the primary regulated step in overall mitochondrial fatty acid oxidation. It has been suggested that the fundamental unit of CPT1a exists as a trimer, which, under native conditions, could form a dimer of the trimers, creating a hexamer channel for acylcarnitine translocation. To examine the state of CPT1a in the MOM, we employed a combined approach of sizing by mass and isolation using an immunological method. Blue native electrophoresis followed by detection with immunoblotting and mass spectrometry identified large molecular mass complexes that contained not only CPT1a but also long chain acyl-CoA synthetase (ACSL) and the voltage-dependent anion channel (VDAC). Immunoprecipitation with antisera against the proteins revealed a strong interaction between the three proteins. Immobilized CPT1a-specific antibodies immunocaptured not only CPT1a but also ACSL and VDAC, further strengthening findings with blue native electrophoresis and immunoprecipitation. This study shows strong protein-protein interaction between CPT1a, ACSL, and VDAC. We propose that this complex transfers activated fatty acids through the MOM.	[Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.] Case Western Reserve Univ, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hoppel, CL (corresponding author), Case Western Reserve Univ, Ctr Mitochondrial Dis, 10900 Euclid Ave, Cleveland, OH 44106 USA.	charles.hoppel@case.edu			National Institutes of Health [DK-066107]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-066107.	Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Anflous-Pharayra K, 2011, BBA-BIOENERGETICS, V1807, P150, DOI 10.1016/j.bbabio.2010.09.007; BARTANA J, 1973, BIOCHEM J, V135, P411, DOI 10.1042/bj1350411; BHUIYAN J, 1995, METABOLISM, V44, P1185, DOI 10.1016/0026-0495(95)90013-6; Brdiczka DG, 2006, BBA-MOL BASIS DIS, V1762, P148, DOI 10.1016/j.bbadis.2005.09.007; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Cesar MD, 2004, ARCH BIOCHEM BIOPHYS, V422, P191, DOI 10.1016/j.abb.2003.12.030; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P279, DOI 10.1016/0005-2736(87)90456-1; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Distler AM, 2006, ANAL BIOCHEM, V356, P18, DOI 10.1016/j.ab.2006.03.053; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; FELGNER PL, 1979, J BIOL CHEM, V254, P4946; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Gavish M, 1999, PHARMACOL REV, V51, P629; Hoppel C, 2002, ANAL BIOCHEM, V302, P60, DOI 10.1006/abio.2001.5531; Hoppel C, 2001, ARCH BIOCHEM BIOPHYS, V392, P321, DOI 10.1006/abbi.2001.2463; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; King KL, 2007, ARCH BIOCHEM BIOPHYS, V467, P234, DOI 10.1016/j.abb.2007.08.020; KONIG T, 1982, J BIOENERG BIOMEMBR, V14, P297, DOI 10.1007/BF00743059; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; Nakamura Y, 2004, J BIOL CHEM, V279, P21223, DOI 10.1074/jbc.M314156200; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schenk S, 2006, AM J PHYSIOL-ENDOC M, V291, pE254, DOI 10.1152/ajpendo.00051.2006; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Turkaly P, 1999, FEBS LETT, V460, P241, DOI 10.1016/S0014-5793(99)01354-X; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; ZAMMIT VA, 1989, BIOCHEM J, V263, P89, DOI 10.1042/bj2630089; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5	44	153	156	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25655	25662		10.1074/jbc.M111.228692	http://dx.doi.org/10.1074/jbc.M111.228692			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622568	Green Published, hybrid			2022-12-25	WOS:000293073000027
J	Spivey, VL; Molle, V; Whalan, RH; Rodgers, A; Leiba, J; Stach, L; Walker, KB; Smerdon, SJ; Buxton, RS				Spivey, Vicky L.; Molle, Virginie; Whalan, Rachael H.; Rodgers, Angela; Leiba, Jade; Stach, Lasse; Walker, K. Barry; Smerdon, Stephen J.; Buxton, Roger S.			Forkhead-associated (FHA) Domain Containing ABC Transporter Rv1747 Is Positively Regulated by Ser/Thr Phosphorylation in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PROTEIN-KINASES; MYCOLIC ACID BIOSYNTHESIS; CELL-DIVISION; DNA-DAMAGE; PKNB; SPECIFICITY; SUBSTRATE; TRANSCRIPTION; MECHANISMS; VIRULENCE	One major signaling method employed by Mycobacterium tuberculosis, the causative agent of tuberculosis, is through reversible phosphorylation of proteins mediated by protein kinases and phosphatases. This study concerns one of these enzymes, the serine/threonine protein kinase PknF, that is encoded in an operon with Rv1747, an ABC transporter that is necessary for growth of M. tuberculosis in vivo and contains two forkhead-associated (FHA) domains. FHA domains are phosphopeptide recognition motifs that specifically recognize phosphothreonine-containing epitopes. Experiments to determine how PknF regulates the function of Rv1747 demonstrated that phosphorylation occurs on two specific threonine residues, Thr150 and Thr-208. To determine the in vivo consequences of phosphorylation, infection experiments were performed in bone marrow-derived macrophages and in mice using threonine-to-alanine mutants of Rv1747 that prevent specific phosphorylation and revealed that phosphorylation positively modulates Rv1747 function in vivo. The role of the FHA domains in this regulation was further demonstrated by isothermal titration calorimetry, using peptides containing both phosphothreonine residues. FHA-1 domain mutation resulted in attenuation in macrophages highlighting the critical role of this domain in Rv1747 function. A mutant deleted for pknF did not, however, have a growth phenotype in an infection, suggesting that other kinases can fulfill its role when it is absent. This study provides the first information on the molecular mechanism(s) regulating Rv1747 through PknF-dependent phosphorylation but also indicates that phosphorylation activates Rv1747, which may have important consequences in regulating growth of M. tuberculosis.	[Molle, Virginie; Leiba, Jade] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Molle, Virginie; Leiba, Jade] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Spivey, Vicky L.; Whalan, Rachael H.; Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England; [Rodgers, Angela; Walker, K. Barry] Natl Inst Biol Stand & Controls, Immunol & Cellular Immun Sect, Bacteriol Div, Potters Bar EN6 3QG, Herts, England; [Stach, Lasse; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; MRC National Institute for Medical Research; National Institute for Biological Standards & Control; MRC National Institute for Medical Research	Molle, V (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	virginie.molle@univ-montp2.fr; rbuxton@nimr.mrc.ac.uk	MOLLE, Virginie/D-4050-2019	MOLLE, Virginie/0000-0002-6573-3411; Rowlands, Vicky/0000-0002-1352-938X; Smerdon, Stephen/0000-0001-5688-8465; Leiba, Jade/0000-0003-0584-9524	Medical Research Council [U117585867, U117584228]; National Research Agency [ANR-06-MIME-027-01, ANR-09-MIEN-004]; Health Protection Agency; MRC [MC_U117585867, MC_U117584228] Funding Source: UKRI; Medical Research Council [MC_U117584228, MC_U117585867] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Agency(French National Research Agency (ANR)); Health Protection Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council studentships (to V. L. S. and L. S.), Medical Research Council Grants U117585867 and U117584228, National Research Agency Grants ANR-06-MIME-027-01 and ANR-09-MIEN-004, and by the Health Protection Agency.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; KONG DQ, 1995, INFECT IMMUN, V63, P799, DOI 10.1128/IAI.63.3.799-803.1995; Li J, 2008, J BIOL CHEM, V283, P36019, DOI 10.1074/jbc.M804075200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lougheed K. E., 2011, TUBERCULOSIS; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Oatway WH, 1936, J INFECT DIS, V59, P306, DOI 10.1093/infdis/59.3.306; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Springer B, 2001, INT J MED MICROBIOL, V290, P669; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Umeyama T, 2002, APPL MICROBIOL BIOT, V59, P419, DOI 10.1007/s00253-002-1045-1; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006	46	28	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26198	26209		10.1074/jbc.M111.246132	http://dx.doi.org/10.1074/jbc.M111.246132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622570	hybrid, Green Published			2022-12-25	WOS:000293073000077
J	Ye, HH; Zhao, T; Tan, YLJ; Liu, JH; Pallen, CJ; Xiao, ZC				Ye, Haihong; Zhao, Tian; Tan, Yen Ling Jessie; Liu, Jianghong; Pallen, Catherine J.; Xiao, Zhi-Cheng			Receptor-like Protein-tyrosine Phosphatase alpha Enhances Cell Surface Expression of Neural Adhesion Molecule NB-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTP-ALPHA; RPTP-ALPHA; FUNCTIONAL INTERACTIONS; CONTACTIN/F3 SUBGROUP; DENDRITE ORIENTATION; NEURONAL MIGRATION; DOWN-REGULATION; CANCER CELLS; SRC; DIFFERENTIATION	Neural adhesion molecule NB-3 plays an important role in the apical dendrite development of layer V pyramidal neurons in the visual cortex, and receptor-like protein-tyrosine phosphatase alpha (PTP alpha) mediates NB-3 signaling in this process. Here we investigated the role of PTP alpha in regulating cell surface expression of NB-3. We found that cortical neurons from PTP alpha knock-out mice exhibited a lower level of NB-3 at the cell surface. When expressed in COS1 cells, NB-3 was enriched in the Golgi apparatus with a low level of cell surface expression. However, co-expression of PTP alpha increased the cell surface distribution of NB-3. Further analysis showed that PTP alpha facilitated Golgi exit of NB-3 and stabilized NB-3 protein at the cell surface by preventing its release from the plasma membrane. The extracellular region of PTP alpha but not its catalytic activity is necessary for its effect on NB-3 expression. Thus, the PTP alpha-mediated increase of NB-3 level at the cell surface represents a novel function of PTP alpha in NB-3 signaling in neural development.	[Ye, Haihong; Zhao, Tian; Liu, Jianghong] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Tan, Yen Ling Jessie; Xiao, Zhi-Cheng] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Pallen, Catherine J.] Univ British Columbia, Dept Paediat, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia	Chinese Academy of Sciences; Institute of Biophysics, CAS; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Kunming Medical University; Monash University	Ye, HH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Room 8821,15 Datun Rd, Beijing 100101, Peoples R China.	yehaihong@gmail.com		Ye, Haihong/0000-0001-7282-6280; xiao, zhicheng/0000-0001-5172-762X; Pallen, Catherine/0000-0002-3576-5295	Ministry of Science and Technology [2009CB825402, 2010CB529603]; National Science Foundation in China [30900845]; Canadian Institutes of Health Research [MOP-62759]; Child & Family Research Institute; Talent Program of Yunnan Province, China; Monash University, Australia	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Talent Program of Yunnan Province, China; Monash University, Australia(Monash University)	This work was supported in part by Ministry of Science and Technology Grants 2009CB825402 and 2010CB529603 and National Science Foundation Grant 30900845 in China (to H. Y.) and by Canadian Institutes of Health Research Grant MOP-62759 (to C. J. P.).; Recipient of an Investigator Award from the Child & Family Research Institute.; Recipient of financial support from both Talent Program of Yunnan Province, China, and Monash Professorial Fellowships Program, Monash University, Australia.	Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Cuoco C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-12; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Drumheller T, 1996, J MED GENET, V33, P842, DOI 10.1136/jmg.33.10.842; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Ogawa J, 1996, NEUROSCI LETT, V218, P173, DOI 10.1016/S0304-3940(96)13156-6; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pohjola P, 2010, AM J MED GENET A, V152A, P441, DOI 10.1002/ajmg.a.33215; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Stetak A, 2001, BIOCHEM BIOPH RES CO, V288, P564, DOI 10.1006/bbrc.2001.5811; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Vacaru AM, 2010, MOL CELL BIOL, V30, P2850, DOI 10.1128/MCB.01202-09; VERJAAL M, 1978, AM J DIS CHILD, V132, P43, DOI 10.1001/archpedi.1978.02120260045012; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	41	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26071	26080		10.1074/jbc.M110.214080	http://dx.doi.org/10.1074/jbc.M110.214080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622556	Green Published, hybrid			2022-12-25	WOS:000293073000065
J	Durand, E; Alphonse, S; Brochier-Armanet, C; Ball, G; Douzi, B; Filloux, A; Bernard, C; Voulhoux, R				Durand, Eric; Alphonse, Sebastien; Brochier-Armanet, Celine; Ball, Genevieve; Douzi, Badreddine; Filloux, Alain; Bernard, Cedric; Voulhoux, Rome			The Assembly Mode of the Pseudopilus A HALLMARK TO DISTINGUISH A NOVEL SECRETION SYSTEM SUBTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; XCP GENES; PILUS; LOCALIZATION; SPECIFICITY; APPARATUS; COMPLEX	In Gram-negative bacteria, type II secretion systems assemble a piston-like structure, called pseudopilus, which expels exoproteins out of the cell. The pseudopilus is constituted by a major pseudopilin that when overproduced multimerizes into a long cell surface structure named hyper-pseudopilus. Pseudomonas aeruginosa possesses two type II secretion systems, Xcp and Hxc. Although major pseudopilins are exchangeable among type II secretion systems, we show that XcpT and HxcT are not. We demonstrate that HxcT does not form a hyper-pseudopilus and is different in amino acid sequence and multimerization properties. Using structure-based mutagenesis, we observe that five mutations are sufficient to revert HxcT into a functional XcpT-like protein, which also becomes capable of forming a hyper-pseudopilus. Phylogenetic and experimental analysis showed that the whole Hxc system was acquired by P. aeruginosa PAO1 and other Pseudomonas species through horizontal gene transfer. We thus identified a new type II secretion subfamily, of which the P. aeruginosa Hxc system is the archetype. This finding demonstrates how similar bacterial machineries evolve toward distinct mechanisms that may contribute specific functions.	[Durand, Eric; Ball, Genevieve; Douzi, Badreddine; Voulhoux, Rome] Univ Mediterranee, CNRS, Lab Ingn Syst Macromol LISM UPR9027, Inst Microbiol Mediterranee, F-13402 Marseille 20, France; [Alphonse, Sebastien; Douzi, Badreddine; Bernard, Cedric] Univ Aix Marseille 1, CNRS, Architecture & Fonct Macromol Biol AFMB UMR6098, F-13288 Marseille 9, France; [Alphonse, Sebastien; Douzi, Badreddine; Bernard, Cedric] Univ Mediterranee, F-13288 Marseille 9, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, CNRS, Lab Chim Bacterienne LCB UPR9043, Inst Microbiol Mediterranee, F-13402 Marseille 20, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, CMMI, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Voulhoux, R (corresponding author), Univ Mediterranee, CNRS, Lab Ingn Syst Macromol LISM UPR9027, Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; Durand, Eric/E-6739-2017; Brochier-Armanet, Celine/B-7898-2011; Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019	Durand, Eric/0000-0002-0577-8220; Douzi, Badreddine/0000-0003-3140-4713; Alphonse, Sebastien/0000-0002-2054-2005; Brochier-Armanet, Celine/0000-0003-4669-3589	Royal Society; 3D-Pilus Young Researcher Grant [ANR-JC 07-183230]	Royal Society(Royal Society of London); 3D-Pilus Young Researcher Grant	This work was supported by 3D-Pilus Young Researcher Grant ANR-JC 07-183230 (to E. D.).; Supported by the Royal Society.	Alphonse S, 2010, J STRUCT BIOL, V169, P75, DOI 10.1016/j.jsb.2009.09.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; BALLY M, 1992, MOL MICROBIOL, V6, P1121, DOI 10.1111/j.1365-2958.1992.tb01550.x; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; deGroot A, 1996, MOL GEN GENET, V250, P491, DOI 10.1007/s004380050102; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Kagami Y, 1998, MOL MICROBIOL, V27, P221, DOI 10.1046/j.1365-2958.1998.00679.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2009, J BIOL CHEM, V284, P25466, DOI 10.1074/jbc.C109.037655; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Michel Gerard P. F., 2009, P67; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	30	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24407	24416		10.1074/jbc.M111.234278	http://dx.doi.org/10.1074/jbc.M111.234278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586577	hybrid, Green Published			2022-12-25	WOS:000292294900080
J	Lowenstein, J				Lowenstein, Jerome			The anglerfish and uremic	FASEB JOURNAL			English	Article							RESIDUAL RENAL-FUNCTION; ORGANIC ANION TRANSPORTERS; INDOXYL SULFATE; RELATIVE CONTRIBUTION; GENE-EXPRESSION; DIALYSIS; INDUCTION; ADEQUACY; KIDNEY		NYU, Sch Med, Div Nephrol, New York, NY 10016 USA	New York University	Lowenstein, J (corresponding author), NYU, Sch Med, Div Nephrol, 530 1st Ave,4D, New York, NY 10016 USA.	jerome.lowenstein@nyumc.org		Lowenstein, Jerome/0000-0002-2090-2015				Aoyama I, 2003, AM J KIDNEY DIS, V41, pS8, DOI 10.1053/ajkd.2003.50075; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Beyenbach KW, 2004, AM J PHYSIOL-RENAL, V286, pF811, DOI 10.1152/ajprenal.00351.2003; BOWMER CJ, 1982, BIOCHEM PHARMACOL, V31, P319, DOI 10.1016/0006-2952(82)90177-0; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; EVENEPOEL P, 2009, KIDNEY INT S114, V76, P512; Grantham JJ, 2002, AM J PHYSIOL-RENAL, V282, pF1, DOI 10.1152/ajprenal.2002.282.1.F1; Himmelfarb J, 2006, CLIN J AM SOC NEPHRO, V1, P896, DOI 10.2215/CJN.10911105; Launay-Vacher V, 2006, NEPHRON PHYSIOL, V103, P97, DOI 10.1159/000092212; LOWENSTEIN J, 1985, B MOUNT DESERT BIOL, V25, P66; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421; OLIVER J, 1950, J UROLOGY, V63, P373, DOI 10.1016/S0022-5347(17)68776-7; Oliver J., 1939, ARCHITECTURE KIDNEY; Rettig RA, 2011, NEW ENGL J MED, V364, P596, DOI 10.1056/NEJMp1014193; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Sekine T, 2000, PFLUG ARCH EUR J PHY, V440, P337, DOI 10.1007/s004240000297; Sekine T, 2006, AM J PHYSIOL-RENAL, V290, pF251, DOI 10.1152/ajprenal.00439.2004; Smith HW, 1941, PORTER LECT SERIES, V9; Smith HW., 1951, KIDNEY STRUCTURE FUN, P552; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610	31	20	21	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1781	1785		10.1096/fj.11-0602ufm	http://dx.doi.org/10.1096/fj.11-0602ufm			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21622695				2022-12-25	WOS:000291023800002
J	Xue, JH; Chen, LH; Zhao, HZ; Pu, YD; Feng, HZ; Ma, YG; Ma, J; Chang, YM; Zhang, ZM; Xie, MJ				Xue, Jun-Hui; Chen, Lian-Hong; Zhao, Hua-Zhou; Pu, Yong-Dong; Feng, Han-Zhong; Ma, Yu-Guang; Ma, Jin; Chang, Yao-Ming; Zhang, Zuo-Ming; Xie, Man-Jiang			Differential Regulation and Recovery of Intracellular Ca2+ in Cerebral and Small Mesenteric Arterial Smooth Muscle Cells of Simulated Microgravity Rat	PLOS ONE			English	Article							ION CHANNELS; ACTIVATION; SPACEFLIGHT; ADAPTATION; K+	Background: The differential adaptations of cerebrovasculature and small mesenteric arteries could be one of critical factors in postspaceflight orthostatic intolerance, but the cellular mechanisms remain unknown. We hypothesize that there is a differential regulation of intracellular Ca2+ determined by the alterations in the functions of plasma membrane Ca-L channels and ryanodine-sensitive Ca2+ releases from sarcoplasmic reticulum (SR) in cerebral and small mesenteric vascular smooth muscle cells (VSMCs) of simulated microgravity rats, respectively. Methodology/Principal Findings: Sprague-Dawley rats were subjected to 28-day hindlimb unweighting to simulate microgravity. In addition, tail-suspended rats were submitted to a recovery period of 3 or 7 days after removal of suspension. The function of Ca-L channels was evaluated by patch clamp and Western blotting. The function of ryanodine-sensitive Ca2+ releases in response to caffeine were assessed by a laser confocal microscope. Our results indicated that simulated microgravity increased the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases in cerebral VSMCs, whereas, simulated microgravity decreased the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases in small mesenteric VSMCs. In addition, 3- or 7-day recovery after removal of suspension could restore the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases to their control levels in cerebral and small mesenteric VSMCs, respectively. Conclusions: The differential regulation of Ca-L channels and ryanodine-sensitive Ca2+ releases in cerebral and small mesenteric VSMCs may be responsible for the differential regulation of intracellular Ca2+, which leads to the altered autoregulation of cerebral vasculature and the inability to adequately elevate peripheral vascular resistance in postspaceflight orthostatic intolerance.	[Xue, Jun-Hui; Chang, Yao-Ming; Zhang, Zuo-Ming] Fourth Mil Med Univ, Dept Aerosp Clin Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China; [Chen, Lian-Hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Chest Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhao, Hua-Zhou; Pu, Yong-Dong] Gen Hosp PLA, Clin Div 309, Dept Gen Surg, Beijing, Peoples R China; [Feng, Han-Zhong; Ma, Yu-Guang; Ma, Jin; Chang, Yao-Ming; Xie, Man-Jiang] Fourth Mil Med Univ, Dept Aerosp Physiol, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University	Xue, JH (corresponding author), Fourth Mil Med Univ, Dept Aerosp Clin Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China.	xuejunhui@fmmu.edu.cn; manjiangxie@hotmail.com			National Natural Science Foundation of China [30800545, 30900283, 31070768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30800545, 30900283 and 31070768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist GC, 1996, MED SCI SPORT EXER, V28, pS9; Brini M, 2004, BIOCHEM BIOPH RES CO, V322, P1245, DOI 10.1016/j.bbrc.2004.08.029; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Chalmers S, 2007, CELL CALCIUM, V42, P447, DOI 10.1016/j.ceca.2007.05.010; CHANG H, 2010, J CELL PHYSL; Colleran PN, 2008, AM J PHYSIOL-REG I, V294, pR1577, DOI 10.1152/ajpregu.00084.2008; Dong L, 2009, CLIN EXP PHARMACOL P, V36, pe57, DOI 10.1111/j.1440-1681.2009.05222.x; Essin K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/135249; Fu ZJ, 2004, AM J PHYSIOL-HEART C, V287, pH1505, DOI 10.1152/ajpheart.00143.2004; GAZENKO OG, 1981, ACTA ASTRONAUT, V8, P907, DOI 10.1016/0094-5765(81)90061-8; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Li XQ, 2009, PFLUG ARCH EUR J PHY, V457, P771, DOI 10.1007/s00424-008-0556-8; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Ma YG, 2010, APOPTOSIS, V15, P426, DOI 10.1007/s10495-009-0423-x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Peng HL, 2010, PFLUG ARCH EUR J PHY, V460, P791, DOI 10.1007/s00424-010-0850-0; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; Rainbow RD, 2009, CELL CALCIUM, V46, P313, DOI 10.1016/j.ceca.2009.09.001; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Wilkerson MK, 1999, J APPL PHYSIOL, V87, P2115, DOI 10.1152/jappl.1999.87.6.2115; Wray S, 2005, CELL CALCIUM, V38, P397, DOI 10.1016/j.ceca.2005.06.018; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Xue JH, 2007, AM J PHYSIOL-HEART C, V293, pH691, DOI 10.1152/ajpheart.01229.2006; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhao O, 2007, SHOCK, V28, P717, DOI 10.1097/shk.0b013e318050c914	29	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19775	10.1371/journal.pone.0019775	http://dx.doi.org/10.1371/journal.pone.0019775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611118	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200031
J	Luikart, BW; Bensen, AL; Washburn, EK; Perederiy, JV; Su, KG; Li, Y; Kernie, SG; Parada, LF; Westbrook, GL				Luikart, Bryan W.; Bensen, AeSoon L.; Washburn, Eric K.; Perederiy, Julia V.; Su, Kimmy G.; Li, Yun; Kernie, Steven G.; Parada, Luis F.; Westbrook, Gary L.			miR-132 Mediates the Integration of Newborn Neurons into the Adult Dentate Gyrus	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; REGULATED MICRORNA; GRANULE CELLS; EXPRESSION; TRANSCRIPTION; MATURATION; PLASTICITY; MECHANISMS; PROTEINS	Neuronal activity enhances the elaboration of newborn neurons as they integrate into the synaptic circuitry of the adult brain. The role microRNAs play in the transduction of neuronal activity into growth and synapse formation is largely unknown. MicroRNAs can influence the expression of hundreds of genes and thus could regulate gene assemblies during processes like activity-dependent integration. Here, we developed viral-based methods for the in vivo detection and manipulation of the activity-dependent microRNA, miR-132, in the mouse hippocampus. We find, using lentiviral and retroviral reporters of miR-132 activity, that miR-132 is expressed at the right place and right time to influence the integration of newborn neurons. Retroviral knockdown of miR-132 using a specific 'sponge' containing multiple target sequences impaired the integration of newborn neurons into the excitatory synaptic circuitry of the adult brain. To assess potential miR-132 targets, we used a whole-genome microarray in PC12 cells, which have been used as a model of neuronal differentiation. miR-132 knockdown in PC12 cells resulted in the increased expression of hundreds of genes. Functional grouping indicated that genes involved in inflammatory/immune signaling were the most enriched class of genes induced by miR-132 knockdown. The correlation of miR-132 knockdown to increased proinflammatory molecular expression may indicate a mechanistic link whereby miR-132 functions as an endogenous mediator of activity-dependent integration in vivo.	[Luikart, Bryan W.; Bensen, AeSoon L.; Washburn, Eric K.; Perederiy, Julia V.; Su, Kimmy G.; Westbrook, Gary L.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Li, Yun; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Li, Yun; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Res Nerve Growth & Regenerat, Dallas, TX 75390 USA	Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luikart, BW (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	Bryan.W.Luikart@dartmouth.edu	Luikart, Bryan/D-2683-2012; Li, Yun/C-3367-2011; Kernie, Steven/AAT-9912-2020; Parada, luis F/B-9400-2014	Li, Yun/0000-0002-5849-5910; Kernie, Steven/0000-0003-1371-0549	Vertex pharmaceuticals [T32NS007381, F32MH079548, MH46613]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046613, F32MH079548, R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007381, P30NS061800] Funding Source: NIH RePORTER	Vertex pharmaceuticals(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by T32NS007381, F32MH079548, a National Alliance for Research on Schizophrenia and Depression Young Investigator Award (BWL), MH46613 (GLW), and an Oregon Health & Science University sponsored research project grant from Vertex pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gorski JA, 2003, J NEUROSCI, V23, P6856; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee B, 2007, NEUROBIOL DIS, V25, P80, DOI 10.1016/j.nbd.2006.08.015; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Tovar KR, 1999, J NEUROSCI, V19, P4180; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vereyken EJF, 2007, EUR J NEUROSCI, V25, P3605, DOI 10.1111/j.1460-9568.2007.05615.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	118	120	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19077	10.1371/journal.pone.0019077	http://dx.doi.org/10.1371/journal.pone.0019077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611182	Green Published, Green Submitted, gold			2022-12-25	WOS:000290657500003
J	Racz, E; Kurek, D; Kant, M; Baerveldt, EM; Florencia, E; Mourits, S; de Ridder, D; Laman, JD; van der Fits, L; Prens, EP				Racz, Emoke; Kurek, Dorota; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; de Ridder, Dick; Laman, Jon D.; van der Fits, Leslie; Prens, Errol P.			GATA3 Expression Is Decreased in Psoriasis and during Epidermal Regeneration; Induction by Narrow-Band UVB and IL-4	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; OLIGONUCLEOTIDE ARRAY; GENE-EXPRESSION; T-CELL; HUMAN KERATINOCYTES; SKIN; INFLAMMATION; PROLIFERATION; NORMALIZATION; DISRUPTION	Psoriasis is characterized by hyperproliferation of keratinocytes and by infiltration of activated Th1 and Th17 cells in the (epi) dermis. By expression microarray, we previously found the GATA3 transcription factor significantly downregulated in lesional psoriatic skin. Since GATA3 serves as a key switch in both epidermal and T helper cell differentiation, we investigated its function in psoriasis. Because psoriatic skin inflammation shares many characteristics of epidermal regeneration during wound healing, we also studied GATA3 expression under such conditions. Psoriatic lesional skin showed decreased GATA3 mRNA and protein expression compared to non-lesional skin. GATA3 expression was also markedly decreased in inflamed skin of mice with a psoriasiform dermatitis induced with imiquimod. Tape-stripping of non-lesional skin of patients with psoriasis, a standardized psoriasis-triggering and skin regeneration-inducing technique, reduced the expression of GATA3. In wounded skin of mice, low GATA3 mRNA and protein expression was detected. Taken together, GATA3 expression is downregulated under regenerative and inflammatory hyperproliferative skin conditions. GATA3 expression could be re-induced by successful narrow-band UVB treatment of both human psoriasis and imiquimod-induced psoriasiform dermatitis in mice. The prototypic Th2 cytokine IL-4 was the only cytokine capable of inducing GATA3 in skin explants from healthy donors. Based on these findings we argue that GATA3 serves as a key regulator in psoriatic inflammation, keratinocyte hyperproliferation and skin barrier dysfunction.	[Racz, Emoke; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; van der Fits, Leslie; Prens, Errol P.] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Racz, Emoke; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; Laman, Jon D.; van der Fits, Leslie; Prens, Errol P.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kurek, Dorota] Erasmus Univ, Dept Cell Biol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Racz, E (corresponding author), Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands.	e.prens@erasmusmc.nl	de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310; Florencia, Edwin/0000-0001-9005-4464; Racz, Emoke/0000-0001-5119-6451; Kurek, Dorota/0000-0002-7168-8944; Prens, Errol/0000-0002-8158-660X				Arshad SH, 2008, BRIT J DERMATOL, V158, P1315, DOI 10.1111/j.1365-2133.2008.08565.x; Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breternitz M, 2007, BRIT J DERMATOL, V156, P231, DOI 10.1111/j.1365-2133.2006.07632.x; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Companjen AR, 2001, ARCH DERMATOL RES, V293, P184, DOI 10.1007/s004030100219; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Ghadially R, 1996, J INVEST DERMATOL, V107, P558, DOI 10.1111/1523-1747.ep12582813; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guenova E, 2008, EUR J IMMUNOL, V38, P3138, DOI 10.1002/eji.200838463; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Loffler H, 2004, BRIT J DERMATOL, V151, P746, DOI 10.1111/j.1365-2133.2004.06084.x; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Prens E, 1996, AM J PATHOL, V148, P1493; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Racz E, 2011, J INVEST DERMATOL; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Schuff M, 2007, DEV DYNAM, V236, P226, DOI 10.1002/dvdy.21007; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Son DN, 2009, GENE, V436, P121, DOI 10.1016/j.gene.2009.02.002; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tschachler E, 2007, CLIN DERMATOL, V25, P589, DOI 10.1016/j.clindermatol.2007.09.021; van der Fits L, 2003, J PATHOL, V199, P107, DOI 10.1002/path.1263; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	49	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19806	10.1371/journal.pone.0019806	http://dx.doi.org/10.1371/journal.pone.0019806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611195	Green Published, Green Submitted, gold			2022-12-25	WOS:000290657500023
J	Carmona, D; Rodriguez-Almazan, C; Munoz-Garay, C; Portugal, L; Perez, C; de Maagd, RA; Bakker, P; Soberon, M; Bravo, A				Carmona, Daniela; Rodriguez-Almazan, Claudia; Munoz-Garay, Carlos; Portugal, Leivi; Perez, Claudia; de Maagd, Ruud A.; Bakker, Petra; Soberon, Mario; Bravo, Alejandra			Dominant Negative Phenotype of Bacillus thuringiensis Cry1Ab, Cry11Aa and Cry4Ba Mutants Suggest Hetero-Oligomer Formation among Different Cry Toxins	PLOS ONE			English	Article							SUBSP ISRAELENSIS; DELTA-ENDOTOXIN; MANDUCA-SEXTA; ALKALINE-PHOSPHATASE; PROTECTIVE ANTIGEN; MOSQUITO; CRYSTAL; AMINOPEPTIDASE; EXPRESSION; COMPONENTS	Background: Bacillus thuringiensis Cry toxins are used worldwide in the control of different insect pests important in agriculture or in human health. The Cry proteins are pore-forming toxins that affect the midgut cell of target insects. It was shown that non-toxic Cry1Ab helix alpha-4 mutants had a dominant negative (DN) phenotype inhibiting the toxicity of wildtype Cry1Ab when used in equimolar or sub-stoichiometric ratios (1:1, 0.5:1, mutant:wt) indicating that oligomer formation is a key step in toxicity of Cry toxins. Methodology/Principal Findings: The DN Cry1Ab-D136N/T143D mutant that is able to block toxicity of Cry1Ab toxin, was used to analyze its capacity to block the activity against Manduca sexta larvae of other Cry1 toxins, such as Cry1Aa, Cry1Ac, Cry1Ca, Cry1Da, Cry1Ea and Cry1Fa. Cry1Ab-DN mutant inhibited toxicity of Cry1Aa, Cry1Ac and Cry1Fa. In addition, we isolated mutants in helix alpha-4 of Cry4Ba and Cry11Aa, and demonstrate that Cry4Ba-E159K and Cry11Aa-V142D are inactive and completely block the toxicity against Aedes aegypti of both wildtype toxins, when used at sub-stoichiometric ratios, confirming a DN phenotype. As controls we analyzed Cry1Ab-R99A or Cry11Aa-E97A mutants that are located in helix alpha-3 and are affected in toxin oligomerization. These mutants do not show a DN phenotype but were able to block toxicity when used in 10:1 or 100:1 ratios (mutant: wt) probably by competition of binding with toxin receptors. Conclusions/Significance: We show that DN phenotype can be observed among different Cry toxins suggesting that may interact in vivo forming hetero-oligomers. The DN phenotype cannot be observed in mutants affected in oligomerization, suggesting that this step is important to inhibit toxicity of other toxins.	[Carmona, Daniela; Rodriguez-Almazan, Claudia; Munoz-Garay, Carlos; Portugal, Leivi; Perez, Claudia; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [de Maagd, Ruud A.; Bakker, Petra] Plant Res Int, Biosci, Wageningen, Netherlands	Universidad Nacional Autonoma de Mexico	Carmona, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico.	bravo@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017; de Maagd, Ruud A/A-5859-2012	de Maagd, Ruud A/0000-0001-7049-2029; Bakker, Petra/0000-0001-7019-0258; Munoz-Garay, Carlos/0000-0002-7218-4027; Bravo, Alejandra/0000-0002-7573-7475	CONACyT [024967, 224926]; DGAPA-UNAM [IN206209]; National Institutes of Health [1R01 AI066014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CONACyT 024967, 224926 (www.conacyt.mx); DGAPA-UNAM IN206209 (http://dgapa.unam.mx/); and National Institutes of Health, 1R01 AI066014 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Mohd Amir F., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-16; Angsuthanasombat C, 2001, J BIOCHEM MOL BIOL, V34, P402; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bravo A., 2005, BACILLUS THURINGIENS, P175, DOI DOI 10.1016/B0-44-451924-6/00081-8; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; CRICKMORE N, 1995, FEMS MICROBIOL LETT, V131, P249; DELECLUSE A, 1993, APPL ENVIRON MICROB, V59, P3922; Canton PE, 2011, PEPTIDES, V32, P595, DOI 10.1016/j.peptides.2010.06.005; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Hernandez-Soto A, 2009, APPL ENVIRON MICROB, V75, P4661, DOI 10.1128/AEM.00409-09; HOFTE H, 1986, EUR J BIOCHEM, V161, P273, DOI 10.1111/j.1432-1033.1986.tb10443.x; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Lee MK, 1996, APPL ENVIRON MICROB, V62, P583, DOI 10.1128/AEM.62.2.583-586.1996; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Munoz-Garay C, 2009, APPL ENVIRON MICROB, V75, P7548, DOI 10.1128/AEM.01303-09; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; PONCET S, 1995, J INVERTEBR PATHOL, V66, P131, DOI 10.1006/jipa.1995.1075; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sharma P, 2010, LETT APPL MICROBIOL, V51, P42, DOI 10.1111/j.1472-765X.2010.02856.x; Siebert MW, 2008, J ECON ENTOMOL, V101, P1950, DOI 10.1603/0022-0493-101.6.1950; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Sramala I., 2001, J BIOCH MOL BIOL BIO, V5, P219; Taveecharoenkool T., 2010, PMC BIOPHYS, V3, P1; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; THOMAS WE, 1983, J CELL SCI, V60, P181; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Zhang R, 2008, BIOCHEMISTRY-US, V47, P11263, DOI 10.1021/bi801181g	37	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19952	10.1371/journal.pone.0019952	http://dx.doi.org/10.1371/journal.pone.0019952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603577	Green Published, gold			2022-12-25	WOS:000290656300043
J	Lefeuvre, P; Harkins, GW; Lett, JM; Briddon, RW; Chase, MW; Moury, B; Martin, DP				Lefeuvre, Pierre; Harkins, Gordon W.; Lett, Jean-Michel; Briddon, Rob W.; Chase, Mark W.; Moury, Benoit; Martin, Darren P.			Evolutionary Time-Scale of the Begomoviruses: Evidence from Integrated Sequences in the Nicotiana Genome	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; PHYLOGENETIC EVIDENCE; MOLECULAR EVOLUTION; VIRUS EVOLUTION; GEMINIVIRAL DNA; RATES; ORIGIN; PATTERNS; RECOMBINATION; ENDOSYMBIONTS	Despite having single stranded DNA genomes that are replicated by host DNA polymerases, viruses in the family Geminiviridae are apparently evolving as rapidly as some RNA viruses. The observed substitution rates of geminiviruses in the genera Begomovirus and Mastrevirus are so high that the entire family could conceivably have originated less than a million years ago (MYA). However, the existence of geminivirus related DNA (GRD) integrated within the genomes of various Nicotiana species suggests that the geminiviruses probably originated > 10 MYA. Some have even suggested that a distinct New-World (NW) lineage of begomoviruses may have arisen following the separation by continental drift of African and American proto-begomoviruses similar to 110 MYA. We evaluate these various geminivirus origin hypotheses using Bayesian coalescent-based approaches to date firstly the Nicotiana GRD integration events, and then the divergence of the NW and Old-World (OW) begomoviruses. Besides rejecting the possibility of a<2 MYA OW-NW begomovirus split, we could also discount that it may have occurred concomitantly with the breakup of Gondwanaland 110 MYA. Although we could only confidently narrow the date of the split down to between 2 and 80 MYA, the most plausible (and best supported) date for the split is between 20 and 30 MYA - a time when global cooling ended the dispersal of temperate species between Asia and North America via the Beringian land bridge.	[Lefeuvre, Pierre; Lett, Jean-Michel] Univ Reunion, CIRAD, UMR PVBMT CIRAD 53, St Pierre, Reunion, France; [Harkins, Gordon W.] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Briddon, Rob W.] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, England; [Moury, Benoit] INRA, Pathol Vegetale UR407, Montfavet, France; [Lefeuvre, Pierre; Martin, Darren P.] Univ Cape Town, Computat Biol Grp, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	CIRAD; University of La Reunion; South African National Biodiversity Institute; University of the Western Cape; Pakistan Institute of Engineering & Applied Science; Royal Botanic Gardens, Kew; INRAE; University of Cape Town	Lefeuvre, P (corresponding author), Univ Reunion, CIRAD, UMR PVBMT CIRAD 53, St Pierre, Reunion, France.	pierre.lefeuvre@cirad.fr	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008; Chase, Mark W/A-6642-2011; Briddon, Rob W./I-5921-2012	Briddon, Rob W./0000-0001-8738-0365; Lefeuvre, Pierre/0000-0003-2645-8098; LETT, Jean-Michel/0000-0003-1585-5338; harkins, gordon w/0000-0003-0041-8047	GIS CRVOI [PRAO/AIRD/CRVOI/08/03]; CIRAD; European Union; Wellcome Trust; South African National Research Foundation; Higher Education Commission, Government of Pakistan; Royal Botanic Gardens, Kew; GIS CRVOI [PRAO/AIRD/CRVOI/08/03]; CIRAD; European Union; Wellcome Trust; South African National Research Foundation; Higher Education Commission, Government of Pakistan; Royal Botanic Gardens, Kew	GIS CRVOI; CIRAD; European Union(European Commission); Wellcome Trust(Wellcome Trust); South African National Research Foundation(National Research Foundation - South Africa); Higher Education Commission, Government of Pakistan(Higher Education Commission of Pakistan); Royal Botanic Gardens, Kew; GIS CRVOI; CIRAD; European Union(European Commission); Wellcome Trust(Wellcome Trust); South African National Research Foundation(National Research Foundation - South Africa); Higher Education Commission, Government of Pakistan(Higher Education Commission of Pakistan); Royal Botanic Gardens, Kew	PL is funded by GIS CRVOI through the EmerGe grant (N<SUP>o</SUP>PRAO/AIRD/CRVOI/08/03). JML was funded by CIRAD and European Union (FEDER). DPM is funded by the Wellcome Trust. GWH is supported by a grant from the South African National Research Foundation. RWB is supported by the Higher Education Commission, Government of Pakistan, under the "Foreign Faculty Hiring Program". MWC is funded by the Royal Botanic Gardens, Kew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MK, 1997, PLANT MOL BIOL, V35, P313, DOI 10.1023/A:1005885200550; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bejarano ER, 1996, P NATL ACAD SCI USA, V93, P759, DOI 10.1073/pnas.93.2.759; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Fargette D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000125; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Gilbert C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000425; Grasso C, 2004, BIOINFORMATICS, V20, P1546, DOI 10.1093/bioinformatics/bth126; Ha C, 2006, J GEN VIROL, V87, P997, DOI 10.1099/vir.0.81631-0; Harkins GW, 2009, J GEN VIROL, V90, P3066, DOI 10.1099/vir.0.015537-0; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isnard M, 1998, J GEN VIROL, V79, P3091, DOI 10.1099/0022-1317-79-12-3091; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; Krupovic M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-112; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; LEMEY P, 2009, PLOS CURR INFLUENZA; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Owor BE, 2007, J GEN VIROL, V88, P3154, DOI 10.1099/vir.0.83144-0; Pagan I, 2010, J MOL EVOL, V71, P298, DOI 10.1007/s00239-010-9385-4; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Polani S, 2010, VIROLOGY, V405, P397, DOI 10.1016/j.virol.2010.06.010; Posada D, 2001, MOL BIOL EVOL, V18, P1976, DOI 10.1093/oxfordjournals.molbev.a003738; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; RYBICKI EP, 1994, ARCH VIROL, V139, P49, DOI 10.1007/BF01309454; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Walt E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-104; Wu BL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-335	57	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19193	10.1371/journal.pone.0019193	http://dx.doi.org/10.1371/journal.pone.0019193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603653	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300002
J	Wang, QD; Zhou, YN; Weiss, HL; Chow, CW; Evers, BM				Wang, Qingding; Zhou, Yuning; Weiss, Heidi L.; Chow, Chi-Wing; Evers, B. Mark			NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INFLAMMATORY-BOWEL-DISEASE; ACTIVATED T-CELLS; GLYCOGEN-SYNTHASE KINASE-3; COLON-CANCER CELLS; NUCLEAR-FACTOR; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR; REPRESS TRANSCRIPTION; EPITHELIAL-CELLS	TNF-related apoptosis-inducing ligand (TRAIL; Apo2) has been shown to promote intestinal cell differentiation. Nuclear factor of activated T cells (NFAT) participates in the regulation of a variety of cellular processes, including differentiation. Here, we examined the role of NFAT in the regulation of TRAIL in human intestinal cells. Treatment with a combination of phorbol 12-myristate 13-acetate (PMA) plus the calcium ionophore A23187 (Io) increased NFAT activation and TRAIL expression; pretreatment with the calcineurin inhibitor cyclosporine A (CsA), an antagonist of NFAT signaling, diminished NFAT activation and TRAIL induction. In addition, knockdown of NFATc1, NFATc2, NFATc3, and NFATc4 blocked PMA/Io increased TRAIL protein expression. Expression of NFATc1 activated TRAIL promoter activity and increased TRAIL mRNA and protein expression. Deletion of NFAT binding sites from the TRAIL promoter did not significantly abrogate NFATc1-increased TRAIL promoter activity, suggesting an indirect regulation of TRAIL expression by NFAT activation. Knockdown of NFATc1 increased Sp1 transcription factor binding to the TRAIL promoter and, importantly, inhibition of Sp1, by chemical inhibition or RNA interference, increased TRAIL expression. These studies identify a novel mechanism for TRAIL regulation by which activation of NFATc1 increases TRAIL expression through negative regulation of Sp1 binding to the TRAIL promoter.	[Wang, Qingding; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Wang, Qingding; Zhou, Yuning; Weiss, Heidi L.; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	University of Kentucky; University of Kentucky; Yeshiva University; Albert Einstein College of Medicine	Wang, QD (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40506 USA.	mark.evers@uky.edu			National Institutes of Health [R01 DK048498, P20CA150343]; NATIONAL CANCER INSTITUTE [P20CA150343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481, R01DK048498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01 DK048498 and P20CA150343 (UK GI SPORE) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chai WR, 2007, ASIAN J ANDROL, V9, P623, DOI 10.1111/j.1745-7262.2007.00257.x; Chai WR, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-31; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cho YS, 2010, IMMUNOLOGY, V130, P504, DOI 10.1111/j.1365-2567.2010.03266.x; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; EVERS BM, 1995, MOL CELL BIOL, V15, P3870; Feng DX, 2005, P NATL ACAD SCI USA, V102, P9896, DOI 10.1073/pnas.0502041102; Garcia A, 2000, J BIOL CHEM, V275, P9385, DOI 10.1074/jbc.275.13.9385; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kang-Park S, 2003, FEBS LETT, V545, P203, DOI 10.1016/S0014-5793(03)00535-0; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; POTTEN CS, 1997, AM J PHYSIOL, V273, P253; Rankin SL, 2009, BIOCHEM BIOPH RES CO, V379, P721, DOI 10.1016/j.bbrc.2008.12.075; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Shih TC, 2008, WORLD J GASTROENTERO, V14, P1759, DOI 10.3748/wjg.14.1759; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Souza HSP, 2005, INT J COLORECTAL DIS, V20, P277, DOI 10.1007/s00384-004-0639-8; Sternthal MB, 2008, AM J GASTROENTEROL, V103, P937, DOI 10.1111/j.1572-0241.2007.01718.x; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; TRABER PG, 1994, J LAB CLIN MED, V123, P467; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang Q, 2008, CELL DEATH DIFFER, V15, P908, DOI 10.1038/cdd.2008.2; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang QD, 2000, BIOCHEM BIOPH RES CO, V276, P466, DOI 10.1006/bbrc.2000.3512; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Wang QD, 2007, CANCER RES, V67, P7773, DOI 10.1158/0008-5472.CAN-07-0187; Wang XF, 2010, MOL CANCER THER, V9, P2389, DOI 10.1158/1535-7163.MCT-09-1080; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Xu J, 2008, CANCER RES, V68, P6718, DOI 10.1158/0008-5472.CAN-08-0657; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19882	10.1371/journal.pone.0019882	http://dx.doi.org/10.1371/journal.pone.0019882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603612	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300034
J	Jiang, B; Yap, MKH; Leung, KH; Ng, PW; Fung, WY; Lam, WW; Gu, YS; Yip, SP				Jiang, Bo; Yap, Maurice K. H.; Leung, Kim Hung; Ng, Po Wah; Fung, Wai Yan; Lam, Wai Wa; Gu, Yang-shun; Yip, Shea Ping			PAX6 Haplotypes Are Associated with High Myopia in Han Chinese	PLOS ONE			English	Article							REFRACTIVE ERROR; HUMAN GENES; LINKAGE; EYE; POLYMORPHISMS; HERITABILITY; POPULATION; PREVALENCE; MUTATIONS; LOCUS	Background: The paired box 6 (PAX6) gene is considered as a master gene for eye development. Linkage of myopia to the PAX6 region on chromosome 11p13 was shown in several studies, but the results for association between myopia and PAX6 were inconsistent so far. Methodology/Principal Findings: We genotyped 16 single nucleotide polymorphisms (SNPs) in the PAX6 gene and its regulatory regions in an initial study for 300 high myopia cases and 300 controls (Group 1), and successfully replicated the positive results with another independent group of 299 high myopia cases and 299 controls (Group 2). Five SNPs were genotyped in the replication study. The spherical equivalent of subjects with high myopia was <= -8.0 dioptres. The PLINK package was used for genetic data analysis. No association was found between each of the SNPs and high myopia. However, exhaustive sliding-window haplotype analysis highlighted an important role for rs12421026 because haplotypes containing this SNP were found to be associated with high myopia. The most significant results were given by the 4-SNP haplotype window consisting of rs2071754, rs3026393, rs1506 and rs12421026 (P = 3.54 x 10(-10), 4.06 x 10(-11) and 1.56 x 10(-18) for Group 1, Group 2 and Combined Group, respectively) and the 3-SNP haplotype window composed of rs3026393, rs1506 and rs12421026 (P = 5.48 x 10(-10), 7.93 x 10(-12) and 6.28 x 10(-23) for the three respective groups). The results remained significant after correction for multiple comparisons by permutations. The associated haplotyes found in a previous study were also successfully replicated in this study. Conclusions/Significance: PAX6 haplotypes are associated with susceptibility to the development of high myopia in Chinese. The PAX6 locus plays a role in high myopia.	[Jiang, Bo; Gu, Yang-shun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Bo; Leung, Kim Hung; Ng, Po Wah; Fung, Wai Yan; Lam, Wai Wa; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Jiang, Bo; Yap, Maurice K. H.; Ng, Po Wah] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Jiang, B (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China.	shea.ping.yip@inet.polyu.edu.hk	Yip, Shea Ping/A-1185-2016; Yap, Maurice KH/K-4927-2016	Yip, Shea Ping/0000-0002-2170-8185; Yap, Maurice KH/0000-0003-4687-4101; LEUNG, Kim Hung/0000-0001-8769-0144	Centre for Myopia Research, The Hong Kong Polytechnic University; Hong Kong Polytechnic University [1-ZV70, J-BB7P]	Centre for Myopia Research, The Hong Kong Polytechnic University(Hong Kong Polytechnic University); Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work is a contribution from the Centre for Myopia Research, The Hong Kong Polytechnic University, and was supported by grants from the Hong Kong Polytechnic University (1-ZV70 and J-BB7P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000220; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Ciner E, 2009, AM J OPHTHALMOL, V147, P512, DOI 10.1016/j.ajo.2008.09.004; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P3324, DOI 10.1167/iovs.07-1498; Edwards MH, 2004, ANN ACAD MED SINGAP, V33, P34; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2873, DOI 10.1167/iovs.03-1155; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Guggenheim JA, 2000, J MED GENET, V37, P227, DOI 10.1136/jmg.37.3.227; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Han W, 2009, INVEST OPHTH VIS SCI, V50, P47, DOI 10.1167/iovs.07-0813; Han W, 2006, INVEST OPHTH VIS SCI, V47, P2291, DOI 10.1167/iovs.05-1344; Hewitt AW, 2007, OPHTHALMIC GENET, V28, P179, DOI 10.1080/13816810701356676; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Mutti DO, 2007, MOL VIS, V13, P1012; Ng TK, 2009, MOL VIS, V15, P2239; Nielsen DM, 2008, GENET EPIDEMIOL, V32, P546, DOI 10.1002/gepi.20328; Plaza S, 1999, DEV GENES EVOL, V209, P165, DOI 10.1007/s004270050240; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Simpson CL, 2007, INVEST OPHTH VIS SCI, V48, P4421, DOI 10.1167/iovs.07-0231; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Tang WC, 2007, MOL VIS, V13, P534; Tsai YY, 2008, EYE, V22, P576, DOI 10.1038/sj.eye.6702982; Tsonis PA, 2006, EXP EYE RES, V83, P233, DOI 10.1016/j.exer.2005.11.019; Tzoulaki I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-27; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Wu MMM, 1999, OPTOMETRY VISION SCI, V76, P387, DOI 10.1097/00006324-199906000-00018; Xu ZP, 1997, J BIOL CHEM, V272, P3430, DOI 10.1074/jbc.272.6.3430; Zadnik K, 1997, OPTOMETRY VISION SCI, V74, P603, DOI 10.1097/00006324-199708000-00021; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322	47	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19587	10.1371/journal.pone.0019587	http://dx.doi.org/10.1371/journal.pone.0019587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589860	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100020
J	Zinger, L; Lejon, DPH; Baptist, F; Bouasria, A; Aubert, S; Geremia, RA; Choler, P				Zinger, Lucie; Lejon, David P. H.; Baptist, Florence; Bouasria, Abderrahim; Aubert, Serge; Geremia, Roberto A.; Choler, Philippe			Contrasting Diversity Patterns of Crenarchaeal, Bacterial and Fungal Soil Communities in an Alpine Landscape	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY; PLANT DIVERSITY; GLOBAL PATTERNS; GRADIENT; ECOSYSTEM; DYNAMICS; MICROORGANISMS; BIOGEOGRAPHY; ARCHAEA	Background: The advent of molecular techniques in microbial ecology has aroused interest in gaining an understanding about the spatial distribution of regional pools of soil microbes and the main drivers responsible of these spatial patterns. Here, we assessed the distribution of crenarcheal, bacterial and fungal communities in an alpine landscape displaying high turnover in plant species over short distances. Our aim is to determine the relative contribution of plant species composition, environmental conditions, and geographic isolation on microbial community distribution. Methodology/Principal Findings: Eleven types of habitats that best represent the landscape heterogeneity were investigated. Crenarchaeal, bacterial and fungal communities were described by means of Single Strand Conformation Polymorphism. Relationships between microbial beta diversity patterns were examined by using Bray-Curtis dissimilarities and Principal Coordinate Analyses. Distance-based redundancy analyses and variation partitioning were used to estimate the relative contributions of different drivers on microbial beta diversity. Microbial communities tended to be habitat-specific and did not display significant spatial autocorrelation. Microbial beta diversity correlated with soil pH. Fungal beta-diversity was mainly related to soil organic matter. Though the effect of plant species composition was significant for all microbial groups, it was much stronger for Fungi. In contrast, geographic distances did not have any effect on microbial beta diversity. Conclusions/Significance: Microbial communities exhibit non-random spatial patterns of diversity in alpine landscapes. Crenarcheal, bacterial and fungal community turnover is high and associated with plant species composition through different set of soil variables, but is not caused by geographical isolation.	[Zinger, Lucie; Lejon, David P. H.; Baptist, Florence; Bouasria, Abderrahim; Aubert, Serge; Geremia, Roberto A.; Choler, Philippe] Univ Grenoble, CNRS UMR 5553, Lab Ecol Alpine, Grenoble, France; [Aubert, Serge; Choler, Philippe] Univ Grenoble, CNRS UMS 3370, Stn Alpine J Fourier, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Zinger, L (corresponding author), Max Planck Inst Marine Microbiol, Microbial Habitat Grp, Bremen, Germany.	lucie@zinger.fr	Geremia, Roberto A/A-7972-2010; Zinger, Lucie/D-2527-2010; Choler, Philippe/A-7270-2008	Zinger, Lucie/0000-0002-3400-5825; Choler, Philippe/0000-0002-9062-2721	'Microalpes' project [ANR-06-BLAN-0301]	'Microalpes' project	This work was supported by the ANR-06-BLAN-0301 'Microalpes' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2007, BIO HABIT, P1; Benichou P., 1987, METEOROLOGIE, V7, P23; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bjork RG, 2008, SOIL BIOL BIOCHEM, V40, P266, DOI 10.1016/j.soilbio.2007.07.017; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Choler P, 2005, ARCT ANTARCT ALP RES, V37, P444, DOI 10.1657/1523-0430(2005)037[0444:CSIAPT]2.0.CO;2; Choler P, 2002, J VEG SCI, V13, P851, DOI 10.1111/j.1654-1103.2002.tb02114.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Delbes C, 2000, ENVIRON MICROBIOL, V2, P506, DOI 10.1046/j.1462-2920.2000.00132.x; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; KORNER C, 1995, ECOL STUD-ANAL SYNTH, V113, P45; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kudo G, 1996, ECOSCIENCE, V3, P483, DOI 10.1080/11956860.1996.11682367; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Mummey DL, 2003, FEMS MICROBIOL ECOL, V46, P113, DOI 10.1016/S0168-6496(03)00208-3; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Noll M, 2008, SOIL BIOL BIOCHEM, V40, P2611, DOI 10.1016/j.soilbio.2008.07.012; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peu P, 2006, APPL ENVIRON MICROB, V72, P3578, DOI 10.1128/AEM.72.5.3578-3585.2006; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; R Development Core Team, 2009, R FDN STAT COMP; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schulte E.E., 1996, SSSA SPEC PUBL, V46, P21, DOI DOI 10.2136/SSSASPECPUB46.C3; Schwarzenbach K, 2007, J MICROBIOL METH, V68, P358, DOI 10.1016/j.mimet.2006.09.015; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Singh BK, 2009, APPL SOIL ECOL, V41, P239, DOI 10.1016/j.apsoil.2008.10.003; Sliwinski MK, 2004, APPL ENVIRON MICROB, V70, P1811, DOI 10.1128/AEM.70.3.1811-1820.2004; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yan F, 1996, SOIL BIOL BIOCHEM, V28, P617, DOI 10.1016/0038-0717(95)00180-8; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x; Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005; Zinger L, 2009, ISME J, V3, P850, DOI 10.1038/ismej.2009.20	59	85	87	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19950	10.1371/journal.pone.0019950	http://dx.doi.org/10.1371/journal.pone.0019950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589876	Green Published, gold			2022-12-25	WOS:000290531100034
J	Bakayan, A; Vaquero, CF; Picazo, F; Llopis, J				Bakayan, Adil; Vaquero, Cecilia F.; Picazo, Fernando; Llopis, Juan			Red Fluorescent Protein-Aequorin Fusions as Improved Bioluminescent Ca2+ Reporters in Single Cells and Mice	PLOS ONE			English	Article							IN-VIVO; ENERGY-TRANSFER; MONOMERIC RED; CALCIUM; LIGHT; COELENTERAZINE; LUMINESCENCE; PHOTOPROTEIN; APOAEQUORIN; SENSITIVITY	Bioluminescence recording of Ca2+ signals with the photoprotein aequorin does not require radiative energy input and can be measured with a low background and good temporal resolution. Shifting aequorin emission to longer wavelengths occurs naturally in the jellyfish Aequorea victoria by bioluminescence resonance energy transfer (BRET) to the green fluorescent protein (GFP). This process has been reproduced in the molecular fusions GFP-aequorin and monomeric red fluorescent protein (mRFP)-aequorin, but the latter showed limited transfer efficiency. Fusions with strong red emission would facilitate the simultaneous imaging of Ca2+ in various cell compartments. In addition, they would also serve to monitor Ca2+ in living organisms since red light is able to cross animal tissues with less scattering. In this study, aequorin was fused to orange and various red fluorescent proteins to identify the best acceptor in red emission bands. Tandem-dimer Tomato-aequorin (tdTA) showed the highest BRET efficiency (largest energy transfer critical distance R-0) and percentage of counts in the red band of all the fusions studied. In addition, red fluorophore maturation of tdTA within cells was faster than that of other fusions. Light output was sufficient to image ATP-induced Ca2+ oscillations in single HeLa cells expressing tdTA. Ca2+ rises caused by depolarization of mouse neuronal cells in primary culture were also recorded, and changes in fine neuronal projections were spatially resolved. Finally, it was also possible to visualize the Ca2+ activity of HeLa cells injected subcutaneously into mice, and Ca2+ signals after depositing recombinant tdTA in muscle or the peritoneal cavity. Here we report that tdTA is the brightest red bioluminescent Ca2+ sensor reported to date and is, therefore, a promising probe to study Ca2+ dynamics in whole organisms or tissues expressing the transgene.	[Bakayan, Adil] Univ Castilla La Mancha, Fac Med, Albacete, Spain; Univ Castilla La Mancha, CRIB, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Bakayan, A (corresponding author), Univ Castilla La Mancha, Fac Med, Albacete, Spain.	juan.llopis@uclm.es	Llopis, Juan/I-2622-2012; Romo, José A./J-3024-2012	Llopis, Juan/0000-0002-9460-0642; Romo, José A./0000-0003-2907-580X; Fernandez Vaquero, Cecilia/0000-0002-7415-9060	Spanish Ministry of Science and Innovation [BFU2008-03288, BFU2005-02078]; European Union [MRTN-CT-2005-019481]; Consejeria de Sanidad; Junta de Comunidades de Castilla-La Mancha [JI4002R2]; Centro Regional de Investigaciones Biomedicas (CRIB)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Consejeria de Sanidad; Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Centro Regional de Investigaciones Biomedicas (CRIB)	This work was supported by grants from the Spanish Ministry of Science and Innovation MICINN/FEDER BFU2008-03288 and BFU2005-02078 (JL) and European Union project "From FLIM to FLIN'', MRTN-CT-2005-019481 (JL, AB fellowship holder). FP held a fellowship from Consejeria de Sanidad, Junta de Comunidades de Castilla-La Mancha (JI4002R2) and Centro Regional de Investigaciones Biomedicas (CRIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1977, SCIENCE, V195, P996, DOI 10.1126/science.841325; Alonso MT, 2009, ACTA PHYSIOL, V195, P37, DOI 10.1111/j.1748-1716.2008.01920.x; Badminton MN, 1995, BIOCHEM BIOPH RES CO, V217, P950, DOI 10.1006/bbrc.1995.2862; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caysa H, 2009, PHOTOCH PHOTOBIO SCI, V8, P52, DOI 10.1039/b814566k; Creton R, 1999, MICROSC RES TECHNIQ, V46, P390, DOI 10.1002/(SICI)1097-0029(19990915)46:6<390::AID-JEMT7>3.0.CO;2-S; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; GRYNKIEWICZ G, 1985, NEW GENERATION CA2 I, P3440; Hink MA, 2003, J FLUORESC, V13, P185, DOI 10.1023/A:1022947411788; Inouye S, 2006, FEBS LETT, V580, P1977, DOI 10.1016/j.febslet.2006.02.065; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P443, DOI DOI 10.1007/978-0-387-46312-4_13; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Manjarres IM, 2008, PFLUG ARCH EUR J PHY, V455, P961, DOI 10.1007/s00424-007-0349-5; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; NOMURA M, 1991, FEBS LETT, V295, P63, DOI 10.1016/0014-5793(91)81385-L; Ohmiya Y, 1996, CHEM BIOL, V3, P337, DOI 10.1016/S1074-5521(96)90116-7; Okuda A, 2003, CELL BIOCHEM FUNCT, V21, P61, DOI 10.1002/cbf.992; PRASHER D, 1985, BIOCHEM BIOPH RES CO, V126, P1259, DOI 10.1016/0006-291X(85)90321-3; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; RUEGG JC, 1987, NATURWISSENSCHAFTEN, V74, P579, DOI 10.1007/BF00368515; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1993, BIOCHEM J, V296, P549, DOI 10.1042/bj2960549; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHIMOMURA O, 1995, BIOCHEM J, V306, P537, DOI 10.1042/bj3060537; Stamatas GN, 2006, J INVEST DERMATOL, V126, P1753, DOI 10.1038/sj.jid.5700329; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Waud JP, 2001, BIOCHEM J, V357, P687, DOI 10.1042/0264-6021:3570687; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	43	36	45	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19520	10.1371/journal.pone.0019520	http://dx.doi.org/10.1371/journal.pone.0019520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589654	gold, Green Submitted, Green Published			2022-12-25	WOS:000290483600014
J	Renaud, S; Pantalacci, S; Auffray, JC				Renaud, Sabrina; Pantalacci, Sophie; Auffray, Jean-Christophe			Differential Evolvability Along Lines of Least Resistance of Upper and Lower Molars in Island House Mice	PLOS ONE			English	Article							MAMMALIAN TEETH; MURINE RODENTS; MORPHOLOGICAL VARIATION; PHENOTYPIC VARIATION; PARALLEL EVOLUTION; VARIATION PATTERNS; CANARY-ISLANDS; CLIMATE-CHANGE; BODY-SIZE; SHAPE	Variation within a population is a key feature in evolution, because it can increase or impede response to selection, depending on whether or not the intrapopulational variance is correlated to the change under selection. Hence, main directions of genetic variance have been proposed to constitute "lines of least resistance to evolution'' along which evolution would be facilitated. Yet, the screening of selection occurs at the phenotypic level, and the phenotypic variance is not only the product of the underlying genetic variance, but also of developmental processes. It is thus a key issue for interpreting short and long term evolutionary patterns to identify whether main directions of phenotypic variance indeed constitute direction of facilitated evolution, and whether this is favored by developmental processes preferably generating certain phenotypes. We tackled these questions by a morphometric quantification of the directions of variance, compared to the direction of evolution of the first upper and lower molars of wild continental and insular house mice. The main phenotypic variance indeed appeared as channeling evolution between populations. The upper molar emerged as highly evolvable, because a strong allometric component contributed to its variance. This allometric relationship drove a repeated but independent evolution of a peculiar upper molar shape whenever size increased. This repeated evolution, together with knowledge about the molar development, suggest that the main direction of phenotypic variance correspond here to a "line of least developmental resistance'' along which evolution between population is channeled.	[Renaud, Sabrina] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Pantalacci, Sophie] Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France; [Auffray, Jean-Christophe] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Renaud, S (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	Sabrina.Renaud@univ-lyon1.fr	Auffray, jean-christophe/HCI-4881-2022; AUFFRAY, Jean-Christophe/H-1907-2011; Renaud, Sabrina/AAV-3141-2020; Auffray, Jean-Christophe/AAW-1052-2020; Auffray, Jean-Christophe/AAH-6131-2019; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Auffray, Jean-Christophe/0000-0002-5184-0507; Renaud, Sabrina/0000-0002-8730-3113	CNRS [GDR 2474]; ANR Quenottes	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR Quenottes(French National Research Agency (ANR))	This work was supported by the GDR 2474 CNRS and the ANR Quenottes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; ALIBERT P, 1995, THESIS U MONTPELLIER; Arnold SJ, 2001, GENETICA, V112, P9, DOI 10.1023/A:1013373907708; Badyaev AV, 2000, P ROY SOC B-BIOL SCI, V267, P371, DOI 10.1098/rspb.2000.1011; Begin M, 2003, EVOLUTION, V57, P1107; Berry RJ, 1996, PHILOS T R SOC B, V351, P753, DOI 10.1098/rstb.1996.0070; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Butler PM., 1985, EVOLUTIONARY RELATIO, P381; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Jacobs L.L., 1990, EUROPEAN NEOGENE MAM, P573; JACOBS LL, 1989, PAPERS FOSSIL RODENT, P157; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; KANKOUASSI S, 2008, MAMMALIA, V72, P237; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Klingenberg CP, 2001, GENETICS, V157, P785; Kuhl F.P., 1982, COMPUTER GRAPHICS IM, V18, P259; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Ledevin R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015470; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Marroig G, 2001, EVOLUTION, V55, P2576; Michaux J, 2007, J BIOGEOGR, V34, P1412, DOI 10.1111/j.1365-2699.2007.01701.x; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pantalacci S, 2009, EVOL DEV, V11, P422, DOI 10.1111/j.1525-142X.2009.00348.x; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterkova R, 1996, INT J DEV BIOL, V40, P1009; Polly PD, 2005, EVOL DEV, V7, P29, DOI 10.1111/j.1525-142X.2005.05004.x; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Renaud S, 2002, PALAEOGEOGR PALAEOCL, V184, P163, DOI 10.1016/S0031-0182(02)00255-9; Renaud S, 2006, EVOLUTION, V60, P1701; Renaud S, 2009, EVOL DEV, V11, P590, DOI 10.1111/j.1525-142X.2009.00365.x; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Shimizu T, 2004, J DENT RES, V83, P45, DOI 10.1177/154405910408300109; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; VIGNE JD, 1993, MAMMALIA, V57, P85, DOI 10.1515/mamm.1993.57.1.85; Zhang XS, 2005, EVOLUTION, V59, P1237	53	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18951	10.1371/journal.pone.0018951	http://dx.doi.org/10.1371/journal.pone.0018951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589657	gold, Green Published, Green Submitted			2022-12-25	WOS:000290483600003
J	Mul, JD; la Fleur, SE; Toonen, PW; Afrasiab-Middelman, A; Binnekade, R; Schetters, D; Verheij, MMM; Sears, RM; Homberg, JR; Schoffelmeer, ANM; Adan, RAH; DiLeone, RJ; De Vries, TJ; Cuppen, E				Mul, Joram D.; la Fleur, Susanne E.; Toonen, Pim W.; Afrasiab-Middelman, Anthonieke; Binnekade, Rob; Schetters, Dustin; Verheij, Michel M. M.; Sears, Robert M.; Homberg, Judith R.; Schoffelmeer, Anton N. M.; Adan, Roger A. H.; DiLeone, Ralph J.; De Vries, Taco J.; Cuppen, Edwin			Chronic Loss of Melanin-Concentrating Hormone Affects Motivational Aspects of Feeding in the Rat	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; MESOLIMBIC DOPAMINE SYSTEM; PROTEIN-COUPLED RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LATERAL HYPOTHALAMUS; FOOD SEEKING; BODY-WEIGHT; MONOAMINE TRANSPORTER; GLUTAMATE RECEPTORS; PALATABLE FOOD	Current epidemic obesity levels apply great medical and financial pressure to the strenuous economy of obesity-prone cultures, and neuropeptides involved in body weight regulation are regarded as attractive targets for a possible treatment of obesity in humans. The lateral hypothalamus and the nucleus accumbens shell (AcbSh) form a hypothalamic-limbic neuropeptide feeding circuit mediated by Melanin-Concentrating Hormone (MCH). MCH promotes feeding behavior via MCH receptor-1 (MCH1R) in the AcbSh, although this relationship has not been fully characterized. Given the AcbSh mediates reinforcing properties of food, we hypothesized that MCH modulates motivational aspects of feeding. Here we show that chronic loss of the rat MCH-precursor Pmch decreased food intake predominantly via a reduction in meal size during rat development and reduced high-fat food-reinforced operant responding in adult rats. Moreover, acute AcbSh administration of Neuropeptide-GE and Neuropeptide-EI (NEI), both additional neuropeptides derived from Pmch, or chronic intracerebroventricular infusion of NEI, did not affect feeding behavior in adult pmch(+/+) or pmch(-/-) rats. However, acute administration of MCH to the AcbSh of adult pmch(-/-) rats elevated feeding behavior towards wild type levels. Finally, adult pmch(-/-) rats showed increased ex vivo electrically evoked dopamine release and increased limbic dopamine transporter levels, indicating that chronic loss of Pmch in the rat affects the limbic dopamine system. Our findings support the MCH-MCH1R system as an amplifier of consummatory behavior, confirming this system as a possible target for the treatment of obesity. We propose that MCH-mediated signaling in the AcbSh positively mediates motivational aspects of feeding behavior. Thereby it provides a crucial signal by which hypothalamic neural circuits control energy balance and guide limbic brain areas to enhance motivational or incentive-related aspects of food consumption.	[Mul, Joram D.; Toonen, Pim W.; Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [la Fleur, Susanne E.; Adan, Roger A. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Afrasiab-Middelman, Anthonieke; Homberg, Judith R.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Verheij, Michel M. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [Binnekade, Rob; Schetters, Dustin; Schoffelmeer, Anton N. M.; De Vries, Taco J.] Free Univ Med Ctr, Ctr Neurogen & Cognit Res, Dept Anat & Neurosci, Amsterdam, Netherlands; [Sears, Robert M.; DiLeone, Ralph J.] Yale Univ, Sch Med, Ribicoff Res Facil, Dept Psychiat, New Haven, CT USA; [DiLeone, Ralph J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Yale University; Yale University; Utrecht University; Utrecht University Medical Center	Mul, JD (corresponding author), Univ Cincinnati, Dept Med, Metab Dis Unit, Cincinnati, OH 45221 USA.	e.cuppen@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; De Vries, Taco J/B-2831-2014; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019; Mul, Joram/C-3125-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Mul, Joram/0000-0003-0453-2568; DiLeone, Ralph/0000-0002-4770-2590; De Vries, Taco/0000-0002-0340-4946; , robert/0000-0001-5688-1853	European Science Foundation; Netherlands Organisation for Scientific Research (NWO) [86410003]; National Institutes of Health [DK073677]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073677] Funding Source: NIH RePORTER	European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the European Science Foundation EURYI (to EC), by grant DK073677, from the National Institutes of Health (to RJD), and by The Netherlands Organisation for Scientific Research (NWO) grant #86410003 (to JRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; Bittencourt J, 2008, PEPTIDES, V29, P1441, DOI 10.1016/j.peptides.2008.03.012; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bittencourt JC, 1998, BRAIN RES, V805, P1, DOI 10.1016/S0006-8993(98)00598-8; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; CHUNG S, 2009, P NATL ACAD SCI US; Della-Zuana O, 2002, INT J OBESITY, V26, P1289, DOI 10.1038/sj.ijo.0802079; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Gomori A, 2003, AM J PHYSIOL-ENDOC M, V284, pE583, DOI 10.1152/ajpendo.00350.2002; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Guesdon B, 2009, AM J PHYSIOL-REG I, V296, pR469, DOI 10.1152/ajpregu.90556.2008; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HODOS W, 1963, J EXP ANAL BEHAV, V6, P387, DOI 10.1901/jeab.1963.6-387; Holtje M, 2000, J NEUROSCI, V20, P2131; Inoue K, 2003, J PHARMACOL EXP THER, V305, P385, DOI 10.1124/jpet.102.047712; Ito M, 2003, AM J PHYSIOL-ENDOC M, V284, pE940, DOI 10.1152/ajpendo.00529.2002; ITO M, 2009, BR J PHARM; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kowalski TJ, 2004, EUR J PHARMACOL, V497, P41, DOI 10.1016/j.ejphar.2004.06.027; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lembo PMC, 1999, NAT CELL BIOL, V1, P267, DOI 10.1038/12978; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mashiko S, 2005, ENDOCRINOLOGY, V146, P3080, DOI 10.1210/en.2004-1150; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Morens C, 2005, BRAIN RES, V1062, P32, DOI 10.1016/j.brainres.2005.09.005; Mul JD, 2010, AM J PHYSIOL-ENDOC M, V298, pE477, DOI 10.1152/ajpendo.00154.2009; NAHON JL, 1989, ENDOCRINOLOGY, V125, P2056, DOI 10.1210/endo-125-4-2056; Nair SG, 2008, BRIT J PHARMACOL, V154, P406, DOI 10.1038/bjp.2008.3; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; NAIR SG, 2009, PSYCHOPHARMACOLOGY B; PANKSEPP J, 1973, J COMP PHYSIOL PSYCH, V82, P78, DOI 10.1037/h0033812; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETER D, 1995, J NEUROSCI, V15, P6179; Pissios P, 2003, ENDOCRINOLOGY, V144, P3514, DOI 10.1210/en.2002-0004; Pissios P, 2008, BIOL PSYCHIAT, V64, P184, DOI 10.1016/j.biopsych.2007.12.011; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; REDMOND DE, 1979, LIFE SCI, V25, P2149, DOI 10.1016/0024-3205(79)90087-0; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rossi M, 1997, ENDOCRINOLOGY, V138, P351, DOI 10.1210/en.138.1.351; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SCHOFFELMEER ANM, 1988, EUR J PHARMACOL, V154, P169, DOI 10.1016/0014-2999(88)90094-5; Sears RM, 2010, J NEUROSCI, V30, P8263, DOI 10.1523/JNEUROSCI.5858-09.2010; Shearman LP, 2003, EUR J PHARMACOL, V475, P37, DOI 10.1016/S0014-2999(03)02146-0; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Sita LV, 2007, NEUROSCIENCE, V148, P949, DOI 10.1016/j.neuroscience.2007.07.010; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 1997, J NEUROSCI, V17, P4434; Stratford TR, 1998, BEHAV BRAIN RES, V93, P43, DOI 10.1016/S0166-4328(97)00140-X; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Tyhon A, 2008, PHARMACOL BIOCHEM BE, V88, P446, DOI 10.1016/j.pbb.2007.10.001; Tyhon A, 2006, BEHAV BRAIN RES, V173, P94, DOI 10.1016/j.bbr.2006.06.007; Verheij MMM, 2008, J NEUROCHEM, V105, P2122, DOI 10.1111/j.1471-4159.2008.05323.x; Verheij MMM, 2007, J NEUROCHEM, V100, P810, DOI 10.1111/j.1471-4159.2006.04259.x; ZAMIR N, 1986, BRAIN RES, V373, P240, DOI 10.1016/0006-8993(86)90337-9; Zheng H, 2005, NEUROSCIENCE, V135, P611, DOI 10.1016/j.neuroscience.2005.06.055	72	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19600	10.1371/journal.pone.0019600	http://dx.doi.org/10.1371/journal.pone.0019600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573180	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400032
J	Priyandoko, D; Ishii, T; Kaul, SC; Wadhwa, R				Priyandoko, Didik; Ishii, Tetsuro; Kaul, Sunil C.; Wadhwa, Renu			Ashwagandha Leaf Derived Withanone Protects Normal Human Cells Against the Toxicity of Methoxyacetic Acid, a Major Industrial Metabolite	PLOS ONE			English	Article							GLYCOL MONOMETHYL ETHER; HUMAN BREAST-MILK; DEVELOPMENTAL TOXICITY; CANCER-CELLS; IN-VITRO; EXPOSURE; RAT; APOPTOSIS; EXTRACT; PATHWAY	The present day lifestyle heavily depends on industrial chemicals in the form of agriculture, cosmetics, textiles and medical products. Since the toxicity of the industrial chemicals has been a concern to human health, the need for alternative nontoxic natural products or adjuvants that serve as antidotes are in high demand. We have investigated the effects of Ayurvedic herb Ashwagandha (Withania somnifera) leaf extract on methoxyacetic acid (MAA) induced toxicity. MAA is a major metabolite of ester phthalates that are commonly used in industry as gelling, viscosity and stabilizer reagents. We report that the MAA cause premature senescence of normal human cells by mechanisms that involve ROS generation, DNA and mitochondrial damage. Withanone protects cells from MAA-induced toxicity by suppressing the ROS levels, DNA and mitochondrial damage, and induction of cell defense signaling pathways including Nrf2 and proteasomal degradation. These findings warrant further basic and clinical studies that may promote the use of withanone as a health adjuvant in a variety of consumer products where the toxicity has been a concern because of the use of ester phthalates.	[Priyandoko, Didik; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Priyandoko, Didik; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Priyandoko, D (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Priyandoko, Didik/GNP-1593-2022; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Priyandoko, Didik/0000-0001-8601-9818; Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	Indonesian Government	Indonesian Government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	DP is a recipient of the Indonesian Government Scholarship. Authors thank Nashi Widodo, Ran Gao and Navjot Shah for technical help and advice.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; Bagchi G, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-65; Bagchi G, 2009, TOXICOL APPL PHARM, V238, P101, DOI 10.1016/j.taap.2008.03.015; BEATTIE P J, 1986, Journal of Biochemical Toxicology, V1, P61, DOI 10.1002/jbt.2570010307; BROWN NA, 1984, TOXICOL LETT, V22, P93, DOI 10.1016/0378-4274(84)90051-1; Davis BJ, 1997, TOXICOL APPL PHARM, V142, P328, DOI 10.1006/taap.1996.8035; de Jong E, 2009, TOXICOL SCI, V110, P117, DOI 10.1093/toxsci/kfp083; Elkin ND, 2010, TOXICOL SCI, V117, P439, DOI 10.1093/toxsci/kfq210; Henley DV, 2009, ENVIRON HEALTH PERSP, V117, P1702, DOI 10.1289/ehp.0900800; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Jindo T, 2001, TOXICOL PATHOL, V29, P607, DOI 10.1080/019262301753385933; Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002; Louisse J, 2010, TOXICOL APPL PHARM, V245, P236, DOI 10.1016/j.taap.2010.03.005; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Miller R R, 1982, Fundam Appl Toxicol, V2, P158, DOI 10.1016/S0272-0590(82)80039-0; Rao AVSK, 2002, FEBS LETT, V527, P133, DOI 10.1016/S0014-5793(02)03196-4; Ruyani A, 2005, BIRTH DEFECTS RES A, V73, P517, DOI 10.1002/bdra.20146; Ruyani A, 2003, TOXICOL SCI, V75, P148, DOI 10.1093/toxsci/kfg159; Scofield EH, 2006, REPROD TOXICOL, V22, P718, DOI 10.1016/j.reprotox.2006.05.005; Syed V, 1998, ENDOCRINOLOGY, V139, P3503, DOI 10.1210/en.139.8.3503; Takagi A, 2002, IND HEALTH, V40, P371, DOI 10.2486/indhealth.40.371; Welsch F, 2005, TOXICOL LETT, V156, P13, DOI 10.1016/j.toxlet.2003.08.010; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Yates MS, 2007, DRUG NEWS PERSPECT, V20, P109, DOI 10.1358/dnp.2007.20.2.1083437	28	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19552	10.1371/journal.pone.0019552	http://dx.doi.org/10.1371/journal.pone.0019552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573189	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800033
J	Thobe, MN; Gray, JK; Gurusamy, D; Paluch, AM; Wagh, PK; Pathrose, P; Lentsch, AB; Waltz, SE				Thobe, M. N.; Gray, J. K.; Gurusamy, D.; Paluch, A. M.; Wagh, P. K.; Pathrose, P.; Lentsch, A. B.; Waltz, S. E.			The Ron receptor promotes prostate tumor growth in the TRAMP mouse model	ONCOGENE			English	Article						Ron receptor; hepatoctye growth factor-like protein; prostate cancer; MST1R; receptor tyrosine kinase	TYROSINE KINASE RON; NF-KAPPA-B; TRANSGENIC MOUSE; CANCER CELLS; MURINE MODEL; BETA-CATENIN; MET FAMILY; FACTOR-I; OVEREXPRESSION; ACTIVATION	The Ron receptor tyrosine kinase (TK) is overexpressed in many cancers, including prostate cancer. To examine the significance of Ron in prostate cancer in vivo, we utilized a genetically engineered mouse model, referred to as TRAMP mice, that is predisposed to develop prostate tumors. In this model, we show that prostate tumors from 30-week-old TRAMP mice have increased Ron expression compared with age-matched wild-type prostates. Based on the upregulation of Ron in human prostate cancers and in this murine model of prostate tumorigenesis, we hypothesized that this receptor has a functional role in the development of prostate tumors. To test this hypothesis, we crossed TRAMP mice with mice that are deficient in Ron signaling (TK-/-). Interestingly, TK-/- TRAMP+ mice show a significant decrease in prostate tumor mass relative to TRAMP mice containing functional Ron. Moreover, TK-/- TRAMP+ prostate tumors exhibited decreased tumor vascularization relative to TK+/+ TRAMP+ prostate tumors, which correlated with reduced levels of the angiogenic molecules vascular endothelial growth factor and CXCL2. Although Ron loss did not alter tumor cell proliferation, a significant decrease in cell survival was observed. Similarly, murine prostate cancer cell lines containing a Ron deficiency exhibited decreased levels of active nuclear factor-kappa B, suggesting that Ron may be important in regulating prostate cell survival at least partly through this pathway. In total, our data show for the first time that Ron promotes prostate tumor growth, prostate tumor angiogenesis and prostate cancer cell survival in vivo. Oncogene (2011) 30, 4990-4998; doi:10.1038/onc.2011.205; published online 30 May 2011	[Thobe, M. N.; Gray, J. K.; Gurusamy, D.; Paluch, A. M.; Wagh, P. K.; Pathrose, P.; Waltz, S. E.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Lentsch, A. B.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Waltz, S. E.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Waltz, SE (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Vontz Bldg Mol Studies,3125 Eden Ave, Cincinnati, OH 45267 USA.	susan.waltz@uc.edu	Gurusamy, Devikala/T-3410-2019	Gurusamy, Devikala/0000-0002-1727-8653; Waltz, Susan/0000-0003-3572-4642	National Institutes of Health [CA-125379]; Department of Defense [PC060821]; NATIONAL CANCER INSTITUTE [R01CA125379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Sandy Schwemberger for her assistance with the flow cytometry experiments as well as Gina Ciovacco for her technical contributions. This work was supported by Public Health Services Grant CA-125379 (SEW) from the National Institutes of Health, and by Grant Project No. PC060821 (MNT) from the Department of Defense Congressionally Directed Medical Research Program.	Agus DB, 1999, CANCER RES, V59, P4761; Becker CM, 2002, CANCER BIOL THER, V1, P548, DOI 10.4161/cbt.1.5.176; Chan EL, 2005, ONCOGENE, V24, P479, DOI 10.1038/sj.onc.1208231; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Chen YQ, 2002, ONCOGENE, V21, P6382, DOI 10.1038/sj.onc.1205783; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Leonis NA, 2002, HEPATOLOGY, V36, P1053, DOI 10.1053/jhep.2002.36822; Logan-Collins J, 2010, CANCER RES, V70, P1130, DOI 10.1158/0008-5472.CAN-09-0761; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; Mallakin A, 2006, AM J RESP CELL MOL, V34, P15, DOI 10.1165/rcmb.2005-0093OC; Meyer SE, 2009, DEV BIOL, V333, P173, DOI 10.1016/j.ydbio.2009.06.028; Meyer SE, 2009, MOL CARCINOGEN, V48, P995, DOI 10.1002/mc.20551; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; RONSIN C, 1993, ONCOGENE, V8, P1195; Shen H, 2004, AM J PHYSIOL-CELL PH, V286, pC840, DOI 10.1152/ajpcell.00335.2003; Shen H, 2006, PROSTATE, V66, P1721, DOI 10.1002/pros.20476; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Vicentini C, 2003, J CANCER RES CLIN, V129, P165, DOI 10.1007/s00432-003-0420-3; Wagh PK, 2011, ONCOGENE, V30, P3694, DOI 10.1038/onc.2011.86; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Wang Jun, 2007, J Carcinog, V6, P3, DOI 10.1186/1477-3163-6-3; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	35	17	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4990	4998		10.1038/onc.2011.205	http://dx.doi.org/10.1038/onc.2011.205			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21625214	Green Accepted			2022-12-25	WOS:000298346500007
J	Besaratinia, A; Yoon, JI; Schroeder, C; Bradforth, SE; Cockburn, M; Pfeifer, GP				Besaratinia, Ahmad; Yoon, Jae-in; Schroeder, Christi; Bradforth, Stephen E.; Cockburn, Myles; Pfeifer, Gerd P.			Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight	FASEB JOURNAL			English	Article						carcinogenesis; mutagenesis	UV-LIGHT; IN-VIVO; 2-PHOTON IONIZATION; MAMMALIAN-CELLS; SINGLET OXYGEN; ACTION SPECTRA; SKIN-CANCER; REPAIR; MUTATIONS; PHOTOPRODUCTS	To elucidate the involvement of specific ultraviolet (UV) wavelengths in solar mutagenesis, we used a laser system to investigate the induction of DNA damage, both in the overall genome and at the nucleotide resolution level, in the genomic DNA of transgenic Big Blue mouse fibroblasts irradiated with a series of UV wavelengths, inclusive of UVC (lambda<280 nm), UVB (lambda=280-320 nm), and UVA (lambda>320 nm). Subsequently, we sought correlation between the locations of UV-induced DNA lesions in the cII transgene of irradiated DNA samples and the frequency distribution and codon position of the induced cII mutations in counterpart mouse cells irradiated with simulated sunlight. Using a combination of enzymatic digestion assays coupled with gel electrophoresis, immunodot blot assays, and DNA footprinting assays, we demonstrated a unique wavelength-dependent formation of photodimeric lesions, i.e., cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts [(6-4) PPs], based on direct UV absorption of DNA, in irradiated mouse genomic DNA, which could partially explain the induction of mutations in mouse cells irradiated with simulated sunlight. Most notably, there was a divergence of CPD and (6-4) PP formation at an irradiation wavelength of 296 nm in mouse genomic DNA. Whereas substantial formation of (6-4) PPs was detectable in samples irradiated at this wavelength, which intensified as the irradiation wavelength decreased, only small quantities of these lesions were found in samples irradiated at wavelengths of 300-305 nm, with no detectable level of (6-4) PPs in samples irradiated with longer wavelengths. Although CPD formation followed the same pattern of increase with decreasing wavelengths of irradiation, there were substantial levels of CPDs in samples irradiated with UVB wavelengths borderlined with UVA, and small but detectable levels of these lesions in samples irradiated with longer wavelengths. Because the terrestrial sunlight spectrum rolls off sharply at wavelengths similar to 300 nm, our findings suggest that CPDs are the principal lesion responsible for most DNA damage-dependent biological effects of sunlight.-Besaratinia, A., Yoon, J. -I., Schroeder, C., Bradforth, S. E., Cockburn, M., Pfeifer, G. P. Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight. FASEB J. 25, 3079-3091 (2011). www.fasebj.org	[Besaratinia, Ahmad; Yoon, Jae-in; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Schroeder, Christi; Bradforth, Stephen E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Cockburn, Myles] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	City of Hope; Beckman Research Institute of City of Hope; University of Southern California; University of Southern California	Besaratinia, A (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ania@coh.org	Bradforth, Stephen E/B-5186-2008; Bradforth, Stephen/GSM-7470-2022	Bradforth, Stephen E/0000-0002-6164-3347; Besaratinia, Ahmad/0000-0001-7231-228X	American Cancer Society [RSG-11-083-01-CNE]; National Institute of Environmental Health Sciences [ES06070]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES006070, R01ES006070] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from the American Cancer Society (RSG-11-083-01-CNE) to A. B., and the National Institute of Environmental Health Sciences (ES06070) to G. P. P.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Besaratinia A, 2005, P NATL ACAD SCI USA, V102, P10058, DOI 10.1073/pnas.0502311102; Besaratinia A, 2008, FASEB J, V22, P2379, DOI 10.1096/fj.07-105437; Besaratinia A, 2006, CARCINOGENESIS, V27, P1526, DOI 10.1093/carcin/bgi311; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Besaratinia A, 2009, METHODS, V48, P35, DOI 10.1016/j.ymeth.2009.02.008; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; Cadet J, 2009, PHOTOCH PHOTOBIO SCI, V8, P903, DOI 10.1039/b905343n; CHEN HH, 2001, SCI STKE, pPL1; Courdavault S, 2005, DNA REPAIR, V4, P836, DOI 10.1016/j.dnarep.2005.05.001; Courdavault S, 2004, MUTAT RES-FUND MOL M, V556, P135, DOI 10.1016/j.mrfmmm.2004.07.011; Dahle J, 2008, CANCER LETT, V267, P18, DOI 10.1016/j.canlet.2008.03.002; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Diffey BL, 2002, METHODS, V28, P4, DOI 10.1016/S1046-2023(02)00204-9; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; DROUIN R, 1996, TECHNOLOGIES DETECTI, V1, P37; Elles CG, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217738; FREYER GA, 1995, MOL CELL BIOL, V15, P4572; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; HAMER DH, 1975, CHROMOSOMA, V49, P243, DOI 10.1007/BF00361069; Ikehata H, 2003, MUTAGENESIS, V18, P511, DOI 10.1093/mutage/geg030; Jacovides CP, 1998, THEOR APPL CLIMATOL, V59, P107, DOI 10.1007/s007040050016; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Jiang Y, 2009, BIOPHYS J, V96, P1151, DOI 10.1016/j.bpj.2008.10.030; Kappes UP, 2006, J INVEST DERMATOL, V126, P667, DOI 10.1038/sj.jid.5700093; Kappes UP, 2005, RADIAT RES, V164, P440, DOI 10.1667/RR3434.1; Kaur B, 1998, BIOCHEMISTRY-US, V37, P11599, DOI 10.1021/bi981008c; KELFKENS G, 1990, PHOTOCHEM PHOTOBIOL, V52, P819, DOI 10.1111/j.1751-1097.1990.tb08687.x; Komura J, 1998, NUCLEIC ACIDS RES, V26, P1807, DOI 10.1093/nar/26.7.1807; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Marguet S, 2006, J PHYS CHEM B, V110, P11037, DOI 10.1021/jp062578m; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; MITCHELL DL, 1992, NUCLEIC ACIDS RES, V20, P225, DOI 10.1093/nar/20.2.225; MITCHELL DL, 1987, PHOTOCHEM PHOTOBIOL, V45, P781, DOI 10.1111/j.1751-1097.1987.tb07882.x; MITCHELL DL, 1991, PHOTOCHEM PHOTOBIOL, V54, P741, DOI 10.1111/j.1751-1097.1991.tb02084.x; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Palmer CM, 1997, PHOTOCHEM PHOTOBIOL, V65, P543, DOI 10.1111/j.1751-1097.1997.tb08602.x; Perdiz D, 2000, J BIOL CHEM, V275, P26732; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; PFLAUM M, 1994, CARCINOGENESIS, V15, P297, DOI 10.1093/carcin/15.2.297; ROSENSTEIN BS, 1987, PHOTOCHEM PHOTOBIOL, V45, P775, DOI 10.1111/j.1751-1097.1987.tb07881.x; Runger TM, 2008, PHOTODERMATOL PHOTO, V24, P2, DOI 10.1111/j.1600-0781.2008.00319.x; Sage E, 1996, P NATL ACAD SCI USA, V93, P176, DOI 10.1073/pnas.93.1.176; SAGE E, 1993, PHOTOCHEM PHOTOBIOL, V57, P163, DOI 10.1111/j.1751-1097.1993.tb02273.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SETLOW RB, 1966, J MOL BIOL, V17, P237, DOI 10.1016/S0022-2836(66)80105-5; Slavicek P, 2009, J AM CHEM SOC, V131, P6460, DOI 10.1021/ja8091246; SUTHERLAND JC, 1981, RADIAT RES, V86, P399, DOI 10.2307/3575456; Tanford C., 1961, PHYS CHEM MACROMOLEC; TAYLOR JS, 1990, PHOTOCHEM PHOTOBIOL, V51, P161, DOI 10.1111/j.1751-1097.1990.tb01698.x; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Tyrrell RM, 2000, METHOD ENZYMOL, V319, P290; von Thaler AK, 2010, EXP DERMATOL, V19, P81, DOI 10.1111/j.1600-0625.2009.01025.x; Vreeswijk MPG, 2009, MUTAT RES-FUND MOL M, V663, P7, DOI 10.1016/j.mrfmmm.2008.12.007; Willis C E, 1988, Appl Theor Electrophor, V1, P11; Woodhead A D, 1999, J Epidemiol, V9, pS102; Woollons A, 1999, BRIT J DERMATOL, V140, P1023; YAJIMA H, 1995, EMBO J, V14, P2393, DOI 10.1002/j.1460-2075.1995.tb07234.x; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; ZHANG Y, J PHYS CHEM B, V115, P1889	72	99	101	0	58	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3079	3091		10.1096/fj.11-187336	http://dx.doi.org/10.1096/fj.11-187336			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21613571	Green Published			2022-12-25	WOS:000294435200022
J	Shchedrina, VA; Kabil, H; Vorbruggen, G; Lee, BC; Turanov, AA; Hirosawa-Takamori, M; Kim, HY; Harshman, LG; Hatfield, DL; Gladyshev, VN				Shchedrina, Valentina A.; Kabil, Hadise; Vorbruggen, Gerd; Lee, Byung Cheon; Turanov, Anton A.; Hirosawa-Takamori, Mitsuko; Kim, Hwa-Young; Harshman, Lawrence G.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Analyses of Fruit Flies That Do Not Express Selenoproteins or Express the Mouse Selenoprotein, Methionine Sulfoxide Reductase B1, Reveal a Role of Selenoproteins in Stress Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DROSOPHILA-MELANOGASTER; OXIDATIVE DAMAGE; SELENOPHOSPHATE SYNTHETASE; SELENOCYSTEINE INCORPORATION; ANTIOXIDANT DEFENSE; BINDING-PROTEIN; GENE; LONGEVITY; OVEREXPRESSION	Selenoproteins are essential in vertebrates because of their crucial role in cellular redox homeostasis, but some invertebrates that lack selenoproteins have recently been identified. Genetic disruption of selenoprotein biosynthesis had no effect on lifespan and oxidative stress resistance of Drosophila melanogaster. In the current study, fruit flies with knock-out of the selenocysteine-specific elongation factor were metabolically labeled with Se-75; they did not incorporate selenium into proteins and had the same lifespan on a chemically defined diet with or without selenium supplementation. These flies were, however, more susceptible to starvation than controls, and this effect could be ascribed to the function of selenoprotein K. We further expressed mouse methionine sulfoxide reductase B1 (MsrB1), a selenoenzyme that catalyzes the reduction of oxidized methionine residues and has protein repair function, in the whole body or the nervous system of fruit flies. This exogenous selenoprotein could only be expressed when the Drosophila selenocysteine insertion sequence element was used, whereas the corresponding mouse element did not support selenoprotein synthesis. Ectopic expression of MsrB1 in the nervous system led to an increase in the resistance against oxidative stress and starvation, but did not affect lifespan and reproduction, whereas ubiquitous MsrB1 expression had no effect. Dietary selenium did not influence lifespan of MsrB1-expressing flies. Thus, in contrast to vertebrates, fruit flies preserve only three selenoproteins, which are not essential and play a role only under certain stress conditions, thereby limiting the use of the micronutrient selenium by these organisms.	[Shchedrina, Valentina A.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Shchedrina, Valentina A.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kabil, Hadise; Harshman, Lawrence G.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Vorbruggen, Gerd; Hirosawa-Takamori, Mitsuko] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; Max Planck Society; Yeungnam University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), New Res Bldg,77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; shchedrina, valentina a/B-8398-2015	shchedrina, valentina a/0000-0003-1627-982X; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518, GM061603, DK074136]; Center for Cancer Research, NCI; National Research Foundation of Korea [2010-0001240]; NATIONAL CANCER INSTITUTE [ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021518, GM061603 (to V. N. G.), and DK074136 (to L. G. H.), the Intramural Research Program at the Center for Cancer Research, NCI (to D. L. H.), and National Research Foundation of Korea Grant 2010-0001240 (to H. Y. K.).	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Alsina B, 1998, MOL GEN GENET, V257, P113, DOI 10.1007/s004380050630; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chapple CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002968; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Chung H, 2010, FEBS LETT, V584, P3609, DOI 10.1016/j.febslet.2010.07.033; Conrad M, 2006, SELENIUM ITS MOL BIO, P195; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hirosawa-Takamori M, 2000, EMBO REP, V1, P441, DOI 10.1093/embo-reports/kvd087; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kwon SY, 2003, MOL CELL BIOL, V23, P8495, DOI 10.1128/MCB.23.23.8495-8504.2003; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Mockett RJ, 2010, FREE RADICAL BIO MED, V49, P2028, DOI 10.1016/j.freeradbiomed.2010.09.029; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Oien D, 2007, AMINO ACIDS, V32, P603, DOI 10.1007/s00726-006-0448-1; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; PALLARES C, 2006, SELENIUM ITS MOL BIO, P343; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Persson BC, 1997, J MOL BIOL, V274, P174, DOI 10.1006/jmbi.1997.1371; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Shchedrina VA, 2009, MECH AGEING DEV, V130, P429, DOI 10.1016/j.mad.2009.04.003; Squires JE, 2008, IUBMB LIFE, V60, P232, DOI 10.1002/iub.38; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	59	21	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29449	29461		10.1074/jbc.M111.257600	http://dx.doi.org/10.1074/jbc.M111.257600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21622567	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000294046600002
J	Bellomo, EA; Meur, G; Rutter, GA				Bellomo, Elisa A.; Meur, Gargi; Rutter, Guy A.			Glucose Regulates Free Cytosolic Zn2+ Concentration, Slc39 (ZiP), and Metallothionein Gene Expression in Primary Pancreatic Islet beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ZINC TRANSPORTER ZNT8; INSULIN-SECRETION; INTRACELLULAR ZINC; BUFFERING CAPACITY; ENDOCRINE PANCREAS; DIABETIC-RATS; CELLULAR ZINC; ALPHA-CELLS; RISK LOCI	Zn2+ is an important cofactor for insulin biosynthesis and storage in pancreatic beta-cells. Correspondingly, polymorphisms in the SLC30A8 gene, encoding the secretory granule Zn2+ transporter ZnT8, are associated with type 2 diabetes risk. Using a genetically engineered (FRET)-based sensor (eCALWY-4), we show here that elevated glucose time-dependently increases free cytosolic Zn2+ ([Zn2+](cyt)) in mouse pancreatic beta-cells. These changes become highly significant (853 +/- 96 pM versus 452 +/- 42 pM, p < 0.001) after 24 h and are associated with increased expression of the Zn2+ importer family members Slc39a6, Slc39a7, and Slc39a8, and decreased expression of metallothionein 1 and 2. Arguing that altered expression of the above genes is not due to altered [Zn2+] cyt, elevation of extracellular (and intracellular) [Zn2+] failed to mimic the effects of high glucose. By contrast, increases in intracellular cAMP prompted by 3-isobutyl-1-methylxanthine and forskolin partially mimicked the effects of glucose on metallothionein, although not ZiP, gene expression. Modulation of intracellular Ca2+ and insulin secretion with pharmacological agents (tolbutamide and diazoxide) suggested a possible role for changes in these parameters in the regulation of Slc39a6 and Slc39a7 but not Slc39a8, nor metallothionein expression. In summary, 1) glucose induces increases in [Zn2+] cyt, which are then likely to facilitate the processing and/or the storage of insulin and its cocrystallization with Zn2+, and 2) these increases are associated with elevated expression of zinc importers. Conversely, a chronic increase in [Zn2+] cyt following sustained hyperglycemia may contribute to beta-cell dysfunction and death in some forms of diabetes.	[Bellomo, Elisa A.; Meur, Gargi; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, London SW7 2AZ, England	Imperial College London	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	g.rutter@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343; Bellomo, Elisa/0000-0003-4823-2209; Meur, Gargi/0000-0002-8466-2997	Wellcome Trust [081958/Z/07/Z]; Servier IdS; Royal Society; Medical Research Council [G0401641] Funding Source: researchfish; MRC [G0401641] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Servier IdS; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Programme Grant 081958/Z/07/Z and Servier IdS. This work was also supported by a Royal Society Wolfson Research merit award (to G. A. R.).	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Bryan J, 1997, CURR OPIN CELL BIOL, V9, P553, DOI 10.1016/S0955-0674(97)80033-6; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; CORDOVA A, 1994, BIOL TRACE ELEM RES, V42, P209, DOI 10.1007/BF02911518; CROUCH RK, 1984, EXP MOL PATHOL, V41, P377, DOI 10.1016/0014-4800(84)90026-1; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; el-Yazigi A, 1993, Diabetes Res, V22, P67; ELAYAT AA, 1995, J ANAT, V186, P629; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; GHAFGHAZI T, 1981, DIABETES, V30, P341, DOI 10.2337/diabetes.30.4.341; GRILL V, 1973, FEBS LETT, V33, P311, DOI 10.1016/0014-5793(73)80218-2; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; HUTTON JC, 1990, BIOCHEM SOC T, V18, P122, DOI 10.1042/bst0180122; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Kahn SE, 2001, INT J CLIN PRACT, P13; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; KENNEDY ML, 1987, J NUTR, V117, P886, DOI 10.1093/jn/117.5.886; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; Meur G, 2011, J BIOL CHEM, V286, P13647, DOI 10.1074/jbc.M110.204248; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; ORCI L, 1975, J CLIN INVEST, V56, P1066, DOI 10.1172/JCI108154; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; RAZ I, 1988, DIABETOLOGIA, V31, P329; Sanchez-Alvarez R, 2006, GLIA, V54, P125, DOI 10.1002/glia.20363; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott DA, 1938, J CLIN INVEST, V17, P725, DOI 10.1172/JCI101000; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sensi SL, 2003, CELL CALCIUM, V34, P281, DOI 10.1016/S0143-4160(03)00122-2; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Sondergaard LG, 2003, APMIS, V111, P1147, DOI 10.1111/j.1600-0463.2003.apm1111211.x; SOUTHON S, 1988, BRIT J NUTR, V60, P499, DOI 10.1079/BJN19880122; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Trayhurn P, 2000, HORM METAB RES, V32, P542, DOI 10.1055/s-2007-978683; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wijesekara N, 2009, DIABETES OBES METAB, V11, P202, DOI 10.1111/j.1463-1326.2009.01110.x; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	77	89	92	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25778	25789		10.1074/jbc.M111.246082	http://dx.doi.org/10.1074/jbc.M111.246082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613223	Green Published, hybrid			2022-12-25	WOS:000293073000040
J	Ortiz-Meoz, RF; Green, R				Ortiz-Meoz, Rodrigo F.; Green, Rachel			Helix 69 Is Key for Uniformity during Substrate Selection on the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; TRANSLATION TERMINATION; CRYSTAL-STRUCTURE; 70S RIBOSOME; DECODING CENTER; ACTIVE-ROLE; STOP CODON; CRYO-EM; RECOGNITION; ANTICODON	Structural studies of ribosome complexes with bound tRNAs and release factors show considerable contacts between these factors and helix 69 (H69) of 23 S rRNA. Although biochemical and genetic studies have provided some general insights into the role of H69 in tRNA and RF selection, a detailed understanding of these contributions remains elusive. Here, we present a pre-steady-state kinetic analysis establishing that two distinct regions of H69 make critical contributions to substrate selection. The loop of H69 (A1913) forms contacts necessary for the efficient accommodation of a subset of natural tRNA species, whereas the base of the stem (G1922) is specifically critical for UGA codon recognition by the class 1 release factor RF2. These data define a broad and critical role for this centrally located intersubunit helix (H69) in accurate and efficient substrate recognition by the ribosome.	[Ortiz-Meoz, Rodrigo F.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 702 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Ortiz-Meoz, Rodrigo/0000-0003-2134-8762	National Institutes of Health [GM059425]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059425, R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059425 and the Howard Hughes Medical Institute (to R. G.).	Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Cochella L, 2007, NAT STRUCT MOL BIOL, V14, P30, DOI 10.1038/nsmb1183; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P683, DOI 10.1093/nar/23.4.683; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Kipper K, 2011, BIOCHIMIE, V93, P834, DOI 10.1016/j.biochi.2010.12.018; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Li W, 2008, EMBO J, V27, P3322, DOI 10.1038/emboj.2008.243; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; O'Connor M, 2009, MOL GENET GENOMICS, V282, P371, DOI 10.1007/s00438-009-0470-6; OCONNOR M, 1995, J MOL BIOL, V254, P838, DOI 10.1006/jmbi.1995.0659; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ortiz-Meoz RF, 2010, RNA, V16, P2002, DOI 10.1261/rna.2232710; Pai RD, 2008, J MOL BIOL, V376, P1334, DOI 10.1016/j.jmb.2007.12.048; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2005, METHODS, V36, P305, DOI 10.1016/j.ymeth.2005.04.007	34	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25604	25610		10.1074/jbc.M111.256255	http://dx.doi.org/10.1074/jbc.M111.256255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622559	Green Published, hybrid			2022-12-25	WOS:000293073000022
J	Chavadi, SS; Edupuganti, UR; Vergnolle, O; Fatima, I; Singh, SM; Soll, CE; Quadri, LEN				Chavadi, Sivagami Sundaram; Edupuganti, Uthamaphani R.; Vergnolle, Olivia; Fatima, Itrat; Singh, Shaneen M.; Soll, Clifford E.; Quadri, Luis E. N.			Inactivation of tesA Reduces Cell Wall Lipid Production and Increases Drug Susceptibility in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHTHIOCEROL DIMYCOCEROSATE LOCUS; SIGNATURE-TAGGED MUTAGENESIS; SMALL-MOLECULE INHIBITION; STRUCTURAL BASIS; TUBERCULOSIS; VIRULENCE; THIOESTERASE; BIOSYNTHESIS; GENE; IDENTIFICATION	Phthiocerol dimycocerosates (PDIMs) and phenolic glycolipids (PGLs) are structurally related lipids noncovalently bound to the outer cell wall layer of Mycobacterium tuberculosis, Mycobacterium leprae, and several opportunistic mycobacterial human pathogens. PDIMs and PGLs are important effectors of virulence. Elucidation of the biosynthesis of these complex lipids will not only expand our understanding of mycobacterial cell wall biosynthesis, but it may also illuminate potential routes to novel therapeutics against mycobacterial infections. We report the construction of an in-frame deletion mutant of tesA (encoding a type II thioesterase) in the opportunistic human pathogen Mycobacterium marinum and the characterization of this mutant and its corresponding complemented strain control in terms of PDIM and PGL production. The growth and antibiotic susceptibility of these strains were also probed and compared with the parental wild-type strain. We show that deletion of tesA leads to a mutant that produces only traces of PDIMs and PGLs, has a slight growth yield increase and displays a substantial hypersusceptibility to several antibiotics. We also provide a robust model for the three-dimensional structure of M. marinum TesA (TesAmm) and demonstrate that a Ser-to-Ala substitution in the predicted catalytic Ser of TesAmm renders a mutant that recapitulates the phenotype of the tesA deletion mutant. Overall, our studies demonstrate a critical role for tesA in mycobacterial biology, advance our understanding of the biosynthesis of an important group of polyketide synthase-derived mycobacterial lipids, and suggest that drugs aimed at blocking PDIM and/or PGL production might synergize with antibiotic therapy in the control of mycobacterial infections.	[Chavadi, Sivagami Sundaram; Edupuganti, Uthamaphani R.; Vergnolle, Olivia; Fatima, Itrat; Singh, Shaneen M.; Quadri, Luis E. N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Soll, Clifford E.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY)	Quadri, LEN (corresponding author), CUNY Brooklyn Coll, Dept Biol, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	LQuadri@brooklyn.cuny.edu			National Institutes of Health [R01AI069209, 1S10RR022649-01]; CUNY Instrumentation Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUNY Instrumentation Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI069209 (to L. E. N. Q.).; We acknowledge funding for the LC-MS system provided by NIH Shared Instrumentation Grant 1S10RR022649-01 and the CUNY Instrumentation Fund. We are grateful to Richard Moy (Quadri laboratory) for assistance in mutant construction.	Andreu N, 2008, TUBERCULOSIS, V88, P553, DOI 10.1016/j.tube.2008.03.005; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Collins DM, 2005, INFECT IMMUN, V73, P2379, DOI 10.1128/IAI.73.4.2379-2386.2005; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crick D. C., 2008, HDB TUBERCULOSIS MOL, P1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhungel S, 2008, Nepal Med Coll J, V10, P1; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; He WG, 2009, J AM CHEM SOC, V131, P16744, DOI 10.1021/ja904792q; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Murry JP, 2009, J INFECT DIS, V200, P774, DOI 10.1086/605128; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Onwueme KC, 2005, J BACTERIOL, V187, P4760, DOI 10.1128/JB.187.14.4760-4766.2005; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P1, DOI 10.1385/0-89603-471-2:1; Quadri LEN, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P341; Quadri Luis E. N., 2007, Infectious Disorders - Drug Targets, V7, P230, DOI 10.2174/187152607782110040; Rallis E, 2007, EXPERT OPIN PHARMACO, V8, P2965, DOI 10.1517/14656566.8.17.2965; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Robinson N, 2008, TRAFFIC, V9, P1936, DOI 10.1111/j.1600-0854.2008.00804.x; Ruley KM, 2004, FEMS MICROBIOL LETT, V232, P75, DOI 10.1016/S0378-1097(04)00017-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J, 2001, MOL CLONING LAB MANU; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stirrett KL, 2008, BIOORG MED CHEM LETT, V18, P2662, DOI 10.1016/j.bmcl.2008.03.025; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x	55	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24616	24625		10.1074/jbc.M111.247601	http://dx.doi.org/10.1074/jbc.M111.247601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592957	Green Published, hybrid			2022-12-25	WOS:000292547900012
J	Kocher, O; Birrane, G; Yesilaltay, A; Shechter, S; Pal, R; Daniels, K; Krieger, M				Kocher, Olivier; Birrane, Gabriel; Yesilaltay, Ayce; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen; Krieger, Monty			Identification of the PDZ3 Domain of the Adaptor Protein PDZK1 as a Second, Physiologically Functional Binding Site for the C Terminus of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; SR-BI; APOLIPOPROTEIN-E; HOMOLOGOUS RECOMBINATION; SURFACE LOCALIZATION; TARGETED DISRUPTION; METABOLISM; EXPRESSION; GENE; HYPERCHOLESTEROLEMIA	The normal expression, cell surface localization, and function of the murine high density lipoprotein receptor scavenger receptor class B type I (SR-BI) in hepatocytes in vivo, and thus normal lipoprotein metabolism, depend on its four PDZ domain (PDZ1-PDZ4) containing cytoplasmic adaptor protein PDZK1. Previous studies showed that the C terminus of SR-BI ("target peptide") binds directly to PDZ1 and influences hepatic SR-BI protein expression. Unexpectedly an inactivating mutation in PDZ1 (Tyr(20) -> Ala) only partially, rather than completely, suppresses the ability of PDZK1 to control hepatic SR-BI. We used isothermal titration calorimetry to show that PDZ3, but not PDZ2 or PDZ4, can also bind the target peptide (K-d = 37.0 mu M), albeit with similar to 10-fold lower affinity than PDZ1. This binding is abrogated by a Tyr(253) -> Ala substitution. Comparison of the 1.5-angstrom resolution crystal structure of PDZ3 with its bound target peptide ((505)QEAKL(509)) to that of peptide-bound PDZ1 indicated fewer target peptide stabilizing atomic interactions (hydrogen bonds and hydrophobic interactions) in PDZ3. A double (Tyr(20) -> Ala (PDZ1) + Tyr(253) -> Ala (PDZ3)) substitution abrogated all target peptide binding to PDZK1. In vivo hepatic expression of a singly substituted (Tyr(253) -> Ala (PDZ3)) PDZK1 transgene (Tg) was able to correct all of the SR-BI-related defects in PDZK1 knock-out mice, whereas the doubly substituted [Tyr(20) -> Ala (PDZ1) + Tyr(253) -> Ala (PDZ3)] Tg was unable to correct these defects. Thus, we conclude that PDZK1-mediated control of hepatic SR-BI requires direct binding of the SR-BIC terminus to either the PDZ1 or PDZ3 domains, and that binding to both domains simultaneously is not required for PDZK1 control of hepatic SR-BI.	[Kocher, Olivier; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Kocher, Olivier; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Birrane, Gabriel] Harvard Univ, Sch Med, Div Expt Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kocher, O (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL077780, HL52212, HL66105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL052212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.), HL52212 and HL66105 (to M. K.).	Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; DeLano W, 2002, PYMOL 0 99; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25171	25186		10.1074/jbc.M111.242362	http://dx.doi.org/10.1074/jbc.M111.242362			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602281	Green Published, hybrid			2022-12-25	WOS:000292547900064
J	Verma, R; Malik, C; Azmi, S; Srivastava, S; Ghosh, S; Ghosh, JK				Verma, Richa; Malik, Chetan; Azmi, Sarfuddin; Srivastava, Saurabh; Ghosh, Subhendu; Ghosh, Jimut Kanti			A Synthetic S6 Segment Derived from KvAP Channel Self-assembles, Permeabilizes Lipid Vesicles, and Exhibits Ion Channel Activity in Bilayer Lipid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER POTASSIUM CHANNELS; DEPENDENT K+ CHANNEL; ZIPPER-LIKE MOTIF; FORMING PEPTIDE ALAMETHICIN; 4-HELIX BUNDLE PROTEINS; PORE-LINING STRUCTURE; SENDAI-VIRUS FUSION; TOXIN HEMOLYSIN-E; TRANSMEMBRANE SEGMENT; FUNCTIONAL-CHARACTERIZATION	KvAP is a voltage-gated tetrameric K+ channel with six transmembrane (S1-S6) segments in each monomer from the archaeon Aeropyrum pernix. The objective of the present investigation was to understand the plausible role of the S6 segment, which has been proposed to form the inner lining of the pore, in the membrane assembly and functional properties of KvAP channel. For this purpose, a 22-residue peptide, corresponding to the S6 transmembrane segment of KvAP (amino acids 218-239), and a scrambled peptide (S6-SCR) with rearrangement of only hydrophobic amino acids but without changing its composition were synthesized and characterized structurally and functionally. Although both peptides bound to the negatively charged phosphatidylcholine/phosphatidylglycerol model membrane with comparable affinity, significant differences were observed between these peptides in their localization, self-assembly, and aggregation properties onto this membrane. S6-SCR also exhibited reduced helical structures in SDS micelles and phosphatidylcholine/phosphatidylglycerol lipid vesicles as compared with the S6 peptide. Furthermore, the S6 peptide showed significant membrane-permeabilizing capability as evidenced by the release of calcein from the calcein-entrapped lipid vesicles, whereas S6-SCR showed much weaker efficacy. Interestingly, although the S6 peptide showed ion channel activity in the bilayer lipid membrane, despite having the same amino acid composition, S6-SCR was significantly inactive. The results demonstrated sequence-specific structural and functional properties of the S6 wild type peptide. The selected S6 segment is probably an important structural element that could play an important role in the membrane interaction, membrane assembly, and functional property of the KvAP channel.	[Verma, Richa; Azmi, Sarfuddin; Srivastava, Saurabh; Ghosh, Jimut Kanti] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India; [Malik, Chetan; Ghosh, Subhendu] Univ Delhi S Campus, Dept Biophys, New Delhi 110021, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Delhi	Ghosh, JK (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Chattar Manzil Palace, Lucknow 226001, Uttar Pradesh, India.	jighosh@yahoo.com	Ghosh, Subhendu/GSN-2467-2022; Srivastava, Saurabh/L-1188-2017; Azmi, Sarfuddin/AAE-7602-2022	Srivastava, Saurabh/0000-0003-3159-7826; Azmi, Sarfuddin/0000-0002-1868-3458; Malik, Dr. Chetan/0000-0003-3428-7567	Central Drug Research Institute (CDRI) [MLP0007M]; Council for Scientific and Industrial Research India	Central Drug Research Institute (CDRI); Council for Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Central Drug Research Institute (CDRI) In-house Project MLP0007M. The CDRI communication number of this manuscript is 8068.; Received fellowships from the Council for Scientific and Industrial Research India.	Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; BAILIN G, 1990, FEBS LETT, V259, P254, DOI 10.1016/0014-5793(90)80021-A; Banerjee J, 2006, J NEUROCHEM, V98, P670, DOI 10.1111/j.1471-4159.2006.03853.x; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BENEFRAIM I, 1993, BIOCHEMISTRY-US, V32, P2371, DOI 10.1021/bi00060a031; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Biggin PC, 2000, CURR OPIN STRUC BIOL, V10, P456, DOI 10.1016/S0959-440X(00)00114-7; Bouchayer E, 2001, J PEPT RES, V57, P39, DOI 10.1034/j.1399-3011.2001.00792.x; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Choe S, 2002, NAT REV NEUROSCI, V3, P115, DOI 10.1038/nrn727; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Ding SH, 2003, BIOPHYS J, V84, P295, DOI 10.1016/S0006-3495(03)74850-4; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P12363, DOI 10.1021/bi00097a013; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Ghosh JK, 1998, J BIOL CHEM, V273, P27182, DOI 10.1074/jbc.273.42.27182; Ghosh JK, 1997, BIOCHEMISTRY-US, V36, P15451, DOI 10.1021/bi971152i; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GROVE A, 1992, METHOD ENZYMOL, V207, P510; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HARIS PI, 1994, PROTEIN ENG, V7, P255, DOI 10.1093/protein/7.2.255; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; IWAMOTO T, 1994, INT J PEPT PROT RES, V43, P597, DOI 10.1111/j.1399-3011.1994.tb00562.x; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Katsu T, 2007, ANAL SCI, V23, P517, DOI 10.2116/analsci.23.517; KENNEDY SJ, 1977, SCIENCE, V196, P1341, DOI 10.1126/science.867034; KENNEDY SJ, 1978, J MEMBRANE BIOL, V42, P265, DOI 10.1007/BF01870362; KENNER RA, 1971, BIOCHEMISTRY-US, V10, P4433, DOI 10.1021/bi00800a013; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lee J, 2009, J PEPT SCI, V15, P601, DOI 10.1002/psc.1157; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; OBLATTMONTAL M, 1993, J BIOL CHEM, V268, P14601; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; OIKI S, 1988, P NATL ACAD SCI USA, V85, P2393, DOI 10.1073/pnas.85.7.2393; Pandey BK, 2011, BIOCHEM J, V436, P609, DOI 10.1042/BJ20110056; PAWLAK M, 1994, BIOCHEMISTRY-US, V33, P283, DOI 10.1021/bi00167a037; PeledZehavi H, 1996, BIOCHEMISTRY-US, V35, P6828, DOI 10.1021/bi952988t; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1992, TRENDS PHARMACOL SCI, V13, P359, DOI 10.1016/0165-6147(92)90109-J; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; REDDY GL, 1993, J BIOL CHEM, V268, P14608; Rich TC, 2002, AM J PHYSIOL-CELL PH, V282, pC161, DOI 10.1152/ajpcell.00232.2001; Riquelme G, 2004, J BIOL CHEM, V279, P50601, DOI 10.1074/jbc.M407859200; RIZZO V, 1987, BIOCHEMISTRY-US, V26, P2751, DOI 10.1021/bi00384a015; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; SCHWARZ G, 1989, BIOCHIM BIOPHYS ACTA, V979, P82, DOI 10.1016/0005-2736(89)90526-9; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; SCHWARZ G, 1987, BIOPHYS J, V52, P685, DOI 10.1016/S0006-3495(87)83263-0; SHAI Y, 1991, J BIOL CHEM, V266, P22346; SHINOZAKI K, 1994, BIOCHEM BIOPH RES CO, V198, P445, DOI 10.1006/bbrc.1994.1065; SPUHLER P, 1994, J BIOL CHEM, V269, P23904; Swartz KJ, 2005, J GEN PHYSIOL, V126, P413, DOI 10.1085/jgp.200509430; TAGLIALATELA M, 1994, J BIOL CHEM, V269, P13867; Thundimadathil J, 2005, BIOCHEM BIOPH RES CO, V330, P585, DOI 10.1016/j.bbrc.2005.02.184; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; TOSTESON MT, 1989, P NATL ACAD SCI USA, V86, P707, DOI 10.1073/pnas.86.2.707; Trauner D, 2003, ANGEW CHEM INT EDIT, V42, P5671, DOI 10.1002/anie.200301724; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Verma R, 2010, BBA-BIOMEMBRANES, V1798, P461, DOI 10.1016/j.bbamem.2009.12.014; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Yadav SP, 2007, BBA-BIOMEMBRANES, V1768, P1574, DOI 10.1016/j.bbamem.2007.03.019; Yadav SP, 2009, BBA-BIOMEMBRANES, V1788, P538, DOI 10.1016/j.bbamem.2008.11.013; Yadav SP, 2003, J BIOL CHEM, V278, P51023, DOI 10.1074/jbc.M310052200; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	106	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24828	24841		10.1074/jbc.M110.209676	http://dx.doi.org/10.1074/jbc.M110.209676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592970	Green Published, hybrid			2022-12-25	WOS:000292547900033
J	Yuan, KY; Jing, G; Chen, JF; Liu, H; Zhang, K; Li, YB; Wu, H; McDonald, JM; Chen, YB				Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; Liu, Hui; Zhang, Kui; Li, Yuebin; Wu, Hui; McDonald, Jay M.; Chen, Yabing			Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GASTROINTESTINAL TUMOR-CELLS; DEATH DOMAIN PROTEIN; INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; INHIBITORY PROTEIN; GROWTH-FACTORS; IMMUNE-SYSTEM; CD95 LIGAND; PROLIFERATION	Pancreatic cancer remains a devastating malignancy with a poor prognosis and is largely resistant to current therapies. To understand the resistance of pancreatic tumors to Fas death receptor-induced apoptosis, we investigated the molecular mechanisms of Fas-activated survival signaling in pancreatic cancer cells. We found that knockdown of the Fas-associated protein with death domain (FADD), the adaptor that mediates downstream signaling upon Fas activation, rendered Fas-sensitive MiaPaCa-2 and BxPC-3 pancreatic cells resistant to Fas-induced apoptosis. By contrast, Fas activation promoted the survival of the FADD knockdown MiaPaCa-2 and BxPC-3 cells in a concentration-dependent manner. The pharmacological inhibitor of ERK, PD98059, abrogated Fas-promoted cell survival in FADD knockdown MiaPaCa-2 and BxPC-3 cells. Furthermore, increased phosphorylation of Src was demonstrated to mediate Fas-induced ERK activation and cell survival. Immunoprecipitation of Fas in the FADD knockdown cells identified the presence of increased calmodulin, Src, and phosphorylated Src in the Fas-associated protein complex upon Fas activation. Trifluoperazine, a calmodulin antagonist, inhibited Fas-induced recruitment of calmodulin, Src, and phosphorylated Src. Consistently, trifluoperazine blocked Fas-promoted cell survival. A direct interaction of calmodulin and Src and their binding site were identified with recombinant proteins. These results support an essential role of calmodulin in mediating Fas-induced FADD-independent activation of Src-ERK signaling pathways, which promote survival signaling in pancreatic cancer cells. Understanding the molecular mechanisms responsible for the resistance of pancreatic cells to apoptosis induced by Fas-death receptor signaling may provide molecular insights into designing novel therapies to treat pancreatic tumors.	[Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; McDonald, Jay M.; Chen, Yabing] Univ Alabama, Sch Dent, Dept Pathol, Birmingham, AL 35294 USA; [Liu, Hui] Univ Alabama, Sch Dent, Dept Physiol, Birmingham, AL 35294 USA; [Zhang, Kui] Univ Alabama, Sch Dent, Dept Biostat, Birmingham, AL 35294 USA; [Li, Yuebin; Wu, Hui] Univ Alabama, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Li, Yuebin; Wu, Hui] Univ Alabama, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; McDonald, Jay M.; Chen, Yabing] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; [Liu, Hui] Univ Alabama, Sch Med, Dept Physiol, Birmingham, AL 35294 USA; [Zhang, Kui] Univ Alabama, Sch Med, Dept Biostat, Birmingham, AL 35294 USA; [McDonald, Jay M.; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Chen, YB (corresponding author), Univ Alabama, Sch Dent, Dept Pathol, 710 Shelby Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.	ybchen@uab.edu			Department of Pathology, University of Alabama at Birmingham; Veterans Affairs merit review award	Department of Pathology, University of Alabama at Birmingham; Veterans Affairs merit review award(US Department of Veterans Affairs)	This work was supported in part by start-up funds from the Department of Pathology, University of Alabama at Birmingham (to Y. C.), and a Veterans Affairs merit review award (to J. M. M.).	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Ametller E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-161; BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chen KC, 2010, J CELL PHYSIOL, V222, P625, DOI 10.1002/jcp.21979; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Christgen M, 2005, CANCER LETT, V227, P193, DOI 10.1016/j.canlet.2005.01.016; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Griffiths GJ, 2004, J BIOL CHEM, V279, P46113, DOI 10.1074/jbc.M408550200; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kornmann M, 2000, PANCREAS, V20, P123, DOI 10.1097/00006676-200003000-00003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Nabissi M, 2010, CARCINOGENESIS, V31, P794, DOI 10.1093/carcin/bgq019; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Park MA, 2008, MOL CANCER THER, V7, P2633, DOI 10.1158/1535-7163.MCT-08-0400; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Pawar P, 2009, CLIN CANCER RES, V15, P1288, DOI 10.1158/1078-0432.CCR-08-1150; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Suzuki I, 2000, J IMMUNOL, V165, P5537, DOI 10.4049/jimmunol.165.10.5537; Ungefroren H, 1998, CANCER RES, V58, P1741; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; Wallach D, 1998, CURR OPIN IMMUNOL, V10, P279, DOI 10.1016/S0952-7915(98)80166-0; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	59	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24776	24784		10.1074/jbc.M110.202804	http://dx.doi.org/10.1074/jbc.M110.202804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613217	Green Published, hybrid			2022-12-25	WOS:000292547900028
J	Celigoy, J; Ramirez, B; Tao, L; Rong, LJ; Yan, LY; Feng, YR; Quinnan, GV; Broder, CC; Caffrey, M				Celigoy, Jessica; Ramirez, Benjamin; Tao, Lin; Rong, Lijun; Yan, Lianying; Feng, Yan-Ru; Quinnan, Gerald V.; Broder, Christopher C.; Caffrey, Michael			Probing the HIV gp120 Envelope Glycoprotein Conformation by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; 44 KDA ECTODOMAIN; DUAL ANTAGONIST; GP41; SPECTROSCOPY; RECEPTOR; ENTRY; TRIMERS; LIGANDS	The HIV envelope glycoprotein gp120 plays a critical role in virus entry, and thus, its structure is of extreme interest for the development of novel therapeutics and vaccines. To date, high resolution structural information about gp120 in complex with gp41 has proven intractable. In this study, we characterize the structural properties of gp120 in the presence and absence of gp41 domains by NMR. Using the peptide probe 12p1 (sequence, RINNIPWSEAMM), which was identified previously as an entry inhibitor that binds to gp120, we identify atoms of 12p1 in close contact with gp120 in the monomeric and trimeric states. Interestingly, the binding mode of 12p1 with gp120 is similar for clades B and C. In addition, we show a subtle difference in the binding mode of 12p1 in the presence of gp41 domains, i.e. the trimeric state, which we interpret as small differences in the gp120 structure in the presence of gp41.	[Celigoy, Jessica; Ramirez, Benjamin; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Tao, Lin] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Rong, Lijun] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Yan, Lianying; Feng, Yan-Ru; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Quinnan, Gerald V.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland, Chicago, IL 60607 USA.	caffrey@uic.edu	Feng, YanRu/AAA-2183-2020; Broder, Christopher/E-1169-2013		National Institutes of Health [AI066709, AI077767]; Chicago Developmental Center for AIDS Research [AI082151]; University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151, U01AI066709, U01AI077767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Developmental Center for AIDS Research; University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI066709 and AI077767. This work was also supported by Chicago Developmental Center for AIDS Research Grant AI082151.; We acknowledge support of the University of Illinois at Chicago Center for Structural Biology.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Assadi-Porter FM, 2008, J AM CHEM SOC, V130, P7212, DOI 10.1021/ja8016939; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Biorn AC, 2004, BIOCHEMISTRY-US, V43, P1928, DOI 10.1021/bi035088i; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas NW, 1997, J MOL BIOL, V273, P122, DOI 10.1006/jmbi.1997.1277; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gopi H, 2008, J MED CHEM, V51, P2638, DOI 10.1021/jm070814r; Gopi HN, 2006, CHEMMEDCHEM, V1, P54, DOI 10.1002/cmdc.200500037; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haselhorst T, 2008, ANGEW CHEM INT EDIT, V47, P1910, DOI 10.1002/anie.200704872; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104	32	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23975	23981		10.1074/jbc.M111.251025	http://dx.doi.org/10.1074/jbc.M111.251025			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592971	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000292294900040
J	Peil, K; Varv, S; Looke, M; Kristjuhan, K; Kristjuhan, A				Peil, Kadri; Vaerv, Signe; Loeoke, Marko; Kristjuhan, Kersti; Kristjuhan, Arnold			Uniform Distribution of Elongating RNA Polymerase II Complexes in Transcribed Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOMAL BARRIER; GENOME-WIDE; YEAST; INITIATION; REGION	The intensity of gene transcription is generally reflected by the level of RNA polymerase II (RNAPII) recruitment to the gene. However, genome-wide studies of polymerase occupancy indicate that RNAPII distribution varies among genes. In some loci more polymerases are found in the 5' region, whereas in other loci, in the 3' region of the gene. We studied the distribution of elongating RNAPII complexes at highly transcribed GAL-VPS13 locus in Saccharomyces cerevisiae and found that in the cell population the amount of polymerases gradually decreased toward the 3' end of the gene. However, the conventional chromatin immunoprecipitation assay averages the signal from the cell population, and no data on single cell level can be gathered. To study the spacing of elongating polymerases on single chromosomes, we used a sequential chromatin immunoprecipitation assay for the detection of multiple RNAPII complexes on the same DNA fragment. Our results demonstrate uniform distribution of elongating polymerases throughout all regions of the GAL-VPS13 gene.	[Peil, Kadri; Vaerv, Signe; Loeoke, Marko; Kristjuhan, Kersti; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia	University of Tartu	Kristjuhan, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee		Kristjuhan, Arnold/0000-0002-5842-4952	Wellcome Trust [081756]; European Molecular Biology Organization [1454]	Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by Wellcome Trust International Senior Research Fellowship Grant 081756 and European Molecular Biology Organization Installation Grant 1454.	Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Varv S, 2007, BIOCHEM BIOPH RES CO, V358, P666, DOI 10.1016/j.bbrc.2007.05.003; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	28	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23817	23822		10.1074/jbc.M111.230805	http://dx.doi.org/10.1074/jbc.M111.230805			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606489	hybrid, Green Published			2022-12-25	WOS:000292294900024
J	Springauf, A; Bresenitz, P; Grunder, S				Springauf, Andreas; Bresenitz, Pia; Gruender, Stefan			The Interaction between Two Extracellular Linker Regions Controls Sustained Opening of Acid-sensing Ion Channel 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL-NEURONS; ACTIVATED CURRENTS; SENSORY NEURONS; DESENSITIZATION; PH; ION-CHANNEL-1; ASIC1; PAIN; CONTRIBUTES	Activation of acid-sensing ion channels (ASICs) contributes to neuronal death during stroke, to axonal degeneration during neuroinflammation, and to pain during inflammation. Although understanding ASIC gating may help to modulate ASIC activity during these pathologic situations, at present it is poorly understood. The ligand, H+, probably binds to several sites, among them amino acids within the large extracellular domain. The extracellular domain is linked to the two transmembrane domains by the wrist region that is connected to two anti-parallel beta-strands, beta 1 and beta 12. Thus, the wrist region together with those beta-strands may have a crucial role in transmitting ligand binding to pore opening and closing. Here we show that amino acids in the beta 1-beta 2 linker determine constitutive opening of ASIC1b from shark. The most crucial residue within the beta 1-beta 2 linker (Asp(110)), when mutated from aspartate to cysteine, can be altered by cysteine-modifying reagents much more readily when channels are closed than when they are desensitized. Finally, engineering of a cysteine at position 110 and at an adjacent position in the beta 11-beta 12 linker leads to spontaneous formation of a disulfide bond that traps the channel in the desensitized conformation. Collectively, our results suggest that the beta 1-beta 2 and beta 11-beta 12 linkers are dynamic during gating and tightly appose to each other during desensitization gating. Hindrance of this tight apposition leads to reopening of the channel. It follows that the beta 1-beta 2 and beta 11-beta 12 linkers modulate gating movements of ASIC1 and may thus be drug targets to modulate ASIC activity.	[Springauf, Andreas; Bresenitz, Pia; Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany	RWTH Aachen University	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883	Deutsche Forschungsgemeinschaft [GR1771/3-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GR1771/3-5 (to S. G.).	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	34	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24374	24384		10.1074/jbc.M111.230797	http://dx.doi.org/10.1074/jbc.M111.230797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576243	Green Published, hybrid			2022-12-25	WOS:000292294900077
J	Msalya, G; Shimogiri, T; Ohno, S; Okamoto, S; Kawabe, K; Minezawa, M; Maeda, Y				Msalya, George; Shimogiri, Takeshi; Ohno, Shotaro; Okamoto, Shin; Kawabe, Kotaro; Minezawa, Mitsuru; Maeda, Yoshizane			Evaluation of PRNP Expression Based on Genotypes and Alleles of Two Indel Loci in the Medulla Oblongata of Japanese Black and Japanese Brown Cattle	PLOS ONE			English	Article							PRION-PROTEIN GENE; POLYMORPHISMS; SEQUENCE; HOLSTEIN; PROMOTER; MODULATE	Background: Prion protein (PrP) level plays the central role in bovine spongiform encephalopathy (BSE) susceptibility. Increasing the level of PrP decreases incubation period for this disease. Therefore, studying the expression of the cellular PrP or at least the messenger RNA might be used in selection for preventing the propagation of BSE and other prion diseases. Two insertion/deletion (indel) variations have been tentatively associated with susceptibility/resistance of cattle to classical BSE. Methodology/Principal Findings: We studied the expression of each genotype at the two indel sites in Japanese Black (JB) and Japanese Brown (JBr) cattle breeds by a standard curve method of real-time PCR. Five diplotypes subdivided into two categories were selected from each breed. The two cattle breeds were considered differently. Expression of PRNP was significantly (p<0.0001) greater in the homozygous deletion genotype at the 23-bp locus in JB breed. Compared to the homozygous genotypes, the expression of PRNP was significantly greater in the heterozygous genotype at the 12-bp locus in JB (p<0.0001) and in JBr (p = 0.0394) breeds. In addition, there was a statistical significance in the PRNP levels between the insertion and the deletion alleles of the 23-bp locus in JB (p = 0.0003) as well as in JBr (p = 0.0032). There was no significance in relation to sex, age, geographical location or due to their interactions (p>0.05). Conclusion: Our results suggest that the del/del genotype or at least its del allele may modulate the expression of PRNP at the 23-bp locus in the medulla oblongata of these cattle breeds.	[Msalya, George] Kagoshima Univ, United Grad Sch Agr, Kagoshima 890, Japan; [Shimogiri, Takeshi; Ohno, Shotaro; Okamoto, Shin; Maeda, Yoshizane] Kagoshima Univ, Fac Agr, Kagoshima 890, Japan; [Kawabe, Kotaro] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 890, Japan; [Minezawa, Mitsuru] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Msalya, George] NARCO Kikulula Karagwe, Heifer Breeding Project, Kagera, Tanzania	Kagoshima University; Kagoshima University; Kagoshima University; National Institute of Agrobiological Sciences - Japan	Msalya, G (corresponding author), Kagoshima Univ, United Grad Sch Agr, Kagoshima 890, Japan.	msalya@yahoo.com						Brunelle BW, 2008, J DAIRY SCI, V91, P338, DOI 10.3168/jds.2007-0423; Brunelle BW, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-36; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; FALCONER DS, 1961, INTRO QUANTITATIVE G, P54; Haigh CL, 2007, J MOL BIOL, V368, P915, DOI 10.1016/j.jmb.2007.02.086; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Msalya G, 2010, ANIM GENET, V41, P218, DOI 10.1111/j.1365-2052.2009.01983.x; MSALYA G, 2008, THESIS KAGOSHIMA U J; Msalya G, 2009, ANIM SCI J, V80, P520, DOI 10.1111/j.1740-0929.2009.00669.x; Murdoch BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012786; Nakamitsu S, 2006, J VET MED SCI, V68, P27, DOI 10.1292/jvms.68.27; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Seabury CM, 2004, MAMM GENOME, V15, P828, DOI 10.1007/s00335-004-2400-6; Shimogiri T, 2010, BIOCHEM GENET, V48, P829, DOI 10.1007/s10528-010-9364-x; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204	26	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18787	10.1371/journal.pone.0018787	http://dx.doi.org/10.1371/journal.pone.0018787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611160	gold, Green Submitted, Green Published			2022-12-25	WOS:000290720200002
J	Hlavackova, P; Franco, C; Diot, B; Vuillerme, N				Hlavackova, Petra; Franco, Celine; Diot, Bruno; Vuillerme, Nicolas			Contribution of Each Leg to the Control of Unperturbed Bipedal Stance in Lower Limb Amputees: New Insights Using Entropy	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; POSTURAL CONTROL; APPROXIMATE ENTROPY; SAMPLE ENTROPY; HEALTHY-YOUNG; SWAY; BALANCE; REGULARITY; PATTERNS; CHILDREN	The present study was designed to assess the relative contribution of each leg to unperturbed bipedal posture in lower limb amputees. To achieve this goal, eight unilateral traumatic trans-femoral amputees (TFA) were asked to stand as still as possible on a plantar pressure data acquisition system with their eyes closed. Four dependent variables were computed to describe the subject's postural behavior: (1) body weight distribution, (2) amplitude, (3) velocity and (4) regularity of centre of foot pressure (CoP) trajectories under the amputated (A) leg and the non-amputated (NA) leg. Results showed a larger body weight distribution applied to the NA leg than to the A leg and a more regular CoP profiles (lower sample entropy values) with greater amplitude and velocity under the NA leg than under the A leg. Taken together, these findings suggest that the NA leg and the A leg do not equally contribute to the control of unperturbed bipedal posture in TFA. The observation that TFA do actively control unperturbed bipedal posture with their NA leg could be viewed as an adaptive process to the loss of the lower leg afferents and efferents because of the unilateral lower-limb amputation. From a methodological point of view, these results demonstrate the suitability of computing bilateral CoP trajectories regularity for the assessment of lateralized postural control under pathological conditions.	[Hlavackova, Petra; Franco, Celine; Vuillerme, Nicolas] EPHE, AGIM, FRE 3405, CNRS,UJF, Grenoble, France; [Hlavackova, Petra] Palacky Univ, Fac Phys Culture, CR-77147 Olomouc, Czech Republic; [Franco, Celine; Vuillerme, Nicolas] IMAG, TIMC, UJF Grenoble 1, CNRS,UMR 5525, Grenoble, France; [Franco, Celine; Diot, Bruno] IDS SA, Montceau Les Mines, France; [Vuillerme, Nicolas] Hop Raymond Poincare, AP HP, INSERM, CIC,IT 805,EA 4497, Garches, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Palacky University Olomouc; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hlavackova, P (corresponding author), EPHE, AGIM, FRE 3405, CNRS,UJF, Grenoble, France.	nicolas.vuillerme@agim.eu	Nicolas, Vuillerme/C-6692-2009; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; VUILLERME, Nicolas/0000-0003-3773-393X	Garches Foundation; AXA Research Fund; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959221]	Garches Foundation; AXA Research Fund(AXA Research Fund); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This research was granted by the Garches Foundation, the AXA Research Fund and the Ministry of Education, Youth and Sports of the Czech Republic (No. MSM 6198959221) Physical Activity and Inactivity of the Inhabitants of the Czech Republic in the Context of Behavioral Changes to the first author and by the Centre National de La Recherche Scientifique (France) to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Duclos C, 2007, GAIT POSTURE, V26, P595, DOI 10.1016/j.gaitpost.2006.12.005; Duclos Cyril, 2009, J Electromyogr Kinesiol, V19, pe214, DOI 10.1016/j.jelekin.2008.04.007; Gauthier-Gagnon C., 1986, PHYSIOTHER CAN, V38, P137; GHOMASHCHI H, 2010, INT J BIFURCAT CHAOS, V20, P1; Hlavackova P, 2009, ARCH PHYS MED REHAB, V90, P1960, DOI 10.1016/j.apmr.2009.05.016; ISAKOV E, 1992, ARCH PHYS MED REHAB, V73, P174; KIRBY RL, 1987, J BIOMECH, V20, P423, DOI 10.1016/0021-9290(87)90049-2; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Nadollek Heidi, 2002, Physiother Res Int, V7, P203, DOI 10.1002/pri.260; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quai TM, 2005, CLIN REHABIL, V19, P668, DOI 10.1191/0269215505cr857oa; RAMDANI S, 2010, ANN BIOMED ENG, P1; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROERDINK M, 2010, HUM MOV SCI; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P267, DOI 10.1177/1545968308323928; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Stins JF, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-42; Summers G D, 1988, Int Disabil Stud, V10, P1; Vuillerme N, 2010, EUR J APPL PHYSIOL, V110, P207, DOI 10.1007/s00421-010-1449-z; Vuillerme N, 2009, GAIT POSTURE, V30, P122, DOI 10.1016/j.gaitpost.2009.03.004	31	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19661	10.1371/journal.pone.0019661	http://dx.doi.org/10.1371/journal.pone.0019661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603630	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500018
J	Inoue, D; Wittbrodt, J				Inoue, Daigo; Wittbrodt, Joachim			One for All-A Highly Efficient and Versatile Method for Fluorescent Immunostaining in Fish Embryos	PLOS ONE			English	Article							ANTIGEN RETRIEVAL TECHNIQUES; IN-VIVO; PROTEIN; IMMUNOHISTOCHEMISTRY; NEUROGENESIS; MICROWAVE; SECTIONS; RETINA	Background: For the detection and sub-cellular (co)-localization of proteins in the context of the tissue or organism immunostaining in whole mount preparations or on sections is still the best approach. So far, each antibody required its own fixation and antigen retrieval protocol so that optimizing immunostaining turned out to be tedious and time consuming. Methodology/Principal Finding: Here we present a novel method to efficiently retrieve the antigen in a widely applicable standard protocol, facilitating fluorescent immunostaining of both cryosections and whole mount preparations in zebrafish (Danio rerio) and medaka (Oryzias latipes). Conclusions/Significance: Our method overcomes the loss of sections and damage of tissue and cell morphology, and allows parallel immunostaining in multiple colors, co-immunostaining with fluorescent proteins in transgenic fish lines and in combination with whole mount in situ hybridization.	[Inoue, Daigo; Wittbrodt, Joachim] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany; [Wittbrodt, Joachim] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Inoue, D (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.	daigo.inoue@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377	HFSP; Uehara memorial Foundation; Naito Foundation; German Research Foundation [SFB 488]	HFSP(Human Frontier Science Program); Uehara memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); German Research Foundation(German Research Foundation (DFG))	DI was supported by HFSP long-term and Cellular Networks postdoctral fellowships, and by the Uehara memorial and Naito Foundations. This work was supported by the SFB 488 of the German Research Foundation (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Brown KE, 2010, DEV BIOL, V339, P14, DOI 10.1016/j.ydbio.2009.12.003; Buchwalow IB, 2005, ACTA HISTOCHEM, V107, P143, DOI 10.1016/j.acthis.2005.01.003; D'Amico F, 2009, J IMMUNOL METHODS, V341, P1, DOI 10.1016/j.jim.2008.11.007; Del Bene F, 2007, PLOS GENET, V3, P1661, DOI 10.1371/journal.pgen.0030159; Hoetelmans RWM, 2002, BIOTECH HISTOCHEM, V77, P137, DOI 10.1080/714028191; Kim SH, 2004, J MOL HISTOL, V35, P409; Nakamura KC, 2008, J HISTOCHEM CYTOCHEM, V56, P647, DOI 10.1369/jhc.2008.950915; Martinez-Morales JR, 2009, DEVELOPMENT, V136, P2165, DOI 10.1242/dev.033563; ShanRongShi, 1996, BIOTECH HISTOCHEM, V71, P190, DOI 10.3109/10520299609117158; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Souren M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r92; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Taylor CR, 1996, BIOTECH HISTOCHEM, V71, P263, DOI 10.3109/10520299609117171; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	17	98	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19713	10.1371/journal.pone.0019713	http://dx.doi.org/10.1371/journal.pone.0019713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603650	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500026
J	Perez-Llamas, C; Lopez-Bigas, N				Perez-Llamas, Christian; Lopez-Bigas, Nuria			Gitools: Analysis and Visualisation of Genomic Data Using Interactive Heat-Maps	PLOS ONE			English	Article							GENE SET ENRICHMENT; ONTOLOGY TOOL; EXPRESSION; PLATFORM; SUITE	Intuitive visualization of data and results is very important in genomics, especially when many conditions are to be analyzed and compared. Heat-maps have proven very useful for the representation of biological data. Here we present Gitools (http://www.gitools.org), an open-source tool to perform analyses and visualize data and results as interactive heat-maps. Gitools contains data import systems from several sources (i.e. IntOGen, Biomart, KEGG, Gene Ontology), which facilitate the integration of novel data with previous knowledge.	[Perez-Llamas, Christian; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain	Pompeu Fabra University	Perez-Llamas, C (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain.	nuria.lopez@upf.edu	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988	Spanish Ministry of Science and Technology [SAF2009-06954]; Spanish National Institute of Bioinformatics (INB)	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics (INB)	The authors acknowledge funding from the Spanish Ministry of Science and Technology (grant number SAF2009-06954) and the Spanish National Institute of Bioinformatics (INB: http://www.inab.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAV MAV SOFTW PROJ M; [Anonymous], FLEX PROJ MAN WEB AP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; HOLM S, 1979, SCAND J STAT, V6, P65; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Weinstein John N, 2004, Breast Dis, V19, P11; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	33	202	206	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19541	10.1371/journal.pone.0019541	http://dx.doi.org/10.1371/journal.pone.0019541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602921	gold, Green Published			2022-12-25	WOS:000290558500014
J	Fonseca, F; de la Torre, R; Diaz, L; Pastor, A; Cuyas, E; Pizarro, N; Khymenets, O; Farre, M; Torrens, M				Fonseca, Francina; de la Torre, Rafael; Diaz, Laura; Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Khymenets, Olha; Farre, Magi; Torrens, Marta			Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; COMORBID PSYCHIATRIC-DISORDERS; STEADY-STATE CONCENTRATIONS; MULTIDRUG-RESISTANCE GENE; HUMAN LIVER-MICROSOMES; ONE-YEAR OUTCOMES; MAINTENANCE TREATMENT; PATIENT SATISFACTION; N-DEMETHYLATION; DOSAGE REQUIREMENTS	Although the efficacy of methadone maintenance treatment (MMT) in opioid dependence disorder has been well established, the influence of methadone pharmacokinetics in dose requirement and clinical outcome remains controversial. The aim of this study is to analyze methadone dosage in responder and nonresponder patients considering pharmacogenetic and pharmacokinetic factors that may contribute to dosage adequacy. Opioid dependence patients (meeting Diagnostic and Statistical Manual of Mental Disorders, [4(th) Edition] criteria) from a MMT community program were recruited. Patients were clinically assessed and blood samples were obtained to determine plasma concentrations of (R, S)-, (R) and (S)-methadone and to study allelic variants of genes encoding CYP3A5, CYP2D6, CYP2B6, CYP2C9, CYP2C19, and P-glycoprotein. Responders and nonresponders were defined by illicit opioid consumption detected in random urinalysis. The final sample consisted in 105 opioid dependent patients of Caucasian origin. Responder patients received higher doses of methadone and have been included into treatment for a longer period. No differences were found in terms of genotype frequencies between groups. Only CYP2D6 metabolizing phenotype differences were found in outcome status, methadone dose requirements, and plasma concentrations, being higher in the ultrarapid metabolizers. No other differences were found between phenotype and responder status, methadone dose requirements, neither in methadone plasma concentrations. Pharmacokinetic factors could explain some but not all differences in MMT outcome and methadone dose requirements.	[Fonseca, Francina; Diaz, Laura; Torrens, Marta] Inst Neuropsiquiatria & Addicc, Barcelona, Spain; [Fonseca, Francina; de la Torre, Rafael] Univ Pompeu Fabra CEXS UPF, Barcelona, Spain; [Fonseca, Francina; Diaz, Laura; Torrens, Marta] IMIM Hosp Mar Res Inst, Inst Municipal Invest Med, Disorders Use Subst Res Grp, Neuropsychopharmacol Res Program, Barcelona, Spain; [de la Torre, Rafael; Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Khymenets, Olha; Farre, Magi] IMIM Hosp Mar Res Inst, Human Pharmacol & Clin Neurosci Res Grp, Neuropsychopharmacol Res Program, Inst Municipal Invest Med, Barcelona, Spain; [de la Torre, Rafael; Khymenets, Olha] Univ Santiago de Compostela, Hosp Clin, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Farre, Magi] Autonomous Univ Barcelona, Dept Pharmacol, Barcelona, Spain; [Torrens, Marta] Autonomous Univ Barcelona, Dept Psychiat, Barcelona, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Autonomous University of Barcelona; Autonomous University of Barcelona	Fonseca, F (corresponding author), Inst Neuropsiquiatria & Addicc, Parc Salut Mar, Barcelona, Spain.	rtorre@imim.es; mtorrens@hospitaldelmar.cat	Lozano, Nieves Pizarro/G-8390-2017; Khymenets, Olha/I-9752-2014; de la Torre, Rafael/D-3561-2018; Pastor, Antoni/AAD-4638-2020; Cuyas, Elisabet/G-8582-2018	Khymenets, Olha/0000-0002-8668-580X; de la Torre, Rafael/0000-0002-6765-1866; Pastor, Antoni/0000-0003-3692-0696; Cuyas, Elisabet/0000-0001-5353-440X; Fonseca, Francina/0000-0002-0779-6545; Pizarro Lozano, Nieves/0000-0003-2671-7184	TV3 Marato [01/810]; Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS [PI040632, PI040619]; Instituto Carlos III [RTA 06/0001/1009]	TV3 Marato; Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS(Instituto de Salud Carlos III); Instituto Carlos III(Instituto de Salud Carlos III)	Financial support was received from the TV3 Marato (01/810), Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS (PI040632, PI040619), and the Instituto Carlos III (RTA 06/0001/1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenaz I, 2010, FUND CLIN PHARMACOL, V24, P247, DOI 10.1111/j.1472-8206.2009.00753.x; Begre S, 2002, J CLIN PSYCHOPHARM, V22, P211, DOI 10.1097/00004714-200204000-00017; Bell J, 2006, DRUG ALCOHOL DEPEN, V81, P55, DOI 10.1016/j.drugalcdep.2005.05.010; Bruijnzeel AW, 2009, BRAIN RES REV, V62, P127, DOI 10.1016/j.brainresrev.2009.09.008; Bunten H, 2011, ADDICT BIOL, V16, P142, DOI 10.1111/j.1369-1600.2010.00274.x; Carlson MJ, 2001, PSYCHIATR SERV, V52, P1230, DOI 10.1176/appi.ps.52.9.1230; Coller JK, 2007, INT J CLIN PHARM TH, V45, P410; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Crettol S, 2008, CLIN PHARMACOL THER, V83, P668, DOI 10.1038/sj.clpt.6100305; Crettol S, 2005, CLIN PHARMACOL THER, V78, P593, DOI 10.1016/j.clpt.2005.08.011; Crettol S, 2008, PROG NEURO-PSYCHOPH, V32, P1722, DOI 10.1016/j.pnpbp.2008.07.009; Crettol S, 2007, PHARMACOLOGY, V80, P304, DOI 10.1159/000107104; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Cuyas E, 2010, PHARMACOGENOMICS, V11, P257, DOI 10.2217/PGS.09.165; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Eap CB, 1997, J CLIN PSYCHOPHARM, V17, P113, DOI 10.1097/00004714-199704000-00010; Eap CB, 2001, J CLIN PSYCHOPHARM, V21, P229, DOI 10.1097/00004714-200104000-00016; Eap CB, 2000, DRUG ALCOHOL DEPEN, V61, P47, DOI 10.1016/S0376-8716(00)00121-6; Elkader AK, 2009, J CLIN PSYCHOPHARM, V29, P231, DOI 10.1097/JCP.0b013e3181a39113; Elkader AK, 2009, J CLIN PSYCHOPHARM, V29, P77, DOI 10.1097/JCP.0b013e318192eb00; Epstein DH, 2009, DRUG ALCOHOL DEPEN, V101, P92, DOI 10.1016/j.drugalcdep.2008.11.006; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Foster DJR, 1999, BRIT J CLIN PHARMACO, V47, P403, DOI 10.1046/j.1365-2125.1999.00921.x; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Gerber JG, 2004, CHIRALITY, V16, P36, DOI 10.1002/chir.10303; Gonzalez F., 2002, INSTRUMENTOS EVALUAC, P271; Haile CN, 2008, AM J DRUG ALCOHOL AB, V34, P355, DOI 10.1080/00952990802122564; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Iribarne C, 1996, CHEM RES TOXICOL, V9, P365, DOI 10.1021/tx950116m; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kelly T, 2003, ELECTROPHORESIS, V24, P2106, DOI 10.1002/elps.200305418; Kharasch ED, 2004, CLIN PHARMACOL THER, V76, P250, DOI 10.1016/j.clpt.2004.05.003; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kristensen K., 1995, LIFE SCI, V56, P45; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Le Meur Y, 2006, CLIN PHARMACOL THER, V80, P51, DOI 10.1016/j.clpt.2006.03.012; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Li YF, 2008, MOL DIAGN THER, V12, P109, DOI 10.1007/BF03256276; Mann A, 2008, NEUROPHARMACOLOGY, V55, P1147, DOI 10.1016/j.neuropharm.2008.07.017; Maxwell S, 1999, J PSYCHOACTIVE DRUGS, V31, P95, DOI 10.1080/02791072.1999.10471730; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mitchell TB, 2004, BRIT J CLIN PHARMACO, V58, P609, DOI 10.1111/j.1365-2125.2004.02221.x; de los Cobos JP, 2007, DRUG ALCOHOL DEPEN, V89, P190, DOI 10.1016/j.drugalcdep.2006.12.018; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Reynolds KK, 2008, CLIN LAB MED, V28, P581, DOI 10.1016/j.cll.2008.10.003; Senbanjo R, 2009, DRUG ALCOHOL REV, V28, P608, DOI 10.1111/j.1465-3362.2009.00064.x; Shiran MR, 2009, BRIT J CLIN PHARMACO, V67, P29, DOI 10.1111/j.1365-2125.2008.03312.x; Shiran MR, 2003, BRIT J CLIN PHARMACO, V56, P220, DOI 10.1046/j.1365-2125.2003.01851.x; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; SOLANS A, 1990, J PHARMACEUT BIOMED, V8, P905, DOI 10.1016/0731-7085(90)80140-K; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torrens M, 1998, DRUG ALCOHOL DEPEN, V52, P193, DOI 10.1016/S0376-8716(98)00096-9; Totah RA, 2008, ANESTHESIOLOGY, V108, P363, DOI 10.1097/ALN.0b013e3181642938; Totah RA, 2007, J PHARMACOL EXP THER, V321, P389, DOI 10.1124/jpet.106.117580; Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116; *US GEN ACC OFF, 1990, GAOHRD90104; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang JS, 2003, DRUG METAB DISPOS, V31, P742, DOI 10.1124/dmd.31.6.742; Wojnowski L, 2004, THER DRUG MONIT, V26, P192, DOI 10.1097/00007691-200404000-00019; WOLFF K, 1992, CLIN CHEM, V38, P438; Wolff K, 2000, ADDICTION, V95, P1771, DOI 10.1046/j.1360-0443.2000.951217717.x; WU D, 1993, BRIT J CLIN PHARMACO, V35, P30, DOI 10.1111/j.1365-2125.1993.tb05666.x; Wu WD, 2009, MOL DIAGN THER, V13, P331, DOI 10.2165/11317320-000000000-00000; Yuferov V, 2004, PHARMACOGENETICS, V14, P793, DOI 10.1097/00008571-200412000-00002; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000	76	73	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19527	10.1371/journal.pone.0019527	http://dx.doi.org/10.1371/journal.pone.0019527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589866	Green Published, gold			2022-12-25	WOS:000290531100015
J	Kelly-Spratt, KS; Pitteri, SJ; Gurley, KE; Liggitt, D; Chin, A; Kennedy, J; Wong, CH; Zhang, Q; Buson, TB; Wang, H; Hanash, SM; Kemp, CJ				Kelly-Spratt, Karen S.; Pitteri, Sharon J.; Gurley, Kay E.; Liggitt, Denny; Chin, Alice; Kennedy, Jacob; Wong, Chee-Hong; Zhang, Qing; Buson, Tina Busald; Wang, Hong; Hanash, Samir M.; Kemp, Christopher J.			Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer	PLOS ONE			English	Article							BREAST-CANCER; BIOMARKER DISCOVERY; TGF-BETA; MASS-SPECTROMETRY; OVARIAN-CANCER; MOUSE MODEL; PROTEINS; GROWTH; PROGRESSION; METASTASIS	Tumor development is accompanied by a complex host systemic response, which includes inflammatory and angiogenic reactions. Both tumor-derived and systemic response proteins are detected in plasma from cancer patients. However, given their non-specific nature, systemic response proteins can confound the detection or diagnosis of neoplasia. Here, we have applied an in-depth quantitative proteomic approach to analyze plasma protein changes in mouse models of subacute irritant-driven inflammation, autoreactive inflammation, and matrix associated angiogenesis and compared results to previously described findings from mouse models of polyoma middle T-driven breast cancer and Pdx1-Cre Kras(G12D) Ink4a/Arf(lox/lox) -induced pancreatic cancer. Among the confounding models, approximately 1/3 of all quantified plasma proteins exhibited a significant change in abundance compared to control mice. Of the proteins that changed in abundance, the majority were unique to each model. Altered proteins included those involved in acute phase response, inflammation, extracellular matrix remodeling, angiogenesis, and TGF beta signaling. Comparison of changes in plasma proteins between the confounder models and the two cancer models revealed proteins that were restricted to the cancer-bearing mice, reflecting the known biology of these tumors. This approach provides a basis for distinguishing between protein changes in plasma that are cancer-related and those that are part of a non-specific host response.	[Kelly-Spratt, Karen S.; Gurley, Kay E.; Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Pitteri, Sharon J.; Chin, Alice; Kennedy, Jacob; Wong, Chee-Hong; Zhang, Qing; Buson, Tina Busald; Wang, Hong; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Liggitt, Denny] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kelly-Spratt, KS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	cjkemp@fhcrc.org		Wong, Chee Hong/0000-0003-4546-4979; Pitteri, Sharon/0000-0002-3119-873X	The Paul G. Allen Family Foundation; NCI; Canary Foundation	The Paul G. Allen Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation	This work was funded by The Paul G. Allen Family Foundation, the NCI Mouse Models of Human Cancer Consortium (MMHCC) program and the Canary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; ALAM R, 1994, J IMMUNOL, V153, P3155; Bell R, 1998, BRIT J OBSTET GYNAEC, V105, P1136, DOI 10.1111/j.1471-0528.1998.tb09966.x; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Carmeliet P, 2001, SCIENCE, V293, P1602, DOI 10.1126/science.1064981; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chen WJ, 1998, J IMMUNOL, V161, P6297; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Etzioni R, 2002, J NATL CANCER I, V94, P981; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Girardi G, 2006, AM J REPROD IMMUNOL, V55, P396; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Jacobs JM, 2005, J PROTEOME RES, V4, P1073, DOI 10.1021/pr0500657; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly-Spratt KS, 2008, J PROTEOME RES, V7, P3613, DOI 10.1021/pr800210b; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Maiuri MC, 2004, AM J PATHOL, V165, P115, DOI 10.1016/S0002-9440(10)63280-4; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Prenzel KL, 2006, ONCOL REP, V15, P1397; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHAW CA, 2009, CANCER EPIDEM BIOMAR, V18, P1365; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye B, 2003, CLIN CANCER RES, V9, P2904; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	52	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19721	10.1371/journal.pone.0019721	http://dx.doi.org/10.1371/journal.pone.0019721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589862	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100023
J	Liu, LS; Li, Q; Sapolsky, R; Liao, M; Mehta, K; Bhargava, A; Pasricha, PJ				Liu, Liansheng; Li, Qian; Sapolsky, Robert; Liao, Min; Mehta, Kshama; Bhargava, Aditi; Pasricha, Pankaj J.			Transient Gastric Irritation in the Neonatal Rats Leads to Changes in Hypothalamic CRF Expression, Depression- and Anxiety-Like Behavior as Adults	PLOS ONE			English	Article							FORCED SWIM TEST; FUNCTIONAL DYSPEPSIA; NEUROENDOCRINE RESPONSES; PSYCHOSOCIAL FACTORS; MATERNAL SEPARATION; COLON IRRITATION; GUT AXIS; STRESS; RECEPTOR; GABA(A)	Aims: A disturbance of the brain-gut axis is a prominent feature in functional bowel disorders (such as irritable bowel syndrome and functional dyspepsia) and psychological abnormalities are often implicated in their pathogenesis. We hypothesized that psychological morbidity in these conditions may result from gastrointestinal problems, rather than causing them. Methods: Functional dyspepsia was induced by neonatal gastric irritation in male rats. 10-day old male Sprague-Dawley rats received 0.1% iodoacetamide (IA) or vehicle by oral gavage for 6 days. At 8-10 weeks of age, rats were tested with sucrose preference and forced-swimming tests to examine depression-like behavior. Elevated plus maze, open field and light-dark box tests were used to test anxiety-like behaviors. ACTH and corticosterone responses to a minor stressor, saline injection, and hypothalamic CRF expression were also measured. Results: Behavioral tests revealed changes of anxiety-and depression-like behaviors in IA-treated, but not control rats. As compared with controls, hypothalamic and amygdaloid CRF immunoreactivity, basal levels of plasma corticosterone and stress-induced ACTH were significantly higher in IA-treated rats. Gastric sensory ablation with resiniferatoxin had no effect on behaviors but treatment with CRF type 1 receptor antagonist, antalarmin, reversed the depression-like behavior in IA-treated rats Conclusions: The present results suggest that transient gastric irritation in the neonatal period can induce a long lasting increase in depression-and anxiety-like behaviors, increased expression of CRF in the hypothalamus, and an increased sensitivity of HPA axis to stress. The depression-like behavior may be mediated by the CRF1 receptor. These findings have significant implications for the pathogenesis of psychological co-morbidity in patients with functional bowel disorders.	[Liu, Liansheng; Mehta, Kshama; Pasricha, Pankaj J.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Li, Qian] Univ Kansas, Dept Pharmacol & Toxicol, Kansas City, KS USA; [Sapolsky, Robert] Stanford Univ, Dept Biol, Sch Humanities & Sci, Stanford, CA 94305 USA; [Liao, Min; Bhargava, Aditi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Stanford University; University of Kansas; Stanford University; University of California System; University of California San Francisco	Liu, LS (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.	Pasricha@stanford.edu			National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK [080787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080787] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK 080787 (AB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Anand KJS, 2004, J PEDIATR-US, V144, P449, DOI 10.1016/j.jpeds.2003.12.035; Appendino G, 1997, LIFE SCI, V60, P681, DOI 10.1016/S0024-3205(96)00567-X; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Barry S, 2006, WORLD J GASTROENTERO, V12, P2701, DOI 10.3748/wjg.v12.i17.2701; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Choung RS, 2006, WORLD J GASTROENTERO, V12, P673, DOI 10.3748/wjg.v12.i5.673; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Ehlert U, 2005, J PSYCHOSOM RES, V59, P7, DOI 10.1016/j.jpsychores.2005.03.005; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Gluckman PD, 2007, J INTERN MED, V261, P461, DOI 10.1111/j.1365-2796.2007.01802.x; Goncalves L, 2008, EXP NEUROL, V213, P48, DOI 10.1016/j.expneurol.2008.04.043; Griebel G, 2002, J PHARMACOL EXP THER, V301, P333, DOI 10.1124/jpet.301.1.333; Hiroi R, 2006, BEHAV BRAIN RES, V166, P93, DOI 10.1016/j.bbr.2005.07.021; Hsu FC, 2003, P NATL ACAD SCI USA, V100, P12213, DOI 10.1073/pnas.2131679100; Hsu YC, 2009, AM J GASTROENTEROL, V104, P2534, DOI 10.1038/ajg.2009.328; Hu B, 2009, PAIN, V143, P206, DOI 10.1016/j.pain.2009.02.018; Jutkiewicz EM, 2005, PSYCHOPHARMACOLOGY, V180, P215, DOI 10.1007/s00213-005-2164-z; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Katagiri F, 2006, PHARMACOLOGY, V77, P115, DOI 10.1159/000093485; Kehne John H., 2007, CNS & Neurological Disorders-Drug Targets, V6, P163, DOI 10.2174/187152707780619344; Kehne JH, 2010, PHARMACOL THERAPEUT, V128, P460, DOI 10.1016/j.pharmthera.2010.08.011; Kellow JE, 2006, GASTROENTEROLOGY, V130, P1412, DOI 10.1053/j.gastro.2005.08.061; LANGELUDDECKE P, 1990, J PSYCHOSOM RES, V34, P215, DOI 10.1016/0022-3999(90)90055-9; Lee KJ, 2004, BEST PRACT RES CL GA, V18, P707, DOI 10.1016/j.bpg.2004.04.007; LI Q, 1993, BRAIN RES, V630, P148, DOI 10.1016/0006-8993(93)90652-4; Li Q, 1999, J PHARMACOL EXP THER, V291, P999; Liu LS, 2008, GASTROENTEROLOGY, V134, P2070, DOI 10.1053/j.gastro.2008.02.093; MAGNI G, 1987, AM J PSYCHIAT, V144, P1222; Mayer EA, 2006, ALIMENT PHARM THER, V24, P919, DOI 10.1111/j.1365-2036.2006.03078.x; McCool BA, 2003, BRAIN RES, V963, P165, DOI 10.1016/S0006-8993(02)03966-5; Michl T, 2001, PAIN, V92, P19, DOI 10.1016/S0304-3959(00)00467-X; Mimidis K, 2008, DIGEST DIS, V26, P194, DOI 10.1159/000121346; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Sena LM, 2003, BEHAV BRAIN RES, V142, P125, DOI 10.1016/S0166-4328(02)00399-6; Slawecki CJ, 2005, BEHAV NEUROSCI, V119, P1477, DOI 10.1037/0735-7044.119.6.1477; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Tache Y, 2001, AM J PHYSIOL-GASTR L, V280, pG173, DOI 10.1152/ajpgi.2001.280.2.G173; TOWELL A, 1987, PSYCHOPHARMACOLOGY, V92, P262; Van Oudenhove L, 2008, GUT, V57, P1666, DOI 10.1136/gut.2008.158162; Van Oudenhove L, 2009, GASTROENTEROLOGY, V137, P23, DOI 10.1053/j.gastro.2009.05.012; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang J, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-28; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Winston J, 2007, GASTROENTEROLOGY, V132, P615, DOI 10.1053/j.gastro.2006.11.014; Witteveen AB, 2010, PSYCHONEUROENDOCRINO, V35, P1113, DOI 10.1016/j.psyneuen.2009.12.013; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038	56	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19498	10.1371/journal.pone.0019498	http://dx.doi.org/10.1371/journal.pone.0019498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589865	Green Submitted, gold, Green Published			2022-12-25	WOS:000290531100014
J	Tousif, S; Singh, Y; Prasad, DVR; Sharma, P; Van Kaer, L; Das, G				Tousif, Sultan; Singh, Yogesh; Prasad, Durbaka Vijaya Raghava; Sharma, Pawan; Van Kaer, Luc; Das, Gobardhan			T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							DEFENSE-MECHANISM; INTERFERON-GAMMA; HOST IMMUNITY; PD-1 BLOCKADE; STEM-CELLS; AUTOPHAGY; LIGANDS; AUTOIMMUNITY; MACROPHAGES; MOLECULE	Background: Programmed Death-1 (PD-1; CD279) receptor molecule is widely believed to be a negative regulator predominantly expressed by exhausted/activated mouse T cells. Upon interaction with its ligands, PD-L1 and PD-L2, PD-1 inhibits activation of T cells and cytokine production, which has been documented in various viral and fungal infections as well as in vitro studies. Therefore, inhibition of T cell responses by PD-1 resulted in disease resistance in a variety of mouse infection models studied heretofore. Methodology/Principal Findings: Here, we report that PD-1 deficient (PD-1(-/-)) mice infected with Mycobacterium tuberculosis (M. tb) H37Rv by the aerosol route have increased susceptibility as compared with their wild type littermates. Surprisingly, M. tb antigen-specific T cell proliferation was dramatically reduced in PD-1 deficient animals compared with wild-type littermates, and this was due to increased numbers of regulatory T cells (Tregs) and recruitment of mesenchymal stem cells. Furthermore, PD-1(-/-) mice exhibited decreases in the autophagy-induced LC3-B marker protein in macrophages. Conclusions/Significance: Our findings suggest that PD-1 does not play an inhibitory role during M. tb infection and instead promotes mycobacterial clearance in mice.	[Tousif, Sultan; Singh, Yogesh; Sharma, Pawan; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Singh, Yogesh] Univ London Royal Vet Coll, Dept Vet Basic Sci, MicroRNA & Lymphocyte Dev Res Grp, London, England; [Prasad, Durbaka Vijaya Raghava] Yogi Vamana Univ, Dept Microbiol, Kadapa, Andhra Pradesh, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of London; University of London Royal Veterinary College; Yogi Vemana University; Vanderbilt University	Tousif, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	dasgo@icgeb.res.in	Van Kaer, Luc/H-1033-2015; Sharma, Pawan/F-7806-2010; Singh, Yogesh/T-8230-2017	Van Kaer, Luc/0000-0001-5275-2309; Sharma, Pawan/0000-0002-2525-5451; Singh, Yogesh/0000-0001-6919-6273; Tousif, Sultan/0000-0001-6174-6541	Wellcome Trust [WT01/GD/09/339]; Department of Biotechnology (DBT) Alliance; DBT, Government of India [DB/03/GD/08/306]; DBT; Wellcome-DBT	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biotechnology (DBT) Alliance(Department of Biotechnology (DBT) IndiaWellcome Trust DBT India Alliance); DBT, Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Wellcome-DBT(Wellcome Trust DBT India Alliance)	This research work was supported by Grant WT01/GD/09/339 from the Wellcome Trust and Department of Biotechnology (DBT) Alliance (http://www.wellcomedbt.org) and DB/03/GD/08/306 from DBT(http://dbtindia.nic.in/index.asp), Government of India. ST is supported by a DBT grant and YS is supported by a Wellcome-DBT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; BROWN KE, 2010, CURR OPIN IMMUNOL; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chamie G, 2010, CLIN INFECT DIS, V50, pS245, DOI 10.1086/651498; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; KOKKINOPOULOS D, 1992, J IMMUNOL METHODS, V154, P1, DOI 10.1016/0022-1759(92)90205-8; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhong XM, 2004, INT IMMUNOL, V16, P1181, DOI 10.1093/intimm/dxh121	47	64	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19864	10.1371/journal.pone.0019864	http://dx.doi.org/10.1371/journal.pone.0019864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589883	Green Published, gold			2022-12-25	WOS:000290531100032
J	Beckage, N; Smith, L; Hills, T				Beckage, Nicole; Smith, Linda; Hills, Thomas			Small Worlds and Semantic Network Growth in Typical and Late Talkers	PLOS ONE			English	Article							LEXICAL DEVELOPMENT; LANGUAGE; EMERGENCE	Network analysis has demonstrated that systems ranging from social networks to electric power grids often involve a small world structure-with local clustering but global access. Critically, small world structure has also been shown to characterize adult human semantic networks. Moreover, the connectivity pattern of these mature networks is consistent with lexical growth processes in which children add new words to their vocabulary based on the structure of the language-learning environment. However, thus far, there is no direct evidence that a child's individual semantic network structure is associated with their early language learning. Here we show that, while typically developing children's early networks show small world structure as early as 15 months and with as few as 55 words, children with language delay ( late talkers) have this structure to a smaller degree. This implicates a maladaptive bias in word acquisition for late talkers, potentially indicating a preference for "oddball'' words. The findings provide the first evidence of a link between small-world connectivity and lexical development in individual children.	[Beckage, Nicole] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Smith, Linda] Indiana Univ, Bloomington, IN USA; [Hills, Thomas] Univ Basel, Dept Psychol, Basel, Switzerland	University of California System; University of California Irvine; Indiana University System; Indiana University Bloomington; University of Basel	Beckage, N (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	nbeckage@uci.edu			NICCHD [HD028675]; Swiss National Science Foundation [100014 130397/1]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028675] Funding Source: NIH RePORTER	NICCHD; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by NICCHD grant HD028675 to Linda Smith and a grant from the Swiss National Science Foundation (100014 130397/1) to Thomas Hills. The first author is supported by the National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RC, 1985, THEORETICAL MODELS P, V3, P343; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BATES E, 1994, J CHILD LANG, V21, P85, DOI 10.1017/S0305000900008680; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; DALE PS, 1989, J CHILD LANG, V16, P239, DOI 10.1017/S0305000900010394; DAVIS GF, 1941, DEEP S; Dupuy H. J., 1974, RATIONALE DEV STANDA; Erdos P., 1960, MATH I HUNG ACAD SCI, V5, P7; Fenson L, 2002, MACARTHUR COMMUNICAT; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Hills TT, 2009, COGNITION, V112, P381, DOI 10.1016/j.cognition.2009.06.002; Hills TT, 2009, PSYCHOL SCI, V20, P729, DOI 10.1111/j.1467-9280.2009.02365.x; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Li P, 2004, NEURAL NETWORKS, V17, P1345, DOI 10.1016/j.neunet.2004.07.004; MACWHINNEY B, 1995, CHILDES PROJECT TOOL; Moyle MJ, 2007, J SPEECH LANG HEAR R, V50, P508, DOI 10.1044/1092-4388(2007/035); Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Rescorla L, 2002, J SPEECH LANG HEAR R, V45, P360, DOI 10.1044/1092-4388(2002/028); SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Thal DJ, 1997, DEV NEUROPSYCHOL, V13, P239, DOI 10.1080/87565649709540681; VIGIL DC, 2005, CHILD LANG TEACH THE, V21, P107, DOI DOI 10.1191/0265659005CT284OA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEISMER SE, 2006, ESSAYS HONOR RS CHAP, V83; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	33	125	125	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19348	10.1371/journal.pone.0019348	http://dx.doi.org/10.1371/journal.pone.0019348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589924	Green Published, gold			2022-12-25	WOS:000290483600009
J	Huang, YH; Wu, CC; Chou, CK; Huang, CYF				Huang, Yei-Hsuan; Wu, Chun-Chi; Chou, Chen-Kung; Huang, Chi-Ying F.			A Translational Regulator, PUM2, Promotes Both Protein Stability and Kinase Activity of Aurora-A	PLOS ONE			English	Article							B1 MESSENGER-RNA; OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION; BINDING PROTEINS; CELL-CYCLE; PHOSPHORYLATION; COMPLEX; SPINDLE; IDENTIFICATION; DEGRADATION	Aurora-A, a centrosomal serine-threonine kinase, orchestrates several key aspects of cell division. However, the regulatory pathways for the protein stability and kinase activity of Aurora-A are still not completely understood. In this study, PUM2, an RNA-binding protein, is identified as a novel substrate and interacting protein of Aurora-A. Overexpression of the PUM2 mutant which fails to interact with Aurora-A, and depletion of PUM2 result in a decrease in the amount of Aurora-A. PUM2 physically binds to the D-box of Aurora-A, which is recognized by APC/C(Cdh1). Overexpression of PUM2 prevents ubiquitination and enhances the protein stability of Aurora-A, suggesting that PUM2 protects Aurora-A from APC/C(Cdh1)-mediated degradation. Moreover, association of PUM2 with Aurora-A not only makes Aurora-A more stable but also enhances the kinase activity of Aurora-A. Our study suggests that PUM2 plays two different but important roles during cell cycle progression. In interphase, PUM2 localizes in cytoplasm and plays as translational repressor through its RNA binding domain. However, in mitosis, PUM2 physically associates with Aurora-A to ensure enough active Aurora-A at centrosomes for mitotic entry. This is the first time to reveal the moonlight role of PUM2 in mitosis.	[Huang, Yei-Hsuan; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; Chung Shan Medical University; Chang Gung University	Huang, YH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	ckchou@mail.cgu.edu.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937	Ministry of Education, (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH100-TD-C-111-007]; NSC [NSC99-3112-B-010-008, NSC98-3112-B-010-021-CC1]	Ministry of Education, (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital; NSC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the Ministry of Education, Aim for the Top University Plan (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH100-TD-C-111-007) and NSC (NSC99-3112-B-010-008 and NSC98-3112-B-010-021-CC1) to Chi-Ying F. Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Cotteret S, 2005, DEV CELL, V9, P573, DOI 10.1016/j.devcel.2005.10.005; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lin YS, 2006, GENE EXPRESSION, V13, P15, DOI 10.3727/000000006783991962; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zamore PD, 1997, RNA, V3, P1421; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19718	10.1371/journal.pone.0019718	http://dx.doi.org/10.1371/journal.pone.0019718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589936	gold, Green Submitted, Green Published			2022-12-25	WOS:000290483600027
J	Sousa-Ferreira, L; Alvaro, AR; Aveleira, C; Santana, M; Brandao, I; Kugler, S; de Almeida, LP; Cavadas, C				Sousa-Ferreira, Ligia; Alvaro, Ana Rita; Aveleira, Celia; Santana, Magda; Brandao, Ines; Kuegler, Sebastian; de Almeida, Luis Pereira; Cavadas, Claudia			Proliferative Hypothalamic Neurospheres Express NPY, AGRP, POMC, CART and Orexin-A and Differentiate to Functional Neurons	PLOS ONE			English	Article							LATERAL TUBERAL NUCLEUS; NEUROPEPTIDE-Y; HUNTINGTONS-DISEASE; SUBVENTRICULAR ZONE; ARCUATE NUCLEUS; ENERGY-BALANCE; ADULT MICE; BODY-WEIGHT; NEUROGENESIS; LEPTIN	Some pathological conditions with feeding pattern alterations, including obesity and Huntington disease (HD) are associated with hypothalamic dysfunction and neuronal cell death. Additionally, the hypothalamus is a neurogenic region with the constitutive capacity to generate new cells of neuronal lineage, in adult rodents. The aim of the present work was to evaluate the expression of feeding-related neuropeptides in hypothalamic progenitor cells and their capacity to differentiate to functional neurons which have been described to be affected by hypothalamic dysfunction. Our study shows that hypothalamic progenitor cells from rat embryos grow as floating neurospheres and express the feeding-related neuropeptides Neuropeptide Y (NPY), Agouti-related Protein (AGRP), Pro-OpioMelanocortin (POMC), Cocaine-and-Amphetamine Responsive Transcript (CART) and Orexin-A/Hypocretin-1. Moreover the relative mRNA expression of NPY and POMC increases during the expansion of hypothalamic neurospheres in proliferative conditions. Mature neurons were obtained from the differentiation of hypothalamic progenitor cells including NPY, AGRP, POMC, CART and Orexin-A positive neurons. Furthermore the relative mRNA expression of NPY, CART and Orexin-A increases after the differentiation of hypothalamic neurospheres. Similarly to the adult hypothalamic neurons the neurospheres-derived neurons express the glutamate transporter EAAT3. The orexigenic and anorexigenic phenotype of these neurons was identified by functional response to ghrelin and leptin hormones, respectively. This work demonstrates the presence of appetite-related neuropeptides in hypothalamic progenitor cells and neurons obtained from the differentiation of hypothalamic neurospheres, including the neuronal phenotypes that have been described by others as being affected by hypothalamic neurodegeneration. These in vitro models can be used to study hypothalamic progenitor cells aiming a therapeutic intervention to mitigate feeding dysfunction that are associated with hypothalamic neurodegeneration.	[Sousa-Ferreira, Ligia; Alvaro, Ana Rita; Aveleira, Celia; Santana, Magda; Brandao, Ines; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alvaro, Ana Rita] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal; [Kuegler, Sebastian] Univ Med Gottingen, Viral Vectors Lab, Dept Neurol, Gottingen, Germany; [Sousa-Ferreira, Ligia; Santana, Magda; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; University of Gottingen; Universidade de Coimbra	Sousa-Ferreira, L (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	ccavadas@ci.uc.pt	Cavadas, Claudia/AAB-6904-2021; Cavadas, Claudia/K-8271-2014; Sousa-Ferreira, Lígia/M-4181-2013; de Almeida, Luis Pereira/O-8196-2019; Aveleira, Célia/AAI-2455-2021; Alvaro, Ana Rita/A-8168-2013; de Almeida, Luis Pereira/A-4605-2009; Brandão, Inês/Y-4252-2019; Santana, Magda/P-4244-2017; Aveleira, Célia A/L-1325-2014	Cavadas, Claudia/0000-0001-8020-9266; Cavadas, Claudia/0000-0001-8020-9266; Sousa-Ferreira, Lígia/0000-0002-7169-9491; de Almeida, Luis Pereira/0000-0001-5831-3307; Aveleira, Célia/0000-0002-2191-0682; Alvaro, Ana Rita/0000-0002-2387-374X; de Almeida, Luis Pereira/0000-0001-5831-3307; Brandão, Inês/0000-0003-3767-9515; Santana, Magda/0000-0003-4076-7516; Aveleira, Célia A/0000-0002-2191-0682	Portuguese Foundation for Science and Technology; FEDER; COMPETE [PTDC/SAU-FCF/099082/2008, SFRH/BD/30608/2006, PTDC/SAU-FCF/70384/2006, PTDC/SAU-NEU/73119/2006, SFRH/BPD/46086/2008, SFRH/BD/44664/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); COMPETE	This work was supported by grants from the Portuguese Foundation for Science and Technology, FEDER and COMPETE (PTDC/SAU-FCF/099082/2008; SFRH/BD/30608/2006; PTDC/SAU-FCF/70384/2006; PTDC/SAU-NEU/73119/2006; SFRH/BPD/46086/2008; SFRH/BD/44664/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Alvaro AR, 2009, J NEUROCHEM, V109, P1508, DOI 10.1111/j.1471-4159.2009.06079.x; Alvaro AR, 2008, J NEUROCHEM; Aziz A, 2008, BRAIN PATHOL, V18, P474, DOI 10.1111/j.1750-3639.2008.00135.x; Bergonzelli GE, 2001, DIABETES, V50, P2666, DOI 10.2337/diabetes.50.12.2666; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Decressac M, 2009, NEUROBIOL DIS, V34, P441, DOI 10.1016/j.nbd.2009.02.017; Gabery S, 2010, ACTA NEUROPATHOL; Grayson BE, 2010, FRONT NEUROENDOCRIN, V31, P16, DOI 10.1016/j.yfrne.2009.10.001; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; KREMER HPH, 1991, NEUROSCI LETT, V132, P101, DOI 10.1016/0304-3940(91)90443-W; KREMER HPH, 1990, J NEUROPATH EXP NEUR, V49, P371, DOI 10.1097/00005072-199007000-00002; Kugler S, 2003, VIROLOGY, V311, P89, DOI 10.1016/S0042-6822(03)00162-4; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Li SH, 2003, J NEUROSCI, V23, P6956; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Muroya S, 2004, EUR J NEUROSCI, V19, P1524, DOI 10.1111/j.1460-9568.2004.03255.x; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; MYERS RH, 1991, ARCH NEUROL-CHICAGO, V48, P800, DOI 10.1001/archneur.1991.00530200036015; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Salvi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004392; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Susaki E, 2010, AGING-US, V2, P453, DOI 10.18632/aging.100172; Tiesjema B, 2007, OBESITY, V15, P2424, DOI 10.1038/oby.2007.288; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	40	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19745	10.1371/journal.pone.0019745	http://dx.doi.org/10.1371/journal.pone.0019745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589937	Green Published, gold			2022-12-25	WOS:000290483600029
J	Teacher, AGF; Shikano, T; Karjalainen, ME; Merila, J				Teacher, Amber G. F.; Shikano, Takahito; Karjalainen, Marika E.; Merila, Juha			Phylogeography and Genetic Structuring of European Nine-Spined Sticklebacks (Pungitius pungitius)-Mitochondrial DNA Evidence	PLOS ONE			English	Article							SALMON SALMO-SALAR; BALTIC SEA AREA; POSTGLACIAL COLONIZATION; FRESH-WATER; MITOCHONDRIAL-DNA; GLACIAL REFUGIA; NORTHERN EUROPE; GASTEROSTEUS-ACULEATUS; THYMALLUS-THYMALLUS; PUNGITIUS-PUNGITIUS	As a consequence of colonisation from different glacial refugia, many northern European taxa are split into distinct western and eastern lineages. However, as for the nine-spined stickleback (Pungitius pungitius), the exact location of the contact zone between lineages often remains poorly known. We assessed the genetic differentiation and diversity in the nine-spined stickleback within Europe using 1037 base pairs of cytochrome b sequence for 320 individuals from 57 locations, including pond, lake, river, and coastal habitats. Our main aims were (i) to locate the contact zone between the previously recognized western and eastern lineages, (ii) investigate latitudinal patterns in genetic diversity, (iii) compare genetic diversity among different habitat types, and (iv) date the known split between eastern and western lineages. The data revealed the split between eastern and western to be located across the Danish Straits and roughly following the Norway/Sweden border to the North. Reference sites from Canada form their own clades, and one of the Canadian sites was found to have a haplotype common to the Eastern European lineage, possibly representing an ancestral polymorphism. The split between the two European clades was dated to approximately 1.48 million years ago (Mya), and between Canada and Europe to approximately 1.62 Mya. After controlling for habitat effects, nucleotide (but not haplotype) diversity across populations decreased with increasing latitude. Coastal populations showed significantly higher haplotype diversity (but not nucleotide diversity) than pond populations, but there were no detectable differences in haplotype diversity among different freshwater habitat types (viz. river, lake and pond populations), or between coastal and lake/river populations. Sequences were found to cluster according to their geographic proximity, rather than by habitat type, and all habitat types were found within each major clade, implying that colonisation and adaptation between the coastal and freshwater environments in different regions must have occurred in parallel.	[Teacher, Amber G. F.; Shikano, Takahito; Karjalainen, Marika E.; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Teacher, AGF (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	amber.teacher@helsinki.fi	Teacher, Amber/G-9107-2012; Merila, Juha/A-4061-2008; Shikano, Takahito/D-7347-2015	Merila, Juha/0000-0001-9614-0072; Griffiths, Amber/0000-0002-7455-6795	Academy of Finland [138043, 129662, 134728]; European Community [FP/2007-2013, 217246]; Japan Society for the Promotion of Science	Academy of Finland(Academy of Finland); European Community(European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by the Academy of Finland (grants 138043 to AGFT, and 129662 and 134728 to JM) and the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no. 217246 made with the joint Baltic Sea research and development programme BONUS. TS was supported by the Japan Society for the Promotion of Science and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven JT, 2010, MOL ECOL, V19, P4061, DOI 10.1111/j.1365-294X.2010.04801.x; Asplund T, 2004, ANN ZOOL FENN, V41, P465; BANARESCU PM, 2001, FRESHWATER FISHES EU; BELL MA, 1994, EVOLUTIONARY BIOL TH, P14; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; BERNATCHEZ L, 1995, MOL ECOL, V4, P285, DOI 10.1111/j.1365-294X.1995.tb00222.x; Cano JM, 2008, J INTEGRATIVE FIELD, V5, P1; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Drummond A, 2010, GENEIOUS V5 1; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Garcia-Marin JL, 1999, HEREDITY, V82, P46, DOI 10.1038/sj.hdy.6884470; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GYLLENSTEN U, 1985, J FISH BIOL, V26, P691, DOI 10.1111/j.1095-8649.1985.tb04309.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Kontula T, 2001, MOL ECOL, V10, P1983, DOI 10.1046/j.1365-294X.2001.01328.x; Koskinen MT, 2000, MOL ECOL, V9, P1609, DOI 10.1046/j.1365-294x.2000.01065.x; Koskinen MT, 2002, HEREDITY, V88, P391, DOI 10.1038/sj.hdy.6800072; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makhrov AA, 2006, RUSS J GENET+, V42, P1101, DOI 10.1134/S1022795406100036; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; McCartney MA, 2010, COPEIA, P103, DOI 10.1643/CG-07-169; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; NEI M, 1981, GENETICS, V97, P145; Nesbo CL, 1999, MOL ECOL, V8, P1387, DOI 10.1046/j.1365-294x.1999.00699.x; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Paepke Hans-Joachim, 2001, P277; R Core Team, 2022, R LANG ENV STAT COMP; Rambaut A, TRACER V1 5; RAWLINSON SE, 1982, J PALEONTOL, V56, P583; Saisa M, 2005, CAN J FISH AQUAT SCI, V62, P1887, DOI 10.1139/F05-094; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; TIKKANEN M, 2002, FENNIA, V180, P1; Tonteri A, 2007, J FISH BIOL, V70, P381, DOI 10.1111/j.1095-8649.2007.01519.x; Tonteri A, 2005, ANN ZOOL FENN, V42, P1; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Verspoor E, 1999, BIOL J LINN SOC, V68, P129, DOI 10.1111/j.1095-8312.1999.tb01162.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21	52	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19476	10.1371/journal.pone.0019476	http://dx.doi.org/10.1371/journal.pone.0019476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589917	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600011
J	Turner, SD; Berg, RL; Linneman, JG; Peissig, PL; Crawford, DC; Denny, JC; Roden, DM; McCarty, CA; Ritchie, MD; Wilke, RA				Turner, Stephen D.; Berg, Richard L.; Linneman, James G.; Peissig, Peggy L.; Crawford, Dana C.; Denny, Joshua C.; Roden, Dan M.; McCarty, Catherine A.; Ritchie, Marylyn D.; Wilke, Russell A.			Knowledge-Driven Multi-Locus Analysis Reveals Gene-Gene Interactions Influencing HDL Cholesterol Level in Two Independent EMR-Linked Biobanks	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; MISSING HERITABILITY; LOCI; DISEASE; RISK; EPISTASIS; FAMILIES; TRAITS; TOOL	Genome-wide association studies (GWAS) are routinely being used to examine the genetic contribution to complex human traits, such as high-density lipoprotein cholesterol (HDL-C). Although HDL-C levels are highly heritable (h(2)similar to 0.7), the genetic determinants identified through GWAS contribute to a small fraction of the variance in this trait. Reasons for this discrepancy may include rare variants, structural variants, gene-environment (GxE) interactions, and gene-gene (GxG) interactions. Clinical practice-based biobanks now allow investigators to address these challenges by conducting GWAS in the context of comprehensive electronic medical records (EMRs). Here we apply an EMR-based phenotyping approach, within the context of routine care, to replicate several known associations between HDL-C and previously characterized genetic variants: CETP (rs3764261, p = 1.22e-25), LIPC (rs11855284, p = 3.92e-14), LPL (rs12678919, p = 1.99e-7), and the APOA1/C3/A4/A5 locus (rs964184, p = 1.06e-5), all adjusted for age, gender, body mass index (BMI), and smoking status. By using a novel approach which censors data based on relevant co-morbidities and lipid modifying medications to construct a more rigorous HDL-C phenotype, we identified an association between HDL-C and TRIB1, a gene which previously resisted identification in studies with larger sample sizes. Through the application of additional analytical strategies incorporating biological knowledge, we further identified 11 significant GxG interaction models in our discovery cohort, 8 of which show evidence of replication in a second biobank cohort. The strongest predictive model included a pairwise interaction between LPL (which modulates the incorporation of triglyceride into HDL) and ABCA1 (which modulates the incorporation of free cholesterol into HDL). These results demonstrate that gene-gene interactions modulate complex human traits, including HDL cholesterol.	[Turner, Stephen D.; Crawford, Dana C.; Ritchie, Marylyn D.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Berg, Richard L.; Linneman, James G.; Peissig, Peggy L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Roden, Dan M.; Wilke, Russell A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Turner, SD (corresponding author), Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	russell.a.wilke@Vanderbilt.Edu	Crawford, Dana/C-1054-2012; Turner, Stephen/GXM-4654-2022; Denny, Josh/AAL-3359-2021; Ritchie, Marylyn/C-1114-2012; Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021	Denny, Josh/0000-0002-3049-7332; Crawford, Dana/0000-0002-6437-6248; McCarty, Catherine/0000-0003-1089-0142	National Institutes of Health (NIH) [F31-NS066638, R01-LM010040, R01-DK080007, U01-HG004608, U01-HG04603, UL1-RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004608, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066638] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is supported by National Institutes of Health (NIH) grants F31-NS066638, R01-LM010040, R01-DK080007, U01-HG004608, U01-HG04603, and UL1-RR024975. No other external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DENNY JC, 2010, CIRCULATION IN PRESS; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Edmondson AC, 2008, CIRC-CARDIOVASC GENE, V1, P3, DOI 10.1161/CIRCGENETICS.108.815530; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ghosh SS, 2004, AM J HYPERTENS, V17, p91A; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Johnson LW, 2006, MAYO CLIN PROC, V81, P1615, DOI 10.4065/81.12.1615; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarty CA, 2007, PERS MED, V4, P183, DOI 10.2217/17410541.4.2.183; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Miller SG, 2007, CIRCULATION, V116, P126; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Peissig P, 2007, BASIC CLIN PHARMACOL, V100, P286, DOI 10.1111/j.1742-7843.2006.00035.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sillanpaa MJ, 2004, ANN HUM GENET, V68, P646, DOI 10.1046/j.1529-8817.2004.00122.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; TURNER SD, 2010, QUALITY CONTROL PROC, pCH1; Turner Stephen D, 2009, Expert Rev Clin Pharmacol, V2, P559, DOI 10.1586/ecp.09.32; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WILKE RA, 2010, PREVENTIVE CARDIOLOG; Wilke RA, 2008, BASIC CLIN PHARMACOL, V103, P354, DOI 10.1111/j.1742-7843.2008.00291.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Zhang Y, 2009, PHARMACOGENOMICS, V10, P1929, DOI [10.2217/pgs.09.122, 10.2217/PGS.09.122]	76	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19586	10.1371/journal.pone.0019586	http://dx.doi.org/10.1371/journal.pone.0019586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589926	gold, Green Published			2022-12-25	WOS:000290483600017
J	Ferrand, J; Noel, D; Lehours, P; Prochazkova-Carlotti, M; Chambonnier, L; Menard, A; Megraud, F; Varon, C				Ferrand, Jonathan; Noel, Daniele; Lehours, Philippe; Prochazkova-Carlotti, Martina; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine			Human Bone Marrow-Derived Stem Cells Acquire Epithelial Characteristics through Fusion with Gastrointestinal Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; IN-VITRO DIFFERENTIATION; PROGENITOR CELLS; GROWTH; REGENERATION; HEPATOCYTES; CONTRIBUTE; THERAPY; REPAIR; LIVER	Bone marrow-derived mesenchymal stem cells (MSC) have the ability to differentiate into a variety of cell types and are a potential source for epithelial tissue repair. Several studies have demonstrated their ability to repopulate the gastrointestinal tract (GIT) in bone marrow transplanted patients or in animal models of gastrointestinal carcinogenesis where they were the source of epithelial cancers. However, mechanism of MSC epithelial differentiation still remains unclear and controversial with trans-differentiation or fusion events being evoked. This study aimed to investigate the ability of MSC to acquire epithelial characteristics in the particular context of the gastrointestinal epithelium and to evaluate the role of cell fusion in this process. In vitro coculture experiments were performed with three gastrointestinal epithelial cell lines and MSC originating from two patients. After an 8 day coculture, MSC expressed epithelial markers. Use of a semi-permeable insert did not reproduce this effect, suggesting importance of cell contacts. Tagged cells coculture or FISH on gender-mismatched cells revealed clearly that epithelial differentiation resulted from cellular fusion events, while expression of mesenchymal markers on fused cells decreased over time. In vivo cell xenograft in immunodeficient mice confirmed fusion of MSC with gastrointestinal epithelial cells and self-renewal abilities of these fused cells. In conclusion, our results indicate that fusion could be the predominant mechanism by which human MSC may acquire epithelial characteristics when in close contact with epithelial cells from gastrointestinal origin. These results could contribute to a better understanding of the cellular and molecular mechanisms allowing MSC engraftment into the GIT epithelium.	[Ferrand, Jonathan; Lehours, Philippe; Prochazkova-Carlotti, Martina; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine] Univ Bordeaux, Bacteriol Lab, Bordeaux, France; [Ferrand, Jonathan; Lehours, Philippe; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine] INSERM, U853, Bordeaux, France; [Noel, Daniele] Univ Montpellier I, Montpellier, France; [Noel, Daniele] INSERM, U844, Montpellier, France; [Prochazkova-Carlotti, Martina] Univ Bordeaux, EA2406, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite de Bordeaux	Ferrand, J (corresponding author), Univ Bordeaux, Bacteriol Lab, Bordeaux, France.	francis.megraud@chu-bordeaux.fr	Lehours, Philippe/I-2780-2014; Noel, Daniele/E-5719-2016	Prochazkova-Carlotti, Martina/0000-0002-7719-7679; menard, armelle/0000-0002-6130-736X; Ferrand, Jonathan/0000-0001-5797-2693; Varon, Christine/0000-0003-4026-2016; Noel, Daniele/0000-0002-3498-3776	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche [66]; Association pour la Recherche contre le Cancer, Universite Victor Segalen Bordeaux [8412]; Institut National du Cancer [07/3D1616/IABC-23-12/NC-NG]; French Ministry of Education, Research, and Technologies; ARC	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche; Association pour la Recherche contre le Cancer, Universite Victor Segalen Bordeaux(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); French Ministry of Education, Research, and Technologies; ARC(Australian Research Council)	This project was financially supported by the Institut de Recherche des Maladies de l'Appareil Digestif, the Institut Federatif de Recherche 66 (http://www.ifr66.u-bordeaux2.fr, Universite Victor Segalen Bordeaux 2, France), the Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/, ARC, project number: 8412) and the Institut National du Cancer (http://www.e-cancer.fr, project number: 07/3D1616/IABC-23-12/NC-NG). J. Ferrand is the recipient of fellowships from the French Ministry of Education, Research, and Technologies and ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Gruson KI, 2009, BULL HOSP JT DIS, V67, P6; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Lange C, 2006, WORLD J GASTROENTERO, V12, P2394, DOI 10.3748/wjg.v12.i15.2394; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Maestroni GJM, 1999, CELL MOL LIFE SCI, V55, P663, DOI 10.1007/s000180050322; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; Matsumoto T, 2005, GASTROENTEROLOGY, V128, P1851, DOI 10.1053/j.gastro.2005.03.085; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Ohlsson LB, 2003, EXP MOL PATHOL, V75, P248, DOI 10.1016/j.yexmp.2003.06.001; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okumura T, 2009, LAB INVEST, V89, P1410, DOI 10.1038/labinvest.2009.88; Parris GE, 2005, MED HYPOTHESES, V65, P846, DOI 10.1016/j.mehy.2005.05.036; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Popov BV, 2007, TISSUE ENG, V13, P2441, DOI 10.1089/ten.2007.0001; Popp Felix C, 2006, Curr Stem Cell Res Ther, V1, P411; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Singaravelu K, 2009, RENAL FAILURE, V31, P492, DOI 10.1080/08860220902928981; Sivamani RK, 2011, FASEB J, V25, P122, DOI 10.1096/fj.09-148775; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tzaribachev N, 2008, ISR MED ASSOC J, V10, P232; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	48	80	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19569	10.1371/journal.pone.0019569	http://dx.doi.org/10.1371/journal.pone.0019569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573181	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400026
J	Blank, M; Kiger, L; Thielebein, A; Gerlach, F; Hankeln, T; Marden, MC; Burmester, T				Blank, Miriam; Kiger, Laurent; Thielebein, Anke; Gerlach, Frank; Hankeln, Thomas; Marden, Michael C.; Burmester, Thorsten			Oxygen Supply from the Bird's Eye Perspective GLOBIN E IS A RESPIRATORY PROTEIN IN THE CHICKEN RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROGLOBIN; CYTOGLOBIN; MYOGLOBIN; EVOLUTION; GENOME; GENE; HEMOGLOBINS; MECHANISMS; SEQUENCE; SEARCH	The visual process in the vertebrate eye requires high amounts of metabolic energy and thus oxygen. Oxygen supply of the avian retina is a challenging task because birds have large eyes, thick retinae, and high metabolic rates but neither deep retinal nor superficial capillaries. Respiratory proteins such as myoglobin may enhance oxygen supply to certain tissues, and thus the mammalian retina harbors high amounts of neuroglobin. Globin E (GbE) was recently identified as an eye-specific globin of chicken (Gallus gallus). Orthologous GbE genes were found in zebra finch and turkey genomes but appear to be absent in non-avian vertebrate classes. Analyses of globin phylogeny and gene synteny showed an ancient origin of GbE but did not help to assign it to any specific globin type. We show that the photoreceptor cells of the chicken retina have a high level ofGbE protein, which accumulates to similar to 10 mu M in the total eye. Quantitative real-time RT-PCR revealed an similar to 50,000-fold higher level of GbE mRNA in the eye than in the brain. Spectroscopic analysis and ligand binding kinetics of recombinant chicken GbE reveal a penta-coordinated globin with an oxygen affinity of P-50 = 5.8 torrs at 25 degrees C and 15 torrs at 41 degrees C. Together these data suggest that GbE helps to sustain oxygen supply to the avian retina.	[Blank, Miriam; Thielebein, Anke; Gerlach, Frank; Burmester, Thorsten] Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; [Burmester, Thorsten] Univ Hamburg, Zool Museum, Bioctr Grindel, D-20146 Hamburg, Germany; [Kiger, Laurent; Marden, Michael C.] Univ Paris 11, INSERM U779, F-94275 Le Kremlin Bicetre, France; [Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55099 Mainz, Germany	University of Hamburg; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Marden, Michael/AAA-5923-2020; Kiger, Laurent/Q-1686-2018; Marden, Michael C/G-3139-2012; Burmester, Thorsten/I-7225-2013; Götting, Miriam/I-8222-2014	Marden, Michael C/0000-0002-5254-6385; Burmester, Thorsten/0000-0002-5772-7863; Götting, Miriam/0000-0001-5336-1422	Deutsche Forschungsgemeinschaft [Bu956/11, Ha2103/3]; INSERM	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Grants Bu956/11 and Ha2103/3) and INSERM.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Burr AHJ, 2000, J BIOL CHEM, V275, P4810, DOI 10.1074/jbc.275.7.4810; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dickerson AE, 1983, HEMOGLOBIN STRUCTURE; ENOKI Y, 1984, BIOCHIM BIOPHYS ACTA, V789, P334, DOI 10.1016/0167-4838(84)90189-4; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Gillemans N, 2003, BLOOD, V101, P2842, DOI 10.1182/blood-2002-09-2850; Griffin DK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-168; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Mitz SA, 2009, NEUROSCIENCE, V163, P552, DOI 10.1016/j.neuroscience.2009.06.058; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Nicholas K. B., 1997, EMBNET NEWS, V4, P14; Organisciak D T, 1989, Prog Clin Biol Res, V314, P493; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Patel VS, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-34; PENN JS, 1987, EXP EYE RES, V44, P779, DOI 10.1016/S0014-4835(87)80041-6; PETTIGREW JD, 1990, NATURE, V343, P362, DOI 10.1038/343362a0; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SONO M, 1976, J BIOL CHEM, V251, P1418; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; [No title captured]	45	34	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26507	26515		10.1074/jbc.M111.224634	http://dx.doi.org/10.1074/jbc.M111.224634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21622558	Green Published, hybrid			2022-12-25	WOS:000293078200029
J	Meyer, EH; Solheim, C; Tanz, SK; Bonnard, G; Millar, AH				Meyer, Etienne H.; Solheim, Cory; Tanz, Sandra K.; Bonnard, Geraldine; Millar, A. Harvey			Insights into the Composition and Assembly of the Membrane Arm of Plant Complex I through Analysis of Subcomplexes in Arabidopsis Mutant Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CARBONIC-ANHYDRASE SUBUNITS; MITOCHONDRIAL-COMPLEX; NUCLEAR GENE; OXIDATIVE-PHOSPHORYLATION; ESCHERICHIA-COLI; THALIANA; IDENTIFICATION; DEHYDROGENASE; DEFICIENCY	NADH-ubiquinone oxidoreductase (Complex I, EC 1.6.5.3) is the largest complex of the mitochondrial respiratory chain. In eukaryotes, it is composed of more than 40 subunits that are encoded by both the nuclear and mitochondrial genomes. Plant Complex I differs from the enzyme described in other eukaryotes, most notably due to the large number of plant-specific subunits in the membrane arm of the complex. The elucidation of the assembly pathway of Complex I has been a long-standing research aim in cellular biochemistry. We report the study of Arabidopsis mutants in Complex I subunits using a combination of Blue-Native PAGE and immunodetection to identify stable subcomplexes containing Complex I components, along with mass spectrometry analysis of Complex I components in membrane fractions and two-dimensional diagonal Tricine SDS-PAGE to study the composition of the largest subcomplex. Four subcomplexes of the membrane arm of Complex I with apparent molecular masses of 200, 400, 450, and 650 kDa were observed. We propose a working model for the assembly of the membrane arm of Complex I in plants and assign putative roles during the assembly process for two of the subunits studied.	[Meyer, Etienne H.; Bonnard, Geraldine] Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, F-67084 Strasbourg, France; [Meyer, Etienne H.; Solheim, Cory; Tanz, Sandra K.; Millar, A. Harvey] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Western Australia	Meyer, EH (corresponding author), Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	etienne.meyer@ibmp-cnrs.unistra.fr	Millar, A. Harvey/A-5452-2008; Meyer, Etienne H/C-1952-2008; Tanz, Sandra K/C-2686-2011	Millar, A. Harvey/0000-0001-9679-1473; Meyer, Etienne H/0000-0003-4712-9824; Tanz, Sandra/0000-0002-0632-4095	Centre National pour le Recherche Scientifique; Australian Research Council (ARC) Centre of Excellence; University of Western Australia; ARC	Centre National pour le Recherche Scientifique; Australian Research Council (ARC) Centre of Excellence(Australian Research Council); University of Western Australia; ARC(Australian Research Council)	This work was supported by the Centre National pour le Recherche Scientifique, an Australian Research Council (ARC) Centre of Excellence Grant, a grant from the University of Western Australia Research Grants Scheme (to E. H. M.), and an ARC Australian Professorial Fellowship (to A. H. M.).	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Barbieri MR, 2011, GENETICS, V188, P349, DOI 10.1534/genetics.111.128827; Braun HP, 2007, PHYSIOL PLANTARUM, V129, P114, DOI 10.1111/j.1399-3054.2006.00773.x; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Keren I, 2009, RNA, V15, P2299, DOI 10.1261/rna.1776409; Klodmann J, 2011, PHYTOCHEMISTRY, V72, P1071, DOI 10.1016/j.phytochem.2010.11.012; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kuhn K, 2009, PLANT CELL, V21, P2762, DOI 10.1105/tpc.109.068536; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Nakagawa N, 2006, PLANT CELL PHYSIOL, V47, P772, DOI 10.1093/pcp/pcj051; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	49	75	77	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26081	26092		10.1074/jbc.M110.209601	http://dx.doi.org/10.1074/jbc.M110.209601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21606486	hybrid, Green Published			2022-12-25	WOS:000293073000066
J	Kinney, SM; Chin, HG; Vaisvila, R; Bitinaite, J; Zheng, Y; Esteve, PO; Feng, SH; Stroud, H; Jacobsen, SE; Pradhan, S				Kinney, Shannon Morey; Chin, Hang Gyeong; Vaisvila, Romualdas; Bitinaite, Jurate; Zheng, Yu; Esteve, Pierre-Olivier; Feng, Suhua; Stroud, Hume; Jacobsen, Steven E.; Pradhan, Sriharsa			Tissue-specific Distribution and Dynamic Changes of 5-Hydroxymethylcytosine in Mammalian Genomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; BINDING; 5-METHYLCYTOSINE; CPG; TRANSCRIPTION; CONVERSION; REVEALS; PROTEIN; DOMAIN	Cytosine residues in the vertebrate genome are enzymatically modified to 5-methylcytosine, which participates in transcriptional repression of genes during development and disease progression. 5-Methylcytosine can be further enzymatically modified to 5-hydroxymethylcytosine by the TET family of methylcytosine dioxygenases. Analysis of 5-methylcytosine and 5-hydroxymethylcytosine is confounded, as these modifications are indistinguishable by traditional sequencing methods even when supplemented by bisulfite conversion. Here we demonstrate a simple enzymatic approach that involves cloning, identification, and quantification of 5-hydroxymethylcytosine in various CCGG loci within murine and human genomes. 5-Hydroxymethylcytosine was prevalent in human and murine brain and heart genomic DNAs at several regions. The cultured cell lines NIH3T3 and HeLa both displayed very low or undetectable amounts of 5-hydroxymethylcytosine at the examined loci. Interestingly, 5-hydroxymethylcytosine levels in mouse embryonic stem cell DNA first increased then slowly decreased upon differentiation to embryoid bodies, whereas 5-methylcytosine levels increased gradually over time. Finally, using a quantitative PCR approach, we established that a portion of VANGL1 and EGFR gene body methylation in human tissue DNA samples is indeed hydroxymethylation.	[Kinney, Shannon Morey; Chin, Hang Gyeong; Vaisvila, Romualdas; Bitinaite, Jurate; Zheng, Yu; Esteve, Pierre-Olivier; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Feng, Suhua; Stroud, Hume; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	New England Biolabs; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Pradhan, S (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	pradhan@neb.com	Stroud, Hume/ABF-1325-2021; Kinney, Shannon/AAW-5301-2021	Bitinaite, Jurate/0000-0002-9190-6355	Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; New England Biolabs, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398] Funding Source: NIH RePORTER	Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; New England Biolabs, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an innovation award from the Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (to S. E. J.).; We thank Jack Benner for nucleotide analysis of the genomic DNA and Thomas C. Evans and William Jack for reading the manuscript. We thank Drs. Donald G. Comb, Richard J. Roberts, James V. Ellard, and New England Biolabs, Inc. for supporting the basic research.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dahlmann HA, 2009, BIOCHEMISTRY-US, V48, P9347, DOI 10.1021/bi901059k; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Goosen N, 2010, DNA REPAIR, V9, P593, DOI 10.1016/j.dnarep.2010.02.015; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P3231, DOI 10.1093/nar/5.9.3231; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	34	129	141	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24685	24693		10.1074/jbc.M110.217083	http://dx.doi.org/10.1074/jbc.M110.217083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610077	Green Published, hybrid			2022-12-25	WOS:000292547900019
J	Finke, C; Ostendorf, F; Braun, M; Ploner, CJ				Finke, Carsten; Ostendorf, Florian; Braun, Mischa; Ploner, Christoph J.			Impaired Representation of Geometric Relationships in Humans with Damage to the Hippocampal Formation	PLOS ONE			English	Article							SPATIAL MEMORY DEFICITS; MEDIAL TEMPORAL-LOBE; SHORT-TERM-MEMORY; PARAHIPPOCAMPAL CORTEX; REORIENTATION; LOCATION; LESIONS; BOUNDARIES; NAVIGATION; INSIGHTS	The pivotal role of the hippocampus for spatial memory is well-established. However, while neurophysiological and imaging studies suggest a specialization of the hippocampus for viewpoint-independent or allocentric memory, results from human lesion studies have been less conclusive. It is currently unclear whether disproportionate impairment in allocentric memory tasks reflects impairment of cognitive functions that are not sufficiently supported by regions outside the medial temporal lobe or whether the deficits observed in some studies are due to experimental factors. Here, we have investigated whether hippocampal contributions to spatial memory depend on the spatial references that are available in a certain behavioral context. Patients with medial temporal lobe lesions affecting systematically the right hippocampal formation performed a series of three oculomotor tasks that required memory of a spatial cue either in retinal coordinates or relative to a single environmental reference across a delay of 5000 ms. Stimulus displays varied the availability of spatial references and contained no complex visuo-spatial associations. Patients showed a selective impairment in a condition that critically depended on memory of the geometric relationship between spatial cue and environmental reference. We infer that regions of the medial temporal lobe, most likely the hippocampal formation, contribute to behavior in conditions that exceed the potential of viewpoint-dependent or egocentric representations. Apparently, this already applies to short-term memory of simple geometric relationships and does not necessarily depend on task difficulty or integration of landmarks into more complex representations. Deficient memory of basic geometric relationships may represent a core deficit that contributes to impaired performance in allocentric spatial memory tasks.	[Finke, Carsten; Ostendorf, Florian; Braun, Mischa; Ploner, Christoph J.] Charite, Neurol Klin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Finke, C (corresponding author), Charite, Neurol Klin, D-13353 Berlin, Germany.	christoph.ploner@charite.de	Ostendorf, Florian/AAE-1348-2019; Finke, Carsten/H-6479-2017; Ostendorf, Florian/E-8342-2013	Ostendorf, Florian/0000-0002-4544-7610; Finke, Carsten/0000-0002-7665-1171; Ostendorf, Florian/0000-0002-4544-7610; Ploner, Christoph Johannes/0000-0003-0983-4530	Deutsche Forschungsgemeinschaft [Pl 248/3-1, Pl 248/4-1]; Bundesministerium fur Bildung und Forschung [01GW0653]; Sonnenfeld-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sonnenfeld-Stiftung	Supported by the Deutsche Forschungsgemeinschaft (grants Pl 248/3-1, Pl 248/4-1), the Bundesministerium fur Bildung und Forschung (grant 01GW0653), and the Sonnenfeld-Stiftung (grant to M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Altman D.G., 1991, PRACTICAL STATISTIC; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bird CM, 2010, J NEUROSCI, V30, P11688, DOI 10.1523/JNEUROSCI.0723-10.2010; Bohbot VD, 2004, NEUROPSYCHOLOGY, V18, P418, DOI 10.1037/0894-4105.18.3.418; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Braun M, 2008, BRAIN, V131, P2742, DOI 10.1093/brain/awn191; Braun M, 2011, HIPPOCAMPUS, V21, P309, DOI 10.1002/hipo.20752; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Finke C, 2008, NEUROPSYCHOLOGIA, V46, P614, DOI 10.1016/j.neuropsychologia.2007.10.004; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Glikmann-Johnston Y, 2008, BRAIN, V131, P3006, DOI 10.1093/brain/awn213; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Hermer L, 1996, COGNITION, V61, P195, DOI 10.1016/S0010-0277(96)00714-7; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Hornak J, 1997, NEUROPSYCHOLOGIA, V35, P1311, DOI 10.1016/S0028-3932(97)00062-6; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lakusta L, 2010, P NATL ACAD SCI USA, V107, P2813, DOI 10.1073/pnas.0909155107; Landau B, 2009, CURR OPIN NEUROBIOL, V19, P12, DOI 10.1016/j.conb.2009.02.001; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Morris R., 2007, HIPPOCAMPUS BOOK, P581; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Parslow DM, 2005, ACTA PSYCHOL, V118, P123, DOI 10.1016/j.actpsy.2004.10.006; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; RAINS GD, 1994, NEUROPSYCHOLOGIA, V32, P1233; Shrager Y, 2007, P NATL ACAD SCI USA, V104, P2961, DOI 10.1073/pnas.0611233104; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Suthana NA, 2009, J NEUROSCI, V29, P10512, DOI 10.1523/JNEUROSCI.0621-09.2009; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19507	10.1371/journal.pone.0019507	http://dx.doi.org/10.1371/journal.pone.0019507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611122	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200009
J	Menkhorst, E; Zhang, JG; Sims, NA; Morgan, PO; Soo, P; Poulton, IJ; Metcalf, D; Alexandrou, E; Gresle, M; Salamonsen, LA; Butzkueven, H; Nicola, NA; Dimitriadis, E				Menkhorst, Ellen; Zhang, Jian-Guo; Sims, Natalie A.; Morgan, Phillip O.; Soo, Priscilla; Poulton, Ingrid J.; Metcalf, Donald; Alexandrou, Estella; Gresle, Melissa; Salamonsen, Lois A.; Butzkueven, Helmut; Nicola, Nicos A.; Dimitriadis, Evdokia			Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation and Eliminated Non-Target Effects on Bone in Mice	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; HUMAN ENDOMETRIUM; INFERTILE WOMEN; BLASTOCYST IMPLANTATION; RECEPTOR; UTERUS; LEVONORGESTREL; INTERLEUKIN-11; PROGESTERONE; EXPRESSION	Female-controlled contraception/HIV prevention is critical to address health issues associated with gender inequality. Therefore, a contraceptive which can be administered in tandem with a microbicide to inhibit sexually transmitted infections, is desirable. Uterine leukemia inhibitory factor (LIF) is obligatory for blastocyst implantation in mice and associated with infertility in women. We aimed to determine whether a PEGylated LIF inhibitor (PEGLA) was an effective contraceptive following vaginal delivery and to identify non-uterine targets of PEGLA in mice. Vaginally-applied (125)I-PEGLA accumulated in blood more slowly (30 min vs 10 min) and showed reduced tissue and blood retention (24 h vs 96 h) compared to intraperitoneal injection in mice. Vaginally-applied PEGLA blocked implantation. PEGLA administered by intraperitoneal injection inhibited bone remodelling whereas vaginally-applied PEGLA had no effect on bone. Further, PEGLA had no effect in an animal model of multiple sclerosis, experimental auto-immune encephalomyelitis, suggesting PEGLA cannot target the central nervous system. Vaginally-administered PEGLA is a promising non-hormonal contraceptive, one which could be delivered alone, or in tandem with a microbicide. Vaginal application reduced the total dose of PEGLA required to block implantation and eliminated the systemic effect on bone, showing the vagina is a promising site of administration for larger drugs which target organs within the reproductive tract.	[Menkhorst, Ellen; Salamonsen, Lois A.; Dimitriadis, Evdokia] Prince Henrys Inst, Clayton, Vic, Australia; [Zhang, Jian-Guo; Morgan, Phillip O.; Soo, Priscilla; Metcalf, Donald; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Sims, Natalie A.; Poulton, Ingrid J.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Alexandrou, Estella; Gresle, Melissa; Butzkueven, Helmut] Howard Florey Inst, Melbourne, Vic, Australia; [Alexandrou, Estella; Butzkueven, Helmut] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Prince Henry's Institute of Medical Research; Walter & Eliza Hall Institute; St. Vincent's Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Menkhorst, E (corresponding author), Prince Henrys Inst, Clayton, Vic, Australia.	ellen.menkhorst@princehenrys.org	Salamonsen, Lois/J-9822-2019; Menkhorst, Ellen/AAU-4329-2021; dimitriadis, e/AAD-7601-2021; Sims, Natalie Ann/A-7192-2012; Menkhorst, Ellen/P-5759-2014; Nicola, Nicos/D-2989-2011	Menkhorst, Ellen/0000-0003-2440-6665; Sims, Natalie Ann/0000-0003-1421-8468; Nicola, Nicos/0000-0003-1054-7889; Dimitriadis, Eva/0000-0001-8698-1927; gresle, melissa/0000-0003-0738-1136; Salamonsen, Lois/0000-0003-0558-7325; Butzkueven, Helmut/0000-0003-3940-8727; dimitriadis, eva/0000-0003-1425-950X	Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School [CIG-07-116]; NHMRC (Australia) [461219, 345401, 516730, 388920]; Lalor Foundation; Victorian Government's (Australia); CASS Foundation; Harold Mitchell Foundation	Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Lalor Foundation; Victorian Government's (Australia); CASS Foundation; Harold Mitchell Foundation	This work was supported by the Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School (Sub-project CIG-07-116 [ED]), the NHMRC (Australia) (Program grants: 461219 [NN]; 345401 [NAS]; project grants 516730 [JGZ]; 388920 [ED] and fellowships to LAS, NAS and EM), the Lalor Foundation (Postdoctoral Fellowship [EM]) and the Victorian Government's (Australia) Operational Infrastructure Support Program. EM received travel support from The CASS Foundation and the Harold Mitchell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; [Anonymous], 2009, LANCET, V374, P949; Bahamondes L, 2006, HUM REPROD, V21, P1316, DOI 10.1093/humrep/dei457; Benagiano G, 2008, EXPERT REV MED DEVIC, V5, P639, DOI 10.1586/17434440.5.5.639; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Brache V, 2007, CONTRACEPTION, V76, P111, DOI 10.1016/j.contraception.2007.04.005; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; Cicinelli E, 2004, FERTIL STERIL, V81, P1414, DOI 10.1016/j.fertnstert.2003.12.016; Cicinelli E, 1999, HUM REPROD UPDATE, V5, P365, DOI 10.1093/humupd/5.4.365; Cicinelli E, 2001, FERTIL STERIL, V76, P1108, DOI 10.1016/S0015-0282(01)02905-3; Cicinelli E, 2000, OBSTET GYNECOL, V95, P403, DOI 10.1016/S0029-7844(99)00542-6; CORNISH J, 1993, ENDOCRINOLOGY, V132, P1359, DOI 10.1210/en.132.3.1359; Devoto L, 2005, FERTIL STERIL, V84, P46, DOI 10.1016/j.fertnstert.2005.01.106; deZiegler D, 1997, ANN NY ACAD SCI, V828, P291; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Dimitriadis E, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-44; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Ficicioglu C, 2004, GYNECOL ENDOCRINOL, V18, P240, DOI 10.1080/09513590410001692519; Herrmann M, 2010, CLIN ENDOCRINOL, V72, P571, DOI 10.1111/j.1365-2265.2009.03688.x; HILTON DJ, 1991, J CELL PHYSIOL, V148, P430, DOI 10.1002/jcp.1041480315; Hussain A, 2005, J CONTROL RELEASE, V103, P301, DOI 10.1016/j.jconrel.2004.11.034; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; KOJIMA K, 1994, BIOL REPROD, V50, P882, DOI 10.1095/biolreprod50.4.882; KOPF GS, 2007, SOC REPROD FERTIL S, V63, P21; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; KUROSAWA K, 1985, TOHOKU J EXP MED, V147, P261, DOI 10.1620/tjem.147.261; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Martin TJ, 2007, CLIN SCI, V112, P77, DOI 10.1042/CS20060046; Marwood M, 2009, ENDOCRINOLOGY, V150, P2915, DOI 10.1210/en.2008-1538; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Mikolajczyk M, 2007, AM J REPROD IMMUNOL, V58, P65, DOI 10.1111/j.1600-0897.2007.00492.x; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tsai HD, 2000, J ASSIST REPROD GEN, V17, P415, DOI 10.1023/A:1009457016871; Vogiagis D, 1996, J ENDOCRINOL, V148, P95, DOI 10.1677/joe.0.1480095; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; WARE CB, 1995, DEVELOPMENT, V121, P1283; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104	48	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19665	10.1371/journal.pone.0019665	http://dx.doi.org/10.1371/journal.pone.0019665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611124	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200024
J	Semaan, N; Frenzel, L; Alsaleh, G; Suffert, G; Gottenberg, JE; Sibilia, J; Pfeffer, S; Wachsmann, D				Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Suffert, Guillaume; Gottenberg, Jacques-Eric; Sibilia, Jean; Pfeffer, Sebastien; Wachsmann, Dominique			miR-346 Controls Release of TNF-alpha Protein and Stability of Its mRNA in Rheumatoid Arthritis via Tristetraprolin Stabilization	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; BRUTONS TYROSINE KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MICRORNA; EXPRESSION; CELLS; INFLAMMATION; ACTIVATION; PATHWAYS	TNF-alpha is a major cytokine implicated in rheumatoid arthritis. Its expression is regulated both at the transcriptional and posttranscriptional levels and recent data demonstrated that miRNAs are implicated in TNF-alpha response in macrophages. LPS-activated FLS isolated from RA patients express TNF-alpha mRNA but not the mature protein. This prompted us to look for miRNAs which could be implicated in this anti-inflammatory effect. Using a microarray, we found two miRNAs, miR-125b and miR-939 predicted to target the 3'-UTR of TNF-alpha mRNA, to be up-regulated in RA FLS in response to LPS, but their repression did not restore mature TNF-alpha expression in FLS. We showed previously that miR-346, which is upregulated in LPS-activated FLS, inhibited Btk expression that stabilized TNF-alpha mRNA. Blocking miR-346 reestablished TNF-alpha expression in activated FLS. Interestingly, transfection of miR-346 in LPS-activated THP-1 cells inhibited TNF-alpha secretion. We also demonstrated that TTP, a RNA binding protein which inhibited TNF-alpha synthesis, is overexpressed in activated FLS and that inhibition of miR-346 decreases its expression. Conversely, transfection of miR-346 in LPS-activated THP-1 cells increased TTP mRNA expression and inhibited TNF-alpha release. These results indicate that miR-346 controls TNF-alpha synthesis by regulating TTP expression.	[Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Gottenberg, Jacques-Eric; Sibilia, Jean; Wachsmann, Dominique] Univ Strasbourg, UFR Sci Pharmaceut, Lab Physiopathol Arthrit, EA4438, Illkirch Graffenstaden, France; [Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Gottenberg, Jacques-Eric; Sibilia, Jean; Wachsmann, Dominique] Hop Univ Strasbourg, Dept Rhumatol, Strasbourg Hautepierre, France; [Suffert, Guillaume; Pfeffer, Sebastien] Univ Strasbourg, Architecture & React ARN, Inst Biol Mol & Cellulaire, CNRS, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Semaan, N (corresponding author), Univ Strasbourg, UFR Sci Pharmaceut, Lab Physiopathol Arthrit, EA4438, Illkirch Graffenstaden, France.	s.pfeffer@ibmc-cnrs.unistra.fr; dominique.wachsmann@pharma.u-strasbg.fr	Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019	Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Sibilia, Jean/0000-0002-1601-4795; alsaleh, ghada/0000-0002-4211-3420	CNRS; Bristol Myers Squibb; Roche; Pfizer; Courtin Fundation; CAMPLP	CNRS(Centre National de la Recherche Scientifique (CNRS)); Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Pfizer(Pfizer); Courtin Fundation; CAMPLP	This work was supported by an ATIP starting grant from CNRS to Sebastien Pfeffer and by grants from Bristol Myers Squibb, Roche, Pfizer, Courtin Fundation and CAMPLP to Dominique Wachsmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chatenay-Rivauday C, 1998, MOL MICROBIOL, V29, P39, DOI 10.1046/j.1365-2958.1998.00881.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DECHANET J, 1994, EUR J IMMUNOL, V24, P3222, DOI 10.1002/eji.1830241247; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harashima SI, 2004, RHEUMATOLOGY, V43, P396, DOI 10.1093/rheumatology/keh022; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Neff L, 2001, CELL MICROBIOL, V3, P703, DOI 10.1046/j.1462-5822.2001.00148.x; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; O'Connell RM, NAT REV IMMUNOL, V10, P111; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Semaan N, 2008, J IMMUNOL, V180, P3485, DOI 10.4049/jimmunol.180.5.3485; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Tili Esmerina, 2008, Int J Med Sci, V5, P73; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Zorn CN, 2009, CELL SIGNAL, V21, P79, DOI 10.1016/j.cellsig.2008.09.010	39	80	89	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19827	10.1371/journal.pone.0019827	http://dx.doi.org/10.1371/journal.pone.0019827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611196	Green Published, Green Submitted, gold			2022-12-25	WOS:000290657500026
J	Le, LP; Nielsen, GP; Rosenberg, AE; Thomas, D; Batten, JM; Deshpande, V; Schwab, J; Duan, ZF; Xavier, RJ; Hornicek, FJ; Iafrate, AJ				Le, Long Phi; Nielsen, G. Petur; Rosenberg, Andrew Eric; Thomas, Dafydd; Batten, Julie M.; Deshpande, Vikram; Schwab, Joseph; Duan, Zhenfeng; Xavier, Ramnik J.; Hornicek, Francis J.; Iafrate, A. John			Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; FAMILIAL CHORDOMA; SKULL BASE; METHYLATION STATUS; EXPRESSION; CANCER; RECEPTOR; REGIONS; LOCUS	The molecular events in chordoma pathogenesis have not been fully delineated, particularly with respect to copy number changes. Understanding copy number alterations in chordoma may reveal critical disease mechanisms that could be exploited for tumor classification and therapy. We report the copy number analysis of 21 sporadic chordomas using array comparative genomic hybridization (CGH). Recurrent copy changes were further evaluated with immunohistochemistry, methylation specific PCR, and quantitative real-time PCR. Similar to previous findings, large copy number losses, involving chromosomes 1p, 3, 4, 9, 10, 13, 14, and 18, were more common than copy number gains. Loss of CDKN2A with or without loss of CDKN2B on 9p21.3 was observed in 16/20 (80%) unique cases of which six (30%) showed homozygous deletions ranging from 76 kilobases to 4.7 megabases. One copy loss of the 10q23.31 region which encodes PTEN was found in 16/20 (80%) cases. Loss of CDKN2A and PTEN expression in the majority of cases was not attributed to promoter methylation. Our sporadic chordoma cases did not show hotspot point mutations in some common cancer gene targets. Moreover, most of these sporadic tumors are not associated with T (brachyury) duplication or amplification. Deficiency of CDKN2A and PTEN expression, although shared across many other different types of tumors, likely represents a key aspect of chordoma pathogenesis. Sporadic chordomas may rely on mechanisms other than copy number gain if they indeed exploit T/brachyury for proliferation.	[Le, Long Phi; Nielsen, G. Petur; Rosenberg, Andrew Eric; Batten, Julie M.; Deshpande, Vikram; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Thomas, Dafydd] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Schwab, Joseph; Duan, Zhenfeng; Hornicek, Francis J.] Harvard Univ, Orthopaed Oncol Serv, Massachusetts Gen Hosp, Sch Med,Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Le, LP (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	lple@partners.org	Pillay, Nischalan/F-9536-2012		Stephan Harris Chordoma Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Stephan Harris Chordoma Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the Stephan Harris Chordoma Center, Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrakli F, 2007, SURG NEUROL, V68, P425, DOI 10.1016/j.surneu.2006.11.046; Casali PG, 2007, CURR OPIN ONCOL, V19, P367, DOI 10.1097/CCO.0b013e3281214448; CHUANG LSH, 2010, ONCOGENE; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Eisenberg MB, 1997, SURG NEUROL, V47, P156, DOI 10.1016/S0090-3019(96)00432-6; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Hallor KH, 2008, BRIT J CANCER, V98, P434, DOI 10.1038/sj.bjc.6604130; Han S, 2009, CLIN CANCER RES, V15, P1940, DOI 10.1158/1078-0432.CCR-08-2364; HEFFELFINGER MJ, 1973, CANCER-AM CANCER SOC, V32, P410, DOI 10.1002/1097-0142(197308)32:2<410::AID-CNCR2820320219>3.0.CO;2-S; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hof H, 2006, ONKOLOGIE, V29, P572, DOI 10.1159/000096283; Kelley MJ, 2001, AM J HUM GENET, V69, P454, DOI 10.1086/321982; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuzniacka A, 2004, CANCER GENET CYTOGEN, V151, P178, DOI 10.1016/j.cancergencyto.2003.09.015; Lee-Jones L, 2004, GENE CHROMOSOME CANC, V41, P80, DOI 10.1002/gcc.20052; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Miozzo M, 2000, INT J CANCER, V87, P68, DOI 10.1002/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V; Naka T, 2005, CANCER-AM CANCER SOC, V104, P1255, DOI 10.1002/cncr.21296; Pallini R, 2003, J NEUROSURG, V98, P812, DOI 10.3171/jns.2003.98.4.0812; PRESNEAU N, 2010, J PATHOL; Riva P, 2003, INT J CANCER, V107, P493, DOI 10.1002/ijc.11421; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Shalaby AAE, 2009, MODERN PATHOL, V22, P996, DOI 10.1038/modpathol.2009.63; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; STACCHIOTTI S, 2009, ANN ONCOL; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tirabosco R, 2008, AM J SURG PATHOL, V32, P572, DOI 10.1097/PAS.0b013e31815b693a; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	31	72	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e18846	10.1371/journal.pone.0018846	http://dx.doi.org/10.1371/journal.pone.0018846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602918	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500002
J	Oliver, L; Hue, E; Rossignol, J; Bougras, G; Hulin, P; Naveilhan, P; Heymann, D; Lescaudron, L; Vallette, FM				Oliver, Lisa; Hue, Erika; Rossignol, Julien; Bougras, Gwenola; Hulin, Philippe; Naveilhan, Philippe; Heymann, Dominique; Lescaudron, Laurent; Vallette, Francois M.			Distinct Roles of Bcl-2 and Bcl-XI in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during Differentiation	PLOS ONE			English	Article							NEGATIVE SELECTION; STROMAL CELLS; NUR77; SENESCENCE; EXPOSURE; FAMILY; DEATH; LIFE	Background: Adult mesenchymal stem cells (MSCs) can be maintained over extended periods of time before activation and differentiation. Little is known about the programs that sustain the survival of these cells. Principal Findings: Undifferentiated adult human MSCs (hMSCs) did not undergo apoptosis in response to different cell death inducers. Conversely, the same inducers can readily induce apoptosis when hMSCs are engaged in the early stages of differentiation. The survival of undifferentiated cells is linked to the expression of Bcl-Xl and Bcl-2 in completely opposite ways. Bcl-Xl is expressed at similar levels in undifferentiated and differentiated hMSCs while Bcl-2 is expressed only in differentiated cells. In undifferentiated hMSCs, the down-regulation of Bcl-Xl is associated with an increased sensitivity to apoptosis while the ectopic expression of Bcl-2 induced apoptosis. This apoptosis is linked to the presence of cytoplasmic Nur 77 in undifferentiated hMSCs. Significance: In hMSCs, the expression of Bcl-2 depends on cellular differentiation and can be either pro-or anti-apoptotic. Bcl-Xl, on the other hand, exhibits an anti-apoptotic activity under all conditions.	[Oliver, Lisa; Hue, Erika; Bougras, Gwenola; Vallette, Francois M.] INSERM, UMR 892, Equipe Labellisee Ligue Canc, Nantes, France; [Oliver, Lisa; Hue, Erika; Rossignol, Julien; Bougras, Gwenola; Naveilhan, Philippe; Heymann, Dominique; Lescaudron, Laurent; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Rossignol, Julien; Naveilhan, Philippe; Lescaudron, Laurent] INSERM, UMR 643, Nantes, France; [Hulin, Philippe] Univ Nantes, Cellular & Tissular Imaging Core Facil MicroPICel, Nantes, France; [Heymann, Dominique] INSERM, UMR 957, Nantes, France; [Lescaudron, Laurent] Univ Nantes, UFR Sci & Tech, Serv Physiol Anim & Humaine, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Oliver, L (corresponding author), INSERM, UMR 892, Equipe Labellisee Ligue Canc, Nantes, France.	francois.vallette@inserm.fr	Oliver, Lisa J/L-3070-2015; Heymann, Dominique/AAC-6014-2019; Vallette, Francois M/K-9047-2015; Rossignol, Julien/I-1013-2019; Vallette, Francois/N-2361-2018; Naveilhan, Philippe/K-2377-2015	Oliver, Lisa J/0000-0002-5588-7564; Heymann, Dominique/0000-0001-7777-0669; Vallette, Francois M/0000-0002-3296-8572; Rossignol, Julien/0000-0002-8662-0547; Naveilhan, Philippe/0000-0003-4093-4513; HUE, Erika/0000-0001-6930-3606	INSERM (Insitut National de la Sante et la Recherche Medicale); "Ligue Nationale contre le Cancer" (programme Equipe Labellisee)	INSERM (Insitut National de la Sante et la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Ligue Nationale contre le Cancer" (programme Equipe Labellisee)	This work was supported by grants from INSERM (Insitut National de la Sante et la Recherche Medicale) and a special grant from the "Ligue Nationale contre le Cancer" (programme Equipe Labellisee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; CAPLAN AI, 2007, J PATHOL, V217, P318; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Haughn L, 2003, J BIOL CHEM, V278, P25158, DOI 10.1074/jbc.M212849200; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Ishii M, 2005, BIOCHEM BIOPH RES CO, V332, P297, DOI 10.1016/j.bbrc.2005.04.118; Kennea NL, 2005, CELL DEATH DIFFER, V12, P1439, DOI 10.1038/sj.cdd.4401641; Koester SK, 1997, CYTOMETRY, V29, P306; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mueller LP, 2006, STEM CELLS, V24, P2753, DOI 10.1634/stemcells.2006-0108; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; PARK JR, 1995, BLOOD, V86, P868; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2008, REGEN MED, V3, P731, DOI 10.2217/17460751.3.5.731; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Streetz KL, 2008, HEPATOLOGY, V47, P706, DOI 10.1002/hep.22012; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	35	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19820	10.1371/journal.pone.0019820	http://dx.doi.org/10.1371/journal.pone.0019820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589877	Green Published, Green Accepted, gold			2022-12-25	WOS:000290531100029
J	Sarfo, FS; Lavender, CJ; Fyfe, JAM; Johnson, PDR; Stinear, TP; Phillips, RO				Sarfo, Fred S.; Lavender, Caroline J.; Fyfe, Janet A. M.; Johnson, Paul D. R.; Stinear, Timothy P.; Phillips, Richard O.			Mycobacterium ulcerans DNA Not Detected in Faecal Samples from Buruli Ulcer Patients: Results of a Pilot Study	PLOS ONE			English	Article							AUSTRALIA; MAMMALS	It has recently been shown that in a Buruli ulcer (BU) endemic region of southeastern Australia, significant numbers of possums (native tree-dwelling marsupials) have clinical BU disease. Furthermore, based on quantitative PCR (qPCR) analysis, animals with BU lesions (and some without) shed M. ulcerans DNA in their faeces, indicative of bacterial loads of up to 10 8 organisms/gram. These findings led us to propose that humans might also harbour M. ulcerans in their gastrointestinal tract and shed the bacterium in their faeces. We conducted a pilot study and collected faecal swabs from 26 patients with confirmed BU and 31 healthy household controls. Faecal samples were also collected from 10 healthy controls from non-endemic regions in Ghana. All 67 specimens were negative when tested by IS2404 PCR. The detection sensitivity of this method was >= 10(4) bacteria per gram (wet-weight) of human faecal material. We conclude that the human gastrointestinal tract is unlikely to be a significant reservoir of M. ulcerans.	[Sarfo, Fred S.; Phillips, Richard O.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Lavender, Caroline J.; Fyfe, Janet A. M.] Victorian Infect Dis Reference Lab, Mycobacterium Reference Lab, Melbourne, Vic, Australia; [Johnson, Paul D. R.] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia; [Johnson, Paul D. R.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Johnson, Paul D. R.; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Kwame Nkrumah University Science & Technology; Victorian Infectious Diseases Reference Laboratory; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Sarfo, FS (corresponding author), Komfo Anokye Teaching Hosp, Kumasi, Ghana.	tstinear@unimelb.edu.au	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222; Stinear, Timothy/0000-0003-0150-123X; Lavender, Caroline/0000-0002-2213-4005	UBS Optimus Foundation	UBS Optimus Foundation	This research was supported by the UBS Optimus Foundation www.stopburuli.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Durnez L, 2010, APPL ENVIRON MICROB, V76, P4574, DOI 10.1128/AEM.00199-10; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson PDR, 2009, EMERG INFECT DIS, V15, P614, DOI 10.3201/eid1504.081162; PIDOT S, 2010, PLOS NEGL T IN PRESS; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751	7	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19611	10.1371/journal.pone.0019611	http://dx.doi.org/10.1371/journal.pone.0019611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573192	Green Published, Green Submitted, gold			2022-12-25	WOS:000290224800039
J	Choi, HH; Gully, C; Su, CH; Velazquez-Torres, G; Chou, PC; Tseng, C; Zhao, R; Phan, L; Shaiken, T; Chen, J; Yeung, SC; Lee, MH				Choi, H. H.; Gully, C.; Su, C-H; Velazquez-Torres, G.; Chou, P-C; Tseng, C.; Zhao, R.; Phan, L.; Shaiken, T.; Chen, J.; Yeung, S. C.; Lee, M-H			COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3 sigma	ONCOGENE			English	Article						14-3-3 sigma; CSN6; COP1; ubiquitination	REGULATES C-JUN; DNA-DAMAGE; NEGATIVE REGULATOR; LIGHT CONTROL; TUMOR-GROWTH; ARABIDOPSIS; PROTEINS; BREAST; CANCER; P53	14-3-3 sigma, a gene upregulated by p53 in response to DNA damage, exists as part of a positive-feedback loop, which activates p53 and is a human cancer epithelial marker downregulated in various cancer types. 14-3-3 sigma levels are critical for maintaining p53 activity in response to DNA damage and regulating signal mediators such as Akt. In this study, we identify mammalian constitutive photomorphogenic 1 (COP1) as a novel E3 ubiquitin ligase for targeting 14-3-3 sigma through proteasomal degradation. We show for the first time that COP9 signalosome subunit 6 (CSN6) associates with COP1 and is involved in 14-3-3 sigma ubiquitin-mediated degradation. Mechanistic studies show that CSN6 expression leads to stabilization of COP1 through reducing COP1 self-ubiquitination and decelerating COP1's turnover rate. We also show that CSN6-mediated 14-3-3 sigma ubiquitination is compromised when COP1 is knocked down. Thus, CSN6-mediates 14-3-3 sigma ubiquitination through enhancing COP1 stability. Subsequently, we show that CSN6 causes 14-3-3 sigma downregulation, thereby activating Akt and promoting cell survival. Also, CSN6 overexpression leads to increased cell growth, transformation and promotes tumorigenicity. Significantly, 14-3-3 sigma expression can correct the abnormalities mediated by CSN6 expression. These data suggest that the CSN6-COP1 axis is involved in 14-3-3 sigma degradation, and that deregulation of this axis will promote cell growth and tumorigenicity. Oncogene (2011) 30, 4791-4801; doi:10.1038/onc.2011.192; published online 30 May 2011	[Yeung, S. C.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med Ambulatory Treatment & Emer, Houston, TX 77030 USA; [Yeung, S. C.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Choi, H. H.; Gully, C.; Su, C-H; Velazquez-Torres, G.; Chou, P-C; Tseng, C.; Zhao, R.; Phan, L.; Shaiken, T.; Chen, J.; Lee, M-H] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Choi, H. H.; Velazquez-Torres, G.; Chou, P-C; Tseng, C.; Lee, M-H] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Biol, Houston, TX USA; [Gully, C.; Su, C-H; Lee, M-H] Univ Texas Grad Sch Biomed Sci Houston, Program Genes & Dev, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yeung, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med Ambulatory Treatment & Emer, 1515 Holcombe Blvd, Houston, TX 77030 USA.	syeung@mdanderson.org; mhlee@mdanderson.org	Yeung, Sai-Ching/AAI-6178-2021; Yeung, Sai-Ching/AAP-8079-2020	Yeung, Sai-Ching/0000-0001-5170-0822; Lee, Mong-Hong/0000-0001-8675-8215; Shaiken (Shaikenov), Tattym/0000-0002-8808-6229	National Institutes of Health (NIH) [R01CA089266]; Directed Medical Research Programs [DOD SIDA BC062166]; Susan G Komen Breast Cancer Foundation [KG081048]; cancer prevention fellowship [R25T CA57730]; NIH [CA16672]; NATIONAL CANCER INSTITUTE [R56CA089266, R01CA089266, R25CA057730, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directed Medical Research Programs; Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); cancer prevention fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (NIH) (R01CA089266), Directed Medical Research Programs (DOD SIDA BC062166 to SJY and MHL) and Susan G Komen Breast Cancer Foundation (KG081048). This research was supported in part, by a cancer prevention fellowship for GVT (R25T CA57730). The University of Texas MD Anderson Cancer Center is supported by NIH core Grant CA16672.	Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Li L, 2003, TRENDS CELL BIOL, V13, P507, DOI 10.1016/j.tcb.2003.08.002; Li ZM, 2009, AM J TRANSL RES, V1, P326; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Peng ZH, 2001, PLANT CELL, V13, P2393, DOI 10.1105/tpc.13.11.2393; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Savio MG, 2008, ONCOGENE, V27, P2401, DOI 10.1038/sj.onc.1210892; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Su CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-243; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1992, PLANT CELL, V4, P1507, DOI 10.1105/tpc.4.12.1507; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang HY, 2007, ONCOGENE, V26, P7355, DOI 10.1038/sj.onc.1210540; Yang HL, 2006, CANCER RES, V66, P3096, DOI 10.1158/0008-5472.CAN-05-3620; Yang HL, 2005, ONCOGENE, V24, P1924, DOI 10.1038/sj.onc.1208352; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	45	46	50	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	48					4791	4801		10.1038/onc.2011.192	http://dx.doi.org/10.1038/onc.2011.192			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21625211	Green Accepted			2022-12-25	WOS:000298134700003
J	Cisse, M; Duplan, E; Guillot-Sestier, MV; Rumigny, J; Bauer, C; Pages, G; Orzechowski, HD; Slack, BE; Checler, F; Vincent, B				Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Pages, Gilles; Orzechowski, Hans-Dieter; Slack, Barbara E.; Checler, Frederic; Vincent, Bruno			The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated alpha-Secretase-mediated Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE PROTEIN-1; NECROSIS-FACTOR-ALPHA; CASPASE-3 ACTIVATION; FUNCTIONAL-CHARACTERIZATION; MUSCARINIC RECEPTORS; SIGNAL-TRANSDUCTION; CONVERTING ENZYME; TRUNCATED PRION; ISCHEMIC-INJURY; NEURONAL CELLS	The alpha-secretases A disintegrin and metalloprotease 10 (ADAM10) and ADAM17 trigger constitutive and regulated processing of the cellular prion protein (PrPc) yielding N1 fragment. The latter depends on protein kinase C (PKC)-coupled M1/M3 muscarinic receptor activation and subsequent phosphorylation of ADAM17 on its intracytoplasmic threonine 735. Here we show that regulated PrPc processing and ADAM17 phosphorylation and activation are controlled by the extracellular-regulated kinase-1/MAP-ERK kinase (ERK1/MEK) cascade. Thus, reductions of ERK1 or MEK activities by dominant-negative analogs, pharmacological inhibition, or genetic ablation all impair N1 secretion, whereas constitutively active proteins increase N1 recovery in the conditioned medium. Interestingly, we also observed an ERK1-mediated enhanced expression of PrPc. We demonstrate that the ERK1-associated increase in PrPc promoter transactivation and mRNA levels involve transcription factor AP-1 as a downstream effector. Altogether, our data identify ERK1 as an important regulator of PrPc cellular homeostasis and indicate that this kinase exerts a dual control of PrPc levels through transcriptional and post-transcriptional mechanisms.	[Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Checler, Frederic; Vincent, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, F-06560 Valbonne, France; [Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Checler, Frederic; Vincent, Bruno] Univ Nice Sophia Antipolis, Inst Neuromed Mol, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, F-06560 Valbonne, France; [Pages, Gilles] Univ Nice Sophia Antipolis, Inst Dev Biol & Canc, Unite Mixte Rech 6543, Ctr Antoine Lacassagne,CNRS, F-06189 Nice, France; [Orzechowski, Hans-Dieter] Charite, Inst Clin Pharmacol & Toxicol, D-10117 Berlin, Germany; [Slack, Barbara E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Boston University	Checler, F (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr; mbbvc@mahidol.ac.th	Duplan, Eric/AAK-8224-2020; CISSE, Moustapha/AAM-1022-2021; Pages, Gilles/N-7135-2017; Slack, Barbara/AAU-9917-2021; Checler, Frederic/C-1241-2009	Duplan, Eric/0000-0002-1348-1507; Checler, Frederic/0000-0003-2098-1750; Slack, Barbara/0000-0002-7619-410X; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114; Vincent, Bruno/0000-0003-3876-2118; CISSE, Moustapha/0000-0003-3890-9183	Fondation pour la Recherche Medicale; Conseil General des Alpes-Maritimes	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur)	This work was supported by the Fondation pour la Recherche Medicale and the Conseil General des Alpes-Maritimes.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arantes C, 2009, GLIA, V57, P1439, DOI 10.1002/glia.20861; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BRUNET A, 1994, ONCOGENE, V9, P3379; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burgess STG, 2009, J BIOL CHEM, V284, P6716, DOI 10.1074/jbc.M807065200; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; Cisse MA, 2008, MOL CELL NEUROSCI, V39, P400, DOI 10.1016/j.mcn.2008.07.013; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Funke-Kaiser H, 2001, J MOL MED-JMM, V79, P529, DOI 10.1007/s001090100270; Gavin R, 2005, FEBS LETT, V579, P4099, DOI 10.1016/j.febslet.2005.06.037; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	63	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29192	29206		10.1074/jbc.M110.208249	http://dx.doi.org/10.1074/jbc.M110.208249			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21586567	hybrid, Green Published			2022-12-25	WOS:000293837000055
J	Seminario-Vidal, L; Okada, SF; Sesma, JI; Kreda, SM; van Heusden, CA; Zhu, YX; Jones, LC; O'Neal, WK; Penuela, S; Laird, DW; Boucher, RC; Lazarowski, ER				Seminario-Vidal, Lucia; Okada, Seiko F.; Sesma, Juliana I.; Kreda, Silvia M.; van Heusden, Catharina A.; Zhu, Yunxiang; Jones, Lisa C.; O'Neal, Wanda K.; Penuela, Silvia; Laird, Dale W.; Boucher, Richard C.; Lazarowski, Eduardo R.			Rho Signaling Regulates Pannexin 1-mediated ATP Release from Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SURFACE LIQUID VOLUME; FIND-ME SIGNAL; CILIARY ACTIVITY; MUCIN SECRETION; TRPV4 CHANNEL; SHEAR-STRESS; ACTIVATION; CELLS; MEMBRANE	ATP released from airway epithelial cells promotes purinergic receptor-regulated mucociliary clearance activities necessary for innate lung defense. Cell swelling-induced membrane stretch/strain is a common stimulus that promotes airway epithelial ATP release, but the mechanisms transducing cell swelling into ATP release are incompletely understood. Using knockdown and knockout approaches, we tested the hypothesis that pannexin 1 mediates ATP release from hypotonically swollen airway epithelia and investigated mechanisms regulating this activity. Well differentiated primary cultures of human bronchial epithelial cells subjected to hypotonic challenge exhibited enhanced ATP release, which was paralleled by the uptake of the pannexin probe propidium iodide. Both responses were reduced by pannexin 1 inhibitors and by knocking down pannexin 1. Importantly, hypotonicity-evoked ATP release from freshly excised tracheas and dye uptake in primary tracheal epithelial cells were impaired in pannexin 1 knockout mice. Hypotonicity-promoted ATP release and dye uptake in primary well differentiated human bronchial epithelial cells was accompanied by RhoA activation and myosin light chain phosphorylation and was reduced by the RhoA dominant negative mutant RhoA(T19N) and Rho and myosin light chain kinase inhibitors. ATP release and Rho activation were reduced by highly selective inhibitors of transient receptor potential vanilloid 4 (TRPV4). Lastly, knocking down TRPV4 impaired hypotonicity-evoked airway epithelial ATP release. Our data suggest that TRPV4 and Rho transduce cell membrane stretch/strain into pannexin 1-mediated ATP release in airway epithelia.	[Seminario-Vidal, Lucia; Okada, Seiko F.; Sesma, Juliana I.; Kreda, Silvia M.; van Heusden, Catharina A.; Zhu, Yunxiang; Jones, Lisa C.; O'Neal, Wanda K.; Boucher, Richard C.; Lazarowski, Eduardo R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Seminario-Vidal, Lucia] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Lazarowski, ER (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7017 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	eduardo_lazarowski@med.unc.edu	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Seminario-Vidal, Lucia/AAR-3314-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Seminario-Vidal, Lucia/0000-0002-6004-2451	National Institutes of Health [P01-HL034322]; Cystic Fibrosis Foundation [CFF-SEMINA08FO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL034322. This work was also supported by Cystic Fibrosis Foundation Grant CFF-SEMINA08FO.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Blum AE, 2010, AM J PHYSIOL-CELL PH, V298, pC386, DOI 10.1152/ajpcell.00430.2009; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Donaldson SH, 2000, MOL MED, V6, P969, DOI 10.1007/BF03401831; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; Hirakawa M, 2004, J PHYSIOL-LONDON, V558, P479, DOI 10.1113/jphysiol.2004.065334; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kreda SM, 2010, J PHYSIOL-LONDON, V588, P2255, DOI 10.1113/jphysiol.2009.186643; Krepinsky JC, 2003, J AM SOC NEPHROL, V14, P2790, DOI 10.1097/01.ASN.0000094085.04161.A7; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Silva GB, 2008, AM J PHYSIOL-RENAL, V295, pF1090, DOI 10.1152/ajprenal.90365.2008; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tatur S, 2007, J PHYSIOL-LONDON, V584, P419, DOI 10.1113/jphysiol.2007.133314; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310; Zsembery A, 2004, J BIOL CHEM, V279, P10720, DOI 10.1074/jbc.M313391200	75	166	170	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26277	26286		10.1074/jbc.M111.260562	http://dx.doi.org/10.1074/jbc.M111.260562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21606493	Green Published, hybrid			2022-12-25	WOS:000293078200004
J	Martinez, G; Forment, J; Llave, C; Pallas, V; Gomez, G				Martinez, German; Forment, Javier; Llave, Cesar; Pallas, Vicente; Gomez, Gustavo			High-Throughput Sequencing, Characterization and Detection of New and Conserved Cucumber miRNAs	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLANT MICRORNAS; MESSENGER-RNA; GENES; IDENTIFICATION; EVOLUTION; TARGETS; ANNOTATION; EXPRESSION; CLEAVAGE	Micro RNAS (miRNAs) are a class of endogenous small non coding RNAs involved in the post-transcriptional regulation of gene expression. In plants, a great number of conserved and specific miRNAs, mainly arising from model species, have been identified to date. However less is known about the diversity of these regulatory RNAs in vegetal species with agricultural and/or horticultural importance. Here we report a combined approach of bioinformatics prediction, high-throughput sequencing data and molecular methods to analyze miRNAs populations in cucumber (Cucumis sativus) plants. A set of 19 conserved and 6 known but non-conserved miRNA families were found in our cucumber small RNA dataset. We also identified 7 (3 with their miRNA* strand) not previously described miRNAs, candidates to be cucumber-specific. To validate their description these new C. sativus miRNAs were detected by northern blot hybridization. Additionally, potential targets for most conserved and new miRNAs were identified in cucumber genome. In summary, in this study we have identified, by first time, conserved, known non-conserved and new miRNAs arising from an agronomically important species such as C. sativus. The detection of this complex population of regulatory small RNAs suggests that similarly to that observe in other plant species, cucumber miRNAs may possibly play an important role in diverse biological and metabolic processes.	[Martinez, German; Forment, Javier; Pallas, Vicente; Gomez, Gustavo] Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain; [Llave, Cesar] CSIC, CIB, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, G (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain.	ggomez@ibmcp.upv.es	Martínez, Germán/ABE-7261-2020; Gomez, Gustavo/E-3663-2012; Llave, Cesar/ABF-5827-2021; Pallas, Vicente/N-1317-2014	Martínez, Germán/0000-0002-5215-0866; Gomez, Gustavo/0000-0003-3715-7792; Pallas, Vicente/0000-0003-4954-989X	Spanish granting agency DGICYT [BIO2008-03528]; Generalitat Valenciana [ACOMP/2010/214]	Spanish granting agency DGICYT; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grant BIO2008-03528 from the Spanish granting agency DGICYT and by grant ACOMP/2010/214 from the Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/J.1364-3703.2009.00608.X, 10.1111/j.1364-3703.2009.00608.x]; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96	34	90	97	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19523	10.1371/journal.pone.0019523	http://dx.doi.org/10.1371/journal.pone.0019523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603611	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300011
J	Ovadia, G; Shifman, S				Ovadia, Galit; Shifman, Sagiv			The Genetic Variation of RELN Expression in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							C-TERMINAL REGION; HUMAN REELIN GENE; COMMON VARIANT; BRAIN; PROMOTER; ASSOCIATION; NEURONS; HYPERMETHYLATION; HIPPOCAMPUS; DECREASE	Reelin plays an important role in the development and function of the brain and has been linked to different neuropsychiatric diseases. To further clarify the connection between reelin and psychiatric disorders, we studied the factors that influence the expression of reelin gene (RELN) and its different isoforms. We examined the total expression of RELN, allelic expression, and two alternative RELN isoforms in postmortem brain samples from patients with schizophrenia and bipolar disorder, as well as unaffected controls. We did not find a significant reduction in the total expression of RELN in schizophrenia or bipolar disorder. However, we did find a significant reduction of the proportion of the short RELN isoform, missing the C-terminal region in bipolar disorder, and imbalance in the allelic expression of RELN in schizophrenia. In addition, we tested the association between variation in RELN expression and rs7341475, an intronic SNP that was found to be associated with schizophrenia in women. We did not find an association between rs7341474 and the total expression of RELN either in women or in the entire sample. However, we observed a nominally significant effect of genotype-by-sex interaction on the variation in microexon skipping. Women with the risk genotype of rs7341475 (GG) had a higher proportion of microexon skipping, which is the isoform predominant in tissues outside the brain, while men had the opposite trend. Finally, we tested 83 SNPs in the gene region for association with expression variation of RELN, but none were significant. Our study further supports the connection between RELN dysfunction and psychiatric disorders, and provides a possible functional role for a schizophrenia associated SNP. Nevertheless, the positive associations observed in this study needs further replication as it may have implications for understanding the biological causes of schizophrenia and bipolar disorder.	[Ovadia, Galit; Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Ovadia, G (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	sagiv@vms.huji.ac.il	Shifman, Sagiv/D-8749-2017	Shifman, Sagiv/0000-0003-4071-5361	National Alliance for Research on Schizophrenia and Depression (NARSAD)	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD)	This work was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Ben-David E, 2010, AM J MED GENET B, V153B, P1244, DOI 10.1002/ajmg.b.31093; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P229, DOI 10.1006/exnr.1999.7019; Eastwood SL, 2006, AM J PSYCHIAT, V163, P540, DOI 10.1176/appi.ajp.163.3.540; Eastwood SL, 2003, MOL PSYCHIATR, V8, P821, DOI 10.1038/sj.mp.4001371; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hamburgh M., 1963, DEV BIOL, V19, P165; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; LEE MT, 2010, MOL PSYCHIAT; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Liu YP, 2010, PSYCHIAT GENET, V20, P184, DOI 10.1097/YPG.0b013e32833a220b; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Pappas GD, 2001, J NEUROCYTOL, V30, P413; Persico AM, 2006, J NEURAL TRANSM, V113, P1373, DOI 10.1007/s00702-006-0441-6; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tost H, 2010, BIOL PSYCHIAT, V68, P105, DOI 10.1016/j.biopsych.2010.02.023	33	47	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19955	10.1371/journal.pone.0019955	http://dx.doi.org/10.1371/journal.pone.0019955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603580	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300044
J	Rousseau, K; Cardwell, JM; Humphrey, E; Newton, R; Knight, D; Clegg, P; Thornton, DJ				Rousseau, Karine; Cardwell, Jacqueline M.; Humphrey, Emma; Newton, Richard; Knight, David; Clegg, Peter; Thornton, David J.			Muc5b Is the Major Polymeric Mucin in Mucus from Thoroughbred Horses With and Without Airway Mucus Accumulation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; OLIGOMERIC MUCINS; RESPIRATORY-DISEASE; BRONCHOALVEOLAR LAVAGE; UP-REGULATION; GENE MUC5B; GEL-PHASE; EXPRESSION; IDENTIFICATION	Mucus accumulation is a feature of inflammatory airway disease in the horse and has been associated with reduced performance in racehorses. In this study, we have analysed the two major airways gel-forming mucins Muc5b and Muc5ac in respect of their site of synthesis, their biochemical properties, and their amounts in mucus from healthy horses and from horses with signs of airway mucus accumulation. Polyclonal antisera directed against equine Muc5b and Muc5ac were raised and characterised. Immunohistochemical staining of normal equine trachea showed that Muc5ac and Muc5b are produced by cells in the submucosal glands, as well as surface epithelial goblet cells. Western blotting after agarose gel electrophoresis of airway mucus from healthy horses, and horses with mucus accumulation, was used to determine the amounts of these two mucins in tracheal wash samples. The results showed that in healthy horses Muc5b was the predominant mucin with small amounts of Muc5ac. The amounts of Muc5b and Muc5ac were both dramatically increased in samples collected from horses with high mucus scores as determined visually at the time of endoscopy and that this increase also correlated with increase number of bacteria present in the sample. The change in amount of Muc5b and Muc5ac indicates that Muc5b remains the most abundant mucin in mucus. In summary, we have developed mucin specific polyclonal antibodies, which have allowed us to show that there is a significant increase in Muc5b and Muc5ac in mucus accumulated in equine airways and these increases correlated with the numbers of bacteria.	[Rousseau, Karine; Knight, David; Clegg, Peter; Thornton, David J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Cardwell, Jacqueline M.; Newton, Richard] Anim Hlth Trust, Newmarket, Suffolk, England; [Humphrey, Emma; Clegg, Peter] Univ Liverpool, Dept Musculoskeletal Biol, Neston, England	University of Manchester; Animal Health Trust; University of Liverpool	Rousseau, K (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	dave.thornton@manchester.ac.uk	Cardwell, Jacqueline Martina/I-3273-2014	Clegg, Peter/0000-0003-0632-0032; Knight, David/0000-0001-8895-8560; Thornton, David/0000-0001-7148-1970	Horserace Betting Levy Board [VET/PRJ/714, VET/PRJ/74]; Horses Trust	Horserace Betting Levy Board; Horses Trust	The work described here was funded by the Horserace Betting Levy Board grants VET/PRJ/714 and VET/PRJ/74 and by a grant from the Horses Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Equine Veterinary Education, V15, P61; BHASKAR KR, 1985, EXP LUNG RES, V9, P289, DOI 10.3109/01902148509057529; BHASKAR KR, 1991, AM REV RESPIR DIS, V143, P640, DOI 10.1164/ajrccm/143.3.640; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Bullimore SR, 2001, RES VET SCI, V70, P149, DOI 10.1053/rvsc.2001.0455; Burrell MH, 1996, VET REC, V139, P308, DOI 10.1136/vr.139.13.308; BURRELL MH, 1985, EQUINE VET J, V17, P99, DOI 10.1111/j.2042-3306.1985.tb02059.x; Cardwell JM, 2010, EQUINE VET IN PRESS; Cardwell JM, 2007, THESIS OPEN U; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Christley RM, 2001, VET REC, V148, P99, DOI 10.1136/vr.148.4.99; Christley RM, 2001, EQUINE VET J, V33, P256, DOI 10.2746/042516401776249796; COOK WR, 1976, VET REC, V99, P448, DOI 10.1136/vr.99.23.448; DEBOLOS C, 1995, GASTROENTEROLOGY, V109, P723, DOI 10.1016/0016-5085(95)90379-8; DERKSEN FJ, 1985, AM REV RESPIR DIS, V132, P1066; DERKSEN FJ, 1993, EQUINE VET J, V25, P257, DOI 10.1111/j.2042-3306.1993.tb02958.x; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; Dixon PM, 1995, EQUINE VET J, V27, P416, DOI 10.1111/j.2042-3306.1995.tb04421.x; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Gerber V, 2004, EQUINE VET J, V36, P576, DOI 10.2746/0425164044864525; Gerber V, 2003, EQUINE VET J, V35, P252, DOI 10.2746/042516403776148291; Groneberg DA, 2002, RESP MED, V96, P81, DOI 10.1053/rmed.2001.1221; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kirkham S, 2008, AM J RESP CRIT CARE, V178, P1033, DOI 10.1164/rccm.200803-391OC; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Louahed J, 2000, AM J RESP CELL MOL, V22, P649, DOI 10.1165/ajrcmb.22.6.3927; MACNAMARA B, 1990, J AM VET MED ASSOC, V196, P443; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; MOORE BR, 1995, AM J VET RES, V56, P562; Nordman H, 2002, BIOCHEM J, V364, P191, DOI 10.1042/bj3640191; NUYTTEN J, 1983, ZBL VET MED A, V30, P114; NUYTTEN J, 1981, VLAAMS DIERGEN TIJDS, V50, P417; Oslund KL, 2010, AM J VET RES, V71, P690, DOI 10.2460/ajvr.71.6.690; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; PETTS DN, 1984, J CLIN MICROBIOL, V19, P4, DOI 10.1128/JCM.19.1.4-7.1984; Robinson N E, 1979, Vet Clin North Am Large Anim Pract, V1, P17; Robinson NE, 1997, P AM ASS EQUINE PRAC, V43, P106; ROHRBACH BW, 1990, J AM VET MED ASSOC, V196, P1563; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Ryhner T, 2008, VET IMMUNOL IMMUNOP, V125, P8, DOI 10.1016/j.vetimm.2008.05.011; SCHWAB UE, 2009, IN VITRO CELL DEV BI; Sheehan JK, 2000, METH MOL B, V125, P87; SHEEHAN JK, 1987, BIOCHEM J, V245, P757, DOI 10.1042/bj2450757; Sheehan JK, 1999, BIOCHEM J, V338, P507, DOI 10.1042/0264-6021:3380507; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; THORNTON DJ, 1994, AM J RESP CRIT CARE, V150, P823, DOI 10.1164/ajrccm.150.3.8087358; THORNTON DJ, 1991, BIOCHEM J, V276, P667, DOI 10.1042/bj2760667; THORNTON DJ, 1990, BIOCHEM J, V265, P179, DOI 10.1042/bj2650179; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; VIEL L, 1985, CAN VET J, V26, P33; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; WOODS PSA, 1993, EQUINE VET J, V25, P208, DOI 10.1111/j.2042-3306.1993.tb02945.x; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu L, 2010, AM J RESP C IN PRESS; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19678	10.1371/journal.pone.0019678	http://dx.doi.org/10.1371/journal.pone.0019678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602926	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500021
J	Robinson, MM; Turner, SM; Hellerstein, MK; Hamilton, KL; Miller, BF				Robinson, Matthew M.; Turner, Scott M.; Hellerstein, Marc K.; Hamilton, Karyn L.; Miller, Benjamin F.			Long-term synthesis rates of skeletal muscle DNA and protein are higher during aerobic training in older humans than in sedentary young subjects but are not altered by protein supplementation	FASEB JOURNAL			English	Article						stable isotope tracer; kinetics; deuterium oxide; heavy water; endurance; satellite cell	IN-VIVO; RESISTANCE EXERCISE; SATELLITE CELLS; MITOCHONDRIAL BIOGENESIS; NITROGEN-BALANCE; DOSE-RESPONSE; TURNOVER; INGESTION; MASS; MEN	Consuming protein following exercise has been shown to stimulate protein synthesis acutely in skeletal muscle and has been recommended to prevent sarcopenia. It is not known, however, whether acute stimulation persists long term or includes muscle cell division. We asked here whether consuming protein following exercise during aerobic training increases long-term protein and DNA synthesis rates in skeletal muscle of adult humans. Sixteen previously untrained participants (50 +/- 8 yr) consumed either a carbohydrate or carbohydrate and protein drink following each session during 6 wk of treadmill training. A younger untrained group provided a nonexercising comparison. Participants were administered heavy water ((H2O)-H-2; deuterium oxide) continuously for 6 wk to isotopically label newly synthesized skeletal muscle proteins and DNA. Muscle biopsies were performed after 6 wk of training. Contrary to acute studies, consuming protein after exercise did not increase skeletal muscle protein synthesis rates. In contrast, muscle protein synthesis, DNA, and phospholipid synthesis were significantly higher in the older exercise groups than the younger sedentary group. The higher DNA replication rate could not be attributed to mitochondrial DNA and may be due to satellite cell activation. We conclude that postexercise protein supplementation does not increase rates of mixed protein synthesis over 6 wk and that aerobic exercise may stimulate long-term cell division (DNA synthesis) in skeletal muscle of humans. Measurements of long-term synthesis rates provide important insights into aging and exercise adaptations.-Robinson, M. M., Turner, S. M., Hellerstein, M. K., Hamilton, K. L., Miller, B. F. Long-term synthesis rates of skeletal muscle DNA and protein are higher during aerobic training in older humans than in sedentary young subjects but are not altered by protein supplementation. FASEB J. 25, 3240-3249 (2011). www.fasebj.org	[Robinson, Matthew M.; Hamilton, Karyn L.; Miller, Benjamin F.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Turner, Scott M.; Hellerstein, Marc K.] KineMed Inc, Emeryville, CA USA; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA	Colorado State University; University of California System; University of California Berkeley	Miller, BF (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, 200 Moby B Complex, Ft Collins, CO 80523 USA.	benjamin.f.miller@colostate.edu		Miller, Benjamin/0000-0003-1647-0122	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK048520]; Colorado State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Colorado State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors appreciate the enthusiasm of all the study participants during the project and thank everyone who helped with exercise training and heavy water preparation: Jon Land, Kyle Barnes, Karen Warnersdorfer, Rebecca Peterson, Carrie Sousek, Shannon Wells, and the Adult Fitness Program at Colorado State University. The authors also thank Christopher Bell, Rebecca Scalzo, and Garrett Peltonen for providing the sedentary control data and Wyatt Voyles for providing medical oversight. Claire Emson and Kelvin Li (KineMed Inc.) provided technical expertise for deuterium analysis. Funding for the project was provided to B. F. M. by U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases pilot grant P30 DK048520 and Colorado State University.	Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Cristea A, 2010, AGING CELL, V9, P685, DOI 10.1111/j.1474-9726.2010.00594.x; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; Henderson GC, 2009, FASEB J, V23, P631, DOI 10.1096/fj.08-117200; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jordan LY, 2010, J GERONTOL A-BIOL, V65, P1068, DOI 10.1093/gerona/glq123; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Koopman R, 2009, J APPL PHYSIOL, V106, P2040, DOI 10.1152/japplphysiol.91551.2008; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; Levenhagen DK, 2001, AM J PHYSIOL-ENDOC M, V280, pE982, DOI 10.1152/ajpendo.2001.280.6.E982; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Menshikova EV, 2007, J APPL PHYSIOL, V103, P21, DOI 10.1152/japplphysiol.01228.2006; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Miller BF, 2007, EXERC SPORT SCI REV, V35, P50, DOI 10.1097/jes.0b013e31803eac78; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Murphy C, 2010, APPL PHYSIOL NUTR ME, V35, P583, DOI 10.1139/H10-047; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Neese RA, 2001, ANAL BIOCHEM, V298, P189, DOI 10.1006/abio.2001.5375; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Previs SF, 2004, AM J PHYSIOL-ENDOC M, V286, pE665, DOI 10.1152/ajpendo.00271.2003; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Roberts MD, 2010, MED SCI SPORT EXER, V42, P1861, DOI 10.1249/MSS.0b013e3181da8a29; Robinson MM, 2009, J APPL PHYSIOL, V107, P8, DOI 10.1152/japplphysiol.00343.2009; Roohk DJ, 2010, J PHARMACOL EXP THER, V333, P281, DOI 10.1124/jpet.109.162487; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13; Thornell LE, 2003, SCAND J MED SCI SPOR, V13, P48, DOI 10.1034/j.1600-0838.2003.20285.x; Tipton KD, 2001, AM J PHYSIOL-ENDOC M, V281, pE197, DOI 10.1152/ajpendo.2001.281.2.E197; Tipton KD, 2007, AM J PHYSIOL-ENDOC M, V292, pE71, DOI 10.1152/ajpendo.00166.2006; TODD KS, 1984, J NUTR, V114, P2107, DOI 10.1093/jn/114.11.2107; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916	54	101	106	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3240	3249		10.1096/fj.11-186437	http://dx.doi.org/10.1096/fj.11-186437			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21613572	Green Published			2022-12-25	WOS:000294435200036
J	Albrecht, R; Zeth, K				Albrecht, Reinhard; Zeth, Kornelius			Structural Basis of Outer Membrane Protein Biogenesis in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; YAET COMPLEX; BAM COMPLEX; DOMAIN; SECRETION; INSIGHTS; CONSERVATION; ARCHITECTURE; FLEXIBILITY; RECOGNITION	In Escherichia coli, a multicomponent BAM (beta-barrel assembly machinery) complex is responsible for recognition and assembly of outer membrane beta-barrel proteins. The functionality of BAM in protein biogenesis is mainly orchestrated through the presence of two essential components, BamA and BamD. Here, we present crystal structures of four lipoproteins (BamBE). Monomeric BamB and BamD proteins display scaffold architectures typically implied in transient protein interactions. BamB is a beta-propeller protein comprising eight WD40 repeats. BamD shows an elongated fold on the basis of five tetratricopeptide repeats, three of which form the scaffold for protein recognition. The rod-shaped BamC protein has evolved through the gene duplication of two conserved domains known to mediate protein interactions in structurally related complexes. By contrast, the dimeric BamE is formed through a domain swap and indicates fold similarity to the beta-lactamase inhibitor protein family, possibly integrating cell wall stability in BAM function. Structural and biochemical data show evidence for the specific recognition of amphipathic sequences through the tetratricopeptide repeat architecture of BamD. Collectively, our data advance the understanding of the BAM complex and highlight the functional importance of BamD in amphipathic outer membrane beta-barrel protein motif recognition and protein delivery.	[Albrecht, Reinhard; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	Kornelius.Zeth@tuebingen.mpg.de						Albrecht R, 2010, ACTA CRYSTALLOGR F, V66, P1586, DOI 10.1107/S1744309110034160; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Barta ML, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-21; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRASCH CE, 1978, J BACTERIOL, V136, P1127, DOI 10.1128/JB.136.3.1127-1134.1978; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; HAGAN CL, 2010, ANN REV BIOCH; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; HEUCK A, 2011, J MOL BIOL; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; POOLMAN JT, 1980, INFECT IMMUN, V30, P642; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Ryan KR, 2010, MICROBIOL-SGM, V156, P742, DOI 10.1099/mic.0.035055-0; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Soo PC, 2005, INFECT IMMUN, V73, P6075, DOI 10.1128/IAI.73.9.6075-6084.2005; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1997, PROTEINS, V27, P110; Vanini MMT, 2008, PROTEINS, V71, P2051, DOI 10.1002/prot.21886; Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219	62	68	74	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27792	27803		10.1074/jbc.M111.238931	http://dx.doi.org/10.1074/jbc.M111.238931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21586578	Green Published, hybrid			2022-12-25	WOS:000293268700071
J	Brewer, PD; Romenskaia, I; Kanow, MA; Mastick, CC				Brewer, Paul Duffield; Romenskaia, Irina; Kanow, Mark A.; Mastick, Cynthia Corley			Loss of AS160 Akt Substrate Causes Glut4 Protein to Accumulate in Compartments That Are Primed for Fusion in Basal Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RAT ADIPOSE-CELLS; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; GLUCOSE-TRANSPORTER; SUBCELLULAR TRAFFICKING; INTRACELLULAR RETENTION; STORAGE-VESICLES; INSULIN ACTION; MUSCLE-CELLS	The Akt substrate AS160 (TCB1D4) regulates Glut4 exocytosis; shRNA knockdown of AS160 increases surface Glut4 in basal adipocytes. AS160 knockdown is only partially insulin-mimetic; insulin further stimulates Glut4 translocation in these cells. Insulin regulates translocation as follows: 1) by releasing Glut4 from retention in a slowly cycling/noncycling storage pool, increasing the actively cycling Glut4 pool, and 2) by increasing the intrinsic rate constant for exocytosis of the actively cycling pool (k(ex)). Kinetic studies were performed in 3T3-L1 adipocytes to measure the effects of AS160 knockdown on the rate constants of exocytosis (k(ex)), endocytosis (k(en)), and release from retention into the cycling pool. AS160 knockdown released Glut4 into the actively cycling pool without affecting k(ex) or k(en). Insulin increased k(ex) in the knockdown cells, further increasing cell surface Glut4. Inhibition of phosphatidylinositol 3-kinase or Akt affected both k(ex) and release from retention in control cells but only k(ex) in AS160 knockdown cells. Glut4 vesicles accumulate in a primed pre-fusion pool in basal AS160 knockdown cells. Akt regulates the rate of exocytosis of the primed vesicles through an AS160-independent mechanism. Therefore, there is an additional Akt substrate that regulates the fusion of Glut4 vesicles that remain to be identified. Mathematical modeling was used to test the hypothesis that this substrate regulates vesicle priming (release from retention), whereas AS160 regulates the reverse step by stimulating GTP turnover of a Rab protein required for vesicle tethering/docking/fusion. Our analysis indicates that fusion of the primed vesicles with the plasma membrane is an additional non-Akt-dependent insulin-regulated step.	[Brewer, Paul Duffield; Romenskaia, Irina; Kanow, Mark A.; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health [DK56197]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56197. This work was also supported by grants from the American Diabetes Association.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2007, J CELL SCI, V120, P1168, DOI 10.1242/jcs.03413; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; YANG J, 1993, J BIOL CHEM, V268, P4600; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333; Zhou LX, 1999, MOL ENDOCRINOL, V13, P505, DOI 10.1210/me.13.3.505	43	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26287	26297		10.1074/jbc.M111.253880	http://dx.doi.org/10.1074/jbc.M111.253880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613213	hybrid, Green Published			2022-12-25	WOS:000293078200005
J	Haldar, S; Bevers, LE; Tosha, T; Theil, EC				Haldar, Suranjana; Bevers, Loes E.; Tosha, Takehiko; Theil, Elizabeth C.			Moving Iron through Ferritin Protein Nanocages Depends on Residues throughout Each Four alpha-Helix Bundle Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CHAIN FERRITIN; CORE FORMATION; HYDROGEN-PEROXIDE; FERROXIDASE REACTION; ANGSTROM RESOLUTION; DNA-BINDING; MINERALIZATION; SITE; INTERMEDIATE; MECHANISM	Eukaryotic Hferritins move iron through protein cages to form biologically required, iron mineral concentrates. The biominerals are synthesized during protein-based Fe2+/O-2 oxidoreduction and formation of [Fe3+O](n) multimers within the protein cage, en route to the cavity, at sites distributed over similar to 50 angstrom. Recent NMR and Co2+-protein x-ray diffraction (XRD) studies identified the entire iron path andnewmetal-protein interactions: (i) lines of metal ions in 8 Fe2+ ion entry channels with three-way metal distribution points at channel exits and (ii) interior Fe3+O nucleation channels. To obtain functional information on the newly identified metal-protein interactions, weanalyzed effects of amino acid substitution on formation of the earliest catalytic intermediate (diferric peroxo-A(650 nm)) and on mineral growth (Fe3+O-A(350) (nm)), in A26S, V42G, D127A, E130A, and T149C. The results show that all of the residues influenced catalysis significantly (p < 0.01), with effects on four functions: (i) Fe2+ access/selectivity to the active sites (Glu(130)), (ii) distribution of Fe2+ to each of the three active sites near each ion channel (Asp(127)), (iii) product (diferric oxo) release into the Fe3+O nucleation channels (Ala(26)), and (iv) [Fe3+O](n) transit through subunits (Val(42), Thr(149)). Synthesis of ferritin biominerals depends on residues along the entire length of H subunits from Fe2+ substrate entry at 3-fold cage axes at one subunit end through active sites and nucleation channels, at the other subunit end, inside the cage at 4-fold cage axes. Ferritin subunit-subunit geometry contributes to mineral order and explains the physiological impact of ferritin H and L subunits.	[Haldar, Suranjana; Bevers, Loes E.; Tosha, Takehiko; Theil, Elizabeth C.] CHORI, Oakland, CA 94609 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Mol Toxicol, Berkeley, CA 94720 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Theil, EC (corresponding author), CHORI, 5700 Martin Luther King, Oakland, CA 94609 USA.	etheil@CHORI.org	Tosha, Takehiko/AAR-2404-2020	Tosha, Takehiko/0000-0002-8971-0759	National Institutes of Health [DK-20251]; Netherlands Organization for Scientific Research; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-20251 (to L. E. B., S. H., T. T., and E. C. T.). This work was also supported by grants from The Netherlands Organization for Scientific Research (to L. E. B.) and the Japan Society for the Promotion of Science (to T. T.).	BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiancone E, 2010, FRONT BIOSCI, V15, P122, DOI 10.2741/3610; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Fetter J, 1997, J BIOL INORG CHEM, V2, P652, DOI 10.1007/s007750050180; Gallois B, 1997, J BIOL INORG CHEM, V2, P360, DOI 10.1007/s007750050143; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Jameson GNL, 2002, BIOCHEMISTRY-US, V41, P13435, DOI 10.1021/bi026478s; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MERTZ JR, 1983, J BIOL CHEM, V258, P1719; Moenne-Loccoz P, 1999, BIOCHEMISTRY-US, V38, P5290, DOI 10.1021/bi990095l; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; ROHRER JS, 1987, J BIOL CHEM, V262, P13385; ROHRER JS, 1989, INORG CHEM, V28, P3393, DOI 10.1021/ic00316a031; Schwartz JK, 2008, J AM CHEM SOC, V130, P9441, DOI 10.1021/ja801251q; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; STPIERRE TG, 1991, BIOL MET, V4, P162, DOI 10.1007/BF01141308; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tosha T, 2008, P NATL ACAD SCI USA, V105, P18182, DOI 10.1073/pnas.0805083105; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	44	45	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25620	25627		10.1074/jbc.M110.205278	http://dx.doi.org/10.1074/jbc.M110.205278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592958	hybrid, Green Published			2022-12-25	WOS:000293073000024
J	Ishijima, N; Suzuki, M; Ashida, H; Ichikawa, Y; Kanegae, Y; Saito, I; Boren, T; Haas, R; Sasakawa, C; Mimuro, H				Ishijima, Nozomi; Suzuki, Masato; Ashida, Hiroshi; Ichikawa, Yusuke; Kanegae, Yumi; Saito, Izumu; Boren, Thomas; Haas, Rainer; Sasakawa, Chihiro; Mimuro, Hitomi			BabA-mediated Adherence Is a Potentiator of the Helicobacter pylori Type IV Secretion System Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-BINDING ADHESIN; OUTER-MEMBRANE PROTEINS; CAG PATHOGENICITY ISLAND; GASTRIC EPITHELIAL-CELLS; BLOOD-GROUP ANTIGENS; MONGOLIAN GERBILS; INTESTINAL METAPLASIA; INFECTION; EXPRESSION; STOMACH	Chronic infection of Helicobacter pylori in the stomach mucosa with translocation of the bacterial cytotoxin-associated gene A (CagA) effector protein via the cag-Type IV secretion system (TFSS) into host epithelial cells are major risk factors for gastritis, gastric ulcers, and cancer. The blood group antigen-binding adhesin BabA mediates the adherence of H. pylori to ABO/Lewis b (Le(b)) blood group antigens in the gastric pit region of the human stomach mucosa. Here, we show both in vitro and in vivo that BabA-mediated binding of H. pylori to Le(b) on the epithelial surface augments TFSS-dependent H. pylori pathogenicity by triggering the production of proinflammatory cytokines and precancer-related factors. We successfully generated Le(b)-positive cell lineages by transfecting Le(b)-negative cells with several glycosyltransferase genes. Using these established cell lines, we found increased mRNA levels of proinflammatory cytokines (CCL5 and IL-8) as well as precancer-related factors (CDX2 and MUC2) after the infection of Le(b)-positive cells with WTH. pylori but not with babA or TFSS deletion mutants. This increased mRNA expression was abrogated when Le(b)-negative cells were infected with WT H. pylori. Thus, H. pylori can exploit BabA-Le(b) binding to trigger TFSS-dependent host cell signaling to induce the transcription of genes that enhance inflammation, development of intestinal metaplasia, and associated precancerous transformations.	[Ishijima, Nozomi; Suzuki, Masato; Ashida, Hiroshi; Ichikawa, Yusuke; Sasakawa, Chihiro; Mimuro, Hitomi] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kanegae, Yumi; Saito, Izumu] Univ Tokyo, Minato Ku, Mol Genet Lab, Inst Med Sci, Tokyo 1088639, Japan; [Boren, Thomas] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Haas, Rainer] Univ Munich, Dept Bakteriol, Max von Pettenkofer Inst Hyg & Med Mikrobiol, D-80336 Munich, Germany	University of Tokyo; University of Tokyo; University of Tokyo; Umea University; University of Munich	Mimuro, H (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mim@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013	Suzuki, Masato/0000-0001-8975-2193; Ashida, Hiroshi/0000-0003-1408-6864	Founding Research Centers for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Naito Foundation;  [23390102];  [20229006];  [23659220];  [18073003];  [23790472]	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; ; ; ; 	This work was supported by Grant-in-aid for Scientific Research (B) 23390102 (to H. M.), (S) 20229006 (to C. S.), Grant-in-aid for Challenging Exploratory Research 23659220 (to H. M.), Grant-in-aid for Scientific Research on Priority Areas 18073003 (to C. S.), Grant-in-aid for Young Scientists (B) 23790472 (to H. A.), and the Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (to C. S.), from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. This work was also supported in part by grants from the Naito Foundation (to H. M.).	Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Bai YQ, 2002, CANCER LETT, V176, P47, DOI 10.1016/S0304-3835(01)00753-4; BAKER BW, 1992, NUCLEIC ACIDS RES, V20, P5234, DOI 10.1093/nar/20.19.5234; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; CRABTREE JE, 1993, SCAND J IMMUNOL, V37, P65, DOI 10.1111/j.1365-3083.1993.tb01666.x; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Dossumbekova A, 2006, J INFECT DIS, V194, P1346, DOI 10.1086/508426; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Hirayama F, 1996, J GASTROENTEROL, V31, P755, DOI 10.1007/BF02347631; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Isomoto H, 2000, AM J GASTROENTEROL, V95, P2768, DOI 10.1016/S0002-9270(00)01096-0; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Kikuchi T, 2000, J PATHOL, V192, P243, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH688>3.0.CO;2-D; Kodama K, 2002, HELICOBACTER, V7, P9, DOI 10.1046/j.1523-5378.2002.00050.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mimuro H, 2008, BIOESSAYS, V30, P515, DOI 10.1002/bies.20768; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P257, DOI 10.1078/1438-4221-00205; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Osawa H, 2001, DIGEST DIS SCI, V46, P69, DOI 10.1023/A:1005657708342; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pride DT, 2001, INFECT IMMUN, V69, P1160, DOI 10.1128/IAI.69.2.1160-1171.2001; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Shimoyama T, 1998, J CLIN PATHOL, V51, P765, DOI 10.1136/jcp.51.10.765; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Sugiyama A, 1998, CANCER RES, V58, P2067; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 2008, WORLD J GASTROENTERO, V14, P4265, DOI 10.3748/wjg.14.4265; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	52	120	123	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25256	25264		10.1074/jbc.M111.233601	http://dx.doi.org/10.1074/jbc.M111.233601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596743	hybrid, Green Published			2022-12-25	WOS:000292547900071
J	Lorent, N; Sebatunzi, O; Mukeshimana, G; Van den Ende, J; Clerinx, J				Lorent, Natalie; Sebatunzi, Osee; Mukeshimana, Gloria; Van den Ende, Jef; Clerinx, Joannes			Incidence and Risk Factors of Serious Adverse Events during Antituberculous Treatment in Rwanda: A Prospective Cohort Study	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; DRUG-INDUCED HEPATOTOXICITY; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; TUBERCULOSIS PATIENTS; CLINICAL DETERIORATION; PULMONARY TUBERCULOSIS; DISEASE; AFRICA; COUNTRIES	Background: Tuberculosis (TB) and TB-human immunodeficiency virus infection (HIV) coinfection is a major public health concern in resource-limited settings. Although TB treatment is challenging in HIV-infected patients because of treatment interactions, immunopathological reactions, and concurrent infections, few prospective studies have addressed this in sub-Saharan Africa. In this study we aimed to determine incidence, causes of, and risk factors for serious adverse events among patients on first-line antituberculous treatment, as well as its impact on antituberculous treatment outcome. Methods and findings: Prospective observational cohort study of adults treated for TB at the Internal Medicine department of the Kigali University Hospital from May 2008 through August 2009. Of 263 patients enrolled, 253 were retained for analysis: median age 35 (Interquartile range, IQR 28-40), 55% male, 66% HIV-positive with a median CD4 count 104 cells/mm(3) (IQR 44-248 cells/mm(3)). Forty percent had pulmonary TB, 43% extrapulmonary TB and 17% a mixed form. Sixty-four (26%) developed a serious adverse event; 58/167 (35%) HIV-infected vs. 6/86 (7%) HIV-uninfected individuals. Commonest events were concurrent infection (n = 32), drug-induced hepatitis (n = 24) and paradoxical reactions/TB-IRIS (n = 23). HIV-infection (adjusted Hazard Ratio, aHR 3.4, 95% Confidence Interval, CI 1.4-8.7) and extrapulmonary TB (aHR 2, 95% CI 1.1-3.7) were associated with an increased risk of serious adverse events. For TB/HIV co-infected patients, extrapulmonary TB (aHR 2.0, 95% CI 1.1-3.9) and CD4 count <100 cells/mm(3) at TB diagnosis (aHR 1.7, 95% CI 1.0-2.9) were independent predictors. Adverse events were associated with an almost two-fold higher risk of unsuccessful treatment outcome at 6 months (HR 1.89, 95% CI 1.3-3.0). Conclusion: Adverse events frequently complicate the course of antituberculous treatment and worsen treatment outcome, particularly in patients with extrapulmonary TB and advanced immunodeficiency. Concurrent infection accounts for most events. Our data suggest that deterioration in a patient already receiving antituberculous treatment should prompt an aggressive search for additional infections.	[Lorent, Natalie; Sebatunzi, Osee; Mukeshimana, Gloria] Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda; [Lorent, Natalie; Van den Ende, Jef; Clerinx, Joannes] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Lorent, N (corresponding author), Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda.	nlorent@itg.be	Clerinx, Joannes/GLT-1172-2022		Tibotec's REACH Initiative; Belgian Technical Cooperation in Rwanda; Flemisch Research Foundation (FWO), Belgium	Tibotec's REACH Initiative; Belgian Technical Cooperation in Rwanda; Flemisch Research Foundation (FWO), Belgium(FWO)	The study was funded by Tibotec's REACH Initiative grant. NL was supported by the Belgian Technical Cooperation in Rwanda. She received a grant from the Flemisch Research Foundation (FWO), Belgium, in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CHEST; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Colebunders R, 2006, INT J TUBERC LUNG D, V10, P946; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Fernandez-Villar A, 2004, INT J TUBERC LUNG D, V8, P1499; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kumarasamy N, 2004, JAIDS-J ACQ IMM DEF, V37, P1574, DOI 10.1097/00126334-200412150-00007; Lanternier F, 2007, INT J TUBERC LUNG D, V11, P1203; Lawn SD, 2007, AIDS, V21, P2362, DOI 10.1097/QAD.0b013e3282f1be39; Lawn SD, 2007, CURR OPIN HIV AIDS, V2, P339, DOI 10.1097/COH.0b013e3281a3c0a6; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; LORENT N, 2009, INT J TUBERC LUNG D, V13, pS199; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Tost JR, 2005, INT J TUBERC LUNG D, V9, P534; Tostmann A, 2007, TROP MED INT HEALTH, V12, P852, DOI 10.1111/j.1365-3156.2007.01871.x; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; WHO, 2009, WHOHTMTB2009411; World Health Organization, 2008, WHOHTMTB2008401; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	38	33	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19566	10.1371/journal.pone.0019566	http://dx.doi.org/10.1371/journal.pone.0019566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611117	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200016
J	Gruss, A; Kaplan, DM; Hart, DR				Gruess, Arnaud; Kaplan, David M.; Hart, Deborah R.			Relative Impacts of Adult Movement, Larval Dispersal and Harvester Movement on the Effectiveness of Reserve Networks	PLOS ONE			English	Article							MARINE PROTECTED AREAS; FISHERIES MANAGEMENT; HOME-RANGE; SCIENCE; CONNECTIVITY; MODEL; OCEAN; SUSTAINABILITY; POPULATIONS; PERSISTENCE	Movement of individuals is a critical factor determining the effectiveness of reserve networks. Marine reserves have historically been used for the management of species that are sedentary as adults, and, therefore, larval dispersal has been a major focus of marine-reserve research. The push to use marine reserves for managing pelagic and demersal species poses significant questions regarding their utility for highly-mobile species. Here, a simple conceptual metapopulation model is developed to provide a rigorous comparison of the functioning of reserve networks for populations with different admixtures of larval dispersal and adult movement in a home range. We find that adult movement produces significantly lower persistence than larval dispersal, all other factors being equal. Furthermore, redistribution of harvest effort previously in reserves to remaining fished areas ('fishery squeeze') and fishing along reserve borders ('fishing-the-line') considerably reduce persistence and harvests for populations mobile as adults, while they only marginally changes results for populations with dispersing larvae. Our results also indicate that adult home-range movement and larval dispersal are not simply additive processes, but rather that populations possessing both modes of movement have lower persistence than equivalent populations having the same amount of 'total movement' (sum of larval and adult movement spatial scales) in either larval dispersal or adult movement alone.	[Gruess, Arnaud; Kaplan, David M.] Univ Montpellier 2, IRD, IFREMER, Ctr Rech Halieut Mediterraneenne & Trop,UMR EME 2, Sete, France; [Hart, Deborah R.] NE Fisheries Sci Ctr, Woods Hole, MA USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Oceanic Atmospheric Admin (NOAA) - USA	Gruss, A (corresponding author), Univ Montpellier 2, IRD, IFREMER, Ctr Rech Halieut Mediterraneenne & Trop,UMR EME 2, Sete, France.	arnaud.gruss@ird.fr	Kaplan, David/G-5230-2010; Hart, Deborah/E-6917-2016	Kaplan, David/0000-0001-6087-359X; Hart, Deborah/0000-0002-0406-0751	French National Research Agency (ANR) [ANR-08-STRA-03]	French National Research Agency (ANR)(French National Research Agency (ANR))	AG and DMK were supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Program, grant number ANR-08-STRA-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, S AFR SHIPP NEWS FIS; Attwood CG, 1995, S AFR J MARINE SCI, V16, P227; Barrowman NJ, 2000, CAN J FISH AQUAT SCI, V57, P665, DOI 10.1139/cjfas-57-4-665; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Carr MH, 2003, ECOL APPL, V13, pS90; CAVERIVIERE A, 1976, CAH ORSTOM OCEANOGR, V14, P201; Cayre P., 1986, P ICCAT INT SKIPJACK, P252; Cayre P, 1986, P ICCAT C INT SKIPJA, V1, P335; Dawson MN, 2006, SCIENCE, V313, P43; FONTENEAU A, 2005, IOTC2005WPTT21; FONTENEAU A, 1996, 84123 FAO; FONTENEAU A, 1999, COL VOL SCI PAP ICCA, V49, P446; FROESE R, 2006, FISHBASE VERSION; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gascuel D, 1992, AQUAT LIVING RESOUR, V5, P155, DOI 10.1051/alr:1992016; Gerber LR, 2005, CAN J FISH AQUAT SCI, V62, P863, DOI 10.1139/F05-046; Grantham BA, 2003, ECOL APPL, V13, pS108; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; GUNDERSON DR, 1977, FISH B-NOAA, V75, P369; Gurd DB, 2001, CONSERV BIOL, V15, P1355, DOI 10.1046/j.1523-1739.2001.00188.x; Hallier J.-P., 2006, COL VOL SC PAP ICCAT, V59, P411; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Hart DR, 2006, CAN J FISH AQUAT SCI, V63, P1445, DOI 10.1139/F06-071; Harvey CJ, 2006, ECOL APPL, V16, P1502, DOI 10.1890/1051-0761(2006)016[1502:CIBSAA]2.0.CO;2; Hastings A, 2003, ECOL APPL, V13, pS65; Holland D. S., 1996, MAR RESOUR ECON, V11, P157, DOI DOI 10.1086/MRE.11.3.42629158; *ICCAT, 2008, ICCAT MANUAL; Jensen OP, 2010, PROG OCEANOGR, V86, P176, DOI 10.1016/j.pocean.2010.04.020; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Kaplan DM, 2006, ECOL APPL, V16, P2248, DOI 10.1890/1051-0761(2006)016[2248:DPRAEM]2.0.CO;2; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Lubchenco J, 2003, ECOL APPL, V13, pS3; Maury O, 2001, AQUAT LIVING RESOUR, V14, P203, DOI 10.1016/S0990-7440(01)01115-9; Methot RD, 2005, STATUS US CANARY ROC; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Murawski SA, 2000, B MAR SCI, V66, P775; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Nelson J, 2010, MAR POLLUT BULL, V60, P635, DOI 10.1016/j.marpolbul.2010.04.009; Neubert MG, 2003, ECOL LETT, V6, P843, DOI 10.1046/j.1461-0248.2003.00493.x; Norse Elliott A., 2005, P302; O'Farrell MR, 2006, ECOL APPL, V16, P977, DOI 10.1890/1051-0761(2006)016[0977:ETSONR]2.0.CO;2; Pala C, 2009, SCIENCE, V324, P1133, DOI 10.1126/science.324_1133; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pelletier D, 2005, FISH FISH, V6, P307, DOI 10.1111/j.1467-2979.2005.00199.x; PHILLIPS JB, 1964, CALIFORNIA DEP FISH, V127; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; ROBERTS C, 2007, P NATL ACAD SCI USA, V103, P6067; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Shanks AL, 2003, ECOL APPL, V13, pS159; Sibert J, 2003, MAR POLICY, V27, P87, DOI 10.1016/S0308-597X(02)00057-X; Smith MD, 2003, J ENVIRON ECON MANAG, V46, P183, DOI 10.1016/S0095-0696(03)00024-X; Starr R.M., 2007, SPECIES COMPOSITION; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; Stokstad E, 2010, SCIENCE, V327, P1574, DOI 10.1126/science.327.5973.1574; VanKirk RW, 1997, B MATH BIOL, V59, P107, DOI 10.1016/S0092-8240(96)00060-2; Walters CJ, 2007, CAN J FISH AQUAT SCI, V64, P1009, DOI 10.1139/F07-072; White JW, 2010, ECOL APPL, V20, P1523, DOI 10.1890/09-0962.1; Zudaire I, 2010, IOTC 2010	68	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19960	10.1371/journal.pone.0019960	http://dx.doi.org/10.1371/journal.pone.0019960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611148	gold, Green Submitted, Green Published			2022-12-25	WOS:000290657500037
J	Pietropaolo, S; Delage, P; Cayzac, S; Crusio, WE; Cho, YH				Pietropaolo, Susanna; Delage, Pauline; Cayzac, Sebastien; Crusio, Wim E.; Cho, Yoon H.			Sex-Dependent Changes in Social Behaviors in Motor Pre-Symptomatic R6/1 Mice	PLOS ONE			English	Article							DISEASE TRANSGENIC MICE; ACOUSTIC STARTLE REFLEX; PRECLINICAL HUNTINGTONS-DISEASE; ULTRASONIC VOCALIZATIONS; PREPULSE INHIBITION; MOUSE MODEL; MUS-MUSCULUS; FEMALE MICE; PSYCHIATRIC-SYMPTOMS; SYNAPTIC PLASTICITY	Background: The R6/1 mouse line is one of the most widely employed models of Huntington Disease (HD), a complex syndrome characterized by motor and non-motor deficits. Surprisingly, its behavioral phenotype during the early phases of the pathology when the motor impairments are not manifest yet has been poorly investigated. It is also not clear whether the expression of HD-like symptoms at the pre-motor stage in this mouse model differs between the two sexes. Methods: Male and female 12 weeks-old R6/1 mice and their wild-type littermates were tested on a battery of tests modeling some of the major neuropsychiatric non-motor symptoms of HD: alterations in social interest, social interaction and communication, as well as disturbances in prepulse inhibition of the acoustic startle response (PPI) and circadian patterns of activity. The lack of motor symptoms was confirmed during the entire experimental period by means of the tail test for clasping. Results: R6/1 mice displayed marked alterations in all social behaviors which were mainly observed in males. Male R6/1 animals were also the only ones showing reduced body weight. Both male and female transgenic mice displayed mild alterations in the circadian activity patterns, but no deficits in PPI. Conclusions: These results demonstrate the validity of the R6/1 mouse in mimicking selected neuropsychiatric symptoms of HD, the social deficits being the clearest markers of the pre-motor phase of the pathology. Furthermore, our data suggest that male R6/1 mice are more suitable for future studies on the early stages of HD.	[Pietropaolo, Susanna] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France; CNRS, UMR 5287, Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pietropaolo, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France.	y.cho@cnic.u-bordeaux1.fr	Crusio, Wim/A-7070-2008; Crusio, Wim/ABE-1287-2021; Crusio, Wim/ABD-5214-2021	Crusio, Wim/0000-0001-6638-202X; Crusio, Wim/0000-0001-6638-202X; pietropaolo, susanna/0000-0002-8993-1922	March of Dimes [12-FY05-1198]; Conseil Regional d'Aquitaine; CNRS; University of Bordeaux; Hereditary Disease Foundation	March of Dimes(March of Dimes); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Hereditary Disease Foundation	This work was supported by grants from the March of Dimes (12-FY05-1198), Conseil Regional d'Aquitaine, CNRS, and the University of Bordeaux 1 to W. E. Crusio, and from The Hereditary Disease Foundation and the University of Bordeaux 1 to Y. H. Cho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Barquero-Jimenez S, 2001, REV NEUROLOGIA, V32, P1067, DOI 10.33588/rn.3211.2000158; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bolivar VJ, 2004, BRAIN RES, V1005, P29, DOI 10.1016/j.brainres.2004.01.021; CHAMPLIN AK, 1971, J REPROD FERTIL, V27, P233, DOI 10.1530/jrf.0.0270233; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Csomor PA, 2005, BEHAV BRAIN RES, V162, P256, DOI 10.1016/j.bbr.2005.03.020; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; DAmato FR, 1996, NEUROBIOL LEARN MEM, V65, P9, DOI 10.1006/nlme.1996.0002; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dowie MJ, 2009, NEUROSCIENCE, V163, P456, DOI 10.1016/j.neuroscience.2009.06.014; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fattore L, 2010, EXP NEUROL, V224, P23, DOI 10.1016/j.expneurol.2010.03.020; FOLSTEIN SE, 1983, PSYCHIAT DEV, V1, P193; Giralt A, 2009, NEUROSCIENCE, V158, P1234, DOI 10.1016/j.neuroscience.2008.11.024; Graham KL, 2011, AM J PRIMATOL; HANSOTIA P, 1985, NEUROLOGY, V35, P1672, DOI 10.1212/WNL.35.11.1672; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kloppel S, 2010, NEUROPSYCHOLOGIA, V48, P549, DOI 10.1016/j.neuropsychologia.2009.10.016; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAGGIO JC, 1983, PHYSIOL BEHAV, V31, P269, DOI 10.1016/0031-9384(83)90186-5; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006456.pub2; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; MIRANDA RC, 1994, HORM BEHAV, V28, P367, DOI 10.1006/hbeh.1994.1033; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1983, BEHAV NEURAL BIOL, V38, P32, DOI 10.1016/S0163-1047(83)90354-0; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paradiso S, 2008, PSYCHIAT RES-NEUROIM, V162, P73, DOI 10.1016/j.pscychresns.2007.04.001; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pietropaolo S, 2009, BEHAV GENET; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P505, DOI 10.1037/0735-7044.122.3.505; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Puca F M, 1984, Boll Soc Ital Biol Sper, V60, P989; Rebec GV, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0006.2002; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Snowden JS, 2002, J CLIN EXP NEUROPSYC, V24, P133, DOI 10.1076/jcen.24.2.133.998; SOHRABJI F, 1994, J NEUROSCI, V14, P459; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; WeigellWeber M, 1996, AM J MED GENET, V67, P53, DOI 10.1002/(SICI)1096-8628(19960216)67:1<53::AID-AJMG9>3.0.CO;2-T; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P240, DOI 10.1038/sj.npp.1300323	80	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19965	10.1371/journal.pone.0019965	http://dx.doi.org/10.1371/journal.pone.0019965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603578	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300045
J	Sinauridze, EI; Romanov, AN; Gribkova, IV; Kondakova, OA; Surov, SS; Gorbatenko, AS; Butylin, AA; Monakov, MY; Bogolyubov, AA; Kuznetsov, YV; Sulimov, VB; Ataullakhanov, FI				Sinauridze, Elena I.; Romanov, Alexey N.; Gribkova, Irina V.; Kondakova, Olga A.; Surov, Stepan S.; Gorbatenko, Aleksander S.; Butylin, Andrey A.; Monakov, Mikhail Yu; Bogolyubov, Alexey A.; Kuznetsov, Yuryi V.; Sulimov, Vladimir B.; Ataullakhanov, Fazoyl I.			New Synthetic Thrombin Inhibitors: Molecular Design and Experimental Verification	PLOS ONE			English	Article							DRUG DESIGN; OXYGUANIDINES; HEMODILUTION; COAGULATION; ETEXILATE; PROTEASES; SALINE; MODEL	Background: The development of new anticoagulants is an important goal for the improvement of thromboses treatments. Objectives: The design, synthesis and experimental testing of new safe and effective small molecule direct thrombin inhibitors for intravenous administration. Methods: Computer-aided molecular design of new thrombin inhibitors was performed using our original docking program SOL, which is based on the genetic algorithm of global energy minimization in the framework of a Merck Molecular Force Field. This program takes into account the effects of solvent. The designed molecules with the best scoring functions (calculated binding energies) were synthesized and their thrombin inhibitory activity evaluated experimentally in vitro using a chromogenic substrate in a buffer system and using a thrombin generation test in isolated plasma and in vivo using the newly developed model of hemodilution-induced hypercoagulation in rats. The acute toxicities of the most promising new thrombin inhibitors were evaluated in mice, and their stabilities in aqueous solutions were measured. Results: New compounds that are both effective direct thrombin inhibitors (the best K-1 was <1 nM) and strong anticoagulants in plasma (an IC50 in the thrombin generation assay of approximately 100 nM) were discovered. These compounds contain one of the following new residues as the basic fragment: isothiuronium, 4-aminopyridinium, or 2-aminothiazolinium. LD50 values for the best new inhibitors ranged from 166.7 to >1111.1 mg/kg. A plasma-substituting solution supplemented with one of the new inhibitors prevented hypercoagulation in the rat model of hemodilution-induced hypercoagulation. Activities of the best new inhibitors in physiological saline (1 mu M solutions) were stable after sterilization by autoclaving, and the inhibitors remained stable at long-term storage over more than 1.5 years at room temperature and at 4 degrees C. Conclusions: The high efficacy, stability and low acute toxicity reveal that the inhibitors that were developed may be promising for potential medical applications.	[Sinauridze, Elena I.; Gribkova, Irina V.; Gorbatenko, Aleksander S.; Butylin, Andrey A.; Monakov, Mikhail Yu; Ataullakhanov, Fazoyl I.] Russian Acad Med Sci, Lab Phys Biochem, Natl Res Ctr Hematol, Moscow, Russia; [Romanov, Alexey N.; Kondakova, Olga A.; Sulimov, Vladimir B.] Moscow MV Lomonosov State Univ, Ctr Res Comp, Moscow, Russia; [Sinauridze, Elena I.; Gribkova, Irina V.; Surov, Stepan S.; Ataullakhanov, Fazoyl I.] Russian Acad Sci, Lab Biophys & Physiol Cell, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Butylin, Andrey A.; Ataullakhanov, Fazoyl I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Bogolyubov, Alexey A.; Kuznetsov, Yuryi V.] Russian Acad Sci, Inst Organ Chem, Moscow V71, Russia; [Sulimov, Vladimir B.] Dimonta Ltd, Moscow, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences	Sinauridze, EI (corresponding author), Russian Acad Med Sci, Lab Phys Biochem, Natl Res Ctr Hematol, Moscow, Russia.	sinaurid@list.ru	Ataullakhanov, Fazoil/J-8076-2012; Sinauridze, Elena Ivanovna/E-4058-2014; Kondakova, Olga/H-7930-2017; Sulimov, Vladimir/AAD-6890-2019; Kuznetsov, Yury/AAC-1880-2019; Romanov, Alexey/J-8253-2018	Sinauridze, Elena Ivanovna/0000-0002-5948-3444; Kuznetsov, Yury/0000-0001-6308-4916; Romanov, Alexey/0000-0002-4534-0493	Russian Foundation for Basic Researches [08-04-12060, 09-04-00357-a]; Federal Agency for Science and Innovation (Rosnauka) [02.514.11.4084]	Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Federal Agency for Science and Innovation (Rosnauka)(Federal Agency for Science & Innovations (FASI))	This work was supported in part by grants 08-04-12060 (oriented basic research) and 09-04-00357-a of the Russian Foundation for Basic Researches (http://www.rfbr.ru), and by contract number 02.514.11.4084 of August 08, 2008 from the Federal Agency for Science and Innovation (Rosnauka). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As V. B. Sulimov was employed by Dimonta, Dimonta had a role in analyzing the data and designed the software used in analysis.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; FILAMOFITSKY MP, 2004, NUMERICAL METHODS PR, V5, P1; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; GRIGORIEV FV, 2006, NUMERICAL METHODS PR, V7, P128; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Illig C, 1998, MED CHEM RES, V8, P244; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Lau A, 2007, THROMB RES, V119, P667, DOI 10.1016/j.thromres.2006.05.008; LOTTENBERG R, 1982, THROMB RES, V28, P313, DOI 10.1016/0049-3848(82)90114-1; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; Lu TB, 2004, BIOORG MED CHEM LETT, V14, P3727, DOI 10.1016/j.bmcl.2004.05.002; Lu TB, 1998, BIOORG MED CHEM LETT, V8, P1595, DOI 10.1016/S0960-894X(98)00290-X; MANO T, 2001, Patent No. 0565897; MATSUO T, 2007, ARGATROBAN ANTITHROM; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; *NAT CANC I, OP REP COLL DIV SET; Ng KFJ, 2002, BRIT J ANAESTH, V88, P475, DOI 10.1093/bja/88.4.475; [Романов А.Н. Romanov A.N.], 2008, [Вычислительные методы и программирование: новые вычислительные технологии, Vychislitel'nye metody i programmirovanie: novye vychislitel'nye tekhnologii], V9, P213; Romanov AN, 2004, J PHYS CHEM A, V108, P9323, DOI 10.1021/jp046721s; Ruttmann TG, 1998, BRIT J ANAESTH, V80, P612, DOI 10.1093/bja/80.5.612; SCHWARZ RP, 1997, ANTICOAGULANTS CARDI, P231; [Синауридзе Елена Ивановна Sinauridze B.I.], 2008, [Технологии живых систем, Technologies of Living Systems, Tekhnologii zhivykh sistem], V5, P3; SINAURIDZE EI, 2005, Patent No. 2005140841; SINAURIDZE EI, 2008, NEW COMPOUNDS ANTITH; SOBOLEV SI, 2008, NUMER METH PART D E, P249; Soll RM, 2000, BIOORG MED CHEM LETT, V10, P1, DOI 10.1016/S0960-894X(99)00632-0; Sorbera LA, 2005, DRUG FUTURE, V30, P877, DOI 10.1358/dof.2005.030.09.938760; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Tomczuk B, 2003, BIOORG MED CHEM LETT, V13, P1495, DOI 10.1016/S0960-894X(03)00125-2; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; ZHABIN SN, 2006, REGISTRATION PROGRAM; GUIDE CARE USE LAB A, P21	37	38	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19969	10.1371/journal.pone.0019969	http://dx.doi.org/10.1371/journal.pone.0019969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603576	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300046
J	Czupryna, J; Tsourkas, A				Czupryna, Julie; Tsourkas, Andrew			Firefly Luciferase and Rluc8 Exhibit Differential Sensitivity to Oxidative Stress in Apoptotic Cells	PLOS ONE			English	Article							CASPASE-INDEPENDENT MECHANISM; HYDROGEN-PEROXIDE; PROTEASOME INHIBITOR; LEUKEMIA-CELLS; CANCER CELLS; AMINO-ACIDS; PROTEIN; DEATH; DEGRADATION; ACTIVATION	Over the past decade, firefly Luciferase (fLuc) has been used in a wide range of biological assays, providing insight into gene regulation, protein-protein interactions, cell proliferation, and cell migration. However, it has also been well established that fLuc activity can be highly sensitive to its surrounding environment. In this study, we found that when various cancer cell lines (HeLa, MCF-7, and 293T) stably expressing fLuc were treated with staurosporine (STS), there was a rapid loss in bioluminescence. In contrast, a stable variant of Renilla luciferase (RLuc), RLuc8, exhibited significantly prolonged functionality under the same conditions. To identify the specific underlying mechanism(s) responsible for the disparate sensitivity of RLuc8 and fLuc to cellular stress, we conducted a series of inhibition studies that targeted known intracellular protein degradation/modification pathways associated with cell death. Interestingly, these studies suggested that reactive oxygen species, particularly hydrogen peroxide (H(2)O(2)), was responsible for the diminution of fLuc activity. Consistent with these findings, the direct application of H(2)O(2) to HeLa cells also led to a reduction in fLuc bioluminescence, while H(2)O(2) scavengers stabilized fLuc activity. Comparatively, RLuc8 was far less sensitive to ROS. These observations suggest that fLuc activity can be substantially altered in studies where ROS levels become elevated and can potentially lead to ambiguous or misleading findings.	[Czupryna, Julie; Tsourkas, Andrew] Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Czupryna, J (corresponding author), Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/A-1074-2007; Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753	American Cancer Society [RSG-07-005-01]; National Science Foundation [0953583]	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the American Cancer Society (RSG-07-005-01) and the National Science Foundation CAREER Award (0953583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; ALTER SC, 1986, BIOCHEMISTRY-US, V25, P1599, DOI 10.1021/bi00355a022; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Branchini BR, 1997, J BIOL CHEM, V272, P19359, DOI 10.1074/jbc.272.31.19359; Branchini BR, 1997, ARCH BIOCHEM BIOPHYS, V340, P52, DOI 10.1006/abbi.1997.9894; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DELIC J, 1993, MOL CELL BIOL, V13, P4875, DOI 10.1128/MCB.13.8.4875; FRANKE JC, BIOCH PHARM, V79, P575; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Han YH, 2008, CHEM-BIOL INTERACT, V171, P67, DOI 10.1016/j.cbi.2007.08.011; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; JARVIS WD, 1994, CANCER RES, V54, P1707; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kocha T, 1997, BBA-PROTEIN STRUCT M, V1337, P319, DOI 10.1016/S0167-4838(96)00180-X; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Los M, 1997, BLOOD, V90, P3118, DOI 10.1182/blood.V90.8.3118; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Martinet W, 2004, EUR J CLIN INVEST, V34, P323, DOI 10.1111/j.1365-2362.2004.01343.x; Martinez-Lorenzo MJ, 1998, INT J CANCER, V75, P473, DOI 10.1002/(SICI)1097-0215(19980130)75:3<473::AID-IJC23>3.0.CO;2-8; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Rudolf E, 2008, CELL BIOL TOXICOL, V24, P123, DOI 10.1007/s10565-007-9022-1; SALANEWBY GB, 1994, BBA-PROTEIN STRUCT M, V1206, P155, DOI 10.1016/0167-4838(94)90084-1; SENSIBAR JA, 1990, PROSTATE, V16, P263, DOI 10.1002/pros.2990160310; Simizu S, 1996, CANCER RES, V56, P4978; Sohn JH, 2010, MOL CANCER RES, V8, P246, DOI 10.1158/1541-7786.MCR-09-0141; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Sung D, 1998, PHOTOCHEM PHOTOBIOL, V68, P749, DOI 10.1111/j.1751-1097.1998.tb02540.x; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Wu HM, 2002, FEBS LETT, V526, P101, DOI 10.1016/S0014-5793(02)03151-4; Ye JP, 1999, MOL CELL BIOCHEM, V202, P9, DOI 10.1023/A:1007078915585	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20073	10.1371/journal.pone.0020073	http://dx.doi.org/10.1371/journal.pone.0020073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603648	Green Submitted, Green Published, gold			2022-12-25	WOS:000290558500044
J	Pluznick, JL; Rodriguez-Gil, DJ; Hull, M; Mistry, K; Gattone, V; Johnson, CA; Weatherbee, S; Greer, CA; Caplan, MJ				Pluznick, Jennifer L.; Rodriguez-Gil, Diego J.; Hull, Michael; Mistry, Kavita; Gattone, Vincent; Johnson, Colin A.; Weatherbee, Scott; Greer, Charles A.; Caplan, Michael J.			Renal Cystic Disease Proteins Play Critical Roles in the Organization of the Olfactory Epithelium	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MECKEL-GRUBER-SYNDROME; SENSORY NEURONS; MOUSE MODEL; RAT MODEL; WPK RAT; CILIA; EXPRESSION; MUTATIONS; REVEALS	It was reported that some proteins known to cause renal cystic disease (NPHP6; BBS1, and BBS4) also localize to the olfactory epithelium (OE), and that mutations in these proteins can cause anosmia in addition to renal cystic disease. We demonstrate here that a number of other proteins associated with renal cystic diseases - polycystin 1 and 2 (PC1, PC2), and Meckel-Gruber syndrome 1 and 3 (MKS1, MKS3) - localize to the murine OE. PC1, PC2, MKS1 and MKS3 are all detected in the OE by RT-PCR. We find that MKS3 localizes specifically to dendritic knobs of olfactory sensory neurons (OSNs), while PC1 localizes to both dendritic knobs and cilia of mature OSNs. In mice carrying mutations in MKS1, the expression of the olfactory adenylate cyclase (AC3) is substantially reduced. Moreover, in rats with renal cystic disease caused by a mutation in MKS3, the laminar organization of the OE is perturbed and there is a reduced expression of components of the odor transduction cascade (G(olf), AC3) and alpha-acetylated tubulin. Furthermore, we show with electron microscopy that cilia in MKS3 mutant animals do not manifest the proper microtubule architecture. Both MKS1 and MKS3 mutant animals show no obvious alterations in odor receptor expression. These data show that multiple renal cystic proteins localize to the OE, where we speculate that they work together to regulate aspects of the development, maintenance or physiological activities of cilia.	[Pluznick, Jennifer L.; Hull, Michael; Mistry, Kavita; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Rodriguez-Gil, Diego J.; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Rodriguez-Gil, Diego J.; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Gattone, Vincent] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Johnson, Colin A.] Univ Leeds, Leeds Inst Mol Med, Dept Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Weatherbee, Scott] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Leeds; Yale University	Pluznick, JL (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	Michael.caplan@yale.edu		Caplan, Michael/0000-0001-5768-4405; Johnson, Colin/0000-0002-2979-8234; Weatherbee, Scott/0000-0002-0915-1329	NIH [K99-DK081610, DK068581, DC00210, DK57328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068581, R01DK068581, K99DK081610, P50DK057328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Medical Research Council [G0700073] Funding Source: researchfish; MRC [G0700073] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH K99-DK081610 (to JLP), NIH DK068581 (to VG), NIH DC00210 (to CAG), and NIH DK57328 (to MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; FRISCH D, 1967, AM J ANAT, V121, P87, DOI 10.1002/aja.1001210107; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Jenkins PM, 2009, CHEM SENSES, V34, P451, DOI 10.1093/chemse/bjp020; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Logan CV, 2011, MOL NEUROBIOL, V43, P12, DOI 10.1007/s12035-010-8154-0; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; MENCO BPM, 1985, J CELL SCI, V78, P283; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Nauta J, 2000, J AM SOC NEPHROL, V11, P2272, DOI 10.1681/ASN.V11122272; Nomura T, 2004, ARCH HISTOL CYTOL, V67, P159, DOI 10.1679/aohc.67.159; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Rodriguez-Gil DJ, 2008, J COMP NEUROL, V511, P301, DOI 10.1002/cne.21834; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tahvanainen E, 2005, ANN MED, V37, P546, DOI 10.1080/07853890500389181; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Treloar HB, 2005, J COMP NEUROL, V482, P201, DOI 10.1002/cne.20431; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Weisz OA, 2000, J BIOL CHEM, V275, P24341, DOI 10.1074/jbc.M000671200; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zaidi AU, 1998, DEV BRAIN RES, V109, P157, DOI 10.1016/S0165-3806(98)00076-5	33	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19694	10.1371/journal.pone.0019694	http://dx.doi.org/10.1371/journal.pone.0019694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21614130	gold, Green Published, Green Submitted			2022-12-25	WOS:000290558500024
J	Guthoff, M; Stingl, KT; Tschritter, O; Rogic, M; Heni, M; Stingl, K; Hallschmid, M; Haring, HU; Fritsche, A; Preissl, H; Hennige, AM				Guthoff, Martina; Stingl, Krunoslav T.; Tschritter, Otto; Rogic, Maja; Heni, Martin; Stingl, Katarina; Hallschmid, Manfred; Haering, Hans-Ulrich; Fritsche, Andreas; Preissl, Hubert; Hennige, Anita M.			The Insulin-Mediated Modulation of Visually Evoked Magnetic Fields Is Reduced in Obese Subjects	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIMODAL FOOD PERCEPTION; INTRANASAL INSULIN; NEUROCOGNITIVE BASES; IMPROVES MEMORY; BRAIN ACTIVITY; BODY-WEIGHT; HUMANS; LEPTIN; LOCALIZATION	Background: Insulin is an anorexigenic hormone that contributes to the termination of food intake in the postprandial state. An alteration in insulin action in the brain, named "cerebral insulin resistance'', is responsible for overeating and the development of obesity. Methodology/Principal Findings: To analyze the direct effect of insulin on food-related neuronal activity we tested 10 lean and 10 obese subjects. We conducted a magnetencephalography study during a visual working memory task in both the basal state and after applying insulin or placebo spray intranasally to bypass the blood brain barrier. Food and non-food pictures were presented and subjects had to determine whether or not two consecutive pictures belonged to the same category. Intranasal insulin displayed no effect on blood glucose, insulin or C-peptide concentrations in the periphery; however, it led to an increase in the components of evoked fields related to identification and categorization of pictures (at around 170 ms post stimuli in the visual ventral stream) in lean subjects when food pictures were presented. In contrast, insulin did not modulate food-related brain activity in obese subjects. Conclusions/Significance: We demonstrated that intranasal insulin increases the cerebral processing of food pictures in lean whereas this was absent in obese subjects. This study further substantiates the presence of a "cerebral insulin resistance'' in obese subjects and might be relevant in the pathogenesis of obesity.	[Guthoff, Martina; Tschritter, Otto; Heni, Martin; Haering, Hans-Ulrich; Fritsche, Andreas; Hennige, Anita M.] Univ Tubingen, Univ Hosp, Dept Endocrinol & Diabet Angiol Nephrol & Clin Ch, Tubingen, Germany; [Stingl, Krunoslav T.; Rogic, Maja; Preissl, Hubert] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Stingl, Katarina] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hallschmid, Manfred] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Preissl, Hubert] Univ Arkansas, Coll Med, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Lubeck; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Guthoff, M (corresponding author), Univ Tubingen, Univ Hosp, Dept Endocrinol & Diabet Angiol Nephrol & Clin Ch, Tubingen, Germany.	andreas.fritsche@med.uni-tuebingen.de	Vidaković, Maja Rogić/AAL-3081-2020; Preißl, Hubert/E-9070-2012; Rogić Vidaković, Maja/D-5871-2017; Guthoff, Martina/D-3960-2018	Preißl, Hubert/0000-0002-8859-4661; Rogić Vidaković, Maja/0000-0001-8516-9718; Guthoff, Martina/0000-0002-4294-980X; Heni, Martin/0000-0002-8462-3832	Deutsche Forschungsgemeinschaft [KFO 114 Fr1561/3-3]; German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the Deutsche Forschungsgemeinschaft (KFO 114 Fr1561/3-3), and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193; Benedict L, 2006, NEUROENDOCRINOLOGY, V83, P20, DOI 10.1159/000093338; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Cornier MA, 2010, PHYSIOL BEHAV, V99, P538, DOI 10.1016/j.physbeh.2010.01.008; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Frank TC, 2010, BRAIN RES, V1363, P81, DOI 10.1016/j.brainres.2010.09.071; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; MARKS JL, 1991, ADV EXP MED BIOL, V293, P459; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Mattout J., 2007, COMPUT INTELL NEUROS; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Popovic V, 2005, NUTR NEUROSCI, V8, P1, DOI 10.1080/10284150400027107; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; SCHWARTZ MW, 1990, PEPTIDES, V11, P467, DOI 10.1016/0196-9781(90)90044-6; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seaquist ER, 2007, J CEREBR BLOOD F MET, V27, P154, DOI 10.1038/sj.jcbfm.9600316; STINGL K, 2010, NEUROIMAGE; Stockburger J, 2008, BEHAV NEUROSCI, V122, P936, DOI 10.1037/a0012517; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Verhagen JV, 2007, BRAIN RES REV, V53, P271, DOI 10.1016/j.brainresrev.2006.09.002; Verhagen JV, 2006, NEUROSCI BIOBEHAV R, V30, P613, DOI 10.1016/j.neubiorev.2005.11.003; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	43	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19482	10.1371/journal.pone.0019482	http://dx.doi.org/10.1371/journal.pone.0019482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589921	Green Submitted, Green Published, gold			2022-12-25	WOS:000290483600012
J	Vockel, M; Pollok, S; Breitenbach, U; Ridderbusch, I; Kreienkamp, HJ; Brandner, JM				Vockel, Matthias; Pollok, Simone; Breitenbach, Ute; Ridderbusch, Ina; Kreienkamp, Hans-Juergen; Brandner, Johanna M.			Somatostatin Inhibits Cell Migration and Reduces Cell Counts of Human Keratinocytes and Delays Epidermal Wound Healing in an Ex Vivo Wound Model	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; HUMAN NEUROBLASTOMA; GROWTH-FACTORS; RECEPTOR; ACTIVATION; RAC; EXPRESSION; MOTILITY; PROLIFERATION; CARCINOMA	The peptide hormone somatostatin (SST) and its five G protein-coupled receptors (SSTR1-5) were described to be present in the skin, but their cutaneous function(s) and skin-specific signalling mechanisms are widely unknown. By using receptor specific agonists we show here that the SSTRs expressed in keratinocytes are functionally coupled to the inhibition of adenylate cyclase. In addition, treatment with SSTR4 and SSTR5/1 specific agonists significantly influences the MAP kinase signalling pathway. As epidermal hormone receptors in general are known to regulate re-epithelialization following skin injury, we investigated the effect of SST on cell counts and migration of human keratinocytes. Our results demonstrate a significant inhibition of cell migration and reduction of cell counts by SST. We do not observe an effect on apoptosis and necrosis. Analysis of signalling pathways showed that somatostatin inhibits cell migration independent of its effect on cAMP. Migrating keratinocytes treated with SST show altered cytoskeleton dynamics with delayed lamellipodia formation. Furthermore, the activity of the small GTPase Rac1 is diminished, providing evidence for the control of the actin cytoskeleton by somatostatin receptors in keratinocytes. While activation of all receptors leads to redundant effects on cell migration, only treatment with a SSTR5/1 specific agonist resulted in decreased cell counts. In accordance with reduced cell counts and impaired migration we observe delayed re-epithelialization in an ex vivo wound healing model. Consequently, our experiments suggest SST as a negative regulator of epidermal wound healing.	[Vockel, Matthias; Pollok, Simone; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Vockel, Matthias; Breitenbach, Ute] Beiersdorf AG, Hamburg, Germany; [Vockel, Matthias; Kreienkamp, Hans-Juergen] Univ Hosp Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Ridderbusch, Ina] Univ Hosp Hamburg Eppendorf, Dept Pediat Surg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Beiersdorf AG; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Vockel, M (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	brandner@uke.de		Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Beiersdorf AG	Beiersdorf AG	MV was financially supported via a grant to Johanna Brandner and HJK by Beiersdorf AG, but was employed at University Hospital Hamburg-Eppendorf during this study. The grant comprised the salary of MV and consumables. The grant ended in 2009. UB is an employee of Beiersdorf AG. UB, who is employed by the funder, played a role in data analysis. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bousquet C, 2004, DIGEST LIVER DIS, V36, pS2, DOI 10.1016/j.dld.2003.11.007; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brandner JM., 2006, EWMA J, V6, P11; Cattaneo MG, 2006, MOL CELL ENDOCRINOL, V256, P34, DOI 10.1016/j.mce.2006.05.006; Cattaneo MG, 1996, FEBS LETT, V397, P164, DOI 10.1016/S0014-5793(96)01159-3; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2002, J INVEST DERMATOL, V119, P1261, DOI 10.1046/j.1523-1747.2002.19611.x; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Cordelier P, 1997, P NATL ACAD SCI USA, V94, P9343, DOI 10.1073/pnas.94.17.9343; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fantini F, 1995, Exp Dermatol, V4, P365, DOI 10.1111/j.1600-0625.1995.tb00061.x; Gaudillere A, 1997, BRIT J DERMATOL, V137, P376, DOI 10.1111/j.1365-2133.1997.tb03741.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HAEGERSTRAND A, 1989, P NATL ACAD SCI USA, V86, P5993, DOI 10.1073/pnas.86.15.5993; Hagstromer L, 2006, EXP DERMATOL, V15, P950, DOI 10.1111/j.1600-0625.2006.00487.x; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; JOHANSSON O, 1987, NEUROSCI LETT, V73, P225, DOI 10.1016/0304-3940(87)90249-7; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Khurana S, 2008, EXP CELL RES, V314, P530, DOI 10.1016/j.yexcr.2007.10.028; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Liew CW, 2009, FEBS LETT, V583, P49, DOI 10.1016/j.febslet.2008.11.048; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McCawley LJ, 2000, MOL PHARMACOL, V58, P145, DOI 10.1124/mol.58.1.145; MERINEY SD, 1994, NATURE, V369, P336, DOI 10.1038/369336a0; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1994, ENDOCRINOLOGY, V135, P2814, DOI 10.1210/en.135.6.2814; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollok S, 2010, J CELL MOL MED; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737; Sauer B, 2004, J INVEST DERMATOL, V123, P840, DOI 10.1111/j.0022-202X.2004.23458.x; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; SENAPATI A, 1986, NEUROSCI LETT, V71, P101, DOI 10.1016/0304-3940(86)90264-8; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Vockel M, 2010, EXP DERMATOL, V19, P888, DOI 10.1111/j.1600-0625.2010.01101.x; Waddell BE, 1997, AM SURGEON, V63, P446; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Wente W, 2005, FEBS LETT, V579, P6305, DOI 10.1016/j.febslet.2005.10.009; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	57	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19740	10.1371/journal.pone.0019740	http://dx.doi.org/10.1371/journal.pone.0019740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589940	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600028
J	Prochnow, N; Gebing, T; Ladage, K; Krause-Finkeldey, D; El Ouardi, A; Bitz, A; Streckert, J; Hansen, V; Dermietzel, R				Prochnow, Nora; Gebing, Tina; Ladage, Kerstin; Krause-Finkeldey, Dorothee; El Ouardi, Abdessamad; Bitz, Andreas; Streckert, Joachim; Hansen, Volkert; Dermietzel, Rolf			Electromagnetic Field Effect or Simply Stress? Effects of UMTS Exposure on Hippocampal Longterm Plasticity in the Context of Procedure Related Hormone Release	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MOBILE PHONE; GLUCOCORTICOID-RECEPTOR; EMOTIONAL MEMORIES; COGNITIVE FUNCTION; KETAMINE-XYLAZINE; BRAIN TEMPERATURE; POTENTIATION; RAT; PSD-95	Harmful effects of electromagnetic fields (EMF) on cognitive and behavioural features of humans and rodents have been controversially discussed and raised persistent concern about adverse effects of EMF on general brain functions. In the present study we applied radio-frequency (RF) signals of the Universal Mobile Telecommunications System (UMTS) to full brain exposed male Wistar rats in order to elaborate putative influences on stress hormone release (corticosteron; CORT and adrenocorticotropic hormone; ACTH) and on hippocampal derived synaptic long-term plasticity (LTP) and depression (LTD) as electrophysiological hallmarks for memory storage and memory consolidation. Exposure was computer controlled providing blind conditions. Nominal brain-averaged specific absorption rates (SAR) as a measure of applied mass-related dissipated RF power were 0, 2, and 10 W/kg over a period of 120 min. Comparison of cage exposed animals revealed, regardless of EMF exposure, significantly increased CORT and ACTH levels which corresponded with generally decreased field potential slopes and amplitudes in hippocampal LTP and LTD. Animals following SAR exposure of 2 W/kg (averaged over the whole brain of 2.3 g tissue mass) did not differ from the sham-exposed group in LTP and LTD experiments. In contrast, a significant reduction in LTP and LTD was observed at the high power rate of SAR (10 W/kg). The results demonstrate that a rate of 2 W/kg displays no adverse impact on LTP and LTD, while 10 W/kg leads to significant effects on the electrophysiological parameters, which can be clearly distinguished from the stress derived background. Our findings suggest that UMTS exposure with SAR in the range of 2 W/kg is not harmful to critical markers for memory storage and memory consolidation, however, an influence of UMTS at high energy absorption rates (10 W/kg) cannot be excluded.	[Prochnow, Nora; Gebing, Tina; Ladage, Kerstin; Krause-Finkeldey, Dorothee; Dermietzel, Rolf] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany; [El Ouardi, Abdessamad; Bitz, Andreas; Streckert, Joachim; Hansen, Volkert] Univ Wuppertal, Chair Elect Theory, Wuppertal, Germany	Ruhr University Bochum; University of Wuppertal	Prochnow, N (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany.	rolf.dermietzel@rub.de						Abraham WC, 1997, HIPPOCAMPUS, V7, P137, DOI 10.1002/(SICI)1098-1063(1997)7:2<137::AID-HIPO3>3.0.CO;2-K; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bohus B, 1980, Acta Psychiatr Belg, V80, P714; Burkhardt M, 1997, HEALTH PHYS, V73, P770, DOI 10.1097/00004032-199711000-00004; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Chou CK, 1999, PHYS REV E, V60, P5998, DOI 10.1103/PhysRevE.60.5998; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Curcio G, 2004, NEUROREPORT, V15, P161, DOI 10.1097/00001756-200401190-00031; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Diamond DM, 2004, HIPPOCAMPUS, V14, P281, DOI 10.1002/hipo.10186; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Eltiti S, 2009, BIOELECTROMAGNETICS, V30, P556, DOI 10.1002/bem.20504; Erickson KM, 2003, ANESTH ANALG, V96, P1460, DOI 10.1213/01.ANE.0000061221.23197.CE; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; Garcia R, 1997, NEUROSCI LETT, V233, P41, DOI 10.1016/S0304-3940(97)00621-6; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Hansen VW, 1999, IEEE T ELECTROMAGN C, V41, P487, DOI 10.1109/15.809852; HANSEN VW, 2004, WAVES GTEM CELLS COM, P435; Howland JG, 2008, PROG BRAIN RES, V169, P145, DOI 10.1016/S0079-6123(07)00008-8; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JOELS M, 1992, NEUROENDOCRINOLOGY, V55, P344, DOI 10.1159/000126135; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Joels Marian, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/93202; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P479, DOI 10.1002/bem.20419; KLEMM W, 1975, J ENDOCRINOL, V65, pP12; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Koivisto M, 2000, NEUROREPORT, V11, P1641, DOI 10.1097/00001756-200006050-00009; LaManna J C, 1988, Adv Exp Med Biol, V222, P383; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Levine S, 1977, Acta Physiol Pol, V28, P93; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mbonjo HNM, 2004, BIOELECTROMAGNETICS, V25, P415, DOI 10.1002/bem.20007; Mcewen B S, 1970, Prog Brain Res, V32, P200, DOI 10.1016/S0079-6123(08)61536-8; MCEWEN BS, 1969, BRAIN RES, V16, P227, DOI 10.1016/0006-8993(69)90096-1; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; MCGAUGH JL, 1983, ANNU REV PSYCHOL, V34, P297, DOI 10.1146/annurev.ps.34.020183.001501; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mockett B, 2002, EUR J NEUROSCI, V15, P1819, DOI 10.1046/j.1460-9568.2002.02008.x; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Preece AW, 1999, INT J RADIAT BIOL, V75, P447, DOI 10.1080/095530099140375; Regel SJ, 2006, ENVIRON HEALTH PERSP, V114, P1270, DOI 10.1289/ehp.8934; Riddervold IS, 2008, BIOELECTROMAGNETICS, V29, P257, DOI 10.1002/bem.20388; RYAN BK, 2009, HIPPOCAMPUS; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; SARA SJ, 1994, J PHYSIOLOGY-PARIS, V88, P337, DOI 10.1016/0928-4257(94)90026-4; SARA SJ, 1995, COGNITIVE BRAIN RES, V2, P181, DOI 10.1016/0926-6410(95)90007-1; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; Shors TJ, 1997, SYNAPSE, V26, P209, DOI 10.1002/(SICI)1098-2396(199707)26:3<209::AID-SYN2>3.0.CO;2-B; Stein V, 2003, J NEUROSCI, V23, P5503; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Tsoory MM, 2007, PROG BRAIN RES, V167, P35, DOI 10.1016/S0079-6123(07)67003-4; Unterlechner M, 2008, BIOELECTROMAGNETICS, V29, P145, DOI 10.1002/bem.20374; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; VARRO P, 2009, BIOELECTROMAGNETICS; Wang BM, 2000, BIOELECTROMAGNETICS, V21, P52, DOI 10.1002/(SICI)1521-186X(200001)21:1<52::AID-BEM8>3.0.CO;2-6; WIXSON SK, 1987, LAB ANIM SCI, V37, P743; *WORKSH FGF, 2003, 281 COST FORSCH FUNK; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yao Li-Jun, 2004, Sheng Li Ke Xue Jin Zhan, V35, P73; Zhu MM, 2009, J COMP PHYSIOL B, V179, P701, DOI 10.1007/s00360-009-0352-6; Zhu MM, 2004, J THERM BIOL, V29, P599, DOI 10.1016/j.jtherbio.2004.08.029; Zwamborn APM, 2003, EFFECTS GLOBAL COMMU	80	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19437	10.1371/journal.pone.0019437	http://dx.doi.org/10.1371/journal.pone.0019437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573218	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400011
J	Song, WH; Dyer, E; Stuckey, DJ; Copeland, O; Leung, MC; Bayliss, C; Messer, A; Wilkinson, R; Tremoleda, JL; Schneider, MD; Harding, SE; Redwood, CS; Clarke, K; Nowak, K; Monserrat, L; Wells, D; Marston, SB				Song, Weihua; Dyer, Emma; Stuckey, Daniel J.; Copeland, O'Neal; Leung, Man-Ching; Bayliss, Christopher; Messer, Andrew; Wilkinson, Ross; Tremoleda, Jordi Lopez; Schneider, Michael D.; Harding, Sian E.; Redwood, Charles S.; Clarke, Kieran; Nowak, Kristen; Monserrat, Lorenzo; Wells, Dominic; Marston, Steven B.			Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITRO MOTILITY ANALYSIS; TROPONIN-T MUTATIONS; THIN FILAMENT; DILATED CARDIOMYOPATHY; HUMAN HEART; REGULATORY PROPERTIES; FUNCTIONAL CONSEQUENCES; CONTRACTILE PROTEINS; MUSCLE CONTRACTION; ALTERED REGULATION	We generated a transgenic mouse model expressing the apical hypertrophic cardiomyopathy-causing mutation ACTC E99K at 50% of total heart actin and compared it with actin from patients carrying the same mutation. The actin mutation caused a higher Ca2+ sensitivity in reconstituted thin filaments measured by in vitro motility assay (2.3-fold for mice and 1.3-fold for humans) and in skinned papillary muscle. The mutation also abolished the change in Ca2+ sensitivity normally linked to troponin I phosphorylation. MyBP-C and troponin I phosphorylation levels were the same as controls in transgenic mice and human carrier heart samples. ACTC E99K mice exhibited a high death rate between 28 and 45 days (48% females and 22% males). At 21 weeks, the hearts of the male survivors had enlarged atria, increased interstitial fibrosis, and sarcomere disarray. MRI showed hypertrophy, predominantly at the apex of the heart. End-diastolic volume and end-diastolic pressure were increased, and relaxation rates were reduced compared with non-transgenic littermates. End-systolic pressures and volumes were unaltered. ECG abnormalities were present, and the contractile response to beta-adrenergic stimulation was much reduced. Older mice (29-week-old females and 38-week-old males) developed dilated cardiomyopathy with increased end-systolic volume and continuing increased end-diastolic pressure and slower contraction and relaxation rates. ECG showed atrial flutter and frequent atrial ectopic beats at rest in some ACTC E99K mice. We propose that the ACTC E99K mutation causes higher myofibrillar Ca2+ sensitivity that is responsible for the sudden cardiac death, apical hypertrophy, and subsequent development of heart failure in humans and mice.	[Song, Weihua; Dyer, Emma; Stuckey, Daniel J.; Copeland, O'Neal; Leung, Man-Ching; Bayliss, Christopher; Messer, Andrew; Wilkinson, Ross; Schneider, Michael D.; Harding, Sian E.; Marston, Steven B.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW32 6LY, England; [Redwood, Charles S.] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Nowak, Kristen] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Monserrat, Lorenzo] Complejo Hos Univ Juan Canalejo, Dept Cardiol, La Coruna 15006, Spain; [Tremoleda, Jordi Lopez] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London W12 0NN, England; [Wells, Dominic] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, London W12 0NN, England; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	Imperial College London; University of Oxford; University of Western Australia; Complejo Hospitalario Universitario A Coruna; Imperial College London; Imperial College London; University of Oxford	Marston, SB (corresponding author), Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	s.marston@imperial.ac.uk		Schneider, Michael/0000-0001-9645-1938; stuckey, daniel/0000-0001-8888-627X; Wells, Dominic/0000-0002-1425-6344; Monserrat, Lorenzo/0000-0001-5776-0623; Harding, Sian/0000-0002-3651-6354	British Heart Foundation; British Heart Foundation Centre of Research Excellence; European Union [241577]; British Heart Foundation [RG/07/004/22659, PG/08/077/25587, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Research Excellence(British Heart Foundation); European Union(European Commission); British Heart Foundation(British Heart Foundation)	This work was funded by grants from the British Heart Foundation, a generous donation from The Dr. E. G. J. Olsen Charitable Fund, the British Heart Foundation Centre of Research Excellence, and the 7th Framework Program of the European Union Grant 241577 ("BIG-HEART").	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Bing W, 1997, BIOCHEM J, V327, P335, DOI 10.1042/bj3270335; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Bottinelli R, 1998, CIRC RES, V82, P106; Copeland O, 2010, J MUSCLE RES CELL M, V31, P207, DOI 10.1007/s10974-010-9224-7; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Hoskins AC, 2010, J MOL CELL CARDIOL, V49, P737, DOI 10.1016/j.yjmcc.2010.06.006; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huke S, 2010, J MOL CELL CARDIOL, V48, P824, DOI 10.1016/j.yjmcc.2010.01.011; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Jacques A, 2008, J MUSCLE RES CELL M, V29, P239, DOI 10.1007/s10974-009-9174-0; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; Jweied E, 2007, J MOL CELL CARDIOL, V42, P722, DOI 10.1016/j.yjmcc.2007.02.002; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Knott A, 2002, J MOL CELL CARDIOL, V34, P469, DOI 10.1006/jmcc.2002.1528; Kumar A, 2004, TRANSGENIC RES, V13, P531, DOI 10.1007/s11248-004-2823-6; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Marston S, 2003, J MUSCLE RES CELL M, V24, P149, DOI 10.1023/A:1026097313020; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Mason SA, 2009, BIOCHEM BIOPH RES CO, V388, P565, DOI 10.1016/j.bbrc.2009.08.050; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; Mogensen J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010447; Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Nier V, 1999, FEBS LETT, V461, P246, DOI 10.1016/S0014-5793(99)01433-7; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Redwood C, 2000, CIRC RES, V86, P1146; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P1354; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891	60	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27582	27593		10.1074/jbc.M111.252320	http://dx.doi.org/10.1074/jbc.M111.252320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21622575	hybrid, Green Published			2022-12-25	WOS:000293268700052
J	Imashimizu, M; Bernat, G; Sunamura, EI; Broekmans, M; Konno, H; Isato, K; Rogner, M; Hisabori, T				Imashimizu, Mari; Bernat, Gabor; Sunamura, Ei-Ichiro; Broekmans, Martin; Konno, Hiroki; Isato, Kota; Roegner, Matthias; Hisabori, Toru			Regulation of F0F1-ATPase from Synechocystis sp PCC 6803 by gamma and epsilon Subunits Is Significant for Light/Dark Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; C-TERMINAL DOMAIN; COUPLING FACTOR-I; GREEN-ALGA; ACTIVATION; F-1-ATPASE; BINDING; MUTAGENESIS; INHIBITION; EVOLUTION	The gamma and epsilon subunits of F0F1-ATP synthase from photosynthetic organisms display unique properties not found in other organisms. Although the gamma subunit of both chloroplast and cyanobacterial F0F1 contains an extra amino acid segment whose deletion results in a high ATP hydrolysis activity (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., Sugano, Y., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855-865), its epsilon subunit strongly inhibits ATP hydrolysis activity. To understand the physiological significance of these phenomena, we studied mutant strains with (i) a C-terminally truncated epsilon (epsilon(Delta C)), (ii) gamma lacking the inserted sequence (gamma(Delta 198-222)), and (iii) a double mutation of (i) and (ii) in Synechocystis sp. PCC 6803. Although thylakoid membranes from the epsilon(Delta C) strain showed higher ATP hydrolysis and lower ATP synthesis activities than those of the wild type, no significant difference was observed in growth rate and in intracellular ATP level both under light conditions and during light-dark cycles. However, both the epsilon(Delta C) and gamma(Delta 198-222) and the double mutant strains showed a lower intracellular ATP level and lower cell viability under prolonged dark incubation compared with the wild type. These data suggest that internal inhibition of ATP hydrolysis activity is very important for cyanobacteria that are exposed to prolonged dark adaptation and, in general, for the survival of photosynthetic organisms in an ever-changing environment.	[Imashimizu, Mari; Sunamura, Ei-Ichiro; Konno, Hiroki; Isato, Kota; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Bernat, Gabor; Broekmans, Martin; Roegner, Matthias] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany	Tokyo Institute of Technology; Ruhr University Bochum	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Bernat, Gabor/J-6333-2017; Hisabori, Toru/E-5205-2014	Bernat, Gabor/0000-0001-6147-9391; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18074002]; German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 480, C1]; German Federal Ministry of Education and Research (BMBF); European Union [Solar-H2]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in-aid for Scientific Research on Priority Areas 18074002; to T. H.), the German Research Foundation (Deutsche Forschungsgemeinschaft, SFB 480, project C1 (to M. R.)), the German Federal Ministry of Education and Research (BMBF, project Bio-H<INF>2</INF> (to G. B. and M. R.)), and the European Union project Solar-H<INF>2</INF> (to M. B. and M. R.)	ARANA JL, 1982, J BIOL CHEM, V257, P1125; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; BOTTOMLEY PJ, 1976, ARCH MICROBIOL, V108, P249, DOI 10.1007/BF00454849; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; DANN MS, 1992, PLANT PHYSIOL, V99, P153, DOI 10.1104/pp.99.1.153; Das A, 2003, J BACTERIOL, V185, P5527, DOI 10.1128/JB.185.18.5527-5535.2003; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frasch WD, 1994, MOL BIOL CYANOBACTER, P361; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GRIMME LH, 1972, BIOCHEM BIOPH RES CO, V49, P1617, DOI 10.1016/0006-291X(72)90527-X; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson EA, 2008, PHOTOSYNTH RES, V96, P153, DOI 10.1007/s11120-008-9296-z; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; KLIONSKY DJ, 1985, J BIOL CHEM, V260, P1200; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; MAMEDOV MD, 1991, FEBS LETT, V294, P271, DOI 10.1016/0014-5793(91)81446-F; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; OHTA Y, 1993, PLANT CELL PHYSIOL, V34, P523; PATRIE WJ, 1984, J BIOL CHEM, V259, P1121; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; ROBERTSON D, 1990, MOL GEN GENET, V221, P155, DOI 10.1007/BF00261715; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STERNWEIS PC, 1978, J BIOL CHEM, V253, P3123; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Teuber M, 2001, BBA-BIOENERGETICS, V1506, P31, DOI 10.1016/S0005-2728(01)00178-5; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Waschewski N., 2010, BIOMASS BIOFUELS, P388; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WERNER S, 1990, FEBS LETT, V261, P204, DOI 10.1016/0014-5793(90)80671-5; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Xu M, 2008, PLANT CELL PHYSIOL, V49, P1672, DOI 10.1093/pcp/pcn139; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2010, BIOCHEM J, V425, P85, DOI 10.1042/BJ20091247; YOSHIDA M, 1977, P NATL ACAD SCI USA, V74, P936, DOI 10.1073/pnas.74.3.936; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	49	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26595	26602		10.1074/jbc.M111.234138	http://dx.doi.org/10.1074/jbc.M111.234138			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21610078	hybrid, Green Published			2022-12-25	WOS:000293078200038
J	Zhou, H; Zhang, Y; Fu, Y; Chan, LR; Lee, AS				Zhou, Hui; Zhang, Yi; Fu, Yong; Chan, Lauren; Lee, Amy S.			Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78) ENDOCRINE RESISTANCE FACTOR IN BREAST CANCER, THROUGH RELEASE OF B-CELL LYMPHOMA 2 (BCL-2) FROM BCL-2-INTERACTING KILLER (BIK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; CYTOCHROME-C RELEASE; CELL-DEATH; BH3-ONLY PROTEINS; AROMATASE INHIBITORS; FAMILY PROTEINS; X-L; INDUCTION; STRESS; BAX	Activation of the intrinsic apoptotic pathway represents a major mechanism for breast cancer regression resulting from anti-estrogen therapy. The BH3-only protein BIK is inducible by estrogen-starvation and anti-estrogen treatment and plays an important role in anti-estrogen induced apoptosis of breast cancer cells. BIK is predominantly localized to the endoplasmic reticulum where it regulates BAX/BAK-dependent release of Ca2+ from the endoplasmic reticulum stores and cooperates with other BH3-only proteins such as NOXA to cause rapid release of cytochrome c from mitochondria and activate apoptosis. BIK is also known to inactivate BCL-2 through complex formation. Previously, we demonstrated that apoptosis triggered by BIK in estrogen-starved human breast cancer cells is suppressed by GRP78, a major endoplasmic reticulum chaperone. Here we described the isolation of a novel clonal human breast cancer cell line (MCF-7/BUS-10) resistant to long-term estrogen deprivation. These cells exhibit elevated level of GRP78, which protects them from estrogen starvation-induced apoptosis. Our studies revealed that overexpression of GRP78 suppresses apoptosis induced by BIK and NOXA, either alone or in combination. Surprisingly, the interaction of GRP78 with BIK does not require its BH3 domain, which has been implicated in all previous BIK protein interactions. We further showed GRP78 and BCL-2 form independent complex with BIK and that increased expression of GRP78 decreases BIK binding to BCL-2. Our findings provide the first evidence that GRP78 can decrease BCL-2 sequestration by BIK at the endoplasmic reticulum, thus uncovering a potential new mechanism whereby GRP78 confers endocrine resistance in breast cancer.	[Zhou, Hui; Zhang, Yi; Fu, Yong; Chan, Lauren; Lee, Amy S.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu	Fu, Yong/A-4247-2012	Fu, Yong/0000-0002-8423-8803; Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607, CA111700]; Department of Defense [W81XWH-07-1-0480]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [R01CA111700, R37CA027607, P30CA014089, R01CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027607 and CA111700 and Department of Defense Grant W81XWH-07-1-0480.; We thank Drs. Gordon Shore for the gift of BIK expression plasmids, John Nicholas for BIM expression plasmid, Jianze Li for the NOXA expression plasmid, Parkash Gill for purified GRP78 protein, Cheng Ji for the antibody against BIM, and Ana Soto for MCF-7/BUS cell line. We thank Brenda Lee and Minal Patel for technical assistance. The FACS analysis was performed in the USC Norris Cancer Center Flow Cytometry Core Facility supported in part by Grant P30CA014089 from the National Cancer Institute.	BOYD JM, 1995, ONCOGENE, V11, P1921; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Choi YB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001031; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Daidone MG, 2000, BRIT J CANCER, V82, P270; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nikrad M, 2005, MOL CANCER THER, V4, P443; Oppermann M, 2005, ONCOGENE, V24, P7369, DOI 10.1038/sj.onc.1208890; Penas C., 2011, CELL DEATH IN PRESS; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Teles AVF, 2008, NEUROSCI LETT, V442, P96, DOI 10.1016/j.neulet.2008.06.073; Thiantanawat A, 2003, CANCER RES, V63, P8037; Tripathy D, 2009, J CLIN ONCOL, V27, P2580, DOI 10.1200/JCO.2008.21.2142; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu F, 1998, NUCLEIC ACIDS RES, V26, P4837, DOI 10.1093/nar/26.21.4837; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	43	97	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25687	25696		10.1074/jbc.M110.212944	http://dx.doi.org/10.1074/jbc.M110.212944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622563	Green Published, hybrid			2022-12-25	WOS:000293073000030
J	Witney, TH; Kettunen, MI; Brindle, KM				Witney, Timothy H.; Kettunen, Mikko I.; Brindle, Kevin M.			Kinetic Modeling of Hyperpolarized C-13 Label Exchange between Pyruvate and Lactate in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE ISOZYMES; INHIBITION; METABOLISM; TRANSPORT; SPECTROSCOPY; SUBSTRATE; H-1-NMR	Measurements of the kinetics of hyperpolarized C-13 label exchange between [1-C-13] pyruvate and lactate in suspensions of intact and lysed murine lymphoma cells, and in cells in which lactate dehydrogenase expression had been modulated by inhibition of the PI3K pathway, were used to determine quantitatively the role of enzyme activity and membrane transport in controlling isotope flux. Both steps were shown to share in the control of isotope flux in these cells. The kinetics of label exchange were well described by a kinetic model that employed rate constants for the lactate dehydrogenase reaction that had been determined previously from steady state kinetic studies. The enzyme showed pyruvate inhibition in steady state kinetic measurements, which the kinetic model predicted should also be observed in the isotope exchange measurements. However, no such pyruvate inhibition was observed in either intact cells or cell lysates and this could be explained by the much higher enzyme concentrations present in the isotope exchange experiments. The kinetic analysis presented here shows how lactate dehydrogenase activity can be determined from the isotope exchange measurements. The kinetic model should be useful for modeling the exchange reaction in vivo, particularly as this technique progresses to the clinic.	[Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	kmb1001@cam.ac.uk	Kettunen, Mikko I/K-2299-2012; Witney, Timothy/R-9440-2017	Kettunen, Mikko I/0000-0002-2004-660X; Witney, Timothy/0000-0002-9475-2873	Cancer Research UK [C197/A3514]; Leukemia and Lymphoma Society; GE Healthcare-Biotechnology and Biosciences Research Council	Cancer Research UK(Cancer Research UK); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); GE Healthcare-Biotechnology and Biosciences Research Council	*The work was supported in part by Cancer Research UK Programme Grant C197/A3514 (to K. M. B.) and by a Translational Research Program Award from The Leukemia and Lymphoma Society. This research was conducted under a research agreement with GE Healthcare, who provided the polarizer and related materials. K. M. B. holds two patents with GE Healthcare.; <SUP>1</SUP>Supported by a GE Healthcare-Biotechnology and Biosciences Research Council CASE studentship.	ARAGON JJ, 1980, P NATL ACAD SCI-BIOL, V77, P6324, DOI 10.1073/pnas.77.11.6324; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Bohndiek SE, 2010, EXPERT REV MOL DIAGN, V10, P417, DOI [10.1586/erm.10.20, 10.1586/ERM.10.20]; BORGMANN U, 1974, BIOCHEMISTRY-US, V13, P5152, DOI 10.1021/bi00722a016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLE KM, 1986, EUR J BIOCHEM, V158, P299, DOI 10.1111/j.1432-1033.1986.tb09751.x; BRINDLE KM, 1982, BIOCHEM J, V208, P583, DOI 10.1042/bj2080583; BURGNER JW, 1978, BIOCHEMISTRY-US, V17, P1646, DOI 10.1021/bi00602a011; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gallagher FA, 2009, PROG NUCL MAG RES SP, V55, P285, DOI 10.1016/j.pnmrs.2009.06.001; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Merritt ME, 2008, MAGN RESON MED, V60, P1029, DOI 10.1002/mrm.21760; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Simaga S, 2008, INT J GYNECOL CANCER, V18, P1272, DOI 10.1111/j.1525-1438.2008.01196.x; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2009, NEOPLASIA, V11, P574, DOI 10.1593/neo.09254; WUNTCH T, 1970, SCIENCE, V169, P480, DOI 10.1126/science.169.3944.480; WUNTCH T, 1970, SCIENCE, V167, P63, DOI 10.1126/science.167.3914.63; YAGIL G, 1969, BIOCHEMISTRY-US, V8, P352, DOI 10.1021/bi00829a049; ZEWE V, 1962, J BIOL CHEM, V237, P1668; Zierhut ML, 2010, J MAGN RESON, V202, P85, DOI 10.1016/j.jmr.2009.10.003	34	116	117	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24572	24580		10.1074/jbc.M111.237727	http://dx.doi.org/10.1074/jbc.M111.237727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596745	hybrid, Green Published			2022-12-25	WOS:000292547900007
J	Huang, L; Mollet, S; Souquere, S; Le Roy, F; Ernoult-Lange, M; Pierron, G; Dautry, F; Weil, D				Huang, Lue; Mollet, Stephanie; Souquere, Sylvie; Le Roy, Florence; Ernoult-Lange, Michele; Pierron, Gerard; Dautry, Francois; Weil, Dominique			Mitochondria Associate with P-bodies and Modulate MicroRNA-mediated RNA Interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS GRANULES; HUMAN-CELLS; PROCESSING BODIES; TRANSLATIONAL REPRESSION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BINDING PROTEIN; BODY FORMATION; IN-VIVO; DECAY	P-bodies are cytoplasmic granules that are linked to mRNA decay, mRNA storage, and RNA interference (RNAi). They are known to interact with stress granules in stressed cells, and with late endosomes. Here, we report that P-bodies also interact with mitochondria, as previously described for P-body-related granules in germ cells. The interaction is dynamic, as a large majority of P-bodies contacts mitochondria at least once within a 3-min interval, and for about 18 s. This association requires an intact microtubule network. The depletion of P-bodies does not seem to affect mitochondria, nor the mitochondrial activity to be required for their contacts with P-bodies. However, inactivation of mitochondria leads to a strong decrease of miRNA-mediated RNAi efficiency, and to a lesser extent of siRNA-mediated RNAi. The defect occurs during the assembly of active RISC and is associated with a specific delocalization of endogeneous Ago2 from P-bodies. Our study reveals the possible involvement of RNAi defect in pathologies involving mitochondrial deficiencies.	[Mollet, Stephanie; Le Roy, Florence; Ernoult-Lange, Michele; Weil, Dominique] Univ Paris 06, CNRS FRE 3402, F-75005 Paris, France; [Huang, Lue; Dautry, Francois] Ecole Normale Super, LBPA, CNRS, F-94230 Cachan, France; [Souquere, Sylvie; Pierron, Gerard] Inst Gustave Roussy, CNRS UMR 8122, F-94800 Villejuif, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Weil, D (corresponding author), Univ Paris 06, CNRS FRE 3402, 9 Quai St Bernard, F-75005 Paris, France.	dominique.weil@upmc.fr	Le Roy, florence/J-7455-2013; WEIL, Dominique/AAE-4214-2020	WEIL, Dominique/0000-0001-7630-1772; HUANG, LUE/0000-0001-8450-8781	Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer; Agence Nationale pour la Recherche; Ligue Nationale contre le Cancer; Ministere de l'Enseignement Superieur; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique, the Association pour la Recherche contre le Cancer, the Agence Nationale pour la Recherche, and the Ligue Nationale contre le Cancer.; Supported by the Ministere de l'Enseignement Superieur.; Supported by the Ministere de l'Enseignement Superieur.; Supported by the Fondation pour la Recherche Medicale.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Souquere S, 2009, J CELL SCI, V122, P3619, DOI 10.1242/jcs.054437; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Thomson T, 2008, MECH DEVELOP, V125, P865, DOI 10.1016/j.mod.2008.06.005; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611	47	75	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24219	24230		10.1074/jbc.M111.240259	http://dx.doi.org/10.1074/jbc.M111.240259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576251	Green Published, hybrid			2022-12-25	WOS:000292294900064
J	Kajiho, H; Sakurai, K; Minoda, T; Yoshikawa, M; Nakagawa, S; Fukushima, S; Kontani, K; Katada, T				Kajiho, Hiroaki; Sakurai, Kyoko; Minoda, Tomohiro; Yoshikawa, Manabu; Nakagawa, Satoshi; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki			Characterization of RIN3 as a Guanine Nucleotide Exchange Factor for the Rab5 Subfamily GTPase Rab31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY ENDOCYTIC PATHWAY; GROWTH-FACTOR RECEPTOR; TRANS-GOLGI NETWORK; ENDOSOME DYNAMICS; MOLECULAR-CLONING; STRUCTURAL BASIS; BINDING-PROTEIN; MEMBRANE-FUSION; DOMAIN; TRAFFICKING	The small GTPase Rab5, which cycles between GDP-bound inactive and GTP-bound active forms, plays essential roles in membrane budding and trafficking in the early endocytic pathway. Rab5 is activated by various vacuolar protein sorting 9 (VPS9) domain-containing guanine nucleotide exchange factors. Rab21, Rab22, and Rab31 (members of the Rab5 subfamily) are also involved in the trafficking of early endosomes. Mechanisms controlling the activation Rab5 subfamily members remain unclear. RIN (Ras and Rab interactor) represents a family of multifunctional proteins that have a VPS9 domain in addition to Src homology 2 (SH2) and Ras association domains. We investigated whether RIN family members act as guanine nucleotide exchange factors (GEFs) for the Rab5 subfamily on biochemical and cell morphological levels. RIN3 stimulated the formation of GTP-bound Rab31 in cell-free and in cell GEF activity assays. RIN3 also formed enlarged vesicles and tubular structures, where it colocalized with Rab31 in HeLa cells. In contrast, RIN3 did not exhibit any apparent effects on Rab21. We also found that serine to alanine substitutions in the sequences between SH2 and RIN family homology domain of RIN3 specifically abolished its GEF action on Rab31 but not Rab5. We examined whether RIN3 affects localization of the cation-dependent mannose 6-phosphate receptor (CD-MPR), which is transported between trans-Golgi network and endocytic compartments. We found that RIN3 partially translocates CD-MPR from the trans-Golgi network to peripheral vesicles and that this is dependent on its Rab31-GEF activity. These results indicate that RIN3 specifically acts as a GEF for Rab31.	[Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Katada, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	katada@mol.f.u-tokyo.ac.jp		Kajiho, Hiroaki/0000-0001-6376-7629	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants (to H. K., K. K., and T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science.	Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Hadano S, 2004, FEBS LETT, V575, P64, DOI 10.1016/j.febslet.2004.07.092; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hunker CM, 2006, EXP CELL RES, V312, P1106, DOI 10.1016/j.yexcr.2005.12.021; Hunker CM, 2006, BIOCHEM BIOPH RES CO, V340, P967, DOI 10.1016/j.bbrc.2005.12.099; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Kong C, 2007, J BIOL CHEM, V282, P15294, DOI 10.1074/jbc.M611538200; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mesa R, 2001, J CELL SCI, V114, P4041; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Saito K, 2005, METHOD ENZYMOL, V403, P276, DOI 10.1016/S0076-6879(05)03023-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 2001, GENOME BIOL, V2; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Suzuki-Utsunomiya K, 2007, BIOCHEM BIOPH RES CO, V354, P491, DOI 10.1016/j.bbrc.2006.12.229; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	49	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24364	24373		10.1074/jbc.M110.172445	http://dx.doi.org/10.1074/jbc.M110.172445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586568	hybrid, Green Published			2022-12-25	WOS:000292294900076
J	Kriebel, M; Metzger, J; Trinks, S; Chugh, D; Harvey, RJ; Harvey, K; Volkmer, H				Kriebel, Martin; Metzger, Jennifer; Trinks, Sabine; Chugh, Deepti; Harvey, Robert J.; Harvey, Kirsten; Volkmer, Hansjuergen			The Cell Adhesion Molecule Neurofascin Stabilizes Axo-axonic GABAergic Terminals at the Axon Initial Segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL BETA-1; INHIBITORY SYNAPSES; HETEROPHILIC INTERACTIONS; PYRAMIDAL NEURONS; GEPHYRIN; SUBUNITS; RANVIER; COLLYBISTIN; HIPPOCAMPUS; CHANDELIER	Cell adhesion molecules regulate synapse formation and maintenance via transsynaptic contact stabilization involving both extracellular interactions and intracellular postsynaptic scaffold assembly. The cell adhesion molecule neurofascin is localized at the axon initial segment of granular cells in rat dentate gyrus, which is mainly targeted by chandelier cells. Lentiviral shRNA-mediated knockdown of neurofascin in adult rat brain indicates that neurofascin regulates the number and size of postsynaptic gephyrin scaffolds, the number of GABA(A) receptor clusters as well as presynaptic glutamate decarboxylase-positive terminals at the axon initial segment. By contrast, overexpression of neurofascin in hippocampal neurons increases gephyrin cluster size presumably via stimulation of fibroblast growth factor receptor 1 signaling pathways.	[Kriebel, Martin; Metzger, Jennifer; Trinks, Sabine; Chugh, Deepti; Volkmer, Hansjuergen] Univ Tubingen, NMI, D-72770 Reutlingen, Germany; [Harvey, Robert J.; Harvey, Kirsten] Univ London, Dept Pharmacol, Sch Pharm, London WC1N 1AX, England; [Chugh, Deepti] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; University of London; University College London; University of London School of Pharmacy; Eberhard Karls University of Tubingen	Volkmer, H (corresponding author), Univ Tubingen, NMI, Markwiesenstr 55, D-72770 Reutlingen, Germany.	volkmer@nmi.de	Harvey, Robert/D-3994-2016; Volkmer, Hansjuergen/AAU-9641-2021	Harvey, Robert/0000-0001-5956-6664; Volkmer, Hansjuergen/0000-0002-3867-0603	European Union [LSHM-CT-2005-512012]; Bundesministerium fur Bildung und Forschung [0315512]; Medical Research Council [G0501258, G0800498]; Hertie-Institute for Clinical Brain Research; MRC [G0800498, G0501258] Funding Source: UKRI	European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hertie-Institute for Clinical Brain Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by European Union Grant LSHM-CT-2005-512012 and Bundesministerium fur Bildung und Forschung Grant 0315512 (to H. V.) and Medical Research Council Grants G0501258 and G0800498 (to K. H. and R. J. H.).; Supported by a scholarship from the Hertie-Institute for Clinical Brain Research.	Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hardwick C, 2005, BRAIN RES, V1031, P238, DOI 10.1016/j.brainres.2004.10.047; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kirschbaum K, 2009, J BIOL CHEM, V284, P28533, DOI 10.1074/jbc.M109.004440; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schultz C, 2006, MOL CELL NEUROSCI, V33, P68, DOI 10.1016/j.mcn.2006.06.008; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; SOMOGYI P, 1983, J NEUROSCI, V3, P1450; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Woodruff AR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00201; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	45	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24385	24393		10.1074/jbc.M110.212191	http://dx.doi.org/10.1074/jbc.M110.212191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576239	Green Published, hybrid			2022-12-25	WOS:000292294900078
J	Luo, XY; Prior, M; He, WX; Hu, XY; Tang, XY; Shen, WZ; Yadav, S; Kiryu-Seo, S; Miller, R; Trapp, BD; Yan, RQ				Luo, Xiaoyang; Prior, Marguerite; He, Wanxia; Hu, Xiangyou; Tang, Xiaoying; Shen, Weizhen; Yadav, Satya; Kiryu-Seo, Sumiko; Miller, Robert; Trapp, Bruce D.; Yan, Riqiang			Cleavage of Neuregulin-1 by BACE1 or ADAM10 Protein Produces Differential Effects on Myelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; ALPHA-SECRETASE; NEURAL DEVELOPMENT; PERIPHERAL-NERVE; APP; INHIBITORS; DOMAIN; SCHIZOPHRENIA; REMYELINATION	Neuregulin-1 (Nrg1) is encoded by a single gene and exists in naturally secreted and transmembrane isoforms. Nrg1 exerts its signaling activity through interaction with its cognate ErbB receptors. Multiple membrane-anchored Nrg1 isoforms, present in six different membrane topologies, must be processed by a protease to initiate a signaling cascade. Here, we demonstrate that BACE1 and ADAM10 can process type I and III Nrg1 at two adjacent sites. Our cleavage site mapping experiments showed that the BACE1 cleavage site is located eight amino acids downstream of the ADAM10 cleavage site, and this order of cleavage is the opposite of amyloid precursor protein cleavage by these two enzymes. Cleavages were further confirmed via optimized electrophoresis. Cleavage of type I or III Nrg1 by ADAM10 and BACE1 released a signaling-capable N-terminal fragment (ntf), either Nrg1-ntf alpha or Nrg1-ntf beta, which could similarly activate an ErbB receptor as evidenced by increased phosphorylation of Akt and ERK, two downstream signaling molecules. Although both Nrg1-ntf alpha and Nrg1-ntf beta could initiate a common signaling cascade, inhibition or down-regulation of ADAM10 alone in a co-culture system did not affect normal myelination, whereas specific inhibition of BACE1 impaired normal myelination. Thus, processing of Nrg1 by BACE1 appears to be more critical for regulating myelination. Our results imply that a significant inhibition of BACE1 could potentially impair Nrg1 signaling activity in vivo.	[Luo, Xiaoyang; Prior, Marguerite; He, Wanxia; Hu, Xiangyou; Tang, Xiaoying; Trapp, Bruce D.; Yan, Riqiang] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Kiryu-Seo, Sumiko] Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Osaka 5458585, Japan; [Miller, Robert] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Osaka Metropolitan University; Case Western Reserve University	Yan, RQ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org	Kiryu-Seo, Sumiko/M-8865-2014	Kiryu-Seo, Sumiko/0000-0001-6213-1258; Yan, Riqiang/0000-0001-7195-7617	National Multiple Sclerosis Society [RG4012]; American Health Assistance Foundation; National Institutes of Health [AG025493]; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Multiple Sclerosis Society Grant RG4012 and by an American Health Assistance Foundation Research Fellowship (to M. P.).; Supported by National Institutes of Health Grant AG025493. To whom correspondence should be addressed: Dept. of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-2690; Fax: 216-444-7927; E-mail: yanr@ccf.org.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Brady SF, 2004, BIOORG MED CHEM LETT, V14, P601, DOI 10.1016/j.bmcl.2003.11.061; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; Gersbacher MT, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-61; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jangouk P, 2009, GLIA, V57, P1765, DOI 10.1002/glia.20889; Kiryu-Seo S, 2010, J NEUROSCI, V30, P6658, DOI 10.1523/JNEUROSCI.5265-09.2010; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Neve RL, 2003, TRENDS NEUROSCI, V26, P461, DOI 10.1016/S0166-2236(03)00231-5; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pietrak BL, 2005, ANAL BIOCHEM, V342, P144, DOI 10.1016/j.ab.2005.04.019; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200	36	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23967	23974		10.1074/jbc.M111.251538	http://dx.doi.org/10.1074/jbc.M111.251538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576249	hybrid, Green Published			2022-12-25	WOS:000292294900039
J	Zhao, RB; Shin, DS; Diop-Bove, N; Ovits, CG; Goldman, ID				Zhao, Rongbao; Shin, Daniel Sanghoon; Diop-Bove, Ndeye; Ovits, Channa Gila; Goldman, I. David			Random Mutagenesis of the Proton-coupled Folate Transporter (SLC46A1), Clustering of Mutations, and the Bases for Associated Losses of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELA-CELL LINE; AMINO-ACID; MALABSORPTION; PCFT-SLC46A1; RESIDUES; GENE; TRANSLATION; INITIATION; REVEALS; CARRIER	Loss-of-function mutations in the proton-coupled folate transporter (PCFT, SLC46A1) result in the autosomal recessive disorder, hereditary folate malabsorption (HFM). Identification and characterization of HFM mutations provide a wealth of information on the structure-function relationship of this transporter. In the current study, PCR-based random mutagenesis was employed to generate unbiased loss-of-function mutations of PCFT, simulating the spectrum of alterations that might occur in the human disorder. A total of 26 mutations were generated and 4 were identical to HFM mutations. Eleven were base deletion or insertion mutations that led to a frameshift and, along with similar HFM mutations, are predominantly localized to two narrow regions of the pcft gene at the 5'-end. Base substitution mutations identified in the current study and HFM patients were largely distributed across the pcft gene. Elimination of the ATG initiation codon by a one-base substitution (G > A) did not result in a complete lack of translation at the same codon consistent with rare non-ATG translation initiation. Among six missense mutants evaluated, three mutant PCFTs were not detected at the plasma membrane, one mutation resulted in decreased binding to folate substrate, and one had a reduced rate of conformational change associated with substrate translocation. The remaining PCFT mutant had defects in both processes. These results broaden understanding of the regions of the pcft gene prone to base insertion and deletion and inform further approaches to the analysis of the structure-function of PCFT.	[Zhao, Rongbao] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zhao, RB (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	rzhao@aecom.yu.edu		Shin, Daniel/0000-0002-3784-5336	National Institutes of Health [CA-82621]; NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-82621.	Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; MAHADEO K, 2011, J PEDIAT IN PRESS; MAHADEO KM, 2010, GENEREVIEWS; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24150	24158		10.1074/jbc.M111.236539	http://dx.doi.org/10.1074/jbc.M111.236539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602279	Green Published, hybrid			2022-12-25	WOS:000292294900057
J	Carthy, JM; Garmaroudi, FS; Luo, ZS; McManus, BM				Carthy, Jon M.; Garmaroudi, Farshid S.; Luo, Zongshu; McManus, Bruce M.			Wnt3a Induces Myofibroblast Differentiation by Upregulating TGF-beta Signaling Through SMAD2 in a beta-Catenin-Dependent Manner	PLOS ONE			English	Article							SMOOTH-MUSCLE; TRANSFORMING GROWTH-FACTOR-BETA-1; PATHWAY; CANCER; EXPRESSION; DISEASE; KINASE; STROMA; CELLS	Growing evidence suggests the Wnt family of secreted glycoproteins and their associated signaling pathways, linked to development, are recapitulated during wound repair and regeneration events. However, the role of the Wnt pathway in such settings remains unclear. In the current study, we treated mouse fibroblasts with 250 ng/mL of recombinant Wnt3a for 72 hours and examined its affect on cell morphology and function. Wnt3a induced a spindle-like morphology in fibroblasts characterized by the increased formation of stress fibres. Wnt3a decreased the proliferation of fibroblasts, but significantly increased cell migration as well as fibroblast-mediated contraction of a collagen lattice. Wnt3a significantly increased the expression of TGF-beta and its associated signaling through SMAD2. Consistent with this, we observed significantly increased smooth muscle alpha-actin expression and incorporation of this contractile protein into stress fibres following Wnt3a treatment. Knockdown of beta-catenin using siRNA reversed the Wnt3a-induced smooth muscle alpha-actin expression, suggesting these changes were dependent on canonical Wnt signaling through beta-catenin. Neutralization of TGF-beta with a blocking antibody significantly inhibited the Wnt3a-induced smooth muscle alpha-actin expression, indicating these changes were dependent on the increased TGF-beta signaling. Collectively, this data strongly suggests Wnt3a promotes the formation of a myofibroblast-like phenotype in cultured fibroblasts, in part, by upregulating TGF-beta signaling through SMAD2 in a beta-catenin-dependent mechanism. As myofibroblasts are critical regulators of wound healing responses, these findings may have important implications for our understanding of normal and aberrant injury and repair events.	[Carthy, Jon M.; Garmaroudi, Farshid S.; Luo, Zongshu; McManus, Bruce M.] Univ British Columbia, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Carthy, JM (corresponding author), Univ British Columbia, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	bruce.mcmanus@hli.ubc.ca			Heart and Stroke Foundation of British Columbia; Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" [F08-00086]	Heart and Stroke Foundation of British Columbia; Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling"	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" F08-00086. (www.heartandstroke.ca) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; CARRE AL, PLAST RECONSTR SURG, V125, P74; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x; LAEREMANS H, CARDIOVASC RES, V87, P514; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARCHAND A, AGING CELL; Marchant D, 2009, J GEN VIROL, V90, P854, DOI 10.1099/vir.0.005868-0; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rezai N, 2005, LAB INVEST, V85, P982, DOI 10.1038/labinvest.3700302; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhao JS, 2009, TRENDS BIOTECHNOL, V27, P131, DOI 10.1016/j.tibtech.2008.11.007	32	121	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19809	10.1371/journal.pone.0019809	http://dx.doi.org/10.1371/journal.pone.0019809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611174	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200035
J	Corley, M; Hartsuiker, RJ				Corley, Martin; Hartsuiker, Robert J.			Why Um Helps Auditory Word Recognition: The Temporal Delay Hypothesis	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; SPONTANEOUS SPEECH; DISFLUENCIES; INFORMATION; LISTENERS; UH; HESITATIONS; INTEGRATION; SPEAKING; SET	Several studies suggest that speech understanding can sometimes benefit from the presence of filled pauses (uh, um, and the like), and that words following such filled pauses are recognised more quickly. Three experiments examined whether this is because filled pauses serve to delay the onset of upcoming words and these delays facilitate auditory word recognition, or whether the fillers themselves serve to signal upcoming delays in a way which informs listeners' reactions. Participants viewed pairs of images on a computer screen, and followed recorded instructions to press buttons corresponding to either an easy (unmanipulated, with a high-frequency name) or a difficult (visually blurred, low-frequency) image. In all three experiments, participants were faster to respond to easy images. In 50% of trials in each experiment, the name of the image was directly preceded by a delay; in the remaining trials an equivalent delay was included earlier in the instruction. Participants were quicker to respond when a name was directly preceded by a delay, regardless of whether this delay was filled with a spoken um, was silent, or contained an artificial tone. This effect did not interact with the effect of image difficulty, nor did it change over the course of each experiment. Taken together, our consistent finding that delays of any kind help word recognition indicates that natural delays such as fillers need not be seen as 'signals' to explain the benefits they have to listeners' ability to recognise and respond to the words which follow them.	[Corley, Martin] Univ Edinburgh, Sch Philosophy Psychol & Language Sci PPLS, Edinburgh, Midlothian, Scotland; [Hartsuiker, Robert J.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	University of Edinburgh; Ghent University	Corley, M (corresponding author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci PPLS, Edinburgh, Midlothian, Scotland.	Martin.Corley@ed.ac.uk	Hartsuiker, Robert J./N-1668-2019	Hartsuiker, Robert/0000-0002-3680-6765; Corley, Martin/0000-0001-7011-428X	University of Edinburgh	University of Edinburgh	This research was funded internally at the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold JE, 2004, PSYCHOL SCI, V15, P578, DOI 10.1111/j.0956-7976.2004.00723.x; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bailey KGD, 2003, J MEM LANG, V49, P183, DOI 10.1016/S0749-596X(03)00027-5; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; Collard P, 2008, J EXP PSYCHOL LEARN, V34, P696, DOI 10.1037/0278-7393.34.3.696; Corley M, 2007, COGNITION, V105, P658, DOI 10.1016/j.cognition.2006.10.010; Corley M, 2010, LANG COGNITIVE PROC, V25, P706, DOI 10.1080/01690960903512489; Ferreira F, 2004, COGNITIVE SCI, V28, P721, DOI 10.1016/j.cogsci.2003.10.006; HOWELL P, 1991, Q J EXP PSYCHOL-A, V43, P733, DOI 10.1080/14640749108400994; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; MacGregor LJ, 2010, NEUROPSYCHOLOGIA, V48, P3982, DOI 10.1016/j.neuropsychologia.2010.09.024; MARKEL N, 1990, LANG SOC, V19, P81, DOI 10.1017/S0047404500014123; MEHTA G, 1988, LANG SPEECH, V31, P135, DOI 10.1177/002383098803100203; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tree JEF, 2001, MEM COGNITION, V29, P320, DOI 10.3758/BF03194926; Tree JEF, 1999, J MEM LANG, V40, P280, DOI 10.1006/jmla.1998.2613; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032	27	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19792	10.1371/journal.pone.0019792	http://dx.doi.org/10.1371/journal.pone.0019792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611164	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200033
J	Sol, D; Griffin, AS; Bartomeus, I; Boyce, H				Sol, Daniel; Griffin, Andrea S.; Bartomeus, Ignasi; Boyce, Hayley			Exploring or Avoiding Novel Food Resources? The Novelty Conflict in an Invasive Bird	PLOS ONE			English	Article							ACRIDOTHERES-TRISTIS; INDIAN MYNAHS; INNOVATION; PREDICTS; PATTERNS; SUCCESS	For an animal invading a novel region, the ability to develop new behaviors should facilitate the use of novel food resources and hence increase its survival in the new environment. However, the need to explore new resources may entail costs such as exposing the animal to unfamiliar predators. These two opposing forces result in an exploration-avoidance conflict, which can be expected to interfere with the acquisition of new resources. However, its consequences should be less dramatic in highly urbanized environments where new food opportunities are common and predation risk is low. We tested this hypothesis experimentally by presenting three foraging tasks to introduced common mynas (Acridotheres tristis) from environments with low and high urbanization levels from Australia. Individuals from the highly urbanized environments, where mynas are both more opportunistic when foraging and less fearful to predators, resolved a technical task faster than those from less urbanized environments. These differences did not reflect innovative 'personalities' and were not confounded by sex, morphology or motivational state. Rather, the principal factors underlying differences in mynas' problem-solving ability were neophobic-neophilic responses, which varied across habitats. Thus, mynas seem to modulate their problem-solving ability according to the benefits and costs of innovating in their particular habitat, which may help us understand the great success of the species in highly urbanized environments.	[Sol, Daniel; Bartomeus, Ignasi] Autonomous Univ Barcelona, Ctr Ecol Res & Forestry Applicat CREAF, Bellaterra, Catalonia, Spain; [Sol, Daniel] CSIC, Spanish Natl Res Council, Ctr Adv Studies Blanes CEAB, Blanes, Spain; [Griffin, Andrea S.; Boyce, Hayley] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Newcastle	Sol, D (corresponding author), Autonomous Univ Barcelona, Ctr Ecol Res & Forestry Applicat CREAF, Bellaterra, Catalonia, Spain.	d.sol@creaf.uab.es	Bartomeus, Ignasi/F-2382-2010; Sol, Daniel/A-5238-2008; Galef, Bennett G/A-5678-2008; Griffin, Andrea S/GWM-8557-2022	Sol, Daniel/0000-0001-6346-6949; Griffin, Andrea S/0000-0003-4624-9904; Bartomeus, Ignasi/0000-0001-7893-4389	Proyecto de Investigacion [CGL2007-66257]; Spanish government [CSD 2008-00040]; Generalitat de Catalunya; Australian Research Council (ARC)	Proyecto de Investigacion; Spanish government(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Australian Research Council (ARC)(Australian Research Council)	Financial support was provided by a Proyecto de Investigacion (CGL2007-66257) and a Consolider project (CSD 2008-00040) from the Spanish government, a DURSI travel grant, a grant from the "Grup de Qualitat en Ecologia evolutiva, comportament i conservacio de la biodiversitat" from Generalitat de Catalunya, and an Australian Research Council (ARC) Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle J. L., 2007, AMOS USERS GUIDE VER; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Blumstein DT., 2010, JWATCHER SOFTWARE; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Crawley M. J, 2002, STAT COMPUTING INTRO; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg RS, 2003, ANIMAL INNOVATION; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2010, ANIM BEHAV, V79, P459, DOI 10.1016/j.anbehav.2009.11.029; Griffin AS, 2009, ANIM BEHAV, V78, P79, DOI 10.1016/j.anbehav.2009.03.012; HONE J, 1978, EMU, V78, P227, DOI 10.1071/MU9780227; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lever C., 2006, NATURALISED BIRDS WO; LIKER A, 2009, P NATL ACAD SCI US; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Mayr E., 1965, P29; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Reader S.M., 2003, ANIMAL INNOVATION; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tideman C. R., 2006, INDIAN MYNAH	31	155	157	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19535	10.1371/journal.pone.0019535	http://dx.doi.org/10.1371/journal.pone.0019535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611168	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200012
J	Su, XC; Jin, XG; Min, Y; Mo, LJ; Yang, JG				Su, Xianchuang; Jin, Xiaogang; Min, Yong; Mo, Linjian; Yang, Jiangang			A Curve Shaped Description of Large Networks, with an Application to the Evaluation of Network Models	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; COMMUNITY STRUCTURE; COMPLEX NETWORKS; SCALE-FREE; EVOLUTION; DYNAMICS; INTERNET; GENE	Background: Understanding the structure of complex networks is a continuing challenge, which calls for novel approaches and models to capture their structure and reveal the mechanisms that shape the networks. Although various topological measures, such as degree distributions or clustering coefficients, have been proposed to characterize network structure from many different angles, a comprehensive and intuitive representation of large networks that allows quantitative analysis is still difficult to achieve. Methodology/Principal Findings: Here we propose a mesoscopic description of large networks which associates networks of different structures with a set of particular curves, using breadth-first search. After deriving the expressions of the curves of the random graphs and a small-world-like network, we found that the curves possess a number of network properties together, including the size of the giant component and the local clustering. Besides, the curve can also be used to evaluate the fit of network models to real-world networks. We describe a simple evaluation method based on the curve and apply it to the Drosophila melanogaster protein interaction network. The evaluation method effectively identifies which model better reproduces the topology of the real network among the given models and help infer the underlying growth mechanisms of the Drosophila network. Conclusions/Significance: This curve-shaped description of large networks offers a wealth of possibilities to develop new approaches and applications including network characterization, comparison, classification, modeling and model evaluation, differing from using a large bag of topological measures.	[Su, Xianchuang; Jin, Xiaogang; Min, Yong; Mo, Linjian; Yang, Jiangang] Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Xianchuang; Jin, Xiaogang; Min, Yong; Yang, Jiangang] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Su, XC (corresponding author), Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China.	xiaogangj@cise.zju.edu.cn	Jin, Xiaogang/G-6994-2011		National Science Foundation of China [61070069, 60803110]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China grants 61070069 and 60803110 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achlioptas D., 2005, P 37 ANN ACM S THEOR, P694, DOI DOI 10.1145/1060590; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 2001, RANDOM GRAPHS, DOI 10.1017/CBO9780511814068.008; Dall'Asta L, 2006, THEOR COMPUT SCI, V355, P6, DOI 10.1016/j.tcs.2005.12.009; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Eckmann JP, 2002, P NATL ACAD SCI USA, V99, P5825, DOI 10.1073/pnas.032093399; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guclu H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066115; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Korniss G, 2003, SCIENCE, V299, P677, DOI 10.1126/science.1079382; Lakhina A, 2003, IEEE INFOCOM SER, P332; Li WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002541; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2010, TAXONOMY NETWORKS; Petermann T, 2004, EUR PHYS J B, V38, P201, DOI [10.1140/epjb/e2004-00021-5, 10.1140/epjb/e2004-00021-4]; PRICE DJD, 1965, SCIENCE, V149, P510; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061901	40	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19784	10.1371/journal.pone.0019784	http://dx.doi.org/10.1371/journal.pone.0019784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611192	Green Submitted, Green Published, gold			2022-12-25	WOS:000290657500021
J	Anand-Ivell, R; Hiendleder, S; Vinoles, C; Martin, GB; Fitzsimmons, C; Eurich, A; Hafen, B; Ivell, R				Anand-Ivell, Ravinder; Hiendleder, Stefan; Vinoles, Carolina; Martin, Graeme B.; Fitzsimmons, Carolyn; Eurich, Andrea; Hafen, Bettina; Ivell, Richard			INSL3 in the Ruminant: A Powerful Indicator of Gender- and Genetic-Specific Feto-Maternal Dialogue	PLOS ONE			English	Article							RELAXIN-LIKE FACTOR; INSULIN-LIKE FACTOR-3; FETAL GENDER; CIRCULATING HORMONE; BOVINE OVARY; Y-CHROMOSOME; BOS-TAURUS; FACTOR RLF; EXPRESSION; RECEPTOR	The hormone Insulin-like peptide 3 (INSL3) is a major secretory product of the Leydig cells from both fetal and adult testes. Consequently, it is a major gender-specific circulating hormone in the male fetus, where it is responsible for the first phase of testicular descent, and in the adult male. In most female mammals, circulating levels are very low, corresponding to only a small production of INSL3 by the mature ovaries. Female ruminants are exceptional in exhibiting high INSL3 gene expression by the thecal cells of antral follicles and by the corpora lutea. We have developed a specific and sensitive immunoassay to measure ruminant INSL3 and show that, corresponding to the high ovarian gene expression, non-pregnant adult female sheep and cows have up to four times the levels observed in other female mammals. Significantly, this level declines during mid-pregnancy in cows carrying a female fetus, in which INSL3 is undetectable. However, in cows carrying a male fetus, circulating maternal INSL3 becomes elevated further, presumably due to the transplacental transfer of fetal INSL3 into the maternal circulation. Within male fetal blood, INSL3 is high in mid-pregnancy (day 153) corresponding to the first transabdominal phase of testicular descent, and shows a marked dependence on paternal genetics, with pure bred or hybrid male fetuses of Bos taurus (Angus) paternal genome having 30% higher INSL3 levels than those of Bos indicus (Brahman) paternity. Thus INSL3 provides the first example of a gender-specific fetal hormone with the potential to influence both placental and maternal physiology.	[Anand-Ivell, Ravinder] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Anand-Ivell, Ravinder] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Anand-Ivell, Ravinder] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Hiendleder, Stefan; Fitzsimmons, Carolyn; Eurich, Andrea; Hafen, Bettina; Ivell, Richard] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Hiendleder, Stefan; Fitzsimmons, Carolyn] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Vinoles, Carolina; Martin, Graeme B.] Univ Western Australia, Sch Anim Biol M092, Fac Nat & Agr Sci, Crawley, WA, Australia; [Eurich, Andrea; Hafen, Bettina; Ivell, Richard] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of South Australia; University of South Australia; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Western Australia; University of Adelaide	Anand-Ivell, R (corresponding author), FBN Leibniz Inst Farm Anim Biol, Dummerstorf, Germany.	ivell@fbn-dummerstorf.de	Martin, Graeme B/A-2618-2008; Hiendleder, Stefan/J-8008-2012	Martin, Graeme B/0000-0002-1905-7934; Anand-Ivell, Ravinder/0000-0002-4976-4314; Ivell, Richard/0000-0001-6513-2109	JS Davies Bequest; Meat and Livestock Australia [MS. 027]; BioInnovation SA; Australian Research Council	JS Davies Bequest; Meat and Livestock Australia(Meat and Livestock Australia); BioInnovation SA; Australian Research Council(Australian Research Council)	SH is a JS Davies Fellow and part of this study was supported by the JS Davies Bequest. The authors are also grateful to Meat and Livestock Australia (Project MS. 027) for helping fund the sheep studies, and BioInnovation SA and the Australian Research Council for financial support to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Ivell R, 2008, HUM REPROD, V23, P1180, DOI 10.1093/humrep/den038; Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4; Bamberger AM, 1999, INT J GYNECOL PATHOL, V18, P163, DOI 10.1097/00004347-199904000-00011; Bathgate R, 1999, BIOL REPROD, V61, P1090, DOI 10.1095/biolreprod61.4.1090; Bathgate R, 1996, BIOL REPROD, V55, P1452, DOI 10.1095/biolreprod55.6.1452; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bay K, 2005, J CLIN ENDOCR METAB, V90, P3410, DOI 10.1210/jc.2004-2257; Bazzett LB, 1998, AM J MED GENET, V76, P369, DOI 10.1002/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Bullesbach EE, 2002, BIOCHEMISTRY-US, V41, P274, DOI 10.1021/bi0117302; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI [10.1359/jbmr.080204, 10.1359/JBMR.080204]; Fitzsimmons C, 2008, REPROD FERT DEVELOP, V20, P131, DOI 10.1071/RDv20n1Ab101; Foresta C, 2004, J CLIN ENDOCR METAB, V89, P5952, DOI 10.1210/jc.2004-0575; Gambineri A, 2007, J CLIN ENDOCR METAB, V92, P2066, DOI 10.1210/jc.2006-1678; Goldammer T, 1997, CYTOGENET CELL GENET, V77, P238, DOI 10.1159/000134584; Gray CA, 2000, BIOL REPROD, V62, P448, DOI 10.1095/biolreprod62.2.448; Havelock JC, 2005, FERTIL STERIL, V84, pS3, DOI 10.1016/j.fertnstert.2005.07.019; Heng K, 2008, MOL HUM REPROD, V14, P603, DOI 10.1093/molehr/gan051; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Hiendleder S, 2004, BIOL REPROD, V71, P217, DOI 10.1095/biolreprod.103.026062; Hombach-Klonisch S, 2000, MOL CELL ENDOCRINOL, V159, P147, DOI 10.1016/S0303-7207(99)00190-2; Hombach-Klonisch S, 2001, MOL HUM REPROD, V7, P349, DOI 10.1093/molehr/7.4.349; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Ivell R, 2006, TRENDS ENDOCRIN MET, V17, P123, DOI 10.1016/j.tem.2006.03.004; IVELL R, 1995, BIOL REPROD, V53, P553, DOI 10.1095/biolreprod53.3.553; Ivell R, LEYDIG CELL HLTH DIS, P279; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Kageyama S, 2004, J VET MED SCI, V66, P509, DOI 10.1292/jvms.66.509; Klonisch T, 2001, BIOL REPROD, V64, P442, DOI 10.1095/biolreprod64.2.442; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lowndes K, 2006, PLACENTA, V27, P610, DOI 10.1016/j.placenta.2005.07.011; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Quinones JN, 2005, AM J OBSTET GYNECOL, V193, P1233, DOI 10.1016/j.ajog.2005.05.053; R?sse I., 1991, LEHRBUCH EMBRYOLOGIE; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; STJEAN G, 1992, THERIOGENOLOGY, V38, P951, DOI 10.1016/0093-691X(92)90169-R; van der Westhuizen ET, 2010, MOL PHARMACOL, V77, P759, DOI 10.1124/mol.109.061432; Vodstrcil LA, 2007, REPROD FERT DEVELOP, V19, P530, DOI 10.1071/RD07007; Zarreh-Hoshyari-Khah MR, 1999, BIOL REPROD, V60, P445, DOI 10.1095/biolreprod60.2.445	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19821	10.1371/journal.pone.0019821	http://dx.doi.org/10.1371/journal.pone.0019821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603619	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000290656300030
J	Chen, SC; Frett, E; Marx, J; Bosnakovski, D; Reed, X; Kyba, M; Kennedy, BK				Chen, Steven C.; Frett, Ellie; Marx, Joseph; Bosnakovski, Darko; Reed, Xylena; Kyba, Michael; Kennedy, Brian K.			Decreased Proliferation Kinetics of Mouse Myoblasts Overexpressing FRG1	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; 4Q35 LOCUS; DNA REARRANGEMENTS; RNA PATHOGENESIS; GENE-EXPRESSION; MESSENGER-RNA; CYCLIN-E; FSHD; CELL	Although recent publications have linked the molecular events driving facioscapulohumeral muscular dystrophy (FSHD) to expression of the double homeobox transcription factor DUX4, overexpression of FRG1 has been proposed as one alternative causal agent as mice overexpressing FRG1 present with muscular dystrophy. Here, we characterize proliferative defects in two independent myoblast lines overexpressing FRG1. Myoblasts isolated from thigh muscle of FRG1 transgenic mice, an affected dystrophic muscle, exhibit delayed proliferation as measured by decreased clone size, whereas myoblasts isolated from the unaffected diaphragm muscle proliferated normally. To confirm the observation that overexpression of FRG1 could impair myoblast proliferation, we examined C2C12 myoblasts with inducible overexpression of FRG1, finding increased doubling time and G1-phase cells in mass culture after induction of FRG1 and decreased levels of pRb phosphorylation. We propose that depressed myoblast proliferation may contribute to the pathology of mice overexpressing FRG1 and may play a part in FSHD.	[Chen, Steven C.; Frett, Ellie; Marx, Joseph; Reed, Xylena; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Bosnakovski, Darko; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Bosnakovski, Darko; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Kennedy, Brian K.] Buck Inst Age Res, Novato, CA USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Buck Institute for Research on Aging	Chen, SC (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkennedy@buckinstitute.org	Bosnakovski, Darko/T-8292-2019	Kennedy, Brian/0000-0002-5754-1874; Kyba, Michael/0000-0002-5579-7534; Bosnakovski, Darko/0000-0002-7198-2019	Pacific Northwest Friends of FSHD; NIH [T32 HL007312]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	Pacific Northwest Friends of FSHD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Pacific Northwest Friends of FSHD. S.C.C. is supported by the cardiovascular pathology training grant NIH T32 HL007312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Barro M, 2008, J CELL MOL MED; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; D'Antona G, 2007, J PHYSIOL-LONDON, V584, P997, DOI 10.1113/jphysiol.2007.141481; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Hanel ML, DIFFERENTIATION; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lemmers RJ, SCIENCE, V329, P1650; Liu Q, J CELL SCI, V1116-1123; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; Masny PS, 2009, EUR J HUM GENET; Melone MAB, 2000, J CELL BIOCHEM, V76, P118; Mittelbronn M, 2008, BRAIN PATHOL, V18, P338, DOI 10.1111/j.1750-3639.2008.00123.x; Mumberg D, 1997, NUCLEIC ACIDS RES, V25, P2098, DOI 10.1093/nar/25.11.2098; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Porter DC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.23.e101; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; SEWING A, 1994, J CELL SCI, V107, P581; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386	59	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19780	10.1371/journal.pone.0019780	http://dx.doi.org/10.1371/journal.pone.0019780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603621	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000290656300027
J	Inacio, AS; Mesquita, KA; Baptista, M; Ramalho-Santos, J; Vaz, WLC; Vieira, OV				Inacio, Angela S.; Mesquita, Katia A.; Baptista, Marta; Ramalho-Santos, Joao; Vaz, Winchil L. C.; Vieira, Otilia V.			In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CATIONIC SURFACTANTS; HIV-INFECTION; CONTROLLED-TRIAL; LIPID-BILAYERS; DOSE-RESPONSE; NONOXYNOL 9; THERMODYNAMICS; MICROBICIDES; CELLS	Background: The need for woman-controlled, cheap, safe, effective, easy-to-use and easy-to-store topical applications for prophylaxis against sexually transmitted infections (STIs) makes surfactant-containing formulations an interesting option that requires a more fundamental knowledge concerning surfactant toxicology and structure-activity relationships. Methodology/Principal Findings: We report in vitro effects of surfactant concentration, exposure time and structure on the viability of mammalian cell types typically encountered in the vagina, namely, fully polarized and confluent epithelial cells, confluent but non-polarized epithelial-like cells, dendritic cells, and human sperm. Representatives of the different families of commercially available surfactants - nonionic (Triton X-100 and monolaurin), zwitterionic (DDPS), anionic (SDS), and cationic (C(n)TAB (n = 10 to 16), C12PB, and C(12)BZK) - were examined. Triton X-100, monolaurin, DDPS and SDS were toxic to all cell types at concentrations around their critical micelle concentration (CMC) suggesting a non-selective mode of action involving cell membrane destabilization and/or destruction. All cationic surfactants were toxic at concentrations far below their CMC and showed significant differences in their toxicity toward polarized as compared with non-polarized cells. Their toxicity was also dependent on the chemical nature of the polar head group. Our results suggest an intracellular locus of action for cationic surfactants and show that their structure-activity relationships could be profitably exploited for STI prophylaxis in vaginal gel formulations. The therapeutic indices comparing polarized epithelial cell toxicity to sperm toxicity for all surfactants examined, except C12PB and C(12)BZK, does not justify their use as contraceptive agents. C12PB and C(12)BZK are shown to have a narrow therapeutic index recommending caution in their use in contraceptive formulations. Conclusions/Significance: Our results contribute to understanding the mechanisms involved in surfactant toxicity, have a predictive value with regard to their safety, and may be used to design more effective and less harmful surfactants for use in topical applications for STI prophylaxis.	[Inacio, Angela S.; Mesquita, Katia A.; Baptista, Marta; Ramalho-Santos, Joao; Vieira, Otilia V.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Hosp Coimbra, Human Reprod Serv, Coimbra, Portugal; [Vaz, Winchil L. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Inacio, AS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	vieira@cnc.cj.uc.pt	Ramalho-Santos, João/F-8641-2012; Vieira, Otilia V/O-8660-2017; Vaz, Winchil/N-4320-2013; Santos, João/HHZ-5595-2022; Inácio, Ângela S./AAE-1653-2020; Vieira, O V/C-4860-2013; Mesquita, Katia/AAD-1225-2019	Ramalho-Santos, João/0000-0002-1172-4018; Vieira, Otilia V/0000-0003-4924-1780; Vaz, Winchil/0000-0002-3797-4330; Inácio, Ângela S./0000-0002-5401-8455; Mesquita, Katia/0000-0001-9832-5548	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT) [PTDC/SAU-MII/66285/2006, PTDC/BIA-BCM/112138/2009]; FCT [SFRH/BD/38397/2007, SFRH/BD/46078/2008]	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the research grants PTDC/SAU-MII/66285/2006 and PTDC/BIA-BCM/112138/2009 from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT). ASI is a holder of a doctoral fellowship (ref. SFRH/BD/38397/2007) from the FCT. MB is a holder of a doctoral fellowship (ref. SFRH/BD/46078/2008) from the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MSC, 2004, BIOPHYS J, V87, P353, DOI [10.1529/biophysj.104.040576, 10.1529/biophysi.104.040576]; Ackermann Leane, 2002, Health Care Women Int, V23, P163, DOI 10.1080/073993302753429031; Ayotte N, 2002, ADV THER, V19, P219, DOI 10.1007/BF02850362; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; BRITO RMM, 1986, ANAL BIOCHEM, V152, P250, DOI 10.1016/0003-2697(86)90406-9; Burns M, 1999, J THROMB THROMBOLYS, V7, P137, DOI 10.1023/A:1008829403320; BUTOR C, 1992, EXP CELL RES, V203, P115, DOI 10.1016/0014-4827(92)90046-B; Carpo Beatriz G, 2007, J Drugs Dermatol, V6, P991; Catalone BJ, 2005, ANTIMICROB AGENTS CH, V49, P1509, DOI 10.1128/AAC.49.4.1509-1520.2005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Dymond MK, 2008, LANGMUIR, V24, P11743, DOI 10.1021/la8017612; Ekelund K, 2005, J PHARM SCI-US, V94, P730, DOI 10.1002/jps.20283; Enomoto R, 2007, ANN NY ACAD SCI, V1095, P1, DOI 10.1196/annals.1397.001; Estronca LMBB, 2007, BIOPHYS J, V93, P4244, DOI 10.1529/biophysj.107.112847; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Finkel R, 2009, PHARMACOLOGY, P33; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GIROLOMONI G, 1995, EUR J IMMUNOL, V25, P2163, DOI 10.1002/eji.1830250807; Hitchcock PJ, 2000, SEXUALLY TRANSMITTED, P149; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Kopecky F, 1996, PHARMAZIE, V51, P135; Krebs FC, 1999, ANTIVIR RES, V43, P157, DOI 10.1016/S0166-3542(99)00044-3; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Masurier C, 1998, J VIROL, V72, P7822, DOI 10.1128/JVI.72.10.7822-7829.1998; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miller V, 1998, ANTIMICROB AGENTS CH, V42, P3123, DOI 10.1128/AAC.42.12.3123; Moreno MJ, 2006, BIOPHYS J, V91, P873, DOI 10.1529/biophysj.106.082115; Neves BM, 2008, TOXICOL LETT, V177, P74, DOI 10.1016/j.toxlet.2007.12.006; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Perani A, 2001, AMINO ACIDS, V21, P185, DOI 10.1007/s007260170025; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Piao J, 2006, COLLOID SURFACE A, V277, P15, DOI 10.1016/j.colsurfa.2005.10.053; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; Simoncic B, 1998, ACTA CHIM SLOV, V45, P143; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Spink CH, 1997, J AM CHEM SOC, V119, P10920, DOI 10.1021/ja964324s; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanford C., 1991, HYDROPHOBIC EFFECT F, pix; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS153, DOI 10.1097/01.olq.0000235177.30718.84; VED HS, 1990, LIPIDS, V25, P119, DOI 10.1007/BF02562216; Velarde G, 1999, TOXICOL IN VITRO, V13, P719, DOI 10.1016/S0887-2333(99)00055-7; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105; World Health Organization, 2007, GLOB STRAT PREV CONT; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Zhu DM, 2006, LANGMUIR, V22, P3735, DOI 10.1021/la052161s	64	88	91	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19850	10.1371/journal.pone.0019850	http://dx.doi.org/10.1371/journal.pone.0019850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603626	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300031
J	Caracciolo, L; Barbon, A; Palumbo, S; Mora, C; Toscano, CD; Bosetti, F; Barlati, S				Caracciolo, Luca; Barbon, Alessandro; Palumbo, Sara; Mora, Cristina; Toscano, Christopher D.; Bosetti, Francesca; Barlati, Sergio			Altered mRNA Editing and Expression of Ionotropic Glutamate Receptors after Kainic Acid Exposure in Cyclooxygenase-2 Deficient Mice	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; GLUR6 KAINATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; CEREBRAL-ISCHEMIA; NEURONAL DEATH; MEDIATED EXCITOTOXICITY; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; KINETIC-PROPERTIES	Kainic acid (KA) binds to the AMPA/KA receptors and induces seizures that result in inflammation, oxidative damage and neuronal death. We previously showed that cyclooxygenase-2 deficient (COX-2(-/-)) mice are more vulnerable to KA-induced excitotoxicity. Here, we investigated whether the increased susceptibility of COX-2(-/-) mice to KA is associated with altered mRNA expression and editing of glutamate receptors. The expression of AMPA GluR2, GluR3 and KA GluR6 was increased in vehicle-injected COX-2(-/-) mice compared to wild type (WT) mice in hippocampus and cortex, whereas gene expression of NMDA receptors was decreased. KA treatment decreased the expression of AMPA, KA and NMDA receptors in the hippocampus, with a significant effect in COX-2(-/-) mice. Furthermore, we analyzed RNA editing levels and found that the level of GluR3 R/G editing site was selectively increased in the hippocampus and decreased in the cortex in COX-2(-/-) compared with WT mice. After KA, GluR4 R/G editing site, flip form, was increased in the hippocampus of COX-2(-/-) mice. Treatment of WT mice with the COX-2 inhibitor celecoxib for two weeks decreased the expression of AMPA/KA and NMDAR subunits after KA, as observed in COX-2(-/-) mice. After KA exposure, COX-2(-/-) mice showed increased mRNA expression of markers of inflammation and oxidative stress, such as cytokines (TNF-alpha, IL-1 beta and IL-6), inducible nitric oxide synthase (iNOS), microglia (CD11b) and astrocyte (GFAP). Thus, COX-2 gene deletion can exacerbate the inflammatory response to KA. We suggest that COX-2 plays a role in attenuating glutamate excitotoxicity by modulating RNA editing of AMPA/KA and mRNA expression of all ionotropic glutamate receptor subunits and, in turn, neuronal excitability. These changes may contribute to the increased vulnerability of COX-2(-/-) mice to KA. The overstimulation of glutamate receptors as a consequence of COX-2 gene deletion suggests a functional coupling between COX-2 and the glutamatergic system.	[Caracciolo, Luca; Palumbo, Sara; Toscano, Christopher D.; Bosetti, Francesca] NIA, Mol Neurosci Unit, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA; [Caracciolo, Luca; Barbon, Alessandro; Mora, Cristina; Barlati, Sergio] Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Caracciolo, Luca; Barbon, Alessandro; Mora, Cristina; Barlati, Sergio] Univ Brescia, Natl Inst Neurosci, Brescia, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Brescia; University of Brescia	Caracciolo, L (corresponding author), NIA, Mol Neurosci Unit, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.	frances@mail.nih.gov	Barbon, Alessandro/E-7037-2010; Palumbo, Sara/B-1603-2013; Mora, Cristina/K-1222-2018	Barbon, Alessandro/0000-0002-1127-7764; Palumbo, Sara/0000-0002-3809-6058; Mora, Cristina/0000-0003-3896-7893	National Institute on Aging, National Institutes of Health	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Barbon A, 2007, EXP NEUROL, V208, P54, DOI 10.1016/j.expneurol.2007.07.009; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; BEAL MF, 1994, NEUROBIOL AGING, V15, P275; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; BERNARD A, 1994, J NEUROCHEM, V62, P2057, DOI 10.1046/j.1471-4159.1994.62052057.x; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Borbely S, 2009, NEUROSCIENCE, V159, P358, DOI 10.1016/j.neuroscience.2008.12.027; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1989, NEUROBIOL AGING, V10, P605, DOI 10.1016/0197-4580(89)90145-0; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Gascon S, 2005, J BIOL CHEM, V280, P35018, DOI 10.1074/jbc.M504108200; Gluck MR, 2000, EPILEPSY RES, V39, P63, DOI 10.1016/S0920-1211(99)00111-4; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grigorenko EV, 1998, NEUROREPORT, V9, P2219, DOI 10.1097/00001756-199807130-00013; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hou ST, 2002, INT REV CYTOL, V221, P93; ISHII T, 1993, J BIOL CHEM, V268, P2836; Katori M, 2000, INFLAMM RES, V49, P367, DOI 10.1007/s000110050605; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KORCZAK B, 1995, RECEPTOR CHANNEL, V3, P41; Kortenbruck G, 2001, NEUROBIOL DIS, V8, P459, DOI 10.1006/nbdi.2001.0394; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Milatovic D, 2002, BRAIN RES, V957, P330, DOI 10.1016/S0006-8993(02)03669-7; Minghetti Luisa, 2007, Subcell Biochem, V42, P127; Molinuevo Jose L, 2005, Am J Alzheimers Dis Other Demen, V20, P77, DOI 10.1177/153331750502000206; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Ohno K, 1997, NEUROCHEM INT, V31, P715, DOI 10.1016/S0197-0186(97)00011-9; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Pereno GI, 2010, BRAIN RES, V1328, P130, DOI 10.1016/j.brainres.2010.01.087; Rapoport SI, 2002, ARCH GEN PSYCHIAT, V59, P592, DOI 10.1001/archpsyc.59.7.592; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; SUN AY, 1992, PROG BRAIN RES, V94, P271; Sun AY, 1998, J BIOMED SCI, V5, P401; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Toscano CD, 2008, BRAIN RES BULL, V75, P598, DOI 10.1016/j.brainresbull.2007.10.004; Toscano CD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r14; Vollmar W, 2004, NEUROBIOL DIS, V15, P371, DOI 10.1016/j.nbd.2003.11.006; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; WEISS JH, 1991, CAN J NEUROL SCI, V18, P394, DOI 10.1017/S0317167100032522; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	66	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19398	10.1371/journal.pone.0019398	http://dx.doi.org/10.1371/journal.pone.0019398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589914	Green Submitted, gold, Green Published			2022-12-25	WOS:000290531100007
J	McAlpin, S; Duckett, P; Stow, A				McAlpin, Steve; Duckett, Paul; Stow, Adam			Lizards Cooperatively Tunnel to Construct a Long-Term Home for Family Members	PLOS ONE			English	Article							MICROSATELLITE LOCI; EGERNIA; EVOLUTION; SYSTEMATICS; SOCIALITY; INFERENCE	Constructing a home to protect offspring while they mature is common in many vertebrate groups, but has not previously been reported in lizards. Here we provide the first example of a lizard that constructs a long-term home for family members, and a rare case of lizards behaving cooperatively. The great desert skink, Liopholis kintorei from Central Australia, constructs an elaborate multi-tunnelled burrow that can be continuously occupied for up to 7 years. Multiple generations participate in construction and maintenance of burrows. Parental assignments based on DNA analysis show that immature individuals within the same burrow were mostly full siblings, even when several age cohorts were present. Parents were always captured at burrows containing their offspring, and females were only detected breeding with the same male both within- and across seasons. Consequently, the individual investments made to construct or maintain a burrow system benefit their own offspring, or siblings, over several breeding seasons.	[McAlpin, Steve; Duckett, Paul; Stow, Adam] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	McAlpin, S (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	adam.stow@mq.edu.au		Stow, Adam/0000-0002-6796-4854	Parks Australia; Macquarie University	Parks Australia; Macquarie University	Funding and considerable in kind support was provided by Parks Australia for all monitoring and the direct observations of lizard behaviour carried out at Uluru - Kata Tjuta National Park, Northern Territory, Australia. Parks Australia designed the monitoring program for Liopholis kintorei; data for the monitoring program was collected by the first author under contract to Parks Australia. Macquarie University funded most of the collection and analysis of genetic material used in this study. This paper results from the partnership between Parks Australia and Macquarie University. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; DAVIS AR, 2010, P R SOC LONDON B; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Gardner MG, 1999, J HERED, V90, P301, DOI 10.1093/jhered/90.2.301; Gardner MG, 2008, ZOOL J LINN SOC-LOND, V154, P781, DOI 10.1111/j.1096-3642.2008.00422.x; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McAlpin S., 2001, RECOVERY PLAN GREAT; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; O'Connor D, 2003, MOL ECOL, V12, P743, DOI 10.1046/j.1365-294X.2003.01777.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Stow AJ, 2002, MOL ECOL NOTES, V2, P256, DOI 10.1046/j.1471-8286.2002.00209.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; While GM, 2009, BEHAV ECOL, V20, P245, DOI 10.1093/beheco/arp015	22	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19041	10.1371/journal.pone.0019041	http://dx.doi.org/10.1371/journal.pone.0019041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589923	Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600006
J	Isogai, E; Ohira, M; Ozaki, T; Oba, S; Nakamura, Y; Nakagawara, A				Isogai, Eriko; Ohira, Miki; Ozaki, Toshinori; Oba, Shigeyuki; Nakamura, Yohko; Nakagawara, Akira			Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; LIM DOMAIN; IN-VITRO; GENE; DIFFERENTIATION; PROTEINS; ACTS; MICE	Expression of Mash1 is dysregulated in human neuroblastoma. We have also reported that LMO3 (LIM-only protein 3) has an oncogenic potential in collaboration with neuronal transcription factor HEN2 in neuroblastoma. However, the precise molecular mechanisms of its transcriptional regulation remain elusive. Here we found that LMO3 forms a complex with HEN2 and acts as an upstream mediator for transcription of Mash1 in neuroblastoma. The high levels of LMO3 or Mash1 mRNA expression were significantly associated with poor prognosis in 100 primary neuroblastomas. The up-regulation of Mash1 remarkably accelerated the proliferation of SH-SY5Y neuroblastoma cells, while siRNA-mediated knockdown of LMO3 induced inhibition of growth of SH-SY5Y cells in association with a significant down-regulation of Mash1. Additionally, overexpression of both LMO3 and HEN2 induced expression of Mash1, suggesting that they might function as a transcriptional activator for Mash1. Luciferase reporter assay demonstrated that the co-expression of LMO3 and HEN2 attenuates HES1 (a negative regulator for Mash1)-dependent reduction of luciferase activity driven by the Mash1 promoter. Chromatin immunoprecipitation assay revealed that LMO3 and HEN2 reduce the amount of HES1 recruited onto putative HES1-binding sites and E-box within the Mash1 promoter. Furthermore, both LMO3 and HEN2 are physically associated with HES1 by immunoprecipitation assay. Thus, our present results suggest that a transcriptional complex of LMO3 and HEN2 may contribute to the genesis and malignant phenotype of neuroblastoma by inhibiting HES1 which suppresses the transactivation of Mash1.	[Isogai, Eriko; Nakamura, Yohko; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh ku, Chiba, Japan; [Isogai, Eriko; Ohira, Miki] Chiba Canc Ctr Res Inst, Lab Canc Gen, Chuoh ku, Chiba, Japan; [Ozaki, Toshinori] Chiba Canc Ctr Res Inst, Lab Antitumor Res, Chuoh ku, Chiba, Japan; [Oba, Shigeyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Integrated Syst Biol Lab, Kyoto, Japan	Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center; Kyoto University	Isogai, E (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh ku, Chiba, Japan.	akiranak@chiba-cc.jp			Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21591376, 21390317] Funding Source: KAKEN	Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BAGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38; Bao JX, 2000, DEVELOPMENT, V127, P425; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BROWN L, 1994, MOL CELL BIOL, V14, P1245, DOI 10.1128/MCB.14.2.1245; Gestblom C, 1999, LAB INVEST, V79, P67; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P132, DOI 10.1002/1096-911X(20010101)36:1<132::AID-MPO1031>3.0.CO;2-A; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Lanigan TM, 1998, J NEUROBIOL, V34, P126, DOI 10.1002/(SICI)1097-4695(19980205)34:2<126::AID-NEU3>3.0.CO;2-4; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; NAKAGAWARA A, 2004, PROGR BRAIN RES, P14633; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Watt F, 2007, CANCER GENE THER, V14, P287, DOI 10.1038/sj.cgt.7701012; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783	25	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19297	10.1371/journal.pone.0019297	http://dx.doi.org/10.1371/journal.pone.0019297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573214	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400005
J	Bascove, M; Gueguinou, N; Schaerlinger, B; Gauquelin-Koch, G; Frippiat, JP				Bascove, Matthieu; Gueguinou, Nathan; Schaerlinger, Berenice; Gauquelin-Koch, Guillemette; Frippiat, Jean-Pol			Decrease in antibody somatic hypermutation frequency under extreme, extended spaceflight conditions	FASEB JOURNAL			English	Article						microgravity; immune response; immunoglobulin; affinity maturation; B lymphocytes	AMPHIBIAN PLEURODELES-WALTL; INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY-CHAINS; T-CELL-ACTIVATION; GENE-EXPRESSION; AFFINITY MATURATION; HUMAN-LYMPHOCYTES; SPACE-FLIGHT; TERM SPACEFLIGHT; ANTIGEN RECEPTOR	Somatic hypermutation diversifies antibody binding sites by introducing point mutations in the variable domains of rearranged immunoglobulin genes. In this study, we analyzed somatic hypermutation in variable heavy-chain (VH) domains of specific IgM antibodies of the urodele amphibian Pleurodeles waltl, immunized either on Earth or onboard the Mir space station. To detect somatic hypermutation, we aligned the variable domains of IgM heavy-chain transcripts with the corresponding VH gene. We also quantified NF-kappa B and activation-induced cytidine deaminase transcripts. Results were compared with those obtained using control animals immunized on Earth. Our data show that, as in most species of ectotherms, somatic hypermutation in P. waltl exhibits a mutational bias toward G and C bases. Furthermore, we show for the first time that somatic hypermutation occurs in space following immunization but at a lower frequency. This decrease is not due to a decrease in food intake or of the B-cell receptor/antigen interaction or to the absence of the germinal center-associated nuclear protein. It likely results from the combination of several spaceflight-associated changes, such as the severe reduction in T-cell activation, important perturbations of the cytoskeleton, and changes in the distribution of lymphocyte subpopulations and adhesion molecule expression.-Bascove, M., Gueguinou, N., Schaerlinger, B., Gauquelin-Koch, G., Frippiat, J.-P. Decrease in antibody somatic hypermutation frequency under extreme, extended spaceflight conditions. FASEB J. 25, 2947-2955 (2011). www.fasebj.org	[Frippiat, Jean-Pol] Nancy Univ, Fac Med Dev & Immunogenet, JE 2537, F-54500 Vandoeuvre Les Nancy, France; [Gauquelin-Koch, Guillemette] French Natl Space Agcy, Paris, France	Universite de Lorraine	Frippiat, JP (corresponding author), Nancy Univ, Fac Med Dev & Immunogenet, JE 2537, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@scbiol.uhp-nancy.fr	Schaerlinger, Berenice/AAU-8024-2021	Schaerlinger, Berenice/0000-0002-7449-2752; Frippiat, Jean-Pol/0000-0002-4027-6269	French National Space Agency (CNES); National Research Agency [ANR NT09-632666]; French Ministry of Higher Education and Research; University of Nancy	French National Space Agency (CNES)(Centre National D'etudes Spatiales); National Research Agency(French National Research Agency (ANR)); French Ministry of Higher Education and Research; University of Nancy	The authors thank the French cosmonaut J.-P. Haignere for performing the Genesis experiment onboard the Mir space station; Prof. A. Dalloul for critical reading and suggestions; our Russian colleagues for the preparation of the space mission; and the French National Space Agency (CNES), the National Research Agency (ANR NT09-632666), the French Ministry of Higher Education and Research, and the University of Nancy for financial support.	Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2010, MOL IMMUNOL, V47, P1640, DOI 10.1016/j.molimm.2010.01.005; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; COGOLIGREUTER M, 2004, J GRAVIT PHYSL, V11, P53; Criscitiello MF, 2007, EUR J IMMUNOL, V37, P2683, DOI 10.1002/eji.200737263; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Diaz M, 1999, INT IMMUNOL, V11, P825, DOI 10.1093/intimm/11.5.825; Dorner T, 1997, J IMMUNOL, V158, P2779; Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GONZALEZFERNANDEZ A, 1994, P NATL ACAD SCI USA, V91, P12614, DOI 10.1073/pnas.91.26.12614; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hashemi BB, 1999, FASEB J, V13, P2071, DOI 10.1096/fasebj.13.14.2071; HINDSFREY KR, 1993, J EXP MED, V178, P815, DOI 10.1084/jem.178.3.815; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford M, 2006, J CELL BIOCHEM, V99, P435, DOI 10.1002/jcb.20883; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Kuwahara K, 2004, P NATL ACAD SCI USA, V101, P1010, DOI 10.1073/pnas.0307609100; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Lebsack TW, 2010, J CELL BIOCHEM, V110, P372, DOI 10.1002/jcb.22547; Lee SS, 2002, IMMUNITY, V16, P571, DOI 10.1016/S1074-7613(02)00300-X; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Marr S, 2007, J IMMUNOL, V179, P6783, DOI 10.4049/jimmunol.179.10.6783; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Maule Jake, 2003, J Gravit Physiol, V10, P47; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pippia P, 1996, J BIOTECHNOL, V47, P215, DOI 10.1016/0168-1656(96)01387-9; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Sonnenfeld G, 1992, J APPL PHYSIOL, V73, p191S; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; Wilson M, 1995, DEV IMMUNOL, V4, P227, DOI 10.1155/1995/38639; Yang FX, 2006, J IMMUNOL, V176, P1655, DOI 10.4049/jimmunol.176.3.1655; YELAMOS J, 1995, NATURE, V376, P225	63	30	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2947	2955		10.1096/fj.11-185215	http://dx.doi.org/10.1096/fj.11-185215			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21593434				2022-12-25	WOS:000294435200010
J	Soesanto, Y; Luo, B; Parker, G; Jones, D; Cooksey, RC; McClain, DA				Soesanto, Yudi; Luo, Bai; Parker, Glendon; Jones, Deborah; Cooksey, Robert C.; McClain, Donald A.			Pleiotropic and Age-dependent Effects of Decreased Protein Modification by O-Linked N-Acetylglucosamine on Pancreatic beta-Cell Function and Vascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; STIMULATED INSULIN-SECRETION; TRANSGENIC MICE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; CYTOSOLIC PROTEINS; GLYCOGEN-SYNTHASE; VEGF-A; GLUCOSE; GLCNAC; EXPRESSION	The hexosamine biosynthesis pathway (HBP) regulates the post-translational modification of nuclear and cytoplasmic protein by O-linked N-acetylglucosamine (O-GlcNAc). Numerous studies have demonstrated increased flux through this pathway contributes to the development of beta-cell dysfunction. The effect of decreased O-GlcNAc on the maintenance of normal beta-cell function, however, is not well understood. We studied transgenic mice that over express beta-N-acetylglucosaminidase (O-GlcNAcase), an enzyme that catalyzes the removal of O-GlcNAc from proteins, in the pancreatic beta-cell under control of the rat insulin promoter. 3-4-Month-old O-GlcNAcase transgenic mice have higher glucose excursions with a concomitant decrease in circulating insulin levels, insulin mRNA levels, and total islet insulin content. In older (8-9-month-old) O-GlcNAcase transgenic mice glucose tolerance is no longer impaired. This is associated with increased serum insulin, islet insulin content, and insulin mRNA in the O-GlcNAcase transgenic mice. These improvements in beta-cell function with aging are associated with increased angiogenesis and increased VEGF expression, with parallel increases in activation of Akt and expression of PGC1 alpha. The biphasic effects as a function of age are consistent with published observations of mice with increased O-GlcNAc in islets and demonstrate that O-GlcNAc signaling exerts multiple effects on both insulin secretion and islet survival.	[McClain, Donald A.] Univ Utah, Div Endocrinol, Dept Biochem, Sch Med, Salt Lake City, UT 84132 USA; [Soesanto, Yudi; Luo, Bai; Parker, Glendon; Jones, Deborah; Cooksey, Robert C.; McClain, Donald A.] Univ Utah, Dept Internal Med, Sch Med, Salt Lake City, UT 84132 USA; [McClain, Donald A.] Vet Adm Med Ctr, Res Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Div Endocrinol, Dept Biochem, Sch Med, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health [DK-43526, UL1-RR025764, C06-RR11234]; Research Service of the Veterans Administration; Robinson Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011234, UL1RR025764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842, R29DK043526, R01DK043526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Veterans Administration; Robinson Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-43526, UL1-RR025764, and C06-RR11234 and the Research Service of the Veterans Administration. This work was also supported by the Robinson Family Foundation.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Cooksey RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE334, DOI 10.1152/ajpendo.00265.2005; Cooksey RC, 1999, ENDOCRINOLOGY, V140, P1151, DOI 10.1210/en.140.3.1151; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hanover JA, 2010, CHEM BIOL, V17, P1272, DOI 10.1016/j.chembiol.2010.12.001; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kaneto H, 2001, J BIOL CHEM, V276, P31099, DOI 10.1074/jbc.M104115200; Kidszun A, 2006, CELL TRANSPLANT, V15, P489, DOI 10.3727/000000006783981774; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KURODA M, 1995, J CLIN ENDOCR METAB, V80, P3196, DOI 10.1210/jc.80.11.3196; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Tang JP, 2000, DIABETES, V49, P1492, DOI 10.2337/diabetes.49.9.1492; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Vosseller K, 2010, AGING-US, V2, P749, DOI 10.18632/aging.100225; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035	43	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26118	26126		10.1074/jbc.M111.249508	http://dx.doi.org/10.1074/jbc.M111.249508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622566	Green Published, hybrid			2022-12-25	WOS:000293073000069
J	Gregor, CR; Cerasoli, E; Schouten, J; Ravi, J; Slootstra, J; Horgan, A; Martyna, GJ; Ryadnov, MG; Davis, P; Crain, J				Gregor, Craig R.; Cerasoli, Eleonora; Schouten, James; Ravi, Jascindra; Slootstra, Jerry; Horgan, Adrian; Martyna, Glenn J.; Ryadnov, Maxim G.; Davis, Paul; Crain, Jason			Antibody Recognition of a Human Chorionic Gonadotropin Epitope (hCG beta(66-80)) Depends on Local Structure Retained in the Free Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN HORMONES; SECONDARY STRUCTURE; HCG; PROTEINS; STANDARDIZATION; IMMUNOASSAYS; ASSIGNMENT; PREGNANCY; SUBUNITS; DYNAMICS	Human chorionic gonadotropin (hCG) is an important biomarker in pregnancy and oncology, where it is routinely detected and quantified by specific immunoassays. Intelligent epitope selection is essential to achieving the required assay performance. We present binding affinity measurements demonstrating that a typical beta 3-loop-specific monoclonal antibody (8G5) is highly selective in competitive immunoassays and distinguishes between hCG beta(66-80) and the closely related luteinizing hormone (LH) fragment LH beta(86-100), which differ only by a single amino acid residue. A combination of optical spectroscopic measurements and atomistic computer simulations on these free peptides reveals differences in turn type stabilized by specific hydrogen bonding motifs. We propose that these structural differences are the basis for the observed selectivity in the full protein.	[Gregor, Craig R.; Ryadnov, Maxim G.; Crain, Jason] Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; [Cerasoli, Eleonora; Ravi, Jascindra; Horgan, Adrian; Ryadnov, Maxim G.; Crain, Jason] Natl Phys Lab, Teddington TW11 0WL, Middx, England; [Schouten, James; Davis, Paul] Mologic Ltd, Sharnbrook MK44 1LQ, Beds, England; [Slootstra, Jerry] Pepscan Presto BV, NL-8243 RC Lelystad, Netherlands; [Martyna, Glenn J.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	University of Edinburgh; National Physical Laboratory - UK; Pepscan Therapeutics B.V.; International Business Machines (IBM)	Crain, J (corresponding author), Univ Edinburgh, Sch Phys, Mayfield Rd, Edinburgh EH9 3JZ, Midlothian, Scotland.	jason.crain@npl.co.uk			National Physical Laboratory; Engineering and Physical Sciences Research Council	National Physical Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Strategic Research Programme of the National Physical Laboratory and the Engineering and Physical Sciences Research Council.	BANDEKAR J, 1979, P NATL ACAD SCI USA, V76, P774, DOI 10.1073/pnas.76.2.774; Berger P, 2002, TUMOR BIOL, V23, P1, DOI 10.1159/000048686; BIRKEN S, 1988, ENDOCRINOLOGY, V123, P572, DOI 10.1210/endo-123-1-572; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cole LA, 2007, PLACENTA, V28, P977, DOI 10.1016/j.placenta.2007.01.011; Elliott MM, 1997, ENDOCRINE, V7, P15, DOI 10.1007/BF02778058; Gronowski AM, 2009, CLIN CHEM, V55, P1447, DOI 10.1373/clinchem.2009.129205; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lund T, 1998, REV REPROD, V3, P71, DOI 10.1530/ror.0.0030071; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meloen R. H., 1997, IMMUNOLOGY METHODS M, P982; Mitchell H, 2007, MOL CELL ENDOCRINOL, V260, P310, DOI 10.1016/j.mce.2006.09.003; OCONNOR JF, 1994, ENDOCR REV, V15, P650, DOI 10.1210/er.15.5.650; OZTURK M, 1987, ENDOCRINOLOGY, V120, P549, DOI 10.1210/endo-120-2-549; OZTURK M, 1988, AM J OBSTET GYNECOL, V158, P193, DOI 10.1016/0002-9378(88)90809-5; PERCZEL A, 1992, PROTEIN SCI, V1, P378; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PIERCE JG, 1971, ENDOCRINOLOGY, V89, P1331, DOI 10.1210/endo-89-6-1331; Samuelson S, 1997, J PHYS CHEM B, V101, P7592, DOI 10.1021/jp9704269; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Stenman UH, 2001, CLIN CHEM, V47, P815; Sturgeon CM, 2009, CLIN CHEM, V55, P1484, DOI 10.1373/clinchem.2009.124578; Sturgeon CM, 1998, ANN CLIN BIOCHEM, V35, P460, DOI 10.1177/000456329803500402; Tuckerman ME, 2000, COMPUT PHYS COMMUN, V128, P333, DOI 10.1016/S0010-4655(00)00077-1; Valenti LE, 2011, ANAL BIOCHEM, V410, P118, DOI 10.1016/j.ab.2010.11.006; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	28	4	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25016	25026		10.1074/jbc.M111.246637	http://dx.doi.org/10.1074/jbc.M111.246637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592960	Green Published, hybrid			2022-12-25	WOS:000292547900050
J	Kilmartin, JR; Maher, MJ; Krusong, K; Noble, CJ; Hanson, GR; Bernhardt, PV; Riley, MJ; Kappler, U				Kilmartin, James R.; Maher, Megan J.; Krusong, Kuakarun; Noble, Christopher J.; Hanson, Graeme R.; Bernhardt, Paul V.; Riley, Mark J.; Kappler, Ulrike			Insights into Structure and Function of the Active Site of SoxAX Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTROPIC SULFUR-OXIDATION; MAGNETIC CIRCULAR-DICHROISM; CHARGE-TRANSFER TRANSITIONS; PARACOCCUS-PANTOTROPHUS; THIOSULFATE OXIDATION; PROTEIN; MODEL; IDENTIFICATION; HEMOPROTEINS; REFINEMENT	SoxAX cytochromes catalyze the formation of heterodisulfide bonds between inorganic sulfur compounds and a carrier protein, SoxYZ. They contain unusual His/Cys-ligated heme groups with complex spectroscopic signatures. The heme-ligating cysteine has been implicated in SoxAX catalysis, but neither the SoxAX spectroscopic properties nor its catalysis are fully understood at present. We have solved the first crystal structure for a group 2 SoxAX protein (SnSoxAX), where an N-terminal extension of SoxX forms a novel structure that supports dimer formation. Crystal structures of SoxAX with a heme ligand substitution (C236M) uncovered an inherent flexibility of this SoxA heme site, with both bonding distances and relative ligand orientation differing between asymmetric units and the new residue, Met(236), representing an unusual rotamer of methionine. The flexibility of the SnSoxAX(C236M) SoxA heme environment is probably the cause of the four distinct, new EPR signals, including a high spin ferric heme form, that were observed for the enzyme. Despite the removal of the catalytically active cysteine heme ligand and drastic changes in the redox potential of the SoxA heme (WT, -479 mV; C236M, +85 mV), the substituted enzyme was catalytically active in glutathione-based assays although with reduced turnover numbers (WT, 3.7 s(-1); C236M, 2.0 s(-1)). SnSoxAX(C236M) was also active in assays using SoxYZ and thiosulfate as the sulfur substrate, suggesting that Cys(236) aids catalysis but is not crucial for it. The SoxYZ-based SoxAX assay is the first assay for an isolated component of the Sox multienzyme system.	[Kilmartin, James R.; Bernhardt, Paul V.; Riley, Mark J.; Kappler, Ulrike] Univ Queensland, Sch Chem & Mol Biosci, Ctr Met Biol, St Lucia, Qld 4072, Australia; [Noble, Christopher J.; Hanson, Graeme R.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Maher, Megan J.] Centenary Inst, Struct Biol Program, Sydney, NSW 2042, Australia; [Maher, Megan J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Krusong, Kuakarun] Chulalongkorn Univ, Dept Biochem, Bangkok 10330, Thailand	University of Queensland; University of Queensland; University of Sydney; Centenary Institute; University of Sydney; Chulalongkorn University	Kappler, U (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Ctr Met Biol, St Lucia, Qld 4072, Australia.	u.kappler@uq.edu.au	Maher, Megan/B-2239-2012; Riley, Mark/E-1251-2011; Kappler, Ulrike/A-9483-2013; Bernhardt, Paul V/J-8008-2013; /C-3940-2008	Kappler, Ulrike/0000-0002-2642-1319; Bernhardt, Paul V/0000-0001-6839-1763; /0000-0003-0306-4360; Maher, Megan/0000-0003-0848-9640	Australian Research Council [DP0878525]; Society of Biological Inorganic Chemistry; Biotechnology and Biological Sciences Research Council [BB/C51725]; European Membrane Protein Consortium [LSHG-CT-2004-504601]; Cancer Institute of New South Wales	Australian Research Council(Australian Research Council); Society of Biological Inorganic Chemistry(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Membrane Protein Consortium; Cancer Institute of New South Wales	This work was supported by Australian Research Council Grant and Fellowship DP0878525 (to U. K.).; Recipient of a Society of Biological Inorganic Chemistry travel award.; Supported by Biotechnology and Biological Sciences Research Council Grant BB/C51725, European Membrane Protein Consortium Grant LSHG-CT-2004-504601, and a Cancer Institute of New South Wales Career Development Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frausto da Silva J. J. R., 2001, BIOL CHEM ELEMENTS I, P370; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kappler U, 2005, FEBS LETT, V579, P2491, DOI 10.1016/j.febslet.2005.03.060; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Kappler U, 2006, BIOCHEMISTRY-US, V45, P9696, DOI 10.1021/bi060058b; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa T, 2008, J BACTERIOL, V190, P6097, DOI 10.1128/JB.00634-08; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Quentmeier A, 2008, FEBS LETT, V582, P3701, DOI 10.1016/j.febslet.2008.09.043; Quentmeier A, 2007, BIOCHEMISTRY-US, V46, P10990, DOI 10.1021/bi700378k; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spilotros A, 2010, BIOPHYS CHEM, V147, P8, DOI 10.1016/j.bpc.2009.12.001; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; THOMSON AJ, 1990, J CHEM SOC DALTON, P1921, DOI 10.1039/dt9900001921; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Wilson JJ, 2009, BBA-BIOENERGETICS, V1787, P1516, DOI 10.1016/j.bbabio.2009.07.005	48	17	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24872	24881		10.1074/jbc.M110.212183	http://dx.doi.org/10.1074/jbc.M110.212183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592966	Green Published, hybrid			2022-12-25	WOS:000292547900037
J	Park, E; Iaccarino, C; Lee, J; Kwon, I; Baik, SM; Kim, M; Seong, JY; Son, GH; Borrelli, E; Kim, K				Park, Eonyoung; Iaccarino, Ciro; Lee, Jiwon; Kwon, Ilmin; Baik, Sun Mi; Kim, Myungjin; Seong, Jae Young; Son, Gi Hoon; Borrelli, Emiliana; Kim, Kyungjin			Regulatory Roles of Heterogeneous Nuclear Ribonucleoprotein M and Nova-1 Protein in Alternative Splicing of Dopamine D2 Receptor Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; RIBONUCLEIC-ACID; D-2; DROSOPHILA; ENHANCER; BRAIN; MICE; SPECIFICITY; INCLUSION; ISOFORMS	The dopamine D2 receptor (D2R) plays a crucial role in the regulation of diverse key physiological functions, including motor control, reward, learning, and memory. This receptor is present in vivo in two isoforms, D2L and D2S, generated from the same gene by alternative pre-mRNA splicing. Each isoform has a specific role in vivo, underlining the importance of a strict control of its synthesis, yet the molecular mechanism modulating alternative D2R pre-mRNA splicing has not been completely elucidated. Here, we identify heterogeneous nuclear ribonucleoprotein M(hnRNP M) as a key molecule controlling D2R splicing. We show that binding of hnRNP M to exon 6 inhibited the inclusion of this exon in the mRNA. Importantly, the splicing factor Nova-1 counteracted hnRNP M effects on D2R pre-mRNA splicing. Indeed, mutations of the putative Nova-1-binding site on exon 6 disrupted Nova-1 RNA assembly and diminished the inhibitory effect of Nova-1 on hnRNP M-dependent exon 6 exclusion. These results identify Nova-1 and hnRNP M as D2R pre-mRNA-binding proteins and show their antagonistic role in the alternative splicing of D2R pre-mRNA.	[Iaccarino, Ciro; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, INSERM, U904, Irvine, CA 92697 USA; [Park, Eonyoung; Lee, Jiwon; Kwon, Ilmin; Baik, Sun Mi; Kim, Myungjin; Son, Gi Hoon; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea	Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Borrelli, E (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, INSERM, U904, 3113 Gillespie, Irvine, CA 92697 USA.	borrelli@uci.edu; kyungjin@snu.ac.kr	Seong, Jae Young/A-5794-2012; Borrelli, Emiliana/M-8994-2018	Seong, Jae Young/0000-0002-3312-6924; 	National Institute on Drug Abuse [DA 024689-02]; Ministry of Science and Technology, Republic of Korea; INSERM; Korea Ministry of Education and Human Resources; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Korea Ministry of Education and Human Resources(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA 024689-02 from the National Institute on Drug Abuse (to E.B.). This work was also supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program in Neuroscience funded by the Ministry of Science and Technology, Republic of Korea (to K.K.), INSERM (to E.B.), and Brain Korea 21 research fellowships from the Korea Ministry of Education and Human Resources (to E.P., J.L., I.K., S.M.B., and G.H.S.).	BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jain RA, 2008, DEVELOPMENT, V135, P973, DOI 10.1242/dev.015438; Kiesler E, 2005, J CELL BIOL, V168, P1013, DOI 10.1083/jcb.200407173; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sasabe T, 2011, J NEUROCHEM, V116, P76, DOI 10.1111/j.1471-4159.2010.07086.x; Seong JY, 2002, MOL ENDOCRINOL, V16, P2426, DOI 10.1210/me.2001-0297; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Tirotta E, 2010, RECEPT SER, P303, DOI 10.1007/978-1-60327-333-6_12; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	37	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25301	25308		10.1074/jbc.M110.206540	http://dx.doi.org/10.1074/jbc.M110.206540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622564	hybrid, Green Published			2022-12-25	WOS:000292547900076
J	Allahverdiyeva, Y; Ermakova, M; Eisenhut, M; Zhang, PP; Richaud, P; Hagemann, M; Cournac, L; Aro, EM				Allahverdiyeva, Yagut; Ermakova, Maria; Eisenhut, Marion; Zhang, Pengpeng; Richaud, Pierre; Hagemann, Martin; Cournac, Laurent; Aro, Eva-Mari			Interplay between Flavodiiron Proteins and Photorespiration in Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO2 CONCENTRATING MECHANISMS; PHOTOSYNTHETIC ORGANISMS; OXYGEN; PHOTOPROTECTION; CHLAMYDOMONAS; CYANOBACTERIA; CHLOROPLASTS; RESPIRATION; COMPONENTS; REDUCTION	Flavodiiron (Flv) proteins are involved in detoxification of O-2 and NO in anaerobic bacteria and archaea. Cyanobacterial Flv proteins, on the contrary, function in oxygenic environment and possess an extra NAD(P) H: flavin oxidoreductase module. Synechocystis sp. PCC 6803 has four genes (sll1521, sll0219, sll0550, and sll0217) encoding Flv proteins (Flv1, Flv2, Flv3, and Flv4). Previous in vitro studies with recombinant Flv3 protein from Synechocystis provided evidence that it functions as a NAD(P) H: oxygen oxidoreductase, and subsequent in vivo studies with Synechocystis confirmed the role of Flv1 and Flv3 proteins in the Mehler reaction (photoreduction of O-2 to H2O). Interestingly, homologous proteins to Flv1 and Flv3 can be found also in green algae, mosses, and Selaginella. Here, we addressed the function of Flv1 and Flv3 in Synechocystis using the Delta flv1, Delta flv3, and Delta flv1/Delta flv3 mutants and applying inorganic carbon (C-i)-deprivation conditions. We propose that only the Flv1/Flv3 heterodimer form is functional in the Mehler reaction in vivo. O-18(2) labeling was used to discriminate between O-2 evolution in photosynthetic water splitting and O-2 consumption. In wild type, similar to 20% of electrons originated from water was targeted to O-2 under air level CO2 conditions but increased up to 60% in severe limitation of C-i. Gas exchange experiments with Delta flv1, Delta flv3, and Delta flv1/Delta flv3 mutants demonstrated that a considerable amount of electrons in these mutants is directed to photorespiration under C-i deprivation. This assumption is in line with increased transcript abundance of photorespiratory genes and accumulation of photorespiratory intermediates in the WT and to a higher extent in mutant cells under C-i deprivation.	[Allahverdiyeva, Yagut; Ermakova, Maria; Eisenhut, Marion; Zhang, Pengpeng; Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Chem, Plant Mol Biol Lab, FI-20014 Turku, Finland; [Richaud, Pierre; Cournac, Laurent] CEN Cadarache, CEA, Inst Biol Environm & Biotechnol, Direct Sci Vivant,Lab Bioenerget & Biotechnol Bac, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] CNRS, UMR Biol Vegetale & Microbiol Environm, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Hagemann, Martin] Univ Rostock, Inst Biowissensch, D-18059 Rostock, Germany	University of Turku; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Rostock	Aro, EM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Plant Mol Biol Lab, FI-20014 Turku, Finland.	evaaro@utu.fi	Cournac, Laurent/G-2564-2010; Allahverdiyeva, Yagut/I-5652-2013; Aro, Eva-Mari/Q-8664-2017	Allahverdiyeva, Yagut/0000-0002-9262-1757; Aro, Eva-Mari/0000-0002-2922-1435; Cournac, Laurent/0000-0003-0371-938X; Ermakova, Maria/0000-0001-8466-4186	Academy of Finland Center of Excellence [118637]; European Union [212508]; CNRS/Japan Science and Technology Agency; Nordic Energy Research Program; European Union; Region Provence Alpes Cote d'Azur; French Ministry of Research; Commissariat a l'Energie Atomique	Academy of Finland Center of Excellence(Academy of Finland); European Union(European Commission); CNRS/Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Centre National de la Recherche Scientifique (CNRS)); Nordic Energy Research Program; European Union(European Commission); Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by Academy of Finland Center of Excellence Project 118637, the European Union Project Solar-H2 (FP7 Contract 212508), CNRS/Japan Science and Technology Agency (Program "Structure and Function of Biomolecules: Response Mechanism to Environments"), and the Nordic Energy Research Program (Project Nordic BioH<INF>2</INF>). This work was also supported by the HelioBiotec platform (funded by the European Union (European Regional Development Fund)), the Region Provence Alpes Cote d'Azur, the French Ministry of Research, and the Commissariat a l'Energie Atomique.	Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; ARTUS NN, 1986, CRIT REV PLANT SCI, V4, P121, DOI 10.1080/07352688609382221; ASADA K, 1974, J BIOL CHEM, V249, P2175; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BATTCHIKOVA N, 2010, BIOCH BIOPH IN PRESS; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200; DIMON B, 1988, METHOD ENZYMOL, V167, P686; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Hackenberg C, 2009, PLANTA, V230, P625, DOI 10.1007/s00425-009-0972-9; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; MILLER AG, 1989, PLANT PHYSIOL, V91, P1044, DOI 10.1104/pp.91.3.1044; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; OSMOND CB, 1981, BIOCHIM BIOPHYS ACTA, V639, P77, DOI 10.1016/0304-4173(81)90006-9; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Talling J.F., 1985, INORGANIC CARBON UPT, P403; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2009, ARCH BIOCHEM BIOPHYS, V488, P9, DOI 10.1016/j.abb.2009.06.011; WILDNER GF, 1976, BIOCHEM BIOPH RES CO, V69, P268, DOI 10.1016/S0006-291X(76)80302-6; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331	35	91	94	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24007	24014		10.1074/jbc.M111.223289	http://dx.doi.org/10.1074/jbc.M111.223289			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602273	Green Published, hybrid			2022-12-25	WOS:000292294900043
J	Severe, N; Miraoui, H; Marie, PJ				Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.			The Casitas B Lineage Lymphoma (Cbl) Mutant G306E Enhances Osteogenic Differentiation in Human Mesenchymal Stromal Cells in Part by Decreased Cbl-mediated Platelet-derived Growth Factor Receptor alpha and Fibroblast Growth Factor Receptor 2 Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; STEM-CELLS; C-CBL; OSTEOBLAST DIFFERENTIATION; LIGASE CBL; IN-VITRO; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; DOWN-REGULATION	Human bone marrow-derived mesenchymal stromal cells (hMSCs) have the capacity to differentiate into several cell types including osteoblasts and are therefore an important cell source for bone tissue regeneration. A crucial issue is to identify mechanisms that trigger hMSC osteoblast differentiation to promote osteogenic potential. Casitas B lineage lymphoma (Cbl) is an E3 ubiquitin ligase that ubiquitinates and targets several molecules for degradation. We hypothesized that attenuation of Cbl-mediated degradation of receptor tyrosine kinases (RTKs) may promote osteogenic differentiation in hMSCs. We show here that specific inhibition of Cbl interaction with RTKs using a Cbl mutant (G306E) promotes expression of osteoblast markers (Runx2, alkaline phosphatase, type 1 collagen, osteocalcin) and increases osteogenic differentiation in clonal bone marrow-derived hMSCs and primary hMSCs. Analysis of molecular mechanisms revealed that the Cbl mutant increased PDGF receptor alpha and FGF receptor 2 but not EGF receptor expression in hMSCs, resulting in increased ERK1/2 and PI3K signaling. Pharmacological inhibition of FGFR or PDGFR abrogated in vitro osteogenesis induced by the Cbl mutant. The data reveal that specific inhibition of Cbl interaction with RTKs promotes the osteogenic differentiation program in hMSCs in part by decreased Cbl-mediated PDGFR alpha and FGFR2 ubiquitination, providing a novel mechanistic approach targeting Cbl to promote the osteogenic capacity of hMSCs.	[Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.] Hop Lariboisiere, INSERM, U606, Lab Osteoblast Biol & Pathol, F-75475 Paris 10, France; [Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.] Univ Paris Diderot, UMR606, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, U606, Lab Osteoblast Biol & Pathol, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr			Institut National de la Sante et de la Recherche Medicale; Ministere de la Recherche (Paris, France)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche (Paris, France)(Ministry of Research, France)	This work was supported in part by Institut National de la Sante et de la Recherche Medicale.; Recipients of a Ph.D. award from the Ministere de la Recherche (Paris, France).	Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Charbord P, 2011, STEM CELL REV REP, V7, P32, DOI 10.1007/s12015-010-9125-6; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Dufour C, 2008, BONE, V42, P1032, DOI 10.1016/j.bone.2008.02.009; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Gronthos S, 2007, STEM CELLS DEV, V16, P953, DOI 10.1089/scd.2007.0069; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Guenou H, 2006, AM J PATHOL, V169, P1303, DOI 10.2353/ajpath.2006.060102; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Miraoui H, 2010, HUM MOL GENET, V19, P1678, DOI 10.1093/hmg/ddq045; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mitlak BH, 1996, J BONE MINER RES, V11, P238; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moenning A, 2009, MOL CELL BIOL, V29, P881, DOI 10.1128/MCB.00885-08; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Orosco A, 2007, CANCER RES, V67, P3708, DOI 10.1158/0008-5472.CAN-06-4164; Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; SANJAY A, 2001, SCI STKE, pPE40; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Suzue N, 2006, J BONE MINER RES, V21, P722, DOI 10.1359/JBMR.060207; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Ueno H, 1997, J BIOL CHEM, V272, P8739, DOI 10.1074/jbc.272.13.8739; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	61	24	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24443	24450		10.1074/jbc.M110.197525	http://dx.doi.org/10.1074/jbc.M110.197525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596750	Green Published, hybrid			2022-12-25	WOS:000292294900084
J	Tsui, S; Fernando, R; Chen, BL; Smith, TJ				Tsui, Shanli; Fernando, Roshini; Chen, Beiling; Smith, Terry J.			Divergent Sp1 Protein Levels May Underlie Differential Expression of UDP-Glucose Dehydrogenase by Fibroblasts ROLE IN SUSCEPTIBILITY TO ORBITAL GRAVES DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; THYROID-ASSOCIATED OPHTHALMOPATHY; MAMMALIAN HYALURONAN SYNTHASES; HUMAN-SKIN FIBROBLASTS; BREAST-CANCER CELLS; MOLECULAR-CLONING; BOVINE LIVER; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; RECEPTOR-ALPHA	UDP-glucose dehydrogenase (UGDH) catalyzes the formation of UDP-glucuronate. Glucuronate represents an integral component of the glycosaminoglycan, hyaluronan, which accumulates in orbital Graves disease. Here we report that orbital fibroblasts express higher levels of UGDH than do those from skin. This is a consequence of greater UGDH gene promoter activity and more abundant steady-state UGDH mRNA. Six Sp1 sites located in the proximal 550 bp of the UGDH gene promoter appear to determine basal promoter activity, as does a previously unrecognized 49-bp sequence spanning -1436 nucleotides (nt) and -1388 nt that negatively affects activity. Nuclear Sp1 protein is more abundant in orbital fibroblasts, and its binding to specific sites on DNA is greater than that in dermal fibroblasts. Mutating each of these Sp1 sites in a UGDH gene promoter fragment, extending from -1387 to +71 nt and fused to a luciferase reporter, results in divergent activities when transfected in orbital and dermal fibroblasts. Reducing Sp1 attenuated UGDH gene promoter activity, lowered steady-state UGDH mRNA levels, and reduced UGDH enzyme activity. Targeting Sp1 and UGDH with specific siRNAs also lowered hyaluronan synthase-1 (HAS-1) and HAS-2 levels and reduced hyaluronan accumulation in orbital fibroblasts. These findings suggest that orbital fibroblasts express high levels of UGDH in an anatomic-specific manner, apparently the result of greater constitutive Sp1. These high UGDH levels may underlie susceptibility of the orbit to localized overproduction of hyaluronan in Graves disease.	[Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; Harbor UCLA Med Ctr, Dept Med, Div Mol Med, Torrance, CA 90502 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	National Institutes of Health [EY008976, EY011708, DK063121]; Research to Prevent Blindness Award; Bell Charitable Trust; NATIONAL EYE INSTITUTE [R01EY011708, R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Award(Research to Prevent Blindness (RPB)); Bell Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008976, EY011708, and DK063121. This work was also supported by a Research to Prevent Blindness Award and by the Bell Charitable Trust.	Bontemps Y, 2000, BIOCHEM BIOPH RES CO, V275, P981, DOI 10.1006/bbrc.2000.3389; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELUCA G, 1981, BASIC APPL HISTOCHEM, V25, P67; DREYER C, 1978, NUCLEIC ACIDS RES, V5, P3325, DOI 10.1093/nar/5.9.3325; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; GRUBB MF, 1993, BIOCHEM MOL BIOL INT, V30, P819; Guo NX, 2010, J BIOL CHEM, V285, P15794, DOI 10.1074/jbc.M109.074534; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; HUFNAGEL TJ, 1984, OPHTHALMOLOGY, V91, P1411; Huh JW, 2004, J BIOL CHEM, V279, P37491, DOI 10.1074/jbc.M404234200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; KORNFELD R, 1980, BIOCH GLYCOPROTEINS, P38; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Lapointe J, 1999, ENDOCRINOLOGY, V140, P4486, DOI 10.1210/en.140.10.4486; Lind T, 1999, GLYCOBIOLOGY, V9, P595, DOI 10.1093/glycob/9.6.595; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; Marcu O, 1999, CYTOGENET CELL GENET, V86, P244, DOI 10.1159/000015350; Martin B, 1999, NUCLEIC ACIDS RES, V27, P3402, DOI 10.1093/nar/27.17.3402; Mijakovic I, 2004, J MOL MICROB BIOTECH, V8, P19, DOI 10.1159/000082077; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; Peng Hwei-Ling, 1998, Proceedings of the National Science Council Republic of China Part B Life Sciences, V22, P166; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; RIZZOTTI M, 1986, BASIC APPL HISTOCHEM, V30, P85; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Smith H S, 1991, Basic Life Sci, V57, P329; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1987, J CLIN INVEST, V79, P1493, DOI 10.1172/JCI112979; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; STROMINGER JL, 1957, J BIOL CHEM, V224, P79; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; TOMIDA M, 1974, BIOCHIM BIOPHYS ACTA, V338, P352, DOI 10.1016/0304-4165(74)90295-5; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600; Vatsyayan J, 2005, J BIOCHEM MOL TOXIC, V19, P279, DOI 10.1002/jbt.20099; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wegrowski Y, 1998, BIOCHEM BIOPH RES CO, V250, P206, DOI 10.1006/bbrc.1998.9262; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Yeo TK, 1996, AM J PATHOL, V148, P1733; ZALITIS J, 1968, BIOCHEM BIOPH RES CO, V31, P693, DOI 10.1016/0006-291X(68)90617-7; Zhang JH, 2003, J BIOL CHEM, V278, P29192, DOI 10.1074/jbc.M213043200; Zhang L, 2009, J BIOL CHEM, V284, P26447, DOI 10.1074/jbc.M109.003616	69	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24487	24499		10.1074/jbc.M111.241166	http://dx.doi.org/10.1074/jbc.M111.241166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576248	hybrid, Green Published			2022-12-25	WOS:000292294900089
J	Xia, S; Sha, HB; Yang, L; Ji, YW; Ostrand-Rosenberg, S; Qi, L				Xia, Sheng; Sha, Haibo; Yang, Liu; Ji, Yewei; Ostrand-Rosenberg, Suzanne; Qi, Ling			Gr-1(+) CD11b(+) Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; ADIPOSE-TISSUE; PPAR-GAMMA; ALTERNATIVE ACTIVATION; TUMOR-GROWTH; MACROPHAGES; RESISTANCE; MONOCYTES; MECHANISM; CANCER	Activation of immune cells, including macrophages and CD8(+) T cells, contributes significantly to the advancement of obesity and its associated medical complications, such as atherosclerosis, insulin resistance, and type 2 diabetes. However, how the activation of these immune cells is regulated in vivo remains largely unexplored. Here we show that a group of immature myeloid cells with cell surface markers of Gr-1(+) CD11b(+) are highly enriched in peripheral tissues (i.e. liver and adipose tissues) during obesity. Down-regulation of these cells in obese animals significantly increases inflammation and impairs insulin sensitivity and glucose tolerance, whereas elevation of these cells via adoptive transfer has the opposite effects. Mechanistically, we show that under obese conditions, the Gr-1(+) cells suppress proliferation and induce apoptosis of CD8(+) T cells and are capable of skewing differentiation of macrophages into insulin-sensitizing, alternatively activated M2 macrophages. Taken together, our study demonstrates that immature myeloid cells provide a checks-and-balances platform to counter proinflammatory immune cells in the liver and adipose tissue during obesity to prevent overt immune responses.	[Xia, Sheng; Sha, Haibo; Ji, Yewei; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Yang, Liu; Qi, Ling] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xia, Sheng] Jiangsu Univ, Dept Immunol, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China; [Ostrand-Rosenberg, Suzanne] Univ Maryland, Dept Biol Sci, Baltimore, MD 21201 USA	Cornell University; Cornell University; Jiangsu University; University System of Maryland; University of Maryland Baltimore	Xia, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	sx43@cornell.edu; lq35@cornell.edu	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812; Qi, Ling/0000-0001-8229-0184	National Institutes of Health [RO1DK082582]; Cornell Center for Vertebrate Genomics Scholarship; Rosalinde and Arthur Foundation; American Diabetes Association [7-08-JF47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Center for Vertebrate Genomics Scholarship; Rosalinde and Arthur Foundation; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK082582 (to L. Q.). This work was also supported by the Cornell Center for Vertebrate Genomics Scholarship (to H. S.), the 2008 Rosalinde and Arthur Foundation/AFAR New Investigator Award (to L. Q.), the American Diabetes Association Junior Faculty Award (to L. Q.), and the American Diabetes Association Grant 7-08-JF47 (to L. Q.).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; BRUMMER E, 1984, J LEUKOCYTE BIOL, V36, P505, DOI 10.1002/jlb.36.4.505; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nausch N, 2008, BLOOD, V112, P4080, DOI 10.1182/blood-2008-03-143776; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PAK AS, 1995, CLIN CANCER RES, V1, P95; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Saio M, 2001, J IMMUNOL, V167, P5583, DOI 10.4049/jimmunol.167.10.5583; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; YOUNG MRI, 1992, CANCER RES, V52, P6335; Young MRI, 1999, CLIN EXP METASTAS, V17, P881, DOI 10.1023/A:1006708607666	44	115	120	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23591	23599		10.1074/jbc.M111.237123	http://dx.doi.org/10.1074/jbc.M111.237123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21592961	Green Published, hybrid			2022-12-25	WOS:000292025000089
J	Olsson, M; Ahlin, S; Olsson, B; Svensson, PA; Stahlman, M; Boren, J; Carlsson, LMS; Sjoholm, K				Olsson, Maja; Ahlin, Sofie; Olsson, Bob; Svensson, Per-Arne; Stahlman, Marcus; Boren, Jan; Carlsson, Lena M. S.; Sjoholm, Kajsa			Establishment of a Transgenic Mouse Model Specifically Expressing Human Serum Amyloid A in Adipose Tissue	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACUTE-PHASE RESPONSE; CHOLESTEROL TRANSPORT; HDL CHOLESTEROL; GENE-EXPRESSION; IN-VIVO; APOA-I; ADIPOCYTE; OBESITY; SIZE	Obesity and obesity co-morbidities are associated with a low grade inflammation and elevated serum levels of acute phase proteins, including serum amyloid A (SAA). In the non-acute phase in humans, adipocytes are major producers of SAA but the function of adipocyte-derived SAA is unknown. To clarify the role of adipocyte-derived SAA, a transgenic mouse model expressing human SAA1 (hSAA) in adipocytes was established. hSAA expression was analysed using real-time PCR analysis. Male animals were challenged with a high fat (HF) diet. Plasma samples were subjected to fast protein liquid chromatography (FPLC) separation. hSAA, cholesterol and triglyceride content were measured in plasma and in FPLC fractions. Real-time PCR analysis confirmed an adipose tissue-specific hSAA gene expression. Moreover, the hSAA gene expression was not influenced by HF diet. However, hSAA plasma levels in HF fed animals (37.7 +/- 4.0 mu g/mL, n = 7) were increased compared to those in normal chow fed animals (4.8 +/- 0.5 mu g/mL, n = 10; p<0.001), and plasma levels in the two groups were in the same ranges as in obese and lean human subjects, respectively. In FPLC separated plasma samples, the concentration of hSAA peaked in high-density lipoprotein (HDL) containing fractions. In addition, cholesterol distribution over the different lipoprotein subfractions as assessed by FPLC analysis was similar within the two experimental groups. The established transgenic mouse model demonstrates that adipose tissue produced hSAA enters the circulation, resulting in elevated plasma levels of hSAA. This new model will enable further studies of metabolic effects of adipose tissue-derived SAA.	[Olsson, Maja; Ahlin, Sofie; Olsson, Bob; Svensson, Per-Arne; Stahlman, Marcus; Boren, Jan; Carlsson, Lena M. S.; Sjoholm, Kajsa] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Olsson, M (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden.	maja.olsson@gu.se	StÃhlman, Marcus/M-4597-2019; Svensson, Per-Arne/R-4626-2019; Carlsson, Lena/F-7570-2018	Carlsson, Lena/0000-0003-4145-6242; Sjoholm, Kajsa/0000-0003-0146-8193; Ahlin, Sofie/0000-0003-0619-2683; Henricsson, Marcus/0000-0002-4202-0339; Olsson, Bob/0000-0002-6368-6172; Svensson, Per-Arne/0000-0002-6731-806X	Swedish Research Council [K2008-65p-20758-01-4, K2010-55X-11285-13]; Swedish Federal Government; Sahlgrenska Academy; VINNOVA-VINNMER program; Jeansson Foundations; Ake Wiberg Foundation; Royal Physiographic Society in Lund (Nilsson-Ehle); Emelle Foundation; Swedish Knowledge Foundation through Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Federal Government; Sahlgrenska Academy; VINNOVA-VINNMER program(Vinnova); Jeansson Foundations; Ake Wiberg Foundation; Royal Physiographic Society in Lund (Nilsson-Ehle); Emelle Foundation; Swedish Knowledge Foundation through Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Research Council (K2008-65p-20758-01-4 and K2010-55X-11285-13), the Swedish Federal Government under the LUA/ALF agreement, the Sahlgrenska Academy, the VINNOVA-VINNMER program, the Jeansson Foundations, the Ake Wiberg Foundation, the Royal Physiographic Society in Lund (Nilsson-Ehle), the Emelle Foundation and the Swedish Knowledge Foundation through the Industrial PhD programme in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Buyukhatipoglu H, 2007, NEPHROLOGY, V12, P25, DOI 10.1111/j.1440-1797.2006.00742.x; Cabana VG, 2003, J LIPID RES, V44, P780, DOI 10.1194/jlr.M200432-JLR200; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DEBEER MC, 2010, J LIPID RES; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hatanaka E, 2007, IMMUNOL LETT, V108, P160, DOI 10.1016/j.imlet.2006.12.005; Hosoai H, 1999, J LIPID RES, V40, P648; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Jylhava J, 2009, J INTERN MED, V266, P286, DOI 10.1111/j.1365-2796.2009.02120.x; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415; Kindy MS, 2000, ARTERIOSCL THROM VAS, V20, P1543, DOI 10.1161/01.ATV.20.6.1543; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sjoholm K, 2009, CYTOKINE, V48, P260, DOI 10.1016/j.cyto.2009.08.005; Soukas A, 2000, GENE DEV, V14, P963; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Uurtuya S, 2009, J ATHEROSCLER THROMB, V16, P299, DOI 10.5551/jat.E901; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; WANG YC, 2009, J NUTR BIOCH; Wilson PG, 2008, AM J PATHOL, V173, P1902, DOI 10.2353/ajpath.2008.080201; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19609	10.1371/journal.pone.0019609	http://dx.doi.org/10.1371/journal.pone.0019609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611116	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200019
J	Michaelis, M; Geiler, J; Naczk, P; Sithisarn, P; Leutz, A; Doerr, HW; Cinatl, J				Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.			Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression	PLOS ONE			English	Article							OSELTAMIVIR-RESISTANT INFLUENZA; BRONCHIAL EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; IFN REGULATORY FACTOR-3; AVIAN INFLUENZA; PANDEMIC INFLUENZA; ANTIVIRAL THERAPY; SIGNALING PATHWAYS; A(H1N1) VIRUSES; LICORICE ROOTS	Glycyrrhizin is known to exert antiviral and anti-inflammatory effects. Here, the effects of an approved parenteral glycyrrhizin preparation (Stronger Neo-Minophafen C) were investigated on highly pathogenic influenza A H5N1 virus replication, H5N1-induced apoptosis, and H5N1-induced pro-inflammatory responses in lung epithelial (A549) cells. Therapeutic glycyrrhizin concentrations substantially inhibited H5N1-induced expression of the pro-inflammatory molecules CXCL10, interleukin 6, CCL2, and CCL5 (effective glycyrrhizin concentrations 25 to 50 mu g/ml) but interfered with H5N1 replication and H5N1-induced apoptosis to a lesser extent (effective glycyrrhizin concentrations 100 mg/ml or higher). Glycyrrhizin also diminished monocyte migration towards supernatants of H5N1-infected A549 cells. The mechanism by which glycyrrhizin interferes with H5N1 replication and H5N1-induced pro-inflammatory gene expression includes inhibition of H5N1-induced formation of reactive oxygen species and (in turn) reduced activation of NFkB, JNK, and p38, redox-sensitive signalling events known to be relevant for influenza A virus replication. Therefore, glycyrrhizin may complement the arsenal of potential drugs for the treatment of H5N1 disease.	[Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.] Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Michaelis, M (corresponding author), Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany.	Cinatl@em.uni-frankfurt.de		Michaelis, Martin/0000-0002-5710-5888	EU [512054, 512864, 044512]; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder	EU(European Commission); Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder	The work was supported by the EU grants SARS/FLU vaccine (proposal no. 512054), Chimeric Vaccines (proposal no. 512864), and Intranasal H5 vaccine (proposal no. 044512), by the Hilfe fur krebskranke Kinder Frankfurt e.V. and by the Frankfurter Stiftung fur krebskranke Kinder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cinatl J, 2005, ANTIVIR RES, V66, P81, DOI 10.1016/j.antiviral.2005.03.002; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P203, DOI 10.1007/s00430-007-0048-z; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P191, DOI 10.1007/s00430-007-0045-2; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P181, DOI 10.1007/s00430-007-0042-5; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P213, DOI 10.1007/s00430-007-0052-3; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DeFlora S, 1997, EUR RESPIR J, V10, P1535, DOI 10.1183/09031936.97.10071535; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Geiss GK, 2001, J VIROL, V75, P4321, DOI 10.1128/JVI.75.9.4321-4331.2001; Hampson AW, 2008, ANN ACAD MED SINGAP, V37, P510; Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kieny MP, 2008, VACCINE, V26, pD3, DOI 10.1016/j.vaccine.2008.07.046; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Michaelis M, 2010, MED MICROBIOL IMMUN, V199, P291, DOI 10.1007/s00430-010-0155-0; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Michaelis M, 2009, CURR MOL MED, V9, P131, DOI 10.2174/156652409787581565; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; NARDONE LL, 1979, BIOCHIM BIOPHYS ACTA, V573, P276, DOI 10.1016/0005-2760(79)90061-4; Ogbomo H, 2010, BIOCHEM PHARMACOL, V79, P188, DOI 10.1016/j.bcp.2009.07.026; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Saito R, 2008, J INFECT DIS, V197, P630, DOI 10.1086/525055; Saito R, 2007, J MED VIROL, V79, P1569, DOI 10.1002/jmv.20946; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sugrue RJ, 2008, ANN ACAD MED SINGAP, V37, P518; Sumbayev VV, 2006, SCAND J IMMUNOL, V63, P391, DOI 10.1111/j.1365-3083.2006.001764.x; Suzuki Y, 2009, J CLIN MICROBIOL, V47, P623, DOI 10.1128/JCM.01760-08; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; van Rossum TGJ, 1999, CLIN THER, V21, P2080, DOI 10.1016/S0149-2918(00)87239-2; Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang Xiu-qin, 2006, Zhong Yao Cai, V29, P692; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	61	162	170	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19705	10.1371/journal.pone.0019705	http://dx.doi.org/10.1371/journal.pone.0019705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611183	Green Submitted, Green Published, gold			2022-12-25	WOS:000290657500015
J	Smalley-Freed, WG; Efimov, A; Short, SP; Jia, PL; Zhao, ZM; Washington, MK; Robine, S; Coffey, RJ; Reynolds, AB				Smalley-Freed, Whitney G.; Efimov, Andrey; Short, Sarah P.; Jia, Peilin; Zhao, Zhongming; Washington, M. Kay; Robine, Sylvie; Coffey, Robert J.; Reynolds, Albert B.			Adenoma Formation following Limited Ablation of p120-Catenin in the Mouse Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN COLORECTAL-CANCER; E-CADHERIN; CELL-ADHESION; MOLECULAR-BASIS; ALPHA-CATENIN; F-ACTIN; MICE; EXPRESSION; TUMORS	p120 loss destabilizes E-cadherin and could therefore result in tumor and/or metastasis-promoting activities similar to those caused by E-cadherin downregulation. Previously, we reported that p120 is essential in the intestine for barrier function, epithelial homeostasis and survival. Conditional p120 ablation in the mouse intestine induced severe inflammatory bowel disease, but long-term cancer-related studies were impossible because none of the animals survived longer than 21 days. Here, we used a tamoxifen-inducible mouse model (Vil-Cre-ER(T2); p120(fl/fl)) to limit the extent of p120 ablation and thereby enable long-term studies. Reducing p120 KO to similar to 10% of the intestinal epithelium produced long-lived animals outwardly indistinguishable from controls. Effects of prolonged p120 absence were then evaluated at intervals spanning 2 to 18 months. At all time points, immunostaining revealed microdomains of p120-null epithelium interspersed with normal epithelium. Thus, stochastic p120 ablation is compatible with crypt progenitor cell function and permitted lifelong renewal of the p120-null cells. Consistent with previous observations, a barrier defect and frequent infiltration of neutrophils was observed, suggesting that focal p120 loss generates a microenvironment disposed to chronic inflammation. We report that 45% of these animals developed tumors within 18 months of tamoxifen induction. Interestingly, beta-catenin was upregulated in the majority, but none of the tumors were p120 null. Although further work is required to directly establish mechanism, we conclude that limited p120 ablation can promote tumorigenesis by an indirect non-cell autonomous mechanism. Given that byproducts of inflammation are known to be highly mutagenic, we suggest that tumorigenesis in this model is ultimately driven by the lifelong inability to heal chronic wounds and the substantially increased rates of stochastic gene mutation in tissue microenvironments subjected to chronic inflammation. Indeed, although technical issues precluded direct identification of mutations, beta-catenin upregulation in human colon cancer almost invariably reflects mutations in APC and/or beta-catenin.	[Smalley-Freed, Whitney G.; Efimov, Andrey; Short, Sarah P.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Dept Bioinformat, Nashville, TN USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Robine, Sylvie] Inst Curie, CNRS, Dept Morphogenesis & Intracellular Signaling, F-75231 Paris, France; [Coffey, Robert J.] VA Tennessee Valley Healthcare Syst, Med Serv, Nashville, TN USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Smalley-Freed, WG (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA.	al.reynolds@vanderbilt.edu	Jia, Peilin/B-4519-2013	Short, Sarah/0000-0001-9606-7370	Vanderbilt Cancer Center [P30- CA068485]; Research Project Grant [CA111947, CA055724, CA46413]; Vanderbilt GI SPORE [P50 95103]; GI SPORE [P50 95103]; Mouse Models of Human Cancer Consortium [V01 084239]; NATIONAL CANCER INSTITUTE [R29CA055724, P30CA068485, T32CA009592, R01CA111947, R01CA055724, R01CA046413] Funding Source: NIH RePORTER	Vanderbilt Cancer Center; Research Project Grant; Vanderbilt GI SPORE; GI SPORE; Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Vanderbilt Cancer Center Support Grant (P30- CA068485), Research Project Grant CA111947, and the Vanderbilt GI SPORE (P50 95103). Andrey Efimov was supported in part by Research Project Grant CA055724. Robert J. Coffey was supported by Research Project Grant CA46413, GI SPORE (P50 95103), and the Mouse Models of Human Cancer Consortium (V01 084239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berx G, 1996, ONCOGENE, V13, P1919; Brown MV, 2009, EXP CELL RES, V315, P39, DOI 10.1016/j.yexcr.2008.09.025; Campbell RJ, 2002, J CLIN PATHOL-MOL PA, V55, P80, DOI 10.1136/mp.55.2.80; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kim JC, 2008, CANCER SCI, V99, P1348, DOI 10.1111/j.1349-7006.2008.00819.x; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Maltzman T, 1997, CARCINOGENESIS, V18, P2435, DOI 10.1093/carcin/18.12.2435; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Ogawa Y, 1991, Growth Factors, V5, P57, DOI 10.3109/08977199109000271; OKA H, 1992, VIRCHOWS ARCH A, V421, P149, DOI 10.1007/BF01607048; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Skoudy A, 1996, INT J CANCER, V68, P14, DOI 10.1002/(SICI)1097-0215(19960927)68:1<14::AID-IJC3>3.0.CO;2-#; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Vagefi Parsia A, 2005, Clin Colorectal Cancer, V4, P313, DOI 10.3816/CCC.2005.n.003; Valizadeh A, 1997, AM J PATHOL, V150, P1977; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	54	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19880	10.1371/journal.pone.0019880	http://dx.doi.org/10.1371/journal.pone.0019880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611205	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500031
J	Barbier, M; Faille, D; Loriod, B; Textoris, J; Camus, C; Puthier, D; Flori, L; Wassmer, SC; Victorero, G; Alessi, MC; Fusai, T; Nguyen, C; Grau, GE; Rihet, P				Barbier, Mathieu; Faille, Dorothee; Loriod, Beatrice; Textoris, Julien; Camus, Claire; Puthier, Denis; Flori, Laurence; Wassmer, Samuel Crocodile; Victorero, Genevieve; Alessi, Marie-Christine; Fusai, Thierry; Nguyen, Catherine; Grau, Georges E.; Rihet, Pascal			Platelets Alter Gene Expression Profile in Human Brain Endothelial Cells in an In Vitro Model of Cerebral Malaria	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PLASMODIUM-FALCIPARUM; TNF; APOPTOSIS; ERYTHROPOIETIN; INFLAMMATION; MICROARRAYS; ACTIVATION; ADHERENCE; PARASITES	Platelet adhesion to the brain microvasculature has been associated with cerebral malaria (CM) in humans, suggesting that platelets play a role in the pathogenesis of this syndrome. In vitro co-cultures have shown that platelets can act as a bridge between Plasmodium falciparum-infected red blood cells (pRBC) and human brain microvascular endothelial cells (HBEC) and potentiate HBEC apoptosis. Using cDNA microarray technology, we analyzed transcriptional changes of HBEC in response to platelets in the presence or the absence of tumor necrosis factor (TNF) and pRBC, which have been reported to alter gene expression in endothelial cells. Using a rigorous statistical approach with multiple test corrections, we showed a significant effect of platelets on gene expression in HBEC. We also detected a strong effect of TNF, whereas there was no transcriptional change induced specifically by pRBC. Nevertheless, a global ANOVA and a two-way ANOVA suggested that pRBC acted in interaction with platelets and TNF to alter gene expression in HBEC. The expression of selected genes was validated by RT-qPCR. The analysis of gene functional annotation indicated that platelets induce the expression of genes involved in inflammation and apoptosis, such as genes involved in chemokine-, TREM1-, cytokine-, IL10-, TGF beta-, death-receptor-, and apoptosis-signaling. Overall, our results support the hypothesis that platelets play a pathogenic role in CM.	[Barbier, Mathieu; Camus, Claire; Rihet, Pascal] Aix Marseille Univ, Fac Pharm, IFR 48, Lab Pharmacogenet Malad Parasitaires,EA 864, Marseille, France; [Loriod, Beatrice; Textoris, Julien; Camus, Claire; Puthier, Denis; Victorero, Genevieve; Nguyen, Catherine; Rihet, Pascal] Aix Marseille Univ, INSERM U928, TAGC, IFR137, Marseille, France; [Faille, Dorothee; Fusai, Thierry] Inst Rech Biomed Armees Antenne Marseille, URMITE, IMTSSA, Unite Rech Biol & Epidemiol Parasitaires,UMR 6236, Marseille, France; [Faille, Dorothee; Alessi, Marie-Christine] Aix Marseille Univ, Fac Med, INSERM, UMR 626, Marseille, France; [Flori, Laurence] INRA AgroParisTech, Lab Genet Anim & Biol Integrat, Jouy En Josas, France; [Grau, Georges E.] Univ Sydney, Dept Pathol, Vasc Immunol Unit, Camperdown, NSW, Australia; [Wassmer, Samuel Crocodile] NYU, Sch Med, Dept Med Parasitol, New York, NY USA	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; INRAE; University of Sydney; New York University	Barbier, M (corresponding author), Aix Marseille Univ, Fac Pharm, IFR 48, Lab Pharmacogenet Malad Parasitaires,EA 864, Marseille, France.	rihet@tagc.univ-mrs.fr; rihet@tagc.univ-mrs.fr	ALESSI, Marie-christine/AAK-3582-2020; Rihet, Pascal/L-2173-2016; Rihet, Pascal/GQP-1381-2022; Grau, Georges/AGR-7139-2022; puthier, denis/AFV-1973-2022; Faille, Dorothée/AFO-5088-2022; Puthier, Denis/N-5018-2016; loriod, beatrice bl/L-2948-2016; Flori, Laurence/H-3683-2013; Textoris, Julien/H-3317-2019; Nguyen, Catherine/M-4119-2016; Rihet, Pascal/AAD-2018-2022; Wassmer, Samuel/F-8539-2018	ALESSI, Marie-christine/0000-0003-3927-5792; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Grau, Georges/0000-0002-0442-0462; puthier, denis/0000-0002-7240-5280; Faille, Dorothée/0000-0003-4414-739X; loriod, beatrice bl/0000-0001-5801-2264; Textoris, Julien/0000-0002-3821-9337; Nguyen, Catherine/0000-0001-9376-6360; Rihet, Pascal/0000-0002-9459-3905; Barbier, Mathieu/0000-0002-5154-2163; Wassmer, Samuel/0000-0002-6753-3376	French Ministry of Research and Technology; INSERM; Aix-Marseille University; NHMRC; Australian Research Council; AL Kerr Bequest, Sydney Medical School	French Ministry of Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); AL Kerr Bequest, Sydney Medical School	MB was supported by a studentship from the French Ministry of Research and Technology. The study was supported by INSERM, by Aix-Marseille University, by NHMRC, by Australian Research Council and by the AL Kerr Bequest, Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715; Bertucci F, 2007, ANTICANCER RES, V27, P3441; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; CHAKRAVORTY SJ, 2007, INT J PARASITOL; Chen LC, 2008, EXP MOL PATHOL, V84, P145, DOI 10.1016/j.yexmp.2007.11.004; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; HEIDRICH HG, 1982, J PARASITOL, V68, P443, DOI 10.2307/3280956; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Lou JN, 1997, AM J PATHOL, V151, P1397; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Susomboon P, 2006, PARASITOL INT, V55, P107, DOI 10.1016/j.parint.2005.11.054; Talby L, 2006, LEUKEMIA RES, V30, P665, DOI 10.1016/j.leukres.2005.10.007; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Viebig NK, 2005, INFECT IMMUN, V73, P3271, DOI 10.1128/IAI.73.6.3271-3277.2005; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761; ZOELLNER H, 1993, THROMB HAEMOSTASIS, V69, P135	44	30	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19651	10.1371/journal.pone.0019651	http://dx.doi.org/10.1371/journal.pone.0019651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603600	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300016
J	Dong, QF; Nelson, DE; Toh, E; Diao, LX; Gao, X; Fortenberry, JD; Van Der Pol, B				Dong, Qunfeng; Nelson, David E.; Toh, Evelyn; Diao, Lixia; Gao, Xiang; Fortenberry, J. Dennis; Van Der Pol, Barbara			The Microbial Communities in Male First Catch Urine Are Highly Similar to Those in Paired Urethral Swab Specimens	PLOS ONE			English	Article							NONGONOCOCCAL URETHRITIS; ASSOCIATION; INFECTION; CHLAMYDIA; VAGINALIS	Urine is the CDC-recommended specimen for STI testing. It was unknown if the bacterial communities (microbiomes) in urine reflected those in the distal male urethra. We compared microbiomes of 32 paired urine and urethral swab specimens obtained from adult men attending an STD clinic, by 16S rRNA PCR and deep pyrosequencing. Microbiomes of urine and swabs were remarkably similar, regardless of STI status of the subjects. Thus, urine can be used to characterize urethral microbiomes when swabs are undesirable, such as in population-based studies of the urethral microbiome or where multiple sampling of participants is required.	[Dong, Qunfeng; Gao, Xiang] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Nelson, David E.; Toh, Evelyn] Indiana Univ, Dept Biol, Bloomington, IN USA; [Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN USA; [Van Der Pol, Barbara] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dong, QF (corresponding author), Univ N Texas, Dept Biol, Denton, TX 76203 USA.	nelsonde@indiana.edu; bvanderp@indiana.edu		Toh, Evelyn/0000-0003-2932-4060; Van Der Pol, Barbara/0000-0003-3064-8564	Indiana Clinical and Translational Sciences Institute; National Institutes of Health [1UH2DK083980-01, 1RC2HG005806-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083980] Funding Source: NIH RePORTER	Indiana Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Indiana Clinical and Translational Sciences Institute [to B.V. and D.E.N.] and National Institutes of Health [grant number 1UH2DK083980-01 to J.D.F. and 1RC2HG005806-01 to Q.D., D.E.N. and J.D.F.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Centers for Disease Control and Prevention, 2009, LAB DIAGN TEST CHLAM; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Riemersma WA, 2003, J CLIN MICROBIOL, V41, P1977, DOI 10.1128/JCM.41.5.1977-1986.2003; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Torok MR, 2007, J INFECT DIS, V196, P1102, DOI 10.1086/521307; Van Der Pol B, 2006, J CLIN MICROBIOL, V44, P366, DOI 10.1128/JCM.44.2.366-373.2006	14	116	123	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19709	10.1371/journal.pone.0019709	http://dx.doi.org/10.1371/journal.pone.0019709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603636	gold, Green Submitted, Green Published			2022-12-25	WOS:000290558500025
J	He, L; Whistler, JL				He, Li; Whistler, Jennifer L.			Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis	PLOS ONE			English	Article							ALCOHOL DEPENDENCE; MORPHINE-TOLERANCE; CROSS-TOLERANCE; SPINAL-CORD; INTRATHECAL MORPHINE; NUCLEUS-ACCUMBENS; BETA-ENDORPHIN; KNOCKOUT MICE; BRAIN; DESENSITIZATION	It is well known that the mu-opioid receptor (MOR) plays an important role in the rewarding properties of ethanol. However, it is less clear how chronic ethanol consumption affects MOR signaling. Here, we demonstrate that rats with prolonged voluntary ethanol consumption develop antinociceptive tolerance to opioids. Signaling through the MOR is controlled at many levels, including via the process of endocytosis. Importantly, agonists at the MOR that promote receptor endocytosis, such as the endogenous peptides enkephalin and beta-endorphin, show a reduced propensity to promote antinociceptive tolerance than do agonists, like morphine, which do not promote receptor endocytosis. These observations led us to examine whether chronic ethanol consumption produced opioid tolerance by interfering with MOR endocytosis. Indeed, here we show that chronic ethanol consumption inhibits the endocytosis of MOR in response to opioid peptide. This loss of endocytosis was accompanied by a dramatic decrease in G protein coupled receptor kinase 2 (GRK2) protein levels after chronic drinking, suggesting that loss of this component of the trafficking machinery could be a mechanism by which endocytosis is lost. We also found that MOR coupling to G-protein was decreased in ethanol-drinking rats, providing a functional explanation for loss of opioid antinociception. Together, these results suggest that chronic ethanol drinking alters the ability of MOR to endocytose in response to opioid peptides, and consequently, promotes tolerance to the effects of opioids.	[He, Li; Whistler, Jennifer L.] Univ Calif, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	He, L (corresponding author), Univ Calif, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	jwhistler@gallo.ucsf.edu			ABMRF; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco	ABMRF; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System)	This study was supported by an ABMRF grant (to L.H.) and by funds provided by the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco (to J.L.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2000, J PHARMACOL EXP THER, V295, P1012; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Anton RF, 2004, PSYCHOPHARMACOLOGY, V173, P32, DOI 10.1007/s00213-003-1720-7; Berger AC, 2010, ANN NEUROL, V67, P559, DOI 10.1002/ana.22002; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Campbell VC, 2007, ALCOHOL CLIN EXP RES, V31, P1435, DOI 10.1111/j.1530-0277.2007.00432.x; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; Chen F, 2000, J PHARMACOL EXP THER, V293, P159; deWaele JP, 1997, ALCOHOL CLIN EXP RES, V21, P754, DOI 10.1097/00000374-199706000-00031; DEWAELE JP, 1995, J PHARMACOL EXP THER, V275, P518; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Grecksch G, 2006, PSYCHOPHARMACOLOGY, V186, P177, DOI 10.1007/s00213-006-0365-8; Hall FS, 2001, PSYCHOPHARMACOLOGY, V154, P43, DOI 10.1007/s002130000622; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; He L, 2007, PHARMACOLOGY, V79, P193, DOI 10.1159/000100893; He L, 2009, J PAIN, V10, P369, DOI 10.1016/j.jpain.2008.09.011; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kamdar NK, 2007, PSYCHOPHARMACOLOGY, V192, P207, DOI 10.1007/s00213-007-0711-5; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Koch T, 2004, J NEUROCHEM, V88, P680, DOI 10.1046/j.1471-4159.2003.02189.x; Lam M, 2008, PSYCHOPHARMACOLOGY, V201, P261, DOI 10.1007/s00213-008-1267-8; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Maher CE, 2001, BRAIN RES, V895, P1, DOI 10.1016/S0006-8993(00)03093-6; Marinelli PW, 2003, PSYCHOPHARMACOLOGY, V169, P60, DOI 10.1007/s00213-003-1490-2; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Narita M, 2007, NEUROSCIENCE, V144, P777, DOI 10.1016/j.neuroscience.2006.10.028; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Paxinos G., 2005, STEREOTAXIC COORDINA, V7th; Riba P, 2002, J PHARMACOL EXP THER, V300, P265, DOI 10.1124/jpet.300.1.265; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Saland LC, 2004, ALCOHOL CLIN EXP RES, V28, P98, DOI 10.1097/01.ALC.0000108658.00243.BF; Sanchis-Segura C, 2005, ALCOHOL CLIN EXP RES, V29, P1522, DOI 10.1097/01.alc.0000174913.60384.e8; Shah S, 1997, ALCOHOL, V14, P361, DOI 10.1016/S0741-8329(96)00184-X; SIM LJ, 1995, P NATL ACAD SCI USA, V92, P7242, DOI 10.1073/pnas.92.16.7242; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2002, ALCOHOL CLIN EXP RES, V26, P688, DOI 10.1097/00000374-200205000-00014; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SOSNOWSKI M, 1990, ANESTHESIOLOGY, V73, P1141, DOI 10.1097/00000542-199012000-00012; Trafton JA, 2000, J NEUROSCI, V20, P8578; TSENG LF, 1993, EUR J PHARMACOL, V241, P63, DOI 10.1016/0014-2999(93)90933-9; Ueda H, 2001, J NEUROSCI, V21, P2967, DOI 10.1523/JNEUROSCI.21-09-02967.2001; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Walker EA, 2001, PSYCHOPHARMACOLOGY, V154, P131, DOI 10.1007/s002130000620; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	52	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19372	10.1371/journal.pone.0019372	http://dx.doi.org/10.1371/journal.pone.0019372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602922	gold, Green Published, Green Submitted			2022-12-25	WOS:000290558500008
J	Nikolopoulos, G; Bagos, P; Lytras, T; Bonovas, S				Nikolopoulos, Georgios; Bagos, Pantelis; Lytras, Theodoros; Bonovas, Stefanos			An Ecological Study of the Determinants of Differences in 2009 Pandemic Influenza Mortality Rates between Countries in Europe	PLOS ONE			English	Article							INCOME INEQUALITY; AIR-POLLUTION; HEALTH-CARE; DEATH; UNEMPLOYMENT; INFECTION; OUTCOMES; CRISES	Background: Pandemic A (H1N1) 2009 mortality rates varied widely from one country to another. Our aim was to identify potential socioeconomic determinants of pandemic mortality and explain between-country variation. Methodology: Based on data from a total of 30 European countries, we applied random-effects Poisson regression models to study the relationship between pandemic mortality rates (May 2009 to May 2010) and a set of representative environmental, health care-associated, economic and demographic country-level parameters. The study was completed by June 2010. Principal Findings: Most regression approaches indicated a consistent, statistically significant inverse association between pandemic influenza-related mortality and per capita government expenditure on health. The findings were similar in univariable [coefficient: -0.00028, 95% Confidence Interval (CI): -0.00046, -0.00010, p = 0.002] and multivariable analyses (including all covariates, coefficient: -0.00107, 95% CI: -0.00196, -0.00018, p = 0.018). The estimate was barely insignificant when the multivariable model included only significant covariates from the univariate step (coefficient: -0.00046, 95% CI: -0.00095, 0.00003, p = 0.063). Conclusions: Our findings imply a significant inverse association between public spending on health and pandemic influenza mortality. In an attempt to interpret the estimated coefficient (-0.00028) for the per capita government expenditure on health, we observed that a rise of 100 international dollars was associated with a reduction in the pandemic influenza mortality rate by approximately 2.8%. However, further work needs to be done to unravel the mechanisms by which reduced government spending on health may have affected the 2009 pandemic influenza mortality.	[Nikolopoulos, Georgios; Lytras, Theodoros; Bonovas, Stefanos] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Nikolopoulos, Georgios; Bagos, Pantelis] Univ Cent Greece, Dept Comp Sci & Biomed Informat, Lamia, Greece	University of Central Greece	Nikolopoulos, G (corresponding author), Hellen Ctr Dis Control & Prevent, Athens, Greece.	sbonovas@med.uoa.gr	Bonovas, Stefanos/GZG-4609-2022; Nikolopoulos, Georgios/H-5698-2011; Bonovas, Stefanos/H-5653-2011; Bagos, Pantelis G/H-5658-2011; Bagos, Pantelis/U-7140-2019	Nikolopoulos, Georgios/0000-0002-3307-0246; Bagos, Pantelis G/0000-0003-4935-2325; Bagos, Pantelis/0000-0003-4935-2325; Lytras, Theodore/0000-0002-4146-4122; Bonovas, Stefanos/0000-0001-6102-6579				Afkhami A, 2003, B HIST MED, V77, P367, DOI 10.1353/bhm.2003.0049; Akinkugbe O, 2009, SOC WORK PUBLIC HLTH, V24, P131, DOI 10.1080/19371910802569716; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Bezruchka S, 2009, CAN MED ASSOC J, V181, P281, DOI 10.1503/cmaj.090553; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; Chan M., 2009, WORLD NOW START 2009; Chan MF, 2010, J CLIN NURS, V19, P884, DOI 10.1111/j.1365-2702.2009.02863.x; Chauhan AJ, 2003, BRIT MED BULL, V68, P95, DOI 10.1093/bmb/ldg022; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Vogli R, 2005, J EPIDEMIOL COMMUN H, V59, P158, DOI 10.1136/jech.2004.020651; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Ferguson N, 2006, LANCET, V368, P2187, DOI 10.1016/S0140-6736(06)69870-X; Gani A, 2009, HEALTH POLICY PLANN, V24, P72, DOI 10.1093/heapol/czn044; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Granados JAT, 2008, J HEALTH ECON, V27, P544, DOI 10.1016/j.jhealeco.2007.09.006; Gupta S, 2003, HEALTH ECON, V12, P685, DOI 10.1002/hec.759; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; La Ruche G, 2009, EURO SURVEILL, V14; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lynch J, 2001, LANCET, V358, P194, DOI 10.1016/S0140-6736(01)05407-1; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nixon John, 2006, Eur J Health Econ, V7, P7, DOI 10.1007/s10198-005-0336-8; Pebody RG, 2010, EUROSURVEILLANCE, V15; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Salvi S, 2007, PAEDIATR RESPIR REV, V8, P275, DOI 10.1016/j.prrv.2007.08.008; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; Stuckler D, 2008, PLOS MED, V5, P1079, DOI 10.1371/journal.pmed.0050143; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Stuckler David, 2009, Ulster Med J, V78, P142; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Sydenstricker E, 1931, PUBLIC HEALTH REP, V46, P154, DOI 10.2307/4579923; World Health Organization, 2010, PAND H1N1 2009	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19432	10.1371/journal.pone.0019432	http://dx.doi.org/10.1371/journal.pone.0019432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589928	Green Submitted, Green Published, gold			2022-12-25	WOS:000290483600010
J	Wells, WA; Ge, CF; Patel, N; Oh, T; Gardiner, E; Kimerling, ME				Wells, William A.; Ge, Colin Fan; Patel, Nitin; Oh, Teresa; Gardiner, Elizabeth; Kimerling, Michael E.			Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; INDIA; PRACTITIONERS; MIX; COLLABORATION; PHILIPPINES; PROVIDERS; RESISTANT; DOTS; CARE	Background: Tuberculosis (TB) control is considered primarily a public health concern, and private sector TB treatment has attracted less attention. Thus, the size and characteristics of private sector TB drug sales remain largely unknown. Methodology/Principal Findings: We used IMS Health data to analyze private TB drug consumption in 10 high burden countries (HBCs), after first mapping how well IMS data coverage overlapped with private markets. We defined private markets as any channels not used or influenced by national TB programs. Private markets in four countries - Pakistan, the Philippines, Indonesia and India - had the largest relative sales volumes; annually, they sold enough first line TB drugs to provide 65-117% of the respective countries' estimated annual incident cases with a standard 6-8 month regimen. First line drug volumes in five countries were predominantly fixed dose combinations (FDCs), but predominantly loose drugs in the other five. Across 10 countries, these drugs were available in 37 (loose drug) plus 74 (FDCs) distinct strengths. There were 54 distinct, significant first line manufacturers (range 2-11 per country), and most companies sold TB drugs in only a single study country. FDC markets were, however, more concentrated, with 4 companies capturing 69% of FDC volume across the ten countries. Among second line drugs, fluoroquinolones were widely available, with significant volumes used for TB in India, Pakistan and Indonesia. However, certain WHO-recommended drugs were not available and in general there were insufficient drug volumes to cover the majority of the expected burden of multidrug-resistant TB (MDR-TB). Conclusions/Significance: Private TB drug markets in several HBCs are substantial, stable, and complicated. This calls for appropriate policy and market responses, including expansion of Public-Private Mix (PPM) programs, greater reach, flexibility and appeal of public programs, regulatory and quality enforcement, and expansion of public MDR-TB treatment programs.	[Wells, William A.; Gardiner, Elizabeth] Global Alliance TB Drug Dev, New York, NY USA; [Ge, Colin Fan; Patel, Nitin; Oh, Teresa] IMS Hlth, New York, NY USA; [Kimerling, Michael E.] Bill & Melinda Gates Fdn, Seattle, WA USA	Bill & Melinda Gates Foundation	Wells, WA (corresponding author), Global Alliance TB Drug Dev, New York, NY USA.	william.wells@tballiance.org		oh, teresa/0000-0002-4194-381X	Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS) [14848]; United Kingdom Department for International Development (DfID) [733637048]; Bill & Melinda Gates Foundation [40827]; IMS Health, Inc.; Bill & Melinda Gates Foundation	Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS); United Kingdom Department for International Development (DfID); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); IMS Health, Inc.; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this study came from The Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS; http://www.minbuza.nl/en; Grant #14848), The United Kingdom Department for International Development (DfID; http://www.dfid.gov.uk/; Grant code 733637048) and the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org; Grant #40827). Three of the authors are employed by IMS Health, Inc., a for-profit company, which is also considered a funder. Certain individuals are employed by two of the sponsors (CGF, TO and NP by IMS Health, Inc., and MEK by the Bill & Melinda Gates Foundation). Although they did not initiate the study concept, they were involved in subsequent steps of developing the methodology, and conducting and writing up the study. Apart from this involvement of these individuals, the sponsoring organizations for the study had no role in study design, data collection, data analysis, data interpretation, or writing of this report. The corresponding author had access to all data in the study and had final responsibility for the decision to submit for publication.	Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; Ahmed Jameel, 2009, J Pak Med Assoc, V59, P82; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Ipuge YAI, 1997, E AFR MED J, V74, P816; Jaggarajamma K, 2009, Indian J Tuberc, V56, P185; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Mantala MJ, 2003, TUBERCULOSIS, V83, P173, DOI 10.1016/S1472-9792(02)00067-7; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Quy HT, 2003, INT J TUBERC LUNG D, V7, P1139; Schwalbe NR, 2008, INT J TUBERC LUNG D, V12, P1173; *TB ALL, 2007, PATHW PAT CHART DYN; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wells WA, 2010, INT J TUBERC LUNG D, V14, P1538; WELLS WA, 2011, INT J TUBERC IN PRES; WHO, 2009, TREATM TUB GUID; World Health Organization, 2010, GLOB TUB CONTR WHO R; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization, 1999, FIX DOS COMB TABL TR	31	78	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18964	10.1371/journal.pone.0018964	http://dx.doi.org/10.1371/journal.pone.0018964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573227	Green Published, gold			2022-12-25	WOS:000290224800009
J	Yazama, F; Tai, A				Yazama, Futoshi; Tai, Akihiro			Unexpected Role of alpha-Fetoprotein in Spermatogenesis	PLOS ONE			English	Article							BLOOD-TESTIS BARRIER; EXPERIMENTAL CRYPTORCHIDISM; PARTIAL-HEPATECTOMY; TESTICULAR CELLS; GERM-CELLS; HEAT-SHOCK; IN-VITRO; MOUSE; RAT; PROTEINS	Background: Heat shock severely affects sperm production (spermatogenesis) and results in a rapid loss of haploid germ cells, or in other words, sperm formation (spermiogenesis) is inhibited. However, the mechanisms behind the effects of heat shock on spermatogenesis are obscure. Methodology/Principal Findings: To identify the inhibitory factor of spermiogenesis, experimental cryptorchid (EC) mice were used in this study. Here we show that alpha-fetoprotein (AFP) is specifically expressed in the testes of EC mice by proteome analysis. AFP was also specifically localized spermatocytes by immunohistochemical analysis and was secreted into the circulation system of EC mice by immunoblot analysis. Since spermatogenesis of an advanced mammal cannot be reproduced with in vitro, we performed the microinjection of AFP into the seminiferous tubules of normal mice to determine whether AFP inhibits spermiogenesis in vivo. AFP was directly responsible for the block in spermiogenesis of normal mice. To investigate whether AFP inhibits cell differentiation in other models, using EC mice we performed a partial hepatectomy (PH) that triggers a rapid regenerative response in the remnant liver tissue. We also found that liver regeneration is inhibited in EC mice with PH. The result suggests that AFP released into the blood of EC mice regulates liver regeneration by inhibiting the cell division of hepatocytes. Conclusions/Significance: AFP is a well-known cancer-specific marker, but AFP has no known function in healthy human beings. Our findings indicate that AFP expressed under EC conditions plays a role as a regulatory factor in spermatogenesis and in hepatic generation.	[Yazama, Futoshi; Tai, Akihiro] Prefectural Univ Hiroshima, Dept Life Sci, Shobara City, Hiroshima, Japan		Yazama, F (corresponding author), Prefectural Univ Hiroshima, Dept Life Sci, Shobara City, Hiroshima, Japan.	fyzma@pu-hiroshima.ac.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the Japan Science and Technology Agency to FY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BERGSTRAND CG, 1957, SCAND J CLIN LAB INV, V9, P277, DOI 10.3109/00365515709079971; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; FUJISAWA M, 1988, J REPROD FERTIL, V84, P123, DOI 10.1530/jrf.0.0840123; HAGENAS L, 1977, ANDROLOGIA, V9, P250; HENRIKSEN K, 1995, INT J ANDROL, V18, P256, DOI 10.1111/ijan.1995.18.5.256; HIRANO H, 1989, J PROTEIN CHEM, V8, P115, DOI 10.1007/BF01025083; Hirano H., 1989, METHODS PROTEIN SEQU, P42; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Inderbitzin D, 2006, MICROSURG, V26, P465, DOI 10.1002/micr.20271; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nikfarjam M, 2004, J INVEST SURG, V17, P291, DOI 10.1080/08941930490502871; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Sailer BL, 1997, J ANDROL, V18, P294; SETCHELL BP, 1975, HDB PHYSIOLOGY, V5, P143; Setchell BP, 1982, REPRODUCTION MAMMALS, P63; SHIOJIRI N, 1991, CANCER RES, V51, P2611; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Tatarinov Y S, 1966, Fed Proc Transl Suppl, V25, P344; Yazama F, 2000, ANAT RECORD, V260, P402, DOI 10.1002/1097-0185(20001201)260:4<402::AID-AR100>3.0.CO;2-0; Yazama F, 2008, J REPROD DEVELOP, V54, P299, DOI 10.1262/jrd.19169; Yazama F, 2006, ANAT SCI INT, V81, P115, DOI 10.1111/j.1447-073X.2006.00139.x	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19387	10.1371/journal.pone.0019387	http://dx.doi.org/10.1371/journal.pone.0019387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573244	gold, Green Published, Green Submitted			2022-12-25	WOS:000290224800027
J	Poschl, J; Lorenz, A; Hartmann, W; von Bueren, AO; Kool, M; Li, S; Peraud, A; Tonn, JC; Herms, J; Xiang, M; Rutkowski, S; Kretzschmar, HA; Schuller, U				Poeschl, J.; Lorenz, A.; Hartmann, W.; von Bueren, A. O.; Kool, M.; Li, S.; Peraud, A.; Tonn, J-C; Herms, J.; Xiang, M.; Rutkowski, S.; Kretzschmar, H. A.; Schueller, U.			Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans	ONCOGENE			English	Article						cerebellum; medulloblastoma; Barhl1; survival; Sonic hedgehog; tumor	CENTRAL-NERVOUS-SYSTEM; HEDGEHOG PATHWAY; GENE-EXPRESSION; HOMEOBOX GENE; MOUSE MODEL; CELLS; CEREBELLUM; SUBTYPES; GROWTH	Medulloblastoma is the most common malignant brain tumor in childhood, and development of targeted therapies is highly desired. Although the molecular mechanisms of malignant transformation are not fully understood, it is known that medulloblastomas may arise from cerebellar granule neuron precursors. The homeodomain transcription factor Barhl1 is known to regulate migration and survival of granule cell precursors, but its functional role in medulloblastoma is unknown. We show here that the expression of BARHL1 is significantly upregulated during human cerebellar development and in human medulloblastoma samples as compared with the normal adult cerebellum. We also detected high levels of Barhl1 expression in medulloblastomas of Math1-cre:SmoM2 mice, a mouse model for Sonic hedgehog-associated medulloblastomas that we developed previously. To investigate Barhl1 function in vivo during tumor development, we generated Barhl1(-/-) Math1-cre: SmoM2 mice. Interestingly, tumors that developed in these mice displayed increased mitotic activity and decreased neuronal differentiation. Moreover, survival of these mice was significantly decreased. Similarly, low expression of BARHL1 in human medulloblastoma cases was associated with a less favorable prognosis for patients. These results suggest that the expression of Barhl1 decelerates tumor growth both in human and in murine medulloblastomas and should be further investigated with respect to potential implications for individualized therapeutic strategies. Oncogene (2011) 30, 4721-4730; doi:10.1038/onc.2011.173; published online 23 May 2011	[Poeschl, J.; Lorenz, A.; Herms, J.; Kretzschmar, H. A.; Schueller, U.] Univ Munich, Ctr Neuropathol, D-81377 Munich, Germany; [Hartmann, W.] Univ Bonn, Med Ctr, Dept Pathol, Bonn, Germany; [von Bueren, A. O.; Rutkowski, S.] Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Kool, M.] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Li, S.; Xiang, M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Li, S.; Xiang, M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; [Peraud, A.; Tonn, J-C] Univ Munich, Dept Neurosurg, D-81377 Munich, Germany	University of Munich; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Amsterdam; Academic Medical Center Amsterdam; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Munich	Schuller, U (corresponding author), Univ Munich, Ctr Neuropathol, Feodor Lynen Str 23, D-81377 Munich, Germany.	ulrich.schueller@lmu.de	von Bueren, Andre/AAF-2065-2020; Kool, Marcel/H-2541-2013; Hartmann, Wolfgang/G-1893-2017; Tonn, Joerg/AAK-8509-2021; Herms, Jochen/D-3518-2011	Hartmann, Wolfgang/0000-0002-7609-5021; von Bueren, Andre/0000-0003-4197-6264; Schuller, Ulrich/0000-0002-8731-1121; Neumann, Julia E./0000-0002-1162-8771	Wilhelm-Sander-Stiftung; Friedrich-Baur-Stiftung; German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung); Fordergemeinschaft Kinderkrebszentrum Hamburg e. V.; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012020, R01EY015777] Funding Source: NIH RePORTER	Wilhelm-Sander-Stiftung; Friedrich-Baur-Stiftung; German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung); Fordergemeinschaft Kinderkrebszentrum Hamburg e. V.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are indebted to Michael Schmidt, Veronika Kaltenbrunn, Dagmar Metzger, Philipp Neumann and Silvia Occhionero for excellent technical support, to Dr Mehdi Shakarami and Dr Stefanie Ohlemeyer for animal husbandry. We acknowledge Dr Rosalind Segal for providing Zic antibodies. This work was supported by grants from the Wilhelm-Sander-Stiftung and the Friedrich-Baur-Stiftung (all to US). US is a member of the Max-Eder-junior-research-program of the German Cancer Aid. The HIT-trial-office at the University Medical Center Hamburg-Eppendorf is supported by the German Children's Cancer Foundation (Deutsche Kinderkrebsstiftung) and by the Fordergemeinschaft Kinderkrebszentrum Hamburg e. V.	Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Eberhart CG, 2001, J NEUROPATH EXP NEUR, V60, P462, DOI 10.1093/jnen/60.5.462; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Li SG, 2002, DEVELOPMENT, V129, P3523; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; The WHO, 2020, CLASSIFICATION TUMOU; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Yokota N, 1996, CANCER RES, V56, P377	27	15	15	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	47					4721	4730		10.1038/onc.2011.173	http://dx.doi.org/10.1038/onc.2011.173			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21602885	Green Accepted			2022-12-25	WOS:000298033700004
J	Bonnefond, A; Lomberk, G; Buttar, N; Busiah, K; Vaillant, E; Lobbens, S; Yengo, L; Dechaume, A; Mignot, B; Simon, A; Scharfmann, R; Neve, B; Tanyolac, S; Hodoglugil, U; Pattou, F; Cave, H; Iovanna, J; Stein, R; Polak, M; Vaxillaire, M; Froguel, P; Urrutia, R				Bonnefond, Amelie; Lomberk, Gwen; Buttar, Navtej; Busiah, Kanetee; Vaillant, Emmanuel; Lobbens, Stephane; Yengo, Loic; Dechaume, Aurelie; Mignot, Brigitte; Simon, Albane; Scharfmann, Raphael; Neve, Bernadette; Tanyolac, Sinan; Hodoglugil, Ugur; Pattou, Francois; Cave, Helene; Iovanna, Juan; Stein, Roland; Polak, Michel; Vaxillaire, Martine; Froguel, Philippe; Urrutia, Raul			Disruption of a Novel Kruppel-like Transcription Factor p300-regulated Pathway for Insulin Biosynthesis Revealed by Studies of the c.-331 INS Mutation Found in Neonatal Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR KLF11; GENE; GLUCOSE; EXPRESSION; FINGER; P300; PURIFICATION; SUBFAMILY; VARIANTS; FAMILY	Kruppel-like transcription factors (KLFs) have elicited significant attention because of their regulation of essential biochemical pathways and, more recently, because of their fundamental role in the mechanisms of human diseases. Neonatal diabetes mellitus is a monogenic disorder with primary alterations in insulin secretion. We here describe a key biochemical mechanism that underlies neonatal diabetes mellitus insulin biosynthesis impairment, namely a homozygous mutation within the insulin gene (INS) promoter, c.-331C>G, which affects a novel KLF-binding site. The combination of careful expression profiling, electromobility shift assays, reporter experiments, and chromatin immunoprecipitation demonstrates that, among 16 different KLF proteins tested, KLF11 is the most reliable activator of this site. Congruently, the c.-331C>G INS mutation fails to bind KLF11, thus inhibiting activation by this transcription factor. Klf11(-/-) mice recapitulate the disruption in insulin production and blood levels observed in patients. Thus, these data demonstrate an important role for KLF11 in the regulation of INS transcription via the novel c.-331 KLF site. Lastly, our screening data raised the possibility that other members of the KLF family may also regulate this promoter under distinct, yet unidentified, cellular contexts. Collectively, this study underscores a key role for KLF proteins in biochemical mechanisms of human diseases, in particular, early infancy onset diabetes mellitus.	[Polak, Michel] Univ Paris 05, Hop Necker Enfants Malad, AP HP,INSERM,U845, Dept Pediat Endocrinol,Serv Endocrinol Pediat, F-75015 Paris, France; [Bonnefond, Amelie; Vaillant, Emmanuel; Lobbens, Stephane; Yengo, Loic; Dechaume, Aurelie; Neve, Bernadette; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Lille Pasteur Inst, CNRS, UMR 8199, F-59800 Lille, France; [Lomberk, Gwen; Buttar, Navtej; Urrutia, Raul] Mayo Clin, Gastroenterol Res Unit, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Mignot, Brigitte] Ctr Hosp Univ CHU St Jacques, Dept Pediat Endocrinol, F-25030 Besancon, France; [Tanyolac, Sinan] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Med, San Francisco, CA 94115 USA; [Tanyolac, Sinan] Univ Calif San Francisco, Mt Zion Med Ctr, Ctr Diabet, San Francisco, CA 94115 USA; [Hodoglugil, Ugur] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Pattou, Francois] Univ Lille Nord France, Univ Hosp Lille, INSERM, U859, F-75019 Paris, France; [Cave, Helene] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Iovanna, Juan] INSERM, U624, F-13288 Marseille, France; [Stein, Roland] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Mayo Clinic; Universite de Franche-Comte; CHU Besancon; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; The J David Gladstone Institutes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Vanderbilt University; Imperial College London	Polak, M (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP,INSERM,U845, Dept Pediat Endocrinol,Serv Endocrinol Pediat, F-75015 Paris, France.	michel.polak@nck.aphp.fr; p.froguel@imperial.ac.uk; urrutia.raul@mayo.edu	Iovanna, Juan/M-9805-2017; Tanyolac, Sinan/AAP-5966-2021; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Neve, Bernadette/J-6008-2014; scharfmann, raphael/L-3296-2017; Yengo, Loic/D-2692-2017; Kanetee, BUSIAH/AAP-8292-2020; Lomberk, Gwen/AAL-8490-2020; Pattou, Francois/O-6151-2017	Iovanna, Juan/0000-0003-1822-2237; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Neve, Bernadette/0000-0003-1516-1379; Yengo, Loic/0000-0002-4272-9305; Kanetee, BUSIAH/0000-0002-1059-0791; Lomberk, Gwen/0000-0001-5463-789X; Pattou, Francois/0000-0001-8388-3766; Scharfmann, Raphael/0000-0001-7619-337X; Cave, Helene/0000-0003-2840-1511	National Institutes of Health [DK52913, DK050203]; Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR) [ANR-07-MRAR-000]; Transnational European Research Grant on Rare Diseases [ERANET-09-RARE-005]; European Union of the European Community [LSHM-CT-2006-518153]; Conseil Regional du Nord Pas de Calais (France); Centre National de la Recherche Scientifique; Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche; HRA Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK050203, R01DK052913, R01DK050203, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR)(French National Research Agency (ANR)); Transnational European Research Grant on Rare Diseases; European Union of the European Community; Conseil Regional du Nord Pas de Calais (France)(Region Hauts-de-FranceRegion Ile-de-France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche; HRA Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.) and DK050203 (to R. S.). This work was also supported by Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR) Research Program Grant ANR-07-MRAR-000 (to M. P.), Transnational European Research Grant on Rare Diseases ERANET-09-RARE-005 (to M. V. and M. P.), and European Union Integrated Project EuroDia LSHM-CT-2006-518153 in Framework Programme 6 of the European Community (to P. F.).; Supported by a research fellowship from the Conseil Regional du Nord Pas de Calais (France) and the Centre National de la Recherche Scientifique.; Supported by Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche and HRA Pharma.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Alevizos I, 2007, CELL CYCLE, V6, P1631, DOI 10.4161/cc.6.13.4380; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bieker JJ, 2010, NAT GENET, V42, P733, DOI 10.1038/ng0910-733; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Greeley SAW, 2010, TRENDS ENDOCRIN MET, V21, P464, DOI 10.1016/j.tem.2010.03.004; Gutierrez-Aguilar R, 2008, J CLIN ENDOCR METAB, V93, P3128, DOI 10.1210/jc.2007-2504; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nagai R, 2009, BIOLOGY OF KRUPPEL-LIKE FACTORS, P3, DOI 10.1007/978-4-431-87775-2_1; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Song CZ, 2005, BLOOD CELL MOL DIS, V34, P53, DOI 10.1016/j.bcmd.2004.08.027; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Vaxillaire Martine, 2009, Pediatr Endocrinol Rev, V6, P405; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039	45	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28414	28424		10.1074/jbc.M110.215822	http://dx.doi.org/10.1074/jbc.M110.215822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21592955	hybrid, Green Published			2022-12-25	WOS:000293557800057
J	Aramini, JM; Ma, LC; Zhou, LG; Schauder, CM; Hamilton, K; Amer, BR; Mack, TR; Lee, HW; Ciccosanti, CT; Zhao, L; Xiao, R; Krug, RM; Montelione, GT				Aramini, James M.; Ma, Li-Chung; Zhou, Ligang; Schauder, Curtis M.; Hamilton, Keith; Amer, Brendan R.; Mack, Timothy R.; Lee, Hsiau-Wei; Ciccosanti, Colleen T.; Zhao, Li; Xiao, Rong; Krug, Robert M.; Montelione, Gaetano T.			Dimer Interface of the Effector Domain of Non-structural Protein 1 from Influenza A Virus AN INTERFACE WITH MULTIPLE FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; TORSION ANGLE DYNAMICS; DOUBLE-STRANDED-RNA; PRE-MESSENGER-RNAS; X-RAY-STRUCTURE; NS1 PROTEIN; BACKBONE DYNAMICS; BINDING-SITE; RESONANCE ASSIGNMENTS; ESCHERICHIA-COLI	Non-structural protein 1 from influenza A virus, NS1A, is a key multifunctional virulence factor composed of two domains: an N-terminal double-stranded RNA (dsRNA)-binding domain and a C-terminal effector domain (ED). Isolated RNA-binding and effector domains of NS1A both exist as homodimers in solution. Despite recent crystal structures of isolated ED and full-length NS1A proteins from different influenza virus strains, controversy remains over the actual biologically relevant ED dimer interface. Here, we report the biophysical properties of the NS1A ED from H3N2 influenza A/Udorn/307/1972 (Ud) virus in solution. Several lines of evidence, including N-15 NMR relaxation, NMR chemical shift perturbations, static light scattering, and analytical sedimentation equilibrium, demonstrate that Ud NS1A ED forms a relatively weak dimer in solution (K-d = 90 +/- 2 mu M), featuring a symmetric helix-helix dimer interface. Mutations within and near this interface completely abolish dimerization, whereas mutations consistent with other proposed ED dimer interfaces have no effect on dimer formation. In addition, the critical Trp-187 residue in this interface serves as a sensitive NMR spectroscopic marker for the concentration-dependent dimerization of NS1A ED in solution. Finally, dynamic light scattering and gel shift binding experiments demonstrate that the ED interface plays a role in both the oligomerization and the dsRNA binding properties of the full-length NS1A protein. In particular, mutation of the critical tryptophan in the ED interface substantially reduces the propensity of full-length NS1A from different strains to oligomerize and results in a reduction in dsRNA binding affinity for full-length NS1A.	[Mack, Timothy R.; Ciccosanti, Colleen T.; Zhao, Li; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Zhou, Ligang; Krug, Robert M.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Lee, Hsiau-Wei] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Dept Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Austin; University System of Georgia; University of Georgia; Rutgers State University New Brunswick; Rutgers State University Medical Center	Montelione, GT (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	jma@cabm.rutgers.edu; guy@cabm.rutgers.edu	LEE, HSIAU-WEI/A-1415-2012; Zhou, Ligang/I-9516-2012	Zhou, Ligang/0000-0002-1297-0288; Lee, Hsiau-Wei/0000-0002-6060-6341; Amer, Brendan/0000-0001-6564-3347; Montelione, Gaetano/0000-0002-9440-3059	National Institutes of Health through the NIGMS Protein Structure Initiative [U54-GM094597]; National Institutes of Health [U01 AI074497, R01 AI11772]; National Institutes of Health through Protein Structure Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074497, R01AI011772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS Protein Structure Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54-GM094597 through the NIGMS Protein Structure Initiative (to G. T. M.) and National Institutes of Health Grants U01 AI074497 (to G. T. M. and R. M. K.) and R01 AI11772 (to R. M. K.).; We thank Paolo Rossi, Christopher Barbieri, Arthur Clark, Brian Radvansky, Alexander Lemak, and Rongjin Guan for valuable scientific discussions. Yeast SUMO protease was kindly provided by Prof. Steven Brill. Structures were determined through the Northeast Structural Genomics Consortium (NESG), which is supported by the National Institutes of Health through the PSI-Biology program of the Protein Structure Initiative.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Basu D, 2009, J VIROL, V83, P1881, DOI 10.1128/JVI.01805-08; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Goddard T. D., 2006, SPARKY 3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jansson M, 1996, J BIOMOL NMR, V7, P131; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kerry PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017946; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Krug RM, 2009, TRENDS PHARMACOL SCI, V30, P269, DOI 10.1016/j.tips.2009.03.002; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PELTON JG, 1993, PROTEIN SCI, V2, P543; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Xia SL, 2010, ARCH BIOCHEM BIOPHYS, V494, P198, DOI 10.1016/j.abb.2009.12.008; Xia SL, 2009, ACTA CRYSTALLOGR D, V65, P11, DOI 10.1107/S0907444908032186; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	59	50	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26050	26060		10.1074/jbc.M111.248765	http://dx.doi.org/10.1074/jbc.M111.248765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622573	Green Published, hybrid			2022-12-25	WOS:000293073000063
J	Duex, JE; Comeau, L; Sorkin, A; Purow, B; Kefas, B				Duex, Jason E.; Comeau, Laurey; Sorkin, Alexander; Purow, Benjamin; Kefas, Benjamin			Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-SPECIFIC PROTEASE; LUNG-CANCER; ISG15; APOPTOSIS; UBP43; BIOGENESIS; KINASE; GLIOMA; IDENTIFICATION; STIMULATION	Epidermal growth factor receptor (EGFR) is involved in development and progression of many human cancers. We have previously demonstrated that the ubiquitin-specific peptidase Usp18 (Ubp43) is a potent regulator of EGFR protein expression. Here we report that the 3'-untranslated region (3'-UTR) of the EGFR message modulates RNA translation following cell treatment with Usp18 siRNA, suggesting microRNA as a possible mediator. Given earlier evidence of EGFR regulation by the microRNA miR-7, we assessed whether miR-7 mediates Usp18 siRNA effects. We found that Usp18 depletion elevates miR-7 levels in several cancer cell lines because of a transcriptional activation and/or mRNA stabilization of miR-7 host genes and that miR-7 acts downstream of Usp18 to regulate EGFR mRNA translation via the 3'-UTR. Also, depletion of Usp18 led to a decrease in protein levels of other known oncogenic targets of miR-7, reduced cell proliferation and soft agar colony formation, and increased apoptosis. Notably, all of these phenotypes were reversed by a specific inhibitor of miR-7. Thus, our findings support a model in which Usp18 inhibition promotes upregulation of miR-7, which in turn inhibits EGFR expression and the tumorigenic activity of cancer cells.	[Duex, Jason E.; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Purow, Benjamin; Kefas, Benjamin] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Old Med Sch, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 Biomed Sci Tower S,3500 Terrace St, Pittsburgh, PA 15261 USA.	sorkin@pitt.edu; bwp5g@virginia.edu; bak4x@virginia.edu		Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health [R01 CA136803, R01 CA089151]; Howard Hughes Medical Institute;  [F32CA126344]; NATIONAL CANCER INSTITUTE [F32CA126344, R01CA136803, R01CA089151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136803 (to B.P.) and a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to B.P.), a F32CA126344 fellowship (to J.E.D.), and National Institutes of Health Grant R01 CA089151 (to A.S. and J.E.D.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Duex JE, 2010, EXP CELL RES, V316, P2136, DOI 10.1016/j.yexcr.2010.04.017; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lemmon M. A., J CELL, V141, P1117; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Shen L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-232; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weiss GJ, 2008, ANN ONCOL, V19, P1053, DOI 10.1093/annonc/mdn006; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	50	52	55	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25377	25386		10.1074/jbc.M111.222760	http://dx.doi.org/10.1074/jbc.M111.222760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592959	Green Published, hybrid			2022-12-25	WOS:000292547900083
J	Joshi, P; Stoddart, CA				Joshi, Pheroze; Stoddart, Cheryl A.			Impaired Infectivity of Ritonavir-resistant HIV Is Rescued by Heat Shock Protein 90AB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CAPSID PROTEIN; CYCLOPHILIN-A; GAG PROTEIN; MATURATION; HSP90; REPLICATION; INHIBITORS; GLYCOPROTEIN; MECHANISM	Certain ritonavir resistance mutations impair HIV infectivity through incomplete Gag processing by the mutant viral protease. Analysis of the mutant virus phenotype indicates that accumulation of capsid-spacer peptide 1 precursor protein in virus particles impairs HIV infectivity and that the protease mutant virus is arrested during the early postentry stage of HIV infection before proviral DNA synthesis. However, activation of the target cell can rescue this defect, implying that specific host factors expressed in activated cells can compensate for the defect in ritonavir-resistant HIV. This ability to rescue impaired HIV replication presented a unique opportunity to identify host factors involved in postentry HIV replication, and we designed a functional genetic screen so that expression of a given host factor extracted from activated T cells would lead directly to its discovery by rescuing mutant virus replication in nonactivated T cells. We identified the cellular heat shock protein 90 kDa alpha (cytosolic), class B member 1 (HSP90AB1) as a host factor that can rescue impaired replication of ritonavir-resistant HIV. Moreover, we show that pharmacologic inhibition of HSP90AB1 with 17-(allylamino)-17-demethoxygeldanamycin (tanespimycin) has potent in vitro anti-HIV activity and that ritonavir-resistant HIV is hypersensitive to the drug. These results suggest a possible role for HSP90AB1 in postentry HIV replication and may provide an attractive target for therapeutic intervention.	[Joshi, Pheroze; Stoddart, Cheryl A.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Stoddart, CA (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	cheryl.stoddart@ucsf.edu			National Institutes of Health, NIAID [N01-AI-70002]; California HIV/AIDS Research Program [ID09-SF-051]; University of California; San Francisco AIDS Research Institute; Harvey V. Berneking Living Trust	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California HIV/AIDS Research Program; University of California(University of California System); San Francisco AIDS Research Institute; Harvey V. Berneking Living Trust	This work was supported, in whole or in part, by a National Institutes of Health grant from NIAID under Contract N01-AI-70002. This work was also supported by California HIV/AIDS Research Program Grant ID09-SF-051 (to C. A. S.) and in part by the University of California, San Francisco AIDS Research Institute and the Harvey V. Berneking Living Trust.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Anderson Jeffrey, 2009, V189, P85; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chadli A, 2008, BIOCHEMISTRY-US, V47, P2850, DOI 10.1021/bi7023332; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cornetta Kenneth, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.top29; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001251; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yin PD, 2006, CELL MOL LIFE SCI, V63, P1706, DOI 10.1007/s00018-006-6009-7; Yu Hong, 2008, V433, P1, DOI 10.1007/978-1-59745-237-3_1; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200	47	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24581	24592		10.1074/jbc.M111.248021	http://dx.doi.org/10.1074/jbc.M111.248021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602280	hybrid, Green Published			2022-12-25	WOS:000292547900008
J	Li, YP; Zhang, CZ; Chen, XD; Yu, J; Wang, Y; Yang, Y; Du, MJ; Jin, HL; Ma, YJ; He, B; Cao, YJ				Li, Yapeng; Zhang, Cuizhu; Chen, Xiangdong; Yu, Jia; Wang, Yu; Yang, Yin; Du, Mingjuan; Jin, Huali; Ma, Yijie; He, Bin; Cao, Youjia			ICP34.5 Protein of Herpes Simplex Virus Facilitates the Initiation of Protein Translation by Bridging Eukaryotic Initiation Factor 2 alpha (eIF2 alpha) and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; MOLECULAR-WEIGHT COMPLEX; GAMMA(1)34.5 PROTEIN; LIVING CELLS; DNA-DAMAGE; CARBOXYL-TERMINUS; GROWTH ARREST; ARGININE-RICH; ALPHA-SUBUNIT; KINASE	The ICP34.5 protein of herpes simplex virus type 1 is a neurovirulence factor that plays critical roles in viral replication and anti-host responses. One of its functions is to recruit protein phosphatase 1 (PP1) that leads to the dephosphorylation of the alpha subunit of translation initiation factor eIF2 (eIF2 alpha), which is inactivated by infection-induced phosphorylation. As PP1 is a protein phosphatase with a wide range of substrates, the question remains to be answered how ICP34.5 directs PP1 to specifically dephosphorylate eIF2 alpha. Here we report that ICP34.5 not only binds PP1 but also associates with eIF2 alpha by in vitro and in vivo assays. The binding site of eIF2 alpha is identified at amino acids 233-248 of ICP34.5, which falls in the highly homologous region with human gene growth arrest and DNA damage 34. The interaction between ICP34.5 and eIF2 alpha is independent of the phosphorylation status of eIF2 alpha at serine 51. Deletion mutation of this region results in the failure of dephosphorylation of eIF2 alpha by PP1 and, consequently, interrupts viral protein synthesis and replication. Our data illustrated that the binding between viral protein ICP34.5 and the host eIF2 alpha is crucial for the specific dephosphorylation of eIF2 alpha by PP1. We propose that herpes simplex virus protein ICP34.5 bridges PP1 and eIF2 alpha via their binding motifs and thereby facilitates the protein synthesis and viral replication.	[Li, Yapeng; Zhang, Cuizhu; Chen, Xiangdong; Yu, Jia; Wang, Yu; Yang, Yin; Du, Mingjuan; Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Jin, Huali; Ma, Yijie; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cao, YJ (corresponding author), Mol Biol Inst Bldg,Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn	Jin, Huali/F-3650-2011		National Natural Science Foundation of China [30670080, 30870128]; Ministry of Science and Technology of China [2007CB914800, 2006DFB32420]; National Institute of Allergy and Infectious Diseases [AI092230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092230] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 30670080 and 30870128 (to Y. C.), Ministry of Science and Technology of China Grants 2007CB914800 and 2006DFB32420, and National Institute of Allergy and Infectious Diseases Grant AI092230 (to B. H.).	Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; Cheng GF, 2001, J VIROL, V75, P3666, DOI 10.1128/JVI.75.8.3666-3674.2001; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; GUNNERY S, 1990, P NATL ACAD SCI USA, V87, P8687, DOI 10.1073/pnas.87.22.8687; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1996, J VIROL, V70, P84, DOI 10.1128/JVI.70.1.84-90.1996; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Khoo D, 2002, J VIROL, V76, P11971, DOI 10.1128/JVI.76.23.11971-11981.2002; LORD KA, 1990, NUCLEIC ACIDS RES, V18, P2823, DOI 10.1093/nar/18.9.2823; Mao HW, 2002, J BIOL CHEM, V277, P11423, DOI 10.1074/jbc.M111553200; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang CZ, 2008, FEBS LETT, V582, P171, DOI 10.1016/j.febslet.2007.11.082	28	71	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24785	24792		10.1074/jbc.M111.232439	http://dx.doi.org/10.1074/jbc.M111.232439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622569	Green Published, hybrid			2022-12-25	WOS:000292547900029
J	Sathe, MN; Woo, K; Kresge, C; Bugde, A; Luby-Phelps, K; Lewis, MA; Feranchak, AP				Sathe, Meghana N.; Woo, Kangmee; Kresge, Charles; Bugde, Abhijit; Luby-Phelps, Kate; Lewis, Matthew A.; Feranchak, Andrew P.			Regulation of Purinergic Signaling in Biliary Epithelial Cells by Exocytosis of SLC17A9-dependent ATP-enriched Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ADENOSINE-TRIPHOSPHATE RELEASE; PROTEIN-KINASE-C; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR NUCLEOTIDES; BICARBONATE SECRETION; VESICULAR EXOCYTOSIS; DEPENDENT REGULATION; VOLUME REGULATION; CHOLANGIOCYTES	ATP in bile is a potent secretogogue, stimulating biliary epithelial cell (BEC) secretion through binding apical purinergic receptors. In response to mechanosensitive stimuli, BECs release ATP into bile, although the cellular basis of ATP release is unknown. The aims of this study in human and mouse BECs were to determine whether ATP release occurs via exocytosis of ATP-enriched vesicles and to elucidate the potential role of the vesicular nucleotide transporter SLC17A9 in purinergic signaling. Dynamic, multiscale, live cell imaging (confocal and total internal reflection fluorescence microscopy and a luminescence detection system with a high sensitivity charge-coupled device camera) was utilized to detect vesicular ATP release from cell populations, single cells, and the submembrane space of a single cell. In response to increases in cell volume, BECs release ATP, which was dependent on intact microtubules and vesicular trafficking pathways. ATP release occurred as stochastic point source bursts of luminescence consistent with exocytic events. Parallel studies identified ATP-enriched vesicles ranging in size from 0.4 to 1 mu m that underwent fusion and release in response to increases in cell volume in a protein kinase C-dependent manner. Present in all models, SLC17A9 contributed to ATP vesicle formation and regulated ATP release. The findings are consistent with the existence of an SLC17A9-dependent ATP-enriched vesicular pool in biliary epithelium that undergoes regulated exocytosis to initiate purinergic signaling.	[Sathe, Meghana N.; Woo, Kangmee; Kresge, Charles; Feranchak, Andrew P.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bugde, Abhijit; Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lewis, Matthew A.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	NIDDK [DK078587]; Cystic Fibrosis Foundation [FERANC08G0]; Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078587] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK078587 from the NIDDK (to A.P.F.). This work was also supported by Cystic Fibrosis Foundation Grant FERANC08G0 and the Children's Medical Center Foundation (to A.P.F.).	Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Burnstock G, 2003, CURR TOP MEMBR, V54, P307, DOI 10.1016/S1063-5823(03)01010-X; BURNSTOCK G, 1970, BRIT J PHARMACOL, V40, P668, DOI 10.1111/j.1476-5381.1970.tb10646.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Dutta AK, 2009, AM J PHYSIOL-GASTR L, V297, pG1009, DOI 10.1152/ajpgi.00223.2009; Feranchak AP, 2007, GASTROENTEROLOGY, V133, P1726, DOI 10.1053/j.gastro.2007.09.050; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Feranchak AP, 2002, SEMIN LIVER DIS, V22, P251, DOI 10.1055/s-2002-34503; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; IRVIN JL, 1954, J BIOL CHEM, V210, P45; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; Roman RM, 1998, HEPATOLOGY, V28, P1073, DOI 10.1002/hep.510280423; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Spivey J. R., 1993, J CLIN INVEST, V92, P17; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Thevananther S, 2004, HEPATOLOGY, V39, P393, DOI 10.1002/hep.20075; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Woo K, 2010, HEPATOLOGY, V52, P1819, DOI 10.1002/hep.23883; Yang W, 2001, ACTA PHYSIOL SCAND, V171, P413, DOI 10.1046/j.1365-201X.2001.00809.x; Yu J, 2009, AM J PHYSIOL-GASTR L, V296, pG563, DOI 10.1152/ajpgi.90502.2008; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao YQ, 2007, J BIOL CHEM, V282, P1249, DOI 10.1074/jbc.M606998200	50	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25363	25376		10.1074/jbc.M111.232868	http://dx.doi.org/10.1074/jbc.M111.232868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613220	Green Published, hybrid			2022-12-25	WOS:000292547900082
J	Moon, JS; Kim, HE; Koh, E; Park, SH; Jin, WJ; Park, BW; Park, SW; Kim, KS				Moon, Jong-Seok; Kim, Hee Eun; Koh, Eunjin; Park, Se Ho; Jin, Won-Ji; Park, Byeong-Woo; Park, Sahng Wook; Kim, Kyung-Sup			Kruppel-like Factor 4 (KLF4) Activates the Transcription of the Gene for the Platelet Isoform of Phosphofructokinase (PFKP) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; DNA-DAMAGE; EXPRESSION; OVEREXPRESSION; TRANSFORMATION; PROGRESSION; ONCOGENE; PROMOTER; CLONING; GROWTH	Kruppel-like factor 4 (KLF4) is a transcription factor that plays an important role in cell differentiation, proliferation, and survival, especially in the context of cancers. This study revealed that KLF4 activates glycolytic metabolism in breast cancer cells by up-regulating the platelet isoform of phosphofructokinase (PFKP). KLF4 activated the transcription of the PFKP gene by directly binding to the PFKP promoter. Whereas glucose uptake and lactate production were inhibited by the knockdown of KLF4, they were activated by the overexpression of KLF4. Unlike PFKP, the expressions of the other isoforms of phosphofructokinase and glycolytic genes were unaffected by KLF4. The human breast cancer tissues showed a close correlation between KLF4 and PFKP expression. This study also showed that PFKP plays a critical role in cell proliferation in breast cancer cells. In conclusion, it is suggested that KLF4 plays a role in maintenance of high glycolytic metabolism by transcriptional activation of the PFKP gene in breast cancer cells.	[Moon, Jong-Seok; Kim, Hee Eun; Koh, Eunjin; Jin, Won-Ji; Park, Sahng Wook; Kim, Kyung-Sup] Yonsei Univ, Ctr Chron Metab Dis Res, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol,Coll Med,Inst Genet Sci, Seoul 120752, South Korea; [Park, Se Ho; Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Brain Korea Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, SW (corresponding author), Yonsei Univ, Ctr Chron Metab Dis Res, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol,Coll Med,Inst Genet Sci, 134 Shinchon Dong, Seoul 120752, South Korea.	swpark64@yuhs.ac; kyungsup59@yuhs.ac		Park, Seho/0000-0001-8089-2755; Koh, Eunjin/0000-0001-8967-6266; Park, Sahng Wook/0000-0002-9594-7074; Park, Byeong-Woo/0000-0003-1353-2607; Kim, Kyung-sup/0000-0001-8483-8537	Korea government (MEST) [2010-0028364]; Yonsei University College of Medicine [6-2009-0073]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Yonsei University College of Medicine(General Electric)	This work was supported by the National Research Foundation funded by the Korea government (MEST) (grant number 2010-0028364) and Yonsei University College of Medicine Faculty Research Grant 6-2009-0073 for 2009.	Atsumi T, 2002, CANCER RES, V62, P5881; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Minchenko OH, 2005, BIOCHIMIE, V87, P1005, DOI 10.1016/j.biochi.2005.04.007; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VORA S, 1985, CANCER RES, V45, P2993; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	28	69	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23808	23816		10.1074/jbc.M111.236737	http://dx.doi.org/10.1074/jbc.M111.236737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586797	Green Published, hybrid			2022-12-25	WOS:000292294900023
J	Andersen, S; Donnem, T; Al-Shibli, K; Al-Saad, S; Stenvold, H; Busund, LT; Bremnes, RM				Andersen, Sigve; Donnem, Tom; Al-Shibli, Khalid; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M.			Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; EXPRESSION; ANGIOGENESIS; CARCINOMA; SURVIVAL; TIE-1; METASTASIS; MARKER; SYSTEM	Introduction: Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. Methods: 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and stroma were collected in tissue microarrays (TMAs). Immunohistochemistry (IHC) was used to semiquantitatively evaluate the expression of markers in duplicate tumor and stroma cores. Principal Findings: In univariate analyses, low tumor cell expression of Ang-4 (P = 0.046) and low stromal expressions of Ang-4 (P = 0.009) and Ang-2 (P = 0.017) were individually associated with a poor survival. In the multivariate analysis, low stromal Ang-2 (HR 1.88; CI 95% 1.15-3.08) and Ang-4 (HR 1.47, CI 95% 1.02-2.11, P = 0.04) expressions were independently associated with a poor prognosis. In patients with high tumor cell expression of Ang-2, a concomitantly high tumor VEGF-A expression mediated a dramatic survival reduction (P<0.001). In the multivariate analysis of patients with high Ang-2 expression, high tumor VEGF-A expression appeared an independent poor prognosticator (HR 6.43; CI 95% 2.46-16.8; P<0.001). Conclusions: In tumor cells, only Ang-4 expression has prognostic impact in NSCLC. In tumor stroma, Ang-4 and Ang-2 are independently associated with survival. The prognostic impact of tumor cell VEGF-A in NSCLC appears strongly associated with a concomitantly high tumor cell expression of Ang-2.	[Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Al-Shibli, Khalid; Al-Saad, Samer; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway; [Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp N Norway, Dept Pathol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Andersen, S (corresponding author), Univ Tromso, Inst Clin Med, Tromso, Norway.	sigve.andersen@uit.no		Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The study was solely funded by the Northern Norway Regional Health Authority (Helse Nord RHF), which is responsible for the public hospitals in northern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Chien CY, 2008, J SURG ONCOL, V97, P273, DOI 10.1002/jso.20930; Chung YC, 2006, J SURG ONCOL, V94, P631, DOI 10.1002/jso.20423; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holopainen T, 2009, CANCER RES, V69, P4656, DOI 10.1158/0008-5472.CAN-08-4654; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Huang JZ, 2009, INT J ONCOL, V34, P79, DOI 10.3892/ijo_00000131; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Nakayama T, 2004, HISTOPATHOLOGY, V44, P232, DOI 10.1111/j.0309-0167.2004.01817.x; Nakayama T, 2007, WORLD J GASTROENTERO, V13, P4473; Olsen MWB, 2006, NEOPLASIA, V8, P364, DOI 10.1593/neo.06127; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Reinmuth N, 2007, LUNG CANCER, V55, P53, DOI 10.1016/j.lungcan.2006.09.025; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sie M, 2009, J NEUROSURG, V110, P147, DOI 10.3171/2008.6.17612; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Szarvas T, 2008, CLIN CANCER RES, V14, P8253, DOI 10.1158/1078-0432.CCR-08-0677; Tanaka F, 2002, CANCER RES, V62, P7124; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; *WHO, 1999, HIST TYP LUNG PLEUR; Wong MP, 2000, LUNG CANCER-J IASLC, V29, P11, DOI 10.1016/S0169-5002(00)00118-5	33	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19773	10.1371/journal.pone.0019773	http://dx.doi.org/10.1371/journal.pone.0019773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603628	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300026
J	Luk, SU; Lee, TKW; Liu, J; Lee, DTW; Chiu, YT; Ma, S; Ng, IOL; Wong, YC; Chan, FL; Ling, MT				Luk, Sze-Ue; Lee, Terence Kin-Wah; Liu, Ji; Lee, Davy Tak-Wing; Chiu, Yung-Tuen; Ma, Stephanie; Ng, Irene Oi-Lin; Wong, Yong-Chuan; Chan, Franky Leung; Ling, Ming-Tat			Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population	PLOS ONE			English	Article							PROTEIN-BOUND POLYSACCHARIDE; TUMOR-INITIATING CELLS; IN-VITRO; VERSICOLOR; IDENTIFICATION; MODEL; TRIAL; GENE; EXPRESSION; INDUCTION	Recent evidence suggested that prostate cancer stem/progenitor cells (CSC) are responsible for cancer initiation as well as disease progression. Unfortunately, conventional therapies are only effective in targeting the more differentiated cancer cells and spare the CSCs. Here, we report that PSP, an active component extracted from the mushroom Turkey tail (also known as Coriolus versicolor), is effective in targeting prostate CSCs. We found that treatment of the prostate cancer cell line PC-3 with PSP led to the down-regulation of CSC markers (CD133 and CD44) in a time and dose-dependent manner. Meanwhile, PSP treatment not only suppressed the ability of PC-3 cells to form prostaspheres under non-adherent culture conditions, but also inhibited their tumorigenicity in vivo, further proving that PSP can suppress prostate CSC properties. To investigate if the anti-CSC effect of PSP may lead to prostate cancer chemoprevention, transgenic mice (TgMAP) that spontaneously develop prostate tumors were orally fed with PSP for 20 weeks. Whereas 100% of the mice that fed with water only developed prostate tumors at the end of experiment, no tumors could be found in any of the mice fed with PSP, suggesting that PSP treatment can completely inhibit prostate tumor formation. Our results not only demonstrated the intriguing anti-CSC effect of PSP, but also revealed, for the first time, the surprising chemopreventive property of oral PSP consumption against prostate cancer.	[Luk, Sze-Ue; Lee, Davy Tak-Wing; Chiu, Yung-Tuen; Wong, Yong-Chuan] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liu, Ji; Ling, Ming-Tat] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Liu, Ji; Ling, Ming-Tat] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lee, Terence Kin-Wah; Ma, Stephanie; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Franky Leung] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Hong Kong; Chinese University of Hong Kong	Luk, SU (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	mingtat.ling@qut.edu.au	Chan, Franky L./M-1043-2018; Ma, Stephanie Kwai Yee/C-4766-2009	Chan, Franky L./0000-0003-0567-2052; Ma, Stephanie Kwai Yee/0000-0002-2029-7943; Lee, Kin Wah/0000-0003-0682-322X; Ng, Irene Oi-lin/0000-0001-7532-2029	Vice Chancellor Research Fellowship	Vice Chancellor Research Fellowship	Vice Chancellor Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISSON I, 2009, CELL RES; Chow LWC, 2003, AM J CHINESE MED, V31, P1, DOI 10.1142/S0192415X03000758; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dong Y, 1996, RES COMMUN MOL PATH, V92, P140; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Gabril MY, 2002, GENE THER, V9, P1589, DOI 10.1038/sj.gt.3301895; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Ho CY, 2005, CANCER BIOL THER, V4, P638, DOI 10.4161/cbt.4.6.1721; Howard EW, 2007, CLIN CANCER RES, V13, P1847, DOI 10.1158/1078-0432.CCR-06-2074; Hsieh TC, 2001, INT J ONCOL, V18, P81; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jimenez-Medina E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-78; Joniau S, 2005, EUR UROL, V48, P379, DOI 10.1016/j.eururo.2005.03.015; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LEE TK, 2011, HEPATOLOGY; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; LUK SU, 2011, INT J CANC; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Musquera M, 2008, EXPERT REV ANTICANC, V8, P1073, DOI 10.1586/14737140.8.7.1073; Ng TB, 1998, GEN PHARMACOL, V30, P1, DOI 10.1016/S0306-3623(97)00076-1; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pomerantz M, 2007, ANNU REV MED, V58, P205, DOI 10.1146/annurev.med.58.101505.115650; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SAKAGAMI H, 1991, ANTICANCER RES, V11, P993; Sarvis JA, 2008, CURR ONCOL REP, V10, P529, DOI 10.1007/s11912-008-0080-1; Scopelliti A, 2009, EXPERT OPIN BIOL TH, V9, P1005, DOI 10.1517/14712590903066687; Singh RP, 2006, ENDOCR-RELAT CANCER, V13, P751, DOI 10.1677/erc.1.01126; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wan JMF, 2008, INT J ONCOL, V32, P689; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	38	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19804	10.1371/journal.pone.0019804	http://dx.doi.org/10.1371/journal.pone.0019804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603625	Green Published, gold			2022-12-25	WOS:000290656300028
J	Forsberg, JA; Eberhardt, J; Boland, PJ; Wedin, R; Healey, JH				Forsberg, Jonathan Agner; Eberhardt, John; Boland, Patrick J.; Wedin, Rikard; Healey, John H.			Estimating Survival in Patients with Operable Skeletal Metastases: An Application of a Bayesian Belief Network	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; BREAST-CANCER; LUNG-CANCER; MODEL; PREDICTION; PROGNOSIS; ONCOLOGY; SURGERY; DISEASE	Background: Accurate estimations of life expectancy are important in the management of patients with metastatic cancer affecting the extremities, and help set patient, family, and physician expectations. Clinically, the decision whether to operate on patients with skeletal metastases, as well as the choice of surgical procedure, are predicated on an individual patient's estimated survival. Currently, there are no reliable methods for estimating survival in this patient population. Bayesian classification, which includes Bayesian belief network (BBN) modeling, is a statistical method that explores conditional, probabilistic relationships between variables to estimate the likelihood of an outcome using observed data. Thus, BBN models are being used with increasing frequency in a variety of diagnoses to codify complex clinical data into prognostic models. The purpose of this study was to determine the feasibility of developing Bayesian classifiers to estimate survival in patients undergoing surgery for metastases of the axial and appendicular skeleton. Methods: We searched an institution-owned patient management database for all patients who underwent surgery for skeletal metastases between 1999 and 2003. We then developed and trained a machine-learned BBN model to estimate survival in months using candidate features based on historical data. Ten-fold cross-validation and receiver operating characteristic (ROC) curve analysis were performed to evaluate the BNN model's accuracy and robustness. Results: A total of 189 consecutive patients were included. First-degree predictors of survival differed between the 3-month and 12-month models. Following cross validation, the area under the ROC curve was 0.85 (95% CI: 0.80-0.93) for 3-month probability of survival and 0.83 (95% CI: 0.77-0.90) for 12-month probability of survival. Conclusions: A robust, accurate, probabilistic naive BBN model was successfully developed using observed clinical data to estimate individualized survival in patients with operable skeletal metastases. This method warrants further development and must be externally validated in other patient populations.	[Forsberg, Jonathan Agner; Boland, Patrick J.; Healey, John H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, New York, NY 10021 USA; [Forsberg, Jonathan Agner; Wedin, Rikard] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Sect Orthopaed & Sports Med, Stockholm, Sweden; [Eberhardt, John] DecisionQ Corp, Bioinformat Div, Washington, DC USA	Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Karolinska University Hospital	Forsberg, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, 1275 York Ave, New York, NY 10021 USA.	jaforsberg@mac.com	Forsberg, Jonathan/K-2116-2012	Wedin, Rikard/0000-0002-2440-1218; Healey, John/0000-0002-0802-1186				Adamina M, 2009, CANCER-AM CANCER SOC, V115, P5371, DOI 10.1002/cncr.24628; Cheng SH, 2006, INT J RADIAT ONCOL, V64, P1401, DOI 10.1016/j.ijrobp.2005.11.015; DAMATO B, 2008, OPHTHALMOLOGY; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Hansen BH, 2004, ACTA ORTHOP SCAND, V75, P11, DOI 10.1080/00016470410001708270; Hartsell WF, 2008, J PALLIAT MED, V11, P723, DOI 10.1089/jpm.2007.0259; Heriot AG, 2006, DIS COLON RECTUM, V49, P816, DOI 10.1007/s10350-006-0523-4; Jerez-Aragones JM, 2003, ARTIF INTELL MED, V27, P45, DOI 10.1016/S0933-3657(02)00086-6; Katagiri H, 2005, J BONE JOINT SURG BR, V87B, P698, DOI 10.1302/0301-620X.87B5.15185; LEVITT SH, 1995, ACTA ONCOL, V34, P839, DOI 10.3109/02841869509127194; Lin PP, 2007, J BONE JOINT SURG AM, V89A, P1794, DOI 10.2106/JBJS.F.00603; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; Muers MF, 1996, THORAX, V51, P894, DOI 10.1136/thx.51.9.894; Narazaki Douglas Kenji, 2006, Clinics, V61, P313, DOI 10.1590/S1807-59322006000400007; Nathan SS, 2005, J CLIN ONCOL, V23, P6072, DOI 10.1200/JCO.2005.08.104; Oken M. M., 1982, AM J CLIN ONCOL; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Saad F, 2007, CANCER-AM CANCER SOC, V110, P1860, DOI 10.1002/cncr.22991; Schneiderbauer MM, 2004, J BONE JOINT SURG AM, V86A, P1684, DOI 10.2106/00004623-200408000-00011; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0; Taktak AFG, 2004, PHYS MED BIOL, V49, P87, DOI 10.1088/0031-9155/49/1/006; WEDIN R, 2001, ACTA ORHTOP SCAND  S, V72, pP1	25	115	121	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19956	10.1371/journal.pone.0019956	http://dx.doi.org/10.1371/journal.pone.0019956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603644	gold, Green Submitted, Green Published			2022-12-25	WOS:000290558500039
J	Vibhuti, A; Gupta, K; Subramanian, H; Guo, Q; Ali, H				Vibhuti, Arpana; Gupta, Kshitij; Subramanian, Hariharan; Guo, Qiang; Ali, Hydar			Distinct and Shared Roles of beta-Arrestin-1 and beta-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; KAPPA-B ACTIVATION; DROSOPHILA NONVISUAL ARRESTIN; FC-EPSILON-RI; BETA-ARRESTIN; CHEMOKINE PRODUCTION; PEPTIDE CHEMOATTRACTANTS; CROSS-DESENSITIZATION; KINASE ACTIVATION; ERK1/2 ACTIVATION	Background: The complement component C3a induces degranulation in human mast cells via the activation of cell surface G protein coupled receptors (GPCR; C3aR). For most GPCRs, agonist-induced receptor phosphorylation leads to the recruitment of beta-arrestin-1/beta-arrestin-2; resulting in receptor desensitization and internalization. Activation of GPCRs also leads to ERK1/2 phosphorylation via two temporally distinct pathways; an early response that reflects G protein activation and a delayed response that is G protein independent but requires beta-arrestins. The role of b-arrestins on C3aR activation/regulation in human mast cells, however, remains unknown. Methodology/Principal Findings: We utilized lentivirus short hairpin (sh) RNA to stably knockdown the expression of beta-arrestin-1 and beta-arrrestin-2 in human mast cell lines, HMC-1 and LAD2 that endogenously expresses C3aR. Silencing beta-arrestin-2 attenuated C3aR desensitization, blocked agonist-induced receptor internalization and rendered the cells responsive to C3a for enhanced NF-kappa B activity as well as chemokine generation. By contrast, silencing beta-arrestin-1 had no effect on these responses but resulted in a significant decrease in C3a-induced mast cell degranulation. In shRNA control cells, C3a caused a transient ERK1/2 phosphorylation, which peaked at 5 min but disappeared by 10 min. Knockdown of beta-arrestin-1, beta-arrestin-2 or both enhanced the early response to C3a and rendered the cells responsive for ERK1/2 phosphorylation at later time points (10-30 min). Treatment of cells with pertussis toxin almost completely blocked both early and delayed C3a-induced ERK1/2 phosphorylation in beta-arrestin1/2 knockdown cells. Conclusion/Significance: This study demonstrates distinct roles for beta-arrestins-1 and beta-arrestins-2 on C3aR desensitization, internalization, degranulation, NF-kappa B activation and chemokine generation in human mast cells. It also shows that both beta-arrestin-1 and beta-arrestin-2 play a novel and shared role in inhibiting G protein-dependent ERK1/2 phosphorylation. These findings reveal a new level of complexity for C3aR regulation by beta-arrestins in human mast cells.	[Vibhuti, Arpana; Gupta, Kshitij; Subramanian, Hariharan; Guo, Qiang; Ali, Hydar] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Vibhuti, A (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [HL085774, AI080852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL085774 and AI080852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; ALI H, 1994, J BIOL CHEM, V269, P24557; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; BUTTERFIELD JH, 1989, INT ARCH ALLER A IMM, V89, P297, DOI 10.1159/000234963; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Johnson EC, 2008, INSECT BIOCHEM MOLEC, V38, P1016, DOI 10.1016/j.ibmb.2008.09.003; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kubo Y, 2007, INFLAMM RES, V56, P70, DOI 10.1007/s00011-006-6064-4; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Lappalainen J, 2007, CLIN EXP ALLERGY, V37, P1404, DOI 10.1111/j.1365-2222.2007.02778.x; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Oskeritzian CA, 2005, J ALLERGY CLIN IMMUN, V115, P1162, DOI 10.1016/j.jaci.2005.02.022; OSKERITZIAN CA, J EXP MED, V207, P465; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; TIPPING M, EMBO J; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Vines CM, 2002, J IMMUNOL, V169, P6760, DOI 10.4049/jimmunol.169.12.6760; WEI H, 2003, P NATL ACAD SCI US; WITHEROW DS, 2004, P NATL ACAD SCI US; Woolhiser MR, 2004, CLIN IMMUNOL, V110, P172, DOI 10.1016/j.clim.2003.11.007; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	49	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19585	10.1371/journal.pone.0019585	http://dx.doi.org/10.1371/journal.pone.0019585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589858	Green Submitted, gold, Green Published			2022-12-25	WOS:000290531100019
J	Karjala, Z; Neal, D; Rohrer, J				Karjala, Zuzana; Neal, Diane; Rohrer, James			Association between HSV1 Seropositivity and Obesity: Data from the National Health and Nutritional Examination Survey, 2007-2008	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INFECTION; TYPE-2; INFLAMMATION; RISK; FAT; MEN; SEROPREVALENCE; MANAGEMENT; ADENOVIRUS	Background: Herpes simplex virus (HSV) is among the most common sexually transmitted pathogens in the United States and worldwide. HSV has a high incidence of undetected cases. In addition, there is no treatment, and there is a lack of knowledge why disparities among populations exist. Research studies suggest that fat tissue may participate in body's immune responses, and the impact of obesity on susceptibility to HSV1 infection is not clear. The purpose of this study was to examine whether obesity is a risk factor for HSV1 infection using a large sample from the general population. Methods/Principal Findings: This cross-sectional study used data from the National Health and Examination and Nutritional Examination Survey (NHANES) from 2007-2008. Variables, gender, age, race/ethnicity, marital status, education, poverty level, and diabetes represented potential confounders and were included in analyses. The two-tailed Pearson's chi square, student's t test, and a multiple logistic regression analysis were applied to evaluate associations using a significance value of p <= 0.05. Adjusted odds ratios with 95% confidence interval represented the degree of these associations. The prevalence of HSV1 infection in US population between 20 and 49 years old was 60.3% (n = 1,536). In this study, having a BMI classified as the obese group (BMI 30-39.9) was significantly associated with HSV1 infection before [unadjusted OR = 1.74 (95% CI 1.20-2.51), p = 0.006] and after controlling for socio-demographic factors [adjusted OR = 1.50 (95% CI 1.06-2.13)], p = 0.026]. This association was stronger than three already established risk factors of age, female gender, and poverty level. Conclusions/Significance: This study provides evidence that obesity may play a role in the susceptibility to HSV1 infection. Findings from this study suggest that obesity should be considered when designing preventive measures for HSV1 infection. These results may also explain why some people acquire HSV1 infections and some do not. Further, these findings may justify an increased emphasis on the control and prevention of HSV1 transmission and other pathogens in overweight and obese populations.	[Karjala, Zuzana; Neal, Diane] Walden Univ, Minneapolis, MN USA; [Rohrer, James] Mayo Clin, Rochester, MN USA	Walden University; Mayo Clinic	Karjala, Z (corresponding author), Walden Univ, Minneapolis, MN USA.	zkarjala@yahoo.com	Sriwisit, Sukhumaphorn/G-1405-2011	rohrer, james/0000-0003-3074-1857				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Bassols J, 2010, OBESITY, V18, P239, DOI 10.1038/oby.2009.250; Carr DJJ, 2006, CURR TOP MICROBIOL, V303, P47, DOI 10.1007/978-3-540-33397-5_3; *CDCP, 2009, NIIANES 2007 2008 PU; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Donoval BA, 2006, SEX TRANSM DIS, V33, P170, DOI 10.1097/01.olq.0000187203.27918.45; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Fernaandez-Real JM, 2007, OBESITY, V15, P245, DOI 10.1038/oby.2007.541; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; Hill J, 2005, CLIN PERINATOL, V32, P657, DOI 10.1016/j.clp.2005.05.008; KALIMO KOK, 1983, INFECT IMMUN, V39, P24, DOI 10.1128/IAI.39.1.24-28.1983; Knezevic A, 2007, EMERG INFECT DIS, V13, P302, DOI 10.3201/eid1302.060907; Kopacova M, 2007, EUR J EPIDEMIOL, V22, P67, DOI 10.1007/s10654-006-9090-1; Krolczyk S, 2003, J CHILD NEUROL, V18, P356, DOI 10.1177/08830738030180050201; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Rantala A, 2010, EPIDEMIOL INFECT, V138, P1267, DOI 10.1017/S0950268809991452; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; Schillinger JA, 2008, SEX TRANSM DIS, V35, P599, DOI 10.1097/OLQ.0b013e3181666fb1; Schwartz EJ, 2007, HUM VACCINES, V3, P231, DOI 10.4161/hv.4529; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Starr JR, 2001, CANCER RES, V61, P8459; *STATCORP LP, 2010, DAT AN SOFTW; Sun YH, 2005, DIABETES CARE, V28, P435, DOI 10.2337/diacare.28.2.435; Szucs TD, 2001, BMC INFECT DIS, V1, part. no., DOI 10.1186/1471-2334-1-5; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	40	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19092	10.1371/journal.pone.0019092	http://dx.doi.org/10.1371/journal.pone.0019092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589933	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600008
J	Roder, G; Rahier, M; Naisbit, RE				Roeder, Gregory; Rahier, Martine; Naisbit, Russell E.			Do Induced Responses Mediate the Ecological Interactions Between the Specialist Herbivores and Phytopathogens of an Alpine Plant?	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; LEAF BEETLE; NICOTIANA-ATTENUATA; INSECT HERBIVORES; PATHOGENS; DEFENSE; JASMONATE; ASTERACEAE; ELICITORS; TOBACCO	Plants are not passive victims of the myriad attackers that rely on them for nutrition. They have a suite of physical and chemical defences, and are even able to take advantage of the enemies of their enemies. These strategies are often only deployed upon attack, so may lead to indirect interactions between herbivores and phytopathogens. In this study we test for induced responses in wild populations of an alpine plant (Adenostyles alliariae) that possesses constitutive chemical defence (pyrrolizidine alkaloids) and specialist natural enemies (two species of leaf beetle, Oreina elongata and Oreina cacaliae, and the phytopathogenic rust Uromyces cacaliae). Plants were induced in the field using chemical elicitors of the jasmonic acid (JA) and salicylic acid (SA) pathways and monitored for one month under natural conditions. There was evidence for induced resistance, with lower probability and later incidence of attack by beetles in JA-induced plants and of rust infection in SA-induced plants. We also demonstrate ecological cross-effects, with reduced fungal attack following JA-induction, and a cost of SA-induction arising from increased beetle attack. As a result, there is the potential for negative indirect effects of the beetles on the rust, while in the field the positive indirect effect of the rust on the beetles appears to be over-ridden by direct effects on plant nutritional quality. Such interactions resulting from induced susceptibility and resistance must be considered if we are to exploit plant defences for crop protection using hormone elicitors or constitutive expression. More generally, the fact that induced defences are even found in species that possess constitutively-expressed chemical defence suggests that they may be ubiquitous in higher plants.	[Roeder, Gregory; Rahier, Martine] Univ Neuchatel, Lab Evolutionary Entomol, Inst Biol, CH-2000 Neuchatel, Switzerland; [Naisbit, Russell E.] Univ Fribourg, Unit Ecol & Evolut, Dept Biol, CH-1700 Fribourg, Switzerland	University of Neuchatel; University of Fribourg	Roder, G (corresponding author), Univ Neuchatel, Lab Evolutionary Entomol, Inst Biol, CH-2000 Neuchatel, Switzerland.	russell.naisbit@gmail.com	Naisbit, Russell E/B-9658-2011	Naisbit, Russell E/0000-0003-0190-9323; Roder, Gregory/0000-0002-7110-294X	Swiss National Science Foundation [31-64864.01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was financed by Swiss National Science Foundation (grant 31-64864.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; [Anonymous], 2005, S PLUS 7 0 GUID STAT, V1; [Anonymous], 2001, DESIGN ANAL ECOLOGIC; Borer M, 2010, EVOLUTION, V64, P3629, DOI 10.1111/j.1558-5646.2010.01137.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; CUMMINS GB, 2003, ILLUSTRATED GENERA R; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAUMANN E, 1959, ROSTPILZE MITTELEURO, P218; Hagele BF, 1999, OIKOS, V85, P234, DOI 10.2307/3546489; Hagele BF, 2000, J EVOLUTION BIOL, V13, P131, DOI 10.1046/j.1420-9101.2000.00145.x; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Held M, 2005, ECOL APPL, V15, P1689, DOI 10.1890/03-5208; Hol WHG, 2002, J CHEM ECOL, V28, P1763, DOI 10.1023/A:1020557000707; Inbar M, 1998, J CHEM ECOL, V24, P135, DOI 10.1023/A:1022397130895; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lohse G.A., 1994, KAFER MITTELEUROPAS, V14; Margraf N, 2007, MOL ECOL, V16, P2333, DOI 10.1111/j.1365-294X.2007.03318.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Mauch-Mani B, 1998, ANN BOT-LONDON, V82, P535, DOI 10.1006/anbo.1998.0726; Preston CA, 2002, J CHEM ECOL, V28, P2343, DOI 10.1023/A:1021065703276; RODER G, 2007, THESIS U NEUCHATEL; Roder G, 2008, P ROY SOC B-BIOL SCI, V275, P879, DOI 10.1098/rspb.2007.1649; Roder G, 2007, OIKOS, V116, P1514, DOI [10.1111/j.2007.0030-1299.16057.x, 10.1111/j.0030-1299.2007.16057.x]; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Taylor JE, 2004, J EXP BOT, V55, P159, DOI 10.1093/jxb/erh053; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Verdon A, 2007, ECOL ENTOMOL, V32, P62, DOI 10.1111/j.1365-2311.2006.00842.x; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9	37	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19571	10.1371/journal.pone.0019571	http://dx.doi.org/10.1371/journal.pone.0019571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573247	Green Published, gold			2022-12-25	WOS:000290224800035
J	Kim, JH; Lee, SR; Li, LH; Park, HJ; Park, JH; Lee, KY; Kim, MK; Shin, BA; Choi, SY				Kim, Jin Hee; Lee, Sang-Rok; Li, Li-Hua; Park, Hye-Jeong; Park, Jeong-Hoh; Lee, Kwang Youl; Kim, Myeong-Kyu; Shin, Boo Ahn; Choi, Seok-Yong			High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice	PLOS ONE			English	Article							MULTIPLE PROTEINS; POLYPROTEIN; VIRUS; APHTHOVIRUS; EXPRESSION; SEQUENCES; EMBRYOS	When expression of more than one gene is required in cells, bicistronic or multicistronic expression vectors have been used. Among various strategies employed to construct bicistronic or multicistronic vectors, an internal ribosomal entry site (IRES) has been widely used. Due to the large size and difference in expression levels between genes before and after IRES, however, a new strategy was required to replace IRES. A self-cleaving 2A peptide could be a good candidate to replace IRES because of its small size and high cleavage efficiency between genes upstream and downstream ofthe 2A peptide. Despite the advantages of the 2A peptides, its use is not widespread because (i) there are no publicly available cloning vectors harboring a 2A peptide gene and (ii) comprehensive comparison of cleavage efficiency among various 2A peptides reported to date has not been performed in different contexts. Here, we generated four expression plasmids each harboring different 2A peptides derived from the foot-and-mouth disease virus, equine rhinitis A virus, Thoseaasigna virus and porcine teschovirus-1, respectively, and evaluated their cleavage efficiency in three commonly used human cell lines, zebrafish embryos and adult mice. Western blotting and confocal microscopic analyses revealed that among the four 2As, the one derived from porcine teschovirus-1 (P2A) has the highest cleavage efficiency in all the contexts examined. We anticipate that the 2A-harboring cloning vectors we generated and the highest efficiency of the P2A peptide we demonstrated would help biomedical researchers easily adopt the 2A technology when bicistronic or multicistronic expression is required.	[Kim, Jin Hee; Park, Hye-Jeong; Park, Jeong-Hoh; Choi, Seok-Yong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea; [Kim, Jin Hee; Li, Li-Hua; Shin, Boo Ahn] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju, South Korea; [Lee, Sang-Rok] Chosun Univ, Dept Biol, Kwangju, South Korea; [Lee, Sang-Rok] Kim & Jung Co Ltd, Res Inst, Hwasun, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju, South Korea; [Li, Li-Hua] Hainan Med Univ, Dept Pathogen Biol, Haikou, Peoples R China; [Kim, Myeong-Kyu] Chonnam Natl Univ, Dept Neurol, Sch Med, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chosun University; Chonnam National University; Chonnam National University; Hainan Medical University; Chonnam National University	Kim, JH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea.	bashin@chonnam.ac.kr; zebrafish@chonnam.ac.kr		Choi, Seok-Yong/0000-0001-7193-292X	Ministry of Education, Science and Technology [2009-0071597, 2009-0070204]; Korean Health Technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100402]; Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University [R13-2002-013-06002-0]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University(Korea Science and Engineering Foundation)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0071597 and 2009-0070204), a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100402) and the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation (R13-2002-013-06002-0) at Chonnam National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramel-Verheije MHG, 2000, VIROLOGY, V278, P380, DOI 10.1006/viro.2000.0525; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P., 2002, Current Gene Therapy, V2, P355, DOI 10.2174/1566523023347742; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957	18	587	681	5	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18556	10.1371/journal.pone.0018556	http://dx.doi.org/10.1371/journal.pone.0018556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21602908	gold, Green Published			2022-12-25	WOS:000290024700014
J	Tang, HB; Lee, M; Budak, MT; Pietras, N; Hittinger, S; Vu, M; Khuong, A; Hoang, CD; Hussain, SNA; Levine, S; Shrager, JB				Tang, Huibin; Lee, Myung; Budak, Murat T.; Pietras, Nicole; Hittinger, Scott; Vu, Michael; Khuong, Andy; Hoang, Chuong D.; Hussain, Sabah N. A.; Levine, Sanford; Shrager, Joseph B.			Intrinsic apoptosis in mechanically ventilated human diaphragm: linkage to a novel Fos/FoxO1/Stat3-Bim axis	FASEB JOURNAL			English	Article						oxidative stress; skeletal muscle; dysfunction; atrophy; respiratory muscle	MUSCLE PROTEIN-DEGRADATION; CONTRACTILE PROPERTIES; OXIDATIVE STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; WEANING FAILURE; DYSFUNCTION; ACTIVATION; ATROPHY; TERM	Mechanical ventilation (MV) is a life-saving measure in many critically ill patients. However, prolonged MV results in diaphragm dysfunction that contributes to the frequent difficulty in weaning patients from the ventilator. The molecular mechanisms underlying ventilator-induced diaphragm dysfunction (VIDD) remain poorly understood. We report here that MV induces myonuclear DNA fragmentation (3-fold increase; P<0.01) and selective activation of caspase 9 (P<0.05) and Bcl2-interacting mediator of cell death (Bim; 2- to 7-fold increase; P<0.05) in human diaphragm. MV also statistically significantly down-regulates mitochondrial gene expression and induces oxidative stress. In cultured muscle cells, we show that oxidative stress activates each of the catabolic pathways thought to underlie VIDD: apoptotic (P<0.05), proteasomal (P<0.05), and autophagic (P<0.01). Further, silencing Bim expression blocks (P<0.05) oxidative stress-induced apoptosis. Overlapping the gene expression profiles of MV human diaphragm and H2O2-treated muscle cells, we identify Fos, FoxO1, and Stat3 as regulators of Bim expression as well as of expression of the catabolic markers atrogin and LC3. We thus identify a novel Fos/FoxO1/Stat3-Bim intrinsic apoptotic pathway and establish the centrality of oxidative stress in the development of VIDD. This information may help in the design of specific drugs to prevent this condition.-Tang, H., Lee, M., Budak, M. T., Pietras, N., Hittinger, S., Vu, M., Khuong, A., Hoang, C. D., Hussain, S. N. A., Levine, S., Shrager, J. B. Intrinsic apoptosis in mechanically ventilated human diaphragm: linkage to a novel Fos/FoxO1/Stat3-Bim axis. FASEB J. 25, 2921-2936 (2011). www.fasebj.org	[Tang, Huibin; Lee, Myung; Pietras, Nicole; Hittinger, Scott; Vu, Michael; Khuong, Andy; Hoang, Chuong D.; Shrager, Joseph B.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, Stanford, CA 94305 USA; [Tang, Huibin; Lee, Myung; Pietras, Nicole; Hittinger, Scott; Vu, Michael; Khuong, Andy; Hoang, Chuong D.; Shrager, Joseph B.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; [Budak, Murat T.; Levine, Sanford] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Budak, Murat T.; Levine, Sanford] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Hussain, Sabah N. A.] McGill Univ, Royal Victoria Hosp, Div Resp, Montreal, PQ H3A 1A1, Canada; [Hussain, Sabah N. A.] McGill Univ, Royal Victoria Hosp, Crit Care Div, Montreal, PQ H3A 1A1, Canada	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Shrager, JB (corresponding author), Stanford Univ, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, 300 Pasteur Dr, Stanford, CA 94305 USA.	shrager@stanford.edu	Hussain, Sabah/ABC-5315-2021; Budak, Murat/I-8358-2013	Budak, Murat/0000-0002-5059-9651	Veterans Affairs; U.S. National Institutes of Health [HL078834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078834] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Kevin Hoang (summer student at University of California, San Diego, CA, USA) and Donna Minagawa (Stanford University) for technical assistance and Xiaohua Zhang (Stanford University) for assistance in bioinformatics analysis. This research was supported by a Veterans Affairs merit review grant awarded to J.B.S. and also in part by U.S. National Institutes of Health grant HL078834. The authors declare that they have no financial relationship with a commercial entity.	Afessa B, 1999, CHEST, V116, P456, DOI 10.1378/chest.116.2.456; Alia I, 2000, CRIT CARE, V4, P72, DOI 10.1186/cc660; Anzueto A, 1997, CRIT CARE MED, V25, P1187, DOI 10.1097/00003246-199707000-00021; Argiles JA, 2008, INT J BIOCHEM CELL B, V40, P1674, DOI 10.1016/j.biocel.2008.02.001; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Buczko W, 2009, HEALTH CARE FINANC R, V31, P1; Capdevila X, 2003, INTENS CARE MED, V29, P103, DOI 10.1007/s00134-002-1548-3; Cattapan SE, 2003, THORAX, V58, P58, DOI 10.1136/thorax.58.1.58; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Criswell DS, 2003, CHEST, V124, P2302, DOI 10.1378/chest.124.6.2302; Dasgupta A, 1999, CHEST, V116, P447, DOI 10.1378/chest.116.2.447; DeRuisseau KC, 2005, AM J RESP CRIT CARE, V172, P1267, DOI 10.1164/rccm.200503-403OC; DeRuisseau KC, 2005, J APPL PHYSIOL, V98, P1314, DOI 10.1152/japplphysiol.00993.2004; Douglas SL, 2002, CRIT CARE MED, V30, P2655, DOI 10.1097/00003246-200212000-00008; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Du J, 2005, EUR J CLIN INVEST, V35, P157, DOI 10.1111/j.1365-2362.2005.01473.x; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Falk DJ, 2006, J APPL PHYSIOL, V101, P1017, DOI 10.1152/japplphysiol.00104.2006; Gayan-Ramirez G, 2002, EUR RESPIR J, V20, P1579, DOI 10.1183/09031936.02.00063102; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Laghi F, 1998, J APPL PHYSIOL, V85, P1103, DOI 10.1152/jappl.1998.85.3.1103; Laghi F, 2003, AM J RESP CRIT CARE, V167, P120, DOI 10.1164/rccm.200210-1246OC; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Levine S, 2011, AM J RESP CRIT CARE, V183, P483, DOI 10.1164/rccm.200910-1487OC; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; Martin AD, 2002, CHEST, V122, P192, DOI 10.1378/chest.122.1.192; McClung JM, 2008, AM J PHYSIOL-REG I, V294, pR1608, DOI 10.1152/ajpregu.00044.2008; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; McClung JM, 2009, CRIT CARE MED, V37, P1373, DOI 10.1097/CCM.0b013e31819cef63; Modawal A, 2002, ARCH PHYS MED REHAB, V83, P154, DOI 10.1053/apmr.2002.29614; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Nguyen T, 2005, J APPL PHYSIOL, V98, P2004, DOI 10.1152/japplphysiol.00767.2004; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Purro A, 2000, AM J RESP CRIT CARE, V161, P1115, DOI 10.1164/ajrccm.161.4.9812160; Racz GZ, 2003, AM J RESP CRIT CARE, V168, P297, DOI 10.1164/rccm.200206-541OC; Restrepo MI, 2010, INFECT CONT HOSP EP, V31, P509, DOI 10.1086/651669; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sassoon CSH, 2002, J APPL PHYSIOL, V92, P2585, DOI 10.1152/japplphysiol.01213.2001; Sassoon CSH, 2004, AM J RESP CRIT CARE, V170, P626, DOI 10.1164/rccm.200401-042OC; Scheinhorn D J, 2000, Respir Care Clin N Am, V6, P437, DOI 10.1016/S1078-5337(05)70080-0; Scheinhorn DJ, 2001, CHEST, V120, p482S, DOI 10.1378/chest.120.6_suppl.482S; Scheinhorn DJ, 2002, CRIT CARE CLIN, V18, P569, DOI 10.1016/S0749-0704(02)00016-7; Scheinhorn DJ, 1997, CHEST, V111, P1654, DOI 10.1378/chest.111.6.1654; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Shanely RA, 2003, CHEST, V123, P195, DOI 10.1378/chest.123.1.195; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Sprague SS, 2003, PHYS THER, V83, P171, DOI 10.1093/ptj/83.2.171; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; SWARTZ MA, 1985, CHEST, V88, P736, DOI 10.1378/chest.88.5.736; Testelmans D, 2006, CRIT CARE MED, V34, P3018, DOI 10.1097/01.CCM.0000245783.28478.AD; Vassilakopoulos T, 2006, CRIT CARE, V10, DOI 10.1186/cc3917; Watson AC, 2001, CRIT CARE MED, V29, P1325, DOI 10.1097/00003246-200107000-00005; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu E, 2005, J APPL PHYSIOL, V99, P747, DOI 10.1152/japplphysiol.00126.2005	67	57	62	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					2921	2936		10.1096/fj.11-183798	http://dx.doi.org/10.1096/fj.11-183798			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21597002	Green Published			2022-12-25	WOS:000294435200008
J	Debnath, S; Chatterjee, S; Arif, M; Kundu, TK; Roy, S				Debnath, Subrata; Chatterjee, Snehajyoti; Arif, Mohammed; Kundu, Tapas K.; Roy, Siddhartha			Peptide-Protein Interactions Suggest That Acetylation of Lysines 381 and 382 of p53 Is Important for Positive Coactivator 4-p53 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; PC4; COMPLEX; GENE; DNA; PHOSPHORYLATION; TRANSACTIVATION; MDM2; DEGRADATION; PROMOTES	The human transcriptional positive coactivator 4 (PC4) activates several p53-dependent genes. It has been demonstrated that this is a consequence of direct interaction with p53. Previously, we have concluded that PC4 interacts mainly with the C-terminal negative regulatory domain of p53 through its DNA binding C-terminal half. NMR chemical shift perturbation studies with peptide fragments indicated that amino acids 380-386 of p53 are crucial for interaction with PC4. This was verified by fluorescence anisotropy and sedimentation velocity studies. A peptide consisting of p53-(380-386) sequence, when attached to a cell penetration tag and nuclear localization signal, localizes to the nucleus and inhibits luciferase gene expression from a transfected plasmid carrying a Luc gene under a p53-dependent promoter. Acetylation of lysine 382/381 enhanced the binding of this peptide to PC4 by about an order of magnitude. NMR and mutagenesis studies indicated that serine 73 of PC4 is an important residue for recognition of p53. Intermolecular nuclear Overhauser effect placed aspartate 76 in the vicinity of lysine 381, indicating that the region around residues 73-76 of PC4 is important for p53 recognition. We conclude that the 380-386 region of p53 interacts with the region around residues 73-76 of PC4, and acetylation of lysine 382/381 of p53 may play an important role in modulating p53-PC4 interaction and as a consequence PC4 mediated activation of p53 target genes.	[Chatterjee, Snehajyoti; Arif, Mohammed; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Debnath, Subrata; Roy, Siddhartha] Council Sci & Ind Res India, Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata 700032, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in; sidroykolkata@gmail.com	Debnath, Subrata/X-8773-2019; Chatterjee, Snehajyoti/AAV-3919-2021; Chatterjee, Snehajyoti/D-1609-2011	Chatterjee, Snehajyoti/0000-0002-4873-9416; MOHAMMED, ARIF/0000-0003-1300-5081; Kundu, Tapas/0000-0001-7790-214X	Council of Scientific and Industrial Research (India); Department of Science and Technology (Government of India)	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Government of India)(Department of Science & Technology (India))	Recipient of a Council of Scientific and Industrial Research (India) and Department of Science and Technology (Government of India) J. C. Bose Fellowship. To whom correspondence may be addressed. E-mail: sidroykolkata@gmail.com.	Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FESIK SW, 1988, BIOCHEMISTRY-US, V27, P8297, DOI 10.1021/bi00422a001; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kishore AH, 2007, BIOCHEM J, V406, P437, DOI 10.1042/BJ20070390; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Polley S, 2008, J MOL BIOL, V376, P8, DOI 10.1016/j.jmb.2007.11.082; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044	27	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25076	25087		10.1074/jbc.M110.205328	http://dx.doi.org/10.1074/jbc.M110.205328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586571	hybrid, Green Published			2022-12-25	WOS:000292547900056
J	Liu, HJ; Roose, JL; Cameron, JC; Pakrasi, HB				Liu, Haijun; Roose, Johnna L.; Cameron, Jeffrey C.; Pakrasi, Himadri B.			A Genetically Tagged Psb27 Protein Allows Purification of Two Consecutive Photosystem II (PSII) Assembly Intermediates in Synechocystis 6803, a Cyanobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE CLUSTER; THERMOSYNECHOCOCCUS-VULCANUS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; D1 PROTEIN; RESOLUTION; COMPLEXES; POLYPEPTIDE; BIOGENESIS; BINDING	Photosystem II (PSII) is a large membrane bound molecular machine that catalyzes light-driven oxygen evolution from water. PSII constantly undergoes assembly and disassembly because of the unavoidable damage that results from its normal photochemistry. Thus, under physiological conditions, in addition to the active PSII complexes, there are always PSII subpopulations incompetent of oxygen evolution, but are in the process of undergoing elaborate biogenesis and repair. These transient complexes are difficult to characterize because of their low abundance, structural heterogeneity, and thermodynamic instability. In this study, we show that a genetically tagged Psb27 protein allows for the biochemical purification of two monomeric PSII assembly intermediates, one with an unprocessed form of D1 (His27 Delta ctpAPSII) and a second one with a mature form of D1 (His27PSII). Both forms were capable of light-induced charge separation, but unable to photooxidize water, largely because of the absence of a functional tetramanganese cluster. Unexpectedly, there was a significant amount of the extrinsic lumenal PsbO protein in the His27PSII, but not in the His27 Delta ctpAPSII complex. In contrast, two other lumenal proteins, PsbU and PsbV, were absent in both of these PSII intermediate complexes. Additionally, the only cytoplasmic extrinsic protein, Psb28 was detected in His27PSII complex. Based on these data, we have presented a refined model of PSII biogenesis, illustrating an important role of Psb27 as a gate-keeper during the complex assembly process of the oxygen-evolving centers in PSII.	[Liu, Haijun; Roose, Johnna L.; Cameron, Jeffrey C.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu		Liu, Haijun/0000-0003-0537-0302	National Science Foundation [NSF-MCB0745611]; Direct For Biological Sciences [0745611] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant NSF-MCB0745611 (to H. B. P.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Becker K, 2011, J PHOTOCH PHOTOBIO B, V104, P204, DOI 10.1016/j.jphotobiol.2011.02.005; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BRICKER TM, 1987, ARCH BIOCHEM BIOPHYS, V256, P295, DOI 10.1016/0003-9861(87)90449-8; BRICKER TM, 1990, PHOTOSYNTH RES, V24, P1, DOI 10.1007/BF00032639; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; CHENIAE GM, 1971, BIOCHIM BIOPHYS ACTA, V253, P167, DOI 10.1016/0005-2728(71)90242-8; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frasch WD, 2001, PHOTOSYNTH RES, V70, P245, DOI 10.1023/A:1014773304784; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Ikeuchi M, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL III, P297; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, PLANT CELL PHYSIOL, V43, P1366, DOI 10.1093/pcp/pcf168; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; METZ JG, 1986, FEBS LETT, V205, P269, DOI 10.1016/0014-5793(86)80911-5; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2010, EUR J CELL BIOL, V89, P974, DOI 10.1016/j.ejcb.2010.08.008; ODOM WR, 1992, BIOCHEMISTRY-US, V31, P5616, DOI 10.1021/bi00139a027; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SEIBERT M, 1989, BIOCHIM BIOPHYS ACTA, V974, P185, DOI 10.1016/S0005-2728(89)80371-8; Shagger H., 1991, ANAL BIOCHEM, V199, P223; Stull JA, 2010, J AM CHEM SOC, V132, P446, DOI 10.1021/ja908688t; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	42	42	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24865	24871		10.1074/jbc.M111.246231	http://dx.doi.org/10.1074/jbc.M111.246231			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592967	hybrid, Green Published			2022-12-25	WOS:000292547900036
J	Moore, SF; Hunter, RW; Hers, I				Moore, Samantha F.; Hunter, Roger W.; Hers, Ingeborg			mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; SUBSTRATE-SPECIFICITY; RAPAMYCIN MTOR; ACTIVATION; INSULIN; RICTOR; MICE; INHIBITOR; PATHWAY; AGGREGATION	Protein kinase B (PKB, Akt) is a Ser/Thr kinase involved in the regulation of cell survival, proliferation, and metabolism and is activated by dual phosphorylation on Thr(308) in the activation loop and Ser(473) in the hydrophobic motif. It plays a contributory role to platelet function, although little is known about its regulation. In this study, we investigated the role of the mammalian target of rapamycin complex (mTORC)-2 in Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1. Both PP242 and Torin1 blocked thrombin and insulin-like growth factor 1-mediated Akt Ser(473) phosphorylation with an IC50 between 1 and 5 nM, whereas the mTORC1 inhibitor rapamycin had no effect. Interestingly, PP242 and Torin1 had no effect on Akt Thr(308) phosphorylation, Akt1 activity, and phosphorylation of the Akt substrate glycogen synthase kinase 3 beta, indicating that Ser(473) phosphorylation is not necessary for Thr(308) phosphorylation and maximal Akt1 activity. In contrast, Akt2 activity was significantly reduced, concurrent with inhibition of PRAS40 phosphorylation, in the presence of PP242 and Torin1. Other signaling pathways, including phospholipase C/PKC and the MAPK pathway, were unaffected by PP242 and Torin1. Together, these results demonstrate that mTORC2 is the kinase that phosphorylates Akt Ser(473) in human platelets but that this phosphorylation is dispensable for Thr(308) phosphorylation and Akt1 activity.	[Moore, Samantha F.; Hunter, Roger W.; Hers, Ingeborg] Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Hers, I (corresponding author), Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020	Moore, Samantha/0000-0003-0944-7055; Hers, Ingeborg/0000-0002-6467-5715	British Heart Foundation [PG/08/113/25515, FS/05/047/18875, PG/08/056/25325]; British Heart Foundation [PG/10/100/28658] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/08/113/25515, FS/05/047/18875, and PG/08/056/25325 (to I. H.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gresele P, 2008, TRENDS PHARMACOL SCI, V29, P352, DOI 10.1016/j.tips.2008.05.002; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hayashi H, 2009, THROMB HAEMOSTASIS, V102, P327, DOI 10.1160/TH08-12-0781; Hers I, 2005, BIOCHEM J, V388, P713, DOI 10.1042/BJ20041531; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Hunter RW, 2009, J THROMB HAEMOST, V7, P2123, DOI 10.1111/j.1538-7836.2009.03637.x; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; O'Brien KA, 2010, CIRCULATION, V122; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	44	72	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24553	24560		10.1074/jbc.M110.202341	http://dx.doi.org/10.1074/jbc.M110.202341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592956	Green Published, hybrid			2022-12-25	WOS:000292547900005
J	Yamanaka, K; Saito, Y; Yamamori, T; Urano, Y; Noguchi, N				Yamanaka, Kazunori; Saito, Yoshiro; Yamamori, Tohru; Urano, Yasuomi; Noguchi, Noriko			24(S)-Hydroxycholesterol Induces Neuronal Cell Death through Necroptosis, a Form of Programmed Necrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ADAPTIVE RESPONSE; UP-REGULATION; HYDROGEN-PEROXIDE; BRAIN CHOLESTEROL; OXIDATIVE STRESS; APOPTOSIS; GLUTATHIONE; PATHWAY; 24S-HYDROXYCHOLESTEROL	24(S)-Hydroxycholesterol (24S-OHC) produced by cholesterol 24-hydroxylase expressed mainly in neurons plays an important physiological role in the brain. Conversely, it has been reported that 24S-OHC possesses potent cytotoxicity. The molecular mechanisms of 24S-OHC-induced cell death have not yet been fully elucidated. In this study, using human neuroblastoma SH-SY5Y cells and primary cortical neuronal cells derived from rat embryo, we characterized the form of cell death induced by 24S-OHC. SH-SY5Y cells treated with 24S-OHC exhibited neither fragmentation of the nucleus nor caspase activation, which are the typical characteristics of apoptosis. 24S-OHC-treated cells showed necrosis-like morphological changes but did not induce ATP depletion, one of the features of necrosis. When cells were treated with necrostatin-1, an inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1) required for necroptosis, 24S-OHC-induced cell death was significantly suppressed. The knockdown of RIPK1 by transfection of small interfering RNA of RIPK1 effectively attenuated 24S-OHC-induced cell death. It was found that neither SH-SY5Y cells nor primary cortical neuronal cells expressed caspase-8, which was regulated for RIPK1-dependent apoptosis. Collectively, these results suggest that 24S-OHC induces neuronal cell death by necroptosis, a form of programmed necrosis.	[Yamanaka, Kazunori; Saito, Yoshiro; Yamamori, Tohru; Urano, Yasuomi; Noguchi, Noriko] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan; [Yamamori, Tohru] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido 0600818, Japan	Doshisha University; Hokkaido University	Saito, Y (corresponding author), Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan.	ysaito@mail.doshisha.ac.jp; nnoguchi@mail.doshisha.ac.jp	Saito, Yoshiro/H-4597-2019; Yamamori, Tohru/A-7285-2012	Saito, Yoshiro/0000-0002-0559-5889; Urano, Yasuomi/0000-0002-4901-1937	Ministry of Education, Culture, Sports, Science, and Technology; Cosmetology Research Foundation; Science and Engineering Research Institute; Japan Society for the Promotion of Science [21800075]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cosmetology Research Foundation; Science and Engineering Research Institute; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Academic Frontier Research Project on "New Frontier of Biomedical Engineering Research" from the Ministry of Education, Culture, Sports, Science, and Technology (to N. N.), by the Cosmetology Research Foundation (to Y. S.), by a research grant from the Science and Engineering Research Institute (to Y. S.), and by Grant-in-aid for Research Activity Start-Up 21800075 (to Y. U.) from the Japan Society for the Promotion of Science.	Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Berthier A, 2004, CELL DEATH DIFFER, V11, P897, DOI 10.1038/sj.cdd.4401434; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2007, LIPIDS, V42, P5, DOI 10.1007/s11745-006-1003-2; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Chen TY, 2009, FREE RADICAL BIO MED, V46, P643, DOI 10.1016/j.freeradbiomed.2008.11.022; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Ogawa Y, 2008, FREE RADICAL RES, V42, P674, DOI 10.1080/10715760802277396; Panza F, 2007, J AM GERIATR SOC, V55, P133, DOI 10.1111/j.1532-5415.2006.01003.x; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Saito Y, 2007, J NEUROCHEM, V102, P1625, DOI 10.1111/j.1471-4159.2007.04701.x; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Shafaati M, 2007, NEUROSCI LETT, V425, P78, DOI 10.1016/j.neulet.2007.08.014; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vejux A, 2009, J NUTR BIOCHEM, V20, P45, DOI 10.1016/j.jnutbio.2007.12.001; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	42	92	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24666	24673		10.1074/jbc.M111.236273	http://dx.doi.org/10.1074/jbc.M111.236273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613228	hybrid, Green Published			2022-12-25	WOS:000292547900017
J	Nalloor, R; Bunting, K; Vazdarjanova, A				Nalloor, Rebecca; Bunting, Kristopher; Vazdarjanova, Almira			Predicting Impaired Extinction of Traumatic Memory and Elevated Startle	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANIMAL-MODEL; PLUS-MAZE; NEURAL PLASTICITY; PREDATOR STRESS; EXPOSURE; PTSD; ANXIETY; VULNERABILITY; EXPERIENCE	Background: Emotionally traumatic experiences can lead to debilitating anxiety disorders, such as phobias and Post-Traumatic Stress Disorder (PTSD). Exposure to such experiences, however, is not sufficient to induce pathology, as only up to one quarter of people exposed to such events develop PTSD. These statistics, combined with findings that smaller hippocampal size prior to the trauma is associated with higher risk of developing PTSD, suggest that there are pre-disposing factors for such pathology. Because prospective studies in humans are limited and costly, investigating such predispositions, and thus advancing understanding of the genesis of such pathologies, requires the use of animal models where predispositions are identified before the emotional trauma. Most existing animal models are retrospective: they classify subjects as those with or without a PTSD-like phenotype long after experiencing a traumatic event. Attempts to create prospective animal models have been largely unsuccessful. Methodology/Principal Findings: Here we report that individual predispositions to a PTSD-like phenotype, consisting of impaired rate and magnitude of extinction of an emotionally traumatic event coupled with long-lasting elevation of acoustic startle responses, can be revealed following exposure to a mild stressor, but before experiencing emotional trauma. We compare, in rats, the utility of several classification criteria and report that a combination of criteria based on acoustic startle responses and behavior in an anxiogenic environment is a reliable predictor of a PTSD-like phenotype. Conclusions/Significance: There are individual predispositions to developing impaired extinction and elevated acoustic startle that can be identified after exposure to a mildly stressful event, which by itself does not induce such a behavioral phenotype. The model presented here is a valuable tool for studying the etiology and pathophysiology of anxiety disorders and provides a platform for testing behavioral and pharmacological interventions that can reduce the probability of developing pathologic behaviors associated with such disorders.	[Nalloor, Rebecca] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Nalloor, R (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	avazdarjanova@georgiahealth.edu	; Vazdarjanova, Almira/D-8254-2018	Bunting, Kristopher/0000-0002-7252-8598; Vazdarjanova, Almira/0000-0002-3848-8895; Nalloor, Rebecca/0000-0003-1753-8010	National Institute of Mental Health [083188]; Georgia Health Sciences University	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Georgia Health Sciences University	The work was funded by National Institute of Mental Health 083188 (AV), Georgia Health Sciences University Startup (AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, EUR J PHARMACOL, V504, P65, DOI 10.1016/j.ejphar.2004.09.009; Adamec RE, 2006, NEUROSCI BIOBEHAV R, V30, P356, DOI 10.1016/j.neubiorev.2005.04.004; ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Adamec R, 2008, NEUROSCI BIOBEHAV R, V32, P1287, DOI 10.1016/j.neubiorev.2008.05.005; Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; Blanchard D Caroline, 2005, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0819s30; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2006, ANN NY ACAD SCI, V1071, P335, DOI 10.1196/annals.1364.026; Davis M, 2006, J TRAUMA STRESS, V19, P571, DOI 10.1002/jts.20149; DAWSON GR, 1994, PSYCHOPHARMACOLOGY, V113, P570, DOI 10.1007/BF02245242; *DEF HLTH BOARD TA, MENT HLTH TASK FORC; Ehring T, 2007, J NERV MENT DIS, V195, P1004, DOI 10.1097/NMD.0b013e31815c1999; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FILE SE, 1993, PSYCHOPHARMACOLOGY, V111, P491, DOI 10.1007/BF02253541; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Kozlovsky N, 2007, INT J NEUROPSYCHOPH, V10, P741, DOI 10.1017/S1461145707007560; Kozlovsky N, 2008, EUR NEUROPSYCHOPHARM, V18, P107, DOI 10.1016/j.euroneuro.2007.04.009; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mackenzie L, 2010, NEUROSCIENCE, V169, P733, DOI 10.1016/j.neuroscience.2010.05.005; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; NEUMANN ID, PROGR NEURO IN PRESS; Rasmussen DD, 2008, PSYCHONEUROENDOCRINO, V33, P282, DOI 10.1016/j.psyneuen.2007.11.010; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Roth T.L., J PSYCHIAT IN PRESS; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	34	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19760	10.1371/journal.pone.0019760	http://dx.doi.org/10.1371/journal.pone.0019760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611173	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200030
J	Beck, AJ; Vitale, JM; Zhao, QS; Schneider, JS; Chang, C; Altaf, A; Michaels, J; Bhaumik, M; Grange, R; Fraidenraich, D				Beck, Amanda J.; Vitale, Joseph M.; Zhao, Qingshi; Schneider, Joel S.; Chang, Corey; Altaf, Aneela; Michaels, Jennifer; Bhaumik, Mantu; Grange, Robert; Fraidenraich, Diego			Differential Requirement for Utrophin in the Induced Pluripotent Stem Cell Correction of Muscle versus Fat in Muscular Dystrophy Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; RESTORES DYSTROPHIN; SKELETAL-MUSCLE; ALPHA-DYSTROBREVIN; SYSTEMIC DELIVERY; FULL-LENGTH; MDX; EXPRESSION; INJECTION; PROTEIN	Duchenne muscular dystrophy (DMD) is an incurable degenerative muscle disorder. We injected WT mouse induced pluripotent stem cells (iPSCs) into mdx and mdx: utrophin mutant blastocysts, which are predisposed to develop DMD with an increasing degree of severity (mdx <<< mdx: utrophin). In mdx chimeras, iPSC-dystrophin was supplied to the muscle sarcolemma to effect corrections at morphological and functional levels. Dystrobrevin was observed in dystrophin-positive and, at a lesser extent, utrophin-positive areas. In the mdx: utrophin mutant chimeras, although iPSC-dystrophin was also supplied to the muscle sarcolemma, mice still displayed poor skeletal muscle histopathology, and negligible levels of dystrobrevin in dystrophin-and utrophin-negative areas. Not only dystrophin-expressing tissues are affected by iPSCs. Mdx and mdx: utrophin mice have reduced fat/body weight ratio, but iPSC injection normalized this parameter in both mdx and mdx: utrophin chimeras, despite the fact that utrophin was compromised in the mdx: utrophin chimeric fat. The results suggest that the presence of utrophin is required for the iPSC-corrections in skeletal muscle. Furthermore, the results highlight a potential (utrophin-independent) non-cell autonomous role for iPSC-dystrophin in the corrections of non-muscle tissue like fat, which is intimately related to the muscle.	[Beck, Amanda J.; Vitale, Joseph M.; Zhao, Qingshi; Schneider, Joel S.; Chang, Corey; Altaf, Aneela; Fraidenraich, Diego] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Michaels, Jennifer] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Newark, NJ 07103 USA; [Bhaumik, Mantu] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; [Grange, Robert] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Polytechnic Institute & State University	Beck, AJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	fraidedi@umdnj.edu	Zhao, Qingshi/H-9839-2013		NIH [HL094905]; Muscular Dystrophy Association [68648]; Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NIH (HL094905), the Muscular Dystrophy Association (68648) and the Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, J CELL SCI, V121, P48, DOI 10.1242/jcs.020701; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Odom GL, 2010, MOL THER; Odom GL, 2008, MOL THER, V16, P1539, DOI 10.1038/mt.2008.149; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Schneider JS, 2009, STEM CELL REV REP; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Stillwell E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004759; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wolff AV, 2006, MUSCLE NERVE, V34, P304, DOI 10.1002/mus.20588; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2010, NATURE, V467, P280, DOI 10.1038/467280a	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20065	10.1371/journal.pone.0020065	http://dx.doi.org/10.1371/journal.pone.0020065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603573	Green Submitted, gold, Green Published			2022-12-25	WOS:000290656300050
J	He, W; Zhu, F; Ma, XG; Zhao, XY; Zheng, M; Chen, Z; Heymsfield, SB; Zhu, SK				He, Wei; Zhu, Fei; Ma, Xiaoguang; Zhao, Xinyu; Zheng, Min; Chen, Zhao; Heymsfield, Steven B.; Zhu, Shankuan			Actinic Skin Damage and Mortality - the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study	PLOS ONE			English	Article							VITAMIN-D; SUN PROTECTION; EXPOSURE; SUNLIGHT; PREVENTION; DETERMINANTS; PREVALENCE; RADIATION; VALIDITY; SMOKING	Background: Exposure to sunlight may decrease the risk of several diseases through the synthesis of vitamin D, whereas solar radiation is the main cause of some skin and eye diseases. However, to the best of our knowledge, the association of sun-induced skin damage with mortality remains unknown. Methodology/Principal Findings: Subjects were 8472 white participants aged 25-74 years in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cardiovascular disease mortality, cancer mortality, and all-cause mortality were obtained by either a death certificate or a proxy interview, or both. Actinic skin damage was examined and recorded by the presence and severity (absent, minimal, moderate, or severe) of overall actinic skin damage and its components (i.e., fine telangiectasia, solar elastosis, and actinic keratoses). Cox regression and Kaplan-Meier methods were applied to explore the associations. A total of 672 cancer deaths, 1500 cardiovascular disease deaths, and 2969 deaths from all causes were documented through the follow-up between 1971 and 1992. After controlling for potential confounding variables, severe overall actinic skin damage was associated with a 45% higher risk for all-cause mortality (95% CI: 1.22, 1.72; P<0.001), moderate overall skin damage with a 20% higher risk (95% CI: 1.08., 1.32; P<0.001), and minimal overall skin damage with no significant mortality difference, when compared to those with no skin damage. Similar results were obtained for all-cause mortality with fine telangiectasia, solar elastosis, and actinic keratoses. The results were similar for cancer and cardiovascular disease mortality. Conclusions: The present study gives an indication of an association of actinic skin damage with cardiovascular disease, cancer and all-cause mortality in white subjects. Given the lack of support in the scientific literature and potential unmeasured confounding factors, this finding should be interpreted with caution. More independent studies are needed before any practical recommendations can be made.	[He, Wei; Zhu, Fei; Zhao, Xinyu; Zhu, Shankuan] Zhejiang Univ, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Xiaoguang; Zhu, Shankuan] Med Coll Wisconsin, Injury Res Ctr, Milwaukee, WI 53226 USA; [Ma, Xiaoguang] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC USA; [Zheng, Min] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhao] Univ Arizona, Div Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Zhejiang University; Medical College of Wisconsin; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Zhejiang University; University of Arizona; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	He, W (corresponding author), Zhejiang Univ, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	zsk@zju.edu.cn	Ma, Xiaoguang/AAS-6923-2020; MA, XIAO/HHN-5611-2022; Heymsfield, Steven B/N-1968-2017; He, Wei/C-8441-2015	Heymsfield, Steven B/0000-0003-1127-9425; He, Wei/0000-0003-0161-3274	Zhejiang University, Hangzhou, China	Zhejiang University, Hangzhou, China	This study was supported in part by the "985" development initiative from Zhejiang University, Hangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM AC DERM, 2009, AM AC DERM ISS UPD P; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; ARTHEY S, 1995, SOC SCI MED, V40, P265, DOI 10.1016/0277-9536(94)E0063-X; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Brown TT, 2006, J AM ACAD DERMATOL, V55, P577, DOI 10.1016/j.jaad.2006.05.029; CALDERONE DC, 1995, J AM ACAD DERMATOL, V32, P1016, DOI 10.1016/0190-9622(95)91342-4; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Cox C S, 1997, Vital Health Stat 1, P1; COX DR, 1972, J R STAT SOC B, V34, P187; Davis KJ, 2002, PEDIATRICS, V110, P27, DOI 10.1542/peds.110.1.27; Engel A, 1978, Vital Health Stat 1, P1; ENGEL A, 1988, ARCH DERMATOL, V124, P72, DOI 10.1001/archderm.124.1.72; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FRANCES C, 1991, BRIT J DERMATOL, V125, P43, DOI 10.1111/j.1365-2133.1991.tb06037.x; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Gillie O, 2006, BRIT J DERMATOL, V154, P1052, DOI 10.1111/j.1365-2133.2006.07261.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2008, ADV EXP MED BIOL, V624, P1, DOI 10.1007/978-0-387-77574-6_1; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOLMAN CDJ, 1984, AM J EPIDEMIOL, V120, P414, DOI 10.1093/oxfordjournals.aje.a113906; Ingram D D, 1994, Vital Health Stat 2, P1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koh HK, 1997, AM J PUBLIC HEALTH, V87, P1214, DOI 10.2105/AJPH.87.7.1214; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lucas RM, 2006, B WORLD HEALTH ORGAN, V84, P485, DOI 10.2471/BLT.05.026559; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARKS R, 1994, PIGM CELL RES, V7, P104, DOI 10.1111/j.1600-0749.1994.tb00029.x; Matts PJ, 2010, PHOTOCH PHOTOBIO SCI, V9, P421, DOI 10.1039/b9pp00166b; Miller H W, 1973, Vital Health Stat 1, P1; Moller P, 2002, FASEB J, V16, P45, DOI 10.1096/fj.01-0386com; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Narbutt J, 2009, ARCH DERMATOL, V145, P133, DOI 10.1001/archdermatol.2008.574; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ness AR, 1999, BRIT MED J, V319, P114, DOI 10.1136/bmj.319.7202.114; Purba MB, 2001, AGE AGEING, V30, P227, DOI 10.1093/ageing/30.3.227; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Robinson JK, 2000, J AM ACAD DERMATOL, V42, P746, DOI 10.1067/mjd.2000.103984; SAFAVI K, 1994, J INVEST DERMATOL, V102, pS51, DOI 10.1111/1523-1747.ep12388611; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; *US BUR CENS, 1971, 1970 CENS POP ALPH I; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vural P, 1999, J EUR ACAD DERMATOL, V13, P96, DOI 10.1111/j.1468-3083.1999.tb00860.x; World Health Organization, 2003, INTERSUN GLOB UV PRO; Wulf HC, 2004, MICRON, V35, P185, DOI 10.1016/j.micron.2003.11.005; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x	50	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19907	10.1371/journal.pone.0019907	http://dx.doi.org/10.1371/journal.pone.0019907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21603643	gold, Green Published, Green Submitted			2022-12-25	WOS:000290558500036
J	Olsson, M; Andersson, S; Wapstra, E				Olsson, Mats; Andersson, Staffan; Wapstra, Erik			UV-Deprived Coloration Reduces Success in Mate Acquisition in Male Sand Lizards (Lacerta agilis)	PLOS ONE			English	Article							NUPTIAL COLORATION; SELECTION; SIGNALS; PREFERENCES; PATERNITY; ABILITY	Background: Recent work on animal signals has revealed a wide occurrence of UV signals in tetrapods, in particular birds, but also in lizards (and perhaps other Squamate reptiles). Our previous work on the Swedish sand lizard (Lacerta agilis) has verified, both in correlative selection analyses in the wild and with laboratory and field experiments, the importance of the green 'badge' on the body sides of adult males for securing mating opportunities, probably mostly through deterring rival males rather than attracting females. The role of UV in communication has, however, never been examined. Methodology/Principal Findings: Here we show that when measured immediately after spring skin shedding, there is also signaling in the UV. By UV-depriving the signal (reflectance) with sun block chemicals fixated with permeable, harmless spray dressing, we show that males in the control group (spray dressing only) had significantly higher success in mate acquisition than UV-deprived males. Conclusions/Significance: These results suggest that at least two colour traits in sand lizards, badge area and UV, contribute to rival deterrence and/or female choice on UV characters, which elevates success in mate acquisition in UV intact male sand lizards.	[Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Olsson, Mats; Andersson, Staffan] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia	University of Sydney; University of Gothenburg; University of Tasmania	Olsson, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	mats.olsson@sydney.edu.au	Wapstra, Erik/J-7482-2014; Andersson, Staffan/B-1534-2010; Olsson, Mats/AAK-5565-2021	Wapstra, Erik/0000-0002-2050-8026; Andersson, Staffan/0000-0003-1474-3596; Olsson, Mats/0000-0002-4130-1323	Australian Research Council (ARC) [DP0453116]	Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Australian Research Council (ARC) with grant DP0453116. The ARC can be found at www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderholm S, 2004, BIOL LETT, V271, P142; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; [Anonymous], 2005, MG BEH ECOL; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; de Lanuza GPI, 2007, AMPHIBIA-REPTILIA, V28, P438, DOI 10.1163/156853807781374764; Delhey K, 2003, P ROY SOC B-BIOL SCI, V270, P2057, DOI 10.1098/rspb.2003.2460; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gullberg A, 1997, MOL ECOL, V6, P105, DOI 10.1046/j.1365-294X.1997.t01-1-00156.x; Hasson O, 1997, J THEOR BIOL, V185, P139, DOI 10.1006/jtbi.1996.0258; Li DQ, 2005, ANIM BEHAV, V70, P771, DOI 10.1016/j.anbehav.2004.12.021; Losey GS, 2003, ANIM BEHAV, V66, P299, DOI 10.1006/anbe.2003.2214; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P249, DOI 10.1007/s002650050095; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P169, DOI 10.1007/s002650050084; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Olsson M, 2000, P ROY SOC LOND B BIO, V267, P1; Pryke SR, 2003, ANIM BEHAV, V66, P217, DOI 10.1006/anbe.2003.2193; ROHWER S, 1982, AM ZOOL, V22, P531; Stapley J, 2006, BIOL LETTERS, V2, P169, DOI 10.1098/rsbl.2005.0419; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	26	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19360	10.1371/journal.pone.0019360	http://dx.doi.org/10.1371/journal.pone.0019360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602928	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500007
J	Litvintseva, AP; Carbone, I; Rossouw, J; Thakur, R; Govender, NP; Mitchell, TG				Litvintseva, Anastasia P.; Carbone, Ignazio; Rossouw, Jenny; Thakur, Rameshwari; Govender, Nelesh P.; Mitchell, Thomas G.			Evidence that the Human Pathogenic Fungus Cryptococcus neoformans var. grubii May Have Evolved in Africa	PLOS ONE			English	Article							POPULATION GENETIC-ANALYSIS; MULTILOCUS GENOTYPE DATA; MATING-TYPE; SEROTYPE-A; COLOPHOSPERMUM-MOPANE; COMPUTER-PROGRAM; RECOMBINATION; GATTII; INFERENCE; MODEL	Most of the species of fungi that cause disease in mammals, including Cryptococcus neoformans var. grubii (serotype A), are exogenous and non-contagious. Cryptococcus neoformans var. grubii is associated worldwide with avian and arboreal habitats. This airborne, opportunistic pathogen is profoundly neurotropic and the leading cause of fungal meningitis. Patients with HIV/AIDS have been ravaged by cryptococcosis - an estimated one million new cases occur each year, and mortality approaches 50%. Using phylogenetic and population genetic analyses, we present evidence that C. neoformans var. grubii may have evolved from a diverse population in southern Africa. Our ecological studies support the hypothesis that a few of these strains acquired a new environmental reservoir, the excreta of feral pigeons (Columba livia), and were globally dispersed by the migration of birds and humans. This investigation also discovered a novel arboreal reservoir for highly diverse strains of C. neoformans var. grubii that are restricted to southern Africa, the mopane tree (Colophospermum mopane). This finding may have significant public health implications because these primal strains have optimal potential for evolution and because mopane trees contribute to the local economy as a source of timber, folkloric remedies and the edible mopane worm.	[Litvintseva, Anastasia P.; Mitchell, Thomas G.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA; [Carbone, Ignazio] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Rossouw, Jenny] Natl Inst Communicable Dis, Special Bacterial Pathogens Reference Unit, Johannesburg, South Africa; [Thakur, Rameshwari] Minist Hlth, Natl Hlth Lab, Dept Mycol, Gaborone, Botswana; [Govender, Nelesh P.] Natl Inst Communicable Dis, Mycol Reference Unit, Johannesburg, South Africa	Duke University; University of North Carolina; North Carolina State University; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD)	Litvintseva, AP (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	litvi001@mc.duke.edu	Govender, Nelesh/ABI-6429-2020; Mitchell, Thomas G./A-2356-2008	Rossouw, Jennifer/0000-0003-2840-5563; Thakur, Rameshwari/0000-0002-6739-6383; Govender, Nelesh/0000-0001-7869-9462	U. S. Public Health Service NIH [5R01 AI 25783]; NIH [P30 AI 64518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, R01AI093257, R01AI025783] Funding Source: NIH RePORTER	U. S. Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U. S. Public Health Service NIH grant 5R01 AI 25783 and by a grant from the Duke University Center for AIDS Research, which is funded by NIH grant P30 AI 64518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; DRUMMOND AJ, 2010, GENEIOS PRO V 5 1; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2004, INFERRING PHYLOGENIE, P664; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FU YX, 1993, GENETICS, V133, P693; Grzimek B., 2004, GRZIMEKS ANIMAL LIFE; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hempson GP, 2007, AUSTRAL ECOL, V32, P429, DOI 10.1111/j.1442-9993.2007.01712.x; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005; Litvintseva AP, 2003, EUKARYOT CELL, V2, P1162, DOI 10.1128/EC.2.6.1162-1168.2003; Lyngso RB, 2008, LECT N BIOINFORMAT, V4955, P463; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Mapaure I., 1994, Kirkia, V15, P1; Mashabane LG, 2001, S AFR J BOT, V67, P199, DOI 10.1016/S0254-6299(15)31120-0; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Mooney H.A., 2000, INVASIVE SPECIES CHA; Myers SR, 2003, GENETICS, V163, P375; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; NIELSEN K, 2007, EUKARYOT CELL; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Pritchard JK, 2000, GENETICS, V155, P945; RANDHAWA HS, 2008, MED MYCOL, P1; Sebego RJ, 2008, S AFR GEOGR J, V90, P41, DOI 10.1080/03736245.2008.9725310; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; STAIB F, 1989, MYCOSES, V32, P448, DOI 10.1111/j.1439-0507.1989.tb02280.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Swofford David L., 1996, P407; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Venter F., 2002, PRETORIA S AFR; Vogel G, 2010, SCIENCE, V327, P811, DOI 10.1126/science.327.5967.811; Wright S, 1978, VARIABILITY NATURAL; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x	62	75	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19688	10.1371/journal.pone.0019688	http://dx.doi.org/10.1371/journal.pone.0019688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589919	Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600022
J	Switzer, WM; Jia, HW; Zheng, HQ; Tang, SH; Heneine, W				Switzer, William M.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Heneine, Walid			No Association of Xenotropic Murine Leukemia Virus-Related Viruses with Prostate Cancer	PLOS ONE			English	Article							XMRV INFECTION; BLOOD-DONORS; GENE-THERAPY; RETROVIRUS; SEQUENCES; ASSAY; CONTAMINATION; ANTIBODIES; MULTIPLE; TISSUE	Background: The association of the xenotropic murine leukemia virus-related virus (XMRV) with prostate cancer continues to receive heightened attention as studies report discrepant XMRV prevalences ranging from zero up to 23%. It is unclear if differences in the diagnostic testing, disease severity, geography, or other factors account for the discordant results. We report here the prevalence of XMRV in a population with well-defined prostate cancers and RNase L polymorphism. We used broadly reactive PCR and Western blot (WB) assays to detect infection with XMRV and related murine leukemia viruses (MLV). Methodology/Principal Findings: We studied specimens from 162 US patients diagnosed with prostate cancer with a intermediate to advanced stage (Gleason Scores of 5-10; moderate (46%) poorly differentiated tumors (54%)). Prostate tissue DNA was tested by PCR assays that detect XMRV and MLV variants. To exclude contamination with mouse DNA, we also designed and used a mouse-specific DNA PCR test. Detailed phylogenetic analysis was used to infer evolutionary relationships. RNase L typing showed that 9.3% were homozygous (QQ) for the R462Q RNase L mutation, while 45.6% and 45.1% were homozygous or heterozygous, respectively. Serologic testing was performed by a WB test. Three of 162 (1.9%) prostate tissue DNA were PCR-positive for XMRV and had undetectable mouse DNA. None was homozygous for the QQ mutation. Plasma from all three persons was negative for viral RNA by RT-PCR. All 162 patients were WB negative. Phylogenetic analysis inferred a distinct XMRV. Conclusions and Their Significance: We found a very low prevalence of XMRV in prostate cancer patients. Infection was confirmed by phylogenetic analysis and absence of contaminating mouse DNA. The finding of undetectable antibodies and viremia in all three patients may reflect latent infection. Our results do not support an association of XMRV or MLV variants with prostate cancer.	[Switzer, William M.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	bis3@cdc.gov			Centers for Disease Control and Prevention per annual appropriations of the United States Government	Centers for Disease Control and Prevention per annual appropriations of the United States Government(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the study was provided by the Centers for Disease Control and Prevention per annual appropriations of the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANC RES; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Busch MP, 2000, TRANSFUSION, V40, P443, DOI 10.1046/j.1537-2995.2000.40040443.x; DANIELSON BX, 2010, J INFECT DIS; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; HENRICH TX, 2010, J INFECT DIS; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lerche NW, 1997, LAB ANIM SCI, V47, P263; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Matthews AL, 1999, TRANSPLANTATION, V67, P939, DOI 10.1097/00007890-199904150-00002; Mo ZN, 2009, PROSTATE, V69, P662, DOI 10.1002/pros.20907; Moorthy HK, 2008, INDIAN J UROL, V24, P295, DOI 10.4103/0970-1591.42608; Morse II H. C., 2007, MOUSE BIOMEDICAL RES, V2, P269; MURAD A, 2009, PROSTATE CANC PROSTA; Odedina Folakemi T, 2009, Infect Agent Cancer, V4 Suppl 1, pS2, DOI 10.1186/1750-9378-4-S1-S2; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; SHARMA P, 2010, C RETR OPP INF SAN F; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh G. W., 2010, PROSTATE; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5	40	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19065	10.1371/journal.pone.0019065	http://dx.doi.org/10.1371/journal.pone.0019065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573232	Green Published, gold			2022-12-25	WOS:000290224800015
J	Borgstrom, E; Lundin, S; Lundeberg, J				Borgstrom, Erik; Lundin, Sverker; Lundeberg, Joakim			Large Scale Library Generation for High Throughput Sequencing Authors and Affiliations	PLOS ONE			English	Article							CELL-LINES	Background: Large efforts have recently been made to automatethe sample preparation protocols for massively parallel sequencing in order to match the increasing instrument throughput. Still, the size selection through agarose gel electrophoresis separation is a labor-intensive bottleneck of these protocols. Methodology/Principal Findings: In this study a method for automatic library preparation and size selection on a liquid handling robot is presented. The method utilizes selective precipitation of certain sizes of DNA molecules on to paramagnetic beads for cleanup and selection after standard enzymatic reactions. Conclusions/Significance: The method is used to generate libraries for de novo and re-sequencing on the Illumina HiSeq 2000 instrument with a throughput of 12 samples per instrument in approximately 4 hours. The resulting output data show quality scores and pass filter rates comparable to manually prepared samples. The sample size distribution can be adjusted for each application, and are suitable for all high throughput DNA processing protocols seeking to control size intervals.	[Borgstrom, Erik; Lundin, Sverker; Lundeberg, Joakim] Sch Biotechnol, Royal Inst Technol KTH, Sci Life Lab, Div Gene Technol, Solna, Sweden	Royal Institute of Technology	Borgstrom, E (corresponding author), Sch Biotechnol, Royal Inst Technol KTH, Sci Life Lab, Div Gene Technol, Solna, Sweden.	Joakim.lundeberg@scilifelab.se	Palacios, Luis/GVT-3145-2022; Pages, Teresa/G-4244-2011	Pages, Teresa/0000-0002-4969-1522	Swedish research council; Knut and Alice Wallenberg Foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was financially supported by grants from the Swedish research council and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Klevebring D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/396808; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Linnarsson S, 2010, EXP CELL RES, V316, P1339, DOI 10.1016/j.yexcr.2010.02.036; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]	17	117	118	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19119	10.1371/journal.pone.0019119	http://dx.doi.org/10.1371/journal.pone.0019119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21589638	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400031
J	Arozarena, I; Bischof, H; Gilby, D; Belloni, B; Dummer, R; Wellbrock, C				Arozarena, I.; Bischof, H.; Gilby, D.; Belloni, B.; Dummer, R.; Wellbrock, C.			In melanoma, beta-catenin is a suppressor of invasion	ONCOGENE			English	Article						melanoma; invasion; Rho; ROCK; MMP; MITF	TRANSCRIPTION FACTOR; COLORECTAL-CANCER; PROGNOSTIC MARKER; CELL-MIGRATION; EXPRESSION; MITF; PROLIFERATION; PROGRESSION; TARGET; P16(INK4A)	Cell-type-specific signalling determines cell fate under physiological conditions, but it is increasingly apparent that also in cancer development the impact of any given oncogenic pathway on the individual cancer pathology is dependent on cell-lineage-specific molecular traits. For instance in colon and liver cancer canonical Wnt signalling produces increased cytoplasmic and nuclear localised beta-catenin, which correlates with invasion and poor prognosis. In contrast, in melanoma increased cytoplasmic and nuclear beta-catenin is currently emerging as a marker for good prognosis, and thus seems to have a different function compared with other cancer types; however, this function is unknown. We discovered that in contrast to its function in other cancers, in melanoma, beta-catenin blocks invasion. We demonstrate that this opposing role of nuclear beta-catenin in melanoma is mediated through MITF, a melanoma-specific protein that defines the lineage background of this cancer type. Downstream of beta-catenin MITF not only suppresses the Rho-GTPase-regulated cell morphology of invading melanoma cells, but also interferes with beta-catenin-induced expression of the essential collagenase MT1-MMP, thus affecting all aspects of an invasive phenotype. Importantly, overexpression of MITF in invasive colon cancer cells modifies beta-catenin-directed signalling and induces a 'melanoma phenotype'. In summary, the cell-type-specific presence of MITF in melanoma affects beta-catenin's pro-invasive properties otherwise active in colon or liver cancer. Thus our study reveals the general importance of considering cell-type-specific signalling for the accurate interpretation of tumour markers and ultimately for the design of rational therapies. Oncogene (2011) 30, 4531-4543; doi:10.1038/onc.2011.162; published online 16 May 2011	[Arozarena, I.; Bischof, H.; Gilby, D.; Wellbrock, C.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Belloni, B.; Dummer, R.] Univ Spital Zurich, Dept Dermatol, Zurich, Switzerland	University of Manchester; University of Zurich; University Zurich Hospital	Wellbrock, C (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	claudia.wellbrock@manchester.ac.uk	Arozarena, Imanol/A-5981-2017	Arozarena, Imanol/0000-0001-6349-2442; Wellbrock, Claudia/0000-0002-3825-6381	BBSRC [BB/G001111/1]; Wellcome Trust; University of Manchester; Cancer Research UK [C11591/A10202]; Biotechnology and Biological Sciences Research Council [BB/G001111/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Steven Rosenberg (NCI) for the 501mel, 888mel and 1290mel cells and Hector Palmer (Vall d'Hebron) for the beta-catenin reporter plasmids. We thank Peter March for his help with microscopy. The Bioimaging Facility microscopes were funded by the BBSRC, the Wellcome Trust and the University of Manchester Strategic Fund. This work was funded by Cancer Research UK (grant C11591/A10202) and the BBSRC (grant BB/G001111/1).	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Adachi Y, 2001, INT J CANCER, V95, P290, DOI 10.1002/1097-0215(20010920)95:5<290::AID-IJC1050>3.0.CO;2-I; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Boye K, 2010, EUR J CANCER, V46, P2919, DOI 10.1016/j.ejca.2010.07.013; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Demirkan NC, 2007, CLIN EXP DERMATOL, V32, P733, DOI 10.1111/j.1365-2230.2007.02507.x; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jung A, 2001, AM J PATHOL, V159, P1613, DOI 10.1016/S0002-9440(10)63007-6; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Nazarian RM, 2010, J CUTAN PATHOL, V37, P41, DOI 10.1111/j.1600-0560.2010.01505.x; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Pecina-Slaus N, 2007, J CUTAN PATHOL, V34, P239, DOI 10.1111/j.1600-0560.2006.00601.x; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; ROBBINS PF, 1995, J IMMUNOL, V154, P5944; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Salti GI, 2000, CANCER RES, V60, P5012; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wagenaar-Miller RA, 2004, CANCER METAST REV, V23, P119, DOI 10.1023/A:1025819214508; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	50	87	88	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2011	30	45					4531	4543		10.1038/onc.2011.162	http://dx.doi.org/10.1038/onc.2011.162			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21577209	Green Accepted			2022-12-25	WOS:000296890700001
J	Uzawa, K; Ishigami, T; Fushimi, K; Kawata, T; Shinozuka, K; Kasamatsu, A; Sakamoto, Y; Ogawara, K; Shiiba, M; Bukawa, H; Ito, H; Tanzawa, H				Uzawa, K.; Ishigami, T.; Fushimi, K.; Kawata, T.; Shinozuka, K.; Kasamatsu, A.; Sakamoto, Y.; Ogawara, K.; Shiiba, M.; Bukawa, H.; Ito, H.; Tanzawa, H.			Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells	ONCOGENE			English	Article						fibroblast growth factor receptor 3 gene; FGFR3; radiosensitivity; squamous cell carcinoma	DIFFERENTIATION; INHIBITION; EXPRESSION	Conventional therapies including radiation therapy cannot cure squamous cell carcinoma (SCC), and new treatments are clearly required. Our recent studies have shown that SCC cell lines exhibiting radioresistance show significant upregulation of the fibroblast growth factor receptor 3 (FGFR3) gene. We hypothesized that inhibiting FGFR3 would suppress tumor cell radioresistance and provide a new treatment approach for human SCCs. In the present study, we found that RNA interference-mediated FGFR3 depletion in HSC-2 cells, a radioresistant cell line, induced radiosensitivity and inhibited tumor growth. Use of an FGFR3 inhibitor (PD173074) obtained similar results with suppression of the autophosphorylation extracellular signal-regulated kinase pathway in HSC-2 cells and lung cancer cell lines. Moreover, the antitumor growth effect of the combination of PD173074 and radiation in vivo was also greater than that with either drug alone or radiation alone. Our results provided novel information on which to base further mechanistic study of radiosensitization by inhibiting FGFR3 in human SCC cells and for developing strategies to improve outcomes with concurrent radiotherapy. Oncogene (2011) 30, 4447-4452; doi:10.1038/onc.2011.159; published online 16 May 2011	[Uzawa, K.] Chiba Univ, Dept Clin Mol Biol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Uzawa, K.; Kasamatsu, A.; Sakamoto, Y.; Ogawara, K.; Shiiba, M.; Tanzawa, H.] Chiba Univ Hosp, Div Dent Oral & Maxillofacial Surg, Chiba, Japan; [Kawata, T.; Ito, H.] Chiba Univ, Dept Radiol, Grad Sch Med, Chiba 2608670, Japan; [Shinozuka, K.; Bukawa, H.] Univ Tsukuba, Dept Oral & Maxillofacial Surg, Inst Clin Med, Grad Sch Comprehens Human Sci, Ibaraki, Japan	Chiba University; Chiba University; Chiba University; University of Tsukuba	Uzawa, K (corresponding author), Chiba Univ, Dept Clin Mol Biol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Science, Sports and Culture of Japan [22659364]; Japan Society for Promotion of Science [1952163]; 21st Century Center of Excellence Programs grant;  [19659520]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence Programs grant; 	We thank Lynda C Charters for proofreading this manuscript. This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (no. 22659364), a grant-in-aid from the Japan Society for Promotion of Science Fellows (1952163), a grant-in-aid for Exploratory Research (19659520) and the 21st Century Center of Excellence Programs grant.	BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FOWLER JF, 1974, INT J RADIAT BIOL, V25, P213, DOI 10.1080/09553007414550271; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Henson B J, 2010, Cytogenet Genome Res, V128, P192, DOI 10.1159/000308303; Ishigami T, 2007, INT J CANCER, V120, P2262, DOI 10.1002/ijc.22561; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Knowles MA, 2008, FUTURE ONCOL, V4, P71, DOI 10.2217/14796694.4.1.71; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Masih-Khan E, 2006, BLOOD, V108, P3465, DOI 10.1182/blood-2006-04-017087; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Rosty C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-15; Shintani S, 2003, INT J CANCER, V107, P1030, DOI 10.1002/ijc.11437; Studer G, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-16; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650	18	21	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	43					4447	4452		10.1038/onc.2011.159	http://dx.doi.org/10.1038/onc.2011.159			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21577207				2022-12-25	WOS:000296356500007
J	Waldeck-Weiermair, M; Jean-Quartier, C; Rost, R; Khan, MJ; Vishnu, N; Bondarenko, AI; Imamura, H; Malli, R; Graier, WF				Waldeck-Weiermair, Markus; Jean-Quartier, Claire; Rost, Rene; Khan, Muhammad Jadoon; Vishnu, Neelanjan; Bondarenko, Alexander I.; Imamura, Hiromi; Malli, Roland; Graier, Wolfgang F.			Leucine Zipper EF Hand-containing Transmembrane Protein 1 (Letm1) and Uncoupling Proteins 2 and 3 (UCP2/3) Contribute to Two Distinct Mitochondrial Ca2+ Uptake Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL LINE; ENDOPLASMIC-RETICULUM; CALCIUM MICRODOMAINS; INTRACELLULAR CA2+; T-LYMPHOCYTES; CRAC CHANNELS; STIMULATION; ACTIVATION; INDICATORS; MEMBRANE	Cytosolic Ca2+ signals are transferred into mitochondria over a huge concentration range. In our recent work we described uncoupling proteins 2 and 3 (UCP2/3) to be fundamental for mitochondrial uptake of high Ca2+ domains in mitochondria-ER junctions. On the other hand, the leucine zipper EF hand-containing transmembrane protein 1 (Letm1) was identified as a mitochondrial Ca2+/H+ antiporter that achieved mitochondrial Ca2+ sequestration at small Ca2+ increases. Thus, the contributions of Letm1 and UCP2/3 to mitochondrial Ca2+ uptake were compared in endothelial cells. Knock-down of Letm1 did not affect the UCP2/3-dependent mitochondrial uptake of intracellularly released Ca2+ but strongly diminished the transfer of entering Ca2+ into mitochondria, subsequently, resulting in a reduction of store-operated Ca2+ entry (SOCE). Knock-down of Letm1 and UCP2/3 did neither impact on cellular ATP levels nor the membrane potential. The enhanced mitochondrial Ca2+ signals in cells overexpressing UCP2/3 rescued SOCE upon Letm1 knock-down. In digitonin-permeabilized cells, Letm1 exclusively contributed to mitochondrial Ca2+ uptake at low Ca2+ conditions. Neither the Letm1-nor the UCP2/3-dependent mitochondrial Ca2+ uptake was affected by a knock-down of mRNA levels of mitochondrial calcium uptake 1 (MICU1), a protein that triggers mitochondrial Ca2+ uptake in HeLa cells. Our data indicate that Letm1 and UCP2/3 independently contribute to two distinct, mitochondrial Ca2+ uptake pathways in intact endothelial cells.	[Waldeck-Weiermair, Markus; Jean-Quartier, Claire; Rost, Rene; Khan, Muhammad Jadoon; Vishnu, Neelanjan; Bondarenko, Alexander I.; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Mol & Cellular Physiol Res Unit, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Imamura, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci, Chiyoda Ku, Tokyo 1020075, Japan	Medical University of Graz; Japan Science & Technology Agency (JST)	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Mol & Cellular Physiol Res Unit, Inst Mol Biol & Biochem, Harrachgasse 21-3, A-8010 Graz, Austria.	wolfgang.graier@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Bondarenko, Alexander I/B-3080-2013; Imamura, Hiromi/AAD-5109-2019; Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020	Graier, Wolfgang F./0000-0003-1871-3298; Imamura, Hiromi/0000-0002-1896-0443; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Malli, Roland/0000-0001-6327-8729; Bondarenko, Oleksandr/0000-0003-2629-5962; Rost, Rene/0000-0002-5393-0370; Jean-Quartier, Claire/0000-0002-0840-2173; Vishnu, Neelanjan/0000-0001-6395-4686	Austrian Science Funds (FWF) [P20181-B05, P21857-B18, P22553-B18, W 1226-B18]; FWF at the Medical University of Graz; Austrian Science Fund (FWF) [P 21857, P 22553] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); FWF at the Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF, P20181-B05, P21857-B18, and P22553-B18). C. J.-Q. and N. V. are funded by the FWF (W 1226-B18, DKplus Metabolic and Cardiovascular Disease), and M. J. K. is funded by the FWF within the program Molecular Medicine at the Medical University of Graz.	Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Bondarenko A, 2004, BRIT J PHARMACOL, V143, P9, DOI 10.1038/sj.bjp.0705866; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V461, P177, DOI 10.1007/s00424-010-0898-x; Collins S, 2010, NATURE, V467, P283, DOI 10.1038/467283a; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Frieden M, 2000, J PHYSIOL-LONDON, V524, P715, DOI 10.1111/j.1469-7793.2000.00715.x; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Frieden M, 2002, J PHYSIOL-LONDON, V540, P73, DOI 10.1113/jphysiol.2002.017053; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Graier WF, 1998, J PHYSIOL-LONDON, V506, P109, DOI 10.1111/j.1469-7793.1998.109bx.x; GRAIER WF, 1992, BIOCHEM BIOPH RES CO, V186, P1539, DOI 10.1016/S0006-291X(05)81582-7; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Koncz P, 2006, CELL CALCIUM, V40, P347, DOI 10.1016/j.ceca.2006.04.003; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; RIZZUTO R, 1994, METHOD CELL BIOL, V40, P339; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2009, ACTA PHYSIOL, V195, P139, DOI 10.1111/j.1748-1716.2008.01928.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004	53	76	77	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28444	28455		10.1074/jbc.M111.244517	http://dx.doi.org/10.1074/jbc.M111.244517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21613221	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000293557800060
J	Meruvu, S; Hugendubler, L; Mueller, E				Meruvu, Sunitha; Hugendubler, Lynne; Mueller, Elisabetta			Regulation of Adipocyte Differentiation by the Zinc Finger Protein ZNF638	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING NUCLEAR-PROTEIN; TRANSCRIPTIONAL CONTROL; DOMAIN; ZFP423; FAMILY; MOTIF	Zinc finger proteins constitute the largest family of transcription regulators in eukaryotes. These factors are involved in diverse processes in many tissues, including development and differentiation. We report here the characterization of the zinc finger protein ZNF638 as a novel regulator of adipogenesis. ZNF638 is induced early during adipocyte differentiation. Ectopic expression of ZNF638 increases adipogenesis in vitro, whereas its knockdown inhibits differentiation and decreases the expression of adipocyte-specific genes. ZNF638 physically interacts and transcriptionally cooperates with CCAAT/enhancer-binding protein (C/EBP) beta and C/EBP delta. This interaction leads to the expression of peroxisome proliferator-activated receptor gamma, which is the key regulator of adipocyte differentiation. In summary, ZNF638 is a novel and early regulator of adipogenesis that works as a transcription cofactor of C/EBPs.	[Meruvu, Sunitha; Hugendubler, Lynne; Mueller, Elisabetta] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mueller, E (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bldg 10,Rm 8D12B,9000 Rockville Pike, Bethesda, MD 20892 USA.	elisabettam@niddk.nih.gov			National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056023, ZIADK075004] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole by the National Institutes of Health NIDDK Intramural Research Program.	Auboeuf D, 2005, MOL CELL BIOL, V25, P5307, DOI 10.1128/MCB.25.13.5307-5316.2005; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Inagaki H, 1996, J BIOL CHEM, V271, P12525, DOI 10.1074/jbc.271.21.12525; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Matsushima Y, 1996, BIOCHEM BIOPH RES CO, V223, P427, DOI 10.1006/bbrc.1996.0910; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Ng EKO, 2002, J CELL BIOCHEM, V84, P556, DOI 10.1002/jcb.10041.abs; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05	14	49	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26516	26523		10.1074/jbc.M110.212506	http://dx.doi.org/10.1074/jbc.M110.212506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21602272	Green Published, hybrid			2022-12-25	WOS:000293078200030
J	Katz, RA; Merkel, G; Andrake, MD; Roder, H; Skalka, AM				Katz, Richard A.; Merkel, George; Andrake, Mark D.; Roder, Heinrich; Skalka, Anna Marie			Retroviral Integrases Promote Fraying of Viral DNA Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA VIRUS INTEGRASE; HIV-1 INTEGRASE; MOLECULAR-MECHANISMS; CA DINUCLEOTIDE; RECOGNITION; SUBSTRATE; SITE; CONFORMATION; FLUORESCENCE; INHIBITION	In the initial step of integration, retroviral integrase (IN) introduces precise nicks in the degenerate, short inverted repeats at the ends of linear viral DNA. The scissile phosphodiester bond is located immediately 3' of a highly conserved CA/GT dinucleotide, usually 2 bp from the ends. These nicks create new recessed 3'-OH viral DNA ends that are required for joining to host cell DNA. Previous studies have indicated that unpairing, "fraying," of the viral DNA ends by IN contributes to end recognition or catalysis. Here, we report that end fraying can be detected independently of catalysis with both avian sarcoma virus (ASV) and human immunodeficiency virus type 1 (HIV-1) IN proteins by use of fluorescence resonance energy transfer (FRET). The results were indicative of an IN-induced intramolecular conformational change in the viral DNA ends (cis FRET). Fraying activity is tightly coupled to the DNA binding capabilities of these enzymes, as follows: an inhibitor effective against both IN proteins was shown to block ASV IN DNA binding and end fraying, with similar dose responses; ASV IN substitutions that reduced DNA binding also reduced end fraying activity; and HIV-1 IN DNA binding and end fraying were both undetectable in the absence of a metal cofactor. Consistent with our previous results, end fraying is sequence-independent, suggesting that the DNA terminus per se is a major structural determinant for recognition. We conclude that frayed ends represent a functional intermediate in which DNA termini can be sampled for suitability for endonucleolytic processing.	[Katz, Richard A.; Merkel, George; Andrake, Mark D.; Roder, Heinrich; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Skalka, AM (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Roder, Heinrich/B-3455-2009	Roder, Heinrich/0000-0003-1860-2491	National Institutes of Health [AI40385, CA71515, CA006927]; NATIONAL CANCER INSTITUTE [R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927.	Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; Aiyar A, 1996, J VIROL, V70, P3571, DOI 10.1128/JVI.70.6.3571-3580.1996; Andrake Mark D, 2009, AIDS Res Ther, V6, P14, DOI 10.1186/1742-6405-6-14; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Iqbal A, 2008, BIOCHEMISTRY-US, V47, P7857, DOI 10.1021/bi800773f; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; Katzman M, 1999, ADV VIRUS RES, V52, P371, DOI 10.1016/S0065-3527(08)60307-3; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lee I, 2003, NUCLEIC ACIDS RES, V31, P4531, DOI 10.1093/nar/gkg499; Lee I, 2003, J MOL BIOL, V330, P261, DOI 10.1016/S0022-2836(03)00574-6; Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lubkowski J, 1998, P NATL ACAD SCI USA, V95, P4831, DOI 10.1073/pnas.95.9.4831; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Montano SP, 2006, NUCLEIC ACIDS RES, V34, P5353, DOI 10.1093/nar/gkl693; Oh J, 2008, J VIROL, V82, P11480, DOI 10.1128/JVI.01353-08; Oh J, 2008, J VIROL, V82, P503, DOI 10.1128/JVI.01441-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramreddy T, 2007, J PHYS CHEM B, V111, P5757, DOI 10.1021/jp068818f; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Spring BQ, 2007, J PHYS CHEM B, V111, P10040, DOI 10.1021/jp0725782; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Vandegraaff Nick, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000257; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n	40	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25710	25718		10.1074/jbc.M111.229179	http://dx.doi.org/10.1074/jbc.M111.229179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622554	Green Published, hybrid			2022-12-25	WOS:000293073000032
J	Kolte, D; Osman, N; Yang, J; Shariat-Madar, Z				Kolte, Dhaval; Osman, Noah; Yang, Jia; Shariat-Madar, Zia			High Molecular Weight Kininogen Activates B-2 Receptor Signaling Pathway in Human Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; CYTOKERATIN 1; INTRACELLULAR CALCIUM; EXTRACELLULAR CALCIUM; ION CHANNELS; FACTOR-XII; IN-VIVO; BRADYKININ; IDENTIFICATION; PREKALLIKREIN	The nonenzymatic cofactor high molecular weight kininogen (HK) is a precursor of bradykinin (BK). The production of BK from HK by plasma kallikrein has been implicated in the pathogenesis of inflammation and vascular injury. However, the functional role of HK in the absence of prekallikrein (PK), the proenzyme of plasma kallikrein, on vascular endothelial cells is not fully defined. In addition, no clinical abnormality is seen in PK-deficient patients. Therefore, an investigation into the effect of HK, in the absence of PK, on human pulmonary artery endothelial cell (HPAEC) function was performed. HK caused a marked and dose-dependent increase in the intracellular calcium [Ca2+](i) level in HPAEC. Gd3+ and verapamil potentiated the HK-induced increase in [Ca2+](i). HK-induced Ca2+ increase stimulated endothelial nitric oxide (NO) and prostacyclin (PGI(2)) production. The inhibitors of B-2 receptor-dependent signaling pathway impaired HK-mediated signal transduction in HPAEC. HK had no effect on endothelial permeability at physiological concentration. This study demonstrated that HK regulates endothelial cell function. HK could play an important role in maintaining normal endothelial function and blood flow and serve as a cardioprotective peptide.	[Kolte, Dhaval; Yang, Jia; Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA; [Shariat-Madar, Zia] Univ Mississippi, Pharmaceut Sci Res Inst, University, MS 38677 USA	University of Mississippi; University of Mississippi	Shariat-Madar, Z (corresponding author), Univ Mississippi, Dept Pharmacol, University, MS 38677 USA.	madar@olemiss.edu	Kolte, Dhaval/AAL-4032-2020; Kolte, Dhaval/G-9294-2015	Kolte, Dhaval/0000-0002-7107-3667	NCRR/National Institutes of Health [P20RR021929]; National Science Foundation [MRI 0619774]; American Heart Association [0330193N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER	NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by NCRR/National Institutes of Health Grant P20RR021929 (to Z. S.-M.), National Science Foundation Grant MRI 0619774, and American Heart Association Grant 0330193N.	ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; Berkels, 1999, J Cardiovasc Pharmacol Ther, V4, P175, DOI 10.1177/107424849900400307; Berkels R, 2003, PHARMACOLOGY, V69, P171, DOI 10.1159/000073659; Bior AD, 2007, J THROMB HAEMOST, V5, P403, DOI 10.1111/j.1538-7836.2007.02352.x; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Chajkowski SM, 2011, BIOCHEM BIOPH RES CO, V405, P338, DOI 10.1016/j.bbrc.2010.12.036; COLDENSTANFIELD M, 1987, CIRC RES, V61, P632, DOI 10.1161/01.RES.61.5.632; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Dedio J, 1996, FEBS LETT, V399, P255, DOI 10.1016/S0014-5793(96)01339-7; DOLOR RJ, 1992, AM J PHYSIOL, V262, pC171, DOI 10.1152/ajpcell.1992.262.1.C171; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fernando AN, 2005, AM J PHYSIOL-HEART C, V289, pH251, DOI 10.1152/ajpheart.00206.2004; Gryglewski RJ, 2002, PEDIATR PATHOL MOL M, V21, P279, DOI 10.1080/02770930290056514; HASAN AAK, 1994, J BIOL CHEM, V269, P31822; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Imamura T, 1996, LAB INVEST, V74, P861; Isordia-Salas I, 2005, ARCH MED RES, V36, P87, DOI 10.1016/j.arcmed.2005.02.001; Isordia-Salas I, 2002, INT IMMUNOPHARMACOL, V2, P1895, DOI 10.1016/S1567-5769(02)00183-2; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Joseph K, 1999, CLIN IMMUNOL, V92, P246, DOI 10.1006/clim.1999.4753; Lombardi AM, 2003, THROMB HAEMOSTASIS, V90, P1040, DOI 10.1160/TH03-05-0275; Ma JX, 1996, EXP EYE RES, V63, P19, DOI 10.1006/exer.1996.0087; Mahdi F, 2004, J BIOL CHEM, V279, P16621, DOI 10.1074/jbc.M313850200; Mashiko H, 1999, IMMUNOPHARMACOLOGY, V45, P103, DOI 10.1016/S0162-3109(99)00061-2; McGinnis KM, 1998, J NEUROCHEM, V70, P139; MURPHY HS, 1994, AM J PHYSIOL, V267, pL145, DOI 10.1152/ajplung.1994.267.2.L145; Nakazawa Y, 2002, INT IMMUNOPHARMACOL, V2, P1875, DOI 10.1016/S1567-5769(02)00182-0; Ngo ML, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-3; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Nilius B, 1997, ANNU REV PHYSIOL, V59, P145, DOI 10.1146/annurev.physiol.59.1.145; OCONNOR ER, 1993, J NEUROSCI, V13, P2638, DOI 10.1523/JNEUROSCI.13-06-02638.1993; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; PATRASSI G M, 1982, Folia Haematologica (Leipzig), V109, P644; Perkins R, 2008, BIOCHEM BIOPH RES CO, V366, P938, DOI 10.1016/j.bbrc.2007.12.042; Pixley RA, 2011, THROMB HAEMOSTASIS, V105, P1053, DOI 10.1160/TH10-09-0591; POON MC, 1982, AM J HEMATOL, V12, P261, DOI 10.1002/ajh.2830120308; Sainz IM, 2005, ARTHRITIS RHEUM-US, V52, P2549, DOI 10.1002/art.21202; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SAUVE R, 1990, J HYPERTENS, V8, pS193; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Shariat-Madar Z, 1999, TRENDS CARDIOVAS MED, V9, P238, DOI 10.1016/S1050-1738(00)00028-1; Shariat-Madar Z, 1999, J BIOL CHEM, V274, P7137, DOI 10.1074/jbc.274.11.7137; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; Takano M, 1997, BBA-GENE STRUCT EXPR, V1352, P222, DOI 10.1016/S0167-4781(97)00018-3; UENO A, 1995, BRIT J PHARMACOL, V114, P1250, DOI 10.1111/j.1476-5381.1995.tb13340.x; White PJ, 1996, J EXP BOT, V47, P713, DOI 10.1093/jxb/47.5.713; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	51	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24561	24571		10.1074/jbc.M110.211557	http://dx.doi.org/10.1074/jbc.M110.211557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586566	Green Published, hybrid			2022-12-25	WOS:000292547900006
J	Singh, RP; Prasad, HK; Sinha, I; Agarwal, N; Natarajan, K				Singh, Rana Pratap; Prasad, Himanshu K.; Sinha, Ishani; Agarwal, Neha; Natarajan, Krishnamurthy			Cap2-HAP Complex Is a Critical Transcriptional Regulator That Has Dual but Contrasting Roles in Regulation of Iron Homeostasis in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-BINDING FACTOR; YEAST SCHIZOSACCHAROMYCES-POMBE; FACTOR NF-Y; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; OXIDATIVE STRESS; FISSION YEAST; DNA-BINDING; MULTIDRUG-RESISTANCE; BIOLOGICAL NETWORKS	Iron homeostasis is highly regulated in organisms across evolutionary time scale as iron is essential for various cellular processes. In a computational screen, we identified the Yap/bZIP domain family in Candida clade genomes. Cap2/Hap43 is essential for C. albicans growth under iron-deprivation conditions and for virulence in mouse. Cap2 has an amino-terminal bipartite domain comprising a fungal-specific Hap4-like domain and a bZIP domain. Our mutational analyses showed that both the bZIP and Hap4-like domains perform critical and independent functions for growth under iron-deprivation conditions. Transcriptome analysis conducted under iron-deprivation conditions identified about 16% of the C. albicans ORFs that were differentially regulated in a Cap2-dependent manner. Microarray data also suggested that Cap2 is required to mobilize iron through multiple mechanisms; chiefly by activation of genes in three iron uptake pathways and repression of iron utilizing and iron storage genes. The expression of HAP2, HAP32, and HAP5, core components of the HAP regulatory complex was induced in a Cap2-dependent manner indicating a feed-forward loop. In a feed-back loop, Cap2 repressed the expression of Sfu1, a negative regulator of iron uptake genes. Cap2 was coimmunoprecipitated with Hap5 from cell extracts prepared from iron-deprivation conditions indicating an in vivo association. ChIP assays demonstrated Hap32-dependent recruitment of Hap5 to the promoters of FRP1 (Cap2-induced) and ACO1 (Cap2-repressed). Together our data indicates that the Cap2-HAP complex functions both as a positive and a negative regulator to maintain iron homeostasis in C. albicans.	[Singh, Rana Pratap; Prasad, Himanshu K.; Sinha, Ishani; Agarwal, Neha; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	nat0200@mail.jnu.ac.in		Singh, Rana Pratap/0000-0003-4261-7044	Department of Biotechnology, Ministry of Science and Technology, Government of India; Jawaharlal Nehru University; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Jawaharlal Nehru University; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India, and the UPOE and DST-PURSE grants from Jawaharlal Nehru University.; Supported by Junior and Senior Research Fellowships from Council of Scientific and Industrial Research, New Delhi.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; BOWTELL D, 2003, DNA MICROARRAYS MOL; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; De Freitas JM, 2000, J BIOL CHEM, V275, P11645, DOI 10.1074/jbc.275.16.11645; Fairhead C, 1996, YEAST, V12, P1439; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Hu CJ, 2002, J BIOL CHEM, V277, P30598, DOI 10.1074/jbc.M204545200; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Knight SAB, 2005, INFECT IMMUN, V73, P5482, DOI 10.1128/IAI.73.9.5482-5492.2005; Knight SAB, 2002, MICROBIOL-SGM, V148, P29, DOI 10.1099/00221287-148-1-29; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Liang Y, 2010, MICROBIOL-SGM, V156, P2912, DOI 10.1099/mic.0.037978-0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Natarajan K., 2007, METHODS GEN MOL MICR, P978; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; PU WT, 1991, MOL CELL BIOL, V11, P4918, DOI 10.1128/MCB.11.10.4918; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Santos R, 2004, MOL MICROBIOL, V54, P507, DOI 10.1111/j.1365-2958.2004.04281.x; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yang XS, 2001, YEAST, V18, P1217, DOI 10.1002/yea.770; Yatskou Mikalai, 2008, BMC Res Notes, V1, P80, DOI 10.1186/1756-0500-1-80; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	82	68	933	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25154	25170		10.1074/jbc.M111.233569	http://dx.doi.org/10.1074/jbc.M111.233569			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592964	Green Published, hybrid			2022-12-25	WOS:000292547900063
J	Yu, W; Chiaw, PK; Bear, CE				Yu, Wilson; Chiaw, Patrick Kim; Bear, Christine E.			Probing Conformational Rescue Induced by a Chemical Corrector of F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; CYSTIC-FIBROSIS; DELTA-F508 MUTATION; PROCESSING MUTANTS; CHANNEL FUNCTION; TRAFFICKING; IDENTIFICATION; BINDING; MATURATION; STABILITY	Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that cause loss of function of the CFTR channel on the apical surface of epithelial cells. The major CF-causing mutation, F508del-CFTR, is misfolded, retained in the endoplasmic reticulum, and degraded. Small molecule corrector compounds have been identified using high throughput screens, which partially rescue the trafficking defect of F508del-CFTR, allowing a fraction of the mutant protein to escape endoplasmic reticulum retention and traffic to the plasma membrane, where it exhibits partial function as a cAMP-regulated chloride channel. A subset of such corrector compounds binds directly to the mutant protein, prompting the hypothesis that they rescue the biosynthetic defect by inducing improved protein conformation. We tested this hypothesis directly by evaluating the consequences of a corrector compound on the conformation of each nucleotide binding domain (NBD) in the context of the full-length mutant protein in limited proteolytic digest studies. Interestingly, we found that VRT-325 was capable of partially restoring compactness in NBD1. However, VRT-325 had no detectable effect on the conformation of the second half of the molecule. In comparison, ablation of the di-arginine sequence, (RXR555)-X-553 (F508del-KXK-CFTR), modified protease susceptibility of NBD1, NBD2, and the full-length protein. Singly, each intervention led to a partial correction of the processing defect. Together, these interventions restored processing of F508del-CFTR to near wild type. Importantly, however, a defect in NBD1 conformation persisted, as did a defect in channel activation after the combined interventions. Importantly, this defect in channel activation can be fully corrected by the addition of the potentiator, VX-770.	[Yu, Wilson; Chiaw, Patrick Kim; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, Toronto, ON M5G 1X8, Canada; [Chiaw, Patrick Kim; Bear, Christine E.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Chiaw, Patrick Kim; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Yu, Wilson; Bear, Christine E.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, 555 Univ Ave,Rm 3203B, Toronto, ON M5G 1X8, Canada.	bear@sickkids.ca	yu, wilson/I-1292-2014; yu, wilson/AAC-8459-2021	yu, wilson/0000-0002-4030-1620; yu, wilson/0000-0002-7743-0872	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR); Cystic Fibrosis Foundation	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	*This work was supported by operating grants from the Cystic Fibrosis Canada (CFC), the Canadian Institutes of Health Research (CIHR), and the Cystic Fibrosis Foundation (to C. E. B.).	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Kartner N, 1998, METHOD ENZYMOL, V292, P629; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	46	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24714	24725		10.1074/jbc.M111.239699	http://dx.doi.org/10.1074/jbc.M111.239699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602569	Green Published, hybrid			2022-12-25	WOS:000292547900022
J	Lu, JP; Wang, Y; Sliter, DA; Pearce, MMP; Wojcikiewicz, RJH				Lu, Justine P.; Wang, Yuan; Sliter, Danielle A.; Pearce, Margaret M. P.; Wojcikiewicz, Richard J. H.			RNF170 Protein, an Endoplasmic Reticulum Membrane Ubiquitin Ligase, Mediates Inositol 1,4,5-Trisphosphate Receptor Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; PATHWAY; COMPLEX; CELLS; ER	Inositol 1,4,5-trisphosphate (IP3) receptors are endoplasmic reticulum membrane calcium channels that, upon activation, are degraded via the ubiquitin-proteasome pathway. While searching for novel mediators of IP3 receptor processing, we discovered that RNF170, an uncharacterized RING domain-containing protein, associates rapidly with activated IP3 receptors. RNF170 is predicted to have three membrane-spanning helices, is localized to the ER membrane, and possesses ubiquitin ligase activity. Depletion of endogenous RNF170 by RNA interference inhibited stimulus-induced IP3 receptor ubiquitination, and degradation and overexpression of a catalytically inactive RNF170 mutant suppressed stimulus-induced IP3 receptor processing. A substantial proportion of RNF170 is constitutively associated with the erlin1/2 (SPFH1/2) complex, which has been shown previously to bind to IP3 receptors immediately after their activation. Depletion of RNF170 did not affect the binding of the erlin1/2 complex to stimulated IP3 receptors, whereas erlin1/2 complex depletion inhibited RNF170 binding. These results suggest a model in which the erlin1/2 complex recruits RNF170 to activated IP3 receptors where it mediates IP3 receptor ubiquitination. Thus, RNF170 plays an essential role in IP3 receptor processing via the ubiquitin-proteasome pathway.	[Lu, Justine P.; Wang, Yuan; Sliter, Danielle A.; Pearce, Margaret M. P.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Panning Pearce, Margaret/0000-0002-5846-9632	National Institutes of Health [DK049194]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194, R01DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK049194.	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; BEZPROZVANNY I, 2011, NEUROCHEM R IN PRESS; Darom A, 2010, MOL BIOL CELL, V21, P1788, DOI 10.1091/mbc.E09-09-0774; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; KAHN MT, 2003, BIOCHEM J, V375, P603; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Maruyama Y, 2008, BIOCHEM BIOPH RES CO, V374, P737, DOI 10.1016/j.bbrc.2008.07.126; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Ogawa M, 2008, GENES CELLS, V13, P397, DOI 10.1111/j.1365-2443.2008.01169.x; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Peng Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-41; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhu CC, 2000, BIOCHEM J, V348, P551, DOI 10.1042/0264-6021:3480551	30	63	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24426	24433		10.1074/jbc.M111.251983	http://dx.doi.org/10.1074/jbc.M111.251983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21610068	Green Published, hybrid			2022-12-25	WOS:000292294900082
J	Patel, SJ; Jindal, R; King, KR; Tilles, AW; Yarmush, ML				Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.			The Inflammatory Response to Double Stranded DNA in Endothelial Cells Is Mediated by NF kappa B and TNF alpha	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; INTRACELLULAR DNA; BACTERIAL-DNA; RECOGNITION; EXPRESSION; INFECTION; DISEASE; VIRUS; AIM2; ACTIVATION	Endothelial cells represent an important barrier between the intravascular compartment and extravascular tissues, and therefore serve as key sensors, communicators, and amplifiers of danger signals in innate immunity and inflammation. Double stranded DNA (dsDNA) released from damaged host cells during injury or introduced by pathogens during infection, has emerged as a potent danger signal. While the dsDNA-mediated immune response has been extensively studied in immune cells, little is known about the direct and indirect effects of dsDNA on the vascular endothelium. In this study we show that direct dsDNA stimulation of endothelial cells induces a potent proinflammatory response as demonstrated by increased expression of ICAM1, E-selectin and VCAM1, and enhanced leukocyte adhesion. This response was dependent on the stress kinases JNK and p38 MAPK, required the activation of proinflammatory transcription factors NF kappa B and IRF3, and triggered the robust secretion of TNF alpha for sustained secondary activation of the endothelium. DNA-induced TNF alpha secretion proved to be essential in vivo, as mice deficient in the TNF receptor were unable to mount an acute inflammatory response to dsDNA. Our findings suggest that the endothelium plays an active role in mediating dsDNA-induced inflammatory responses, and implicate its importance in establishing an acute inflammatory response to sterile injury or systemic infection, where host or pathogen derived dsDNA may serve as a danger signal.	[Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Shriners Burns Hosp, Boston, MA USA; [Patel, Suraj J.; Yarmush, Martin L.] Harvard Univ, MIT, Sch Med, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jindal, Rohit; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Patel, SJ (corresponding author), Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA.	ireis@sbi.org		Yarmush, Martin/0000-0003-4986-8444	Department of Defense CDMRP; NIH BioMEMS Resource Center [P41 EB-002503]; NIH [RO1AI063795]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	Department of Defense CDMRP(United States Department of Defense); NIH BioMEMS Resource Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	SJP was supported in part by a Department of Defense CDMRP Predoctoral Training Award. The work was supported by NIH BioMEMS Resource Center Grant P41 EB-002503, NIH Grant RO1AI063795, and a grant from the Shriners Hospital for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; GERSON SL, 1985, J CLIN INVEST, V76, P1382, DOI 10.1172/JCI112114; Grundy JE, 1998, J INFECT DIS, V177, P1465, DOI 10.1086/515300; Heidemann J, 2006, INFECT IMMUN, V74, P5425, DOI 10.1128/IAI.00248-06; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jindal R, 2011, TISSUE ENG PART C-ME, V17, P113, DOI [10.1089/ten.tec.2009.0782, 10.1089/ten.TEC.2009.0782]; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; JONES K, 1995, J EXP MED, V182, P1213, DOI 10.1084/jem.182.5.1213; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuvin JT, 2003, CIRCULATION, V107, P3243, DOI 10.1161/01.CIR.0000075928.54461.33; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Rafii S, 2001, CIRC RES, V88, P903, DOI 10.1161/hh0901.089884; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; VANE JR, 1990, NEW ENGL J MED, V323, P27; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wieder KJ, 2005, BIOMED MICRODEVICES, V7, P213, DOI 10.1007/s10544-005-3028-3; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19910	10.1371/journal.pone.0019910	http://dx.doi.org/10.1371/journal.pone.0019910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611132	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200046
J	Da Lage, JL; Maczkowiak, F; Cariou, ML				Da Lage, Jean-Luc; Maczkowiak, Frederique; Cariou, Marie-Louise			Phylogenetic Distribution of Intron Positions in AlphaAmylase Genes of Bilateria Suggests Numerous Gains and Losses	PLOS ONE			English	Article							AMYLASE MULTIGENE FAMILY; SPLICEOSOMAL INTRONS; MOLECULAR PHYLOGENY; DIVERGENCE TIMES; AMYREL GENE; RICH GENES; EVOLUTION; EXON; SEQUENCE; GENOME	Most eukaryotes have at least some genes interrupted by introns. While it is well accepted that introns were already present at moderate density in the last eukaryote common ancestor, the conspicuous diversity of intron density among genomes suggests a complex evolutionary history, with marked differences between phyla. The question of the rates of intron gains and loss in the course of evolution and factors influencing them remains controversial. We have investigated a single gene family, alpha-amylase, in 55 species covering a variety of animal phyla. Comparison of intron positions across phyla suggests a complex history, with a likely ancestral intronless gene undergoing frequent intron loss and gain, leading to extant intron/exon structures that are highly variable, even among species from the same phylum. Because introns are known to play no regulatory role in this gene and there is no alternative splicing, the structural differences may be interpreted more easily: intron positions, sizes, losses or gains may be more likely related to factors linked to splicing mechanisms and requirements, and to recognition of introns and exons, or to more extrinsic factors, such as life cycle and population size. We have shown that intron losses outnumbered gains in recent periods, but that "resets'' of intron positions occurred at the origin of several phyla, including vertebrates. Rates of gain and loss appear to be positively correlated. No phase preference was found. We also found evidence for parallel gains and for intron sliding. Presence of introns at given positions was correlated to a strong protosplice consensus sequence AG/G, which was much weaker in the absence of intron. In contrast, recent intron insertions were not associated with a specific sequence. In animal Amy genes, population size and generation time seem to have played only minor roles in shaping gene structures.	[Da Lage, Jean-Luc; Maczkowiak, Frederique; Cariou, Marie-Louise] CNRS, UPR 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Maczkowiak, Frederique] Univ Paris 11, Inst Curie, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Da Lage, JL (corresponding author), CNRS, UPR 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France.	jldl@legs.cnrs-gif.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was funded by regular annual funding from the CNRS (www.cnrs.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Ahmadinejad N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-57; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; BASU MK, 2007, MOL BIOL EV IN PRESS; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BREATHNACH R, 1977, NATURE, V270, P314, DOI 10.1038/270314a0; BROWN CJ, 1990, GENETICS, V126, P131; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CAVALIERSMITH T, 2006, PHILOS T ROYAL SOC, V361; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Coulombe-Huntington J, 2008, INTRON LOSS GAIN EUK; Coulombe-Huntington J, 2007, MOL BIOL EVOL, V24, P2842, DOI 10.1093/molbev/msm235; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Da Lage JL, 2007, FEBS LETT, V581, P3927, DOI 10.1016/j.febslet.2007.07.019; Da Lage JL, 2002, BIOLOGIA, V57, P181; Da Lage JL, 2003, J MOL EVOL, V57, P355, DOI 10.1007/s00239-003-2488-4; DaLage JL, 1996, J MOL EVOL, V43, P334, DOI 10.1007/PL00006093; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; DENOEUD F, 2010, SCIENCE; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Doddapaneni H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-92; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drouin G, 1997, J MOL EVOL, V45, P509, DOI 10.1007/PL00006255; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Edvardsen RB, 2004, J MOL EVOL, V59, P448, DOI 10.1007/s00239-004-2636-5; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Feiber AL, 2002, J MOL EVOL, V55, P401, DOI 10.1007/s00239-002-2336-y; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Frugoli JA, 1998, GENETICS, V149, P355; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Grimaldi David, 2005, pi; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; Hager KP, 1996, FEBS LETT, V387, P94, DOI 10.1016/0014-5793(96)00477-2; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HUANG N, 1992, P NATL ACAD SCI USA, V89, P7526, DOI 10.1073/pnas.89.16.7526; JANECEK S, 1994, EUR J BIOCHEM, V224, P519, DOI 10.1111/j.1432-1033.1994.00519.x; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Knowles DG, 2006, MOL BIOL EVOL, V23, P1548, DOI 10.1093/molbev/msl017; KOONIN EV, 2006, BIOL DIRECT, V1, DOI DOI 10.1186/1745-6150-1181-1122; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Krzywinski J, 2002, MOL BIOL EVOL, V19, P362, DOI 10.1093/oxfordjournals.molbev.a004091; Kvist AP, 1999, MATRIX BIOL, V18, P261, DOI 10.1016/S0945-053X(99)00018-9; Lecointre G., 2017, CLASSIFICATION PHYLO; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; LOH TH, 2008, MOL BIOL EVOL, V25, P526; Long MY, 2000, MOL BIOL EVOL, V17, P1789, DOI 10.1093/oxfordjournals.molbev.a026279; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, ORIGINS GENOME ARCHI; Maczkowiak F, 2006, GENETICA, V128, P145, DOI 10.1007/s10709-005-5578-y; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Matthews CM, 1998, J MOL EVOL, V47, P763, DOI 10.1007/PL00006435; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; RAGG H, 2010, CELLULAR MOL LIFE SC; RAGG H, 2009, BMC EVOLUTIONARY BIO, V9, DOI DOI 10.1186/1471-2148/1189/1208; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; Roy SW, 2006, TRENDS GENET, V22, P468, DOI 10.1016/j.tig.2006.07.002; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schmitt DM, 2001, J MOL EVOL, V53, P703, DOI 10.1007/s002390010257; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stoltzfus A, 2004, CURR BIOL, V14, pR351, DOI 10.1016/j.cub.2004.04.024; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Sullivan James C, 2006, Genome Inform, V17, P219; SUTLIFF TD, 1991, PLANT MOL BIOL, V16, P579, DOI 10.1007/BF00023423; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Sverdlov AV, 2004, GENE, V338, P85, DOI 10.1016/j.gene.2004.05.027; Sverdlov AV, 2004, CURR BIOL, V14, P1505, DOI 10.1016/j.cub.2004.08.027; Sverdlov AV, 2003, CURR BIOL, V13, P2170, DOI 10.1016/j.cub.2003.12.003; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinogradov AE, 2001, J MOL EVOL, V52, P2, DOI 10.1007/s002390010128; Wada H, 2002, J MOL EVOL, V54, P118, DOI 10.1007/s00239-001-0024-y; WALCHLI C, 1992, EUR J BIOCHEM, V205, P583, DOI 10.1111/j.1432-1033.1992.tb16816.x; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Zhang Z, 2003, J MOL EVOL, V56, P121, DOI 10.1007/s00239-002-2384-3	116	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19673	10.1371/journal.pone.0019673	http://dx.doi.org/10.1371/journal.pone.0019673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611157	Green Published, Green Submitted, gold			2022-12-25	WOS:000290657500011
J	Moura-Alves, P; Neves-Costa, A; Raquel, H; Pacheco, TR; D'Almeida, B; Rodrigues, R; Cadima-Couto, I; Chora, A; Oliveira, M; Gama-Carvalho, M; Hacohen, N; Moita, LF				Moura-Alves, Pedro; Neves-Costa, Ana; Raquel, Helena; Pacheco, Teresa Raquel; D'Almeida, Bruno; Rodrigues, Raquel; Cadima-Couto, Iris; Chora, Angelo; Oliveira, Mariana; Gama-Carvalho, Margarida; Hacohen, Nir; Moita, Luis F.			An shRNA-Based Screen of Splicing Regulators Identifies SFRS3 as a Negative Regulator of IL-1 beta Secretion	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; SIGNALING PATHWAY; IMMUNE-RESPONSES; INFLAMMASOME; ACTIVATION; RECEPTOR; RIBONUCLEOPROTEIN; TRANSCRIPTION; CONSEQUENCES; SPLICEOSOME	The generation of diversity and plasticity of transcriptional programs are key components of effective vertebrate immune responses. The role of Alternative Splicing has been recognized, but it is underappreciated and poorly understood as a critical mechanism for the regulation and fine-tuning of physiological immune responses. Here we report the generation of loss-of-function phenotypes for a large collection of genes known or predicted to be involved in the splicing reaction and the identification of 19 novel regulators of IL-1 beta secretion in response to E. coli challenge of THP-1 cells. Twelve of these genes are required for IL-1 beta secretion, while seven are negative regulators of this process. Silencing of SFRS3 increased IL-1 beta secretion due to elevation of IL-1 beta and caspase-1 mRNA in addition to active caspase-1 levels. This study points to the relevance of splicing in the regulation of auto-inflammatory diseases.	[Moura-Alves, Pedro; Neves-Costa, Ana; Raquel, Helena; Pacheco, Teresa Raquel; D'Almeida, Bruno; Rodrigues, Raquel; Cadima-Couto, Iris; Chora, Angelo; Moita, Luis F.] Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal; [Oliveira, Mariana; Gama-Carvalho, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Func & Integrat BioFIG, Lisbon, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA USA; [Hacohen, Nir] MIT & Harvard, Broad Inst, Cambridge, MA USA	Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Moura-Alves, P (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.	lmoita@fm.ul.pt	Moura-Alves, Pedro/R-7727-2016; Ferreira Chora, Angelo/AAZ-6503-2021; Moita, Luis F./L-1296-2013; Gama-Carvalho, Margarida/E-6180-2012; Carvalho, Margarida/GZA-4406-2022; Alves, Pedro Moura/AAX-6854-2020; Rodrigues, Raquel/GZM-7677-2022; Moita, Luis/HCI-2793-2022; Neves-Costa, Ana/AAJ-7066-2021	Moura-Alves, Pedro/0000-0003-4337-9113; Ferreira Chora, Angelo/0000-0002-7941-7196; Moita, Luis F./0000-0003-0707-315X; Gama-Carvalho, Margarida/0000-0002-0365-6916; Moita, Luis/0000-0003-0707-315X; Neves-Costa, Ana/0000-0001-6506-7829; Rodrigues, Raquel/0000-0002-7557-1815; Pacheco, Teresa/0000-0002-5506-0233; Raquel, Helena/0000-0001-6008-6852	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/100780/2008, PIC/IC/82991/2007]	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	L.F.M. is a Young Investigator from the Human Frontier Science Program (www.hfsp.org) and receives support from Fundacao Luso-Americana para o Desenvolvimento (http://www.flad.pt/) and Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/); (PTDC/SAU-MII/100780/2008 and PIC/IC/82991/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraldi PG, 2003, J MED CHEM, V46, P1318, DOI 10.1021/jm021049d; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MISHRA BB, CELL MICROBIOL; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; NETEA MG, PLOS PATHOG, V6; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; SIMS GP, ANN REV IMMUNOL, V28, P367; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Swiggard WJ., 2001, CURR PROTOC IMMUNOL, V86, P1, DOI [DOI 10.1002/0471142735.IM0307S25, 10.1002/0471142735.im0307s25]; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WEINTZ G, MOL SYST BIOL, V6, P371; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19829	10.1371/journal.pone.0019829	http://dx.doi.org/10.1371/journal.pone.0019829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611201	Green Submitted, Green Published, gold			2022-12-25	WOS:000290657500027
J	Tian, LC; Yang, PZ; Lei, B; Shao, J; Wang, CK; Xiang, Q; Wei, L; Peng, ZG; Kijlstra, A				Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui; Kijlstra, Aize			AAV2-Mediated Subretinal Gene Transfer of hIFN-alpha Attenuates Experimental Autoimmune Uveoretinitis in Mice	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; LEBERS CONGENITAL AMAUROSIS; REDUCES LYSOSOMAL STORAGE; IMPROVES RETINAL FUNCTION; INTERFERON-ALPHA; VII MICE; IN-VIVO; THERAPY; UVEITIS; SAFETY	Background: Recent reports show that gene therapy may provide a long-term, safe and effective intervention for human diseases. In this study, we investigated the effectiveness of adeno-associated virus 2 (AAV2) based human interferon-alpha (hIFN-alpha) gene therapy in experimental autoimmune uveoretinitis (EAU), a classic model for human uveitis. Methodology/Principal Findings: An AAV2 vector harboring the hIFN-alpha gene (AAV2.hIFN-alpha) was subretinally injected into B10RIII mice at two doses (1.5x10(6) vg, 1.5x10(8) vg). AAV2 vector encoding green fluorescent protein (AAV2.GFP) was used as a control (5x10(8) vg). The expression of hIFN-alpha in homogenized eyes and serum was detected by ELISA three weeks after injection. The biodistribution of vector DNA in the injected eyes, contralateral eyes and distant organs was determined by PCR. EAU was induced by immunization with IRBP(161-180) three weeks following vector injections, and evaluated clinically and pathologically. IRBP-specific proliferation and IL-17 expression of lymphocytes from the spleen and lymph nodes were assayed to test the influence of the subretinal delivery of AAV2. hIFN-alpha on the systemic immune response. hIFN-alpha was effectively expressed in the eyes from three weeks to three months following subretinal injection of AAV2. hIFN-alpha vector. DNA of AAV2.GFP was observed only in the injected eyes, but not in the distant organs or contralateral eyes. Subretinal injection of both doses significantly attenuated EAU activity clinically and histologically. For the lower dose, there was no difference concerning lymphocyte proliferation and IL-17 production among the AAV2.hIFN-alpha, AAV2.GFP and PBS injected mice. However, the higher dose of AAV2.hIFN-alpha significantly suppressed lymphocyte proliferation and IL-17 production. Conclusions/Significance: Subretinal delivery of AAV2.hIFN-alpha lead to an effective expression within the eye for at least three months and significantly attenuated EAU activity. AAV2.hIFN-alpha was shown to inhibit the systemic IRBP-specific immune response.	[Tian, Lichun] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Sun Yat Sen University; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Natural Science Foundation [30910103912]; National Basic Research Program of China (973 Program) [2011CB510200]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC)	This work was funded by Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), http://159.226.244.15/portal/Proj_List.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml; National Basic Research Program of China (973 Program) (2011CB510200), http://www.most.gov.cn/tztg/201010/W020101021511061090978.pdf; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037) http://www. ctin.ac.cn/Class.aspx?clsId = 226; Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), http://www.ctin.ac.cn/View.aspx?id = 14380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; CASPI RR, 2003, EXPT AUTOIMMUNE UVEO, pCH15; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Goldstein H, 1980, Adv Ophthalmol, V40, P1; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hennig AK, 2004, MOL THER, V10, P106, DOI 10.1016/j.ymthe.2004.03.018; Hennig AK, 2003, J NEUROSCI, V23, P3302; Imrie FR, 2007, CURR OPIN OPHTHALMOL, V18, P481, DOI 10.1097/ICU.0b013e3282f03d42; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Lai YKY, 2002, GENE THER, V9, P804, DOI 10.1038/sj.gt.3301695; Lei B, 2009, MOL VIS, V15, P1374; Li QH, 2008, MOL VIS, V14, P1760; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Rolling F, 2004, GENE THER, V11, pS26, DOI 10.1038/sj.gt.3302366; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; Sobaci G, 2010, OPHTHALMOLOGY, V117, P1430, DOI 10.1016/j.ophtha.2009.11.022; Srivastava A, 2010, CLIN CHIM ACTA, V411, P1165, DOI 10.1016/j.cca.2010.04.017; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; UCHIO E, 1994, INVEST OPHTH VIS SCI, V35, P2626; Wang W, 2008, CLIN CANCER RES, V14, P8314, DOI 10.1158/1078-0432.CCR-08-0705; Yang DSF, 2008, BRIT J HOSP MED, V69, P575, DOI 10.12968/hmed.2008.69.10.31317; Yeh Steven, 2007, Expert Rev Clin Immunol, V3, P781, DOI 10.1586/1744666X.3.5.781	33	26	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19542	10.1371/journal.pone.0019542	http://dx.doi.org/10.1371/journal.pone.0019542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611186	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500007
J	Premji, A; Rai, N; Nelson, A				Premji, Azra; Rai, Navjot; Nelson, Aimee			Area 5 Influences Excitability within the Primary Motor Cortex in Humans	PLOS ONE			English	Article							THETA-BURST-STIMULATION; POSTERIOR PARIETAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED POTENTIALS; INTERVAL INTRACORTICAL INHIBITION; FUNCTIONAL-ANATOMY; FRONTAL-CORTEX; RHESUS-MONKEY; MOVEMENT; CIRCUITS	In non-human primates, Brodmann's area 5 (BA 5) has direct connectivity with primary motor cortex (M1), is largely dedicated to the representation of the hand and may have evolved with the ability to perform skilled hand movement. Less is known about human BA 5 and its interaction with M1 neural circuits related to hand control. The present study examines the influence of BA 5 on excitatory and inhibitory neural circuitry within M1 bilaterally before and after continuous (cTBS), intermittent (iTBS), and sham theta-burst stimulation (sham TBS) over left hemisphere BA 5. Using single and paired-pulse TMS, measurements of motor evoked potentials (MEPs), short interval intracortical inhibition (SICI), and intracortical facilitation (ICF) were quantified for the representation of the first dorsal interosseous muscle. Results indicate that cTBS over BA 5 influences M1 excitability such that MEP amplitudes are increased bilaterally for up to one hour. ITBS over BA 5 results in an increase in MEP amplitude contralateral to stimulation with a delayed onset that persists up to one hour. SICI and ICF were unaltered following TBS over BA 5. Similarly, F-wave amplitude and latency were unaltered following cTBS over BA 5. The data suggest that BA 5 alters M1 output directed to the hand by influencing corticospinal neurons and not interneurons that mediate SICI or ICF circuitry. Targeting BA 5 via cTBS and iTBS is a novel mechanism to powerfully modulate activity within M1 and may provide an avenue for investigating hand control in healthy populations and modifying impaired hand function in clinical populations.	[Premji, Azra; Rai, Navjot; Nelson, Aimee] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Premji, A (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	ajnelson@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research is funded by the Natural Sciences and Engineering Research Council of Canada operating grant to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2003, J NEUROSCI, V23, P4689; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; CARDENASMORALES L, 2008, MECH APPL THETA BURS, P1; Chen R, 1997, NEUROLOGY, V49, P1054, DOI 10.1212/WNL.49.4.1054; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; COULTER JD, 1977, BRAIN RES, V129, P335, DOI 10.1016/0006-8993(77)90012-9; DI LV, 2006, J NEUROPHYSIOL, V96, P1765; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gardner EP, 2007, J NEUROPHYSIOL, V97, P387, DOI 10.1152/jn.00558.2006; Garey LJ, 1994, LOCALISATION CEREBRA; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Huang YZ, 2010, MOVEMENT DISORD, V25, P696, DOI 10.1002/mds.22814; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel FC, 2009, NEUROLOGY, V72, P1766, DOI 10.1212/WNL.0b013e3181a609c5; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Katayama T, 2007, CLIN NEUROPHYSIOL, V118, P2506, DOI 10.1016/j.clinph.2007.08.011; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Ni Z, 2007, J PHYSIOL-LONDON, V583, P971, DOI 10.1113/jphysiol.2007.135749; Orth M, 2009, J NEUROL NEUROSUR PS, V80, P29, DOI 10.1136/jnnp.2008.149484; Padberg J, 2005, CEREB CORTEX, V15, P1938, DOI 10.1093/cercor/bhi071; Padberg J, 2007, J NEUROSCI, V27, P10106, DOI 10.1523/JNEUROSCI.2632-07.2007; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Poreisz C, 2008, EXP BRAIN RES, V185, P611, DOI 10.1007/s00221-007-1188-5; Premji A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-91; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; Stoeckel MC, 2004, EUR J NEUROSCI, V19, P1067, DOI 10.1111/j.0953-816X.2004.03185.x; STRICK PL, 1978, BRAIN RES, V157, P325, DOI 10.1016/0006-8993(78)90035-5; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Talairach J., 1988, COPLANAR STEREOTAXIC; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P1815, DOI 10.1016/j.clinph.2007.05.062; Taoka M, 2000, EXP BRAIN RES, V134, P139, DOI 10.1007/s002210000464; Voller B, 2005, J NEUROPHYSIOL, V94, P1115, DOI 10.1152/jn.00333.2005; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006; ZARZECKI P, 1978, BRAIN RES, V157, P331, DOI 10.1016/0006-8993(78)90036-7; Zhang HQ, 2001, J NEUROPHYSIOL, V85, P1823, DOI 10.1152/jn.2001.85.5.1823	53	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20023	10.1371/journal.pone.0020023	http://dx.doi.org/10.1371/journal.pone.0020023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603571	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300048
J	Richter, F; Leaver-Fay, A; Khare, SD; Bjelic, S; Baker, D				Richter, Florian; Leaver-Fay, Andrew; Khare, Sagar D.; Bjelic, Sinisa; Baker, David			De Novo Enzyme Design Using Rosetta3	PLOS ONE			English	Article							TRIOSEPHOSPHATE ISOMERASE; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION	The Rosetta de novo enzyme design protocol has been used to design enzyme catalysts for a variety of chemical reactions, and in principle can be applied to any arbitrary chemical reaction of interest, The process has four stages: 1) choice of a catalytic mechanism and corresponding minimal model active site, 2) identification of sites in a set of scaffold proteins where this minimal active site can be realized, 3) optimization of the identities of the surrounding residues for stabilizing interactions with the transition state and primary catalytic residues, and 4) evaluation and ranking the resulting designed sequences. Stages two through four of this process can be carried out with the Rosetta package, while stage one needs to be done externally. Here, we demonstrate how to carry out the Rosetta enzyme design protocol from start to end in detail using for illustration the triosephosphate isomerase reaction.	[Richter, Florian; Khare, Sagar D.; Bjelic, Sinisa; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Richter, Florian; Baker, David] Univ Washington, Interdisciplinary Program Biomol Struct & Design, Seattle, WA 98195 USA; [Leaver-Fay, Andrew] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Richter, F (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	floric@u.washington.edu		Bjelic, Sinisa/0000-0002-9300-614X	Defense Advanced Reasearch Projects Agency (DARPA); Howard Hughes Medical Institute (HHMI)	Defense Advanced Reasearch Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	Defense Advanced Reasearch Projects Agency (DARPA), Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM J, 2008, J AM CHEM SOC, V130, P15361; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Guallar V, 2004, J MOL BIOL, V337, P227, DOI 10.1016/j.jmb.2003.11.016; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Khersonsky O, 2010, J MOL BIOL, V396, P1025, DOI 10.1016/j.jmb.2009.12.031; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang X, 2008, J ORG CHEM, V73, P889, DOI 10.1021/jo701974n	17	185	196	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19230	10.1371/journal.pone.0019230	http://dx.doi.org/10.1371/journal.pone.0019230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603656	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300004
J	Doretto, S; Malerba, M; Ramos, M; Ikrar, T; Kinoshita, C; De Mei, C; Tirotta, E; Xu, XM; Borrelli, E				Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Ikrar, Taruna; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Xu, Xiangmin; Borrelli, Emiliana			Oligodendrocytes as Regulators of Neuronal Networks during Early Postnatal Development	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NMDA-RECEPTOR; DEVELOPING CEREBELLUM; NEURITE OUTGROWTH; SYNAPSE ELIMINATION; CORTICAL-NEURONS; AXONAL GROWTH; GRANULE CELLS; PLASTICITY; ABLATION	Oligodendrocytes are the glial cells responsible for myelin formation. Myelination occurs during the first postnatal weeks and, in rodents, is completed during the third week after birth. Myelin ensures the fast conduction of the nerve impulse; in the adult, myelin proteins have an inhibitory role on axon growth and regeneration after injury. During brain development, oligodendrocytes precursors originating in multiple locations along the antero-posterior axis actively proliferate and migrate to colonize the whole brain. Whether the initial interactions between oligodendrocytes and neurons might play a functional role before the onset of myelination is still not completely elucidated. In this article, we addressed this question by transgenically targeted ablation of proliferating oligodendrocytes during cerebellum development. Interestingly, we show that depletion of oligodendrocytes at postnatal day 1 (P1) profoundly affects the establishment of cerebellar circuitries. We observed an impressive deregulation in the expression of molecules involved in axon growth, guidance and synaptic plasticity. These effects were accompanied by an outstanding increase of neurofilament staining observed 4 hours after the beginning of the ablation protocol, likely dependent from sprouting of cerebellar fibers. Oligodendrocyte ablation modifies localization and function of ionotropic glutamate receptors in Purkinje neurons. These results show a novel oligodendrocyte function expressed during early postnatal brain development, where these cells participate in the formation of cerebellar circuitries, and influence its development.	[Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, INSERM UCI U904, Irvine, CA 92717 USA; [Ikrar, Taruna; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Doretto, S (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	borrelli@uci.edu	Ikrar, Taruna/I-3357-2014; Kinoshita, Chisato/AAW-5116-2020; Borrelli, Emiliana/M-8994-2018	Kinoshita, Chisato/0000-0001-5877-0196; 	Institut National de la Sante et de la Recherche Medicale; ARSEP; ACI; UCI; NIH [DA-023700, DA-023700-04S1]; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ARSEP; ACI; UCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the Institut National de la Sante et de la Recherche Medicale, ARSEP, ACI and UCI (to E. B.) and NIH (DA-023700 and DA-023700-04S1 to X. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; CHEDOTAL A, 1993, DEV BRAIN RES, V76, P207, DOI 10.1016/0165-3806(93)90209-S; Collin L, 2004, P NATL ACAD SCI USA, V101, P325, DOI 10.1073/pnas.0305994101; Collin L, 2007, EXP CELL RES, V313, P2946, DOI 10.1016/j.yexcr.2007.05.003; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; DELASSALLE A, 1981, J NEUROSCI RES, V6, P303, DOI 10.1002/jnr.490060305; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Goldowitz D, 2000, J NEUROSCI, V20, P4129; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hu FH, 2004, SEMIN PERINATOL, V28, P371, DOI 10.1053/j.semperi.2004.10.001; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Hulo S, 2002, EUR J NEUROSCI, V15, P1976, DOI 10.1046/j.1460-9568.2002.02026.x; Jackson RE, 2009, CURR BIOL, V19, pR504, DOI 10.1016/j.cub.2009.04.055; KANEKO T, 1989, NEUROSCIENCE, V32, P79, DOI 10.1016/0306-4522(89)90109-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Mathis C, 2003, DEVELOPMENT, V130, P4709, DOI 10.1242/dev.00675; Mathis C, 2001, DEVELOPMENT, V128, P4881; Mathis C, 2000, J NEUROSCI, V20, P7698; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; Rabacchi SA, 1999, J NEUROSCI, V19, P4437; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	44	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19849	10.1371/journal.pone.0019849	http://dx.doi.org/10.1371/journal.pone.0019849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589880	Green Published, gold			2022-12-25	WOS:000290531100031
J	Sung, HJ; Ma, WZ; Starost, MF; Lago, CU; Lim, PK; Sack, MN; Kang, JG; Wang, PY; Hwang, PM				Sung, Ho Joong; Ma, Wenzhe; Starost, Matthew F.; Lago, Cory U.; Lim, Philip K.; Sack, Michael N.; Kang, Ju-Gyeong; Wang, Ping-yuan; Hwang, Paul M.			Ambient Oxygen Promotes Tumorigenesis	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; DNA-DAMAGE; MITOCHONDRIAL-FUNCTION; ANTIOXIDANT DEFENSE; LIFE-SPAN; CANCER; HYPEROXIA; MICE; REQUIREMENT; HYPOXIA	Oxygen serves as an essential factor for oxidative stress, and it has been shown to be a mutagen in bacteria. While it is well established that ambient oxygen can also cause genomic instability in cultured mammalian cells, its effect on de novo tumorigenesis at the organismal level is unclear. Herein, by decreasing ambient oxygen exposure, we report a similar to 50% increase in the median tumor-free survival time of p53-/- mice. In the thymus, reducing oxygen exposure decreased the levels of oxidative DNA damage and RAG recombinase, both of which are known to promote lymphomagenesis in p53-/- mice. Oxygen is further shown to be associated with genomic instability in two additional cancer models involving the APC tumor suppressor gene and chemical carcinogenesis. Together, these observations represent the first report directly testing the effect of ambient oxygen on de novo tumorigenesis and provide important physiologic evidence demonstrating its critical role in increasing genomic instability in vivo.	[Sung, Ho Joong; Ma, Wenzhe; Starost, Matthew F.; Lago, Cory U.; Lim, Philip K.; Sack, Michael N.; Kang, Ju-Gyeong; Wang, Ping-yuan; Hwang, Paul M.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Sung, Ho Joong] Eulji Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Gyeonggi Do, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Eulji University	Sung, HJ (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov	lim, philip/AAY-1053-2021	lim, philip/0000-0003-3947-090X	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006051] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004630; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; [Anonymous], 2002, HIST PHIL LIFE SCI; Bardia A, 2008, MAYO CLIN PROC, V83, P23, DOI 10.4065/83.1.23; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; BRUYNINCKX WJ, 1978, NATURE, V274, P606, DOI 10.1038/274606a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cooper HS, 2005, MOL CARCINOGEN, V44, P31, DOI 10.1002/mc.20114; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hochachka PW, 1998, J EXP BIOL, V201, P1243; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Kulkarni A, 2008, AM J PHYSIOL-LUNG C, V294, pL998, DOI 10.1152/ajplung.00004.2008; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; LINDENSCHMIDT RC, 1986, CANCER RES, V46, P1994; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; LUONGO C, 1994, CANCER RES, V54, P5947; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Spector LG, 2005, J PEDIATR-US, V147, P27, DOI 10.1016/j.jpeds.2005.03.008; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stucker M, 2002, J PHYSIOL-LONDON, V538, P985, DOI 10.1013/jphysiol.2001.013067; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Uchida K, 1998, ZOOL SCI, V15, P703, DOI 10.2108/zsj.15.703; Unt E, 2008, J SPORT SCI MED, V7, P344; VAUPEL P, 1989, CANCER RES, V49, P6449; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265; Welford SM, 2010, MOL CELL BIOL, V30, P4595, DOI 10.1128/MCB.01618-09	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19785	10.1371/journal.pone.0019785	http://dx.doi.org/10.1371/journal.pone.0019785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589870	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100026
J	Vigouroux, Y; Mariac, C; De Mita, S; Pham, JL; Gerard, B; Kapran, I; Sagnard, F; Deu, M; Chantereau, J; Ali, A; Ndjeunga, J; Luong, V; Thuillet, AC; Saidou, AA; Bezancon, G				Vigouroux, Yves; Mariac, Cedric; De Mita, Stephane; Pham, Jean-Louis; Gerard, Bruno; Kapran, Issoufou; Sagnard, Fabrice; Deu, Monique; Chantereau, Jacques; Ali, Abdou; Ndjeunga, Jupiter; Luong, Viviane; Thuillet, Anne-Celine; Saidou, Abdoul-Aziz; Bezancon, Gilles			Selection for Earlier Flowering Crop Associated with Climatic Variations in the Sahel	PLOS ONE			English	Article							L. R. BR.; FOOD SECURITY; POPULATION-STRUCTURE; GENETIC DIVERSITY; INFERENCE; RAINFALL; AGRICULTURE; IMPACTS; PATTERN; NIGER	Climate changes will have an impact on food production and will require costly adaptive responses. Adapting to a changing environment will be particularly challenging in sub-Saharan Africa where climate change is expected to have a major impact. However, one important phenomenon that is often overlooked and is poorly documented is the ability of agro-systems to rapidly adapt to environmental variations. Such an adaptation could proceed by the adoption of new varieties or by the adaptation of varieties to a changing environment. In this study, we analyzed these two processes in one of the driest agro-ecosystems in Africa, the Sahel. We performed a detailed study in Niger where pearl millet is the main crop and covers 65% of the cultivated area. To assess how the agro-system is responding to recent recurrent drought, we analyzed samples of pearl millet landraces collected in the same villages in 1976 and 2003 throughout the entire cultivated area of Niger. We studied phenological and morphological differences in the 1976 and 2003 collections by comparing them over three cropping seasons in a common garden experiment. We found no major changes in the main cultivated varieties or in their genetic diversity. However, we observed a significant shift in adaptive traits. Compared to the 1976 samples, samples collected in 2003 displayed a shorter lifecycle, and a reduction in plant and spike size. We also found that an early flowering allele at the PHYC locus increased in frequency between 1976 and 2003. The increase exceeded the effect of drift and sampling, suggesting a direct effect of selection for earliness on this gene. We conclude that recurrent drought can lead to selection for earlier flowering in a major Sahelian crop. Surprisingly, these results suggest that diffusion of crop varieties is not the main driver of short term adaptation to climatic variation.	[Vigouroux, Yves; Mariac, Cedric; De Mita, Stephane; Pham, Jean-Louis; Luong, Viviane; Thuillet, Anne-Celine; Saidou, Abdoul-Aziz] Inst Rech Dev, Montpellier, France; [Vigouroux, Yves; Mariac, Cedric; Saidou, Abdoul-Aziz; Bezancon, Gilles] Inst Rech Dev, Niamey, Niger; [Gerard, Bruno; Ndjeunga, Jupiter] Int Ctr Res Semiarid Trop, Niamey, Niger; [Kapran, Issoufou] Inst Natl Rech Agron Niger, Niamey, Niger; [Sagnard, Fabrice; Deu, Monique; Chantereau, Jacques] Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Ali, Abdou] Ctr Reg AGHRYMET, Niamey, Niger; [Saidou, Abdoul-Aziz] Univ Abdou Moumouni, Niamey, Niger	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); CIRAD	Vigouroux, Y (corresponding author), Inst Rech Dev, Montpellier, France.	yves.vigouroux@ird.fr	thuillet, anne-céline c/J-9836-2016; vigouroux, Yves/A-9056-2011; mariac, cedric/H-9868-2017; Gerard, Bruno/AAG-6592-2019	thuillet, anne-céline c/0000-0003-0774-2421; vigouroux, Yves/0000-0002-8361-6040; mariac, cedric/0000-0001-6439-115X; Gerard, Bruno/0000-0002-1079-7493	"Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite"; IRD; National Research Agency of France [ANR-07-JCJC-0116]; Agropolis Fondation	"Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite"; IRD; National Research Agency of France; Agropolis Fondation	This study was supported by the "Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite" (www.fondationbiodiversite.fr); by IRD (www.ird.fr); by the National Research Agency of France (ANR-07-JCJC-0116 to Y.V., www.agence-nationale-recherche.fr); by the Agropolis Fondation (http://www.agropolis-fondation.fr). The Ph.D. student, A.-A.S., is granted by IRD and Agropolis Fondation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, J APPL METEOROL, V44, P1691, DOI 10.1175/JAM2304.1; Allinne C, 2008, GENETICA, V133, P167, DOI 10.1007/s10709-007-9197-7; Bezancon G, 2009, GENET RESOUR CROP EV, V56, P223, DOI 10.1007/s10722-008-9357-3; Biasutti M, 2008, J CLIMATE, V21, P3471, DOI 10.1175/2007JCLI1896.1; Biasutti M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041303; BORGEL A, 1977, FIELD TRIP 1976 NIGE; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Challinor AJ, 2009, J EXP BOT, V60, P2775, DOI 10.1093/jxb/erp062; Cook KH, 2008, NAT GEOSCI, V1, P647, DOI 10.1038/ngeo320; Falush D, 2003, GENETICS, V164, P1567; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Liu K., 2005, POWERMARKER NEW GENE; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Mariac C, 2006, THEOR APPL GENET, V113, P1003, DOI 10.1007/s00122-006-0360-9; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; MARSHAL A, 1950, AGRON TROP, V5, P582; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Narisma GT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028628; Ndjeunga J, 2002, EXP AGR, V38, P149, DOI 10.1017/S0014479702000224; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Pritchard JK, 2000, GENETICS, V155, P945; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Sokal RR, 1995, BIOMETRY; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Weir BS., 1996, GENETIC DATA ANAL	38	63	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19563	10.1371/journal.pone.0019563	http://dx.doi.org/10.1371/journal.pone.0019563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573243	Green Published, gold			2022-12-25	WOS:000290224800034
J	Li, C; Ao, J; Fu, J; Lee, DF; Xu, J; Lonard, D; O'Malley, BW				Li, C.; Ao, J.; Fu, J.; Lee, D-F; Xu, J.; Lonard, D.; O'Malley, B. W.			Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1	ONCOGENE			English	Article						SRC-3/AIB1; tumor suppressor; SPOP; ubiquitin ligase; steroid receptor co-activator; breast cancer	STEROID-RECEPTOR COACTIVATOR-1; CANCER CELL-PROLIFERATION; REG-GAMMA-PROTEASOME; KINASE-I-EPSILON; F-BOX PROTEINS; BREAST-CANCER; NUCLEAR RECEPTORS; TRANSCRIPTIONAL COACTIVATOR; BETA-CATENIN; E3 LIGASE	Steroid receptor co-activator-3 (SRC-3/AIB1) is an oncogene that is amplified and overexpressed in many human cancers. However, the molecular mechanisms that regulate 'activated SRC-3 oncoprotein' turnover during tumorigenesis remain to be elucidated. Here, we report that speckle-type POZ protein (SPOP), a cullin 3 (CUL3)-based ubiquitin ligase, is responsible for SRC-3 ubiquitination and proteolysis. SPOP interacts directly with an SRC-3 phospho-degron in a phosphorylation-dependent manner. Casein kinase I epsilon phosphorylates the S102 in this degron and promotes SPOP-dependent turnover of SRC-3. Short hairpin RNA knockdown and overexpression experiments substantiated that the SPOP/CUL3/Rbx1 ubiquitin ligase complex promotes SRC-3 turnover. A systematic analysis of the SPOP genomic locus revealed that a high percentage of genomic loss or loss of heterozygosity occurs at this locus in breast cancers. Furthermore, we demonstrate that restoration of SPOP expression inhibited SRC-3-mediated oncogenic signaling and tumorigenesis, thus positioning SPOP as a tumor suppressor. Oncogene (2011) 30, 4350-4364; doi: 10.1038/onc.2011.151; published online 16 May 2011	[Li, C.; Ao, J.] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China; [Li, C.; Fu, J.; Xu, J.; Lonard, D.; O'Malley, B. W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lee, D-F] Mt Sinai Sch Med, Black Family Stem Cell Res Inst, Dept Gene & Cell Med, New York, NY USA	Shanghai Jiao Tong University; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Li, C (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China.	01chao@gmail.com; berto@bcm.edu		Lee, Dung-Fang/0000-0003-2387-597X	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute; National Natural Science Foundation of China [81072163]; NIH [HD-08188, HD-07857]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, R01HD008188] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857, F32HD008188] Funding Source: NIH RePORTER	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Ming-Jer Tsai and Sophia Y Tsai for their suggestions and Dr Kevin White (University of Chicago) for the monoclonal antibodies against SPOP. This work was supported by funding from State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute and grants (81072163) from National Natural Science Foundation of China (CL), and NIH HD-08188 and HD-07857 grants (BWO).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bunce MW, 2008, J BIOL CHEM, V283, P8678, DOI 10.1074/jbc.M710222200; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; DeMarchis L, 2004, BRIT J CANCER, V90, P2384, DOI 10.1038/sj.bjc.6601848; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Glass CK, 2000, GENE DEV, V14, P121; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; KUMAR RPD, 2008, NR COREGULATORS HUMA, V11; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Lerebours F, 2002, INT J CANCER, V102, P618, DOI 10.1002/ijc.10729; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li B, 2008, CANCER LETT, V261, P64, DOI 10.1016/j.canlet.2007.11.013; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; ONATE SA, 1995, SCIENCE, V270, P1354; Orsetti B, 1999, ONCOGENE, V18, P6262, DOI 10.1038/sj.onc.1203006; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Planas-Silva MD, 2001, CANCER RES, V61, P3858; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; RADFORD DM, 1995, CANCER RES, V55, P3399; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	70	104	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	42					4350	4364		10.1038/onc.2011.151	http://dx.doi.org/10.1038/onc.2011.151			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21577200	Green Accepted			2022-12-25	WOS:000296356400006
J	Barthet, G; Shioi, J; Shao, ZP; Ren, YM; Georgakopoulos, A; Robakis, NK				Barthet, Gael; Shioi, Junichi; Shao, Zhiping; Ren, Yimin; Georgakopoulos, Anastasios; Robakis, Nikolaos K.			Inhibitors of gamma-secretase stabilize the complex and differentially affect processing of amyloid precursor protein and other substrates	FASEB JOURNAL			English	Article						Alzheimer's disease; A beta; presenilin; N-cadherin	C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; PRESENILIN; BETA; NICASTRIN; BINDING; TARGET; APH-1; GLYCOSYLATION; TOLERABILITY	gamma-Secretase inhibitors (GSIs) are drugs used in research to inhibit production of A beta and in clinical trials to treat Alzheimer's disease (AD). They inhibit proteolytic activities of gamma-secretase noncompetitively by unknown mechanisms. Here, we used cortical neuronal cultures expressing endogenous levels of enzymes and substrates to study the effects of GSIs on the structure and function of gamma-secretase. We show that GSIs stabilize the interactions between the C-terminal fragment of presenilin (PS-CTF), the central component of the gamma-secretase complex, and its partners the APH-1/nicastrin and PS1-NTF/PEN-2 subcomplexes. This stabilization dose-dependently correlates with inhibition of N-cadherin cleavage, a process limited by enzyme availability. In contrast, production of amyloid precursor protein (APP) intracellular domain (AICD) is insensitive to low concentrations of GSIs and is limited by substrate availability. Interestingly, APP is processed by both PS1- and PS2-containing gamma-secretase complexes, while N-cadherin and ephrinB1 are processed only by PS1-containing complexes. Paradoxically, low concentrations of GSIs specifically increased the levels of A beta without affecting its catabolism, indicating increased A beta production. Our data reveal a mechanism of gamma-secretase inhibition by GSIs and provide evidence that distinct gamma-secretase complexes process specific substrates. Furthermore, our observations have implications for GSIs as therapeutics because processing of functionally important substrates may be inhibited at lower concentrations than A beta.-Barthet, G., Shioi, J., Shao, Z., Ren, Y., Georgakopoulos, A., Robakis, N. K. Inhibitors of gamma-secretase stabilize the complex and differentially affect processing of amyloid precursor protein and other substrates. FASEB J. 25, 2937-2946 (2011). www.fasebj.org	[Robakis, Nikolaos K.] NYU, Mt Sinai Sch Med, Dept Psychiat, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA; [Robakis, Nikolaos K.] NYU, Mt Sinai Sch Med, Dept Neurosci, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University	Robakis, NK (corresponding author), NYU, Mt Sinai Sch Med, Dept Psychiat, Ctr Mol Biol & Genet Neurodegenerat, 1 Gustave L Levy Pl,Box 1229, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Barthet, Gael/0000-0003-4025-1616; Georgakopoulos, Anastasios/0000-0001-8241-6306	U.S. National Institutes of Health [AG-017926, NS047229, AG-008200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, RF1AG008200, R01AG008200, R01AG017926] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health grants AG-017926, NS047229, and AG-008200.	Agiostratidou G, 2006, J NEUROCHEM, V96, P1182, DOI 10.1111/j.1471-4159.2005.03616.x; AHN K, 2010, P NATL ACAD SCI USA, P1; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Siemers ER, 2007, CLIN NEUROPHARMACOL, V30, P317, DOI 10.1097/WNF.0b013e31805b7660; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Waldron E, 2008, EXP CELL RES, V314, P2419, DOI 10.1016/j.yexcr.2008.05.003; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200	34	21	22	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2937	2946		10.1096/fj.11-183806	http://dx.doi.org/10.1096/fj.11-183806			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21597003	Green Published			2022-12-25	WOS:000294435200009
J	Larsen, FJ; Schiffer, TA; Sahlin, K; Ekblom, B; Weitzberg, E; Lundberg, JO				Larsen, Filip J.; Schiffer, Tomas A.; Sahlin, Kent; Ekblom, Bjorn; Weitzberg, Eddie; Lundberg, Jon O.			Mitochondrial oxygen affinity predicts basal metabolic rate in humans	FASEB JOURNAL			English	Article						proton leak; cytochrome c oxidase; efficiency	CYTOCHROME-C-OXIDASE; DIETARY NITRATE SUPPLEMENTATION; HUMAN SKELETAL-MUSCLE; NITRIC-OXIDE; CYCLING EFFICIENCY; ENERGY-EXPENDITURE; CELLULAR RESPIRATION; WORLD-CLASS; IN-VIVO; EXERCISE	The basal metabolic rate (BMR) is referred to as the minimal rate of metabolism required to support basic body functions. It is well known that individual BMR varies greatly, even when correcting for body weight, fat content, and thyroid hormone levels, but the mechanistic determinants of this phenomenon remain unknown. Here, we show in humans that mass-related BMR correlates strongly to the mitochondrial oxygen affinity (p50(mito); R-2 = 0.66, P = 0.0004) measured in isolated skeletal muscle mitochondria. A similar relationship was found for oxygen affinity and efficiency during constant-load submaximal exercise (R-2 = 0.46, P = 0.007). In contrast, BMR did not correlate to overall mitochondrial density or to proton leak. Mechanistically, part of the p50(mito) seems to be controlled by the excess of cytochrome c oxidase (COX) protein and activity relative to other mitochondrial proteins. This is illustrated by the 5-fold increase in p50(mito) after partial cyanide inhibition of COX at doses that do not affect maximal mitochondrial electron flux through the ETS. These data suggest that the interindividual variation in BMR in humans is primarily explained by differences in mitochondrial oxygen affinity. The implications of these findings are discussed in terms of a trade-off between aerobic efficiency and power.-Larsen, F. J., Schiffer, T. A., Sahlin, K., Ekblom, B., Weitzberg, E., Lundberg, J. O. Mitochondrial oxygen affinity predicts basal metabolic rate in humans. FASEB J. 25, 2843-2852 (2011). www.fasebj.org	[Larsen, Filip J.; Schiffer, Tomas A.; Sahlin, Kent; Ekblom, Bjorn; Weitzberg, Eddie; Lundberg, Jon O.] Karolinska Inst, Dept Physiol & Pharmacol, S-11486 Stockholm, Sweden; [Larsen, Filip J.; Sahlin, Kent; Ekblom, Bjorn] Karolinska Inst, Swedish Sch Sport & Hlth Sci, S-11486 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Swedish School of Sport & Health Sciences	Larsen, FJ (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-11486 Stockholm, Sweden.	filip.larsen@ki.se	Schiffer, Tomas/X-1343-2018	Schiffer, Tomas/0000-0002-9077-2682; Lundberg, Jon/0000-0002-0174-5210				ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Bailey SJ, 2010, J APPL PHYSIOL, V109, P135, DOI 10.1152/japplphysiol.00046.2010; Befroy DE, 2008, P NATL ACAD SCI USA, V105, P16701, DOI 10.1073/pnas.0808889105; BESCOS R, 2011, MED SCI SPORTS EXERC; BIENFAIT HF, 1975, BIOCHIM BIOPHYS ACTA, V376, P446, DOI 10.1016/0005-2728(75)90166-8; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Cooper CE, 2003, BBA-BIOENERGETICS, V1607, P27, DOI 10.1016/j.bbabio.2003.08.003; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581, DOI 10.1016/S0300-595X(84)80039-0; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; GAESSER GA, 1975, J APPL PHYSIOL, V38, P1132, DOI 10.1152/jappl.1975.38.6.1132; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; KARLSSON J, 1967, J APPL PHYSIOL, V22, P1061, DOI 10.1152/jappl.1967.22.6.1061; Lansley KE, 2011, J APPL PHYSIOL, V110, P591, DOI 10.1152/japplphysiol.01070.2010; Lanza IR, 2010, AM J PHYSIOL-REG I, V299, pR1415, DOI 10.1152/ajpregu.00225.2010; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2010, FREE RADICAL BIO MED, V48, P342, DOI 10.1016/j.freeradbiomed.2009.11.006; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Mole PA, 1999, AM J PHYSIOL-REG I, V277, pR173, DOI 10.1152/ajpregu.1999.277.1.R173; MORGAN DW, 1994, INT J SPORTS MED, V15, P426, DOI 10.1055/s-2007-1021082; Moseley L, 2004, INT J SPORTS MED, V25, P374, DOI 10.1055/s-2004-815848; Nickleberry BL, 1996, MED SCI SPORT EXER, V28, P1396, DOI 10.1097/00005768-199611000-00008; Pecina P, 2004, AM J PHYSIOL-CELL PH, V287, pC1384, DOI 10.1152/ajpcell.00286.2004; Pierre S, 2006, EUR J APPL PHYSIOL, V97, P133, DOI 10.1007/s00421-006-0132-x; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Richardson RS, 1999, J APPL PHYSIOL, V87, P325, DOI 10.1152/jappl.1999.87.1.325; ROBERTS SB, 1988, NEW ENGL J MED, V318, P461, DOI 10.1056/NEJM198802253180801; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; SCHOLANDER PF, 1950, BIOL BULL, V99, P259, DOI 10.2307/1538742; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; Sharpe MA, 1998, J BIOL CHEM, V273, P30961, DOI 10.1074/jbc.273.47.30961; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; STEINLECHNERMAR.R, 2006, AM J PHYSIOL, V271, pC2053; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; SULLIVAN MJ, 1994, J APPL PHYSIOL, V77, P2194, DOI 10.1152/jappl.1994.77.5.2194; Vanhatalo A, 2010, AM J PHYSIOL-REG I, V299, pR1121, DOI 10.1152/ajpregu.00206.2010; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0	50	48	50	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2843	2852		10.1096/fj.11-182139	http://dx.doi.org/10.1096/fj.11-182139			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21576503				2022-12-25	WOS:000293337800032
J	Wu, SF; Morrison, A; Sun, HZ; De Luca, F				Wu, Shufang; Morrison, Allison; Sun, Hongzhi; De Luca, Francesco			Nuclear Factor-kappa B (NF-kappa B) p65 Interacts with Stat5b in Growth Plate Chondrocytes and Mediates the Effects of Growth Hormone on Chondrogenesis and on the Expression of Insulin-like Growth Factor-1 and Bone Morphogenetic Protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GH RECEPTOR; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; ACTIVATION; GENE; TRANSCRIPTION; INSENSITIVITY; MOUSE; CELLS; IDENTIFICATION	Growth hormone (GH) stimulates growth plate chondrogenesis and longitudinal bone growth with its stimulatory effects primarily mediated by insulin-like growth factor-1 (IGF-1) both systemically and locally in the growth plate. It has been shown that the transcription factor Stat5b mediates the GH promoting effect on IGF-1 expression and on chondrogenesis, yet it is not known whether other signaling molecules are activated by GH in growth plate chondrocytes. We have previously demonstrated that nuclear factor-kappa B p65 is a transcription factor expressed in growth plate chondrocytes where it facilitates chondrogenesis. We have also shown that fibroblasts isolated from a patient with growth failure and a heterozygous mutation of inhibitor-kappa B alpha (I kappa B; component of the nuclear factor-kappa B (NF-kappa B) signaling pathway) exhibit GH insensitivity. In this study, we cultured rat metatarsal bones in the presence of GH and/or pyrrolidine dithiocarbamate (PDTC), a known NF-kappa B inhibitor. The GH-mediated stimulation of metatarsal longitudinal growth and growth plate chondrogenesis was neutralized by PDTC. In cultured chondrocytes isolated from rat metatarsal growth plates, GH induced NF-kappa B-DNA binding and chondrocyte proliferation and differentiation and prevented chondrocyte apoptosis. The inhibition of NF-kappa B p65 expression and activity (by NF-kappa B p65 siRNA and PDTC, respectively) in chondrocytes reversed the GH-mediated effects on chondrocyte proliferation, differentiation, and apoptosis. Lastly, the inhibition of Stat5b expression in chondrocytes prevented the GH promoting effects on NF-kappa B-DNA binding, whereas the inhibition of NF-kappa B p65 expression or activity prevented the GH-dependent activation of IGF-1 and bone morphogenetic protein-2 expression.	[Wu, Shufang; Morrison, Allison; De Luca, Francesco] Drexel Univ, Sect Endocrinol & Diabet, St Christophers Hosp Children, Coll Med, Philadelphia, PA 19134 USA; [Wu, Shufang; Morrison, Allison; De Luca, Francesco] Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19134 USA; [Wu, Shufang; Sun, Hongzhi] Xi An Jiao Tong Univ, Sch Med, Xian 710061, Shannxi, Peoples R China	Drexel University; Drexel University; Xi'an Jiaotong University	De Luca, F (corresponding author), Drexel Univ, Sect Endocrinol & Diabet, St Christophers Hosp Children, Coll Med, 3601 A St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu			Novo Nordisk	Novo Nordisk(Novo Nordisk)	This work was supported by a grant from Novo Nordisk.	APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; BARNARD R, 1988, ENDOCRINOLOGY, V122, P2562, DOI 10.1210/endo-122-6-2562; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Choi HK, 2000, GROWTH HORM IGF RES, V10, P1, DOI 10.1016/S1096-6374(00)80002-7; Costoya JA, 1999, ENDOCRINOLOGY, V140, P5937, DOI 10.1210/en.140.12.5937; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; FOSTER CM, 1988, BIOCHEMISTRY-US, V27, P326, DOI 10.1021/bi00401a049; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; ISAKSSON OGP, 1982, SCIENCE, V216, P1237, DOI 10.1126/science.7079756; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Jeay S, 2001, ENDOCRINOLOGY, V142, P147, DOI 10.1210/en.142.1.147; Jeay S, 2000, MOL ENDOCRINOL, V14, P650, DOI 10.1210/me.14.5.650; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Liang L, 2000, ENDOCRINOLOGY, V141, P3328, DOI 10.1210/en.141.9.3328; Liu ZH, 2002, ACTA PHARMACOL SIN, V23, P887; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; ROSENFELD RG, 1994, ENDOCR REV, V15, P369, DOI 10.1210/er.15.3.369; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; SILVA CM, 1993, ENDOCRINOLOGY, V133, P2307, DOI 10.1210/en.133.5.2307; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; WERTHER GA, 1993, ACTA PAEDIATR, V82, P50, DOI 10.1111/j.1651-2227.1993.tb12929.x; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; Wit JM, 1996, PEDIATR RES, V39, P295, DOI 10.1203/00006450-199602000-00018; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Wu SF, 2010, J CLIN ENDOCR METAB, V95, P1220, DOI 10.1210/jc.2009-1662; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Yau TO, 2009, J PATHOL, V217, P353, DOI 10.1002/path.2451; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24726	24734		10.1074/jbc.M110.175364	http://dx.doi.org/10.1074/jbc.M110.175364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592969	Green Published, hybrid			2022-12-25	WOS:000292547900023
J	Yonesu, K; Kubota, K; Tamura, M; Inaba, S; Honda, T; Yahara, C; Watanabe, N; Matsuoka, T; Nara, F				Yonesu, Kiyoaki; Kubota, Kazuishi; Tamura, Masakazu; Inaba, Shin-ichi; Honda, Tomohiro; Yahara, Chizuko; Watanabe, Nobuaki; Matsuoka, Tatsuji; Nara, Futoshi			Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELAPSING MULTIPLE-SCLEROSIS; FRUCTOSAMINE 3-KINASE-RELATED PROTEIN; FUNCTIONAL-CHARACTERIZATION; IMMUNOSUPPRESSANT FTY720; IMMUNOMODULATOR FTY720; SUBSTRATE-SPECIFICITY; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; ORAL FINGOLIMOD; KINASE TYPE-2	CS-0777 is a selective sphingosine 1-phosphate (S1P) receptor 1 modulator with potential benefits in the treatment of autoimmune diseases, including multiple sclerosis. CS-0777 is a prodrug that requires phosphorylation to an active S1P analog, similar to the first-in-class S1P receptor modulator FTY720 (fingolimod). We sought to identify the kinase(s) involved in phosphorylation of CS-0777, anticipating sphingosine kinase (SPHK) 1 or 2 as likely candidates. Unlike kinase activity for FTY720, which is found predominantly in platelets, CS-0777 kinase activity was found mainly in red blood cells (RBCs). N,N-Dimethylsphingosine, an inhibitor of SPHK1 and -2, did not inhibit CS-0777 kinase activity. We purified CS-0777 kinase activity from human RBCs by more than 10,000-fold using ammonium sulfate precipitation and successive chromatography steps, and we identified fructosamine 3-kinase (FN3K) and fructosamine 3-kinase-related protein (FN3K-RP) by mass spectrometry. Incubation of human RBC lysates with 1-deoxy-1-morpholinofructose, a competitive inhibitor of FN3K, inhibited similar to 10% of the kinase activity, suggesting FN3K-RP is the principal kinase responsible for activation of CS-0777 in blood. Lysates from HEK293 cells overexpressing FN3K or FN3K-RP resulted in phosphorylation of CS-0777 and structurally related molecules but showed little kinase activity for FTY720 and no kinase activity for sphingosine. Substrate preference was highly correlated among FN3K, FN3K-RP, and rat RBC lysates. FN3K and FN3K-RP are known to phosphorylate sugar moieties on glycosylated proteins, but this is the first report that these enzymes can phosphorylate hydrophobic xenobiotics. Identification of the kinases responsible for CS-0777 activation will permit a better understanding of the pharmacokinetics and pharmacodynamics of this promising new drug.	[Yonesu, Kiyoaki; Nara, Futoshi] Daiichi Sankyo Co Ltd, Cardiovasc Metab Res Labs, Tokyo 1348630, Japan; [Kubota, Kazuishi] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Tokyo 1348630, Japan; [Tamura, Masakazu; Matsuoka, Tatsuji] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo 1348630, Japan; [Inaba, Shin-ichi; Honda, Tomohiro; Yahara, Chizuko; Watanabe, Nobuaki] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1348630, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Kubota, K (corresponding author), 1-16-13 Kitakasai,Edogawa Ku, Tokyo 1348630, Japan.	kubota.kazuishi.ht@daiichisankyo.co.jp; nara.futoshi.fm@daiichisankyo.co.jp		Matsuoka, Tatsuji/0000-0001-5982-4248				Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Bohler T, 2004, NEPHROL DIAL TRANSPL, V19, P702, DOI 10.1093/ndt/gfg599; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Budde K, 2003, AM J TRANSPLANT, V3, P846, DOI 10.1034/j.1600-6143.2003.00130.x; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Collard F, 2004, BIOCHEM J, V382, P137, DOI 10.1042/BJ20040307; Collard FO, 2003, DIABETES, V52, P2888, DOI 10.2337/diabetes.52.12.2888; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; Delpierre G, 2000, BIOCHEM J, V352, P835, DOI 10.1042/0264-6021:3520835; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Fujita T, 1996, J MED CHEM, V39, P4451, DOI 10.1021/jm960391l; Galetta SL, 2005, CNS DRUGS, V19, P239, DOI 10.2165/00023210-200519030-00005; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Horga A, 2010, EXPERT OPIN PHARMACO, V11, P1183, DOI 10.1517/14656561003769866; Ishizuka T, 2010, J BIOL CHEM, V285, P11892, DOI 10.1074/jbc.M109.072629; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kovarik JM, 2009, J CLIN PHARMACOL, V49, P212, DOI 10.1177/0091270008329553; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kubota K, 2003, PROTEOMICS, V3, P616, DOI 10.1002/pmic.200300410; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Kubota K, 2009, NAT BIOTECHNOL, V27, P933, DOI 10.1038/nbt.1566; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moberly J., 2011, J CLIN PHAR IN PRESS; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; Nishi T, 2011, ACS MED CHEM LETT, V2, P368, DOI 10.1021/ml100301k; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Szwergold B, 2007, BIOCHEM BIOPH RES CO, V361, P870, DOI 10.1016/j.bbrc.2007.07.127; Szwergold BS, 2001, DIABETES, V50, P2139, DOI 10.2337/diabetes.50.9.2139; Van Schaftingen E., 2010, AMINO ACIDS IN PRESS; Van Schaftingen E, 2007, ADV ENZYME REGUL, V47, P261, DOI 10.1016/j.advenzreg.2006.12.002	51	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24765	24775		10.1074/jbc.M110.217299	http://dx.doi.org/10.1074/jbc.M110.217299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613209	hybrid, Green Published			2022-12-25	WOS:000292547900027
J	Ehlting, C; Ronkina, N; Bohmer, O; Albrecht, U; Bode, KA; Lang, KS; Kotlyarov, A; Radzioch, D; Gaestel, M; Haussinger, D; Bode, JG				Ehlting, Christian; Ronkina, Natalia; Boehmer, Oliver; Albrecht, Ute; Bode, Konrad A.; Lang, Karl S.; Kotlyarov, Alexey; Radzioch, Danuta; Gaestel, Matthias; Haeussinger, Dieter; Bode, Johannes G.			Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3 MK2 MEDIATES LIPOPOLYSACCHARIDE-INDUCED SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 3 (STAT3) ACTIVATION BY PREVENTING NEGATIVE REGULATORY EFFECTS OF MK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SOCS3 MESSENGER-RNA; GENE-EXPRESSION; TNF-ALPHA; CYTOKINE SIGNALING-3; HUMAN MACROPHAGES; CUTTING EDGE; BETA; IL-10	In LPS-treated macrophages, activation of STAT3 is considered to be crucial for terminating the production of inflammatory cytokines. By analyzing the role of MAPK-activated protein kinase (MK) 2 and MK3 for LPS-induced STAT3 activation in macrophages, the present study provides evidence that MK2 is crucial for STAT3 activation in response to LPS because it prevents MK3 from impeding IFN beta gene expression. Accordingly, LPS-induced IFN beta gene expression is down-regulated in MK2-deficient macrophages and can be reconstituted by additional ablation of the MK3 gene in MK2/3(-/-) macrophages. This is in contrast to LPS-induced IL-10 expression, which essentially requires the presence of MK2. Further analysis of downstream signaling events involved in the transcriptional regulation of IFN beta gene expression suggests that, in the absence of MK2, MK3 impairs interferon regulatory factor 3 protein expression and activation and inhibits nuclear translocation of p65. This inhibition of p65 nuclear translocation coincides with enhanced expression and delayed degradation of I kappa B alpha, whereas expression of I kappa B alpha mRNA and protein is impaired in the absence of MK2. The observation that siRNA directed against I kappa B alpha is able to reconstitute I kappa B alpha expression in MK2(-/-) macrophages suggests that enhanced expression and delayed degradation of I kappa B alpha and impaired NF kappa B-dependent I kappa B alpha expression are functionally linked. In summary, evidence is provided that MK2 regulates LPS-induced IFN beta expression and downstream STAT3 activation as it restrains MK3 from mediating negative regulatory effects on NF kappa B-and interferon regulatory factor 3-dependent LPS signaling.	[Ehlting, Christian; Boehmer, Oliver; Albrecht, Ute; Lang, Karl S.; Haeussinger, Dieter; Bode, Johannes G.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Fac Med, D-40225 Dusseldorf, Germany; [Ronkina, Natalia; Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Dept Physiol Chem, D-30625 Hannover, Germany; [Bode, Konrad A.] Univ Heidelberg, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada	Heinrich Heine University Dusseldorf; Hannover Medical School; Ruprecht Karls University Heidelberg; McGill University	Bode, JG (corresponding author), Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Fac Med, Moorenstr 5, D-40225 Dusseldorf, Germany.	Johannes.Bode@med.uni-duesseldorf.de	Gaestel, Matthias/A-6560-2013; Lang, Karl S/R-2505-2016; Ehlting, Christian/AAI-3791-2020	Gaestel, Matthias/0000-0002-4944-4652; Ehlting, Christian/0000-0003-0103-1856; Lang, Karl/0000-0001-9783-7605; Radzioch, Danuta/0000-0002-1601-2757	Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers [575, 542]; Deutsche Forschungsgemeinschaft;  [Ga 453/11]	Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers 575 (to J.G.B. and D. H.), and 542 to J.B.) and through Project Ga 453/11 (to M. G.).; Supported by the Heisenberg Program of the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Dept. of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Dusseldorf, Germany. Fax: 49-211-81-18752; E-mail: Johannes. Bode@med.uni-duesseldorf.de.	Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Bode KA, 2009, J IMMUNOL, V182, P2176, DOI 10.4049/jimmunol.0802560; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kiu H, 2007, GROWTH FACTORS, V25, P319, DOI 10.1080/08977190701830151; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PEPPEL K, 1991, J EXP MED, V173, P349, DOI 10.1084/jem.173.2.349; PEPPEL K, 1991, J BIOL CHEM, V266, P6663; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	37	60	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24113	24124		10.1074/jbc.M111.235275	http://dx.doi.org/10.1074/jbc.M111.235275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586572	Green Published, hybrid			2022-12-25	WOS:000292294900053
J	Ting, TC; Miyazaki-Anzai, S; Masuda, M; Levi, M; Demer, LL; Tintut, Y; Miyazaki, M				Ting, Tabitha C.; Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Demer, Linda L.; Tintut, Yin; Miyazaki, Makoto			Increased Lipogenesis and Stearate Accelerate Vascular Calcification in Calcifying Vascular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESATURASE-1 DEFICIENCY PROTECTS; ENDOPLASMIC-RETICULUM STRESS; UNSATURATED FATTY-ACIDS; X-RECEPTOR; GENE-EXPRESSION; SIGNALING PATHWAYS; BETA-CELLS; BILE-ACIDS; LIVER; LXR	Vascular calcification is recognized as an independent predictor of cardiovascular mortality, particularly in subjects with chronic kidney disease. However, the pathways by which dysregulation of lipid and mineral metabolism simultaneously occur in this particular population remain unclear. We have shown that activation of the farnesoid X receptor (FXR) blocks mineralization of bovine calcifying vascular cells (CVCs) and in ApoE knock-out mice with 5/6 nephrectomy. In contrast to FXR, this study showed that liver X receptor (LXR) activation by LXR agonists and adenovirus-mediated LXR overexpression by VP16-LXR alpha and VP16-LXR beta accelerated mineralization of CVCs. Conversely, LXR inhibition by dominant negative (DN) forms of LXR alpha and LXR beta reduced calcium content in CVCs. The regulation of mineralization by FXR and LXR agonists was highly correlated with changes in lipid accumulation, fatty acid synthesis, and the expression of sterol regulatory element binding protein-1 (SREBP-1). The rate of lipogenesis in CVCs through the SREBP-1c dependent pathway was reduced by FXR activation, but increased by LXR activation. SREBP-1c overexpression augmented mineralization in CVCs, whereas SREBP-1c DN inhibited alkaline phosphatase activity and mineralization induced by LXR agonists. LXR and SREBP-1c activations increased, whereas FXR activation decreased, saturated and monounsaturated fatty acids derived from lipogenesis. In addition, we found that stearate markedly promoted mineralization of CVCs as compared with other fatty acids. Furthermore, inhibition of either acetyl-CoA carboxylase or acyl-CoA synthetase reduced mineralization of CVCs, whereas inhibition of stearoyl-CoA desaturase induced mineralization. Therefore, a stearate metabolite derived from lipogenesis might be a risk factor for the development of vascular calcification.	[Miyazaki, Makoto] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Ting, Tabitha C.; Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Miyazaki, Makoto] Denver VA Med Ctr, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Miyazaki, Makoto] Denver VA Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Aurora, CO 80045 USA; [Demer, Linda L.; Tintut, Yin] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of California System; University of California Los Angeles	Miyazaki, M (corresponding author), Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, 12700 E 19th Ave,C281, Aurora, CO 80045 USA.	Makoto.Miyazaki@ucdenver.edu	Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895; Ting, Tabitha/0000-0001-5206-9243; Masuda, Masashi/0000-0003-3762-2770; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [HL081202, DK081346]; American Heart Association [10BGIA458005]; Colorado Clinical Nutrition Research Unit (National Institutes of Health) [5P30DK048520]; UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health) [P30DK57516]; NIGMS-IMSD [R25GM083333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202, R21HL109628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076009, R01DK081346, P30DK048520, P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Colorado Clinical Nutrition Research Unit (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS-IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081202 and DK081346, the American Heart Association Grant 10BGIA458005, as well as the Colorado Clinical Nutrition Research Unit (National Institutes of Health Grant 5P30DK048520), and the UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health Grant P30DK57516). T. C. T. was supported by NIGMS-IMSD #R25GM083333.	Achenbach S, 2002, CIRCULATION, V106, P1077, DOI 10.1161/01.CIR.0000027567.49283.FF; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hsu JJ, 2009, FEBS LETT, V583, P1344, DOI 10.1016/j.febslet.2009.03.039; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2003, CURR OPIN PHARMACOL, V3, P192, DOI 10.1016/S1471-4892(03)00009-2; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Matsuzaka T, 2002, J LIPID RES, V43, P911; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015	48	34	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23938	23949		10.1074/jbc.M111.237065	http://dx.doi.org/10.1074/jbc.M111.237065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596756	Green Published, hybrid			2022-12-25	WOS:000292294900036
J	Wang, JW; Valentijn, KM; de Boer, HC; Dirven, RJ; van Zonneveld, AJ; Koster, AJ; Voorberg, J; Reitsma, PH; Eikenboom, J				Wang, Jiong-Wei; Valentijn, Karine M.; de Boer, Hetty C.; Dirven, Richard J.; van Zonneveld, Anton Jan; Koster, Abraham J.; Voorberg, Jan; Reitsma, Pieter H.; Eikenboom, Jeroen			Intracellular Storage and Regulated Secretion of Von Willebrand Factor in Quantitative Von Willebrand Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEIBEL-PALADE BODIES; MUTATED CYSTEINE RESIDUES; HUMAN ENDOTHELIAL-CELLS; FACTOR PROPEPTIDE; DEFECTIVE MULTIMERIZATION; D3 DOMAIN; MUTATIONS; PHENOTYPE; VWF; MCMDM-1VWD	Several missense mutations in the von Willebrand Factor (VWF) gene of von Willebrand disease (VWD) patients have been shown to cause impaired constitutive secretion and intracellular retention of VWF. However, the effects of those mutations on the intracellular storage in Weibel-Palade bodies (WPBs) of endothelial cells and regulated secretion of VWF remain unknown. We demonstrate, by expression of quantitative VWF mutants in HEK293 cells, that four missense mutations in the D3 and CK-domain of VWF diminished the storage in pseudo-WPBs, and led to retention of VWF within the endoplasmic reticulum (ER). Immunofluorescence and electron microscopy data showed that the pseudo-WPBs formed by missense mutant C1060Y are indistinguishable from those formed by normal VWF. C1149R, C2739Y, and C2754W formed relatively few pseudo-WPBs, which were often short and sometimes round rather than cigar-shaped. The regulated secretion of VWF was impaired slightly for C1060Y but severely for C1149R, C2739Y, and C2754W. Upon co-transfection with wild-type VWF, both intracellular storage and regulated secretion of all mutants were (partly) corrected. In conclusion, defects in the intracellular storage and regulated secretion of VWF following ER retention may be a common mechanism underlying VWD with a quantitative deficiency of VWF.	[Wang, Jiong-Wei; de Boer, Hetty C.; Dirven, Richard J.; van Zonneveld, Anton Jan; Reitsma, Pieter H.; Eikenboom, Jeroen] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2333 ZA Leiden, Netherlands; [Wang, Jiong-Wei; Dirven, Richard J.; Reitsma, Pieter H.; Eikenboom, Jeroen] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, NL-2333 ZA Leiden, Netherlands; [Valentijn, Karine M.; Koster, Abraham J.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZC Leiden, Netherlands; [de Boer, Hetty C.; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, NL-2333 ZA Leiden, Netherlands; [Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Eikenboom, J (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, C2-R,POB 9600, NL-2300 RC Leiden, Netherlands.	h.c.j.eikenboom@LUMC.nl	Wang, Jiong-Wei/C-5346-2012; van Zonneveld, Anton Jan/D-8060-2018; Eikenboom, Jeroen/F-9156-2018; Wang, Jiong-Wei/AAW-9118-2021; Koster, Abraham/I-7665-2017	van Zonneveld, Anton Jan/0000-0002-1676-7738; Eikenboom, Jeroen/0000-0002-3268-5759; Wang, Jiong-Wei/0000-0001-7986-6082; Dirven, Richard/0000-0001-9626-9925; Voorberg, Jan/0000-0003-4585-2621; Koster, Abraham/0000-0003-1717-2549	China Scholarship Council [2007U21083]; Netherlands Organization for Scientific Research (NWO) [91209006]	China Scholarship Council(China Scholarship Council); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the China Scholarship Council (2007U21083) and in part, by a grant from the Netherlands Organization for Scientific Research (NWO), Grant No. 91209006.	Allen S, 2000, BLOOD, V96, P560; Allen S, 2000, BLOOD, V95, P2000, DOI 10.1182/blood.V95.6.2000; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Berriman JA, 2009, P NATL ACAD SCI USA, V106, P17407, DOI 10.1073/pnas.0902977106; Bodo I, 2001, BLOOD, V98, P2973, DOI 10.1182/blood.V98.10.2973; Casonato A, 2004, J LAB CLIN MED, V144, P254, DOI 10.1016/j.lab.2004.08.002; Casonato A, 2003, BLOOD, V101, P151, DOI 10.1182/blood-2002-04-1046; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Castaman G, 2010, J THROMB HAEMOST, V8, P2011, DOI 10.1111/j.1538-7836.2010.03971.x; Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Eikenboom J, 2009, J THROMB HAEMOST, V7, P1304, DOI 10.1111/j.1538-7836.2009.03486.x; Eikenboom JCJ, 1996, BLOOD, V88, P2433, DOI 10.1182/blood.V88.7.2433.bloodjournal8872433; Eikenboom JCJ, 2001, BEST PRACT RES CL HA, V14, P365, DOI 10.1053/beha.2001.0139; EWENSTEIN BM, 1987, J CELL BIOL, V104, P1423, DOI 10.1083/jcb.104.5.1423; Federici AB, 2008, HAEMOPHILIA, V14, P5, DOI 10.1111/j.1365-2516.2007.01610.x; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; Hampshire DJ, 2010, HAEMATOL-HEMATOL J, V95, P2163, DOI 10.3324/haematol.2010.027177; Hommais A, 2006, J THROMB HAEMOST, V4, P148, DOI 10.1111/j.1538-7836.2005.01652.x; Hop C, 2000, ARTERIOSCL THROM VAS, V20, P1763, DOI 10.1161/01.ATV.20.7.1763; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; MAYADAS T, 1989, BLOOD, V73, P706; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; MOMMAAS AM, 1995, EUR J IMMUNOL, V25, P520, DOI 10.1002/eji.1830250232; Rosenberg JB, 2002, BLOOD, V100, P1699, DOI 10.1182/blood-2002-03-0789; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Schooten CJ, 2005, J THROMB HAEMOST, V3, P2228, DOI 10.1111/j.1538-7836.2005.01571.x; SPORN LA, 1987, BLOOD, V69, P1531; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Tjernberg P, 2006, BRIT J HAEMATOL, V133, P409, DOI 10.1111/j.1365-2141.2006.06055.x; Tjernberg P, 2004, J THROMB HAEMOST, V2, P257, DOI 10.1111/j.1538-7836.2003.00435.x; Tjernberg P, 2006, THROMB HAEMOSTASIS, V96, P717, DOI 10.1160/TH06-08-0460; Valentijn KM, 2008, J STRUCT BIOL, V161, P447, DOI 10.1016/j.jsb.2007.08.001; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Wang JW, 2010, HAMOSTASEOLOGIE, V30, P150, DOI 10.1055/s-0037-1619048; WIT TD, 2003, ARTERIOSCLER THROMB, V23, P755; Zenner HL, 2007, J CELL SCI, V120, P2117, DOI 10.1242/jcs.007781; ZHANG ZP, 1994, GENOMICS, V21, P188, DOI 10.1006/geno.1994.1241	48	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24180	24188		10.1074/jbc.M110.215194	http://dx.doi.org/10.1074/jbc.M110.215194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596755	hybrid, Green Published			2022-12-25	WOS:000292294900060
J	Dugue, L; Marque, P; VanRullen, R				Dugue, Laura; Marque, Philippe; VanRullen, Rufin			Transcranial Magnetic Stimulation Reveals Attentional Feedback to Area V1 during Serial Visual Search	PLOS ONE			English	Article							FRONTAL EYE FIELDS; PARIETAL CORTEX; TIME-COURSE; SET-SIZE; CONJUNCTION; PERCEPTION; BRAIN; MODEL	Visual search tasks have been used to understand how, where and when attention influences visual processing. Current theories suggest the involvement of a high-level "saliency map'' that selects a candidate location to focus attentional resources. For a parallel (or "pop-out'') task, the first chosen location is systematically the target, but for a serial (or "difficult'') task, the system may cycle on a few distractors before finally focusing on the target. This implies that attentional effects upon early visual areas, involving feedback from higher areas, should be visible at longer latencies during serial search. A previous study from Juan & Walsh (2003) had used Transcranial Magnetic Stimulation (TMS) to support this conclusion; however, only a few post-stimulus delays were compared, and no control TMS location was used. Here we applied TMS double-pulses (sub-threshold) to induce a transient inhibition of area V1 at every post-stimulus delay between 100 ms and 500 ms (50 ms steps). The search array was presented either at the location affected by the TMS pulses (previously identified by applying several pulses at supra-threshold intensity to induce phosphene perception), or in the opposite hemifield, which served as a retinotopically-defined control location. Two search tasks were used: a parallel (+ among Ls) and a serial one (T among Ls). TMS specifically impaired the serial, but not the parallel search. We highlight an involvement of V1 in serial search 300 ms after the onset; conversely, V1 did not contribute to parallel search at delays beyond 100 ms. This study supports the idea that serial search differs from parallel search by the presence of additional cycles of a select-and-focus iterative loop between V1 and higher-level areas.	[Dugue, Laura; VanRullen, Rufin] Univ Toulouse 3, F-31062 Toulouse, France; [Dugue, Laura; VanRullen, Rufin] CNRS, Ctr Rech Cerveau & Cognit, UMR5549, Fac Med Purpan, Toulouse, France; [Marque, Philippe] CHU Rangueil, F-31054 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Dugue, L (corresponding author), Univ Toulouse 3, F-31062 Toulouse, France.	laura.dugue@cerco.ups-tlse.fr	MARQUE, Philippe/AAC-4798-2019; MARQUE, PHILIPPE/F-9303-2013; VanRullen, Rufin/B-2150-2008	VanRullen, Rufin/0000-0002-3611-7716; Dugue, Laura/0000-0003-3085-1458	EURYI Award; ANR [06JCJC-0154]	EURYI Award(European Science Foundation (ESF)); ANR(French National Research Agency (ANR))	This research was funded by a EURYI Award and an ANR grant 06JCJC-0154 to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Barker AT, 1999, HIST BASIC PRINCIPLE; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; Deco G, 2002, VISION RES, V42, P2925, DOI 10.1016/S0042-6989(02)00358-9; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Green DM, 1966, SIGNAL DETECTION THE; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kalla R, 2008, NEUROREPORT, V19, P1067, DOI 10.1097/WNR.0b013e328304d9c4; Muggleton NG, 2008, NEUROPSYCHOLOGIA, V46, P2198, DOI 10.1016/j.neuropsychologia.2008.02.016; Muggleton NG, 2010, CORTEX, V46, P178, DOI 10.1016/j.cortex.2009.01.011; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Sommer M, 2008, TMS WAVEFORM CURRENT; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2010, CURR BIOL, V20, pR346, DOI 10.1016/j.cub.2010.02.016; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	29	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19712	10.1371/journal.pone.0019712	http://dx.doi.org/10.1371/journal.pone.0019712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611188	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500016
J	Jeffery, NW; Elias-Gutierrez, M; Adamowicz, SJ				Jeffery, Nicholas W.; Elias-Gutierrez, Manuel; Adamowicz, Sarah J.			Species Diversity and Phylogeographical Affinities of the Branchiopoda (Crustacea) of Churchill, Manitoba, Canada	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; CLADOCERA; COLONIZATION; PATTERNS; BARCODE; LIFE	The region of Churchill, Manitoba, contains a wide variety of habitats representative of both the boreal forest and arctic tundra and has been used as a model site for biodiversity studies for nearly seven decades within Canada. Much previous work has been done in Churchill to study the Daphnia pulex species complex in particular, but no study has completed a wide-scale survey on the crustacean species that inhabit Churchill's aquatic ecosystems using molecular markers. We have employed DNA barcoding to study the diversity of the Branchiopoda (Crustacea) in a wide variety of freshwater habitats and to determine the likely origins of the Churchill fauna following the last glaciation. The standard animal barcode marker (COI) was sequenced for 327 specimens, and a 3% divergence threshold was used to delineate potential species. We found 42 provisional and valid branchiopod species from this survey alone, including several cryptic lineages, in comparison with the 25 previously recorded from previous ecological works. Using published sequence data, we explored the phylogeographic affinities of Churchill's branchiopods, finding that the Churchill fauna apparently originated from all directions from multiple glacial refugia (including southern, Beringian, and high arctic regions). Overall, these microcrustaceans are very diverse in Churchill and contain multiple species complexes. The present study introduces among the first sequences for some understudied genera, for which further work is required to delineate species boundaries and develop a more complete understanding of branchiopod diversity over a larger spatial scale.	[Jeffery, Nicholas W.; Adamowicz, Sarah J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Jeffery, Nicholas W.; Adamowicz, Sarah J.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Elias-Gutierrez, Manuel] Colegio Frontera Sur, Dept Systemat & Aquat Ecol, Chetumal Unit, Quintana Roo, Mexico	University of Guelph; University of Guelph; El Colegio de la Frontera Sur (ECOSUR)	Jeffery, NW (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	njeffery@uoguelph.ca	Elias-Gutierrez, Manuel/A-8952-2013; Jeffery, Nicholas W/J-5859-2019	Elias-Gutierrez, Manuel/0000-0003-2562-4584; Jeffery, Nicholas W/0000-0003-4242-5712	Natural Sciences and Engineering Research Council of Canada (NSERC); Genome Canada; Northern Scientific Training Program; Northern Research Fund award; Ontario Genomics Institute [2008-OGI-ICI-03]; Mexican Barcode of Life (MEXBOL) project	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Northern Scientific Training Program; Northern Research Fund award; Ontario Genomics Institute; Mexican Barcode of Life (MEXBOL) project	This project was supported by an International Polar Year (IPY) grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and a Genome Canada grant to Paul Hebert. This work was also funded by the Northern Scientific Training Program to NWJ (http://www.ainc-inac.gc.ca/nth/st/nstp/index-eng.asp), and a Northern Research Fund award to SJA (http://www.churchillscience.ca/index.php?page = re_funding). This project was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03). The work conducted by ME-G was supported in part by the Mexican Barcode of Life (MEXBOL) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P455, DOI 10.1111/j.1466-822x.2005.00164.x; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BERNER DB, 1986, EPA600486032, P1; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; HANN BJ, 1995, HYDROBIOLOGIA, V307, P9, DOI 10.1007/BF00031992; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEBERT PDN, 1986, CAN J FISH AQUAT SCI, V43, P1416, DOI 10.1139/f86-175; HEBERT PDN, 1987, HYDROBIOLOGIA, V145, P183, DOI 10.1007/BF02530279; HEBERT PDN, 1982, ANN ZOOL FENN, V19, P349; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; McClure H. Elliot, 1943, ECOL MONOGR, V13, P1, DOI 10.2307/1943588; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Quiroz-Vazquez P, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2236.1.4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rowe Chad L., 2007, Zootaxa, V1656, P1; Shelford VE, 1941, ECOLOGY, V22, P47, DOI 10.2307/1930008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THORP JH, 2001, ECOLOGY CLASSIFICATI; Weider LJ, 2010, P ROY SOC B-BIOL SCI, V277, P139, DOI 10.1098/rspb.2009.1326; WEIDER LJ, 1987, ECOLOGY, V68, P188, DOI 10.2307/1938819; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x	40	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e18364	10.1371/journal.pone.0018364	http://dx.doi.org/10.1371/journal.pone.0018364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21610864	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500001
J	Lammer, AB; Beck, A; Grummich, B; Forschler, A; Krugel, T; Kahn, T; Schneider, D; Illes, P; Franke, H; Krugel, U				Laemmer, Alexandra B.; Beck, Alexander; Grummich, Benjamin; Foerschler, Annette; Kruegel, Thomas; Kahn, Thomas; Schneider, Dietmar; Illes, Peter; Franke, Heike; Kruegel, Ute			The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; TUMOR-NECROSIS-FACTOR; FOCAL BRAIN ISCHEMIA; EXTRACELLULAR ATP; MICROGLIAL ACTIVATION; PURINERGIC MODULATION; NUCLEUS-ACCUMBENS; P2X(7) RECEPTORS; INDUCED INJURY; UP-REGULATION	Background: After ischemia of the CNS, extracellular adenosine 5'-triphosphate (ATP) can reach high concentrations due to cell damage and subsequent increase of membrane permeability. ATP may cause cellular degeneration and death, mediated by P2X and P2Y receptors. Methodology/Principal Findings: The effects of inhibition of P2 receptors by pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) on electrophysiological, functional and morphological alterations in an ischemia model with permanent middle cerebral artery occlusion (MCAO) were investigated up to day 28. Spontaneously hypertensive rats received PPADS or vehicle intracerebroventricularly 15 minutes prior MCAO for up to 7 days. The functional recovery monitored by qEEG was improved by PPADS indicated by an accelerated recovery of ischemia-induced qEEG changes in the delta and alpha frequency bands along with a faster and sustained recovery of motor impairments. Whereas the functional improvements by PPADS were persistent at day 28, the infarct volume measured by magnetic resonance imaging and the amount of TUNEL-positive cells were significantly reduced by PPADS only until day 7. Further, by immunohistochemistry and confocal laser scanning microscopy, we identified both neurons and astrocytes as TUNEL-positive after MCAO. Conclusion: The persistent beneficial effect of PPADS on the functional parameters without differences in the late (day 28) infarct size and apoptosis suggests that the early inhibition of P2 receptors might be favourable for the maintenance or early reconstruction of neuronal connectivity in the periinfarct area after ischemic incidents.	[Laemmer, Alexandra B.; Beck, Alexander] Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany; [Laemmer, Alexandra B.; Schneider, Dietmar] Univ Leipzig, Dept Neurol, Leipzig, Germany; [Grummich, Benjamin; Kruegel, Thomas; Illes, Peter; Franke, Heike; Kruegel, Ute] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Foerschler, Annette; Kahn, Thomas] Univ Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany	University of Erlangen Nuremberg; Leipzig University; Leipzig University; Leipzig University	Lammer, AB (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany.	ute.kruegel@medizin.uni-leipzig.de	Forschler, Annette/O-9390-2015	Forschler, Annette/0000-0001-9665-5228; Krugel, Ute/0000-0002-2317-2302	Deutsche Forschungsgemeinschaft (DFG) [KI677, KR3614]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de; KI677, KR3614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Beaumont E, 2004, MUSCLE NERVE, V29, P234, DOI 10.1002/mus.10539; Boltze J, 2006, ARTIF ORGANS, V30, P756, DOI 10.1111/j.1525-1594.2006.00297.x; Braun N, 1998, J NEUROSCI, V18, P4891; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Burnstock G, 2011, CURR TOP ME IN PRESS; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Cavaliere F, 2004, EXP CELL RES, V300, P149, DOI 10.1016/j.yexcr.2004.07.009; Cavaliere F, 2003, NEUROSCIENCE, V120, P85, DOI 10.1016/S0306-4522(03)00228-8; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Dijkhuizen RM, 2003, J CEREBR BLOOD F MET, V23, P1383, DOI 10.1097/01.WCB.0000100341.78607.EB; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Ferrari D, 1997, J IMMUNOL, V159, P1451; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Finnigan SP, 2006, CLIN NEUROPHYSIOL, V117, P2338, DOI 10.1016/j.clinph.2006.06.718; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Franke H, 2004, NEUROSCIENCE, V127, P431, DOI 10.1016/j.neuroscience.2004.05.003; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Jacobson KA, 1998, J MED CHEM, V41, P2201, DOI 10.1021/jm980183o; Juranyi Z, 1999, BRAIN RES, V823, P183, DOI 10.1016/S0006-8993(99)01169-5; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Krugel U, 2004, INT J DEV NEUROSCI, V22, P565, DOI 10.1016/j.ijdevneu.2004.07.009; Krugel U, 2003, SYNAPSE, V47, P134, DOI 10.1002/syn.10162; Krugel U, 2001, EUR J PHARMACOL, V420, pR3, DOI 10.1016/S0014-2999(01)01001-9; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Le Feuvre RA, 2003, J CEREBR BLOOD F MET, V23, P381, DOI 10.1097/01.WCB.0000048519.34839.97; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Moyanova S, 1998, ARCH PHYSIOL BIOCHEM, V106, P384, DOI 10.1076/apab.106.5.384.4362; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Noto T, 2004, MOL BRAIN RES, V128, P30, DOI 10.1016/j.molbrainres.2004.06.003; NUWER MR, 1987, NEUROLOGY, V37, P1153, DOI 10.1212/WNL.37.7.1153; Paxinos P., 1986, RAT BRAIN STEREOTAXI; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; Thomalla G, 2006, STROKE, V37, P852, DOI 10.1161/01.STR.0000204120.79399.72; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang YC, 2006, J NEUROPHYSIOL, V95, P1537, DOI 10.1152/jn.01166.2005	68	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19983	10.1371/journal.pone.0019983	http://dx.doi.org/10.1371/journal.pone.0019983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611146	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500038
J	Meissner, B; Rogalski, T; Viveiros, R; Warner, A; Plastino, L; Lorch, A; Granger, L; Segalat, L; Moerman, DG				Meissner, Barbara; Rogalski, Teresa; Viveiros, Ryan; Warner, Adam; Plastino, Lorena; Lorch, Adam; Granger, Laure; Segalat, Laurent; Moerman, Donald G.			Determining the Sub-Cellular Localization of Proteins within Caenorhabditis elegans Body Wall Muscle	PLOS ONE			English	Article							INTEGRIN ADHESION COMPLEXES; OPEN READING FRAMES; C-ELEGANS; FOCAL ADHESIONS; MECHANOSENSORY FUNCTION; FUNCTIONAL GENOMICS; FLUORESCENT PROTEIN; CELL-ADHESION; LINKED KINASE; GENE	Determining the sub-cellular localization of a protein within a cell is often an essential step towards understanding its function. In Caenorhabditis elegans, the relatively large size of the body wall muscle cells and the exquisite organization of their sarcomeres offer an opportunity to identify the precise position of proteins within cell substructures. Our goal in this study is to generate a comprehensive "localizome'' for C. elegans body wall muscle by GFP-tagging proteins expressed in muscle and determining their location within the cell. For this project, we focused on proteins that we know are expressed in muscle and are orthologs or at least homologs of human proteins. To date we have analyzed the expression of about 227 GFP-tagged proteins that show localized expression in the body wall muscle of this nematode (e.g. dense bodies, M-lines, myofilaments, mitochondria, cell membrane, nucleus or nucleolus). For most proteins analyzed in this study no prior data on sub-cellular localization was available. In addition to discrete sub-cellular localization we observe overlapping patterns of localization including the presence of a protein in the dense body and the nucleus, or the dense body and the M-lines. In total we discern more than 14 sub-cellular localization patterns within nematode body wall muscle. The localization of this large set of proteins within a muscle cell will serve as an invaluable resource in our investigation of muscle sarcomere assembly and function.	[Meissner, Barbara; Rogalski, Teresa; Viveiros, Ryan; Warner, Adam; Plastino, Lorena; Lorch, Adam; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Moerman, Donald G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Granger, Laure; Segalat, Laurent] Univ Lyon 1, CNRS, CGMC, F-69622 Villeurbanne, France	University of British Columbia; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Meissner, B (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	moerman@zoology.ubc.ca			Canadian Institute for Health Research; National Science and Engineering Research Council	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Canadian Institute for Health Research and the National Science and Engineering Research Council to DGM. RV is a research trainee of the Michael Smith Foundation for Health Research. DGM is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; GHOSH SR, 2010, EUR J CELL BIOL, DOI DOI 10.1016/JEJCB.2009.11.027; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heyman JA, 1999, GENOME RES, V9, P383; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Labouesse M, 2003, CURR BIOL, V13, pR528, DOI 10.1016/S0960-9822(03)00448-2; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; MELLO C, 1995, CAENORHABDITIS ELEGA, P452; MOERMAN DG, 1997, MUSCLE STRUCTURE FUN, P417; MOERMAN DG, 2006, SARCOMERE ASSEMBLY C, DOI DOI 10.1895/WORMBOOK.1.81.1; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moulder GL, 1996, MOL BIOL CELL, V7, P1181, DOI 10.1091/mbc.7.8.1181; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; POOT YZ, 1996, J HISTOCHEM CYTOCHEM, V44, P1363; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Ruksana R, 2005, GENES CELLS, V10, P261, DOI 10.1111/j.1365-2443.2005.00829.x; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Waterston R., 1988, NEMATODE C ELEGANS, P281; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Zervas CG, 2002, CURR BIOL, V12, pR350, DOI 10.1016/S0960-9822(02)00856-4; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	58	31	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19937	10.1371/journal.pone.0019937	http://dx.doi.org/10.1371/journal.pone.0019937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611156	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500035
J	Wu, B; Benrashid, E; Lu, PJ; Cloer, C; Zillmer, A; Shaban, M; Lu, QL				Wu, Bo; Benrashid, Ehsan; Lu, Peijuan; Cloer, Caryn; Zillmer, Allen; Shaban, Mona; Lu, Qi Long			Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development	PLOS ONE			English	Article							MUSCLE-CELLS; EXPRESSION; RESTORATION; DELIVERY; DELETION; GENE; MICE	Antisense therapy has recently been demonstrated with great potential for targeted exon skipping and restoration of dystrophin production in cultured muscle cells and in muscles of Duchenne Muscular Dystrophy (DMD) patients. Therapeutic values of exon skipping critically depend on efficacy of the drugs, antisense oligomers (AOs). However, no animal model has been established to test AO targeting human dystrophin exon in vivo systemically. In this study, we applied Vivo-Morpholino to the hDMD mouse, a transgenic model carrying the full-length human dystrophin gene, and achieved for the first time more than 70% efficiency of targeted human dystrophin exon skipping in vivo systemically. We also established a GFP-reporter myoblast culture to screen AOs targeting human dystrophin exon 50. Antisense efficiency for most AOs is consistent between the reporter cells, human myoblasts and in the hDMD mice in vivo. However, variation in efficiency was also clearly observed. A combination of in vitro cell culture and a Vivo-Morpholino based evaluation in vivo systemically in the hDMD mice therefore may represent a prudent approach for selecting AO drug and to meet the regulatory requirement.	[Wu, Bo; Benrashid, Ehsan; Lu, Peijuan; Cloer, Caryn; Zillmer, Allen; Shaban, Mona; Lu, Qi Long] Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Dept Neurol, Charlotte, NC 28203 USA	Carolinas Medical Center	Wu, B (corresponding author), Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Dept Neurol, Charlotte, NC 28203 USA.	bo.wu@carolinashealthcare.org; qi.lu@carolinashealthcare.org	lu, qi/HHS-2115-2022	Benrashid, Ehsan/0000-0003-4216-6095	Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation; Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA; U.S. Army Medical Research, Department of Defense [W81XWH-05-1-0616]	Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation; Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA; U.S. Army Medical Research, Department of Defense(United States Department of Defense)	This work was supported by the Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation and Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA and by U.S. Army Medical Research, Department of Defense (W81XWH-05-1-0616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HU Y, 2010, MOL THER JAN, P19; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Mirabella M, 1998, NEUROLOGY, V51, P592, DOI 10.1212/WNL.51.2.592; Sazani P, 2001, NUCLEIC ACIDS RES, V29, P3965, DOI 10.1093/nar/29.19.3965; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; Takeshima Y, 2001, BRAIN DEV-JPN, V23, P788, DOI 10.1016/S0387-7604(01)00326-6; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	24	11	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19906	10.1371/journal.pone.0019906	http://dx.doi.org/10.1371/journal.pone.0019906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611204	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500032
J	Carnes, LM; Nunn, CL; Lewis, RJ				Carnes, Laurel Mariah; Nunn, Charles L.; Lewis, Rebecca J.			Effects of the Distribution of Female Primates on the Number of Males	PLOS ONE			English	Article							EXAGGERATED SEXUAL SWELLINGS; MALE REPRODUCTIVE SUCCESS; EXTRA-PAIR COPULATIONS; MALE MATING STRATEGIES; MALE VERREAUXS SIFAKA; MALE RHESUS MACAQUES; INTER-TROOP TRANSFER; SOCIAL-ORGANIZATION; JAPANESE MACAQUES; ANIMAL SOCIETIES	The spatiotemporal distribution of females is thought to drive variation in mating systems, and hence plays a central role in understanding animal behavior, ecology and evolution. Previous research has focused on investigating the links between female spatiotemporal distribution and the number of males in haplorhine primates. However, important questions remain concerning the importance of spatial cohesion, the generality of the pattern across haplorhine and strepsirrhine primates, and the consistency of previous findings given phylogenetic uncertainty. To address these issues, we examined how the spatiotemporal distribution of females influences the number of males in primate groups using an expanded comparative dataset and recent advances in Bayesian phylogenetic and statistical methods. Specifically, we investigated the effect of female distributional factors (female number, spatial cohesion, estrous synchrony, breeding season duration and breeding seasonality) on the number of males in primate groups. Using Bayesian approaches to control for uncertainty in phylogeny and the model of trait evolution, we found that the number of females exerted a strong influence on the number of males in primate groups. In a multiple regression model that controlled for female number, we found support for temporal effects, particularly involving female estrous synchrony: the number of males increases when females are more synchronously receptive. Similarly, the number of males increases in species with shorter birth seasons, suggesting that greater breeding seasonality makes defense of females more difficult for male primates. When comparing primate suborders, we found only weak evidence for differences in traits between haplorhines and strepsirrhines, and including suborder in the statistical models did not affect our conclusions or give compelling evidence for different effects in haplorhines and strepsirrhines. Collectively, these results demonstrate that male monopolization is driven primarily by the number of females in groups, and secondarily by synchrony of female reproduction within groups.	[Carnes, Laurel Mariah] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Nunn, Charles L.] Harvard Univ, Peabody Museum, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Lewis, Rebecca J.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	University of Chicago; Harvard University; University of Texas System; University of Texas Austin	Carnes, LM (corresponding author), Univ Chicago, Sch Law, Chicago, IL 60637 USA.	rjlewis@mail.utexas.edu	Lewis, Rebecca/M-9205-2019	Lewis, Rebecca/0000-0003-3533-6105	Harvard University; National Science Foundation [BCS-0923791]; Rapaport-King Thesis Scholarship	Harvard University; National Science Foundation(National Science Foundation (NSF)); Rapaport-King Thesis Scholarship	CLN was supported by Harvard University and the National Science Foundation (BCS-0923791). RJL was supported by a Rapaport-King Thesis Scholarship (http://www.utexas.edu/cola/progs/lahonors/scholarships/lah/rapoport-king-thesis.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; ALTMANN J, 1990, ANIM BEHAV, V39, P193, DOI 10.1016/S0003-3472(05)80740-7; Andelman S.J, 1986, P201; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BERARD JD, 1994, BEHAVIOUR, V129, P177, DOI 10.1163/156853994X00604; BOINSKI S, 1987, BEHAV ECOL SOCIOBIOL, V21, P13, DOI 10.1007/BF00324430; Boinski S, 2005, BEHAVIOUR, V142, P525, DOI 10.1163/1568539054352888; Borries C, 2000, PRIMATE MALES, P146; Brauch K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1453, DOI 10.1007/s00265-008-0575-7; Brown GP, 1999, BEHAV ECOL SOCIOBIOL, V47, P9, DOI 10.1007/s002650050644; Campbell CJ., 2010, PRIMATES PERSPECTIVE; Cant MA, 1998, ANIM BEHAV, V55, P163, DOI 10.1006/anbe.1997.0589; Cappozzo HL, 2008, NATURWISSENSCHAFTEN, V95, P625, DOI 10.1007/s00114-008-0363-2; Carlson AA, 2001, ANIM BEHAV, V62, P1047, DOI 10.1006/anbe.2001.1849; Chapman CA, 2009, PRIMATES, V50, P12, DOI 10.1007/s10329-008-0123-0; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; CHENEY DL, 1983, AM NAT, V122, P392, DOI 10.1086/284142; Clarke MR, 2010, PRIMATES, V51, P241, DOI 10.1007/s10329-010-0195-5; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; CLUTTONB.TH, 1974, NATURE, V250, P539, DOI 10.1038/250539a0; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Cords M, 2000, PRIMATE MALES, P84; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; Dixson A, 2002, EVOL ANTHROPOL, V11, P195, DOI 10.1002/evan.10090; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Dunbar RIM, 1999, PRIMATE MALES; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P91, DOI [10.1007/s00265-004-0823-4, 10.1007/s00265-004-0826-1]; EISENBER.JF, 1972, SCIENCE, V176, P863, DOI 10.1126/science.176.4037.863; Eisenberg J.F., 1981, MAMMALIAN RAD; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Engelhardt A, 2006, BEHAV ECOL SOCIOBIOL, V59, P740, DOI 10.1007/s00265-005-0104-x; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GLANDER KE, 1992, INT J PRIMATOL, V13, P415, DOI 10.1007/BF02547826; GRANT JWA, 1995, ANIM BEHAV, V49, P367, DOI 10.1006/anbe.1995.9998; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hayakawa S, 2007, INT J PRIMATOL, V28, P73, DOI 10.1007/s10764-006-9109-1; HEWS DK, 1993, ANIM BEHAV, V46, P279, DOI 10.1006/anbe.1993.1189; Heymann EW, 2000, PRIMATE MALES, P64; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Ims, 1988, NATURE, V335, P541; IMS RA, 1987, AM NAT, V130, P475, DOI 10.1086/284725; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Isaac JL, 2003, BEHAV ECOL, V14, P818, DOI 10.1093/beheco/arg076; Janson C, 2005, CAM S BIO EVOL ANTHR, V44, P307, DOI 10.1017/CBO9780511542343.012; Janson Charles H., 1992, P95; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Johnson DDP, 2000, MAMMAL REV, V30, P171, DOI 10.1046/j.1365-2907.2000.00066.x; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; JONES KC, 1983, FOLIA PRIMATOL, V40, P145, DOI 10.1159/000156096; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 2000, PRIMATE MALES, P55; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; KEDDYHECTOR AC, 1992, AM ZOOL, V32, P62; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kraus C, 2003, ANIM BEHAV, V66, P225, DOI 10.1006/anbe.2003.2192; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Kutsukake N, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P165, DOI 10.1017/CBO9780511641954.009; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis RJ, 2008, INT J PRIMATOL, V29, P1249, DOI 10.1007/s10764-008-9304-3; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lindenfors P, 2004, P ROY SOC B-BIOL SCI, V271, pS101, DOI 10.1098/rsbl.2003.0114; Martin JK, 2007, OECOLOGIA, V154, P227, DOI 10.1007/s00442-007-0823-y; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; Meade A., 2007, BAYESTRAITS; Mitani JC, 1996, AM J PRIMATOL, V38, P315, DOI 10.1002/(SICI)1098-2345(1996)38:4<315::AID-AJP3>3.0.CO;2-1; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Muller AE, 2000, BIOL REV, V75, P405, DOI 10.1017/S0006323100005533; Muller AE, 2005, AM J PHYS ANTHROPOL, V128, P399, DOI 10.1002/ajpa.20086; NELSON J, 1995, BEHAV ECOL SOCIOBIOL, V37, P217, DOI 10.1007/BF00177400; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; PACKER C, 1979, ANIM BEHAV, V27, P1, DOI 10.1016/0003-3472(79)90126-X; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 2002, BIOL EVOLUTION STAT, P148; PALOMBIT RA, 1994, ANIM BEHAV, V47, P721, DOI 10.1006/anbe.1994.1097; PEREIRA ME, 1991, PHYSIOL BEHAV, V49, P47, DOI 10.1016/0031-9384(91)90228-G; Perrin WF, 2003, MAR MAMMAL SCI, V19, P462, DOI 10.1111/j.1748-7692.2003.tb01315.x; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; REICHARD U, 1995, ETHOLOGY, V100, P99; RIDLEY M, 1986, ANIM BEHAV, V34, P1848, DOI 10.1016/S0003-3472(86)80271-8; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; ROWELL TE, 1975, J REPROD FERTIL, V43, P419; Say L, 2001, P ROY SOC B-BIOL SCI, V268, P1049, DOI 10.1098/rspb.2001.1583; Setchell JM, 2005, ANIM BEHAV, V70, P1105, DOI 10.1016/j.anbehav.2005.02.021; SMALL MF, 1989, YEARB PHYS ANTHROPOL, V32, P103; Smuts B. B., 1987, PRIMATE SOC; Sokal RR, 1995, BIOMETRY; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Soltis J, 1997, ANIM BEHAV, V54, P737, DOI 10.1006/anbe.1997.0568; SPRAGUE DS, 1991, FOLIA PRIMATOL, V57, P156, DOI 10.1159/000156577; Strier KB, 2003, YEARB PHYS ANTHROPOL, V46, P2, DOI 10.1002/ajpa.10383; Strier KB, 1996, HUM NATURE-INT BIOS, V7, P105, DOI 10.1007/BF02692107; Struhsaker TT, 2008, INT J PRIMATOL, V29, P19, DOI 10.1007/s10764-007-9146-4; TERBORGH J, 1986, ANNU REV ECOL SYST, V17, P111; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Treatman-Clark K, 2006, THESIS STONY BROOK U; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Noordwijk MA, 1985, J COMP ETHOL, V70, P277; van Schaik CP., 1989, COMP SOCIOECOLOGY BE, P195; VANHOOFF JARAM, 1994, BEHAVIOUR, V130, P309, DOI 10.1163/156853994X00587; vanSchaik CP, 1996, ETHOLOGY, V102, P915; VEHRENCAMP SL, 1983, AM ZOOL, V23, P327; Verdolin JL, 2007, BEHAVIOUR, V144, P1361, DOI 10.1163/156853907782418231; WEBSTER MS, 1994, CONDOR, V96, P722, DOI 10.2307/1369475; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; ZABEL CJ, 1989, ANIM BEHAV, V38, P830, DOI 10.1016/S0003-3472(89)80114-9	128	25	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19853	10.1371/journal.pone.0019853	http://dx.doi.org/10.1371/journal.pone.0019853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603570	Green Submitted, Green Published, gold			2022-12-25	WOS:000290656300032
J	Krumm, SA; Ndungu, JM; Yoon, JJ; Dochow, M; Sun, AM; Natchus, M; Snyder, JP; Plemper, RK				Krumm, Stefanie A.; Ndungu, J. Maina; Yoon, Jeong-Joong; Dochow, Melanie; Sun, Aiming; Natchus, Michael; Snyder, James P.; Plemper, Richard K.			Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PERIPHERAL-BLOOD LYMPHOCYTES; INFLUENZA-A VIRUSES; NF-KAPPA-B; MEASLES-VIRUS; IN-VITRO; TYPE-1 REPLICATION; YOUNG-CHILDREN; CELL-LINE; PROTEIN	Therapeutic targeting of host cell factors required for virus replication rather than of pathogen components opens new perspectives to counteract virus infections. Anticipated advantages of this approach include a heightened barrier against the development of viral resistance and a broadened pathogen target spectrum. Myxoviruses are predominantly associated with acute disease and thus are particularly attractive for this approach since treatment time can be kept limited. To identify inhibitor candidates, we have analyzed hit compounds that emerged from a large-scale high-throughput screen for their ability to block replication of members of both the orthomyxovirus and paramyxovirus families. This has returned a compound class with broad anti-viral activity including potent inhibition of different influenza virus and paramyxovirus strains. After hit-to-lead chemistry, inhibitory concentrations are in the nanomolar range in the context of immortalized cell lines and human PBMCs. The compound shows high metabolic stability when exposed to human S-9 hepatocyte subcellular fractions. Antiviral activity is host-cell species specific and most pronounced in cells of higher mammalian origin, supporting a host-cell target. While the compound induces a temporary cell cycle arrest, host mRNA and protein biosynthesis are largely unaffected and treated cells maintain full metabolic activity. Viral replication is blocked at a post-entry step and resembles the inhibition profile of a known inhibitor of viral RNA-dependent RNA-polymerase (RdRp) activity. Direct assessment of RdRp activity in the presence of the reagent reveals strong inhibition both in the context of viral infection and in reporter-based minireplicon assays. In toto, we have identified a compound class with broad viral target range that blocks host factors required for viral RdRp activity. Viral adaptation attempts did not induce resistance after prolonged exposure, in contrast to rapid adaptation to a pathogen-directed inhibitor of RdRp activity.	[Krumm, Stefanie A.; Yoon, Jeong-Joong; Dochow, Melanie; Plemper, Richard K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Krumm, Stefanie A.; Yoon, Jeong-Joong; Dochow, Melanie; Plemper, Richard K.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Ndungu, J. Maina; Sun, Aiming; Natchus, Michael; Snyder, James P.] Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30322 USA; [Snyder, James P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Plemper, Richard K.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University	Krumm, SA (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	rplempe@emory.edu			NIH/NIAID [AI071002, AI085328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085328, R01AI071002] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by Public Health Service Grants AI071002 and AI085328 (to R. K. P.) from the NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvesalo J, 2008, J INFECT DIS, V197, P156, DOI 10.1086/524142; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Borghouts C, 2008, COMB CHEM HIGH T SCR, V11, P135; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boyd DR, 2004, ORG BIOMOL CHEM, V2, P2530, DOI 10.1039/b409149c; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Carsillo M, 2010, J VIROL, V84, P2180, DOI 10.1128/JVI.01316-09; Coiras M, 2008, PROTEOMICS, V8, P852, DOI 10.1002/pmic.200700664; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Ding XR, 2008, PHARMACOGENOMICS J, V8, P61, DOI 10.1038/sj.tpj.6500459; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Engelking O, 1999, J GEN VIROL, V80, P1599, DOI 10.1099/0022-1317-80-7-1599; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fisher MB, 1997, TETRAHEDRON-ASYMMETR, V8, P613, DOI 10.1016/S0957-4166(97)00033-5; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Fry AM, 2006, CLIN INFECT DIS, V43, P1016, DOI 10.1086/507638; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Garcia M, 2005, J VIROL, V79, P9197, DOI 10.1128/JVI.79.14.9197-9205.2005; Garcia M, 2008, J GEN VIROL, V89, P984, DOI 10.1099/vir.0.83601-0; GRANT DM, 1991, J INHERIT METAB DIS, V14, P421, DOI 10.1007/BF01797915; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Hilpert K, 2007, NAT PROTOC, V2, P1652, DOI 10.1038/nprot.2007.203; Honda A, 2008, J BIOTECHNOL, V133, P208, DOI 10.1016/j.jbiotec.2007.08.019; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; KAGAN HB, 2000, CATALYTIC ASYMMETRIC, P327; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kaur G, 2008, EXPERT OPIN INV DRUG, V17, P43, DOI 10.1517/13543784.17.1.43; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Koch-Weser J, 1974, Cardiovasc Clin, V6, P63; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; LAMB RA, 2007, FIELDS VIROLOGY, V5, P1449; Lee JK, 2007, J VIROL, V81, P8821, DOI 10.1128/JVI.00754-07; Leung Alexander K C, 2004, J Pediatr Health Care, V18, P297, DOI 10.1016/S0891-5245(04)00268-8; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Luthra P, 2008, J VIROL, V82, P10887, DOI 10.1128/JVI.00806-08; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Moyle G, 2008, 48 ANN ICAAC IDSA 46; Moyle Graeme, 2010, Antimicrob Agents Chemother, V54, P3170, DOI 10.1128/AAC.00268-10; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Plemper RK, 2005, ANTIMICROB AGENTS CH, V49, P3755, DOI 10.1128/AAC.49.9.3755-3761.2005; Plemper RK, 2004, P NATL ACAD SCI USA, V101, P5628, DOI 10.1073/pnas.0308520101; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Schang Luis M, 2006, Expert Rev Anti Infect Ther, V4, P953, DOI 10.1586/14787210.4.6.953; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stiver G, 2003, CAN MED ASSOC J, V168, P49; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sun A, 2008, J MED CHEM, V51, P3731, DOI 10.1021/jm701239a; Sun M, 2008, J VIROL, V82, P105, DOI 10.1128/JVI.01520-07; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; White LK, 2007, ANTIMICROB AGENTS CH, V51, P2293, DOI 10.1128/AAC.00289-07; WHO, 2009, CONC FRAM INT CLASS, P1; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yoon JJ, 2008, J BIOMOL SCREEN, V13, P591, DOI 10.1177/1087057108321089; Yoon JJ, 2009, ANTIMICROB AGENTS CH, V53, P3860, DOI 10.1128/AAC.00503-09; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	80	38	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20069	10.1371/journal.pone.0020069	http://dx.doi.org/10.1371/journal.pone.0020069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603574	gold, Green Submitted, Green Published			2022-12-25	WOS:000290656300051
J	Dugatkin, LA; Dugatkin, AD				Dugatkin, Lee Alan; Dugatkin, Aaron David			Overestimating Resource Value and Its Effects on Fighting Decisions	PLOS ONE			English	Article							EVOLUTION; STRATEGY	Much work in behavioral ecology has shown that animals fight over resources such as food, and that they make strategic decisions about when to engage in such fights. Here, we examine the evolution of one, heretofore unexamined, component of that strategic decision about whether to fight for a resource. We present the results of a computer simulation that examined the evolution of over-or underestimating the value of a resource ( food) as a function of an individual's current hunger level. In our model, animals fought for food when they perceived their current food level to be below the mean for the environment. We considered seven strategies for estimating food value: 1) always underestimate food value, 2) always overestimate food value, 3) never over-or underestimate food value, 4) overestimate food value when hungry, 5) underestimate food value when hungry, 6) overestimate food value when relatively satiated, and 7) underestimate food value when relatively satiated. We first competed all seven strategies against each other when they began at approximately equal frequencies. In such a competition, two strategies-"always overestimate food value,'' and "overestimate food value when hungry''-were very successful. We next competed each of these strategies against the default strategy of "never overor underestimate,'' when the default strategy was set at 99% of the population. Again, the strategies of "always overestimate food value'' and "overestimate food value when hungry'' fared well. Our results suggest that overestimating food value when deciding whether to fight should be favored by natural selection.	[Dugatkin, Lee Alan] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Dugatkin, Aaron David] Murray Hill Acad, Louisville, KY USA	University of Louisville	Dugatkin, LA (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	lee.dugatkin@louisville.edu						Dugatkin L. A., 2009, PRINCIPLES ANIMAL BE; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; Houston AI, 1999, MODELS ADAPTIVE BEHA; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Mangel M., 1988, DYNAMIC MODELING BEH; Maynard Smith J., 1982, pi; Mesterton-Gibbons M, 2009, J THEOR BIOL, V256, P263, DOI 10.1016/j.jtbi.2008.10.004; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Wilensky U., 1999, NET LOGO	12	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19924	10.1371/journal.pone.0019924	http://dx.doi.org/10.1371/journal.pone.0019924			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603640	gold, Green Published, Green Submitted			2022-12-25	WOS:000290558500037
J	Hopkins, R; Bridgeman, A; Joseph, J; Gilbert, SC; McShane, H; Hanke, T				Hopkins, Richard; Bridgeman, Anne; Joseph, Joan; Gilbert, Sarah C.; McShane, Helen; Hanke, Tomas			Dual Neonate Vaccine Platform against HIV-1 and M-tuberculosis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIME-BOOST IMMUNIZATION; BACILLUS-CALMETTE-GUERIN; CYTOTOXIC T-LYMPHOCYTES; MHC CLASS-II; ANTIGEN PRESENTATION; PROTECTIVE EFFICACY; RECOMBINANT BCG; ENHANCED IMMUNOGENICITY; CHILD TRANSMISSION	Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guerin (BCG) as a prevention against TB. BCG protects against disseminated disease in the first 10 years of life, but provides a variable protection against pulmonary TB and enhancing boost delivered by recombinant modified vaccinia virus Ankara (rMVA) expressing antigen 85A (Ag85A) of M. tuberculosis is currently in phase IIb evaluation in African neonates. If the newborn's mother is positive for human immunodeficiency virus type 1 (HIV-1), the baby is at high risk of acquiring HIV-1 through breastfeeding. We suggested that a vaccination consisting of recombinant BCG expressing HIV-1 immunogen administered at birth followed by a boost with rMVA sharing the same immunogen could serve as a strategy for prevention of mother-to-child transmission of HIV-1 and rMVA expressing an African HIV-1-derived immunogen HIVA is currently in phase I trials in African neonates. Here, we aim to develop a dual neonate vaccine platform against HIV-1 and TB consisting of BCG. HIVA administered at birth followed by a boost with MVA.HIVA.85A. Thus, mMVA.HIVA.85A and sMVA.HIVA.85A vaccines were constructed, in which the transgene transcription is driven by either modified H5 or short synthetic promoters, respectively, and tested for immunogenicity alone and in combination with BCG. HIVA(222). mMVA.HIVA.85A was produced markerless and thus suitable for clinical manufacture. While sMVA.HIVA.85A expressed higher levels of the immunogens, it was less immunogenic than mMVA.HIVA.85A in BALB/cmice. A BCG. HIVA(222)-mMVA.HIVA.85A prime-boost regimen induced robust T cell responses to both HIV-1 and M. tuberculosis. Therefore, proof-of-principle for a dual anti-HIV-1/M. tuberculosis infant vaccine platform is established. Induction of immune responses against these pathogens soon after birth is highly desirable and may provide a basis for lifetime protection maintained by boosts later in life.	[Hopkins, Richard; Bridgeman, Anne; Hanke, Tomas] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Joseph, Joan] Univ Barcelona, Sch Med, AIDS Res Unit, Hosp Clin,IDIBAPS,HIVACAT, Barcelona, Spain; [Gilbert, Sarah C.; McShane, Helen; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; Jenner Institute	Hopkins, R (corresponding author), Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	tomas.hanke@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Hopkins, Richard/AAI-5007-2020	Gilbert, Sarah C./0000-0002-6823-9750; Bridgeman, Anne/0000-0002-9478-6125; McShane, Helen/0000-0002-2126-5142	Medical Research Council of UK; HIVACAT; Foundation for Research and Prevention of AIDS in Spain [FIPSE 36338/02]; Medical Research Council [G1000800d] Funding Source: researchfish	Medical Research Council of UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HIVACAT; Foundation for Research and Prevention of AIDS in Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council of UK and HIVACAT, the Foundation for Research and Prevention of AIDS in Spain (FIPSE 36338/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami Y, 2005, J VIROL, V79, P12871, DOI 10.1128/JVI.79.20.12871-12879.2005; Bridgeman A, 2009, VACCINE, V28, P474, DOI 10.1016/j.vaccine.2009.09.136; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chege GK, 2009, VACCINE, V27, P4857, DOI 10.1016/j.vaccine.2009.05.064; Chen ZW, 2008, JAIDS-J ACQ IMM DEF, V47, P412, DOI 10.1097/QAI.0b013e3181651bb2; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Im Eung-Jun, 2004, Expert Rev Vaccines, V3, pS89, DOI 10.1586/14760584.3.4.S89; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Lugosi L, 1989, Acta Leprol, V7 Suppl 1, P256; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Safrit JT, 2004, JAIDS-J ACQ IMM DEF, V35, P169, DOI 10.1097/00126334-200402010-00012; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Uhlig U, 2009, AM J RESP CRIT CARE, V179; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Wang ZB, 2010, IMAGE VISION COMPUT, V28, P5, DOI 10.1016/j.imavis.2009.06.007; Wang ZD, 2007, VACCINE, V25, P1132, DOI 10.1016/j.vaccine.2006.09.067; Webb TJR, 2006, EUR J IMMUNOL, V36, P2595, DOI 10.1002/eji.200636024; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; World Health Organization, 2009, 2008 2013 ACT PLAN G, V416, P1; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; YASUTOMI Y, 1993, J IMMUNOL, V150, P3101	54	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20067	10.1371/journal.pone.0020067	http://dx.doi.org/10.1371/journal.pone.0020067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603645	gold, Green Published, Green Submitted			2022-12-25	WOS:000290558500043
J	Moore, RA; Warren, RL; Freeman, JD; Gustavsen, JA; Chenard, C; Friedman, JM; Suttle, CA; Zhao, YJ; Holt, RA				Moore, Richard A.; Warren, Rene L.; Freeman, J. Douglas; Gustavsen, Julia A.; Chenard, Caroline; Friedman, Jan M.; Suttle, Curtis A.; Zhao, Yongjun; Holt, Robert A.			The Sensitivity of Massively Parallel Sequencing for Detecting Candidate Infectious Agents Associated with Human Tissue	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO; SYNECHOCOCCUS; CYANOPHAGES; HARNAV	Massively parallel sequencing technology now provides the opportunity to sample the transcriptome of a given tissue comprehensively. Transcripts at only a few copies per cell are readily detectable, allowing the discovery of low abundance viral and bacterial transcripts in human tissue samples. Here we describe an approach for mining large sequence data sets for the presence of microbial sequences. Further, we demonstrate the sensitivity of this approach by sequencing human RNA-seq libraries spiked with decreasing amounts of an RNA-virus. At a modest depth of sequencing, viral transcripts can be detected at frequencies less than 1 in 1,000,000. With current sequencing platforms approaching outputs of one billion reads per run, this is a highly sensitive method for detecting putative infectious agents associated with human tissues.	[Moore, Richard A.; Warren, Rene L.; Freeman, J. Douglas; Zhao, Yongjun; Holt, Robert A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Gustavsen, Julia A.; Chenard, Caroline] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Vancouver, BC, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Moore, RA (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada.	rmoore@bcgsc.ca	Holt, Robert A/C-3303-2009; suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008; Gustavsen, Julia/AAR-9433-2020; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Gustavsen, Julia/0000-0002-4764-4802; Warren, Rene/0000-0002-9890-2293; Friedman, Jan/0000-0002-7482-9570	British Columbia Clinical Genomics Network	British Columbia Clinical Genomics Network	Funding for this study was provided by the British Columbia Clinical Genomics Network (http://www.bccgn.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Garza DR, 1998, MICROB ECOL, V36, P281, DOI 10.1007/s002489900115; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x	16	46	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19838	10.1371/journal.pone.0019838	http://dx.doi.org/10.1371/journal.pone.0019838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603639	Green Published, gold, Green Submitted			2022-12-25	WOS:000290558500032
J	Lin, TC; Gombos, L; Neuner, A; Sebastian, D; Olsen, JV; Hrle, A; Benda, C; Schiebel, E				Lin, Tien-chen; Gombos, Linda; Neuner, Annett; Sebastian, Dominik; Olsen, Jesper V.; Hrle, Ajla; Benda, Christian; Schiebel, Elmar			Phosphorylation of the Yeast gamma-Tubulin Tub4 Regulates Microtubule Function	PLOS ONE			English	Article							SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; RING COMPLEX; PHOSPHOPROTEOME ANALYSIS; COMPONENT SPC110P; MASS-SPECTROMETRY; MITOTIC SPINDLE; SHUTTLE VECTORS	The yeast gamma-tubulin Tub4 is assembled with Spc97 and Spc98 into the small Tub4 complex. The Tub4 complex binds via the receptor proteins Spc72 and Spc110 to the spindle pole body (SPB), the functional equivalent of the mammalian centrosome, where the Tub4 complex organizes cytoplasmic and nuclear microtubules. Little is known about the regulation of the Tub4 complex. Here, we isolated the Tub4 complex with the bound receptors from yeast cells. Analysis of the purified Tub4 complex by mass spectrometry identified more than 50 phosphorylation sites in Spc72, Spc97, Spc98, Spc110 and Tub4. To examine the functional relevance of the phosphorylation sites, phospho-mimicking and non-phosphorylatable mutations in Tub4, Spc97 and Spc98 were analyzed. Three phosphorylation sites in Tub4 were found to be critical for Tub4 stability and microtubule organization. One of the sites is highly conserved in gamma-tubulins from yeast to human.	[Lin, Tien-chen; Gombos, Linda; Neuner, Annett; Sebastian, Dominik; Schiebel, Elmar] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-6900 Heidelberg, Germany; [Olsen, Jesper V.; Hrle, Ajla; Benda, Christian] MPI Biochem, Martinsried, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Lin, TC (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-6900 Heidelberg, Germany.	schiebel.elmar@zmbh.uni-heidelberg.de	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938; Benda, Christian/0000-0001-5551-1332	German Research Council (DFG) [Schi-295/4-1]	German Research Council (DFG)(German Research Foundation (DFG))	The work of E.S. is supported by the grant Schi-295/4-1 of the German Research Council (DFG, http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Guthrie C., 1991, METHOD ENZYMOL, V194, P429; Hardwick KG, 1999, GENETICS, V152, P509; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Huisman SM, 2007, J CELL SCI, V120, P435, DOI 10.1242/jcs.03342; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Pereira G, 1997, J CELL SCI, V110, P295; Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775; Santamaria A., 2010, MOL CELL PROTEOMICS; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SIKORSKI RS, 1989, GENETICS, V122, P19; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; Spang A, 1996, J CELL SCI, V109, P2229; Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226	72	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19700	10.1371/journal.pone.0019700	http://dx.doi.org/10.1371/journal.pone.0019700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573187	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400040
J	Kesanakurti, D; Chetty, C; Bhoopathi, P; Lakka, SS; Gorantla, B; Tsung, AJ; Rao, JS				Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Tsung, Andrew J.; Rao, Jasti S.			Suppression of MMP-2 Attenuates TNF-alpha Induced NF-kappa B Activation and Leads to JNK Mediated Cell Death in Glioma	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-NECROSIS-FACTOR; FAS-INDUCED APOPTOSIS; C-JUN; SIGNAL-TRANSDUCTION; MOLECULAR-MECHANISMS; TERMINAL KINASE; PATHWAY; INHIBITION; RIP	Background: Abrogation of apoptosis for prolonged cell survival is essential in cancer progression. In our previous studies, we showed the MMP-2 downregulation induced apoptosis in cancer cell lines. Here, we attempt to investigate the exact molecular mechanism of how MMP-2 depletion leads to apoptosis in glioma xenograft cell lines. Methodology/Principal Findings: MMP-2 transcriptional suppression by MMP-2siRNA (pM) induces apoptosis associated with PARP, caspase-8 and -3 cleavage in human glioma xenograft cells 4910 and 5310. Western blotting and cytokine array showed significant decrease in the cellular and secreted levels of TNF-alpha with concomitant reduction in TNFR1, TRADD, TRAF2, RIP, IKK beta and pI kappa B alpha expression levels resulting in inhibition of p65 phosphorylation and nuclear translocation in pM-treated cells when compared to mock and pSV controls. In addition MMP-2 suppression led to elevated Fas-L, Fas and FADD expression levels along with increased p38 and JNK phosphorylation. The JNK-activity assay showed prolonged JNK activation in pM-transfected cells. Specific inhibition of p38 with SB203580 did not show any effect whereas inhibition of JNK phosphorylation with SP600125 notably reversed pM-induced cleavage of PARP, caspase-8 and -3, demonstrating a significant role of JNK in pM-induced cell death. Supplementation of rhMMP-2 counteracted the effect of pM by remarkably elevating TNF-alpha, TRADD, IKK beta and pI kappa B alpha expression and decreasing FADD, Fas-L, and phospho-JNK levels. The EMSA analysis indicated significant reversal of pM-inhibited NF-kappa B activity by rhMMP-2 treatment which rescued cells from pM-induced cell death. In vivo studies indicated that pM treatment diminished intracranial tumor growth and the immuno histochemical analysis showed decreased phospho-p65 and enhanced phospho-JNK levels that correlated with increased TUNEL-positive apoptotic cells in pM-treated tumor sections. Conclusion/Significance: In summary, our study implies a role of MMP-2 in the regulation of TNF-alpha mediated constitutive NF-kappa B activation and Fas-mediated JNK mediated apoptosis in glioma xenograft cells in vitro and in vivo.	[Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol, Peoria, IL 61656 USA; [Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Rao, Jasti S.] Univ Illinois, Dept Pharmacol, Peoria, IL USA; [Tsung, Andrew J.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Kesanakurti, D (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol, Peoria, IL 61656 USA.	jsrao@uic.edu			N.I.N.D.S. [NS64535-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064535] Funding Source: NIH RePORTER	N.I.N.D.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from N.I.N.D.S., NS64535-01A1 (to JSR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia RN, 2003, CELL IMMUNOL, V226, P78, DOI 10.1016/j.cellimm.2003.11.006; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Curtin JF, 2003, BRIT J CANCER, V89, P1950, DOI 10.1038/sj.bjc.6601393; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Gibson S, 1999, J BIOL CHEM, V274, P10916, DOI 10.1074/jbc.274.16.10916; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jia L, 2008, PROSTATE, V68, P427, DOI 10.1002/pros.20716; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Nupponen N. N., 2006, CURRENT DIAGNOSTIC P, V12, P394; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Qin YM, 2007, CELL MOL IMMUNOL, V4, P43; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shimada K, 2003, PROSTATE, V55, P265, DOI 10.1002/pros.10227; Shrivastava P, 2004, MOL CELL BIOL, V24, P6763, DOI 10.1128/MCB.24.15.6763-6772.2004; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	44	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19341	10.1371/journal.pone.0019341	http://dx.doi.org/10.1371/journal.pone.0019341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573233	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800024
J	Belleudi, F; Leone, L; Purpura, V; Cannella, F; Scrofani, C; Torrisi, MR				Belleudi, F.; Leone, L.; Purpura, V.; Cannella, F.; Scrofani, C.; Torrisi, M. R.			HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic	ONCOGENE			English	Article						HPV16 E5; FGFR2b; KGFR; endocytic pathway; receptor tyrosine kinase; human keratinocytes	HUMAN FORESKIN KERATINOCYTES; LIGAND-DEPENDENT ACTIVATION; DOWN-REGULATION; PROTEIN; ONCOPROTEIN; KGF; EGF; DIFFERENTIATION; CELLS; PROLIFERATION	The E5 oncoprotein of the human papillomavirus type 16 (HPV16 E5) cooperates in cervical carcinogenesis and in epithelial transformation deregulating cell growth, survival and differentiation through the modulation of growth factor receptors. Among the epithelial receptor tyrosine kinases, the keratinocyte growth factor receptor/fibroblast growth factor receptor 2b (KGFR/FGFR2b) is a major paracrine mediator of epithelial homeostasis and appears to have an unique and unusual role in epithelial tissues, exerting a tumor-suppressive function in vitro and in vivo. With the aim to better elucidate the molecular events involved in the pathological activity of 16E5, we investigated if the viral protein would be able to affect the KGFR expression, signaling and turnover by interference with its degradative and recycling endocytic pathways. Quantitative reverse transcriptase-PCR and biochemical approaches on human keratinocytes transfected with 16E5-HA showed that E5 protein is able to induce KGFR down-modulation at both transcript and protein levels. Immunofluorescence microscopy in double-transfected cells expressing both E5 and KGFR revealed that the viral protein alters the receptor endocytic trafficking and triggers its endosomal sorting to the indirect juxtanuclear recycling pathway. The shift from lysosomal degradation to recycling at the plasma membrane correlates with a reduced phosphorylation of the fibroblast growth factor receptor substrate-2 alpha tyrosine 196, the major docking site for Grb2-Cbl complexes responsible for receptor ubiquitination and degradation. 5'-Bromo-deoxyuridine incorporation assay demonstrated that expression of 16E5 induces a decrease in the growth response to the receptor ligands as a consequence of KGFR down-modulation, suggesting that 16E5 might have a role on HPV infection in perturbing the KGFR-mediated physiological behavior of confluent keratinocytes committed to differentiation. Oncogene (2011) 30, 4963-4976; doi:10.1038/onc.2011.203; published online 30 May 2011	[Belleudi, F.; Leone, L.; Purpura, V.; Cannella, F.; Scrofani, C.; Torrisi, M. R.] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Med Clin & Mol, I-00161 Rome, Italy; [Torrisi, M. R.] Azienda Osped S Andrea, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Torrisi, MR (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Med Clin & Mol, Piazza Sassari 3, I-00161 Rome, Italy.	mara.torrisi@uniroma1.it	Purpura, Valeria/K-3052-2018	PURPURA, VALERIA/0000-0002-1272-313X	MIUR; AIRC-Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC-Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from MIUR and from AIRC-Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy.	Ashrafi GH, 2006, INT J CANCER, V119, P2105, DOI 10.1002/ijc.22089; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; Barbaresi S, 2010, J GEN VIROL, V91, P521, DOI 10.1099/vir.0.016295-0; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belleudi F, 2006, FASEB J, V20, P395, DOI 10.1096/fj.05-3934fje; Belleudi F, 2009, EXP CELL RES, V315, P2181, DOI 10.1016/j.yexcr.2009.03.022; Capone A, 2000, CELL GROWTH DIFFER, V11, P607; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Chen SL, 2007, ONCOGENE, V26, P42, DOI 10.1038/sj.onc.1209768; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Crusius K, 1998, EXP CELL RES, V241, P76, DOI 10.1006/excr.1998.4024; Crusius K, 1997, ONCOGENE, V15, P1437, DOI 10.1038/sj.onc.1201312; Fehrmann F, 2003, ONCOGENE, V22, P5201, DOI 10.1038/sj.onc.1206554; Feng S, 1997, CANCER RES, V58, P1509; Fey A, 2004, APPL ENVIRON MICROB, V70, P3618, DOI 10.1128/aem.70.6.3618-3623.2004; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; HWANG ES, 1995, VIROLOGY, V211, P227, DOI 10.1006/viro.1995.1395; Kivi N, 2008, ONCOGENE, V27, P2532, DOI 10.1038/sj.onc.1210916; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; LAROCHELLE WJ, 1995, J CELL BIOL, V129, P357, DOI 10.1083/jcb.129.2.357; LEPTAK C, 1991, J VIROL, V65, P7078, DOI 10.1128/JVI.65.12.7078-7083.1991; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Marchese C, 2001, J INVEST DERMATOL, V116, P623, DOI 10.1046/j.0022-202x.2001.01280.x; Maufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; Pedroza-Saavedra A, 2010, VIROLOGY, V400, P44, DOI 10.1016/j.virol.2010.01.009; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PIM D, 1992, ONCOGENE, V7, P27; Regan JA, 2008, J VIROL, V82, P10042, DOI 10.1128/JVI.01240-08; Rodriguez MI, 2000, ONCOGENE, V19, P3727, DOI 10.1038/sj.onc.1203718; STRAIGHT SW, 1993, J VIROL, V67, P4521, DOI 10.1128/JVI.67.8.4521-4532.1993; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Suprynowicz FA, 2010, J VIROL, V84, P10619, DOI 10.1128/JVI.00831-10; Talbert-Slagle K, 2009, VIROLOGY, V384, P345, DOI 10.1016/j.virol.2008.09.033; Thomsen P, 2000, ONCOGENE, V19, P6023, DOI 10.1038/sj.onc.1204010; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453; Zhang BY, 2003, VIROLOGY, V310, P100, DOI 10.1016/S0042-6822(03)00103-X; Zhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P11336, DOI 10.1073/pnas.191377098	49	27	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4963	4976		10.1038/onc.2011.203	http://dx.doi.org/10.1038/onc.2011.203			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21625213	Bronze			2022-12-25	WOS:000298346500005
J	Rosner, M; Hengstschlager, M				Rosner, M.; Hengstschlaeger, M.			Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR	ONCOGENE			English	Article						TSC2; mTOR; S6K1; localization	MAMMALIAN TARGET; PROTEIN; MTOR; PHOSPHORYLATION; KINASE; P27(KIP1); COMPLEXES	The tuberous sclerosis complex gene 2 (TSC2)/mammalian target of rapamycin (mTOR) pathway controls many cellular functions via phosphorylation of ribosomal protein S6 kinases (S6Ks). Alternative splicing and translation generate three S6K1 proteins. Although nuclear and cytoplasmic S6K targets are known, the nucleocytoplasmic localization of the S6K1 proteins has not been comparatively elucidated so far. We show that in primary fibroblasts p85 S6K1 is cytoplasmic, p70 can be found in both compartments and p31 is exclusively nuclear. As already known for p70 and p85, our data suggest that p31 is also a target of mTOR-mediated phosphorylation. Blocking mTOR kinase activity via rapamycin and its activation in TSC2(-/-) cells and via TSC2 small interfering RNAs revealed that it regulates the localization of p70, but not of p85 and p31. The mTOR-dependent phosphorylation of p70 S6K1 at T389 is essential for its nuclear localization and exclusively hyperphosphorylated p70 S6K1 can be found in the nucleus. We further demonstrate this mTOR-controlled p70 S6K1 localization to be growth factor dependent. During the cell-cycle phosphorylation and nuclear localization of p70 S6K1 occur in mid G1 phase. We report that the different S6K1 proteins exhibit different nucleocytoplasmic localizations and that the TSC2/mTOR cascade not only regulates p70 S6K1 activity, but also its localization. These findings provide new important insights into the temporal and spatial dynamics of TSC2/mTOR/S6K regulation. Oncogene (2011) 30, 4509-4522; doi:10.1038/onc.2011.165; published online 23 May 2011	[Rosner, M.; Hengstschlaeger, M.] Med Univ Vienna, Inst Med Genet, A-1090 Vienna, Austria	Medical University of Vienna	Hengstschlager, M (corresponding author), Med Univ Vienna, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria.	markus.hengstschlaeger@meduniwien.ac.at			Herzfelder'sche Familienstiftung; Osterreichische Nationalbank	Herzfelder'sche Familienstiftung; Osterreichische Nationalbank	Research in our laboratory is supported via grants from the Herzfelder'sche Familienstiftung and the Osterreichische Nationalbank.	CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Hengstschlager M, 2001, PRENATAL DIAG, V21, P897, DOI 10.1002/pd.154; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim D, 2009, GROWTH FACTORS, V27, P12, DOI 10.1080/08977190802556986; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699; Knowles MA, 2003, CANCER RES, V63, P7652; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Plas DR, 2009, CURR OPIN CELL BIOL, V21, P230, DOI 10.1016/j.ceb.2008.12.013; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rosner M, 2007, HUM MOL GENET, V16, P1541, DOI 10.1093/hmg/ddm103; Rosner M, 2010, NAT PROTOC, V5, P1081, DOI 10.1038/nprot.2010.74; Rosner M, 2009, HUM MOL GENET, V18, P3298, DOI 10.1093/hmg/ddp271; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	31	56	61	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	44					4509	4522		10.1038/onc.2011.165	http://dx.doi.org/10.1038/onc.2011.165			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21602892				2022-12-25	WOS:000296733200006
J	Kato, H; Gruenwald, A; Suh, JH; Miner, JH; Barisoni-Thomas, L; Taketo, MM; Faul, C; Millar, SE; Holzman, LB; Susztak, K				Kato, Hideki; Gruenwald, Antje; Suh, Jung Hee; Miner, Jeffrey H.; Barisoni-Thomas, Laura; Taketo, Makoto M.; Faul, Christian; Millar, Sarah E.; Holzman, Lawrence B.; Susztak, Katalin			Wnt/beta-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; KIDNEY; BETA-1-INTEGRIN; ALPHA-ACTININ-4; NEPHROPATHY; PROTEINURIA; PROGRESSION; VARIANTS; DELETION; DISEASE	Diabetic kidney disease (DKD) is the single most common cause of albuminuria and end-stage kidney disease in the United States. We found increased expression of Wnt/beta-catenin (Ctnnb1) pathway transcripts and proteins in glomeruli and podocytes of patients and mouse models of DKD. Mice with podocyte-specific expression of stabilized Ctnnb1 exhibited basement membrane abnormalities, albuminuria, and increased susceptibility to glomerular injury. Mice with podocyte-specific deletion of Ctnnb1 or podocyte-specific expression of the canonical Wnt inhibitor Dickkopf-related protein 1 (Dkk1) also showed increased susceptibility to DKD. Podocytes with stabilized Ctnnb1 were less motile and less adhesive to different matrices. Deletion of Ctnnb1 in cultured podocytes increased the expression of podocyte differentiation markers and enhanced cell motility; however, these cells were more susceptible to apoptosis. These results indicate that Wnt/Ctnnb1 signaling in podocytes plays a critical role in integrating cell adhesion, motility, cell death, and differentiation. Balanced Ctnnb1 expression is critical for glomerular filtration barrier maintenance.	[Kato, Hideki; Gruenwald, Antje; Susztak, Katalin] Albert Einstein Coll Med, Div Nephrol, Dept Med, Bronx, NY 10461 USA; [Suh, Jung Hee; Miner, Jeffrey H.] Washington Univ Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Barisoni-Thomas, Laura] New York Univ Sch Med, Dept Pathol, New York, NY 10016 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Faul, Christian] Univ Miami, Dept Med, Div Nephrol, Miller Sch Med, Coral Gables, FL 33136 USA; [Millar, Sarah E.] Univ Penn Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Holzman, Lawrence B.] Univ Penn Sch Med, Dept Med, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA; [Susztak, Katalin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); New York University; Kyoto University; University of Miami; University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Susztak, K (corresponding author), Albert Einstein Coll Med, Div Nephrol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	katalin.susztak@einstein.yu.edu	Susztak, Katalin/ABE-7474-2021	Susztak, Katalin/0000-0002-1005-3726; Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health [5R01DK076077-04, R01DK078314]; American Diabetes Association; NephCure Foundation; Uehara Memorial Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078314, R01DK076077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NephCure Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DK076077-04 (to K. S.) and R01DK078314 (to J. H. M.). This work was also supported by the American Diabetes Association (to K. S.), the NephCure Foundation, and the Uehara Memorial Foundation (to H. K.).	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Brault V, 2001, DEVELOPMENT, V128, P1253; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harvey SJ, 2008, CURR OPIN NEPHROL HY, V17, P393, DOI 10.1097/MNH.0b013e32830464de; Heikkila E, 2010, NEPHROL DIAL TRANSPL, V25, P2437, DOI 10.1093/ndt/gfq076; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kottgen A, 2008, J AM SOC NEPHROL, V19, P1989, DOI 10.1681/ASN.2007121291; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Lin CL, 2010, J AM SOC NEPHROL, V21, P124, DOI 10.1681/ASN.2008101059; Lorenzen J, 2008, J AM SOC NEPHROL, V19, P884, DOI 10.1681/ASN.2007040486; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Sale MM, 2007, DIABETES, V56, P2638, DOI 10.2337/db07-0012; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	42	151	157	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26003	26015		10.1074/jbc.M111.223164	http://dx.doi.org/10.1074/jbc.M111.223164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613219	Green Published, hybrid			2022-12-25	WOS:000293073000059
J	Barnes, J; Lim, JM; Godard, A; Blanchard, F; Wells, L; Steet, R				Barnes, Jarrod; Lim, Jae-Min; Godard, Anne; Blanchard, Frederic; Wells, Lance; Steet, Richard			Extensive Mannose Phosphorylation on Leukemia Inhibitory Factor (LIF) Controls Its Extracellular Levels by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; PROTEIN RECOGNITION DETERMINANTS; LYSOSOMAL-ENZYME PHOSPHORYLATION; COLONY-STIMULATING FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; PROCATHEPSIN-D; SECRETORY GLYCOPROTEIN; 6-PHOSPHATE RECEPTORS; CATHEPSIN-D; DNASE I	In addition to soluble acid hydrolases, many nonlysosomal proteins have been shown to bear mannose 6-phosphate (Man-6-P) residues. Quantification of the extent of mannose phosphorylation and the relevance to physiological function, however, remain poorly defined. In this study, we investigated the mannose phosphorylation status of leukemia inhibitory factor (LIF), a previously identified high affinity ligand for the cation-independent mannose 6-phosphate receptor (CI-MPR), and we analyzed the effects of this modification on its secretion and uptake in cultured cells. When media from LIF-overexpressing cells were fractionated using a CI-MPR affinity column, 35-45% of the total LIF molecules were bound and specifically eluted with free Man-6-P thus confirming LIF as a bona fide Man-6-P-modified protein. Surprisingly, mass spectrometric analysis of LIF glycopeptides enriched on the CI-MPR column revealed that all six N-glycan sites could be Man-6-P-modified. The relative utilization of these sites, however, was not uniform. Analysis of glycan-deleted LIF mutants demonstrated that loss of glycans bearing the majority of Man-6-P residues leads to higher steady-state levels of secreted LIF. Using mouse embryonic stem cells, we showed that the mannose phosphorylation of LIF mediates its internalization thereby reducing extracellular levels and stimulating embryonic stem cell differentiation. Finally, immunofluorescence experiments indicate that LIF is targeted directly to lysosomes following its biosynthesis, providing another mechanism whereby mannose phosphorylation serves to control extracellular levels of LIF. Failure to modify LIF in the context of mucolipidosis II and its subsequent accumulation in the extracellular space may have important implications for disease pathogenesis.	[Barnes, Jarrod; Lim, Jae-Min; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Godard, Anne] Univ Nantes, INSERM, CRCNA, U892, F-44035 Nantes, France; [Blanchard, Frederic] Univ Nantes, INSERM, U957, F-44035 Nantes, France	University System of Georgia; University of Georgia; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Barnes, Jarrod/V-6127-2019; Blanchard, Frederic/AAS-1930-2021; Blanchard, Frederic/K-8018-2015; Wells, Lance/H-3118-2013	Blanchard, Frederic/0000-0003-1055-2573; Blanchard, Frederic/0000-0003-1055-2573; Barnes, Jarrod/0000-0002-1027-6591; Wells, Lance/0000-0003-4956-5363	NIGMS [1R01GM086524-01]; NCRR [5P41RR018502]; Cousins Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cousins Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM086524-01 from NIGMS (to R. S.) and Grant 5P41RR018502 from NCRR (to L. W.).; Recipient of a graduate fellowship from the Cousins Foundation.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMANN SW, 1992, ARCH BIOCHEM BIOPHYS, V293, P349, DOI 10.1016/0003-9861(92)90405-L; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; ELIAS JA, 1994, AM J PHYSIOL, V266, pL426, DOI 10.1152/ajplung.1994.266.4.L426; FAUST PL, 1987, J CELL BIOL, V105, P1947, DOI 10.1083/jcb.105.5.1947; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; GODARD A, 1992, J BIOL CHEM, V267, P3214; Gonzalez-Perez Oscar, 2010, Current Immunology Reviews, V6, P167; Grimaud E, 2002, CYTOKINE, V20, P224, DOI 10.1006/cyto.2002.2002; Hering KW, 2005, J ORG CHEM, V70, P9892, DOI 10.1021/jo0516382; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Knight DA, 1999, AM J RESP CELL MOL, V20, P834, DOI 10.1165/ajrcmb.20.4.3429; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; LAZZARINO DA, 1989, J BIOL CHEM, V264, P5015; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Lim JM, 2009, J PROTEOME RES, V8, P673, DOI 10.1021/pr800855f; LOTZ M, 1992, J CLIN INVEST, V90, P888, DOI 10.1172/JCI115964; Maruta S, 2009, CLIN EXP METASTAS, V26, P133, DOI 10.1007/s10585-008-9223-x; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; OKAMOTO M, 1991, ARCH BIOCHEM BIOPHYS, V286, P562, DOI 10.1016/0003-9861(91)90080-3; Olson LJ, 2010, P NATL ACAD SCI USA, V107, P12493, DOI 10.1073/pnas.1004232107; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Ruan M, 2010, ENDOCRINOLOGY, V151, P1713, DOI 10.1210/en.2009-0813; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Slaets H, 2010, TRENDS MOL MED, V16, P493, DOI 10.1016/j.molmed.2010.08.007; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Upadhyay A, 2009, CYTOKINE, V46, P332, DOI 10.1016/j.cyto.2009.03.001; VILLIGER PM, 1993, J CLIN INVEST, V91, P1575, DOI 10.1172/JCI116363; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; Yang LJ, 2000, WOUND REPAIR REGEN, V8, P538, DOI 10.1046/j.1524-475x.2000.00538.x	61	17	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24855	24864		10.1074/jbc.M111.221432	http://dx.doi.org/10.1074/jbc.M111.221432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613225	hybrid, Green Published			2022-12-25	WOS:000292547900035
J	Jenkins, JL; Krucinska, J; McCarty, RM; Bandarian, V; Wedekind, JE				Jenkins, Jermaine L.; Krucinska, Jolanta; McCarty, Reid M.; Bandarian, Vahe; Wedekind, Joseph E.			Comparison of a PreQ(1) Riboswitch Aptamer in Metabolite-bound and Free States with Implications for Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; STRUCTURAL BASIS; ESCHERICHIA-COLI; TPP RIBOSWITCH; MESSENGER-RNA; BINDING; SCATTERING; PROTEIN; BIOSYNTHESIS; NUCLEOSIDES	Riboswitches are RNA regulatory elements that govern gene expression by recognition of small molecule ligands via a high affinity aptamer domain. Molecular recognition can lead to active or attenuated gene expression states by controlling accessibility to mRNA signals necessary for transcription or translation. Key areas of inquiry focus on how an aptamer attains specificity for its effector, the extent to which the aptamer folds prior to encountering its ligand, and how ligand binding alters expression signal accessibility. Here we present crystal structures of the preQ(1) riboswitch from Thermoanaerobacter tengcongensis in the preQ(1)-bound and free states. Although the mode of preQ(1) recognition is similar to that observed for preQ(0), surface plasmon resonance revealed an apparent K-D of 2.1 +/- 0.3 nM for preQ(1) but a value of 35.1 +/- 6.1 nM for preQ(0). This difference can be accounted for by interactions between the preQ(1) methylamine and base G5 of the aptamer. To explore conformational states in the absence of metabolite, the free-state aptamer structure was determined. A14 from the ceiling of the ligand pocket shifts into the preQ(1)-binding site, resulting in "closed" access to the metabolite while simultaneously increasing exposure of the ribosome-binding site. Solution scattering data suggest that the free-state aptamer is compact, but the "closed" free-state crystal structure is inadequate to describe the solution scattering data. These observations are distinct from transcriptional preQ(1) riboswitches of the same class that exhibit strictly ligand-dependent folding. Implications for gene regulation are discussed.	[Jenkins, Jermaine L.; Krucinska, Jolanta; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [McCarty, Reid M.; Bandarian, Vahe] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Rochester; University of Arizona	Wedekind, JE (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu		Jenkins, Jermaine/0000-0003-2548-3275	National Institutes of Health [GM072623, GM063162, RR026501, RR027241]; National Science Foundation [DMR-0225180]; NCRR, National Institutes of Health [RR-01646SSRL]; Department of Energy; NIGMS, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027241, S10RR026501, P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072623, R01GM063162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072623 (to V. B.) and GM063162 and RR026501 (to J. E. W.).; We thank Nils Walter and Robert Batey for critical remarks on the manuscript. We thank Jason Salter and other members of the Wedekind laboratory for helpful discussions. We thank Clara L. Kielkopf for assistance with SPR, which was obtained through National Institutes of Health Grant RR027241 (to Clara L. Kielkopf). We thank Richard Gillilan and the staff of MacCHESS for assistance with SAXS and crystallography. We thank the staff of SSRL for help with remote data collection. MacCHESS is supported by National Science Foundation Award DMR-0225180 and NCRR, National Institutes of Health, Award RR-01646SSRL. SSRL is operated by Stanford on behalf of the United States Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy and by NCRR and NIGMS, National Institutes of Health.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Ali M, 2010, J MOL BIOL, V396, P153, DOI 10.1016/j.jmb.2009.11.030; Ando N, 2008, J APPL CRYSTALLOGR, V41, P167, DOI 10.1107/S0021889807056944; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baird NJ, 2010, RNA BIOL, V7, P328, DOI 10.4161/rna.7.3.11932; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; DAVOLL J, 1960, J CHEM SOC, P131, DOI 10.1039/jr9600000131; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feigin L.A., 1987, STRUCTURE ANAL SMALL; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Forconi M, 2010, BIOCHEMISTRY-US, V49, P2753, DOI 10.1021/bi902200n; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Grosjean H, 2004, TRENDS BIOCHEM SCI, V29, P519, DOI 10.1016/j.tibs.2004.08.005; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; HUANG BS, 1992, CANCER RES, V52, P4696; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Meyer MM, 2008, RNA, V14, P685, DOI 10.1261/rna.937308; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rieder U, 2010, P NATL ACAD SCI USA, V107, P10804, DOI 10.1073/pnas.0914925107; Rieder U, 2009, CHEMBIOCHEM, V10, P1141, DOI 10.1002/cbic.200900155; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Spitale RC, 2009, J BIOL CHEM, V284, P11012, DOI 10.1074/jbc.C900024200; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wedekind JE, 2000, METHOD ENZYMOL, V317, P149; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	66	80	91	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24626	24637		10.1074/jbc.M111.230375	http://dx.doi.org/10.1074/jbc.M111.230375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592962	hybrid, Green Published			2022-12-25	WOS:000292547900013
J	Ramachandran, R; Mihara, K; Chung, H; Renaux, B; Lau, CS; Muruve, DA; DeFea, KA; Bouvier, M; Hollenberg, MD				Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Lau, Chang S.; Muruve, Daniel A.; DeFea, Kathryn A.; Bouvier, Michel; Hollenberg, Morley D.			Neutrophil Elastase Acts as a Biased Agonist for Proteinase-activated Receptor-2 (PAR(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; LUNG EPITHELIAL-CELLS; BETA-ARRESTINS; THROMBIN; EXPRESSION; DESENSITIZATION; PANCREATITIS; TRAFFICKING; RESPONSES; COLITIS	Human neutrophil proteinases (elastase, proteinase-3, and cathepsin-G) are released at sites of acute inflammation. We hypothesized that these inflammation-associated proteinases can affect cell signaling by targeting proteinase-activated receptor-2 (PAR(2)). The PAR family of G protein-coupled receptors is triggered by a unique mechanism involving the proteolytic unmasking of an N-terminal self-activating tethered ligand (TL). Proteinases can either activate PAR signaling by unmasking the TL sequence or disarm the receptor for subsequent enzyme activation by cleaving downstream from the TL sequence. We found that none of neutrophil elastase, cathepsin-G, and proteinase-3 can activate G(q)-coupled PAR(2) calcium signaling; but all of these proteinases can disarm PAR(2), releasing the N-terminal TL sequence, thereby preventing G(q)-coupled PAR(2) signaling by trypsin. Interestingly, elastase (but neither cathepsin-G nor proteinase-3) causes a TL-independent PAR(2)-mediated activation of MAPK that, unlike the canonical trypsin activation, does not involve either receptor internalization or recruitment of beta-arrestin. Cleavage of synthetic peptides derived from the extracellular N terminus of PAR(2), downstream of the TL sequence, demonstrated distinct proteolytic sites for all three neutrophil-derived enzymes. We conclude that in inflammation, neutrophil proteinases can modulate PAR(2) signaling by preventing/disarming the G(q)/calcium signal pathway and, via elastase, can selectively activate the p44/42MAPK pathway. Our data illustrate a new mode of PAR regulation that involves biased PAR(2) signaling by neutrophil elastase and a disarming/silencing effect of cathepsin-G and proteinase-3.	[Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Muruve, Daniel A.; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Lau, Chang S.; DeFea, Kathryn A.] Univ Calif Riverside, Div Biomed Sci & Biochem & Mol Biol, Riverside, CA 92521 USA; [Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	University of Calgary; University of Calgary; University of California System; University of California Riverside; Universite de Montreal	Ramachandran, R (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rramacha@ucalgary.ca	Bouvier, Michel/H-2758-2014; Ramachandran, Rithwik/N-7815-2015; Hollenberg, Morley/AFV-6966-2022	Bouvier, Michel/0000-0003-1128-0100; Ramachandran, Rithwik/0000-0001-9557-9905; 	Canadian Institutes of Health Research; National Institutes of Health [RO1GM066151]; CHO/FoMD University of Alberta; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHO/FoMD University of Alberta(University of Alberta); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Canadian Institutes of Health Research (to M. D. H. and M. B.). This work was also supported in part by National Institutes of Health Grant RO1GM066151 (to K. D.).; Supported by a CHO/FoMD University of Alberta Emerging Teams Grant graduate scholarship.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Goh FG, 2009, BRIT J PHARMACOL, V158, P1695, DOI 10.1111/j.1476-5381.2009.00415.x; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Laukkarinen JM, 2008, J BIOL CHEM, V283, P20703, DOI 10.1074/jbc.M801779200; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006	43	120	124	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24638	24648		10.1074/jbc.M110.201988	http://dx.doi.org/10.1074/jbc.M110.201988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21576245	hybrid, Green Published			2022-12-25	WOS:000292547900014
J	Attia, RR; Sharma, P; Janssen, RC; Friedman, JE; Deng, X; Lee, JS; Elam, MB; Cook, GA; Park, EA				Attia, Ramy R.; Sharma, Pragya; Janssen, Rachel C.; Friedman, Jacob E.; Deng, Xiong; Lee, Jae Seung; Elam, Marshall B.; Cook, George A.; Park, Edwards A.			Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by CCAAT/Enhancer-binding Protein beta (C/EBP beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; THYROID-HORMONE; GENE-EXPRESSION; I-ALPHA; TRANSCRIPTIONAL REGULATION; RETINOIC ACID; FATTY-ACIDS; PROMOTER; LIVER	The conversion of pyruvate to acetyl-CoA in mitochondria is catalyzed by the pyruvate dehydrogenase complex (PDC). Activity of PDC is inhibited by phosphorylation via the pyruvate dehydrogenase kinases (PDKs). Here, we examined the regulation of Pdk4 gene expression by the CCAAT/enhancer-binding protein beta (C/EBP beta). C/EBP beta modulates the expression of multiple hepatic genes including those involved in metabolism, development, and inflammation. We found that C/EBP beta induced Pdk4 gene expression and decreased PDC activity. This transcriptional induction was mediated through two C/EBP beta binding sites in the Pdk4 promoter. C/EBP beta participates in the hormonal regulation of gluconeogenic genes. Previously, we reported that Pdk4 was induced by thyroid hormone (T-3). Therefore, we investigated the role of C/EBP beta in the T-3 regulation of Pdk4. T-3 increased C/EBP beta abundance in primary rat hepatocytes. Knockdown of C/EBP beta with siRNA diminished the T-3 induction of the Pdk4 and carnitine palmitoyltransferase (Cpt1a) genes. CPT1a is an initiating step in the mitochondrial oxidation of long chain fatty acids. Our results indicate that C/EBP beta stimulates Pdk4 expression and participates in the T-3 induction of the Cpt1a and Pdk4 genes.	[Attia, Ramy R.; Sharma, Pragya; Deng, Xiong; Lee, Jae Seung; Elam, Marshall B.; Cook, George A.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38105 USA; [Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado, Dept Pediat Biochem & Mol Genet, Aurora, CO 80045 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [NIH-DK0059368, NIH-DK059767, NIH-DK075504, T35DK007405]; American Heart Association [4590018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, T35DK007405, R01DK059767, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH-DK0059368 (to E. A. P.), American Heart Association Grant 4590018 (to E. A. P.), NIH-DK059767 (to J. E. F.), and NIH-DK075504 (to M. B. E.).; Supported by a National Institutes of Health medical student training grant (T35DK007405).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; De Leo V, 2009, J LIPID RES, V50, P256, DOI 10.1194/jlr.M800312-JLR200; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Ghosh AK, 2001, J BIOL CHEM, V276, P8507, DOI 10.1074/jbc.M008541200; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HEIMBERG M, 1985, ENDOCR REV, V6, P590, DOI 10.1210/edrv-6-4-590; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; IYNEDJIAN PB, 1984, EUR J BIOCHEM, V145, P489, DOI 10.1111/j.1432-1033.1984.tb08583.x; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Krus U, 2010, BIOCHEM J, V429, P205, DOI 10.1042/BJ20100142; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MenendezHurtado A, 1997, BIOCHEM BIOPH RES CO, V234, P605, DOI 10.1006/bbrc.1997.6635; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PARK EA, 1993, J BIOL CHEM, V268, P613; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Stenson BM, 2009, ENDOCRINOLOGY, V150, P4104, DOI 10.1210/en.2009-0676; Sugden MC, 2000, BIOCHEM J, V352, P731, DOI 10.1042/0264-6021:3520731; Sugden MC, 2000, J ENDOCRINOL, V167, P339, DOI 10.1677/joe.0.1670339; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Teixido N, 2006, MOL ENDOCRINOL, V20, P389, DOI 10.1210/me.2005-0229; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	52	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23799	23807		10.1074/jbc.M111.246389	http://dx.doi.org/10.1074/jbc.M111.246389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586575	Green Published, hybrid			2022-12-25	WOS:000292294900022
J	Peng, H; Wang, XS; Barnes, PF; Tang, H; Townsend, JC; Samten, B				Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Tang, Hua; Townsend, James C.; Samten, Buka			The Mycobacterium tuberculosis Early Secreted Antigenic Target of 6 kDa Inhibits T Cell Interferon-gamma Production through the p38 Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT4 SERINE PHOSPHORYLATION; ANTHRAX LETHAL FACTOR; PORE-FORMING TOXINS; IFN-GAMMA; CALMETTE-GUERIN; BOVIS BCG; RECEPTOR; MACROPHAGES; IMMUNITY; ESAT-6	We reported previously that the early secreted antigenic target of 6 kDa (ESAT-6) from Mycobacterium tuberculosis directly inhibits human T cell IFN-gamma production and proliferation in response to stimulation with anti-CD3 and anti-CD28. To determine the mechanism of this effect, we treated T cells with kinase inhibitors before stimulation with ESAT-6. Only the p38 MAPK inhibitor, SB203580, abrogated ESAT-6-mediated inhibition of IFN-gamma production in a dose-dependent manner. SB203580 did not reverse ESAT-6-mediated inhibition of IL-17 and IL-10 production, suggesting a specific effect of SB203580 on IFN-gamma production. SB203580 did not act through inhibition of AKT (PKB) as an AKT inhibitor did not affect ESAT-6 inhibition of T cell IFN-gamma production and proliferation. ESAT-6 did not reduce IFN-gamma production by expanding FoxP3(+) T regulatory cells. Incubation of T cells with ESAT-6 induced phosphorylation and increased functional p38 MAPK activity, but not activation of ERK or JNK. Incubation of peripheral blood mononuclear cells with ESAT-6 induced activation of p38 MAPK, and inhibition of p38 MAPK with SB203580 reversed ESAT-6 inhibition of M. tuberculosis-stimulated IFN-gamma production by peripheral blood mononuclear cells from subjects with latent tuberculosis infection. Silencing of p38 alpha MAPK with siRNA rendered T cells resistant to ESAT-6 inhibition of IFN-gamma production. Taken together, our results demonstrate that ESAT-6 inhibits T cell IFN-gamma production in a p38 MAPK-dependent manner.	[Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Townsend, James C.; Samten, Buka] Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA; [Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Townsend, James C.; Samten, Buka] Univ Texas Hlth Sci Ctr Tyler, Dept Microbiol & Immunol, Tyler, TX 75708 USA; [Barnes, Peter F.] Univ Texas Hlth Sci Ctr Tyler, Dept Med, Tyler, TX 75708 USA; [Tang, Hua] Univ Texas Hlth Sci Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Samten, B (corresponding author), Univ Texas Hlth Sci Ctr Tyler, CPIDC, 11937 US Hwy 271, Tyler, TX 75708 USA.	buka.samten@uthct.edu	, Hui/AAT-5093-2020; Samten, Buka/AAV-3140-2021	, Hui/0000-0002-2646-129X; 	National Institutes of Health [AI082335, AI063514]; James Byers Cain Research Endowment; Center for Pulmonary and Infectious Disease Control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063514, R21AI082335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Byers Cain Research Endowment; Center for Pulmonary and Infectious Disease Control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI082335 (to B. S.) and AI063514 (to P. F. B. and B. S.) and by funds from the James Byers Cain Research Endowment and the Center for Pulmonary and Infectious Disease Control.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Aleman M, 2004, INFECT IMMUN, V72, P5150, DOI 10.1128/IAI.72.9.5150-5158.2004; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Ceponis PJM, 2005, CAN J GASTROENTEROL, V19, P415, DOI 10.1155/2005/731817; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Daley CL, 2010, AM J RESP CRIT CARE, V181, P550, DOI 10.1164/rccm.201001-0140UP; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Gagliardi MC, 2009, INFECT IMMUN, V77, P4947, DOI 10.1128/IAI.00607-09; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003302; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Juffermans NP, 2000, J INFECT DIS, V182, P888, DOI 10.1086/315750; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li C, 2011, IMMUNOLOGY, V132, P104, DOI 10.1111/j.1365-2567.2010.03345.x; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Ohkusu-Tsukada K, 2010, EUR J IMMUNOL, V40, P1011, DOI 10.1002/eji.200939513; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959; Porta H, 2011, PEPTIDES, V32, P601, DOI 10.1016/j.peptides.2010.06.012; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Samten B, 2008, J LEUKOCYTE BIOL, V84, P115, DOI 10.1189/jlb.1207835; Singh G, 2005, IMMUNOL LETT, V98, P180, DOI 10.1016/j.imlet.2004.11.011; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stuart JK, 2010, INT IMMUNOPHARMACOL, V10, P1068, DOI 10.1016/j.intimp.2010.06.007; Veiopoulou C, 2004, NEUROIMMUNOMODULAT, V11, P199, DOI 10.1159/000078437; Verhagen CE, 2000, J EXP MED, V192, P517, DOI 10.1084/jem.192.4.517; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Yang LF, 2010, BIOCHEM BIOPH RES CO, V400, P16, DOI 10.1016/j.bbrc.2010.07.126; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374	59	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24508	24518		10.1074/jbc.M111.234062	http://dx.doi.org/10.1074/jbc.M111.234062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586573	Green Published, hybrid			2022-12-25	WOS:000292294900091
J	Hasegawa, Y; Ikeno, H				Hasegawa, Yuji; Ikeno, Hidetoshi			How Do Honeybees Attract Nestmates Using Waggle Dances in Dark and Noisy Hives?	PLOS ONE			English	Article							APIS-MELLIFERA; HEARING; BEES; COMMUNICATION; HYMENOPTERA; DROSOPHILA; COURTSHIP; DIRECTION; LANGUAGE; BEHAVIOR	It is well known that honeybees share information related to food sources with nestmates using a dance language that is representative of symbolic communication among non-primates. Some honeybee species engage in visually apparent behavior, walking in a figure-eight pattern inside their dark hives. It has been suggested that sounds play an important role in this dance language, even though a variety of wing vibration sounds are produced by honeybee behaviors in hives. It has been shown that dances emit sounds primarily at about 250-300 Hz, which is in the same frequency range as honeybees' flight sounds. Thus the exact mechanism whereby honeybees attract nestmates using waggle dances in such a dark and noisy hive is as yet unclear. In this study, we used a flight simulator in which honeybees were attached to a torque meter in order to analyze the component of bees' orienting response caused only by sounds, and not by odor or by vibrations sensed by their legs. We showed using single sound localization that honeybees preferred sounds around 265 Hz. Furthermore, according to sound discrimination tests using sounds of the same frequency, honeybees preferred rhythmic sounds. Our results demonstrate that frequency and rhythmic components play a complementary role in localizing dance sounds. Dance sounds were presumably developed to share information in a dark and noisy environment.	[Hasegawa, Yuji] Honda Res Inst Japan Co Ltd, Wako, Saitama, Japan; [Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo, Japan	Honda Motor Company; University of Hyogo	Hasegawa, Y (corresponding author), Honda Res Inst Japan Co Ltd, Wako, Saitama, Japan.	yuji.hasegawa@jp.honda-ri.com	Ikeno, Hidetoshi/O-3034-2018	Ikeno, Hidetoshi/0000-0002-5134-5485				ALEXANDER BA, 1991, ANN ENTOMOL SOC AM, V84, P137, DOI 10.1093/aesa/84.2.137; BASTIAN J, 1972, J COMP PHYSIOL, V77, P126, DOI 10.1007/BF00693602; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; DRELLER C, 1993, J COMP PHYSIOL A, V173, P275, DOI 10.1007/BF00212691; DRELLER C, 1994, INSECT SOC, V41, P291, DOI 10.1007/BF01242300; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Engel MS, 1997, ANN ENTOMOL SOC AM, V90, P43, DOI 10.1093/aesa/90.1.43; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HEDWING T, 2006, J COMP PHYSIOL A, V192, P677; HEISENBERG M, 1993, VISUAL MOTION ITS RO, P265; IKENO H, 2005, IEICE T INF SYST, V88, P2144; Kilpinen O, 1997, J COMP PHYSIOL A, V181, P309, DOI 10.1007/s003590050117; Kirchner WH, 1996, APIDOLOGIE, V27, P331, DOI 10.1051/apido:19960501; KIRCHNER WH, 1988, NATURWISSENSCHAFTEN, V75, P629, DOI 10.1007/BF00366482; KIRCHNER WH, 1991, J COMP PHYSIOL A, V168, P85, DOI 10.1007/BF00217106; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; MICHELSEN A, 1987, J COMP PHYSIOL A, V161, P633, DOI 10.1007/BF00605005; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Nieh JC, 2000, J EXP BIOL, V203, P1573; PRINGLE JWS, 1968, ADV INSECT PHYSL; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; SEELEY TD, 1995, WISDOM HIVE SOCIAL P, P69; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Tautz J, 2001, J EXP BIOL, V204, P3737; TOWNE WF, 1989, SCIENCE, V244, P686, DOI 10.1126/science.244.4905.686; Tsujiuchi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000234; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; von Frisch K., 1967, DANCE LANGUAGE ORIEN	28	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19619	10.1371/journal.pone.0019619	http://dx.doi.org/10.1371/journal.pone.0019619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603608	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300014
J	Almberg, ES; Cross, PC; Johnson, CJ; Heisey, DM; Richards, BJ				Almberg, Emily S.; Cross, Paul C.; Johnson, Christopher J.; Heisey, Dennis M.; Richards, Bryan J.			Modeling Routes of Chronic Wasting Disease Transmission: Environmental Prion Persistence Promotes Deer Population Decline and Extinction	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; WILDLIFE EPIDEMIC; INFECTIOUS PRIONS; GROWTH-RATES; DYNAMICS; ELK; PATTERNS; COLORADO; SCRAPIE	Chronic wasting disease (CWD) is a fatal disease of deer, elk, and moose transmitted through direct, animal-to-animal contact, and indirectly, via environmental contamination. Considerable attention has been paid to modeling direct transmission, but despite the fact that CWD prions can remain infectious in the environment for years, relatively little information exists about the potential effects of indirect transmission on CWD dynamics. In the present study, we use simulation models to demonstrate how indirect transmission and the duration of environmental prion persistence may affect epidemics of CWD and populations of North American deer. Existing data from Colorado, Wyoming, and Wisconsin's CWD epidemics were used to define plausible short-term outcomes and associated parameter spaces. Resulting long-term outcomes range from relatively low disease prevalence and limited host-population decline to host-population collapse and extinction. Our models suggest that disease prevalence and the severity of population decline is driven by the duration that prions remain infectious in the environment. Despite relatively low epidemic growth rates, the basic reproductive number, R-0, may be much larger than expected under the direct-transmission paradigm because the infectious period can vastly exceed the host's life span. High prion persistence is expected to lead to an increasing environmental pool of prions during the early phases (i.e. approximately during the first 50 years) of the epidemic. As a consequence, over this period of time, disease dynamics will become more heavily influenced by indirect transmission, which may explain some of the observed regional differences in age and sex-specific disease patterns. This suggests management interventions, such as culling or vaccination, will become increasingly less effective as CWD epidemics progress.	[Almberg, Emily S.; Cross, Paul C.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Almberg, Emily S.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Johnson, Christopher J.; Heisey, Dennis M.] US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA	United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Almberg, ES (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA.	esa5046@psu.edu	Johnson, Christopher/B-1436-2009; Cross, Paul/K-6987-2012	Johnson, Christopher/0000-0003-4539-2581; Cross, Paul/0000-0001-8045-5213	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	This work was funded by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; ANDERSON R M, 1991; Barlow ND, 2000, J ANIM ECOL, V69, P703, DOI 10.1046/j.1365-2656.2000.00428.x; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; BINFET J, 2009, JOB COMPLETION REPOR, P177; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; David Walter W, 2011, Nat Commun, V2, P200, DOI 10.1038/ncomms1203; DUSEK GL, 1989, WILDLIFE MONOGR, P1; EDMUNDS D, 2010, VECTOR NEWSLETTER WI; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; GILL RB, 1999, DECLINING MULE DEER, P1; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; HALEY NJ, 2009, PLOS ONE, V4; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2011, J TOXICOL ENV HEAL A, V74, P161, DOI 10.1080/15287394.2011.529066; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; KEELING MJ, 2008, MODELING INFECT DIS, V366; Keyser PD, 2005, WILDLIFE SOC B, V33, P222, DOI 10.2193/0091-7648(2005)33[222:DRPIWD]2.0.CO;2; KREEGER TJ, 2008, CHRON WAST DIS WORKS, P8; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McCaffery Keith R., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P249; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; RILEY SJ, 1984, J WILDLIFE MANAGE, V48, P1302, DOI 10.2307/3801790; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Schauber EM, 2003, WILDLIFE SOC B, V31, P610; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; SMITH W P, 1991, Mammalian Species, P1, DOI 10.2307/3504281; Swihart RK, 1998, CAN J ZOOL, V76, P1932, DOI 10.1139/cjz-76-10-1932; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TANNER JT, 1975, ECOLOGY, V56, P855, DOI 10.2307/1936296; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; *WI DEP NAT RES, 2009, FALL DEER POP DENS 2; *WI DEP NAT RES, 2010, WISC CHRON WAST DIS; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123	62	103	104	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19896	10.1371/journal.pone.0019896	http://dx.doi.org/10.1371/journal.pone.0019896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603638	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500035
J	Takahashi, J; Misawa, M; Iwahashi, H				Takahashi, Junko; Misawa, Masaki; Iwahashi, Hitoshi			Oligonucleotide Microarray Analysis of Age-Related Gene Expression Profiles in Miniature Pigs	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; ANIMAL-MODEL; WHOLE-BLOOD; CORD-BLOOD; GENOME; TOXICOGENOMICS; HLA	Miniature pigs are useful model animals for humans because they have similar anatomy and digestive physiology to humans and are easy to breed and handle. In this study, whole blood microarray analyses were conducted to evaluate variations of correlation among individuals and ages using specific pathogen-free (SPF) Clawn miniature pigs. Whole blood RNA is easy to handle compared to isolated white blood cell RNA and can be used for health and disease monitoring and animal control. In addition, whole blood is a heterogeneous mixture of subpopulation cells. Once a great change occurs in composition and expressing condition of subpopulations, their associated change will be reflected on whole blood RNA. From 12 to 30 weeks of age, fractions of lymphocytes, monocytes, neutrophils, eosinophils, and basophils in white blood cells showed insignificant differences with age as a result of ANOVA analysis. This study attempted to identify characteristics of age-related gene expression by taking into account the change in the number of expressed genes by age and similarities of gene expression intensity between individuals. As a result, the number of expressed genes was less in fetal stage and infancy period but increased with age, reaching a steady state of gene expression after 20 weeks of age. Variation in gene expression intensity within the same age was great in fetal stage and infancy period, but converged with age. The variation between 20 and 30 weeks of age was comparable to that among 30 weeks individuals. These results indicate that uniformity of laboratory animals is expected for miniature pigs after 20 weeks of age. Furthermore, a possibility was shown that whole blood RNA analysis is applicable to evaluation of physiological state.	[Takahashi, Junko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Misawa, Masaki] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Iwahashi, Hitoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Kagawa, Japan; [Iwahashi, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Takahashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	junko-takahashi@aist.go.jp	Iwahashi, Hitoshi/S-1360-2019; Misawa, Masaki/M-8235-2018; Takahashi, Junko/L-6921-2018	Misawa, Masaki/0000-0002-3685-5612; Takahashi, Junko/0000-0002-1941-0136				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Beijar ECE, 2006, PLACENTA, V27, P322, DOI 10.1016/j.placenta.2004.12.012; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Forster-Waldl E, 2005, PEDIATR RES, V58, P121, DOI 10.1203/01.PDR.0000163397.53466.0F; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; HUNT DWC, 1994, BLOOD, V84, P4333, DOI 10.1182/blood.V84.12.4333.bloodjournal84124333; Komatsu T, 1998, HUM REPROD, V13, P2246, DOI 10.1093/humrep/13.8.2246; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Pennie W, 2004, ENVIRON HEALTH PERSP, V112, P417, DOI 10.1289/ehp.6674; PURI S, 1993, TISSUE ANTIGENS, V42, P67, DOI 10.1111/j.1399-0039.1993.tb02169.x; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Williams-Devane CR, 2009, TOXICOL SCI, V109, P358, DOI 10.1093/toxsci/kfp061; IMMUNOPOLYMORPHISM D	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19761	10.1371/journal.pone.0019761	http://dx.doi.org/10.1371/journal.pone.0019761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603646	Green Published, gold, Green Submitted			2022-12-25	WOS:000290558500029
J	Han, DH; Hancock, CR; Jung, SR; Higashida, K; Kim, SH; Holloszy, JO				Han, Dong-Ho; Hancock, Chad R.; Jung, Su Ryun; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.			Deficiency of the Mitochondrial Electron Transport Chain in Muscle Does Not Cause Insulin Resistance	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAT SKELETAL-MUSCLE; HIGH-FAT DIET; GLUCOSE-TRANSPORT; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; IRON-DEFICIENCY; ACID OXIDATION; LIPID-CONTENT; IN-VITRO	Background: It has been proposed that muscle insulin resistance in type 2 diabetes is due to a selective decrease in the components of the mitochondrial electron transport chain and results from accumulation of toxic products of incomplete fat oxidation. The purpose of the present study was to test this hypothesis. Methodology/Principal Findings: Rats were made severely iron deficient, by means of an iron-deficient diet. Iron deficiency results in decreases of the iron containing mitochondrial respiratory chain proteins without affecting the enzymes of the fatty acid oxidation pathway. Insulin resistance was induced by feeding iron-deficient and control rats a high fat diet. Skeletal muscle insulin resistance was evaluated by measuring glucose transport activity in soleus muscle strips. Mitochondrial proteins were measured by Western blot. Iron deficiency resulted in a decrease in expression of iron containing proteins of the mitochondrial respiratory chain in muscle. Citrate synthase, a non-iron containing citrate cycle enzyme, and long chain acyl-CoA dehydrogenase (LCAD), used as a marker for the fatty acid oxidation pathway, were unaffected by the iron deficiency. Oleate oxidation by muscle homogenates was increased by high fat feeding and decreased by iron deficiency despite high fat feeding. The high fat diet caused severe insulin resistance of muscle glucose transport. Iron deficiency completely protected against the high fat diet-induced muscle insulin resistance. Conclusions/Significance: The results of the study argue against the hypothesis that a deficiency of the electron transport chain (ETC), and imbalance between the ETC and beta-oxidation pathways, causes muscle insulin resistance.	[Han, Dong-Ho; Hancock, Chad R.; Jung, Su Ryun; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.] Washington Univ, Div Geriatr & Nutr Sci, Dept Med, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Han, DH (corresponding author), Washington Univ, Div Geriatr & Nutr Sci, Dept Med, Sch Med, St Louis, MO 63130 USA.	jhollosz@dom.wustl.edu	Hancock, Chad R./X-4803-2018	Hancock, Chad R./0000-0002-1578-5301	National Institutes of Health [AG000425, DK18986]; American Diabetes Association [DK070425]; Korean Research Foundation [KRF-2008-G00013]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070425, P30DK056341, R01DK018986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG000425, Z01AG000425, R01AG000425, R37AG000425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Korean Research Foundation(National Research Foundation of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grants AG000425 and DK18986. CRH was supported by an American Diabetes Association Mentor-Based Postdoctoral Fellowship and Individual National Research Service Award DK070425. SRJ was supported by an American Diabetes Association Mentor-Based Postdoctoral Fellowship and by Korean Research Foundation KRF-2008-G00013. KH was supported by a Research Fellow of the Japan Society for the Promotion of Science grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brown AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE97, DOI 10.1152/ajpendo.00267.2007; CARTIER LJ, 1986, J BIOL CHEM, V261, P3827; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; De Feyter HM, 2008, FASEB J, V22, P3947, DOI 10.1096/fj.08-112318; DENTON RM, 1967, BIOCHEM J, V104, P416, DOI 10.1042/bj1040416; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAYN KN, 1980, J LIPID RES, V21, P139; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Han DH, 1997, DIABETES, V46, P1761, DOI 10.2337/diabetes.46.11.1761; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hansen PA, 1998, J BIOL CHEM, V273, P26157, DOI 10.1074/jbc.273.40.26157; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HENRIKSEN EJ, 1991, ACTA PHYSIOL SCAND, V143, P381, DOI 10.1111/j.1748-1716.1991.tb09249.x; Hernandez-Alvarez MI, 2009, DIABETOLOGIA, V52, P1618, DOI 10.1007/s00125-009-1403-y; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; IJLST L, 1993, ANN CLIN BIOCHEM, V30, P293, DOI 10.1177/000456329303000311; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-REG I, V279, pR2057, DOI 10.1152/ajpregu.2000.279.6.R2057; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MCLANE JA, 1981, AM J PHYSIOL, V241, pC47, DOI 10.1152/ajpcell.1981.241.1.C47; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ojuka EO, 2000, J APPL PHYSIOL, V88, P1072, DOI 10.1152/jappl.2000.88.3.1072; PATTI ME, 2003, PNAS, V100, P104; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; ROSHOLT MN, 1994, AM J PHYSIOL, V266, pR95, DOI 10.1152/ajpregu.1994.266.1.R95; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Taylor R, 2004, NEW ENGL J MED, V350, P639, DOI 10.1056/NEJMp038239; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; YOUNG DA, 1986, J BIOL CHEM, V261, P6049	52	52	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19739	10.1371/journal.pone.0019739	http://dx.doi.org/10.1371/journal.pone.0019739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589859	Green Published, gold, Green Submitted			2022-12-25	WOS:000290531100025
J	Carrion, V; Donlan, CJ; Campbell, KJ; Lavoie, C; Cruz, F				Carrion, Victor; Donlan, C. Josh; Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe			Archipelago-Wide Island Restoration in the Galapagos Islands: Reducing Costs of Invasive Mammal Eradication Programs and Reinvasion Risk	PLOS ONE			English	Article							FERAL GOATS; SEABIRDS; RATS	Invasive alien mammals are the major driver of biodiversity loss and ecosystem degradation on islands. Over the past three decades, invasive mammal eradication from islands has become one of society's most powerful tools for preventing extinction of insular endemics and restoring insular ecosystems. As practitioners tackle larger islands for restoration, three factors will heavily influence success and outcomes: the degree of local support, the ability to mitigate for non-target impacts, and the ability to eradicate non-native species more cost-effectively. Investments in removing invasive species, however, must be weighed against the risk of reintroduction. One way to reduce reintroduction risks is to eradicate the target invasive species from an entire archipelago, and thus eliminate readily available sources. We illustrate the costs and benefits of this approach with the efforts to remove invasive goats from the Galapagos Islands. Project Isabela, the world's largest island restoration effort to date, removed >140,000 goats from >500,000 ha for a cost of US$ 10.5 million. Leveraging the capacity built during Project Isabela, and given that goat reintroductions have been common over the past decade, we implemented an archipelago-wide goat eradication strategy. Feral goats remain on three islands in the archipelago, and removal efforts are underway. Efforts on the Galapagos Islands demonstrate that for some species, island size is no longer the limiting factor with respect to eradication. Rather, bureaucratic processes, financing, political will, and stakeholder approval appear to be the new challenges. Eradication efforts have delivered a suite of biodiversity benefits that are in the process of revealing themselves. The costs of rectifying intentional reintroductions are high in terms of financial and human resources. Reducing the archipelago-wide goat density to low levels is a technical approach to reducing reintroduction risk in the short-term, and is being complemented with a longer-term social approach focused on education and governance.	[Carrion, Victor; Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe] Galapagos Natl Pk Serv, Galapagos, Ecuador; [Donlan, C. Josh] Adv Conservat Strategies, Midway, UT USA; [Donlan, C. Josh] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe] Charles Darwin Fdn, Quito, Ecuador; [Campbell, Karl J.] Univ Queensland, Sch Integrat Syst, Gatton, Qld, Australia; [Campbell, Karl J.] Isl Conservat, Santa Cruz, CA USA; [Lavoie, Christian] United Nations Dev Program, Quito, Ecuador	Cornell University; University of Queensland	Carrion, V (corresponding author), Galapagos Natl Pk Serv, Galapagos, Ecuador.	jdonlan@advancedconservation.org			GNPS; CDF; Charles Darwin Foundation (now Galapagos Conservancy); European Friends of Galapagos Organizations; Stewart Foundation; Merrill Foundation; Lindblad Expeditions [ECU/00/G31]; Galapagos Conservancy	GNPS; CDF; Charles Darwin Foundation (now Galapagos Conservancy); European Friends of Galapagos Organizations; Stewart Foundation; Merrill Foundation; Lindblad Expeditions; Galapagos Conservancy	Funding was provided by GNPS, CDF, Charles Darwin Foundation (now Galapagos Conservancy), European Friends of Galapagos Organizations, Stewart Foundation, Merrill Foundation and Lindblad Expeditions (Galapagos Conservation Fund) in collaboration with Project ECU/00/G31 "Control of Invasive Species in the Galapagos Archipelago'', a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The authors also thank the Galapagos Conservancy for their support in financing this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x; Aguirre-Munoz A, 2008, AMBIO, V37, P101, DOI 10.1579/0044-7447(2008)37[101:HCIMEF]2.0.CO;2; ALGAR D, 2010, J ROYAL SOC W AUSTR, V93; Atkinson R., 2008, GALAPAGOS REPORT 200, P121; BONNAUD E, 2011, BIOL INVASI IN PRESS; Campbell K, 2005, CONSERV BIOL, V19, P1362, DOI 10.1111/j.1523-1739.2005.00228.x; Campbell K, 2004, ORYX, V38, P328, DOI 10.1017/S0030605304000572; Campbell KJ, 2007, APPL ANIM BEHAV SCI, V102, P12, DOI 10.1016/j.applanim.2006.03.003; Campbell KJ, 2005, WILDLIFE RES, V32, P737, DOI 10.1071/WR05033; CAMPBELL KJ, 2007, THESIS U QUEENSLAND; Carrion V, 2007, BIODIVERS CONSERV, V16, P437, DOI 10.1007/s10531-005-5825-7; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Cruz F, 2009, J WILDLIFE MANAGE, V73, P191, DOI 10.2193/2007-551; Donlan CJ, 2008, BIOL INVASIONS, V10, P1053, DOI 10.1007/s10530-007-9183-0; Donlan CJ, 2007, BIOL CONSERV, V138, P520, DOI 10.1016/j.biocon.2007.05.013; DONLAN CJ, 2010, TRENDS ECOL EVOL, V26, P624; DONLAN CJ, 2008, STATE WILD GLOBAL PO, P226; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; *IS PROJ, 1997, PLAN PROT NO IS IS G; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; KEEGAN DR, 1994, WILDLIFE SOC B, V22, P56; Keitt B., 2011, ISLAND INVASIVES ERA, P74; Lavoie C., 2007, THEMATIC ATLAS PROJE; Lavoie C, 2007, BIOL INVASIONS, V9, P139, DOI 10.1007/s10530-006-9011-y; McClelland P, 2002, NZ GEOGRAPHIC, V58, P86; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; OPPEL S, 2011, CONSERVATIO IN PRESS; Rainbolt Raymond E., 1999, Biological Invasions, V1, P363, DOI 10.1023/A:1010024429207; RAMSEY DSL, 2011, NZ J ECOL IN PRESS, V35; Rosenberg D.K., 1990, MONOGR SYST BOT MISS, V32, P169; Russell JC, 2008, WILDLIFE RES, V35, P215, DOI 10.1071/WR07032; SPRINGER K, 2011, ISLAND INVASIVES ERA; TAYLOR D, 1988, WILDLIFE SOC B, V16, P297; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; TYE A, 2007, INFORM GALAPAGOS 200, P101; VEITCH CR, TURNING TIDE ERADICA	36	65	65	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18835	10.1371/journal.pone.0018835	http://dx.doi.org/10.1371/journal.pone.0018835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589656	gold, Green Published, Green Submitted			2022-12-25	WOS:000290483600002
J	Cuthbert, R; Taggart, MA; Prakash, V; Saini, M; Swarup, D; Upreti, S; Mateo, R; Chakraborty, SS; Deori, P; Green, RE				Cuthbert, Richard; Taggart, Mark A.; Prakash, Vibhu; Saini, Mohini; Swarup, Devendra; Upreti, Suchitra; Mateo, Rafael; Chakraborty, Soumya Sunder; Deori, Parag; Green, Rhys E.			Effectiveness of Action in India to Reduce Exposure of Gyps Vultures to the Toxic Veterinary Drug Diclofenac	PLOS ONE			English	Article							POPULATION DECLINES; RESIDUES; CARCASSES	Contamination of their carrion food supply with the non-steroidal anti-inflammatory drug diclofenac has caused rapid population declines across the Indian subcontinent of three species of Gyps vultures endemic to South Asia. The governments of India, Pakistan and Nepal took action in 2006 to prevent the veterinary use of diclofenac on domesticated livestock, the route by which contamination occurs. We analyse data from three surveys of the prevalence and concentration of diclofenac residues in carcasses of domesticated ungulates in India, carried out before and after the implementation of a ban on veterinary use. There was little change in the prevalence and concentration of diclofenac between a survey before the ban and one conducted soon after its implementation, with the percentage of carcasses containing diclofenac in these surveys estimated at 10.8 and 10.7%, respectively. However, both the prevalence and concentration of diclofenac had fallen markedly 7-31 months after the implementation of the ban, with the true prevalence in this third survey estimated at 6.5%. Modelling of the impact of this reduction in diclofenac on the expected rate of decline of the oriental white-backed vulture (Gyps bengalensis) in India indicates that the decline rate has decreased to 40% of the rate before the ban, but is still likely to be rapid (about 18% year(-1)). Hence, further efforts to remove diclofenac from vulture food are still needed if the future recovery or successful reintroduction of vultures is to be feasible.	[Cuthbert, Richard; Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Taggart, Mark A.; Mateo, Rafael] CSIC UCLM JCCM, IREC, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Taggart, Mark A.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen, Scotland; [Prakash, Vibhu; Chakraborty, Soumya Sunder; Deori, Parag] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Saini, Mohini; Swarup, Devendra; Upreti, Suchitra] Indian Vet Res Inst, Ctr Wildlife Conservat Management & Dis Surveilla, Izatnagar 243122, Uttar Pradesh, India; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Royal Society for Protection of Birds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of Cambridge	Cuthbert, R (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	reg29@cam.ac.uk	Mateo, Rafael/AAU-1480-2020; Mateo, Rafael/A-3117-2011	Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Taggart, Mark/0000-0002-0649-8490	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB)	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB)	This project was funded by the Darwin Initiative of the United Kingdom government http://darwin.defra.gov.uk/ and the Royal Society for the Protection of Birds (RSPB) http://www.rspb.org.uk. RC and REG are authors of the paper and members of the research staff of the Conservation Science Department of RSPB. Beyond this, the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arshad M, 2009, J ORNITHOL, V150, P495, DOI 10.1007/s10336-008-0368-9; C?lix M., 2018, EUROPEAN RED LIST SA; Gilbert M, 2006, ORYX, V40, P388, DOI 10.1017/S0030605306001347; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000686; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; Kalbfleisch JG., 1985, PROBABILITY STAT INF, DOI 10.1007/978-1-4612-1096-2; Meteyer CU, 2005, J WILDLIFE DIS, V41, P707, DOI 10.7589/0090-3558-41.4.707; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; Risebrough Robert W., 2006, Journal of the Bombay Natural History Society, V103, P239; Seigel S., 1988, NONPARAMETRIC STAT B; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066; Swan GE, 2006, BIOL LETT-UK, V2, P279, DOI 10.1098/rsbl.2005.0425; Swarup D, 2007, ANIM CONSERV, V10, P192, DOI 10.1111/j.1469-1795.2006.00086.x; Taggart MA, 2007, ENVIRON INT, V33, P759, DOI 10.1016/j.envint.2007.02.010; Taggart MA, 2009, ENVIRON SCI TECHNOL, V43, P4561, DOI 10.1021/es9002026; [No title captured]	22	61	67	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19069	10.1371/journal.pone.0019069	http://dx.doi.org/10.1371/journal.pone.0019069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589920	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600007
J	Harvey, RM; Stroeher, UH; Ogunniyi, AD; Smith-Vaughan, HC; Leach, AJ; Paton, JC				Harvey, Richard M.; Stroeher, Uwe H.; Ogunniyi, Abiodun D.; Smith-Vaughan, Heidi C.; Leach, Amanda J.; Paton, James C.			A Variable Region within the Genome of Streptococcus pneumoniae Contributes to Strain-Strain Variation in Virulence	PLOS ONE			English	Article							A1 PROTEASE GENE; PNEUMOCOCCAL PILUS; PSAA MUTANTS; IRON UPTAKE; EXPRESSION; DIVERSITY; SEQUENCE; SEROTYPE; MITIS; IDENTIFICATION	The bacterial factors responsible for the variation in invasive potential between different clones and serotypes of Streptococcus pneumoniae are largely unknown. Therefore, the isolation of rare serotype 1 carriage strains in Indigenous Australian communities provided a unique opportunity to compare the genomes of non-invasive and invasive isolates of the same serotype in order to identify such factors. The human virulence status of non-invasive, intermediately virulent and highly virulent serotype 1 isolates was reflected in mice and showed that whilst both human non-invasive and highly virulent isolates were able to colonize the murine nasopharynx equally, only the human highly virulent isolates were able to invade and survive in the murine lungs and blood. Genomic sequencing comparisons between these isolates identified 8 regions >1 kb in size that were specific to only the highly virulent isolates, and included a version of the pneumococcal pathogenicity island 1 variable region (PPI-1v), phage-associated adherence factors, transporters and metabolic enzymes. In particular, a phage-associated endolysin, a putative iron/lead permease and an operon within PPI-1v exhibited niche-specific changes in expression that suggest important roles for these genes in the lungs and blood. Moreover, in vivo competition between pneumococci carrying PPI-1v derivatives representing the two identified versions of the region showed that the version of PPI-1v in the highly virulent isolates was more competitive than the version from the less virulent isolates in the nasopharyngeal tissue, blood and lungs. This study is the first to perform genomic comparisons between serotype 1 isolates with distinct virulence profiles that correlate between mice and humans, and has highlighted the important role that hypervariable genomic loci, such as PPI-1v, play in pneumococcal disease. The findings of this study have important implications for understanding the processes that drive progression from colonization to invasive disease and will help direct the development of novel therapeutic strategies.	[Harvey, Richard M.; Stroeher, Uwe H.; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Smith-Vaughan, Heidi C.; Leach, Amanda J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia	University of Adelaide; Charles Darwin University; Menzies School of Health Research	Harvey, RM (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	james.paton@adelaide.edu.au	Paton, James C/A-9920-2008	Ogunniyi, Abiodun/0000-0001-9308-5629; Stroeher, Uwe/0000-0001-5705-7751	National Health and Medical Research Council (NHMRC) of Australia [565526, 627142]; Channel 7 Children's Research Foundation (CRF); Wellcome Trust	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation (CRF); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by Program Grant 565526 and Project Grant 627142 from the National Health and Medical Research Council (NHMRC) of Australia and a Channel 7 Children's Research Foundation (CRF) grant (www.crf.org.au). JCP is a NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andrew Lawrence from the Women's and Children's Hospital, North Adelaide, South Australia, for the provision of strain 4496 in this study. We acknowledge BmG@S (the Bacterial Microarray Group at St. George's Hospital, University of London) for supply of the microarray slides and advice. We also acknowledge the use of the pneumococcal MLST database which is located at Imperial College London and is funded by the Wellcome Trust.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AYOUBI P, 1991, J BACTERIOL, V173, P1617, DOI 10.1128/jb.173.5.1617-1622.1991; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Camilli R, 2006, MICROBIOL-SGM, V152, P313, DOI 10.1099/mic.0.28417-0; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Henderson-Begg SK, 2009, INT J ANTIMICROB AG, V33, P364, DOI 10.1016/j.ijantimicag.2008.10.002; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; KILIAN M, 1979, INFECT IMMUN, V26, P143, DOI 10.1128/IAI.26.1.143-149.1979; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACRINA FL, 1983, GENE, V25, P145; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Martin B, 1995, DEV BIOL STAND, V85, P293; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; Melin M, 2010, INFECT IMMUN; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Munoz-Najar U, 1999, J BACTERIOL, V181, P2782, DOI 10.1128/JB.181.9.2782-2788.1999; Nunes S, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01871.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Orihuela CJ, 2009, J INFECT DIS, V200, P1180, DOI 10.1086/605649; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Poulsen K, 1996, INFECT IMMUN, V64, P3957, DOI 10.1128/IAI.64.10.3957-3966.1996; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Smith BT, 1998, GENETICS, V148, P1599; Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; van der Ploeg JR, 2010, VIRUS GENES; Wani JH, 1996, INFECT IMMUN, V64, P3967, DOI 10.1128/IAI.64.10.3967-3974.1996; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	82	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19650	10.1371/journal.pone.0019650	http://dx.doi.org/10.1371/journal.pone.0019650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573186	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400038
J	Valente, MJ; Henrique, R; Costa, VL; Jeronimo, C; Carvalho, F; Bastos, ML; de Pinho, PG; Carvalho, M				Valente, Maria Joao; Henrique, Rui; Costa, Vera L.; Jeronimo, Carmen; Carvalho, Felix; Bastos, Maria L.; de Pinho, Paula Guedes; Carvalho, Marcia			A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical Specimens	PLOS ONE			English	Article							HUMAN PROXIMAL TUBULE; IN-VITRO; CARCINOMA; NEPHROTOXICITY; RAT; INHIBITION; APOPTOSIS; KIDNEY; GROWTH; CLEAR	The kidney is a target organ for the toxicity of several xenobiotics and is also highly susceptible to the development of malignant tumors. In both cases, in vitro studies provide insight to cellular damage, and represent adequate models to study either the mechanisms underlying the toxic effects of several nephrotoxicants or therapeutic approaches in renal cancer. The development of efficient methods for the establishment of human normal and tumor renal cell models is hence crucial. In this study, a technically simple and rapid protocol for the isolation and culture of human proximal tubular epithelial cells and human renal tumor cells from surgical specimens is presented. Tumor and normal tissues were processed by using the same methodology, based on mechanical disaggregation of tissue followed by enzymatic digestion and cell purification by sequential sieving. The overall procedure takes roughly one hour. The resulting cell preparations have excellent viabilities and yield. Establishment of primary cultures from all specimens was achieved successfully. The origin of primary cultured cells was established through morphological evaluation. Normal cells purity was confirmed by immunofluorescent staining and reverse transcription-polymerase chain reaction analysis for expression of specific markers.	[Valente, Maria Joao; Carvalho, Felix; Bastos, Maria L.; de Pinho, Paula Guedes; Carvalho, Marcia] Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Toxicol, P-4100 Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal; [Henrique, Rui; Jeronimo, Carmen] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Henrique, Rui; Costa, Vera L.; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Canc Epigenet Grp, Res Ctr, Oporto, Portugal; [Carvalho, Marcia] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal	Universidade do Porto; Portuguese Institute of Oncology; Universidade do Porto; Portuguese Institute of Oncology; Universidade Fernando Pessoa	Valente, MJ (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Toxicol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mjoao.pcv@gmail.com; mcarv@ufp.edu.pt	Jerónimo, Carmen/H-3284-2013; de Lourdes Bastos, Maria/D-8588-2013; Valente, Maria João/T-3646-2017; Carvalho, Félix/D-4914-2013; Valente, Maria João/M-9694-2019; Henrique, Rui Manuel Ferreira/I-2757-2013; de Pinho, P. Guedes/D-4847-2013; Carvalho, Marcia/D-5999-2013	Jerónimo, Carmen/0000-0003-4186-5345; de Lourdes Bastos, Maria/0000-0001-9895-503X; Valente, Maria João/0000-0001-6162-2426; Carvalho, Félix/0000-0003-3858-3494; Valente, Maria João/0000-0001-6162-2426; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; de Pinho, P. Guedes/0000-0002-7395-5700; Carvalho, Marcia/0000-0001-9884-4751				ANGLARD P, 1992, CANCER RES, V52, P348; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Bodmer D, 2002, HUM MOL GENET, V11, P2489, DOI 10.1093/hmg/11.20.2489; Carvalho M, 2002, ARCH TOXICOL, V76, P581, DOI 10.1007/s00204-002-0381-3; EBERT T, 1990, CANCER RES, V50, P5531; GERHARZ CD, 1993, AM J PATHOL, V142, P851; Glynne PA, 2000, METH MOLEC MED, V36, P197, DOI 10.1385/1-59259-216-3:197; Hawksworth Gabrielle M, 2005, Methods Mol Med, V107, P283; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson DW, 1997, NEPHROLOGY, V3, P183; Kim FJ, 2008, J ENDOUROL, V22, P2361, DOI 10.1089/end.2008.9703; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Lash LH, 2007, TOXICOL APPL PHARM, V221, P349, DOI 10.1016/j.taap.2007.03.023; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Liu L, 2007, ARCH PATHOL LAB MED, V131, P1290; MCATEER JA, 1991, J TISSUE CULT METHOD, V13, P143; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Park JG, 2004, METH MOLEC MED, V88, P111; Pfaller W, 1998, ENVIRON HEALTH PERSP, V106, P559, DOI 10.2307/3433806; Pittoggi C, 2008, INT BRAZ J UROL, V34, P492, DOI 10.1590/S1677-55382008000400012; Price KL, 2009, UROL RES, V37, P127, DOI 10.1007/s00240-009-0185-5; Qi W, 2007, NEPHROLOGY, V12, P155, DOI 10.1111/j.1440-1797.2007.00779.x; Schaaf GJ, 2001, CHEM-BIOL INTERACT, V134, P167, DOI 10.1016/S0009-2797(01)00151-X; Schwerdt G, 2007, TOXICOLOGY, V232, P57, DOI 10.1016/j.tox.2006.12.008; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; TUNE BM, 1980, KIDNEY INT, V18, P591, DOI 10.1038/ki.1980.177; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Vesey David A., 2009, V466, P19, DOI 10.1007/978-1-59745-352-3_2; WILSON PD, 1985, AM J PHYSIOL, V248, pF436, DOI 10.1152/ajprenal.1985.248.3.F436; Wu XX, 2000, CANCER RES, V60, P2912; Yang XMJ, 2005, CANCER RES, V65, P5628, DOI 10.1158/0008-5472.CAN-05-0533; Yusenko MV, 2010, INT J UROL, V17, P592, DOI 10.1111/j.1442-2042.2010.02558.x; ZBAR B, 1995, J UROLOGY, V153, P907, DOI 10.1016/S0022-5347(01)67601-8	35	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19337	10.1371/journal.pone.0019337	http://dx.doi.org/10.1371/journal.pone.0019337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573239	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800023
J	Lai, AL; Tamm, LK; Ellena, JF; Cafiso, DS				Lai, Alex L.; Tamm, Lukas K.; Ellena, Jeffrey F.; Cafiso, David S.			Synaptotagmin 1 Modulates Lipid Acyl Chain Order in Lipid Bilayers by Demixing Phosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND ORIENTATION; PHASE-BEHAVIOR; C2 DOMAINS; PHOSPHOLIPID-MEMBRANES; VESICLE FUSION; BASIC PEPTIDES; SNARE FUNCTION; ACIDIC LIPIDS; BINDING; SPECTROSCOPY	Synaptotagmin 1 (syt1) functions as the Ca2+ sensor in neuronal exocytosis, and it has been proposed to act by modulating lipid bilayer curvature. Here we examine the effect of the two C2 domains (C2A and C2B) of syt1 on membrane lipid order and lateral organization. In mixtures of phosphatidylcholine and phosphatidylserine (PS), attenuated total internal reflection Fourier transform infrared spectroscopy indicates that a fragment containing both domains (C2AB) or C2B alone disorders the lipid acyl chains, whereas the C2A domain has little effect upon chain order. Two observations suggest that these changes reflect a demixing of PS. First, the changes in acyl chain order are reversed at higher protein concentration; second, selective lipid deuteration demonstrates that the changes in lipid order are associated only with the PS component of the bilayer. Independent evidence for lipid demixing is obtained from fluorescence self-quenching of labeled lipid and from natural abundance C-13 NMR, where heteronuclear single quantum correlation spectra reveal Ca2+-dependent chemical shift changes for PS, but not for phosphatidylcholine, in the presence of the syt1 C2 domains. The ability of syt1 to demix PS is observed in a range of lipid mixtures that includes cholesterol, phosphatidylethanolamine, and varied PS content. These data suggest that syt1 might facilitate SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors)-mediated membrane fusion by phase separating PS, a process that is expected to locally buckle bilayers and disorder lipids due to the curvature tendencies of PS.	[Lai, Alex L.; Ellena, Jeffrey F.; Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22904 USA; [Lai, Alex L.; Tamm, Lukas K.; Ellena, Jeffrey F.; Cafiso, David S.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22904 USA	University of Virginia; University of Virginia; University of Virginia	Cafiso, DS (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.	cafiso@virginia.edu	Lai, Alex/G-8668-2014		National Institutes of Health (NIGMS) [GM 072694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 072694 (NIGMS; to D. S. C. and L. K. T.).	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; BACH D, 1992, CHEM PHYS LIPIDS, V63, P105, DOI 10.1016/0009-3084(92)90027-M; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; BOROCHOV N, 1995, CHEM PHYS LIPIDS, V76, P85, DOI 10.1016/0009-3084(94)02411-W; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Connell E, 2008, J MOL BIOL, V380, P42, DOI 10.1016/j.jmb.2008.01.084; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Garg S, 2009, J STRUCT BIOL, V168, P11, DOI 10.1016/j.jsb.2009.04.001; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; GRUNER SM, 1989, J PHYS CHEM-US, V93, P7562, DOI 10.1021/j100359a011; Han X, 1999, BIOCHEMISTRY-US, V38, P15052, DOI 10.1021/bi991232h; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hinderliter A, 2001, BIOCHEMISTRY-US, V40, P4181, DOI 10.1021/bi0024299; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P1055, DOI 10.1021/bi00534a036; Huang H, 2008, BIOCHEMISTRY-US, V47, P12380, DOI 10.1021/bi801470m; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; LEPORE LS, 1992, BIOPHYS J, V61, P767, DOI 10.1016/S0006-3495(92)81881-7; LUNA EJ, 1977, BIOCHIM BIOPHYS ACTA, V470, P303, DOI 10.1016/0005-2736(77)90108-0; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; NEUMANN JM, 1985, EUR BIOPHYS J BIOPHY, V11, P219, DOI 10.1007/BF00261998; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Shahin V, 2008, BIOCHEMISTRY-US, V47, P2143, DOI 10.1021/bi701879g; SILVIUS JR, 1984, BIOCHEMISTRY-US, V23, P3232, DOI 10.1021/bi00309a018; STEWART TP, 1979, BIOCHIM BIOPHYS ACTA, V556, P1, DOI 10.1016/0005-2736(79)90415-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wolf C, 2001, BIOPHYS CHEM, V89, P163, DOI 10.1016/S0301-4622(00)00226-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	50	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25291	25300		10.1074/jbc.M111.258848	http://dx.doi.org/10.1074/jbc.M111.258848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610074	Green Published, hybrid			2022-12-25	WOS:000292547900075
J	Zhang, JH; Ge, L; Qi, W; Zhang, LQ; Miao, HH; Li, BL; Yang, MJ; Song, BL				Zhang, Jin-Hui; Ge, Liang; Qi, Wei; Zhang, Liqing; Miao, Hong-Hua; Li, Bo-Liang; Yang, Maojun; Song, Bao-Liang			The N-terminal Domain of NPC1L1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK C1 PROTEIN; REGULATED TRANSLOCATION; STEROL BINDING; CELL-SURFACE; C2 DISEASE; METABOLISM; ABSORPTION; EZETIMIBE; REVEALS; IDENTIFICATION	Niemann-Pick C1-like 1 (NPC1L1) is a multitransmembrane protein playing a crucial role in dietary and biliary cholesterol absorption. Cholesterol promotes the formation and endocytosis of NPC1L1-flotillin-cholesterol membrane microdomains, which is an early step in cholesterol uptake. How cholesterol is sensed in this step is unknown. Here, we find that the N-terminal domain (NTD) of NPC1L1 binds cholesterol. Mutation of residue Leu-216 in NPC1L1-NTD eliminates cholesterol binding, decreases the formation of NPC1L1-flotillin-cholesterol membrane microdomains, and prevents NPC1L1-mediated cholesterol uptake in culture cells and mice livers. NPC1L1-NTD specifically binds cholesterol but not plant sterols, which may account for the selective cholesterol absorption in intestine. Furthermore, 25- or 27-hydroxycholesterol competes with cholesterol to bind NPC1L1-NTD and inhibits the cholesterol induced endocytosis of NPC1L1. Together, these results demonstrate that plasma membrane-localized NPC1L1 binds exogenous cholesterol via its NTD, and facilitates the formation of NPC1L1-flotillin-cholesterol membrane microdomains that are then internalized into cells through the clathrin-AP2 pathway. Our study uncovers the mechanism of cholesterol sensing by NPC1L1 and proposes a mechanism for selective cholesterol absorption.	[Zhang, Jin-Hui; Ge, Liang; Qi, Wei; Miao, Hong-Hua; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhang, Liqing; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Song, BL (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	zhang, jinhui/GXF-6528-2022	Song, Bao-Liang/0000-0002-6397-5935; Qi, Wei/0000-0003-0813-5316; Yang, Maojun/0000-0002-6798-3094; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the Ministry of Science and Technology of China (Grants 2009CB919000 and 2011CB910900), the National Natural Science Foundation of China (Grant 30925012), and the Shanghai Science and Technology Committee (Grant 10QH1402900).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chen HY, 2010, J MOL CELL BIOL, V2, P366, DOI 10.1093/jmcb/mjq034; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; GLOVER J, 1958, BRIT MED BULL, V14, P226, DOI 10.1093/oxfordjournals.bmb.a069688; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nies AT, 1998, HEPATOLOGY, V28, P1332, DOI 10.1002/hep.510280523; Schoenheimer R, 1931, SCIENCE, V74, P579, DOI 10.1126/science.74.1928.579; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	35	77	86	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25088	25097		10.1074/jbc.M111.244475	http://dx.doi.org/10.1074/jbc.M111.244475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602275	hybrid, Green Published			2022-12-25	WOS:000292547900057
J	Bolbecker, AR; Hong, SL; Kent, JS; Klaunig, MJ; O'Donnell, BF; Hetrick, WP				Bolbecker, Amanda R.; Hong, S. Lee; Kent, Jerillyn S.; Klaunig, Mallory J.; O'Donnell, Brian F.; Hetrick, William P.			Postural Control in Bipolar Disorder: Increased Sway Area and Decreased Dynamical Complexity	PLOS ONE			English	Article							SOFT NEUROLOGICAL SIGNS; GRAY-MATTER LOSS; PARKINSONS-DISEASE; CHRONIC LITHIUM; HUNTINGTONS-DISEASE; CEREBELLAR VERMIS; EUTHYMIC PATIENTS; MOOD DISORDERS; FRONTAL-LOBE; MRI ANALYSIS	Structural, neurochemical, and functional abnormalities have been identified in the brains of individuals with bipolar disorder, including in key brain structures implicated in postural control, i.e. the cerebellum, brainstem, and basal ganglia. Given these findings, we tested the hypothesis that postural control deficits are present in individuals with bipolar disorder. Sixteen participants with bipolar disorder (BD) and 16 age-matched non-psychiatric healthy controls were asked to stand as still as possible on a force platform for 2 minutes under 4 conditions: (1) eyes open-open base; (2) eyes closed-open base; (3) eyes open-closed base; and (4) eyes closed-closed base. Postural sway data were submitted to conventional quantitative analyses of the magnitude of sway area using the center of pressure measurement. In addition, data were submitted to detrended fluctuation analysis, a nonlinear dynamical systems analytic technique that measures complexity of a time-series, on both the anterior-posterior and medio-lateral directions. The bipolar disorder group had increased sway area, indicative of reduced postural control. Decreased complexity in the medio-lateral direction was also observed for the bipolar disorder group, suggesting both a reduction in dynamic range available to them for postural control, and that their postural corrections were primarily dominated by longer time-scales. On both of these measures, significant interactions between diagnostic group and visual condition were also observed, suggesting that the BD participants were impaired in their ability to make corrections to their sway pattern when no visual information was available. Greater sway magnitude and reduced complexity suggest that individuals with bipolar disorder have deficits in sensorimotor integration and a reduced range of timescales available on which to make postural corrections.	[Bolbecker, Amanda R.; Kent, Jerillyn S.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bolbecker, Amanda R.; Klaunig, Mallory J.; O'Donnell, Brian F.; Hetrick, William P.] Larue D Carter Mem Hosp, Indianapolis, IN USA; [Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bolbecker, AR (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	whetrick@indiana.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute of Mental Health [R01 MH074983]; clinical research team at Larue D. Carter Memorial Hospital; Indiana University Neuroscience Clinical Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074983] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); clinical research team at Larue D. Carter Memorial Hospital; Indiana University Neuroscience Clinical Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a 2007 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant awarded to Amanda R. Bolbecker and National Institute of Mental Health grant R01 MH074983 to William P. Hetrick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jennifer Forsyth, Colleen Merrill, Ashley Steffen, and Sam Kaiser for their assistance in collecting postural sway data. We also thank the clinical research team at Larue D. Carter Memorial Hospital and the Indiana University Neuroscience Clinical Research Center for their support.	Adler CM, 2007, BIOL PSYCHIAT, V61, P776, DOI 10.1016/j.biopsych.2006.05.042; Baumann B, 1999, J AFFECT DISORDERS, V54, P217, DOI 10.1016/S0165-0327(98)00168-2; Bolbecker AR, 2009, BIPOLAR DISORD, V11, P19, DOI 10.1111/j.1399-5618.2008.00642.x; Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020; Brambilla P, 2001, PSYCHIAT RES-NEUROIM, V106, P65, DOI 10.1016/S0925-4927(01)00073-7; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cecil KM, 2003, J CHILD ADOL PSYCHOP, V13, P545, DOI 10.1089/104454603322724931; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chang TT, 2010, BIPOLAR DISORD, V12, P102, DOI 10.1111/j.1399-5618.2009.00771.x; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; CUTTING JC, 1976, PSYCHOL MED, V6, P635; DelBello MP, 1999, NEUROPSYCHOPHARMACOL, V21, P63, DOI 10.1016/S0893-133X(99)00026-3; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; First M. B., 2002, STRUCTURED CLIN INTE; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; Forssberg H, 1999, CURR OPIN NEUROBIOL, V9, P676, DOI 10.1016/S0959-4388(99)00037-9; Friedrich M, 2008, EXP BRAIN RES, V186, P305, DOI 10.1007/s00221-007-1233-4; Goswami U, 2006, BRIT J PSYCHIAT, V188, P366, DOI 10.1192/bjp.188.4.366; Goswami U, 2007, J AFFECT DISORDERS, V103, P99, DOI 10.1016/j.jad.2007.01.009; Green MJ, 2007, J AFFECT DISORDERS, V103, P29, DOI 10.1016/j.jad.2007.01.024; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guy W., 1976, ECDEU ASSESSMENT MAN; Hong SL, 2007, NEUROSCI LETT, V423, P104, DOI 10.1016/j.neulet.2007.06.043; Katz Donald B, 2002, Behav Cogn Neurosci Rev, V1, P229, DOI 10.1177/1534582302001003004; Keshavan MS, 1999, J PSYCHIATR RES, V33, P513, DOI 10.1016/S0022-3956(99)00033-3; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; LEINER HC, 1991, BEHAV BRAIN RES, V44, P113, DOI 10.1016/S0166-4328(05)80016-6; LIPPMANN S, 1982, AM J PSYCHIAT, V139, P667; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lohr JB, 2006, J NEUROPSYCH CLIN N, V18, P342, DOI 10.1176/appi.neuropsych.18.3.342; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Manji HK, 2000, J CLIN PSYCHIAT, V61, P82; Marvel CL, 2004, PSYCHIAT CLIN N AM, V27, P19, DOI 10.1016/S0193-953X(03)00106-0; MAYBERG HS, 1992, NEUROLOGY, V42, P1791, DOI 10.1212/WNL.42.9.1791; MENDEZ MF, 1994, INT J PSYCHIAT MED, V24, P189, DOI 10.2190/HU6W-3K7Q-NAEL-XU6K; Mills NP, 2005, AM J PSYCHIAT, V162, P1530, DOI 10.1176/appi.ajp.162.8.1530; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moorhead TWJ, 2007, BIOL PSYCHIAT, V62, P894, DOI 10.1016/j.biopsych.2007.03.005; NAKAGAWA H, 1993, ACTA OTO-LARYNGOL, P112; NASRALLAH HA, 1982, J CLIN PSYCHIAT, V43, P439; NASRALLAH HA, 1981, LANCET, V1, P1102; Negash A, 2004, J AFFECT DISORDERS, V80, P221, DOI 10.1016/S0165-0327(03)00116-2; Newell KM, 2002, AM J MENT RETARD, V107, P270, DOI 10.1352/0895-8017(2002)107<0270:OODACI>2.0.CO;2; NEWELL KM, 1998, DEGREES FREEDOM DEV; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Nonaka S, 1998, NEUROREPORT, V9, P2081, DOI 10.1097/00001756-199806220-00031; Ogendahl BK, 2006, PSYCHOL MED, V36, P1219, DOI 10.1017/S0033291706008269; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sanches M, 2005, BIPOLAR DISORD, V7, P153, DOI 10.1111/j.1399-5618.2004.00178.x; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Tandberg E, 1996, ARCH NEUROL-CHICAGO, V53, P175, DOI 10.1001/archneur.1996.00550020087019; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; VANEMMERIK REA, 1993, MOVEMENT DISORD, V8, P305, DOI 10.1002/mds.870080309; Venault P, 2001, NEUROREPORT, V12, P3091, DOI 10.1097/00001756-200110080-00022; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Wei HF, 2000, EUR J PHARMACOL, V392, P117, DOI 10.1016/S0014-2999(00)00127-8; Williams LM, 2008, SCHIZOPHR RES, V99, P182, DOI 10.1016/j.schres.2007.10.019; Wiste AK, 2008, BIPOLAR DISORD, V10, P349, DOI 10.1111/j.1399-5618.2007.00528.x; Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; YADALAM KG, 1985, AM J PSYCHIAT, V142, P1067; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zheng J, 2009, J HUAZHONG U SCI-MED, V29, P725, DOI 10.1007/s11596-009-0610-6; Zimbelman JL, 2007, J INT NEUROPSYCH SOC, V13, P758, DOI 10.1017/S1355617707071214	80	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19824	10.1371/journal.pone.0019824	http://dx.doi.org/10.1371/journal.pone.0019824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611126	gold, Green Submitted, Green Published			2022-12-25	WOS:000290720200037
J	Carrier, DR				Carrier, David R.			The Advantage of Standing Up to Fight and the Evolution of Habitual Bipedalism in Hominins	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; REPRODUCTIVE SUCCESS; FUNCTIONAL-ANATOMY; NATIONAL-PARK; INTERGROUP AGGRESSION; PHYSICAL HEIGHT; PELVIC LIMB; CHIMPANZEES; BEHAVIOR; ORIGIN	Background: Many quadrupedal species stand bipedally on their hindlimbs to fight. This posture may provide a performance advantage by allowing the forelimbs to strike an opponent with the range of motion that is intrinsic to high-speed running, jumping, rapid braking and turning; the range of motion over which peak force and power can be produced. Methodology/Principal Findings: To test the hypothesis that bipedal (i.e., orthograde) posture provides a performance advantage when striking with the forelimbs, I measured the force and energy produced when human subjects struck from "quadrupedal' (i.e., pronograde) and bipedal postures. Downward and upward directed striking energy was measured with a custom designed pendulum transducer. Side and forward strikes were measured with a punching bag instrumented with an accelerometer. When subjects struck downward from a bipedal posture the work was 43.70 +/- 12.59% (mean +/- S. E.) greater than when they struck from a quadrupedal posture. Similarly, 47.49 +/- 17.95% more work was produced when subjects struck upward from a bipedal stance compared to a quadrupedal stance. Importantly, subjects did 229.69 +/- 44.19% more work in downward than upward directed strikes. During side and forward strikes the force impulses were 30.12 +/- 3.68 and 43.04 +/- 9.00% greater from a bipedal posture than a quadrupedal posture, respectively. Conclusions/Significance: These results indicate that bipedal posture does provide a performance advantage for striking with the forelimbs. The mating systems of great apes are characterized by intense male-male competition in which conflict is resolved through force or the threat of force. Great apes often fight from bipedal posture, striking with both the fore-and hindlimbs. These observations, plus the findings of this study, suggest that sexual selection contributed to the evolution of habitual bipedalism in hominins.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Carrier, DR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	carrier@biology.utah.edu			National Science Foundation [IOS-0817782]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from The National Science Foundation (IOS-0817782). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Brewer G, 2009, EVOL PSYCHOL-US, V7, P477; Buunk AP, 2008, EVOL HUM BEHAV, V29, P133, DOI 10.1016/j.evolhumbehav.2007.11.006; Carrier D, 2004, FROM BIPED TO STRIDER, P135; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; Carrier DR, 2007, EVOLUTION, V61, P596, DOI 10.1111/j.1558-5646.2007.00061.x; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; CASE A, 2006, NBER WORKING PAPER S, V1246; Chagnon N.A., 1979, EVOLUTIONARY BIOL HU, P86; Daly M, 2001, CAN J CRIMINOL, V43, P219; Darwin Charles, 1871, DESCENT MAN; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8; ENQUIST M, 1985, ANIM BEHAV, V33, P1152, DOI 10.1016/S0003-3472(85)80175-5; ETKIN W, 1954, AM NAT, V88, P129, DOI 10.1086/281823; FEINGOLD A, 1982, PSYCHOL REP, V50, P810, DOI 10.2466/pr0.1982.50.3.810; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; GALDIKAS BMF, 1985, FOLIA PRIMATOL, V45, P9, DOI 10.1159/000156188; Garner BA, 2003, ANN BIOMED ENG, V31, P207, DOI 10.1114/1.1540105; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; Goodall J., 1986, CHIMPANZEES GOMBE PA; Guthrie, 1970, EVOLUTIONARY BIOL, V4, P257; HARCOURT AH, 1978, Z TIERPSYCHOL, V48, P401; Hohmann G, 2003, BEHAVIOUR, V140, P1389, DOI 10.1163/156853903771980648; Hunt KD, 1996, S AFR J SCI, V92, P77; Iwamoto M., 1985, P251; JABLONSKI NG, 1993, J HUM EVOL, V24, P259, DOI 10.1006/jhev.1993.1021; JENKINS FA, 1979, J ZOOL, V188, P379; Johnson GR, 1996, J BIOMECH, V29, P1039, DOI 10.1016/0021-9290(95)00176-X; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Jurmain R, 1997, PRIMATES, V38, P1, DOI 10.1007/BF02385918; Kano T., 1992, LAST APE PYGMY CHIMP; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KORTLANDT A, 1963, P 16 INT C ZOOL, V3, P64; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; LIVINGSTONE FB, 1962, AM ANTHROPOL, V64, P301, DOI 10.1525/aa.1962.64.2.02a00050; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; LYNN M, 1984, PERS SOC PSYCHOL B, V10, P349, DOI 10.1177/0146167284103002; MANNING JT, 1995, ETHOL SOCIOBIOL, V16, P145, DOI 10.1016/0162-3095(94)00074-H; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; Mueller U, 2001, BEHAV ECOL SOCIOBIOL, V50, P302, DOI 10.1007/s002650100370; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; Nishida T., 1990, P63; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pawlowski B, 2002, EVOL HUM BEHAV, V23, P139, DOI 10.1016/S1090-5138(01)00092-7; Plavcan J. Michael, 1999, P241, DOI 10.1017/CBO9780511542466.012; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Plavcan JM, 2000, J HUM EVOL, V39, P327, DOI 10.1006/jhev.2000.0423; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; SHEPPERD JA, 1989, PERS SOC PSYCHOL B, V15, P617, DOI 10.1177/0146167289154014; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Szalai F, 2009, ANIM BEHAV, V78, P949, DOI 10.1016/j.anbehav.2009.06.025; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; THORNHILL R, 1983, ETHOL SOCIOBIOL, V4, P137, DOI 10.1016/0162-3095(83)90027-4; THORNHILL R, 2003, PSYCHOL EVOL GENDER, V4, P283; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Thorpe S.K.S., 2002, P231; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Walter M., 2004, Human Evolution, V19, P19, DOI 10.1007/BF02438907; Walther F.R., 1984, COMMUNICATION EXPRES; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; WESCOTT RW, 1967, MAN, V2, P630; WHEELER PE, 1984, J HUM EVOL, V13, P91, DOI 10.1016/S0047-2484(84)80079-2; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P491, DOI 10.1111/j.1469-7580.2007.00703.x; WILSON M, 1995, CAN J CRIMINOL, V37, P331; Wilson M, 1993, Violence Vict, V8, P271; Wilson M., 1998, THEORETICAL CRIMINOL, V2, P291, DOI DOI 10.1177/1362480698002003001; Witte TH, 2006, J EXP BIOL, V209, P4389, DOI 10.1242/jeb.02518; Wrangham Richard, 1996, DEMONIC MALES APES O; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; [No title captured]	86	45	45	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19630	10.1371/journal.pone.0019630	http://dx.doi.org/10.1371/journal.pone.0019630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611167	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200021
J	Schmidt, FA; Goktas, O; Harms, L; Bohner, G; Erb, K; Dahlslett, B; Fleiner, F				Schmidt, Felix Alexander; Goktas, Onder; Harms, Lutz; Bohner, Georg; Erb, Katharina; Dahlslett, Bettina; Fleiner, Franca			Structural Correlates of Taste and Smell Loss in Encephalitis Disseminatae	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; ODOR IDENTIFICATION; DIAGNOSTIC-CRITERIA; TEMPORAL-LOBES; DYSFUNCTION; TESTS; DISCRIMINATION; SCHIZOPHRENIA	Background: Olfactory dysfunction in MS patients is reported in the literature. MRI of the olfactory bulb (OB) is discussed as a promising new testing method for measuring olfactory function (OF). Aim of this study was to explore reasons for and optimize the detection of olfactory dysfunction in MS patients with MRI. Materials and Methods: OB and olfactory brain volume was assessed within 34 MS patients by manual segmentation. Olfactory function was tested using the Threshold-Discrimination-Identification-Test (TDI), gustatory function was tested using Taste Strips (TST). Results: 41% of the MS patients displayed olfactory dysfunction (8% of the control group), 16% displayed gustatory dysfunction (5% of the control group). There was a correlation between the OB volume and the number and volume of MS lesions in the olfactory brain. Olfactory brain volume correlated with the volume of lesions in the olfactory brain and the EDSS score. The TST score correlated with the number and volume of lesions in the olfactory brain. Conclusion: The correlation between a higher number and volume of MS lesions with a decreased OB and olfactory brain volume could help to explain olfactory dysfunction.	[Schmidt, Felix Alexander; Goktas, Onder; Dahlslett, Bettina; Fleiner, Franca] Univ Berlin, Dept Otolaryngol Head & Neck Surg, Charite Campus Mitte, Smell & Taste Consultat Serv, Berlin, Germany; [Schmidt, Felix Alexander; Harms, Lutz] Univ Berlin, Dept Neurol, Charite Campus Mitte, Consultat Serv Multiple Sclerosis, Berlin, Germany; [Bohner, Georg; Erb, Katharina] Univ Berlin, Dept Radiol, Charite Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, FA (corresponding author), Univ Berlin, Dept Otolaryngol Head & Neck Surg, Charite Campus Mitte, Smell & Taste Consultat Serv, Berlin, Germany.	oender.goektas@charite.de		Bohner, Georg/0000-0002-1919-092X				Abolmaali N, 2009, LARYNGO RHINO OTOL, V88, P10, DOI 10.1055/s-2008-1077630; Abolmaali N, 2008, NEUROIMAG CLIN N AM, V18, P233, DOI 10.1016/j.nic.2007.10.002; BAUKNECHT, 2010, RO FO, V182, P163; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Doty RL, 1998, ANN NY ACAD SCI, V855, P781, DOI 10.1111/j.1749-6632.1998.tb10658.x; FOLEY FW, 1992, ARCH NEUROL-CHICAGO, V49, P238, DOI 10.1001/archneur.1992.00530270052018; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; Heilmann S, 2004, LARYNGO RHINO OTOL, V83, P729, DOI 10.1055/s-2004-825676; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; HUMMEL T, 2009, RIECH SCHMECKSTORUNG, P20; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Mueller C, 2003, RHINOLOGY, V41, P2; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Rombaux P, 2006, LARYNGOSCOPE, V116, P436, DOI 10.1097/01.MLG.0000195291.36641.1E; Rombaux P, 2009, RHINOLOGY, V47, P3; Thomann PA, 2009, NEUROBIOL AGING, V30, P838, DOI 10.1016/j.neurobiolaging.2007.08.001; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Wattendorf E, 2009, J NEUROSCI, V29, P15410, DOI 10.1523/JNEUROSCI.1909-09.2009; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Zorzon M, 2000, MULT SCLER J, V6, P386, DOI 10.1191/135245800701566368	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19702	10.1371/journal.pone.0019702	http://dx.doi.org/10.1371/journal.pone.0019702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611177	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500014
J	Grosberg, LE; Radosevich, AJ; Asfaha, S; Wang, TC; Hillman, EMC				Grosberg, Lauren E.; Radosevich, Andrew J.; Asfaha, Samuel; Wang, Timothy C.; Hillman, Elizabeth M. C.			Spectral Characterization and Unmixing of Intrinsic Contrast in Intact Normal and Diseased Gastric Tissues Using Hyperspectral Two-Photon Microscopy	PLOS ONE			English	Article							IN-VIVO; FLUORESCENCE SPECTROSCOPY; MULTIPHOTON MICROSCOPY; EXTRACELLULAR-MATRIX; HUMAN SKIN; CANCER; RESOLUTION; NAD(P)H; SYSTEM	Background: Living tissues contain a range of intrinsic fluorophores and sources of second harmonic generation which provide contrast that can be exploited for fresh tissue imaging. Microscopic imaging of fresh tissue samples can circumvent the cost and time associated with conventional histology. Further, intrinsic contrast can provide rich information about a tissue's composition, structure and function, and opens the potential for in-vivo imaging without the need for contrast agents. Methodology/Principal Findings: In this study, we used hyperspectral two-photon microscopy to explore the characteristics of both normal and diseased gastrointestinal (GI) tissues, relying only on their endogenous fluorescence and second harmonic generation to provide contrast. We obtained hyperspectral data at subcellular resolution by acquiring images over a range of two-photon excitation wavelengths, and found excitation spectral signatures of specific tissue types based on our ability to clearly visualize morphology. We present the two-photon excitation spectral properties of four major tissue types that are present throughout the GI tract: epithelium, lamina propria, collagen, and lymphatic tissue. Using these four excitation signatures as basis spectra, linear unmixing strategies were applied to hyperspectral data sets of both normal and neoplastic tissue acquired in the colon and small intestine. Our results show that hyperspectral unmixing with excitation spectra allows segmentation, showing promise for blind identification of tissue types within a field of view, analogous to specific staining in conventional histology. The intrinsic spectral signatures of these tissue types provide information relating to their biochemical composition. Conclusions/Significance: These results suggest hyperspectral two-photon microscopy could provide an alternative to conventional histology either for in-situ imaging, or intraoperative 'instant histology' of fresh tissue biopsies.	[Grosberg, Lauren E.; Radosevich, Andrew J.; Hillman, Elizabeth M. C.] Columbia Univ, Lab Funct Opt Imaging, Dept Biomed Engn, New York, NY 10027 USA; [Grosberg, Lauren E.; Radosevich, Andrew J.; Hillman, Elizabeth M. C.] Columbia Univ, Lab Funct Opt Imaging, Dept Radiol, New York, NY USA; [Asfaha, Samuel; Wang, Timothy C.] Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY USA	Columbia University; Columbia University; Columbia University	Grosberg, LE (corresponding author), Columbia Univ, Lab Funct Opt Imaging, Dept Biomed Engn, New York, NY 10027 USA.	leg2137@columbia.edu	Asfaha, Samuel/I-8245-2015; Hillman, Elizabeth M C/B-9854-2009	Asfaha, Samuel/0000-0001-6972-0338; Wang, Timothy/0000-0001-5730-3019; Hillman, Elizabeth M. C./0000-0001-5511-1451	National Institutes of Health [R21NS053684, R01NS063226, U54CA126513]; National Science Foundation [0954796]; Human Frontier Science Program; Wallace H. Coulter Foundation; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063226, R21NS053684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); Wallace H. Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (R21NS053684, R01NS063226, and U54CA126513), the National Science Foundation (0954796), the Human Frontier Science Program and the Wallace H. Coulter Foundation. L. Grosberg receives National Science Foundation graduate fellowship funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohorfoush AG, 1996, ENDOSCOPY, V28, P372, DOI 10.1055/s-2007-1005484; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Chen J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/289; COTHREN RM, 1990, GASTROINTEST ENDOSC, V36, P105, DOI 10.1016/S0016-5107(90)70961-3; Dela Cruz JM, 2010, BIOMED OPT EXPRESS, V1, P1320, DOI 10.1364/BOE.1.001320; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Georgakoudi I, 2002, CANCER RES, V62, P682; Grosberg LE, 2009, ADV OPTICS BIOTECHNO; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Laiho LH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891370; LIOTTA LA, 1985, ANN NY ACAD SCI, V460, P333, DOI 10.1111/j.1749-6632.1985.tb51180.x; Liu JTC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363363; McCaslin AFH, 2010, J CEREB BLOOD FLOW M; Molitoris BA, 2005, AM J PHYSIOL-RENAL, V288, pF1084, DOI 10.1152/ajprenal.00473.2004; Mukherjee S, 2009, P SOC PHOTO OPT INST, V7161; OHTSUKA A, 1992, CELL TISSUE RES, V269, P403, DOI 10.1007/BF00353895; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Paoli J, 2008, J INVEST DERMATOL, V128, P1248, DOI 10.1038/sj.jid.5701139; Pavlova I, 2010, PROC SPIE, V7569, DOI 10.1117/12.841017; Radosevich AJ, 2008, OPT LETT, V33, P2164, DOI 10.1364/OL.33.002164; Ramanujam N, 2000, NEOPLASIA, V2, P89, DOI 10.1038/sj.neo.7900077; Rogart JN, 2008, CLIN GASTROENTEROL H, V6, P95, DOI 10.1016/j.cgh.2007.10.008; Ross M. H., 2006, HISTOLOGY TEXT ATLAS; SAYER P, 1974, BIOCHEM MED METAB B, V10, P24, DOI 10.1016/0006-2944(74)90005-2; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tang S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127203; Wallace MB, 2010, GASTROENTEROLOGY, V138, P2140, DOI 10.1053/j.gastro.2009.12.067; Williams RM, 2010, TRANSL ONCOL, V3, P181, DOI 10.1593/tlo.09310; Wu YC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2362741; Wu YC, 2009, OPT EXPRESS, V17, P7907, DOI 10.1364/OE.17.007907; Zakaryan A, 2001, INT IMMUNOL, V13, P1141, DOI 10.1093/intimm/13.9.1141; Zhao YB, 2010, BIOMED OPT EXPRESS, V1, P1159, DOI 10.1364/BOE.1.001159; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	37	34	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19925	10.1371/journal.pone.0019925	http://dx.doi.org/10.1371/journal.pone.0019925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603623	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300039
J	Hlavova, M; Cizkova, M; Vitova, M; Bisova, K; Zachleder, V				Hlavova, Monika; Cizkova, Maria; Vitova, Milada; Bisova, Katerina; Zachleder, Vilem			DNA Damage during G2 Phase Does Not Affect Cell Cycle Progression of the Green Alga Scenedesmus quadricauda	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; P53-DEPENDENT G(1) ARREST; HISTONE H1 KINASE; FISSION YEAST; CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; MIDBLASTULA TRANSITION; REPRODUCTIVE EVENTS; IONIZING-RADIATION; DIVISION PROCESSES	DNA damage is a threat to genomic integrity in all living organisms. Plants and green algae are particularly susceptible to DNA damage especially that caused by UV light, due to their light dependency for photosynthesis. For survival of a plant, and other eukaryotic cells, it is essential for an organism to continuously check the integrity of its genetic material and, when damaged, to repair it immediately. Cells therefore utilize a DNA damage response pathway that is responsible for sensing, reacting to and repairing damaged DNA. We have studied the effect of 5-fluorodeoxyuridine, zeocin, caffeine and combinations of these on the cell cycle of the green alga Scenedesmus quadricauda. The cells delayed S phase and underwent a permanent G2 phase block if DNA metabolism was affected prior to S phase; the G2 phase block imposed by zeocin was partially abolished by caffeine. No cell cycle block was observed if the treatment with zeocin occurred in G2 phase and the cells divided normally. CDKA and CDKB kinases regulate mitosis in S. quadricauda; their kinase activities were inhibited by Wee1. CDKA, CDKB protein levels were stabilized in the presence of zeocin. In contrast, the protein level of Wee1 was unaffected by DNA perturbing treatments. Wee1 therefore does not appear to be involved in the DNA damage response in S. quadricauda. Our results imply a specific reaction to DNA damage in S. quadricauda, with no cell cycle arrest, after experiencing DNA damage during G2 phase.	[Hlavova, Monika; Cizkova, Maria; Vitova, Milada; Bisova, Katerina; Zachleder, Vilem] ASCR, Inst Microbiol, Lab Cell Cycles Algae, Trebon, Czech Republic; [Hlavova, Monika] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Hlavova, M (corresponding author), ASCR, Inst Microbiol, Lab Cell Cycles Algae, Trebon, Czech Republic.	bisova@alga.cz	Hlavova, Monika/J-9800-2014; Bišová, Kateřina/H-2625-2014; Vítová, Milada/H-3953-2014; Cizkova, Maria/T-9121-2018	Bišová, Kateřina/0000-0003-1997-0894; Vítová, Milada/0000-0002-0552-3295; Cizkova, Maria/0000-0002-2328-8583	Grant Agency of the Academy of Sciences of the Czech Republic [A500200614, M200200904]; Grant Agency of the Czech Republic [204/09/0111, 525/09/0102]; Academy of Sciences of the Czech Republic [AV0Z50200510]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was financially supported by the Grant Agency of the Academy of Sciences of the Czech Republic (grant numbers A500200614, M200200904); the Grant Agency of the Czech Republic (grant numbers 204/09/0111, and 525/09/0102), and the Institutional Research Concept (number AV0Z50200510) funded by the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Bennett RAO, 1996, INT J RADIAT BIOL, V70, P623; Bisova K, 2000, PLANT PHYSIOL BIOCH, V38, P755, DOI 10.1016/S0981-9428(00)01179-7; Bisova K, 2003, FOLIA MICROBIOL, V48, P805, DOI 10.1007/BF02931518; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Calonge TM, 2008, DNA REPAIR, V7, P136, DOI 10.1016/j.dnarep.2007.07.017; Chankova SG, 2007, RADIAT ENVIRON BIOPH, V46, P409, DOI 10.1007/s00411-007-0123-2; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; DECALLONNE JR, 1976, ANAL BIOCHEM, V74, P448, DOI 10.1016/0003-2697(76)90225-6; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; EHRENFELD GM, 1987, BIOCHEMISTRY-US, V26, P931, DOI 10.1021/bi00377a038; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; GATIGNOL A, 1988, FEBS LETT, V230, P17; Hanawalt PC, 1996, ENVIRON HEALTH PERSP, V104, P547, DOI 10.2307/3432821; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Howard A, 1953, HEREDITY           S, V6, P261; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Janke R, 2010, NUCLEIC ACIDS RES, V38, P2302, DOI 10.1093/nar/gkp1222; JOHN PCL, 1984, MICROBIOL SCI, V1, P96; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KOSTRUB CF, 1997, MOL GEN GENET, V254, P38999; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU CC, 1982, P NATL ACAD SCI-BIOL, V79, P2942, DOI 10.1073/pnas.79.9.2942; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee MW, 2007, YEAST, V24, P145, DOI 10.1002/yea.1446; Lukavsky J., 1973, ARCH HYDROBIOL SUPPL, V9, P416; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pelayo HR, 2001, PLANTA, V212, P444, DOI 10.1007/s004250000415; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; PICKETTHEAPS JD, 1975, J PHYCOL, V11, P186, DOI 10.1111/j.0022-3646.1975.00186.x; Poon RYC, 1997, CANCER RES, V57, P5168; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sarkaria JN, 1999, CANCER RES, V59, P4375; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SETLIK I, 1972, Algological Studies, V7, P172; Setlik I., 1984, MICROBIAL CELL CYCLE, P253; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siede W, 1996, GENETICS, V142, P91; Slaninova M, 2003, DNA REPAIR, V2, P737, DOI 10.1016/S1568-7864(03)00047-8; Tao Y, 2010, CHEMOSPHERE, V78, P541, DOI 10.1016/j.chemosphere.2009.11.016; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vitova M, 2005, FOLIA MICROBIOL, V50, P333, DOI 10.1007/BF02931414; Vitova M, 2005, FOLIA MICROBIOL, V50, P141, DOI 10.1007/BF02931463; Vitova M, 2008, PLANT CELL PHYSIOL, V49, P1805, DOI 10.1093/pcp/pcn162; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; WANKA F, 1962, PLANTA, V58, P594, DOI 10.1007/BF01914751; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1993, GENETICS, V134, P63; Weingartner M, 2003, J CELL SCI, V116, P487, DOI 10.1242/jcs.00250; WOOLLARD A, 1995, BIOESSAYS, V17, P481, DOI 10.1002/bies.950170604; ZACHLEDER, 1990, J CELL SCI, V97, P631; ZACHLEDER, 1988, J CELL SCI, V91, P531; ZACHLEDER V, 1982, BIOL PLANTARUM, V24, P341, DOI 10.1007/BF02909100; ZACHLEDER V, 1994, J PHYCOL, V30, P274, DOI 10.1111/j.0022-3646.1994.00274.x; Zachleder V, 2002, EUR J PHYCOL, V37, P361, DOI 10.1017/S0967026202003815; Zachleder V, 1997, J PHYCOL, V33, P673, DOI 10.1111/j.0022-3646.1997.00673.x; Zachleder V, 1996, PROTOPLASMA, V192, P228, DOI 10.1007/BF01273894; ZACHLEDER V, 1989, PROTOPLASMA, V150, P160, DOI 10.1007/BF01403672; ZACHLEDER V, 1995, J PHYCOL, V30, P941; Zachleder V., 1984, ARCH HYDROBIOL SUPPL, V67, P313, DOI [10.1127/algol_stud/67/1984/313, DOI 10.1127/ALGOL_STUD/67/1984/313]; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	88	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19626	10.1371/journal.pone.0019626	http://dx.doi.org/10.1371/journal.pone.0019626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603605	Green Submitted, Green Published, gold			2022-12-25	WOS:000290656300015
J	Khan, SH; Arnott, JA; Kumar, R				Khan, Shagufta H.; Arnott, John A.; Kumar, Raj			Naturally Occurring Osmolyte, Trehalose Induces Functional Conformation in an Intrinsically Disordered Activation Domain of Glucocorticoid Receptor	PLOS ONE			English	Article							IN-VITRO; PROTEINS	Intrinsically disordered (ID) regions are frequently found in the activation domains of many transcription factors including nuclear hormone receptors. It is believed that these ID regions promote molecular recognition by creating large surfaces suitable for interactions with their specific protein binding partners, which is a critical component of gene regulation by transcription factors. It has been hypothesized that conditional folding of these activation domains may be a prerequisite for their efficient interaction with specific coregulatory proteins, and subsequent transcriptional activity leading to the regulation of target gene(s). In this study, we tested whether a naturally occurring osmolyte, trehalose can promote functionally ordered conformation in glucocorticoid receptor's major activation function domain, AF1, which is found to exist as an ID protein, and requires an efficient interaction with coregulatory proteins for optimal activity. Our data show that trehalose induces an ordered conformation in AF1 such that its interaction with steroid receptor coactivator-1 (SRC-1), a critical coregulator of glucocorticoid receptor's activity, is greatly enhanced.	[Khan, Shagufta H.; Arnott, John A.; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Khan, SH (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	rkumar@tcmedc.org			National Institutes of Health [RO1DK058829, 1R03AR057193-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants, RO1DK058829 (RK) and 1R03AR057193-01 (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19689	10.1371/journal.pone.0019689	http://dx.doi.org/10.1371/journal.pone.0019689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603604	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300018
J	Brandt, R; Navas, CA				Brandt, Renata; Navas, Carlos A.			Life-History Evolution on Tropidurinae Lizards: Influence of Lineage, Body Size and Climate	PLOS ONE			English	Article							RELATIVE CLUTCH MASS; LOWLAND RAIN-FOREST; PHYLOGENETIC SIGNAL; EGG SIZE; LOCOMOTOR PERFORMANCE; REPRODUCTIVE ECOLOGY; SOUTHEASTERN BRAZIL; IGUANID LIZARDS; EASTERN BRAZIL; SQUAMATA	The study of life history variation is central to the evolutionary theory. In many ectothermic lineages, including lizards, life history traits are plastic and relate to several sources of variation including body size, which is both a factor and a life history trait likely to modulate reproductive parameters. Larger species within a lineage, for example tend to be more fecund and have larger clutch size, but clutch size may also be influenced by climate, independently of body size. Thus, the study of climatic effects on lizard fecundity is mandatory on the current scenario of global climatic change. We asked how body and clutch size have responded to climate through time in a group of tropical lizards, the Tropidurinae, and how these two variables relate to each other. We used both traditional and phylogenetic comparative methods. Body and clutch size are variable within Tropidurinae, and both traits are influenced by phylogenetic position. Across the lineage, species which evolved larger size produce more eggs and neither trait is influenced by temperature components. A climatic component of precipitation, however, relates to larger female body size, and therefore seems to exert an indirect relationship on clutch size. This effect of precipitation on body size is likely a correlate of primary production. A decrease in fecundity is expected for Tropidurinae species on continental landmasses, which are predicted to undergo a decrease in summer rainfall.	[Brandt, Renata; Navas, Carlos A.] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo	Brandt, R (corresponding author), Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil.	rbrandt@ib.usp.br	Navas, Carlos/B-2138-2013; Brandt, Renata/H-4112-2013	Navas, Carlos/0000-0002-9859-0568; Brandt, Renata/0000-0002-8725-2360	FAPESP [03/13235-4, 2003/01577-8, 2008/57687-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	R. B. was supported by a doctoral fellowship of FAPESP (03/13235-4). C.A.N. was funded by FAPESP (2003/01577-8 and 2008/57687-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton KG, 2004, J EVOLUTION BIOL, V17, P1157, DOI 10.1111/j.1420-9101.2004.00764.x; BARBAULT R, 1975, B SOC ZOOL FR, V100, P153; Bauwens D, 1997, AM NAT, V149, P91, DOI 10.1086/285980; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bock BC, 2009, REV BIOL TROP, V57, P1253; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; Cruz FB, 1998, HERPETOL J, V8, P107; Cruz FB, 1997, STUD NEOTROP FAUNA E, V32, P28, DOI 10.1076/snfe.32.1.28.13465; Cruz FB, 1997, J HERPETOL, V31, P444, DOI 10.2307/1565679; Du WG, 2005, BIOL LETTERS, V1, P98, DOI 10.1098/rsbl.2004.0268; Dunham A.E., 1988, Biology of Reptilia, V16, P441; Dunham A. E., 1981, MISC PUBL MUS ZOOL, V158, P1; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Ellinger N, 2001, J HERPETOL, V35, P395, DOI 10.2307/1565957; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitch H. S., 1985, U KANSAS MUS NAT HIS, V76, P1; Fitch H. S., 1970, U KANSAS MUS NAT HIS, V52, P1; FITCH HS, 1982, OCCAS PAPERS MUS NAT, V96, P1; FROST D R, 1992, American Museum Novitates, P1; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Galdino CAB, 2003, J HERPETOL, V37, P687, DOI 10.1670/114-02A; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grizante MB, 2010, J EVOLUTION BIOL, V23, P98, DOI 10.1111/j.1420-9101.2009.01868.x; Harvey MB, 2000, ZOOL J LINN SOC-LOND, V128, P189; Heins DC, 2004, ECOL FRESHW FISH, V13, P258, DOI 10.1111/j.1600-0633.2004.00064.x; HOWLAND JM, 1990, CAN J ZOOL, V68, P1366, DOI 10.1139/z90-204; IPCC, 2007, CONTR WORK GROUP 1 2; JAMES C, 1988, OECOLOGIA, V75, P307, DOI 10.1007/BF00378615; Kiefer MC, 2008, CAN J ZOOL, V86, P1376, DOI 10.1139/Z08-106; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Kohlsdorf T, 2006, EVOL ECOL, V20, P549, DOI 10.1007/s10682-006-9116-x; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison W, MESQUITE MODULAR SYS; MARENGO JA, 2010, NOVA ACTA LEOPOLDINA, V112, P1; Martori Ricardo, 1994, Amphibia-Reptilia, V15, P317, DOI 10.1163/156853894X00092; Midford PE, 2010, PDAP PACKAGE MESQUIT; Miles DB, 2000, EVOLUTION, V54, P1386; MILES DB, 1992, AM NAT, V139, P848, DOI 10.1086/285361; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; POPP J L, 1983, Primates, V24, P198, DOI 10.1007/BF02381082; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RAND AS, 1982, HERPETOLOGICA, V38, P171; Rochet MJ, 2000, ICES J MAR SCI, V57, P228, DOI 10.1006/jmsc.2000.0641; Shine R, 2003, OECOLOGIA, V136, P450, DOI 10.1007/s00442-003-1281-9; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Taylor HL, 2003, SOUTHWEST NAT, V48, P680, DOI 10.1894/0038-4909(2003)048<0680:PPARRO>2.0.CO;2; TINKLE DW, 1970, EVOLUTION, V24, P55, DOI 10.1111/j.1558-5646.1970.tb01740.x; Van Sluys M, 2002, HERPETOL J, V12, P89; Van Sluys M, 2010, AMPHIBIA-REPTILIA, V31, P117, DOI 10.1163/156853810790457920; VANSLUYS M, 1993, J HERPETOL, V27, P28; Vitt L.J., 1992, P135; VITT LJ, 1982, HERPETOLOGICA, V38, P237; VITT LJ, 1981, AM NAT, V117, P506, DOI 10.1086/283731; Vitt LJ, 1996, HERPETOLOGICA, V52, P121; VITT LJ, 1991, CAN J ZOOL, V69, P504, DOI 10.1139/z91-077; Vitt LJ, 1997, CAN J ZOOL, V75, P1876, DOI 10.1139/z97-817; VITT LJ, 1978, AM NAT, V112, P595, DOI 10.1086/283300; VITT LJ, 1993, CAN J ZOOL, V71, P2370, DOI 10.1139/z93-333; VITT LJ, 1983, COPEIA, P131; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wiederhecker HC, 2002, J HERPETOL, V36, P82, DOI 10.1670/0022-1511(2002)036[0082:REOTTS]2.0.CO;2; Yom-Tov Y, 2006, OECOLOGIA, V148, P213, DOI 10.1007/s00442-006-0364-9; YOMTOV Y, 1986, BIOL J LINN SOC, V29, P245, DOI 10.1111/j.1095-8312.1986.tb00278.x	72	36	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20040	10.1371/journal.pone.0020040	http://dx.doi.org/10.1371/journal.pone.0020040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603641	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500042
J	Nitzsche, A; Paszkowski-Rogacz, M; Matarese, F; Janssen-Megens, EM; Hubner, NC; Schulz, H; de Vries, I; Ding, L; Huebner, N; Mann, M; Stunnenberg, HG; Buchholz, F				Nitzsche, Anja; Paszkowski-Rogacz, Maciej; Matarese, Filomena; Janssen-Megens, Eva M.; Hubner, Nina C.; Schulz, Herbert; de Vries, Ingrid; Ding, Li; Huebner, Norbert; Mann, Matthias; Stunnenberg, Hendrik G.; Buchholz, Frank			RAD21 Cooperates with Pluripotency Transcription Factors in the Maintenance of Embryonic Stem Cell Identity	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CCCTC-BINDING FACTOR; DE-LANGE-SYNDROME; GENE-EXPRESSION; CHROMOSOME SEGREGATION; BAC TRANSGENEOMICS; SMC PROTEINS; RNAI SCREEN; NIPPED-B; CTCF	For self-renewal, embryonic stem cells (ESCs) require the expression of specific transcription factors accompanied by a particular chromosome organization to maintain a balance between pluripotency and the capacity for rapid differentiation. However, how transcriptional regulation is linked to chromosome organization in ESCs is not well understood. Here we show that the cohesin component RAD21 exhibits a functional role in maintaining ESC identity through association with the pluripotency transcriptional network. ChIP-seq analyses of RAD21 reveal an ESC specific cohesin binding pattern that is characterized by CTCF independent co-localization of cohesin with pluripotency related transcription factors Oct4, Nanog, Sox2, Esrrb and Klf4. Upon ESC differentiation, most of these binding sites disappear and instead new CTCF independent RAD21 binding sites emerge, which are enriched for binding sites of transcription factors implicated in early differentiation. Furthermore, knock-down of RAD21 causes expression changes that are similar to expression changes after Nanog depletion, demonstrating the functional relevance of the RAD21 - pluripotency transcriptional network association. Finally, we show that Nanog physically interacts with the cohesin or cohesin interacting proteins STAG1 and WAPL further substantiating this association. Based on these findings we propose that a dynamic placement of cohesin by pluripotency transcription factors contributes to a chromosome organization supporting the ESC expression program.	[Nitzsche, Anja; Paszkowski-Rogacz, Maciej; de Vries, Ingrid; Ding, Li; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Matarese, Filomena; Janssen-Megens, Eva M.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Hubner, Nina C.; Mann, Matthias] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schulz, Herbert; Huebner, Norbert] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Radboud University Nijmegen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Nitzsche, A (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	buchholz@mpi-cbg.de	Mann, Matthias/A-3454-2013; Buchholz, Frank/B-4700-2017; Hubner, Nina C/C-4298-2008; Stunnenberg, Hendrik G./D-6875-2012	Mann, Matthias/0000-0003-1292-4799; Buchholz, Frank/0000-0002-4577-3344; Hubner, Nina C/0000-0002-7864-2877; Stunnenberg, Hendrik G./0000-0002-0066-1576	DFG [SPP1356]; DFG-SFB [655 BU1400/3-1]; EU [242129]; NGFN [01GS0859]	DFG(German Research Foundation (DFG)); DFG-SFB(German Research Foundation (DFG)); EU(European Commission); NGFN	This work was supported by the DFG SPP1356 'Pluripotency and cellular reprogramming'; DFG-SFB 655 BU1400/3-1 'Cells into tissues'; EU FP7 (242129) 'SyBoSS' and NGFN DiGtoP (01GS0859) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Carretero M, 2010, CURR OPIN CELL BIOL, V22, P781, DOI 10.1016/j.ceb.2010.07.004; CHEESEMAN IM, 2005, SCI STKE, pP11, DOI DOI 10.1126/STKE.2662005P11; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Merkenschlager M, 2010, CURR OPIN GENET DEV, V20, P555, DOI 10.1016/j.gde.2010.05.007; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Xu H., 2010, PLOS ONE, V5; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	89	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19470	10.1371/journal.pone.0019470	http://dx.doi.org/10.1371/journal.pone.0019470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589869	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000290531100011
J	Voorman, A; Lumley, T; McKnight, B; Rice, K				Voorman, Arend; Lumley, Thomas; McKnight, Barbara; Rice, Kenneth			Behavior of QQ-Plots and Genomic Control in Studies of Gene-Environment Interaction	PLOS ONE			English	Article								Genome-wide association studies of gene-environment interaction (GxE GWAS) are becoming popular. As with main effects GWAS, quantile-quantile plots (QQ-plots) and Genomic Control are being used to assess and correct for population substructure. However, in G x E work these approaches can be seriously misleading, as we illustrate; QQ-plots may give strong indications of substructure when absolutely none is present. Using simulation and theory, we show how and why spurious QQ-plot inflation occurs in G x E GWAS, and how this differs from main-effects analyses. We also explain how simple adjustments to standard regression-based methods used in G x E GWAS can alleviate this problem.	[Voorman, Arend; Lumley, Thomas; McKnight, Barbara; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Voorman, A (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	kenrice@u.washington.edu	Rice, Kenneth M/A-4150-2013	Rice, Kenneth M/0000-0001-5779-4495	NIH/NHLBI [T32 HL07183-34, R01 HL074745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, T32HL007183] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded in part by NIH/NHLBI training grant T32 HL07183-34 and by research grant R01 HL074745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox D.R, 2006, PRINCIPLES STAT INFE; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Draper NR, 1998, APPL REGRESSION ANAL, P706, DOI 10.1002/9781118625590; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; GLAZER NL, 2010, GENOME WIDE IN PRESS; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Nolte IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006138; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Development Core Team, 2009, R FDN STAT COMP; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; StataCorp, 2019, STATA STAT SOFTWARE; Therneau T, 2009, SURVIVAL SURVIVAL AN; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zeileis A, 2006, J STAT SOFTW, V16; Zhang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003392	18	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19416	10.1371/journal.pone.0019416	http://dx.doi.org/10.1371/journal.pone.0019416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589913	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100008
J	Koop, JAH; Huber, SK; Laverty, SM; Clayton, DH				Koop, Jennifer A. H.; Huber, Sarah K.; Laverty, Sean M.; Clayton, Dale H.			Experimental Demonstration of the Fitness Consequences of an Introduced Parasite of Darwin's Finches	PLOS ONE			English	Article							PHILORNIS-DOWNSI DIPTERA; SMALL GROUND FINCH; PEARLY-EYED THRASHERS; HEMATOPHAGOUS ECTOPARASITES; GROWTH; EXTINCTION; GEOSPIZA; MUSCIDAE; FLY; POPULATION	Background: Introduced parasites are a particular threat to small populations of hosts living on islands because extinction can occur before hosts have a chance to evolve effective defenses. An experimental approach in which parasite abundance is manipulated in the field can be the most informative means of assessing a parasite's impact on the host. The parasitic fly Philornis downsi, recently introduced to the Galapagos Islands, feeds on nestling Darwin's finches and other land birds. Several correlational studies, and one experimental study of mixed species over several years, reported that the flies reduce host fitness. Here we report the results of a larger scale experimental study of a single species at a single site over a single breeding season. Methodology/Principal Findings: We manipulated the abundance of flies in the nests of medium ground finches (Geospiza fortis) and quantified the impact of the parasites on nestling growth and fledging success. We used nylon nest liners to reduce the number of parasites in 24 nests, leaving another 24 nests as controls. A significant reduction in mean parasite abundance led to a significant increase in the number of nests that successfully fledged young. Nestlings in parasite-reduced nests also tended to be larger prior to fledging. Conclusions/Significance: Our results confirm that P. downsi has significant negative effects on the fitness of medium ground finches, and they may pose a serious threat to other species of Darwin's finches. These data can help in the design of management plans for controlling P. downsi in Darwin's finch breeding populations.	[Koop, Jennifer A. H.; Huber, Sarah K.; Clayton, Dale H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Laverty, Sean M.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Koop, JAH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	koop@utah.edu		Koop, Jennifer/0000-0002-5332-3618	National Science Foundation [DEB-0118794, DEB-0816877]; Society for the Study of Evolution; Division Of Environmental Biology [0816877] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Society for the Study of Evolution; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Science Foundation (grants DEB-0118794 and DEB-0816877 to DHC) and the Society for the Study of Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT WJ, 1985, AUK, V102, P281, DOI 10.2307/4086770; ARENDT WJ, 1985, AUK, V102, P270, DOI 10.2307/4086769; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; BOAG PT, 1984, J ZOOL, V204, P413, DOI 10.1111/j.1469-7998.1984.tb02380.x; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Charmantier A, 2004, EVOLUTION, V58, P203, DOI 10.1111/j.0014-3820.2004.tb01588.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; Cleaveland S., 2002, P139; COURI M S, 1985, Revista Brasileira de Entomologia, V29, P17; DODGE HR, 1971, STUDIA ENTOMOLOGIA, V14, P258; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; Dudaniec RY, 2006, EMU, V106, P13, DOI 10.1071/MU04040; Dudaniec RY, 2006, AUSTRAL ECOL, V31, P88, DOI 10.1111/j.1442-9993.2006.01553.x; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Fessl B, 2002, IBIS, V144, P445, DOI 10.1046/j.1474-919X.2002.00076.x; Fessl B, 2006, BIOL CONSERV, V127, P55, DOI 10.1016/j.biocon.2005.07.013; Fessl B, 2006, PARASITOLOGY, V133, P739, DOI 10.1017/S0031182006001089; Fessl B., 2001, STUDIA DIPTEROLOGICA, V8, P317; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; Galligan TH, 2009, BIOL J LINN SOC, V98, P577, DOI 10.1111/j.1095-8312.2009.01309.x; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2005, BIOL CONSERV, V122, P499, DOI 10.1016/j.biocon.2004.09.001; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; HurtrezBousses S, 1997, OECOLOGIA, V112, P514, DOI 10.1007/s004420050339; JACKSON JA, 1985, SIALIA, V7, P17; Lafferty KD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P111; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morrison BL, 2002, CONDOR, V104, P183, DOI 10.1650/0010-5422(2002)104[0183:FOHWNA]2.0.CO;2; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; O'Brien EL, 2001, J AVIAN BIOL, V32, P73, DOI 10.1034/j.1600-048X.2001.320110.x; O'Connor JA, 2010, ORYX, V44, P588, DOI 10.1017/S0030605310000086; O'Connor JA, 2010, J TROP ECOL, V26, P285, DOI 10.1017/S0266467409990678; O'Connor JA, 2010, BIODIVERS CONSERV, V19, P853, DOI 10.1007/s10531-009-9740-1; Parker PG, 2006, AUK, V123, P625, DOI 10.1642/0004-8038(2006)123[625:CMOTGI]2.0.CO;2; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Simon A, 2004, PHYSIOL BIOCHEM ZOOL, V77, P492, DOI 10.1086/383512; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Tarwater CE, 2009, ANIM BEHAV, V78, P1239, DOI 10.1016/j.anbehav.2009.07.040; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wiedenfeld David A., 2007, Pacific Conservation Biology, V13, P14; Wikelski M, 2004, ECOL SOC, V9	46	52	53	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19706	10.1371/journal.pone.0019706	http://dx.doi.org/10.1371/journal.pone.0019706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589659	Green Published, gold			2022-12-25	WOS:000290483600025
J	Gu, C; Gu, YZ				Gu, Chen; Gu, Yuanzheng			Clustering and Activity Tuning of Kv1 Channels in Myelinated Hippocampal Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS PATIENTS; K+ CHANNELS; NEURITE OUTGROWTH; NEURONAL POLARITY; GLIA INTERACTIONS; JUXTAPARANODAL REGIONS; SURFACE EXPRESSION; POTASSIUM CHANNELS; SIGNALING PATHWAY; SCHWANN-CELLS	Precise localization of axonal ion channels is crucial for proper electrical and chemical functions of axons. In myelinated axons, Kv1 (Shaker) voltage-gated potassium (Kv) channels are clustered in the juxtaparanodal regions flanking the node of Ranvier. The clustering can be disrupted by deletion of various proteins in mice, including contactin-associated protein-like 2 (Caspr2) and transient axonal glycoprotein-1 (TAG-1), a glycosylphosphatidylinositol-anchored cell adhesion molecule. However, the mechanism and function of Kv1 juxtaparanodal clustering remain unclear. Here, using a new myelin coculture of hippocampal neurons and oligodendrocytes, we report that tyrosine phosphorylation plays a critical role in TAG-1-mediated clustering of axonal Kv1.2 channels. In the coculture, myelin specifically ensheathed axons but not dendrites of hippocampal neurons and clustered endogenous axonal Kv1.2 into internodes. The trans-homophilic interaction of TAG-1 was sufficient to position Kv1.2 clusters on axonal membranes in a neuron/HEK293 coculture. Mutating a tyrosine residue (Tyr(458)) in the Kv1.2 C terminus or blocking tyrosine phosphorylation disrupted myelin-and TAG-1-mediated clustering of axonal Kv1.2. Furthermore, Kv1.2 voltage dependence and activation threshold were reduced by TAG-1 coexpression. This effect was eliminated by the Tyr(458) mutation or by cholesterol depletion. Taken together, our studies suggest that myelin regulates both trafficking and activity of Kv1 channels along hippocampal axons through TAG-1.	[Gu, Chen] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gu, C (corresponding author), Ohio State Univ, Dept Neurosci, 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		National Institutes of Health, NINDS [R01NS062720]; National Multiple Sclerosis Society [TA3012A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01NS062720 (to C. G.). This work was also supported by a Career Transition Fellowship Award from the National Multiple Sclerosis Society (Grant TA3012A1).	Bel C, 2009, J CELL SCI, V122, P3403, DOI 10.1242/jcs.050526; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Devaux J, 2003, J NEUROSCI, V23, P4509; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Geurts JJG, 2007, J NEUROPATH EXP NEUR, V66, P819, DOI 10.1097/nen.0b013e3181461f54; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011931; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kajta M, 2007, NEUROSCIENCE, V145, P592, DOI 10.1016/j.neuroscience.2006.11.059; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; Rivera JF, 2005, EUR J NEUROSCI, V22, P1853, DOI 10.1111/j.1460-9568.2005.04384.x; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Savvaki M, 2008, MOL CELL NEUROSCI, V39, P478, DOI 10.1016/j.mcn.2008.07.025; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Schaeren-Wiemers N, 2004, J CELL BIOL, V166, P731, DOI 10.1083/jcb.200406092; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Tanaka H, 2009, J NEUROSCI, V29, P8363, DOI 10.1523/JNEUROSCI.3216-08.2009; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Waxman SG, 2002, ARCH NEUROL-CHICAGO, V59, P1377, DOI 10.1001/archneur.59.9.1377; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Zhou L, 1998, J NEUROSCI, V18, P7200	66	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25835	25847		10.1074/jbc.M111.219113	http://dx.doi.org/10.1074/jbc.M111.219113			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21602278	Green Published, hybrid			2022-12-25	WOS:000293073000045
J	Alhashem, YN; Vinjamur, DS; Basu, M; Klingmuller, U; Gaensler, KML; Lloyd, JA				Alhashem, Yousef N.; Vinjamur, Divya S.; Basu, Mohua; Klingmueller, Ursula; Gaensler, Karin M. L.; Lloyd, Joyce A.			Transcription Factors KLF1 and KLF2 Positively Regulate Embryonic and Fetal beta-Globin Genes through Direct Promoter Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTORS; FACTOR EKLF; PRIMITIVE ERYTHROPOIESIS; TRANSGENIC MICE; STEM-CELLS; IN-VIVO; ERYTHROID-DIFFERENTIATION; DEVELOPMENTAL REGULATION; YOLK-SAC; LOCUS	Kruppel-like factors (KLFs) control cell differentiation and embryonic development. KLF1 (erythroid Kruppel-like factor) plays essential roles in embryonic and adult erythropoiesis. KLF2 is a positive regulator of the mouse and human embryonic beta-globin genes. KLF1 and KLF2 have highly homologous zinc finger DNA-binding domains. They have overlapping roles in embryonic erythropoiesis, as demonstrated using single and double KO mouse models. Ablation of the KLF1 or KLF2 gene causes embryonic lethality, but double KO embryos are more anemic and die sooner than either single KO. In this work, a dual human beta-globin locus transgenic and KLF knockout mouse model was used. The results demonstrate that the human epsilon-(embryonic) and gamma-globin (fetal) genes are positively regulated by KLF1 and KLF2 in embryos. Conditional KO mouse experiments indicate that the effect of KLF2 on embryonic globin gene regulation is at least partly erythroid cell-autonomous. KLF1 and KLF2 bind directly to the promoters of the human epsilon- and gamma-globin genes, the mouse embryonic Ey- and beta h1-globin genes, and also to the beta-globin locus control region, as demonstrated by ChIP assays with mouse embryonic blood cells. H3K9Ac and H3K4me3 marks indicate open chromatin and active transcription, respectively. These marks are diminished at the Ey-, beta h1-, epsilon- and gamma-globin genes and locus control region in KLF1(-/-) embryos, correlating with reduced gene expression. Therefore, KLF1 and KLF2 positively regulate the embryonic and fetal beta-globin genes through direct promoter binding. KLF1 is required for normal histone modifications in the beta-globin locus in mouse embryos.	[Alhashem, Yousef N.; Vinjamur, Divya S.; Basu, Mohua; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Klingmueller, Ursula] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Gaensler, Karin M. L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Virginia Commonwealth University; Virginia Commonwealth University; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Francisco	Lloyd, JA (corresponding author), 401 Coll St,POB 980035, Richmond, VA 23298 USA.	jlloyd@vcu.edu	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099; Alhashem, Yousef N./0000-0003-4435-3003; Vinjamur, Divya/0000-0002-9369-0412	National Institutes of Health [R01 DK074694]; Ministry of Higher Education, Saudi Arabia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Higher Education, Saudi Arabia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK074694 (to J. A. L.). This work was also supported by the Ministry of Higher Education, Saudi Arabia (to Y. N. A.).	Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Baron MH, 2005, CURR OPIN HEMATOL, V12, P217, DOI 10.1097/01.moh.0000163217.14462.58; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fang XD, 2009, J MOL BIOL, V394, P197, DOI 10.1016/j.jmb.2009.09.046; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; Fromm G, 2009, BLOOD, V114, P3479, DOI 10.1182/blood-2009-03-210690; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hosey AM, 2010, EPIGENETICS-US, V5, P273, DOI 10.4161/epi.5.4.11522; Hosoya-Ohmura S, 2006, J BIOL CHEM, V281, P32820, DOI 10.1074/jbc.M605735200; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Isern J, 2010, BLOOD, V116, P3972, DOI 10.1182/blood-2010-04-281196; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; LLOYD JA, 1989, NUCLEIC ACIDS RES, V17, P4339, DOI 10.1093/nar/17.11.4339; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	56	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24819	24827		10.1074/jbc.M111.247536	http://dx.doi.org/10.1074/jbc.M111.247536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610079	Green Published, hybrid			2022-12-25	WOS:000292547900032
J	Jiao, YX; Jalan-Sakrikar, N; Robison, AJ; Baucum, AJ; Bass, MA; Colbran, RJ				Jiao, Yuxia; Jalan-Sakrikar, Nidhi; Robison, A. J.; Baucum, Anthony J., II; Bass, Martha A.; Colbran, Roger J.			Characterization of a Central Ca2+/Calmodulin-dependent Protein Kinase II alpha/beta Binding Domain in Densin That Selectively Modulates Glutamate Receptor Subunit Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; NR2B SUBUNIT; REGULATED INTERACTIONS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; REPEAT PROTEIN; CAM KINASE; LOCALIZATION; BRAIN	The densin C-terminal domain can target Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) in cells. Although the C-terminal domain selectively binds CaMKII alpha in vitro, full-length densin associates with CaMKII alpha or CaMKII beta in brain extracts and in transfected HEK293 cells. This interaction requires a second central CaMKII binding site, the densin-IN domain, and an "open" activated CaMKII conformation caused by Ca2+/calmodulin binding, autophosphorylation at Thr-286/287, or mutation of Thr-286/287 to Asp. Mutations in the densin-IN domain (L815E) or in the CaMKII alpha/beta catalytic domain (I205/206K) disrupt the interaction. The amino acid sequence of the densin-IN domain is similar to the CaMKII inhibitor protein, CaMKIIN, and a CaMKIIN peptide competitively blocks CaMKII binding to densin. CaMKII is inhibited by both CaMKIIN and the densin-IN domain, but the inhibition by densin is substrate-selective. Phosphorylation of a model peptide substrate, syntide-2, or of Ser-831 in AMPA receptor GluA1 subunits is fully inhibited by densin. However, CaMKII phosphorylation of Ser-1303 in NMDA receptor GluN2B subunits is not effectively inhibited by densin in vitro or in intact cells. Thus, densin can target multiple CaMKII isoforms to differentially modulate phosphorylation of physiologically relevant downstream targets.	[Jiao, Yuxia; Jalan-Sakrikar, Nidhi; Robison, A. J.; Baucum, Anthony J., II; Bass, Martha A.; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Robison, Alfred J/P-8521-2018; Baucum, Anthony/I-5109-2013; Jiao, Yuxia/H-3300-2019; Jalan-Sakrikar, Nidhi/S-8653-2019	Colbran, Roger/0000-0001-7401-8244; Robison, Alfred J/0000-0002-4150-9570; Baucum, Anthony/0000-0002-4756-9865; Jiao, Yuxia/0000-0002-8633-7047; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121	National Institutes of Health [R01-MH063232, F32-MH068129, T32-MH065215]; American Heart Association [0815090E]; UNCF-Merck; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215, F31MH068129, R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); UNCF-Merck(Merck & Company); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-MH063232 (to R. J. C.), F32-MH068129 (to A. J. R.), and T32-MH065215 (to A. J. B.). This work was also supported by American Heart Association Predoctoral Fellowship 0815090E (to N. J.-S.) and a UNCF-Merck postdoctoral fellowship (to A. J. B.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Apperson ML, 1996, J NEUROSCI, V16, P6839; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; BROCKE L, 1995, J NEUROSCI, V15, P6797; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	46	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24806	24818		10.1074/jbc.M110.216010	http://dx.doi.org/10.1074/jbc.M110.216010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610080	Green Published, hybrid			2022-12-25	WOS:000292547900031
J	Musikacharoen, T; Bandow, K; Kakimoto, K; Kusuyama, J; Onishi, T; Yoshikai, Y; Matsuguchi, T				Musikacharoen, Tipayaratn; Bandow, Kenjiro; Kakimoto, Kyoko; Kusuyama, Joji; Onishi, Tomokazu; Yoshikai, Yasunobu; Matsuguchi, Tetsuya			Functional Involvement of Dual Specificity Phosphatase 16 (DUSP16), a c-Jun N-terminal Kinase-specific Phosphatase, in the Regulation of T Helper Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; HISTONE ACETYLATION; LINEAGE COMMITMENT; TH2 CELLS; IN-VIVO; EXPRESSION; PROTEIN; ACTIVATION; BET; INFLAMMATION	Naive CD4(+) Thelper (Th) cells differentiate into distinct subsets of effector cells (Th1, Th2, Th17, and induced regulatory T cells (iTreg)) expressing different sets of cytokines upon encounter with presented foreign antigens. It has been well established that Th1/Th2 balance is critical for the nature of the following immune responses. Previous reports have demonstrated important roles of c-Jun N-terminal kinase (JNK) in Th1/Th2 balance, whereas the regulatory mechanisms of JNK activity in Th cells have not been elucidated. Here, we show that dual specificity phosphatase 16 (DUSP16, also referred to as MKP-M or MKP-7), which preferentially inactivates JNK, is selectively expressed in Th2 cells. In the in vitro differentiation assay of naive CD4(+) cells, DUSP16 expression is up-regulated during Th2 differentiation and down-regulated during Th1 differentiation. Chromatin immunoprecipitation revealed the increased acetylation of histone H3/H4 at the dusp16 gene promoter in CD4(+) T cells under the Th2 condition. Adenoviral transduction of naive CD4(+) T cells with DUSP16 resulted in increased mRNA expression of IL-4 and GATA-3 in Th2 and decreased expression of IFN gamma and T-bet in Th1 differentiation. In contrast, transduction of a dominant negative form of DUSP16 had the reverse effects. Furthermore, upon immunization, T cell-specific dusp16 transgenic mice produced antigen-specific IgG2a at lower amounts, whereas DN dusp16 transgenic mice produced higher amounts of antigen-specific IgG2a accompanied by decreased amounts of antigen-specific IgG1 and IgE than those of control mice. Together, these data suggest the functional role of DUSP16 in Th1/Th2 balance.	[Musikacharoen, Tipayaratn; Bandow, Kenjiro; Kakimoto, Kyoko; Kusuyama, Joji; Onishi, Tomokazu; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, Kagoshima 8908544, Japan; [Musikacharoen, Tipayaratn] Prince Songkla Univ, Fac Vet Sci, Hat Yai 90110, Thailand; [Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Res Ctr Prevent Infect Dis, Fukuoka 8128582, Japan	Kagoshima University; Prince of Songkla University; Kyushu University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Musikacharoen, Tipayaratn/AAV-6514-2021; Matsuguchi, Tetsuya/HGU-0412-2022; Kusuyama, Joji/AAQ-7547-2020	Kusuyama, Joji/0000-0003-4054-1939; Bandow, Kenjiro/0000-0002-1362-3034	Ministry of Education, Science, and Culture of the Japanese Government	Ministry of Education, Science, and Culture of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from Ministry of Education, Science, and Culture of the Japanese Government.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Glimcher LH, 2000, GENE DEV, V14, P1693; Ishimitsu R, 2001, J IMMUNOL, V166, P1991, DOI 10.4049/jimmunol.166.3.1991; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Musikacharoen T, 2003, J BIOL CHEM, V278, P9167, DOI 10.1074/jbc.M211829200; NAKAYAMA T, 1988, EUR J IMMUNOL, V18, P761, DOI 10.1002/eji.1830180516; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; REINER SL, 1994, J IMMUNOL METHODS, V173, P133, DOI 10.1016/0022-1759(94)90291-7; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon Mercedes, 1997, Genes and Function, V1, P51; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Strempel JM, 2007, J BIOL CHEM, V282, P3738, DOI 10.1074/jbc.M606615200; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	35	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24896	24905		10.1074/jbc.M111.245019	http://dx.doi.org/10.1074/jbc.M111.245019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613215	hybrid, Green Published			2022-12-25	WOS:000292547900039
J	Tiwari, V; Liu, J; Valyi-Nagy, T; Shukla, D				Tiwari, Vaibhav; Liu, Jian; Valyi-Nagy, Tibor; Shukla, Deepak			Anti-heparan Sulfate Peptides That Block Herpes Simplex Virus Infection in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 ENTRY; HUMAN CYTOMEGALOVIRUS; PHAGE DISPLAY; HSV-1 ENTRY; BINDING; CELLS; RECEPTOR; SPREAD; PROTEOGLYCANS; ACTIVATION	Heparan sulfate (HS) and its highly modified form, 3-O-sulfated heparan sulfate (3-OS HS), contribute strongly to herpes simplex virus type-1 (HSV-1) infection in vitro. Here we report results from a random M13-phage display library screening to isolate 12-mer peptides that bind specifically to HS, 3-OS HS, and block HSV-1 entry. The screening identified representative candidates from two-different groups of anti-HS peptides with high positive charge densities. Group 1, represented by G1 peptide (LRSRTKIIRIRH), belongs to a class with alternating charges (XRXRXKXXRXRX), and group 2, represented by G2 peptide (MPRRRRIRRRQK), shows repetitive charges (XXR-RRRXRRRXK). Viral entry and glycoprotein D binding assays together with fluorescent microscopy data indicated that both G1 and G2 were potent in blocking HSV-1 entry into primary cultures of human corneal fibroblasts and CHO-K1 cells transiently expressing different glycoprotein D receptors. Interestingly, G2 peptide isolated against 3-OS HS displayed wider ability to inhibit entry of clinically relevant strains of HSV-1 and some divergent members of herpesvirus family including cytomegalovirus and human herpesvirus-8. To identify functional residues within G1 and G2, we performed point mutations and alanine-scanning mutagenesis. Several arginine and a lysine residues were needed for anti-HSV-1 activity, suggesting the importance of the positively charged residues in virus-cell binding and virus-induced membrane fusion. In vivo administration of G1 or G2 peptide as a prophylactic eye drop completely blocked HSV-1 spread in the mouse cornea as evident by immunohistochemistry. This result also highlights an in vivo significance of HS and 3-OS HS during ocular herpes infection.	[Tiwari, Vaibhav; Shukla, Deepak] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [Shukla, Deepak] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Valyi-Nagy, Tibor] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Tiwari, Vaibhav] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA; [Liu, Jian] Univ N Carolina, Coll Pharm, Dept Med Chem, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences; University of North Carolina; University of North Carolina Chapel Hill	Shukla, D (corresponding author), 1855 W Taylor St,M-C 648, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health [RO1 AI057860, AI050050]; Glaucoma Foundation;  [EY001792]; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R01AI057860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI057860 (to D.S.) and AI050050 (to J.L.) and Core Grant EY001792 (to the University of Illinois at Chicago). Part of this work was made possible by an award from the Glaucoma Foundation (to D.S.).	Akhtar J, 2008, INVEST OPHTH VIS SCI, V49, P4026, DOI 10.1167/iovs.08-1807; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; De Witte L, 2007, IMMUNOBIOLOGY, V212, P679, DOI 10.1016/j.imbio.2007.09.006; DEAN HJ, 1994, VIROLOGY, V199, P67, DOI 10.1006/viro.1994.1098; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Luganini A, 2010, ANTIVIR RES, V85, P532, DOI 10.1016/j.antiviral.2010.01.003; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mullen LM, 2006, TRENDS MICROBIOL, V14, P141, DOI 10.1016/j.tim.2006.01.006; O'Donnell CD, 2006, VIROLOGY, V346, P452, DOI 10.1016/j.virol.2005.11.003; O'Donnell CD, 2010, VIROLOGY, V397, P389, DOI 10.1016/j.virol.2009.11.011; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P13049, DOI 10.1021/bi701255m; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Tiwari V, 2005, BIOCHEM BIOPH RES CO, V338, P930, DOI 10.1016/j.bbrc.2005.10.056; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Tiwari V, 2008, FEBS J, V275, P5272, DOI 10.1111/j.1742-4658.2008.06655.x; Tiwari V, 2007, FEBS LETT, V581, P4468, DOI 10.1016/j.febslet.2007.08.029; Tiwari V, 2007, J GEN VIROL, V88, P1075, DOI 10.1099/vir.0.82476-0; Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06; Tiwari V, 2009, BIOCHEM BIOPH RES CO, V390, P382, DOI 10.1016/j.bbrc.2009.08.174; Trybala E, 2002, VIROLOGY, V302, P413, DOI 10.1006/viro.2002.1639; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Zhang ZZ, 2010, VIROLOGY, V406, P280, DOI 10.1016/j.virol.2010.07.030	43	79	86	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25406	25415		10.1074/jbc.M110.201103	http://dx.doi.org/10.1074/jbc.M110.201103			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596749	Green Published, hybrid			2022-12-25	WOS:000292547900086
J	Zaiss, AK; Lawrence, R; Elashoff, D; Esko, JD; Herschman, HR				Zaiss, Anne K.; Lawrence, Roger; Elashoff, David; Esko, Jeffrey D.; Herschman, Harvey R.			Differential Effects of Murine and Human Factor X on Adenovirus Transduction via Cell-surface Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; COAGULATION-FACTORS; BINDING-PROPERTIES; GENE-TRANSFER; LIVER; HEXON; PROTEOGLYCANS; INFECTION; RECEPTOR	Serum coagulation factor X (FX) is proposed to play a major role in adenovirus tropism, promoting transduction by bridging the virus to cell-surface heparan sulfate proteoglycans (HSPGs). Both murine FX and human FX increased transduction by Ad. CMVfLuc, an adenovirus vector, in murine hepatocyte-like cells and human hepatocarcinoma cells. In contrast, only hFX increased transduction of several non-hepatic cancer cell lines and Chinese hamster ovary (CHO) cells. Not only was mFX unable to promote transduction in these cells, it competitively blocked hFX-enhanced transduction. Competition and HSPG digestion experiments suggested mFX- and hFX-enhanced transduction in hepatocyte-derived cells, and hFX-enhanced transduction in epithelial cancer cells were dependent on HSPGs. Ad.hFX-mediated transduction of CHO mutants unable to produce HSPGs was also curtailed. Hepatocyte-derived cells expressed substantially more HSPGs than the cancer cell lines. Dose-response curves and heparin-Sepharose binding suggested Ad.hFX has greater affinity for HSPGs than does Ad.mFX. In coagulation factor-depleted mice hFX also had enhanced ability, compared with mFX, to reconstitute hepatic adenovirus transduction. The results suggest that differences in Ad.hFX and Ad.mFX affinity to HSPGs may result in differences in their ability to enhance adenovirus transduction of many cells. These findings may have implications for murine models of adenovirus vector targeting.	[Zaiss, Anne K.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zaiss, Anne K.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego	Herschman, HR (corresponding author), 611 Charles E Young Dr E,341 MBI, Los Angeles, CA 90095 USA.	hherschman@mednet.ucla.edu			National Institutes of Health [P50 CA086306-08, HL57345, GM33063]; UCLA In Vivo Cellular and Molecular Imaging Center; NATIONAL CANCER INSTITUTE [P50CA086306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA In Vivo Cellular and Molecular Imaging Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA086306-08 (to H. R. H.) and HL57345 and GM33063 (to J. D. E.).; Recipient of a UCLA In Vivo Cellular and Molecular Imaging Center Career Development Award.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Gimenez-Alejandre M, 2008, HUM GENE THER, V19, P1415, DOI [10.1089/hum.2008.053, 10.1089/hgt.2008.053]; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Liang QW, 2004, MOL IMAGING BIOL, V6, P395, DOI 10.1016/j.mibio.2004.09.002; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; ZOU S, 1992, COMP BIOCHEM PHYS B, V103, P889, DOI 10.1016/0305-0491(92)90210-I	34	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24535	24543		10.1074/jbc.M111.241562	http://dx.doi.org/10.1074/jbc.M111.241562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596747	Green Published, hybrid			2022-12-25	WOS:000292547900003
J	Banerjee, D; Das, S; Molina, SA; Madgwick, D; Katz, MR; Jena, S; Bossmann, LK; Pal, D; Takemoto, DJ				Banerjee, Debarshi; Das, Satyabrata; Molina, Samuel A.; Madgwick, Dan; Katz, Melanie R.; Jena, Snehalata; Bossmann, Leonie K.; Pal, Debjani; Takemoto, Dolores J.			Investigation of the Reciprocal Relationship between the Expression of Two Gap Junction Connexin Proteins, Connexin46 and Connexin43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-CELL COMMUNICATION; INTERCELLULAR COMMUNICATION; DOWN-REGULATION; LIFE-CYCLE; PLASMA-MEMBRANE; GROWTH-CONTROL; PHORBOL-ESTER; BREAST-CANCER; LENS; PHOSPHORYLATION	Connexins are the transmembrane proteins that form gap junctions between adjacent cells. The function of the diverse connexin molecules is related to their tissue-specific expression and highly dynamic turnover. Although multiple connexins have been previously reported to compensate for each other's functions, little is known about how connexins influence their own expression or intracellular regulation. Of the three vertebrate lens connexins, two connexins, connexin43 (Cx43) and connexin46 (Cx46), show reciprocal expression and subsequent function in the lens and in lens cell culture. In this study, we investigate the reciprocal relationship between the expression of Cx43 and Cx46. Forced depletion of Cx43, by tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate, is associated with an up-regulation of Cx46 at both the protein and message level in human lens epithelial cells. An siRNA-mediated down-regulation of Cx43 results in an increase in the level of Cx46 protein, suggesting endogenous Cx43 is involved in the regulation of endogenous Cx46 turnover. Overexpression of Cx46, in turn, induces the depletion of Cx43 in rabbit lens epithelial cells. Cx46-induced Cx43 degradation is likely mediated by the ubiquitin-proteasome pathway, as (i) treatment with proteasome inhibitors restores the Cx43 protein level and (ii) there is an increase in Cx43 ubiquitin conjugation in Cx46-overexpressing cells. We also present data that shows that the C-terminal intracellular tail domain of Cx46 is essential to induce degradation of Cx43. Therefore, our study shows that Cx43 and Cx46 have novel functions in regulating each other's expression and turnover in a reciprocal manner in addition to their conventional roles as gap junction proteins in lens cells.	[Banerjee, Debarshi; Das, Satyabrata; Molina, Samuel A.; Madgwick, Dan; Katz, Melanie R.; Jena, Snehalata; Bossmann, Leonie K.; Pal, Debjani; Takemoto, Dolores J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Molina, SA (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	smolina@ksu.edu	Das, Satyabrata/J-2629-2019; Molina, Samuel/I-5555-2015; banerjee, debarshi/AAF-5704-2020; PAL, DEBJANI/AAB-6284-2020	Molina, Samuel/0000-0002-5861-3390; PAL, DEBJANI/0000-0002-3030-2590	National Institutes of Health [EY13421]; NIH K-INBRE [P20RR016475]; Terry C. Johnson Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH K-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY13421 (to D. J. T.) and NIH K-INBRE Grant P20RR016475 (to D. M.). This work was also supported by Terry C. Johnson Cancer Center Innovative Research Grant (to D. J. T.) and Terry C. Johnson Cancer Center Summer Stipend (to D. B. and S. D.).	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Akoyev V, 2009, INVEST OPHTH VIS SCI, V50, P1271, DOI 10.1167/iovs.08-2599; Avanzo JL, 2006, LIFE SCI, V79, P2202, DOI 10.1016/j.lfs.2006.07.033; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Dahm R, 1999, EXP EYE RES, V69, P45, DOI 10.1006/exer.1999.0670; Das S, 2011, CURR EYE RES, V36, P620, DOI 10.3109/02713683.2011.573899; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Kanczuga-Koda L, 2005, ONCOL REP, V14, P325; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2007, J MEMBRANE BIOL, V217, P43, DOI 10.1007/s00232-007-9050-z; Li GY, 1998, GENE, V209, P139, DOI 10.1016/S0378-1119(98)00039-0; Loewenstein W R, 1980, Ann N Y Acad Sci, V339, P39, DOI 10.1111/j.1749-6632.1980.tb15966.x; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; RIVEDAL E, 1994, CARCINOGENESIS, V15, P689, DOI 10.1093/carcin/15.4.689; Rong P, 2002, DEVELOPMENT, V129, P167; Salameh A, 2006, ADV CARDIOL, V42, P57, DOI 10.1159/000092562; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; TENBROEK EM, 1994, INVEST OPHTH VIS SCI, V35, P215; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zampighi GA, 2005, INVEST OPHTH VIS SCI, V46, P3247, DOI 10.1167/iovs.04-1504	52	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24519	24533		10.1074/jbc.M110.217208	http://dx.doi.org/10.1074/jbc.M110.217208			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606502	Green Published, hybrid			2022-12-25	WOS:000292294900092
J	Hu, JH; Xie, F; Li, C; Jiang, JP				Hu, Junhua; Xie, Feng; Li, Cheng; Jiang, Jianping			Elevational Patterns of Species Richness, Range and Body Size for Spiny Frogs	PLOS ONE			English	Article							SMALL MAMMAL DIVERSITY; TRIBE PAINI AMPHIBIA; BERGMANNS RULE; RAPOPORTS RULE; SUBGENUS-PAA; GENUS-RANA; PHYLOGENETIC-RELATIONSHIPS; LATITUDINAL GRADIENTS; HENGDUAN MOUNTAINS; ENDEMIC RICHNESS	Quantifying spatial patterns of species richness is a core problem in biodiversity theory. Spiny frogs of the subfamily Painae (Anura: Dicroglossidae) are widespread, but endemic to Asia. Using spiny frog distribution and body size data, and a digital elevation model data set we explored altitudinal patterns of spiny frog richness and quantified the effect of area on the richness pattern over a large altitudinal gradient from 0-5000 m a.s.l. We also tested two hypotheses: (i) the Rapoport's altitudinal effect is valid for the Painae, and (ii) Bergmann's clines are present in spiny frogs. The species richness of Painae across four different altitudinal band widths (100 m, 200 m, 300 m and 400 m) all showed hump-shaped patterns along altitudinal gradient. The altitudinal changes in species richness of the Paini and Quasipaini tribes further confirmed this finding, while the peak of Quasipaini species richness occurred at lower elevations than the maxima of Paini. The area did not explain a significant amount of variation in total, nor Paini species richness, but it did explain variation in Quasipaini. Five distinct groups across altitudinal gradient were found. Species altitudinal ranges did not expand with an increase in the midpoints of altitudinal ranges. A significant negative correlation between body size and elevation was exhibited. Our findings demonstrate that Rapoport's altitudinal rule is not a compulsory attribute of spiny frogs and also suggest that Bergmann's rule is not generally applicable to amphibians. The study highlights a need to explore the underlying mechanisms of species richness patterns, particularly for amphibians in macroecology.	[Hu, Junhua; Xie, Feng; Li, Cheng; Jiang, Jianping] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Hu, JH (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	jiangjp@cib.ac.cn	hu, jh/B-4853-2010	hu, jh/0000-0002-6669-8443	National Natural Sciences Foundation of China [31071906, 30730029]; Chinese Academy of Sciences [GJHZ0954, Y0B3021, Y1B3021, KSCX2-EW-J-22]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Natural Sciences Foundation of China (31071906, 30730029), the International Collaborate Project of the Chinese Academy of Sciences (GJHZ0954), and the Field Front Project of the Knowledge Innovation Program of the Chinese Academy of Sciences (Y0B3021, Y1B3021, KSCX2-EW-J-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2008, EVOLUTION, V62, P413, DOI 10.1111/j.1558-5646.2007.00297.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Ashton KG, 2002, CAN J ZOOL, V80, P708, DOI 10.1139/Z02-049; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Beck J, 2008, J BIOGEOGR, V35, P1452, DOI 10.1111/j.1365-2699.2008.01886.x; Beketov MA, 2009, GLOBAL ECOL BIOGEOGR, V18, P498, DOI 10.1111/j.1466-8238.2009.00466.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Blackburn TM, 2001, GLOBAL ECOL BIOGEOGR, V10, P245, DOI 10.1046/j.1466-822X.2001.00237.x; Bordoloi S, 2001, CURR SCI INDIA, V80, P1219; Brehm G, 2004, GLOBAL ECOL BIOGEOGR, V13, P7, DOI 10.1111/j.1466-882X.2004.00069.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; BROWN WALTER C., 1961, ECOLOGY, V42, P628; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; DUBOIS A, 1983, COPEIA, P895; DUBOIS A, 1979, J HERPETOL, V13, P403, DOI 10.2307/1563474; Dubois Alain, 1992, Bulletin Mensuel de la Societe Linneenne de Lyon, V61, P305; FAUTH JE, 1989, BIOTROPICA, V21, P178, DOI 10.2307/2388708; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Fischer J, 2005, DIVERS DISTRIB, V11, P225, DOI 10.1111/j.1366-9516.2005.00139.x; Freckleton RP, 2003, AM NAT, V161, P821, DOI 10.1086/374346; Frost DR, 2010, AMPHIBIAN SPECIES WO; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes J.A., 2007, ENCY BIODIVERSITY, V2, P1, DOI DOI 10.1016/B978-012226865-6/00503-1; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hausdorf B, 2003, GLOBAL ECOL BIOGEOGR, V12, P389, DOI 10.1046/j.1466-822X.2003.00050.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; Hu Junhua, 2007, Chinese Journal of Applied and Environmental Biology, V13, P731; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P547, DOI DOI 10.5169/SEALS-266450; Jiang J, 2010, HERPETOLOGICA SINICA, V12, P1; Jiang JP, 2005, ZOOL SCI, V22, P353, DOI 10.2108/zsj.22.353; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; KHAN MS, 1989, J HERPETOL, V23, P419, DOI 10.2307/1564055; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Krizmanic I, 2005, HERPETOL J, V15, P205; Laugen AT, 2005, EVOL ECOL RES, V7, P717; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; LINDSEY CC, 1966, EVOLUTION, V20, P456, DOI 10.1111/j.1558-5646.1966.tb03380.x; Lomolino M.V., 2004, FDN BIOGEOGRAPHY CLA; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MAC ARTHUR ROBERT H., 1967; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; Measey GJ, 2006, EVOL ECOL RES, V8, P1049; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nathan R, 1999, ISRAEL J ZOOL, V45, P1; Ohler A, 2006, ZOOSYSTEMA, V28, P769; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olalla-Tarraga MA, 2007, GLOBAL ECOL BIOGEOGR, V16, P606, DOI 10.1111/j.1466-8238.2007.00309.x; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Qian H, 1998, J BIOGEOGR, V25, P829, DOI 10.1046/j.1365-2699.1998.00247.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ribas CR, 2006, GLOBAL ECOL BIOGEOGR, V15, P614, DOI 10.1111/j.1466-8238.2006.00265.x; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Ruggiero A, 1998, BIOL J LINN SOC, V63, P283, DOI 10.1111/j.1095-8312.1998.tb01518.x; Ruggiero A, 2007, GLOBAL ECOL BIOGEOGR, V16, P401, DOI 10.1111/j.1466-8238.2006.00303.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Williams C. B., 1964, PATTERNS BALANCE NAT; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5	90	39	45	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19817	10.1371/journal.pone.0019817	http://dx.doi.org/10.1371/journal.pone.0019817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611199	Green Submitted, gold, Green Published			2022-12-25	WOS:000290657500024
J	Masharani, UB; Maddux, BA; Li, XJ; Sakkas, GK; Mulligan, K; Schambelan, M; Goldfine, ID; Youngren, JF				Masharani, Umesh B.; Maddux, Betty A.; Li, Xiaojuan; Sakkas, Giorgos K.; Mulligan, Kathleen; Schambelan, Morris; Goldfine, Ira D.; Youngren, Jack F.			Insulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal Muscle	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TYPE-2 DIABETIC PARENTS; PROTEIN-KINASE-C; BETA-CELL; SERINE PHOSPHORYLATION; TRIGLYCERIDE CONTENT; GLUCOSE-TRANSPORT; ANGIOTENSIN-II; ABDOMINAL FAT; BODY-FAT	Background: The pathogenesis of insulin resistance in the absence of obesity is unknown. In obesity, multiple stress kinases have been identified that impair the insulin signaling pathway via serine phosphorylation of key second messenger proteins. These stress kinases are activated through various mechanisms related to lipid oversupply locally in insulin target tissues and in various adipose depots. Methodology/Principal Findings: To explore whether specific stress kinases that have been implicated in the insulin resistance of obesity are potentially contributing to insulin resistance in non-obese individuals, twenty healthy, non-obese, normoglycemic subjects identified as insulin sensitive or resistant were studied. Vastus lateralis muscle biopsies obtained during euglycemic, hyperinsulinemic clamp were evaluated for insulin signaling and for activation of stress kinase pathways. Total and regional adipose stores and intramyocellular lipids (IMCL) were assessed by DXA, MRI and (1)H-MRS. In muscle of resistant subjects, phosphorylation of JNK was increased (1.36 +/- 0.23 vs. 0.78 +/- 0.10 OD units, P < 0.05), while there was no evidence for activation of p38 MAPK or IKK beta. IRS-1 serine phosphorylation was increased (1.30 +/- 0.09 vs. 0.22 +/- 0.03 OD units, P < 0.005) while insulin-stimulated tyrosine phosphorylation decreased (10.97 +/- 0.95 vs. 0.89 +/- 0.50 OD units, P < 0.005). IMCL levels were twice as high in insulin resistant subjects (3.26 +/- 0.48 vs. 1.58 +/- 0.35% H(2)O peak, P < 0.05), who also displayed increased total fat and abdominal fat when compared to insulin sensitive controls. Conclusions: This is the first report demonstrating that insulin resistance in non-obese, normoglycemic subjects is associated with activation of the JNK pathway related to increased IMCL and higher total body and abdominal adipose stores. While JNK activation is consistent with a primary impact of muscle lipid accumulation on metabolic stress, further work is necessary to determine the relative contributions of the various mediators of impaired insulin signaling in this population.	[Masharani, Umesh B.; Maddux, Betty A.; Goldfine, Ira D.; Youngren, Jack F.] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Li, Xiaojuan] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Sakkas, Giorgos K.; Mulligan, Kathleen; Schambelan, Morris] San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Masharani, UB (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	jack.youngren@ucsf.edu	Sakkas, Giorgos K./AAJ-4745-2021	Sakkas, Giorgos K./0000-0002-2462-995X	National Institutes of Health [R01DK59358]; CTSI NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK59358 and CTSI NIH/NCRR UCSF-CTSI UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Gan SK, 2003, OBES RES, V11, P1295, DOI 10.1038/oby.2003.176; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Li XJ, 2008, MAGN RESON IMAGING, V26, P188, DOI 10.1016/j.mri.2007.06.006; Masharani U, 2009, METABOLISM, V58, P1602, DOI 10.1016/j.metabol.2009.05.012; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; NEWELLMORRIS LL, 1989, AM J CLIN NUTR, V50, P9, DOI 10.1093/ajcn/50.1.9; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sakkas GK, 2008, AM J PHYSIOL-REG I, V295, pR1721, DOI 10.1152/ajpregu.00935.2007; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Youngren JF, 2001, AM J PHYSIOL-ENDOC M, V280, pE528, DOI 10.1152/ajpendo.2001.280.3.E528	49	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19878	10.1371/journal.pone.0019878	http://dx.doi.org/10.1371/journal.pone.0019878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589939	gold, Green Submitted, Green Published			2022-12-25	WOS:000290483600034
J	Stepanek, O; Brdicka, T; Angelisova, P; Horvath, O; Spicka, J; Stockbauer, P; Man, P; Horejsi, V				Stepanek, Ondrej; Brdicka, Tomas; Angelisova, Pavla; Horvath, Ondrej; Spicka, Jiri; Stockbauer, Petr; Man, Petr; Horejsi, Vaclav			Interaction of Late Apoptotic and Necrotic Cells with Vitronectin	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; SERUM SPREADING FACTOR; MONOCLONAL-ANTIBODY; EPITHELIAL REPAIR; RECEPTOR; EXPRESSION; LOCALIZATION; CLEARANCE; INTEGRIN; NECROSIS	Background: Vitronectin is an abundant plasma glycoprotein identified also as a part of extracellular matrix. Vitronectin is substantially enriched at sites of injured, fibrosing, inflamed, and tumor tissues where it is believed to be involved in wound healing and tissue remodeling. Little is known about the mechanism of vitronectin localization into the damaged tissues. Methodology/Principal Findings: 2E12 antibody has been described to bind a subset of late apoptotic cells. Using immunoisolation followed by mass spectrometry, we identified the antigen recognized by 2E12 antibody as vitronectin. Based on flow cytometry, we described that vitronectin binds to the late apoptotic and necrotic cells in cell cultures in vitro as well as in murine thymus and spleen in vivo. Confocal microscopy revealed that vitronectin binds to an intracellular cytoplasmic structure after the membrane rupture. Conclusions/Significance: We propose that vitronectin could serve as a marker of membrane disruption in necrosis and apoptosis for flow cytometry analysis. Moreover, we suggest that vitronectin binding to dead cells may represent one of the mechanisms of vitronectin incorporation into the injured tissues.	[Stepanek, Ondrej; Brdicka, Tomas; Angelisova, Pavla; Horvath, Ondrej; Spicka, Jiri; Horejsi, Vaclav] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Stockbauer, Petr] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic; [Man, Petr] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institute of Hematology Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Stepanek, O (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	vaclav.horejsi@img.cas.cz	Horejsi, Vaclav/G-3113-2014; Stepanek, Ondrej/F-8882-2013; Brdicka, Tomas/G-6205-2014; Angelisova, Pavla/G-3131-2014; Man, Petr/H-2451-2014; Stepanek, Ondrej/AAG-3180-2020	Horejsi, Vaclav/0000-0003-4925-0142; Stepanek, Ondrej/0000-0002-2735-3311; Brdicka, Tomas/0000-0002-1560-4398; Man, Petr/0000-0002-1485-2197; Stepanek, Ondrej/0000-0002-2735-3311	Academy of Sciences of the Czech Republic [AV0Z50520514]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic) [1M0506]; Academy of Sciences of the Czech Republic, P.S. [AVOZ50200510]; Faculty of Science, Charles University, Prague, Czech Republic;  [IGA-MZ 0002373601]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic, P.S.(Czech Academy of Sciences); Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government); 	This work was supported in part by project No. AV0Z50520514 awarded by the Academy of Sciences of the Czech Republic, and by Center of Molecular and Cellular Immunology (project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic). P.M. is supported from project No. AVOZ50200510 awarded by the Academy of Sciences of the Czech Republic, P.S. from grant IGA-MZ 0002373601, O.S. is a PhD student supported in part by Faculty of Science, Charles University, Prague, Czech Republic. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; BASARA ML, 1985, CANCER RES, V45, P2487; BUJA LM, 1993, ARCH PATHOL LAB MED, V117, P1208; Carpagnano GE, 2003, RESPIRATION, V70, P154, DOI 10.1159/000070062; Cermakova P, 2007, FEBS J, V274, P3150, DOI 10.1111/j.1742-4658.2007.05847.x; Chen J, 2001, TOXICOL APPL PHARM, V171, P1, DOI 10.1006/taap.2000.9105; D'mello V, 2009, J BIOL CHEM, V284, P17030, DOI 10.1074/jbc.M109.010066; DAHLBACK K, 1988, ACTA DERM-VENEREOL, V68, P107; deBoer HC, 1995, J BIOL CHEM, V270, P30733, DOI 10.1074/jbc.270.51.30733; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fay WP, 1999, BLOOD, V93, P1825, DOI 10.1182/blood.V93.6.1825.406k37_1825_1830; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HINTNER H, 1989, J INVEST DERMATOL, V93, P656, DOI 10.1111/1523-1747.ep12319824; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hradcova M, 2002, LEUKEMIA RES, V26, P45, DOI 10.1016/S0145-2126(01)00097-2; Huang XZ, 1998, J CELL SCI, V111, P2189; Isik FF, 1998, J CELL PHYSIOL, V175, P149, DOI 10.1002/(SICI)1097-4652(199805)175:2<149::AID-JCP4>3.0.CO;2-O; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Man P, 2005, PROTEOMICS, V5, P113, DOI 10.1002/pmic.200400887; McCutcheon JC, 1998, J LEUKOCYTE BIOL, V64, P600, DOI 10.1002/jlb.64.5.600; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; PARKER CJ, 1988, BLOOD, V71, P86; PODOR TJ, 1992, ANN NY ACAD SCI, V667, P173, DOI 10.1111/j.1749-6632.1992.tb51609.x; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Stibrikova G, 2005, NEOPLASMA, V52, P18; TOMASINIJOHANSSON BR, 1994, EXP CELL RES, V214, P303, DOI 10.1006/excr.1994.1262; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; vanAken BE, 1997, HISTOCHEM CELL BIOL, V107, P313, DOI 10.1007/s004180050116; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; VOLKER W, 1993, J HISTOCHEM CYTOCHEM, V41, P1823, DOI 10.1177/41.12.7504009	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19243	10.1371/journal.pone.0019243	http://dx.doi.org/10.1371/journal.pone.0019243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573223	Green Published, gold			2022-12-25	WOS:000290224800019
J	Shen, S; Kepp, O; Michaud, M; Martins, I; Minoux, H; Metivier, D; Maiuri, MC; Kroemer, RT; Kroemer, G				Shen, S.; Kepp, O.; Michaud, M.; Martins, I.; Minoux, H.; Metivier, D.; Maiuri, M. C.; Kroemer, R. T.; Kroemer, G.			Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study	ONCOGENE			English	Article						high-content screen; autophagy; cell death; systematic analysis; cancer therapy	PROGRAMMED CELL-DEATH; DEGRADATION; INHIBITION; STRESS; LYSOSOMES; INDUCTION; PROTEINS; DISEASE; MTORC1; LC3	To address the question of whether established or experimental anticancer chemotherapeutics can exert their cytotoxic effects by autophagy, we performed a high-content screen on a set of cytotoxic agents. We simultaneously determined parameters of autophagy, apoptosis and necrosis on cells exposed to similar to 1400 compounds. Many agents induced a 'pure' autophagic, apoptotic or necrotic phenotype, whereas less than 100 simultaneously induced autophagy, apoptosis and necrosis. A systematic analysis of the autophagic flux induced by the most potent 80 inducers of GFP-LC3 puncta among the NCI panel agents showed that 59 among them truly induced autophagy. The remaining 21 compounds were potent inducers of apoptosis or necrosis, yet failed to stimulate an autophagic flux, which were characterized as microtubule inhibitors. Knockdown of ATG7 was efficient in preventing GFP-LC3 puncta, yet failed to attenuate cell death by the agents that induce GFP-LC3 puncta. Thus there is not a single compound that would induce cell death by autophagy in our screening, underscoring the idea that cell death is rarely, if ever, executed by autophagy in human cells. Oncogene (2011) 30, 4544-4556; doi: 10.1038/onc.2011.168; published online 16 May 2011	[Shen, S.; Kepp, O.; Michaud, M.; Martins, I.; Metivier, D.; Maiuri, M. C.; Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Shen, S.; Kepp, O.; Michaud, M.; Martins, I.; Metivier, D.; Maiuri, M. C.] Univ Paris 11, Villejuif, France; [Minoux, H.; Kroemer, R. T.] Sanofi Aventis, Struct Design & Informat, Vitry Sur Seine, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, G.] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, Pavillon Rech 1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Kepp, Oliver/GPX-8627-2022; Kroemer, Guido/AAY-9859-2020; SHEN, Shensi/AAW-2735-2020; Kepp, Oliver/N-2763-2017	KROEMER, Guido/0000-0002-9334-4405; SHEN, Shensi/0000-0002-5087-8220; Kepp, Oliver/0000-0002-6081-9558	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR); European Commission; Fondation pour la Recherche Medicale (FRM); Fondation Bettencourt-Schueller; Institut National du Cancer (INCa); Canceropole Ile-de-France; European Commission Apo-Sys; La Ligue contre le Cancer	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); European Commission Apo-Sys(European CommissionEuropean Commission Joint Research Centre); La Ligue contre le Cancer(Ligue nationale contre le cancer)	GK is supported by the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain), Fondation pour la Recherche Medicale (FRM), Fondation Bettencourt-Schueller, Institut National du Cancer (INCa) and Canceropole Ile-de-France. SS is supported by European Commission Apo-Sys and IM is supported by La Ligue contre le Cancer.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; ARLIN ZA, 1992, J CLIN ONCOL, V10, P169; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carmona-Gutierrez D, 2006, MOL CELL, V24, P167, DOI 10.1016/j.molcel.2006.10.004; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Shen S, 2010, CELL CYCLE, V9, P377, DOI 10.4161/cc.9.2.10468; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan Junying, 2004, Cell, VS116, pS53, DOI 10.1016/S0092-8674(04)00028-5; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	55	126	131	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2011	30	45					4544	4556		10.1038/onc.2011.168	http://dx.doi.org/10.1038/onc.2011.168			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21577201				2022-12-25	WOS:000296890700002
J	Rodriguez, MI; Gonzalez-Flores, A; Dantzer, F; Collard, J; de Herreros, AG; Oliver, FJ				Rodriguez, M. I.; Gonzalez-Flores, A.; Dantzer, F.; Collard, J.; de Herreros, A. G.; Oliver, F. J.			Poly(ADP-ribose)-dependent regulation of Snail1 protein stability	ONCOGENE			English	Article						snail1; E-cadherin; PARP-1; poly(ADP-ribosyl)ation; EMT; melanoma	EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN EXPRESSION; TRANSCRIPTION FACTOR SNAIL; TUMOR-CELLS; DNA-DAMAGE; TGF-BETA; POLYMERASE; CANCER; PROGRESSION; PARP-1	Snail1 is a master regulator of the epithelial-mesenchymal transition (EMT) and has been implicated in key tumor biological processes such as invasion and metastasis. It has been previously shown that poly(ADP-ribose) polymerase-1 (PARP-1) knockdown, but not PARP inhibition, down-regulates the expression of Snail1. In this study we have characterized a novel regulatory mechanism controlling Snail1 protein expression through poly(ADP-ribosyl)ation. The effect is not only limited to repression of Snail1 transcription but also to downregulated Snail1 protein stability. PARP-1 (but not PARP-2) poly(ADP) ribosylates Snail1, both in vivo and in vitro, and interacts with Snail1, an association that is sensitive to PARP inhibitors. PARP inhibition has also clear effects on EMT phenotype of different tumor cells, including Snail1 downregulation, E-cadherin upregulation, decreased cell elongation and invasiveness. Therefore, this study reveals a new regulatory mechanism of Snail1 activation through poly(ADP-ribosyl) ation with consequences in malignant transformation through EMT. Oncogene (2011) 30, 4365-4372; doi: 10.1038/onc.2011.153; published online 16 May 2011	[Rodriguez, M. I.; Gonzalez-Flores, A.; Oliver, F. J.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Dantzer, F.] Ecole Super Biotechnol Strasbourg, Dept Integr Genome, UMR 7175, Strasbourg, France; [Collard, J.] Netherlands Canc Inst, Amsterdam, Netherlands; [de Herreros, A. G.] IMIM Hosp del Mar, Programa Recerca Canc, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Netherlands Cancer Institute; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Oliver, FJ (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18100, Spain.	joliver@ipb.csic.es	Lara, María Isabel Rodríguez/A-1961-2017; Dantzer, Françoise/O-2126-2016; de Herreros, A Garcia/H-3104-2014; Oliver, Javier/S-1725-2018	Lara, María Isabel Rodríguez/0000-0002-2270-0070; de Herreros, A Garcia/0000-0001-5270-0808; Oliver, Javier/0000-0001-8468-1998; Dantzer, Francoise/0000-0003-0945-8483	CSIC; Junta de Andalucia; Ecole Superieure de Biotechnologie de Strasbourg, Strasbourg, France; Ministerio de Ciencia; Netherlands Cancer Institute, Amsterdam, The Netherlands; Ministerio de Ciencia e Innovacion [SAF2006-01094, SAF2009-13281-C02-01]; Fundacion La Caixa [BM06-219-0]; Junta de Andalucia [P07-CTS-0239]; Ministerio de Educacion y Ciencia [SAF2007-64597, SAF2006-03399]; la Fundacion Cientifica de la Asociacion Espanola contra el Cancer	CSIC; Junta de Andalucia(Junta de Andalucia); Ecole Superieure de Biotechnologie de Strasbourg, Strasbourg, France; Ministerio de Ciencia(Spanish Government); Netherlands Cancer Institute, Amsterdam, The Netherlands(Netherlands Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion La Caixa(La Caixa Foundation); Junta de Andalucia(Junta de Andalucia); Ministerio de Educacion y Ciencia(Spanish Government); la Fundacion Cientifica de la Asociacion Espanola contra el Cancer	We acknowledge Laura Lopez for her technical assistance. MIR is recipient of a postdoctoral fellowship financed by the program JAE-Doc of CSIC. She was also funded by Junta de Andalucia Short-Term Fellowships to stay at the Departement Integrite du Genome' de I'UMR 7175, Ecole Superieure de Biotechnologie de Strasbourg, Strasbourg, France and Ministerio de Ciencia 'Programa Jose Castillejo' to stay at the Department of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands. This work was supported by Ministerio de Ciencia e Innovacion SAF2006-01094; SAF2009-13281-C02-01, Fundacion La Caixa BM06-219-0; and Junta de Andalucia P07-CTS-0239 to FJO; Ministerio de Educacion y Ciencia SAF2007-64597 and 'Ministerio de Ciencia y Tecnologia' (SAF2006-03399) and 'la Fundacion Cientifica de la Asociacion Espanola contra el Cancer' to AGH.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; GUARINO M, 1995, HISTOL HISTOPATHOL, V10, P171; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Lasfar A, 2010, CARCINOGENESIS, V31, P1710, DOI 10.1093/carcin/bgq155; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; McPhee TR, 2008, DEV DYNAM, V237, P2737, DOI 10.1002/dvdy.21685; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	34	51	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	42					4365	4372		10.1038/onc.2011.153	http://dx.doi.org/10.1038/onc.2011.153			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21577210				2022-12-25	WOS:000296356400007
J	Dong, YF; Kataoka, K; Tokutomi, Y; Nako, H; Nakamura, T; Toyama, K; Sueta, D; Koibuchi, N; Yamamoto, E; Ogawa, H; Kim-Mitsuyama, S				Dong, Yi-Fei; Kataoka, Keiichiro; Tokutomi, Yoshiko; Nako, Hisato; Nakamura, Taishi; Toyama, Kensuke; Sueta, Daisuke; Koibuchi, Nobutaka; Yamamoto, Eiichiro; Ogawa, Hisao; Kim-Mitsuyama, Shokei			Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid-beta; inflammation; oxidative stress; cognitive function; blood-brain barrier	AMYLOID BETA-PROTEIN; BLOOD-PRESSURE; NITRIC-OXIDE; MEMORY; DEMENTIA; BRAIN; ACE; HYPERTENSION; ASSOCIATION; DEPOSITION	The purpose of this work was to test whether brain-penetrating angiotensin-converting enzyme (ACE) inhibitors (e. g., perindopril), as opposed to non-brain-penetrating ACE inhibitors (e. g., enalapril and imidapril), may reduce the cognitive decline and brain injury in Alzheimer's disease (AD). We first compared the effect of perindopril, enalapril, and imidapril on cognitive impairment and brain injury in a mouse model of AD induced by intracerebroventricular (i.c.v.) injection of amyloid-beta (A beta)(1-40). Perindopril, with significant inhibition of hippocampal ACE, significantly prevented cognitive impairment in this AD mouse model. This beneficial effect was attributed to the suppression of microglia/astrocyte activation and the attenuation of oxidative stress caused by iNOS induction and extracellular superoxide dismutase down-regulation. In contrast, neither enalapril nor imidapril prevented cognitive impairment and brain injury in this AD mouse. We next examined the protective effects of perindopril on cognitive impairment in PS2APP-transgenic mice overexpressing A beta in the brain. Perindopril, without affecting brain A beta deposition, significantly suppressed the increase in hippocampal ACE activity and improved cognition in PS2APP-transgenic mice, being associated with the suppression of hippocampal astrocyte activation and attenuation of superoxide. Our data demonstrated that the brain-penetrating ACE inhibitor perindopril, as compared to non-brain-penetrating ACE inhibitors, protected against cognitive impairment and brain injury in experimental AD models.-Dong, Y. -F., Kataoka, K., Tokutomi, Y., Nako, H., Nakamura, T., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Ogawa, H., Kim-Mitsuyama, S. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J. 25, 2911-2920 (2011). www.fasebj.org	[Dong, Yi-Fei; Kataoka, Keiichiro; Tokutomi, Yoshiko; Nako, Hisato; Nakamura, Taishi; Toyama, Kensuke; Sueta, Daisuke; Koibuchi, Nobutaka; Yamamoto, Eiichiro; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University	Kim-Mitsuyama, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, 1-1-1 Honjyo, Kumamoto 8608556, Japan.	kimmitsu@gpo.kumamoto-u.ac.jp	Nakamura, Taishi/O-9297-2019	Nakamura, Taishi/0000-0002-1205-3252	Japan Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23390058] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology.	Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; ARREGUI A, 1982, J NEUROCHEM, V38, P1490, DOI 10.1111/j.1471-4159.1982.tb07930.x; Dong YF, 2010, DIABETOLOGIA, V53, P180, DOI 10.1007/s00125-009-1575-5; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Miners S, 2009, AM J TRANSL RES, V1, P163; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Ohrui T, 2004, NEUROLOGY, V63, P1324, DOI 10.1212/01.WNL.0000140705.23869.E9; Ohrui T, 2004, J AM GERIATR SOC, V52, P649, DOI 10.1111/j.1532-5415.2004.52178_7.x; Oyama F, 1998, J NEUROCHEM, V71, P313; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Pohjasvaara T, 1997, STROKE, V28, P785, DOI 10.1161/01.STR.28.4.785; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Richards JG, 2003, J NEUROSCI, V23, P8989; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; TATEMICHI TK, 1994, NEUROLOGY, V44, P1885, DOI 10.1212/WNL.44.10.1885; Tran MH, 2003, MOL PSYCHIATR, V8, P407, DOI 10.1038/sj.mp.4001240; Tran MH, 2001, FASEB J, V15, P1407, DOI 10.1096/fj.00-0719fje; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Wright JW, 2010, EXP NEUROL, V223, P326, DOI 10.1016/j.expneurol.2009.09.012; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yamamoto E, 2007, ARTERIOSCL THROM VAS, V27, P556, DOI 10.1161/01.ATV.0000254855.24394.f9	35	107	109	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					2911	2920		10.1096/fj.11-182873	http://dx.doi.org/10.1096/fj.11-182873			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21593435				2022-12-25	WOS:000294435200007
J	De la Rosa, MB; Nelson, SW				De la Rosa, Metzere Bierlein; Nelson, Scott W.			An Interaction between the Walker A and D-loop Motifs Is Critical to ATP Hydrolysis and Cooperativity in Bacteriophage T4 Rad50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA END-RESECTION; BIOCHEMICAL-CHARACTERIZATION; RECOMBINATION; COMPLEX; MRE11; 2-AMINOPURINE; MECHANISMS; FURIOSUS; BINDING; REPAIR	The ATP binding cassette (ABC) proteins make up a large superfamily with members coming from all kingdoms. The functional form of the ABC protein nucleotide binding domain (NBD) is dimeric with ATP binding sites shared between subunits. The NBD is defined by six motifs: the Walker A, Q-loop, Signature, Walker-B, D-loop, and H-loop. The D-loop contains a conserved aspartate whose function is not clear but has been proposed to be involved in cross-talk between ATP binding sites. Structures of various ABC proteins suggest an interaction between the D-loop aspartate and an asparagine residue located in Walker A loop of the opposing subunit. Here, we evaluate the functional role of the D-loop using a bacteriophage T4 ABC protein, Rad50 (gp46). Mutation of either the D-loop aspartate or the Walker A asparagine results in dramatic reductions in ATP affinity, hydrolysis rate, and cooperativity. The mutant proteins bind Mre11 (gp47) and DNA normally, but no longer support the ATP-dependent nuclease activities of Mre11. We propose that the D-loop aspartate functions to stabilize the Walker A asparagine in a position favorable for catalysis. We find that the asparagine is crucially important to the mechanism of ATP hydrolysis by increasing the affinity for ATP and positioning the gamma-phosphate of ATP for catalysis. Additionally, we propose that the asparagine acts as a gamma-phosphate sensor and, through its interaction with the conserved D-loop aspartate, transmits conformational changes across the dimer interface to the second ATP binding site.	[De la Rosa, Metzere Bierlein; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [De la Rosa, Metzere Bierlein] Iowa State Univ, Program Women Sci & Engn, Ames, IA 50011 USA; [De la Rosa, Metzere Bierlein] Grinnell Coll, Grinnell, IA 50112 USA	Iowa State University; Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu			Carver Trust [10-3603]; Iowa State University	Carver Trust; Iowa State University	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.) and Iowa State University institutional support (to S. W. N.).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bareil C, 2010, HUM MUTAT, V31, P1011, DOI 10.1002/humu.21316; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Herdendorf T. J., 2011, BIOCHEMISTR IN PRESS; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	37	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26258	26266		10.1074/jbc.M111.256305	http://dx.doi.org/10.1074/jbc.M111.256305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21610075	Green Published, hybrid			2022-12-25	WOS:000293073000083
J	Klemmer, P; Meredith, RM; Holmgren, CD; Klychnikov, OI; Stahl-Zeng, J; Loos, M; van der Schors, RC; Wortel, J; de Wit, H; Spijker, S; Rotaru, DC; Mansvelder, HD; Smit, AB; Li, KW				Klemmer, Patricia; Meredith, Rhiannon M.; Holmgren, Carl D.; Klychnikov, Oleg I.; Stahl-Zeng, Jianru; Loos, Maarten; van der Schors, Roel C.; Wortel, Joke; de Wit, Heidi; Spijker, Sabine; Rotaru, Diana C.; Mansvelder, Huibert D.; Smit, August B.; Li, Ka Wan			Proteomics, Ultrastructure, and Physiology of Hippocampal Synapses in a Fragile X Syndrome Mouse Model Reveal Presynaptic Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMR1 KNOCKOUT MICE; MENTAL-RETARDATION SYNDROME; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; SOMATOSENSORY CORTEX; NEUROBLASTOMA-CELLS; SPINE MORPHOGENESIS; DENDRITIC SPINES; ACTIN DYNAMICS	Fragile X syndrome (FXS), the most common form of hereditary mental retardation, is caused by a loss-of-function mutation of the Fmr1 gene, which encodes fragile X mental retardation protein (FMRP). FMRP affects dendritic protein synthesis, thereby causing synaptic abnormalities. Here, we used a quantitative proteomics approach in an FXS mouse model to reveal changes in levels of hippocampal synapse proteins. Sixteen independent pools of Fmr1 knock-out mice and wild type mice were analyzed using two sets of 8-plex iTRAQ experiments. Of 205 proteins quantified with atleast three distinct peptides in both iTRAQ series, the abundance of 23 proteins differed between Fmr1 knock-out and wild type synapses with a false discovery rate (q-value) <5%. Significant differences were confirmed by quantitative immunoblotting. A group of proteins that are known to be involved in cell differentiation and neurite outgrowth was regulated; they included Basp1 and Gap43, known PKC substrates, and Cend1. Basp1 and Gap43 are predominantly expressed in growth cones and presynaptic terminals. In line with this, ultrastructural analysis in developing hippocampal FXS synapses revealed smaller active zones with corresponding postsynaptic densities and smaller pools of clustered vesicles, indicative of immature presynaptic maturation. Asecond group of proteins involved in synaptic vesicle release was up-regulated in the FXS mouse model. In accordance, paired-pulse and short-term facilitation were significantly affected in these hippocampal synapses. Together, the altered regulation of presynaptically expressed proteins, immature synaptic ultrastructure, and compromised short-term plasticity points to presynaptic changes underlying glutamatergic transmission in FXS at this stage of development.	[Klemmer, Patricia; Klychnikov, Oleg I.; Loos, Maarten; van der Schors, Roel C.; Spijker, Sabine; Rotaru, Diana C.; Smit, August B.; Li, Ka Wan] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Meredith, Rhiannon M.; Holmgren, Carl D.; Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Wortel, Joke; de Wit, Heidi] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Stahl-Zeng, Jianru] AB Sciex, D-64293 Darmstadt, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Li, KW (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	ka.wan.li@cncr.vu.nl	Loos, Maarten/A-2768-2012; Spijker, Sabine/F-2300-2011; Klychnikov, Oleg I./AAN-6167-2020; Meredith, Rhiannon/A-4657-2010; Smit, August B/E-8410-2011; Rotaru, Diana/AAZ-9058-2020; Mansvelder, Huibert/N-6138-2018	Loos, Maarten/0000-0003-1629-2928; Klychnikov, Oleg I./0000-0002-0383-9237; Mansvelder, Huibert/0000-0003-1365-5340; Meredith, Rhiannon/0000-0003-0228-4169; Spijker, Sabine/0000-0002-6814-2019; li, ka wan/0000-0001-6983-5055; Rotaru, Diana/0000-0002-0724-3596	NeuroBsik grant; Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO) [91710372]; Hersenstichting Nederland; Neuromics Marie Curie Early stage Training Grant [MEST-CT-2005-020919]	NeuroBsik grant; Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Hersenstichting Nederland; Neuromics Marie Curie Early stage Training Grant	This work was supported by the NeuroBsik grant to the Dutch Mouse Phenomics consortium and support of the Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO) (Grant 91710372) (to A. B. S., K. W. L., and R. C. v. d. S.), funding from Hersenstichting Nederland (to R. M. M.), and funding from Neuromics Marie Curie Early stage Training Grant MEST-CT-2005-020919 (to P. K.).	Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Klychnikov OI, 2010, PROTEOMICS, V10, P2531, DOI 10.1002/pmic.200900733; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; MAMALAKI A, 1995, J BIOL CHEM, V270, P14201, DOI 10.1074/jbc.270.23.14201; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Massey PV, 2001, EUR J NEUROSCI, V14, P145, DOI 10.1046/j.0953-816x.2001.01631.x; Meredith R. M., 2010, FRONT SYNAPTIC NEURO, V10, P2; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Meredith RM, 2011, NEUROBIOL DIS, V41, P104, DOI 10.1016/j.nbd.2010.08.026; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Roxas BAP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-187; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008	50	71	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25495	25504		10.1074/jbc.M110.210260	http://dx.doi.org/10.1074/jbc.M110.210260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596744	Green Published, hybrid			2022-12-25	WOS:000293073000012
J	Zhang, L; Jin, Y; Chen, M; Huang, M; Harvey, RG; Blair, IA; Penning, TM				Zhang, Li; Jin, Yi; Chen, Mo; Huang, Meng; Harvey, Ronald G.; Blair, Ian A.; Penning, Trevor M.			Detoxication of Structurally Diverse Polycyclic Aromatic Hydrocarbon (PAH) o-Quinones by Human Recombinant Catechol-O-methyltransferase (COMT) via O-Methylation of PAH Catechols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; REACTIVE OXYGEN; A549 CELLS; IN-VITRO; ACTIVATION; METABOLISM; REDUCTASE; ADDUCTS; DNA; CARCINOGENESIS	Polycyclic aromatic hydrocarbons (PAH) are environmental and tobacco carcinogens. Metabolic activation of intermediate PAH trans-dihydrodiols by aldo-keto reductases (AKRs) leads to the formation of electrophilic and redox-active o-quinones. We investigated whether O-methylation by human recombinant soluble catechol-O-methyltransferase (S-COMT) is a feasible detoxication step for a panel of structurally diverse PAH-catechols produced during the redox-cycling process. Classes of PAH non-K-region o-quinones (bay region, methylated bay region, and fjord region o-quinones) produced by AKRs were employed in the studies. PAH o-quinones were reduced to the corresponding catechols by dithiothreitol under anaerobic conditions and then further O-methylated by human S-COMT in the presence of S-[H-3]adenosyl-L-methionine as a methyl group donor. The formation of the O-methylated catechols was detected by HPLC-UV coupled with in-line radiometric detection, and unlabeled products were also characterized by LC-MS/MS. Human S-COMT was able to catalyze O-methylation of all of the PAH-catechols and generated two isomeric metabolites in different proportions. LC-MS/MS showed that each isomer was a mono-O-methylated metabolite. H-1 NMR was used to assign the predominant positional isomer of benzo[a]pyrene-7,8-catechol as the O-8-monomethylated catechol. The catalytic efficiency (k(cat)/K-m) varied among different classes of PAH-catechols by 500-fold. The ability of S-COMT to produce two isomeric products from PAH-catechols was rationalized using the crystal structure of the enzyme. We provide evidence that O-8-monomethylated benzo[a]pyrene-7,8-catechol is formed in three different human lung cell lines. It is concluded that human S-COMT may play a critical role in the detoxication of PAH o-quinones generated by AKRs.	[Zhang, Li; Jin, Yi; Huang, Meng; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Zhang, Li; Jin, Yi; Huang, Meng; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Harvey, Ronald G.; Blair, Ian A.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Chicago	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Excellence Environm Toxicol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu	Zhang, Li/F-9782-2013	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [P30-ES-013508, R01-CA39504, PA-DOH4100038714]; NATIONAL CANCER INSTITUTE [R01CA039504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES-013508, R01-CA39504, and PA-DOH4100038714.	AXELROD J, 1958, J BIOL CHEM, V233, P702; AXELROD J, 1966, PHARMACOL REV, V18, P95; Bai HW, 2007, CHEM RES TOXICOL, V20, P1409, DOI 10.1021/tx700174w; BALL P, 1972, J CLIN ENDOCR METAB, V34, P736, DOI 10.1210/jcem-34-4-736; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Bolchi C, 2004, BIOORGAN MED CHEM, V12, P4937, DOI 10.1016/j.bmc.2004.06.040; Burczynski ME, 1998, BIOCHEMISTRY-US, V37, P6781, DOI 10.1021/bi972725u; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; CHENG KC, 1992, J BIOL CHEM, V267, P166; CONNEY AH, 1982, CANCER RES, V42, P4875; Cote ML, 2009, CARCINOGENESIS, V30, P626, DOI 10.1093/carcin/bgp033; Dawling S, 2001, CANCER RES, V61, P6716; FU PP, 1979, J ORG CHEM, V44, P4265, DOI 10.1021/jo01338a010; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Goodman JE, 2002, PHARMACOGENETICS, V12, P517, DOI 10.1097/00008571-200210000-00003; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; GROSSMAN MH, 1985, J NEUROCHEM, V44, P421, DOI 10.1111/j.1471-4159.1985.tb05432.x; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; JEFFERY DR, 1984, J NEUROCHEM, V42, P826, DOI 10.1111/j.1471-4159.1984.tb02755.x; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kim YH, 2004, J IND MICROBIOL BIOT, V31, P507, DOI 10.1007/s10295-004-0178-x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MURTY VS, 1992, CHEM-BIOL INTERACT, V84, P169, DOI 10.1016/0009-2797(92)90077-X; MURTY VS, 1992, BIOCONJUGATE CHEM, V3, P218, DOI 10.1021/bc00015a003; Nolan KA, 2000, PSYCHIAT GENET, V10, P117, DOI 10.1097/00041444-200010030-00003; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 1996, CANCER RES, V56, P2979; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Syvanen AC, 1997, PHARMACOGENETICS, V7, P65; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; UELAND PM, 1982, PHARMACOL REV, V34, P223; ULMANEN I, 1991, EUR J BIOCHEM, V202, P1013, DOI 10.1111/j.1432-1033.1991.tb16464.x; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	46	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25644	25654		10.1074/jbc.M111.240739	http://dx.doi.org/10.1074/jbc.M111.240739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622560	Green Published, hybrid			2022-12-25	WOS:000293073000026
J	Kim, EK; Park, JM; Lim, S; Choi, JW; Kim, HS; Seok, H; Seo, JK; Oh, K; Lee, DS; Kim, KT; Ryu, SH; Suh, PG				Kim, Eung-Kyun; Park, Ji-Man; Lim, Seyoung; Choi, Jung Woong; Kim, Hyeon Soo; Seok, Heon; Seo, Jeong Kon; Oh, Keunhee; Lee, Dong-Sup; Kim, Kyong Tai; Ryu, Sung Ho; Suh, Pann-Ghill			Activation of AMP-activated Protein Kinase Is Essential for Lysophosphatidic Acid-induced Cell Migration in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHOLIPASE-D; ENDOTHELIAL-CELLS; UP-REGULATION; RHO-GTPASES; PHOSPHORYLATION; PATHWAY; GROWTH; MOTILITY; ENERGY; RECEPTORS	Lysophosphatidic acid (LPA) is a bioactive phospholipid that affects various biological functions, such as cell proliferation, migration, and survival, through LPA receptors. Among them, the motility of cancer cells is an especially important activity for invasion and metastasis. Recently, AMP-activated protein kinase (AMPK), an energy-sensing kinase, was shown to regulate cell migration. However, the specific role of AMPK in cancer cell migration is unknown. The present study investigated whether LPA could induce AMPK activation and whether this process was associated with cell migration in ovarian cancer cells. We found that LPA led to a striking increase in AMPK phosphorylation in pathways involving the phospholipase C-beta 3 (PLC-beta 3) and calcium/calmodulin-dependent protein kinase kinase beta (CaMKK beta) in SKOV3 ovarian cancer cells. siRNA-mediated knockdown of AMPK beta 1, PLC-beta 3, or (CaMKK beta) impaired the stimulatory effects of LPA on cell migration. Furthermore, we found that knockdown of AMPK beta 1 abrogated LPA-induced activation of the small GTPase RhoA and ezrin/radixin/moesin proteins regulating membrane dynamics as membrane-cytoskeleton linkers. In ovarian cancer xenograft models, knockdown of AMPK significantly decreased peritoneal dissemination and lung metastasis. Taken together, our results suggest that activation of AMPK by LPA induces cell migration through the signaling pathway to cytoskeletal dynamics and increases tumor metastasis in ovarian cancer.	[Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, BioSignal Network Lab, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Kim, Eung-Kyun; Choi, Jung Woong; Kim, Kyong Tai; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Oh, Keunhee; Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Transplantat Res Inst, Seoul 110799, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan 367805, Chungcheongbukd, South Korea	Ulsan National Institute of Science & Technology (UNIST); Pohang University of Science & Technology (POSTECH); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Jungwon University	Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, BioSignal Network Lab, Sch Nanobiosci & Chem Engn, Engn Bldg 104,100 Banyeon Ri, Ulsan 689798, South Korea.	pgsuh@unist.ac.kr	Lee, Dong-Sup/J-2777-2012; Seo, Jeong Kon/H-4770-2016; Suh, Pann-Ghill/F-3610-2010	KIM, KYONG-TAI/0000-0001-7292-2627; Ryu, Sung Ho/0000-0003-0913-3048	Korean Government [KRF-2007-341-C00027]; Korean Ministry of Education, Science and Technology (Anti-aging and Well-being Research Center)	Korean Government(Korean Government); Korean Ministry of Education, Science and Technology (Anti-aging and Well-being Research Center)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation of Korea Grant KRF-2007-341-C00027 funded by the Korean Government and by a grant of the Korean Ministry of Education, Science and Technology (The Regional Core Research Program/Anti-aging and Well-being Research Center).	Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Eder AM, 2000, CLIN CANCER RES, V6, P2482; Estrella VC, 2007, INT J ONCOL, V31, P441; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; LIM S, 2010, STEM CELLS DEV; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Motobayashi Y, 2009, HYPERTENS RES, V32, P188, DOI 10.1038/hr.2008.19; Nakamoto T, 2005, J OBSTET GYNAECOL RE, V31, P344, DOI 10.1111/j.1447-0756.2005.00299.x; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Natsuizaka M, 2007, EXP CELL RES, V313, P3337, DOI 10.1016/j.yexcr.2007.06.013; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park SY, 2006, CELL SIGNAL, V18, P1063, DOI 10.1016/j.cellsig.2005.08.018; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sengupta S, 2003, FASEB J, V17, P1570, DOI 10.1096/fj.02-1145fje; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; Tang CH, 2009, PROSTATE, V69, P1781, DOI 10.1002/pros.21029; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Wang P, 2007, GYNECOL ONCOL, V104, P714, DOI 10.1016/j.ygyno.2006.10.016; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	56	50	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24036	24045		10.1074/jbc.M110.209908	http://dx.doi.org/10.1074/jbc.M110.209908			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602274	Green Published, hybrid			2022-12-25	WOS:000292294900046
J	Miller, KJ; Rowden, AA; Williams, A; Haussermann, V				Miller, Karen J.; Rowden, Ashley A.; Williams, Alan; Hauessermann, Vreni			Out of Their Depth? Isolated Deep Populations of the Cosmopolitan Coral Desmophyllum dianthus May Be Highly Vulnerable to Environmental Change	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SCLERACTINIAN CORALS; INTEGRATED SOFTWARE; SECONDARY STRUCTURE; MARINE ECOSYSTEMS; SEA; CONNECTIVITY; DIVERSITY; SEQUENCES; SEAMOUNTS	Deep sea scleractinian corals will be particularly vulnerable to the effects of climate change, facing loss of up to70% of their habitat as the Aragonite Saturation Horizon (below which corals are unable to form calcium carbonate skeletons) rises. Persistence of deep sea scleractinian corals will therefore rely on the ability of larvae to disperse to, and colonise, suitable shallow-water habitat. We used DNA sequence data of the internal transcribed spacer (ITS), the mitochondrial ribosomal subunit (16S) and mitochondrial control region (MtC) to determine levels of gene flow both within and among populations of the deep sea coral Desmophyllum dianthus in SE Australia, New Zealand and Chile to assess the ability of corals to disperse into different regions and habitats. We found significant genetic subdivision among the three widely separated geographic regions consistent with isolation and limited contemporary gene flow. Furthermore, corals from different depth strata (shallow <600 m, mid 1000-1500 m, deep >1500 m) even on the same or nearby seamounts were strongly differentiated, indicating limited vertical larval dispersal. Genetic differentiation with depth is consistent with the stratification of the Subantarctic Mode Water, Antarctic Intermediate Water, the Circumpolar Deep and North Pacific Deep Waters in the Southern Ocean, and we propose that coral larvae will be retained within, and rarely migrate among, these water masses. The apparent absence of vertical larval dispersal suggests deep populations of D. dianthus are unlikely to colonise shallow water as the aragonite saturation horizon rises and deep waters become uninhabitable. Similarly, assumptions that deep populations will act as refuges for shallow populations that are impacted by activities such as fishing or mining are also unlikely to hold true. Clearly future environmental management strategies must consider both regional and depth-related isolation of deep-sea coral populations.	[Miller, Karen J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Rowden, Ashley A.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Williams, Alan] Commonwealth Sci & Ind Res Org, Hobart, Tas, Australia; [Hauessermann, Vreni] Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Fac Recursos Nat, Valparaiso, Chile; [Hauessermann, Vreni] Huinay Sci Field Stn, Puerto Montt, Chile	University of Tasmania; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Pontificia Universidad Catolica de Valparaiso	Miller, KJ (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Karen.Miller@utas.edu.au	Williams, Alan/C-6999-2012; Miller, Karen/A-7902-2011; Rowden, Ashley/ABG-6010-2020; Miller, Karen/V-4098-2019; Rowden, Ashley/O-9358-2019	Williams, Alan/0000-0002-2867-7713; Rowden, Ashley/0000-0003-2975-2524	New Zealand Foundation for Research, Science and Technology; Ministry of Fisheries; Australian Government Department of Environment and Heritage; CSIRO Wealth; Global Census of Marine Life on Seamounts (CenSeam)	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Ministry of Fisheries; Australian Government Department of Environment and Heritage(Australian Government); CSIRO Wealth; Global Census of Marine Life on Seamounts (CenSeam)	This research was supported by the Global Census of Marine Life on Seamounts (CenSeam), the NIWA project 'Seamounts: their importance for fisheries and marine ecosystems' funded by the New Zealand Foundation for Research, Science and Technology and the Ministry of Fisheries, the Australian Government Department of Environment and Heritage and the CSIRO Wealth from Oceans Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Arantes RCM, 2009, MAR ECOL PROG SER, V397, P71, DOI 10.3354/meps08230; Audzijonyte A, 2010, EVOLUTION, V64, P2369, DOI 10.1111/j.1558-5646.2010.00987.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Cairns S.D., 1995, NZ OCEANOGRAPHIC I M, V103; Cairns S.D, 1994, SMITHSONIAN CONTRIBU, V557, P150; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Chen CA, 2004, ZOOL STUD, V43, P759; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; CLARK MR, 2007, IMPACTS FISHERIES SE, P413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coleman AW, 2008, J MOL EVOL, V67, P389, DOI 10.1007/s00239-008-9160-y; Costantini F, 2010, MAR ECOL-EVOL PERSP, V31, P261, DOI 10.1111/j.1439-0485.2009.00333.x; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Duenas LF, 2009, MAR ECOL PROG SER, V397, P11, DOI 10.3354/meps08307; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Forsterra G., 2003, ZOOL VERH, V345, P117; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P304; GRANGE KR, 1981, NEW ZEAL J ZOOL, V8, P209, DOI 10.1080/03014223.1981.10427963; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Haussermann V, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P195; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; MCCULLOCH M, 2005, 3 INT S DEEP SEA COR, V3; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; SCHMITZ WJ, 1996, WORLD OCEAN CIRCULAT, V1, P141; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Smith PJ, 2004, MAR BIOL, V144, P253, DOI 10.1007/s00227-003-1206-5; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Swofford DL, 1998, PHYLOGENETIC ANAL US; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Vezina AF, 2008, MAR ECOL PROG SER, V373, P199, DOI 10.3354/meps07868; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; Wright S, 1931, GENETICS, V16, P0097; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	55	32	33	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19004	10.1371/journal.pone.0019004	http://dx.doi.org/10.1371/journal.pone.0019004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611159	Green Published, gold			2022-12-25	WOS:000290720200004
J	Benson, RW; Norton, MD; Lin, I; Du Comb, WS; Godoy, VG				Benson, Ryan W.; Norton, Matthew D.; Lin, Ida; Du Comb, William S.; Godoy, Veronica G.			An Active Site Aromatic Triad in Escherichia coli DNA Pol IV Coordinates Cell Survival and Mutagenesis in Different DNA Damaging Agents	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; POLYMERASE-III HOLOENZYME; Y-FAMILY; IN-VITRO; BETA-CLAMP; REPLICATION; BYPASS; ROLES; LESIONS; METHYL	DinB (DNA Pol IV) is a translesion (TLS) DNA polymerase, which inserts a nucleotide opposite an otherwise replication-stalling N-2-dG lesion in vitro, and confers resistance to nitrofurazone (NFZ), a compound that forms these lesions in vivo. DinB is also known to be part of the cellular response to alkylation DNA damage. Yet it is not known if DinB active site residues, in addition to aminoacids involved in DNA synthesis, are critical in alkylation lesion bypass. It is also unclear which active site aminoacids, if any, might modulate DinB's bypass fidelity of distinct lesions. Here we report that along with the classical catalytic residues, an active site "aromatic triad'', namely residues F12, F13, and Y79, is critical for cell survival in the presence of the alkylating agent methyl methanesulfonate (MMS). Strains expressing dinB alleles with single point mutations in the aromatic triad survive poorly in MMS. Remarkably, these strains show fewer MMS-than NFZ-induced mutants, suggesting that the aromatic triad, in addition to its role in TLS, modulates DinB's accuracy in bypassing distinct lesions. The high bypass fidelity of prevalent alkylation lesions is evident even when the DinB active site performs error-prone NFZ-induced lesion bypass. The analyses carried out with the active site aromatic triad suggest that the DinB active site residues are poised to proficiently bypass distinctive DNA lesions, yet they are also malleable so that the accuracy of the bypass is lesion-dependent.	[Benson, Ryan W.; Norton, Matthew D.; Lin, Ida; Du Comb, William S.; Godoy, Veronica G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Benson, RW (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	v.godoycarter@neu.edu			NIGMS [1RO1GM088230-01A1]; RSFD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088230] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); RSFD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the 1RO1GM088230-01A1 award from NIGMS to V. G. Godoy and in part by an RSFD award to V. G. Godoy by the office of the Provost of Northeastern University (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson DI, 2010, MOL MICROBIOL, V77, P540, DOI 10.1111/j.1365-2958.2010.07260.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becherel OJ, 2002, DNA REPAIR, V1, P703, DOI 10.1016/S1568-7864(02)00106-4; Benson RW, 2011, J MICROBIOL METH, V84, P479, DOI 10.1016/j.mimet.2010.12.020; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; Bjedov I, 2003, DNA REPAIR, V2, P417, DOI 10.1016/S1568-7864(02)00241-0; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURCH LH, 2011, CELL CYCLE, P10; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Foti JJ, 2010, J BIOL CHEM, V285, P23084, DOI 10.1074/jbc.M110.115774; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Godoy VG, 2000, GENETICS, V154, P49; GODOY VG, 2005, ENCY BIOL CHEM, P546; Grzesiuk E, 2001, MUTAT RES-FUND MOL M, V480, P77, DOI 10.1016/S0027-5107(01)00171-3; Jarosz DF, 2009, P NATL ACAD SCI USA, V106, P21137, DOI 10.1073/pnas.0907257106; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Johnson RE, 2007, MOL CELL BIOL, V27, P7198, DOI 10.1128/MCB.01079-07; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; KIM HS, 1994, P NATL ACAD SCI USA, V91, P3725, DOI 10.1073/pnas.91.9.3725; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KWONSHIN O, 1987, J BIOL CHEM, V262, P2121; Kyrtopoulos SA, 1998, MUTAT RES-FUND MOL M, V405, P135, DOI 10.1016/S0027-5107(98)00130-4; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lawley P D, 1966, Prog Nucleic Acid Res Mol Biol, V5, P89, DOI 10.1016/S0079-6603(08)60232-9; LENGELER J, 1980, ARCH MICROBIOL, V128, P196, DOI 10.1007/BF00406158; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MAGUIN E, 1986, J BACTERIOL, V166, P733, DOI 10.1128/jb.166.3.733-738.1986; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monti P, 2004, BIOCHEMISTRY-US, V43, P5592, DOI 10.1021/bi035968x; MURRAYLY.IM, 1968, LANCET, V2, P895; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ona KR, 2009, J BACTERIOL, V191, P4959, DOI 10.1128/JB.00495-09; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; Pillaire MJ, 2010, ONCOGENE, V29, P876, DOI 10.1038/onc.2009.378; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; Rodgers G. L., 1997, Journal of Burn Care and Rehabilitation, V18, P406, DOI 10.1097/00004630-199709000-00006; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SENGUPTA S, 1990, MUTAT RES, V244, P55, DOI 10.1016/0165-7992(90)90108-V; Shah D, 2001, BIOCHEMISTRY-US, V40, P1796, DOI 10.1021/bi0024658; SHAVITT O, 1989, J BIOL CHEM, V264, P11275; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; WANG H, 2010, NEURO ONCOL; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	76	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19944	10.1371/journal.pone.0019944	http://dx.doi.org/10.1371/journal.pone.0019944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21614131	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500036
J	Franklin, BS; Vitorino, BLF; Coelho, HC; Menezes-Neto, A; Santos, MLS; Campos, FMF; Brito, CF; Fontes, CJ; Lacerda, MV; Carvalho, LH				Franklin, Bernardo S.; Vitorino, Barbara L. F.; Coelho, Helena C.; Menezes-Neto, Armando; Santos, Marina L. S.; Campos, Fernanda M. F.; Brito, Cristiana F.; Fontes, Cor J.; Lacerda, Marcus V.; Carvalho, Luzia H.			Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; CELL-FREE DNA; CANCER-PATIENTS; MYOCARDIAL-INFARCTION; MICROARRAY ANALYSIS; FALCIPARUM MALARIA; NORTHWESTERN INDIA; PROGNOSTIC MARKER; BRAZILIAN AMAZON	Background: Given the increasing evidence of Plasmodium vivax infections associated with severe and fatal disease, the identification of sensitive and reliable markers for vivax severity is crucial to improve patient care. Circulating nucleic acids (CNAs) have been increasingly recognized as powerful diagnostic and prognostic tools for various inflammatory diseases and tumors as their plasma concentrations increase according to malignancy. Given the marked inflammatory status of P. vivax infection, we investigated here the usefulness of CNAs as biomarkers for malaria morbidity. Methods and Findings: CNAs levels in plasma from twenty-one acute P. vivax malaria patients from the Brazilian Amazon and 14 malaria non-exposed healthy donors were quantified by two different methodologies: amplification of the human telomerase reverse transcriptase (hTERT) genomic sequence by quantitative real time PCR (qPCR), and the fluorometric dsDNA quantification by Pico Green. CNAs levels were significantly increased in plasma from P. vivax patients as compared to healthy donors (p<0.0001). Importantly, plasma CNAs levels were strongly associated with vivax morbidity (p<0.0001), including a drop in platelet counts (p = 0.0021). These findings were further sustained when we assessed CNAS levels in plasma samples from 14 additional P. vivax patients of a different endemic area in Brazil, in which CNAS levels strongly correlated with thrombocytopenia (p = 0.0072). We further show that plasma CNAs levels decrease and reach physiological levels after antimalarial treatment. Although we found both host and parasite specific genomic sequences circulating in plasma, only host CNAs clearly reflected the clinical spectrum of P. vivax malaria. Conclusions: Here, we provide the first evidence of increased plasma CNAs levels in malaria patients and reveal their potential as sensitive biomarkers for vivax malaria morbidity.	[Franklin, Bernardo S.; Vitorino, Barbara L. F.; Menezes-Neto, Armando; Santos, Marina L. S.; Campos, Fernanda M. F.; Brito, Cristiana F.; Carvalho, Luzia H.] Fundacao Oswaldo Cruz, Lab Malaria, Ctr Pesquisa Rene, Belo Horizonte, MG, Brazil; [Coelho, Helena C.; Lacerda, Marcus V.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Fontes, Cor J.] Univ Fed Mato Grosso, Dept Clin Med, Cuiaba, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso	Franklin, BS (corresponding author), Fundacao Oswaldo Cruz, Lab Malaria, Ctr Pesquisa Rene, Belo Horizonte, MG, Brazil.	bernardo@cpqrr.fiocruz.br; lhcarvalho@cpqrr.fiocruz.br	Fontes, Cor JF/G-7331-2018; carvalho, luzia H/C-4087-2013; Franklin, Bernardo S/G-8186-2012; Campos, Fernanda/GRR-6776-2022; Carvalho, Luzia H/AAW-3461-2021	Fontes, Cor JF/0000-0003-2756-0588; Franklin, Bernardo S/0000-0003-2591-9833; Menezes-Neto, Armando/0000-0002-2003-908X	Research Foundation of Minas Gerais State (FAPEMIG); Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Pronex Malaria; CNPq/DECIT/MS; FAPEMIG; CNPq-FIOCRUZ; CNPq; Helixis Young Investigator Award	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Pronex Malaria; CNPq/DECIT/MS(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Helixis Young Investigator Award	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), The Brazilian National Research Council (CNPq), and Oswaldo Cruz Foundation (FIOCRUZ, PAPES V), Pronex Malaria, CNPq/DECIT/MS; scholarships from FAPEMIG (FMFC), CNPq-FIOCRUZ (BSF), and CNPq (LHC, ATC, and CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Program for Technological Development in Tools for Health - PDTIS - FIOCRUZ for use of its facilities; Belisa Maria Lopes Magalhaes and Raimunda Ericilda da Silva for their help with patients in the endemic area. The authors would also like to thank the Helixis Incorporation (currently Illumina) for the PIXO Real Time PCR Instrumet awarded to BSF as the 2009 winner of the Helixis Young Investigator Award.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Anker P, 2002, CLIN CHEM, V48, P1210; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001; Atamaniuk J, 2006, CLIN CHEM, V52, P523, DOI 10.1373/clinchem.2005.058883; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Chen JA, 2007, AUTOIMMUNITY, V40, P307, DOI 10.1080/08916930701356317; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; ELLINGER J, 2009, UROL ONCOL; Ellinger J, 2008, CANCER LETT, V264, P274, DOI 10.1016/j.canlet.2008.01.038; Ellinger J, 2009, J UROLOGY, V181, P363, DOI 10.1016/j.juro.2008.08.118; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang ZH, 2006, CANCER LETT, V243, P64, DOI 10.1016/j.canlet.2005.11.027; Jahr S, 2001, CANCER RES, V61, P1659; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jung K, 2004, CANCER LETT, V205, P173, DOI 10.1016/j.canlet.2003.11.023; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Karunaweera ND, 1998, AM J TROP MED HYG, V58, P204, DOI 10.4269/ajtmh.1998.58.204; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KOFFLER D, 1973, J CLIN INVEST, V52, P198, DOI 10.1172/JCI107165; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Mandel P., 1948, CR HEBD ACAD SCI, P142; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miu J, 2008, INFECT IMMUN, V76, P1812, DOI 10.1128/IAI.01650-07; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ombrello C, 2010, J CARDIOVASC TRANSL, V3, P538, DOI 10.1007/s12265-010-9213-7; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Rani S, 2007, CLIN CHEM, V53, P1936, DOI 10.1373/clinchem.2007.087973; Shaikh Qurban Hussain, 2009, J Coll Physicians Surg Pak, V19, P708, DOI 11.2009/JCPSP.708710; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sozzi G, 2001, CANCER RES, V61, P4675; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trejo-Becerril C, 2003, INT J CANCER, V104, P663, DOI 10.1002/ijc.11003; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; World Health Organization, 2000, SEV FALC MAL	59	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19842	10.1371/journal.pone.0019842	http://dx.doi.org/10.1371/journal.pone.0019842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611202	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500028
J	Arndt, PG; Strahan, B; Wang, Y; Long, CM; Horiuchi, K; Walcheck, B				Arndt, Patrick G.; Strahan, Brian; Wang, Yue; Long, Chunmei; Horiuchi, Keisuke; Walcheck, Bruce			Leukocyte ADAM17 Regulates Acute Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; NECROSIS-FACTOR-ALPHA; IN-VIVO; TNF-ALPHA; FUNCTIONAL-CHARACTERIZATION; NEUTROPHIL ACCUMULATION; CHEMOKINE KC; CELLS; LIPOPOLYSACCHARIDE; EXPRESSION	The transmembrane protease ADAM17 regulates the release and density of various leukocyte cell surface proteins that modulate inflammation, including L-selectin, TNF-alpha, and IL-6R. At this time, its in vivo substrates and role in pulmonary inflammation have not been directly examined. Using conditional ADAM17 knock-out mice, we investigated leukocyte ADAM17 in acute lung inflammation. Alveolar TNF-a levels were significantly reduced (>95%) in ADAM17-null mice following LPS administration, as was the shedding of L-selectin, a neutrophil-expressed adhesion molecule. Alveolar IL-6R levels, however, were reduced by only approximate to 25% in ADAM17-null mice, indicating that ADAM17 is not its primary sheddase in our model. Neutrophil infiltration into the alveolar compartment is a key event in the pathophysiology of acute airway inflammation. Following LPS inhalation, alveolar neutrophil levels and lung inflammation in ADAM17-null mice were overall reduced when compared to control mice. Interestingly, however, neutrophil recruitment to the alveolar compartment occurred earlier in ADAM17-null mice after exposure to LPS. This decrease in alveolar neutrophil recruitment in ADAM17-null mice was accompanied by significantly diminished alveolar levels of the neutrophil-tropic chemokines CXCL1 and CXCL5. Altogether, our study suggests that leukocyte ADAM17 promotes inflammation in the lung, and thus this sheddase may be a potential target in the design of pharmacologic therapies for acute lung injury.	[Arndt, Patrick G.; Strahan, Brian] Univ Minnesota, Dept Internal Med, Div Pulm Allergy & Crit Care Med, St Paul, MN 55108 USA; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan	University of Minnesota System; University of Minnesota Twin Cities; Keio University	Arndt, PG (corresponding author), Univ Minnesota, Dept Internal Med, Div Pulm Allergy & Crit Care Med, St Paul, MN 55108 USA.	walch003@umn.edu	Horiuchi, Keisuke/L-2277-2013	Horiuchi, Keisuke/0000-0001-7063-9609	National Institutes of Health [HL61613, AI083521, HL84201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084201, R01HL061613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by research funding HL61613, AI083521 (BW) and HL84201 (PGA) from the National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Arndt PG, 2005, J IMMUNOL, V175, P4049, DOI 10.4049/jimmunol.175.6.4049; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Calkins CM, 2001, J SURG RES, V101, P232, DOI 10.1006/jsre.2001.6274; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; Elizur A, 2008, AM J RESP CELL MOL, V38, P8, DOI 10.1165/rcmb.2007-0203OC; FREVERT CW, 1995, J IMMUNOL, V154, P335; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McColl SR, 1999, J IMMUNOL, V163, P2829; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Neumann B, 1996, J IMMUNOL, V156, P1587; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zhang XW, 2001, EUR J PHARMACOL, V427, P277, DOI 10.1016/S0014-2999(01)01235-3	43	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19938	10.1371/journal.pone.0019938	http://dx.doi.org/10.1371/journal.pone.0019938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603616	Green Submitted, gold, Green Published			2022-12-25	WOS:000290656300041
J	Hagen, M; Wikelski, M; Kissling, WD				Hagen, Melanie; Wikelski, Martin; Kissling, W. Daniel			Space Use of Bumblebees (Bombus spp.) Revealed by Radio-Tracking	PLOS ONE			English	Article							FORAGING RANGE; TERRESTRIS HYMENOPTERA; LANDSCAPE-SCALE; BEES; DISTANCES; POLLINATORS; CONSERVATION; PATTERNS; DENSITY; APIDAE	Background: Accurate estimates of movement behavior and distances travelled by animals are difficult to obtain, especially for small-bodied insects where transmitter weights have prevented the use of radio-tracking. Methodology/Principal Findings: Here, we report the first successful use of micro radio telemetry to track flight distances and space use of bumblebees. Using ground surveys and Cessna overflights in a Central European rural landscape mosaic we obtained maximum flight distances of 2.5 km, 1.9 km and 1.3 km for Bombus terrestris (workers), Bombus ruderatus (worker), and Bombus hortorum (young queens), respectively. Bumblebee individuals used large areas (0.25-43.53 ha) within one or a few days. Habitat analyses of one B. hortorum queen at the landscape scale indicated that gardens within villages were used more often than expected from habitat availability. Detailed movement trajectories of this individual revealed that prominent landscape structures (e. g. trees) and flower patches were repeatedly visited. However, we also observed long (i.e. >45 min) resting periods between flights (B. hortorum) and differences in flower-handling between bumblebees with and without transmitters (B. terrestris) suggesting that the current weight of transmitters (200 mg) may still impose significant energetic costs on the insects. Conclusions/Significance: Spatio-temporal movements of bumblebees can now be tracked with telemetry methods. Our measured flight distances exceed many previous estimates of bumblebee foraging ranges and suggest that travelling long distances to food resources may be common. However, even the smallest currently available transmitters still appear to compromise flower handling performance and cause an increase in resting behavior of bees. Future reductions of transmitter mass and size could open up new avenues for quantifying landscape-scale space use of insect pollinators and could provide novel insights into the behavior and requirements of bumblebees during critical life stages, e. g. when searching for mates, nest locations or hibernation sites.	[Hagen, Melanie] Univ Bielefeld, Bielefeld, Germany; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Kissling, W. Daniel] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark	University of Bielefeld; Max Planck Society; Aarhus University	Hagen, M (corresponding author), Univ Bielefeld, Bielefeld, Germany.	melanie.hagen@web.de	Kissling, W. Daniel/B-1749-2009; Hagen, Melanie/I-7939-2013		Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MR, 2007, J APPL ENTOMOL, V131, P537, DOI 10.1111/j.1439-0418.2007.01162.x; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Carvell C, 2006, APIDOLOGIE, V37, P326, DOI 10.1051/apido:2006002; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Comba L, 1999, ETHOL ECOL EVOL, V11, P243, DOI 10.1080/08927014.1999.9522826; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Dramstad WE, 1996, J INSECT BEHAV, V9, P163, DOI 10.1007/BF02213863; Eddy W. F., 1977, ACM Transactions on Mathematical Software, V3, P398, DOI 10.1145/355759.355766; Elliott SE, 2009, ENVIRON ENTOMOL, V38, P748, DOI 10.1603/022.038.0327; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Heinrich B., 1979, BUMBLEBEE EC; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Jenness J, 2008, ARCVIEW 3 X EXTENSIO; Kenward R., 1987, WILDLIFE RADIO TAGGI; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PFLUMM W, 1977, APIDOLOGIE, V8, P401, DOI 10.1051/apido:19770410; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Riley JR, 1998, J INSECT BEHAV, V11, P287, DOI 10.1023/A:1021004209198; Saure Christoph, 1996, Linnean Society Symposium Series, V18, P47; Saville NM, 1997, AGR ECOSYST ENVIRON, V61, P145, DOI 10.1016/S0167-8809(96)01100-0; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; Tommasi D, 2004, CAN ENTOMOL, V136, P851; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; White G.C., 1990, ANAL WILDLIFE RADIO; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Williams P, 2000, BRITAIN PRELIMINARY; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Williams P, 2009, CONSERV BIOL, V23, P931, DOI 10.1111/j.1523-1739.2009.01176.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; WILLMER PG, 1994, ECOL ENTOMOL, V19, P271, DOI 10.1111/j.1365-2311.1994.tb00419.x; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	60	135	141	3	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19997	10.1371/journal.pone.0019997	http://dx.doi.org/10.1371/journal.pone.0019997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603569	Green Submitted, gold, Green Published			2022-12-25	WOS:000290656300047
J	Oelkers, JM; Vinzenz, M; Nemethova, M; Jacob, S; Lai, FPL; Block, J; Szczodrak, M; Kerkhoff, E; Backert, S; Schluter, K; Stradal, TEB; Small, JV; Koestler, SA; Rottner, K				Oelkers, J. Margit; Vinzenz, Marlene; Nemethova, Maria; Jacob, Sonja; Lai, Frank P. L.; Block, Jennifer; Szczodrak, Malgorzata; Kerkhoff, Eugen; Backert, Steffen; Schlueter, Kai; Stradal, Theresia E. B.; Small, J. Victor; Koestler, Stefan A.; Rottner, Klemens			Microtubules as Platforms for Assaying Actin Polymerization In Vivo	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; FILOPODIA FORMATION; WASP/SCAR PROTEINS; NUCLEATION FACTOR; CELL-ADHESION; LEADING-EDGE; CORDON-BLEU	The actin cytoskeleton is continuously remodeled through cycles of actin filament assembly and disassembly. Filaments are born through nucleation and shaped into supramolecular structures with various essential functions. These range from contractile and protrusive assemblies in muscle and non-muscle cells to actin filament comets propelling vesicles or pathogens through the cytosol. Although nucleation has been extensively studied using purified proteins in vitro, dissection of the process in cells is complicated by the abundance and molecular complexity of actin filament arrays. We here describe the ectopic nucleation of actin filaments on the surface of microtubules, free of endogenous actin and interfering membrane or lipid. All major mechanisms of actin filament nucleation were recapitulated, including filament assembly induced by Arp2/3 complex, formin and Spir. This novel approach allows systematic dissection of actin nucleation in the cytosol of live cells, its genetic re-engineering as well as screening for new modifiers of the process.	[Oelkers, J. Margit; Lai, Frank P. L.; Block, Jennifer; Szczodrak, Malgorzata; Schlueter, Kai; Stradal, Theresia E. B.; Koestler, Stefan A.; Rottner, Klemens] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Vinzenz, Marlene; Nemethova, Maria; Jacob, Sonja; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Lai, Frank P. L.] Inst Med Biol, Dept Dev & Regenerat Biol, Singapore, Singapore; [Kerkhoff, Eugen] Univ Hosp Regensburg, Mol Cell Biol Lab, Dept Neurol, Bavarian Genome Res Network, Regensburg, Germany; [Backert, Steffen] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Schlueter, Kai; Stradal, Theresia E. B.] Univ Munster, Inst Mol Cell Biol, Munster, Germany; [Oelkers, J. Margit; Block, Jennifer; Koestler, Stefan A.; Rottner, Klemens] Univ Bonn, Inst Genet, D-5300 Bonn, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Regensburg; University College Dublin; University of Munster; University of Bonn	Oelkers, JM (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	krottner@uni-bonn.de	Rottner, Klemens/AAE-5030-2020	Koestler, Stefan/0000-0002-7223-8291; Rottner, Klemens/0000-0003-4244-4198; Stradal, Theresia/0000-0002-0352-9474	Deutsche Forschungsgemeinschaft; European Community [MEST-2004-504990]; Austrian Science Foundation [FWF 1516-B09, FWF P21292-B09]; Austrian Science Fund (FWF) [I 516, P 21292] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (to KR and TEBS). MS was supported through a Marie Curie Early stage Training (contract MEST-2004-504990) of the European Community's Sixth Framework Programme. JVS acknowledges grants from the Austrian Science Foundation (projects FWF 1516-B09 and FWF P21292-B09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; KERKHOFF E, 2010, EUROPEAN J CELL BIOL; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; ROTTNER K, 2006, CELL BIOL LAB HDB, P111; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Schmauch C, 2009, EUR J CELL BIOL, V88, P385, DOI 10.1016/j.ejcb.2009.02.185; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Tanaka S, 2009, GENESIS, V47, P638, DOI 10.1002/dvg.20544; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	68	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19931	10.1371/journal.pone.0019931	http://dx.doi.org/10.1371/journal.pone.0019931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603613	Green Submitted, Green Published, gold			2022-12-25	WOS:000290656300040
J	Lushnikova, T; Bouska, A; Odvody, J; Dupont, WD; Eischen, CM				Lushnikova, T.; Bouska, A.; Odvody, J.; Dupont, W. D.; Eischen, C. M.			Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression	ONCOGENE			English	Article						aging; Mdm2; p53; chromosome instability; aneuploidy	NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; DNA-DAMAGE; P53; CANCER; CELLS; NBS1; OVEREXPRESSION; TUMORIGENESIS	Aging is thought to negatively affect multiple cellular processes including the ability to maintain chromosome stability. Chromosome instability (CIN) is a common property of cancer cells and may be a contributing factor to cellular transformation. The types of DNA aberrations that arise during aging before tumor development and that contribute to tumorigenesis are currently unclear. Mdm2, a key regulator of the p53 tumor suppressor and modulator of DNA break repair, is frequently over-expressed in malignancies and contributes to CIN. To determine the relationship between aging and CIN and the role of Mdm2, precancerous wild-type C57Bl/6 and littermate-matched Mdm2 transgenic mice at various ages were evaluated. Metaphase analyses of wild-type cells showed a direct correlation between age and increased chromosome and chromatid breaks, chromosome fusions and aneuploidy, but the frequency of polyploidy remained stable over time. Elevated levels of Mdm2 in precancerous mice increased both the numerical and the structural chromosomal abnormalities observed. Chromosome and chromatid breaks, chromosome fusions, aneuploidy and polyploidy were increased in older Mdm2 transgenic mice compared with wild-type littermates. Unexpectedly, chromosome fusions, aneuploidy and polyploidy rates in Mdm2 transgenic mice, but not chromosome and chromatid breaks, showed cooperation between Mdm2 overexpression and age. Notably, Mdm2 overexpression promoted gains in one or more chromosomes with age, while it did not affect the rate of chromosome loss. Therefore, aging increased specific forms of genomic instability, and elevated Mdm2 expression cooperated with aging to increase the likelihood of gaining certain chromosomal abnormalities of the kind thought to lead to cancer development. Oncogene (2011) 30, 4622-4631; doi:10.1038/onc.2011.172; published online 23 May 2011	[Eischen, C. M.] Vanderbilt Univ, Dept Pathol, Med Ctr, Sch Med, Nashville, TN 37232 USA; [Bouska, A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Dupont, W. D.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; University of Nebraska System; University of Nebraska Medical Center; Vanderbilt University	Eischen, CM (corresponding author), Vanderbilt Univ, Dept Pathol, Med Ctr, Sch Med, 1161 21st Ave S,C3321 MCN, Nashville, TN 37232 USA.	christine.eischen@vanderbilt.edu	Dupont, William D./I-4430-2012		NIH/NCI [R01 CA117935]; Vanderbilt Cancer Center [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA117935] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Eischen lab for thoughtful discussions. This work was supported by the NIH/NCI grants: R01 CA117935 (CME) and the Vanderbilt Cancer Center grant P30 CA068485.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Bouska A, 2009, CANCER RES, V69, P1697, DOI 10.1158/0008-5472.CAN-08-3732; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Morgan WF, 1998, MUTAT RES-FUND MOL M, V404, P125, DOI 10.1016/S0027-5107(98)00104-3; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tucker JD, 1999, MUTAT RES-FUND MOL M, V425, P135, DOI 10.1016/S0027-5107(99)00036-6; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Zietkiewicz E, 2009, J APPL GENET, V50, P261, DOI 10.1007/BF03195682	38	22	23	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	46					4622	4631		10.1038/onc.2011.172	http://dx.doi.org/10.1038/onc.2011.172			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	851EV	21602883	Green Accepted			2022-12-25	WOS:000297252100002
J	King, CE; Wang, L; Winograd, R; Madison, BB; Mongroo, PS; Johnstone, CN; Rustgi, AK				King, C. E.; Wang, L.; Winograd, R.; Madison, B. B.; Mongroo, P. S.; Johnstone, C. N.; Rustgi, A. K.			LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms	ONCOGENE			English	Article						LIN28B; LIN28; Let-7; colon cancer; LGR5; PROM1	LET-7 MICRORNA; C-MYC; STEM-CELLS; EXPRESSION; IDENTIFICATION; LIN-28; CONSERVATION; ASSOCIATION; SUPPRESSOR; MATURATION	Lin28b is an RNA-binding protein that inhibits biogenesis of let-7 microRNAs. LIN28B is overexpressed in diverse cancers, yet a specific role in the molecular pathogenesis of colon cancer has to be elucidated. We have determined that human colon tumors exhibit decreased levels of mature let-7 isoforms and increased expression of LIN28B. To determine LIN28B's mechanistic role in colon cancer, we expressed LIN28B in immortalized colonic epithelial cells and human colon cancer cell lines. We found that LIN28B promotes cell migration, invasion and transforms immortalized colonic epithelial cells. In addition, constitutive LIN28B expression increases expression of intestinal stem cell markers LGR5 and PROM1 in the presence of let-7 restoration. This may occur as a result of Lin28b protein binding LGR5 and PROM1 mRNA, suggesting that a subset of LIN28B functions is independent of its ability to repress let-7. Our findings establish a new role for LIN28B in human colon cancer pathogenesis, and suggest LIN28B post-transcriptionally regulates LGR5 and PROM1 through a let-7-independent mechanism. Oncogene (2011) 30, 4185-4193; doi:10.1038/onc.2011.131; published online 30 May 2011	[Rustgi, A. K.] Univ Penn, Dept Med, Dept Genet, Div Gastroenterol,Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Rustgi, AK (corresponding author), Univ Penn, Dept Med, Dept Genet, Div Gastroenterol,Abramson Canc Ctr, 415 Curie Blvd,600 CRB, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu			Pfizer; NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; NIH [U01-DK085551]; NIH ARRA [NIH P30 DK050306];  [R01-DK056645]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085551, R01DK056645, P30DK050306] Funding Source: NIH RePORTER	Pfizer(Pfizer); NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01-DK056645 (AR, CK and PM). Hauser Foundation, National Colon Cancer Research Alliance (EIF) and American Cancer Society Research Professorship (AR). Catrina King is a Pfizer Animal Health scholarship recipient, a doctoral candidate in Biomedical Graduate Studies, and a student of the School of Veterinary Medicine at the University of Pennsylvania. We thank Dr Joshua Mendell for gifts of LIN28B expression vectors, as well as Ben Rhoades and Mark Bowser for technical assistance. We also acknowledge help from the NIH/NIDDK P30-DK050306 Center for Molecular Studies in Digestive and Liver Diseases and its Molecular Biology and Cell Culture Core Facilities and NIH U01-DK085551. Louise Wang was supported by an NIH ARRA student fellowship through the NIH P30 DK050306.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; STEWART J, 1986, BRIT J CANCER, V53, P1, DOI 10.1038/bjc.1986.1; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	40	95	104	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	40					4185	4193		10.1038/onc.2011.131	http://dx.doi.org/10.1038/onc.2011.131			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21625210	Green Accepted			2022-12-25	WOS:000295924600005
J	Dang, LT; Purvis, AR; Huang, RH; Westfield, LA; Sadler, JE				Dang, Luke T.; Purvis, Angie R.; Huang, Ren-Huai; Westfield, Lisa A.; Sadler, J. Evan			Phylogenetic and Functional Analysis of Histidine Residues Essential for pH-dependent Multimerization of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN VONWILLEBRAND-FACTOR; SEQUENCE POLYMORPHISMS; TERMINAL DOMAINS; PROPEPTIDE; IDENTIFICATION; MUCIN; CDNA; ACTIVATION; EVOLUTION; CLEAVAGE	von Willebrand factor (VWF) is a multimeric plasma protein that mediates platelet adhesion to sites of vascular injury. The hemostatic function of VWF depends upon the formation of disulfide-linked multimers, which requires the VWF propeptide (D1D2 domains) and adjacent D'D3 domains. VWF multimer assembly occurs in the trans-Golgi at pH similar to 6.2 but not at pH 7.4, which suggests that protonation of one or more His residues (pK(a) similar to 6.0) mediates the pH dependence of multimerization. Alignment of 30 vertebrate VWF sequences identified 13 highly conserved His residues in the D1D2D'D3 domains, and His-to-Ala mutagenesis identified His(395) and His(460) in the D2 domain as critical for VWF multimerization. Replacement of His(395) with Lys or Arg prevented multimer assembly, suggesting that reversible protonation of this His residue is essential. In contrast, replacement of His(460) with Lys or Arg preserved normal multimer assembly, whereas Leu, Met, and Gln did not, indicating that the function of His(460) depends primarily upon the presence of a positive charge. These results suggest that pH sensing by evolutionarily conserved His residues facilitates the assembly and packaging of VWF multimers upon arrival in the trans-Golgi.	[Sadler, J. Evan] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid,Box 8125, St Louis, MO 63110 USA.	esadler@dom.wustl.edu		Sadler, J. Evan/0000-0001-5705-469X	National Institutes of Health [HL72917]; American Heart Association [0825817G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL72917 (to J. E. S.) and by American Heart Association Midwest Affiliate Postdoctoral Fellowship Award 0825817G (to R. H. H.).	Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Bodo I, 2001, BLOOD, V98, P2973, DOI 10.1182/blood.V98.10.2973; BONTHRON D, 1986, NUCLEIC ACIDS RES, V14, P7125, DOI 10.1093/nar/14.17.7125; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; Purvis AR, 2004, J BIOL CHEM, V279, P49982, DOI 10.1074/jbc.M408727200; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; REHEMTULLA A, 1992, BLOOD, V79, P2349; Rosenberg JB, 2002, BLOOD, V100, P1699, DOI 10.1182/blood-2002-03-0789; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; SHELTONINLOES BB, 1987, BIOCHEM BIOPH RES CO, V144, P657, DOI 10.1016/S0006-291X(87)80016-5; TULEY EA, 1991, P NATL ACAD SCI USA, V88, P6377, DOI 10.1073/pnas.88.14.6377; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	37	21	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25763	25769		10.1074/jbc.M111.249151	http://dx.doi.org/10.1074/jbc.M111.249151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592973	Green Published, hybrid			2022-12-25	WOS:000293073000038
J	Dey, N; Das, F; Mariappan, MM; Mandal, CC; Ghosh-Choudhury, N; Kasinath, BS; Choudhury, GG				Dey, Nirmalya; Das, Falguni; Mariappan, Meenalakshmi M.; Mandal, Chandi Charan; Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR-BETA; MESANGIAL CELLS; FIBRONECTIN EXPRESSION; SUPEROXIDE-DISMUTASE; EPITHELIAL-CELLS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; TRANSGENIC MICE	Hyperglycemia induces a wide array of signaling pathways in the kidney that lead to hypertrophy and matrix expansion, eventually culminating in progressive kidney failure. High glucose-induced reduction of the tumor suppressor protein phosphatase and tensin homolog deleted in chromosome 10 (PTEN) contributes to renal cell hypertrophy and matrix expansion. We identified microRNA-21 (miR-21) as the molecular link between high glucose and PTEN suppression. Renal cortices from OVE26 type 1 diabetic mice showed significantly elevated levels of miR-21 associated with reduced PTEN and increased fibronectin content. In renal mesangial cells, high glucose increased the expression of miR-21, which targeted the 3'-UTR of PTEN mRNA to inhibit PTEN protein expression. Overexpression of miR-21 mimicked the action of high glucose, which included a reduction in PTEN expression and a concomitant increase in Akt phosphorylation. In contrast, expression of miR-21 Sponge, to inhibit endogenous miR-21, prevented down-regulation of PTEN and phosphorylation of Akt induced by high glucose. Interestingly, high glucose-stimulated miR-21 inactivated PRAS40, a negative regulator of TORC1. Finally, miR-21 enhanced high glucose-induced TORC1 activity, resulting in renal cell hypertrophy and fibronectin expression. Thus, our results identify a previously unrecognized function of miR-21 that is the reciprocal regulation of PTEN levels and Akt/TORC1 activity that mediate critical pathologic features of diabetic kidney disease.	[Dey, Nirmalya; Das, Falguni; Mariappan, Meenalakshmi M.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Mandal, Chandi Charan; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 DK50190, RO1 AR52425, DK077295, RC2A 036613]; Juvenile Diabetes Research Foundation [1-2008-185]; Veterans Affairs; Cancer Therapy and Research Center, San Antonio, TX; Veterans Affairs Research Service; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio, TX; Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK50190 (to G. G. C.), RO1 AR52425 (to N. G. C.), and DK077295 and RC2A 036613 (to B. S. K.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2008-185 (to G. G. C.).; Supported by a Veterans Affairs merit review grant and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio, TX.; Supported by a grant from the Veterans Affairs Research Service.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Choundhury GG, 1999, J BIOL CHEM, V274, P10897; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; DeRubertis FR, 2007, METABOLISM, V56, P1256, DOI 10.1016/j.metabol.2007.04.024; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Heilig Charles W., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010490; Heilig CW, 2001, AM J PHYSIOL-RENAL, V280, pF657, DOI 10.1152/ajprenal.2001.280.4.F657; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Huang HC, 2000, KIDNEY INT, V58, P162, DOI 10.1046/j.1523-1755.2000.00151.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Linden KC, 2006, AM J PHYSIOL-RENAL, V290, pF205, DOI 10.1152/ajprenal.00237.2004; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang G, 2010, LAB INVEST, V90, P98, DOI 10.1038/labinvest.2009.118; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wilson-O'Brien AL, 2008, ENDOCRINOLOGY, V149, P917, DOI 10.1210/en.2007-0985; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248	81	184	200	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25586	25603		10.1074/jbc.M110.208066	http://dx.doi.org/10.1074/jbc.M110.208066			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613227	Green Published, hybrid			2022-12-25	WOS:000293073000021
J	Liu, Y; Han, ZP; Zhang, SS; Jing, YY; Bu, XX; Wang, CY; Sun, K; Jiang, GC; Zhao, X; Li, R; Gao, L; Zhao, QD; Wu, MC; Wei, LX				Liu, Yan; Han, Zhi-peng; Zhang, Shan-shan; Jing, Ying-ying; Bu, Xin-xin; Wang, Chen-yang; Sun, Kai; Jiang, Guo-cheng; Zhao, Xue; Li, Rong; Gao, Lu; Zhao, Qiu-dong; Wu, Meng-chao; Wei, Li-xin			Effects of Inflammatory Factors on Mesenchymal Stem Cells and Their Role in the Promotion of Tumor Angiogenesis in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CHICK CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL GROWTH-FACTOR; INTERFERON-GAMMA; STROMAL CELLS; IFN-GAMMA; INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; GENE-THERAPY	Mesenchymal stem cells (MSCs), which are modulated by cytokines present in the tumor microenvironment, play an important role in tumor progression. It is well documented that inflammation is an important part of the tumor microenvironment, so we investigated whether stimulation of MSCs by inflammatory cytokines would contribute to their ability to promote tumor growth. We first showed that MSCs could increase C26 colon cancer growth in mice. This growth-promoting effect was further accelerated when the MSCs were pre-stimulated by inflammatory factors IFN-gamma and TNF-alpha. At the same time, we demonstrated that MSCs pre-stimulated by both inflammatory factors could promote tumor angiogenesis in vivo to a greater degree than untreated MSCs or MSCs pre-stimulated by either IFN-gamma or TNF-alpha alone. A hen egg test-chorioallantoic membrane (HET-CAM) assay showed that treatment of MSC-conditioned medium can promote chorioallantoic membrane angiogenesis in vitro, especially treatment with conditioned medium of MSCs pretreated with IFN-gamma and TNF-alpha together. This mechanism of promoting angiogenesis appears to take place via an increase in the expression of vascular endothelial growth factor (VEGF), which itself takes place through an increase in signaling in the hypoxia-inducible factor 1 alpha (HIF-1 alpha)-dependent pathway. Inhibition of HIF-1 alpha in MSCs by siRNA was found to effectively reduce the ability of MSC to affect the growth of colon cancer in vivo in the inflammatory microenviroment. These results indicate that MSCs stimulated by inflammatory cytokines such as IFN-gamma and TNF-alpha in the tumor microenvironment express higher levels of VEGF via the HIF-1 alpha signaling pathway and that these MSCs then enhance tumor angiogenesis, finally leading to colon cancer growth in mice.	[Liu, Yan; Han, Zhi-peng; Zhang, Shan-shan; Jing, Ying-ying; Bu, Xin-xin; Wang, Chen-yang; Sun, Kai; Jiang, Guo-cheng; Zhao, Xue; Li, Rong; Gao, Lu; Zhao, Qiu-dong; Wu, Meng-chao; Wei, Li-xin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China; [Liu, Yan; Han, Zhi-peng; Sun, Kai] Second Mil Med Univ, Stem Cell & Med Res Ctr, Shanghai 200438, Peoples R China	Naval Medical University; Naval Medical University	Wei, LX (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, 225 Changhai Rd, Shanghai 200438, Peoples R China.	lixinwei@smmu.edu.cn		Wei, Lixin/0000-0002-9526-5348	National Natural Science Foundation of China [30870974, 30801347, 30901722, 81000970, 81030041]; Shanghai Science and Technology Committee [11ZR1449500, 10411963100, 10ZR1439900, 10ZR1439600]; Key Basic Research Project of China [2010CB945600, 2011CB966200]; NSFC, China [30921006]; Stem Cell and Medicine Research Center; Second Military Medical University [SCOP101913, SCOP102004, SCOP101812]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Key Basic Research Project of China; NSFC, China(National Natural Science Foundation of China (NSFC)); Stem Cell and Medicine Research Center; Second Military Medical University	This work was supported by National Natural Science Foundation of China Grants 30870974, 30801347, 30901722, 81000970, and 81030041, Shanghai Science and Technology Committee Grants 11ZR1449500, 10411963100, 10ZR1439900, and 10ZR1439600, Key Basic Research Project of China Grants 2010CB945600 and 2011CB966200, Science Fund for Creative Research Groups, NSFC, China Grant 30921006, the Stem Cell and Medicine Research Center's Innovation Research Program, and Second Military Medical University Grants SCOP101913, SCOP102004, and SCOP101812.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Aller MA, 2004, EXP BIOL MED, V229, P170, DOI 10.1177/153537020422900206; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BALKWILL FR, 1987, CANCER RES, V47, P4755; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67; Chiou SH, 2005, J REPROD IMMUNOL, V67, P35, DOI 10.1016/j.jri.2005.06.002; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; D'Agostino B, 2010, EXPERT OPIN BIOL TH, V10, P681, DOI 10.1517/14712591003610614; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eriksson F, 2007, CANCER IMMUNOL IMMUN, V56, P677, DOI 10.1007/s00262-006-0227-6; Forooghian F, 2007, AM J OPHTHALMOL, V144, P761, DOI 10.1016/j.ajo.2007.07.022; Gessi S, 2010, ARTERIOSCL THROM VAS, V30, P90, DOI 10.1161/ATVBAHA.109.194902; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; HATTORI A, 1994, FEBS LETT, V340, P177, DOI 10.1016/0014-5793(94)80132-0; Hiroishi K, 2000, J IMMUNOL, V164, P567, DOI 10.4049/jimmunol.164.2.567; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; Moreno M, 2008, J IMMUNOL, V181, P2446, DOI 10.4049/jimmunol.181.4.2446; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzo V, 1996, MICROVASC RES, V52, P245, DOI 10.1006/mvre.1996.0062; Sekine N, 2000, J CELL PHYSIOL, V184, P46, DOI 10.1002/(SICI)1097-4652(200007)184:1<46::AID-JCP5>3.0.CO;2-L; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Singh SK, 2003, CANCER RES, V63, P5821; Sun B, 2009, CYTOTHERAPY, V11, P289, DOI 10.1080/14653240902807026; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Tang JM, 2009, EUR J CARDIO-THORAC, V36, P644, DOI 10.1016/j.ejcts.2009.04.052; Tang SJ, 2008, INT J CANCER, V123, P2840, DOI 10.1002/ijc.23888; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	50	138	150	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25007	25015		10.1074/jbc.M110.213108	http://dx.doi.org/10.1074/jbc.M110.213108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592963	Green Published, hybrid			2022-12-25	WOS:000292547900049
J	Maesako, M; Uemura, K; Kuzuya, A; Sasaki, K; Asada, M; Watanabe, K; Ando, K; Kubota, M; Kihara, T; Kinoshita, A				Maesako, Masato; Uemura, Kengo; Kuzuya, Akira; Sasaki, Kazuki; Asada, Megumi; Watanabe, Kiwamu; Ando, Koichi; Kubota, Masakazu; Kihara, Takeshi; Kinoshita, Ayae			Presenilin Regulates Insulin Signaling via a gamma-Secretase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-CATENIN; INTRACELLULAR DOMAIN; RECEPTOR; NOTCH; PATHWAY; KINASE; ADIPOGENESIS; CLEAVAGE; DISEASE	Presenilin ( PS), a causative molecule of familial Alzheimer disease, acts as a crucial component of the gamma-secretase complex, which is required to cleave type I transmembrane proteins such as amyloid precursor protein and Notch. However, it also functions through gamma-secretase-independent pathways. Recent reports suggested that PS could regulate the expression level of cell surface receptors, including the PDGF and EGF receptors, followed by modulating their downstream pathways via gamma-secretase-independent mechanisms. The main purpose of this study was to clarify the effect of PS on expression of the insulin receptor (IR) as well as on insulin signaling. Here, we demonstrate that PS inhibited IR transcription and reduced IR expression, and this was followed by down-regulation of insulin signaling. Moreover, we suggest that neither gamma-secretase activity nor Wnt/beta-catenin signaling can reduce the expression of IR, but a PS-mediated increase in the intracellular Ca2+ level can be associated with it. These results clearly indicate that PS can functionally regulate insulin signaling by controlling IR expression.	[Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Uemura, Kengo; Kuzuya, Akira; Watanabe, Kiwamu; Ando, Koichi] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Kinoshita, A (corresponding author), Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, 53 Shogoinkawahara Cho, Kyoto 6068507, Japan.	akinoshita@hs.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20300124]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The work was supported by Grant-in-aid 20300124 from the Ministry of Education, Culture, Sports, Science and Technology and a research grant from the Takeda Science Foundation.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aoyagi N, 2010, BIOCHEM BIOPH RES CO, V391, P1240, DOI 10.1016/j.bbrc.2009.12.051; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Huang Y, 2010, CELL PROLIFERAT, V43, P147, DOI 10.1111/j.1365-2184.2009.00661.x; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; KNUTSON VP, 1991, FASEB J, V5, P2130, DOI 10.1096/fasebj.5.8.2022311; Maesako M, 2011, NEUROSCIENCE, V177, P298, DOI 10.1016/j.neuroscience.2010.12.017; Maesako M, 2010, NEUROSCI LETT, V483, P157, DOI 10.1016/j.neulet.2010.07.055; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meredith JE, 2002, BIOCHEM BIOPH RES CO, V299, P744, DOI 10.1016/S0006-291X(02)02747-X; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Raurell I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004080; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	40	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25309	25316		10.1074/jbc.M111.248922	http://dx.doi.org/10.1074/jbc.M111.248922			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622565	hybrid, Green Published			2022-12-25	WOS:000292547900077
J	Yuen, EY; Yan, Z				Yuen, Eunice Y.; Yan, Zhen			Cellular Mechanisms for Dopamine D-4 Receptor-induced Homeostatic Regulation of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; DEFICIT HYPERACTIVITY DISORDER; PREFRONTAL CORTEX NEURONS; EXON-III POLYMORPHISM; WORKING-MEMORY; GLUTAMATERGIC TRANSMISSION; KINASE-II; CORTICAL-NEURONS; D1 RECEPTORS; MICE LACKING	Aberrant dopamine D-4 receptor function has been implicated in mental illnesses, including schizophrenia and attention deficit-hyperactivity disorder. Recently we have found that D-4 receptor exerts an activity-dependent bi-directional regulation of AMPA receptor (AMPAR)-mediated synaptic currents in pyramidal neurons of prefrontal cortex (PFC) via the dual control of calcium/calmodulin kinase II (CaMKII) activity. In this study, we examined the signaling mechanisms downstream of CaMKII that govern the complex effects of D-4 on glutamatergic transmission. We found that in PFC neurons at high activity state, D-4 suppresses AMPAR responses by disrupting the kinesin motor-based transport of GluR2 along microtubules, which was accompanied by the D-4 reduction of microtubule stability via a mechanism dependent on CaMKII inhibition. On the other hand, in PFC neurons at the low activity state, D-4 potentiates AMPAR responses by facilitating synaptic targeting of GluR1 through the scaffold protein SAP97 via a mechanism dependent on CaMKII stimulation. Taken together, these results have identified distinct signaling mechanisms underlying the homeostatic regulation of glutamatergic transmission by D-4 receptors, which may be important for cognitive and emotional processes in which dopamine is involved.	[Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu			National Institutes of Health [MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233, R25MH077823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH84233 (to Z. Y.).	Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1984, J NEUROSCI, V4, P394; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Diaz-Anzaldua A, 2004, MOL PSYCHIATR, V9, P272, DOI 10.1038/sj.mp.4001411; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Gao C, 2007, J NEUROSCI, V27, P14275, DOI 10.1523/JNEUROSCI.2925-07.2007; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Gu ZL, 2004, MOL PHARMACOL, V66, P948, DOI 10.1124/mol.104.001404; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J BIOL CHEM, V280, P29420, DOI 10.1074/jbc.M504499200; Zhang KH, 2004, NEUROPSYCHOPHARMACOL, V29, P1648, DOI 10.1038/sj.npp.1300491; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24957	24965		10.1074/jbc.M111.221416	http://dx.doi.org/10.1074/jbc.M111.221416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622557	hybrid, Green Published			2022-12-25	WOS:000292547900044
J	Freude, KK; Penjwini, M; Davis, JL; LaFerla, FM; Blurton-Jones, M				Freude, Kristine K.; Penjwini, Mahmud; Davis, Joy L.; LaFerla, Frank M.; Blurton-Jones, Mathew			Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODELS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; BETA-SECRETASE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; NEUROGENESIS; APP; EXPRESSION	Human embryonic stem cells (hESCs) offer tremendous potential for not only treating neurological disorders but also for their ability to serve as vital reagents to model and investigate human disease. To further our understanding of a key protein involved in Alzheimer disease pathogenesis, we stably overexpressed amyloid precursor protein (APP) in hESCs. Remarkably, we found that APP overexpression in hESCs caused a rapid and robust differentiation of pluripotent stem cells toward a neural fate. Despite maintenance in standard hESC media, up to 80% of cells expressed the neural stem cell marker nestin, and 65% exhibited the more mature neural marker beta-3 tubulin within just 5 days of passaging. To elucidate the mechanism underlying the effects of APP on neural differentiation, we examined the proteolysis of APP and performed both gain of function and loss of function experiments. Taken together, our results demonstrate that the N-terminal secreted soluble forms of APP (in particular sAPP beta) robustly drive neural differentiation of hESCs. Our findings not only reveal a novel and intriguing role for APP in neural lineage commitment but also identify a straightforward and rapid approach to generate large numbers of neurons from human embryonic stem cells. These novel APP-hESC lines represent a valuable tool to investigate the potential role of APP in development and neurodegeneration and allow for insights into physiological functions of this protein.	[LaFerla, Frank M.; Blurton-Jones, Mathew] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu; mblurton@uci.edu		Freude, Kristine/0000-0001-9480-2386; Blurton-Jones, Mathew/0000-0002-7770-7157	California Institute for Regenerative Medicine [RS1-00247, TR1-01245, T1-00008, NIA-K01AG029378]; Alzheimer Disease Research project [P50AG16573]; University of California Los Angeles Vector Core [JCCC/P30 CA016042, CURE/P30 DK041301]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029378, P50AG016573, R01AG021982] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alzheimer Disease Research project; University of California Los Angeles Vector Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by California Institute for Regenerative Medicine Grants RS1-00247 and TR1-01245 (to F. M. L.), T1-00008 (to K. K. F.), and NIA-K01AG029378 (M. B.-J.), and an Alzheimer Disease Research project grant funded by P50AG16573 (to M. B. J.). The University of California Los Angeles Vector Core is supported by Grants JCCC/P30 CA016042 and CURE/P30 DK041301.	ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Bergmans BA, 2010, STEM CELLS, V28, P399, DOI 10.1002/stem.296; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; De Strooper B, 2000, J CELL SCI, V113, P1857; Evin Genevieve, 2007, Recent Pat CNS Drug Discov, V2, P188, DOI 10.2174/157488907782411783; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; HAASS C, 1995, ARZNEIMITTEL-FORSCH, V45-1, P398; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Lahiri DK, 2004, ANN NY ACAD SCI, V1030, P310, DOI 10.1196/annals.1329.039; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MIRAGALL F, 1994, J COMP NEUROL, V341, P433, DOI 10.1002/cne.903410402; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Perez RG, 1997, J NEUROSCI, V17, P9407; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; Wen JH, 2008, NEUROREPORT, V19, P413, DOI 10.1097/WNR.0b013e3282f64377; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	46	61	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24264	24274		10.1074/jbc.M111.227421	http://dx.doi.org/10.1074/jbc.M111.227421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606494	Green Published, hybrid			2022-12-25	WOS:000292294900068
J	Margraf-Schonfeld, S; Bohm, C; Watzl, C				Margraf-Schoenfeld, Stefanie; Boehm, Carolin; Watzl, Carsten			Glycosylation Affects Ligand Binding and Function of the Activating Natural Killer Cell Receptor 2B4 (CD244) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTING NK CELLS; CUTTING EDGE; LYMPHOCYTE-ACTIVATION; IMPORTANT DETERMINANT; GRANULE POLARIZATION; IMMUNE REGULATION; CD48; SAP; RECOGNITION; MOLECULE	2B4 (CD244) is an important activating receptor for the regulation of natural killer (NK) cell responses. Here we show that 2B4 is heavily and differentially glycosylated in primary human NK cells and NK cell lines. The differential glycosylation could be attributed to sialic acid residues on N- and O-linked carbohydrates. Using a recombinant fusion protein of the extracellular domain of 2B4, we demonstrate that N-linked glycosylation of 2B4 is essential for the binding to its ligand CD48. In contrast, sialylation of 2B4 has a negative impact on ligand binding, as the interaction between 2B4 and CD48 is increased after the removal of sialic acids. This was confirmed in a functional assay system, where the desialylation of NK cells or the inhibition of O-linked glycosylation resulted in increased 2B4-mediated lysis of CD48-expressing tumor target cells. These data demonstrate that glycosylation has an important impact on 2B4-mediated NK cell function and suggest that regulated changes in glycosylation during NK cell development and activation might be involved in the regulation of NK cell responses.	[Margraf-Schoenfeld, Stefanie; Boehm, Carolin; Watzl, Carsten] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Watzl, C (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	watzl@uni-hd.de	Watzl, Carsten/B-4911-2013	Watzl, Carsten/0000-0001-5195-0995	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [TRR83/TP16, WA1552/2-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by BioFuture Program of the Bundesministerium fur Bildung und Forschung and Deutsche Forschungsgemeinschaft Grant TRR83/TP16 and Grant WA1552/2-1.	Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; CASABO LG, 1994, J IMMUNOL, V152, P397; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Claus M, 2008, FRONT BIOSCI-LANDMRK, V13, P956, DOI 10.2741/2735; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latchman Y, 1998, J IMMUNOL, V161, P5809; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Mathew SO, 2005, J IMMUNOL, V175, P1005, DOI 10.4049/jimmunol.175.2.1005; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Stark S, 2005, J IMMUNOL METHODS, V296, P149, DOI 10.1016/j.jim.2004.11.010; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	36	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24142	24149		10.1074/jbc.M111.225334	http://dx.doi.org/10.1074/jbc.M111.225334			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606496	Green Published, hybrid			2022-12-25	WOS:000292294900056
J	Swietnicki, W; Carmany, D; Retford, M; Guelta, M; Dorsey, R; Bozue, J; Lee, MS; Olson, MA				Swietnicki, Wieslaw; Carmany, Daniel; Retford, Michael; Guelta, Mark; Dorsey, Russell; Bozue, Joel; Lee, Michael S.; Olson, Mark A.			Identification of Small-Molecule Inhibitors of Yersinia pestis Type III Secretion System YscN ATPase	PLOS ONE			English	Article							INFECTIOUS-DISEASES; YOP TRANSLOCATION; VIRULENCE; PLAGUE; ENERGY; ENTEROCOLITICA; GUADINOMINES; EFFICIENT; PROTEINS; PORE	Yersinia pestis is a Gram negative zoonotic pathogen responsible for causing bubonic and pneumonic plague in humans. The pathogen uses a type III secretion system (T3SS) to deliver virulence factors directly from bacterium into host mammalian cells. The system contains a single ATPase, YscN, necessary for delivery of virulence factors. In this work, we show that deletion of the catalytic domain of the yscN gene in Y. pestis CO92 attenuated the strain over three million-fold in the Swiss-Webster mouse model of bubonic plague. The result validates the YscN protein as a therapeutic target for plague. The catalytic domain of the YscN protein was made using recombinant methods and its ATPase activity was characterized in vitro. To identify candidate therapeutics, we tested computationally selected small molecules for inhibition of YscN ATPase activity. The best inhibitors had measured IC50 values below 20 mu M in an in vitro ATPase assay and were also found to inhibit the homologous BsaS protein from Burkholderia mallei animal-like T3SS at similar concentrations. Moreover, the compounds fully inhibited YopE secretion by attenuated Y. pestis in a bacterial cell culture and mammalian cells at mM concentrations. The data demonstrate the feasibility of targeting and inhibiting a critical protein transport ATPase of a bacterial virulence system. It is likely the same strategy could be applied to many other common human pathogens using type III secretion system, including enteropathogenic E. coli, Shigella flexneri, Salmonella typhimurium, and Burkholderia mallei/pseudomallei species.	[Swietnicki, Wieslaw] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Carmany, Daniel] Battelle Eastern Sci & Technol Ctr, Battelle Mem Inst, Aberdeen, MD USA; [Retford, Michael; Guelta, Mark; Dorsey, Russell] Edgewood Chem & Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD USA; [Bozue, Joel] USA, Med Res Inst Infect Dis, Div Bacteriol, Ft Detrick, MD 21702 USA; [Lee, Michael S.; Olson, Mark A.] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Ft Detrick, MD 21702 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Swietnicki, W (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD USA.	wieslaw.swietnicki@usuhs.mil	Bozue, Joel/AAE-4363-2022; Swietnicki, Wieslaw/AAU-1536-2020; Bozue, Joel/AAE-4357-2022; Swietnicki, Wieslaw/AAL-2452-2021; Swietnicki, Wieslaw/GOP-2576-2022	Bozue, Joel/0000-0001-6959-8176; Swietnicki, Wieslaw/0000-0002-9354-8184; Bozue, Joel/0000-0001-6959-8176; 	Defense Threat Reduction Agency [2.10019_08_RD_B]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency project 2.10019_08_RD_B (W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Chen ZW, 2010, VET RES, V41, DOI 10.1051/vetres/2009053; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; De Marcos Lousa Carine, 2009, Commun Integr Biol, V2, P97; Ding C, 2002, J VIROL, V76, P338, DOI 10.1128/JVI.76.1.338-345.2002; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Harmon DE, 2010, ANTIMICROB AGENTS CH, V54, P3241, DOI 10.1128/AAC.00364-10; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Iwatsuki M, 2008, J ANTIBIOT, V61, P230, DOI 10.1038/ja.2008.33; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Journet L, 2005, MOL MEMBR BIOL, V22, P41, DOI 10.1080/09687860500041858; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Kline T, 2008, J MED CHEM, V51, P7065, DOI 10.1021/jm8004515; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Martin CA, 2008, EUR J CLIN MICROBIOL, V27, P635, DOI 10.1007/s10096-008-0489-3; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Motre A, 2008, GENE, V420, P17, DOI 10.1016/j.gene.2008.04.017; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Pan NJ, 2009, ANTIMICROB AGENTS CH, V53, P385, DOI 10.1128/AAC.00670-08; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; PITT ML, 2004, AN MOD CORR PROT PLA; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Ritchie JM, 2005, INFECT IMMUN, V73, P1466, DOI 10.1128/IAI.73.3.1466-1474.2005; Rocke TE, 2008, J WILDLIFE DIS, V44, P930, DOI 10.7589/0090-3558-44.4.930; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Ulrich RL, 2004, INFECT IMMUN, V72, P6589, DOI 10.1128/IAI.72.11.6589-6596.2004; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; WORSHAM P, 1998, MEDISCHE MICROBIOLOG, V6, pS34; Worsham PL, 1995, CONTRIB TO MICROBIOL, V13, P325; Yin Jia-Xiang, 2008, BMC Ecology, V8, P18, DOI 10.1186/1472-6785-8-18; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	65	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19716	10.1371/journal.pone.0019716	http://dx.doi.org/10.1371/journal.pone.0019716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611119	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200028
J	Trian, T; Burgess, JK; Niimi, K; Moir, LM; Ge, Q; Berger, P; Liggett, SB; Black, JL; Oliver, BG				Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Berger, Patrick; Liggett, Stephen B.; Black, Judith L.; Oliver, Brian G.			beta(2)-Agonist Induced cAMP Is Decreased in Asthmatic Airway Smooth Muscle Due to Increased PDE4D	PLOS ONE			English	Article							BETA-ADRENOCEPTOR RESPONSIVENESS; CELL-PROLIFERATION; PHOSPHODIESTERASE-4 INHIBITOR; ROFLUMILAST; EXPRESSION; RECEPTOR; DESENSITIZATION; MECHANISM; ALPHA	Background and Objective: Asthma is associated with airway narrowing in response to bronchoconstricting stimuli and increased airway smooth muscle (ASM) mass. In addition, some studies have suggested impaired beta-agonist induced ASM relaxation in asthmatics, but the mechanism is not known. Objective: To characterize the potential defect in beta-agonist induced cAMP in ASM derived from asthmatic in comparison to non-asthmatic subjects and to investigate its mechanism. Methods: We examined beta(2)-adrenergic (beta(2)AR) receptor expression and basal beta-agonist and forskolin (direct activator of adenylyl cyclase) stimulated cAMP production in asthmatic cultured ASM (n = 15) and non-asthmatic ASM (n = 22). Based on these results, PDE activity, PDE4D expression and cell proliferation were determined. Results: In the presence of IBMX, a pan PDE inhibitor, asthmatic ASM had similar to 50% lower cAMP production in response to isoproterenol, albuterol, formoterol, and forskolin compared to non-asthmatic ASM. However when PDE4 was specifically inhibited, cAMP production by the agonists and forskolin was normalized in asthmatic ASM. We then measured the amount and activity of PDE4, and found similar to 2-fold greater expression and activity in asthmatic ASM compared to non-asthmatic ASM. Furthermore, inhibition of PDE4 reduced asthmatic ASM proliferation but not that of non-asthmatic ASM. Conclusion: Decreased beta-agonist induced cAMP in ASM from asthmatics results from enhanced degradation due to increased PDE4D expression. Clinical manifestations of this dysregulation would be suboptimal beta-agonist-mediated bronchodilation and possibly reduced control over increasing ASM mass. These phenotypes appear to be "hard-wired'' into ASM from asthmatics, as they do not require an inflammatory environment in culture to be observed.	[Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Black, Judith L.; Oliver, Brian G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Black, Judith L.; Oliver, Brian G.] Univ Sydney, Discipline Pharmacol, Sch Med Sci, Sydney, NSW 2006, Australia; [Berger, Patrick] Univ Bordeaux Segalen, Ctr Rech Cardiothorac Bordeaux, INSERM, Bordeaux, France; [Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University System of Maryland; University of Maryland Baltimore	Trian, T (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brian.oliver@sydney.edu.au	Black, Judith L/C-6559-2008; Burgess, Janette/M-7117-2019; Berger, Patrick/D-8779-2012; Moir, Lyn/A-8967-2011; Ge, Qi/D-3988-2013; Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010; liggett, stephen b/E-7453-2012	Berger, Patrick/0000-0003-4702-0343; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Liggett, Stephen B./0000-0002-0128-3669; trian, thomas/0000-0002-2567-4867	National Health and Medical Research Council Australia [464815, 402835]; Asthma Foundation of NSW; NHMRC [571098]; US National Institutes of Health [HL071609, HL065899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899, R01HL071609] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of NSW; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support funding: National Health and Medical Research Council Australia #464815 (http://www.nhmrc.gov.au/), The Asthma Foundation of NSW (http://www.asthmafoundation.org.au); J. K. Burgess is supported by a National Health and Medical Research Council Australia R. Douglas Wright Fellowship #402835 (http://www.nhmrc.gov.au/), and J. L. Black by an NHMRC Senior Principal Research Fellowship #571098 (http://www.nhmrc.gov.au/). S. B. Liggett is supported by the US National Institutes of Health grants HL071609 and HL065899 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; BRODDE OE, 1985, J CLIN INVEST, V76, P1096, DOI 10.1172/JCI112063; Burgess JK, 2006, J ALLERGY CLIN IMMUN, V118, P649, DOI 10.1016/j.jaci.2006.05.019; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Deshpande DA, 2010, NATURE MED IN PRESS; Diab-Assef M, 2002, SCAND J GASTROENTERO, V37, P206, DOI 10.1080/003655202753416894; FRASER CM, 1981, NEW ENGL J MED, V305, P1165, DOI 10.1056/NEJM198111123052001; GINA, 2010, GLOB STRAT ASTHM MAN; GOLDIE RG, 1986, BRIT J CLIN PHARMACO, V22, P669, DOI 10.1111/j.1365-2125.1986.tb02956.x; Goto M, 2009, CELL IMMUNOL, V258, P147, DOI 10.1016/j.cellimm.2009.04.005; Growcott EJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-9; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Laporte JD, 1998, AM J PHYSIOL-LUNG C, V275, pL491, DOI 10.1152/ajplung.1998.275.3.L491; Louw C, 2007, RESPIRATION, V74, P411, DOI 10.1159/000095677; Mahn K, 2010, THORAX, V65, P547, DOI 10.1136/thx.2009.129296; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Moore PE, 2001, J APPL PHYSIOL, V91, P1467, DOI 10.1152/jappl.2001.91.3.1467; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; SPINA D, 1989, AM REV RESPIR DIS, V140, P1410, DOI 10.1164/ajrccm/140.5.1410; Stewart AG, 1997, BRIT J PHARMACOL, V121, P361, DOI 10.1038/sj.bjp.0701128; Togo S, 2009, AM J PHYSIOL-LUNG C, V296, pL959, DOI 10.1152/ajplung.00508.2007; TOMLINSON PR, 1995, BIOCHEM PHARMACOL, V49, P1809, DOI 10.1016/0006-2952(94)00532-Q; Trian T, 2009, AM J RESPIR CELL MOL; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709	35	75	75	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20000	10.1371/journal.pone.0020000	http://dx.doi.org/10.1371/journal.pone.0020000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611147	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500039
J	Paulay, G; Starmer, J				Paulay, Gustav; Starmer, John			Evolution, Insular Restriction, and Extinction of Oceanic Land Crabs, Exemplified by the Loss of an Endemic Geograpsus in the Hawaiian Islands	PLOS ONE			English	Article							TERRESTRIAL DECAPOD CRUSTACEANS; RAIN-FOREST; CHRISTMAS ISLAND; RED CRABS; FRESH-WATER; BRACHYURA; TAXONOMY; MARINE; GENUS; DIVERSIFICATION	Most oceanic islands harbor unusual and vulnerable biotas as a result of isolation. As many groups, including dominant competitors and predators, have not naturally reached remote islands, others were less constrained to evolve novel adaptations and invade adaptive zones occupied by other taxa on continents. Land crabs are an excellent example of such ecological release, and some crab lineages made the macro-evolutionary transition from sea to land on islands. Numerous land crabs are restricted to, although widespread among, oceanic islands, where they can be keystone species in coastal forests, occupying guilds filled by vertebrates on continents. In the remote Hawaiian Islands, land crabs are strikingly absent. Here we show that absence of land crabs in the Hawaiian Islands is the result of extinction, rather than dispersal limitation. Analysis of fossil remains from all major islands show that an endemic Geograpsus was abundant before human colonization, grew larger than any congener, and extended further inland and to higher elevation than other land crabs in Oceania. Land crabs are major predators of nesting sea birds, invertebrates and plants, affect seed dispersal, control litter decomposition, and are important in nutrient cycling; their removal can lead to large-scale shifts in ecological communities. Although the importance of land crabs is obvious on remote and relatively undisturbed islands, it is less apparent on others, likely because they are decimated by humans and introduced biota. The loss of Geograpsus and potentially other land crabs likely had profound consequences for Hawaiian ecosystems.	[Paulay, Gustav; Starmer, John] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Paulay, G (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	paulay@flmnh.ufl.edu; eucidaris@gmail.com		Starmer, John/0000-0003-2926-5048	US National Science Foundation (NSF) [DEB-0529724]; Leila & William Brayfield Scholarship; Southwest Florida Fossil Club	US National Science Foundation (NSF)(National Science Foundation (NSF)); Leila & William Brayfield Scholarship; Southwest Florida Fossil Club	Partially supported with funding from the US National Science Foundation (NSF DEB-0529724), Leila & William Brayfield Scholarship, and the Southwest Florida Fossil Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT R. TUCKER, 1960, INDO PACIFIC MOLLUSCA, V1, P33; Abele L.G., 1974, Bulletin of Zoological Nomenclature, V31, P49; ALEXANDER HGL, 1979, PHILOS T ROY SOC B, V286, P241, DOI 10.1098/rstb.1979.0031; Amesbury SS, 1980, 66 U GUAM MAR LAB; Anger K, 1995, J EXP MAR BIOL ECOL, V193, P119, DOI 10.1016/0022-0981(95)00114-X; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Banerjee S. K., 1960, Temminckia, V10, P132; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; Burney DA, 2006, HUM ECOL, V34, P219, DOI 10.1007/s10745-006-9015-3; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; CARSON HL, 1983, GENETICS, V103, P465; Dai A-Y., 1991, CRABS CHINA SEAS; Dana J. D., 1852, CRUSTACEA 1; Dana JD, 1851, P ACAD NAT SCI PHILA, V5, P247; De Man J. G., 1889, Zoologische Jahrbuecher Abteilungen f Systematik, Viv, P409; Diesel R, 2000, J ZOOL, V250, P141, DOI 10.1111/j.1469-7998.2000.tb01066.x; Edmondson C.H., 1946, REEF SHORE FAUNA HAW; EDMONDSON CHARLES HOWARD, 1962, OCCAS PAPERS BERNICE PAUAHI BISHOP MUS, V23, P1; EDMONDSON CHARLES HOWARD, 1959, OCCAS PAPERS BERNICE P BISHOP MUS, V22, P153; Ehrhardt J. P, 1970, Bull. Soc. zool. Fr., V95, P41; Eldredge Lucius G., 2003, Bishop Museum Occasional Papers, V76, P1; Etpison MT, 2004, PALAU NATURAL HIST; Foale Simon, 1999, Pacific Science, V53, P37; GARTH J S, 1973, Proceedings of the California Academy of Sciences, V39, P311; GEORGE RW, 1974, P 2 INT COR REEF S, V1, P321; Giffin JG, 2003, PUU WAA WAA BIOL ASS; Godwin S., 2006, INVENTORY INTERTIDAL; Grant P.R., 2007, WHY SPECIES MULTIPLY; Green PT, 1997, ECOLOGY, V78, P2474, DOI 10.1890/0012-9658(1997)078[2474:COSRBL]2.0.CO;2; Green PT, 1997, J TROP ECOL, V13, P17, DOI 10.1017/S0266467400010221; Green PT, 1999, OECOLOGIA, V119, P435, DOI 10.1007/s004420050805; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P411, DOI 10.1098/rstb.1971.0020; HADFIELD MG, 1986, MALACOLOGIA, V27, P67; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; Hartnoll RG, 2009, J CRUSTACEAN BIOL, V29, P57, DOI [10.1651/08-2992.1, 10.1561/08-2992.1]; Hedges SB, 1996, ANNU REV ECOL SYST, V27, P163, DOI 10.1146/annurev.ecolsys.27.1.163; Hicks J, 1990, CHRISTMAS CRABS; Holthuis B. V., 1995, EVOLUTION MARINE FRE; Holthuis L. B., 1953, Atoll Research Bulletin, VNo. 24, pUnpaginated; HOWARTH F G, 1990, Bishop Museum Occasional Papers, V30, P4; *ICZN, 1979, B ZOOL NOMENCLATURE, V36, P119; Innocenti G, 2007, CRUSTACEANA, V80, P635, DOI 10.1163/156854007780765632; JAMES HF, 1987, P NATL ACAD SCI USA, V84, P2350, DOI 10.1073/pnas.84.8.2350; James HF, 1991, ORNITHOLOGICAL MONOG, V45, P1, DOI DOI 10.2307/40166713; Jordan S, 2003, SYST BIOL, V52, P89, DOI 10.1080/10635150390132803; Kay E.A., 1984, Bernice P. Bishop Museum Special Publication, V72, P15; Kessler C, 2005, CRUSTACEANA, V78, P761, DOI 10.1163/156854005774353485; Kingsley JS, 1880, P ACAD NAT SCI PHILA, V1880, P187; KIRCH PV, 1982, PAC SCI, V36, P1; Kirch PV, 1986, BISHOP MUSEUM OCCASI, V26, P52; Kolinski Steven P., 1994, Herpetological Review, V25, P120; LEE MAB, 1985, OIKOS, V45, P169, DOI 10.2307/3565702; Liu HC, 2005, J CRUSTACEAN BIOL, V25, P135, DOI 10.1651/C-2499; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MARQUET G, 1991, CRUSTACEANA, V61, P125, DOI 10.1163/156854091X00632; McCormack G., 2007, COOK ISLANDS BIODIVE; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; MURRAY J, 1988, Pacific Science, V42, P150; Naruse T, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.1987.1.3; Naruse Tohru, 2008, Species Diversity, V13, P117; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Ng PKL, 1999, ZOOL STUD, V38, P228; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; ODOWD DJ, 1989, J TROP ECOL, V5, P337, DOI 10.1017/S0266467400003746; ODOWD DJ, 1991, J TROP ECOL, V7, P113, DOI 10.1017/S0266467400005162; ODOWD DJ, 1990, OIKOS, V58, P289, DOI 10.2307/3545219; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Olson SL, 1991, ORNITHOL MONOGR, V45, P1, DOI DOI 10.2307/40166794; PAULAY G, 1994, AM ZOOL, V34, P134; Paulay G, 2002, INTEGR COMP BIOL, V42, P922, DOI 10.1093/icb/42.5.922; Paulay Gustav, 1997, P298; Paulay Gustav, 2003, Micronesica, V35-36, P456; Paulson Dennis R., 2003, International Journal of Odonatology, V6, P39; Pitman Robert L., 2005, Marine Ornithology, V33, P193; POUPIN J, 1998, ATOLL RES B, V451, P1, DOI DOI 10.5479/SI.00775630.451.1; Rathbun M.J., 1906, B US FISH COMM, V23, P829; Rosenberg G, 1996, EVOLUTION, V50, P682, DOI 10.1111/j.1558-5646.1996.tb03878.x; Sachet M. H., 1962, Atoll Research Bulletin, VNo. 86, P1; Sakai T, 1976, CRABS JAPAN ADJACENT; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Schubart CD, 2000, MOL PHYLOGENET EVOL, V15, P179, DOI 10.1006/mpev.1999.0754; Solem A., 1979, HIST BIOGEOGRAPHY PL, P277; Sorbini L., 1988, SMITHSONIAN CONTRIBU, V14, P1; Steadman David W., 2006, P1; Tesch J. J., 1917, Zoologische Mededeelingen Leiden, V3; TITCOMB M, 1978, PAC SCI, V32, P325; Turkay M., 1974, Senckenbergiana Biologica, V55, P223; Vermeij G.J, 1987, EVOLUTION ESCALATION; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wetterer JK, 2006, PAC SCI, V60, P413, DOI 10.1353/psc.2006.0022; Whitelegge T., 1897, MEMOIRS AUSTR MUSEUM, V3, P127, DOI DOI 10.3853/0067-1967.3.1897.492; Williams ST, 2004, EVOLUTION, V58, P2227; WILSON EDWARD O., 1967, PAC INSECTS MONOGR, V14, P1; Wolcott TG, 1988, ECOLOGY, P55; Yaldwyn J.C., 1979, ATOLL RES B, V235, P1; Yeo DCJ, 2008, HYDROBIOLOGIA, V595, P275, DOI 10.1007/s10750-007-9023-3; Zimmerman EC, 1948, INSECT HAWAII, V1	98	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19916	10.1371/journal.pone.0019916	http://dx.doi.org/10.1371/journal.pone.0019916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603620	gold, Green Submitted, Green Published			2022-12-25	WOS:000290656300037
J	Xavier, MJ; Williams, MJ				Xavier, Miguel J.; Williams, Michael J.			The Rho-Family GTPase Rac1 Regulates Integrin Localization Drosophila Immunosurveillance Cells	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; LEPTOPILINA-BOULARDI; ALPHA-V-BETA-3 INTEGRIN; BLOOD-CELLS; PROTEIN; MELANOGASTER; HEMATOPOIESIS; TRAFFICKING; ACTIVATION; INSIGHTS	Background: When the parasitoid wasp Leptopilina boulardi lays an egg in a Drosophila larva, phagocytic cells called plasmatocytes and specialized cells known as lamellocytes encapsulate the egg. The Drosophila beta-integrin Myospheroid (Mys) is necessary for lamellocytes to adhere to the cellular capsule surrounding L. boulardi eggs. Integrins are heterodimeric adhesion receptors consisting of alpha and beta subunits, and similar to other plasma membrane receptors undergo ligand-dependent endocytosis. In mammalian cells it is known that integrin binding to the extracellular matrix induces the activation of Rac GTPases, and we have previously shown that Rac1 and Rac2 are necessary for a proper encapsulation response in Drosophila larvae. We wanted to test the possibility that Myospheroid and Rac GTPases interact during the Drosophila anti-parasitoid immune response. Results: In the current study we demonstrate that Rac1 is required for the proper localization of Myospheroid to the cell periphery of haemocytes after parasitization. Interestingly, the mislocalization of Myospheroid in Rac1 mutants is rescued by hyperthermia, involving the heat shock protein Hsp83. From these results we conclude that Rac1 and Hsp83 are required for the proper localization of Mys after parasitization. Significance: We show for the first time that the small GTPase Rac1 is required for Mysopheroid localization. Interestingly, the necessity of Rac1 in Mys localization was negated by hyperthermia. This presents a problem, in Drosophila we quite often raise larvae at 29 degrees C when using the GAL4/UAS misexpression system. If hyperthermia rescues receptor endosomal recycling defects, raising larvae in hyperthermic conditions may mask potentially interesting phenotypes.	[Xavier, Miguel J.; Williams, Michael J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Xavier, MJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	m.j.williams@abdn.ac.uk	Xavier, Miguel/AAD-4576-2022	Xavier, Miguel/0000-0003-0709-7223	Swedish Research Council; Swedish Cancer Society; Royal Society; College of Life Sciences and Medicine, University of Aberdeen; NICHD	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Royal Society(Royal Society of London); College of Life Sciences and Medicine, University of Aberdeen; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society, the Royal Society and the College of Life Sciences and Medicine, University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ueda, NIG, Japan, for his kind gift of UAS-Rac<SUP>IR</SUP> flies, and Dr. Ando, Hungarian Academy of Sciences, Hungary, for the Nimrod and L1a antibodies. The Myospheroid antibody developed by Dr. D. Brower was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; BREHELIN M, 1982, CELL TISSUE RES, V221, P607; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; di Blasio L, 2010, TRAFFIC, V11, P1107, DOI 10.1111/j.1600-0854.2010.01077.x; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pinon P, 2011, PIGM CELL MELANOMA R, V24, P282, DOI 10.1111/j.1755-148X.2010.00806.x; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	43	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19504	10.1371/journal.pone.0019504	http://dx.doi.org/10.1371/journal.pone.0019504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603603	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300010
J	Lang, SLC; Iverson, SJ; Bowen, WD				Lang, Shelley L. C.; Iverson, Sara J.; Bowen, W. Don			The Influence of Reproductive Experience on Milk Energy Output and Lactation Performance in the Grey Seal (Halichoerus grypus)	PLOS ONE			English	Article							HYDROGEN-ISOTOPE-DILUTION; MAMMARY-GLAND; GRAY SEALS; BREEDING COLONIES; 1ST REPRODUCTION; CELL POPULATION; BODY CONDITION; ELEPHANT SEAL; LITTER SIZE; GUINEA-PIG	Although evidence from domestic and laboratory species suggests that reproductive experience plays a critical role in the development of aspects of lactation performance, whether reproductive experience may have a significant influence on milk energy transfer to neonates in wild populations has not been directly investigated. We compared maternal energy expenditures and pup growth and energy deposition over the course of lactation between primiparous and fully-grown, multiparous grey seal (Halichoerus grypus) females to test whether reproductive experience has a significant influence on lactation performance. Although there was no difference between primiparous females in milk composition and, thus, milk energy content at either early or peak lactation primiparous females had a significantly lower daily milk energy output than multiparous females indicating a reduced physiological capacity for milk secretion. Primiparous females appeared to effectively compensate for lower rates of milk production through an increased nursing effort and, thus, achieved the same relative rate of milk energy transfer to pups as multiparous females. There was no difference between primiparous and multiparous females in the proportion of initial body energy stores mobilised to support the costs of lactation. Although primiparous females allocated a greater proportion of energy stores to maternal maintenance versus milk production than multiparous females, the difference was not sufficient to result in significant differences in the efficiency of energy transfer to pups. Thus, despite a lower physiological capacity for milk production, primiparous females weaned pups of the same relative size and condition as multiparous females without expending proportionally more energy. Although reproductive experience does not significantly affect the overall lactation performance of grey seals, our results suggest that increases in mammary gland capacity with reproductive experience may play a significant role in the age-related increases in neonatal growth rates and weaning masses observed in other free-ranging mammals.	[Lang, Shelley L. C.; Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Bowen, W. Don] Bedford Inst Oceanog, Populat Ecol Div, Dartmouth, NS, Canada	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Lang, SLC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Shelley.Lang@Dal.Ca	Bowen, William/AAE-7204-2022; Bowen, William/D-2758-2012	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094	Canadian Department of Fisheries and Oceans; Natural Science and Engineering Research Council (NSERC); Dalhousie Graduate Studies Fellowship	Canadian Department of Fisheries and Oceans; Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie Graduate Studies Fellowship	This research was supported by the Canadian Department of Fisheries and Oceans, Natural Science and Engineering Research Council (NSERC) grants to SJI and WDB and a Dalhousie Graduate Studies Fellowship to SLCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; ANDERSON RR, 1983, J DAIRY SCI, V66, P29, DOI 10.3168/jds.S0022-0302(83)81749-4; Becker CD, 1998, OIKOS, V81, P81, DOI 10.2307/3546470; Blaxter K, 1989, ENERGY METABOLISM AN; Bowen WD, 2006, J ANIM ECOL, V75, P1340, DOI 10.1111/j.1365-2656.2006.01157.x; BOWEN WD, 1992, J ZOOL, V227, P607, DOI 10.1111/j.1469-7998.1992.tb04418.x; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cowie A, 1980, HORMONAL CONTROL LAC; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; DEROCHER AE, 1994, J ZOOL, V234, P527, DOI 10.1111/j.1469-7998.1994.tb04863.x; FISCHBECK KL, 1987, J NUTR, V117, P1967, DOI 10.1093/jn/117.11.1967; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; FOWLER PA, 1990, J REPROD FERTIL, V89, P367, DOI 10.1530/jrf.0.0890367; GOMENDIO M, 1989, J REPROD FERTIL, V87, P529; Gonzalez-Mariscal Gabriela, 2002, P215; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hoffman PC, 1997, J ANIM SCI, V75, P836; HORWITZ W, 2000, OFFICIAL METHODS ANA, pCH33; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Jacquot JJ, 1998, J MAMMAL, V79, P312, DOI 10.2307/1382867; KENAGY GJ, 1989, OECOLOGIA, V78, P269, DOI 10.1007/BF00377166; King RH, 1997, LIVEST PROD SCI, V47, P169, DOI 10.1016/S0301-6226(96)01404-2; KNIGHT CH, 1984, J DAIRY RES, V51, P29, DOI 10.1017/S0022029900023293; Knight CH, 2000, LIVEST PROD SCI, V66, P169, DOI 10.1016/S0301-6226(00)00224-4; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kunkele J, 1997, PHYSIOL ZOOL, V70, P571; Kunkele J, 2000, CAN J ZOOL, V78, P300, DOI 10.1139/cjz-78-2-300; Lambert KG, 2005, PHYSIOL BEHAV, V84, P799, DOI 10.1016/j.physbeh.2005.03.012; Lang SLC, 2011, MAR MAMMAL SCI, V27, pE153, DOI 10.1111/j.1748-7692.2010.00443.x; Lang SLC, 2009, ECOLOGY, V90, P2513, DOI 10.1890/08-1386.1; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; Michel P, 2003, J ZOOL, V261, P427, DOI 10.1017/S0952836903004291; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Mysterud A, 2002, OIKOS, V97, P177, DOI 10.1034/j.1600-0706.2002.970203.x; Newton I, 1989, LIFETIME REPROD BIRD; Noren SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P269, DOI 10.1086/528777; Numan M, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1921; Oftedal O. T., 1995, HDB MILK COMPOSITION, P790; Oftedal O.T., 1987, APPROACHES MARINE MA, P67; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Rogowitz GL, 1996, AM ZOOL, V36, P197; Tanaka I, 1997, AM J PRIMATOL, V42, P331, DOI 10.1002/(SICI)1098-2345(1997)42:4<331::AID-AJP8>3.3.CO;2-8; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; VONDERHAAR BK, 1978, CANCER RES, V38, P4059; WADA H, 1959, J DAIRY SCI, V42, P1198, DOI 10.3168/jds.S0022-0302(59)90712-X; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wang De-Hua, 1996, Acta Zoologica Sinica, V42, P140; Wartella J, 2003, PHYSIOL BEHAV, V79, P373, DOI 10.1016/S0031-9384(03)00150-1; Weladji RB, 2002, OECOLOGIA, V131, P79, DOI 10.1007/s00442-001-0864-6; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; YANG H, 1989, ANIM PROD, V48, P181, DOI 10.1017/S0003356100003901	58	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19487	10.1371/journal.pone.0019487	http://dx.doi.org/10.1371/journal.pone.0019487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589918	Green Published, gold			2022-12-25	WOS:000290483600013
J	Alami, S; Boutron, I; Desjeux, D; Hirschhorn, M; Meric, G; Rannou, F; Poiraudeau, S				Alami, Sophie; Boutron, Isabelle; Desjeux, Dominique; Hirschhorn, Monique; Meric, Gwendoline; Rannou, Francois; Poiraudeau, Serge			Patients' and Practitioners' Views of Knee Osteoarthritis and Its Management: A Qualitative Interview Study	PLOS ONE			English	Article							OF-LIFE; GENERAL-PRACTITIONERS; RHEUMATOID-ARTHRITIS; PRIMARY-CARE; DISABILITY; IMPACT; HIP	Purpose: To identify the views of patients and care providers regarding the management of knee osteoarthritis (OA) and to reveal potential obstacles to improving health care strategies. Methods: We performed a qualitative study based on semi-structured interviews of a stratified sample of 81 patients (59 women) and 29 practitioners (8 women, 11 general practitioners [GPs], 6 rheumatologists, 4 orthopedic surgeons, and 8 [4 GPs] delivering alternative medicine). Results: Two main domains of patient views were identified: one about the patient-physician relationship and the other about treatments. Patients feel that their complaints are not taken seriously. They also feel that practitioners act as technicians, paying more attention to the knee than to the individual, and they consider that not enough time is spent on information and counseling. They have negative perceptions of drugs and a feeling of medical uncertainty about OA, which leads to less compliance with treatment and a switch to alternative medicine. Patients believe that knee OA is an inevitable illness associated with age, that not much can be done to modify its evolution, that treatments are of little help, and that practitioners have not much to propose. They express unrealistic fears about the impact of knee OA on daily and social life. Practitioners' views differ from those of patients. Physicians emphasize the difficulty in elaborating treatment strategies and the need for a tool to help in treatment choice. Conclusions: This qualitative study suggests several ways to improve the patient-practitioner relationship and the efficacy of treatment strategies, by increasing their acceptability and compliance. Providing adapted and formalized information to patients, adopting more global assessment and therapeutic approaches, and dealing more accurately with patients' paradoxal representation of drug therapy are main factors of improvement that should be addressed.	[Alami, Sophie; Boutron, Isabelle] Univ Paris 05, AP HP, Ctr Epidemiol Clin, Paris, France; [Meric, Gwendoline] Pfizer, Paris, France; [Rannou, Francois; Poiraudeau, Serge] Univ Paris 05, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, INSERM,IFR Handicap 25, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Pfizer; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Alami, S (corresponding author), Univ Paris 05, AP HP, Ctr Epidemiol Clin, Paris, France.	serge.poiraudeau@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Boutron, Isabelle/0000-0002-5263-6241; , ALAMI/0000-0002-2999-8551; Poiraudeau, Serge/0000-0002-1988-9124	Pfizer	Pfizer(Pfizer)	This work was funded by Pfizer. The funders had no role in study design, data collection, data analysis, decision to publish, writing the manuscript.	Alami S, 2009, METHODES QUALITATIVE; BADLEY EM, 1994, J RHEUMATOL, V21, P505; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Boutron I, 2008, OSTEOARTHR CARTILAGE, V16, P1024, DOI 10.1016/j.joca.2008.01.001; Desjeux D., 2002, ITINERARY METHOD COM; Fainzang S, 2001, MEDICAMENTS SOC PATI; Glaser B, 1978, DISCOV GROUNDED THEO; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hewlett S, 2001, ANN RHEUM DIS, V60, P928, DOI 10.1136/ard.60.10.928; KUZEL AJ, 1992, RES METH PR, V3, P31; Lam CLK, 2000, FAM PRACT, V17, P159, DOI 10.1093/fampra/17.2.159; LAPLANTE MP, 1991, MILBANK Q, V69, P55, DOI 10.2307/3350158; Ramond A, 2010, FAM PRACT, V2010; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Strauss AL, 1990, BASICS QUALITATIVE G; Taponier S, 1999, ITINERARY METHOD APP; The Food and Drug Administration, 2006, PAT REP OUTC MEAS US; TUGWELL P, 1990, ARCH INTERN MED, V150, P59, DOI 10.1001/archinte.150.1.59; van der Waal JM, 2005, QUAL LIFE RES, V14, P795, DOI 10.1007/s11136-004-0801-3; vanderGeest S, 1996, ANNU REV ANTHROPOL, V25, P153, DOI 10.1146/annurev.anthro.25.1.153; Wylde V, 2006, MUSCULOSKELET CARE, V4, P152, DOI 10.1002/msc.86; Xie F, 2006, OSTEOARTHR CARTILAGE, V14, P224, DOI 10.1016/j.joca.2005.09.009	23	76	76	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19634	10.1371/journal.pone.0019634	http://dx.doi.org/10.1371/journal.pone.0019634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573185	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400036
J	Meunier, J; Delemont, O; Lucas, C				Meunier, Joel; Delemont, Olivier; Lucas, Christophe			Recognition in Ants: Social Origin Matters	PLOS ONE			English	Article							NEST-MATE RECOGNITION; CUTICULAR HYDROCARBONS; SEX ALLOCATION; DIVERSITY; COLONIES; WORKERS; SIZE; AGGRESSION; EVOLUTION; CONFLICT	The ability of group members to discriminate against foreigners is a keystone in the evolution of sociality. In social insects, colony social structure (number of queens) is generally thought to influence abilities of resident workers to discriminate between nestmates and non-nestmates. However, whether social origin of introduced individuals has an effect on their acceptance in conspecific colonies remains poorly explored. Using egg-acceptance bioassays, we tested the influence of social origin of queen-laid eggs on their acceptance by foreign workers in the ant Formica selysi. We showed that workers from both single-and multiple-queen colonies discriminated against foreign eggs from single-queen colonies, whereas they surprisingly accepted foreign eggs from multiple-queen colonies. Chemical analyses then demonstrated that social origins of eggs and workers could be discriminated on the basis of their chemical profiles, a signal generally involved in nestmate discrimination. These findings provide the first evidence in social insects that social origins of eggs interfere with nestmate discrimination and are encoded by chemical signatures.	[Meunier, Joel; Lucas, Christophe] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Meunier, Joel] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Delemont, Olivier] Univ Lausanne, Inst Police Sci, Ecole Sci Criminelles, Lausanne, Switzerland; [Lucas, Christophe] Univ Tours, CNRS, Inst Rech Biol Insecte, UMR 6035, Tours, France	University of Lausanne; University of Basel; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Meunier, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	joel.meunier@unibas.ch	meunier, joël/E-5376-2010; Meunier, Joël/A-1067-2017; Lucas, Christophe/A-4186-2011	Meunier, Joël/0000-0001-6893-2064; Lucas, Christophe/0000-0003-2839-7583; Delemont, Olivier/0000-0002-4122-7231	University of Lausanne; Swiss National Science Foundation	University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	University of Lausanne and Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; BAGNERES AG, 1991, J CHEM ECOL, V17, P1641, DOI 10.1007/BF00984695; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Cini A, 2009, BIOL LETTERS, V5, P459, DOI 10.1098/rsbl.2009.0140; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DETTORRE G, 2010, ANT ECOLOGY; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Florane CB, 2004, J CHEM ECOL, V30, P2559, DOI 10.1007/s10886-004-7950-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 1996, ETHOLOGY, V102, P510; Helantera H, 2007, BEHAV ECOL SOCIOBIOL, V61, P1143, DOI 10.1007/s00265-006-0327-5; Helantera H, 2009, BEHAV ECOL SOCIOBIOL, V63, P573, DOI 10.1007/s00265-008-0692-3; Holzer B, 2008, OECOLOGIA, V157, P717, DOI 10.1007/s00442-008-1101-3; Ichinose K, 2010, INSECT SOC, V57, P453, DOI 10.1007/s00040-010-0103-4; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lin YK, 2010, SOCIOBIOLOGY, V56, P39; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Lucas C, 2005, J INSECT PHYSIOL, V51, P1148, DOI 10.1016/j.jinsphys.2005.06.003; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Martin SJ, 2008, J INSECT PHYSIOL, V54, P700, DOI 10.1016/j.jinsphys.2008.01.010; Martin SJ, 2011, P ROY SOC B-BIOL SCI, V278, P496, DOI 10.1098/rspb.2010.1047; MCCARTHY ED, 1968, ANAL CHEM, V40, P1475, DOI 10.1021/ac60266a021; Meunier J, 2009, J EVOLUTION BIOL, V22, P1906, DOI 10.1111/j.1420-9101.2009.01805.x; Meunier J, 2011, ANIM BEHAV, V81, P163, DOI 10.1016/j.anbehav.2010.09.029; Meunier J, 2010, BEHAV ECOL SOCIOBIOL, V64, P1655, DOI 10.1007/s00265-010-0979-z; Moore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P1011, DOI 10.1007/s00265-010-0916-1; Nelson D.R., 1978, Advances in Insect Physiology, V13, P1, DOI 10.1016/S0065-2806(08)60263-5; POMONIS JG, 1980, J CHEM ECOL, V6, P965, DOI 10.1007/BF00994653; PROVOST E, 1990, BEHAVIOUR, V115, P114, DOI 10.1163/156853990X00310; PROVOST E, 1994, J CHEM ECOL, V20, P2985, DOI 10.1007/BF02098404; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1995, AM NAT, V145, P969, DOI 10.1086/285779; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Reber A, 2010, ANIM BEHAV, V79, P467, DOI 10.1016/j.anbehav.2009.11.030; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Rosset H, 2006, CURR BIOL, V16, P328, DOI 10.1016/j.cub.2005.12.036; Rosset H, 2007, ANIM BEHAV, V74, P951, DOI 10.1016/j.anbehav.2006.11.028; Rosset H, 2007, EVOL ECOL, V21, P577, DOI 10.1007/s10682-006-9139-3; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; Soroker V, 2003, INSECT SOC, V50, P212, DOI 10.1007/s00040-003-0669-1; Steiger S, 2007, P R SOC B, V274, P2211, DOI 10.1098/rspb.2007.0656; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; VANDERMEER MK, 1998, PHEROMONE COMMUNICAT, P79	51	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19347	10.1371/journal.pone.0019347	http://dx.doi.org/10.1371/journal.pone.0019347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573235	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800025
J	Shelswell, KJ; Beatty, JT				Shelswell, Kristopher John; Beatty, J. Thomas			Coordinated, Long-Range, Solid Substrate Movement of the Purple Photosynthetic Bacterium Rhodobacter capsulatus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; GLIDING MOTILITY; SWARMING MOTILITY; RHODOPSEUDOMONAS-CAPSULATA; SURFACE; GENE; SYSTEM; GROWTH; ULTRASTRUCTURE	The long-range movement of Rhodobacter capsulatus cells in the glass-agar interstitial region of borosilicate Petri plates was found to be due to a subset of the cells inoculated into plates. The macroscopic appearance of plates indicated that a small group of cells moved in a coordinated manner to form a visible satellite cluster of cells. Satellite clusters were initially separated from the point of inoculation by the absence of visible cell density, but after 20 to 24 hours this space was colonized by cells apparently shed from a group of cells moving away from the point of inoculation. Cell movements consisted of flagellum-independent and flagellum-dependent motility contributions. Flagellum-independent movement occurred at an early stage, such that satellite clusters formed after 12 to 24 hours. Subsequently, after 24 to 32 hours, a flagellum-dependent dispersal of cells became visible, extending laterally outward from a line of flagellum-independent motility. These modes of taxis were found in several environmental isolates and in a variety of mutants, including a strain deficient in the production of the R. capsulatus acyl-homoserine lactone quorum-sensing signal. Although there was great variability in the direction of movement in illuminated plates, cells were predisposed to move toward broad spectrum white light. This predisposition was increased by the use of square plates, and a statistical analysis indicated that R. capsulatus is capable of genuine phototaxis. Therefore, the variability in the direction of cell movement was attributed to optical effects on light waves passing through the plate material and agar medium.	[Shelswell, Kristopher John; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Shelswell, KJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	j.beatty@ubc.ca			Canadian Natural Sciences and Engineering Research Council [2796]; Canada Council for the Arts	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Council for the Arts	Funding was provided by Discovery Grant 2796 from the Canadian Natural Sciences and Engineering Research Council, http://www.nserc-crsng.gc.ca/Index_eng.asp, and a Killam Research Fellowship (to JTB) from the Canada Council for the Arts, http://www.canadacouncil.ca/prizes/killam/xy127235773746406250.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Bartnikas TB, 2002, MICROBIOL-SGM, V148, P825, DOI 10.1099/00221287-148-3-825; BEATTY JT, 1981, ARCH MICROBIOL, V129, P335, DOI 10.1007/BF00406457; Berg HC, 2005, CURR BIOL, V15, pR599, DOI 10.1016/j.cub.2005.07.042; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Brahamsha B., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P59; BURCHARD RP, 1981, ANNU REV MICROBIOL, V35, P497, DOI 10.1146/annurev.mi.35.100181.002433; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Cabello P, 2004, J BIOL CHEM, V279, P45485, DOI 10.1074/jbc.M404417200; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; DALDAL F, 1988, J BACTERIOL, V170, P2388, DOI 10.1128/jb.170.5.2388-2391.1988; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; GODCHAUX W, 1991, J BACTERIOL, V173, P7607, DOI 10.1128/jb.173.23.7607-7614.1991; GORSKI L, 1993, ARCH MICROBIOL, V169, P121; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Haselkorn R, 2001, PHOTOSYNTH RES, V70, P43, DOI 10.1023/A:1013883807771; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; HENRICHSEN J, 1975, ACTA PATH MICRO IM B, V83, P179; Hunnicutt DW, 2001, J BACTERIOL, V183, P4167, DOI 10.1128/JB.183.14.4167-4175.2001; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; Kearns DB, 2001, J BACTERIOL, V183, P763, DOI 10.1128/JB.183.2.763-767.2001; Kleinbaum DG, 1998, APPL REGRESSION ANAL, p[xviii, 798]; Lancero H, 2004, MICROBIOL-SGM, V150, P4085, DOI 10.1099/mic.0.27381-0; Lang AS, 2002, J BACTERIOL, V184, P913, DOI 10.1128/jb.184.4.913-918.2002; LEBLANC HN, 1993, J GEN MICROBIOL, V139, P101, DOI 10.1099/00221287-139-1-101; Lindum PW, 1998, J BACTERIOL, V180, P6384; Liu HL, 2001, MICROBIOL-SGM, V147, P3215, DOI 10.1099/00221287-147-12-3215; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Martinez A, 1999, J BACTERIOL, V181, P7331; MATSUYAMA T, 1995, J BACTERIOL, V177, P987, DOI 10.1128/jb.177.4.987-991.1995; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; Niehus E, 2002, MICROBIOL-SGM, V148, P3827, DOI 10.1099/00221287-148-12-3827; PAISLEY JW, 1982, J CLIN MICROBIOL, V15, P61, DOI 10.1128/JCM.15.1.61-63.1982; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; RUSHING BG, 2000, PHOTOSENSORY BEHAV; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Semmler ABT, 2000, MICROBIOL-UK, V146, P1321, DOI 10.1099/00221287-146-6-1321; Shelswell KJ, 2005, J BACTERIOL, V187, P5040, DOI 10.1128/JB.187.14.5040-5043.2005; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stanier RY, 1942, J BACTERIOL, V44, P405, DOI 10.1128/JB.44.4.405-412.1942; STEPHENS LJ, 2004, ADV STAT DEMYSTIFIED, pR12; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x; Youderian P, 1998, CURR BIOL, V8, pR408, DOI 10.1016/S0960-9822(98)70264-7	54	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19646	10.1371/journal.pone.0019646	http://dx.doi.org/10.1371/journal.pone.0019646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573194	gold, Green Submitted, Green Published			2022-12-25	WOS:000290224800042
J	Smerc, A; Sodja, E; Legisa, M				Smerc, Andreja; Sodja, Eva; Legisa, Matic			Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism	PLOS ONE			English	Article							INHIBITION-RESISTANT FORM; ASPERGILLUS-NIGER; SACCHAROMYCES-CEREVISIAE; AEROBIC GLYCOLYSIS; 2-PROMOTER SYSTEM; PHOSPHOFRUCTOKINASE; EXPRESSION; GENE; PROTEIN; AKT	Background: Human cancers consume larger amounts of glucose compared to normal tissues with most being converted and excreted as lactate despite abundant oxygen availability (Warburg effect). The underlying higher rate of glycolysis is therefore at the root of tumor formation and growth. Normal control of glycolytic allosteric enzymes appears impaired in tumors; however, the phenomenon has not been fully resolved. Methodology/Principal Findings: In the present paper, we show evidence that the native 85-kDa 6-phosphofructo-1-kinase (PFK1), a key regulatory enzyme of glycolysis that is normally under the control of feedback inhibition, undergoes posttranslational modification. After proteolytic cleavage of the C-terminal portion of the enzyme, an active, shorter 47-kDa fragment was formed that was insensitive to citrate and ATP inhibition. In tumorigenic cell lines, only the short fragments but not the native 85-kDa PFK1 were detected by immunoblotting. Similar fragments were detected also in a tumor tissue that developed in mice after the subcutaneous infection with tumorigenic B16-F10 cells. Based on limited proteolytic digestion of the rabbit muscle PFK-M, an active citrate inhibition-resistant shorter form was obtained, indicating that a single posttranslational modification step was possible. The exact molecular masses of the active shorter PFK1 fragments were determined by inserting the truncated genes constructed from human muscle PFK1 cDNA into a pfk null E. coli strain. Two E. coli transformants encoding for the modified PFK1s of 45,551 Da and 47,835 Da grew in glucose medium. The insertion of modified truncated human pfkM genes also stimulated glucose consumption and lactate excretion in stable transfectants of non-tumorigenic human HEK cell, suggesting the important role of shorter PFK1 fragments in enhancing glycolytic flux. Conclusions/Significance: Posttranslational modification of PFK1 enzyme might be the pivotal factor of deregulated glycolytic flux in tumors that in combination with altered signaling mechanisms essentially supports fast proliferation of cancer cells.	[Smerc, Andreja; Sodja, Eva; Legisa, Matic] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Smerc, A (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	matic.legisa@ki.si			Slovenian Research Agency [J4-9606, 1000-07-310027]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was funded by the Slovenian Research Agency (Contract No. J4-9606 and 1000-07-310027; http://www.arrs.gov.si/sl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Capuder M, 2009, J BIOTECHNOL, V144, P51, DOI 10.1016/j.jbiotec.2009.04.004; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; Edelmann A, 2000, EUR J BIOCHEM, V267, P4825, DOI 10.1046/j.1432-1327.2000.01540.x; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; ELSON A, 1990, GENOMICS, V7, P47, DOI 10.1016/0888-7543(90)90517-X; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Emmerling M, 1999, METAB ENG, V1, P117, DOI 10.1006/mben.1998.0109; ETO K, 1994, BIOCHEM BIOPH RES CO, V198, P990, DOI 10.1006/bbrc.1994.1141; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Hauf J, 2000, ENZYME MICROB TECH, V26, P688, DOI 10.1016/S0141-0229(00)00160-5; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; Legisa M, 2007, BIOTECHNOL LETT, V29, P181, DOI 10.1007/s10529-006-9235-z; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mesojednik S, 2005, APPL ENVIRON MICROB, V71, P1425, DOI 10.1128/AEM.71.3.1425-1432.2005; Mlakar T, 2006, APPL ENVIRON MICROB, V72, P4515, DOI 10.1128/AEM.00539-06; NAKAJIMA H, 1994, BIOCHEM J, V303, P449, DOI 10.1042/bj3030449; Paliouras M, 2008, TUMOR BIOL, V29, P63, DOI 10.1159/000135686; Paliouras M, 2008, BIOL CHEM, V389, P773, DOI 10.1515/BC.2008.072; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1491, DOI 10.1021/bi00548a036; Sambrook J., MOL CLONING LAB MANU; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; STAAL GEJ, 1987, CANCER RES, V47, P5047; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tevz G, 2010, APPL MICROBIOL BIOT, V87, P1657, DOI 10.1007/s00253-010-2642-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Usenik A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015447; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x	50	31	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19645	10.1371/journal.pone.0019645	http://dx.doi.org/10.1371/journal.pone.0019645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573193	gold, Green Published, Green Submitted			2022-12-25	WOS:000290224800041
J	Mancuso, M; Pasquali, E; Leonardi, S; Rebessi, S; Tanori, M; Giardullo, P; Borra, F; Pazzaglia, S; Naus, CC; Di Majo, V; Saran, A				Mancuso, M.; Pasquali, E.; Leonardi, S.; Rebessi, S.; Tanori, M.; Giardullo, P.; Borra, F.; Pazzaglia, S.; Naus, C. C.; Di Majo, V.; Saran, A.			Role of connexin43 and ATP in long-range bystander radiation damage and oncogenesis in vivo	ONCOGENE			English	Article						Cx43; GJIC; radiation; bystander effect; ATP; brain tumor	DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; IONIZING-RADIATION; SPINAL-CORD; CELLS; EXPRESSION; INVOLVEMENT; METABOLISM	Ionizing radiation is a genotoxic agent and human carcinogen. Recent work has questioned long-held dogmas by showing that cancer-associated genetic alterations occur in cells and tissues not directly exposed to radiation, questioning the robustness of the current system of radiation risk assessment. In vitro, diverse mechanisms involving secreted soluble factors, gap junction intercellular communication (GJIC) and oxidative metabolism are proposed to mediate these indirect effects. In vivo, the mechanisms behind long-range 'bystander' responses remain largely unknown. Here, we investigate the role of GJIC in propagating radiation stress signals in vivo, and in mediating radiation-associated bystander tumorigenesis in mouse central nervous system using a mouse model in which intercellular communication is downregulated by targeted deletion of the connexin43 (Cx43) gene. We show that GJIC is critical for transmission of oncogenic radiation damage to the non-targeted cerebellum, and that a mechanism involving adenosine triphosphate release and upregulation of Cx43, the major GJIC constituent, regulates transduction of oncogenic damage to unirradiated tissues in vivo. Our data provide a novel hypothesis for transduction of distant bystander effects and suggest that the highly branched nervous system, similar to the vascular network, has an important role. Oncogene (2011) 30, 4601-4608; doi: 10.1038/onc.2011.176; published online 23 May 2011	[Mancuso, M.; Pasquali, E.; Leonardi, S.; Rebessi, S.; Tanori, M.; Borra, F.; Pazzaglia, S.; Di Majo, V.; Saran, A.] Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, I-00123 Rome, Italy; [Pasquali, E.; Giardullo, P.] Univ Guglielmo Marconi, Dept Radiat Phys, Rome, Italy; [Naus, C. C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Italian National Agency New Technical Energy & Sustainable Economics Development; Guglielmo Marconi University; University of British Columbia	Mancuso, M (corresponding author), Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, I-00123 Rome, Italy.	mariateresa.mancuso@enea.it; anna.saran@enea.it	Pasquali, Emanuela/CAG-4451-2022	Saran, Anna/0000-0002-5587-064X	Associazione Italiana Ricerca sul Cancro (AIRC) [10357]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Grant 10357 from the Associazione Italiana Ricerca sul Cancro (AIRC) to AS. We are grateful to Maria Pia Toni and Maria Pimpinella for assistance with dosimetry and Monte Carlo simulation. We also thank Alessandro Pannicelli for help with photographs and John Bechberger (University of British Columbia, Canada) for assistance with transfer of Cx43<SUP>+/</SUP> mice.	Amino M, 2006, CARDIOVASC RES, V72, P412, DOI 10.1016/j.cardiores.2006.09.010; Azzam EI, 2002, CANCER RES, V62, P5436; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; BEIR VII, 2006, COMM ASS HLTH RISKS; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chai Yunfei, 2009, Acta Medica Nagasakiensia, V53, P65; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Huang L, 2007, CANCER RES, V67, P1099, DOI 10.1158/0008-5472.CAN-06-3697; Kasper M, 1996, HISTOCHEM CELL BIOL, V106, P419; Liu K, 1997, RADIAT RES, V147, P437, DOI 10.2307/3579500; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; NAGASAWA H, 1992, CANCER RES, V52, P6394; Ojima M, 2011, RADIAT RES, V175, P90, DOI 10.1667/RR2223.1; Pazzaglia S, 2006, ONCOGENE, V25, P5575, DOI 10.1038/sj.onc.1209544; Qu Y, 2002, P NATL ACAD SCI USA, V99, P697, DOI 10.1073/pnas.022324499; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sinclair CJD, 2000, J NEUROCHEM, V75, P1528, DOI 10.1046/j.1471-4159.2000.0751528.x; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Tsuda M, 1999, BRIT J PHARMACOL, V127, P449, DOI 10.1038/sj.bjp.0702582; Tsukimoto M, 2010, RADIAT RES, V173, P298, DOI 10.1667/RR1732.1; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082	29	58	58	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2011	30	45					4601	4608		10.1038/onc.2011.176	http://dx.doi.org/10.1038/onc.2011.176			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21602884				2022-12-25	WOS:000296890700007
J	Hiraoka, D; Okumura, E; Kishimoto, T				Hiraoka, D.; Okumura, E.; Kishimoto, T.			Turn motif phosphorylation negatively regulates activation loop phosphorylation in Akt	ONCOGENE			English	Article						activation-loop; Akt; starfish oocytes; TOR; turn motif	PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; BETA-GAMMA-SUBUNIT; SIGNALING PATHWAY; STARFISH OOCYTES; MAMMALIAN TARGET; CELL-CYCLE; MATURATION; INSULIN; AKT/PKB	Akt, also known as protein kinase B, has a central role in various signaling pathways that regulate cellular processes such as metabolism, proliferation and survival. On stimulation, phosphorylation of the activation loop (A-loop) and hydrophobic motif (HM) of Akt by the kinase phosphoinositide-dependent kinase 1 (PDK1) and the mammalian target of rapamycin complex 2 (mTORC2), respectively, results in Akt activation. A well-conserved threonine in the turn motif (TM) is also constitutively phosphorylated by mTORC2 and contributes to the stability of Akt. The role of TM phosphorylation in HM and A-loop phosphorylation has not been sufficiently evaluated. Using starfish oocytes as a model system, this study provides the first evidence that TM phosphorylation has a negative role in A-loop phosphorylation. In this system, the maturation-inducing hormone, 1-methyladenine, stimulates Akt to reinitiate meiosis through activation of cyclin B-Cdc2. The phosphorylation status of Akt was monitored via introduction of exogenous human Akt (hAkt) in starfish oocytes. TM and HM phosphorylation was inhibited by microinjection of an anti-starfish TOR antibody, but not by rapamycin treatment, suggesting that both phosphorylation events depend on TORC2, as reported in mammalian cells. A single or double alanine substitution at each of three phosphorylation residues revealed that TM phosphorylation renders Akt susceptible to dephosphorylation on the A-loop. When A-loop phosphatase was inhibited by okadaic acid (OA), TMphosphorylation still reduced A-loop phosphorylation, suggesting that the effect is caused at least partially through reduction of sensitivity to PDK1. Negative regulation by TM phosphorylation was also observed in constitutively active Akt and was functionally reflected in meiosis resumption. By contrast, HM phosphorylation enhanced A-loop phosphorylation and achieved full activation of Akt via a mechanism at least partially independent of TM phosphorylation. These observations provide new insight into the mechanism controlling Akt phosphorylation in the cell. Oncogene (2011) 30, 4487-4497; doi:10.1038/onc.2011.155; published online 16 May 2011	[Kishimoto, T.] Tokyo Inst Technol, Grad Sch Biosci, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Kishimoto, T (corresponding author), Tokyo Inst Technol, Grad Sch Biosci, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan.	tkishimo@bio.titech.ac.jp			Ministry of Education, Science and Culture, Japan	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Mark Terasaki for the gift of the pSP64-S vector and Dr Masatoshi Hara for suggestion of eIF4E and 4E-BP1. This work was supported by grants from the Ministry of Education, Science and Culture, Japan to TK.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Borgatti P, 2003, J CELL PHYSIOL, V196, P79, DOI 10.1002/jcp.10279; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CHIBA K, 1993, MOL BIOL CELL, V4, P1027, DOI 10.1091/mbc.4.10.1027; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Goren I, 2008, BIOCHEM BIOPH RES CO, V372, P103, DOI 10.1016/j.bbrc.2008.04.185; GUERRIER P, 1975, DEV BIOL, V47, P341, DOI 10.1016/0012-1606(75)90288-2; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara M, 2009, DEVELOPMENT, V136, P1687, DOI 10.1242/dev.035261; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Hiraoka D, 2004, DEV BIOL, V276, P330, DOI 10.1016/j.ydbio.2004.08.036; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JAFFE LA, 1993, J CELL BIOL, V121, P775, DOI 10.1083/jcb.121.4.775; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; KISHIMOTO T, 1986, METHOD CELL BIOL, V27, P379, DOI 10.1016/S0091-679X(08)60359-3; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Restuccia DF, 2010, DIS MODEL MECH, V3, P705, DOI 10.1242/dmm.004671; Sadler KC, 1998, DEV BIOL, V197, P25, DOI 10.1006/dbio.1998.8869; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tomek W, 2005, REPRODUCTION, V130, P423, DOI 10.1530/rep.1.00754; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004	47	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	44					4487	4497		10.1038/onc.2011.155	http://dx.doi.org/10.1038/onc.2011.155			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21577208				2022-12-25	WOS:000296733200004
J	Hyldahl, RD; Xin, L; Hubal, MJ; Moeckel-Cole, S; Chipkin, S; Clarkson, PM				Hyldahl, Robert D.; Xin, Ling; Hubal, Monica J.; Moeckel-Cole, Stephanie; Chipkin, Stuart; Clarkson, Priscilla M.			Activation of nuclear factor-kappa B following muscle eccentric contractions in humans is localized primarily to skeletal muscle-residing pericytes	FASEB JOURNAL			English	Article						regeneration; inflammation	SATELLITE CELLS; GENE-EXPRESSION; LENGTHENING CONTRACTIONS; CANCER CACHEXIA; STEM-CELLS; EXERCISE; REGENERATION; RESPONSES; MACROPHAGES; MECHANISMS	Limited data exist on the molecular mechanisms that govern skeletal muscle regeneration in humans. This study characterized the early molecular alterations in humans to eccentric contractions (ECs), a stimulus known to induce a muscle regenerative response. Thirty-five subjects completed 100 ECs of the knee extensors with 1 leg, and muscle biopsies were taken from both legs 3 h post-EC. The sample from the non-EC leg served as the control. We first conducted a well-powered transcriptomic screen and network analysis. Our screen identified significant changes in several transcripts with functions relating to inflammation, cell growth, and proliferation. Network analysis then identified the transcription factor NF-kappa B as a key molecular element affected by ECs. A transcription factor ELISA, using nuclear extracts from EC and control muscle samples, showed a 1.6-fold increase in NF-kappa B DNA binding activity following ECs. Immunohistochemical experiments localized the majority of NF-kappa B-positive nuclei to cells in the interstitium, which stained positive for the pericyte markers NG2 proteoglycan and alkaline phosphatase. Our results provide the first evidence of NF-kappa B activation in human muscle following ECs and suggest a novel role for muscle residing pericytes in the early adaptive response to ECs.-Hyldahl, R. D., Xin, L., Hubal, M. J., Moeckel-Cole, S., Chipkin, S., Clarkson, P. M. Activation of nuclear factor-kappa B following muscle eccentric contractions in humans is localized primarily to skeletal muscle-residing pericytes. FASEB J. 25, 2956-2966 (2011). www.fasebj.org	[Clarkson, Priscilla M.] Univ Massachusetts, Dept Kinesiol, Muscle Biol & Imaging Lab, Amherst, MA 01003 USA; [Hubal, Monica J.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	University of Massachusetts System; University of Massachusetts Amherst; Children's National Health System	Clarkson, PM (corresponding author), Univ Massachusetts, Dept Kinesiol, Muscle Biol & Imaging Lab, Totman Bldg,30 Eastman Ln, Amherst, MA 01003 USA.	rhyldahl@kin.umass.edu	Hyldahl, Robert/AAZ-3960-2020	Hubal, Monica/0000-0001-6579-6036; Chipkin, Stuart/0000-0003-2114-9480	Interleukin Genetics	Interleukin Genetics	The authors thank Karen Riska and Brittany Rahmberg (University of Massachusetts, Amherst, MA, USA) and Valerie Greger and Karen Shaver (Interleukin Genetics, Waltham, MA, USA) for valuable contributions to the study design and human subject work; President and Chief Scientific Officer Kenneth S. Kornman of Interleukin Genetics for support of this study; and Dr. Terrance Partridge for insight into the interpretation of the IHC images. This research was supported by Interleukin Genetics.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Boldrin L, 2010, J HISTOCHEM CYTOCHEM, V58, P941, DOI 10.1369/jhc.2010.956201; Bryan BA, 2008, METHOD ENZYMOL, V443, P315, DOI 10.1016/S0076-6879(08)02016-8; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; CHURCH JCT, 1970, J EMBRYOL EXP MORPH, V23, P531; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dahlman JM, 2010, J BIOL CHEM, V285, P5479, DOI 10.1074/jbc.M109.075606; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DIMARIO J, 1988, DIFFERENTIATION, V39, P42, DOI 10.1111/j.1432-0436.1988.tb00079.x; Durham WJ, 2004, J APPL PHYSIOL, V97, P1740, DOI 10.1152/japplphysiol.00088.2004; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Hill M, 2003, J PHYSIOL-LONDON, V549, P409, DOI 10.1113/jphysiol.2002.035832; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Hubal MJ, 2008, AM J PHYSIOL-REG I, V294, pR1628, DOI 10.1152/ajpregu.00853.2007; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Klossner S, 2007, PFLUG ARCH EUR J PHY, V455, P555, DOI 10.1007/s00424-007-0303-6; Kostek MC, 2007, PHYSIOL GENOMICS, V31, P42, DOI 10.1152/physiolgenomics.00151.2006; Lauritzen F, 2009, J APPL PHYSIOL, V107, P1923, DOI 10.1152/japplphysiol.00148.2009; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; Liu YW, 2007, CELL MOL LIFE SCI, V64, P3282, DOI 10.1007/s00018-007-7375-5; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Maruhashi Y, 2007, J PHYSIOL SCI, V57, P211, DOI 10.2170/physiolsci.RP013006; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Paulsen G, 2010, MED SCI SPORT EXER, V42, P75, DOI 10.1249/MSS.0b013e3181ac7adb; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Sekine O, 2002, J BIOL CHEM, V277, P36631, DOI 10.1074/jbc.M206266200; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Tantiwong P, 2010, AM J PHYSIOL-ENDOC M, V299, pE794, DOI 10.1152/ajpendo.00776.2009; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; UEDA A, 1994, J IMMUNOL, V153, P2052; Wang H., 2007, Autonomic & Autacoid Pharmacology, V27, P1, DOI 10.1111/j.1474-8673.2006.00381.x; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	45	44	44	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2956	2966		10.1096/fj.10-177105	http://dx.doi.org/10.1096/fj.10-177105			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21602448				2022-12-25	WOS:000294435200011
J	Pereira, GJS; Hirata, H; Fimia, GM; do Carmo, LG; Bincoletto, C; Han, SW; Stilhano, RS; Ureshino, RP; Bloor-Young, D; Churchill, G; Piacentini, M; Patel, S; Smaili, SS				Pereira, Gustavo J. S.; Hirata, Hanako; Fimia, Gian M.; do Carmo, Lucia G.; Bincoletto, Claudia; Han, Sang W.; Stilhano, Roberta S.; Ureshino, Rodrigo P.; Bloor-Young, Duncan; Churchill, Grant; Piacentini, Mauro; Patel, Sandip; Smaili, Soraya S.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Regulates Autophagy in Cultured Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ SIGNALS; CALCIUM; MACROAUTOPHAGY; ORGANELLES; RECEPTORS; AGONIST; MUSCLE; STORES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent Ca2+-mobilizing messenger that in many cells releases Ca2+ from the endolysosomal system. Recent studies have shown that NAADP-induced Ca2+ mobilization is mediated by the two-pore channels (TPCs). Whether NAADP acts as a messenger in astrocytes is unclear, and downstream functional consequences have yet to be defined. Here, we show that intracellular delivery of NAADP evokes Ca2+ signals from acidic organelles in rat astrocytes and that these signals are potentiated upon overexpression of TPCs. We also show that NAADP increases acidic vesicular organelle formation and levels of the autophagic markers, LC3II and beclin-1. NAADP-mediated increases in LC3II levels were reduced in cells expressing a dominant-negative TPC2 construct. Our data provide evidence that NAADP-evoked Ca2+ signals mediated by TPCs regulate autophagy.	[Pereira, Gustavo J. S.; Hirata, Hanako; do Carmo, Lucia G.; Bincoletto, Claudia; Ureshino, Rodrigo P.; Smaili, Soraya S.] Univ Fed Sao Paulo, UNIFESP, Dept Pharmacol, BR-04044020 Sao Paulo, Brazil; [Fimia, Gian M.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Han, Sang W.; Stilhano, Roberta S.; Piacentini, Mauro] Univ Fed Sao Paulo, Interdisciplinary Ctr Gene Therapy, BR-09210170 Sao Paulo, Brazil; [Bloor-Young, Duncan; Churchill, Grant] Univ Oxford, Dept Pharmacol, Oxford OX1 2JD, England; [Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6, England	Universidade Federal de Sao Paulo (UNIFESP); University of Rome Tor Vergata; Universidade Federal de Sao Paulo (UNIFESP); University of Oxford; University of London; University College London	Smaili, SS (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Pharmacol, Rua Tres de Maio 100, BR-04044020 Sao Paulo, Brazil.	ssmaili@unifesp.br	Piacentini, Mauro/I-2411-2016; Ureshino, Rodrigo/C-4095-2014; Smaili, Soraya/AAH-2129-2019; Pereira, Gustavo José Silva/ABH-1344-2020; Fimia, Gian Maria/K-3232-2016; Han, Sang W/D-4541-2012; STILHANO, roberta/F-6923-2015; Bincoletto, Claudia/H-4936-2012; Patel, Sandip/O-9591-2015; Pereira, Gustavo/H-4636-2012	Piacentini, Mauro/0000-0003-2919-1296; Ureshino, Rodrigo/0000-0003-3371-3376; Smaili, Soraya/0000-0001-5844-1368; Pereira, Gustavo José Silva/0000-0002-6765-1276; Fimia, Gian Maria/0000-0003-4438-3325; STILHANO, roberta/0000-0002-0653-5968; Patel, Sandip/0000-0001-7247-2013; Bincoletto, Claudia/0000-0001-6666-3673; Pereira, Gustavo/0000-0002-1789-3541	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; BBSRC [BB/G013721/1] Funding Source: UKRI	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Fundacao do Amparo a Pesquisa do Estado de Sao Paulo, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and the Biotechnology and Biological Sciences Research Council (Grant BB/G013721/1) (to S. P.).	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carvalho ACP, 2004, CELL DEATH DIFFER, V11, P1265, DOI 10.1038/sj.cdd.4401508; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel SD, 2010, SURG LAPARO ENDO PER, V20, P20, DOI 10.1097/SLE.0b013e3181cd45f2; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	37	84	87	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27875	27881		10.1074/jbc.C110.216580	http://dx.doi.org/10.1074/jbc.C110.216580			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21610076	hybrid, Green Published			2022-12-25	WOS:000293557800006
J	Casabuono, A; Petrocelli, S; Ottado, J; Orellano, EG; Couto, AS				Casabuono, Adriana; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.; Couto, Alicia S.			Structural Analysis and Involvement in Plant Innate Immunity of Xanthomonas axonopodis pv. citri Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; GRAM-NEGATIVE BACTERIA; O-ANTIGEN; OXIDATIVE BURST; DEFENSE GENES; CAMPESTRIS; ARABIDOPSIS; RESISTANCE; INDUCTION; BIOSYNTHESIS	Xanthomonas axonopodis pv. citri (Xac) causes citrus canker, provoking defoliation and premature fruit drop with concomitant economical damage. In plant pathogenic bacteria, lipopolysaccharides are important virulence factors, and they are being increasingly recognized as major pathogen-associated molecular patterns for plants. In general, three domains are recognized in a lipopolysaccharide: the hydrophobic lipid A, the hydrophilic O-antigen polysaccharide, and the core oligosaccharide, connecting lipidA and O-antigen. In this work, we have determined the structure of purified lipopolysaccharides obtained from Xanthomonas axonopodis pv. citri wild type and a mutant of the O-antigen ABC transporter encoded by the wzt gene. High pH anion exchange chromatography and matrix-assisted laser desorption/ionization mass spectrum analysis were performed, enabling determination of the structure not only of the released oligosaccharides and lipid A moieties but also the intact lipopolysaccharides. The results demonstrate that Xac wild type and Xacwzt LPSs are composed mainly of a penta-or tetra-acylated diglucosamine backbone attached to either two pyrophosphorylethanolamine groups or to one pyrophosphorylethanolamine group and one phosphorylethanolamine group. The core region consists of a branched oligosaccharide formed by Kdo(2)Hex(6)GalA(3)Fuc(3)NAcRha(4) and two phosphate groups. As expected, the presence of a rhamnose homo-oligosaccharide as O-antigen was determined only in the Xac wild type lipopolysaccharide. In addition, we have examined how lipopolysaccharides from Xac function in the pathogenesis process. We analyzed the response of the different lipopolysaccharides during the stomata aperture closure cycle, the callose deposition, the expression of defense-related genes, and reactive oxygen species production in citrus leaves, suggesting a functional role of the O-antigen from Xac lipopolysaccharides in the basal response.	[Casabuono, Adriana; Couto, Alicia S.] Univ Buenos Aires, Fac Cs Exactas & Nat, Dept Quim Inorgan, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina; [Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.] Consejo Nacl Invest Cient & Tecn IBR CONICET UNR, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, Div Mol Biol, Rosario, Santa Fe, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Couto, AS (corresponding author), Univ Buenos Aires, Fac Cs Exactas & Nat, Dept Quim Inorgan, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina.	acouto@qo.fcen.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783, PME 125]; University of Buenos Aires; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by a grant from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783) (to E. G. O.), the University of Buenos Aires, and CONICET. The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by an ANPCyT (Grant PME 125).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Braun SG, 2005, MOL PLANT MICROBE IN, V18, P674, DOI 10.1094/MPMI-18-0674; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio LD, 2011, J PLANT PHYSIOL, V168, P382, DOI 10.1016/j.jplph.2010.07.014; Daurelio L. D., 2009, BOOK PLANT BIOASSAYS, P187; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujikawa T, 2006, MOL PLANT MICROBE IN, V19, P342, DOI 10.1094/MPMI-19-0342; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Harvey DJ, 2009, MASS SPECTROM REV, V28, P273, DOI 10.1002/mas.20192; Harvey DJ, 2003, INT J MASS SPECTROM, V226, P1, DOI 10.1016/S1387-3806(02)00968-5; Holst O, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P29; Ingle RA, 2006, BIOESSAYS, V28, P880, DOI 10.1002/bies.20457; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kazan K, 2001, MOL PLANT PATHOL, V2, P177, DOI 10.1046/j.1364-3703.2001.00061.x; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Knirel YA, 2009, CARBOHYD RES, V344, P479, DOI 10.1016/j.carres.2008.12.012; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Lindner B, 2000, METH MOL B, V145, P311; Marolda Cristina L., 2006, V347, P237; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Meyer A, 2001, PLANTA, V213, P214, DOI 10.1007/s004250000493; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Molinaro A, 1999, FEMS MICROBIOL LETT, V181, P49, DOI 10.1111/j.1574-6968.1999.tb08825.x; Molinaro A, 2003, CARBOHYD RES, V338, P277, DOI 10.1016/S0008-6215(02)00433-0; Molinaro A, 2002, EUR J BIOCHEM, V269, P4185, DOI 10.1046/j.1432-1033.2002.03138.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEWMAN MA, 1995, MOL PLANT MICROBE IN, V8, P778, DOI 10.1094/MPMI-8-0778; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rietschel E. T., 1999, ENDOTOXIN HLTH DIS; RIETSCHEL ET, 1975, J BACTERIOL, V122, P1180, DOI 10.1128/JB.122.3.1180-1188.1975; Sambrook J., 2002, MOL CLONING LAB MANU; Shashkov AS, 2000, CARBOHYD RES, V323, P235; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Silipo A, 2004, EUR J ORG CHEM, V2004, P1336, DOI 10.1002/ejoc.200300721; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Worrall TA, 2000, J MASS SPECTROM, V35, P647, DOI 10.1002/(SICI)1096-9888(200005)35:5<647::AID-JMS973>3.0.CO;2-E; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	66	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25628	25643		10.1074/jbc.M110.186049	http://dx.doi.org/10.1074/jbc.M110.186049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596742	hybrid, Green Published			2022-12-25	WOS:000293073000025
J	Yan, JZ; Xu, Z; Ren, SQ; Hu, B; Yao, W; Wang, SH; Liu, SY; Lu, W				Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei			Protein Kinase C Promotes N-Methyl-D-aspartate (NMDA) Receptor Trafficking by Indirectly Triggering Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM-POTENTIATION; SYNAPTIC PLASTICITY; NR2A SUBUNIT; SURFACE EXPRESSION; LTP; PHOSPHORYLATION; TRANSLOCATION; BINDING; SRC; CHANNEL	Regulation of neuronal NMDA receptor (NMDAR) is critical in synaptic transmission and plasticity. Protein kinase C (PKC) promotes NMDAR trafficking to the cell surface via interaction with NMDAR-associated proteins (NAPs). Little is known, however, about the NAPs that are critical to PKC-induced NMDAR trafficking. Here, we showed that calcium/calmodulin-dependent protein kinase II (CaMKII) could be a NAP that mediates the potentiation of NMDAR trafficking by PKC. PKC activation promoted the level of autophosphorylated CaMKII and increased association with NMDARs, accompanied by functional NMDAR insertion, at postsynaptic sites. This potentiation, along with PKC-induced long term potentiation of the AMPA receptor-mediated response, was abolished by CaMKII antagonist or by disturbing the interaction between CaMKII and NR2A or NR2B. Further mutual occlusion experiments demonstrated that PKC and CaMKII share a common signaling pathway in the potentiation of NMDAR trafficking and long-term potentiation (LTP) induction. Our results revealed that PKC promotes NMDA receptor trafficking and induces synaptic plasticity through indirectly triggering CaMKII autophosphorylation and subsequent increased association with NMDARs.	[Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu Prov, Peoples R China; [Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei] Nanjing Med Univ, Key Lab Neurodegenerat Dis Jiangsu Prov, Nanjing 210029, Jiangsu Prov, Peoples R China; [Lu, Wei] Nanjing Med Univ, Lab Reprod Med, Nanjing 210029, Jiangsu Prov, Peoples R China; [Lu, Wei] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu Prov, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu Prov, Peoples R China.	lu@njmu.edu.cn			National Natural Science Foundation of China [31025011, 30970934]; Major State Basic Research Program of China [2010CB912002]; Education Department of Jiangsu Province [08KJA180004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Education Department of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grants 31025011 and 30970934), the Major State Basic Research Program of China (Grant 2010CB912002), and the Education Department of Jiangsu Province (Grant 08KJA180004) (all to W. L.).	AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bultynck G, 2003, BIOCHEM BIOPH RES CO, V311, P1181, DOI 10.1016/j.bbrc.2003.08.084; Caputi A, 1999, EUR J NEUROSCI, V11, P141, DOI 10.1046/j.1460-9568.1999.00414.x; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANGELS LA, 1990, MOL PHARMACOL, V37, P820; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zha XM, 2009, J NEUROSCI RES, V87, P1969, DOI 10.1002/jnr.22033; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zheng CY, 2006, ACTA PHARMACOL SIN, V27, P1580, DOI 10.1111/j.1745-7254.2006.00434.x; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	55	54	56	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25187	25200		10.1074/jbc.M110.192708	http://dx.doi.org/10.1074/jbc.M110.192708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606495	Green Published, hybrid			2022-12-25	WOS:000292547900065
J	Trappetti, C; Ogunniyi, AD; Oggioni, MR; Paton, JC				Trappetti, Claudia; Ogunniyi, Abiodun D.; Oggioni, Marco R.; Paton, James C.			Extracellular Matrix Formation Enhances the Ability of Streptococcus pneumoniae to Cause Invasive Disease	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; NASOPHARYNGEAL COLONIZATION; BIOFILM FORMATION; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; OTITIS-MEDIA; MIDDLE-EAR; CHINCHILLA MODEL; EPITHELIAL-CELLS; GENE-EXPRESSION	During infection, pneumococci exist mainly in sessile biofilms rather than in planktonic form, except during sepsis. However, relatively little is known about how biofilms contribute to pneumococcal pathogenesis. Here, we carried out a biofilm assay on opaque and transparent variants of a clinical serotype 19F strain WCH159. After 4 days incubation, scanning electron microscopy revealed that opaque biofilm bacteria produced an extracellular matrix, whereas the transparent variant did not. The opaque biofilm-derived bacteria translocated from the nasopharynx to the lungs and brain of mice, and showed 100-fold greater in vitro adherence to A549 cells than transparent bacteria. Microarray analysis of planktonic and sessile bacteria from transparent and opaque variants showed differential gene expression in two operons: the lic operon, which is involved in choline uptake, and in the two-component system, ciaRH. Mutants of these genes did not form an extracellular matrix, could not translocate from the nasopharynx to the lungs or the brain, and adhered poorly to A549 cells. We conclude that only the opaque phenotype is able to form extracellular matrix, and that the lic operon and ciaRH contribute to this process. We propose that during infection, extracellular matrix formation enhances the ability of pneumococci to cause invasive disease.	[Trappetti, Claudia; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Oggioni, Marco R.] Univ Siena, Lab Microbiol Mol & Biotecnol, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Adelaide; University of Siena	Trappetti, C (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	david.ogunniyi@adelaide.edu.au	Oggioni, Marco Rinaldo/K-3839-2016; Paton, James C/A-9920-2008	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Ogunniyi, Abiodun/0000-0001-9308-5629; Trappetti, Claudia/0000-0001-8272-0068	National Health and Medical Research Council of Australia (NHMRC) [565526, 627142]; Wellcome Trust	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) program grant 565526 and Project Grant 627142 (www.nhmrc.gov.au). J.C.P. is a NHMRC Australia Fellow (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr Layla Mahdi for advice and assistance with microarray work and animal experiments, Mark van der Hoek for help with statistical analysis of microarray data, and Ursula Talbot for assistance with tissue culture experiments. We thank Prof. David Briles (UAB, Birmingham, AL, USA, for the supply of the serotype 6B strain L82016), and Prof. Michael Jennings (Griffith University, Gold Coast, Queensland, Australia), for the kind gift of TEPC-15 monoclonal antibody. We acknowledge BmG@S (the Bacterial Microarray Group at St George's, University of London) for supply of the microarray and advice and The Wellcome Trust for funding the multi-collaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative.	ALLISON DG, 1984, J MICROBIOL METH, V2, P93, DOI 10.1016/0167-7012(84)90034-4; Arce FT, 2009, J BACTERIOL, V191, P2512, DOI 10.1128/JB.01596-08; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; CORNFORD EM, 1978, J NEUROCHEM, V30, P299, DOI 10.1111/j.1471-4159.1978.tb06530.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUNDELL DR, 1995, INFECT IMMUN, V63, P757, DOI 10.1128/IAI.63.3.757-761.1995; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dagan R, 2009, ADV EXP MED BIOL, V634, P69, DOI 10.1007/978-0-387-79838-7_7; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; Dawid S, 2009, J BACTERIOL, V191, P1509, DOI 10.1128/JB.01213-08; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; GUENZI E, 1994, MOL MICROBIOL, V12, P505, DOI 10.1111/j.1365-2958.1994.tb01038.x; HAKENBECK R, 1978, ANTIMICROB AGENTS CH, V13, P302, DOI 10.1128/AAC.13.2.302; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoa M, 2009, INT J PEDIATR OTORHI, V73, P1242, DOI 10.1016/j.ijporl.2009.05.016; HONE D, 1988, MICROB PATHOGENESIS, V5, P407, DOI 10.1016/0882-4010(88)90002-2; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kobayashi H, 2009, J INFECT CHEMOTHER, V15, P125, DOI 10.1007/s10156-008-0691-3; Konradsen HB, 2002, CLIN DIAGN LAB IMMUN, V9, P358, DOI 10.1128/CDLI.9.2.358-365.2002; Kos MI, 2009, INFECTION, V37, P450, DOI 10.1007/s15010-008-8335-1; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; LOFFELHOLZ K, 1993, PROG BRAIN RES, V98, P197; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; McDaniel LS, 1997, GENE THER, V4, P375, DOI 10.1038/sj.gt.3300401; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, DNA RES, V16, P177, DOI 10.1093/dnares/dsp007; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Serino L, 2000, MOL MICROBIOL, V35, P1550, DOI 10.1046/j.1365-2958.2000.01825.x; Serino L, 2002, MOL MICROBIOL, V43, P437, DOI 10.1046/j.1365-2958.2002.02755.x; Serruto D, 2009, VACCINE, V27, P3245, DOI 10.1016/j.vaccine.2009.01.072; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thurnheer T, 2006, CARIES RES, V40, P163, DOI 10.1159/000091065; Tong HH, 2000, INFECT IMMUN, V68, P4593, DOI 10.1128/IAI.68.8.4593-4597.2000; Tong HH, 2001, INFECT IMMUN, V69, P602, DOI 10.1128/IAI.69.1.602-606.2001; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	77	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19844	10.1371/journal.pone.0019844	http://dx.doi.org/10.1371/journal.pone.0019844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611130	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200039
J	Troupin, C; Schnuriger, A; Duponchel, S; Deback, C; Schnepf, N; Dehee, A; Garbarg-Chenon, A				Troupin, Cecile; Schnuriger, Aurelie; Duponchel, Sarah; Deback, Claire; Schnepf, Nathalie; Dehee, Axelle; Garbarg-Chenon, Antoine			Rotavirus Rearranged Genomic RNA Segments Are Preferentially Packaged into Viruses Despite Not Conferring Selective Growth Advantage to Viruses	PLOS ONE			English	Article							BOVINE ROTAVIRUS; SEQUENCE-ANALYSIS; ENGINEERED SSRNA; STRANDED-RNA; VP6 GENE; STRAIN; MECHANISM; INFECTION; NSP1; REASSORTMENT	The rotavirus (RV) genome consists of 11 double-stranded RNA segments. Sometimes, partial sequence duplication of an RNA segment leads to a rearranged RNA segment. To specify the impact of rearrangement, the replication efficiencies of human RV with rearranged segments 7, 11 or both were compared to these of the homologous human wild-type RV (wt-RV) and of the bovine wt-RV strain RF. As judged by viral growth curves, rotaviruses with a rearranged genome (r-RV) had no selective growth advantage over the homologous wt-RV. In contrast, r-RV were selected over wt-RV during competitive experiments (i.e mixed infections between r-RV and wt-RV followed by serial passages in cell culture). Moreover, when competitive experiments were performed between a human r-RV and the bovine wt-RV strain RF, which had a clear growth advantage, rearranged segments 7, 11 or both always segregated in viral progenies even when performing mixed infections at an MOI ratio of 1 r-RV to 100 wt-RV. Lastly, bovine reassortant viruses that had inherited a rearranged segment 7 from human r-RV were generated. Although substitution of wt by rearranged segment 7 did not result in any growth advantage, the rearranged segment was selected in the viral progenies resulting from mixed infections by bovine reassortant r-RV and wt-RV, even for an MOI ratio of 1 r-RV to 10(7) wt-RV. Lack of selective growth advantage of r-RV over wt-RV in cell culture suggests a mechanism of preferential packaging of the rearranged segments over their standard counterparts in the viral progeny.	[Troupin, Cecile; Schnuriger, Aurelie; Duponchel, Sarah; Deback, Claire; Schnepf, Nathalie; Dehee, Axelle; Garbarg-Chenon, Antoine] Univ Paris 06, Paris, France; [Schnuriger, Aurelie; Duponchel, Sarah; Garbarg-Chenon, Antoine] Inst Natl Sante & Rech Med, ERL U1057, UMR 7203, Paris, France; [Schnuriger, Aurelie; Dehee, Axelle; Garbarg-Chenon, Antoine] Hop Armand Trousseau, AP HP, Lab Virol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Troupin, C (corresponding author), Univ Paris 06, Paris, France.	a.chenon@trs.aphp.fr	Deback, Claire/T-3054-2019; DEBACK, Claire/GQP-1189-2022; DEBACK, Claire/GRE-8739-2022; Troupin, Cécile/AAE-9428-2021; schnuriger, aurelie/A-6628-2011; Deback, Claire/B-2787-2014; Garbarg- Chenon, antoine/B-3397-2010	Deback, Claire/0000-0001-9465-2381; DEBACK, Claire/0000-0001-9465-2381; schnuriger, aurelie/0000-0003-0931-8720; Deback, Claire/0000-0001-9465-2381; Garbarg- Chenon, antoine/0000-0003-2940-6672	MRT; UPMC; ACI microbiologie fondamentale; ADVM	MRT; UPMC; ACI microbiologie fondamentale; ADVM	Cecile Troupin and Sarah Duponchel were supported by PhD fellowships funded by an MRT grant. This work was supported in part by UPMC funds and by grants from the ACI microbiologie fondamentale and ADVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2008, ARCH VIROL, V153, P555, DOI 10.1007/s00705-007-0004-7; ALLEN AM, 1985, J GEN VIROL, V66, P2703, DOI 10.1099/0022-1317-66-12-2703; APONTE C, 1993, ARCH VIROL, V133, P85, DOI 10.1007/BF01309746; BALLARD A, 1992, J GEN VIROL, V73, P633, DOI 10.1099/0022-1317-73-3-633; BELLINZONI RC, 1987, J CLIN MICROBIOL, V25, P952, DOI 10.1128/JCM.25.5.952-954.1987; Chnaiderman J, 1998, ARCH VIROL, V143, P1711, DOI 10.1007/s007050050411; Desselberger U, 1996, ADV VIRUS RES, V46, P69, DOI 10.1016/S0065-3527(08)60070-6; EATON BT, 1987, VIRUS RES, V6, P363, DOI 10.1016/0168-1702(87)90067-0; Estes MK, 2007, FIELDS VIROLOGY, P1917; Gault E, 2001, J VIROL, V75, P7305, DOI 10.1128/JVI.75.16.7305-7314.2001; GIAMBIAGI S, 1994, ARCH VIROL, V136, P415, DOI 10.1007/BF01321070; GRAHAM A, 1987, J GEN VIROL, V68, P115, DOI 10.1099/0022-1317-68-1-115; GUSMAO RHP, 1994, J DIARRHOEAL DIS RES, V12, P129; HUA J, 1994, VIROLOGY, V198, P567, DOI 10.1006/viro.1994.1068; HUNDLEY F, 1987, J VIROL, V61, P3365, DOI 10.1128/JVI.61.11.3365-3372.1987; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; Kojima K, 1996, VIROLOGY, V224, P446, DOI 10.1006/viro.1996.0551; Kojima K, 2000, VIRUS RES, V67, P163, DOI 10.1016/S0168-1702(00)00139-8; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; MATSUI SM, 1990, J VIROL, V64, P120, DOI 10.1128/JVI.64.1.120-124.1990; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006; Matthijnssens J, 2006, BIOCHEM BIOPH RES CO, V340, P140, DOI 10.1016/j.bbrc.2005.11.165; MATTION NM, 1990, J GEN VIROL, V71, P355, DOI 10.1099/0022-1317-71-2-355; MCINTYRE M, 1987, J GEN VIROL, V68, P2961, DOI 10.1099/0022-1317-68-11-2961; MENDEZ E, 1992, ARCH VIROL, V125, P331, DOI 10.1007/BF01309651; Nakagomi T, 1999, J CLIN MICROBIOL, V37, P1213, DOI 10.1128/JCM.37.4.1213-1216.1999; OISHI I, 1991, MICROBIOL IMMUNOL, V35, P953, DOI 10.1111/j.1348-0421.1991.tb01617.x; Palombo EA, 1998, ACTA VIROL, V42, P55; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patton JT, 1999, VIROLOGY, V264, P167, DOI 10.1006/viro.1999.9989; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; PEDLEY S, 1984, J GEN VIROL, V65, P1141, DOI 10.1099/0022-1317-65-7-1141; POCOCK DH, 1987, VET MICROBIOL, V13, P27, DOI 10.1016/0378-1135(87)90095-2; Roner MR, 2007, J GEN VIROL, V88, P3401, DOI 10.1099/vir.0.83209-0; Roner MR, 2007, VIROLOGY, V358, P89, DOI 10.1016/j.virol.2006.08.017; Roner MR, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-1; Roner MR, 2004, VIROLOGY, V329, P348, DOI 10.1016/j.virol.2004.08.026; Schnepf N, 2008, J VIROL, V82, P3689, DOI 10.1128/JVI.01770-07; SHEN S, 1994, J VIROL, V68, P1682, DOI 10.1128/JVI.68.3.1682-1688.1994; THOULESS ME, 1986, ARCH VIROL, V89, P161, DOI 10.1007/BF01309886; TIAN Y, 1993, J VIROL, V67, P6625, DOI 10.1128/JVI.67.11.6625-6632.1993; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Xu ZC, 1996, VET MICROBIOL, V52, P235, DOI 10.1016/S0378-1135(96)00069-7	44	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20080	10.1371/journal.pone.0020080	http://dx.doi.org/10.1371/journal.pone.0020080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611152	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500041
J	Ruetz, T; Cornick, S; Guttman, JA				Ruetz, Tyson; Cornick, Steve; Guttman, Julian Andrew			The Spectrin Cytoskeleton Is Crucial for Adherent and Invasive Bacterial Pathogenesis	PLOS ONE			English	Article							III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; PEDESTAL FORMATION; MEMBRANE-SKELETON; EPITHELIAL-CELLS; MAMMALIAN-CELLS; EUKARYOTIC CELLS; PROTEIN; ACTIN	Various enteric bacterial pathogens target the host cell cytoskeletal machinery as a crucial event in their pathogenesis. Despite thorough studies detailing strategies microbes use to exploit these components of the host cell, the role of the spectrin-based cytoskeleton has been largely overlooked. Here we show that the spectrin cytoskeleton is a host system that is hijacked by adherent (Entropathogenic Escherichia coli [EPEC]), invasive triggering (Salmonella enterica serovar Typhimurium [S. Typhimurium]) and invasive zippering (Listeria monocytogenes) bacteria. We demonstrate that spectrin cytoskeletal proteins are recruited to EPEC pedestals, S. Typhimurium membrane ruffles and Salmonella containing vacuoles (SCVs), as well as sites of invasion and comet tail initiation by L. monocytogenes. Spectrin was often seen co-localizing with actin filaments at the cell periphery, however a disconnect between the actin and spectrin cytoskeletons was also observed. During infections with S. Typhimurium Delta sipA, actin-rich membrane ruffles at characteristic sites of bacterial invasion often occurred in the absence of spectrin cytoskeletal proteins. Additionally, early in the formation of L. monocytogenes comet tails, spectrin cytoskeletal elements were recruited to the surface of the internalized bacteria independent of actin filaments. Further studies revealed the presence of the spectrin cytoskeleton during SCV and Listeria comet tail formation, highlighting novel cytoplasmic roles for the spectrin cytoskeleton. SiRNA targeted against spectrin and the spectrin-associated proteins severely diminished EPEC pedestal formation as well as S. Typhimurium and L. monocytogenes invasion. Ultimately, these findings identify the spectrin cytoskeleton as a ubiquitous target of enteric bacterial pathogens and indicate that this cytoskeletal system is critical for these infections to progress.	[Ruetz, Tyson; Cornick, Steve; Guttman, Julian Andrew] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Ruetz, T (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jguttman@sfu.ca		Ruetz, Tyson/0000-0002-3568-7717; Cornick, Steve/0000-0003-3883-6033	Canadian Institute for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Baumann O, 1998, CELL MOTIL CYTOSKEL, V41, P74, DOI 10.1002/(SICI)1097-0169(1998)41:1<74::AID-CM7>3.0.CO;2-F; Beck KA, 1996, AM J PHYSIOL-CELL PH, V270, pC1263, DOI 10.1152/ajpcell.1996.270.5.C1263; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; DeVinney R, 2001, MOL MICROBIOL, V41, P1445, DOI 10.1046/j.1365-2958.2001.02617.x; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; Figueiredo JF, 2009, MICROBES INFECT, V11, P850, DOI 10.1016/j.micinf.2009.05.003; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Guttman JA, 2010, INFECT IMMUN, V78, P3316, DOI 10.1128/IAI.00161-10; Guttman JA, 2007, ANAT REC, V290, P199, DOI 10.1002/ar.20414; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KOCKS C, 1993, J CELL SCI, V105, P699; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; MARSHALL LM, 1984, J CELL BIOL, V98, P2055, DOI 10.1083/jcb.98.6.2055; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; Park JU, 2000, APMIS, V108, P45, DOI 10.1034/j.1600-0463.2000.d01-4.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; TAKEUCHI A, 1967, AM J PATHOL, V51, P137; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19940	10.1371/journal.pone.0019940	http://dx.doi.org/10.1371/journal.pone.0019940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603579	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300042
J	Walter, D; Satheesha, S; Albrecht, P; Bornhauser, BC; D'Alessandro, V; Oesch, SM; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, FK; Schafer, BW				Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Rehrauer, Hubert; Leuschner, Ivo; Koscielniak, Ewa; Gengler, Carole; Moch, Holger; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.		CWS Study Grp	CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres	PLOS ONE			English	Article							CARCINOMA-CELLS; INITIATING CELLS; DRUG-RESISTANCE; TUMOR-FORMATION; NEURAL-TUBE; CANCER; IDENTIFICATION; EXPRESSION; GROWTH; DIFFERENTIATION	Cancer stem cells (CSCs) have been identified in a number of solid tumors, but not yet in rhabdomyosarcoma (RMS), the most frequently occurring soft tissue tumor in childhood. Hence, the aim of this study was to identify and characterize a CSC population in RMS using a functional approach. We found that embryonal rhabdomyosarcoma (eRMS) cell lines can form rhabdomyosarcoma spheres (short rhabdospheres) in stem cell medium containing defined growth factors over several passages. Using an orthotopic xenograft model, we demonstrate that a 100 fold less sphere cells result in faster tumor growth compared to the adherent population suggesting that CSCs were enriched in the sphere population. Furthermore, stem cell genes such as oct4, nanog, c-myc, pax3 and sox2 are significantly upregulated in rhabdospheres which can be differentiated into multiple lineages such as adipocytes, myocytes and neuronal cells. Surprisingly, gene expression profiles indicate that rhabdospheres show more similarities with neuronal than with hematopoietic or mesenchymal stem cells. Analysis of these profiles identified the known CSC marker CD133 as one of the genes upregulated in rhabdospheres, both on RNA and protein levels. CD133(+) sorted cells were subsequently shown to be more tumorigenic and more resistant to commonly used chemotherapeutics. Using a tissue microarray (TMA) of eRMS patients, we found that high expression of CD133 correlates with poor overall survival. Hence, CD133 could be a prognostic marker for eRMS. These experiments indicate that a CD133(+) CSC population can be enriched from eRMS which might help to develop novel targeted therapies against this pediatric tumor.	[Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland; [Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.] Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland; [Oesch, Susanne M.] Roche Pharma Schweiz, Basel, Switzerland; [Rehrauer, Hubert] Univ Zurich, Funct Genom Ctr, Zurich, Switzerland; [Leuschner, Ivo] Univ Kiel, Dept Pathol, D-2300 Kiel, Germany; [Koscielniak, Ewa] Klinikum Stuttgart, Olgahosp, Stuttgart, Germany; [Gengler, Carole; Moch, Holger] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; Roche Holding; University of Zurich; University of Kiel; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Zurich; University Zurich Hospital	Walter, D (corresponding author), Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch	Bornhauser, Beat/M-4437-2014; Bernasconi, Michele/CAG-2492-2022; Bernasconi, Michele/C-6734-2008; Niggli, Felix/L-6547-2017; Rappaz, Sampoorna/ABD-6160-2021; Bernasconi, Michele/GOH-1815-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Niggli, Felix/0000-0002-7553-3712; Rappaz, Sampoorna/0000-0002-7330-7586; Bernasconi, Michele/0000-0002-5746-8806; Bornhauser, Beat/0000-0003-2890-3191; Schafer, Beat/0000-0001-5988-2915	Swiss National Science Foundation [3100-122562]; Swiss Research Foundation Child and Cancer	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Research Foundation Child and Cancer	This study was supported by grants (3100-122562) from the Swiss National Science Foundation and the Swiss Research Foundation Child and Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Angello JC, 1997, DEV BIOL, V192, P93, DOI 10.1006/dbio.1997.8722; Astolfi A, 2001, GENE, V274, P139, DOI 10.1016/S0378-1119(01)00619-9; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouchard F, 2009, STEM CELLS DEV, V18, P1023, DOI 10.1089/scd.2008.0288; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Dantonello TM, 2008, J CLIN ONCOL, V26, P406, DOI 10.1200/JCO.2007.12.2382; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDowell HP, 2003, ARCH DIS CHILD, V88, P354, DOI 10.1136/adc.88.4.354; Merlino G, 2007, GENE DEV, V21, P1275, DOI 10.1101/gad.1563707; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; *SCI T, 2009, HUM MES STEM CELL PR; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh S, 2007, NEUROSURG CLIN N AM, V18, P31, DOI 10.1016/j.nec.2006.10.014; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; TAJBAKHSH S, 1994, NEURON, V13, P813, DOI 10.1016/0896-6273(94)90248-8; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606	50	84	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19506	10.1371/journal.pone.0019506	http://dx.doi.org/10.1371/journal.pone.0019506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602936	Green Published, gold, Green Submitted			2022-12-25	WOS:000290558500013
J	Maxwell, SM; Breed, GA; Nickel, BA; Makanga-Bahouna, J; Pemo-Makaya, E; Parnell, RJ; Formia, A; Ngouessono, S; Godley, BJ; Costa, DP; Witt, MJ; Coyne, MS				Maxwell, Sara M.; Breed, Greg A.; Nickel, Barry A.; Makanga-Bahouna, Junior; Pemo-Makaya, Edgard; Parnell, Richard J.; Formia, Angela; Ngouessono, Solange; Godley, Brendan J.; Costa, Daniel P.; Witt, Matthew J.; Coyne, Michael S.			Using Satellite Tracking to Optimize Protection of Long-Lived Marine Species: Olive Ridley Sea Turtle Conservation in Central Africa	PLOS ONE			English	Article							LEATHERBACK TURTLES; LEPIDOCHELYS-OLIVACEA; DERMOCHELYS-CORIACEA; BODY-SIZE; FORAGING STRATEGIES; NESTING MIGRATIONS; GREEN TURTLES; MOVEMENT; BEHAVIOR; AREAS	Tractable conservation measures for long-lived species require the intersection between protection of biologically relevant life history stages and a socioeconomically feasible setting. To protect breeding adults, we require knowledge of animal movements, how movement relates to political boundaries, and our confidence in spatial analyses of movement. We used satellite tracking and a switching state-space model to determine the internesting movements of olive ridley sea turtles (Lepidochelys olivacea) (n = 18) in Central Africa during two breeding seasons (2007-08, 2008-09). These movements were analyzed in relation to current park boundaries and a proposed transboundary park between Gabon and the Republic of Congo, both created to reduce unintentional bycatch of sea turtles in marine fisheries. We additionally determined confidence intervals surrounding home range calculations. Turtles remained largely within a 30 km radius from the original nesting site before departing for distant foraging grounds. Only 44.6 percent of high-density areas were found within the current park but the proposed transboundary park would incorporate 97.6 percent of high-density areas. Though tagged individuals originated in Gabon, turtles were found in Congolese waters during greater than half of the internesting period (53.7 percent), highlighting the need for international cooperation and offering scientific support for a proposed transboundary park. This is the first comprehensive study on the internesting movements of solitary nesting olive ridley sea turtles, and it suggests the opportunity for tractable conservation measures for female nesting olive ridleys at this and other solitary nesting sites around the world. We draw from our results a framework for cost-effective protection of long-lived species using satellite telemetry as a primary tool.	[Maxwell, Sara M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Breed, Greg A.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Nickel, Barry A.] Univ Calif Santa Cruz, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Makanga-Bahouna, Junior; Pemo-Makaya, Edgard; Parnell, Richard J.] Parc Natl Mayumba, Wildlife Conservat Soc, Mayumba, Gabon; [Formia, Angela] Global Conservat Program, Wildlife Conservat Soc, New York, NY USA; [Ngouessono, Solange] Agence Natl Parcs Nationaux, Libreville, Gabon; [Godley, Brendan J.; Witt, Matthew J.; Coyne, Michael S.] Univ Exeter, Ctr Ecol & Conservat, Marine Turtle Res Grp, Penyrn, Cornwall, England; [Coyne, Michael S.] SEATURTLE Org, Durham, NC USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Wildlife Conservation Society; University of Exeter	Maxwell, SM (corresponding author), Marine Conservat Inst, Long Marine Lab, Santa Cruz, CA USA.	smaxwell@ucsc.edu	godley, brendan j/A-6139-2009; Witt, Matthew/V-3318-2018; godley, brendan/O-1959-2019; Costa, Daniel/E-2616-2013	godley, brendan j/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan/0000-0003-3845-0034; Maxwell, Sara/0000-0002-4425-9378; Costa, Daniel/0000-0002-0233-5782	Disney Worldwide Conservation Fund [STO-08-01]; Tagging of Pacific Predators Project; Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface; Friends of Long Marine Laboratory; Society for the Study of Amphibians and Reptiles; Marilyn Davis Memorial Scholarship; UCSC Graduate Student Association; Square's Landscaping and Kitchen Gardens, Inc.; National Science Foundation; University of California; United States Fish and Wildlife Service, U.S. Department of the Interior	Disney Worldwide Conservation Fund; Tagging of Pacific Predators Project; Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface; Friends of Long Marine Laboratory; Society for the Study of Amphibians and Reptiles; Marilyn Davis Memorial Scholarship; UCSC Graduate Student Association; Square's Landscaping and Kitchen Gardens, Inc.; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); United States Fish and Wildlife Service, U.S. Department of the Interior(US Fish & Wildlife Service)	This work was supported by the Disney Worldwide Conservation Fund (STO-08-01) and the Tagging of Pacific Predators Project, with additional support from the Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface, Friends of Long Marine Laboratory, Society for the Study of Amphibians and Reptiles, the Marilyn Davis Memorial Scholarship, the UCSC Graduate Student Association, Square's Landscaping and Kitchen Gardens, Inc. SMM was supported by fellowships from the National Science Foundation, University of California Santa Cruz, Achievement Awards for College Scientists and Steve Blank. Sea turtle nest monitoring in Gabon was coordinated through the Gabon Sea Turtle Partnership, with funding from the Marine Turtle Conservation Fund (United States Fish and Wildlife Service, U.S. Department of the Interior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2000, B MAR SCI, V66, P875; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; BALAZS G, 1999, PUBLICATION IUCN SSC, V4; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bernardo J., 2007, BIOL CONSERVATION RI, P59; Blumenthal Janice M., 2006, Endangered Species Research, V7, P1; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; *CLS SERV AGR, 2008, US MAN; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Craig MP, 1999, MAR MAMMAL SCI, V15, P786, DOI 10.1111/j.1748-7692.1999.tb00843.x; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; ECKERT KL, 1989, HERPETOLOGICA, V45, P190; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Ehrenfeld D, 2000, CONSERV BIOL, V14, P105, DOI 10.1046/j.1523-1739.2000.99325.x; Finkelstein ME, 2010, ANIM CONSERV, V13, P148, DOI 10.1111/j.1469-1795.2009.00311.x; Fossette S, 2007, MAR ECOL PROG SER, V338, P233, DOI 10.3354/meps338233; Fretey J, 2001, BIOGEOGRAPHY CONSERV; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Godgenger MC, 2009, ORYX, V43, P556, DOI 10.1017/S0030605309990329; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamel MA, 2008, J EXP MAR BIOL ECOL, V359, P47, DOI 10.1016/j.jembe.2008.02.019; Hays GC, 2001, MAR BIOL, V139, P395; Hays GC, 1999, MAR ECOL PROG SER, V189, P263, DOI 10.3354/meps189263; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Heppell SS, 1999, AM FISH S S, V23, P137; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalb H., 1999, BEHAV PHYSL SOLITARY; Kenward R., 1987, WILDLIFE RADIO TAGGI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; *MAY NAT PARK, UNPUB; Meylan Anne, 1995, P67; Miller Jeffrey D., 1997, P51; Moser BW, 2007, J WILDLIFE MANAGE, V71, P2421, DOI 10.2193/2007-003; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Parnell Richard, 2007, Marine Turtle Newsletter, P12; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; Plotkin PT, 1996, HERPETOLOGICA, V52, P1; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Powell R., 2000, RES TECHNIQUES ANIMA, P64; PRITCHARD PCH, 1980, AM ZOOL, V20, P609; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Roberts CM, 2000, B MAR SCI, V66, P581; Root TL, 2006, CONSERV BIOL, V20, P706, DOI 10.1111/j.1523-1739.2006.00465.x; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Schultz JP, 1975, ZOOL VERH-LEIDEN, V143, P3; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Tucker AD, 2010, J EXP MAR BIOL ECOL, V383, P48, DOI 10.1016/j.jembe.2009.11.009; VANBUSKIRK J, 1994, COPEIA, P66; VANLEEUWE H, 2008, MARINE TURDE SEASON; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Walker JS, 2008, COMPUT ENVIRON URBAN, V32, P19, DOI 10.1016/j.compenvurbsys.2007.02.001; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whiting S. D., 2007, Endangered Species Research, V3, P1, DOI 10.3354/esr003001; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Zbinden JA, 2007, BIOL CONSERV, V137, P157, DOI 10.1016/j.biocon.2007.01.022	82	107	108	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19905	10.1371/journal.pone.0019905	http://dx.doi.org/10.1371/journal.pone.0019905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589942	Green Submitted, Green Published, gold			2022-12-25	WOS:000290483600035
J	Janganan, TK; Bavro, VN; Zhang, L; Matak-Vinkovic, D; Barrera, NP; Venien-Bryan, C; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Bavro, Vassiliy N.; Zhang, Li; Matak-Vinkovic, Dijana; Barrera, Nelson P.; Venien-Bryan, Catherine; Robinson, Carol V.; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.			Evidence for the Assembly of a Bacterial Tripartite Multidrug Pump with a Stoichiometry of 3:6:3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; EFFLUX TRANSPORTER ACRB; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC COMPONENT; BINDING CAPACITY; ABC-TRANSPORTER; TOLC	The multiple transferable resistance (mTR) pump from Neisseria gonorrhoeae MtrCDE multidrug pump is assembled from the inner and outer membrane proteins MtrD and MtrE and the periplasmic membrane fusion protein MtrC. Previously we established that while there is a weak interaction of MtrD and MtrE, MtrC binds with relatively high affinity to both MtrD and MtrE. MtrD conferred antibiotic resistance only when it was expressed with MtrE and MtrC, suggesting that these proteins form a functional tripartite complex in which MtrC bridges MtrD and MtrE. Furthermore, we demonstrated that MtrC interacts with an intraprotomer groove on the surface of MtrE, inducing channel opening. However, a second groove is apparent at the interface of the MtrE sub-units, which might also be capable of engaging MtrC. We have now established that MtrC can be cross-linked to cysteines placed in this interprotomer groove and that mutation of residues in the groove impair the ability of the pump to confer antibiotic resistance by locking MtrE in the closed channel conformation. Moreover, MtrE K390C forms an intermolecular disulfide bond with MtrC E149C locking MtrE in the open channel conformation, suggesting that a functional salt bridge forms between these residues during the transition from closed to open channel conformations. MtrC forms dimers that assemble into hexamers, and electron microscopy studies of single particles revealed that these hexamers are arranged into ring-like structures with an internal aperture sufficiently large to accommodate the MtrE trimer. Cross-linking of single cysteine mutants of MtrC to stabilize the dimer interface in the presence of MtrE, trapped an MtrC-MtrE complex with a molecular mass consistent with a stoichiometry of 3:6 (MtrE(3)MtrC(6)), suggesting that dimers of MtrC interact with MtrE, presumably by binding to the two grooves. As both MtrE and MtrD are trimeric, our studies suggest that the functional pump is assembled with a stoichiometry of 3:6:3.	[Janganan, Thamarai K.; Zhang, Li; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Dept Physiol, Santiago 8331150, Chile; [Venien-Bryan, Catherine] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QU, England	Durham University; University of Oxford; University of Cambridge; Pontificia Universidad Catolica de Chile; University of Oxford; University of Oxford	Walmsley, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	a.r.walmsley@durham.ac.uk	Janganan, Thamarai/AAQ-8705-2020; Bavro, Vassiliy/I-4846-2019	Bavro, Vassiliy/0000-0003-2330-8924; robinson, carol/0000-0001-7829-5505; Venien-Bryan, Catherine/0000-0002-7328-3764; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; European Union; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (to M. I. B. W. and A. R. W.).; Supported by a Marie Curie Fellowship from the European Union during part of this work.; Support by the Biotechnology and Biological Sciences Research Council.	Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; De Angelis F, 2010, P NATL ACAD SCI USA, V107, P11038, DOI 10.1073/pnas.1003908107; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Kim HS, 2010, J BACTERIOL, V192, P1377, DOI 10.1128/JB.01448-09; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Welch A, 2010, BIOCHEM J, V430, P355, DOI 10.1042/BJ20091860; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	45	43	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26900	26912		10.1074/jbc.M111.246595	http://dx.doi.org/10.1074/jbc.M111.246595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21610073	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000293078200064
J	Xu, LM; Salloum, D; Medlin, PS; Saqcena, M; Yellen, P; Perrella, B; Foster, DA				Xu, Limei; Salloum, Darin; Medlin, Phil S.; Saqcena, Mahesh; Yellen, Paige; Perrella, Benjamin; Foster, David A.			Phospholipase D Mediates Nutrient Input to Mammalian Target of Rapamycin Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID REGULATION; HUMAN CANCER-CELLS; TUBEROUS-SCLEROSIS; PHOSPHATIDIC-ACID; SURVIVAL SIGNAL; RAG GTPASES; H-RAS; ACTIVATION; RALA; RHEB	The mammalian target of rapamycin (mTOR) is a critical sensor of nutritional sufficiency. Although much is known about the regulation of mTOR in response to growth factors, much less is known about the regulation of mTOR in response to nutrients. Amino acids have no impact on the signals that regulate Rheb, a GTPase required for the activation of mTOR complex 1 (mTORC1). Phospholipase D (PLD) generates a metabolite, phosphatidic acid, that facilitates association between mTOR and the mTORC1 co-factor Raptor. We report here that elevated PLD activity in human cancer cells is dependent on both amino acids and glucose and that amino acid-and glucose-induced increases in mTORC1 activity are dependent on PLD. Amino acid-and glucose-induced PLD and mTORC1 activity were also dependent on the GTPases RalA and ARF6 and the type III phosphatidylinositol-3-kinase hVps34. Thus, a key stimulatory event for mTORC1 activation in response to nutrients is the generation of phosphatidic acid by PLD.	[Xu, Limei; Salloum, Darin; Medlin, Phil S.; Saqcena, Mahesh; Yellen, Paige; Perrella, Benjamin; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Saqcena, Mahesh/U-5973-2017	Saqcena, Mahesh/0000-0002-2210-3444	National Institutes of Health, NCI [CA148677]; National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CENTER FOR RESEARCH RESOURCES [S03RR003039] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA148677. This work was also supported by Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster David A, 2004, Expert Rev Anticancer Ther, V4, P691, DOI 10.1586/14737140.4.4.691; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Frohman MA, 1999, CHEM PHYS LIPIDS, V98, P127, DOI 10.1016/S0009-3084(99)00025-0; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Garcia AS, 2008, AQUACULT NUTR, V14, P14, DOI 10.1111/j.1365-2095.2007.00500.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	50	72	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25477	25486		10.1074/jbc.M111.249631	http://dx.doi.org/10.1074/jbc.M111.249631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622984	Green Published, hybrid			2022-12-25	WOS:000293073000010
J	Farghaian, H; Turnley, AM; Sutherland, C; Cole, AR				Farghaian, Hovik; Turnley, Ann M.; Sutherland, Calum; Cole, Adam R.			Bioinformatic Prediction and Confirmation of beta-Adducin as a Novel Substrate of Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE MEDIATOR PROTEIN-2; RABBIT SKELETAL-MUSCLE; ALZHEIMERS-DISEASE; PHOSPHOPROTEOMIC ANALYSIS; DIFFERENTIAL REGULATION; IN-VIVO; SYNAPTIC PLASTICITY; MOUSE-BRAIN; A-BETA; PHOSPHORYLATION	It is important to identify the true substrates of protein kinases because this illuminates the primary function of any kinase. Here, we used bioinformatics and biochemical validation to identify novel brain substrates of the Ser/Thr kinase glycogen synthase kinase 3 (GSK3). Briefly, sequence databases were searched for proteins containing a conserved GSK3 phosphorylation consensus sequence ((S/T)PXX(S/T)P or (S/T)PXXX(S/T)P), as well as other criteria of interest (e.g. brain proteins). Importantly, candidates were highlighted if they had previously been reported to be phosphorylated at these sites by large-scale phosphoproteomic studies. These criteria identified the brain-enriched cytoskeleton-associated protein beta-adducin as a likely substrate of GSK3. To confirm this experimentally, it was cloned and subjected to a combination of cell culture and in vitro kinase assays that demonstrated direct phosphorylation by GSK3 in vitro and in cells. Phosphosites were mapped to three separate regions near the C terminus and confirmed using phosphospecific antibodies. Prior priming phosphorylation by Cdk5 enhanced phosphorylation by GSK3. Expression of wild type, but not non-phosphorylatable (GSK3 insensitive), beta-adducin increased axon and dendrite elongation in primary cortical neurons. Therefore, phosphorylation of beta-adducin by GSK3 promotes efficient neurite outgrowth in neurons.	[Farghaian, Hovik; Cole, Adam R.] Garvan Inst Med Res, Neurosignalling Grp, Sydney, NSW 2010, Australia; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Sutherland, Calum] Univ Dundee, Biomed Res Inst, Dundee DD1 9SY, Scotland	Garvan Institute of Medical Research; University of Melbourne; University of Dundee	Cole, AR (corresponding author), Garvan Inst Med Res, Neurosignalling Grp, 384 Victoria St, Sydney, NSW 2010, Australia.	a.cole@garvan.org.au	Turnley, Ann/A-8125-2010	Turnley, Ann/0000-0002-8442-127X; Sutherland, Calum/0000-0003-4398-7434	Mason Foundation; Contributing to Australian Scholarship and Science (CASS) Foundation; Australian National Health and Medical Research Council (NHMRC) [454886]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish	Mason Foundation; Contributing to Australian Scholarship and Science (CASS) Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by grants from the Mason Foundation and the Contributing to Australian Scholarship and Science (CASS) Foundation.; Supported by Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship 454886. To whom correspondence should be addressed: Neurosignalling Group, Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, Sydney, NSW 2010, Australia. Tel.: 61-2-9295-8289; Fax: 61-2-9295-8281; E-mail: a. cole@garvan.org.au.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; BENNETT V, 1988, J BIOL CHEM, V263, P5860; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GARDNER K, 1986, J BIOL CHEM, V261, P1339; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; MIYAZAKI M, 1994, BIOCHEM BIOPH RES CO, V205, P460, DOI 10.1006/bbrc.1994.2688; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; SEIDEL B, 1995, BRAIN RES, V700, P13, DOI 10.1016/0006-8993(95)00962-P; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; YANG SD, 1981, FEBS LETT, V126, P57, DOI 10.1016/0014-5793(81)81032-0; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yotsumoto K, 2009, J BIOL CHEM, V284, P16840, DOI 10.1074/jbc.M109.003277; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130	55	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25274	25283		10.1074/jbc.M111.251629	http://dx.doi.org/10.1074/jbc.M111.251629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606488	hybrid, Green Published			2022-12-25	WOS:000292547900073
J	Ishimaru, Y; Kakei, Y; Shimo, H; Bashir, K; Sato, Y; Sato, Y; Uozumi, N; Nakanishi, H; Nishizawa, NK				Ishimaru, Yasuhiro; Kakei, Yusuke; Shimo, Hugo; Bashir, Khurram; Sato, Yutaka; Sato, Yuki; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			A Rice Phenolic Efflux Transporter Is Essential for Solubilizing Precipitated Apoplasmic Iron in the Plant Stele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALUMINUM TOXICITY; ACID; DEFICIENCY; MECHANISMS; RESISTANCE; TOLERANCE; PROTEIN; GROWTH; IRT1	Iron deficiency is one of the major agricultural problems, as 30% of the arable land of the world is too alkaline for optimal crop production, rendering plants short of available iron despite its abundance. To take up apoplasmic precipitated iron, plants secrete phenolics such as protocatechuic acid (PCA) and caffeic acid. The molecular pathways and genes of iron uptake strategies are already characterized, whereas the molecular mechanisms of phenolics synthesis and secretion have not been clarified, and no phenolics efflux transporters have been identified in plants yet. Here we describe the identification of a phenolics efflux transporter in rice. We identified a cadmium-accumulating rice mutant in which the amount of PCA and caffeic acid in the xylem sap was dramatically reduced and hence named it phenolics efflux zero 1 (pez1). PEZ1 localized to the plasma membrane and transported PCA when expressed in Xenopus laevis oocytes. PEZ1 localized mainly in the stele of roots. In the roots of pez1, precipitated apoplasmic iron increased. The growth of PEZ1 overexpression lines was severely restricted, and these lines accumulated more iron as a result of the high solubilization of precipitated apoplasmic iron in the stele. We show that PEZ1 is responsible for an increase of PCA concentration in the xylem sap and is essential for the utilization of apoplasmic precipitated iron in the stele.	[Ishimaru, Yasuhiro; Kakei, Yusuke; Shimo, Hugo; Bashir, Khurram; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Sato, Yutaka] Natl Inst Agrobiol Sci, Genome Resource Ctr, Tsukuba, Ibaraki 3058602, Japan; [Sato, Yuki; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tohoku University; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Yayoi 1-1-1,Bunkyo Ku, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Bashir, Khurram/C-6870-2011; ISHIMARU, Yasuhiro/AAS-5947-2020; Kakei, Yusuke/AAF-7408-2020; Uozumi, Nobuyuki/AAG-3252-2019; Bashir, Khurram/Z-5650-2019; Nakanishi, Hiromi/C-6461-2015	Bashir, Khurram/0000-0001-7123-8380; ISHIMARU, Yasuhiro/0000-0003-4723-8844; Bashir, Khurram/0000-0001-7123-8380; Uozumi, Nobuyuki/0000-0003-4268-1126; Nakanishi, Hiromi/0000-0001-5556-5058	Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]	Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by the Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Grant GMB0001 from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation).	Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bashir K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1326; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2009, MOL PLANT, V2, P1059, DOI 10.1093/mp/ssp051; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Jin CW, 2007, PLANT PHYSIOL, V144, P278, DOI 10.1104/pp.107.095794; Kakei Y, 2009, PLANT CELL PHYSIOL, V50, P1988, DOI 10.1093/pcp/pcp141; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kidd PS, 2001, J EXP BOT, V52, P1339, DOI 10.1093/jexbot/52.359.1339; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Maron LG, 2010, PLANT J, V61, P728, DOI 10.1111/j.1365-313X.2009.04103.x; Marschner H., 1995, MINERAL NUTR HIGHER, P313, DOI DOI 10.1016/B978-012473542-2/50011-0; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Popa VI, 2008, IND CROP PROD, V27, P144, DOI 10.1016/j.indcrop.2007.07.019; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rios JL, 2009, CURR PHARM DESIGN, V15, P1212, DOI 10.2174/138161209787846874; ROMHELD V, 1983, PLANT PHYSIOL, V71, P949, DOI 10.1104/pp.71.4.949; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Yoshino M, 1998, ANAL BIOCHEM, V257, P40, DOI 10.1006/abio.1997.2522	31	121	127	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24649	24655		10.1074/jbc.M111.221168	http://dx.doi.org/10.1074/jbc.M111.221168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602276	Green Published, hybrid			2022-12-25	WOS:000292547900015
J	Thi, TTT; Poirier, H; Clement, L; Nassir, F; Pelsers, MMAL; Petit, V; Degrace, P; Monnot, MC; Glatz, JFC; Abumrad, NA; Besnard, P; Niot, I				Thi Thu Trang Tran; Poirier, Helene; Clement, Lionel; Nassir, Fatiha; Pelsers, Maurice M. A. L.; Petit, Valerie; Degrace, Pascal; Monnot, Marie-Claude; Glatz, Jan F. C.; Abumrad, Nada A.; Besnard, Philippe; Niot, Isabelle			Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; INTESTINAL-ABSORPTION; DENSITY-LIPOPROTEIN; APOLIPOPROTEIN B48; INSULIN-RESISTANCE; CHOLESTEROL UPTAKE; SKELETAL-MUSCLE; DIETARY LIPIDS; BRUSH-BORDER; HEPG2 CELLS	The membrane glycoprotein CD36 binds nanomolar concentrations of long chain fatty acids (LCFA) and is highly expressed on the luminal surface of enterocytes. CD36 deficiency reduces chylomicron production through unknown mechanisms. In this report, we provide novel insights into some of the underlying mechanisms. Our in vivo data demonstrate that CD36 gene deletion in mice does not affect LCFA uptake and subsequent esterification into triglycerides by the intestinal mucosa exposed to the micellar LCFA concentrations prevailing in the intestine. In rodents, the CD36 protein disappears early from the luminal side of intestinal villi during the postprandial period, but only when the diet contains lipids. This drop is significant 1 h after a lipid supply and associates with ubiquitination of CD36. Using CHO cells expressing CD36, it is shown that the digestion products LCFA and diglycerides trigger CD36 ubiquitination. In vivo treatment with the proteasome inhibitor MG132 prevents the lipid-mediated degradation of CD36. In vivo and ex vivo, CD36 is shown to be required for lipid activation of ERK1/2, which associates with an increase of the key chylomicron synthesis proteins, apolipoprotein B48 and microsomal triglyceride transfer protein. Therefore, intestinal CD36, possibly through ERK1/2-mediated signaling, is involved in the adaptation of enterocyte metabolism to the postprandial lipid challenge by promoting the production of large triglyceride-rich lipoproteins that are rapidly cleared in the blood. This suggests that CD36 may be a therapeutic target for reducing the postprandial hypertriglyceridemia and associated cardiovascular risks.	[Thi Thu Trang Tran; Poirier, Helene; Clement, Lionel; Petit, Valerie; Monnot, Marie-Claude; Besnard, Philippe; Niot, Isabelle] AgroSup Dijon, Physiol Nutr, Univ Bourgogne, INSERM,U866, F-21000 Dijon, France; [Pelsers, Maurice M. A. L.; Glatz, Jan F. C.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Nassir, Fatiha; Abumrad, Nada A.] Washington Univ, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Maastricht University; Washington University (WUSTL)	Niot, I (corresponding author), AgroSup Dijon, Physiol Nutr, Univ Bourgogne, INSERM,U866, 1 Esplanade Erasme, F-21000 Dijon, France.	niot@u-bourgogne.fr	Degrace, Pascal/AAF-5531-2021	Nassir, Fatiha/0000-0002-3653-3621	National Institute of Health and Medical Research (INSERM); French National Research Agency (L'Agence Nationale de la Recherche, ANR); Burgundy Council; National Institutes of Health [R01 DK60022, DK33301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301, R01DK060022] Funding Source: NIH RePORTER	National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency (L'Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR)); Burgundy Council(Region Bourgogne-Franche-Comte); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institute of Health and Medical Research (INSERM) and by grants from the Research Program in Human Nutrition SensoFAT of the French National Research Agency (L'Agence Nationale de la Recherche, ANR) (to P. B.) and from the Burgundy Council (to P. B.). This work was also supported by National Institutes of Health Grants R01 DK60022 and DK33301 (to N. A. A.).	Au WS, 2003, DIABETES, V52, P1073, DOI 10.2337/diabetes.52.5.1073; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Chen CH, 1997, ARTERIOSCL THROM VAS, V17, P1303, DOI 10.1161/01.ATV.17.7.1303; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; DAHLQVIST A, 1970, ENZYMOL BIOL CLIN, V11, P52, DOI 10.1159/000458348; DELSAL JL, 1954, B SOC CHIM BIOL, V36, P1329; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Pardo VG, 2007, BIOGERONTOLOGY, V8, P13, DOI 10.1007/s10522-006-9031-0; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; Hansen GH, 2003, GUT, V52, P1424, DOI 10.1136/gut.52.10.1424; Hevener AL, 2001, DIABETES, V50, P2316, DOI 10.2337/diabetes.50.10.2316; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Lo CM, 2008, AM J PHYSIOL-GASTR L, V294, pG344, DOI 10.1152/ajpgi.00123.2007; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Pelsers MMAL, 1999, BIOCHEM J, V337, P407, DOI 10.1042/0264-6021:3370407; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; QUARFORD.SH, 1966, BIOCHIM BIOPHYS ACTA, V116, P382, DOI 10.1016/0005-2760(66)90019-1; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; SHIRAZIBEECHEY SP, 1990, GASTROENTEROLOGY, V98, P676, DOI 10.1016/0016-5085(90)90288-C; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Tsai J, 2007, ARTERIOSCL THROM VAS, V27, P211, DOI 10.1161/01.ATV.0000249861.80471.96; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4	48	90	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25201	25210		10.1074/jbc.M111.233551	http://dx.doi.org/10.1074/jbc.M111.233551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610069	hybrid, Green Published			2022-12-25	WOS:000292547900066
J	Yan, BX; Boyd, D				Yan, Boxu; Boyd, Daniel			Breaking the Light and Heavy Chain Linkage of Human Immunoglobulin G1 (IgG1) by Radical Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE AMINO-ACIDS; HYDROGEN-PEROXIDE; CATALYTIC DECOMPOSITION; MONOCLONAL-ANTIBODY; SELENOAMINO ACIDS; ELECTRON-TRANSFER; PULSE-RADIOLYSIS; RADIATION DAMAGE; AQUEOUS-SOLUTION; OXYGEN RADICALS	We report that the production of hydrogen peroxide by radical chain reductions of molecular oxygen into water in buffers leads to hinge degradation of a human IgG1 under thermal incubation conditions. The production of the hydrogen peroxide can be accelerated by superoxide dismutase or redox active metal ions or inhibited by free radical scavengers. The hydrogen peroxide production rate correlates well with the hinge cleavage. In addition to radical reaction mechanisms described previously, new degradation pathways and products were observed. These products were determined to be generated via radical reactions initiated by electron transfer and addition to the inter-chain disulfide bond between Cys(215) of the light chain and Cys(225) of the heavy chain. Decomposition of the resulting disulfide bond radical anion breaks the C-S bond at the side chain of Cys, converting it into dehydroalanine and generating a sulfur radical adduct at its counterpart. The hydrolysis of the unsaturated dehydropeptides removes Cys and yields an amide at the C terminus of the new fragment. Meanwhile, the competition between the carbonyl (-(CONH)-O-alpha-) and the side chain of Cys allows an electron transfer to the alpha carbon, forming a new intermediate radical species (-C-center dot(alpha)(O-)NH-) at Cys(225). Dissociative deamidation occurs along the N-C-alpha bond, resulting in backbone cleavage. Given that hydrogen peroxide is a commonly observed product of thermal stress and plays a role in mediating the unique degradation of an IgG1, strategies for improving stability of human antibody therapeutics are discussed.	[Yan, Boxu; Boyd, Daniel] Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA	Roche Holding; Genentech	Yan, BX (corresponding author), Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA.	yan.boxu@gene.com						Barton J. P., 1970, INT J RADIAT PHYS CH, V22, P25; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHAN PC, 1973, J AM CHEM SOC, V95, P5504, DOI 10.1021/ja00798a012; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DAVIES MJ, 1987, CHEM-BIOL INTERACT, V61, P177, DOI 10.1016/0009-2797(87)90038-X; DAVIES MJ, 1987, BIOCHEM J, V246, P725, DOI 10.1042/bj2460725; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gaza-Bulseco G, 2008, PHARM RES-DORDR, V25, P1881, DOI 10.1007/s11095-008-9606-3; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HAYWARD MA, 1987, METHOD ENZYMOL, V143, P279; HILLER KO, 1981, J AM CHEM SOC, V103, P2734, DOI 10.1021/ja00400a042; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jacob C, 2006, BIOL CHEM, V387, P1385, DOI 10.1515/BC.2006.174; Lin SS, 1998, ENVIRON SCI TECHNOL, V32, P1417, DOI 10.1021/es970648k; MacManus-Spencer LA, 2005, J AM CHEM SOC, V127, P8954, DOI 10.1021/ja052045b; Nathan C, 2003, NATURE, V422, P675, DOI 10.1038/422675a; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Ouellette D, 2009, ANAL BIOCHEM, V389, P107, DOI 10.1016/j.ab.2009.03.027; POOLE LB, 1989, J BIOL CHEM, V264, P12322; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; SCHUBERT J, 1968, J AM CHEM SOC, V90, P4476, DOI 10.1021/ja01018a061; SHIMAZU F, 1964, RADIAT RES, V23, P203, DOI 10.2307/3571600; SHIMAZU F, 1964, RADIAT RES, V23, P210, DOI 10.2307/3571601; SHIMAZU F, 1964, RADIAT RES, V22, P276, DOI 10.2307/3571659; SHIMAZU F, 1964, SCIENCE, V143, P369, DOI 10.1126/science.143.3604.369; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; STIPANUK MH, 1987, METHOD ENZYMOL, V143, P155; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Wang PX, 2007, J AM SOC NEPHROL, V18, P1239, DOI 10.1681/ASN.2006111299; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Yates Z, 2010, J BIOL CHEM, V285, P18662, DOI 10.1074/jbc.M110.108597; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	52	14	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24674	24684		10.1074/jbc.M111.255026	http://dx.doi.org/10.1074/jbc.M111.255026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606498	hybrid, Green Published			2022-12-25	WOS:000292547900018
J	Cochran, BJ; Croucher, DR; Lobov, S; Saunders, DN; Ranson, M				Cochran, Blake J.; Croucher, David R.; Lobov, Sergei; Saunders, Darren N.; Ranson, Marie			Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; DENSITY-LIPOPROTEIN RECEPTOR; BREAST-CANCER; COMPLEX-FORMATION; UROKINASE; PROTEIN; SYSTEM; LIGAND; SITE; PAI-2	Tumor overexpression of urokinase-type plasminogen activator (uPA) and its specific inhibitor SerpinE1 (plasminogen activator inhibitor type-1) correlates with poor prognosis and increased metastatic potential. Conversely, tumor expression of uPA and another specific inhibitor, SerpinB2 (plasminogen activator inhibitor type-2), are associated with favorable outcome and relapse-free survival. It is not known how overexpression of these uPA inhibitors results in such disparate outcomes. A possible explanation may be related to the presence of a proposed low density lipoprotein receptor (LDLR)-binding motif in SerpinE1 responsible for mitogenic signaling via ERK that is absent in SerpinB2. We now show that complementation of such a LDLR-binding motif in SerpinB2 by mutagenesis of two key residues enabled high affinity binding to very LDLR (VLDLR). Furthermore, the VLDLR-binding SerpinB2 form behaved in a manner indistinguishable from SerpinE1 in terms of enhanced uPA-SerpinB2 complex endocytosis and subsequent ERK phosphorylation and cell proliferation; that is, the introduction of the LDLR-binding motif to SerpinB2 was necessary and sufficient to allow it to acquire characteristics of SerpinE1 associated with malignancy. In conclusion, this study defines the structural elements underlying the distinct interactions of SerpinE1 versus SerpinB2 with endocytic receptors and how differential VLDLR binding impacts on downstream cellular behavior. This has clear relevance to understanding the paradoxical disease outcomes associated with overexpression of these serpins in cancer.	[Cochran, Blake J.; Ranson, Marie] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cochran, Blake J.; Lobov, Sergei; Ranson, Marie] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Croucher, David R.; Saunders, Darren N.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia	University of Wollongong; University of Wollongong; Garvan Institute of Medical Research	Ranson, M (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.	mranson@uow.edu.au	Lobov, Sergei A/A-8803-2011; Ranson, Marie/AAC-4468-2019; Ranson, Marie/GRO-5792-2022; Saunders, Darren/B-7677-2008; Ranson, Marie/A-6324-2008	Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Saunders, Darren/0000-0003-0924-0513; Cochran, Blake/0000-0002-9615-7939; Croucher, David/0000-0003-4965-8674	Australian Postgraduate Award; University of Wollongong through the Centre for Medical Bioscience; University of Wollongong; Cancer Institute New South Wales	Australian Postgraduate Award(Australian Government); University of Wollongong through the Centre for Medical Bioscience; University of Wollongong; Cancer Institute New South Wales	This work was financially supported by an Australian Postgraduate Award (to B. J. C.), by the University of Wollongong through the Centre for Medical Bioscience, by a University of Wollongong Small Grant, and by Cancer Institute New South Wales Fellowships (to M. R., D. N. S., and D. R. C.).	AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; Al-Ejeh F, 2004, EXP CELL RES, V297, P259, DOI 10.1016/j.yexcr.2004.03.030; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; ASTEDT B, 1987, Fibrinolysis, V1, P203, DOI 10.1016/0268-9499(87)90037-3; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Bouchet C, 1999, J CLIN ONCOL, V17, P3048, DOI 10.1200/JCO.1999.17.10.3048; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cochran BJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-43; Croucher D, 2006, J BIOL CHEM, V281, P10206, DOI 10.1074/jbc.M513645200; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Croucher DR, 2007, BIOCHEM J, V408, P203, DOI 10.1042/BJ20070767; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Di Giusto DA, 2005, J MOL BIOL, V353, P1069, DOI 10.1016/j.jmb.2005.09.008; Di Y, 2010, FEBS LETT, V584, P3469, DOI 10.1016/j.febslet.2010.07.005; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606; ELLIS V, 1990, J BIOL CHEM, V265, P9904; Foekens JA, 2000, CANCER RES, V60, P636; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; MIKUS P, 1993, EUR J BIOCHEM, V218, P1071, DOI 10.1111/j.1432-1033.1993.tb18467.x; Ohba K, 2005, J UROLOGY, V174, P461, DOI 10.1097/01.ju.0000165150.46006.92; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Scherrer A, 1999, BRIT J HAEMATOL, V105, P920, DOI 10.1046/j.1365-2141.1999.01432.x; Schmitt M, 2000, FIBRINOLYSIS PROTEOL, V14, P114, DOI 10.1054/fipr.2000.0079; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	40	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24467	24475		10.1074/jbc.M111.225706	http://dx.doi.org/10.1074/jbc.M111.225706			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606492	Green Published, hybrid			2022-12-25	WOS:000292294900087
J	Karuppiah, V; Derrick, JP				Karuppiah, Vijaykumar; Derrick, Jeremy P.			Structure of the PilM-PilN Inner Membrane Type IV Pilus Biogenesis Complex from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; PATHOGENIC NEISSERIA; CYTOPLASMIC DOMAIN; VIBRIO-CHOLERAE; CELL-DIVISION; X-RAY; PROTEIN; FTSA	Type IV pili are surface-exposed filaments, which extend from a variety of bacterial pathogens and play a major role in pathogenesis, motility, and DNA uptake. Here, we present the crystal structure of a complex between a cytoplasmic component of the type IV pilus biogenesis system from Thermus thermophilus, PilM, in complex with a peptide derived from the cytoplasmic portion of the inner membrane protein PilN. PilM also binds ATP, and its structure is most similar to the actin-like protein FtsA. PilN binds in a narrow channel between the 1A and 1C subdomains in PilM; the binding site is well conserved in other Gram-negative bacteria, notably Neisseria meningitidis, Pseudomonas aeruginosa, and Vibrio cholerae. We find no evidence for the catalysis of ATP hydrolysis by PilM; fluorescence data indicate that the protein is likely to be saturated by ATP at physiological concentrations. In addition, binding of the PilN peptide appears to influence the environment of the ATP binding site. This is the first reported structure of a complex between two type IV pilus biogenesis proteins. We propose a model in which PilM binds ATP and then PilN as one of the first steps in the formation of the inner membrane platform of the type IV pilus biogenesis complex.	[Karuppiah, Vijaykumar; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Derrick@manchester.ac.uk		Karuppiah, Vijaykumar/0000-0002-9645-7958; Derrick, Jeremy/0000-0002-4350-5354				Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; de Graaff RAG, 2001, ACTA CRYSTALLOGR D, V57, P1857, DOI 10.1107/S0907444901016535; Derrick JP, 1999, J MOL BIOL, V293, P81, DOI 10.1006/jmbi.1999.3144; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; Pannu NS, 2004, ACTA CRYSTALLOGR D, V60, P22, DOI 10.1107/S0907444903020808; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonjum T, 2007, FEBS J, V274, P341; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	59	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24434	24442		10.1074/jbc.M111.243535	http://dx.doi.org/10.1074/jbc.M111.243535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596754	hybrid, Green Published			2022-12-25	WOS:000292294900083
J	Cigognini, D; Satta, A; Colleoni, B; Silva, D; Donega, M; Antonini, S; Gelain, F				Cigognini, Daniela; Satta, Alessandro; Colleoni, Bianca; Silva, Diego; Donega, Matteo; Antonini, Stefania; Gelain, Fabrizio			Evaluation of Early and Late Effects into the Acute Spinal Cord Injury of an Injectable Functionalized Self-Assembling Scaffold	PLOS ONE			English	Article							NEURAL STEM-CELLS; PEPTIDE NANOFIBER SCAFFOLD; MATRIX METALLOPROTEINASES; ADULT-RAT; AXONAL GROWTH; SCHWANN-CELLS; BRAIN-TISSUE; TRACT AXONS; REGENERATION; REPAIR	The complex physiopathological events occurring after spinal cord injury (SCI) make this devastating trauma still incurable. Self-assembling peptides (SAPs) are nanomaterials displaying some appealing properties for application in regenerative medicine because they mimic the structure of the extra-cellular matrix (ECM), are reabsorbable, allow biofunctionalizations and can be injected directly into the lesion. In this study we evaluated the putative neurorigenerative properties of RADA16-4G-BMHP1 SAP, proved to enhance in vitro neural stem cells survival and differentiation. This SAP (RADA16-I) has been functionalized with a bone marrow homing motif (BMHP1) and optimized via the insertion of a 4-glycine-spacer that ameliorates scaffold stability and exposure of the biomotifs. We injected the scaffold immediately after contusion in the rat spinal cord, then we evaluated the early effects by semi-quantitative RT-PCR and the late effects by histological analysis. Locomotor recovery over 8 weeks was assessed using Basso, Beattie, Bresnahan (BBB) test. Gene expression analysis showed that at 7 days after lesion the functionalized SAP induced a general upregulation of GAP-43, trophic factors and ECM remodelling proteins, whereas 3 days after SCI no remarkable changes were observed. Hystological analysis revealed that 8 weeks after SCI our scaffold increased cellular infiltration, basement membrane deposition and axon regeneration/sprouting within the cyst. Moreover the functionalized SAP showed to be compatible with the surrounding nervous tissue and to at least partially fill the cavities. Finally SAP injection resulted in a statistically significant improvement of both hindlimbs' motor performance and forelimbs-hindlimbs coordination. Altogether, these results indicate that RADA16-4G-BMHP1 induced favourable reparative processes, such as matrix remodelling, and provided a physical and trophic support to nervous tissue ingrowth. Thus this biomaterial, eventually combined with cells and growth factors, may constitute a promising biomimetic scaffold for regenerative applications in the injured central nervous system.	[Cigognini, Daniela; Satta, Alessandro; Colleoni, Bianca; Silva, Diego; Donega, Matteo; Antonini, Stefania; Gelain, Fabrizio] Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy; [Cigognini, Daniela; Silva, Diego; Antonini, Stefania; Gelain, Fabrizio] Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, Milan, Italy; [Gelain, Fabrizio] Casa Sollievo della Sofferenza Hosp, San Giovanni Rotondo, Italy	University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Casa Sollievo Della Sofferenza	Cigognini, D (corresponding author), Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy.	fabrizio.gelain@unimib.it	Gelain, Fabrizio G/K-5069-2012; Satta, Alessandro/Q-3504-2019	Gelain, Fabrizio G/0000-0002-2624-5853; Satta, Alessandro/0000-0002-3717-9337	CARIPLO Foundation; Regione Lombardia (Local Government)	CARIPLO Foundation(Fondazione Cariplo); Regione Lombardia (Local Government)(Regione Lombardia)	This work was supported by CARIPLO Foundation and Regione Lombardia (Local Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Arcaute K, 2010, ACTA BIOMATER, V6, P1047, DOI 10.1016/j.actbio.2009.08.017; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Fernandes KJL, 1999, J COMP NEUROL, V414, P495, DOI 10.1002/(SICI)1096-9861(19991129)414:4<495::AID-CNE6>3.0.CO;2-S; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; *ICCP, 2007, EXP TREATM SPIN CORD; JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018; King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lu HZ, 2009, ACTA NEUROBIOL EXP, V69, P441; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Andrade MSR, 2010, BRAIN RES, V1346, P266, DOI 10.1016/j.brainres.2010.05.070; Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009; Ringhoffer M, 2001, INT J ONCOL, V19, P983; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004; Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Sinescu Crina, 2010, J Med Life, V3, P254; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsiper MV, 2002, J CELL SCI, V115, P1005; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Yao L, 2010, J BIOMED MATER RES A, V92A, P484, DOI 10.1002/jbm.a.32359; Ye JL, 2004, BRAIN RES, V997, P30, DOI 10.1016/j.brainres.2003.10.036; Ye ZY, 2008, J PEPT SCI, V14, P152, DOI 10.1002/psc.988; Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	66	94	107	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19782	10.1371/journal.pone.0019782	http://dx.doi.org/10.1371/journal.pone.0019782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611127	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200032
J	Martins, AS; Ordonez, JL; Amaral, AT; Prins, F; Floris, G; Debiec-Rychter, M; Hogendoorn, PCW; de Alava, E				Sofia Martins, Ana; Luis Ordonez, Jose; Teresa Amaral, Ana; Prins, Frans; Floris, Giuseppe; Debiec-Rychter, Maria; Hogendoorn, Pancras C. W.; de Alava, Enrique			IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR-I; INSULIN-RECEPTOR SUBSTRATE-1; ADENOCARCINOMA A549 CELLS; MEDIATED ENDOCYTOSIS; INTERNALIZATION; PATHWAY; SENSITIVITY; MECHANISMS; EXPRESSION; CAVEOLAE	Receptor endocytosis is critical for cell signaling. IGF1R mediates an autocrine loop that is de-regulated in Ewing Sarcoma (ES) cells. Here we study the impact of IGF1R internalization, mediated by clathrin and caveolin-1 (CAV1), in ES signaling. We used clathrin and CAV1-siRNA to interfere in clathrin-and caveolin-dependent endocytosis. Chlorpromazine (CPMZ) and methyl-beta-cyclo-dextrin (MCD) were also used in order to inhibit clathrin-and caveolin-dependent endocytosis, respectively. We analyzed IGF1R internalization and co-localization with clathrin and CAV1 upon ligand binding, as well as the status of the IGF1R pathway, cellular proliferation, and the apoptosis of interfered and inhibited ES cells. We performed a high-throughput tyrosine kinase phosphorylation assay to analyze the effects of combining the IGF1R tyrosine kinase inhibitor AEW541 (AEW) with CPMZ or MCD on the intracellular phospho-proteome. We observed that IGF1R is internalized upon ligand binding in ES cells and that this process is dependent on clathrin or CAV1. The blockage of receptor internalization inhibited AKT and MAPK phosphorylation, reducing the proliferative rate of ES cells and increasing the levels of apoptosis. Combination of AEW with CPMZ or MCD largely enhanced these effects. CAV1 and clathrin endocytosis controls IGF1R internalization and signaling and has a profound impact on ES IGF1R-promoted survival signaling. We propose the combination of tyrosine-kinase inhibitors with endocytosis inhibitors as a new therapeutic approach to achieve a stronger degree of receptor inhibition in this, or other neoplasms dependent on IGF1R signaling.	[Sofia Martins, Ana; Luis Ordonez, Jose; Teresa Amaral, Ana; de Alava, Enrique] Univ Salamanca, Lab Mol Pathol 20, Sarcomas Lab, Ctr Invest Canc IBMCC,CSIC, E-37008 Salamanca, Spain; [Prins, Frans; Hogendoorn, Pancras C. W.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Floris, Giuseppe] Catholic Univ Louvain, Expt Oncol Lab, B-3000 Louvain, Belgium; [Debiec-Rychter, Maria] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite Catholique Louvain; Universite Catholique Louvain	Martins, AS (corresponding author), Univ Salamanca, Lab Mol Pathol 20, Sarcomas Lab, Ctr Invest Canc IBMCC,CSIC, E-37008 Salamanca, Spain.	edealava@usal.es	IBIS, SARCOMAS/O-1893-2015; de Alava, Enrique/GOH-0368-2022; Hogendoorn, Pancras/O-6494-2019; Ordóñez, José Luis/B-6069-2017; Hogendoorn, Pancras C.W./H-5859-2015; Floris, Giuseppe/AAG-6754-2022; Floris, Giuseppe/AFL-6620-2022	de Alava, Enrique/0000-0001-8400-046X; Hogendoorn, Pancras/0000-0002-1513-8104; Ordóñez, José Luis/0000-0002-3791-4215; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Floris, Giuseppe/0000-0003-2391-5425; Floris, Giuseppe/0000-0003-2391-5425; Amaral, Ana/0000-0001-7887-4814	EuroBoNet; European research network, European Commission [018814]; Instituto de Salud Carlos Tercero [PI081828]; ISCIII [CD6/00001]	EuroBoNet(European CommissionEuropean Commission Joint Research Centre); European research network, European Commission(European CommissionEuropean Commission Joint Research Centre); Instituto de Salud Carlos Tercero; ISCIII(Instituto de Salud Carlos III)	Funding provided by EuroBoNet, the European research network on bone tumors (FP6-2004-Lifescihealth-5, proposal number 018814)-European Commission and the Instituto de Salud Carlos Tercero, FIS- project PI081828. J.L. Ordonez is supported by the ISCIII (Contratos Perfeccionamiento CD6/00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carelli S, 2006, J CELL PHYSIOL, V208, P354, DOI 10.1002/jcp.20670; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chen J, 2008, J CELL PHYSIOL, V217, P281, DOI 10.1002/jcp.21498; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CHUANG LM, 1993, P NATL ACAD SCI USA, V90, P5172, DOI 10.1073/pnas.90.11.5172; Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dong AQ, 2008, ACTA BIOCH BIOPH SIN, V40, P497, DOI 10.1111/j.1745-7270.2008.00429.x; FURLANETTO RW, 1988, ENDOCRINOLOGY, V122, P2044, DOI 10.1210/endo-122-5-2044; Furukawa M, 2005, CLIN CANCER RES, V11, P3233, DOI 10.1158/1078-0432.CCR-04-1915; GIORGETTI S, 1994, EUR J BIOCHEM, V223, P195, DOI 10.1111/j.1432-1033.1994.tb18983.x; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Ma ZY, 2007, CELL MOL BIOL LETT, V12, P556, DOI 10.2478/s11658-007-0022-1; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Martins AS, 2008, CANCER RES, V68, P6260, DOI 10.1158/0008-5472.CAN-07-3074; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Strammiello R, 2003, HORM METAB RES, V35, P675; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; VANDERVEN LTM, 1994, INT J CANCER, V59, P427, DOI 10.1002/ijc.2910590323; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yang JL, 2007, J SURG ONCOL, V95, P183, DOI 10.1002/jso.20636; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	37	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19846	10.1371/journal.pone.0019846	http://dx.doi.org/10.1371/journal.pone.0019846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611203	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500030
J	Xu, ZF; Yue, M; Zhou, R; Jin, Q; Fan, Y; Bei, WC; Chen, HC				Xu, Zhuofei; Yue, Min; Zhou, Rui; Jin, Qi; Fan, Yang; Bei, Weicheng; Chen, Huanchun			Genomic Characterization of Haemophilus parasuis SH0165, a Highly Virulent Strain of Serovar 5 Prevalent in China	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; ACTINOBACILLUS-PLEUROPNEUMONIAE; MOLECULAR CHARACTERIZATION; MANNHEIMIA-HAEMOLYTICA; IRON ACQUISITION; GENE-CLUSTER; DNA UPTAKE; IDENTIFICATION; SEQUENCE; EXPRESSION	Haemophilus parasuis can be either a commensal bacterium of the porcine respiratory tract or an opportunistic pathogen causing Glasser's disease, a severe systemic disease that has led to significant economical losses in the pig industry worldwide. We determined the complete genomic sequence of H. parasuis SH0165, a highly virulent strain of serovar 5, which was isolated from a hog pen in North China. The single circular chromosome was 2,269,156 base pairs in length and contained 2,031 protein-coding genes. Together with the full spectrum of genes detected by the analysis of metabolic pathways, we confirmed that H. parasuis generates ATP via both fermentation and respiration, and possesses an intact TCA cycle for anabolism. In addition to possessing the complete pathway essential for the biosynthesis of heme, this pathogen was also found to be well-equipped with different iron acquisition systems, such as the TonB system and ABC-type transport complexes, to overcome iron limitation during infection and persistence. We identified a number of genes encoding potential virulence factors, such as type IV fimbriae and surface polysaccharides. Analysis of the genome confirmed that H. parasuis is naturally competent, as genes related to DNA uptake are present. A nine-mer DNA uptake signal sequence (ACAAGCGGT), identical to that found in Actinobacillus pleuropneumoniae and Mannheimia haemolytica, followed by similar downstream motifs, was identified in the SH0165 genome. Genomic and phylogenetic comparisons with other Pasteurellaceae species further indicated that H. parasuis was closely related to another swine pathogenic bacteria A. pleuropneumoniae. The comprehensive genetic analysis presented here provides a foundation for future research on the metabolism, natural competence and virulence of H. parasuis.	[Xu, Zhuofei; Yue, Min; Zhou, Rui; Bei, Weicheng; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Jin, Qi; Fan, Yang] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China	Huazhong Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Xu, ZF (corresponding author), Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	beiwc@mail.hzau.edu.cn; chenhch@mail.hzau.edu.cn	Yue, Min/H-2760-2019	Yue, Min/0000-0002-6787-0794	National Natural Science Foundation of China [30901075, 30970109]; National Programs for High Technology Research [2010AA10A202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Programs for High Technology Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (30901075, 30970109), National Programs for High Technology Research (No. 2010AA10A202) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amano H, 1997, J VET MED SCI, V59, P451, DOI 10.1292/jvms.59.451; Banks KE, 2008, J INFECT DIS, V197, P1531, DOI 10.1086/588001; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BIBERSTEIN EL, 1969, J MED MICROBIOL, V2, P75, DOI 10.1099/00222615-2-1-75; Bigas A, 2005, VET MICROBIOL, V105, P223, DOI 10.1016/j.vetmic.2004.10.015; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bozue JA, 1999, J BIOL CHEM, V274, P4106, DOI 10.1074/jbc.274.7.4106; Brondijk THC, 2002, MOL MICROBIOL, V44, P245, DOI 10.1046/j.1365-2958.2002.02875.x; Buettner FFR, 2008, INFECT IMMUN, V76, P2284, DOI 10.1128/IAI.01540-07; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Challacombe JF, 2007, J BACTERIOL, V189, P1890, DOI 10.1128/JB.01422-06; CHARLAND N, 1995, CAN J MICROBIOL, V41, P70, DOI 10.1139/m95-009; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Del Rio ML, 2006, VET RES, V37, P49, DOI 10.1051/vetres:2005039; del Rio ML, 2005, FEMS IMMUNOL MED MIC, V45, P75, DOI 10.1016/j.femsim.2005.02.008; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erbel PJA, 2003, J BACTERIOL, V185, P1995, DOI 10.1128/JB.185.6.1995-2004.2003; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FINK DL, 2006, PROKARYOTES, V6, P1034; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frase H, 2007, BIOCHEMISTRY-US, V46, P6647, DOI 10.1021/bi7002789; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P1201, DOI 10.1128/IAI.63.4.1201-1210.1995; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jahreis K, 2002, J BACTERIOL, V184, P5307, DOI 10.1128/JB.184.19.5307-5316.2002; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lagergard Teresa, 1995, Trends in Microbiology, V3, P87, DOI 10.1016/S0966-842X(00)88888-5; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lichtensteiger CA, 2003, VET MICROBIOL, V93, P79, DOI 10.1016/S0378-1135(02)00443-1; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; MUNCH S, 1992, J VET MED B, V39, P59, DOI 10.1111/j.1439-0450.1992.tb01138.x; Nedbalcova K, 2006, VET MED-CZECH, V51, P168, DOI 10.17221/5537-VETMED; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Oliveira S, 2003, AM J VET RES, V64, P435, DOI 10.2460/ajvr.2003.64.435; Olvera A, 2006, APPL ENVIRON MICROB, V72, P3984, DOI 10.1128/AEM.02834-05; Olvera A, 2010, VET RES, V41, DOI 10.1051/vetres/2009074; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pina S, 2009, J BACTERIOL, V191, P576, DOI 10.1128/JB.00703-08; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; REID G, 1987, REV INFECT DIS, V9, P470; Rhodes ER, 2005, INFECT IMMUN, V73, P3758, DOI 10.1128/IAI.73.6.3758-3763.2005; Roehrig SC, 2007, VET MICROBIOL, V121, P316, DOI 10.1016/j.vetmic.2006.12.013; Ruiz A, 2001, J CLIN MICROBIOL, V39, P1757, DOI 10.1128/JCM.39.5.1757-1762.2001; Sack M, 2009, VET MICROBIOL, V136, P382, DOI 10.1016/j.vetmic.2008.11.008; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; SIDIBE M, 1993, CAN J VET RES, V57, P204; Stevenson A, 2003, VET MICROBIOL, V92, P121, DOI 10.1016/S0378-1135(02)00351-6; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tullius MV, 1996, J BIOL CHEM, V271, P15373, DOI 10.1074/jbc.271.26.15373; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Watson AA, 1996, GENE, V180, P49, DOI 10.1016/S0378-1119(96)00403-9; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08; Zhou HZ, 2010, VET MICROBIOL, V144, P377, DOI 10.1016/j.vetmic.2010.01.023; Zucker BA, 1996, AM J VET RES, V57, P63	85	39	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19631	10.1371/journal.pone.0019631	http://dx.doi.org/10.1371/journal.pone.0019631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611187	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500009
J	Galian, C; Manon, F; Dezi, M; Torres, C; Ebel, C; Levy, D; Jault, JM				Galian, Carmen; Manon, Florence; Dezi, Manuela; Torres, Cristina; Ebel, Christine; Levy, Daniel; Jault, Jean-Michel			Optimized Purification of a Heterodimeric ABC Transporter in a Highly Stable Form Amenable to 2-D Crystallization	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ANTIGEN-PROCESSING TAP; BINDING CASSETTE TRANSPORTER; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MULTIDRUG-RESISTANCE PROTEIN-1; ATP-BINDING; MEMBRANE-PROTEINS; P-GLYCOPROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI	Optimized protocols for achieving high-yield expression, purification and reconstitution of membrane proteins are required to study their structure and function. We previously reported high-level expression in Escherichia coli of active BmrC and BmrD proteins from Bacillus subtilis, previously named YheI and YheH. These proteins are half-transporters which belong to the ABC (ATP-Binding Cassette) superfamily and associate in vivo to form a functional transporter able to efflux drugs. In this report, high-yield purification and functional reconstitution were achieved for the heterodimer BmrC/BmrD. In contrast to other detergents more efficient for solubilizing the transporter, dodecyl-beta-D-maltoside (DDM) maintained it in a drug-sensitive and vanadate-sensitive ATPase-competent state after purification by affinity chromatography. High amounts of pure proteins were obtained which were shown either by analytical ultracentrifugation or gel filtration to form a monodisperse heterodimer in solution, which was notably stable for more than one month at 4 degrees C. Functional reconstitution using different lipid compositions induced an 8-fold increase of the ATPase activity (k(cat)similar to 5 s(-1)). We further validated that the quality of the purified BmrC/BmrD heterodimer is suitable for structural analyses, as its reconstitution at high protein densities led to the formation of 2-D crystals. Electron microscopy of negatively stained crystals allowed the calculation of a projection map at 20 angstrom resolution revealing that BmrC/BmrD might assemble into oligomers in a lipidic environment.	[Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] CNRS, UMR 5075, Grenoble, France; [Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] CEA, Grenoble, France; [Dezi, Manuela; Levy, Daniel] Inst Curie, Ctr Rech, Paris, France; [Dezi, Manuela; Levy, Daniel] CNRS, UMR 168, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Galian, C (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden.	jean-michel.jault@ibs.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; levy, daniel/0000-0002-8949-4072; Dezi, Manuela/0000-0001-8727-9910; Ebel, Christine/0000-0002-6912-500X	Agence Nationale de la Recherche [ANR-06-Blan-0420, ANR-PCV06-135269]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the 'Agence Nationale de la Recherche', grant No: ANR-06-Blan-0420 (to D.L. & J.-M.J.) and ANR-PCV06-135269 (to J.-M.J.), and initial funding from the CNRS as an ATIP program to J.-M.J. is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bourdineaud JP, 2004, INT J FOOD MICROBIOL, V92, P1, DOI 10.1016/S0168-1605(03)00162-4; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dalmas O, 2005, BIOCHEMISTRY-US, V44, P4312, DOI 10.1021/bi0482809; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Ferreira-Pereira A, 2003, J BIOL CHEM, V278, P11995, DOI 10.1074/jbc.M212198200; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lee EW, 2003, ANTIMICROB AGENTS CH, V47, P3733, DOI 10.1128/AAC.47.12.3733-3738.2003; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Margolles A, 2006, MICROBIOL-SGM, V152, P3497, DOI 10.1099/mic.0.29097-0; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Newby ZER, 2009, NAT PROTOC, V4, P619, DOI 10.1038/nprot.2009.27; Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Robertson GT, 2005, ANTIMICROB AGENTS CH, V49, P4781, DOI 10.1128/AAC.49.11.4781-4783.2005; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Salvay AG, 2006, PROG COLL POL SCI S, V131, P74, DOI 10.1007/2882_006; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Uebel S, 1997, FEBS LETT, V416, P359, DOI 10.1016/S0014-5793(97)01222-2; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Wang J, 2008, BIOCHEMISTRY-US, V47, P5194, DOI 10.1021/bi800292v; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward A, 2009, J STRUCT BIOL, V165, P169, DOI 10.1016/j.jsb.2008.11.006; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	84	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19677	10.1371/journal.pone.0019677	http://dx.doi.org/10.1371/journal.pone.0019677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602923	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500020
J	Li, L; Xiao, XS; Li, SQ; Jia, XY; Wang, PF; Guo, XM; Jiao, XD; Zhang, QJ; Hejtmancik, JF				Li, Lin; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Wang, Panfeng; Guo, Xiangming; Jiao, Xiaodong; Zhang, Qingjiong; Hejtmancik, J. Fielding			Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis	PLOS ONE			English	Article							GENOTYPING MICROARRAY; RETINITIS-PIGMENTOSA; RETINAL DYSTROPHIES; MOLECULAR-GENETICS; MISSENSE MUTATIONS; ALLELES; SPECTRUM; PROTEIN; CRX	Background: Leber congenital amaurosis (LCA) is the earliest onset and most severe form of hereditary retinal dystrophy. So far, full spectrum of variations in the 15 genes known to cause LCA has not been systemically evaluated in East Asians. Therefore, we performed comprehensive detection of variants in these 15 genes in 87 unrelated Han Chinese patients with LCA. Methodology/Principal Findings: The 51 most frequently mutated exons and introns in the 15 genes were selected for an initial scan using cycle sequencing. All the remaining exons in 11 of the 15 genes were subsequently sequenced. Fifty-three different variants were identified in 44 of the 87 patients (50.6%), involving 78 of the 88 alleles (11 homozygous and 56 heterozygous variants). Of the 53 variants, 35 (66%) were novel pathogenic mutations. In these Chinese patients, variants in GUCY2D are the most common cause of LCA (16.1% cases), followed by CRB1 (11.5%), RPGRIP1 (8%), RPE65 (5.7%), SPATA7 (4.6%), CEP290 (4.6%), CRX (3.4%), LCA5 (2.3%), MERTK (2.3%), AIPL1 (1.1%), and RDH12 (1.1%). This differs from the variation spectrum described in other populations. An initial scan of 55 of 215 PCR amplicons, including 214 exons and 1 intron, detected 83.3% (65/78) of the mutant alleles ultimately found in these 87 patients. In addition, sequencing only 9 exons would detect over 50% of the identified variants and require less than 5% of the labor and cost of comprehensive sequencing for all exons. Conclusions/Significance: Our results suggest that specific difference in the variation spectrum found in LCA patients from the Han Chinese and other populations are related by ethnicity. Sequencing exons in order of decreasing risk is a cost-effective way to identify causative mutations responsible for LCA, especially in the context of genetic counseling for individual patients in a clinical setting.	[Li, Lin; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Wang, Panfeng; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Lin; Jiao, Xiaodong; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Li, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	qingjiongzhang@yahoo.com	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Science Fund for Distinguished Young Scholars [30725044]; National 973 Plan of China [2010CB529904]; NATIONAL EYE INSTITUTE [ZIAEY000272] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National 973 Plan of China(National Basic Research Program of China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Science Fund for Distinguished Young Scholars (30725044, http://www.nsfc.gov.cn/Portal0/default124.htm) and National 973 Plan of China (2010CB529904, http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Cremers FPM, 2002, HUM MOL GENET, V11, P1169, DOI 10.1093/hmg/11.10.1169; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Leber T., 1869, ALBRECHT GRAEFES ARC, V15, P1, DOI [DOI 10.1007/BF02721213, 10.1007/BF02721213]; Li YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/iovs.08-2589; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Rozet JM, 2000, INVEST OPHTH VIS SCI, V41, pS533; Seong MW, 2008, MOL VIS, V14, P1429; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Sundaresan P, 2009, MOL VIS, V15, P1781; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; Wang PF, 2007, GRAEF ARCH CLIN EXP, V245, P1401, DOI 10.1007/s00417-007-0554-0; Yoshida S, 2006, MOL VIS, V12, P1558; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111; Zhang Q, 2001, Ophthalmic Genet, V22, P89, DOI 10.1076/opge.22.2.89.2227	36	78	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19458	10.1371/journal.pone.0019458	http://dx.doi.org/10.1371/journal.pone.0019458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602930	Green Published, gold, Green Submitted			2022-12-25	WOS:000290558500010
J	Valenzuela, MS; Chen, YD; Davis, S; Yang, F; Walker, RL; Bilke, S; Lueders, J; Martin, MM; Aladjem, MI; Massion, PP; Meltzer, PS				Valenzuela, Manuel S.; Chen, Yidong; Davis, Sean; Yang, Fan; Walker, Robert L.; Bilke, Sven; Lueders, John; Martin, Melvenia M.; Aladjem, Mirit I.; Massion, Pierre P.; Meltzer, Paul S.			Preferential Localization of Human Origins of DNA Replication at the 5 '-Ends of Expressed Genes and at Evolutionarily Conserved DNA Sequences	PLOS ONE			English	Article							HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; INITIATION; GENOME; SITES; CHROMATIN; ELEMENTS; IDENTIFICATION; ORGANIZATION; METAZOANS	Background: Replication of mammalian genomes requires the activation of thousands of origins which are both spatially and temporally regulated by as yet unknown mechanisms. At the most fundamental level, our knowledge about the distribution pattern of origins in each of the chromosomes, among different cell types, and whether the physiological state of the cells alters this distribution is at present very limited. Methodology/Principal Findings: We have used standard lambda-exonuclease resistant nascent DNA preparations in the size range of 0.7-1.5 kb obtained from the breast cancer cell line MCF-7 hybridized to a custom tiling array containing 50-60 nt probes evenly distributed among genic and non-genic regions covering about 1% of the human genome. A similar DNA preparation was used for high-throughput DNA sequencing. Array experiments were also performed with DNA obtained from BT-474 and H520 cell lines. By determining the sites showing nascent DNA enrichment, we have localized several thousand origins of DNA replication. Our major findings are: (a) both array and DNA sequencing assay methods produced essentially the same origin distribution profile; (b) origin distribution is largely conserved (> 70%) in all cell lines tested; (c) origins are enriched at the 5' ends of expressed genes and at evolutionarily conserved intergenic sequences; and (d) ChIP on chip experiments in MCF-7 showed an enrichment of H3K4Me3 and RNA Polymerase II chromatin binding sites at origins of DNA replication. Conclusions/Significance: Our results suggest that the program for origin activation is largely conserved among different cell types. Also, our work supports recent studies connecting transcription initiation with replication, and in addition suggests that evolutionarily conserved intergenic sequences have the potential to participate in origin selection. Overall, our observations suggest that replication origin selection is a stochastic process significantly dependent upon local accessibility to replication factors.	[Valenzuela, Manuel S.; Chen, Yidong; Davis, Sean; Yang, Fan; Walker, Robert L.; Bilke, Sven; Lueders, John; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Valenzuela, Manuel S.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Martin, Melvenia M.; Aladjem, Mirit I.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Massion, Pierre P.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Meharry Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Valenzuela, MS (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mvalenzuela@mmc.edu; pmeltzer@mail.nih.gov	Davis, Sean/AAD-1801-2021; Aladjem, Mirit/G-2169-2010	Davis, Sean/0000-0002-8991-6458; Aladjem, Mirit/0000-0002-1875-3110; Walker, Robert/0000-0001-8235-4686	NIH [CA138180, CA102353]; NATIONAL CANCER INSTITUTE [ZIABC011091, SC1CA138180, R01CA102353, ZIABC010411] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by NIH intramural funding and by NIH grants [CA138180 to MSV, and CA102353 to PPM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; DePamphilis ML, 1997, METHODS, V13, P211, DOI 10.1006/meth.1997.0521; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; DOBBS DL, 1994, NUCLEIC ACIDS RES, V22, P2479, DOI 10.1093/nar/22.13.2479; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gerbi SA, 1997, METHODS, V13, P271, DOI 10.1006/meth.1997.0526; Gomez M, 2008, GENE DEV, V22, P375, DOI 10.1101/gad.445608; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Hu L, 2004, BIOCHEM BIOPH RES CO, V320, P648, DOI 10.1016/j.bbrc.2004.06.018; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kornberg A., 1992, DNA REPLICATION; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Price GB, 2003, J BIOL CHEM, V278, P19649, DOI 10.1074/jbc.M207002200; Rhind N, 2010, CHROMOSOME RES, V18, P35, DOI 10.1007/s10577-009-9093-3; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; TODOROVIC V, 1999, FRONT BIOSCI, V4, P859; VALENZUELA MS, 1990, MOL GEN GENET, V220, P361, DOI 10.1007/BF00391739; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276	35	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e17308	10.1371/journal.pone.0017308	http://dx.doi.org/10.1371/journal.pone.0017308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602917	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500001
J	Mochizuki, H; Toda, H; Ando, M; Kurusu, M; Tomoda, T; Furukubo-Tokunaga, K				Mochizuki, Hiroaki; Toda, Hirofumi; Ando, Mai; Kurusu, Mitsuhiko; Tomoda, Toshifumi; Furukubo-Tokunaga, Katsuo			Unc-51/ATG1 Controls Axonal and Dendritic Development via Kinesin-Mediated Vesicle Transport in the Drosophila Brain	PLOS ONE			English	Article							BODY NEURONAL MORPHOGENESIS; INHIBITS CELL-GROWTH; CAENORHABDITIS-ELEGANS; C-ELEGANS; MUSHROOM BODIES; SERINE/THREONINE KINASE; EXPRESSION PATTERNS; DEPENDENT TRANSPORT; UNC-51-LIKE KINASE; FASCICLIN-II	Background: Members of the evolutionary conserved Ser/Thr kinase Unc-51 family are key regulatory proteins that control neural development in both vertebrates and invertebrates. Previous studies have suggested diverse functions for the Unc-51 protein, including axonal elongation, growth cone guidance, and synaptic vesicle transport. Methodology/Principal Findings: In this work, we have investigated the functional significance of Unc-51-mediated vesicle transport in the development of complex brain structures in Drosophila. We show that Unc-51 preferentially accumulates in newly elongating axons of the mushroom body, a center of olfactory learning in flies. Mutations in unc-51 cause disintegration of the core of the developing mushroom body, with mislocalization of Fasciclin II (Fas II), an IgG-family cell adhesion molecule important for axonal guidance and fasciculation. In unc-51 mutants, Fas II accumulates in the cell bodies, calyx, and the proximal peduncle. Furthermore, we show that mutations in unc-51 cause aberrant overshooting of dendrites in the mushroom body and the antennal lobe. Loss of unc-51 function leads to marked accumulation of Rab5 and Golgi components, whereas the localization of dendrite-specific proteins, such as Down syndrome cell adhesion molecule (DSCAM) and No distributive disjunction (Nod), remains unaltered. Genetic analyses of kinesin light chain (Klc) and unc-51 double heterozygotes suggest the importance of kinesin-mediated membrane transport for axonal and dendritic development. Moreover, our data demonstrate that loss of Klc activity causes similar axonal and dendritic defects in mushroom body neurons, recapitulating the salient feature of the developmental abnormalities caused by unc-51 mutations. Conclusions/Significance: Unc-51 plays pivotal roles in the axonal and dendritic development of the Drosophila brain. Unc-51-mediated membrane vesicle transport is important in targeted localization of guidance molecules and organelles that regulate elongation and compartmentalization of developing neurons.	[Mochizuki, Hiroaki; Toda, Hirofumi; Ando, Mai; Furukubo-Tokunaga, Katsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Struct Biol Ctr, Natl Inst Genet, Shizuoka, Japan; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Toda, Hirofumi; Tomoda, Toshifumi] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA	University of Tsukuba; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; City of Hope; Beckman Research Institute of City of Hope	Mochizuki, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	furukubo-tokunaga.gm@u.tsukuba.ac.jp	Toda, Hirofumi/U-3521-2018	Toda, Hirofumi/0000-0002-6247-2826	Rose Hills Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [20570196, 20700319]	Rose Hills Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Rose Hills Foundation (http://www.rosehillsfoundation.org/) to T.T. and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (www.mext.go.jp/english/) to K.F.T. (No. 20570196) and to M.K. (No. 20700319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2003, MECH DEVELOP, V120, P1113, DOI 10.1016/j.mod.2003.08.007; Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Clark IE, 1997, DEVELOPMENT, V124, P461; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497; Kurusu M, 2002, DEVELOPMENT, V129, P409; Kurusu M, 2008, MOL CELL NEUROSCI, V38, P53, DOI 10.1016/j.mcn.2008.01.015; Lai T, 2004, DEVELOPMENT, V131, P5991, DOI 10.1242/dev.01457; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yang JSJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003504; YANG MY, 1995, NEURON, V15, P45; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104	66	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19632	10.1371/journal.pone.0019632	http://dx.doi.org/10.1371/journal.pone.0019632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589871	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100021
J	Pepper, DJ; Marais, S; Wilkinson, RJ; Bhaijee, F; De Azevedo, V; Meintjes, G				Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; De Azevedo, Virginia; Meintjes, Graeme			Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; TUBERCULOSIS; CHALLENGES; MORTALITY; EPIDEMIC; GENDER; DURBAN; CARE; ART	Background: In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from initiating life-saving ART. Method: Setting. A South African township clinic with integrated tuberculosis and HIV services. Design. Logistic regression analyses of a prospective cohort of HIV-1 infected adults (>= 18 years) who commenced TB therapy, were eligible for ART, and were followed for 6 months. Findings: Of 100 HIV-1 infected adults eligible for ART during TB therapy, 90 TB patients presented to an ART clinic for assessment, 66 TB patients initiated ART, and 15 TB patients died. 34% of eligible TB patients (95% CI: 25-43%) did not initiate ART. Male gender and younger age (< 36 years) were associated with failure to initiate ART (adjusted odds ratios of 3.7 [95% CI: 1.25-10.95] and 3.3 [95% CI: 1.12-9.69], respectively). Death during TB therapy was associated with a CD4+ count < 100 cells/mL. Conclusion: In a clinic with integrated services for tuberculosis and HIV, one-third of eligible TB patients - particularly young men - did not initiate ART. Strategies are needed to promote ART initiation during TB therapy, especially among young men.	[Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Cape Town, South Africa; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England; [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England; [De Azevedo, Virginia] City Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town; Imperial College London; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	dominiquepepper@gmail.com	Marais, Suzaan/AAG-2750-2019	Marais, Suzaan/0000-0002-8050-9610; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	Perinatal HIV Research Unit; US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [081667, 084323, 088316]; Fogarty International Center South Africa (NIH/FIC) [1U2RTW007373-01A1, 1U2RTW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007370, U2RTW007373] Funding Source: NIH RePORTER; Medical Research Council [MC_U117588499] Funding Source: researchfish	Perinatal HIV Research Unit; US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa (NIH/FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (to DJP and SM); Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316). The data analysis was supported by a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; *BUS TRUST DPLG, 2007, KHAYEL NOD EC DEV PR; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636; *ETR NET S AFR, 2010, EL TUB REG; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Medicins Sans Frontieres, 2007, REP INT TB HIV SERV; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; *S AFR DEP HLTH, 2009, S AFR CLIN GUID MAN; South African Department of Health, 2004, S AFR NAT TUB CONTR; *STOP TB PARTN, 2009, TUB COUNTR; UNAIDS, 2008, REP GLOB AIDS EP; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; Veinot TC, 2006, J ADOLESCENT HEALTH, V38, P261, DOI 10.1016/j.jadohealth.2005.03.008; *WHO, 2007, GLOB TUB DAT PROF S; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	25	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19484	10.1371/journal.pone.0019484	http://dx.doi.org/10.1371/journal.pone.0019484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589868	gold, Green Submitted, Green Published			2022-12-25	WOS:000290531100012
J	Raju, I; Kumarasamy, A; Abraham, EC				Raju, Ilangovan; Kumarasamy, Anbarasu; Abraham, Edathara C.			Multiple Aggregates and Aggresomes of C-Terminal Truncated Human alpha A-Crystallins in Mammalian Cells and Protection by alpha B-Crystallin	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; HUMAN LENS CRYSTALLINS; CHAPERONE ACTIVITY; BOVINE; DEGRADATION; CHAIN; OLIGOMERIZATION; ACCUMULATION; CLEAVAGE; REGION	Background: Cleavage of 11 (alpha A162), 5 (alpha A168) and 1 (alpha A172) residues from the C-terminus of alpha A-crystallin creates structurally and functionally different proteins. The formation of these post-translationally modified alpha A-crystallins is enhanced in diabetes. In the present study, the fate of the truncated alpha A-crystallins expressed in living mammalian cells in the presence and absence of native alpha A- or alpha B-crystallin has been studied by laser scanning confocal microscopy (LSM). Methodology/Principal Findings: YFP tagged alpha Awt, alpha A162, alpha A168 and alpha A172, were individually transfected or co-transfected with CFP tagged alpha Awt or alpha Bwt, expressed in HeLa cells and studied by LSM. Difference in protein aggregation was not caused by different level of alpha-crystallin expression because Western blotting results showed nearly same level of expression of the various alpha-crystallins. The FRET-acceptor photo-bleaching protocol was followed to study in situ protein-protein interaction. alpha A172 interacted with alpha Awt and alpha Bwt better than alpha A168 and alpha A162, interaction of alpha Bwt being two-fold stronger than that of alpha Awt. Furthermore, aggresomes were detected in cells individually expressing alpha A162 and alpha A168 constructs and co-expression with alpha Bwt significantly sequestered the aggresomes. There was no sequestration of aggresomes with alpha Awt co-expression with the truncated constructs, alpha A162 and alpha A168. Double immunocytochemistry technique was used for co-localization of gamma-tubulin with alpha A-crystallin to demonstrate the perinuclear aggregates were aggresomes. Conclusions/Significance: alpha A172 showed the strongest interaction with both alpha Awt and alpha Bwt. Native alpha B-crystallin provided protection to partially unfolded truncated alpha A-crystallins whereas native alpha A-crystallin did not. Aggresomes were detected in cells expressing alpha A162 and alpha A168 and alpha Bwt co-expression with these constructs diminished the aggresome formation. Co-localization of gamma-tubulin in perinuclear aggregates validates for aggresomes.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Kumarasamy, Anbarasu] Bharathidasan Univ, Dept Biotechnol, Tiruchirappalli, India	University of Arkansas System; University of Arkansas Medical Sciences; Bharathidasan University	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu	Kumarasamy, Anbarasu/K-4703-2015	Kumarasamy, Anbarasu/0000-0002-1666-6742	National Institutes of Health [EY11352]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grant EY11352 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aziz A, 2007, BIOCHEMISTRY-US, V46, P2510, DOI 10.1021/bi0618722; Colvis C, 2002, ARCH BIOCHEM BIOPHYS, V397, P319, DOI 10.1006/abbi.2001.2669; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; SHEN D, 2010, CELL BIOCH IN PRESS; Takemoto LJ, 1998, EXP EYE RES, V66, P263, DOI 10.1006/exer.1997.0411; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19876	10.1371/journal.pone.0019876	http://dx.doi.org/10.1371/journal.pone.0019876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589881	Green Published, gold, Green Submitted			2022-12-25	WOS:000290531100033
J	Di Paola, R; Caporarello, N; Marucci, A; Dimatteo, C; Iadicicco, C; Del Guerra, S; Prudente, S; Sudano, D; Miele, C; Parrino, C; Piro, S; Beguinot, F; Marchetti, P; Trischitta, V; Frittitta, L				Di Paola, Rosa; Caporarello, Nunzia; Marucci, Antonella; Dimatteo, Claudia; Iadicicco, Claudia; Del Guerra, Silvia; Prudente, Sabrina; Sudano, Dora; Miele, Claudia; Parrino, Cristina; Piro, Salvatore; Beguinot, Francesco; Marchetti, Piero; Trischitta, Vincenzo; Frittitta, Lucia			ENPP1 Affects Insulin Action and Secretion: Evidences from In Vitro Studies	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; AMINO-ACID POLYMORPHISM; PANCREATIC BETA-CELLS; DEPENDENT DIABETES-MELLITUS; AFFECTS GLUCOSE-METABOLISM; RECEPTOR SUBSTRATE-1; ENDOPLASMIC-RETICULUM; K121Q POLYMORPHISM; RESISTANCE; MUSCLE	The aim of this study was to deeper investigate the mechanisms through which ENPP1, a negative modulator of insulin receptor (IR) activation, plays a role on insulin signaling, insulin secretion and eventually glucose metabolism. ENPP1 cDNA (carrying either K121 or Q121 variant) was transfected in HepG2 liver-, L6 skeletal muscle-and INS1E beta-cells. Insulin-induced IR-autophosphorylation (HepG2, L6, INS1E), Akt-Ser(473), ERK1/2-Thr(202)/Tyr(204) and GSK3-beta Ser(9) phosphorylation (HepG2, L6), PEPCK mRNA levels (HepG2) and 2-deoxy-D-glucose uptake (L6) was studied. GLUT 4 mRNA (L6), insulin secretion and caspase-3 activation (INS1E) were also investigated. Insulin-induced IR-autophosphorylation was decreased in HepG2-K, L6-K, INS1E-K (20%, 52% and 11% reduction vs. untransfected cells) and twice as much in HepG2-Q, L6-Q, INS1E-Q (44%, 92% and 30%). Similar data were obtained with Akt-Ser(473), ERK1/2-Thr(202)/Tyr(204) and GSK3-beta Ser(9) in HepG2 and L6. Insulin-induced reduction of PEPCK mRNA was progressively lower in untransfected, HepG2-K and HepG2-Q cells (65%, 54%, 23%). Insulin-induced glucose uptake in untransfected L6 (60% increase over basal), was totally abolished in L6-K and L6-Q cells. GLUT 4 mRNA was slightly reduced in L6-K and twice as much in L6-Q (13% and 25% reduction vs. untransfected cells). Glucose-induced insulin secretion was 60% reduced in INS1E-K and almost abolished in INS1E-Q. Serum deficiency activated caspase-3 by two, three and four folds in untransfected INS1E, INS1E-K and INS1E-Q. Glyburide-induced insulin secretion was reduced by 50% in isolated human islets from homozygous QQ donors as compared to those from KK and KQ individuals. Our data clearly indicate that ENPP1, especially when the Q121 variant is operating, affects insulin signaling and glucose metabolism in skeletal muscle-and liver-cells and both function and survival of insulin secreting beta-cells, thus representing a strong pathogenic factor predisposing to insulin resistance, defective insulin secretion and glucose metabolism abnormalities.	[Di Paola, Rosa; Marucci, Antonella; Dimatteo, Claudia; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Caporarello, Nunzia; Sudano, Dora; Parrino, Cristina; Frittitta, Lucia] Univ Catania, Sch Med, Garibaldi Hosp, Unit Endocrinol,Dept Clin & Mol Biomed, Catania, Italy; [Iadicicco, Claudia; Miele, Claudia; Beguinot, Francesco] Univ Napoli Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Iadicicco, Claudia; Miele, Claudia; Beguinot, Francesco] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Del Guerra, Silvia; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Prudente, Sabrina; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy; [Piro, Salvatore] Univ Catania, Sch Med, Garibaldi Hosp, Unit Internal Med,Dept Clin & Mol Biomed, Catania, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; University of Pisa; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Catania; Sapienza University Rome	Di Paola, R (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	r.dipaola@operapadrepio.it; v.trischitta@operapadrepio.it; lfritti@unict.it	frittitta, lucia/AAA-4733-2019; frittitta, Lucia/J-2334-2012; Di Paola, Rosa/G-7813-2011; Parrino, Cristina/H-4009-2018; Trischitta, Vincenzo/K-1487-2016; marucci, antonella/B-8722-2017; Piro, Salvatore/H-9353-2012; Prudente, Sabrina/H-2886-2016; Parrino, Cristina/ABA-7496-2020; Piro, Salvatore/P-7585-2019; Marchetti, Piero/J-7439-2013	frittitta, lucia/0000-0002-7941-5828; Di Paola, Rosa/0000-0001-5837-9111; Parrino, Cristina/0000-0002-1367-6208; Trischitta, Vincenzo/0000-0003-1174-127X; marucci, antonella/0000-0001-8131-8317; Piro, Salvatore/0000-0002-1781-0902; Prudente, Sabrina/0000-0001-9220-8981; Parrino, Cristina/0000-0002-1367-6208; Piro, Salvatore/0000-0002-1781-0902; Marchetti, Piero/0000-0003-4907-0635; Caporarello, Nunzia/0000-0002-3183-2868	Italian Ministry of Health [RC2008 RC2009 RC2010, RC2009 RC2011, RF05ED01]; Italian Ministry of University and Research [RBNE01N4Z9_009]; Telethon [E1239, GGP02423]; Fondazione Roma "Sostegno alla ricerca scientifica biomedica''; European Community [201681, RBIP0689BS, 115005]; Telethon, Italy	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon); Fondazione Roma "Sostegno alla ricerca scientifica biomedica''(Fondazione Roma); European Community(European Commission); Telethon, Italy(Fondazione Telethon)	This research was supported by Italian Ministry of Health Grants: RC2008 RC2009 RC2010 (R.D.P.), RC2009 RC2011 (V.T.), RF05ED01 (R.D.P.); Italian Ministry of University and Research Grant: RBNE01N4Z9_009; Telethon Grants: E1239 (V.T.) and GGP02423 (R.D.P.); Fondazione Roma "Sostegno alla ricerca scientifica biomedica 2008'' (V.T.); European Community's PREPOBEDIA 201681 (F.B.) and FIRB RBIP0689BS (F.B.). The financial support of Telethon, Italy, to F.B. is also gratefully acknowledged. P.M. and S.D.G. are supported in part by the European Community, project IMIDIA, N. 115005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2003, J CLIN ENDOCR METAB, V88, P5927, DOI 10.1210/jc.2003-030453; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; Andreozzi F, 2008, ARTERIOSCL THROM VAS, V28, P1355, DOI 10.1161/ATVBAHA.108.162883; Anello M, 2004, AM J PHYSIOL-ENDOC M, V287, pE602, DOI 10.1152/ajpendo.00320.2003; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Bacci S, 2011, DIABETES, V60, P1000, DOI 10.2337/db10-1300; Bacci S, 2009, ARTERIOSCL THROM VAS, V29, P1678, DOI 10.1161/ATVBAHA.109.189191; Baratta R, 2008, DIABETES, V57, P3360, DOI 10.2337/db07-1830; Belfiore A, 1996, MOL ENDOCRINOL, V10, P1318, DOI 10.1210/me.10.11.1318; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Chin CN, 2009, EUR J PHARMACOL, V606, P17, DOI 10.1016/j.ejphar.2009.01.016; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; CLAUSEN JO, 1995, LANCET, V346, P397, DOI 10.1016/S0140-6736(95)92779-4; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Frittitta L, 1998, DIABETES, V47, P1095, DOI 10.2337/diabetes.47.7.1095; Frittitta L, 1997, DIABETOLOGIA, V40, P282, DOI 10.1007/s001250050675; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Grarup N, 2006, DIABETOLOGIA, V49, P2097, DOI 10.1007/s00125-006-0353-x; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Liang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000882; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2002, DIABETES, V51, P1419, DOI 10.2337/diabetes.51.5.1419; Marucci A, 2009, J MOL MED, V87, P139, DOI 10.1007/s00109-008-0429-9; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Oriente F, 2011, DIABETES, V60, P138, DOI 10.2337/db10-0860; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Parker JC, 2004, LIFE SCI, V75, P1479, DOI 10.1016/j.lfs.2004.03.015; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Porzio O, 1999, J CLIN INVEST, V104, P357, DOI 10.1172/JCI5870; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S, 2010, DIABETOLOGIA, V53, P1354, DOI 10.1007/s00125-010-1749-1; Prudente S, 2009, J CLIN ENDOCR METAB, V94, P190, DOI 10.1210/jc.2008-1365; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Raciti GA, 2010, DIABETOLOGIA, V53, P955, DOI 10.1007/s00125-010-1676-1; Stentz Frankie B., 2007, Genomics Proteomics & Bioinformatics, V5, P216, DOI 10.1016/S1672-0229(08)60009-1; Stolerman ES, 2008, DIABETES, V57, P1971, DOI 10.2337/db08-0266; Stumvoll M, 2001, DIABETES, V50, P882, DOI 10.2337/diabetes.50.4.882; Teno S, 1999, DIABETES RES CLIN PR, V45, P25, DOI 10.1016/S0168-8227(99)00056-X; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Zhou HH, 2009, EUR J PHARMACOL, V616, P346, DOI 10.1016/j.ejphar.2009.06.057	54	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19462	10.1371/journal.pone.0019462	http://dx.doi.org/10.1371/journal.pone.0019462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573217	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400012
J	Bond, PJ; Faraldo-Gomez, JD				Bond, Peter J.; Faraldo-Gomez, Jose D.			Molecular Mechanism of Selective Recruitment of Syk Kinases by the Membrane Antigen-Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; PHOSPHORYLATED ITAM PEPTIDE; TERMINAL SH2 DOMAIN; TYROSINE KINASE; SIGNAL-TRANSDUCTION; ACTIVATION MOTIFS; PLASMON RESONANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ZAP-70	ZAP-70 and Syk are essential tyrosine kinases in intracellular immunological signaling. Both contain an inhibitory SH2 domain tandem, which assembles onto the catalytic domain. Upon binding to doubly phosphorylated ITAM motifs on activated antigen receptors, the arrangement of the SH2 domains changes. From available structures, this event is not obviously conducive to dissociation of the autoinhibited complex, yet it ultimately translates into kinase activation through a mechanism not yet understood. We present a comprehensive theoretical study of this molecular mechanism, using atomic resolution simulations and free-energy calculations, totaling >10 mu s of simulation time. Through these, we dissect the microscopic mechanism coupling stepwise ITAM engagement and SH2 tandem structural change and reveal key differences between ZAP-70 and Syk. Importantly, we show that a subtle conformational bias in the inter-SH2 connector causes ITAM to bind preferentially to kinase-dissociated tandems. We thus propose that phosphorylated antigen receptors selectively recruit kinases that are uninhibited and that the resulting population shift in the membrane vicinity sustains signal transduction.	Max Planck Inst Biophys, D-60438 Frankfurt, Germany; Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Max Planck Society	Faraldo-Gomez, JD (corresponding author), Max von Laue Str 3, D-60438 Frankfurt, Germany.	jose.faraldo@biophys.mpg.de	Faraldo-Gomez, Jose/H-7127-2016	Bond, Peter/0000-0003-2900-098X	Deutsche Forschungsgemeinschaft (DFG); Leibniz Supercomputer Center; European Molecular Biology Organization (EMBO) [ALTF 1021-2007]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Supercomputer Center; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Macromolecular Complexes" and by the Leibniz Supercomputer Center.; Supported by a European Molecular Biology Organization (EMBO) long-term fellowship (ALTF 1021-2007).	Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Labadia ME, 1997, ARCH BIOCHEM BIOPHYS, V342, P117, DOI 10.1006/abbi.1997.0118; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Taylor JD, 2008, PROTEINS, V73, P929, DOI 10.1002/prot.22119; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; Vely F, 1997, EUR J IMMUNOL, V27, P3010, DOI 10.1002/eji.1830271138; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhang YY, 2009, BIOCHEMISTRY-US, V48, P11075, DOI 10.1021/bi9012462	28	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25872	25881		10.1074/jbc.M111.223321	http://dx.doi.org/10.1074/jbc.M111.223321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21602568	Green Published, hybrid			2022-12-25	WOS:000293073000048
J	Botelho, TO; Guevara, T; Marrero, A; Arede, P; Fluxa, VS; Reymond, JL; Oliveira, DC; Gomis-Ruth, FX				Botelho, Tiago O.; Guevara, Tibisay; Marrero, Aniebrys; Arede, Pedro; Fluxa, Viviana S.; Reymond, Jean-Louis; Oliveira, Duarte C.; Xavier Gomis-Rueth, F.			Structural and Functional Analyses Reveal That Staphylococcus aureus Antibiotic Resistance Factor HmrA Is a Zinc-dependent Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; METHICILLIN RESISTANCE; CRYSTAL-STRUCTURE; BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; TERNARY COMPLEX; CELL-WALL; GENE; EXPRESSION; MECA	HmrA is an antibiotic resistance factor of methicillin-resistant Staphylococcus aureus. Molecular analysis of this protein revealed that it is not a muramidase or beta-lactamase but a nonspecific double-zinc endopeptidase consisting of a catalytic domain and an inserted oligomerization domain, which probably undergo a relative interdomain hinge rotation upon substrate binding. The active-site cleft is located at the domain interface. Four HmrA protomers assemble to a large similar to 170-kDa homotetrameric complex of 125 angstrom. All four active sites are fully accessible and similar to 50-70 angstrom apart, far enough apart to act on a large meshwork substrate independently but simultaneously. In vivo studies with four S. aureus strains of variable resistance levels revealed that the extracellular addition of HmrA protects against loss of viability in the presence of oxacillin and that this protection depends on proteolytic activity. All of these results indicate that HmrA is a peptidase that participates in resistance mechanisms in vivo in the presence of beta-lactams. Furthermore, our results have implications for most S. aureus strains of known genomic sequences and several other cocci and bacilli, which harbor close orthologs. This suggests that HmrA may be a new widespread antibiotic resistance factor in bacteria.	[Botelho, Tiago O.; Guevara, Tibisay; Marrero, Aniebrys; Xavier Gomis-Rueth, F.] Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Spain; [Arede, Pedro; Oliveira, Duarte C.] Univ Nova Lisboa, Ctr Microbiol Resources, Dept Life Sci, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Fluxa, Viviana S.; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-301 Bern, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Universidade Nova de Lisboa; University of Bern	Botelho, TO (corresponding author), Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	xgrcri@ibmb.csic.es	Oliveira, Duarte/B-4097-2008; Arede, Pedro/H-1690-2015	Arede, Pedro/0000-0002-5693-3147; Oliveira, Duarte/0000-0002-9591-1039; Guevara Puig, Tibisay/0000-0002-1366-8507; Oliveira Botelho, Tiago/0000-0002-2456-8421; Reymond, Jean-Louis/0000-0003-2724-2942; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	European Synchrotron Radiation Facility; Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education [SFRH/BD/15852/2005, SFRH/BD/38316/2007];  [FP7-HEALTH-F3-2009-223101];  [FP7-HEALTH-2010-261460];  [BIO2008-04080-E];  [BIO2009-10334];  [CSD2006-00015];  [PSE-010000-2009-8];  [2009SGR1036];  [100372];  [POCTI/BIA-MIC/60320/2004];  [PTDC/BIA-MIC/64071/2006];  [SNF200020/125020/1]	European Synchrotron Radiation Facility; Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education; ; ; ; ; ; ; ; ; ; ; 	This study was supported in part by grants from European, Portuguese, Spanish, Swiss, and Catalan agencies (FP7-HEALTH-F3-2009-223101 "AntiPathoGN," FP7-HEALTH-2010-261460 " Gums&Joints," BIO2008-04080-E, BIO2009-10334, CSD2006-00015, PSE-010000-2009-8, 2009SGR1036, Fundacio "La Marato de TV3" 100372, POCTI/BIA-MIC/60320/2004, PTDC/BIA-MIC/64071/2006, SNF200020/125020/1). Funding provided by the European Synchrotron Radiation Facility partially covered the cost of data collection.; Recipient of Fellowship SFRH/BD/15852/2005 from the Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education.; Recipient of fellowship SFRH/BD/38316/2007 from the Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education.	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; AULD DS, 2004, HDB PROTEOLYTIC ENZY, P268; AULD DS, 2004, HDB PROTEOLYTIC ENZY, P812; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger-Bachi B, 1999, CELL MOL LIFE SCI, V56, P764, DOI 10.1007/s000180050023; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124; BRANDEN CI, 1980, Q REV BIOPHYS, V13, P317, DOI 10.1017/S0033583500001712; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanella JJ, 2008, J PLANT GROWTH REGUL, V27, P26, DOI 10.1007/s00344-007-9027-2; Carranza C., 1999, 9039 CNRSUPR, P89; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; DELENCASTRE H, 1993, EUR J CLIN MICROBIOL, V12, P13; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Ghuysen JM, 1997, INT J ANTIMICROB AG, V8, P45, DOI 10.1016/S0924-8579(96)00358-5; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Gomis-Ruth F. X., 2011, BIOCH BIOPH IN PRESS, P1814; GomisRuth FX, 1997, J MOL BIOL, V269, P861, DOI 10.1006/jmbi.1997.1040; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; HIRAMATSU K, 1992, FEBS LETT, V298, P133, DOI 10.1016/0014-5793(92)80039-J; HIRAMATSU K, 1995, MICROBIOL IMMUNOL, V39, P531, DOI 10.1111/j.1348-0421.1995.tb02239.x; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ito Teruyo, 2004, Kansenshogaku Zasshi, V78, P459; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Lundgren S, 2007, J BIOL CHEM, V282, P36037, DOI 10.1074/jbc.M705517200; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray SS, 2003, PROTEINS, V50, P170, DOI 10.1002/prot.10272; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi DS, 2007, BIOPHYS CHEM, V126, P86, DOI 10.1016/j.bpc.2006.05.013; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Unno H, 2008, J BIOL CHEM, V283, P27289, DOI 10.1074/jbc.M801657200; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yang YZ, 2005, MOL BIOSYST, V1, P57, DOI 10.1039/b419446b	71	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25697	25709		10.1074/jbc.M111.247437	http://dx.doi.org/10.1074/jbc.M111.247437			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622555	hybrid, Green Published			2022-12-25	WOS:000293073000031
J	Eades, G; Yao, Y; Yang, MH; Zhang, YS; Chumsri, S; Zhou, Q				Eades, Gabriel; Yao, Yuan; Yang, Muhua; Zhang, Yongshu; Chumsri, Saranya; Zhou, Qun			miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; DNA METHYLATION; DOWN-REGULATION; BREAST-CANCER; HISTONE DEACETYLASE; PROSTATE-CANCER; HUMAN GENES; MICRORNAS; FAMILY; GROWTH	Evidence supports a critical role for microRNAs (miRNAs) in regulation of tissue-specific differentiation and development. Signifying a disruption of these programs, expression profiling has revealed extensive miRNA dysregulation in tumors compared with healthy tissue. The miR-200 family has been established as a key regulator of epithelial phenotype and, as such, is deeply involved in epithelial to mesenchymal transition (EMT) processes in breast cancer. However, the effects of the miR-200 family on transformation of normal mammary epithelial cells have yet to be fully characterized. By examining a TGF-beta driven model of transformation of normal mammary epithelium, we demonstrate that the class III histone deacetylase silent information regulator 1 (SIRT1), a proposed oncogene in breast cancer, is overexpressed upon EMT-like transformation and that epigenetic silencing of miR-200a contributes at least in part to the overexpression of SIRT1. We have established the SIRT1 transcript as subject to regulation by miR-200a, through miR-200a targeting of SIRT1 3'-UTR. We also observed SIRT1 and miR-200a participation in a negative feedback regulatory loop. Restoration of miR-200a or the knockdown of SIRT1 prevented transformation of normal mammary epithelial cells evidenced by decreased anchorage-independent growth and decreased cell migration. Finally, we observed SIRT1 overexpression in association with decreased miR-200a in breast cancer patient samples. These observations provide further evidence for a critical tumor suppressive role of the miR-200 family in breast epithelium in addition to identifying a novel regulatory mechanism, which may contribute to SIRT1 up-regulation in breast cancer.	[Eades, Gabriel; Yao, Yuan; Yang, Muhua; Zhang, Yongshu; Zhou, Qun] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chumsri, Saranya] Univ Maryland Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu			Flight Attendants Medical Research Institute [FAMRI YCSA072084]; Maryland Stem Cell Research Fund [2010-MSCRFE-0179-00]; NATIONAL CANCER INSTITUTE [T32CA154274, P30CA134274] Funding Source: NIH RePORTER	Flight Attendants Medical Research Institute; Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Flight Attendants Medical Research Institute Grant FAMRI YCSA072084 (to Q. Z.) and the Maryland Stem Cell Research Fund Grant 2010-MSCRFE-0179-00 (to Q. Z.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536	52	219	228	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25992	26002		10.1074/jbc.M111.229401	http://dx.doi.org/10.1074/jbc.M111.229401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596753	hybrid, Green Published			2022-12-25	WOS:000293073000058
J	Jiang, Y; Guo, Y; Xi, XY; Cui, LX; He, W				Jiang, Yan; Guo, Yang; Xi, Xueyan; Cui, Lianxian; He, Wei			Flanking V and J Sequences of Complementary Determining Region 3 of T Cell Receptor (TCR) delta 1 (CDR3 delta 1) Determine the Structure and Function of TCR gamma 4 delta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-DELTA; PERIPHERAL-BLOOD; ANTIGEN RECEPTOR; PROLIFERATIVE RESPONSES; DAUDI CELLS; IN-VITRO; RECOGNITION; LYMPHOCYTES; EXPRESSION; CHAIN	The gamma delta T cell receptor (TCR) differs from immunoglobulin and alpha beta TCR in its overall binding mode. In human, genes delta 1, delta 2, and delta 3 are used for TCR delta chains. Previously, we have studied antigen binding determinants of TCR delta 2 derived from dominant gamma delta T cells residing in peripheral blood. In this study we have investigated the critical determinants for antigen recognition and TCR function in TCR delta 1 originated from gastric tumor-infiltrating gamma delta T lymphocytes using three independent experimental strategies including complementary determining region 3 (CDR3) of TCR delta 1 (CDR3 delta 1)-peptide mediated binding, CDR3 delta 1-grafted TCR fusion protein-mediated binding, and TCR gamma 4 delta 1- and mutant-expressing cell-mediated binding. All three approaches consistently showed that the conserved flanking V and J sequences but not the diverse D segment in CDR3 delta 1 determine the antigen binding. Most importantly, we found that mutations in the V and J regions of CDR3 delta 1 also abolish the assembly of TCR and TCR-CD3 complexes in TCR gamma 4 delta 1-transduced J. RT3-T3.5 cells. Together with our previous studies on CDR3 delta 2 binding, our finding suggests that both human TCR delta 1 and TCR delta 2 recognize antigen predominately via flanking V and J regions. These results indicate that TCR gamma delta recognizes antigens using conserved parts in their CDR3, which provides an explanation for a diverse repertoire of gamma delta TCRs only recognizing a limited number of antigens.	[He, Wei] Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			Ministry of Science and Technology, China PR [2004CB518706]; Ministry of Science and Technology, China [2006AA02A245, 2007AA021109]; National Natural Science Foundation of China PR [30490244]	Ministry of Science and Technology, China PR(National High Technology Research and Development Program of China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Program for Key Basic Research Projects, Ministry of Science and Technology, China PR (2004CB518706), the National High Technology Research and Development Program, Ministry of Science and Technology, China (2006AA02A245 and 2007AA021109), and by the National Natural Science Foundation of China PR (30490244).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; CHUNG S, 1995, P NATL ACAD SCI USA, V92, P3712, DOI 10.1073/pnas.92.9.3712; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; ELLIOTT JF, 1988, NATURE, V331, P627; FALINI B, 1989, J IMMUNOL, V143, P2480; FISCH P, 1992, J IMMUNOL, V148, P2315; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier W, 2003, CRIT REV IMMUNOL, V23, P473; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; Kabelitz D, 2005, INT ARCH ALLERGY IMM, V137, P73, DOI 10.1159/000085107; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KAUR I, 1994, CELL IMMUNOL, V156, P54, DOI 10.1006/cimm.1994.1152; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Li HS, 2007, J INFECT DIS, V195, P37, DOI 10.1086/509823; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Rothenfusser S, 2002, CELL IMMUNOL, V215, P32, DOI 10.1016/S0008-8749(02)00001-1; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; SCHONDELMAIER S, 1993, IMMUNOL LETT, V38, P121, DOI 10.1016/0165-2478(93)90176-3; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; STINISSEN P, 1995, J IMMUNOL, V154, P4883; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Urban EM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/732893; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Yaacob NS, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-42; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198; Zhu XP, 2008, CHINESE MED J-PEKING, V121, P2180, DOI 10.1097/00029330-200811010-00014; Zocchi MR, 2004, FRONT BIOSCI-LANDMRK, V9, P2588, DOI 10.2741/1419	39	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25611	25619		10.1074/jbc.M111.239624	http://dx.doi.org/10.1074/jbc.M111.239624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21606499	Green Published, hybrid			2022-12-25	WOS:000293073000023
J	Suvasini, R; Shruti, B; Thota, B; Shinde, SV; Friedmann-Morvinski, D; Nawaz, Z; Prasanna, KV; Thennarasu, K; Hegde, AS; Arivazhagan, A; Chandramouli, BA; Santosh, V; Somasundaram, K				Suvasini, Ramaswamy; Shruti, Bhargava; Thota, Balaram; Shinde, Sridevi Vijay; Friedmann-Morvinski, Dinorah; Nawaz, Zahid; Prasanna, Krishnarao Venkatesh; Thennarasu, Kandavel; Hegde, Alangar Sathyaranjandas; Arivazhagan, Arimappamagan; Chandramouli, Bangalore Ashwathnarayanarao; Santosh, Vani; Somasundaram, Kumaravel			Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMAS; MESSENGER-RNA; MALIGNANT GLIOMAS; MOLECULAR-MARKER; PREDICT METASTASIS; IMP3 EXPRESSION; CANCER; BIOMARKER; KOC; INVASION	Glioblastoma is the most common and malignant form of primary astrocytoma. Upon investigation of the insulin-like growth factor (IGF) pathway, we found the IGF2BP3/IMP3 transcript and protein to be up-regulated in GBMs but not in lower grade astrocytomas (p<0.0001). IMP3 is an RNA binding protein known to bind to the 5'-untranslated region of IGF-2 mRNA, thereby activating its translation. Overexpression-and knockdown-based studies establish a role for IMP3 in promoting proliferation, anchorage-independent growth, invasion, and chemoresistance. IMP3 overexpressing B16F10 cells also showed increased tumor growth, angiogenesis, and metastasis, resulting in poor survival in a mouse model. Additionally, the infiltrating front, perivascular, and subpial regions in a majority of the GBMs stained positive for IMP3. Furthermore, two different murine glioma models were used to substantiate the above findings. In agreement with the translation activation functions of IMP3, we also found increased IGF-2 protein in the GBM tumor samples without a corresponding increase in its transcript levels. Also, in vitro IMP3 overexpression/knockdown modulated the IGF-2 protein levels without altering its transcript levels. Additionally, IGF-2 neutralization and supplementation studies established that the proproliferative effects of IMP3 were indeed mediated through IGF-2. Concordantly, PI3K and MAPK, the downstream effectors of IGF-2, are activated by IMP3 and are found to be essential for IMP3-induced cell proliferation. Thus, we have identified IMP3 as a GBM-specific proproliferative and proinvasive marker acting through IGF-2 resulting in the activation of oncogenic PI3K and MAPK pathways.	[Suvasini, Ramaswamy; Shruti, Bhargava; Shinde, Sridevi Vijay; Nawaz, Zahid; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Thennarasu, Kandavel] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India; [Arivazhagan, Arimappamagan; Chandramouli, Bangalore Ashwathnarayanarao] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Thota, Balaram; Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Prasanna, Krishnarao Venkatesh; Hegde, Alangar Sathyaranjandas] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India; [Friedmann-Morvinski, Dinorah] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Salk Institute	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876; Nawaz, Zahid/0000-0002-4972-0637	Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative; Council of Scientific and Industrial Research; IUBMB Wood Whelan fellowship; Indian Council of Medical Research; Department of Biotechnology; Department of Science; University Grants Commission	Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); IUBMB Wood Whelan fellowship; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Department of Science; University Grants Commission(University Grants Commission, India)	This work was supported by a grant from Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative program.; Recipient of a Council of Scientific and Industrial Research fellowship and a IUBMB Wood Whelan fellowship.; We thank professors Inder Verma, M. R. S. Rao, P. Kondaiah, and U. Varshney for help and valuable suggestions. We also thank A. A. Srinivas, Cini Samuel, K. Premkumar, and K. Chandrasekar. Infrastructural support by funding from Indian Council of Medical Research, Department of Biotechnology, Department of Science, and University Grants Commission to the Department of Microbiology and Cell Biology is acknowledged. The Central Animal Facility of the Indian Institute of Science is acknowledged for animal experiments.	Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bellezza G, 2009, HUM PATHOL, V40, P1205, DOI 10.1016/j.humpath.2009.03.019; Do SI, 2008, ONCOL RES, V17, P269, DOI 10.3727/096504008786991639; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Hoffmann NE, 2008, CANCER-AM CANCER SOC, V112, P1471, DOI 10.1002/cncr.23296; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Jerome L, 2003, ENDOCR-RELAT CANCER, V10, P561, DOI 10.1677/erc.0.0100561; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Jiang Z, 2008, CANCER-AM CANCER SOC, V112, P2676, DOI 10.1002/cncr.23484; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kapoor S, 2008, CLIN CANCER RES, V14, P5640, DOI 10.1158/1078-0432.CCR-08-0813; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Li C, 2007, MODERN PATHOL, V20, P1263, DOI 10.1038/modpathol.3800960; Li CZ, 2007, MODERN PATHOL, V20, P242, DOI 10.1038/modpathol.3800735; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Li L, 2008, HUM PATHOL, V39, P1205, DOI 10.1016/j.humpath.2007.12.012; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lonning Per Eystein, 2004, Novartis Found Symp, V262, P205; Lu D, 2009, AM J SURG PATHOL, V33, P521, DOI 10.1097/PAS.0b013e31818aada9; Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Meyer MA, 2008, NEW ENGL J MED, V359, P1850, DOI 10.1056/NEJMc086380; Monzavi R, 2002, BEST PRACT RES CL EN, V16, P433, DOI 10.1053/beem.2002.0212; Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noske A, 2009, INT J GYNECOL PATHOL, V28, P203, DOI 10.1097/PGP.0b013e318189a724; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Riener MO, 2009, HUM PATHOL, V40, P1377, DOI 10.1016/j.humpath.2009.01.024; Sitnikova L, 2008, CLIN CANCER RES, V14, P1701, DOI 10.1158/1078-0432.CCR-07-2039; Slosar M, 2009, ENDOCR PATHOL, V20, P149, DOI 10.1007/s12022-009-9079-x; Sonoda Y, 2001, CANCER RES, V61, P6674; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu HD, 2008, EXPERT REV MOL DIAGN, V8, P557, DOI 10.1586/14737159.8.5.557; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8	50	101	110	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25882	25890		10.1074/jbc.M110.178012	http://dx.doi.org/10.1074/jbc.M110.178012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613208	Green Published, hybrid			2022-12-25	WOS:000293073000049
J	Kulkarni, K; Yang, J; Zhang, ZG; Barford, D				Kulkarni, Kiran; Yang, Jing; Zhang, Ziguo; Barford, David			Multiple Factors Confer Specific Cdc42 and Rac Protein Activation by Dedicator of Cytokinesis (DOCK) Nucleotide Exchange Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; CYTOSKELETAL REORGANIZATION; CRKII/DOCK180/RAC PATHWAY; OVERLAP EXTENSION; STRUCTURAL BASIS; CELL-MIGRATION; BINDING; DOMAIN; MEMBRANE; FAMILY	DOCK (dedicator of cytokinesis) guanine nucleotide exchange factors (GEFs) activate the Rho-family GTPases Rac and Cdc42 to control cell migration, morphogenesis, and phagocytosis. The DOCK A and B subfamilies activate Rac, whereas the DOCK D subfamily activates Cdc42. Nucleotide exchange is catalyzed by a conserved DHR2 domain (DOCKDHR2). Although the molecular basis for DOCKDHR2-mediated GTPase activation has been elucidated through structures of a DOCK9(DHR2)-Cdc42 complex, the factors determining recognition of specific GTPases are unknown. To understand the molecular basis for DOCK-GTPase specificity, we have determined the crystal structure of DOCK2(DHR2) in complex with Rac1. DOCK2(DHR2) and DOCK9(DHR2) exhibit similar tertiary structures and homodimer interfaces and share a conserved GTPase-activating mechanism. Multiple structural differences between DOCK2(DHR2) and DOCK9(DHR2) account for their selectivity toward Rac1 and Cdc42. Key determinants of selectivity of Cdc42 and Rac for their cognate DOCK(DHR)2 are a Phe or Trp residue within beta 3 (residue 56) and the ability of DOCK proteins to exploit differences in the GEF-induced conformational changes of switch 1 dependent on a divergent residue at position 27. DOCK proteins, therefore, differ from DH-PH GEFs that select their cognate GTPases through recognition of structural differences within the beta 2/beta 3 strands.	[Kulkarni, Kiran; Yang, Jing; Zhang, Ziguo; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	David.Barford@icr.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Yang, Jing/0000-0002-8984-4503	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by a program grant from Cancer Research UK (to D.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kwofie MA, 2008, J BIOL CHEM, V283, P3088, DOI 10.1074/jbc.M705170200; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Meller N, 2008, BIOCHEM J, V409, P525, DOI 10.1042/BJ20071263; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wu X, 2011, BIOCHEMISTRY-US, V50, P1070, DOI 10.1021/bi100971y; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	51	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25341	25351		10.1074/jbc.M111.236455	http://dx.doi.org/10.1074/jbc.M111.236455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613211	Green Published, hybrid			2022-12-25	WOS:000292547900080
J	Sasaki, K; Tsurumaru, Y; Yamamoto, H; Yazaki, K				Sasaki, Kanako; Tsurumaru, Yusuke; Yamamoto, Hirobumi; Yazaki, Kazufumi			Molecular Characterization of a Membrane-bound Prenyltransferase Specific for Isoflavone from Sophora flavescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; PRENYLATED ISOFLAVONOIDS; HOMOGENTISATE PHYTYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; UBIQUINONE BIOSYNTHESIS; VAR ANGUSTIFOLIA; FLAVONOIDS; ARABIDOPSIS; GENE; PHYTOALEXIN	Prenylated isoflavones are secondary metabolites that are mainly distributed in legume plants. They often possess divergent biological activities such as anti-bacterial, anti-fungal, and anti-oxidant activities and thus attract much attention in food, medicinal, and agricultural research fields. Prenyltransferase is the key enzyme in the biosynthesis of prenylated flavonoids by catalyzing a rate-limiting step, i.e. the coupling process of two major metabolic pathways, the isoprenoid pathway and shikimate/polyketide pathway. However, so far only two genes have been isolated as prenyltransferases involved in the biosynthesis of prenylated flavonoids, namely naringenin 8-dimethylallyltransferase from Sophora flavescens (SfN8DT-1) specific for some limited flavanones and glycinol 4-dimethylallyltransferase from Glycine max (G4DT), specific for pterocarpan substrate. We have in this study isolated two novel genes coding for membrane-bound flavonoid prenyltransferases from S. flavescens, an isoflavone-specific prenyltransferase (SfG6DT) responsible for the prenylation of the genistein at the 6-position and a chalcone-specific prenyltransferase designated as isoliquiritigenin dimethylallyltransferase (SfiLDT). These prenyltransferases were enzymatically characterized using a yeast expression system. Analysis on the substrate specificity of chimeric enzymes between SfN8DT-1 and SfG6DT suggested that the determinant region for the specificity of the flavonoids was the domain neighboring the fifth transmembrane alpha-helix of the prenyltransferases.	[Sasaki, Kanako; Tsurumaru, Yusuke; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Kyoto 6110011, Japan; [Yamamoto, Hirobumi] Toyo Univ, Plant Regulat Res Ctr, Fac Life Sci, Gunma 3740193, Japan	Kyoto University; Toyo University	Yazaki, K (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Kyoto 6110011, Japan.	yazaki@rish.kyoto-u.ac.jp			Ministry of Economy, Trade, and Industry (METI) of Japan [17310126]; Japan Society for the Promotion of Science [183424]; Grants-in-Aid for Scientific Research [22657014] Funding Source: KAKEN	Ministry of Economy, Trade, and Industry (METI) of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-aid for Scientific Research 17310126 (to K. Y.), by a research and development project "Development of Fundamental Technologies for Production of High-value Materials using Transgenic Plants" funded by the Ministry of Economy, Trade, and Industry (METI) of Japan, and by the Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (Grant 183424 to K. S.).	Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; AHN BZ, 1995, J MED CHEM, V38, P1044, DOI 10.1021/jm00006a025; Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5; Botta B, 2009, CURR MED CHEM, V16, P3414, DOI 10.2174/092986709789057662; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; CORNFORTH RH, 1969, METHOD ENZYMOL, V15, P359; DANIEL M, 1995, HDB PHYTOALEXIN META, P333; DHILLON DS, 1976, ARCH BIOCHEM BIOPHYS, V177, P74, DOI 10.1016/0003-9861(76)90417-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Han AR, 2006, J NAT PROD, V69, P719, DOI 10.1021/np0600346; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Koeduka T, 2011, PLANT BIOLOGY, V13, P411, DOI 10.1111/j.1438-8677.2010.00409.x; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; LAFLAMME P, 1993, PHYTOCHEMISTRY, V34, P147, DOI 10.1016/S0031-9422(00)90796-9; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Maitrejean M, 2000, BIOORG MED CHEM LETT, V10, P157, DOI 10.1016/S0960-894X(99)00636-8; Marks MD, 2009, J EXP BOT, V60, P3715, DOI 10.1093/jxb/erp210; Murakami A, 2000, BIOORG MED CHEM LETT, V10, P59, DOI 10.1016/S0960-894X(99)00578-8; Ohara K, 2006, PLANT CELL PHYSIOL, V47, P581, DOI 10.1093/pcp/pcj025; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okada K, 2004, PLANT MOL BIOL, V55, P567, DOI 10.1007/s11103-004-1298-4; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Sasaki K, 2005, FEBS LETT, V579, P2514, DOI 10.1016/j.febslet.2005.03.066; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2009, BIOSCI BIOTECH BIOCH, V73, P759, DOI 10.1271/bbb.80729; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Schledz M, 2001, FEBS LETT, V499, P15, DOI 10.1016/S0014-5793(01)02508-X; TAHARA S, 1995, PHYTOCHEMISTRY, V38, P1073, DOI 10.1016/0031-9422(94)00788-U; Tsurumaru Y, 2010, PLANT BIOTECHNOL-NAR, V27, P199, DOI 10.5511/plantbiotechnology.27.199; TURBEK CS, 1992, FEMS MICROBIOL LETT, V94, P187, DOI 10.1111/j.1574-6968.1992.tb05312.x; Vitali A, 2004, FEBS LETT, V557, P33, DOI 10.1016/S0014-5793(03)01398-X; Wang BH, 1997, PHYTOCHEMISTRY, V44, P787, DOI 10.1016/S0031-9422(96)00664-4; Xiang W, 2005, J AGR FOOD CHEM, V53, P267, DOI 10.1021/jf0483117; YAMAMOTO H, 1991, Z NATURFORSCH C, V46, P172; Yamamoto H, 1996, PHYTOCHEMISTRY, V43, P603, DOI 10.1016/0031-9422(96)00321-4; Yamamoto H, 2002, PHYTOCHEMISTRY, V60, P263, DOI 10.1016/S0031-9422(02)00111-5; YAMAMOTO H, 1992, Z NATURFORSCH C, V47, P535; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; ZAHRINGER U, 1977, H-S Z PHYSIOL CHEM, V358, P1303	43	62	63	7	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24125	24134		10.1074/jbc.M111.244426	http://dx.doi.org/10.1074/jbc.M111.244426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576242	hybrid, Green Published			2022-12-25	WOS:000292294900054
J	Di Fonzo, MMI; Pelletier, F; Clutton-Brock, TH; Pemberton, JM; Coulson, T				Di Fonzo, Martina M. I.; Pelletier, Fanie; Clutton-Brock, T. H.; Pemberton, Josephine M.; Coulson, Tim			The Population Growth Consequences of Variation in Individual Heterozygosity	PLOS ONE			English	Article							SOAY SHEEP; SELECTION; RELATEDNESS; INSTABILITY; STABILITY; SURVIVAL; FITNESS; TRAITS; RESCUE; AGE	Heterozygosity has been associated with components of fitness in numerous studies across a wide range of taxa. Because heterozygosity is associated with individual performance it is also expected to be associated with population dynamics. However, investigations into the association between heterozygosity and population dynamics have been rare because of difficulties in linking evolutionary and ecological processes. The choice of heterozygosity measure is a further issue confounding such studies as it can be biased by individual differences in the frequencies of the alleles studied, the number of alleles at each locus as well as the total number of loci typed. In this study, we first examine the differences between the principal metrics used to calculate heterozygosity using long-term data from a marked population of Soay sheep (Ovis aries). Next, by means of statistical transformation of the homozygosity weighted by loci index, we determine how heterozygosity contributes to population growth in Soay sheep by modelling individual contributions to population growth (p(t(i))) as a function of several covariates, including sex, weight and faecal egg count - a surrogate of parasitic nematode burden in the gut. We demonstrate that although heterozygosity is associated with some components of fitness, most notably adult male reproductive success, in general it is only weakly associated with population growth.	[Di Fonzo, Martina M. I.; Pelletier, Fanie; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Di Fonzo, Martina M. I.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Clutton-Brock, T. H.] Univ Cambridge, Dept Zool, Cambridge, England; [Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Imperial College London; Zoological Society of London; University of Cambridge; University of Edinburgh	Di Fonzo, MMI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	martina.di-fonzo06@imperial.ac.uk	Di Fonzo, Martina/G-3463-2013; Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021	Di Fonzo, Martina/0000-0002-2033-0598; Coulson, Tim/0000-0001-9371-9003	NERC [NE/G004854/1] Funding Source: UKRI; Natural Environment Research Council [NE/G004854/1, NE/B504314/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACEVEDOWHITEHOU.K, 2003, NATURE, V422; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; BANCROFT DR, 1995, PHILOS T R SOC B, V347, P263, DOI 10.1098/rstb.1995.0026; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Clutton-Brock TH, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P276; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; CLUTTONBROCK TH, 1992, J ANIM ECOL, V61, P381, DOI 10.2307/5330; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Jewell P.A., 1974, ISLAND SURVIVORS ECO; KOEHN RK, 1984, MAR BIOL, V82, P1, DOI 10.1007/BF00392757; LEARY RF, 1985, EVOLUTION, V39, P308, DOI [10.2307/2408364, 10.1111/j.1558-5646.1985.tb05668.x]; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Milner JM, 1999, J ANIM ECOL, V68, P472, DOI 10.1046/j.1365-2656.1999.00299.x; Ministry of Agriculture Fisheries and Food, 1971, MAN VET PAR LAB TECH; Overall ADJ, 2005, MOL ECOL, V14, P3383, DOI 10.1111/j.1365-294X.2005.02682.x; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pemberton JM, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P217; Pemberton JM, 1996, PHILOS T R SOC B, V351, P745, DOI 10.1098/rstb.1996.0069; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SLATE J, 2000, P ROY SOC LOND B BIO, V267, P1656; SNEDDON N, 2004, P ROY SOC LOND B BIO, V271, P1823; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184	39	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19667	10.1371/journal.pone.0019667	http://dx.doi.org/10.1371/journal.pone.0019667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611172	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200025
J	Israeli, E; Yakunin, E; Zarbiv, Y; Hacohen-Solovich, A; Kisos, H; Loeb, V; Lichtenstein, M; Ben-Gedalya, T; Sabag, O; Pikarsky, E; Lorberboum-Galski, H; Sharon, R				Israeli, Eitan; Yakunin, Eugenia; Zarbiv, Yonaton; Hacohen-Solovich, Amir; Kisos, Haya; Loeb, Virginie; Lichtenstein, Michal; Ben-Gedalya, Tziona; Sabag, Ofra; Pikarsky, Eli; Lorberboum-Galski, Haya; Sharon, Ronit			alpha-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease	PLOS ONE			English	Article							BETA-SYNUCLEIN; GAMMA-SYNUCLEIN; CELL-DEATH; IN-VIVO; CANCER; RELEASE; GENE; OVEREXPRESSION; PROGRESSION; MECHANISMS	Alpha Synuclein (alpha-Syn) is a protein implicated in mechanisms of neuronal degeneration in Parkinson's disease (PD). alpha-Syn is primarily a neuronal protein, however, its expression is found in various tumors including ovarian, colorectal and melanoma tumors. It has been hypothesized that neurodegeneration may share common mechanisms with oncogenesis. We tested whether alpha-Syn expression affects tumorigenesis of three types of tumors. Specifically, B16 melanoma, E0771 mammary gland adenocarcinoma and D122 Lewis lung carcinoma. For this aim, we utilized transgenic mice expression the human A53T alpha-Syn form. We found that the in vivo growth of B16 and E0771 but not D122 was enhanced in the A53T alpha-Syn mice. The effect on tumorigenesis was not detected in age-matched APP/PS1 mice, modeling Alzheimer's disease (AD), suggesting a specific effect for alpha-Syn-dependent neurodegeneration. Importantly, transgenic alpha-Syn expression was detected within the three tumor types. We further show uptake of exogenously added, purified alpha-Syn, by the cultured tumor cells. In accord, with the affected tumorigenesis in the young A53T alpha-Syn mice, over-expression of alpha-Syn in cultured B16 and E0771 cells enhanced proliferation, however, had no effect on the proliferation of D122 cells. Based on these results, we suggest that certain forms of alpha-Syn may selectively accelerate cellular mechanisms leading to cancer.	[Israeli, Eitan; Yakunin, Eugenia; Zarbiv, Yonaton; Hacohen-Solovich, Amir; Kisos, Haya; Loeb, Virginie; Lichtenstein, Michal; Sabag, Ofra; Lorberboum-Galski, Haya; Sharon, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Israeli, E (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	ronitsh@ekmd.huji.ac.il	pikarsky, eli/GXV-7099-2022; Lorberboum-Galski, Haya/K-8839-2019	Zarbiv, Yonaton/0000-0002-7040-1913; pikarsky, eli/0000-0003-4186-7105	National Institutes of Health [R01 NS051318]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grant R01 NS051318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bajaj A, 2010, CANCER CAUSE CONTROL, V21, P697, DOI 10.1007/s10552-009-9497-6; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; BYSTRYN JC, 1976, J IMMUNOL, V116, P1302; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; D'Amelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; GARBER K, J NATL CANC I, V102, P371; Garber K, 2010, J NATL CANCER I, V102, P371, DOI 10.1093/jnci/djq081; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Irony-Tur-Sinai M, 2009, INT IMMUNOPHARMACOL, V9, P1236, DOI 10.1016/j.intimp.2009.07.006; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Ji HJ, 1997, CANCER RES, V57, P759; Kawashima M, 2000, ACTA NEUROPATHOL, V99, P154, DOI 10.1007/PL00007419; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Poewe W, 2007, MOVEMENT DISORD, V22, pS374, DOI 10.1002/mds.21681; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POULOGIANNIS G, 2010, P NATL ACAD SCI US; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Staropoli JF, 2008, BIOESSAYS, V30, P719, DOI 10.1002/bies.20784; TAY SP, 2010, J BIOL CHEM; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Ye Q, 2010, ONCOL REP, V23, P429, DOI 10.3892/or_00000652; Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377	66	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19622	10.1371/journal.pone.0019622	http://dx.doi.org/10.1371/journal.pone.0019622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611169	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200020
J	Mouttet, R; Bearez, P; Thomas, C; Desneux, N				Mouttet, Raphaelle; Bearez, Philippe; Thomas, Cecile; Desneux, Nicolas			Phytophagous Arthropods and a Pathogen Sharing a Host Plant: Evidence for Indirect Plant-Mediated Interactions	PLOS ONE			English	Article							INDUCED RESISTANCE; BOTRYTIS-CINEREA; PEST-MANAGEMENT; SOYBEAN APHID; TRADE-OFFS; CROSS-TALK; HERBIVORES; RESPONSES; DEFENSE; FUNGUS	In ecological systems, indirect interactions between plant pathogens and phytophagous arthropods can arise when infestation by a first attacker alters the common host plant so that although a second attacker could be spatially or temporally separated from the first one, the former could be affected. The induction of plant defense reactions leading to the production of secondary metabolites is thought to have an important role since it involves antagonistic and/or synergistic cross-talks that may determine the outcome of such interactions. We carried out experiments under controlled conditions on young rose plants in order to assess the impact of these indirect interactions on life history traits of three pests: the necrotrophic fungus Botrytis cinerea Pers.: Fr. (Helotiales: Sclerotiniaceae), the aphid Rhodobium porosum Sanderson (Hemiptera: Aphididae) and the thrips Frankliniella occidentalis Pergande (Thysanoptera: Thripidae). Our results indicated (i) a bi-directional negative interaction between B. cinerea and R. porosum, which is conveyed by decreased aphid growth rate and reduced fungal lesion area, as well as (ii) an indirect negative effect of B. cinerea on insect behavior. No indirect effect was observed between thrips and aphids. This research highlights several complex interactions that may be involved in structuring herbivore and plant pathogen communities within natural and managed ecosystems.	[Mouttet, Raphaelle; Bearez, Philippe; Thomas, Cecile; Desneux, Nicolas] French Natl Inst Agr Res INRA, UR 880, Sophia Antipolis, France	INRAE	Mouttet, R (corresponding author), French Natl Inst Agr Res INRA, UR 880, Sophia Antipolis, France.	nicolas.desneux@sophia.inra.fr	Desneux, Nicolas/J-6262-2013		French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy)	French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy)	This work was supported by an "Innovative project" grant from the French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; AJLAN AM, 1991, ENTOMOL EXP APPL, V58, P83, DOI 10.1007/BF00163317; ALTIERI MA, 1983, ENVIRON MANAGE, V7, P91, DOI 10.1007/BF01867047; Barbosa P, 1991, MICROBIAL MEDIATION; BARFIELD CS, 1984, FLA ENTOMOL, V67, P42, DOI 10.2307/3494103; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRUN R, 2003, ROSE SERRE FLEUR COU; Cardoza YJ, 2003, ENVIRON ENTOMOL, V32, P220, DOI 10.1603/0046-225X-32.1.220; Chaman ME, 2003, J AGR FOOD CHEM, V51, P2227, DOI 10.1021/jf020953b; De Vos M, 2006, PLANT PHYSIOL, V142, P352, DOI 10.1104/pp.106.083907; Derckel JP, 1999, PHYTOPATHOLOGY, V89, P197, DOI 10.1094/PHYTO.1999.89.3.197; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Fournier V, 2006, ECOL APPL, V16, P2382, DOI 10.1890/1051-0761(2006)016[2382:MPEOAS]2.0.CO;2; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hatcher PE, 2000, NEW PHYTOL, V146, P325, DOI 10.1046/j.1469-8137.2000.00646.x; HATCHER PE, 1994, FUNCT ECOL, V8, P265, DOI 10.2307/2389910; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Hatcher PE, 2004, ECOLOGY, V85, P59, DOI 10.1890/02-0724; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; KARBAN R, 1987, SCIENCE, V235, P678, DOI 10.1126/science.235.4789.678; Klepzig KD, 1997, GREAT LAKES ENTOMOL, V30, P99; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kruess A, 2002, OECOLOGIA, V130, P563, DOI 10.1007/s00442-001-0829-9; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Moran PJ, 1998, OECOLOGIA, V115, P523, DOI 10.1007/s004420050550; Moran PJ, 1998, ENVIRON ENTOMOL, V27, P39, DOI 10.1093/ee/27.1.39; Morin P., 1999, COMMUNITY ECOL; MOUND LA, 1971, B ENTOMOL RES, V60, P547, DOI 10.1017/S0007485300042309; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Paul ND, 2000, TRENDS PLANT SCI, V5, P220, DOI 10.1016/S1360-1385(00)01603-4; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; RAVEN JA, 1983, ADV ECOL RES, V13, P135, DOI 10.1016/S0065-2504(08)60109-9; Rayapuram C, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-109; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Roder G, 2007, OIKOS, V116, P1514, DOI [10.1111/j.2007.0030-1299.16057.x, 10.1111/j.0030-1299.2007.16057.x]; Rostas M, 2003, BASIC APPL ECOL, V4, P43, DOI 10.1078/1439-1791-00132; ROSTAS M, 2002, AGR FOREST ENTOMOL, V4, P1; Russo VM, 1997, CROP PROT, V16, P581, DOI 10.1016/S0261-2194(97)00024-0; Villada ES, 2009, J EXP BOT, V60, P3269, DOI 10.1093/jxb/erp163; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Simon M, 2003, AGR FOREST ENTOMOL, V5, P275, DOI 10.1046/j.1461-9563.2003.00189.x; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Stout MJ, 1996, BIOCHEM SYST ECOL, V24, P611, DOI 10.1016/S0305-1978(97)81205-7; Taylor JE, 2004, J EXP BOT, V55, P159, DOI 10.1093/jxb/erh053; Viswanathan DV, 2008, ECOL ENTOMOL, V33, P86, DOI 10.1111/j.1365-2311.2007.00943.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	68	50	52	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18840	10.1371/journal.pone.0018840	http://dx.doi.org/10.1371/journal.pone.0018840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611161	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200003
J	Planche, A; Bacac, M; Provero, P; Fusco, C; Delorenzi, M; Stehle, JC; Stamenkovic, I				Planche, Anne; Bacac, Marina; Provero, Paolo; Fusco, Carlo; Delorenzi, Mauro; Stehle, Jean-Christophe; Stamenkovic, Ivan			Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR MICROENVIRONMENT; TGF-BETA; PERIOSTIN; CELL; SIGNATURE; GROWTH; FIBROBLASTS; PROGRESSION; SURVIVAL	Primary tumor growth induces host tissue responses that are believed to support and promote tumor progression. Identification of the molecular characteristics of the tumor microenvironment and elucidation of its crosstalk with tumor cells may therefore be crucial for improving our understanding of the processes implicated in cancer progression, identifying potential therapeutic targets, and uncovering stromal gene expression signatures that may predict clinical outcome. A key issue to resolve, therefore, is whether the stromal response to tumor growth is largely a generic phenomenon, irrespective of the tumor type or whether the response reflects tumor-specific properties. To address similarity or distinction of stromal gene expression changes during cancer progression, oligonucleotide-based Affymetrix microarray technology was used to compare the transcriptomes of laser-microdissected stromal cells derived from invasive human breast and prostate carcinoma. Invasive breast and prostate cancer-associated stroma was observed to display distinct transcriptomes, with a limited number of shared genes. Interestingly, both breast and prostate tumor-specific dysregulated stromal genes were observed to cluster breast and prostate cancer patients, respectively, into two distinct groups with statistically different clinical outcomes. By contrast, a gene signature that was common to the reactive stroma of both tumor types did not have survival predictive value. Univariate Cox analysis identified genes whose expression level was most strongly associated with patient survival. Taken together, these observations suggest that the tumor microenvironment displays distinct features according to the tumor type that provides survival-predictive value.	[Planche, Anne; Bacac, Marina; Fusco, Carlo; Stehle, Jean-Christophe; Stamenkovic, Ivan] Univ Lausanne, CHUV, Inst Pathol, Lausanne, Switzerland; [Planche, Anne; Bacac, Marina; Fusco, Carlo; Stehle, Jean-Christophe; Stamenkovic, Ivan] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Delorenzi, Mauro] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Turin; Swiss Institute of Bioinformatics	Planche, A (corresponding author), Univ Lausanne, CHUV, Inst Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Fusco, Carlo/AAC-7332-2022; Provero, Paolo/AAC-1930-2019		Swiss Fonds National pour la Recherche Scientifique (FNRS) [310030-130350]; NCCR Molecular Oncology; Italian Association for Cancer Research [IG9408]	Swiss Fonds National pour la Recherche Scientifique (FNRS)(Swiss National Science Foundation (SNSF)); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Swiss Fonds National pour la Recherche Scientifique (FNRS) grant No. 310030-130350 and the NCCR Molecular Oncology. P. P. gratefully acknowledges support from the Italian Association for Cancer Research under grant IG9408. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; BAUER M, ONCOGENE, V29, P1732; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gillan L, 2002, CANCER RES, V62, P5358; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Ismail RS, 2000, CANCER RES, V60, P6744; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; MICHAYLIRA CZ, CANC RES, V70, P5281; Olumi AF, 1999, CANCER RES, V59, P5002; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Saranac L, 2007, THESCIENTIFICWORLDJO, V7, P1263, DOI 10.1100/tsw.2007.218; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yoshioka N, 2002, EXP CELL RES, V279, P91, DOI 10.1006/excr.2002.5590	35	105	105	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18640	10.1371/journal.pone.0018640	http://dx.doi.org/10.1371/journal.pone.0018640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611158	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200001
J	Wang, SH; Martin, SM; Harris, PS; Knudson, CM				Wang, Sih-han; Martin, Sean M.; Harris, Peter S.; Knudson, C. Michael			Caspase Inhibition Blocks Cell Death and Enhances Mitophagy but Fails to Promote T-Cell Lymphoma	PLOS ONE			English	Article							SOMATIC FRAMESHIFT MUTATIONS; TUMOR-SUPPRESSOR; CHROMOSOMAL INSTABILITY; PROGNOSTIC-SIGNIFICANCE; TRANSGENIC MICE; AUTOPHAGY GENE; APOPTOSIS; APAF-1; BAX; CANCER	Caspase-9 is a component of the apoptosome that mediates cell death following release of cytochrome c from mitochondria. Inhibition of Caspase-9 with a dominant negative construct (Casp9DN) blocks apoptosome function, promotes viability and has been implicated in carcinogenesis. Inhibition of the apoptosome in vitro impairs mitochondrial function and promotes mitophagy. To examine whether inhibition of the apoptosome would enhance mitophagy and promote oncogenesis in vivo, transgenic mice were generated that express Casp9DN in the T cell lineage. The effects of Casp9DN on thymocyte viability, mitophagy and thymic tumor formation were examined. In primary thymocytes, Casp9DN delayed dexamethasone (Dex)-induced cell death, altered mitochondrial structure, and decreased oxidant production. Transmission electron microscopy (TEM) revealed that inhibition of the apoptosome resulted in structurally abnormal mitochondria that in some cases were engulfed by double-membrane structures resembling autophagosomes. Consistent with mitochondria being engulfed by autophagosomes (mitophagy), confocal microscopy showed colocalization of LC3-GFP and mitochondria. However, Casp9DN did not significantly accelerate T-cell lymphoma alone, or in combination with Lck-Bax38/1, or with Beclin 1+/2 mice, two tumor-prone strains in which altered mitochondrial function has been implicated in promoting tumor development. In addition, heterozygous disruption of Beclin 1 had no effect on T-cell lymphoma formation in Lck-Bax38/1 mice. Further studies showed that Beclin 1 levels had no effect on Casp9DN-induced loss of mitochondrial function. These results demonstrate that neither inhibition of apoptosome function nor Beclin 1 haploinsufficiency accelerate T-cell lymphoma development in mice.	[Wang, Sih-han; Martin, Sean M.; Harris, Peter S.; Knudson, C. Michael] Univ Iowa, Dept Pathol, Roy J & Lucille P Carver Coll Med, Iowa City, IA 52242 USA; [Wang, Sih-han; Knudson, C. Michael] Univ Iowa, Free Radical & Radiat Biol Program, Roy J & Lucille P Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa	Wang, SH (corresponding author), Univ Iowa, Dept Pathol, Roy J & Lucille P Carver Coll Med, Iowa City, IA 52242 USA.	c-knudson@uiowa.edu	Wang, Sih-han/M-6523-2013	Wang, Sih-han/0000-0002-9870-3761; Knudson, Charles Michael/0000-0003-3964-5466	National Cancer Institute [CA104695]; National Institutes of Health; Roy J. and Lucille A. Carver College of Medicine; NATIONAL CANCER INSTITUTE [R01CA104695] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. and Lucille A. Carver College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute RO1 #CA104695 (CMK). Lck-Casp9DN transgenic mice were generated at the University of Iowa Transgenic Animal Facility, directed by Curt D. Sigmund, Ph.D. and supported in part by grants from the National Institutes of Health and from the Roy J. and Lucille A. Carver College of Medicine. The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Brown NM, 2007, J BIOL CHEM, V282, P2144, DOI 10.1074/jbc.M607961200; Catchpoole DR, 2001, EUR J CANCER, V37, P2217, DOI 10.1016/S0959-8049(01)00273-8; Cheng N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001911; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; de Wetering CIV, 2008, FREE RADICAL BIO MED, V44, P1677, DOI 10.1016/j.freeradbiomed.2008.01.022; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim MS, 2008, DIGEST LIVER DIS, V40, P599, DOI 10.1016/j.dld.2008.02.008; Knudson CM, 2001, CANCER RES, V61, P659; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Luke JJ, 2003, CELL DEATH DIFFER, V10, P740, DOI 10.1038/sj.cdd.4401233; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Soung YH, 2006, APMIS, V114, P292, DOI 10.1111/j.1600-0463.2006.apm_364.x; Strater J, 2010, INT J CANCER, V127, P873, DOI 10.1002/ijc.25111; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devce1.2010.03.014, 10.1016/j.devcel.2010.03.014]; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Werth JL, 2000, EXP NEUROL, V161, P203, DOI 10.1006/exnr.1999.7241; Yamamoto H, 1998, CANCER RES, V58, P997; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19786	10.1371/journal.pone.0019786	http://dx.doi.org/10.1371/journal.pone.0019786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611191	gold, Green Submitted, Green Published			2022-12-25	WOS:000290657500022
J	Le, CF; Palanisamy, NK; Yusof, MYM; Sekaran, SD				Le, Cheng-Foh; Palanisamy, Navindra Kumari; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi			Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE; CHILDREN; SUSCEPTIBILITIES; MENINGITIS	Background: Streptococcus pneumoniae is a major causative agent of severe infections, including sepsis, pneumonia, meningitis, and otitis media, that has since become a major public health concern. In this study, the serotypes distribution of pneumococcal isolates was investigated to predict the efficacy of the 7-valent pneumococcal conjugate vaccine (PCV7) among the Malaysian populations. Methodology/Principal Findings: A total of 151 clinical isolates were serotyped using multiplex PCR assays. Out of them, there were 21.2% penicillin-resistant, 29.1% penicillin-intermediate, and 49.7% penicillin-susceptible S. pneumoniae strains. Serotypes detected among the Malaysian isolates were 1, 3, 10A, 11A/11D, 12F/12A, 14, 15A, 15B/15C, 16F, 18C/18B/18A/18F, 19A, 19F, 23F, 35B, 35F/47F, 6A/6B, 7C/7B/40, 7F/7A, 9V/9A, and 34. Serotype 19F and 23F were the two most prevalent serotypes detected. Serotypes are highly associated with invasiveness of isolates (p = 0.001) and penicillin susceptibility (p<0.001). Serotype 19F was observed to have increased resistance against penicillin while serotype 19A has high invasive tendency. Age of patients was an important factor underlying the pneumococcal serotypes (p = 0.03) and clinical sites of infections (p<0.001). High prevalence of pneumococcal isolates were detected among children <5 years old at nasopharyngeal sites while elderly adults >= 60 years old were at increased risk for pneumococcal bacteremia. Conclusion/Significance: Current study revealed that a number of serotypes, especially those associated with high penicillin resistance, have been formulated in the PCV7. Therefore, the protections expected from the routine use of PCV7 would be encouraging for the Malaysian. However, it is not possible to predict serotypes that might become predominant in the future and hence continued surveillance of circulating serotypes will be needed.	[Le, Cheng-Foh; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Palanisamy, Navindra Kumari] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia	Universiti Malaya; Universiti Teknologi MARA	Le, CF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	MD YUSOF, MOHD YASIM/B-9133-2010; Sekaran, Shamala Devi/B-8482-2008; Devi, Shamala Devi/B-9735-2010	Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; Le, Cheng Foh/0000-0002-2295-6690	Ministry of Science and Technology, Malaysia [36-02-03-6027]	Ministry of Science and Technology, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by a grant provided by the Ministry of Science and Technology, Malaysia: 36-02-03-6027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arai S, 2001, MICROBIOL IMMUNOL, V45, P159, DOI 10.1111/j.1348-0421.2001.tb01284.x; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; Catterall JR, 1999, THORAX, V54, P929, DOI 10.1136/thx.54.10.929; CHEONG YM, 1988, J TROP PEDIATRICS, V34, P182, DOI 10.1093/tropej/34.4.182; CHOO KE, 1990, ANN TROP PAEDIATR, V10, P89, DOI 10.1080/02724936.1990.11747415; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI; Desa Mohd Nasir Mohd, 2003, International Journal of Infectious Diseases, V7, P190, DOI 10.1016/S1201-9712(03)90051-8; Dobay O, 2003, J ANTIMICROB CHEMOTH, V51, P887, DOI 10.1093/jac/dkg171; Hussain IHMI, 1998, PEDIATR INFECT DIS J, V17, pS189, DOI 10.1097/00006454-199809001-00021; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jacobs MR, 1999, ANTIMICROB AGENTS CH, V43, P1901, DOI 10.1128/AAC.43.8.1901; JAMAL F, 1987, J TROP MED PUBLIC HL, V18, P79; Lim LH, 2007, J PAEDIATR CHILD H, V43, P366, DOI 10.1111/j.1440-1754.2007.01081.x; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pankuch GA, 2003, J ANTIMICROB CHEMOTH, V51, P443, DOI 10.1093/jac/dkg091; Rohani MY, 1999, EPIDEMIOL INFECT, V122, P77, DOI 10.1017/S0950268898001605; Rohani MY, 1999, J ANTIMICROB CHEMOTH, V44, P852, DOI 10.1093/jac/44.6.852; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; SNIADACK DH, 1995, PEDIATR INFECT DIS J, V14, P503, DOI 10.1097/00006454-199506000-00007; TEE AC, 1993, THESIS U MALAYA; UNAL S, 1992, J CLIN MICROBIOL, V30, P1685, DOI 10.1128/JCM.30.7.1685-1691.1992	23	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19547	10.1371/journal.pone.0019547	http://dx.doi.org/10.1371/journal.pone.0019547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603602	gold, Green Submitted, Green Published			2022-12-25	WOS:000290656300012
J	Hu, Y; Mathema, B; Jiang, WL; Kreiswirth, B; Wang, WB; Xu, BA				Hu, Yi; Mathema, Barun; Jiang, Weili; Kreiswirth, Barry; Wang, Weibing; Xu, Biao			Transmission Pattern of Drug-Resistant Tuberculosis and Its Implication for Tuberculosis Control in Eastern Rural China	PLOS ONE			English	Article							TREATMENT-FAILURE PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; NOSOCOMIAL TRANSMISSION; PREVALENCE; STRAINS; GENOTYPE; COUNTIES; TB	Objective: Transmission patterns of drug-resistant Mycobacterium tuberculosis (MTB) may be influenced by differences in socio-demographics, local tuberculosis (TB) endemicity and efficaciousness of TB control programs. This study aimed to investigate the impact of DOTS on the transmission of drug-resistant TB in eastern rural China. Methods: We conducted a cross-sectional study of all patients diagnosed with drug-resistant TB over a one-year period in two rural Chinese counties with varying lengths of DOTS implementation. Counties included Deqing, with over 11 years' DOTS implementation and Guanyun, where DOTS was introduced 1 year prior to start of this study. We combined demographic, clinical and epidemiologic information with IS6110-based restricted fragment length polymorphism (RFLP) and Spoligotyping analysis of MTB isolates. In addition, we conducted DNA sequencing of resistance determining regions to first-line anti-tuberculosis agents. Results: Of the 223 drug-resistant isolates, 73(32.7%) isolates were identified with clustered IS6110RFLP patterns. The clustering proportion among total drug-resistant TB was higher in Guanyun than Deqing (26/101. vs. 47/122; p, 0.04), but not significantly different among the 53 multidrug-resistant isolates (10/18. vs. 24/35; p, 0.35). Patients with cavitary had increased risk of clustering in both counties. In Guanyun, patients with positive smear test or previous treatment history had a higher clustering proportion. Beijing genotype and isolates resistant to isoniazid and/or rifampicin were more likely to be clustered. Of the 73 patients with clustered drug-resistant isolates, 71.2% lived in the same or neighboring villages. Epidemiological link (household and social contact) was confirmed in 12.3% of the clustered isolates. Conclusion: Transmission of drug-resistant TB in eastern rural China is characterized by small clusters and limited geographic spread. Our observations highlight the need for supplementing DOTS with additional strategies, including active case finding at the village level, effective treatment for patients with cavities and drug susceptibility testing for patients at increased risk for drug-resistance.	[Hu, Yi; Jiang, Weili; Wang, Weibing; Xu, Biao] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Hu, Yi; Jiang, Weili; Wang, Weibing; Xu, Biao] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Mathema, Barun; Kreiswirth, Barry] Publ Hlth Res Inst, TB Ctr, Newark, NJ USA	Fudan University; Fudan University	Hu, Y (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China.	bxu@shmu.edu.cn		Mathema, Barun/0000-0003-2772-479X	National Natural Science Foundation of China [30771843, 30901223]; Shanghai Leading Academic Discipline Project [B118]; National Key Project for Infectious Disease [2008ZX10003-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Key Project for Infectious Disease	This study was supported by two grants (PI, Biao Xu, No. 30771843; PI, Yi Hu, No. 30901223) from National Natural Science Foundation of China, Shanghai Leading Academic Discipline Project (No. B118) and National Key Project for Infectious Disease (No. 2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; Ano H, 2008, INT J TUBERC LUNG D, V12, P1300; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; COHN ML, 1970, AM REV RESPIR DIS, V102, P97; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hu Y, 2011, EPIDEMIOL INFECT, V139, P130, DOI 10.1017/S0950268810000890; Hu Y, 2010, INT J TUBERC LUNG D, V14, P210; Hu Y, 2008, MICROB DRUG RESIST, V14, P227, DOI 10.1089/mdr.2008.0823; Hu Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-43; Kelly PM, 2005, INT J TUBERC LUNG D, V9, P81; Li GL, 2010, BIOMED ENVIRON SCI, V23, P188, DOI 10.1016/S0895-3988(10)60051-7; Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985; Mohammadi A., 2008, Eastern Mediterranean Health Journal, V14, P1238; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Ohata Ritsuko, 2004, Kekkaku, V79, P47; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Pritchard AJ, 2003, EPIDEMIOL INFECT, V130, P481, DOI 10.1017/S0950268803008367; Quitugua TN, 2002, J CLIN MICROBIOL, V40, P2716, DOI 10.1128/JCM.40.8.2716-2724.2002; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Sun YJ, 2007, INT J TUBERC LUNG D, V11, P436; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; Valcheva V, 2008, J CLIN MICROBIOL, V46, P3005, DOI 10.1128/JCM.00437-08; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Varela G, 2008, J MED MICROBIOL, V57, P1518, DOI 10.1099/jmm.0.2008/001917-0; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Health Organization (WHO), 2008, WHO IUATLD GLOB PROJ; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	34	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19548	10.1371/journal.pone.0019548	http://dx.doi.org/10.1371/journal.pone.0019548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589863	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100016
J	Cai, K; Qi, DF; Hou, XW; Wang, OM; Chen, J; Deng, B; Qian, LH; Liu, XL; Le, YY				Cai, Kun; Qi, Dongfei; Hou, Xinwei; Wang, Oumei; Chen, Juan; Deng, Bo; Qian, Lihua; Liu, Xiaolong; Le, Yingying			MCP-1 Upregulates Amylin Expression in Murine Pancreatic beta Cells through ERK/JNK-AP1 and NF-kappa B Related Signaling Pathways Independent of CCR2	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DEPENDENT DIABETES-MELLITUS; AORTIC SMOOTH-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; OBESE SUBJECTS; WEIGHT-LOSS; IN-VIVO	Background: Amylin is the most abundant component of islet amyloid implicated in the development of type 2 diabetes. Plasma amylin levels are elevated in individuals with obesity and insulin resistance. Monocyte chemoattractant protein-1 (MCP-1, CCL2) is involved in insulin resistance of obesity and type 2 diabetes. We investigated the effect of MCP-1 on amylin expression and the underlying mechanisms with murine pancreatic beta-cell line MIN6 and pancreatic islets. Methodology/Principal Findings: We found that MCP-1 induced amylin expression at transcriptional level and increased proamylin and intermediate forms of amylin at protein level in MIN6 cells and islets. However, MCP-1 had no effect on the expressions of proinsulin 1 and 2, as well as prohormone convertase (PC) 1/3 and PC2, suggesting that MCP-1 specifically induces amylin expression in beta-cells. Mechanistic studies showed that although there is no detectable CCR2 mRNA in MIN6 cells and islets, pretreatment of MIN6 cells with pertussis toxin inhibited MCP-1 induced amylin expression, suggesting that alternative Gi-coupled receptor(s) mediates the inductive effect of MCP-1. MCP-1 rapidly induced ERK1/2 and JNK phosphorylation. Inhibitors for MEK1/2 (PD98059), JNK (SP600125) or AP1 (curcumin) significantly inhibited MCP-1-induced amylin mRNA expression. MCP-1 failed to induce amylin expression in pancreatic islets isolated from Fos knockout mice. EMSA showed that JNK and ERK1/2 were involved in MCP-1-induced AP1 activation. These results suggest that MCP-1 induces murine amylin expression through AP1 activation mediated by ERK1/2 or JNK. Further studies showed that treatment of MIN6 cells with NF-kappa B inhibitor or overexpression of I kappa B alpha dominant-negative construct in MIN6 cells significantly inhibited MCP-1-induced amylin expression, suggesting that NF-kappa B related signaling also participates in MCP-1-induced murine amylin expression. Conclusions/Significance: MCP-1 induces amylin expression through ERK1/2/JNK-AP1 and NF-kappa B related signaling pathways independent of CCR2. Amylin upregulation by MCP-1 may contribute to elevation of plasma amylin in obesity and insulin resistance.	[Cai, Kun; Qi, Dongfei; Hou, Xinwei; Wang, Oumei; Chen, Juan; Deng, Bo; Qian, Lihua; Le, Yingying] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Liu, Xiaolong] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, K (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	yyle@sibs.ac.cn	Qi, Dongfei/L-9548-2015; Le, Yingying/L-9785-2017; Qi, Dongfei/M-1050-2015; wang, oumei/P-5528-2015	Qi, Dongfei/0000-0001-9104-978X; Le, Yingying/0000-0002-7990-3899; Qi, Dongfei/0000-0001-9104-978X; 	National Basic Research Program of China (973 Program) [2011CB504002]; National Natural Science Foundation of China [30870931]; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences [SIBS2008006]; Science and Technology Commission of Shanghai Municipality [03JC14079, 04DZ14007]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504002), the National Natural Science Foundation of China (30870931); the One Hundred Talents Program of Chinese Academy of Sciences; the Chief Scientist Program of Shanghai Institutes for Biological Sciences (SIBS2008006), Chinese Academy of Sciences; and the Science and Technology Commission of Shanghai Municipality (03JC14079, 04DZ14007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Cai K, 2011, DIABETOLOGIA, V54, P617, DOI 10.1007/s00125-010-1972-9; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Ding WQ, 2001, AM J PHYSIOL-ENDOC M, V281, pE938, DOI 10.1152/ajpendo.2001.281.5.E938; ENOKI S, 1992, DIABETES RES CLIN PR, V15, P97, DOI 10.1016/0168-8227(92)90074-2; ERIKSSON J, 1992, DIABETOLOGIA, V35, P291, DOI 10.1007/BF00400933; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Heesen M, 1996, J NEUROSCI RES, V45, P382; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; HUANG HJS, 1992, HYPERTENSION, V19, pI101, DOI 10.1161/01.HYP.19.1_Suppl.I101; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Marzban L, 2005, MOL ENDOCRINOL, V19, P2154, DOI 10.1210/me.2004-0407; Marzban L, 2005, ENDOCRINOLOGY, V146, P1808, DOI 10.1210/en.2004-1175; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Piemonti L, 2003, DIABETES CARE, V26, P2883, DOI 10.2337/diacare.26.10.2883; PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333; Qi DF, 2010, AM J PHYSIOL-ENDOC M, V298, pE99, DOI 10.1152/ajpendo.00242.2009; Reinehr T, 2007, OBESITY, V15, P2006, DOI 10.1038/oby.2007.239; SANKE T, 1991, DIABETOLOGIA, V34, P129, DOI 10.1007/BF00500385; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schecter AD, 2004, J LEUKOCYTE BIOL, V75, P1079, DOI 10.1189/jlb.0903421; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1989, DIABETES RES CLIN PR, V7, P219, DOI 10.1016/0168-8227(89)90008-9; Young MR, 2003, TRENDS MOL MED, V9, P36, DOI 10.1016/S1471-4914(02)00009-6; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhou C, 2004, J REPROD IMMUNOL, V63, P1, DOI 10.1016/j.jri.2004.03.002; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	64	42	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19559	10.1371/journal.pone.0019559	http://dx.doi.org/10.1371/journal.pone.0019559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589925	Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600016
J	Negri, AP; Hoogenboom, MO				Negri, Andrew P.; Hoogenboom, Mia O.			Water Contamination Reduces the Tolerance of Coral Larvae to Thermal Stress	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; CLIMATE-CHANGE; HEAVY-METALS; TEMPERATURE; COPPER; SETTLEMENT; METAMORPHOSIS; FERTILIZATION; DISPERSAL	Coral reefs are highly susceptible to climate change, with elevated sea surface temperatures (SST) posing one of the main threats to coral survival. Successful recruitment of new colonies is important for the recovery of degraded reefs following mortality events. Coral larvae require relatively uncontaminated substratum on which to metamorphose into sessile polyps, and the increasing pollution of coastal waters therefore constitutes an additional threat to reef resilience. Here we develop and analyse a model of larval metamorphosis success for two common coral species to quantify the interactive effects of water pollution (copper contamination) and SST. We identify thresholds of temperature and pollution that prevent larval metamorphosis, and evaluate synergistic interactions between these stressors. Our analyses show that halving the concentration of Cu can protect corals from the negative effects of a 2-3 degrees C increase in SST. These results demonstrate that effective mitigation of local impacts can reduce negative effects of global stressors.	[Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Hoogenboom, Mia O.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Australian Institute of Marine Science; University of Glasgow	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Hoogenboom, Mia O/D-3664-2012; Negri, Andrew P/G-9909-2017	Hoogenboom, Mia O/0000-0003-3709-6344; Negri, Andrew P/0000-0003-1388-7395	Australian Institute of Marine Science	Australian Institute of Marine Science	This research was funded by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIMS, 2010, SEA TEMP MON PROGR; Apte SC, 2009, DEV EARTH ENV SCI, V9, P321, DOI 10.1016/S1571-9197(08)00409-6; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAIRD AH, 2006, TEMPERATURE TOLERANC, P38; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Bidwell JR, 1998, MAR ECOL PROG SER, V163, P259, DOI 10.3354/meps163259; Bielmyer GK, 2010, AQUAT TOXICOL, V97, P125, DOI 10.1016/j.aquatox.2009.12.021; CAIRNS J, 1975, HYDROBIOLOGIA, V47, P135, DOI 10.1007/BF00036747; Campbell P.G.C., 1995, METAL SPECIATION BIO, P45; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOWARD LS, 1984, OCEANOGR MAR BIOL, V22, P195; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; Jones RJ, 2007, MAR POLLUT BULL, V54, P905, DOI 10.1016/j.marpolbul.2007.02.018; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LI RC, 1993, ANTIMICROB AGENTS CH, V37, P523, DOI 10.1128/AAC.37.3.523; Lough J., 2007, CLIMATE CHANGE GREAT, P15; MCCONCHIE DM, 1988, J COASTAL RES, V4, P37; Mendes JM, 2002, MAR ECOL PROG SER, V227, P241, DOI 10.3354/meps227241; Michel A, 2004, ENVIRON TOXICOL CHEM, V23, P1074, DOI 10.1897/03-256; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; Negri A, 2009, J ENVIRON MANAGE, V90, pS31, DOI 10.1016/j.jenvman.2008.06.009; Negri AP, 2001, MAR ENVIRON RES, V51, P17, DOI 10.1016/S0141-1136(00)00029-5; Negri AP, 2002, MAR POLLUT BULL, V44, P111, DOI 10.1016/S0025-326X(01)00128-X; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; NEGRI AP, LIMNOL OCEA IN PRESS; NOAA, 2009, COR REEF CONS PROGR; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Nystrom M, 2001, MAR BIOL, V138, P1225; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; R Core Team, 2022, R LANG ENV STAT COMP; *REEF PLAN, 2009, REEF WAT QUAL PROT P; REICHELT AJ, 1994, AUST J MAR FRESH RES, V45, P1237, DOI 10.1071/MF9941237; Reichelt-Brushett AJ, 2000, MAR POLLUT BULL, V41, P385, DOI 10.1016/S0025-326X(00)00131-4; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Roth L, 2010, MAR ECOL PROG SER, V411, P73, DOI 10.3354/meps08640; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; SOLI AL, 1989, LIMNOL OCEANOGR, V34, P239, DOI 10.4319/lo.1989.34.1.0239; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; United States Environmental Protection Agency (USEPA), 2003, UPD AMB WAT IN PRESS; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Venn AA, 2009, AQUAT TOXICOL, V93, P188, DOI 10.1016/j.aquatox.2009.05.003; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Watson GJ, 2008, INVERTEBR REPROD DEV, V52, P101, DOI 10.1080/07924259.2008.9652277; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857	60	70	71	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19703	10.1371/journal.pone.0019703	http://dx.doi.org/10.1371/journal.pone.0019703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589934	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600023
J	Hiraoka, M; Ichihara, K; Zhu, WR; Ma, JH; Shimada, S				Hiraoka, Masanori; Ichihara, Kensuke; Zhu, Wenrong; Ma, Jiahai; Shimada, Satoshi			Culture and Hybridization Experiments on an Ulva Clade Including the Qingdao Strain Blooming in the Yellow Sea	PLOS ONE			English	Article							GREEN-TIDE; MACROALGAL BLOOMS; RAPID EVOLUTION; FLOATING ULVA; CHLOROPHYTA; CHLAMYDOMONAS; ULVOPHYCEAE; AQUACULTURE; CHINA; ALGAE	In the summer of 2008, immediately prior to the Beijing Olympics, a massive green tide of the genus Ulva covered the Qingdao coast of the Yellow Sea in China. Based on molecular analyses using the nuclear encoded rDNA internal transcribed spacer (ITS) region, the Qingdao strains dominating the green tide were reported to be included in a single phylogenetic clade, currently regarded as a single species. On the other hand, our detailed phylogenetic analyses of the clade, using a higher resolution DNA marker, suggested that two genetically separate entities could be included within the clade. However, speciation within the Ulva clade has not yet been examined. We examined the occurrence of an intricate speciation within the clade, including the Qingdao strains, via combined studies of culture, hybridization and phylogenetic analysis. The two entities separated by our phylogenetic analyses of the clade were simply distinguished as U. linza and U. prolifera morphologically by the absence or presence of branches in cultured thalli. The inclusion of sexual strains and several asexual strains were found in each taxon. Hybridizations among the sexual strains also supported the separation by a partial gamete incompatibility. The sexually reproducing Qingdao strains crossed with U. prolifera without any reproductive boundary, but a complete reproductive isolation to U. linza occurred by gamete incompatibility. The results demonstrate that the U. prolifera group includes two types of sexual strains distinguishable by crossing affinity to U. linza. Species identification within the Ulva clade requires high resolution DNA markers and/or hybridization experiments and is not possible by reliance on the ITS markers alone.	[Hiraoka, Masanori] Kochi Univ, Usa Marine Biol Inst, Kochi 780, Japan; [Ichihara, Kensuke] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Zhu, Wenrong] Xianshan Xuwen Seaweed Dev Co Ltd, Ningbo, Peoples R China; [Ma, Jiahai] Shanghai Ocean Univ, Shanghai, Peoples R China; [Shimada, Satoshi] Ochanomizu Univ, Grad Sch Humanities & Sci, Div Nat Appl Sci, Bunkyo Ku, Tokyo 112, Japan	Kochi University; Hokkaido University; Shanghai Ocean University; Ochanomizu University	Hiraoka, M (corresponding author), Kochi Univ, Usa Marine Biol Inst, Kochi 780, Japan.	mhiraoka@kochi-u.ac.jp	Hiraoka, Masanori/AAE-4937-2022	Hiraoka, Masanori/0000-0002-1733-6796; Shimada, Satoshi/0000-0003-4810-4303				Bliding C., 1963, OPERA BOT, V8, P1; BRATEN T, 1971, J CELL SCI, V9, P621; BURROW EM, 1991, SEAWEEDS BRIT ISLES, V2; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Ferris PJ, 2005, PLANT CELL, V17, P597, DOI 10.1105/tpc.104.028035; FLETCHER RL, 1996, ECOL STUD, V123, P7; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2003, PHYCOLOGIA, V42, P275, DOI 10.2216/i0031-8884-42-3-275.1; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; KOEMAN R P T, 1984, Cryptogamie Algologie, V5, P21; KOEMAN R P T, 1982, Cryptogamie Algologie, V3, P37; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Leskinen E, 2004, MOL ECOL, V13, P2257, DOI 10.1111/j.1365-294X.2004.02219.x; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; LOVLIE A, 1976, NATURE, V263, P779, DOI 10.1038/263779a0; Maggs C.A., 2007, GREEN SEAWEEDS BRITA, P80; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Miyamura Shinichi, 2004, Cytologia (Tokyo), V69, P197, DOI 10.1508/cytologia.69.197; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nelson TA, 2003, BOT MAR, V46, P263, DOI 10.1515/BOT.2003.024; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Raven J. A., 2003, WATER AIR SOIL POLL, V3, P7, DOI DOI 10.1023/A:1022167722654; Shimada S, 2010, COAST MAR SCI, V34, P117; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; Wang JF, 2010, AQUAT BOT, V93, P25, DOI 10.1016/j.aquabot.2010.03.001; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	39	57	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19371	10.1371/journal.pone.0019371	http://dx.doi.org/10.1371/journal.pone.0019371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573216	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400008
J	Newcombe, V; Chatfield, D; Outtrim, J; Vowler, S; Manktelow, A; Cross, J; Scoffings, D; Coleman, M; Hutchinson, P; Coles, J; Carpenter, TA; Pickard, J; Williams, G; Menon, D				Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Vowler, Sarah; Manktelow, Anne; Cross, Justin; Scoffings, Daniel; Coleman, Martin; Hutchinson, Peter; Coles, Jonathan; Carpenter, T. Adrian; Pickard, John; Williams, Guy; Menon, David			Mapping Traumatic Axonal Injury Using Diffusion Tensor Imaging: Correlations with Functional Outcome	PLOS ONE			English	Article							SEVERE HEAD-INJURY; BRAIN-INJURY; MR-IMAGES; SCALE; DISEASE; LESIONS; BURDEN; STATE	Background: Traumatic brain injury is a major cause of morbidity and mortality worldwide. Ameliorating the neurocognitive and physical deficits that accompany traumatic brain injury would be of substantial benefit, but the mechanisms that underlie them are poorly characterized. This study aimed to use diffusion tensor imaging to relate clinical outcome to the burden of white matter injury. Methodology/Principal Findings: Sixty-eight patients, categorized by the Glasgow Outcome Score, underwent magnetic resonance imaging at a median of 11.8 months (range 6.6 months to 3.7 years) years post injury. Control data were obtained from 36 age-matched healthy volunteers. Mean fractional anisotropy, apparent diffusion coefficient (ADC), and eigenvalues were obtained for regions of interest commonly affected in traumatic brain injury. In a subset of patients where conventional magnetic resonance imaging was completely normal, diffusion tensor imaging was able to detect clear abnormalities. Significant trends of increasing ADC with worse outcome were noted in all regions of interest. In the white matter regions of interest worse clinical outcome corresponded with significant trends of decreasing fractional anisotropy. Conclusions/Significance: This study found that clinical outcome was related to the burden of white matter injury, quantified by diffusivity parameters late after traumatic brain injury. These differences were seen even in patients with the best outcomes and patients in whom conventional magnetic resonance imaging was normal, suggesting that diffusion tensor imaging can detect subtle injury missed by other techniques. An improved in vivo understanding of the pathology of traumatic brain injury, including its distribution and extent, may enhance outcome evaluation and help to provide a mechanistic basis for deficits that remain unexplained by other approaches.	[Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Manktelow, Anne; Coles, Jonathan; Menon, David] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Manktelow, Anne; Coleman, Martin; Hutchinson, Peter; Coles, Jonathan; Carpenter, T. Adrian; Pickard, John; Williams, Guy; Menon, David] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Vowler, Sarah] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England; [Cross, Justin; Scoffings, Daniel] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Hutchinson, Peter; Pickard, John] Univ Cambridge, Acad Neurosurg Unit, Dept Clin Neurosci, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Newcombe, V (corresponding author), Univ Cambridge, Univ Div Anaesthesia, Cambridge, England.	vfjn2@wbic.cam.ac.uk	Scoffings, Daniel/AAA-1649-2022; Scoffings, Daniel/GLS-1219-2022	Outtrim, Joanne/0000-0001-8118-6430; Newcombe, Virginia/0000-0001-6044-9035; Williams, Guy/0000-0001-5223-6654; Coles, Jonathan/0000-0003-4013-679X	Medical Research Council (UK) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at Cambridge; UK Department of Health; Gates Cambridge Trust; Overseas Research Studentship; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences/Health Foundation; Royal College of Anaesthetists; Evelyn Trust; Medical Research Council [G0001354B, G0001354, G9439390, G0001237, G1000183B, G0600986] Funding Source: researchfish; National Institute for Health Research [ACF-2009-14-007, NF-SI-0508-10327] Funding Source: researchfish; MRC [G9439390, G0001237, G0600986] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research Biomedical Research Centre at Cambridge(National Institute for Health Research (NIHR)); UK Department of Health; Gates Cambridge Trust; Overseas Research Studentship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Academy of Medical Sciences/Health Foundation; Royal College of Anaesthetists; Evelyn Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health. VN was supported by the Gates Cambridge Trust and an Overseas Research Studentship. JC and DS are supported by the NIHR Cambridge Biomedical Research Centre. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship. JPC is supported by a Clinician Scientist Award from the Academy of Medical Sciences/Health Foundation. DKM is supported by the BOC Professorship of the Royal College of Anaesthetists and the Evelyn Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, LANCET, V1, P1031; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; NIOGI SN, 2008, AJNR AM J NEURORADIO; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; SIDAROS A, 2007, BRAIN; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	28	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19214	10.1371/journal.pone.0019214	http://dx.doi.org/10.1371/journal.pone.0019214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573228	Green Submitted, gold, Green Published			2022-12-25	WOS:000290224800017
J	Velthuis, AGJ; Mourits, MCM; Saatkamp, HW; de Koeijer, AA; Elbers, ARW				Velthuis, Annet G. J.; Mourits, Monique C. M.; Saatkamp, Helmut W.; de Koeijer, Aline A.; Elbers, Armin R. W.			Financial Evaluation of Different Vaccination Strategies for Controlling the Bluetongue Virus Serotype 8 Epidemic in the Netherlands in 2008	PLOS ONE			English	Article							SHEEP; VACCINES; CATTLE; FIELD	Background: Bluetongue (BT) is a vector-borne disease of ruminants caused by bluetongue virus that is transmitted by biting midges (Culicoides spp.). In 2006, the introduction of BTV serotype 8 (BTV-8) caused a severe epidemic in Western and Central Europe. The principal effective veterinary measure in response to BT was believed to be vaccination accompanied by other measures such as movement restrictions and surveillance. As the number of vaccine doses available at the start of the vaccination campaign was rather uncertain, the Dutch Ministry of Agriculture, Nature and Food Quality and the Dutch agricultural industry wanted to evaluate several different vaccination strategies. This study aimed to rank eight vaccination strategies based on their efficiency (i.e. net costs in relation to prevented losses or benefits) for controlling the bluetongue virus serotype 8 epidemic in 2008. Methodology/Principal Findings: An economic model was developed that included the Dutch professional cattle, sheep and goat sectors together with the hobby farms. Strategies were evaluated based on the least cost - highest benefit frontier, the benefit-cost ratio and the total net returns. Strategy F, where all adult sheep at professional farms in the Netherlands would be vaccinated was very efficient at lowest costs, whereas strategy D, where additional to all adult sheep at professional farms also all adult cattle in the four Northern provinces would be vaccinated, was also very efficient but at a little higher costs. Strategy C, where all adult sheep and cattle at professional farms in the whole of the Netherlands would be vaccinated was also efficient but again at higher costs. Conclusions/Significance: This study demonstrates that a financial analysis differentiates between vaccination strategies and indicates important decision rules based on efficiency.	[Velthuis, Annet G. J.; Mourits, Monique C. M.; Saatkamp, Helmut W.] Wageningen Univ, Wageningen, Netherlands	Wageningen University & Research	Velthuis, AGJ (corresponding author), Wageningen Univ, Wageningen, Netherlands.	Annet.Velthuis@wur.nl		Mourits, Monique/0000-0001-5213-2927; Velthuis, Annet/0000-0002-5869-8144	joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ); Dutch Ministry of Agriculture, Nature and Food Quality	joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ); Dutch Ministry of Agriculture, Nature and Food Quality	This study was funded by the joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ) and by the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backx A, 2007, VET REC, V161, P591, DOI 10.1136/vr.161.17.591; Barkema HW, 2001, TIJDSCHR DIERGENEESK, V126, P158; BARTELS C, 2008, BLUETONGUE INFECT DA, P1; Belli P., 2001, WORLD BANK I DEV STU; BERENDS IBC, 2008, MEMO MATCHING VWA DA, P1; Bruckner L, 2009, SCHWEIZ ARCH TIERH, V151, P101, DOI 10.1024/0036-7281.151.3.101; *BUND ERN LANDW VE, 2009, MULL IMPF GEG BLAUZ; Conraths FJ, 2009, EMERG INFECT DIS, V15, P433, DOI 10.3201/eid1503.081210; *CVI, 2010, SIT; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; Elbers ARW, 2009, PREV VET MED, V92, P1, DOI 10.1016/j.prevetmed.2009.08.007; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; European Council, 2008, OFF J EUR COMM L, VL214, P66; European Council, 2000, OFF J L, V327, P74; Gethmann J, 2009, VACCINE, V27, P4118, DOI 10.1016/j.vaccine.2009.04.072; Kuijk H, 2008, TIJDSCHR DIERGENEESK, V133, P1006; *LEI, 2008, 2008048 LEI; OIE, 2005, TERR AN HLTH COD, V14th; Palisade-Corporation, 2010, RISK; Santman-Berends IMGA, 2011, VET MICROBIOL, V148, P183, DOI 10.1016/j.vetmic.2010.09.010; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; VELTHUIS AGJ, 2009, FOOD EC ACTA AGR SCA, V6, P31; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055	27	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19612	10.1371/journal.pone.0019612	http://dx.doi.org/10.1371/journal.pone.0019612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573195	Green Published, gold			2022-12-25	WOS:000290224800040
J	Dobek, GL; Zhang, XJ; Balazs, DA; Godbey, WT				Dobek, Georgina L.; Zhang, Xiujuan; Balazs, Daniel A.; Godbey, W. T.			Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability	FASEB JOURNAL			English	Article						Cox-2; Her-2; survivin	TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER CELLS; ANTI-APOPTOSIS GENE; HUMAN COLON-CANCER; BREAST-CANCER; COLORECTAL-CANCER; URINARY-BLADDER; IN-VITRO; SURVIVIN; CYCLOOXYGENASE-2	Genes under the control of the cyclooxygenase- 2 (Cox-2), human epidermal growth factor receptor 2 (Her-2), and survivin promoters were constructed and delivered to murine and human carcinoma cells. It was found that (P)Cox-2-driven reporter expression was strong and correlated well with endogenous Cox-2 levels, while (P)Her-2 and (P)survivin yielded poor results, consistent with the three distinct expression mechanisms used by cancer cells to overexpress the endogenous versions of the selected genes. The (P)Cox-2 was then used to drive the expression of caspase genes both in vitro and in vivo to bring about targeted apoptosis of carcinoma cells successfully. The results led to the following conclusions. 1) When selecting a promoter/enhancer for expression-targeted gene delivery, it is not enough to perform a microarray on some tumor tissue and select the control element associated with the greatest amount of gene up-regulation vs. normal controls. The mechanism of expression for the particular gene should be taken into account to prevent lengthy and costly research trials. 2) When overexpression is due to activator binding, a predictive model based on endogenous gene expression levels, overall cell transfectability, and cell doubling rates can be used to predict expression-targeted gene delivery outcomes with significant accuracy.-Dobek, G. L., Zhang, X., Balazs, D. A., Godbey, W. T. Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability. FASEB J. 25, 3219-3228 (2011). www.fasebj.org	[Zhang, Xiujuan; Balazs, Daniel A.; Godbey, W. T.] Tulane Univ, Lab Gene Therapy & Cellular Engn, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA; [Dobek, Georgina L.] Tulane Univ, Dept Comparat Med, New Orleans, LA 70118 USA	Tulane University; Tulane University	Godbey, WT (corresponding author), Tulane Univ, Lab Gene Therapy & Cellular Engn, Dept Chem & Biomol Engn, 6823 St Charles Ave,300 Lindy Boggs Ctr, New Orleans, LA 70118 USA.	godbey@tulane.edu	Godbey, W T/H-9407-2012	Dobek, Georgina/0000-0002-3383-7101	National Science Foundation [CBET-0846395]; Department of Comparative Medicine, Tulane University; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010991] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Department of Comparative Medicine, Tulane University; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. John C. Prindle, Jr. (Tulane University), for assistance with statistical analyses. The authors thank Ariad (Cambridge, MA, USA; http://www.ariad.com/regulationkits) for providing the AP20187. This work was funded by a National Science Foundation CAREER award (CBET-0846395) and the Department of Comparative Medicine, Tulane University. The authors declare no conflicts of interest associated with these investigations.	Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Benoit V, 2004, ONCOGENE, V23, P1631, DOI 10.1038/sj.onc.1207295; Bostrom PJ, 2001, PATHOLOGY, V33, P469, DOI 10.1080/00313020120083188; Box GE., 1978, STAT EXPT; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Dachs GU, 1997, ONCOL RES, V9, P313; Deshane J, 1995, J CLIN INVEST, V96, P2980, DOI 10.1172/JCI118370; Dobek GL, 2011, JOVE-J VIS EXP, DOI 10.3791/2535; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Ferrandez A, 2003, CURR PHARM DESIGN, V9, P2229, DOI 10.2174/1381612033454036; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Ghosh N, 2010, PHARMACOL REP, V62, P233, DOI 10.1016/S1734-1140(10)70262-0; Godbey WT, 2003, GENE THER, V10, P1519, DOI 10.1038/sj.gt.3302012; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Honma I, 2009, CANCER IMMUNOL IMMUN, V58, P1803, DOI 10.1007/s00262-009-0691-x; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; HUNG MC, 1992, CANCER LETT, V61, P95, DOI 10.1016/0304-3835(92)90166-S; Hurst HC, 2001, BREAST CANCER RES, V3, P395, DOI 10.1186/bcr329; Ignatoski KMW, 2000, BRIT J CANCER, V82, P666, DOI 10.1054/bjoc.1999.0979; ISHII S, 1987, P NATL ACAD SCI USA, V84, P4374, DOI 10.1073/pnas.84.13.4374; Jiang MH, 2006, CLIN CANCER RES, V12, P6179, DOI 10.1158/1078-0432.CCR-06-0746; Jin LQ, 2000, NAT GENET, V26, P64, DOI 10.1038/79194; KARGMAN SL, 1995, CANCER RES, V55, P2556; Kato J, 2001, INT J CANCER, V95, P92; Kawasaki H, 1998, CANCER RES, V58, P5071; Kikkawa K, 2009, UROLOGY, V74, P222, DOI 10.1016/j.urology.2008.12.045; Ku JH, 2010, BJU INT, V106, P1812, DOI 10.1111/j.1464-410X.2010.09259.x; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Ma AN, 2010, BIOCHEM BIOPH RES CO, V393, P592, DOI 10.1016/j.bbrc.2010.02.020; Macrinici V, 2010, CLIN BREAST CANCER, V10, pE38, DOI 10.3816/CBC.2010.s.006; Margulis V, 2008, WORLD J UROL, V26, P59, DOI 10.1007/s00345-007-0219-y; McCrann DJ, 2010, BLOOD, V116, P2192, DOI 10.1182/blood-2010-04-280420; Mohammed SI, 1999, CANCER RES, V59, P5647; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2; Pandha HS, 1999, J CLIN ONCOL, V17, P2180, DOI 10.1200/JCO.1999.17.7.2180; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRESS MF, 1993, CANCER RES, V53, P4960; Rajnakova A, 2001, CANCER LETT, V172, P177, DOI 10.1016/S0304-3835(01)00645-0; Ristimaki A, 1997, CANCER RES, V57, P1276; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Shamma A, 2000, CLIN CANCER RES, V6, P1229; Shariat SF, 2007, CANCER-AM CANCER SOC, V109, P1106, DOI 10.1002/cncr.22521; Shirahama T, 2001, CLIN CANCER RES, V7, P558; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Wang G, 2010, CANCER GENE THER, V17, P559, DOI 10.1038/cgt.2010.11; Yoshimura R, 2001, J UROLOGY, V165, P1468, DOI 10.1016/S0022-5347(05)66329-X; Zhang X, 2008, CANCER GENE THER, V15, P543, DOI 10.1038/cgt.2008.7; Zhang XJ, 2009, MOL BIOTECHNOL, V41, P236, DOI 10.1007/s12033-008-9133-9	59	3	3	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3219	3228		10.1096/fj.11-185421	http://dx.doi.org/10.1096/fj.11-185421			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21602450	Green Published			2022-12-25	WOS:000294435200034
J	Rat, D; Schmitt, U; Tippmann, F; Dewachter, I; Theunis, C; Wieczerzak, E; Postina, R; van Leuven, F; Fahrenholz, F; Kojro, E				Rat, Dorothea; Schmitt, Ulrich; Tippmann, Frank; Dewachter, Ilse; Theunis, Clara; Wieczerzak, Ewa; Postina, Rolf; van Leuven, Fred; Fahrenholz, Falk; Kojro, Elzbieta			Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice	FASEB JOURNAL			English	Article						PAC1 receptor; G-protein-coupled receptor; neuroprotection; nasal delivery	VASOACTIVE-INTESTINAL-PEPTIDE; BDNF MESSENGER-RNA; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-DEATH; FACTOR-KAPPA-B; ALPHA-SECRETASE; NEUROTROPHIC FACTOR; GENE-EXPRESSION; INTRANASAL DELIVERY	Pituitary adenylate cyclase-activating polypeptide (PACAP) has neuroprotective and neurotrophic properties and is a potent alpha-secretase activator. As PACAP peptides and their specific receptor PAC1 are localized in central nervous system areas affected by Alzheimer's disease (AD), this study aims to examine the role of the natural peptide PACAP as a valuable approach in AD therapy. We investigated the effect of PACAP in the brain of an AD transgenic mouse model. The long-term intranasal daily PACAP application stimulated the nonamyloidogenic processing of amyloid precursor protein (APP) and increased expression of the brain-derived neurotrophic factor and of the antiapoptotic Bcl-2 protein. In addition, it caused a strong reduction of the amyloid beta-peptide (A beta) transporter receptor for advanced glycation end products (RAGE) mRNA level. PACAP, by activation of the somatostatin-neprilysin cascade, also enhanced expression of the A beta-degrading enzyme neprilysin in the mouse brain. Furthermore, daily PAC1-receptor activation via PACAP resulted in an increased mRNA level of both the PAC1 receptor and its ligand PACAP. Our behavioral studies showed that long-term PACAP treatment of APP[ V717I]-transgenic mice improved cognitive function in animals. Thus, nasal application of PACAP was effective, and our results indicate that PACAP could be of therapeutic value in treating AD.-Rat, D., Schmitt, U., Tippmann, F., Dewachter, I., Theunis, C., Wieczerzak, E, Postina, R., van Leuven, F., Fahrenholz, F., Kojro, E. Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J. 25, 3208-3218 (2011). www.fasebj.org	[Rat, Dorothea; Tippmann, Frank; Postina, Rolf; Kojro, Elzbieta] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Schmitt, Ulrich; Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Univ Med Ctr, D-55128 Mainz, Germany; [Dewachter, Ilse; Theunis, Clara; van Leuven, Fred] Katholieke Univ Leuven, Expt Genet Grp, LEGTEGG, Louvain, Belgium; [Wieczerzak, Ewa] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; KU Leuven; Fahrenheit Universities; University of Gdansk	Kojro, E (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Becherweg 30, D-55128 Mainz, Germany.	kojro@uni-mainz.de	Wieczerzak, Ewa/AAA-9432-2021; Dewachter, Ilse/AAZ-5661-2020	Wieczerzak, Ewa/0000-0003-2539-5160; Dewachter, Ilse/0000-0001-7202-515X	Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany) [07807]	Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany)	The authors thank Dr. C. Haass (Ludwig Maximilians University Munich, Munich, Germany) for providing antibodies and H. Pearson for critically reading the manuscript. The authors also appreciate the technical help of A. Kanarek. This work was supported by a grant from the Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany) to E. K and F. F (07807).	Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; Almkvist O, 1997, ARCH NEUROL-CHICAGO, V54, P641, DOI 10.1001/archneur.1997.00550170111022; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Braas KM, 2007, PEPTIDES, V28, P1856, DOI 10.1016/j.peptides.2007.04.004; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Clement ME, 2006, BIOCHEM BIOPH RES CO, V342, P206, DOI 10.1016/j.bbrc.2006.01.137; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Delgado M, 2002, BIOCHEM BIOPH RES CO, V297, P1181, DOI 10.1016/S0006-291X(02)02305-7; Delgado M, 2001, J BIOL CHEM, V276, P369, DOI 10.1074/jbc.M006923200; Dewachter I, 2002, J NEUROSCI, V22, P3445; Doberer D, 2007, EUR J CLIN INVEST, V37, P665, DOI 10.1111/j.1365-2362.2007.01832.x; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dufes C, 2003, INT J PHARMACEUT, V255, P87, DOI 10.1016/S0378-5173(03)00039-5; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; GOTTSCHALL PE, 1994, BRAIN RES, V637, P197, DOI 10.1016/0006-8993(94)91233-5; Gozes I, 2000, J PHARMACOL EXP THER, V293, P1091; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Illum L, 2006, J AEROSOL MED, V19, P92, DOI 10.1089/jam.2006.19.92; Illum L, 2002, J PHARMACOL EXP THER, V301, P391, DOI 10.1124/jpet.301.1.391; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jarvis CI, 2010, EUR J NEUROSCI, V32, P1246, DOI 10.1111/j.1460-9568.2010.07426.x; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Kojro E, 2010, J ALZHEIMERS DIS, V20, P1215, DOI 10.3233/JAD-2010-091621; Kopp M, 1997, NEUROSCI LETT, V227, P145, DOI 10.1016/S0304-3940(97)00312-1; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Li Songyun, 1996, Molecular Brain Research, V41, P157, DOI 10.1016/0169-328X(96)00086-1; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Masmoudi-Kouki O, 2007, PEPTIDES, V28, P1753, DOI 10.1016/j.peptides.2007.05.015; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Pellegri G, 1998, EUR J NEUROSCI, V10, P272, DOI 10.1046/j.1460-9568.1998.00052.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TATSUNO I, 1990, BIOCHEM BIOPH RES CO, V168, P1027, DOI 10.1016/0006-291X(90)91132-C; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Uchida D, 1996, BRAIN RES, V736, P280, DOI 10.1016/0006-8993(96)00716-0; Vaudry D, 2000, P NATL ACAD SCI USA, V97, P13390, DOI 10.1073/pnas.97.24.13390; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Wu ZL, 2006, NEUROBIOL AGING, V27, P377, DOI 10.1016/j.neurobiolaging.2005.02.010; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zink M, 2004, NEUROSCI LETT, V360, P106, DOI 10.1016/j.neulet.2004.01.030	68	99	105	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3208	3218		10.1096/fj.10-180133	http://dx.doi.org/10.1096/fj.10-180133			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21593432	Green Published			2022-12-25	WOS:000294435200033
J	Wang, H; Hota, PK; Tong, YF; Li, BR; Shen, LM; Nedyalkova, L; Borthakur, S; Kim, S; Tempel, W; Buck, M; Park, HW				Wang, Hui; Hota, Prasanta K.; Tong, Yufeng; Li, Buren; Shen, Limin; Nedyalkova, Lyudmila; Borthakur, Susmita; Kim, SoonJeung; Tempel, Wolfram; Buck, Matthias; Park, Hee-Won			Structural Basis of Rnd1 Binding to Plexin Rho GTPase Binding Domains (RBDs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; SEMAPHORIN RECEPTOR; AXON GUIDANCE; CELLS; COMPLEXES; MODEL; MORPHOGENESIS; INTEGRATION; VALIDATION; REFINEMENT	Plexin receptors regulate cell adhesion, migration, and guidance. The Rho GTPase binding domain (RBD) of plexin-A1 and -B1 can bind GTPases, including Rnd1. By contrast, plexin-C1 and -D1 reportedly bind Rnd2 but associate with Rnd1 only weakly. The structural basis of this differential Rnd1 GTPase binding to plexin RBDs remains unclear. Here, we solved the structure of the plexin-A2 RBD in complex with Rnd1 and the structures of the plexin-C1 and plexin-D1 RBDs alone, also compared with the previously determined plexin-B1 RBD. Rnd1 complex structure. The plexin-A2 RBD.Rnd1 complex is a heterodimer, whereas plexin-B1 and -A2 RBDs homodimerize at high concentration in solution, consistent with a proposed model for plexin activation. Plexin-C1 and -D1 RBDs are monomeric, consistent with major residue changes in the homodimerization loop. In plexin-A2 and -B1, the RBD beta 3-beta 4 loop adjusts its conformation to allow Rnd1 binding, whereas minimal structural changes occur in Rnd1. The plexin-C1 and -D1 RBDs lack several key non-polar residues at the corresponding GTPase binding surface and do not significantly interact with Rnd1. Isothermal titration calorimetry measurements on plexin-C1 and -D1 mutants reveal that the introduction of non-polar residues in this loop generates affinity for Rnd1. Structure and sequence comparisons suggest a similar mode of Rnd1 binding to the RBDs, whereas mutagenesis suggests that the interface with the highly homologous Rnd2 GTPase is different in detail. Our results confirm, from a structural perspective, that Rnd1 does not play a role in the activation of plexin-C1 and -D1. Plexin functions appear to be regulated by subfamily-specific mechanisms, some of which involve different Rho family GTPases.	[Hota, Prasanta K.; Borthakur, Susmita; Kim, SoonJeung; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Wang, Hui; Tong, Yufeng; Li, Buren; Shen, Limin; Nedyalkova, Lyudmila; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; Structural Genomics Consortium; University of Toronto	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Robbins Blvd,Rm E607,10900 Euclid Ave, Cleveland, OH 44106 USA.	matthias.buck@case.edu; heewon.park@utoronto.ca	Buck, Matthias/B-2106-2017; Tong, Yufeng/D-2785-2011; Hota, Prasanta Kumar/J-4319-2019	Buck, Matthias/0000-0002-2958-0403; Tong, Yufeng/0000-0001-7740-1812; Hota, Prasanta Kumar/0000-0002-4057-1831	National Institutes of Health [R01GM73071, K02HL084384, R01GM092851]; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NCI from National Institutes of Health [Y1-CO-1020, Y1-GM-1104]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071, R01GM092851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NCI from National Institutes of Health; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM73071, K02HL084384, and R01GM092851 (to M. B.). This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; We thank Shufen Cao for assistance with Rnd1 and Rnd2 protein preparation and Drs. Christina Kiel and Luis Serrano (EMBL-CRG, Barcelona) for introducing us to Fold-X. Crystallographic data shown in this report were derived from work performed at Argonne National Laboratory, Structural Biology Center, beam line 19ID, at the Advanced Photon Source. Data collection at The National Institute of General Medical Sciences and National Cancer Institute Collaborative Access Team, beam line 23ID-B, was supported by NCI Grant Y1-CO-1020 and NIGM Grant Y1-GM-1104 from the National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiorucci S, 2010, PROTEINS, V78, P3131, DOI 10.1002/prot.22808; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; GIESEN PLA, 1991, J BIOL CHEM, V266, P18720; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Goryachev AB, 2006, PLOS COMPUT BIOL, V2, P1511, DOI 10.1371/journal.pcbi.0020172; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Heo WD, 2003, CELL, V113, P315; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; Janin J, 2010, PROTEINS, V78, P3067, DOI 10.1002/prot.22774; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Li XF, 2010, PROTEINS, V78, P3189, DOI 10.1002/prot.22770; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moretti S, 2006, CURR NEUROVASC RES, V3, P295, DOI 10.2174/156720206778792939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; O'Connor BP, 2008, IMMUNOL RES, V41, P217, DOI 10.1007/s12026-008-8026-0; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Roodink I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-297; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walzer T, 2005, EUR J IMMUNOL, V35, P391, DOI 10.1002/eji.200425669; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	55	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26093	26106		10.1074/jbc.M110.197053	http://dx.doi.org/10.1074/jbc.M110.197053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21610070	Green Published, hybrid			2022-12-25	WOS:000293073000067
J	Zhang, JL; Xue, FQ; Whiteaker, P; Li, CK; Wu, W; Shen, BC; Huang, Y; Lukas, RJ; Chang, YC				Zhang, Jianliang; Xue, Fenqin; Whiteaker, Paul; Li, Chaokun; Wu, Wen; Shen, Benchang; Huang, Yao; Lukas, Ronald J.; Chang, Yongchang			Desensitization of alpha 7 Nicotinic Receptor Is Governed by Coupling Strength Relative to Gate Tightness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTOR; ION-CHANNEL; AGONIST BINDING; RAPID DESENSITIZATION; ALLOSTERIC RECEPTORS; GABA(A) RECEPTOR; OPEN STATE; MECHANISM; DOMAIN	Binding of a neurotransmitter to its membrane receptor opens an integral ion conducting pore. However, prolonged exposure to the neurotransmitter drives the receptor to a refractory state termed desensitization, which plays an important role in shaping synaptic transmission. Despite intensive research in the past, the structural mechanism of desensitization is still elusive. Using mutagenesis and voltage clamp in an oocyte expression system, we provide several lines of evidence supporting a novel hypothesis that uncoupling between binding and gating machinery is the underlying mechanism for alpha 7 nicotinic receptor (nAChR) desensitization. First, the decrease in gate tightness was highly correlated to the reduced desensitization. Second, nonfunctional mutants in three important coupling loops (loop 2, loop 7, and the M2-M3 linker) could be rescued by a gating mutant. Furthermore, the decrease in coupling strength in these rescued coupling loop mutants reversed the gating effect on desensitization. Finally, coupling between M1 and hinge region of the M2-M3 linker also influenced the receptor desensitization. Thus, the uncoupling between N-terminal domain and transmembrane domain, governed by the balance of coupling strength and gate tightness, underlies the mechanism of desensitization for the alpha 7 nAChR.	[Zhang, Jianliang; Xue, Fenqin; Whiteaker, Paul; Li, Chaokun; Shen, Benchang; Lukas, Ronald J.; Chang, Yongchang] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Wu, Wen; Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA; [Shen, Benchang] Guangzhou Med Coll, Dept Med Genet & Cell Biol, Guangzhou 510182, Guangdong, Peoples R China	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Guangzhou Medical University	Chang, YC (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	yongchang.chang@chw.edu	Wu, Wen/V-7065-2017		NIGMS, National Institutes of Health [R01GM085237]; Arizona Biological Research Commission [ABRC0702]; Barrow Neurological Foundation; St. Joseph's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arizona Biological Research Commission; Barrow Neurological Foundation; St. Joseph's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health Grant R01GM085237. This work was also supported by Arizona Biological Research Commission Grant ABRC0702 and the Barrow Neurological Foundation (to Y.C.) and in part by a St. Joseph's Foundation startup fund (to Y.H.).	Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bohler S, 2001, BIOCHEMISTRY-US, V40, P2066, DOI 10.1021/bi0020022; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Chang YC, 2002, J NEUROSCI, V22, P7982; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Fenster CP, 1997, J NEUROSCI, V17, P5747; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hill DG, 2006, BIOPHYS J, V91, P705, DOI 10.1529/biophysj.106.082693; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; McCormack TJ, 2010, J PHYSIOL-LONDON, V588, P4415, DOI 10.1113/jphysiol.2010.195495; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Placzek AN, 2004, MOL PHARMACOL, V66, P169, DOI 10.1124/mol.66.1.169; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zhang JL, 2008, MOL PHARMACOL, V74, P941, DOI 10.1124/mol.108.048710; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	50	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25331	25340		10.1074/jbc.M111.221754	http://dx.doi.org/10.1074/jbc.M111.221754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610071	Green Published, hybrid			2022-12-25	WOS:000292547900079
J	Rao, VS; Clobes, AM; Guilford, WH				Rao, Vijay S.; Clobes, Amy M.; Guilford, William H.			Force Spectroscopy Reveals Multiple "Closed States" of the Muscle Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN COMPLEX; MYOSIN SUBFRAGMENT-1; ACTIN-FILAMENT; COOPERATIVE BINDING; ALPHA-TROPOMYOSIN; ESCHERICHIA-COLI; SKELETAL-MUSCLE; RABBIT SKELETAL; CARDIAC-MUSCLE; FIMH ADHESIN	Tropomyosin (Tm) plays a critical role in regulating the contraction of striated muscle. The three-state model of activation posits that Tm exists in three positions on the thin filament: "blocked" in the absence of calcium when myosin cannot bind, "closed" when calcium binds troponin and Tm partially covers the myosin binding site, and "open" after myosin binding forces Tm completely off neighboring sites. However, we recently showed that actin filaments decorated with phosphorylated Tm are driven by myosin with greater force than bare actin filaments. This result cannot be explained by simple steric hindrance and suggests that Tm may have additional effects on actin-myosin interactions. We therefore tested the hypothesis that Tm and its phosphorylation state affect the rate at which single actin-myosin bonds form and rupture. Using a laser trap, we measured the time necessary for the first bond to form between actin and rigor heavy meromyosin and the load-dependent durations of those bonds. Measurements were repeated in the presence of subsaturating myosin-S1 to force Tm from the closed to the open state. Maximum bond lifetimes increased in the open state, but only when Tm was phosphorylated. While the frequency with which bonds formed was extremely low in the closed state, when a bond did form it took significantly less time to do so than with bare actin. These data suggest there are at least two closed states of the thin filament, and that Tm provides additional points of contact for myosin.	[Rao, Vijay S.; Clobes, Amy M.; Guilford, William H.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia	Guilford, WH (corresponding author), Univ Virginia, Dept Biomed Engn, Box 800759, Charlottesville, VA 22908 USA.	whg2n@virginia.edu		Guilford, William/0000-0002-6543-5713	National Institutes of Health NSF [MCB0718430]; National Institutes of Health [GM080186, HL07284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health NSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NSF Graduate Training Grant MCB0718430 (to the University of Virginia), National Institutes of Health Biophysics Graduate Training Grant GM080186 (to the University of Virginia), and National Institutes of Health Cardiovascular Graduate Training Grant HL07284 (to the University of Virginia).	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EDWARDS BFP, 1980, BIOCHEMISTRY-US, V19, P2577, DOI 10.1021/bi00553a007; EDWARDS BFP, 1981, BIOCHEMISTRY-US, V20, P4193, DOI 10.1021/bi00517a037; EDWARDS BFP, 1978, BIOCHEMISTRY-US, V17, P684, DOI 10.1021/bi00597a020; Gaffin RD, 2006, AM J PHYSIOL-HEART C, V291, pH552, DOI 10.1152/ajpheart.00688.2005; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 2004, ANAL BIOCHEM, V326, P153, DOI 10.1016/j.ab.2003.11.025; Guo B, 2004, CELL MOTIL CYTOSKEL, V59, P264, DOI 10.1002/cm.20040; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Korman VL, 2000, J BIOL CHEM, V275, P22470, DOI 10.1074/jbc.M002939200; LEHRER SS, 1984, J BIOL CHEM, V259, P2070; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pereverzev YV, 2005, BIOPHYS J, V89, P1446, DOI 10.1529/biophysj.105.062158; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Rao VS, 2007, AM J PHYSIOL-HEART C, V293, pH654, DOI 10.1152/ajpheart.01314.2006; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Snook JH, 2010, CELL MOL BIOENG, V3, P128, DOI 10.1007/s12195-010-0110-6; Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VanBuren P, 1999, P NATL ACAD SCI USA, V96, P12488, DOI 10.1073/pnas.96.22.12488; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	51	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24135	24141		10.1074/jbc.M110.167957	http://dx.doi.org/10.1074/jbc.M110.167957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21597115	hybrid, Green Published			2022-12-25	WOS:000292294900055
J	Hu, CX; Wei, H; van den Hoek, AM; Wang, M; van der Heijden, R; Spijksma, G; Reijmers, TH; Bouwman, J; Wopereis, S; Havekes, LM; Verheij, E; Hankemeier, T; Xu, GW; van der Greef, J				Hu, Chunxiu; Wei, Heng; van den Hoek, Anita M.; Wang, Mei; van der Heijden, Rob; Spijksma, Gerwin; Reijmers, Theo H.; Bouwman, Jildau; Wopereis, Suzan; Havekes, Louis M.; Verheij, Elwin; Hankemeier, Thomas; Xu, Guowang; van der Greef, Jan			Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; CARDIOVASCULAR RISK-FACTORS; INCREASES HDL-CHOLESTEROL; CB1 RECEPTOR ANTAGONIST; FREE FATTY-ACIDS; TRANSFER PROTEIN; AGGRAVATES ATHEROSCLEROSIS; OVERWEIGHT PATIENTS; METABOLIC SYNDROME; HEPATIC STEATOSIS	Background: Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes. The first selective cannabinoid-1 receptor blocker rimonabant, an anorectic anti-obesity drug, was frequently used in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m(2) with associated risk factors such as type II diabetes and dyslipidaemia in the past. Less is known about the impact of this drug on the regulation of lipid metabolism in plasma and liver in the early stage of obesity. Methodology/Principal Findings: We designed a four-week parallel controlled intervention on apolipoprotein E3 Leiden cholesteryl ester transfer protein (ApoE*3Leiden. CETP) transgenic mice with mild overweight and hypercholesterolemia. A liquid chromatography-linear ion trap-Fourier transform ion cyclotron resonance-mass spectrometric approach was employed to investigate plasma and liver lipid responses to the rimonabant intervention. Rimonabant was found to induce a significant body weight loss (9.4%, p<0.05) and a significant plasma total cholesterol reduction (24%, p<0.05). Six plasma and three liver lipids in ApoE*3Leiden. CETP transgenic mice were detected to most significantly respond to rimonabant treatment. Distinct lipid patterns between the mice were observed for both plasma and liver samples in rimonabant treatment vs. non-treated controls. This study successfully applied, for the first time, systems biology based lipidomics approaches to evaluate treatment effects of rimonabant in the early stage of obesity. Conclusion: The effects of rimonabant on lipid metabolism and body weight reduction in the early stage obesity were shown to be moderate in ApoE*3Leiden. CETP mice on high-fat diet.	[Hu, Chunxiu; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hu, Chunxiu; van der Heijden, Rob; Spijksma, Gerwin; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Wei, Heng; Wang, Mei; Xu, Guowang; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Wang, Mei; van der Greef, Jan] SU BioMed, Zeist, Netherlands; [van den Hoek, Anita M.; Havekes, Louis M.] TNO, Gaubius Lab, Leiden, Netherlands; [Wei, Heng; Bouwman, Jildau; Wopereis, Suzan; Verheij, Elwin; van der Greef, Jan] TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands; [Bouwman, Jildau; Hankemeier, Thomas] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Netherlands Metab Ctr, Leiden, Netherlands	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; jan.vandergreef@tno.nl	Xu, Guowang/L-6910-2014; van der Heijden, Rob/D-1403-2013; Hankemeier, Thomas/V-5407-2019	Xu, Guowang/0000-0003-4298-3554; Hankemeier, Thomas/0000-0001-7871-2073	Royal Netherlands Academy of Arts and Sciences (KNAW) [05-PhD-07]; Chinese Academy of Sciences (CAS) [05-PhD-07]; Ministry of Science and Technology of China, the Key Foundation [2009DFA41250]; National Natural Science Foundation of China [21021004, 20835006]; SU Biomedicine (SUB) [031.13097]; Netherlands Genomics Initiative	Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Ministry of Science and Technology of China, the Key Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SU Biomedicine (SUB); Netherlands Genomics Initiative	This study was supported by a Joint Ph.D. training grant (number 05-PhD-07) within the China Exchange Program between the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Chinese Academy of Sciences (CAS), by the Sino-Dutch Joint Program supported by the China International Science and Technology Cooperation Program (2009DFA41250) from the Ministry of Science and Technology of China, the Key Foundation (No. 20835006), and the Creative Research Group Project (No. 21021004) from National Natural Science Foundation of China and the Netherlands Genomics Initiative. In addition, the work presented is part of a larger project with Project No. of 031.13097 financially supported by SU Biomedicine (SUB). Authors employed by SUB contributed to experimental conceiving and design, guidance and discussion of the project. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bergheanu SC, 2008, CURR MED RES OPIN, V24, P2477, DOI [10.1185/03007990802321709, 10.1185/03007990802321709 ]; Bijland S, 2010, J LIPID RES, V51, P97, DOI 10.1194/jlr.M900186-JLR200; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dullaart RPF, 1999, EUR J CLIN INVEST, V29, P663; ENGELI S, 2006, CLIN CORNERSTONE S, V4, pS24; Epstein LH, 1998, PEDIATRICS, V101, P554; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; GRASS DS, 1995, J LIPID RES, V36, P1082; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Jong MC, 1996, ARTERIOSCL THROM VAS, V16, P934, DOI 10.1161/01.ATV.16.8.934; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lafontan M, 2007, DIABETES METAB, V33, P85, DOI 10.1016/j.diabet.2007.02.001; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Mathur P, 2007, INDIAN J PEDIATR, V74, P401, DOI 10.1007/s12098-007-0068-0; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miller Wendy M, 2005, Curr Cardiol Rep, V7, P465, DOI 10.1007/s11886-005-0065-8; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; Neuschwander-Tetri BA, 2007, HEPATOLOGY, V46, P12, DOI 10.1002/hep.21821; NISHINA PM, 1990, J LIPID RES, V31, P859; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagotto U, 2005, ANN MED, V37, P270, DOI 10.1080/07853890510037419; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Papandreou D, 2007, CLIN NUTR, V26, P409, DOI 10.1016/j.clnu.2007.02.002; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schwarz E, 2008, J PROTEOME RES, V7, P4266, DOI 10.1021/pr800188y; SOTHERN MS, 1993, ANN NY ACAD SCI, V699, P292, DOI 10.1111/j.1749-6632.1993.tb18870.x; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Westerbacka J, 2010, GASTROENTEROLOGY, V139, P1961, DOI 10.1053/j.gastro.2010.06.064; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	56	14	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19423	10.1371/journal.pone.0019423	http://dx.doi.org/10.1371/journal.pone.0019423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611179	Green Published, gold			2022-12-25	WOS:000290657500004
J	Xin, XR; Fan, B; Flammer, J; Miller, NR; Jaggi, GP; Killer, HE; Meyer, P; Neutzner, A				Xin, Xiaorong; Fan, Bin; Flammer, Josef; Miller, Neil R.; Jaggi, Gregor P.; Killer, Hanspeter E.; Meyer, Peter; Neutzner, Albert			Meningothelial Cells React to Elevated Pressure and Oxidative Stress	PLOS ONE			English	Article							NERVE HEAD ASTROCYTES; OPTIC-NERVE; SUBARACHNOID SPACE; PATHOGENESIS; MENINGIOMAS; ACTIVATION; MENINGES; GLAUCOMA; JUNCTION; IMMUNE	Background: Meningothelial cells (MECs) are the cellular components of the meninges enveloping the brain. Although MECs are not fully understood, several functions of these cells have been described. The presence of desmosomes and tight junctions between MECs hints towards a barrier function protecting the brain. In addition, MECs perform endocytosis and, by the secretion of cytokines, are involved in immunological processes in the brain. However, little is known about the influence of pathological conditions on MEC function; e. g., during diseases associated with elevated intracranial pressure, hypoxia or increased oxidative stress. Methods: We studied the effect of elevated pressure, hypoxia, and oxidative stress on immortalized human as well as primary porcine MECs. We used MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) bioreduction assays to assess the proliferation of MECs in response to treatment and compared to untreated control cells. To assess endocytotic activity, the uptake of fluorescently labeled latex beads was analyzed by fluorescence microscopy. Results: We found that exposure of MECs to elevated pressure caused significant cellular proliferation and a dramatic decrease in endocytotic activity. In addition, mild oxidative stress severely inhibited endocytosis. Conclusion: Elevated pressure and oxidative stress impact MEC physiology and might therefore influence the microenvironment of the subarachnoid space and thus the cerebrospinal fluid within this compartment with potential negative impact on neuronal function.	[Xin, Xiaorong; Fan, Bin; Flammer, Josef; Meyer, Peter; Neutzner, Albert] Univ Basel Hosp, Dept Biomed Ocular Pharmacol & Physiol, CH-4031 Basel, Switzerland; [Xin, Xiaorong; Fan, Bin; Flammer, Josef; Meyer, Peter; Neutzner, Albert] Univ Basel Hosp, Dept Ophthalmol, CH-4031 Basel, Switzerland; [Miller, Neil R.] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA; [Jaggi, Gregor P.; Killer, Hanspeter E.] Kantonsspital, Dept Ophthalmol, Aarau, Switzerland	University of Basel; University of Basel; Johns Hopkins University; Johns Hopkins Medicine; Kantonsspital Aarau AG (KSA)	Xin, XR (corresponding author), Univ Basel Hosp, Dept Biomed Ocular Pharmacol & Physiol, CH-4031 Basel, Switzerland.	albert.neutzner@unibas.ch	Neutzner, Albert/ABC-4368-2020	Jaggi, Gregor/0000-0002-5925-238X; Neutzner, Albert/0000-0001-9254-5558	Messerli Foundation; Zurich; Grieshaber Foundation for Eye Research	Messerli Foundation; Zurich; Grieshaber Foundation for Eye Research	Financial support was provided by the Messerli Foundation, Zurich and the Grieshaber Foundation for Eye Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat K, 2008, CELL TISSUE RES, V331, P401, DOI 10.1007/s00441-007-0512-5; Alomar SA, 2010, SEMIN DIAGN PATHOL, V27, P97, DOI 10.1053/j.semdp.2010.06.001; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x; Hashimoto K, 2005, BRAIN RES, V1054, P103, DOI 10.1016/j.brainres.2005.06.050; Kastenbauer S, 2002, NEUROLOGY, V58, P186, DOI 10.1212/WNL.58.2.186; Killer HE, 2007, BRAIN, V130, P514, DOI 10.1093/brain/awl324; Killer HE, 2008, CLIN EXP OPHTHALMOL, V36, P308, DOI 10.1111/j.1442-9071.2008.01735.x; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Malone P, 2007, GLIA, V55, P1085, DOI 10.1002/glia.20527; Mandal A, 2009, AM J PHYSIOL-CELL PH, V297, pC111, DOI 10.1152/ajpcell.00539.2008; Mattsson N, 2009, ANN NY ACAD SCI, V1180, P28, DOI 10.1111/j.1749-6632.2009.04944.x; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; Pache M, 2006, OPHTHALMOLOGICA, V220, P393, DOI 10.1159/000095867; Puttmann S, 2005, LAB INVEST, V85, P1163, DOI 10.1038/labinvest.3700307; Robinson K, 2004, CELL MICROBIOL, V6, P927, DOI 10.1111/j.1462-5822.2004.00410.x; Sinclair AJ, 2008, J NEUROIMMUNOL, V201, P212, DOI 10.1016/j.jneuroim.2008.06.029; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; XIN X, 2010, GRAEFES ARC IN PRESS	20	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20142	10.1371/journal.pone.0020142	http://dx.doi.org/10.1371/journal.pone.0020142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611150	Green Published, Green Submitted, gold			2022-12-25	WOS:000290657500046
J	Enjuanes, A; Fernandez, V; Hernandez, L; Navarro, A; Bea, S; Pinyol, M; Lopez-Guillermo, A; Rosenwald, A; Ott, G; Campo, E; Jares, P				Enjuanes, Anna; Fernandez, Veronica; Hernandez, Luis; Navarro, Alba; Bea, Silvia; Pinyol, Magda; Lopez-Guillermo, Armando; Rosenwald, Andreas; Ott, German; Campo, Elias; Jares, Pedro			Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; GENOME-WIDE ANALYSIS; DNA HYPERMETHYLATION; CANCER; EXPRESSION; BREAST; DEMETHYLATION; EPIGENETICS; PATTERNS; FREQUENT	Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11; 14)(q13; q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance. Methodology/Principal Findings: To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n = 38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n = 25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9, HOXA9, AHR, NR2F2, and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients. Conclusions: We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.	[Enjuanes, Anna; Fernandez, Veronica; Hernandez, Luis; Navarro, Alba; Bea, Silvia; Campo, Elias; Jares, Pedro] Univ Barcelona, Hematopathol Sect, Dept Anat Pathol, Hosp Clin,Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Pinyol, Magda; Jares, Pedro] Univ Barcelona, Genom Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Lopez-Guillermo, Armando] Univ Barcelona, Hosp Clin, Dept Hematol, Barcelona, Spain; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Enjuanes, A (corresponding author), Univ Barcelona, Hematopathol Sect, Dept Anat Pathol, Hosp Clin,Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.	pjares@clinic.ub.es	Hernandez, Luis/D-4684-2018; Lopez-Guillermo, Armando/Z-5684-2019; bea, silvia/K-7699-2014; ENJUANES, Anna/H-3245-2015; Navarro, Alba/H-2611-2015; Jares, Pedro/T-3778-2019; Campo, Elias/AAC-5593-2019	Hernandez, Luis/0000-0002-4854-3069; bea, silvia/0000-0001-7192-2385; ENJUANES, Anna/0000-0002-4679-6687; Navarro, Alba/0000-0002-4041-0974; Campo, Elias/0000-0001-9850-9793; JARES, PEDRO/0000-0002-8401-579X	Lymphoma Research Foundation [LRF07168]; Spanish Ministry of Science and Innovation [CICYT SAF 08/3869]; Asociacion Espanola Contra el Cancer (AECC) of Barcelona; Instituto de Salud Carlos III-RETIC [RD07/0020/2004]; Spanish Ministry of Education and Science (MEC); FIS; Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany; Robert-Bosch-Stiftung	Lymphoma Research Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Asociacion Espanola Contra el Cancer (AECC) of Barcelona; Instituto de Salud Carlos III-RETIC(Instituto de Salud Carlos III); Spanish Ministry of Education and Science (MEC)(Spanish Government); FIS(Instituto de Salud Carlos III); Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany; Robert-Bosch-Stiftung	This study was supported by grants from Lymphoma Research Foundation LRF07168 (PJ), the CICYT SAF 08/3869 from the Spanish Ministry of Science and Innovation, the Asociacion Espanola Contra el Cancer (AECC) of Barcelona 2008, and the Instituto de Salud Carlos III-RETIC (RD07/0020/2004). VF was a recipient of a predoctoral fellowship from Spanish Ministry of Education and Science (MEC). LH is a researcher from IDIBAPS and supported by FIS and "Programa d'estabilitzacio d'investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut (Generalitat de Catalunya)". AR was, in part, supported by the Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany. GO is supported by the Robert-Bosch-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CLAUS R, 2007, ONCOGENE, V21, P2114; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Drivdahl R, 2004, ONCOGENE, V23, P4584, DOI 10.1038/sj.onc.1207603; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Ripperger T, 2007, HAEMATOLOGICA, V92, P460, DOI 10.3324/haematol.10337; Salaverria I, 2006, HAEMATOLOGICA, V91, P11; Sato N, 2003, CANCER RES, V63, P3735; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sundaresan V, 1998, ONCOGENE, V17, P1723, DOI 10.1038/sj.onc.1202103; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Swerdlow E., 2008, WHO CLASSIFICATION T; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561	38	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19736	10.1371/journal.pone.0019736	http://dx.doi.org/10.1371/journal.pone.0019736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603610	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300022
J	Zappia, MP; Brocco, MA; Billi, SC; Frasch, AC; Ceriani, MF				Paula Zappia, Maria; Adriana Brocco, Marcela; Billi, Silvia C.; Frasch, Alberto C.; Fernanda Ceriani, Maria			M6 Membrane Protein Plays an Essential Role in Drosophila Oogenesis	PLOS ONE			English	Article							FEMALE-STERILE MUTATION; PROTEOLIPID PROTEIN; FOLLICULAR-EPITHELIUM; VITELLINE MEMBRANE; GENE-EXPRESSION; OVARIAN FOLLICLES; NUDEL PROTEASE; STEM-CELLS; MELANOGASTER; MORPHOGENESIS	We had previously shown that the transmembrane glycoprotein M6a, a member of the proteolipid protein (PLP) family, regulates neurite/filopodium outgrowth, hence, M6a might be involved in neuronal remodeling and differentiation. In this work we focused on M6, the only PLP family member present in Drosophila, and ortholog to M6a. Unexpectedly, we found that decreased expression of M6 leads to female sterility. M6 is expressed in the membrane of the follicular epithelium in ovarioles throughout oogenesis. Phenotypes triggered by M6 downregulation in hypomorphic mutants included egg collapse and egg permeability, thus suggesting M6 involvement in eggshell biosynthesis. In addition, RNAi-mediated M6 knockdown targeted specifically to follicle cells induced an arrest of egg chamber development, revealing that M6 is essential in oogenesis. Interestingly, M6-associated phenotypes evidenced abnormal changes of the follicle cell shape and disrupted follicular epithelium in mid-and late-stage egg chambers. Therefore, we propose that M6 plays a role in follicular epithelium maintenance involving membrane cell remodeling during oogenesis in Drosophila.	[Paula Zappia, Maria; Adriana Brocco, Marcela; Billi, Silvia C.; Frasch, Alberto C.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cientif & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Paula Zappia, Maria; Fernanda Ceriani, Maria] CABA, Lab Genet Comportamiento, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Paula Zappia, Maria; Fernanda Ceriani, Maria] CABA, Inst Invest Bioquim Buenos Aires IIB BA, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zappia, MP (corresponding author), Univ Nacl Gen San Martin, Consejo Nacl Invest Cientif & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	mpzappia@iib.unsam.edu.ar; fceriani@leloir.org.ar		Frasch, Alberto Carlos/0000-0001-7532-653X; Ceriani, Maria/0000-0001-8945-3070	HHMI; Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2007-678, PICT 2005-38204]; National Council for Research in Science and Technology (CONICET)	HHMI(Howard Hughes Medical Institute); Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); National Council for Research in Science and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by the International Research Scholar from the HHMI to ACF, and grants from the Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT, PICT 2007-678 to MFC and PICT 2005-38204 to ACF). MPZ is supported by a graduate fellowship from the National Council for Research in Science and Technology (CONICET), SCB is also supported by CONICET, and MFC, MAB and ACF are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, J NEUROSCI RES, V78, P702, DOI 10.1002/jnr.20328; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Biosystems A., 2004, GUIDE PERFORMING REL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DIMARIO PJ, 1987, J CELL BIOL, V105, P199, DOI 10.1083/jcb.105.1.199; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; Dobens LL, 2000, DEV DYNAM, V218, P80, DOI 10.1002/(SICI)1097-0177(200005)218:1<80::AID-DVDY7>3.0.CO;2-8; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Elalayli M, 2008, DEV BIOL, V319, P359, DOI 10.1016/j.ydbio.2008.04.035; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gudz TI, 2002, J NEUROSCI, V22, P7398; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Kalwy SA, 1997, J NEUROSCI RES, V48, P201; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LeMosy EK, 2000, DEV BIOL, V217, P352, DOI 10.1006/dbio.1999.9562; LeMosy EK, 1998, DEVELOPMENT, V125, P4045; Manogaran A, 2004, DEV BIOL, V270, P261, DOI 10.1016/j.ydbio.2004.02.009; MCGUIRE SE, 2004, SCI STKE, P16; Michibata H, 2009, STEM CELLS DEV, V18, P629, DOI 10.1089/scd.2008.0215; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; NEWMAN SM, 1981, DEV BIOL, V86, P393, DOI 10.1016/0012-1606(81)90197-4; Pascucci T, 1996, DEV BIOL, V177, P590, DOI 10.1006/dbio.1996.0188; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAVANT SS, 1989, DEV BIOL, V135, P43, DOI 10.1016/0012-1606(89)90156-5; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Schotman H, 2009, J CELL SCI, V122, P2662, DOI 10.1242/jcs.039347; SCHUPBACH T, 1991, GENETICS, V129, P1119; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; Stecca B, 2000, J NEUROSCI, V20, P4002; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; WILLIAMS JL, 1987, MOL GEN GENET, V209, P360, DOI 10.1007/BF00329666; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19715	10.1371/journal.pone.0019715	http://dx.doi.org/10.1371/journal.pone.0019715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603606	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300020
J	Ma, L; Dong, JL; Jin, YS; Chen, ML; Shen, XY; Wang, T				Ma, Lei; Dong, Jiangli; Jin, Yongsheng; Chen, Mingliang; Shen, Xiaoye; Wang, Tao			RMDAP: A Versatile, Ready-To-Use Toolbox for Multigene Genetic Transformation	PLOS ONE			English	Article							RECOMBINANT-DNA; RAPID CONSTRUCTION; MULTIPLE GENES; BINARY VECTORS; IN-VITRO; EFFICIENT; SYSTEM; MARKER; PLANTS; EXPRESSION	Background: The use of transgenes to improve complex traits in crops has challenged current genetic transformation technology for multigene transfer. Therefore, a multigene transformation strategy for use in plant molecular biology and plant genetic breeding is thus needed. Methodology/Principal Findings: Here we describe a versatile, ready-to-use multigene genetic transformation method, named the Recombination-assisted Multifunctional DNA Assembly Platform (RMDAP), which combines many of the useful features of existing plant transformation systems. This platform incorporates three widely-used recombination systems, namely, Gateway technology, in vivo Cre/loxP and recombineering into a highly efficient and reliable approach for gene assembly. RMDAP proposes a strategy for gene stacking and contains a wide range of flexible, modular vectors offering a series of functionally validated genetic elements to manipulate transgene overexpression or gene silencing involved in a metabolic pathway. In particular, the ability to construct a multigene marker-free vector is another attractive feature. The built-in flexibility of original vectors has greatly increased the expansibility and applicability of the system. A proof-of-principle experiment was confirmed by successfully transferring several heterologous genes into the plant genome. Conclusions/Significance: This platform is a ready-to-use toolbox for full exploitation of the potential for coordinate regulation of metabolic pathways and molecular breeding, and will eventually achieve the aim of what we call "one-stop breeding.''	[Ma, Lei; Dong, Jiangli; Jin, Yongsheng; Chen, Mingliang; Shen, Xiaoye; Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University	Ma, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	wangt@cau.edu.cn			Hi-Tech Research and Development (863) Program of China [2007AA10Z176, 2009AA102108]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by the Hi-Tech Research and Development (863) Program of China (2007AA10Z176, 2009AA102108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmert K, 2000, PLANTA, V211, P841, DOI 10.1007/s004250000350; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chen QJ, 2006, PLANT MOL BIOL, V62, P927, DOI 10.1007/s11103-006-9065-3; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dafhnis-Calas F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni192; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Daniell H, 2002, CURR OPIN BIOTECH, V13, P136, DOI 10.1016/S0958-1669(02)00297-5; Deavours BE, 2005, PLANT PHYSIOL, V138, P2245, DOI 10.1104/pp.105.062539; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Komori T, 2007, PLANT PHYSIOL, V145, P1155, DOI 10.1104/pp.107.105734; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Liang Z, 1997, Chin J Biotechnol, V13, P153; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Sambrook J, 2001, MOL CLONING LAB MANU; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Small I, 2007, CURR OPIN BIOTECH, V18, P148, DOI 10.1016/j.copbio.2007.01.012; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Verweire D, 2007, PLANT PHYSIOL, V145, P1220, DOI 10.1104/pp.107.106526; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yuan Y, 2004, ACTA BOT SIN, V46, P862; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	41	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19883	10.1371/journal.pone.0019883	http://dx.doi.org/10.1371/journal.pone.0019883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603635	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500034
J	Watkins, RL; Pallister, KB; Voyich, JM				Watkins, Robert L.; Pallister, Kyler B.; Voyich, Jovanka M.			The SaeR/S Gene Regulatory System Induces a Pro-Inflammatory Cytokine Response during Staphylococcus aureus Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; IN-VITRO; AGR; GAMMA; EXPRESSION; MUTANT; NEUTROPHILS; INTERFERON	Community-associated methicillin-resistant Staphylococcus aureus accounts for a large portion of the increased staphylococcal disease incidence and can cause illness ranging from mild skin infections to rapidly fatal sepsis syndromes. Currently, we have limited understanding of S. aureus-derived mechanisms contributing to bacterial pathogenesis and host inflammation during staphylococcal disease. Herein, we characterize an influential role for the saeR/S two-component gene regulatory system in mediating cytokine induction using mouse models of S. aureus pathogenesis. Invasive S. aureus infection induced the production of localized and systemic pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), interleukin (IL)-6 and IL-2. In contrast, mice infected with an isogenic saeR/S deletion mutant demonstrated significantly reduced pro-inflammatory cytokine levels. Additionally, secreted factors influenced by saeR/S elicited pro-inflammatory cytokines in human blood ex vivo. Our study further demonstrated robust saeR/S-mediated IFN-gamma production during both invasive and subcutaneous skin infections. Results also indicated a critical role for saeR/S in promoting bacterial survival and enhancing host mortality during S. aureus peritonitis. Taken together, this study provides insight into specific mechanisms used by S. aureus during staphylococcal disease and characterizes a relationship between a bacterial global regulator of virulence and the production of pro-inflammatory mediators.	[Watkins, Robert L.; Pallister, Kyler B.; Voyich, Jovanka M.] Montana State Univ, Dept Immunol Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Watkins, RL (corresponding author), Montana State Univ, Dept Immunol Infect Dis, Bozeman, MT 59717 USA.	jovanka@montana.edu			National Institutes of Health (NIH) [PAR98-072, NIH-RR020185]; Montana State University-Bozeman; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana State University-Bozeman; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH)-PAR98-072, NIH-RR020185 and a Molecular Biosciences Fellowship-Montana State University-Bozeman (to RLW). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Giraudo AT, 1996, CAN J MICROBIOL, V42, P120, DOI 10.1139/m96-019; GIRAUDO AT, 1994, J BASIC MICROB, V34, P317, DOI 10.1002/jobm.3620340507; Grundmeier M, 2010, J INFECT DIS, V201, P871, DOI 10.1086/651023; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; LIANG X, 2006, INFECT IMMUN, V268, P98; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MATIN GS, 2003, NEW ENGL J MED, V348, P1546; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Pantrangi M, 2010, FEMS MICROBIOL LETT, V308, P175, DOI 10.1111/j.1574-6968.2010.02012.x; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; ROZALSKA B, 1993, FEMS IMMUNOL MED MIC, V7, P145; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zhao YX, 1998, IMMUNOLOGY, V93, P80	52	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19939	10.1371/journal.pone.0019939	http://dx.doi.org/10.1371/journal.pone.0019939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603642	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500038
J	Tripathi, SC; Matta, A; Kaur, J; Grigull, J; Chauhan, SS; Thakar, A; Shukla, NK; Duggal, R; Choudhary, AR; DattaGupta, S; Sharma, MC; Ralhan, R; Siu, KWM				Tripathi, Satyendra Chandra; Matta, Ajay; Kaur, Jatinder; Grigull, Jorg; Chauhan, Shyam Singh; Thakar, Alok; Shukla, Nootan Kumar; Duggal, Ritu; Choudhary, Ajoy Roy; DattaGupta, Siddhartha; Sharma, Mehar Chand; Ralhan, Ranju; Siu, K. W. Michael			Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ORAL PREMALIGNANT LESIONS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BLADDER-CANCER; HISTONE H1; IN-VITRO; N-MYC	Background: In our recent study, tissue proteomic analysis of oral pre-malignant lesions (OPLs) and normal oral mucosa led to the identification of a panel of biomarkers, including prothymosin alpha (PTMA), to distinguish OPLs from histologically normal oral tissues. This study aimed to determine the clinical significance of PTMA overexpression in oral squamous cell hyperplasia, dysplasia and head and neck squamous cell carcinoma (HNSCC). Methodology: Immunohistochemistry of PTMA protein was performed in HNSCCs (n = 100), squamous cell hyperplasia (n = 116), dysplasia (n = 50) and histologically normal oral tissues (n = 100). Statistical analysis was carried out to determine the association of PTMA overexpression with clinicopathological parameters and disease prognosis over 7 years for HNSCC patients. Results: Our immunohistochemical analysis demonstrated significant overexpression of nuclear PTMA in squamous cell hyperplasia (63.8%), dysplasia (50%) and HNSCC (61%) in comparison with oral normal mucosa (p(trend)< 0.001). Chi-square analysis showed significant association of nuclear PTMA with advanced tumor stages (III+IV). Kaplan Meier survival analysis indicated reduced disease free survival (DFS) in HNSCC patients (p < 0.001; median survival 11 months). Notably, Cox-multivariate analysis revealed nuclear PTMA as an independent predictor of poor prognosis of HNSCC patients (p < 0.001, Hazard's ratio, HR = 5.2, 95% CI = 2.3-11.8) in comparison with the histological grade, T-stage, nodal status and tumor stage. Conclusions: Nuclear PTMA may serve as prognostic marker in HNSCC to determine the subset of patients that are likely to show recurrence of the disease.	[Tripathi, Satyendra Chandra; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Tripathi, Satyendra Chandra; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Thakar, Alok] All India Inst Med Sci, Dept Otorhinolaryngol, New Delhi 110029, India; [Shukla, Nootan Kumar] All India Inst Med Sci, Dept Surg, Dr BRA Inst Rotary Canc Hosp, New Delhi 110029, India; [Duggal, Ritu; Choudhary, Ajoy Roy] All India Inst Med Sci, Ctr Dent Educ & Res, New Delhi 110029, India; [DattaGupta, Siddhartha; Sharma, Mehar Chand] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; York University - Canada; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tripathi, SC (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	rralhan@mtsinai.on.ca; kwmsiu@yorku.ca	MATTA, AJAY/AFT-2977-2022; Thakar, Alok/V-7701-2019; Tripathi, Satyendra Chandra/L-9352-2017; Bhurji, Jatinder K/B-6767-2013	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Indian Council of Medical Research (ICMR), New Delhi, India; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR); International Science and Technology Partnerships Canada (ISTP Canada); Department of Biotechnology (DBT), India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Science and Technology Partnerships Canada (ISTP Canada); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	SCT is supported by a Senior Research Fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. AM is recipient of MITACS Accelerate Fellow. RR gratefully acknowledges support from Joseph and Mildred Sonshine Centre for Head and Neck Diseases and Temmy Latner/Dynacare Family Foundation, Canada. RR and KWMS acknowledge funding from the Canadian Institutes of Health Research (CIHR), International Science and Technology Partnerships Canada (ISTP Canada) and Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Bettendorf O, 2004, ORAL ONCOL, V40, P110, DOI 10.1016/j.oraloncology.2003.08.010; DOSIL M, 1993, EXP CELL RES, V204, P94, DOI 10.1006/excr.1993.1013; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Franceschi S, 2000, INT J CANCER, V85, P787, DOI 10.1002/(SICI)1097-0215(20000315)85:6&lt;787::AID-IJC8&gt;3.0.CO;2-6; Garnier M, 1997, J NEUROSCI, V17, P4591; Hapke S, 2003, BIOL CHEM, V384, P1073, DOI 10.1515/BC.2003.120; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jayalekshmi PA, 2009, BRIT J CANCER, V100, P848, DOI 10.1038/sj.bjc.6604907; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jou YC, 2009, UROLOGY, V74, P951, DOI 10.1016/j.urology.2008.11.060; Karetsou Z, 1998, NUCLEIC ACIDS RES, V26, P3111, DOI 10.1093/nar/26.13.3111; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Letsas KP, 2006, NEOPLASMA, V53, P92; Letsas KP, 2005, PATHOL INT, V55, P694, DOI 10.1111/j.1440-1827.2005.01899.x; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Magdalena C, 2000, BRIT J CANCER, V82, P584, DOI 10.1054/bjoc.1999.0968; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; Maserejian NN, 2006, CANCER EPIDEM BIOMAR, V15, P774, DOI 10.1158/1055-9965.EPI-05-0842; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Moore SR, 2000, ORAL DIS, V6, P191; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; PAPAMARCAKI T, 1994, FEBS LETT, V345, P71, DOI 10.1016/0014-5793(94)00439-0; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; Romani L, 2007, ANN NY ACAD SCI, V1112, P326, DOI 10.1196/annals.1415.002; Saleh A, 2010, ORAL ONCOL, V46, P379, DOI 10.1016/j.oraloncology.2010.02.022; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Sasaki H, 2001, CANCER LETT, V168, P191, DOI 10.1016/S0304-3835(01)00540-7; Sasaki H, 2001, SURG TODAY, V31, P936, DOI 10.1007/s005950170040; Shiwa M, 2003, BIOCHEM BIOPH RES CO, V309, P18, DOI 10.1016/S0006-291X(03)01520-1; Smith Elaine M, 2010, Infect Agent Cancer, V5, P4, DOI 10.1186/1750-9378-5-4; SMITH EM, 2010, CANC CAUSES CONTROL; Suzuki S, 2006, PROSTATE, V66, P463, DOI 10.1002/pros.20385; Traub F, 2006, LAB INVEST, V86, P246, DOI 10.1038/labinvest.3700385; Tsai YS, 2009, UROLOGY, V73, P188, DOI 10.1016/j.urology.2008.05.031; Tzai TS, 2006, UROLOGY, V67, P294, DOI 10.1016/j.urology.2005.08.034; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu CG, 1997, BRIT J CANCER, V76, P1199, DOI 10.1038/bjc.1997.533; Wu CL, 1997, LIFE SCI, V61, P2091, DOI 10.1016/S0024-3205(97)00882-5; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008	53	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19213	10.1371/journal.pone.0019213	http://dx.doi.org/10.1371/journal.pone.0019213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573209	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400004
J	Kuphal, S; Shaw-Hallgren, G; Eberl, M; Karrer, S; Aberger, F; Bosserhoff, AK; Massoumi, R				Kuphal, S.; Shaw-Hallgren, G.; Eberl, M.; Karrer, S.; Aberger, F.; Bosserhoff, A. K.; Massoumi, R.			GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma	ONCOGENE			English	Article						CYLD; GLI1; Snail1; BCC; Bcl-3	CYCLE PROGRESSION; HEDGEHOG PATHWAY; EXPRESSION; TUMOR; GLI1; MICE; DIFFERENTIATION; TRANSFORMATION; MANIPULATION; INHIBITION	CYLD is a deubiquitination enzyme that regulates different cellular processes, such as cell proliferation and cell survival. Mutation and loss of heterozygosity of the CYLD gene causes development of cylindromatosis, a benign tumour originating from the skin. Our study shows that CYLD expression is dramatically downregulated in basal cell carcinoma (BCC), the most common cancer in humans. Reduced CYLD expression in basal cell carcinoma was mediated by GLI1-dependent activation of the transcriptional repressor Snail. Inhibition of GLI1 restored the CYLD expression-mediated Snail signaling pathway, and caused a significant delay in the G1 to S phase transition, as well as proliferation. Our data suggest that GLI1-mediated suppression of CYLD has a significant role in basal cell carcinoma progression. Oncogene (2011) 30, 4523-4530; doi: 10.1038/onc.2011.163; published online 16 May 2011	[Shaw-Hallgren, G.; Massoumi, R.] Lund Univ, UMAS, Dept Lab Med, S-20502 Malmo, Sweden; [Kuphal, S.; Bosserhoff, A. K.] Univ Regensburg, Inst Pathol, Regensburg, Germany; [Eberl, M.; Aberger, F.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Karrer, S.] Univ Regensburg, Dept Dermatol, Regensburg, Germany	Lund University; Skane University Hospital; University of Regensburg; Salzburg University; University of Regensburg	Massoumi, R (corresponding author), Lund Univ, UMAS, Dept Lab Med, Entrance 78, S-20502 Malmo, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019; Kuphal, Silke/AAW-2702-2020; Bosserhoff, Anja/GNH-4801-2022; Aberger, Fritz/B-6357-2012	Aberger, Fritz/0000-0003-2009-6305; Bosserhoff, Anja/0000-0001-8147-394X	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council; Crafoordska Foundation; Royal Physiographic Society in Lund; Gunnar Nilsson Cancer Foundation; U-MAS Research Foundations; ERC; Austrian Science Fund FWF [P20652]; University of Salzburg; Austrian Genome program Gen-AU	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoordska Foundation; Royal Physiographic Society in Lund; Gunnar Nilsson Cancer Foundation; U-MAS Research Foundations; ERC(European Research Council (ERC)European Commission); Austrian Science Fund FWF(Austrian Science Fund (FWF)); University of Salzburg; Austrian Genome program Gen-AU	We thank Rudolf Jung and Elise Nilsson for excellent technical assistance, Dr Anders Edsjo, for discussion, Dr Ervin H Epstein for the mouse BCC cell line ASZ001 and CSZ-1. This work was supported by the Swedish Society for Medical Research, Swedish Cancer Foundation, Swedish Medical Research Council, Crafoordska Foundation, Royal Physiographic Society in Lund, Gunnar Nilsson Cancer Foundation, U-MAS Research Foundations and ERC grant to RM and the Austrian Science Fund FWF (projects P20652), the priority program of the University of Salzburg and the Austrian Genome program Gen-AU to FA.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper Maria, 2007, V397, P67; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Louro ID, 2002, CANCER RES, V62, P5867; Massoumi R, 2006, J INVEST DERMATOL, V126, P1182, DOI 10.1038/sj.jid.5700218; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Moriwaki K, 2007, J INVEST DERMATOL, V127, pS107; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	28	23	26	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	44					4523	4530		10.1038/onc.2011.163	http://dx.doi.org/10.1038/onc.2011.163			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21577203				2022-12-25	WOS:000296733200007
J	Nitzki, F; Zibat, A; Frommhold, A; Schneider, A; Schulz-Schaeffer, W; Braun, T; Hahn, H				Nitzki, F.; Zibat, A.; Frommhold, A.; Schneider, A.; Schulz-Schaeffer, W.; Braun, T.; Hahn, H.			Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice	ONCOGENE			English	Article						rhabdomyosarcoma; ERMS; time of initiation; hedgehog; patched1	HEDGEHOG SIGNALING PATHWAY; SONIC HEDGEHOG; ALVEOLAR RHABDOMYOSARCOMA; MUTANT MICE; GENE; PTCH; MEDULLOBLASTOMA; INACTIVATION; EXPRESSION; SPECIFICATION	Embryonal rhabdomyosarcoma (ERMS) is a tumor of the skeletal muscle in children and is frequently initiated by heterozygous germline mutations in the Hedgehog (Hh) receptor Patched1 (Ptch), both in humans and mice. Using a conditional knock-out strategy in Ptch(flox/+) mice, we demonstrate that early embryonic stages are more susceptible to ERMS development than later stages and that cells normally not committed to undergo myogenesis at this stage represent the major source of ERMS. We found that deletion of a single copy of the Ptch allele at E9.5 using the ubiquitously active Rosa26CreERT2 resulted in a tumor incidence of 88% but reached only 44% and 12% when the Ptch allele was inactivated at E11.5 and E13.5, respectively. Induction of the Ptch mutation at E9.5 did also significantly shorten ERMS-free survival and increased tumor multiplicity compared with tumor induction at E11.5 and E13.5. Interestingly, we observed a more that 10-fold reduction of ERMS incidence when the Ptch mutation was specifically introduced in Myf5-expressing cells, which is the myogenic factor expressed in all muscle cells at E9.5. We conclude that Myf5-negative cells are more susceptible to ERMS development than Myf5-positive embryonic precursors. As the propensity to undergo tumorigenic transformation declined with age, concomitant with the increase of stably committed muscle cells, it seems likely that the Ptch mutation favors tumor formation in progenitor cells, which have not yet acquired a muscle cell fate. Oncogene (2011) 30, 4428-4436; doi:10.1038/onc.2011.157; published online 23 May 2011	[Nitzki, F.; Zibat, A.; Hahn, H.] Univ Gottingen, Dept Human Genet, D-37073 Gottingen, Lower Saxony, Germany; [Schneider, A.; Braun, T.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany; [Schulz-Schaeffer, W.] Univ Gottingen, Dept Neuropathol, D-37073 Gottingen, Lower Saxony, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Hahn, H (corresponding author), Univ Gottingen, Dept Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Lower Saxony, Germany.	hhahn@gwdg.de	Braun, Thomas/B-2310-2008; Schneider, Andre/C-5270-2013	Braun, Thomas/0000-0002-6165-4804	Wilhelm Sander Stiftung [2003.112.3]	Wilhelm Sander Stiftung	We thank Susan Peter and Stefan Wolf for excellent animal care and Simone Fulda for critical comments on the manuscript. This work was supported by the grant 2003.112.3 of the Wilhelm Sander Stiftung to HH.	Asakura A, 1998, DEV BIOL, V203, P276, DOI 10.1006/dbio.1998.9050; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Biressi S, 2007, DEV BIOL, V304, P633, DOI 10.1016/j.ydbio.2007.01.016; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1994, DEVELOPMENT, V120, P3083; Calzada-Wack J, 2002, CARCINOGENESIS, V23, P727, DOI 10.1093/carcin/23.5.727; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Diwan BA, 1997, CARCINOGENESIS, V18, P2009, DOI 10.1093/carcin/18.10.2009; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hahn H, 2004, GENOMICS, V84, P853, DOI 10.1016/j.ygeno.2004.07.002; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Kappler R, 2004, ONCOGENE, V23, P8785, DOI 10.1038/sj.onc.1208133; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kruger M, 2001, DEVELOPMENT, V128, P743; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Merlino G, 2007, GENE DEV, V21, P1275, DOI 10.1101/gad.1563707; Nagao K, 2005, HUM MOL GENET, V14, P3379, DOI 10.1093/hmg/ddi369; Resende TP, 2010, P NATL ACAD SCI USA, V107, P12907, DOI 10.1073/pnas.1000979107; RIVERA OJ, 2006, 97 AACR ANN M 1 5 AP; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Taniguchi E, 2009, PEDIATR BLOOD CANCER, V53, P136, DOI 10.1002/pbc.21968; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Uhmann A, 2005, INT J ONCOL, V27, P1567; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zibat A, 2010, ONCOGENE, V29, P6323, DOI 10.1038/onc.2010.368; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	39	22	23	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	43					4428	4436		10.1038/onc.2011.157	http://dx.doi.org/10.1038/onc.2011.157			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21602886				2022-12-25	WOS:000296356500005
J	Ye, R; Selby, CP; Ozturk, N; Annayev, Y; Sancar, A				Ye, Rui; Selby, Christopher P.; Ozturk, Nuri; Annayev, Yunus; Sancar, Aziz			Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDBACK LOOP; POSTTRANSLATIONAL REGULATION; TRANSCRIPTIONAL ACTIVATORS; NEGATIVE FEEDBACK; DNA-BINDING; IN-VIVO; PHOSPHORYLATION; MECHANISM; CRYPTOCHROMES; PER2	The current consensus model for the circadian clock in mammals is based on a transcription-translation feedback loop. In this model, CRY and PER proteins repress their own transcription by suppressing the transactivator function of the CLOCK: BMAL1 heterodimer directly (physical model) and by facilitating post-translational modifications (chemical model). Most of the data for this model come from genetic and cell biological experiments. Here, we have purified all of the core clock proteins and performed in vitro and in vivo biochemical experiments to test the physical model. We find that CLOCK:BMAL1 binds to an E-box sequence in DNA and that CRY binds stably to the CLOCK:BMAL1:E-box ternary complex independently of PER. Both CRY and PER bind to CLOCK and BMAL1 off DNA but, in contrast to CRY, PER does not bind to the CLOCK: BMAL1:E-box complex. Unexpectedly, PER actually interferes with the binding of CRY to the CLOCK:BMAL1:E-box ternary complex. CRY likely destabilizes the CLOCK:BMAL1 heterodimer on DNA by a post-translational mechanism after binding to the complex. These findings support some aspects of the canonical model, but also suggest that some key features of the model need to be revised.	[Ye, Rui; Selby, Christopher P.; Ozturk, Nuri; Annayev, Yunus; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), 120 Mason Farm Rd,Genet Med Bldg,Suite 3010,CB 72, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011	Ozturk, Nuri/0000-0001-5206-4127	National Institutes of Health [GM31082]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31082.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2006, CELL CYCLE, V5, P890, DOI 10.4161/cc.5.8.2684; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	49	92	101	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25891	25902		10.1074/jbc.M111.254680	http://dx.doi.org/10.1074/jbc.M111.254680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613214	Green Published, hybrid			2022-12-25	WOS:000293073000050
J	Endsley, MP; Hu, YQ; Deng, Y; He, XL; Warejcka, DJ; Twining, SS; Gonias, SL; Zhang, M				Endsley, Michael P.; Hu, Yanqiu; Deng, Yong; He, Xiaolin; Warejcka, Debra J.; Twining, Sally S.; Gonias, Steven L.; Zhang, Ming			Maspin, the Molecular Bridge between the Plasminogen Activator System and beta 1 Integrin That Facilitates Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT SIGNALING PATHWAYS; TUMOR-SUPPRESSING ACTIVITY; MAMMARY EPITHELIAL-CELLS; RECEPTOR-RELATED PROTEIN; UROKINASE-TYPE; BREAST-CANCER; IN-VITRO; INTRACELLULAR SERPIN; EXTRACELLULAR-MATRIX; CRYSTAL-STRUCTURE	Maspin is a non-inhibitory serine protease inhibitor (serpin) that influences many cellular functions including adhesion, migration, and invasion. The underlying molecular mechanisms that facilitate these actions are still being elucidated. In this study we determined the mechanism by which maspin mediates increased MCF10A cell adhesion. Utilizing competition peptides and mutation analyses, we discovered two unique regions (amino acid residues 190-202 and 260-275) involved in facilitating the increased adhesion function of maspin. In addition, we demonstrate that the urokinase-type plasminogen activator (uPA)/uPA receptor (uPAR) complex is required for the localization and adhesion function of maspin. Finally, we showed that maspin, uPAR, and beta 1 integrin co-immunoprecipitate, suggesting a novel maspin-uPA-uPAR-beta 1 integrin mega-complex that regulates mammary epithelial cell adhesion.	[Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Warejcka, Debra J.; Twining, Sally S.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Medical College of Wisconsin; University of California System; University of California San Diego	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Lurie 6-115,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Endsley, Michael/0000-0002-5915-9281	National Institutes of Health [CA79736, EY12731, T32 CA070085]; NATIONAL CANCER INSTITUTE [R01CA079736, T32CA070085] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014168, R01EY021152, R01EY012731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79736 (to M. Z.) and EY12731 (to S. S. T.).; Supported by NIH Institutional NRSA Training Program in Signal Transduction and Cancer Grant T32 CA070085.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Al-Ayyoubi M, 2007, J BIOL CHEM, V282, P19502, DOI 10.1074/jbc.M702445200; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Biliran H, 2001, CANCER RES, V61, P8676; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Conlon M., 2002, PROTEIN PROTOCOLS HD, P971; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; LANGHOFER M, 1993, J CELL SCI, V105, P753; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Maass N, 2000, ACTA ONCOL, V39, P931; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; McGowen R, 2000, CANCER RES, V60, P4771; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Qin L, 2010, J BIOL CHEM, V285, P32360, DOI 10.1074/jbc.M110.131045; Ravenhill L, 2010, J BIOL CHEM, V285, P36285, DOI 10.1074/jbc.M110.177253; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shi HY, 2002, MOL THER, V5, P755, DOI 10.1006/mthe.2002.0602; Shi HY, 2001, CANCER RES, V61, P6945; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Yebra M, 1999, EXP CELL RES, V250, P231, DOI 10.1006/excr.1999.4510; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zhang M, 1997, MOL MED, V3, P49, DOI 10.1007/BF03401667; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	57	25	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24599	24607		10.1074/jbc.M111.235788	http://dx.doi.org/10.1074/jbc.M111.235788			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606500	Green Published, hybrid			2022-12-25	WOS:000292547900010
J	Novgorodov, SA; Wu, BX; Gudz, TI; Bielawski, J; Ovchinnikova, TV; Hannun, YA; Obeid, LM				Novgorodov, Sergei A.; Wu, Bill X.; Gudz, Tatyana I.; Bielawski, Jacek; Ovchinnikova, Tatiana V.; Hannun, Yusuf A.; Obeid, Lina M.			Novel Pathway of Ceramide Production in Mitochondria THIOESTERASE AND NEUTRAL CERAMIDASE PRODUCE CERAMIDE FROM SPHINGOSINE AND ACYL-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION PORE; RADIATION-INDUCED APOPTOSIS; LONG-CHAIN; SPHINGOLIPID METABOLISM; COA THIOESTERASES; MOLECULAR-CLONING; ENDOPLASMIC-RETICULUM; ENZYMATIC HYDROLYSIS; RESPIRATORY-CHAIN	Reports suggest that excessive ceramide accumulation in mitochondria is required to initiate the intrinsic apoptotic pathway and subsequent cell death, but how ceramide accumulates is unclear. Here we report that liver mitochondria exhibit ceramide formation from sphingosine and palmitoyl-CoA and from sphingosine and palmitate. Importantly, this activity was markedly decreased in liver from neutral ceramidase (NCDase)-deficient mice. Moreover, the levels of ceramide were dissimilar in liver mitochondria of WT and NCDase KO mice. These results suggest that NCDase is a key participant of ceramide formation in liver mitochondria. We also report that highly purified liver mitochondria have ceramidase, reverse ceramidase, and thioesterase activities. Increased accessibility of palmitoyl-CoA to the mitochondrial matrix with the pore-forming peptide zervamicin IIB resulted in 2-fold increases in palmitoyl-CoA hydrolysis by thioesterase. This increased hydrolysis was accompanied by an increase in ceramide formation, demonstrating that both outer membrane and matrix localized thioesterases can regulate ceramide formation. Also, ceramide formation might occur both in the outer mitochondrial membrane and in the mitochondrial matrix, suggesting the existence of distinct ceramide pools. Taken together, these results suggest that the reverse activity of NCDase contributes to sphingolipid homeostasis in this organelle in vivo.	[Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Wu, Bill X.; Bielawski, Jacek; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Gudz, Tatyana I.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Ovchinnikova, Tatiana V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,MSC779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [AG16583, CA87584, P20RR17677-04]; Russian Federal Target Program [NK-602P/19, P1159]; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina; National Center for Research Resources [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, UL1RR029882, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Federal Target Program; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG16583 (to L.M.O.), CA87584 (to Y.A.H.), and P20RR17677-04 (to T.I.G.). This work was also supported by the Russian Federal Target Program "Scientific and Science-Educational Personnel of Innovative Russia" (project NK-602P/19, state contract P1159) (to T.V.O.). This manuscript is based upon work supported in part by a MERIT Awards by the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina (to L.M.O. and T.I.G.).; We thank Kathy Wiita-Fisk for administrative assistance, Stefka Spassieva for critical reading of the manuscript, and Christian Frezza for valuable advice related to isolation of mouse mitochondria. We thank Dr. Richard Proia for generously providing anti-NCDase antibody. We thank Dr. Jennifer G. Schnellmann for help with preparation of the manuscript. Measurement of sphingolipids was conducted by the Lipidomics Core of MUSC in a facility constructed with support from the National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources.	Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Balashova TA, 2000, FEBS LETT, V466, P333, DOI 10.1016/S0014-5793(99)01707-X; BERGE RK, 1979, EUR J BIOCHEM, V96, P393, DOI 10.1111/j.1432-1033.1979.tb13051.x; BERGE RK, 1979, EUR J BIOCHEM, V95, P89, DOI 10.1111/j.1432-1033.1979.tb12942.x; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BRECHER P, 1983, MOL CELL BIOCHEM, V57, P3; Castilla R, 2008, ENDOCRINOLOGY, V149, P3743, DOI 10.1210/en.2007-1580; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GATT S, 1966, J BIOL CHEM, V241, P3724; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Graham J. M., 1999, CURRENT PROTOCOLS CE, V1, P346; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; LEE KY, 1979, J BIOL CHEM, V254, P4516; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; Means G. E., 1971, CHEM MODIFICATION PR, P220; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monette JS, 2010, BIOCHEM BIOPH RES CO, V398, P272, DOI 10.1016/j.bbrc.2010.06.077; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; RENAUD G, 1985, ARCH INT PHYSIOL BIO, V93, P313, DOI 10.3109/13813458509079612; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V21, P369, DOI 10.1007/BF00185864; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; STONER CD, 1969, J CELL BIOL, V43, P521, DOI 10.1083/jcb.43.3.521; SVENSSON LT, 1995, J BIOL CHEM, V270, P12177, DOI 10.1074/jbc.270.20.12177; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580; YAVIN E, 1969, BIOCHEMISTRY-US, V8, P1692, DOI 10.1021/bi00832a052; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	96	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25352	25362		10.1074/jbc.M110.214866	http://dx.doi.org/10.1074/jbc.M110.214866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613224	hybrid, Green Published			2022-12-25	WOS:000292547900081
J	Yu, Y; Li, WG; Chen, Z; Cao, H; Yang, HY; Jiang, HL; Xu, TL				Yu, Ye; Li, Wei-Guang; Chen, Zhi; Cao, Hui; Yang, Huaiyu; Jiang, Hualiang; Xu, Tian-Le			Atomic Level Characterization of the Nonproton Ligand-sensing Domain of ASIC3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; MOLECULAR-DYNAMICS; EXTRACELLULAR DOMAIN; NEURONS; PORE; 1A; DESENSITIZATION; ION-CHANNEL-1; MODULATION; ACIDOSIS	Acid-sensing ion channels (ASICs) are known to be primarily activated by extracellular protons. Recently, we characterized a novel nonproton ligand (2-guanidine-4-methylquinazoline, GMQ), which activates the ASIC3 channel subtype at neutral pH. Using an interactive computational-experimental approach, here we extend our investigation to delineate the architecture of the GMQ-sensing domain in the ASIC3 channels. We first established a GMQ binding mode and revealed that residues Glu-423, Glu-79, Leu-77, Arg-376, Gln-271, and Gln-269 play key roles in forming the GMQ-sensing domain. We then verified the GMQ binding mode using ab initio calculation and mutagenesis and demonstrated the critical role of the above GMQ-binding residues in the interplay among GMQ, proton, and Ca2+ in regulating the function of ASIC3. Additionally, we showed that the same residues involved in coordinating GMQ responses are also critical for activation of the ASIC3(E79C) mutant by thiol-reactive compound DTNB. Thus, a range of complementary techniques provide independent evidence for the structural details of the GMQ-sensing domain at atomic level, laying the foundation for further investigations of endogenous nonproton ligands and gating mechanisms of the ASIC3 channels.	[Chen, Zhi; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jiang, HL (corresponding author), 555 Zu Chong Zhi Rd,Zhang Jiang Hi Tech Pk, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xu-happiness@shsmu.edu.cn		Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [30830035, 9091300]; National Basic Research Program of China [2011CBA00408]; Shanghai Municipal Government [09XD1404900]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported by National Natural Science Foundation of China Grants 30830035 and 9091300, National Basic Research Program of China Grant 2011CBA00408, the Shanghai Municipal Government Grant 09XD1404900, and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program 2009.	Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grabowski SJ, 2004, J PHYS ORG CHEM, V17, P18, DOI 10.1002/poc.685; Gurtovenko AA, 2004, BIOPHYS J, V86, P3461, DOI 10.1529/biophysj.103.038760; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; VANBUUREN AR, 1993, J PHYS CHEM-US, V97, P9206, DOI 10.1021/j100138a023; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang QM, 2002, DRUG METAB DISPOS, V30, P86, DOI 10.1124/dmd.30.1.86; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	48	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24996	25006		10.1074/jbc.M111.239558	http://dx.doi.org/10.1074/jbc.M111.239558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586569	Green Published, hybrid			2022-12-25	WOS:000292547900048
J	Alba, R; Cots, D; Ostapchuk, P; Bosch, A; Hearing, P; Chillon, M				Alba, Raul; Cots, Dan; Ostapchuk, Philomena; Bosch, Assumpcio; Hearing, Patrick; Chillon, Miguel			Altering the Ad5 Packaging Domain Affects the Maturation of the Ad Particles	PLOS ONE			English	Article							DEPENDENT ADENOVIRAL VECTORS; 55-KILODALTON PROTEINS; L1 52-KILODALTON; GENE-TRANSFER; IVA2 PROTEIN; HELPER-VIRUS; SEQUENCES; SYSTEM; DNA; TYPE-5	We have previously described a new family of mutant adenoviruses carrying different combinations of attB/attP sequences from bacteriophage PhiC31 flanking the Ad5 packaging domain. These novel helper viruses have a significantly delayed viral life cycle and a severe packaging impairment, regardless of the presence of PhiC31 recombinase. Their infectious viral titers are significantly lower (100-1000 fold) than those of control adenovirus at 36 hours post-infection, but allow for efficient packaging of helper-dependent adenovirus. In the present work, we have analyzed which steps of the adenovirus life cycle are altered in attB-helper adenoviruses and investigated whether these viruses can provide the necessary viral proteins in trans. The entry of attB-adenoviral genomes into the cell nucleus early at early timepoints post-infection was not impaired and viral protein expression levels were found to be similar to those of control adenovirus. However, electron microscopy and capsid protein composition analyses revealed that attB-adenoviruses remain at an intermediate state of maturation 36 hours post-infection in comparison to control adenovirus which were fully mature and infective at this time point. Therefore, an additional 20-24 hours were found to be required for the appearance of mature attB-adenovirus. Interestingly, attB-adenovirus assembly and infectivity was restored by inserting a second packaging signal close to the right-end ITR, thus discarding the possibility that the attB-adenovirus genome was retained in a nuclear compartment deleterious for virus assembly. The present study may have substantive implications for helper-dependent adenovirus technology since helper attB-adenovirus allows for preferential packaging of helper-dependent adenovirus genomes.	[Alba, Raul; Cots, Dan; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain; [Alba, Raul; Cots, Dan; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Ostapchuk, Philomena; Hearing, Patrick] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; ICREA	Alba, R (corresponding author), Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	miguel.chillon@uab.es	Alba, Raul/B-5859-2012; Bosch, Assumpcio/C-7593-2015; Chillon, Miguel/A-2466-2009	Bosch, Assumpcio/0000-0002-7205-2796; Chillon, Miguel/0000-0003-0840-2111	Instituto Salud Carlos III [PI081162]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR-2009-1300]; Association Francaise contre les Myopathies (AFM) [12277]; EC [FP7-222992]; CAV-4-MPS an E-Rare project [ISCIII PS09/02674]; NIH [AI041636]; FI-Generalitat [2003-0367]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041636] Funding Source: NIH RePORTER	Instituto Salud Carlos III(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); EC(European CommissionEuropean Commission Joint Research Centre); CAV-4-MPS an E-Rare project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FI-Generalitat; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Instituto Salud Carlos III (PI081162)(MC); Agencia de Gestio d'Ajuts Universitaris i de Recerca (SGR-2009-1300)(MC); the Association Francaise contre les Myopathies (AFM#12277) (MC); BrainCAV an EC-FP7 project (FP7-222992)(AB); CAV-4-MPS an E-Rare project (ISCIII PS09/02674)(AB); and NIH AI041636 (PH). RA was a recipient of a FI-Generalitat fellowship # 2003-0367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Alba R, 2007, VIROLOGY, V367, P51, DOI 10.1016/j.virol.2007.05.014; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; CHARDONN.Y, 1970, VIROLOGY, V40, P462, DOI 10.1016/0042-6822(70)90189-3; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HASSON TB, 1989, J VIROL, V63, P3612, DOI 10.1128/JVI.63.9.3612-3621.1989; HASSON TB, 1992, J VIROL, V66, P6133, DOI 10.1128/JVI.66.10.6133-6142.1992; HEARING P, 1987, J VIROL, V61, P2555, DOI 10.1128/JVI.61.8.2555-2558.1987; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Morsy MA, 1998, P NATL ACAD SCI USA, V95, P7866, DOI 10.1073/pnas.95.14.7866; Ng P, 2002, J VIROL, V76, P4181, DOI 10.1128/JVI.76.9.4181-4189.2002; Ng P, 2001, MOL THER, V3, P809, DOI 10.1006/mthe.2001.0323; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Ostapchuk P, 2005, J VIROL, V79, P2831, DOI 10.1128/JVI.79.5.2831-2838.2005; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palmer Donna J., 2008, V433, P33, DOI 10.1007/978-1-59745-237-3_3; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Sandalon Z, 2000, J VIROL, V74, P10381, DOI 10.1128/JVI.74.22.10381-10389.2000; SARNOW P, 1982, J MOL BIOL, V162, P565, DOI 10.1016/0022-2836(82)90389-8; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; STOW ND, 1981, J VIROL, V37, P171, DOI 10.1128/JVI.37.1.171-180.1981; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weber Joseph M., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P95, DOI 10.1556/AMicr.50.2003.1.9; Xue YM, 2005, J VIROL, V79, P2474, DOI 10.1128/JVI.79.4.2474-2483.2005; Zhang W, 2003, J VIROL, V77, P3586, DOI 10.1128/JVI.77.6.3586-3594.2003	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19564	10.1371/journal.pone.0019564	http://dx.doi.org/10.1371/journal.pone.0019564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611162	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000290720200015
J	dos Santos, SS; Ferreira, KS; Almeida, SR				dos Santos, Suelen Silvana; Ferreira, Karen Spadari; Almeida, Sandro Rogerio			Paracoccidioides brasilinsis-Induced Migration of Dendritic Cells and Subsequent T-Cell Activation in the Lung-Draining Lymph Nodes	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; CRYPTOCOCCUS-NEOFORMANS INFECTION; ANTIGEN PRESENTATION; MURINE MODEL; IN-VIVO; BRASILIENSIS; EXPRESSION; INTERLEUKIN-10; MACROPHAGES; RECEPTOR	Paracoccidioidomycosis is a mycotic disease caused by a dimorphic fungus, Paracoccidioides brasiliensis (Pb), that starts with inhalation of the fungus; thus, lung cells such as DC are part of the first line of defense against this microorganism. Migration of DC to the lymph nodes is the first step in initiating T cell responses. The mechanisms involved in resistance to Pb infection are poorly understood, but it is likely that DC play a pivotal role in the induction of effector T cells that control Pb infection. In this study, we showed that after Pb Infection, an important modification of lung DC receptor expression occurred. We observed an increased expression of CCR7 and CD103 on lung DC after infection, as well as MHC-II. After Pb infection, bone marrow-derived DC as well lung DC, migrate to lymph nodes. Migration of lung DC could represent an important mechanism of pathogenesis during PCM infection. In resume our data showed that Pb induced DC migration. Furthermore, we demonstrated that bone marrow-derived DC stimulated by Pb migrate to the lymph nodes and activate a T helper (Th) response. To the best of our knowledge, this is the first reported data showing that Pb induces migration of DC and activate a T helper (Th) response.	[dos Santos, Suelen Silvana; Almeida, Sandro Rogerio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil; [Ferreira, Karen Spadari] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	dos Santos, SS (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil.	sandroal@usp.br	almeida, sandro r/F-5816-2012; Ferreira/Spadari, Karen SF/D-4437-2013; Ferreira, Karen/AAA-4363-2022; Santos, Suelen/F-3048-2014	almeida, sandro r/0000-0002-0562-1610; Spadari, Karen/0000-0003-2832-5942	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo [07/57594-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (research fellowships to SRA) and Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo (proc. no. 07/57594-9) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Beauchamp NM, 2010, J VIROL, V84, P10191, DOI 10.1128/JVI.00892-10; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; Dan JM, 2008, INFECT IMMUN, V76, P2362, DOI 10.1128/IAI.00095-08; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; Ferreira KS, 2004, IMMUNOL LETT, V94, P107, DOI 10.1016/j.imlet.2004.04.005; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Romano CC, 2005, CLIN IMMUNOL, V114, P86, DOI 10.1016/j.clim.2004.09.005; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; WATANABE K, 1991, INFECT IMMUN, V59, P521, DOI 10.1128/IAI.59.2.521-528.1991; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19690	10.1371/journal.pone.0019690	http://dx.doi.org/10.1371/journal.pone.0019690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611175	gold, Green Submitted, Green Published			2022-12-25	WOS:000290720200026
J	Yan, HQ; Chang, SH; Tian, ZX; Zhang, L; Sun, YC; Li, Y; Wang, J; Wang, YP				Yan, Hai-Qin; Chang, Su-Hua; Tian, Zhe-Xian; Zhang, Le; Sun, Yi-Cheng; Li, Yan; Wang, Jing; Wang, Yi-Ping			Novel AroA from Pseudomonas putida Confers Tobacco Plant with High Tolerance to Glyphosate	PLOS ONE			English	Article							RAPESEED BRASSICA-NAPUS; ESCHERICHIA-COLI K12; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; TRANSGENIC PLANTS; CODON USAGE; DNA; TRANSFORMATION; SUBSTITUTION	Glyphosate is a non-selective broad-spectrum herbicide that inhibits 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS, also designated as AroA), a key enzyme in the aromatic amino acid biosynthesis pathway in microorganisms and plants. Previously, we reported that a novel AroA (PpAroA1) from Pseudomonas putida had high tolerance to glyphosate, with little homology to class I or class II glyphosate-tolerant AroA. In this study, the coding sequence of PpAroA1 was optimized for tobacco. For maturation of the enzyme in chloroplast, a chloroplast transit peptide coding sequence was fused in frame with the optimized aroA gene (PparoA1(optimized)) at the 59 end. The PparoA1(optimized) gene was introduced into the tobacco (Nicotiana tabacum L. cv. W38) genome via Agrobacterium-mediated transformation. The transformed explants were first screened in shoot induction medium containing kanamycin. Then glyphosate tolerance was assayed in putative transgenic plants and its T-1 progeny. Our results show that the PpAroA1 from Pseudomonas putida can efficiently confer tobacco plants with high glyphosate tolerance. Transgenic tobacco overexpressing the PparoA1(optimized) gene exhibit high tolerance to glyphosate, which suggest that the novel PpAroA1 is a new and good candidate applied in transgenic crops with glyphosate tolerance in future.	[Yan, Hai-Qin; Tian, Zhe-Xian; Zhang, Le; Sun, Yi-Cheng; Li, Yan; Wang, Yi-Ping] Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Hai-Qin] Bengbu Med Coll, Dept Histol & Embryol, Bengbu Anhui, Peoples R China; [Chang, Su-Hua; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Sun, Yi-Cheng] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Sun, Yi-Cheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Bengbu Medical College; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, HQ (corresponding author), Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	wangyp@pku.edu.cn	Chang, Suhua/AGZ-1921-2022	Wang, Yiping/0000-0002-1995-8521	National Transgenic Research and Industrialization Special Foundation of China [2009ZX08009-057B, 2008ZX08009-003-002]; Ministry of Science and Technology of China [2007AA021307]	National Transgenic Research and Industrialization Special Foundation of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants from the National Transgenic Research and Industrialization Special Foundation of China No. 2009ZX08009-057B, No. 2008ZX08009-003-002, and the Hi-Tech Research and Development "863" Program No. 2007AA021307 from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry G.F., 1992, World Patent, Patent No. [9204449, WO 9. 204: 449]; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; CERA, 2010, GM CROP DAT; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; COMAI L, 1985, NATURE, V317, P741, DOI 10.1038/317741a0; DELLACIOPPA G, 1987, BIO-TECHNOL, V5, P579, DOI 10.1038/nbt0687-579; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Kahrizi D, 2005, FEBS J, V272, P513; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1986, FASEB J, V45, P1506; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sun YC, 2006, FEBS LETT, V580, P1521, DOI 10.1016/j.febslet.2006.01.075; Sun YC, 2005, APPL ENVIRON MICROB, V71, P4771, DOI 10.1128/AEM.71.8.4771-4776.2005; SUN YC, 2007, Patent No. 7214535; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x	28	19	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19732	10.1371/journal.pone.0019732	http://dx.doi.org/10.1371/journal.pone.0019732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611121	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200029
J	Jones, MR; Chua, A; Chen, YDI; Li, XH; Krauss, RM; Rotter, JI; Legro, RS; Azziz, R; Goodarzi, MO				Jones, Michelle R.; Chua, Angela; Chen, Yii-Der I.; Li, Xiaohui; Krauss, Ronald M.; Rotter, Jerome I.; Legro, Richard S.; Azziz, Ricardo; Goodarzi, Mark O.			Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome	PLOS ONE			English	Article							MICROARRAY ANALYSIS; WOMEN; TESTOSTERONE; DICKKOPF-1; FEATURES; HSD17B6; CELLS	Novel pathways in polycystic ovary syndrome (PCOS) are being identified in gene expression studies in PCOS tissues; such pathways may contain key genes in disease etiology. Previous expression studies identified both dickkopf homolog 1 (DKK1) and DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1) as differentially expressed in PCOS tissue, implicating them as candidates for PCOS susceptibility. To test this, we genotyped a discovery cohort of 335 PCOS cases and 198 healthy controls for three DKK1 single nucleotide polymorphisms (SNPs) and four DNAJB1 SNPs and a replication cohort of 396 PCOS cases and 306 healthy controls for 1 DKK1 SNP and 1 DNAJB1 SNP. SNPs and haplotypes were determined and tested for association with PCOS and component phenotypes. We found that no single nucleotide polymorphisms were associated with PCOS risk; however, the major allele of rs1569198 from DKK1 was associated with increased total testosterone (discovery cohort P = 0.0035) and dehydroepiandrosterone sulfate (replication cohort P = 0.05). Minor allele carriers at rs3962158 from DNAJB1 had increased fasting insulin (discovery cohort P = 0.003), increased HOMA-IR (discovery cohort P = 0.006; replication cohort P = 0.036), and increased HOMA-%B (discovery cohort P = 0.004). Carriers of haplotype 2 at DNAJB1 also had increased fasting insulin, HOMA-IR, and HOMA-%B. These findings suggest that genetic variation in DKK1 and DNAJB1 may have a role in the hyperandrogenic and metabolic dysfunction of PCOS, respectively. Our results also demonstrate the utility of gene expression data as a source of novel candidate genes in PCOS, a complex and still incompletely defined disease, for which alternative methods of gene identification are needed.	[Jones, Michelle R.; Chua, Angela; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Chen, Yii-Der I.; Azziz, Ricardo; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Chen, Yii-Der I.; Li, Xiaohui; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rotter, Jerome I.; Azziz, Ricardo; Goodarzi, Mark O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Azziz, Ricardo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Jones, MR (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Azziz, Ricardo/N-7229-2014	Goodarzi, Mark/0000-0001-6364-5103; Azziz, Ricardo/0000-0002-3917-0483; Legro, Richard/0000-0001-9927-7584	National Institutes of Health [R01-HD29364, K24-HD01346, R01-DK79888, U54-HD034449, R01-HL069757]; National Center for Research Resources [M01-RR00425]; Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056510, U54HD034449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001346, R01HD029364] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [R01-HD29364, K24-HD01346 to R. A., R01-DK79888 to M.O.G., U54-HD034449 to R. S. L., R01-HL069757 to R. M. K.]; National Center for Research Resources [M01-RR00425 to the Cedars-Sinai General Clinical Research Center]; Winnick Clinical Scholars Award [to M.O.G.]; and an endowment from the Helping Hand of Los Angeles, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Borro M, 2007, CLIN EXP IMMUNOL, V150, P494, DOI 10.1111/j.1365-2249.2007.03498.x; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1092, P175, DOI 10.1196/annals.1365.015; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Jee S, 2007, INT J MOL MED, V20, P829; Jones MR, 2006, FERTIL STERIL, V86, P1438, DOI 10.1016/j.fertnstert.2006.04.027; Jones MR, 2009, J CLIN ENDOCR METAB, V94, P5034, DOI 10.1210/jc.2009-0931; Ke L, 2010, J WOMENS HEALTH, V19, P2227, DOI 10.1089/jwh.2009.1902; Kwack MH, 2008, J INVEST DERMATOL, V128, P262, DOI 10.1038/sj.jid.5700999; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Mohamed-Hussein ZA, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-18; Piters E, 2010, CALCIFIED TISSUE INT, V86, P271, DOI 10.1007/s00223-010-9334-7; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	25	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20120	10.1371/journal.pone.0020120	http://dx.doi.org/10.1371/journal.pone.0020120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611153	Green Published, gold			2022-12-25	WOS:000290657500044
J	Zhu, DX; Mackenzie, NCW; Millan, JL; Farquharson, C; MacRae, VE				Zhu, Dongxing; Mackenzie, Neil Charles Wallace; Millan, Jose Luis; Farquharson, Colin; MacRae, Vicky Elizabeth			The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							INFANTILE ARTERIAL CALCIFICATION; DENTIN MATRIX PROTEIN-1; IN-VITRO; ALKALINE-PHOSPHATASE; CHONDROCYTE DIFFERENTIATION; BONE MINERALIZATION; UP-REGULATION; OSTEOBLASTS; REGULATORS; MICE	Background: Vascular calcification is an indicator of elevated cardiovascular risk. Vascular smooth muscle cells (VSMCs), the predominant cell type involved in medial vascular calcification, can undergo phenotypic transition to both osteoblastic and chondrocytic cells within a calcifying environment. Methodology/Principal Findings: In the present study, using in vitro VSMC calcification studies in conjunction with ex vivo analyses of a mouse model of medial calcification, we show that vascular calcification is also associated with the expression of osteocyte phenotype markers. As controls, the terminal differentiation of murine calvarial osteoblasts into osteocytes was induced in vitro in the presence of calcifying medium (containing beta-glycerophosphate and ascorbic acid), as determined by increased expression of the osteocyte markers DMP-1, E11 and sclerostin. Culture of murine aortic VSMCs under identical conditions confirmed that the calcification of these cells can also be induced in similar calcifying medium. Calcified VSMCs had increased alkaline phosphatase activity and PiT-1 expression, which are recognized markers of vascular calcification. Expression of DMP-1, E11 and sclerostin was up-regulated during VSMC calcification in vitro. Increased protein expression of E11, an early osteocyte marker, and sclerostin, expressed by more mature osteocytes was also observed in the calcified media of Enpp1 2/2 mouse aortic tissue. Conclusions/Significance: This study has demonstrated the up-regulation of key osteocytic molecules during the vascular calcification process. A fuller understanding of the functional role of osteocyte formation and specifically sclerostin and E11 expression in the vascular calcification process may identify novel potential therapeutic strategies for clinical intervention.	[Zhu, Dongxing; Mackenzie, Neil Charles Wallace; Farquharson, Colin; MacRae, Vicky Elizabeth] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Sanford Burnham Prebys Medical Discovery Institute	Zhu, DX (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	vicky.macrae@roslin.ed.ac.uk	zhu, dongxing/AAM-4330-2020; Zhu, Dongxing/N-5059-2014; farquharson, colin/C-2956-2011	zhu, dongxing/0000-0001-5419-438X; farquharson, colin/0000-0002-4970-4039; MacRae, Vicky/0000-0001-6306-7040	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F023928/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023928/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an Institute Strategic Programme Grant and Institute Career Path Fellowship funding from the Biotechnology and Biological Sciences Research Council (BBSRC) www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarden EM, 1996, BONE, V18, P305, DOI 10.1016/8756-3282(96)00010-5; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Balemans W, 2005, BONE, V36, P943, DOI 10.1016/j.bone.2005.02.019; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Burger E H, 1999, Adv Dent Res, V13, P93; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Dallas SL, 2009, CELLS TISSUES ORGANS, V189, P6, DOI 10.1159/000151745; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Farquharson C, 1999, BONE, V25, P405, DOI 10.1016/S8756-3282(99)00187-8; FARQUHARSON C, 1995, BONE, V17, P279, DOI 10.1016/8756-3282(95)00220-8; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Hadjiargyrou M, 2001, BONE, V29, P149, DOI 10.1016/S8756-3282(01)00489-6; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Irie K, 2008, J HISTOCHEM CYTOCHEM, V56, P561, DOI 10.1369/jhc.2008.950527; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Karsdal MA, 2004, DNA CELL BIOL, V23, P155, DOI 10.1089/104454904322964751; Kneissel M, 2009, IBMS BONEKEY, V6, P259; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; LOMRI A, 1988, BONE, V9, P165, DOI 10.1016/8756-3282(88)90006-3; MacRae VE, 2006, J ENDOCRINOL, V189, P319, DOI 10.1677/joe.1.06609; Macrae VE, 2009, J CELL PHYSIOL, V218, P276, DOI 10.1002/jcp.21593; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Martin-Villar E, 2009, INT J BIOCHEM CELL B, V41, P1421, DOI 10.1016/j.biocel.2008.12.010; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Speer MY, 2005, CARDIOVASC RES, V66, P324, DOI 10.1016/j.cardiores.2005.01.023; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen R L, 2005, J Endocrinol Invest, V28, P15; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	46	175	191	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19595	10.1371/journal.pone.0019595	http://dx.doi.org/10.1371/journal.pone.0019595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611184	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500008
J	Robbins, CM; Hooker, S; Kittles, RA; Carpten, JD				Robbins, Christiane M.; Hooker, Stanley; Kittles, Rick A.; Carpten, John D.			EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men	PLOS ONE			English	Article							8Q24; ASSOCIATIONS; VARIANTS; SINGLE; ELAC2; LOCI; MSR1	The EphB2 gene has been implicated as a tumor suppressor gene somatically altered in both prostate cancer (PC) and colorectal cancer. We have previously shown an association between an EphB2 germline nonsense variant and risk of familial prostate cancer among African American Men (AAM). Here we set out to test the hypothesis that common variation within the EphB2 locus is associated with increased risk of sporadic PC in AAM. We genotyped a set of 341 single nucleotide polymorphisms (SNPs) encompassing the EphB2 locus, including known and novel coding and noncoding variants, in 490 AA sporadic PC cases and 567 matched controls. Single marker-based logistical regression analyses revealed seven EphB2 SNPs showing statistically significant association with prostate cancer risk in our population. The most significant association was achieved for a novel synonymous coding SNP, TGen-624, (Odds Ratio (OR) = 0.22; 95% Confidence Interval (CI) 0.08-0.66, p = 1x10(-5)). Two other SNPs also show significant associations toward a protective effect rs10465543 and rs12090415 (p = 1x10(-4)), OR = 0.49 and 0.7, respectively. Two additional SNPs revealed trends towards an increase in risk of prostate cancer, rs4612601 and rs4263970 (p = 0.001), OR = 1.35 and 1.31, respectively. Furthermore, haplotype analysis revealed low levels of linkage disequilibrium within the region, with two blocks being associated with prostate cancer risk among our population. These data suggest that genetic variation at the EphB2 locus may increase risk of sporadic PC among AAM.	[Robbins, Christiane M.; Carpten, John D.] Translat Genom Res Inst, Div Integrated Canc Gen, Phoenix, AZ USA; [Hooker, Stanley] Univ Chicago, Pritzker Sch Med, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Kittles, Rick A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Kittles, Rick A.] Univ Chicago, Inst Human Genet, Chicago, IL 60637 USA	Translational Genomics Research Institute; University of Chicago; University of Chicago; University of Chicago	Robbins, CM (corresponding author), Translat Genom Res Inst, Div Integrated Canc Gen, Phoenix, AZ USA.	jcarpten@tgen.org		Kittles, Rick/0000-0002-5004-4437	National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities [R01CA122009]; Department of Defense [DAMD W81XWH-07-1-0203]; NATIONAL CANCER INSTITUTE [R01CA122009] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities Grant (R01CA122009) and the Department of Defense (DAMD W81XWH-07-1-0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benford ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-334; Beuten J, 2010, CANCER EPIDEM BIOMAR, V19, P588, DOI 10.1158/1055-9965.EPI-09-0864; Bock CH, 2009, HUM GENET, V126, P637, DOI 10.1007/s00439-009-0712-z; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; GANN PH, 2002, REV UROL S, V5, pS3; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kieffer Nelly, 2006, Bull Soc Sci Med Grand Duche Luxemb, P21; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Oba SM, 2001, CANCER LETT, V164, P97, DOI 10.1016/S0304-3835(00)00716-3; Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Xu B, 2010, PROSTATE CANCER P D, V13, P270, DOI 10.1038/pcan.2010.6; Xu JF, 2009, CANCER EPIDEM BIOMAR, V18, P2145, DOI 10.1158/1055-9965.EPI-09-0091	23	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19494	10.1371/journal.pone.0019494	http://dx.doi.org/10.1371/journal.pone.0019494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603658	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300009
J	Banni, M; Negri, A; Mignone, F; Boussetta, H; Viarengo, A; Dondero, F				Banni, Mohamed; Negri, Alessandro; Mignone, Flavio; Boussetta, Hamadi; Viarengo, Aldo; Dondero, Francesco			Gene Expression Rhythms in the Mussel Mytilus galloprovincialis (Lam.) across an Annual Cycle	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; REAL-TIME PCR; MESSENGER-RNA; MOLECULAR-CLONING; CHITINASE; REPRODUCTION; PROTEIN; TOOL; SPERMATOGENESIS; MATURATION	Seasonal environmental changes may affect the physiology of Mytilus galloprovincialis (Lam.), an intertidal filter-feeder bivalve occurring commonly in Mediterranean and Atlantic coastal areas. We investigated seasonal variations in relative transcript abundance of the digestive gland and the mantle (gonads) of males and females. To identify gene expression trends - in terms of relative mRNA abundance-we used a medium-density cDNA microarray (1.7 K probes) in dual-color competitive hybridization analyses. Hierarchical clustering of digestive gland microarray data showed two main branches, distinguishing profiles associated with the "hot'' months (May-August) from the other months. Genes involved in chitin metabolism, associated with mussel nutrition and digestion showed higher mRNA levels during summer. Moreover, we found different gene transcriptomic patterns in the digestive glands of males when compared to females, during the four stages of mussel gonadal development. Microarray data from gonadal transcripts also displayed clear patterns during the different developmental phases respect to the resting period (stage I) with peak relative mRNA abundance at the ripe phase (stage III) for both sexes. These data showed a clear temporal pattern in transcriptomic profiles of mussels sampled over an annual cycle. Physiological response to thermal variation, food availability, and reproductive status across months may contribute to variation in relative mRNA abundance.	[Banni, Mohamed; Negri, Alessandro; Viarengo, Aldo; Dondero, Francesco] Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy; [Banni, Mohamed; Boussetta, Hamadi] Sousse Univ, ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Tunisia; [Mignone, Flavio] Univ Milan, Dept Struct Chem & Inorgan Stereochem, Milan, Italy	University of Eastern Piedmont Amedeo Avogadro; Universite de Sousse; Universite de Tunis-El-Manar; Institut Salah Azaiez; University of Milan	Banni, M (corresponding author), Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy.	francesco.dondero@mfn.unipmn.it	Banni, Mohamed/M-2144-2014; Dondero, Francesco/J-1528-2012	Banni, Mohamed/0000-0001-9764-0343; Viarengo, Aldo/0000-0002-1557-6526; Dondero, Francesco/0000-0001-7945-3712	European FP7 Integrated Project MEECE2 [212085]; Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia	European FP7 Integrated Project MEECE2; Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia	This work was funded by a grant from the European FP7 Integrated Project MEECE2 (contract n. 212085) and a grant from the Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Au HK, 2005, ANN NY ACAD SCI, V1042, P177, DOI 10.1196/annals.1338.020; Badariotti F, 2007, DEV COMP IMMUNOL, V31, P559, DOI 10.1016/j.dci.2006.09.002; Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bouchut A, 2006, INT J PARASITOL, V36, P175, DOI 10.1016/j.ijpara.2005.09.009; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Chikhaoui MA, 2008, CR BIOL, V331, P389, DOI 10.1016/j.crvi.2008.03.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Dellali M, 2001, COMP BIOCHEM PHYS C, V130, P227, DOI 10.1016/S1532-0456(01)00245-9; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Dondero F, 2006, AQUAT TOXICOL, V78, pS13, DOI 10.1016/j.aquatox.2006.02.025; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dunbar Emily J., 2009, Minnesota Department of Natural Resources Summaries of Wildlife Research Findings, V2008, P13; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Etchian OA, 2004, COMP BIOCHEM PHYS B, V139, P287, DOI 10.1016/j.cbpc.2004.08.006; Farcy E, 2008, MAR ENVIRON RES, V66, P300, DOI 10.1016/j.marenvres.2008.04.006; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; HAKE LE, 1990, DEVELOPMENT, V110, P249; Hecht N B, 1988, Prog Clin Biol Res, V267, P291; Hines A, 2007, ANAL BIOCHEM, V369, P175, DOI 10.1016/j.ab.2007.06.008; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; KENNEDY BP, 1985, EXP CELL RES, V158, P445, DOI 10.1016/0014-4827(85)90468-9; Khan MA, 2006, J AGR FOOD CHEM, V54, P2236, DOI 10.1021/jf051587+; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; Li GP, 2010, J AGR FOOD CHEM, V58, P7831, DOI 10.1021/jf101526c; Liu JX, 2008, GENE EXPR PATTERNS, V8, P237, DOI 10.1016/j.gep.2007.12.004; LOWE DM, 1982, J MAR BIOL ASSOC UK, V62, P133, DOI 10.1017/S0025315400020166; Matocq MD, 2009, MOL ECOL, V18, P2310, DOI 10.1111/j.1365-294X.2009.04172.x; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moraga D, 2005, COMP BIOCHEM PHYS C, V141, P151, DOI 10.1016/j.cca.2005.05.014; Motta PM, 2000, HUM REPROD, V15, P78; Muttray AF, 2008, MAR ENVIRON RES, V66, P412, DOI 10.1016/j.marenvres.2008.06.004; Osada M, 2004, MOL REPROD DEV, V67, P273, DOI 10.1002/mrd.20020; PEARL LH, 2001, ADV PROTEIN CHEM; Petrovic S, 2004, MAR POLLUT BULL, V49, P713, DOI 10.1016/j.marpolbul.2004.05.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Place SP, 2008, MAR ECOL PROG SER, V356, P1, DOI 10.3354/meps07354; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Riginos C, 2003, MOL BIOL EVOL, V20, P200, DOI 10.1093/molbev/msg021; Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; Tachu B, 2008, INFECT IMMUN, V76, P221, DOI 10.1128/IAI.00701-07; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Xu W, 2009, COMP BIOCHEM PHYS B, V154, P143, DOI 10.1016/j.cbpb.2009.05.012	60	86	86	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e18904	10.1371/journal.pone.0018904	http://dx.doi.org/10.1371/journal.pone.0018904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573210	gold, Green Submitted, Green Published			2022-12-25	WOS:000290256400003
J	Baumeister, S; Wiesner, J; Reichenberg, A; Hintz, M; Bietz, S; Harb, OS; Roos, DS; Kordes, M; Friesen, J; Matuschewski, K; Lingelbach, K; Jomaa, H; Seeber, F				Baumeister, Stefan; Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Bietz, Sven; Harb, Omar S.; Roos, David S.; Kordes, Maximilian; Friesen, Johannes; Matuschewski, Kai; Lingelbach, Klaus; Jomaa, Hassan; Seeber, Frank			Fosmidomycin Uptake into Plasmodium and Babesia-Infected Erythrocytes Is Facilitated by Parasite-Induced New Permeability Pathways	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; METHYLERYTHRITOL PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHESIS; IN-VITRO; PHOSPHONIC ACID; MYCOBACTERIUM-TUBERCULOSIS; METABOLIC PATHWAYS; ANTIMALARIAL-DRUGS; FALCIPARUM; RESISTANCE	Background: Highly charged compounds typically suffer from low membrane permeability and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly charged drug fosmidomycin and its more active methyl-derivative FR900098 have proven parasiticidal activity against erythrocytic stages of the malaria parasite Plasmodium falciparum. Both compounds target the isoprenoid biosynthesis pathway present in bacteria and plastid-bearing organisms, like apicomplexan parasites. Surprisingly, the compounds are inactive against a range of apicomplexans replicating in nucleated cells, including Toxoplasma gondii. Methodology/Principal Findings: Since non-infected erythrocytes are impermeable for FR90098, we hypothesized that these drugs are taken up only by erythrocytes infected with Plasmodium. We provide evidence that radiolabeled FR900098 accumulates in theses cells as a consequence of parasite-induced new properties of the host cell, which coincide with an increased permeability of the erythrocyte membrane. Babesia divergens, a related parasite that also infects human erythrocytes and is also known to induce an increase in membrane permeability, displays a similar susceptibility and uptake behavior with regard to the drug. In contrast, Toxoplasma gondii-infected cells do apparently not take up the compounds, and the drugs are inactive against the liver stages of Plasmodium berghei, a mouse malaria parasite. Conclusions/Significance: Our findings provide an explanation for the observed differences in activity of fosmidomycin and FR900098 against different Apicomplexa. These results have important implications for future screens aimed at finding new and safe molecular entities active against P. falciparum and related parasites. Our data provide further evidence that parasite-induced new permeability pathways may be exploited as routes for drug delivery.	[Baumeister, Stefan; Bietz, Sven; Lingelbach, Klaus; Seeber, Frank] Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany; [Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Jomaa, Hassan] Univ Giessen Klinikum, Inst Klin Immunol & Transfus Med, D-6300 Giessen, Germany; [Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Jomaa, Hassan] Marburg GmbH, Giessen, Germany; [Harb, Omar S.; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kordes, Maximilian; Friesen, Johannes; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Seeber, Frank] Robert Koch Inst, Fachgebiet Parasitol 16, D-1000 Berlin, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University of Pennsylvania; Max Planck Society; Robert Koch Institute	Baumeister, S (corresponding author), Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany.	seeberf@rki.de	Kordes, Maximilian/AAE-9646-2019	Kordes, Maximilian/0000-0002-5715-0881; Harb, Omar/0000-0003-4446-6200; Baumeister, Stefan/0000-0002-7784-3474; Matuschewski, Kai/0000-0001-6147-8591; Seeber, Frank/0000-0002-2271-3699; Roos, David Siker/0000-0001-6725-4089	Deutsche Forschungsgemeinschaft [SFB 593, SE622/4-3, WI 2050/2-1]; European Commission [018834]; EviMalaR network of excellence	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); EviMalaR network of excellence	This study was supported by the Deutsche Forschungsgemeinschaft (grants SFB 593 to S.B. and K.L., SE622/4-3 to F.S., and WI 2050/2-1 to J.W.) and by a grant from the European Commission to H.J. (Integrated Project #018834) and via the EviMalaR network of excellence to K.L. and K.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Baumeister S, 2010, PROTOPLASMA, V240, P3, DOI 10.1007/s00709-009-0090-3; Biagini GA, 2003, ANTIMICROB AGENTS CH, V47, P2584, DOI 10.1128/AAC.47.8.2584-2589.2003; Borrmann S, 2005, ANTIMICROB AGENTS CH, V49, P3749, DOI 10.1128/AAC.49.9.3749-3754.2005; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cassera MB, 2004, J BIOL CHEM, V279, P51749, DOI 10.1074/jbc.M408360200; Clastre M, 2007, EXP PARASITOL, V116, P375, DOI 10.1016/j.exppara.2007.02.002; Cooper B, 1998, ARCH BIOCHEM BIOPHYS, V353, P356, DOI 10.1006/abbi.1998.0626; Deng LS, 2009, J MED CHEM, V52, P6539, DOI 10.1021/jm9012592; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Dobson PD, 2009, DRUG DISCOV TODAY, V14, P31, DOI 10.1016/j.drudis.2008.10.011; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Fouts AE, 2007, INFECT IMMUN, V75, P634, DOI 10.1128/IAI.01228-06; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gero AM, 2003, CURR PHARM DESIGN, V9, P867, DOI 10.2174/1381612033455233; Giessmann D, 2008, CHEM BIODIVERS, V5, P643, DOI 10.1002/cbdv.200890060; GINSBURG H, 1987, BIOSCIENCE REP, V7, P455, DOI 10.1007/BF01116501; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Harb OS, 2004, EUKARYOT CELL, V3, P663, DOI 10.1128/EC.3.3.663-674.2004; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; KAMIYA T, 1980, Patent No. 4206156; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KUEMMERLE HP, 1985, INT J CLIN PHARM TH, V23, P521; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Lizundia R, 2009, ANTIMICROB AGENTS CH, V53, P1213, DOI 10.1128/AAC.00126-08; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; MURAKAWA T, 1982, ANTIMICROB AGENTS CH, V21, P224, DOI 10.1128/AAC.21.2.224; Muregi FW, 2010, DRUG DEVELOP RES, V71, P20, DOI 10.1002/ddr.20345; Odom AR, 2010, MOL BIOCHEM PARASIT, V170, P108, DOI 10.1016/j.molbiopara.2009.12.001; OHLER E, 1995, SYNTHESIS-STUTTGART, P539; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prudencio M, 2009, CELL MICROBIOL, V11, P1492, DOI 10.1111/j.1462-5822.2009.01342.x; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sivakumar T., 2008, Journal of Protozoology Research, V18, P71; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2005, COMB CHEM HIGH T SCR, V8, P81, DOI 10.2174/1386207053328138; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Stead AMW, 2001, MOL PHARMACOL, V59, P1298, DOI 10.1124/mol.59.5.1298; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUCHIYA T, 1982, EUR J DRUG METAB PH, V7, P59, DOI 10.1007/BF03189544; Wang WX, 2010, P NATL ACAD SCI USA, V107, P11189, DOI 10.1073/pnas.1000264107; Wang WX, 2010, P NATL ACAD SCI USA, V107, P4522, DOI 10.1073/pnas.0911087107; Wiesner J, 2000, EXP PARASITOL, V96, P182, DOI 10.1006/expr.2000.4566; Wiesner J, 2007, ARCH PHARM, V340, P667, DOI 10.1002/ardp.200700069; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012; Zintl A, 2003, CLIN MICROBIOL REV, V16, P622, DOI 10.1128/CMR.16.4.622-636.2003	74	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19334	10.1371/journal.pone.0019334	http://dx.doi.org/10.1371/journal.pone.0019334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573242	Green Published, Green Submitted, gold			2022-12-25	WOS:000290224800022
J	Hanson, JL; Chandra, A; Wolfe, BL; Pollak, SD				Hanson, Jamie L.; Chandra, Amitabh; Wolfe, Barbara L.; Pollak, Seth D.			Association between Income and the Hippocampus	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; NORMAL BRAIN-DEVELOPMENT; ENVIRONMENTAL ENRICHMENT; COGNITIVE-DEVELOPMENT; SOCIOECONOMIC-STATUS; CHILDHOOD POVERTY; NIH MRI; STRESS; RATS; REGISTRATION	Facets of the post-natal environment including the type and complexity of environmental stimuli, the quality of parenting behaviors, and the amount and type of stress experienced by a child affects brain and behavioral functioning. Poverty is a type of pervasive experience that is likely to influence biobehavioral processes because children developing in such environments often encounter high levels of stress and reduced environmental stimulation. This study explores the association between socioeconomic status and the hippocampus, a brain region involved in learning and memory that is known to be affected by stress. We employ a voxel-based morphometry analytic framework with region of interest drawing for structural brain images acquired from participants across the socioeconomic spectrum (n = 317). Children from lower income backgrounds had lower hippocampal gray matter density, a measure of volume. This finding is discussed in terms of disparities in education and health that are observed across the socioeconomic spectrum.	[Hanson, Jamie L.; Pollak, Seth D.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Hanson, Jamie L.; Pollak, Seth D.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Chandra, Amitabh] Harvard Univ, Harvard Kennedy Sch Govt, Cambridge, MA 02138 USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Wolfe, Barbara L.] Univ Wisconsin, Inst Res Poverty, Madison, WI USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Publ Affairs, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hanson, JL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jlhanson5@wisc.edu; wolfe@lafollette.wisc.edu	Pollak, Seth D/G-2345-2011; Hanson, Jamie/B-9420-2014	Hanson, Jamie/0000-0002-0469-8886; Wolfe, Barbara/0000-0002-8803-9019	US National Institute on Drug Abuse [DA028087]; US National Institute of Mental Health [MH61285, MH68858]; Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium; Russell Sage Foundation; University of Wisconsin-Madison Graduate School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068858, R01MH061285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA028087] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium; Russell Sage Foundation; University of Wisconsin-Madison Graduate School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the US National Institute on Drug Abuse (Grant DA028087 to JLH), the US National Institute of Mental Health (Grants MH61285 and MH68858 to SDP) and the Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium. This project was also supported by the Russell Sage Foundation and the University of Wisconsin-Madison Graduate School grants to BLW. The authors also thank the Russell Sage Foundation for their support of Health and SES working group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Biegler R, 2001, P NATL ACAD SCI USA, V98, P6941, DOI 10.1073/pnas.121034798; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Farah MJ, 2008, DEVELOPMENTAL SCI, V11, P793, DOI 10.1111/j.1467-7687.2008.00688.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; FIALA BA, 1978, EXP NEUROL, V59, P372, DOI 10.1016/0014-4886(78)90229-7; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McLoyd V C, 1990, New Dir Child Dev, P49; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOFFITT TE, 1981, J ABNORM PSYCHOL, V90, P152, DOI 10.1037/0021-843X.90.2.152; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Rao H, 2010, NEUROIMAGE, V49, P1144, DOI 10.1016/j.neuroimage.2009.07.003; Soffie M, 1999, BEHAV BRAIN RES, V101, P37, DOI 10.1016/S0166-4328(98)00139-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Whitwell JL, 2007, PARKINSONISM RELAT D, V13, pS406, DOI 10.1016/S1353-8020(08)70039-7; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; Williams Leanne M, 2008, Expert Rev Neurother, V8, P1049, DOI 10.1586/14737175.8.7.1049; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016	37	186	190	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18712	10.1371/journal.pone.0018712	http://dx.doi.org/10.1371/journal.pone.0018712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759EZ	21573231	Green Submitted, gold, Green Published			2022-12-25	WOS:000290224800005
J	Lusebrink, J; Schildgen, V; Tillmann, RL; Wittleben, F; Bohmer, A; Muller, A; Schildgen, O				Luesebrink, Jessica; Schildgen, Verena; Tillmann, Ramona Liza; Wittleben, Felix; Boehmer, Anne; Mueller, Andreas; Schildgen, Oliver			Detection of Head-to-Tail DNA Sequences of Human Bocavirus in Clinical Samples	PLOS ONE			English	Article							PARVOVIRUS MINUTE VIRUS; REPLICATIVE-FORM DNA; ROLLING CIRCLE MODEL; PROTEIN NS1; MICE; ORIGIN; INFECTIONS; INITIATION; CELLS	Parvoviruses are single stranded DNA viruses that replicate in a so called "rolling-hairpin" mechanism, a variant of the rolling circle replication known for bacteriophages like phi X174. The replication intermediates of parvoviruses thus are concatemers of head-to-head or tail-to-tail structure. Surprisingly, in case of the novel human bocavirus, neither head-to-head nor tail-to-tail DNA sequences were detected in clinical isolates; in contrast head-to-tail DNA sequences were identified by PCR and sequencing. Thereby, the head-to-tail sequences were linked by a novel sequence of 54 bp of which 20 bp also occur as conserved structures of the palindromic ends of parvovirus MVC which in turn is a close relative to human bocavirus.	[Luesebrink, Jessica; Schildgen, Verena; Tillmann, Ramona Liza; Wittleben, Felix; Boehmer, Anne; Schildgen, Oliver] Klinikum Privaten Univ Witten Herdecke, Inst Pathol, Kliniken Stadt Koln gGmbH, Cologne, Germany; [Mueller, Andreas] Univ Hosp Bonn, Dept Paediat, Bonn, Germany	University of Cologne; University of Bonn	Lusebrink, J (corresponding author), Klinikum Privaten Univ Witten Herdecke, Inst Pathol, Kliniken Stadt Koln gGmbH, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627; Wittleben, Felix/0000-0002-1561-8271	Deutsche Lungenstiftung e.V. (Hannover, Germany); Else Kroner-Fresenius Stiftung (Bad Homburg, Germany); Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany)	Deutsche Lungenstiftung e.V. (Hannover, Germany); Else Kroner-Fresenius Stiftung (Bad Homburg, Germany); Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany)	This work was partially supported by unrestricted research grants from the Deutsche Lungenstiftung e.V. (Hannover, Germany), the Else Kroner-Fresenius Stiftung (Bad Homburg, Germany), and the Research Award 2009 from the Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany) to O.S. and A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Baldauf AQ, 1997, J VIROL, V71, P971, DOI 10.1128/JVI.71.2.971-980.1997; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Bohmer A, 2009, J VIROL METHODS, V158, P199, DOI 10.1016/j.jviromet.2009.02.010; CHEN AY, VIROLOGY, V403, P145; CHEN KC, 1988, J VIROL, V62, P3807, DOI 10.1128/JVI.62.10.3807-3813.1988; CHOW BD, J CLIN VIROL, V47, P143; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Cotmore SF, 2005, J VIROL, V79, P2287, DOI 10.1128/JVI.79.4.2287-2300.2005; COTMORE SF, 1989, J VIROL, V63, P1002, DOI 10.1128/JVI.63.2.1002-1006.1989; Cotmore SF, 1998, J VIROL, V72, P8477, DOI 10.1128/JVI.72.11.8477-8484.1998; Cotmore SF, 2000, J VIROL, V74, P1332, DOI 10.1128/JVI.74.3.1332-1341.2000; COTMORE SF, 1993, J VIROL, V67, P1579, DOI 10.1128/JVI.67.3.1579-1589.1993; Cotmore SF, 2007, J VIROL, V81, P13015, DOI 10.1128/JVI.01703-07; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; DOERMANN AH, 1973, ANNU REV GENET, V7, P325, DOI 10.1146/annurev.ge.07.120173.001545; FAUST EA, 1982, NUCLEIC ACIDS RES, V10, P4181, DOI 10.1093/nar/10.14.4181; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Hirt B, 2000, CONTRIB MICROBIOL, V4, P163; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; KAPOOR A, J INFECT DIS, V201, P1633; KOCZOT FJ, 1973, P NATL ACAD SCI USA, V70, P215, DOI 10.1073/pnas.70.1.215; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; SCHRODER CH, 1973, J MOL BIOL, V79, P599, DOI 10.1016/0022-2836(73)90066-1; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Tattersall P., 2006, EVOLUTION PARVOVIRUS, P5; Volz S, 2007, J CLIN VIROL, V40, P229, DOI 10.1016/j.jcv.2007.07.017; Willwand K, 1998, J BIOL CHEM, V273, P1165, DOI 10.1074/jbc.273.2.1165	30	51	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19457	10.1371/journal.pone.0019457	http://dx.doi.org/10.1371/journal.pone.0019457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573237	Green Submitted, Green Published, gold			2022-12-25	WOS:000290224800030
J	Yang, AC; Tsai, SJ; Hong, CJ; Wang, C; Chen, TJ; Liou, YJ; Peng, CK				Yang, Albert C.; Tsai, Shih-Jen; Hong, Chen-Jee; Wang, Cynthia; Chen, Tai-Jui; Liou, Ying-Jay; Peng, Chung-Kang			Clustering Heart Rate Dynamics Is Associated with beta-Adrenergic Receptor Polymorphisms: Analysis by Information-Based Similarity Index	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; POWER SPECTRUM ANALYSIS; RATE-VARIABILITY; SYMBOLIC DYNAMICS; BETA(2)-ADRENERGIC RECEPTOR; ADRENOCEPTOR POLYMORPHISMS; PERIOD VARIABILITY; GENE POLYMORPHISMS; NONLINEAR INDEXES; FRACTAL ANALYSIS	Background: Genetic polymorphisms in the gene encoding the beta-adrenergic receptors (beta-AR) have a pivotal role in the functions of the autonomic nervous system. Using heart rate variability (HRV) as an indicator of autonomic function, we present a bottom-up genotype-phenotype analysis to investigate the association between beta-AR gene polymorphisms and heart rate dynamics. Methods: A total of 221 healthy Han Chinese adults (59 males and 162 females, aged 33.6 +/- 10.8 years, range 19 to 63 years) were recruited and genotyped for three common beta-AR polymorphisms: beta(1)-AR Ser49Gly, beta(2)-AR Arg16Gly and beta(2)-AR Gln27Glu. Each subject underwent two hours of electrocardiogram monitoring at rest. We applied an information-based similarity (IBS) index to measure the pairwise dissimilarity of heart rate dynamics among study subjects. Results: With the aid of agglomerative hierarchical cluster analysis, we categorized subjects into major clusters, which were found to have significantly different distributions of beta(2)-AR Arg16Gly genotype. Furthermore, the non-randomness index, a nonlinear HRV measure derived from the IBS method, was significantly lower in Arg16 homozygotes than in Gly16 carriers. The non-randomness index was negatively correlated with parasympathetic-related HRV variables and positively correlated with those HRV indices reflecting a sympathovagal shift toward sympathetic activity. Conclusions: We demonstrate a bottom-up categorization approach combining the IBS method and hierarchical cluster analysis to detect subgroups of subjects with HRV phenotypes associated with beta-AR polymorphisms. Our results provide evidence that beta(2)-AR polymorphisms are significantly associated with the acceleration/deceleration pattern of heart rate oscillation, reflecting the underlying mode of autonomic nervous system control.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan; [Yang, Albert C.; Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen; Hong, Chen-Jee; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Tsai, Shih-Jen; Hong, Chen-Jee; Liou, Ying-Jay] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hong, Chen-Jee] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wang, Cynthia] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Chen, Tai-Jui] I Shou Univ, Kaohsiung, Taiwan; [Chen, Tai-Jui] E DA Hosp, Kaohsiung, Taiwan; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA	National Central University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Princeton University; I Shou University; E-Da Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yang, AC (corresponding author), Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan.	ccyang@physionet.org; sjtsai@vghtpe.gov.tw	Peng, Chung-Kang/N-1308-2019; Tsai, Shih-Jen/AAK-7944-2020; Peng, Chung-Kang/E-1489-2011	Peng, Chung-Kang/0000-0003-3666-9833; Tsai, Shih-Jen/0000-0002-9987-022X; Peng, Chung-Kang/0000-0003-3666-9833; Wang, Cynthia/0000-0001-9565-9585	Taipei Veterans General Hospital, Taiwan [V97ER3-003, V98ER3-004, V99ER3-004, V97C1-132]; National Science Council (NSC) of Taiwan [NSC 95-2314-B-075-111]; NSC	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan)	This work was supported by grants V97ER3-003, V98ER3-004, V99ER3-004, and V97C1-132 from Taipei Veterans General Hospital, Taiwan; the National Science Council (NSC) of Taiwan (NSC 95-2314-B-075-111); and the NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Busjahn A, 1998, AM J CARDIOL, V81, P755, DOI 10.1016/S0002-9149(97)01019-9; Camm AJ, 1996, CIRCULATION, V93, P1043; Cheng D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007733; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Grandy SA, 2004, AM J PHYSIOL-HEART C, V287, pH1029, DOI 10.1152/ajpheart.00814.2003; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Ho KKL, 1997, CIRCULATION, V96, P842; HO YL, 2011, PLOS ONE IN PRESS; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Humma LM, 2001, AM J CARDIOL, V88, P1034, DOI 10.1016/S0002-9149(01)01986-5; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; Kupper NHM, 2004, CIRCULATION, V110, P2792, DOI 10.1161/01.CIR.0000146334.96820.6E; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; Lohse MJ, 2004, TRENDS MOL MED, V10, P55, DOI 10.1016/j.molmed.2003.12.004; Maestri R, 2005, COMPUT CARDIOL, V32, P981; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Makikallio TH, 1997, AM J CARDIOL, V80, P779; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; MALLIANI A, 1994, BRIT HEART J, V71, P1; Masuo K, 2005, AM J HYPERTENS, V18, P1009, DOI 10.1016/j.amjhyper.2005.01.006; Masuo K, 2005, CIRCULATION, V111, P3429, DOI 10.1161/CIRCULATIONAHA.104.519652; Matsunaga T, 2007, AM HEART J, V154, P759, DOI 10.1016/j.ahj.2007.03.053; Matsunaga T, 2009, J HYPERTENS, V27, P305, DOI 10.1097/HJH.0b013e32831ac967; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Neumann SA, 2005, PSYCHOSOM MED, V67, P168, DOI 10.1097/01.psy.0000155671.90861.c2; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Peng CK, 2007, CHAOS, V17, DOI 10.1063/1.2716147; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Ranade K, 2002, AM J HUM GENET, V70, P935, DOI 10.1086/339621; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Singh JP, 1999, CIRCULATION, V99, P2251, DOI 10.1161/01.CIR.99.17.2251; Sinnreich R, 1999, HUM GENET, V105, P654, DOI 10.1007/s004390051158; Snyder EM, 2006, J PHYSIOL-LONDON, V571, P121, DOI 10.1113/jphysiol.2005.098558; Su SY, 2009, AM J CARDIOL, V104, P1748, DOI 10.1016/j.amjcard.2009.07.063; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Tibby SM, 2003, CRIT CARE MED, V31, P2059, DOI 10.1097/01.CCM.0000069539.65980.58; Tien YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-155; Wang Xiaoling, 2005, Am J Cardiol, V96, P1166, DOI 10.1016/j.amjcard.2005.06.050; Wessel N, 2000, PHYS REV E, V61, P733, DOI 10.1103/PhysRevE.61.733; Wilk JB, 2006, ANN HUM GENET, V70, P566, DOI 10.1111/j.1469-1809.2005.00258.x; Yang ACC, 2005, J COMPUT BIOL, V12, P1103, DOI 10.1089/cmb.2005.12.1103; Yang ACC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108103; Yang ACC, 2003, PHYSICA A, V329, P473, DOI 10.1016/S0378-4371(03)00622-8; Yang AC, 2010, AM J MED GENET B, V153B, P1024, DOI 10.1002/ajmg.b.31069; Yeh RG, 2007, BIOMED ENG-APP BAS C, V19, P303, DOI 10.1142/S1016237207000409; Yeragani VK, 2000, DEPRESS ANXIETY, V12, P67, DOI 10.1002/1520-6394(2000)12:2<67::AID-DA2>3.0.CO;2-C	58	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19232	10.1371/journal.pone.0019232	http://dx.doi.org/10.1371/journal.pone.0019232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573230	Green Submitted, Green Published, gold			2022-12-25	WOS:000290224800018
J	Park, JH; Lee, JY; Shin, DH; Jang, KS; Kim, HJ; Kong, G				Park, J-H; Lee, J-Y; Shin, D-H; Jang, K-S; Kim, H-J; Kong, Gu			Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1 alpha mediated by the PTEN/PI3K/Akt pathway	ONCOGENE			English	Article						Mel-18; polycomb group proteins; Akt; angiogenesis	INDUCIBLE FACTOR 1-ALPHA; FORKHEAD TRANSCRIPTION FACTOR; REGULATES CELL-PROLIFERATION; ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; SUPPRESSOR PROTEIN; UBIQUITIN LIGASE; VEGF EXPRESSION; POOR-PROGNOSIS; HYPOXIA	Mel-18 has been implicated in several processes in tumor progression, in which the Akt pathway is involved as an important key molecular event. However, the function of Mel-18 in human cancers has not been fully established yet. Here, we examined the effect of Mel-18 on tumor angiogenesis in human breast cancer, and found that Mel-18 was a novel regulator of HIF-1 alpha. Mel-18 negatively regulated the HIF-1 alpha expression and its target gene VEGF transcription during both normoxia and hypoxia. We demonstrated that Mel-18 regulated the HIF-1 alpha expression and activity via the PI3K/Akt pathway. Loss of Mel-18 downregulated Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression, consequently activating the PI3K/Akt/MDM2 pathway, and leading to an increase of HIF-1 alpha protein level. Mel-18 modulated the HIF-1 alpha transcriptional activity via regulating the cytoplasmic retention of FOXO3a, a downstream effector of Akt, and recruitment of HIF-1 alpha/CBP complex to the VEGF promoter. Furthermore, our data shows that Mel-18 blocked tumor angiogenesis both in vitro and in vivo. Mel-18 overexpression inhibited in vitro tube formation in human umbilical endothelial cells (HUVECs). Xenografts in NOD/SCID mice derived from stably Mel-18 knocked down MCF7 human breast cancer cells showed increased tumor volume, microvessel density, and phospho-Akt and HIF-1a expression levels. In conclusion, our findings provide that Mel-18 is a novel regulator of tumor angiogenesis through regulating HIF-1 alpha and its target VEGF expressions mediated by the PTEN/PI3K/Akt pathway, suggesting a new tumor-suppressive role of Mel-18 in human breast cancer. Oncogene (2011) 30, 4578-4589; doi: 10.1038/onc.2011.174; published online 23 May 2011	[Park, J-H; Shin, D-H; Jang, K-S; Kim, H-J; Kong, Gu] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Lee, J-Y; Kong, Gu] Hanyang Univ, IBBR, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kong, G (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, 17 Haengdang Dong, Seoul 133791, South Korea.	gkong@hanyang.ac.kr	Jang, Kiseok/P-2048-2015	Jang, Kiseok/0000-0002-6585-3990	National Research Foundation of Korea (NRF); Korean government (MEST) [2010K001350, 2010-0020534]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2010K001350 and 2010-0020534).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Guo BH, 2010, ANN ONCOL, V21, P2361, DOI 10.1093/annonc/mdq241; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JH, 2010, BIOCHEM BIOPH RES CO, V400, P523, DOI 10.1016/j.bbrc.2010.08.086; Kim HJ, 2007, MOL CANCER RES, V5, P321, DOI 10.1158/1541-7786.MCR-06-0218; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Li XY, 2007, ACTA BIOCH BIOPH SIN, V39, P745, DOI 10.1111/j.1745-7270.2007.00337.x; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 2001, EXP NEPHROL, V9, P235; Merritt WM, 2010, MOL CANCER THER, V9, P985, DOI 10.1158/1535-7163.MCT-09-0967; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Qian T, 2010, ONCOGENE, V29, P5818, DOI 10.1038/onc.2010.317; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yoo YG, 2004, J BIOL CHEM, V279, P53365, DOI 10.1074/jbc.M408554200; Zhong H, 2000, CANCER RES, V60, P1541	48	51	55	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 10	2011	30	45					4578	4589		10.1038/onc.2011.174	http://dx.doi.org/10.1038/onc.2011.174			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21602890				2022-12-25	WOS:000296890700005
J	Raspail, C; Graindorge, M; Moreau, Y; Crouzy, S; Lefebvre, B; Robin, AY; Dumas, R; Matringe, M				Raspail, Corinne; Graindorge, Matthieu; Moreau, Yohann; Crouzy, Serge; Lefebvre, Bertrand; Robin, Adeline Y.; Dumas, Renaud; Matringe, Michel			4-Hydroxyphenylpyruvate Dioxygenase Catalysis IDENTIFICATION OF CATALYTIC RESIDUES AND PRODUCTION OF A HYDROXYLATED INTERMEDIATE SHARED WITH A STRUCTURALLY UNRELATED ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLPYRUVATE DIOXYGENASE; NONHEME IRON ENZYMES; (4-HYDROXYPHENYL)PYRUVATE DIOXYGENASE; HYDROXYMANDELATE SYNTHASE; STREPTOMYCES-AVERMITILIS; HEREDITARY TYROSINEMIA; CRYSTAL-STRUCTURES; POTENT INHIBITOR; ACID; DENSITY	4-Hydroxyphenylpyruvate dioxygenase (HPPD) catalyzes the conversion of 4-hydroxyphenylpyruvate (HPP) into homogentisate. HPPD is the molecular target of very effective synthetic herbicides. HPPD inhibitors may also be useful in treating life-threatening tyrosinemia type I and are currently in trials for treatment of Parkinson disease. The reaction mechanism of this key enzyme in both plants and animals has not yet been fully elucidated. In this study, using site-directed mutagenesis supported by quantum mechanical/molecular mechanical theoretical calculations, we investigated the role of catalytic residues potentially interacting with the substrate/intermediates. These results highlight the following: (i) the central role of Gln-272, Gln-286, and Gln-358 in HPP binding and the first nucleophilic attack; (ii) the important movement of the aromatic ring of HPP during the reaction, and (iii) the key role played by Asn-261 and Ser-246 in C1 hydroxylation and the final ortho-rearrangement steps (numbering according to the Arabidopsis HPPD crystal structure 1SQD). Furthermore, this study reveals that the last step of the catalytic reaction, the 1,2 shift of the acetate side chain, which was believed to be unique to the HPPD activity, is also catalyzed by a structurally unrelated enzyme.	[Graindorge, Matthieu; Moreau, Yohann] Univ Grenoble 1, F-38054 Grenoble, France; [Matringe, Michel] Inst Natl Rech Agron, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, UMR 1200, F-38054 Grenoble, France; [Moreau, Yohann; Crouzy, Serge] Commissariat Energie Atom, CNRS UMR Lab Chim & Biol Met 5249, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, F-38054 Grenoble, France; [Dumas, Renaud] CNRS, UMR 5168, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Raspail, Corinne; Graindorge, Matthieu; Robin, Adeline Y.; Dumas, Renaud; Matringe, Michel] Commissariat Energie Atom, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Lefebvre, Bertrand] Ctr Rech Serv Sante Armees, Unite Biospectrometrie, F-38702 La Tronche, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Matringe, M (corresponding author), Inst Natl Rech Agron, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, UMR 1200, 17 Rue Martyrs, F-38054 Grenoble, France.	mmatringe@cea.fr	Dumas, Renaud/E-1835-2011	Robin, Adeline/0000-0002-1199-2135				BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Borowski T, 2004, BIOCHEMISTRY-US, V43, P12331, DOI 10.1021/bi049503y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brownlee JM, 2004, BIOCHEMISTRY-US, V43, P6370, DOI 10.1021/bi049317s; Brownlee J, 2008, BIOCHEMISTRY-US, V47, P2002, DOI 10.1021/bi701438r; Crouch NP, 1997, TETRAHEDRON, V53, P6993, DOI 10.1016/S0040-4020(97)00398-0; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002; Ferre N, 2003, J AM CHEM SOC, V125, P6868, DOI 10.1021/ja035087d; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frisch M., 2016, GAUSSIAN 16 REVISION; Fritze IM, 2004, PLANT PHYSIOL, V134, P1388, DOI 10.1104/pp.103.034082; Garcia I, 1999, PLANT PHYSIOL, V119, P1507, DOI 10.1104/pp.119.4.1507; Garcia I, 2000, BIOCHEMISTRY-US, V39, P7501, DOI 10.1021/bi000135h; Gunsior M, 2004, BIOCHEMISTRY-US, V43, P663, DOI 10.1021/bi035762w; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Johnson-Winters K, 2003, BIOCHEMISTRY-US, V42, P2072, DOI 10.1021/bi026499m; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Luscombe B. M., 1995, BRIGHTON CROP PROT C, V2, P35; Matringe M, 2005, PEST MANAG SCI, V61, P269, DOI 10.1002/ps.997; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; NIEDERWIESER A, 1978, CLIN CHIM ACTA, V90, P195, DOI 10.1016/0009-8981(78)90522-3; PASCAL RA, 1985, BIOCHEMISTRY-US, V24, P3158, DOI 10.1021/bi00334a013; Ponder J.W, 2001, TINKER SOFTWARE TOOL; Prisbylla M. P., 1993, WEEDS, P731; Romagni JG, 2000, FEBS LETT, V480, P301, DOI 10.1016/S0014-5793(00)01907-4; RUNDGREN M, 1977, J BIOL CHEM, V252, P5094; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SECOR J, 1994, PLANT PHYSIOL, V106, P1429, DOI 10.1104/pp.106.4.1429; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Suemori A, 1996, J FERMENT BIOENG, V81, P133, DOI 10.1016/0922-338X(96)87590-8; THOMAS G, 1974, BIOCHEM J, V142, P437, DOI 10.1042/bj1420437; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; Zink O., 2000, Patent application FR, Patent No. [00/13942, 0013942]	45	54	58	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26061	26070		10.1074/jbc.M111.227595	http://dx.doi.org/10.1074/jbc.M111.227595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613226	hybrid, Green Published			2022-12-25	WOS:000293073000064
J	Goulet, A; Lai-Kee-Him, J; Veesler, D; Auzat, I; Robin, G; Shepherd, DA; Ashcroft, AE; Richard, E; Lichiere, J; Tavares, P; Cambillau, C; Bron, P				Goulet, Adeline; Lai-Kee-Him, Josephine; Veesler, David; Auzat, Isabelle; Robin, Gautier; Shepherd, Dale A.; Ashcroft, Alison E.; Richard, Eric; Lichiere, Julie; Tavares, Paulo; Cambillau, Christian; Bron, Patrick			The Opening of the SPP1 Bacteriophage Tail, a Prevalent Mechanism in Gram-positive-infecting Siphophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; MEMBRANE-RECEPTOR; STRUCTURE REVEALS; PROTEIN; LAMBDA; PHAGES; FIBER	The SPP1 siphophage uses its long non-contractile tail and tail tip to recognize and infect the Gram-positive bacterium Bacillus subtilis. The tail-end cap and its attached tip are the critical components for host recognition and opening of the tail tube for genome exit. In the present work, we determined the cryo-electron microscopic (cryo-EM) structure of a complex formed by the cap protein gp19.1 (Dit) and the N terminus of the downstream protein of gp19.1 in the SPP1 genome, gp21(1-552) (Tal). This complex assembles two back-to-back stacked gp19.1 ring hexamers, interacting loosely, and two gp21(1-552) trimers interacting with gp19.1 at both ends of the stack. Remarkably, one gp21(1-552) trimer displays a "closed" conformation, whereas the second is "open" delineating a central channel. The two conformational states dock nicely into the EM map of the SPP1 cap domain, respectively, before and after DNA release. Moreover, the open/closed conformations of gp19.1-gp21(1-552) are consistent with the structures of the corresponding proteins in the siphophage p2 baseplate, where the Tal protein (ORF16) attached to the ring of Dit (ORF15) was also found to adopt these two conformations. Therefore, the present contribution allowed us to revisit the SPP1 tail distal-end architectural organization. Considering the sequence conservation among Dit and the N-terminal region of Tal-like proteins in Gram-positive-infecting Siphoviridae, it also reveals the Tal opening mechanism as a hallmark of siphophages probably involved in the generation of the firing signal initiating the cascade of events that lead to phage DNA release in vivo.	[Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] CNRS, UMR 5048, INSERM, UMR 1054,Ctr Biochim Struct, F-34090 Montpellier, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] Univ Montpellier 1, F-34090 Montpellier, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] Univ Montpellier 2, F-34090 Montpellier, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, Ctr Rech Gif, UPR 3296, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, IFR 115, F-91198 Gif Sur Yvette, France; [Shepherd, Dale A.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Leeds	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr; patrick.bron@cbs.cnrs.fr	Veesler, David/HCH-3986-2022	bron, patrick/0000-0002-3354-9513; Tavares, Paulo/0000-0002-2566-4546; Goulet, Adeline/0000-0002-5971-9488; Richard, Eric/0000-0003-0277-4141; Cooper-Shepherd, Dale/0000-0001-9301-1777; LAI KEE HIM, Josephine/0000-0001-6303-1224	ANR, Structural insights on Siphoviridae Bacteriophages infection [BLAN07-1_191968]; Conseil Regional Languedoc-Roussillon; Montpellier I University; INSERM; Biotechnology and Biological Sciences Research Council [BB/E012558/1] Funding Source: researchfish; BBSRC [BB/E012558/1] Funding Source: UKRI	ANR, Structural insights on Siphoviridae Bacteriophages infection(French National Research Agency (ANR)); Conseil Regional Languedoc-Roussillon(Region Occitanie); Montpellier I University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by ANR BLAN07-1_191968 Structural insights on Siphoviridae Bacteriophages infection, Conseil Regional Languedoc-Roussillon, Montpellier I University and INSERM.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Brondsted L, 2001, APPL ENVIRON MICROB, V67, P5626, DOI 10.1128/AEM.67.12.5626-5633.2001; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Casjens S, 1988, CONTROL MECH DSDNA B; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; HARRIS JR, 1994, J STRUCT BIOL, V112, P216, DOI 10.1006/jsbi.1994.1022; JOHNSEN MG, 1995, VIROLOGY, V212, P595, DOI 10.1006/viro.1995.1517; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Molineux IJ, 2006, VIROLOGY, V344, P221, DOI 10.1016/j.virol.2005.09.014; MONTEVILLE MR, 1994, APPL ENVIRON MICROB, V60, P3204, DOI 10.1128/AEM.60.9.3204-3211.1994; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; SANTOS MA, 1984, J GEN VIROL, V65, P2067, DOI 10.1099/0022-1317-65-11-2067; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; VANHEEL M, 1986, OPTIK, V73, P119; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Veesler D, 2010, PROTEIN SCI, V19, P1812, DOI 10.1002/pro.464; Veesler D, 2010, PROTEIN SCI, V19, P1439, DOI 10.1002/pro.416; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	45	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25397	25405		10.1074/jbc.M111.243360	http://dx.doi.org/10.1074/jbc.M111.243360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622577	Green Published, hybrid			2022-12-25	WOS:000292547900085
J	Norholm, MHH; Shulga, YV; Aoki, S; Epand, RM; von Heijne, G				Norholm, Morten H. H.; Shulga, Yulia V.; Aoki, Satoko; Epand, Richard M.; von Heijne, Gunnar			Flanking Residues Help Determine Whether a Hydrophobic Segment Adopts a Monotopic or Bitopic Topology in the Endoplasmic Reticulum Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL-KINASE-EPSILON; TRANSMEMBRANE HELICES; PROTEIN TOPOLOGY; MOLECULAR CODE; CAVEOLIN; INSERTION; RECOGNITION; PROPENSITY; TRANSLOCON; PREDICTION	Proteins interacting with membranes via a single hydrophobic segment can be classified as either monotopic or bitopic. Here, we probe the topology of a membrane-attached enzyme, the epsilon isoform of human diacylglycerol kinase (DGK epsilon), when inserted into rough microsomes and compare it with the monotopic membrane protein mouse caveolin-1. In contrast to previous findings, the N-terminal hydrophobic stretch in DGK epsilon attains a bitopic rather than a monotopic topology in our experimental system. In addition, we find that charged flanking residues as well as proline residues embedded in the hydrophobic segment are important determinants of monotopic versus bitopic topology.	[Norholm, Morten H. H.; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden; [Shulga, Yulia V.; Aoki, Satoko; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	Stockholm University; Stockholm University; McMaster University	von Heijne, G (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011; , Richard/R-2316-2019	von Heijne, Gunnar/0000-0002-4490-8569; , Richard/0000-0002-9602-9558; Norholm, Morten/0000-0002-7871-5191	Human Frontiers Science Program [RGP0039/2007]; European Research Council [ERC-2008-AdG 232648]; Swedish Foundation for Strategic Research; Swedish Cancer Foundation, the Swedish Cancer Foundation; Natural Sciences and Engineering Research Council of Canada [9848]; Lundbeck Foundation	Human Frontiers Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Foundation, the Swedish Cancer Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Human Frontiers Science Program Grant RGP0039/2007, European Research Council Grant ERC-2008-AdG 232648, grants from the Swedish Foundation for Strategic Research and the Swedish Research Council, the Swedish Cancer Foundation (to G. v. H.), and Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R. M. E.).; Supported by a grant from the Lundbeck Foundation.	Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Dicu AO, 2007, BIOCHEMISTRY-US, V46, P6109, DOI 10.1021/bi6024726; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Glukhov E, 2007, BBA-BIOMEMBRANES, V1768, P2549, DOI 10.1016/j.bbamem.2007.06.012; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; Norholm MHH, 2011, J MOL BIOL, V407, P171, DOI 10.1016/j.jmb.2011.01.035; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214	27	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25284	25290		10.1074/jbc.M111.244616	http://dx.doi.org/10.1074/jbc.M111.244616			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606504	Green Published, hybrid			2022-12-25	WOS:000292547900074
J	Flannery, SM; Keating, SE; Szymak, J; Bowie, AG				Flannery, Sinead M.; Keating, Sinead E.; Szymak, Joanna; Bowie, Andrew G.			Human Interleukin-1 Receptor-associated Kinase-2 Is Essential for Toll-like Receptor-mediated Transcriptional and Post-transcriptional Regulation of Tumor Necrosis Factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CHEMOKINE MESSENGER-RNA; BACTERIAL-INFECTIONS; SIGNALING PATHWAYS; INNATE IMMUNITY; RICH ELEMENTS; MICE LACKING; IL-1; STABILIZATION	Toll-like receptors (TLRs) are pattern-recognition receptors that recognize microbial ligands and subsequently trigger intracellular signaling pathways involving transcription factors such as NF kappa B and MAPKs such as p38. TLR signaling can regulate both transcriptional and post-transcriptional events leading to altered gene expression and thus appropriate immune responses. The interleukin-1 receptor-associated kinase (IRAK) family comprises four kinases that regulate TLR signaling. However, the role of IRAK-2 has remained unclear, especially in human cells. Recent studies using cells from in-bred Irak2(-/-) mice showed that murine IRAK-2 was not required for early TLR signaling events but had a role in delayed NF kappa B activation and in cytokine production. IRAK-2 in mice has four splice variants, two of which are inhibitory, whereas human IRAK-2 has no splice variants. Thus IRAK-2 in mice and humans may function differently, and therefore we analyzed the role of IRAK-2 in TLR responses in primary human cells. siRNA knockdown of IRAK-2 expression in human peripheral blood mononuclear cells showed a role for human IRAK-2 in both TLR4- and TLR8-mediated early NF kappa B and p38 MAPK activation and in induction of TNF mRNA. These data conflict with findings from the in-bred Irak2(-/-) mice but concur with what has been seen in wild-derived mice for TLR2. Moreover, human IRAK-2 was required for regulating MyD88-dependent TNF alpha mRNA stability via the TNF 3'UTR. Collectively, these data demonstrate for the first time an essential role for IRAK-2 in primary human cells for both transcriptional and post-transcriptional TLR responses.	[Flannery, Sinead M.; Keating, Sinead E.; Szymak, Joanna; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation of Ireland; Irish Health Research Board	Science Foundation of Ireland(Science Foundation Ireland); Irish Health Research Board	This work was supported by the Science Foundation of Ireland and by the Irish Health Research Board.	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; Datta S, 2004, J IMMUNOL, V173, P2755, DOI 10.4049/jimmunol.173.4.2755; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rosati O, 2002, BIOCHEM BIOPH RES CO, V297, P52, DOI 10.1016/S0006-291X(02)02130-7; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas JA, 1999, J IMMUNOL, V163, P978; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wan YZ, 2011, J IMMUNOL, V186, P3006, DOI 10.4049/jimmunol.1003217; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yin WG, 2011, J INTERF CYTOK RES, V31, P415, DOI 10.1089/jir.2010.0094; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	43	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23688	23697		10.1074/jbc.M111.248351	http://dx.doi.org/10.1074/jbc.M111.248351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606490	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000292294900010
J	Mendez, JA; Bourque, MJ; Fasano, C; Kortleven, C; Trudeau, LE				Mendez, Jose Alfredo; Bourque, Marie-Josee; Fasano, Caroline; Kortleven, Christian; Trudeau, Louis-Eric			Somatodendritic Dopamine Release Requires Synaptotagmin 4 and 7 and the Participation of Voltage-gated Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA NEURONS; OPERATED CA2+ CHANNELS; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; PARS COMPACTA; PC12 CELLS; RAT; VII	Somatodendritic (STD) dopamine (DA) release is a key mechanism for the autoregulatory control of DA release in the brain. However, its molecular mechanism remains undetermined. We tested the hypothesis that differential expression of synaptotagmin (Syt) isoforms explains some of the differential properties of terminal and STD DA release. Down-regulation of the dendritically expressed Syt4 and Syt7 severely reduced STD DA release, whereas terminal release required Syt1. Moreover, we found that although mobilization of intracellular Ca2+ stores is inefficient, Ca2+ influx through N- and P/Q-type voltage-gated channels is critical to trigger STD DA release. Our findings provide an explanation for the differential Ca2+ requirement of terminal and STD DA release. In addition, we propose that not all sources of intracellular Ca2+ are equally efficient to trigger this release mechanism. Our findings have implications for a better understanding of a fundamental cell biological process mediating transcellular signaling in a system critical for diseases such as Parkinson disease.	[Mendez, Jose Alfredo; Bourque, Marie-Josee; Fasano, Caroline; Kortleven, Christian; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Mendez, J Alfredo/E-2031-2015; Tuluc, Petronel/C-2527-2011; Trudeau, Louis-Eric/AAE-4782-2020	Mendez, J Alfredo/0000-0002-2859-7086; Trudeau, Louis-Eric/0000-0003-4684-1377	Canadian Institutes of Health Research; National Alliance for Research on Schizophrenia and Depression; Neuroscience Canada; Fonds de la Recherche en Sante du Quebec; Groupe de Recherche sur le Systeme Nerveux Central; FRSQ (Quebec)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Neuroscience Canada; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Groupe de Recherche sur le Systeme Nerveux Central; FRSQ (Quebec)(Fonds de la Recherche en Sante du Quebec)	This work was funded by grants from the Canadian Institutes of Health Research, National Alliance for Research on Schizophrenia and Depression, and Neuroscience Canada (to L.-E. T.) and by a Fonds de la Recherche en Sante du Quebec infrastructure grant to the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by a postdoctoral fellowship from the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by a senior investigator grant from the FRSQ (Quebec). To whom correspondence should be addressed: Faculty of Medicine, Universite de Montreal. C. P. 6128, Succursale Centre-Ville, Montreal, Quebec H3C 3J7, Canada. Tel.: 514-343-5692; Fax: 514-343-2291; E-mail: louis-eric.trudeau@umontreal.ca.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Arthur CP, 2010, NEUROSCIENCE, V167, P135, DOI 10.1016/j.neuroscience.2010.01.056; Barber CF, 2009, J CELL BIOL, V187, P295, DOI 10.1083/jcb.200903098; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bergquist F, 2003, NEUROSCIENCE, V120, P757, DOI 10.1016/S0306-4522(03)00385-3; Bergquist F, 1998, J NEUROCHEM, V70, P1532; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Bjijou Y, 1996, J PHARMACOL EXP THER, V277, P1177; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Bustos G, 2004, BRAIN RES REV, V47, P126, DOI 10.1016/j.brainresrev.2004.05.002; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chen BT, 2006, J NEUROCHEM, V96, P645, DOI 10.1111/j.1471-4159.2005.03519.x; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Deng CY, 2009, NEUROPSYCHOPHARMACOL, V34, P1233, DOI 10.1038/npp.2008.143; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; Elverfors A, 1997, SYNAPSE, V26, P359, DOI 10.1002/(SICI)1098-2396(199708)26:4<359::AID-SYN4>3.0.CO;2-5; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FASANO C, 2008, CURR PROTOC NEUROSCI, V44, P1; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Fortin GD, 2006, J NEUROCHEM, V96, P1740, DOI 10.1111/j.1471-4159.2006.03699.x; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Glavan G, 2005, NEUROSCIENCE, V135, P545, DOI 10.1016/j.neuroscience.2005.05.050; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; HEERINGA MJ, 1995, J NEUROCHEM, V65, P192; Hu ZT, 2008, BIOCHEM BIOPH RES CO, V371, P781, DOI 10.1016/j.bbrc.2008.04.174; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Johnson SL, 2010, NAT NEUROSCI, V13, P45, DOI 10.1038/nn.2456; Kim Y, 2008, BIOCHEM BIOPH RES CO, V373, P665, DOI 10.1016/j.bbrc.2008.06.099; Kim Y, 2009, NEUROSCI LETT, V465, P31, DOI 10.1016/j.neulet.2009.08.066; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lindgren N, 2001, EUR J NEUROSCI, V13, P773, DOI 10.1046/j.0953-816x.2000.01443.x; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Patel JC, 2009, J NEUROSCI, V29, P6568, DOI 10.1523/JNEUROSCI.0181-09.2009; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; RICE ME, 1994, EXP BRAIN RES, V100, P395, DOI 10.1007/BF02738400; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Thuret S, 2004, MOL CELL NEUROSCI, V25, P394, DOI 10.1016/j.mcn.2003.11.004; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; Tobin VA, 2004, EUR J NEUROSCI, V19, P2909, DOI 10.1111/j.1460-9568.2004.03388.x; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vezina P, 1996, J NEUROSCI, V16, P2411; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhou FW, 2009, J NEUROSCI, V29, P10424, DOI 10.1523/JNEUROSCI.4402-08.2009	61	42	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23928	23937		10.1074/jbc.M111.218032	http://dx.doi.org/10.1074/jbc.M111.218032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576241	Green Published, hybrid			2022-12-25	WOS:000292294900035
J	Yang, W; Manna, PT; Zou, JE; Luo, JH; Beech, DJ; Sivaprasadarao, A; Jiang, LH				Yang, Wei; Manna, Paul T.; Zou, Jie; Luo, Jianhong; Beech, David J.; Sivaprasadarao, Asipu; Jiang, Lin-Hua			Zinc Inactivates Melastatin Transient Receptor Potential 2 Channels via the Outer Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; TRPM2 CHANNEL; FUNCTIONAL INHIBITION; SUBUNIT INTERACTION; SECRETORY GRANULES; HYDROGEN-PEROXIDE; P2X(7) RECEPTORS; K+ CHANNEL; ADP-RIBOSE; ZN2+	Zinc ion (Zn2+) is an endogenous allosteric modulator that regulates the activity of a wide variety of ion channels in a reversible and concentration-dependent fashion. Here we used patch clamp recording to study the effects of Zn2+ on the melastatin transient receptor potential 2 (TRPM2) channel. Zn2+ inhibited the human (h) TRPM2 channel currents, and the steady-state inhibition was largely not reversed upon washout and concentration-independent in the range of 30-1000 mu M, suggesting that Zn2+ induces channel inactivation. Zn2+ inactivated the channels fully when they conducted inward currents, but only by half when they passed outward currents, indicating profound influence of the permeant ion on Zn2+ inactivation. Alanine substitution scanning mutagenesis of 20 Zn2+-interacting candidate residues in the outer pore region of the hTRPM2 channel showed that mutation of Lys(952) in the extracellular end of the fifth transmembrane segment and Asp(1002) in the large turret strongly attenuated or abolished Zn2+ inactivation, and mutation of several other residues dramatically changed the inactivation kinetics. The mouse (m) TRPM2 channels were also inactivated by Zn2+, but the kinetics were remarkably slower. Reciprocal mutation of His(995) in the hTRPM2 channel and the equivalent Gln(992) in the mTRPM2 channel completely swapped the kinetics, but no such opposing effects resulted from exchanging another pair of species-specific residues, Arg(961)/Ser(958). We conclude from these results that Zn2+ inactivates the TRPM2 channels and that residues in the outer pore are critical determinants of the inactivation.	[Yang, Wei; Manna, Paul T.; Zou, Jie; Beech, David J.; Sivaprasadarao, Asipu; Jiang, Lin-Hua] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Yang, Wei; Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	University of Leeds; Zhejiang University	Jiang, LH (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Jiang, Lin-Hua/AAU-1078-2020; Luo, jian/HGE-7331-2022; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Beech, David/0000-0002-7683-9422; Sivaprasadarao, Asipu/0000-0002-6755-3502; Manna, Paul Thomas/0000-0002-2260-2075	Royal Society; University of Leeds-Chinese Scholarship Council; Alzheimer Research Trust; Alzheimers Research UK [ART-PPG2009A-2] Funding Source: researchfish	Royal Society(Royal Society of London); University of Leeds-Chinese Scholarship Council; Alzheimer Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by a Royal Society Incoming Fellowship (to W. Y.), a University of Leeds-Chinese Scholarship Council Research Scholarship (to J. Z.), and an Alzheimer Research Trust grant (to L.-H. J.).	Amuzescu B, 2003, PFLUG ARCH EUR J PHY, V446, P69, DOI 10.1007/s00424-002-0998-3; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bloc A, 2000, J PHYSIOL-LONDON, V529, P723, DOI 10.1111/j.1469-7793.2000.00723.x; Bradley HJ, 2011, J BIOL CHEM, V286, P8176, DOI 10.1074/jbc.M110.211284; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; FERNANDES G, 1979, P NATL ACAD SCI USA, V76, P457, DOI 10.1073/pnas.76.1.457; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; FRAKER PJ, 1986, FASEB J, V45, P1474; FREDERICKSON CJ, 1983, BRAIN RES, V273, P335, DOI 10.1016/0006-8993(83)90858-2; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gruss M, 2004, MOL PHARMACOL, V66, P530; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARRISON NL, 1994, NEUROPHARMACOLOGY, V33, P935, DOI 10.1016/0028-3908(94)90152-X; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Hou SW, 2010, J BIOL CHEM, V285, P6434, DOI 10.1074/jbc.M109.069211; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; Hubbard PC, 2000, EUR J PHARMACOL, V394, P189, DOI 10.1016/S0014-2999(00)00143-6; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Jia YS, 2002, J PHYSIOL-LONDON, V543, P35, DOI 10.1113/jphysiol.2002.020172; Jiang LH, 2007, BIOCHEM SOC T, V35, P86, DOI 10.1042/BST0350086; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Kerchner GA, 2000, J PHYSIOL-LONDON, V528, P39, DOI 10.1111/j.1469-7793.2000.00039.x; Kim JS, 2005, J PHARMACOL EXP THER, V314, P618, DOI 10.1124/jpet.105.084418; Klionsky L, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-39; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kuo CC, 2004, J GEN PHYSIOL, V124, P27, DOI 10.1085/jgp.200409054; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Noh J, 2010, NEUROSCI RES, V66, P353, DOI 10.1016/j.neures.2009.12.005; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Paoletti P, 1997, J NEUROSCI, V17, P5711; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ragozzino D, 2000, J PHYSIOL-LONDON, V529, P83, DOI 10.1111/j.1469-7793.2000.00083.x; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; Spelta V, 2003, BRIT J PHARMACOL, V138, P131, DOI 10.1038/sj.bjp.0705018; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Teisseyre A, 2002, BIOCHEM PHARMACOL, V64, P595, DOI 10.1016/S0006-2952(02)01227-3; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; WANG TL, 1995, J NEUROSCI, V15, P7684; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WHITE JA, 1993, NEURON, V11, P1037, DOI 10.1016/0896-6273(93)90217-F; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zhang ST, 2001, J PHYSIOL-LONDON, V532, P349, DOI 10.1111/j.1469-7793.2001.0349f.x; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005; ZOU J, 2011, PFLUGERS AR IN PRESS	82	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23789	23798		10.1074/jbc.M111.247478	http://dx.doi.org/10.1074/jbc.M111.247478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602277	hybrid, Green Published			2022-12-25	WOS:000292294900021
J	Re, VE; Culasso, ACA; Mengarelli, S; Farias, AA; Fay, F; Pisano, MB; Elbarcha, O; Contigiani, MS; Campos, RH				Re, Viviana E.; Culasso, Andres C. A.; Mengarelli, Silvia; Farias, Adrian A.; Fay, Fabian; Pisano, Maria B.; Elbarcha, Osvaldo; Contigiani, Marta S.; Campos, Rodolfo H.			Phylodynamics of Hepatitis C Virus Subtype 2c in the Province of Cordoba, Argentina	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH PREVALENCE; GENOTYPE 1B; INFECTION	The Hepatitis C Virus Genotype 2 subtype 2c (HCV-2c) is detected as a low prevalence subtype in many countries, except in Southern Europe and Western Africa. The current epidemiology of HCV in Argentina, a low-prevalence country, shows the expected low prevalence for this subtype. However, this subtype is the most prevalent in the central province of Cordoba. Cruz del Eje (CdE), a small rural city of this province, shows a prevalence for HCV infections of 5%, being 90% of the samples classified as HCV-2c. In other locations of Cordoba Province (OLC) with lower prevalence for HCV, HCV-2c was recorded in about 50% of the samples. The phylogenetic analysis of samples from Cordoba Province consistently conformed a monophyletic group with HCV-2c sequences from all the countries where HCV-2c has been sequenced. The phylogeographic analysis showed an overall association between geographical traits and phylogeny, being these associations significant (alpha = 0.05) for Italy, France, Argentina (places other than Cordoba), Martinique, CdE and OLC. The coalescence analysis for samples from CdE, OLC and France yielded a Time for the Most Common Recent Ancestor of about 140 years, whereas its demographic reconstruction showed a "lag" phase in the viral population until 1880 and then an exponential growth until 1940. These results were also obtained when each geographical area was analyzed separately, suggesting that HCV-2c came into Cordoba province during the migration process, mainly from Europe, which is compatible with the history of Argentina of the early 20th century. This also suggests that the spread of HCV-2c occurred in Europe and South America almost simultaneously, possibly as a result of the advances in medicine technology of the first half of the 20th century.	[Re, Viviana E.; Farias, Adrian A.; Pisano, Maria B.; Contigiani, Marta S.] Univ Cordoba, Inst Virol, Fac Ciencias Med, Cordoba, Argentina; [Re, Viviana E.; Elbarcha, Osvaldo] Univ Catolica Cordoba, Fac Ciencias Quim, Catedra Virol, Cordoba, Argentina; [Culasso, Andres C. A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Mengarelli, Silvia] Hosp San Roque, Serv Gastroenterol, Cordoba, Argentina; [Fay, Fabian] Ctr Diag Mol, Lab CIBIC, Rosario, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba; Catholic University of Cordoba; University of Buenos Aires	Re, VE (corresponding author), Univ Cordoba, Inst Virol, Fac Ciencias Med, Cordoba, Argentina.	rcampos@ffyb.uba.ar			Secyt-Universidad Nacional de Cordoba [Secyt UNC- 69/08]; Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT) [PICT2008, 1229]; Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba [MINCyT-Cba 86/09]; SIP-Universidad Catolica de Cordoba; Universidad de Buenos Aires [SECyT-UBA2008 B037]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112-200801-01169]; CONICET; CONICET, Argentina; Fundacion Roemmers	Secyt-Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); SIP-Universidad Catolica de Cordoba; Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Roemmers	This project was supported by grants from: Fundacion Roemmers, Secyt-Universidad Nacional de Cordoba (Secyt UNC- 69/08), Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT; PICT2008, 1229), Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba (MINCyT-Cba 86/09), SIP-Universidad Catolica de Cordoba, Universidad de Buenos Aires (SECyT-UBA2008 B037) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP 112-200801-01169). M. B. P. and A. C. A. C. are recipients of CONICET doctoral fellowships. V. E. R. and R. C. are members of the researcher career from CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dal Molin G, 2002, J MED VIROL, V68, P352, DOI 10.1002/jmv.10210; Di Lello F, 2008, J MED VIROL, V80, P619, DOI 10.1002/jmv.21112; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Golemba MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008751; Goloboff P, 2008, CLADISTICS, V24, P91; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Mengarelli S, 2006, ACTA GASTROENTEROL L, V36, pS68; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Nakao H, 1996, ARCH VIROL, V141, P701, DOI 10.1007/BF01718327; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Quarleri JF, 2000, J CLIN MICROBIOL, V38, P4560, DOI 10.1128/JCM.38.12.4560-4568.2000; Re V, 2003, MEDICINA-BUENOS AIRE, V63, P205; Re V, 2007, MEM I OSWALDO CRUZ, V102, P995, DOI 10.1590/S0074-02762007000800016; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19471	10.1371/journal.pone.0019471	http://dx.doi.org/10.1371/journal.pone.0019471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611129	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200007
J	Serbecic, N; Aboul-Enein, F; Beutelspacher, SC; Vass, C; Kristoferitsch, W; Lassmann, H; Reitner, A; Schmidt-Erfurth, U				Serbecic, Nermin; Aboul-Enein, Fahmy; Beutelspacher, Sven C.; Vass, Clemens; Kristoferitsch, Wolfgang; Lassmann, Hans; Reitner, Andreas; Schmidt-Erfurth, Ursula			High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years	PLOS ONE			English	Article							NERVE-FIBER LAYER; NEUROMYELITIS-OPTICA; DISABILITY; THICKNESS; LESIONS; INFLAMMATION; PROGRESSION; DISEASE; ATROPHY; WINDOW	Background: "Non-invasive, faster and less expensive than MRI'' and "the eye is a window to the brain'' are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation. Methodology: We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4 +/- 0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded. Principal Findings: Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected. Conclusions: These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS.	[Serbecic, Nermin; Vass, Clemens; Reitner, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Beutelspacher, Sven C.] Univ Heidelberg, Dept Ophthalmol, Fac Med Mannheim, D-6800 Mannheim, Germany; [Lassmann, Hans] Med Univ Vienna, Brain Res Ctr, Vienna, Austria	Medical University of Vienna; Donauspital; Ruprecht Karls University Heidelberg; Medical University of Vienna	Serbecic, N (corresponding author), Med Univ Vienna, Dept Ophthalmol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Lassmann, Hans/Z-2269-2019; Vass, Clemens/AAZ-2564-2020	Lassmann, Hans/0000-0001-8617-5052; Vass, Clemens/0000-0003-4756-9088; Schmidt-Erfurth, Ursula/0000-0002-7788-7311	Medical Research Society Vienna, DC	Medical Research Society Vienna, DC	This study was funded by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Ban M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002891; Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Feigin V, 2009, NEUROEPIDEMIOLOGY, V33, P296, DOI 10.1159/000252942; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Ge YL, 2000, RADIOLOGY, V214, P665, DOI 10.1148/radiology.214.3.r00mr30665; Gilmore CP, 2010, MULT SCLER J, V16, P756, DOI 10.1177/1352458510366014; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Haarmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013568; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Henderson APD, 2010, J NEUROL, V257, P1083, DOI 10.1007/s00415-010-5467-x; Khanifar AA, 2010, CLIN OPHTHALMOL, V4, P1007, DOI 10.2147/OPTH.S13278; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Mostert JP, 2010, EUR J NEUROL, V17, P1471, DOI 10.1111/j.1468-1331.2010.03093.x; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Serbecic N, 2011, BRIT J OPHTHALMOL, V95, P804, DOI 10.1136/bjo.2010.186221; Serbecic N, 2012, ACTA OPHTHALMOL, V90, P540, DOI 10.1111/j.1755-3768.2010.02013.x; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970	35	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19843	10.1371/journal.pone.0019843	http://dx.doi.org/10.1371/journal.pone.0019843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611198	Green Submitted, Green Published, gold			2022-12-25	WOS:000290657500029
J	Vuataz, L; Sartori, M; Wagner, A; Monaghan, MT				Vuataz, Laurent; Sartori, Michel; Wagner, Andre; Monaghan, Michael T.			Toward a DNA Taxonomy of Alpine Rhithrogena (Ephemeroptera: Heptageniidae) Using a Mixed Yule-Coalescent Analysis of Mitochondrial and Nuclear DNA	PLOS ONE			English	Article							PARTITIONED BAYESIAN ANALYSES; SPECIES DELIMITATION; DIVERSITY; SYSTEMATICS; DISPERSAL; PHYLOGENY; ALIGNMENT; MAYFLIES; BARCODES; EXAMPLE	Aquatic larvae of many Rhithrogena mayflies (Ephemeroptera) inhabit sensitive Alpine environments. A number of species are on the IUCN Red List and many recognized species have restricted distributions and are of conservation interest. Despite their ecological and conservation importance, ambiguous morphological differences among closely related species suggest that the current taxonomy may not accurately reflect the evolutionary diversity of the group. Here we examined the species status of nearly 50% of European Rhithrogena diversity using a widespread sampling scheme of Alpine species that included 22 type localities, general mixed Yule-coalescent (GMYC) model analysis of one standard mtDNA marker and one newly developed nDNA marker, and morphological identification where possible. Using sequences from 533 individuals from 144 sampling localities, we observed significant clustering of the mitochondrial (cox1) marker into 31 GMYC species. Twenty-one of these could be identified based on the presence of topotypes (expertly identified specimens from the species' type locality) or unambiguous morphology. These results strongly suggest the presence of both cryptic diversity and taxonomic oversplitting in Rhithrogena. Significant clustering was not detected with protein-coding nuclear PEPCK, although nine GMYC species were congruent with well supported terminal clusters of nDNA. Lack of greater congruence in the two data sets may be the result of incomplete sorting of ancestral polymorphism. Bayesian phylogenetic analyses of both gene regions recovered four of the six recognized Rhithrogena species groups in our samples as monophyletic. Future development of more nuclear markers would facilitate multi-locus analysis of unresolved, closely related species pairs. The DNA taxonomy developed here lays the groundwork for a future revision of the important but cryptic Rhithrogena genus in Europe.	[Vuataz, Laurent; Sartori, Michel; Wagner, Andre] Musee Cantonal Zool, Lausanne, Switzerland; [Vuataz, Laurent] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Monaghan, Michael T.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	University of Lausanne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Vuataz, L (corresponding author), Musee Cantonal Zool, Lausanne, Switzerland.	laurent.vuataz@vd.ch	Vuataz, Laurent/AAD-7486-2022; Monaghan, Michael T/A-2589-2009; Sartori, Michel/AAT-9599-2020	Monaghan, Michael T/0000-0001-6200-2376; Sartori, Michel/0000-0003-3397-3397	Swiss National Science Foundation (FNS) [31003A-116049]; European Union	Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF)); European Union(European Commission)	Research was funded by the Swiss National Science Foundation (FNS nr. 31003A-116049; www.snf.ch) and by the European Union FP7 Project BioFresh (freshwaterbiodiversity.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson S, 2010, EVOLUTION, V64, P986, DOI 10.1111/j.1558-5646.2009.00872.x; Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Belfiore C., 1992, FRAGMENTA ENTOMOLOGI, V23, P235; Bode SNS, 2010, MOL PHYLOGENET EVOL, V54, P542, DOI 10.1016/j.ympev.2009.08.022; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brittain JE., 2008, INT ADV ECOLOGY ZOOG, P1, DOI DOI 10.1525/CALIFORNIA/9780520098688.003.0001; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Espeland M, 2010, J EVOLUTION BIOL, V23, P2112, DOI 10.1111/j.1420-9101.2010.02072.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Friedlander TP, 1996, MOL BIOL EVOL, V13, P594, DOI 10.1093/oxfordjournals.molbev.a025619; Gattolliat JL, 2010, J N AM BENTHOL SOC, V29, P1042, DOI 10.1899/09-119.1; Hauer FR, 1997, HYDROL PROCESS, V11, P903; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacob U., 1974, ENTOMOLOGISCHE NACHR, V11, P167; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Jousselin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-295; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Knispel S, 2006, J N AM BENTHOL SOC, V25, P430, DOI 10.1899/0887-3593(2006)25[430:EDITMO]2.0.CO;2; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; MALZACHER P, 1998, ROTE LISTE GEFAHRDET, P264; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nekola JC, 2009, MOL PHYLOGENET EVOL, V53, P1010, DOI 10.1016/j.ympev.2009.09.012; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pinzon-Navarro S, 2010, MOL PHYLOGENET EVOL, V56, P281, DOI 10.1016/j.ympev.2010.02.022; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, COLLAPSE DESCRIBING; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Renoult JP, 2009, MOL ECOL, V18, P4298, DOI 10.1111/j.1365-294X.2009.04351.x; Robinson CT, 2010, HANDB ENVIRON CHEM, V6, P193, DOI 10.1007/978-3-540-88275-6_10; SARTORI M, 1988, Annales de Limnologie, V24, P261; SARTORI M, 1994, LISTE ROUGE ESPECES, P72; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Soldan Tomas, 1999, Klapalekiana, V35, P25; Sowa R., 1984, P 4 INT C EPH BECH C, P37; STUDEMANN D, 1992, EPHEMEROPTERA; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomka I., 1993, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V66, P255; Weichselbaumer Peter, 1995, Limnologica, V25, P157; Wiens JJ, 2008, BIOSCIENCE, V58, P297, DOI 10.1641/B580405; Yassin A, 2009, MOL PHYLOGENET EVOL, V53, P404, DOI 10.1016/j.ympev.2009.06.012; ZURWERRA A, 1987, ARCH HYDROBIOL, V109, P481	66	77	81	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19728	10.1371/journal.pone.0019728	http://dx.doi.org/10.1371/journal.pone.0019728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611178	gold, Green Published			2022-12-25	WOS:000290657500017
J	Ramsay, SE; Whincup, PH; Hardoon, SL; Lennon, LT; Morris, RW; Wannamethee, SG				Ramsay, Sheena E.; Whincup, Peter H.; Hardoon, Sarah L.; Lennon, Lucy T.; Morris, Richard W.; Wannamethee, S. G.			Social Class Differences in Secular Trends in Established Coronary Risk Factors over 20 Years: A Cohort Study of British Men from 1978-80 to 1998-2000	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEALTH INEQUALITIES; EUROPEAN COUNTRIES; BLOOD-PRESSURE; HEART-DISEASE; POPULATION; CHOLESTEROL; MORTALITY; SMOKING	Background: Coronary heart disease (CHD) mortality in the UK since the late 1970s has declined more markedly among higher socioeconomic groups. However, little is known about changes in coronary risk factors in different socioeconomic groups. This study examined whether changes in established coronary risk factors in Britain over 20 years between 1978-80 and 1998-2000 differed between socioeconomic groups. Methods and Findings: A socioeconomically representative cohort of 7735 British men aged 40-59 years was followed-up from 1978-80 to 1998-2000; data on blood pressure (BP), cholesterol, body mass index (BMI) and cigarette smoking were collected at both points in 4252 survivors. Social class was based on longest-held occupation in middle-age. Compared with men in non-manual occupations, men in manual occupations experienced a greater increase in BMI (mean difference=0.33 kg/m(2); 95%CI 0.14-0.53; p for interaction=0.001), a smaller decline in non-HDL cholesterol (difference in mean change=0.18 mmol/l; 95%CI 0.11-0.25, p for interaction <= 0.0001) and a smaller increase in HDL cholesterol (difference in mean change=0.04 mmol/l; 95%CI 0.02-0.06, p for interaction <= 0.0001). However, mean systolic BP declined more in manual than non-manual groups (difference in mean change=3.6; 95%CI 2.1-5.1, p for interaction <= 0.0001). The odds of being a current smoker in 1978-80 and 1998-2000 did not differ between non-manual and manual social classes (p for interaction = 0.51). Conclusion: Several key risk factors for CHD and type 2 diabetes showed less favourable changes in men in manual occupations. Continuing priority is needed to improve adverse cardiovascular risk profiles in socially disadvantaged groups in the UK.	[Ramsay, Sheena E.; Hardoon, Sarah L.; Lennon, Lucy T.; Morris, Richard W.; Wannamethee, S. G.] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter H.] St Georges Univ London, Div Community Hlth Sci, London, England	University of London; University College London; St Georges University London	Ramsay, SE (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	s.ramsay@ucl.ac.uk	Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Morris, Richard/0000-0001-7240-4563; Whincup, Peter/0000-0002-5589-4107; Wannamethee, Sasiwarang/0000-0001-9484-9977; Ramsay, Sheena/0000-0002-0391-9704	British Heart Foundation; MRC [G0701739, G0501859] Funding Source: UKRI; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [G0701739, G0501859] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Allender S., 2008, CORONARY HEART DIS S; Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; BRUCE NG, 1990, J HYPERTENS        S, V4, pS11; *DEP HLTH, 2005, TACKL HLTH IN STAT R; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P922, DOI 10.1136/jech.56.12.922; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hardoon SL, 2010, EUR J CARDIOV PREV R, V17, P502, DOI 10.1097/HJR.0b013e3283378865; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Lampe FC, 2005, BMJ-BRIT MED J, V330, P1046, DOI 10.1136/bmj.330.7499.1046; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Peltonen M, 1998, J INTERN MED, V244, P1, DOI 10.1046/j.1365-2796.1998.00289.x; Ramsay SE, 2008, J EPIDEMIOL COMMUN H, V62, P75, DOI 10.1136/jech.2006.053207; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; THELLE DS, 1983, BRIT HEART J, V49, P205, DOI 10.1136/hrt.49.3.205; Thomas MC, 2002, J PUBLIC HEALTH MED, V24, P285, DOI 10.1093/pubmed/24.4.285; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295; WHINCUP PH, 1992, J EPIDEMIOL COMMUN H, V46, P164, DOI 10.1136/jech.46.2.164	28	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19742	10.1371/journal.pone.0019742	http://dx.doi.org/10.1371/journal.pone.0019742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21603647	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000290558500028
J	Liou, JW; Gu, MH; Chen, YK; Chen, WY; Chen, YC; Tseng, YH; Hung, YJ; Chang, HH				Liou, Je-Wen; Gu, Ming-Hui; Chen, Yen-Kai; Chen, Wen-Yi; Chen, Yi-Cheng; Tseng, Yao-Hsuan; Hung, Yu-Jiun; Chang, Hsin-Hou			Visible Light Responsive Photocatalyst Induces Progressive and Apical-Terminus Preferential Damages on Escherichia coli Surfaces	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BACTERICIDAL ACTIVITY; STATIONARY-PHASE; MEMBRANE; DOMAINS; VISUALIZATION; LOCALIZATION; SULBACTAM; WATER; TIO2	Background: Recent research shows that visible-light responsive photocatalysts have potential usage in antimicrobial applications. However, the dynamic changes in the damage to photocatalyzed bacteria remain unclear. Methodology/Principal Findings: Facilitated by atomic force microscopy, this study analyzes the visible-light driven photocatalyst-mediated damage of Escherichia coli. Results show that antibacterial properties are associated with the appearance of hole-like structures on the bacteria surfaces. Unexpectedly, these hole-like structures were preferentially induced at the apical terminus of rod shaped E. coli cells. Differentiating the damages into various levels and analyzing the percentage of damage to the cells showed that photocatalysis was likely to elicit sequential damages in E. coli cells. The process began with changing the surface properties on bacterial cells, as indicated in surface roughness measurements using atomic force microscopy, and holes then formed at the apical terminus of the cells. The holes were then subsequently enlarged until the cells were totally transformed into a flattened shape. Parallel experiments indicated that photocatalysis-induced bacterial protein leakage is associated with the progression of hole-like damages, further suggesting pore formation. Control experiments using ultraviolet light responsive titanium-dioxide substrates also obtained similar observations, suggesting that this is a general phenomenon of E. coli in response to photocatalysis. Conclusion/Significance: The photocatalysis-mediated localization-preferential damage to E. coli cells reveals the weak points of the bacteria. This might facilitate the investigation of antibacterial mechanism of the photocatalysis.	[Liou, Je-Wen; Chen, Yen-Kai; Chen, Wen-Yi] Tzu Chi Univ, Dept Biochem, Hualien, Taiwan; [Liou, Je-Wen; Chen, Yi-Cheng; Hung, Yu-Jiun; Chang, Hsin-Hou] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liou, Je-Wen; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Gu, Ming-Hui; Chen, Yi-Cheng] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Tseng, Yao-Hsuan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Dong Hwa University; Tzu Chi University; National Taiwan University of Science & Technology; Tzu Chi University	Liou, JW (corresponding author), Tzu Chi Univ, Dept Biochem, Hualien, Taiwan.	hhchang@mail.tcu.edu.tw	Liou, Je-Wen/ABB-2157-2020; Chang, Hsin-Hou/B-6225-2012	Liou, Je-Wen/0000-0002-6181-7263; Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [94-2120-M-259-003, 95-2314-B-320-009-MY3, 95-2120-M-259-003]; Ministry of Economic Affairs, Taiwan, ROC [98-EC-17-A-19-S2-0111]; Tzu-Chi University [TCIRP 95002-02, TCIRP 96004-01, TCIRP 98001-01, TCRPP 99020-01]; Tzu-Chi University Center for Biomedical Nanotechnology	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan, ROC(Ministry of Economic Affairs, Taiwan); Tzu-Chi University; Tzu-Chi University Center for Biomedical Nanotechnology	This work was supported by National Science Council of Taiwan ROC under grant no. 94-2120-M-259-003, 95-2314-B-320-009-MY3 and 95-2120-M-259-003, and Ministry of Economic Affairs, Taiwan, ROC under grant no. 98-EC-17-A-19-S2-0111, and Tzu-Chi University under grant no. TCIRP 95002-02, TCIRP 9600401, TCIRP 98001-01 and TCRPP 99020-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the support from Tzu-Chi University Center for Biomedical Nanotechnology.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Bantar C, 2008, DIAGN MICR INFEC DIS, V61, P309, DOI 10.1016/j.diagmicrobio.2008.02.014; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braga PC, 1998, ANTIMICROB AGENTS CH, V42, P18, DOI 10.1128/AAC.42.1.18; Buynak JD, 2007, ACS CHEM BIOL, V2, P602, DOI 10.1021/cb700182u; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Chou PW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357879; Christensen H, 1999, MOL MICROBIOL, V31, P1561, DOI 10.1046/j.1365-2958.1999.01304.x; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; DIEDRICH DL, 1974, J BACTERIOL, V119, P1006, DOI 10.1128/JB.119.3.1006-1018.1974; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; Kau JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014289; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; LEGRINI O, 1993, CHEM REV, V93, P671, DOI 10.1021/cr00018a003; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Liou JW, 2002, BIOCHEMISTRY-US, V41, P8535, DOI 10.1021/bi025962s; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2007, MOL MICROBIOL, V64, P1419, DOI 10.1111/j.1365-2958.2007.05766.x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Rasmussen JP, 2008, ENVIRON TOXICOL, V23, P36, DOI 10.1002/tox.20311; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scheuring S, 2010, MOL MICROBIOL, V75, P1327, DOI 10.1111/j.1365-2958.2010.07064.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Treschev SY, 2008, APPL CATAL B-ENVIRON, V79, P8, DOI 10.1016/j.apcatb.2007.09.046; Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476; Tseng YH, 2006, NANOTECHNOLOGY, V17, P2490, DOI 10.1088/0957-4484/17/10/009; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; Wu PG, 2010, BIOMATERIALS, V31, P7526, DOI 10.1016/j.biomaterials.2010.06.032; Yang L, 2006, ANAL CHEM, V78, P7341, DOI 10.1021/ac0604890; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x	41	29	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19982	10.1371/journal.pone.0019982	http://dx.doi.org/10.1371/journal.pone.0019982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589873	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100036
J	Belenky, P; Stebbins, R; Bogan, KL; Evans, CR; Brenner, C				Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Evans, Charles R.; Brenner, Charles			Nrt1 and Tna1-Independent Export of NAD(+) Precursor Vitamins Promotes NAD(+) Homeostasis and Allows Engineering of Vitamin Production	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; DIPHOSPHOPYRIDINE NUCLEOTIDE; MULTIDRUG TRANSPORTER; GENE; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	NAD(+) is both a co-enzyme for hydride transfer enzymes and a substrate of sirtuins and other NAD(+) consuming enzymes. NAD(+) biosynthesis is required for two different regimens that extend lifespan in yeast. NAD(+) is synthesized from tryptophan and the three vitamin precursors of NAD(+): nicotinic acid, nicotinamide and nicotinamide riboside. Supplementation of yeast cells with NAD(+) precursors increases intracellular NAD(+) levels and extends replicative lifespan. Here we show that both nicotinamide riboside and nicotinic acid are not only vitamins but are also exported metabolites. We found that the deletion of the nicotinamide riboside transporter, Nrt1, leads to increased export of nicotinamide riboside. This discovery was exploited to engineer a strain to produce high levels of extracellular nicotinamide riboside, which was recovered in purified form. We further demonstrate that extracellular nicotinamide is readily converted to extracellular nicotinic acid in a manner that requires intracellular nicotinamidase activity. Like nicotinamide riboside, export of nicotinic acid is elevated by the deletion of the nicotinic acid transporter, Tna1. The data indicate that NAD(+) metabolism has a critical extracellular element in the yeast system and suggest that cells regulate intracellular NAD(+) metabolism by balancing import and export of NAD(+) precursor vitamins.	[Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Dept Biochem, Lebanon, NH USA; [Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Evans, Charles R.] Univ Michigan, Nutr & Obes Res Ctr, Ann Arbor, MI 48109 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Iowa; University of Iowa; University of Michigan System; University of Michigan	Belenky, P (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH USA.	charles-brenner@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Evans, Charles/0000-0001-6698-5330; Stebbins, Rebecca/0000-0002-3663-1360; Belenky, Peter/0000-0002-1682-945X	National Science Foundation [MCB-0822581]; National Institutes of Health [DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant MCB-0822581 from the National Science Foundation and by a generous gift from the Roy J. Carver Trust. Metabolomic assays were made possible by utilization of Core Services supported by grant DK089503 from the National Institutes of Health awarded to Charles K. Burant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brachmann CB, 1998, YEAST, V14, P115; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; FRANCHETTI P, 2004, CHEMINFORM, V35, P4655; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Klebl F, 2000, FEBS LETT, V481, P86, DOI 10.1016/S0014-5793(00)01959-1; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Kolodziejska-Huben M, 2002, J LABELLED COMPD RAD, V45, P1005, DOI 10.1002/jlcr.617; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Vargas RC, 2004, ANTIMICROB AGENTS CH, V48, P2531, DOI 10.1128/AAC.48.7.2531-2537.2004; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c	28	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19710	10.1371/journal.pone.0019710	http://dx.doi.org/10.1371/journal.pone.0019710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589930	Green Published, Green Submitted, gold			2022-12-25	WOS:000290483600026
J	Yang, LF; Zhang, J; Ho, B; Ding, JL				Yang, Lifeng; Zhang, Jing; Ho, Bow; Ding, Jeak Ling			Histidine-Mediated pH-Sensitive Regulation of M-Ficolin:GlcNAc Binding Activity in Innate Immunity Examined by Molecular Dynamics Simulations	PLOS ONE			English	Article							PATTERN-RECOGNITION MOLECULES; C-REACTIVE PROTEIN; LECTIN-COMPLEMENT PATHWAY; CONSTANT-PH; FICOLINS; METHODOLOGY; KYOTORPHIN; BACTERIA; ADHESION; CLONING	Background: M-ficolin, a pathogen recognition molecule in the innate immune system, binds sugar residues including N-acetyl-D-glucosamine (GlcNAc), which is displayed on invading microbes and on apoptotic cells. The cis and trans Asp282-Cys283 peptide bond in the M-ficolin, which was found to occur at neutral and acidic pH in crystal structures, has been suggested to represent binding and non-binding activity, respectively. A detailed understanding of the pH-dependent conformational changes in M-ficolin and pH-mediated discrimination mechanism of GlcNAc-binding activity are crucial to both immune-surveillance and clearance of apoptotic cells. Methodology/Principal Findings: By immunodetection analysis, we found that the pH-sensitive binding of GlcNAc is regulated by a conformational equilibrium between the active and inactive states of M-ficolin. We performed constant pH molecular dynamics (MD) simulation at a series of pH values to explore the pH effect on the cis-trans isomerization of the Asp282-Cys283 peptide bond in the M-ficolin fibrinogen-like domain (FBG). Analysis of the hydrogen bond occupancy of wild type FBG compared with three His mutants (H251A, H284A and H297A) corroborates that His284 is indispensible for pH-dependent binding. H251A formed new but weaker hydrogen bonds with GlcNAc. His297, unlike the other two His mutants, is more dependent on the solution pH and also contributes to cis-trans isomerization of the Asp282-Cys283 peptide bond in weak basic solution. Conclusions/Significance: Constant pH MD simulation indicated that the cis active isomer of Asp282-Cys283 peptide bond was predominant around neutral pH while the trans bond gradually prevailed towards acidic environment. The protonation of His284 was found to be associated with the trans-to-cis isomerization of Asp282-Cys283 peptide bond which dominantly regulates the GlcNAc binding. Our MD simulation approach provides an insight into the pH-sensitive proteins and hence, ligand binding activity.	[Yang, Lifeng; Ding, Jeak Ling] SMA, Singapore, Singapore; [Yang, Lifeng; Zhang, Jing; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Zhang, Jing] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn NGS, Singapore 117548, Singapore; [Ho, Bow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Yang, LF (corresponding author), SMA, Singapore, Singapore.	dbsdjl@nus.edu.sg	Zhang, Jing/E-4844-2013; Ding, Jeak/H-8057-2012	Zhang, Jing/0000-0003-0391-7298; 	Singapore-MIT Alliance; Ministry of Education (MoE) [T208B3109]	Singapore-MIT Alliance; Ministry of Education (MoE)	This work was financed by the Singapore-MIT Alliance (Computational Systems Biology) and the Ministry of Education (MoE, T208B3109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Baptista AM, 2002, J CHEM PHYS, V117, P4184, DOI 10.1063/1.1497164; Baptista AM, 2002, J CHEM PHYS, V116, P7766, DOI 10.1063/1.1465399; Baptista AM, 1997, PROTEINS, V27, P523, DOI 10.1002/(SICI)1097-0134(199704)27:4<523::AID-PROT6>3.0.CO;2-B; Borjesson U, 2001, J CHEM PHYS, V114, P9706, DOI 10.1063/1.1370959; Borjesson U, 2004, J PHYS CHEM B, V108, P13551, DOI 10.1021/jp037841n; Burgi R, 2002, PROTEINS, V47, P469, DOI 10.1002/prot.10046; Campos SRR, 2010, J PHYS CHEM B, V114, P12692, DOI 10.1021/jp104753t; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Chen YZ, 2007, COMPUT PHYS COMMUN, V177, P210, DOI 10.1016/j.cpc.2007.02.095; Dlugosz M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021915; Dlugosz M, 2004, CHEM PHYS, V302, P161, DOI 10.1016/j.chemphys.2004.03.031; Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kyte J., 1995, STRUCTURE PROTEIN CH; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Machuqueiro M, 2006, J PHYS CHEM B, V110, P2927, DOI 10.1021/jp056456q; Machuqueiro M, 2008, PROTEINS, V72, P289, DOI 10.1002/prot.21923; Machuqueiro M, 2007, BIOPHYS J, V92, P1836, DOI 10.1529/biophysj.106.092445; Machuqueiro M, 2010, J PHYS CHEM B, V114, P11659, DOI 10.1021/jp104418g; Machuqueiro M, 2009, J AM CHEM SOC, V131, P12586, DOI 10.1021/ja808463e; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Meng YL, 2010, J CHEM THEORY COMPUT, V6, P1401, DOI 10.1021/ct900676b; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Swails JM, 2009, J PHYS CHEM B, V113, P1192, DOI 10.1021/jp806906x; Tanio M, 2008, J SYNCHROTRON RADIAT, V15, P243, DOI 10.1107/S0909049507054325; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2006, ACTA CRYSTALLOGR F, V62, P652, DOI 10.1107/S1744309106019786; Tanio M, 2009, BIOCHEM J, V417, P485, DOI 10.1042/BJ20081640; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Tjong H, 2008, BIOPHYS J, V95, P2601, DOI 10.1529/biophysj.107.127746; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Woods G, 2005, GLYCAM WEB; Zhang J, 2010, J IMMUNOL, V185, P6899, DOI 10.4049/jimmunol.1001225; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	55	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19647	10.1371/journal.pone.0019647	http://dx.doi.org/10.1371/journal.pone.0019647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573188	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400037
J	Craney, A; Tahlan, K; Andrews, D; Nodwell, J				Craney, Arryn; Tahlan, Kapil; Andrews, David; Nodwell, Justin			Bacterial Transmembrane Proteins that Lack N-Terminal Signal Sequences	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; MEMBRANE INSERTION; SEC TRANSLOCON; RECOGNITION; MECHANISMS; SECRETION; PATHWAYS; CHANNEL	Tail-anchored membrane proteins (TAMPs), a class of proteins characterized by their lack of N-terminal signal sequence and Sec-independent membrane targeting, play critical roles in apoptosis, vesicle trafficking and other vital processes in eukaryotic organisms. Until recently, this class of membrane proteins has been unknown in bacteria. Here we present the results of bioinformatic analysis revealing proteins that are superficially similar to eukaryotic TAMPs in the bacterium Streptomyces coelicolor. We demonstrate that at least four of these proteins are bona fide membrane-spanning proteins capable of targeting to the membrane in the absence of their N-terminus and the C-terminal membrane-spanning domain is sufficient for membrane targeting. Several of these proteins, including a serine/threonine kinase and the SecE component of the Sec translocon, are widely conserved in bacteria.	[Craney, Arryn; Tahlan, Kapil; Andrews, David; Nodwell, Justin] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Craney, A (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	nodwellj@mcmaster.ca		Andrews, David/0000-0002-9266-7157	Canadian Institutes for Health Research [MOP-57684]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research grant #MOP-57684. http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Dong HJ, 2009, CURR MICROBIOL, V59, P336, DOI 10.1007/s00284-009-9439-2; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; EICHLER J, 2010, TRENDS BIOCHEM SCI, V29, P3; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gold VAM, 2007, MOL MEMBR BIOL, V24, P387, DOI 10.1080/09687680701416570; HAGEGE J, 1993, J BACTERIOL, V175, P5529; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Hudson ME, 2002, J BACTERIOL, V184, P4920, DOI 10.1128/JB.184.17.4920-4924.2002; JEONG SM, 1993, MOL MICROBIOL, V10, P133, DOI 10.1111/j.1365-2958.1993.tb00910.x; Keiser T, 2000, PRACTICAL STREPTOMYC; Kim BH, 2001, MOL MICROBIOL, V41, P665, DOI 10.1046/j.1365-2958.2001.02544.x; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; KONTINEN VP, 1996, J BIOCH, V1130, P1124; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; PUTTIKHUNT C, 1995, MOL GEN GENET, V247, P118, DOI 10.1007/BF00425829; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; SUN J, 1999, MICROBIOL, V3, P2221; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Valent QA, 2001, ANTON LEEUW INT J G, V79, P17, DOI 10.1023/A:1010256109582; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; VONHEIJNE J, 1992, J MOL BIOL, V225, P487; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19421	10.1371/journal.pone.0019421	http://dx.doi.org/10.1371/journal.pone.0019421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573234	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800028
J	Leung, WKC; Ching, AKK; Chan, AWH; Poon, TCW; Mian, H; Wong, AST; To, KF; Wong, N				Leung, W. K. C.; Ching, A. K. K.; Chan, A. W. H.; Poon, T. C. W.; Mian, H.; Wong, A. S. T.; To, K-F; Wong, N.			A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility	ONCOGENE			English	Article						PFTK1; hepatocellular carcinoma; cell migration; TAGLN2; actin	COMPARATIVE-GENOMIC-HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; ACTIN-BINDING; TRANSGELIN; BREAST; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; PROGRESSION; GENE	The PFTK1 gene encodes a cdc2-related serine/threonine protein kinase that has been shown to confer cell migratory properties in hepatocellular carcinoma (HCC). However, the prognostic value and biological mechanism by which PFTK1 promotes HCC motility remain largely unknown. Here, we showed from tissue microarray that common upregulations of PFTK1 in primary HCC tumors (n = 133/180) correlated significantly with early age onset (<= 40 years), advance tumor grading and presence of microvascular invasion (P <= 0.05). To understand downstream phosphorylated substrate(s) of PFTK1, phospho-proteins in PFTK1 expressing and knockdown Hep3B cells were profiled by two-dimensional- polyacrylamide gel electrophoresis mass spectrometric analysis. Protein identification of differential spots revealed beta-actin (ACTB) and transgelin2 (TAGLN2) as the two most profound phosphorylated changes affected by PFTK1. We verified the presence of TAGLN2 serine phosphorylation and ACTB tyrosine phosphorylation. Moreover, reduced TAGLN2 and ACTB phosphorylations in PFTK1-suppressed Hep3B corresponded to distinct actin depolymerizations and marked inhibition on cell invasion and motility. Given that TAGLN2 is a tumor suppressor whose function has been ascribed in cancer metastasis, we examined if TAGLN2 is an intermediate substrate in the biological path of PFTK1. We showed in PFTK1-suppressed cells that knockdown of TAGLN2 over-rode the inhibitory effect on cell invasion and motility, and a recovery on actin polymerization was evident. Interestingly, we also found that unphosphorylated TAGLN2 in PFTK1-suppressed cells elicited strong actin-binding ability, a mechanism that possibly halts the actin cytoskeleton dynamics. Site-directed mutagenesis of TAGLN2 suggested that PFTK1 regulates the actin-binding affinity of TAGLN2 through the S83 and S163 residues, which if mutated can significantly affect HCC cell motility. Taken together, our data propose a novel, oncogene-tumor suppressor interplay, where oncogenic PFTK1 confers HCC cell motility through inactivating the actin-binding motile suppressing function of TAGLN2 via phosphorylation. Oncogene (2011) 30, 4464-4475; doi: 10.1038/onc.2011.161; published online 16 May 2011	[Leung, W. K. C.; Ching, A. K. K.; Chan, A. W. H.; Mian, H.; To, K-F; Wong, N.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Leung, W. K. C.; Ching, A. K. K.; Poon, T. C. W.; Mian, H.; To, K-F; Wong, N.] Chinese Univ Hong Kong, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China; [Poon, T. C. W.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Wong, N (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China.	natwong@cuhk.edu.hk	Wong, Alice/AFJ-4595-2022; Chan, Anthony Wing Hung/HGB-4311-2022; MIAN, HE/AAK-1900-2021; Chan, Anthony/U-7768-2019; Chan, Anthony W.H./N-6719-2016	Wong, Alice/0000-0002-0676-6475; Chan, Anthony Wing Hung/0000-0002-1771-163X; Chan, Anthony/0000-0002-1771-163X; Chan, Anthony W.H./0000-0002-1771-163X; Leung, Wilson/0000-0002-6196-4984	Hong Kong Research Grants Council [CUHK 4/CRF/08, CUHK 4410/06M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by a Collaborative Research Fund from the Hong Kong Research Grants Council (Ref. No.: CUHK 4/CRF/08) and an Earmarked Grant from the Hong Kong Research Grants Council (Ref. No.: CUHK 4410/06M). We thank AH Bai and NL Wong for technical assistance.	Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Fu YP, 2000, J APPL PHYSIOL, V89, P1985, DOI 10.1152/jappl.2000.89.5.1985; Garcia JL, 2003, LEUKEMIA, V17, P2016, DOI 10.1038/sj.leu.2403080; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Katoh H, 2007, GASTROENTEROLOGY, V133, P1475, DOI 10.1053/j.gastro.2007.08.038; KIRSCHNER M, 1992, TRENDS BIOCHEM SCI, V17, P281, DOI 10.1016/0968-0004(92)90435-C; Knuutila S, 1998, AM J PATHOL, V152, P1107; Kubota H, 2009, J BIOL CHEM, V284, P35251, DOI 10.1074/jbc.M109.013565; Manes T, 2003, J CELL BIOL, V161, P817, DOI 10.1083/jcb.200212172; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nakao K, 2001, CANCER, V91, P721, DOI 10.1002/1097-0142(20010215)91:4<721::AID-CNCR1057>3.3.CO;2-V; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Pang E, 2002, GENE CHROMOSOME CANC, V33, P150, DOI 10.1002/gcc.1220; Pang EYT, 2007, HEPATOLOGY, V46, P436, DOI 10.1002/hep.21691; PINES J, 1992, Current Opinion in Cell Biology, V4, P144, DOI 10.1016/0955-0674(92)90024-7; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shields JM, 2002, J BIOL CHEM, V277, P9790, DOI 10.1074/jbc.M110086200; Solomon MJ, 1993, CURR OPIN CELL BIOL, V5, P180, DOI 10.1016/0955-0674(93)90100-5; STEWART BW, 2003, WHO WORLD CANC REPOR; Strohmeyer DM, 2004, PROSTATE, V59, P43, DOI 10.1002/pros.20028; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wong N, 2009, INT J CANCER, V124, P644, DOI 10.1002/ijc.23968; Wulfkuhle JD, 2002, CANCER RES, V62, P6740; Xu SG, 2010, J CANCER RES CLIN, V136, P1545, DOI 10.1007/s00432-010-0812-0; Yang T, 2001, GENE, V267, P165, DOI 10.1016/S0378-1119(01)00391-2; Yang ZM, 2007, MOL ENDOCRINOL, V21, P343, DOI 10.1210/me.2006-0104; Zhao L, 2009, MODERN PATHOL, V22, P786, DOI 10.1038/modpathol.2009.29	30	68	73	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	44					4464	4475		10.1038/onc.2011.161	http://dx.doi.org/10.1038/onc.2011.161			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21577206				2022-12-25	WOS:000296733200002
J	Sriram, G; Reichman, C; Tunceroglu, A; Kaushal, N; Saleh, T; Machida, K; Mayer, B; Ge, Q; Li, J; Hornbeck, P; Kalodimos, CG; Birge, RB				Sriram, G.; Reichman, C.; Tunceroglu, A.; Kaushal, N.; Saleh, T.; Machida, K.; Mayer, B.; Ge, Q.; Li, J.; Hornbeck, P.; Kalodimos, C. G.; Birge, R. B.			Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation	ONCOGENE			English	Article						Crk tyrosine phosphorylation; SH2 domains; Abl transactivation	ADAPTER PROTEIN CRK; BREAST-CANCER CELLS; C-ABL; SIGNALING PROTEIN; MALIGNANT FEATURE; STRUCTURAL BASIS; FACTOR C3G; GROWTH; ACTIVATION; BINDING	Here, we report the identification and characterization of a novel tyrosine phosphorylation site in the carboxyterminal Src Homology 3 (SH3) (SH3C) domain of the Crk adaptor protein. Y251 is located in the highly conserved RT loop structure of the SH3C, a region of Crk involved in the allosteric regulation of the Abl kinase. Exploiting kinase assays to show that Y251 is phosphorylated by Abl in vitro, we generated affinity-purified antisera against phosphorylated Y251 in Crk and showed that Abl induces phosphorylation at Y251 in vivo, and that the kinetics of phosphorylation at Y251 and the negative regulatory Y221 site in vitro are similar. Y251 on endogenous Crk was robustly phosphorylated in chronic myelogenous leukemia cell lines and in A431 and MDA-MB-468 cells stimulated with epidermal growth factor. Using streptavidin-biotin pull downs and unbiased high-throughput Src Homology 2 (SH2) profiling approaches, we found that a pY251 phospho-peptide binds specifically to a subset of SH2 domains, including Abl and Arg SH2, and that binding of pY251 to Abl SH2 induces transactivation of Abl 1b. Finally, the Y251F Crk mutant significantly abrogates Abl transactivation in vitro and in vivo. These studies point to a yet unrealized positive regulatory role resulting from tyrosine phosphorylation of Crk, and identify a novel mechanism by which an adaptor protein activates a non-receptor tyrosine kinase by SH2 domain displacement. Oncogene (2011) 30, 4645-4655; doi:10.1038/onc.2011.170; published online 23 May 2011	[Sriram, G.; Reichman, C.; Tunceroglu, A.; Kaushal, N.; Birge, R. B.] UMDNJ New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Saleh, T.; Kalodimos, C. G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Machida, K.; Mayer, B.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet Mol Med, Farmington, CT USA; [Ge, Q.; Li, J.; Hornbeck, P.] Cell Signaling Technol, Danvers, MA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; University of Connecticut	Birge, RB (corresponding author), Univ Med & Dent New Jersey, Sch Med, Dept Biochem & Mol Biol, MSB E647,185 S Orange Ave, Newark, NJ 07103 USA.	birgera@umdnj.edu	Hornbeck, Peter V/K-2226-2017; Kalodimos, Charalampos/Q-9846-2018; Saleh, Tamjeed/M-8698-2016	Hornbeck, Peter V/0000-0002-1126-5149; Kalodimos, Charalampos/0000-0001-6354-2796; Saleh, Tamjeed/0000-0002-7539-7300	NIH [RO1GM080308]; NJCCR [08-1093-CCR-EO]; NATIONAL CANCER INSTITUTE [R01CA082258, R01CA165077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055760, R01GM080308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCCR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the NIH grant RO1GM080308 to CK and RBB, as well as NJCCR pre-doctoral fellowship 08-1093-CCR-EO to AT. We thank Leszek Kotula, Eric Haura and Khanh Nguyen for helpful discussion, and Neil Devoe for critical comments on the MS.	Abassi YA, 2002, EMBO J, V21, P4571, DOI 10.1093/emboj/cdf446; Anafi M, 1996, J BIOL CHEM, V271, P21365, DOI 10.1074/jbc.271.35.21365; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Dubielecka PM, 2010, FEBS LETT, V584, P3279, DOI 10.1016/j.febslet.2010.06.029; Escalante M, 2000, J BIOL CHEM, V275, P24787, DOI 10.1074/jbc.M000711200; Fathers KE, 2010, AM J PATHOL, V176, P446, DOI 10.2353/ajpath.2010.090383; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Matsumoto T, 2000, BIOCHEM BIOPH RES CO, V270, P28, DOI 10.1006/bbrc.2000.2374; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sorokin A, 1998, ONCOGENE, V16, P2425, DOI 10.1038/sj.onc.1201781; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	51	13	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	46					4645	4655		10.1038/onc.2011.170	http://dx.doi.org/10.1038/onc.2011.170			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	851EV	21602891	Green Accepted			2022-12-25	WOS:000297252100004
J	Kisko, K; Brozzo, MS; Missimer, J; Schleier, T; Menzel, A; Leppanen, VM; Alitalo, K; Walzthoeni, T; Aebersold, R; Ballmer-Hofer, K				Kisko, Kaisa; Brozzo, Maurice S.; Missimer, John; Schleier, Thomas; Menzel, Andreas; Leppanen, Veli-Matti; Alitalo, Kari; Walzthoeni, Thomas; Aebersold, Ruedi; Ballmer-Hofer, Kurt			Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering	FASEB JOURNAL			English	Article						SAXS; VEGF; cross-linking; mass spectrometry; receptor tyrosine kinase	CRYSTAL-STRUCTURE; RECEPTOR ACTIVATION; PROTEIN STRUCTURES; VEGF; BINDING; IDENTIFICATION; RESOLUTION; CONTACTS	Receptor tyrosine kinases play essential roles in tissue development and homeostasis, and aberrant signaling by these molecules is the basis of many diseases. Understanding the activation mechanism of these receptors is thus of high clinical relevance. We investigated vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs), which regulate blood and lymph vessel formation. We analyzed the structural changes in the extracellular receptor domain that were induced by ligand binding and that represent the initial step in transmembrane signaling, culminating in the activation of the intracellular receptor kinase domain. High-resolution structural information for the ligand binding domain became available recently, but the flexibility of the extracellular domain and inhomogeneous glycosylation of VEGFRs have prevented the production of highly diffracting crystals of the entire extracellular domain so far. Therefore, we chose to further investigate VEGFR structure by small-angle X-ray scattering in solution (SAXS). SAXS data were combined with independent distance restraint determination obtained by mass spectrometric analysis of chemically cross-linked ligand/receptor complexes. With these data, we constructed a structural model of the entire extracellular receptor domain in the unbound form and in complex with VEGF.-Kisko, K., Brozzo, M. S., Missimer, J., Schleier, T., Menzel, A., Leppanen, V.-M., Alitalo, K., Walzthoeni, T., Aebersold, R., Ballmer-Hofer, K. Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering. FASEB J. 25, 2980-2986 (2011). www.fasebj.org	[Kisko, Kaisa; Brozzo, Maurice S.; Missimer, John; Schleier, Thomas; Menzel, Andreas; Ballmer-Hofer, Kurt] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Leppanen, Veli-Matti; Alitalo, Kari] Univ Helsinki, Haartman Inst, Dept Pathol, Biomedicum Helsinki,Mol Canc Biol Program, Helsinki, Finland; [Leppanen, Veli-Matti; Alitalo, Kari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Walzthoeni, Thomas; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Walzthoeni, Thomas] Univ Zurich, ETH Zurich, Mol Life Sci Program, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Ballmer-Hofer, K (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	kurt.ballmer@psi.ch	Menzel, Andreas/C-4388-2012; Alitalo, Kari K/J-5013-2014	Menzel, Andreas/0000-0002-0489-609X; Alitalo, Kari K/0000-0002-7331-0902; Leppanen, Veli-Matti/0000-0001-7100-965X; Ballmer-Hofer, Kurt/0000-0002-3800-9129	Swiss National Science Foundation [3100A-116507]; Oncosuisse [OC2 01200-08-2007]; European Union [HEALTH-F4-2008-201648]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; European Union(European Commission)	The authors thank the Swiss National Science Foundation (grant 3100A-116507) and Oncosuisse (grant OC2 01200-08-2007) for continuous support of their work. This work was supported, in part, by funding from the European Union Seventh Framework Program PROSPECTS (Proteomics Specification in Space and Time grant HEALTH-F4-2008-201648). The authors also thank all members of the X12SA beamline at SLS for their support during data acquisition; and Drs. D. Svergun and M. Roessler (European Molecular Biology Laboratory, Hamburg, Germany) for access to the X33 SAXS beamline at Deutsches Elektronen-Synchrotron (DESY; Hamburg, Germany) and for their competent assistance in establishing SAXS data analysis in the startup phase of this project.	Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pieren M, 2006, J BIOL CHEM, V281, P19578, DOI 10.1074/jbc.M601842200; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Scheidegger P, 1999, BIOL CHEM, V380, P1449, DOI 10.1515/BC.1999.187; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	31	31	32	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					2980	2986		10.1096/fj.11-185397	http://dx.doi.org/10.1096/fj.11-185397			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21613573				2022-12-25	WOS:000294435200013
J	Nagaosa, K; Okada, R; Nonaka, S; Takeuchi, K; Fujita, Y; Miyasaka, T; Manaka, J; Ando, I; Nakanishi, Y				Nagaosa, Kaz; Okada, Ryo; Nonaka, Saori; Takeuchi, Kazuki; Fujita, Yu; Miyasaka, Tomoyuki; Manaka, Junko; Ando, Istvan; Nakanishi, Yoshinobu			Integrin beta nu-mediated Phagocytosis of Apoptotic Cells in Drosophila Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CAENORHABDITIS-ELEGANS; C-ELEGANS; ALPHA-V-BETA-5 INTEGRIN; ENGULFMENT RECEPTOR; CORPSE ENGULFMENT; ACTIVATION; PROTEIN; CLEARANCE; HOMOLOG	To identify molecules that play roles in the clearance of apoptotic cells by Drosophila phagocytes, we examined a series of monoclonal antibodies raised against larval hemocytes for effects on phagocytosis in vitro. One antibody that inhibited phagocytosis recognized terribly reduced optic lobes (Trol), a core protein of the perlecan-type proteoglycan, and the level of phagocytosis in embryos of a Trol-lacking fly line was lower than in a control line. The treatment of a hemocyte cell line with a recombinant Trol protein containing the amino acid sequence RGD augmented the phosphorylation of focal adhesion kinase, a hallmark of integrin activation. A loss of integrin beta nu, one of the two beta subunits of Drosophila integrin, brought about a reduction in the level of apoptotic cell clearance in embryos. The presence of integrin beta nu at the surface of embryonic hemocytes was confirmed, and forced expression of integrin beta nu in hemocytes of an integrin beta nu-lacking fly line recovered the defective phenotype of phagocytosis. Finally, the level of phagocytosis in a fly line that lacks both integrin beta nu and Draper, another receptor required for the phagocytosis of apoptotic cells, was lower than that in a fly line lacking either protein. We suggest that integrin beta nu serves as a phagocytosis receptor responsible for the clearance of apoptotic cells in Drosophila, independent of Draper.	[Nagaosa, Kaz; Okada, Ryo; Nonaka, Saori; Fujita, Yu; Manaka, Junko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Takeuchi, Kazuki; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Miyasaka, Tomoyuki; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan; [Ando, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Kanazawa University; Kanazawa University; Kanazawa University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Nakanishi, Y (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nakanaka@p.kanazawa-u.ac.jp	Nakanishi, Yoshinobu/D-4602-2014; Nagaosa, Kaz/G-3857-2014; Nonaka, Saori/L-4092-2015	Nakanishi, Yoshinobu/0000-0002-8767-3587; Nagaosa, Kaz/0000-0002-1695-2562; Nonaka, Saori/0000-0003-2672-3082	Japan Society for the Promotion of Science [19370051, 22370049, 22657033]; Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap [NK78024]; Fuji Foundation for Protein Research; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research 19370051, 22370049, and 22657033 from the Japan Society for the Promotion of Science (to Y. N.), the Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap (National Scientific Research Fund) Grant NK78024 (to I. A.), and a grant from the Fuji Foundation for Protein Research (to K. N.).	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; BUNCH TA, 1992, GENETICS, V132, P519; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fujimoto J, 1999, J BIOL CHEM, V274, P29196, DOI 10.1074/jbc.274.41.29196; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Metheniti A, 2001, FEBS LETT, V496, P55, DOI 10.1016/S0014-5793(01)02405-X; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, J BIOL CHEM, V283, P10593, DOI 10.1074/jbc.M709105200; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	47	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25770	25777		10.1074/jbc.M110.204503	http://dx.doi.org/10.1074/jbc.M110.204503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592968	Green Published, hybrid			2022-12-25	WOS:000293073000039
J	Zhang, HT; Chen, LL; Chen, J; Jiang, HL; Shen, X				Zhang, Haitao; Chen, Lili; Chen, Jing; Jiang, Hualiang; Shen, Xu			Structural Basis for Retinoic X Receptor Repression on the Tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; THYROID-HORMONE; COREPRESSOR; RESISTANCE	Retinoic X receptor (RXR) is a master nuclear receptor in the processes of cell development and homeostasis. Unliganded RXR exists in an autorepressed tetramer, and agonists can induce RXR dimerization and coactivator recruitment for activation. However, the molecular mechanisms involving the corepressor recruitment and antagonist-mediated repression of RXR are still elusive. Here we report the crystal structure of RXR alpha ligand-binding domain (LBD) complexed with silencing mediator for retinoid and thyroid hormone receptors (SMRT) corepressor motif. As the first structural report on the unliganded nuclear receptor bound to the corepressor motif, RXR alpha LBD-SMRT exhibits a significant structural rearrangement, compared with apoRXR alpha LBD tetramer. To elucidate further the molecular determinants for RXR repression by its antagonist, we also determine the crystal structure of RXR alpha LBD-SMRT complexed with the identified antagonist rhein. In the structure, two rhein molecules and two SMRT peptides are in the RXR alpha LBD tetramer, different from the case in RXR alpha LBD-SMRT structure, where four SMRT peptides bind to RXR alpha LBD tetramer. It seems that rhein induces a displacement of SMRT motif by activation function 2 (AF-2) motif binding to the receptor. Combining our current work with the published results, structural superposition of RXR alpha LBDs in different states reveals that RXR uses an overlapped binding site for coactivator, corepressor, and AF-2 motifs, whereas the AF-2 motif adopts different conformations for agonist or antagonist interaction and coactivator or corepressor recruitment. Taken together, we thus propose a molecular model of RXR repression on the tetramer.	[Zhang, Haitao; Chen, Lili; Chen, Jing; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Haitao/L-7612-2015	Zhang, Haitao/0000-0003-4879-2951	State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National High-Tech R&D Program of China [2011AA090071-2]; National Natural Science Foundation of China [30925040, 30890044, 30801415, 10979072]; Science Foundation of Shanghai [08431902900]; Shanghai Science and Technology Commission [11ZR1444500]; Shanghai Rising-Star Program [09QA1406800]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Rising-Star Program	This work was supported by State Key Program of Basic Research of China Grants 2010CB912501, 2007CB914304, and 2009CB918502, National High-Tech R&D Program of China Grant 2011AA090071-2, National Natural Science Foundation of China Grants 30925040, 30890044, 30801415, and 10979072, Science Foundation of Shanghai Grant 08431902900, Shanghai Basic Research Project from the Shanghai Science and Technology Commission Grant 11ZR1444500, and Shanghai Rising-Star Program Grant 09QA1406800.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Fernandez-Majada V, 2007, CELL CYCLE, V6, P1748, DOI 10.4161/cc.6.14.4429; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gao Q, 2010, PLANTA MED, V76, P27, DOI 10.1055/s-0029-1185948; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Ghosh JC, 2002, P NATL ACAD SCI USA, V99, P5842, DOI 10.1073/pnas.092043399; He ZH, 2009, J ETHNOPHARMACOL, V121, P313, DOI 10.1016/j.jep.2008.11.008; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Jia ZH, 2007, EXP CLIN ENDOCR DIAB, V115, P571, DOI 10.1055/s-2007-981469; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; Uchikawa J, 2003, CANCER, V98, P2207, DOI 10.1002/cncr.11760; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zhang HT, 2011, J MOL BIOL, V407, P13, DOI 10.1016/j.jmb.2011.01.032; Zhang HT, 2011, J BIOL CHEM, V286, P1868, DOI 10.1074/jbc.M110.166215; Zhang JS, 1999, MOL CELL BIOL, V19, P6448	24	37	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24593	24598		10.1074/jbc.M111.245498	http://dx.doi.org/10.1074/jbc.M111.245498			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613212	hybrid, Green Published			2022-12-25	WOS:000292547900009
J	Bhunia, A; Saravanan, R; Mohanram, H; Mangoni, ML; Bhattacharjya, S				Bhunia, Anirban; Saravanan, Rathi; Mohanram, Harini; Mangoni, Maria L.; Bhattacharjya, Surajit			NMR Structures and Interactions of Temporin-1Tl and Temporin-1Tb with Lipopolysaccharide Micelles MECHANISTIC INSIGHTS INTO OUTER MEMBRANE PERMEABILIZATION AND SYNERGISTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DIFFERENCE NMR; HOST-DEFENSE PEPTIDES; HELICAL ANTIMICROBIAL PEPTIDES; GRAM-NEGATIVE BACTERIA; ENDOTOXIN NEUTRALIZATION; INNATE IMMUNITY; MOLECULAR-BASIS; LIGAND-BINDING; SPECTROSCOPY; RESISTANCE	Temporins are a group of closely related short antimicrobial peptides from frog skin. Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, plays important roles in the activity of temporins. Earlier studies have found that LPS induces oligomerization of temporin-1Tb (TB) thus preventing its translocation across the outer membrane and, as a result, reduces its activity on Gram-negative bacteria. On the other hand, temporin-1Tl (TL) exhibits higher activity, presumably because of lack of such oligomerization. A synergistic mechanism was proposed, involving TL and TB in overcoming the LPS-mediated barrier. Here, to gain insights into interactions of TL and TB within LPS, we investigated the structures and interactions of TL, TB, and TL+TB in LPS micelles, using NMR and fluorescence spectroscopy. In the context of LPS, TL assumes a novel antiparallel dimeric helical structure sustained by intimate packing between aromatic-aromatic and aromatic-aliphatic residues. By contrast, independent TB has populations of helical and aggregated conformations in LPS. The LPS-induced aggregated states of TB are largely destabilized in the presence of TL. Saturation transfer difference NMR studies have delineated residues of TL and TB in close contact with LPS and enhanced interactions of these two peptides with LPS, when combined together. Fluorescence resonance energy transfer and P-31 NMR have pointed out the proximity of TL and TB in LPS and conformational changes of LPS, respectively. Importantly, these results provide the first structural insights into the mode of action and synergism of antimicrobial peptides at the level of the LPS-outer membrane.	[Bhunia, Anirban; Saravanan, Rathi; Mohanram, Harini; Bhattacharjya, Surajit] Nanyang Technol Univ, Div Struct & Computat Biol, Sch Biol Sci, Singapore 637551, Singapore; [Mangoni, Maria L.] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Fondazione Cenci Bolognetti; Sapienza University Rome	Bhattacharjya, S (corresponding author), 60 Nanyang Dr, Singapore 637551, Singapore.	surajit@ntu.edu.sg	Bhattacharjya, SURAJIT/A-2183-2011; Mohanram, Harini/L-9207-2019	Mohanram, Harini/0000-0002-8179-2665; Bhunia, Anirban/0000-0002-8752-2842; Saravanan, Rathi/0000-0002-3884-6023; Mangoni, Maria Luisa/0000-0002-5991-5868	A*Star Biomedical Research Council, Singapore [06/1/22/19/446, 08/1/22/19/556]	A*Star Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Grants 06/1/22/19/446 and 08/1/22/19/556 from A*Star Biomedical Research Council, Singapore.	ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2011, BIOPOLYMERS, V96, P273, DOI 10.1002/bip.21530; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Egal M, 1999, INT J ANTIMICROB AG, V13, P57, DOI 10.1016/S0924-8579(99)00094-1; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FINK PF, 1990, HDB CRITICAL CARE, P619; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Haselhorst T, 2001, J AM CHEM SOC, V123, P10705, DOI 10.1021/ja011156h; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mor A, 2009, FEBS J, V276, P6474, DOI 10.1111/j.1742-4658.2009.07358.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Pristovsek P, 2004, CURR TOP MED CHEM, V4, P1185, DOI 10.2174/1568026043388105; Rademacher C, 2008, J AM CHEM SOC, V130, P3669, DOI 10.1021/ja710854r; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Tossi A, 2000, BIOPOLYMERS, V55, P4; Weinstein RA, 2001, EMERG INFECT DIS, V7, P188, DOI 10.3201/eid0702.010206; WILKINSON SG, 1981, BIOCHEM J, V199, P833, DOI 10.1042/bj1990833; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200; Zhao HX, 2002, BIOCHEMISTRY-US, V41, P4425, DOI 10.1021/bi011929e	78	80	81	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24394	24406		10.1074/jbc.M110.189662	http://dx.doi.org/10.1074/jbc.M110.189662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586570	Green Published, hybrid			2022-12-25	WOS:000292294900079
J	Giang, KTN; Zhang, S; Ngan, TKN; Phuong, QTN; Chiu, MS; Hardjojo, A; Tam, JP				Giang Kien Truc Nguyen; Zhang, Sen; Ngan Thi Kim Nguyen; Phuong Quoc Thuc Nguyen; Chiu, Ming Sheau; Hardjojo, Antony; Tam, James P.			Discovery and Characterization of Novel Cyclotides Originated from Chimeric Precursors Consisting of Albumin-1 Chain a and Cyclotide Domains in the Fabaceae Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLITORIA-TERNATEA; ANTIMICROBIAL PEPTIDES; KALATA B1; PLANT CYCLOTIDES; 4-KDA PEPTIDE; BINDING; PROTEIN; DEFENSINS; EXPRESSION; ELEMENTS	The tropical plant Clitoria ternatea is a member of the Fabaceae family well known for its medicinal values. Heat extraction of C. ternatea revealed that the bioactive fractions contained heat-stable cysteine-rich peptides (CRPs). The CRP family of A1b (Albumin-1 chain b/leginsulins), which is a linear cystine knot CRP, has been shown to present abundantly in the Fabaceae. In contrast, the cyclotide family, which also belongs to the cystine knot CRPs but with a cyclic structure, is commonly found in the Rubiaceae, Violaceae, and Cucurbitaceae families. In this study, we report the discovery of a panel of 15 heat-stable CRPs, of which 12 sequences (cliotide T1-T12) are novel. We show unambiguously that the cliotides are cyclotides and not A1bs, as determined by their sequence homology, disulfide connectivity, and membrane active properties indicated by their antimicrobial activities against Escherichia coli and cytotoxicities to HeLa cells. We also show that cliotides are prevalent in C. ternatea and are found in every plant tissue examined, including flowers, seeds, and nodules. In addition, we demonstrate that their precursors are chimeras, half from cyclotide and the other half from Albumin-1, with the cyclotide domain displacing the A1b domain in the precursor. Their chimeric structures likely originate from either horizontal gene transfer or convergent evolution in plant nuclear genomes, which are exceedingly rare events. Such atypical genetic arrangement also implies a different mechanism of biosynthetic processing of cyclotides in the Fabaceae and provides new understanding of their evolution in plants.	[Giang Kien Truc Nguyen; Zhang, Sen; Ngan Thi Kim Nguyen; Phuong Quoc Thuc Nguyen; Chiu, Ming Sheau; Hardjojo, Antony; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Hardjojo, Antony/0000-0002-2823-7996; Zhang, Sen/0000-0003-1409-5795	A*STAR Biomedical Research Council [09/1/22/19/612]; Ministry of Education in Singapore [ARC21/08]	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education in Singapore(Ministry of Education, Singapore)	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/612 and Academic Research Fund Grant ARC21/08 from the Ministry of Education in Singapore.	BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; Daisy P, 2009, AFR J MICROBIOL RES, V3, P287; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Devi BP, 2003, FITOTERAPIA, V74, P345, DOI 10.1016/S0367-326X(03)00057-1; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Graham MA, 2008, CROP SCI, V48, pS3, DOI 10.2135/cropsci2007.04.0236tpg; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Hanada K, 2003, EUR J BIOCHEM, V270, P2583, DOI 10.1046/j.1432-1033.2003.03627.x; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Jain NN, 2003, PHARMACOL BIOCHEM BE, V75, P529, DOI 10.1016/S0091-3057(03)00130-8; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; KULKARNI C, 1988, INDIAN J EXP BIOL, V26, P957; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Le Gall M, 2005, J NUTR, V135, P1215, DOI 10.1093/jn/135.5.1215; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lindholm P, 2002, MOL CANCER THER, V1, P365; Louis S, 2004, PLANT SCI, V167, P705, DOI 10.1016/j.plantsci.2004.04.018; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Mukherjeea PK, 2008, J ETHNOPHARMACOL, V120, P291, DOI 10.1016/j.jep.2008.09.009; NISHIZAWA NK, 1994, PLANT CELL PHYSIOL, V35, P1079; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; Rai Kiranmai S., 2001, Indian Journal of Physiology and Pharmacology, V45, P305; Rai KS, 2002, FITOTERAPIA, V73, P685, DOI 10.1016/S0367-326X(02)00249-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sze SK, 2009, ANAL CHEM, V81, P1079, DOI 10.1021/ac802175r; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tan Jian-zhong, 2003, Yichuan, V25, P168; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WATANABE Y, 1994, EUR J BIOCHEM, V224, P167, DOI 10.1111/j.1432-1033.1994.tb20008.x; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Whittington CM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r95; Yamazaki T, 2003, EUR J BIOCHEM, V270, P1269, DOI 10.1046/j.1432-1033.2003.03489.x	58	128	149	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24275	24287		10.1074/jbc.M111.229922	http://dx.doi.org/10.1074/jbc.M111.229922			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596752	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000292294900069
J	Kim, S; Kunapuli, SP				Kim, Soochong; Kunapuli, Satya P.			Negative Regulation of G(q)-mediated Pathways in Platelets by G(12/13) Pathways through Fyn Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; PROTEIN-TYROSINE KINASES; SHAPE CHANGE; INTEGRIN ALPHA(IIB)BETA(3); ADENOSINE-DIPHOSPHATE; AKT PHOSPHORYLATION; RECEPTOR ACTIVATION; SIGNALING PATHWAYS; THROMBOXANE A(2); GLYCOPROTEIN-VI	Platelets contain high levels of Src family kinases (SFKs), but their functional role downstream of G protein pathways has not been completely understood. We found that platelet shape change induced by selective G(12/13) stimulation was potentiated by SFK inhibitors, which was abolished by intracellular calcium chelation. Platelet aggregation, secretion, and intracellular Ca2+ mobilization mediated by low concentrations of SFLLRN or YFLLRNP were potentiated by SFK inhibitors. However, 2-methylthio-ADP-induced intracellular Ca2+ mobilization and platelet aggregation were not affected by PP2, suggesting the contribution of SFKs downstream of G(12/13), but not G(q)/G(i), as a negative regulator to platelet activation. Moreover, PP2 potentiated YFLLRNP- and AYPGKF-induced PKC activation, indicating that SFKs downstream of G(12/13) regulate platelet responses through the negative regulation of PKC activation as well as calcium response. SFK inhibitors failed to potentiate platelet responses in the presence of G(q)-selective inhibitor YM254890 or in G(q)-deficient platelets, indicating that SFKs negatively regulate platelet responses through modulation of G(q) pathways. Importantly, AYPGKF-induced platelet aggregation and PKC activation were potentiated in Fyn-deficient but not in Lyn-deficient mice compared with wild-type littermates. We conclude that SFKs, especially Fyn, activated downstream of G(12/13) negatively regulate platelet responses by inhibiting intracellular calcium mobilization and PKC activation through G(q) pathways.	[Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Sch Med, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu			National Institutes of Health [HL60683, HL93231, HL81322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060683, R01HL081322, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL60683, HL93231, and HL81322 (to S. P. K.).	Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bauer M, 2001, THROMB HAEMOSTASIS, V85, P331, DOI 10.1055/s-0037-1615689; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BRASS LF, 1988, J BIOL CHEM, V263, P5348; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; FEINSTEIN MB, 1975, J GEN PHYSIOL, V66, P561, DOI 10.1085/jgp.66.5.561; FEINSTEIN MB, 1977, PROSTAGLANDINS, V14, P1075, DOI 10.1016/0090-6980(77)90286-6; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jen CJ, 1996, BLOOD, V87, P3775, DOI 10.1182/blood.V87.9.3775.bloodjournal8793775; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; NEGRESCU EV, 1995, J BIOL CHEM, V270, P1057, DOI 10.1074/jbc.270.3.1057; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Paul BZS, 2003, PLATELETS, V14, P159, DOI 10.1080/0953710031000092794; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Quek LS, 2000, BLOOD, V96, P4246; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Stenberg PE, 1997, BLOOD, V89, P2384, DOI 10.1182/blood.V89.7.2384; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TROTTER PJ, 1995, BIOCHEM J, V308, P591, DOI 10.1042/bj3080591; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WORNER P, 1975, THROMB RES, V6, P295, DOI 10.1016/0049-3848(75)90079-1; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970	54	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24170	24179		10.1074/jbc.M110.212274	http://dx.doi.org/10.1074/jbc.M110.212274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592972	hybrid, Green Published			2022-12-25	WOS:000292294900059
J	Liu, DB; Wang, C; Li, C; Zhang, X; Zhang, BZ; Mi, ZQ; An, XP; Tong, YG				Liu, Dabin; Wang, Chen; Li, Cun; Zhang, Xin; Zhang, Baozhong; Mi, Zhiqiang; An, Xiaoping; Tong, Yigang			Production and Characterization of a Humanized Single-chain Antibody against Human Integrin alpha v alpha 3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(V)BETA(3) INTEGRIN; MONOCLONAL-ANTIBODIES; TUMOR-REGRESSION; ANGIOGENESIS; THERAPY; CANCER; FRAGMENTS; ADHESION; BINDING; VITAXIN	Anti-angiogenesis therapy is an emerging strategy for cancer treatment. This therapy has many advantages over existing treatments, such as fewer side effects, fewer resistance problems, and a broader tumor type spectrum. Integrin alpha v beta 3 is a heterodimeric transmembrane glycoprotein that has been demonstrated to play a key role in tumor angiogenesis and metastasis. We have used a phage antibody display to humanize a mouse monoclonal antibody (mAb E10) against human integrin alpha v beta 3 with a predetermined CDR3 gene. Three human phage antibodies were developed. Analysis of the humanized phage antibodies by phage ELISA revealed that the antibodies retained high antigen-binding activity and detected the same epitope as the parent mAb E10. A humanized single chain Fv (scFv) antibody was expressed in Escherichia coli in a soluble form. Analysis of the purified scFv indicated that it has the same specificity and affinity as the original mAb. Cell viability assays and xenograft model results suggested that the humanized scFv possesses anti-tumor growth activity in vitro and in vivo. This successful production of a humanized scFv with the ability to inhibit alpha v beta 3-mediated cancer cell growth may provide a novel candidate for integrin alpha v beta 3-targeted therapy.	[Liu, Dabin; Wang, Chen; Li, Cun; Zhang, Xin; Zhang, Baozhong; Mi, Zhiqiang; An, Xiaoping; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	tong.yigang@gmail.com	Li, Cun/ABD-9346-2020; Liu, Dabin/GNH-2648-2022	Liu, Dabin/0000-0002-3811-8317; Tong, Yigang/0000-0002-8503-8045	Hi-Tech Research and Development (863) Program of China [2009AA02Z111]; National Natural Science Foundation of China [30872223]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech Research and Development (863) Program of China Grant 2009AA02Z111 and National Natural Science Foundation of China Grant 30872223.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Black WR, 1998, NATURE, V391, P450, DOI 10.1038/35064; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brereton HM, 2007, J BIOTECHNOL, V129, P539, DOI 10.1016/j.jbiotec.2007.01.008; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Keshet E, 1999, J CLIN INVEST, V104, P1497, DOI 10.1172/JCI8849; Klohs WD, 1999, CURR OPIN BIOTECH, V10, P544, DOI 10.1016/S0958-1669(99)00033-6; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Kuan CT, 2010, INT J CANCER, V127, P598, DOI 10.1002/ijc.25062; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; Liu ZF, 2011, MOL IMAGING BIOL, V13, P112, DOI 10.1007/s11307-010-0302-4; Luk JM, 2006, CLIN EXP PHARMACOL P, V33, P482, DOI 10.1111/j.1440-1681.2006.04396.x; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0; Rader C, 2002, FASEB J, V16, P2000, DOI 10.1096/fj.02-0281fje; Rader C, 1998, P NATL ACAD SCI USA, V95, P8910, DOI 10.1073/pnas.95.15.8910; Reinmuth N, 2003, CANCER RES, V63, P2079; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Tsui P, 2002, J IMMUNOL METHODS, V263, P123, DOI 10.1016/S0022-1759(02)00032-7; Wu L, 2008, GRAEF ARCH CLIN EXP, V246, P81, DOI 10.1007/s00417-007-0660-z; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yang J, 2010, APPL MICROBIOL BIOT, V86, P1067, DOI 10.1007/s00253-009-2379-8	33	12	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24500	24507		10.1074/jbc.M110.211847	http://dx.doi.org/10.1074/jbc.M110.211847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606501	hybrid, Green Published			2022-12-25	WOS:000292294900090
J	Tammali, R; Saxena, A; Srivastava, SK; Ramana, KV				Tammali, Ravinder; Saxena, Ashish; Srivastava, Satish K.; Ramana, Kota V.			Aldose Reductase Inhibition Prevents Hypoxia-induced Increase in Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) and Vascular Endothelial Growth Factor (VEGF) by Regulating 26 S Proteasome-mediated Protein Degradation in Human Colon Cancer Cells (Publication with Expression of Concern. See vol. 294, pg. 1634, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern							B SIGNALING PATHWAY; FACTOR-I; UP-REGULATION; EXPRESSION; CARCINOMA; ANGIOGENESIS; ACTIVATION; INVASION; INFLAMMATION; METASTASIS	The development of intratumoral hypoxia, a hallmark of rapidly progressing solid tumors, renders tumor cells resistant to chemotherapy and radiation therapy. We have recently shown that inhibition of aldose reductase (AR), an enzyme that catalyzes the reduction of lipid aldehydes and their glutathione conjugates, prevents human colon cancer cell growth in culture as well as in nude mouse xenografts by inhibiting the NF-kappa B-dependent activation of oxidative stress-mediated inflammatory and carcinogenic markers. However, the role of AR in mediating hypoxic stress signals is not known. We therefore investigated the molecular mechanisms by which AR inhibition prevents the hypoxia-inducedhumancolon cancer cells growth and invasion. Our results indicate that AR inhibition by the pharmacological inhibitor fidarestat or ablation by AR-specific siRNA prevents hypoxia-induced proliferation of HT29, SW480, and Caco-2 colon cancer cells. Furthermore, hypoxia-induced increase in the level of HIF-1 alpha in colon cancer cells was significantly decreased by AR inhibition. During hypoxic conditions, treatment of HT29 cells with the AR inhibitor fidarestat significantly decreased the expression of vascular endothelial growth factor, a down target of HIF-1 alpha, at both mRNA and protein levels and also prevented the activation of PI3K/AKT, GSK3 beta, Snail, and lysyl oxidase. Furthermore, inhibition of hypoxia-induced HIF-1 alpha protein accumulation by AR inhibition was abolished in the presence of MG132, a potent inhibitor of the 26 S proteasome. In addition, AR inhibition also prevented the hypoxia-induced inflammatory molecules such as Cox-2 and PGE2 and expression of extracellular matrix proteins such as MMP2, vimentin, uPAR, and lysyl oxidase 2. In conclusion, our results indicate that AR mediates hypoxic signals, leading to tumor progression and invasion.	[Tammali, Ravinder; Saxena, Ashish; Srivastava, Satish K.; Ramana, Kota V.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Ramana, KV (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	kvramana@utmb.edu	Ramana, Kota/C-5460-2012	Ramana, Kota/0000-0001-6502-7800	National Institutes of Health [GM71036, CA129383, DK36118]; NATIONAL CANCER INSTITUTE [R01CA129383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, R01DK036118, R37DK036118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM71036 (to K. V. R.) and CA129383 and DK36118 (to S. K. S.).	Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Aydemir ABC, 2010, BONE, V46, P167, DOI 10.1016/j.bone.2009.08.061; Bae MK, 2006, ONCOL REP, V15, P1557; Ben-Yosef Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1321, DOI 10.1152/ajpcell.00079.2005; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; DeClerck K, 2010, FRONT BIOSCI-LANDMRK, V15, P213, DOI 10.2741/3616; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gulati N, 2006, ANTICANCER RES, V26, P1177; Hwang MK, 2009, INT J BIOCHEM CELL B, V41, P1592, DOI 10.1016/j.biocel.2009.01.014; Ichikawa H, 2007, CURR PHARM DESIGN, V13, P3400, DOI 10.2174/138161207782360492; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Krishnamachary B, 2003, CANCER RES, V63, P1138; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; Reddy Aramati B M, 2010, Recent Pat Cardiovasc Drug Discov, V5, P25; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Shimizu M, 2010, CHEM-BIOL INTERACT, V185, P247, DOI 10.1016/j.cbi.2010.03.036; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Tafani M, 2010, CANCER SCI, V101, P1014, DOI 10.1111/j.1349-7006.2010.01493.x; Tammali R, 2007, CANCER LETT, V252, P299, DOI 10.1016/j.canlet.2007.01.001; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Tammali R, 2009, CARCINOGENESIS, V30, P799, DOI 10.1093/carcin/bgn246; Tang WH, 2008, FREE RADICAL BIO MED, V45, P602, DOI 10.1016/j.freeradbiomed.2008.05.003; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Yang ZF, 2010, J CELL PHYSIOL, V225, P266, DOI 10.1002/jcp.22261; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang QZ, 2006, MOL CANCER THER, V5, P1227, DOI 10.1158/1535-7163.MCT-05-0490; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	33	35	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24089	24100		10.1074/jbc.M111.219733	http://dx.doi.org/10.1074/jbc.M111.219733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576240	Green Published, hybrid			2022-12-25	WOS:000292294900051
J	Duque-Afonso, J; Yalcin, A; Berg, T; Abdelkarim, M; Heidenreich, O; Lubbert, M				Duque-Afonso, J.; Yalcin, A.; Berg, T.; Abdelkarim, M.; Heidenreich, O.; Luebbert, M.			The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO	ONCOGENE			English	Article						chromosomal translocations; acute myeloid leukemia; adaptor molecule; HDAC inhibitor; epigenetic regulation	ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; T-CELL-ACTIVATION; T(8/21) FUSION PROTEIN; NEGATIVE REGULATION; VALPROIC ACID; DNA METHYLATION; C/EBP-ALPHA; DIFFERENTIATION; EXPRESSION	The chromosomal translocation (8; 21) fuses the hematopoietic transcription factor AML1 (RUNX1) with ETO (RUNX1T1, MTG8), resulting in the leukemia-specific chimeric protein AML1/ETO. This fusion protein has been implicated in epigenetic silencing, recruiting histone deacetylases (HDACs) and DNA methyltransferases to target promoters. Previously, we have identified a novel in vivo AML1/ETO target gene, LAT2 (NTAL/LAB/WBSCR5), which is involved in FceR I, c-Kit, B-cell and T-cell receptor signalling. We have now addressed the molecular mechanisms of AML1/ETO-mediated LAT2 repression. In Kasumi-1 cells, where AML1/ETO bound to the LAT2 gene, small interfering RNA (siRNA)mediated AML1/ETO depletion caused upregulation of LAT2, suggesting a possible direct mechanism of repression. Expression of AML1/ETO was associated with a decrease in acetylation of histones H3, H3K9 and H4, and an increase in H3K9 and H3K27 trimethylation. The class I-specific HDAC inhibitors entinostat (MS-275) and mocetinostat (MGCD0103) induced LAT2 expression specifically in AML1/ETO-expressing cells, resulting in induction of several activating histone marks on the LAT2 gene, including trimethylation of histone H3K4. The combination of entinostat and decitabine increased acetylation of histones H3 and H4, as well as LAT2 mRNA expression, in an at least additive fashion. In conclusion, several repressive histone modifications mark the LAT2 gene in the presence of AML1/ETO, and LAT2 gene derepression is achieved by pharmacological inhibition of HDACs. Oncogene (2011) 30, 3062-3072; doi: 10.1038/onc.2011.32; published online 16 May 2011	[Duque-Afonso, J.; Yalcin, A.; Berg, T.; Abdelkarim, M.; Luebbert, M.] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Hematol Oncol, D-79106 Freiburg, Germany; [Heidenreich, O.] Newcastle Univ, No Inst Canc Res, Dept Mol Paediat Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Berg, T.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of Freiburg; Newcastle University - UK; British Columbia Cancer Agency	Lubbert, M (corresponding author), Univ Freiburg, Med Ctr, Dept Med, Div Hematol Oncol, Hugstetter Str 55, D-79106 Freiburg, Germany.	michael.luebbert@uniklinik-freiburg.de	Heidenreich, Olaf/AAP-5045-2021; Berg, Tobias/AAT-5094-2021	Heidenreich, Olaf/0000-0001-5404-6483; Berg, Tobias/0000-0003-2668-0449	LaCaixa-DAAD [314, A/05/29785]; Department of Hematology/Oncology of the University of Freiburg; German Jose-Carreras Foundation [R 06/40f]; DFG [SPP 1463, Lu 429/7-1]	LaCaixa-DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Department of Hematology/Oncology of the University of Freiburg; German Jose-Carreras Foundation; DFG(German Research Foundation (DFG))	We would like to thank Constanze Bonifer (Leeds, UK) and Manfred Jung (Freiburg, Germany) for critically reviewing the manuscript, Eric Metzger and Roland Schule (Freiburg) for many helpful comments during establishment of the chromatin immunoprecipitation assay, and Harald Binder (Freiburg) for statistical support. Bernhard Kleine performed the bisulfite sequencing analysis of the LAT2 promoter. We are grateful to Joost Martens and Henk Stunnenberg (Nijmegen, The Netherlands) for sharing unpublished data. J Duque-Afonso was funded by a grant from LaCaixa-DAAD (ref. 314, A/05/29785) and the fellowship program of the Department of Hematology/Oncology of the University of Freiburg. This work was supported by the German Jose-Carreras Foundation (R 06/40f). ML is supported by the DFG (SPP 1463, Lu 429/7-1).	Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Barbetti V, 2008, ONCOGENE, V27, P1767, DOI 10.1038/sj.onc.1210820; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berg T, 2007, LEUKEMIA RES, V31, P497, DOI 10.1016/j.leukres.2006.08.008; Berg T, 2008, HAEMATOL-HEMATOL J, V93, P1728, DOI 10.3324/haematol.13044; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Burel SA, 2001, MOL CELL BIOL, V21, P5577, DOI 10.1128/MCB.21.16.5577-5590.2001; Cameron EE, 1999, BLOOD, V94, P2445, DOI 10.1182/blood.V94.7.2445.419k19_2445_2451; Claus R, 2006, J LEUKOCYTE BIOL, V80, P1462, DOI 10.1189/jlb.0106005; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dunne J, 2006, ONCOGENE, V25, P6067, DOI 10.1038/sj.onc.1209638; DUQUEAFONSO J, 2011, BR J HAEMATOL; ERICKSON P, 1992, BLOOD, V80, P1825; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Fliegauf M, 2004, ONCOGENE, V23, P9070, DOI 10.1038/sj.onc.1208042; Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Hauswald S, 2009, CLIN CANCER RES, V15, P3705, DOI 10.1158/1078-0432.CCR-08-2048; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Klisovic MI, 2003, LEUKEMIA, V17, P350, DOI 10.1038/sj.leu.2402776; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Lubbert M, 2003, LEUKEMIA, V17, P1762, DOI 10.1038/sj.leu.2403045; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Maslak P, 2006, LEUKEMIA, V20, P212, DOI 10.1038/sj.leu.2404050; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Paul TA, 2010, BLOOD, V115, P3098, DOI 10.1182/blood-2009-07-233858; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025	51	36	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	27					3062	3072		10.1038/onc.2011.32	http://dx.doi.org/10.1038/onc.2011.32			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21577204				2022-12-25	WOS:000292510100006
J	Meade, J; Nam, KB; Lee, JW; Hatchwell, BJ				Meade, Jessica; Nam, Ki-Baek; Lee, Jin-Won; Hatchwell, Ben J.			An Experimental Test of the Information Model for Negotiation of Biparental Care	PLOS ONE			English	Article							MALE PARENTAL CARE; LONG-TAILED TITS; SEX-DIFFERENCES; REPRODUCTIVE SUCCESS; PARTNER CONTRIBUTION; FICEDULA-HYPOLEUCA; OFFSPRING CARE; HOUSE SPARROWS; BROOD SIZE; TESTOSTERONE	Background: Theoretical modelling of biparental care suggests that it can be a stable strategy if parents partially compensate for changes in behaviour by their partners. In empirical studies, however, parents occasionally match rather than compensate for the actions of their partners. The recently proposed "information model'' adds to the earlier theory by factoring in information on brood value and/or need into parental decision-making. This leads to a variety of predicted parental responses following a change in partner work-rate depending on the information available to parents. Methodology/Principal Findings: We experimentally test predictions of the information model using a population of long-tailed tits. We show that parental information on brood need varies systematically through the nestling period and use this variation to predict parental responses to an experimental increase in partner work-rate via playback of extra chick begging calls. When parental information is relatively high, partial compensation is predicted, whereas when parental information is low, a matching response is predicted. Conclusions/Significance: We find that although some responses are consistent with predictions, parents match a change in their partner's work-rate more often than expected and we discuss possible explanations for our findings.	[Meade, Jessica; Nam, Ki-Baek; Hatchwell, Ben J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Lee, Jin-Won] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	University of Sheffield; Seoul National University (SNU)	Meade, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	J.Meade@sheffield.ac.uk	Hatchwell, Ben J/C-5433-2016; Meade, Jessica/A-6411-2013; Meade, Jessica/O-7771-2019	Hatchwell, Ben J/0000-0002-1039-4782; Lee, Jinwon/0000-0003-4153-0609	Natural Environment Research Council; Nuffield Foundation; Association for the Study of Animal Behaviour; University of Sheffield; NERC [NE/E006655/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006655/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nuffield Foundation; Association for the Study of Animal Behaviour; University of Sheffield; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the Natural Environment Research Council, Nuffield Foundation, Association for the Study of Animal Behaviour, and the University of Sheffield, to whom the authors are most grateful. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CHASE I, 1980, AM NAT, V115, P27; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hatchwell BJ, 2006, ADV STUD BEHAV, V36, P355, DOI 10.1016/S0065-3454(06)36008-1; Hatchwell BJ, 1999, AUK, V116, P355, DOI 10.2307/4089370; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Houston A.I., 1985, P471; Hunt KE, 1999, BEHAV ECOL SOCIOBIOL, V45, P360, DOI 10.1007/s002650050572; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Lee JW, 2010, J ORNITHOL, V151, P483, DOI 10.1007/s10336-009-0484-1; Lessells CM, 1999, MG BEH ECOL, P75; Lifjeld JT, 1990, BEHAV ECOL, V1, P48, DOI 10.1093/beheco/1.1.48; Lozano GA, 1996, ANIM BEHAV, V51, P265, DOI 10.1006/anbe.1996.0027; MacColl ADC, 2003, ANIM BEHAV, V66, P955, DOI 10.1006/anbe.2003.2268; MacGregor NA, 2002, ANIM BEHAV, V63, P923, DOI 10.1006/anbe.2001.1991; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; McDonald PG, 2009, ANIM BEHAV, V77, P369, DOI 10.1016/j.anbehav.2008.10.009; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; McNamara JM, 2003, BEHAV ECOL, V14, P301, DOI 10.1093/beheco/14.3.301; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Moreno J, 1999, BEHAV ECOL SOCIOBIOL, V46, P244, DOI 10.1007/s002650050616; Raihani NJ, 2010, J ANIM ECOL, V79, P44, DOI 10.1111/j.1365-2656.2009.01606.x; SAINO N, 1995, BEHAV ECOL SOCIOBIOL, V36, P151, DOI 10.1007/s002650050135; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Schwagmeyer PL, 2002, BEHAV ECOL, V13, P713, DOI 10.1093/beheco/13.5.713; Shen SF, 2010, BIOL LETTERS, V6, P318, DOI 10.1098/rsbl.2009.0909; SLAGSVOLD T, 1990, ECOLOGY, V71, P1258, DOI 10.2307/1938263; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Stoehr AM, 2000, BEHAV ECOL SOCIOBIOL, V48, P407, DOI 10.1007/s002650000247; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WHITTINGHAM LA, 1994, ETHOLOGY, V96, P260; WOLF L, 1990, ANIM BEHAV, V39, P125, DOI 10.1016/S0003-3472(05)80732-8; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; Wright J, 1999, ANIM BEHAV, V58, P345, DOI 10.1006/anbe.1999.1152; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	43	27	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19684	10.1371/journal.pone.0019684	http://dx.doi.org/10.1371/journal.pone.0019684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611180	gold, Green Published, Green Accepted			2022-12-25	WOS:000290657500012
J	Wilcox, JT; Lai, JKY; Semple, E; Brisson, BA; Gartley, C; Armstrong, JN; Betts, DH				Wilcox, Jared T.; Lai, Jonathan K. Y.; Semple, Esther; Brisson, Brigitte A.; Gartley, Cathy; Armstrong, John N.; Betts, Dean H.			Synaptically-Competent Neurons Derived from Canine Embryonic Stem Cells by Lineage Selection with EGF and Noggin	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TIME RT-PCR; IN-VITRO; NEURAL DIFFERENTIATION; CLINICAL-TRIALS; TRANSPLANTATION; MODEL; DOGS; METHYLPREDNISOLONE; OLIGODENDROCYTES	Pluripotent stem cell lines have been generated in several domestic animal species; however, these lines traditionally show poor self-renewal and differentiation. Using canine embryonic stem cell (cESC) lines previously shown to have sufficient self-renewal capacity and potency, we generated and compared canine neural stem cell (cNSC) lines derived by lineage selection with epidermal growth factor (EGF) or Noggin along the neural default differentiation pathway, or by directed differentiation with retinoic acid (RA)-induced floating sphere assay. Lineage selection produced large populations of SOX2+ neural stem/progenitor cell populations and neuronal derivatives while directed differentiation produced few and improper neuronal derivatives. Primary canine neural lines were generated from fetal tissue and used as a positive control for differentiation and electrophysiology. Differentiation of EGF- and Noggin-directed cNSC lines in N2B27 with low-dose growth factors (BDNF/NT-3 or PDGF alpha alpha) produced phenotypes equivalent to primary canine neural cells including 3CB2+ radial progenitors, MOSP+ glia restricted precursors, VIM+/GFAP+ astrocytes, and TUBB3+/MAP2+/NFH+/SYN+ neurons. Conversely, induction with RA and neuronal differentiation produced inadequate putative neurons for further study, even though appropriate neuronal gene expression profiles were observed by RT-PCR (including Nestin, TUBB3, PSD95, STX1A, SYNPR, MAP2). Co-culture of cESC-derived neurons with primary canine fetal cells on canine astrocytes was used to test functional maturity of putative neurons. Canine ESC-derived neurons received functional GABA(A)- and AMPA-receptor mediated synaptic input, but only when co-cultured with primary neurons. This study presents established neural stem/progenitor cell populations and functional neural derivatives in the dog, providing the proof-of-concept required to translate stem cell transplantation strategies into a clinically relevant animal model.	[Wilcox, Jared T.; Lai, Jonathan K. Y.; Semple, Esther; Armstrong, John N.; Betts, Dean H.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Wilcox, Jared T.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Brisson, Brigitte A.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Gartley, Cathy] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Toronto; University of Guelph; University of Guelph	Wilcox, JT (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	jared.wilcox@utoronto.ca; dean.betts@schulich.uwo.ca	Wilcox, Jared/GLQ-9128-2022; Wilcox, Jared/AAK-6998-2020; Betts, Dean H/B-7414-2015	Wilcox, Jared/0000-0001-5484-7571; Betts, Dean H/0000-0002-5528-9142; Lai, Jonathan/0000-0002-3060-1232	Ontario Veterinary College Pet Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada	Ontario Veterinary College Pet Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Ontario Veterinary College Pet Trust Fund and the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Brisson BA, 2010, VET CLIN N AM-SMALL, V40, P829, DOI 10.1016/j.cvsm.2010.06.001; Bruce CW, 2008, VET COMP ORTHOPAED, V21, P280; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2010, NAT REV NEUROSCI, P1; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Fiester A, 2004, CLONING STEM CELLS, V6, P3, DOI 10.1089/15362300460743772; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626; Lim JH, 2007, J VET SCI, V8, P275, DOI 10.4142/jvs.2007.8.3.275; Liour SS, 2006, GLIA, V53, P43, DOI 10.1002/glia.20257; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marler JR, 2007, STROKE, V38, P3302, DOI 10.1161/STROKEAHA.107.485144; Miller G, 2010, SCIENCE, V327, P1309, DOI 10.1126/science.327.5971.1309; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabinowitz RS, 2008, SPINE, V33, P2260, DOI 10.1097/BRS.0b013e31818786db; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Roybon L, 2006, STEM CELLS, V24, P1594, DOI 10.1634/stemcells.2005-0548; Samson K, 2010, ANN NEUROL, V68, pA11, DOI 10.1002/ana.22249; Schneider MR, 2007, STEM CELLS, V25, P1850, DOI 10.1634/stemcells.2006-0357; Schneider MR, 2009, THERIOGENOLOGY, P1; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Smith PM, 2002, EXP NEUROL, V176, P402, DOI 10.1006/exnr.2002.7936; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; Tecirlioglu RT, 2007, REPROD FERT DEVELOP, V19, P740, DOI 10.1071/RD07039; Tetzlaff W, 2010, J NEUROTRAUMA; Vaags AK, 2009, STEM CELLS, V27, P329, DOI 10.1634/stemcells.2008-0433; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Weiss S, 1996, J NEUROSCI, V16, P7599; WEWETZER K, 2010, EXP NEUROL; Wilcox JT, 2009, STEM CELLS DEV, V18, P1167, DOI 10.1089/scd.2008.0336; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	61	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19768	10.1371/journal.pone.0019768	http://dx.doi.org/10.1371/journal.pone.0019768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611190	Green Published, gold, Green Submitted			2022-12-25	WOS:000290657500019
J	Fortuna, K; van IJzendoorn, MH; Mankuta, D; Kaitz, M; Avinun, R; Ebstein, RP; Knafo, A				Fortuna, Keren; van IJzendoorn, Marinus H.; Mankuta, David; Kaitz, Marsha; Avinun, Reut; Ebstein, Richard P.; Knafo, Ariel			Differential Genetic Susceptibility to Child Risk at Birth in Predicting Observed Maternal Behavior	PLOS ONE			English	Article							PRETERM INFANTS; PARENTING STRESS; ENVIRONMENTAL-INFLUENCES; EXTERNALIZING BEHAVIOR; WEIGHT INFANT; MOTHER-CHILD; LIFE STRESS; POLYMORPHISM; TERM; DRD4	This study examined parenting as a function of child medical risks at birth and parental genotype (dopamine D4 receptor; DRD4). Our hypothesis was that the relation between child risks and later maternal sensitivity would depend on the presence/absence of a genetic variant in the mothers, thus revealing a gene by environment interaction (GXE). Risk at birth was defined by combining risk indices of children's gestational age at birth, birth weight, and admission to the neonatal intensive care unit. The DRD4-III 7-repeat allele was chosen as a relevant genotype as it was recently shown to moderate the effect of environmental stress on parental sensitivity. Mothers of 104 twin pairs provided DNA samples and were observed with their children in a laboratory play session when the children were 3.5 years old. Results indicate that higher levels of risk at birth were associated with less sensitive parenting only among mothers carrying the 7-repeat allele, but not among mothers carrying shorter alleles. Moreover, mothers who are carriers of the 7-repeat allele and whose children scored low on the risk index were observed to have the highest levels of sensitivity. These findings provide evidence for the interactive effects of genes and environment (in this study, children born at higher risk) on parenting, and are consistent with a genetic differential susceptibility model of parenting by demonstrating that some parents are inherently more susceptible to environmental influences, both good and bad, than are others.	[Fortuna, Keren; Kaitz, Marsha; Ebstein, Richard P.; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [van IJzendoorn, Marinus H.] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands; [Mankuta, David] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Avinun, Reut] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	Hebrew University of Jerusalem; Leiden University; Leiden University - Excl LUMC; Hebrew University of Jerusalem; Hebrew University of Jerusalem; National University of Singapore	Fortuna, K (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	keren.fortuna@mail.huji.ac.il	van IJzendoorn, Marinus/P-4907-2019; Knafo-Noam, Ariel/E-8067-2011	van IJzendoorn, Marinus/0000-0003-1144-454X; Knafo-Noam, Ariel/0000-0003-0613-1960; Avinun, Reut/0000-0002-3281-1268; Ebstein, Richard/0000-0002-3626-541X	Israel Science Foundation [31/06]; Science of Generosity Initiative; Center for the Study of Religion and Society; University of Notre Dame; European Research Council [240994]; Israel Ministry of Immigrant Absorption; Center for Absorption in Science	Israel Science Foundation(Israel Science Foundation); Science of Generosity Initiative; Center for the Study of Religion and Society; University of Notre Dame; European Research Council(European Research Council (ERC)European Commission); Israel Ministry of Immigrant Absorption; Center for Absorption in Science	This study was supported in part by grant No. 31/06 from the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (AK). Preparation of this manuscript was supported by a grant from The Science of Generosity Initiative, Center for the Study of Religion and Society, University of Notre Dame (AK) and by a European Research Council Grant (Starting Grant no. 240994) to the last author (AK). KF is the recipient of a post-doctoral fellowship awarded by the Israel Ministry of Immigrant Absorption, The Center for Absorption in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDIN RR, 1990, J CLIN CHILD PSYCHOL, V19, P298, DOI 10.1207/s15374424jccp1904_1; Ainsworth M., 1978, PATTERNS ATTACHMENT; Allhusen V, 2004, DEV PSYCHOPATHOL, V16, P43, DOI 10.1017/S0954579404040404; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; BARNARD KE, 1984, INFANT BEHAV DEV, V7, P101, DOI 10.1016/S0163-6383(84)80026-0; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Belsky J., 2005, ORIGINS SOCIAL MIND, P139; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Belsky J, 2009, PERSPECT PSYCHOL SCI, V4, P345, DOI 10.1111/j.1745-6924.2009.01136.x; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cassidy J., 1999, HDB ATTACHMENT THEOR; Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381; Darlow BA, 2009, J PAEDIATR CHILD H, V45, P181, DOI 10.1111/j.1440-1754.2009.01486.x; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Feeley N, 2005, J DEV BEHAV PEDIATR, V26, P24; Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223; Feldman R, 2004, CHILD DEV, V75, P1774, DOI 10.1111/j.1467-8624.2004.00816.x; Halpern LF, 2001, J PEDIATR PSYCHOL, V26, P93, DOI 10.1093/jpepsy/26.2.93; HARRISON MJ, 1990, RES NURS HEALTH, V13, P173, DOI 10.1002/nur.4770130306; Harrison MJ, 1996, RES NURS HEALTH, V19, P451, DOI 10.1002/(SICI)1098-240X(199612)19:6<451::AID-NUR1>3.0.CO;2-N; Hughes JR, 2004, CHILD ABUSE NEGLECT, V28, P1081, DOI 10.1016/j.chiabu.2004.02.004; Kaitz M, 2010, DEV PSYCHOBIOL, V52, P149, DOI 10.1002/dev.20423; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kochanska G, 1997, CHILD DEV, V68, P94, DOI 10.2307/1131928; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.2307/1131254; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Neiderhiser JM, 2004, DEV PSYCHOL, V40, P335, DOI 10.1037/0012-1649.40.3.335; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; Rutter M., 2006, GENES BEHAV; Sameroff AJ, 1983, HDB CHILD PSYCHOL FO, P237; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Singer LT, 2007, J PEDIATR-US, V151, P463, DOI 10.1016/j.jpeds.2007.04.012; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; van Ijzendoorn MH, 2008, GENES BRAIN BEHAV, V7, P403, DOI 10.1111/j.1601-183X.2007.00362.x; Van Ijzendoorn MH, 2006, ATTACH HUM DEV, V8, P291, DOI 10.1080/14616730601048159; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; VOLLING BL, 1992, CHILD DEV, V63, P1209, DOI 10.2307/1131528; WASHINGTON J, 1986, J AM ACAD CHILD PSY, V25, P493, DOI 10.1016/S0002-7138(10)60008-8; Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I; Zuckerman M., 1999, VULNERABILITY PSYCHO	60	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19765	10.1371/journal.pone.0019765	http://dx.doi.org/10.1371/journal.pone.0019765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603618	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300024
J	Hung, TT; Chan, J; Russell, PJ; Power, CA				Hung, Tzong-Tyng; Chan, Jeffrey; Russell, Pamela J.; Power, Carl A.			Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model	PLOS ONE			English	Article							BREAST-CANCER; MULTIPLE-MYELOMA; OSTEOLYTIC METASTASES; CLINICAL-EVALUATION; IN-VIVO; IBANDRONATE; PROGRESSION; MARKERS; RADIOTHERAPY; TURNOVER	Background: The bisphosphonate, zoledronic acid (ZOL), can inhibit osteoclasts leading to decreased osteoclastogenesis and osteoclast activity in bone. Here, we used a mixed osteolytic/osteoblastic murine model of bone-metastatic prostate cancer, RM1(BM), to determine how inhibiting osteolysis with ZOL affects the ability of these cells to establish metastases in bone, the integrity of the tumour-bearing bones and the survival of the tumour-bearing mice. Methods: The model involves intracardiac injection for arterial dissemination of the RM1(BM) cells in C57BL/6 mice. ZOL treatment was given via subcutaneous injections on days 0, 4, 8 and 12, at 20 and 100 mu g/kg doses. Bone integrity was assessed by micro-computed tomography and histology with comparison to untreated mice. The osteoclast and osteoblast activity was determined by measuring serum tartrate-resistant acid phosphatase 5b (TRAP 5b) and osteocalcin, respectively. Mice were euthanased according to predetermined criteria and survival was assessed using Kaplan Meier plots. Findings: Micro-CT and histological analysis showed that treatment of mice with ZOL from the day of intracardiac injection of RM1(BM) cells inhibited tumour-induced bone lysis, maintained bone volume and reduced the calcification of tumour-induced endochondral osteoid material. ZOL treatment also led to a decreased serum osteocalcin and TRAP 5b levels. Additionally, treated mice showed increased survival compared to vehicle treated controls. However, ZOL treatment did not inhibit the cells ability to metastasise to bone as the number of bone-metastases was similar in both treated and untreated mice. Conclusions: ZOL treatment provided significant benefits for maintaining the integrity of tumour-bearing bones and increased the survival of tumour bearing mice, though it did not prevent establishment of bone-metastases in this model. From the mechanistic view, these observations confirm that tumour-induced bone lysis is not a requirement for establishment of these bone tumours.	[Hung, Tzong-Tyng; Power, Carl A.] Prince Wales Hosp, Prince Wales Clin Sch, Randwick, NSW 2031, Australia; [Chan, Jeffrey] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Hung, Tzong-Tyng; Chan, Jeffrey; Power, Carl A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Russell, Pamela J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Queensland University of Technology (QUT)	Hung, TT (corresponding author), Prince Wales Hosp, Prince Wales Clin Sch, Randwick, NSW 2031, Australia.	c.power@unsw.edu.au	Russell, Pamela/O-8504-2019; Russell, Pamela J/G-1685-2010	Russell, Pamela J/0000-0002-3995-1239; Hung, Tzong/0000-0002-2904-2664	Novartis Australia; Prostate Cancer Foundation of Australia; Sydney Foundation of Medical Research	Novartis Australia(Novartis); Prostate Cancer Foundation of Australia; Sydney Foundation of Medical Research	The authors wish to declare that this work was funded in part by a research grant from Novartis Australia. Novartis also provided the zoledronic acid for this study. TH was partially supported by the Prostate Cancer Foundation of Australia. CAP was partially funded by the Sydney Foundation of Medical Research and is a fellow of the National Imaging Facility, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brubaker KD, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-15; Clezardin P, 2005, CANCER TREAT REV, V31, pS1, DOI 10.1016/j.ctrv.2005.09.002; Corey E, 2003, CLIN CANCER RES, V9, P295; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Dieli F, 2003, BLOOD, V102, P2310, DOI 10.1182/blood-2003-05-1655; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Generali D, 2008, BRIT J CANCER, V98, P1753, DOI 10.1038/sj.bjc.6604390; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hatoum HT, 2010, CURR MED RES OPIN; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Kouloulias V, 2003, INT J RADIAT ONCOL, V57, P143, DOI 10.1016/S0360-3016(03)00525-X; Lee Y, 2003, J ORTHOP RES, V21, P62, DOI 10.1016/S0736-0266(02)00095-5; Lein M, 2007, EUR UROL, V52, P1381, DOI 10.1016/j.eururo.2007.02.033; Liao JH, 2008, INT J CANCER, V123, P2267, DOI 10.1002/ijc.23602; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Menssen HD, 2002, J CLIN ONCOL, V20, P2353, DOI 10.1200/JCO.2002.02.032; Michigami T, 2002, BREAST CANCER RES TR, V75, P249, DOI 10.1023/A:1019905111666; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Power CA, 2009, PROSTATE; Quinn JE, 2005, PROSTATE CANCER P D, V8, P253, DOI 10.1038/sj.pcan.4500815; RALIS ZA, 1992, BIOTECH HISTOCHEM, V67, P339, DOI 10.3109/10520299209110046; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Rucci N, 2004, BONE, V34, P697, DOI 10.1016/j.bone.2003.07.012; Saad F, 2010, UROLOGY, V76, P1175, DOI 10.1016/j.urology.2010.05.026; Vassiliou V, 2007, CLIN EXP METASTAS, V24, P169, DOI 10.1007/s10585-007-9066-x; Vassiliou V, 2007, INT J RADIAT ONCOL, V67, P264, DOI 10.1016/j.ijrobp.2006.08.022; Wang G, 2009, CANCER RES, V69, P3433, DOI 10.1158/0008-5472.CAN-08-3506	28	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19389	10.1371/journal.pone.0019389	http://dx.doi.org/10.1371/journal.pone.0019389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603655	gold, Green Published, Green Submitted			2022-12-25	WOS:000290656300007
J	Garbelli, A; Beermann, S; Di Cicco, G; Dietrich, U; Maga, G				Garbelli, Anna; Beermann, Sandra; Di Cicco, Giulia; Dietrich, Ursula; Maga, Giovanni			A Motif Unique to the Human Dead-Box Protein DDX3 Is Important for Nucleic Acid Binding, ATP Hydrolysis, RNA/DNA Unwinding and HIV-1 Replication	PLOS ONE			English	Article							RNA HELICASE; FAMILY	DEAD-box proteins are enzymes endowed with nucleic acid-dependent ATPase, RNA translocase and unwinding activities. The human DEAD-box protein DDX3 has been shown to play important roles in tumor proliferation and viral infections. In particular, DDX3 has been identified as an essential cofactor for HIV-1 replication. Here we characterized a set of DDX3 mutants biochemically with respect to nucleic acid binding, ATPase and helicase activity. In particular, we addressed the functional role of a unique insertion between motifs I and la of DDX3 and provide evidence for its implication in nucleic acid binding and HIV-1 replication. We show that human DDX3 lacking this domain binds HIV-1 RNA with lower affinity. Furthermore, a specific peptide ligand for this insertion selected by phage display interferes with HIV-1 replication after transduction into HelaP4 cells. Besides broadening our understanding of the structure-function relationships of this important protein, our results identify a specific domain of DDX3 which may be suited as target for antiviral drugs designed to inhibit cellular cofactors for HIV-1 replication.	[Garbelli, Anna; Di Cicco, Giulia; Maga, Giovanni] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Beermann, Sandra; Dietrich, Ursula] Georg Speyer Haus Inst Biomed Res, Frankfurt, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Garbelli, A (corresponding author), CNR, Inst Mol Genet, I-27100 Pavia, Italy.	maga@igm.cnr.it	Dietrich, Ursula/AAD-5704-2020; Maga, Giovanni/C-5409-2009	Maga, Giovanni/0000-0001-8092-1552; Dietrich, Ursula/0000-0003-2491-4758	Italian Association for Cancer Research [AIRC-IG2008-2010-4538]; Italian National Interest Research Project [PRIN2007_N7KYCY]; Italian National AIDS Programme Research Project [40H26]; European Commission [LSHP-CT-2006-037257]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian National Interest Research Project; Italian National AIDS Programme Research Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been partially supported by an Italian Association for Cancer Research Grant (AIRC-IG2008-2010-4538) to GM, by an Italian National Interest Research Project (PRIN2007_N7KYCY) to GM, by an Italian National AIDS Programme Research Project (40H26) to GM and by the European Commission FP6 Project Excellent-Hit (LSHP-CT-2006-037257) to GM and UD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Franca R, 2007, PROTEINS, V67, P1128, DOI 10.1002/prot.21433; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; LIU J, 2011, J NEUROIMMUNE PHARM; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	24	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19810	10.1371/journal.pone.0019810	http://dx.doi.org/10.1371/journal.pone.0019810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589879	gold, Green Published, Green Submitted			2022-12-25	WOS:000290531100028
J	Portelli, G; Ruffier, F; Roubieu, FL; Franceschini, N				Portelli, Geoffrey; Ruffier, Franck; Roubieu, Frederic L.; Franceschini, Nicolas			Honeybees' Speed Depends on Dorsal as Well as Lateral, Ventral and Frontal Optic Flows	PLOS ONE			English	Article							FLIGHT SPEED; VISUAL CONTROL; GROUND SPEED; BEES; VISION; HEIGHT; COMPENSATION; ORGANIZATION; NAVIGATION; DROSOPHILA	Flying insects use the optic flow to navigate safely in unfamiliar environments, especially by adjusting their speed and their clearance from surrounding objects. It has not yet been established, however, which specific parts of the optical flow field insects use to control their speed. With a view to answering this question, freely flying honeybees were trained to fly along a specially designed tunnel including two successive tapering parts: the first part was tapered in the vertical plane and the second one, in the horizontal plane. The honeybees were found to adjust their speed on the basis of the optic flow they perceived not only in the lateral and ventral parts of their visual field, but also in the dorsal part. More specifically, the honeybees' speed varied monotonically, depending on the minimum cross-section of the tunnel, regardless of whether the narrowing occurred in the horizontal or vertical plane. The honeybees' speed decreased or increased whenever the minimum cross-section decreased or increased. In other words, the larger sum of the two opposite optic flows in the horizontal and vertical planes was kept practically constant thanks to the speed control performed by the honeybees upon encountering a narrowing of the tunnel. The previously described ALIS ("AutopiLot using an Insect-based vision System'') model nicely matches the present behavioral findings. The ALIS model is based on a feedback control scheme that explains how honeybees may keep their speed proportional to the minimum local cross-section of a tunnel, based solely on optic flow processing, without any need for speedometers or rangefinders. The present behavioral findings suggest how flying insects may succeed in adjusting their speed in their complex foraging environments, while at the same time adjusting their distance not only from lateral and ventral objects but also from those located in their dorsal visual field.	[Portelli, Geoffrey; Ruffier, Franck; Roubieu, Frederic L.; Franceschini, Nicolas] Univ Aix Marseille 2, Biorobot Dept, Inst Movement Sci, CNRS, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Portelli, G (corresponding author), Univ Aix Marseille 2, Biorobot Dept, Inst Movement Sci, CNRS, F-13284 Marseille 07, France.	franck.ruffier@univmed.fr	RUFFIER, Franck/G-4797-2013	RUFFIER, Franck/0000-0002-7854-1275	CNRS (Life Science; Information and Engineering Science and Technology); Aix-Marseille University; French Defense Agency (DGA) [05 34 022]; French Agency for Research (ANR); European Space Agency (ESA) [08-6303b]; European Commission [237940]	CNRS (Life Science; Information and Engineering Science and Technology)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; French Defense Agency (DGA); French Agency for Research (ANR)(French National Research Agency (ANR)); European Space Agency (ESA)(European Space Agency); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by CNRS (Life Science; Information and Engineering Science and Technology), Aix-Marseille University, the French Defense Agency (DGA, 05 34 022), the French Agency for Research (ANR, EVA project), the European Space Agency (ESA) under contract no 08-6303b and the European Commission via the CURVACE project. The project CURVACE acknowledges the financial support of the Future and Emerging Technologies (FET) program within the Seventh Framework Program for Research of the European Commission, under FETOpen grant number 237940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird E, 2005, J EXP BIOL, V208, P3895, DOI 10.1242/jeb.01818; BAIRD E, 2007, THESIS AUSTR NATL U; Baird E, 2006, LECT NOTES COMPUT SC, V4095, P40; Baird E, 2010, J EXP BIOL, V213, P1625, DOI 10.1242/jeb.038802; Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Beyeler A, 2009, AUTON ROBOT, V27, P201, DOI 10.1007/s10514-009-9139-6; BISHOP LG, 1970, J COMP PHYSIOL A, V70, P374; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1209, DOI 10.1098/rspb.2009.1928; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; Buchner E., 1984, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V74, P561; COLLETT T, 1993, VISUAL MOTION ITS RO, P239; Conroy J, 2009, AUTON ROBOT, V27, P189, DOI 10.1007/s10514-009-9140-0; DAVID CT, 1979, PHYSIOL ENTOMOL, V4, P209, DOI 10.1111/j.1365-3032.1979.tb00197.x; DAVID CT, 1982, J COMP PHYSIOL, V147, P485, DOI 10.1007/BF00612014; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; Eckert MP, 2001, MOTION VISION, P333; Fadamiro HY, 1998, J INSECT BEHAV, V11, P549, DOI 10.1023/A:1022367430354; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Franceschini N., 2009, FUTURA, V3, P15; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; HENGSTENBERG R, 1988, J COMP PHYSIOL A, V163, P151, DOI 10.1007/BF00612425; HENGSTENBERG R, 1992, P 20 GOTT NEUR C; HENGSTENBERG R, 2001, P INV VIS C; KAISER W, 1974, J COMP PHYSIOL, V89, P391, DOI 10.1007/BF00695355; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; KIRCHNER WH, 1989, NATURWISSENSCHAFTEN, V76, P281, DOI 10.1007/BF00368643; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; KUENEN LPS, 1982, PHYSIOL ENTOMOL, V7, P193, DOI 10.1111/j.1365-3032.1982.tb00289.x; MARTIN N, 1994, INTELLIGENT VEHICLES, P381; MENZEL R, 1973, J COMP PHYSIOL, V82, P135, DOI 10.1007/BF00696149; Menzel Randolf, 1991, P262; Netter T, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P129, DOI 10.1109/IRDS.2002.1041376; PICHON JM, 1989, MOBILE ROBOTS 4, V1195, P44; Portelli G, 2010, J PHYSIOL-PARIS, V104, P27, DOI 10.1016/j.jphysparis.2009.11.011; Portelli G, 2010, J COMP PHYSIOL A, V196, P307, DOI 10.1007/s00359-010-0510-z; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; REICHARDT W, 1969, PROCESSING OPTICAL D, P465; Ruffier F, 2005, ROBOT AUTON SYST, V50, P177, DOI 10.1016/j.robot.2004.09.016; Ruffier F, 2003, PROC SPIE, V5119, P1, DOI 10.1117/12.498193; Ruffier F, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1266, DOI 10.1109/IROS.2008.4651089; SANTOSVICTOR J, 1995, INT J COMPUT VISION, V14, P159, DOI 10.1007/BF01418981; Schilstra C, 1999, J EXP BIOL, V202, P1481; Serres J, 2008, AUTON ROBOT, V25, P103, DOI 10.1007/s10514-007-9069-0; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; SRINIVASAN MV, 1991, VISUAL NEUROSCI, V6, P519, DOI 10.1017/S095252380000136X; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; VALETTE F, 2010, P IEEE INT C ROB AUT, P2253; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeil J, 1996, J EXP BIOL, V199, P245; Zeil J, 2008, CURR BIOL, V18, pR320, DOI 10.1016/j.cub.2008.02.017; ZHANG SW, 1990, VISUAL NEUROSCI, V4, P379, DOI 10.1017/S0952523800004582	56	41	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19486	10.1371/journal.pone.0019486	http://dx.doi.org/10.1371/journal.pone.0019486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589861	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100013
J	Signorini, A; Segre, AM; Polgreen, PM				Signorini, Alessio; Segre, Alberto Maria; Polgreen, Philip M.			The Use of Twitter to Track Levels of Disease Activity and Public Concern in the US during the Influenza A H1N1 Pandemic	PLOS ONE			English	Article							SALES; SURVEILLANCE; REMEDIES	Twitter is a free social networking and micro-blogging service that enables its millions of users to send and read each other's "tweets," or short, 140-character messages. The service has more than 190 million registered users and processes about 55 million tweets per day. Useful information about news and geopolitical events lies embedded in the Twitter stream, which embodies, in the aggregate, Twitter users' perspectives and reactions to current events. By virtue of sheer volume, content embedded in the Twitter stream may be useful for tracking or even forecasting behavior if it can be extracted in an efficient manner. In this study, we examine the use of information embedded in the Twitter stream to (1) track rapidly-evolving public sentiment with respect to H1N1 or swine flu, and (2) track and measure actual disease activity. We also show that Twitter can be used as a measure of public interest or concern about health-related events. Our results show that estimates of influenza-like illness derived from Twitter chatter accurately track reported disease levels.	[Signorini, Alessio; Segre, Alberto Maria] Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Signorini, A (corresponding author), Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA.	philip-polgreen@uiowa.edu	Segre, Alberto M/B-1734-2009	Polgreen, Philip/0000-0002-0630-5898	National Institutes of Health [NIAID K01 AI75089, NIAID-R21-AI081164]; Robert Wood Johnson Foundation Pioneer Portfolio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI075089, R21AI081164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Pioneer Portfolio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided by a National Institutes of Health Career Award NIAID K01 AI75089 (PMP), by the National Institutes of Health grant NIAID-R21-AI081164 (AMS, PMP), and by the Robert Wood Johnson Foundation Pioneer Portfolio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biever C, 2010, NEW SCI, V207, P14, DOI 10.1016/S0262-4079(10)61833-7; *CDCP, 2010, OV INFL SURV US; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cooper Crystale Purvis, 2005, J Med Internet Res, V7, pe36, DOI 10.2196/jmir.7.3.e36; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Davies GR, 2003, CLIN MICROBIOL INFEC, V9, P858, DOI 10.1046/j.1469-0691.2003.00693.x; Drucker H, 1997, ADV NEUR IN, V9, P155; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Giles J, 2010, NEW SCI, V206, P20; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; Irvin CB, 2003, ANN EMERG MED, V41, P447, DOI 10.1067/mem.2003.104; KOSTKOVA P, 2010, POTENTIAL TWITTER EA; LAMPOS V, 2010, TRACKING FLU PANDEMI; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; LORICA B, 2010, TWITTER NUMBERS OREI; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; *NLM NIH, 2006, NLM TECHN B MLA 2006; *PEAR AN, 2009, TWITT STUD AUG 2009; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; SAKAKI T, 2010, EARTHQUAKE SHAKES TW; Shawe-Taylor J., 2000, INTRO SUPPORT VECTOR; STROUP DF, 1988, STAT MED, V7, P1045, DOI 10.1002/sim.4780071006; Suyama J, 2003, ACAD EMERG MED, V10, P753, DOI 10.1111/j.1553-2712.2003.tb00070.x; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; VANRIJSBERGEN CJ, 1980, 5587 BRIT LIB RES DE; Weiss S. M., 1991, COMPUTER SYSTEMS LEA; WELLIVER RC, 1979, PEDIATR RES, V13, P1015, DOI 10.1203/00006450-197909000-00014; Yuan Christine M, 2004, MMWR Suppl, V53, P56; 2010, STREAMING API DOCUME; 2010, PLANE HUDSON PHOTOGR	32	676	694	8	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19467	10.1371/journal.pone.0019467	http://dx.doi.org/10.1371/journal.pone.0019467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573238	Green Published, Green Submitted, gold			2022-12-25	WOS:000290224800031
J	Tamez, PA; Liu, H; Wickrema, A; Haldar, K				Tamez, Pamela A.; Liu, Hui; Wickrema, Amittha; Haldar, Kasturi			P. falciparum Modulates Erythroblast Cell Gene Expression in Signaling and Erythrocyte Production Pathways	PLOS ONE			English	Article							PROTEINS; MALARIA; ERYTHROPOIESIS; VIRULENCE; REVEALS	Global, genomic responses of erythrocytes to infectious agents have been difficult to measure because these cells are enucleated. We have previously demonstrated that in vitro matured, nucleated erythroblast cells at the orthochromatic stage can be efficiently infected by the human malaria parasite Plasmodium falciparum. We now show that infection of orthochromatic cells induces change in 609 host genes. 592 of these transcripts are up-regulated and associated with metabolic and chaperone pathways unique to P. falciparum infection, as well as a wide range of signaling pathways that are also induced in related apicomplexan infections of mouse hepatocytes or human fibroblast cells. Our data additionally show that polychromatophilic cells, which precede the orthochromatic stage and are not infected when co-cultured with P. falciparum, up-regulate a small set of genes, at least two of which are associated with pathways of hematopoiesis and/or erythroid cell development. These data support the idea that P. falciparum affects erythropoiesis at multiple stages during erythroblast differentiation. Further P. falciparum may modulate gene expression in bystander erythroblasts and thus influence pathways of erythrocyte development. This study provides a benchmark of the host erythroblast cell response to infection by P. falciparum.	[Tamez, Pamela A.; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Dept Biol Sci, South Bend, IN USA; [Liu, Hui; Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Notre Dame; University of Chicago	Tamez, PA (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Dept Biol Sci, South Bend, IN USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014	Tamez, Pamela/0000-0001-9005-4560	NIH [R01 HL 079397, R01 069630, P01 HL 078826, HL069630]; Giving Tree Foundation [NIH:RO1CA98550]; Northwestern University Dept. Microbiology-Immunology [T32 AI007476]; American Heart Association [0425607Z]; NATIONAL CANCER INSTITUTE [R01CA098550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630, P01HL078826, R01HL079397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giving Tree Foundation; Northwestern University Dept. Microbiology-Immunology; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by grants to KH (NIH: R01 HL 079397, R01 069630, P01 HL 078826), to AW (NIH:RO1CA98550, Giving Tree Foundation), and to PT (Institutional National Research Service Award at Northwestern University Dept. Microbiology-Immunology (T32 AI007476), the American Heart Association (0425607Z), and NIH Research Supplements to Promote Diversity in Health-Related Research (HL069630)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DEMAST Q, 1995, HAEMATOLOGICA, V95, P1068; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lodish H, 2010, IUBMB LIFE, V62, P492, DOI 10.1002/iub.322; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; PASVOL G, 1983, CIBA F SYMP, V94, P174; Prentice AM, 2007, FOOD NUTR BULL, V28, pS524, DOI 10.1177/15648265070284S406; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RUSTEN LS, 1996, BLOOD, V87; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Skorokhod OA, 2010, BLOOD, V116, P4328, DOI 10.1182/blood-2010-03-272781; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; WICKRAMASINGHE SN, 1987, BRIT J HAEMATOL, V66, P295, DOI 10.1111/j.1365-2141.1987.tb06913.x; Zhu J, 2001, BLOOD, V98, P2563, DOI 10.1182/blood.V98.8.2563	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19307	10.1371/journal.pone.0019307	http://dx.doi.org/10.1371/journal.pone.0019307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573240	gold, Green Submitted, Green Published			2022-12-25	WOS:000290224800021
J	Li, CG; Nyman, JE; Braithwaite, AW; Eccles, MR				Li, C. G.; Nyman, J. E.; Braithwaite, A. W.; Eccles, M. R.			PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein	ONCOGENE			English	Article						cell cycle; E2F1; PAX8; RB; senescence	UBIQUITIN-INDEPENDENT DEGRADATION; RETINOBLASTOMA PROTEIN; SUPPRESSOR PROTEIN; PROTEASOME PATHWAY; GENE-EXPRESSION; BINDING-SITES; THYROID-GLAND; WILMS-TUMORS; CYCLE; PRB	The retinoblastoma protein (RB)-E2F1 pathway has a central role in regulating the cell cycle. Several PAX proteins (tissue-specific developmental regulators), including PAX8, interact with the RB protein, and thus regulate the cell cycle directly or indirectly. Here, we report that PAX8 expression is frequent in renal cell carcinoma, bladder, ovarian and thyroid cancer cell lines, and that silencing of PAX8 in cancer cell lines leads to a striking reduction in the expression of E2F1 and its target genes, as well as a proteasome-dependent destabilization of RB protein, with the RB1 mRNA level remaining unaffected. Cancer cells expressing PAX8 undergo a G(1)/S arrest and eventually senesce following PAX8 silencing. We demonstrate that PAX8 transcriptionally regulates the E2F1 promoter directly, and E2F1 transcription is enhanced after RB depletion. RB is recruited to the PAX8-binding site, and is involved in PAX8-mediated E2F1 transcription in cancer cells. Therefore, our results suggest that, in cancer, frequent and persistent expression of PAX8 is required for cell growth control through transcriptional activation of E2F1 expression and upregulation of the RB-E2F1 pathway. Oncogene (2011) 30, 4824-4834; doi: 10.1038/onc.2011.190; published online 23 May 2011	[Li, C. G.; Nyman, J. E.; Braithwaite, A. W.; Eccles, M. R.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin 9054, Otago, New Zealand; [Braithwaite, A. W.] Univ Sydney, Childrens Med Res Inst, Cell Transformat Unit, Sydney, NSW 2006, Australia	University of Otago; Children's Medical Research Institute - Australia; University of Sydney	Eccles, MR (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, POB 913,Great King St, Dunedin 9054, Otago, New Zealand.	michael.eccles@otago.ac.nz			New Zealand Institute for Cancer Research Trust (Otago); CMRI (Sydney); Health Research Council; University of Otago; Dunedin School of Medicine; Health Research Council of New Zealand; University of Otago Faculty of Medicine Trust	New Zealand Institute for Cancer Research Trust (Otago); CMRI (Sydney); Health Research Council; University of Otago; Dunedin School of Medicine; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago Faculty of Medicine Trust	MRE and AWB are supported by funds from the New Zealand Institute for Cancer Research Trust (Otago) and the CMRI (Sydney), respectively. CGL was supported by the Health Research Council, the University of Otago International Fees Scholarship and Postgraduate Publishing Bursary and the Dunedin School of Medicine Finishing Your PhD Scholarship. This work was supported by grants from the Health Research Council of New Zealand and the University of Otago Faculty of Medicine Trust Fund.	Berezutskaya E, 1997, J BIOL CHEM, V272, P30135, DOI 10.1074/jbc.272.48.30135; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Boyer SN, 1996, CANCER RES, V56, P4620; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen YJ, 2008, CANCER RES, V68, P5724, DOI 10.1158/0008-5472.CAN-08-0058; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Daniel L, 2001, HUM PATHOL, V32, P282, DOI 10.1053/hupa.2001.22753; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ECCLES MR, 1995, AM J PATHOL, V146, P40; Esposito C, 1998, BIOCHEM J, V331, P37, DOI 10.1042/bj3310037; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; He SJ, 2010, J INVEST DERMATOL, V130, P1465, DOI 10.1038/jid.2009.434; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Hueber PA, 2006, KIDNEY INT, V69, P1139, DOI 10.1038/sj.ki.5000136; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Little MH, 2009, J AM SOC NEPHROL, V20, P2112, DOI 10.1681/ASN.2009010066; Long KB, 2010, AM J SURG PATHOL, V34, P723, DOI 10.1097/PAS.0b013e3181da0a20; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Miccadei S, 2005, ONCOGENE, V24, P6993, DOI 10.1038/sj.onc.1208861; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POLEEV A, 1995, EUR J BIOCHEM, V228, P899, DOI 10.1111/j.1432-1033.1995.tb20338.x; ROSSI DL, 1995, J BIOL CHEM, V270, P23139, DOI 10.1074/jbc.270.39.23139; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Tong GX, 2009, MODERN PATHOL, V22, P1218, DOI 10.1038/modpathol.2009.88; Tong GX, 2006, MODERN PATHOL, V19, P356, DOI 10.1038/modpathol.3800535; Vilain C, 2001, J CLIN ENDOCR METAB, V86, P234, DOI 10.1210/jc.86.1.234; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Wyllie FS, 1999, BRIT J CANCER, V79, P1111, DOI 10.1038/sj.bjc.6690177; Yen A, 1997, EUR J CELL BIOL, V72, P159; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x	62	42	43	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	48					4824	4834		10.1038/onc.2011.190	http://dx.doi.org/10.1038/onc.2011.190			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21602887	hybrid, Green Published			2022-12-25	WOS:000298134700006
J	Jiang, J; Liu, W; Guo, X; Zhang, R; Zhi, Q; Ji, J; Zhang, J; Chen, X; Li, J; Zhang, J; Gu, Q; Liu, B; Zhu, Z; Yu, Y				Jiang, J.; Liu, W.; Guo, X.; Zhang, R.; Zhi, Q.; Ji, J.; Zhang, J.; Chen, X.; Li, J.; Zhang, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y.			IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer	ONCOGENE			English	Article						gastric carcinoma; IRX1; angiogenesis; vasculogenic mimicry; BDKRB2	VASCULAR CHANNEL FORMATION; ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELL PLASTICITY; VASCULOGENIC MIMICRY; IN-VIVO; DOWN-REGULATION; FACTOR RECEPTOR; MELANOMA-CELLS; BREAST-CANCER; ANGIOGENESIS	The overexpression of IRX1 gene correlates with the growth arrest in gastric cancer. Furthermore, overexpression of IRX1 gene suppresses peritoneal spreading and long distance metastasis. To explore the precise mechanisms, we investigated whether restoring IRX1 expression affects the angiogenesis or vasculogenic mimicry (VM). Human umbilical vein endothelial cells (HUVECs) and chick embryo and SGC-7901 gastric cancer cells were used for angiogenesis and VM analysis. Small interfering RNA was used for analyzing the function of BDKRB2, a downstream target gene of IRX1. As results, the remarkable suppression on peritoneal spreading and pulmonary metastasis of SGC-7901 cells by IRX1 transfectant correlates to reduced angiogenesis as well as VM formation. Using the supernatant from SGC-7901/ IRX1 cells, we found a strong inhibiting effect on angiogenesis both in vitro and in chick embryo. SGC-7901/IRX1 cells revealed strong inhibiting effect on VM formation too. By gene-specific RNA interference for BDKRB2, or its effector PAK1, we got an effective inhibition on tube formation, cell proliferation, cell migration and invasion in vitro. In conclusion, enforcing IRX1 expression effectively suppresses peritoneal spreading and pulmonary metastasis via anti-angiogenesis and anti-VM mechanisms, in addition to previously found cell growth and invasion. BDKRB2 and its downstream effector might be potential targets for anti-cancer strategy. Oncogene (2011) 30, 4498-4508; doi:10.1038/onc.2011.154; published online 23 May 2011	Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai Key Lab Diag & Treatment Gastr Canc, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Ruijin Er Rd 197, Shanghai 200025, Peoples R China.	surgeryzhu@yahoo.com.cn; yingyan3y@yahoo.com.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [30572127, 30770961, 30973486]; Chinese National High Tech Program [863-2006AA02A402, 2006AA02A301]; Shanghai Science and Technology Commission [09DZ1950101, 09JC1409600]; Shanghai Charity Foundation for Cancer Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Tech Program(National High Technology Research and Development Program of China); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Charity Foundation for Cancer Research	This work was supported, in part, by grants from the National Natural Science Foundation of China (30572127, 30770961 and 30973486), the Chinese National High Tech Program (863-2006AA02A402 and 2006AA02A301), Key Research Project from Shanghai Science and Technology Commission (09DZ1950101 and 09JC1409600) and Shanghai Charity Foundation for Cancer Research.	Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Altundag K, 2004, CANCER, V100, P1768, DOI 10.1002/cncr.20175; Andoh T, 2010, PEPTIDES, V31, P238, DOI 10.1016/j.peptides.2009.12.003; Basu GD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1626; Becker MB, 2001, MECH DEVELOP, V106, P155, DOI 10.1016/S0925-4773(01)00412-9; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bennett KL, 2009, CANCER RES, V69, P9301, DOI 10.1158/0008-5472.CAN-09-3073; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Cai XZ, 2009, CANCER BIOL THER, V8, P1360, DOI 10.4161/cbt.8.14.8720; Calderon Adrian J, 2005, P R Health Sci J, V24, P27; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Fujimoto A, 2006, ANTICANCER RES, V26, P59; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; Getmanova EV, 2006, CHEM BIOL, V13, P549, DOI 10.1016/j.chembiol.2005.12.009; Gu Wenyi, 2008, V442, P159, DOI 10.1007/978-1-59745-191-8_12; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hao Xishan, 2002, Zhonghua Yi Xue Za Zhi, V82, P1298; Ikeda Y, 2004, CANCER RES, V64, P5178, DOI 10.1158/0008-5472.CAN-03-3589; Ishihara K, 2002, INT IMMUNOPHARMACOL, V2, P499, DOI 10.1016/S1567-5769(01)00193-X; Kramarenko II, 2010, MOL PHARMACOL, V78, P126, DOI 10.1124/mol.110.064840; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Li XD, 2010, EXPERT OPIN THER TAR, V14, P419, DOI 10.1517/14728221003642019; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Lu Y, 2005, CANCER LETT, V224, P329, DOI 10.1016/j.canlet.2004.11.057; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Matsuda KM, 2000, CANCER GENE THER, V7, P589, DOI 10.1038/sj.cgt.7700147; Mirshahi P, 2009, LEUKEMIA, V23, P1039, DOI 10.1038/leu.2009.10; Nogueras S, 2008, AM J PHYSIOL-HEART C, V294, pH708, DOI 10.1152/ajpheart.00466.2007; Oleinikov AV, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni091; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2003, BREAST CANCER RES, V5, P136, DOI 10.1186/bcr585; Sood AK, 2001, AM J PATHOL, V158, P1279, DOI 10.1016/S0002-9440(10)64079-5; Su M, 2008, INT J GYNECOL CANCER, V18, P476, DOI 10.1111/j.1525-1438.2007.01034.x; Sun BC, 2008, HUM PATHOL, V39, P444, DOI 10.1016/j.humpath.2007.07.018; Sun BC, 2006, ONCOL REP, V16, P693; Sun BC, 2004, INT J ONCOL, V25, P1609; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; Veeravalli KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011583; Wu J, 2002, INT J CANCER, V98, P29, DOI 10.1002/ijc.10142; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zhang J, 2008, J CHONGQING MED U, V33, P1603; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036; Zhang WP, 2008, MOL CANCER RES, V6, P1946, DOI 10.1158/1541-7786.MCR-07-2197	51	52	59	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	44					4498	4508		10.1038/onc.2011.154	http://dx.doi.org/10.1038/onc.2011.154			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21602894	Green Published, hybrid			2022-12-25	WOS:000296733200005
J	Baranova, NS; Nileback, E; Haller, FM; Briggs, DC; Svedhem, S; Day, AJ; Richter, RP				Baranova, Natalia S.; Nileback, Erik; Haller, F. Michael; Briggs, David C.; Svedhem, Sofia; Day, Anthony J.; Richter, Ralf P.			The Inflammation-associated Protein TSG-6 Cross-links Hyaluronan via Hyaluronan-induced TSG-6 Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; QUARTZ-CRYSTAL MICROBALANCE; FACTOR-STIMULATED GENE-6; EXTRACELLULAR-MATRIX; TRYPSIN INHIBITOR; RHEUMATOID-ARTHRITIS; BINDING-PROTEINS; SYNOVIAL-FLUID; OOCYTE COMPLEX; HEAVY-CHAINS	Tumor necrosis factor-stimulated gene-6 (TSG-6) is a hyaluronan (HA)-binding protein that plays important roles in inflammation and ovulation. TSG-6-mediated cross-linking of HA has been proposed as a functional mechanism (e. g. for regulating leukocyte adhesion), but direct evidence for cross-linking is lacking, and we know very little about its impact on HA ultrastructure. Here we used films of polymeric and oligomeric HA chains, end-grafted to a solid support, and a combination of surface-sensitive biophysical techniques to quantify the binding of TSG-6 into HA films and to correlate binding to morphological changes. We find that full-length TSG-6 binds with pronounced positive cooperativity and demonstrate that it can cross-link HA at physiologically relevant concentrations. Our data indicate that cooperative binding of full-length TSG-6 arises from HA-induced protein oligomerization and that the TSG-6 oligomers act as cross-linkers. In contrast, the HA-binding domain of TSG-6 (the Link module) alone binds without positive cooperativity and weaker than the full-length protein. Both the Link module and full-length TSG-6 condensed and rigidified HA films, and the degree of condensation scaled with the affinity between the TSG-6 constructs and HA. We propose that condensation is the result of protein-mediated HA cross-linking. Our findings firmly establish that TSG-6 is a potent HA cross-linking agent and might hence have important implications for the mechanistic understanding of the biological function of TSG-6 (e.g. in inflammation).	[Briggs, David C.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Baranova, Natalia S.; Day, Anthony J.; Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, Donostia San Sebastian 20009, Spain; [Richter, Ralf P.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Nileback, Erik; Svedhem, Sofia] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Nileback, Erik] Q Sense, S-42677 Vastra Frolunda, Sweden; [Haller, F. Michael] Hyalose LLC, Oklahoma City, OK 73104 USA	University of Manchester; CIC biomaGUNE; Max Planck Society; Chalmers University of Technology	Day, AJ (corresponding author), CIC BiomaGUNE, Biosurfaces Unit, Paseo Miramon 182, Donostia San Sebastian 20009, Spain.	anthony.day@manchester.ac.uk; rrichter@cicbiomagune.es	Svedhem, Sofia/AAC-8727-2020; Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; biomaGUNE, CIC/J-9136-2014	Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; Briggs, David/0000-0002-9793-7339; Baranova, Natalia/0000-0002-3086-9124; biomaGUNE, CIC/0000-0001-7690-0660	German Federal Ministry of Education and Research (BMBF) [0315157]; Spanish Ministry of Science and Innovation (MICINN) [MAT2008-04192, RYC2009-04275]; Department of Industry of the Basque Government; Max-Planck-Society; Arthritis Research UK [16539, 18472]; Medical Research Council [G0701180]; Versus Arthritis [18472] Funding Source: researchfish; MRC [G0701180] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Government; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by German Federal Ministry of Education and Research (BMBF) Grant 0315157, Spanish Ministry of Science and Innovation (MICINN) Grants MAT2008-04192 and RYC2009-04275), the Department of Industry of the Basque Government, and the Max-Planck-Society.; Supported by Arthritis Research UK Grants 16539 and 18472 and Medical Research Council Grant G0701180.	Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Day A. J., 2004, HASYLAB DESY ANN REP; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Hook F., 2002, ENCY SURFACE COLLOID, P774; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Rubinstein M, 2003, POLYM PHYS; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Steinmetz NF, 2008, BIOMACROMOLECULES, V9, P456, DOI 10.1021/bm700797b; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200	70	104	111	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25675	25686		10.1074/jbc.M111.247395	http://dx.doi.org/10.1074/jbc.M111.247395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596748	hybrid, Green Published			2022-12-25	WOS:000293073000029
J	Kleinau, G; Hoyer, I; Kreuchwig, A; Haas, AK; Rutz, C; Furkert, J; Worth, CL; Krause, G; Schulein, R				Kleinau, Gunnar; Hoyer, Inna; Kreuchwig, Annika; Haas, Ann-Karin; Rutz, Claudia; Furkert, Jens; Worth, Catherine L.; Krause, Gerd; Schuelein, Ralf			From Molecular Details of the Interplay between Transmembrane Helices of the Thyrotropin Receptor to General Aspects of Signal Transduction in Family A G-protein-coupled Receptors (GPCRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN HORMONE-RECEPTORS; HYPERFUNCTIONING THYROID-NODULES; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; TSH RECEPTOR; CONFORMATIONAL-CHANGES; SQUID RHODOPSIN; LIGAND-BINDING; ACTIVATION; MUTATIONS	Transmembrane helices (TMHs) 5 and 6 are known to be important for signal transduction by G-protein-coupled receptors (GPCRs). Our aim was to characterize the interface between TMH5 and TMH6 of the thyrotropin receptor (TSHR) to gain molecular insights into aspects of signal transduction and regulation. A proline at TMH5 position 5.50 is highly conserved in family A GPCRs and causes a twist in the helix structure. Mutation of the TSHR-specific alanine (Ala-593(5.50)) at this position to proline resulted in a 20-fold reduction of cell surface expression. This indicates that TMH5 in the TSHR might have a conformation different from most other family A GPCRs by forming a regular alpha-helix. Furthermore, linking our own and previous data from directed mutagenesis with structural information led to suggestions of distinct pairs of interacting residues between TMH5 and TMH6 that are responsible for stabilizing either the basal or the active state. Our insights suggest that the inactive state conformation is constrained by a core set of polar interactions among TMHs 2, 3, 6, and 7 and in contrast that the active state conformation is stabilized mainly by non-polar interactions between TMHs 5 and 6. Our findings might be relevant for all family A GPCRs as supported by a statistical analysis of residue properties between the TMHs of a vast number of GPCR sequences.	[Kleinau, Gunnar; Hoyer, Inna; Kreuchwig, Annika; Haas, Ann-Karin; Rutz, Claudia; Furkert, Jens; Krause, Gerd; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Worth, Catherine L.] Charite, Inst Physiol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	GKrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft [KR1273/4-1, KL2334/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants KR1273/4-1 and KL2334/2-1.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Biebermann H, 2010, FRONT BIOSCI-LANDMRK, V15, P913, DOI 10.2741/3654; Blois TM, 2009, PROTEIN SCI, V18, P1335, DOI 10.1002/pro.165; Castro I, 2009, THYROID, V19, P645, DOI 10.1089/thy.2009.0002; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claeysen S, 2002, FEBS LETT, V517, P195, DOI 10.1016/S0014-5793(02)02620-0; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Cordella A., 2007, ENDOCR ABSTR, V14; Deflorian F, 2008, PROTEINS, V71, P783, DOI 10.1002/prot.21763; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fricke-Otto S, 2005, EXP CLIN ENDOCR DIAB, V113, P582, DOI 10.1055/s-2005-865914; Gozu H, 2005, THYROID, V15, P389, DOI 10.1089/thy.2005.15.389; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Hallmen C, 2006, J COMPUT AID MOL DES, V20, P673, DOI 10.1007/s10822-006-9088-5; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karges B, 2005, J ENDOCRINOL, V186, P377, DOI 10.1677/joe.1.06208; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kosugi S, 1996, BIOCHEM BIOPH RES CO, V222, P713, DOI 10.1006/bbrc.1996.0809; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Mueller S, 2010, METHOD ENZYMOL, V485, P421, DOI [10.1016/S0076-6879(10)85023-2, 10.1016/B978-0-12-381296-4.00023-3]; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Neumann S, 2001, MOL ENDOCRINOL, V15, P1294, DOI 10.1210/me.15.8.1294; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rashid M, 2003, LIFE SCI, V73, P193, DOI 10.1016/S0024-3205(03)00227-3; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; Ringkananont U, 2006, MOL ENDOCRINOL, V20, P893, DOI 10.1210/me.2005-0339; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; Schulz A, 2000, J BIOL CHEM, V275, P37860, DOI 10.1074/jbc.M006709200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; SMITH BJ, 1993, APPL BIOCHEM BIOTECH, V41, P189, DOI 10.1007/BF02916422; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Sykiotis GP, 2003, BIOCHEM BIOPH RES CO, V301, P1051, DOI 10.1016/S0006-291X(03)00071-8; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Tikhonova IG, 2008, J AM CHEM SOC, V130, P10141, DOI 10.1021/ja0765520; Tonacchera M, 1998, J CLIN ENDOCR METAB, V83, P492, DOI 10.1210/jc.83.2.492; Tsunekawa K, 2006, THYROID, V16, P471, DOI 10.1089/thy.2006.16.471; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	84	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25859	25871		10.1074/jbc.M110.196980	http://dx.doi.org/10.1074/jbc.M110.196980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21586576	hybrid, Green Published			2022-12-25	WOS:000293073000047
J	Lee, GH; Kim, DS; Kim, HT; Lee, JW; Chung, CH; Ahn, T; Lim, JM; Kim, IK; Chae, HJ; Kim, HR				Lee, Geum-Hwa; Kim, Do-Sung; Kim, Hyung-Tae; Lee, Jung-Wook; Chung, Chin-Ha; Ahn, Taeho; Lim, Jung Min; Kim, In-Ki; Chae, Han-Jung; Kim, Hyung-Ryong			Enhanced Lysosomal Activity Is Involved in Bax Inhibitor-1-induced Regulation of the Endoplasmic Reticulum (ER) Stress Response and Cell Death against ER Stress INVOLVEMENT OF VACUOLAR H+-ATPASE (V-ATPASE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; AUTOPHAGY; APOPTOSIS; PATHWAY; BRAIN; DEGRADATION; BI-1; PH; ACIDIFICATION; ARABIDOPSIS	Bax inhibitor-1 (BI-1) is an evolutionarily conserved protein that protects cells against endoplasmic reticulum (ER) stress while also affecting the ER stress response. In this study, we examined BI-1-induced regulation of the ER stress response as well as the control of the protein over cell death under ER stress. In BI-1-overexpressing cells (BI-1 cells), proteasome activity was similar to that of control cells; however, the lysosomal fraction of BI-1 cells showed sensitivity to degradation of BSA. In addition, areas and polygonal lengths of lysosomes were greater in BI-1 cells than in control cells, as assessed by fluorescence and electron microscopy. In BI-1 cells, lysosomal pH was lower than in control cells and lysosomal vacuolar H+-ATPase(V-ATPase), a proton pump, was activated, suggesting high H+ uptake into lysosomes. Even when exposed to ER stress, BI-1 cells maintained high levels of lysosomal activities, including V-ATPase activity. Bafilomycin, a V-ATPase inhibitor, leads to the reversal of BI-1-induced regulation of ER stress response and cell death due to ER stress. In BI-1 knock-out mouse embryo fibroblasts, lysosomal activity and number per cell were relatively lower than in BI-1 wild-type cells. This study suggests that highly maintained lysosomal activity may be one of the mechanisms by which BI-1 exerts its regulatory effects on the ER stress response and cell death.	[Lee, Geum-Hwa; Kim, Do-Sung; Chae, Han-Jung] Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Lee, Geum-Hwa; Kim, Do-Sung; Chae, Han-Jung] Chonbuk Natl Univ, Cardiovasc Res Inst, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Kim, Hyung-Tae; Lim, Jung Min] Chonbuk Natl Univ, Dept Anat, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Lee, Jung-Wook; Chung, Chin-Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ahn, Taeho] Chonnam Natl Univ, Coll Vet Med, Dept Biochem, Kwangju 500757, South Korea; [Kim, In-Ki] ASAN Inst Life Sci, Seoul 138736, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Wonkwang Dent Res Inst, Dept Dent Pharmacol, Iksan 570749, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Seoul National University (SNU); Chonnam National University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju 570749, Chonbuk, South Korea.	hjchae@chonbuk.ac.kr; hrkimdp@wonkwang.ac.kr		Chae, Han-Jung/0000-0003-4190-9889	Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-20275-0]; Korean government [2010-0029497]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Grant R01-2007-000-20275-0 from the Korea Science and Engineering Foundation (KOSEF). This work was also supported in part by a National Research Foundation of Korea grant funded by the Korean government (Grant 2010-0029497).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Carnevalli LS, 2006, BIOCHEM J, V397, P187, DOI 10.1042/BJ20051643; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; CORAZZI L, 1991, J NEUROCHEM, V56, P207, DOI 10.1111/j.1471-4159.1991.tb02582.x; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Hamanaka R, 2008, BBA-MOL BASIS DIS, V1782, P408, DOI 10.1016/j.bbadis.2008.03.001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoon J, 2010, MOL CELL BIOCHEM, V340, P175, DOI 10.1007/s11010-010-0415-8; Yoshida Y, 2010, BBA-GEN SUBJECTS, V1800, P172, DOI 10.1016/j.bbagen.2009.07.029; Youmans SJ, 2001, J EXP BIOL, V204, P2911	42	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24743	24753		10.1074/jbc.M110.167734	http://dx.doi.org/10.1074/jbc.M110.167734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586565	Green Published, hybrid			2022-12-25	WOS:000292547900025
J	Bernard, E; Rolain, T; Courtin, P; Guillot, A; Langella, P; Hols, P; Chapot-Chartier, MP				Bernard, Elvis; Rolain, Thomas; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Hols, Pascal; Chapot-Chartier, Marie-Pierre			Characterization of O-Acetylation of N-Acetylglucosamine A NOVEL STRUCTURAL VARIATION OF BACTERIAL PEPTIDOGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS PEPTIDOGLYCAN; LACTOBACILLUS-PLANTARUM; ENTEROCOCCUS-FAECALIS; CELL-WALL; D-LACTATE; RESISTANCE; IDENTIFICATION; TRANSFORMATION; DEACETYLATION; BIOSYNTHESIS	Peptidoglycan (PG) N-acetyl muramic acid (MurNAc) O-acetylation is widely spread in Gram-positive bacteria and is generally associated with resistance against lysozyme and endogenous autolysins. We report here the presence of O-acetylation on N-acetylglucosamine (GlcNAc) in Lactobacillus plantarum PG. This modification of glycan strands was never described in bacteria. Fine structural characterization of acetylated muropeptides released from L. plantarum PG demonstrated that both MurNAc and GlcNAc are O-acetylated in this species. These two PG post-modifications rely on two dedicated O-acetyltransferase encoding genes, named oatA and oatB, respectively. By analyzing the resistance to cell wall hydrolysis of mutant strains, we showed that GlcNAc O-acetylation inhibits N-acetylglucosaminidase Acm2, the major L. plantarum autolysin. In this bacterial species, inactivation of oatA, encoding MurNAc O-acetyltransferase, resulted in marked sensitivity to lysozyme. Moreover, MurNAc over-O-acetylation was shown to activate autolysis through the putative N-acetylmuramoyl-L-alanine amidase LytH enzyme. Our data indicate that in L. plantarum, two different O-acetyltransferases play original and antagonistic roles in the modulation of the activity of endogenous autolysins.	[Bernard, Elvis; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Bernard, Elvis; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Bernard, Elvis; Rolain, Thomas; Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Chapot-Chartier, MP (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	Marie-Pierre.Chapot@jouy.inra.fr	Langella, Philippe/N-8368-2017	Langella, Philippe/0000-0001-5960-4341; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); National Fund for Scientific Research; Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute Francaise de Belgique (Concerted Research Action); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture;  [MEST-CT-2004-514428]	Institut National de la Recherche Agronomique (INRA); National Fund for Scientific Research; Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute Francaise de Belgique (Concerted Research Action); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); 	This work was supported by a Jeune Equipe grant from the Institut National de la Recherche Agronomique (INRA) (to M.-P. C.-C.) and the National Fund for Scientific Research, the Universite catholique de Louvain (Fonds Speciaux de Recherche), and the Research Department of the Communaute Francaise de Belgique (Concerted Research Action) (all to P. H.).; Recipient of a Marie Curie Fellowship for Early Stage Research Training of the FP6 LabHeath Project (MEST-CT-2004-514428).; Recipient of a doctoral fellowship from Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture.	Aukrust T W, 1995, Methods Mol Biol, V47, P201; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; CORNETT JB, 1978, J BACTERIOL, V135, P153, DOI 10.1128/JB.135.1.153-160.1978; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emirian A, 2009, FEBS LETT, V583, P3033, DOI 10.1016/j.febslet.2009.08.010; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Goffin P, 2005, J BACTERIOL, V187, P6750, DOI 10.1128/JB.187.19.6750-6761.2005; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Sambrook J, 2001, MOL CLONING LAB MANU; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251	37	82	84	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23950	23958		10.1074/jbc.M111.241414	http://dx.doi.org/10.1074/jbc.M111.241414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586574	hybrid, Green Published			2022-12-25	WOS:000292294900037
J	Lugade, AA; Bianchi-Smiraglia, A; Pradhan, V; Elkin, G; Murphy, TF; Thanavala, Y				Lugade, Amit A.; Bianchi-Smiraglia, Anna; Pradhan, Vandana; Elkin, Galina; Murphy, Timothy F.; Thanavala, Yasmin			Lipid Motif of a Bacterial Antigen Mediates Immune Responses via TLR2 Signaling	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; TOLL-LIKE RECEPTOR-2; T-CELL; VACCINE CANDIDATE; ANTIBODY-RESPONSE; DENDRITIC CELLS; P6 PROTEIN; B-CELLS; AGONIST; LIPOPEPTIDES	The cross-talk between the innate and the adaptive immune system is facilitated by the initial interaction of antigen with dendritic cells. As DCs express a large array of TLRs, evidence has accumulated that engagement of these molecules contributes to the activation of adaptive immunity. We have evaluated the immunostimulatory role of the highly-conserved outer membrane lipoprotein P6 from non-typeable Haemophilus influenzae (NTHI) to determine whether the presence of the lipid motif plays a critical role on its immunogenicity. We undertook a systematic analysis of the role that the lipid motif plays in the activation of DCs and the subsequent stimulation of antigen-specific T and B cells. To facilitate our studies, recombinant P6 protein that lacked the lipid motif was generated. Mice immunized with non-lipidated rP6 were unable to elicit high titers of anti-P6 Ig. Expression of the lipid motif on P6 was also required for proliferation and cytokine secretion by antigen-specific T cells. Upregulation of T cell costimulatory molecules was abrogated in DCs exposed to non-lipidated rP6 and in TLR2(-/-) DCs exposed to native P6, thereby resulting in diminished adaptive immune responses. Absence of either the lipid motif on the antigen or TLR2 expression resulted in diminished cytokine production from stimulated DCs. Collectively; our data suggest that the lipid motif of the lipoprotein antigen is essential for triggering TLR2 signaling and effective stimulation of APCs. Our studies establish the pivotal role of a bacterial lipid motif on activating both innate and adaptive immune responses to an otherwise poorly immunogenic protein antigen.	[Lugade, Amit A.; Bianchi-Smiraglia, Anna; Pradhan, Vandana; Elkin, Galina; Thanavala, Yasmin] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Bianchi-Smiraglia, Anna] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Murphy, Timothy F.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lugade, AA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	yasmin.thanavala@roswellpark.org		Murphy, Timothy/0000-0002-3496-2641; Bianchi-Smiraglia, Anna/0000-0002-5963-103X	NIAID [AI069379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069379] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI069379 from NIAID to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2002, AM J RESP CRIT CARE, V165, P967, DOI 10.1164/ajrccm.165.7.2109009; Adlowitz DG, 2005, INFECT IMMUN, V73, P6601, DOI 10.1128/IAI.73.10.6601-6607.2005; Badr WH, 1999, VACCINE, V18, P29, DOI 10.1016/S0264-410X(99)00166-8; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bettahi I, 2006, VIRAL IMMUNOL, V19, P220, DOI 10.1089/vim.2006.19.220; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Chandran SS, 2009, J IMMUNOL, V183, P7832, DOI 10.4049/jimmunol.0901683; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Chua Brendon Y., 2008, V494, P247, DOI 10.1007/978-1-59745-419-3_14; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GREEN BA, 1990, INFECT IMMUN, V58, P3272, DOI 10.1128/IAI.58.10.3272-3278.1990; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Ishida Y, 2006, CLIN IMMUNOL, V121, P90, DOI 10.1016/j.clim.2006.06.005; Iweala OI, 2009, J IMMUNOL, V183, P2252, DOI 10.4049/jimmunol.0804011; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Lombardi V, 2008, CLIN EXP ALLERGY, V38, P1819, DOI 10.1111/j.1365-2222.2008.03056.x; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; McMahon M, 2005, VACCINE, V23, P3590, DOI 10.1016/j.vaccine.2005.01.151; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mineo TWP, 2010, IMMUNOL CELL BIOL, V88, P825, DOI 10.1038/icb.2010.52; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Neary JM, 2001, INFECT IMMUN, V69, P773, DOI 10.1128/IAI.69.2.773-778.2001; Nomura Y, 2008, J CLIN IMMUNOL, V28, P361, DOI 10.1007/s10875-008-9189-0; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Punturieri A, 2006, J IMMUNOL, V177, P673, DOI 10.4049/jimmunol.177.1.673; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19781	10.1371/journal.pone.0019781	http://dx.doi.org/10.1371/journal.pone.0019781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611194	Green Submitted, gold, Green Published			2022-12-25	WOS:000290657500020
J	Polyzos, NP; Mauri, D; Ioannidis, JPA				Polyzos, Nikolaos P.; Mauri, Davide; Ioannidis, John P. A.			Guidelines on Chemotherapy in Advanced Stage Gynecological Malignancies: An Evaluation of 224 Professional Societies and Organizations	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; METHODOLOGICAL QUALITY; MULTIPLE-TREATMENTS; RANDOMIZED EVIDENCE; CANCER; SURVIVAL; METAANALYSIS; CARE; REGIMENS; THERAPY	Background: Clinical practice guidelines are important for guiding practice, but it is unclear if they are commensurate with available evidence. Methods: We examined guidelines produced by cancer and gynecological societies and organizations and evaluated their coverage of and stance towards chemotherapy for advanced stage disease among 4 gynecological malignancies (breast, ovarian, cervical, endometrial cancer) where the evidence for the use of chemotherapy is very different (substantial and conclusive for breast and ovarian cancer, limited and suggesting no major benefit for cervical and endometrial cancer). Eligible societies and organizations were identified through systematic internet searches (last update June 2009). Pertinent websites were scrutinized for presence of clinical practice guidelines, and relative guidelines were analyzed. Results: Among 224 identified eligible societies and organizations, 69 (31%) provided any sort of guidelines, while recommendations for chemotherapy on advanced stage gynecological malignancies were available in 20 of them. Only 14 had developed their own guideline, and only 5 had developed guidelines for all 4 malignancies. Use of levels of evidence and grades of recommendations, and aspects of the production, implementation, and timeliness of the guidelines did not differ significantly across malignancies. Guidelines on breast and ovarian cancer utilized significantly more randomized trials and meta-analyses. Guidelines differed across malignancies on their coverage of disease-free survival (p = 0.033), response rates (p = 0.024), symptoms relief (p = 0.005), quality of life (p = 0.001) and toxicity (p = 0.039), with breast and ovarian cancer guidelines typically covering more frequently these outcomes. All guidelines explicitly or implicitly endorsed the use of chemotherapy. Conclusions: Clinical practice guidelines are provided by the minority of professional societies and organizations. Available guidelines tend to recommend chemotherapy even for diseases where the effect of chemotherapy is controversial and recommendations are based on scant evidence.	[Polyzos, Nikolaos P.; Mauri, Davide; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Mauri, Davide] Gen Hosp Lamia, Dept Med Oncol, Lamia, Greece; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Tufts Med Ctr,Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; Stanford University; Tufts Medical Center; Tufts University	Polyzos, NP (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@stanford.edu	Polyzos, Nikolaos/D-8896-2011; Ioannidis, John P. A./G-9836-2011; Polyzos, Nikolaos P/O-5130-2014	Polyzos, Nikolaos/0000-0001-6161-0011				[Anonymous], HUMAN DEV REPORTS; Arnau JM, 2006, EUR SPINE J, V15, P543, DOI 10.1007/s00586-005-1027-y; Boluyt N, 2005, PEDIATRICS, V115, P1378, DOI 10.1542/peds.2004-0575; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Eden J, 2008, KNOW WHAT WORKS HLTH; Eikelboom J, 2008, LANCET, V371, P1559, DOI 10.1016/S0140-6736(08)60670-4; Giannakakis IA, 2002, J CLIN EPIDEMIOL, V55, P545, DOI 10.1016/S0895-4356(02)00395-5; Graham ID, 2001, CAN MED ASSOC J, V165, P157; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Hall JC, 1997, LANCET, V350, P1752, DOI 10.1016/S0140-6736(05)63577-5; Harpole LH, 2003, CHEST, V123, p7S, DOI 10.1378/chest.123.1_suppl.7S; Hasenfeld R, 2003, QUAL SAF HEALTH CARE, V12, P428, DOI 10.1136/qhc.12.6.428; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V298, P2907, DOI 10.1001/jama.298.24.2907; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Mauri D, 2008, JNCI-J NATL CANCER I, V100, P1780, DOI 10.1093/jnci/djn414; Nelen WLDM, 2008, HUM REPROD, V23, P1786, DOI 10.1093/humrep/den120; Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA), 2004, COCHRANE DB SYST REV, V2; Patsopoulos N. A., 2009, OPEN MED, V3, P62; Peppercorn J, 2008, J CLIN ONCOL, V26, P5994, DOI 10.1200/JCO.2008.18.1420; Polyzos NP, 2006, EUR J CANCER, V42, P319, DOI 10.1016/j.ejca.2005.09.026; Poynard T, 2002, ANN INTERN MED, V136, P888, DOI 10.7326/0003-4819-136-12-200206180-00010; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Somerfield MR, 2008, J CLIN ONCOL, V26, P4022, DOI 10.1200/JCO.2008.17.7139; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Tzioras S, 2007, CANCER TREAT REV, V33, P24, DOI 10.1016/j.ctrv.2006.09.007; Woolf SH, 1998, CHEST, V113, p166S, DOI 10.1378/chest.113.3_Supplement.166S; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20106	10.1371/journal.pone.0020106	http://dx.doi.org/10.1371/journal.pone.0020106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611154	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500042
J	Barrio, AM; Ekerljung, M; Jern, P; Benachenhou, F; Sperber, GO; Bongcam-Rudloff, E; Blomberg, J; Andersson, G				Barrio, Alvaro Martinez; Ekerljung, Marie; Jern, Patric; Benachenhou, Farid; Sperber, Goran O.; Bongcam-Rudloff, Erik; Blomberg, Jonas; Andersson, Goran			The First Sequenced Carnivore Genome Shows Complex Host-Endogenous Retrovirus Relationships	PLOS ONE			English	Article							AVIAN TUMOR-VIRUSES; ALIGNMENT; GENES; RECOMBINATION; EVOLUTION; ELEMENTS	Host-retrovirus interactions influence the genomic landscape and have contributed substantially to mammalian genome evolution. To gain further insights, we analyzed a female boxer (Canis familiaris) genome for complexity and integration pattern of canine endogenous retroviruses (CfERV). Intriguingly, the first such in-depth analysis of a carnivore species identified 407 CfERV proviruses that represent only 0.15% of the dog genome. In comparison, the same detection criteria identified about six times more HERV proviruses in the human genome that has been estimated to contain a total of 8% retroviral DNA including solitary LTRs. These observed differences in man and dog are likely due to different mechanisms to purge, restrict and protect their genomes against retroviruses. A novel group of gammaretrovirus-like CfERV with high similarity to HERV-Fc1 was found to have potential for active retrotransposition and possibly lateral transmissions between dog and human as a result of close interactions during at least 10.000 years. The CfERV integration landscape showed a non-uniform intra-and inter-chromosomal distribution. Like in other species, different densities of ERVs were observed. Some chromosomal regions were essentially devoid of CfERVs whereas other regions had large numbers of integrations in agreement with distinct selective pressures at different loci. Most CfERVs were integrated in antisense orientation within 100 kb from annotated protein-coding genes. This integration pattern provides evidence for selection against CfERVs in sense orientation relative to chromosomal genes. In conclusion, this ERV analysis of the first carnivorous species supports the notion that different mammals interact distinctively with endogenous retroviruses and suggests that retroviral lateral transmissions between dog and human may have occurred.	[Barrio, Alvaro Martinez; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ekerljung, Marie; Benachenhou, Farid; Bongcam-Rudloff, Erik; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, S-75007 Uppsala, Sweden; [Benachenhou, Farid; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Virol Sect, Uppsala, Sweden; [Sperber, Goran O.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; Uppsala University	Barrio, AM (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Goran.Andersson@hgen.slu.se	Andersson, Goran/AAK-6564-2020; Jern, Patric/AAR-2133-2021	Andersson, Goran/0000-0001-5131-3144; Jern, Patric/0000-0003-3393-5825; Blomberg, Jonas/0000-0001-6492-2491; Bongcam-Rudloff, Erik/0000-0002-1947-8288	European Commission [LHSG-CT-2004-512092]; Wenner-Gren Foundation (Sweden)	European Commission(European CommissionEuropean Commission Joint Research Centre); Wenner-Gren Foundation (Sweden)	This work was supported by the European Commission FP6 Programme (the EMBRACE project, LHSG-CT-2004-512092). PJ was supported by a fellowship from the Wenner-Gren Foundation (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barrio AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S18; BARTHOLOMEW C, 1991, MOL CELL BIOL, V11, P1820, DOI 10.1128/MCB.11.4.1820; BEEMON K, 1974, P NATL ACAD SCI USA, V71, P4254, DOI 10.1073/pnas.71.10.4254; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Blomberg J, 2009, GENE, V448, P115, DOI 10.1016/j.gene.2009.06.007; Chen Wei-Hua, 2009, BMC Res Notes, V2, P155, DOI 10.1186/1756-0500-2-155; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clough JE, 1996, J MOL EVOL, V42, P52, DOI 10.1007/BF00163211; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katzourakis A, 2007, J VIROL, V81, P10712, DOI 10.1128/JVI.00410-07; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-140; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Smit A, 1996, REPEATMASKER OPEN 30; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSICHLIS PN, 1980, J VIROL, V33, P238, DOI 10.1128/JVI.33.1.238-249.1980; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Volff JN, 2009, ANN NY ACAD SCI, V1178, P233, DOI 10.1111/j.1749-6632.2009.05005.x; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19832	10.1371/journal.pone.0019832	http://dx.doi.org/10.1371/journal.pone.0019832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589882	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100030
J	Osborne, C; Cryan, PM; O'Shea, TJ; Oko, LM; Ndaluka, C; Calisher, CH; Berglund, AD; Klavetter, ML; Bowen, RA; Holmes, KV; Dominguez, SR				Osborne, Christina; Cryan, Paul M.; O'Shea, Thomas J.; Oko, Lauren M.; Ndaluka, Christina; Calisher, Charles H.; Berglund, Andrew D.; Klavetter, Mead L.; Bowen, Richard A.; Holmes, Kathryn V.; Dominguez, Samuel R.			Alphacoronaviruses in New World Bats: Prevalence, Persistence, Phylogeny, and Potential for Interaction with Humans	PLOS ONE			English	Article							SARS-LIKE; CORONAVIRUSES; VIRUSES; TRANSMISSION; COLORADO; RABIES; IDENTIFICATION; RECOMBINATION; INFECTION; RESERVOIR	Bats are reservoirs for many different coronaviruses (CoVs) as well as many other important zoonotic viruses. We sampled feces and/or anal swabs of 1,044 insectivorous bats of 2 families and 17 species from 21 different locations within Colorado from 2007 to 2009. We detected alphacoronavirus RNA in bats of 4 species: big brown bats (Eptesicus fuscus), 10% prevalence; long-legged bats (Myotis volans), 8% prevalence; little brown bats (Myotis lucifugus), 3% prevalence; and western long-eared bats (Myotis evotis), 2% prevalence. Overall, juvenile bats were twice as likely to be positive for CoV RNA as adult bats. At two of the rural sampling sites, CoV RNAs were detected in big brown and long-legged bats during the three sequential summers of this study. CoV RNA was detected in big brown bats in all five of the urban maternity roosts sampled throughout each of the periods tested. Individually tagged big brown bats that were positive for CoV RNA and later sampled again all became CoV RNA negative. Nucleotide sequences in the RdRp gene fell into 3 main clusters, all distinct from those of Old World bats. Similar nucleotide sequences were found in amplicons from gene 1b and the spike gene in both a big-brown and a long-legged bat, indicating that a CoV may be capable of infecting bats of different genera. These data suggest that ongoing evolution of CoVs in bats creates the possibility of a continued threat for emergence into hosts of other species. Alphacoronavirus RNA was detected at a high prevalence in big brown bats in roosts in close proximity to human habitations (10%) and known to have direct contact with people (19%), suggesting that significant potential opportunities exist for cross-species transmission of these viruses. Further CoV surveillance studies in bats throughout the Americas are warranted.	[Osborne, Christina; Berglund, Andrew D.; Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Oko, Lauren M.; Holmes, Kathryn V.; Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Cryan, Paul M.; O'Shea, Thomas J.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Klavetter, Mead L.] Pinon Canyon Maneuver Site, Model, CO USA; [Calisher, Charles H.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ndaluka, Christina; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Osborne, C (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	samuel.dominguez@ucdenver.edu	O'Shea, Thomas/AAY-5848-2021	Cryan, Paul/0000-0002-2915-8894	NIH [AI-P01-059576, 5K08-AI073525-03, U54-AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI073525, P01AI059576, U54AI065357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant #AI-P01-059576 (KVH), NIH grant #5K08-AI073525-03 (SRD), and NIH grant #U54-AI065357 (SRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Armstrong D.M., 1994, DISTRIBUTION ECOLOGY; Calisher CH, 2000, EMERG INFECT DIS, V6, P363, DOI 10.3201/eid0604.000406; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491; DONALDSON EF, 2010, J VIROL; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; FITZGERALD J, 1994, MAMMALS COLORADO; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hoofer SR, 2006, J MAMMAL, V87, P981, DOI 10.1644/05-MAMM-A-425R1.1; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; KECK JG, 1988, J VIROL, V62, P1810, DOI 10.1128/JVI.62.5.1810-1813.1988; Kunz T.H., 1982, P1; LAU SK, 2010, J VIROL; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Misra V, 2009, J GEN VIROL, V90, P2015, DOI 10.1099/vir.0.010694-0; Mondul A, 2003, J AM VET MED ASSOC, V222, P633, DOI 10.2460/javma.2003.222.633; MONTO AS, 1974, YALE J BIOL MED, V47, P234; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; O'Shea TJ, 2010, J MAMMAL, V91, P418, DOI 10.1644/08-MAMM-A-295.1; OSHEA TJ, URBAN ECOSY IN PRESS; OSHEA TJ, J MAMMALOGY IN PRESS, V92; Pape WJ, 1999, EMERG INFECT DIS, V5, P433, DOI 10.3201/eid0503.990315; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Piaggio AJ, 2002, J MAMMAL, V83, P386, DOI 10.1644/1545-1542(2002)083<0386:SOMOCV>2.0.CO;2; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; VIJAYKRISHNA D, 2007, J VIROL; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; WONG S, 2006, REV MED VIROL; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94	49	36	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19156	10.1371/journal.pone.0019156	http://dx.doi.org/10.1371/journal.pone.0019156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589915	Green Published, gold, Green Submitted			2022-12-25	WOS:000290531100005
J	Browne, AW; Leddon, JL; Currier, MA; Williams, JP; Frischer, JS; Collins, MH; Ahn, CH; Cripe, TP				Browne, Andrew W.; Leddon, Jennifer L.; Currier, Mark A.; Williams, Jon P.; Frischer, Jason S.; Collins, Margaret H.; Ahn, Chong H.; Cripe, Timothy P.			Cancer Screening by Systemic Administration of a Gene Delivery Vector Encoding Tumor-Selective Secretable Biomarker Expression	PLOS ONE			English	Article							VIRUS; EFFICACY; PROTEIN; NANOPARTICLES; PERMEABILITY; PERSISTENCE; LUCIFERASE; PROMOTER; MARKERS; GROWTH	Cancer biomarkers facilitate screening and early detection but are known for only a few cancer types. We demonstrated the principle of inducing tumors to secrete a serum biomarker using a systemically administered gene delivery vector that targets tumors for selective expression of an engineered cassette. We exploited tumor-selective replication of a conditionally replicative Herpes simplex virus (HSV) combined with a replication-dependent late viral promoter to achieve tumor-selective biomarker expression as an example gene delivery vector. Virus replication, cytotoxicity and biomarker production were low in quiescent normal human foreskin keratinocytes and high in cancer cells in vitro. Following intravenous injection of virus >90% of tumor-bearing mice exhibited higher levels of biomarker than non-tumor-bearing mice and upon necropsy, we detected virus exclusively in tumors. Our strategy of forcing tumors to secrete a serum biomarker could be useful for cancer screening in high-risk patients, and possibly for monitoring response to therapy. In addition, because oncolytic vectors for tumor specific gene delivery are cytotoxic, they may supplement our screening strategy as a "theragnostic'' agent. The cancer screening approach presented in this work introduces a paradigm shift in the utility of gene delivery which we foresee being improved by alternative vectors targeting gene delivery and expression to tumors. Refining this approach will usher a new era for clinical cancer screening that may be implemented in the developed and undeveloped world.	[Browne, Andrew W.; Leddon, Jennifer L.; Currier, Mark A.; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH USA; [Williams, Jon P.; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Frischer, Jason S.] Cincinnati Childrens Hosp Med Ctr, Div Surg, Cincinnati, OH USA; [Collins, Margaret H.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH USA; [Browne, Andrew W.; Leddon, Jennifer L.] Univ Cincinnati, Coll Med, Phys Scientist Training Program, Cincinnati, OH USA; [Browne, Andrew W.; Ahn, Chong H.] Univ Cincinnati, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Browne, AW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH USA.	timothy.cripe@cchmc.org	Williams, Jon/AAP-2761-2020		CancerFree Kids Pediatric Cancer Research Alliance (AWB); NIH [1R01-CA114001-01A2]; NATIONAL CANCER INSTITUTE [R01CA114001] Funding Source: NIH RePORTER	CancerFree Kids Pediatric Cancer Research Alliance (AWB); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the CancerFree Kids Pediatric Cancer Research Alliance (AWB) and NIH award 1R01-CA114001-01A2 (TPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2008, ONCOGENE, V27, P4249, DOI 10.1038/onc.2008.53; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Bharatan NS, 2002, J PEDIAT HEMATOL ONC, V24, P447, DOI 10.1097/00043426-200208000-00008; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Currier MA, 2008, MOL THER, V16, P879, DOI 10.1038/mt.2008.49; Do J, 2008, LAB CHIP, V8, P542, DOI 10.1039/b715569g; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Fu X, 2003, GENE THER, V10, P1458, DOI 10.1038/sj.gt.3302029; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; GUZOWSKI JF, 1994, J VIROL, V68, P7774, DOI 10.1128/JVI.68.12.7774-7789.1994; Harland J, 2003, J NEUROVIROL, V9, P477, DOI 10.1080/13550280390218788; HATAKEYAMA H, 2011, BIOMATERIALS; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Henares TG, 2008, ANAL CHIM ACTA, V611, P17, DOI 10.1016/j.aca.2008.01.064; HENEWEER C, 2011, J NUCL MED; HWANG KJ, 1980, P NATL ACAD SCI-BIOL, V77, P4030, DOI 10.1073/pnas.77.7.4030; Iankov ID, 2009, MOL THER, V17, P1395, DOI 10.1038/mt.2009.92; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012; Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012; Lambright ES, 2000, MOL THER, V2, P387, DOI 10.1006/mthe.2000.0133; Li H, 2010, CANCER GENE THER, V17, P550, DOI 10.1038/cgt.2010.10; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mahller YY, 2006, PEDIATR BLOOD CANCER, V46, P745, DOI 10.1002/pbc.20565; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Marquardt A, 2011, J GEN VIROL; Martuza RL, 2000, J CLIN INVEST, V105, P841, DOI 10.1172/JCI9744; Palumbo JS, 2003, BLOOD, V102, P2819, DOI 10.1182/blood-2003-03-0881; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; QI X, 2009, CANC SELECT IN PRESS; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; RODA A, 2011, BIOSENS BIOELECTRON; SHEN Y, 2006, CANCER GENE THER, V7, P7; Shikano T, 2011, CURR CANCER DRUG TAR, V11, P111, DOI 10.2174/156800911793743673; Stoeva SI, 2006, J AM CHEM SOC, V128, P8378, DOI 10.1021/ja0613106; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TANNOUS BA, 2009, NATURE PROTOCOLS, P582; TERADA K, 2006, GENE THER, V19, P19; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yu W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh049	46	6	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19530	10.1371/journal.pone.0019530	http://dx.doi.org/10.1371/journal.pone.0019530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589655	Green Submitted, Green Published, gold			2022-12-25	WOS:000290483600015
J	Wald, NJ; Simmonds, M; Morris, JK				Wald, Nicholas J.; Simmonds, Mark; Morris, Joan K.			Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age	PLOS ONE			English	Article							BLOOD-PRESSURE; CHOLESTEROL; POPULATION; ACCURACY; SCORE	Background: Risk factors such as blood pressure and serum cholesterol are used, with age, in screening for future cardiovascular disease (CVD) events. The value of using these risk factors with age compared with using age alone is not known. We compared screening for future CVD events using age alone with screening using age and multiple risk factors based on regular Framingham risk assessments. Methods: Ten-year CVD risk was estimated using Framingham risk equations in a hypothetical sample population of 500,000 people aged 0-89 years. Risk estimates were used to identify individuals who did and did not have a CVD event over a ten-year period. For screening using age alone (age screening) and screening using multiple risk factors and age (Framingham screening) we estimated the (i) detection rate (sensitivity); (ii) false-positive rate; (iii) proportion of CVD-free years of life lost in affected individuals with positive results (person-years detection rate); and (iv) cost per CVD-free life year gained from preventive treatment. Results: Age screening using a cut-off of 55 years detected 86% of all first CVD events arising in the population every year and 72% of CVD-free years of life lost for a 24% false-positive rate; for five yearly Framingham screening the false-positive rate was 21% for the same 86% detection rate. The estimated cost per CVD-free year of life gained was 2,000 pound for age screening and 2,200 pound for Framingham screening if a Framingham screen costs 150 pound and the annual cost of preventive treatment is 200 pound. Conclusion: Age screening for future CVD events is simpler than Framingham screening with a similar screening performance and cost-effectiveness. It avoids blood tests and medical examinations. The advantages of age screening in the prevention of heart attack and stroke warrant considering its use in preference to multiple risk factor screening.	[Wald, Nicholas J.; Simmonds, Mark; Morris, Joan K.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021; Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; *EUR MED A, 2008, EMEACHMPEWP311890200; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Law M, 2003, Health Technol Assess, V7, P1; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; *NAT I CLIN EXC, 2008, NICE CLIN GUID, V67; *OFF NAT STAT, 2007, 2005 MORTALITY STAT; *OFF NAT STAT, 2003, HLTH SURVEY ENGLAND; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Wald NJ, 2005, J MED SCREEN, V12, P197, DOI 10.1258/096914105775220642; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	26	79	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18742	10.1371/journal.pone.0018742	http://dx.doi.org/10.1371/journal.pone.0018742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573224	Green Published, gold			2022-12-25	WOS:000290224800006
J	Yoda, K; Murakoshi, M; Tsutsui, K; Kohno, H				Yoda, Ken; Murakoshi, Miku; Tsutsui, Kota; Kohno, Hiroyoshi			Social Interactions of Juvenile Brown Boobies at Sea as Observed with Animal-Borne Video Cameras	PLOS ONE			English	Article							FORAGING ECOLOGY; BEHAVIOR; SEABIRDS; INFORMATION	While social interactions play a crucial role on the development of young individuals, those of highly mobile juvenile birds in inaccessible environments are difficult to observe. In this study, we deployed miniaturised video recorders on juvenile brown boobies Sula leucogaster, which had been hand-fed beginning a few days after hatching, to examine how social interactions between tagged juveniles and other birds affected their flight and foraging behaviour. Juveniles flew longer with congeners, especially with adult birds, than solitarily. In addition, approximately 40% of foraging occurred close to aggregations of congeners and other species. Young seabirds voluntarily followed other birds, which may directly enhance their foraging success and improve foraging and flying skills during their developmental stage, or both.	[Yoda, Ken; Tsutsui, Kota] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Murakoshi, Miku] Tokai Univ, Grad Sch Marine Sci & Technol, Shizuoka, Japan; [Murakoshi, Miku; Kohno, Hiroyoshi] Tokai Univ, Inst Ocean Res & Dev, Shizuoka, Japan; [Kohno, Hiroyoshi] Tokai Univ, Okinawa Reg Res Ctr, Okinawa, Japan	Nagoya University; Tokai University; Tokai University; Tokai University	Yoda, K (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	yoda.ken@nagoya-u.jp			ORRC; Iriomote Project; Research Institute for Humanity and Nature; Japan Society for the Promotion of Science [20519002, 18310153]	ORRC; Iriomote Project; Research Institute for Humanity and Nature; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by grants from ORRC, the Iriomote Project, Research Institute for Humanity and Nature, and grants from the Japan Society for the Promotion of Science to K.Y. and H.K. (20519002, 18310153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Ballance L. T., 1999, ACT 22 C INT ORN, P2057; Bates D. M., 2010, LME4 MIXED EFFECTS M; BURGER J, 1983, CONDOR, V85, P467, DOI 10.2307/1367989; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gremillet D, 2006, MAR BIOL, V148, P1081, DOI 10.1007/s00227-005-0130-2; KISHIMOTO H, 1989, B I OCEANIC RES DEV, V10, P43; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Maransky BP, 2001, WILSON BULL, V113, P350, DOI 10.1676/0043-5643(2001)113[0350:FYEARD]2.0.CO;2; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; R Core Team, 2022, R LANG ENV STAT COMP; Sato K, 2003, MAR MAMMAL SCI, V19, P384, DOI 10.1111/j.1748-7692.2003.tb01116.x; Surman CA, 2003, J ZOOL, V259, P219, DOI 10.1017/S0952836902003047; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2007, DEEP-SEA RES PT II, V54, P321, DOI 10.1016/j.dsr2.2006.11.004	23	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19602	10.1371/journal.pone.0019602	http://dx.doi.org/10.1371/journal.pone.0019602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573196	Green Submitted, Green Published, gold			2022-12-25	WOS:000290224800037
J	Fang, X; Cai, Y; Liu, J; Wang, Z; Wu, Q; Zhang, Z; Yang, CJ; Yuan, L; Ouyang, G				Fang, X.; Cai, Y.; Liu, J.; Wang, Z.; Wu, Q.; Zhang, Z.; Yang, C. J.; Yuan, L.; Ouyang, G.			Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal	ONCOGENE			English	Article						Twist2; epithelial-mesenchymal transition; cancer stem cell; breast cancer; metastasis	UP-REGULATION; EMT; GROWTH; ACTIVATION; DERMO-1; PROTEIN; GENE; MORPHOGENESIS; METASTASIS; INVASION	The epithelial to mesenchymal transition (EMT) is a highly conserved cellular programme that has an important role in normal embryogenesis and in cancer invasion and metastasis. We report here that Twist2, a tissue-specific basic helix-loop-helix transcription factor, is overexpressed in human breast cancers and lymph node metastases. In mammary epithelial cells and breast cancer cells, ectopic overexpression of Twist2 results in morphological transformation, downregulation of epithelial markers and upregulation of mesenchymal markers. Moreover, Twist2 enhances the cell migration and colony-forming abilities of mammary epithelial cells and breast cancer cells in vitro and promotes tumour growth in vivo. Ectopic expression of Twist2 in mammary epithelial cells and breast cancer cells increases the size and number of their CD44(high)/CD24(low) stem-like cell sub-populations, promotes the expression of stem cell markers and enhances the self-renewal capabilities of stem-like cells. In addition, exogenous expression of Twist2 leads to constitutive activation of STAT3 (signal transducer and activator of transcription 3) and downregulation of E-cadherin. Thus, the overexpression of Twist2 may contribute to breast cancer progression by activating the EMT programme and enhancing the self-renewal of cancer stem-like cells. Oncogene (2011) 30, 4707-4720; doi:10.1038/onc.2011.181; published online 23 May 2011	[Fang, X.; Cai, Y.; Liu, J.; Wang, Z.; Yuan, L.; Ouyang, G.] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen 361005, Peoples R China; [Wu, Q.; Zhang, Z.] Xiamen Univ, Affiliated Hosp 1, Dept Breast Surg, Xiamen 361005, Peoples R China; [Yang, C. J.] Xiamen Univ, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Ouyang, G (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen 361005, Peoples R China.	oygldz@yahoo.com.cn	Yang, Chaoyong/Q-5734-2019; yang, chaoyong/F-9741-2010; Fang, Xiaoguang/N-2313-2014	Yang, Chaoyong/0000-0002-2374-5342; yang, chaoyong/0000-0002-2374-5342; 	National Nature Science Foundation of China [30871242, 31071302]; National Basic Research Program of China [2009CB941601, 2010CB732402]; Fundamental Research Funds for the Central Universities [2010121095]; Science Planning Program of Fujian Province [2009J1010]; Outstanding Young Science Foundation of Fujian Province [2010J06013]; Xiamen University [985]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Planning Program of Fujian Province; Outstanding Young Science Foundation of Fujian Province; Xiamen University(Xiamen University)	We thank Professor Kunxin Luo (Department of Molecular and Cell Biology, University of California, Berkeley), Professor Shideng Bao (Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic) and reviewers for critical comments. This work was supported by grants from the National Nature Science Foundation of China (no. 30871242, 31071302), National Basic Research Program of China (no. 2009CB941601, 2010CB732402), the Fundamental Research Funds for the Central Universities (no. 2010121095), the Science Planning Program of Fujian Province (2009J1010), the Outstanding Young Science Foundation of Fujian Province (no. 2010J06013) and the 985 Project grant from Xiamen University.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dimri GP, 2002, CANCER RES, V62, P4736; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lee MS, 2000, BONE, V27, P591, DOI 10.1016/S8756-3282(00)00380-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	57	152	162	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	47					4707	4720		10.1038/onc.2011.181	http://dx.doi.org/10.1038/onc.2011.181			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21602879				2022-12-25	WOS:000298033700003
J	Tanori, M; Pasquali, E; Leonardi, S; Giardullo, P; Di Majo, V; Taccioli, G; Essers, J; Kanaar, R; Mullenders, LH; Atkinson, MJ; Mancuso, M; Saran, A; Pazzaglia, S				Tanori, M.; Pasquali, E.; Leonardi, S.; Giardullo, P.; Di Majo, V.; Taccioli, G.; Essers, J.; Kanaar, R.; Mullenders, L. H.; Atkinson, M. J.; Mancuso, M.; Saran, A.; Pazzaglia, S.			Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum	ONCOGENE			English	Article						radiation; Rad54; DNA-PKcs; LOH; medulloblastoma	DOUBLE-STRAND BREAKS; DNA-DAMAGE; SUPPRESS MEDULLOBLASTOMA; HOMOLOGOUS RECOMBINATION; GENETIC INSTABILITY; GENOME INSTABILITY; REPAIR; RAD54; DISRUPTION; DELETION	Heterozygous Patched1 (Ptc1(+/-)) mice are prone to medulloblastoma (MB), and exposure of newborn mice to ionizing radiation dramatically increases the frequency and shortens the latency of MB. In Ptc1(+/-) mice, MB is characterized by loss of the normal remaining Ptc1 allele, suggesting that genome rearrangements may be key events in MB development. Recent evidence indicates that brain tumors may be linked to defects in DNA-damage repair processes, as various combinations of targeted deletions in genes controlling cell-cycle checkpoints, apoptosis and DNA repair result in MB in mice. Non-homologous end joining (NHEJ) and homologous recombination (HR) contribute to genome stability, and deficiencies in either pathway predispose to genome rearrangements. To test the role of defective HR or NHEJ in tumorigenesis, control and irradiated Ptc1(+/-) mice with two, one or no functional Rad54 or DNA-protein kinase catalytic subunit (DNA-PKcs) alleles were monitored for MB development. We also examined the effect of Rad54 or DNA-PKcs deletion on the processing of endogenous and radiation-induced double-strand breaks (DSBs) in neural precursors of the developing cerebellum, the cells of origin of MB. We found that, although HR and NHEJ collaborate in protecting cells from DNA damage and apoptosis, they have opposite roles in MB tumorigenesis. In fact, although Rad54 deficiency increased both spontaneous and radiation-induced MB development, DNA-PKcs disruption suppressed MB tumorigenesis. Together, our data provide the first evidence that Rad54-mediated HR in vivo is important for suppressing tumorigenesis by maintaining genomic stability. Oncogene (2011) 30, 4740-4749; doi:10.1038/onc.2011.178; published online 23 May 2011	[Tanori, M.; Leonardi, S.; Di Majo, V.; Mancuso, M.; Saran, A.; Pazzaglia, S.] Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, I-00123 Rome, Italy; [Pasquali, E.; Giardullo, P.] Univ Guglielmo Marconi, Dept Radiat Phys, Rome, Italy; [Taccioli, G.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cellular Biol, Boston, MA 02215 USA; [Essers, J.; Kanaar, R.] Erasmus MC, Canc Genom Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Essers, J.; Kanaar, R.] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Mullenders, L. H.] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Atkinson, M. J.] German Res Ctr Environm & Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Essers, J.] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands	Italian National Agency New Technical Energy & Sustainable Economics Development; Guglielmo Marconi University; Boston University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC	Saran, A (corresponding author), Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, I-00123 Rome, Italy.	anna.saran@enea.it; simonetta.pazzaglia@enea.it	Pasquali, Emanuela/CAG-4451-2022; Atkinson, Michael/AAU-5127-2020; Atkinson, Michael J/E-5537-2011	Atkinson, Michael/0000-0003-3358-2089; Atkinson, Michael J/0000-0003-3358-2089; Saran, Anna/0000-0002-5587-064X	EU [FI6R-CT-2003-508842 RISC-RAD]; Associazione Italiana Ricerca sul Cancro (AIRC) [10357]; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	EU(European Commission); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by EU Contract FI6R-CT-2003-508842 RISC-RAD, by Grant 10357 from the Associazione Italiana Ricerca sul Cancro (AIRC) and the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Bakhshi S, 2003, J PEDIAT HEMATOL ONC, V25, P248, DOI 10.1097/00043426-200303000-00013; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Deans B, 2003, CANCER RES, V63, P8181; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Holcomb VB, 2006, ONCOGENE, V25, P7159, DOI 10.1038/sj.onc.1209704; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Lee Y, 2002, CANCER RES, V62, P6395; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu YH, 2010, CARCINOGENESIS, V31, P1762, DOI 10.1093/carcin/bgq141; Mancuso M, 2004, CANCER RES, V64, P934, DOI 10.1158/0008-5472.CAN-03-2460; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Moynahan ME, 1997, P NATL ACAD SCI USA, V19; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Pazzaglia S, 2006, ONCOGENE, V25, P5575, DOI 10.1038/sj.onc.1209544; Pazzaglia S, 2006, ONCOGENE, V25, P1165, DOI 10.1038/sj.onc.1209032; Pazzaglia S, 2000, MOL CARCINOGEN, V27, P219, DOI 10.1002/(SICI)1098-2744(200003)27:3<219::AID-MC9>3.0.CO;2-S; Pazzaglia S, 2002, ONCOGENE, V21, P7580, DOI 10.1038/sj.onc.1205973; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Tanori M, 2008, CARCINOGENESIS, V29, P1911, DOI 10.1093/carcin/bgn174; Tischfield JA, 2003, NAT GENET, V33, P5, DOI 10.1038/ng0103-5; Tong WM, 2003, AM J PATHOL, V162, P343, DOI 10.1016/S0002-9440(10)63825-4; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yan CT, 2006, P NATL ACAD SCI USA, V103, P7378, DOI 10.1073/pnas.0601938103; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087	49	9	9	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	47					4740	4749		10.1038/onc.2011.178	http://dx.doi.org/10.1038/onc.2011.178			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21602895				2022-12-25	WOS:000298033700006
J	Henriques, ST; Huang, YH; Rosengren, KJ; Franquelim, HG; Carvalho, FA; Johnson, A; Sonza, S; Tachedjian, G; Castanho, MARB; Daly, NL; Craik, DJ				Henriques, Sonia Troeira; Huang, Yen-Hua; Rosengren, K. Johan; Franquelim, Henri G.; Carvalho, Filomena A.; Johnson, Adam; Sonza, Secondo; Tachedjian, Gilda; Castanho, Miguel A. R. B.; Daly, Norelle L.; Craik, David J.			Decoding the Membrane Activity of the Cyclotide Kalata B1 THE IMPORTANCE OF PHOSPHATIDYLETHANOLAMINE PHOSPHOLIPIDS AND LIPID ORGANIZATION ON HEMOLYTIC AND ANTI-HIV ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CYCLIC-CYSTINE-KNOT; SURFACE-PLASMON RESONANCE; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; MACROCYCLIC PEPTIDES; MOLECULAR-MECHANISM; OLDENLANDIA-AFFINIS; BIOLOGICAL-ACTIVITY	Cyclotides, a large family of cyclic peptides from plants, have a broad range of biological activities, including insecticidal, cytotoxic, and anti-HIV activities. In all of these activities, cell membranes seem likely to be the primary target for cyclotides. However, the mechanistic role of lipid membranes in the activity of cyclotides remains unclear. To determine the role of lipid organization in the activity of the prototypic cyclotide, kalata B1 (kB1), and synthetic analogs, their bioactivities and affinities for model membranes were evaluated. We found that the bioactivity of kB1 is dependent on the lipid composition of target cell membranes. In particular, the activity of kB1 requires specific interactions with phospholipids containing phosphatidylethanolamine (PE) headgroups but is further modulated by nonspecific peptide-lipid hydrophobic interactions, which are favored in raft-like membranes. Negatively charged phospholipids do not favor high kB1 affinity. This lipid selectivity explains trends in antimicrobial and hemolytic activities of kB1; it does not target bacterial cell walls, which are negatively charged and lacking PE-phospholipids but can insert in the membranes of red blood cells, which have a low PE content and raft domains in their outer layer. We further show that the anti-HIV activity of kB1 is the result of its ability to target and disrupt the membranes of HIV particles, which are raft-like membranes very rich in PE-phospholipids.	[Henriques, Sonia Troeira; Huang, Yen-Hua; Rosengren, K. Johan; Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Henriques, Sonia Troeira; Franquelim, Henri G.; Carvalho, Filomena A.; Castanho, Miguel A. R. B.] Univ Lisbon, Sch Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Johnson, Adam; Sonza, Secondo; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic 3004, Australia; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	University of Queensland; Universidade de Lisboa; Burnet Institute; Monash University; Monash University		d.craik@imb.uq.edu.au	Rosengren, K. Johan/P-4450-2016; Carvalho, Filomena A./M-9202-2013; Tachedjian, Gilda/AAF-1327-2020; Henriques, Sonia Troeira/J-3500-2016; Franquelim, Henri/P-4985-2017; Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Huang, Yen-Hua/J-9056-2014	Rosengren, K. Johan/0000-0002-5007-8434; Carvalho, Filomena A./0000-0001-6088-3894; Tachedjian, Gilda/0000-0002-7733-7037; Henriques, Sonia Troeira/0000-0001-9564-9651; Franquelim, Henri/0000-0001-6229-4276; Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Huang, Yen-Hua/0000-0001-6937-2660; FCCN, Bogus/0000-0003-1034-3552; FCCN, Bogus/0000-0001-6282-8004; Castanho, Miguel/0000-0001-7891-7562	Australian Research Council [DP0880105]; European Community [PIOF-GA-2008-220318]; National Health and Medical Research Council; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39039/2007]	Australian Research Council(Australian Research Council); European Community(European Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by Australian Research Council Grant DP0880105 and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (PIOF-GA-2008-220318).; A National Health and Medical Research Council Biomedical Career Development Award Fellow.; Recipient of a Fundacao para a Ciencia e Tecnologia scholarship (SFRH/BD/39039/2007).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ahn T, 2002, J BIOL CHEM, V277, P26157, DOI 10.1074/jbc.M203445200; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bedoya VI, 2006, AIDS RES HUM RETROV, V22, P897, DOI 10.1089/aid.2006.22.897; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P171, DOI 10.1016/0005-2736(88)90192-7; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P180, DOI 10.1016/0005-2736(88)90193-9; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; DALEKE DL, 1989, J CELL BIOL, V108, P1375, DOI 10.1083/jcb.108.4.1375; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; FATTAL E, 1994, BIOCHEMISTRY-US, V33, P6721, DOI 10.1021/bi00187a044; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2010, CHEMBIOCHEM, V11, P2148, DOI 10.1002/cbic.201000400; Henriques ST, 2010, BIOPOLYMERS, V94, P314, DOI 10.1002/bip.21367; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kol MA, 2003, J BIOL CHEM, V278, P24586, DOI 10.1074/jbc.M301875200; LIN SS, 1994, BIOCHEMISTRY-US, V33, P7337, DOI 10.1021/bi00189a039; Lindholm P, 2002, MOL CANCER THER, V1, P365; Machaidze G, 2003, BIOCHEMISTRY-US, V42, P12570, DOI 10.1021/bi035225b; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Richer SM, 2008, BIOCHEMISTRY-US, V47, P13455, DOI 10.1021/bi801535f; Rusconi S, 2007, CURR TOP MED CHEM, V7, P1273; Schoepke T., 1993, SCI PHARM, V61, P145; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; YANAGIDA N, 1986, J BACTERIOL, V166, P937, DOI 10.1128/jb.166.3.937-944.1986; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	63	126	133	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24231	24241		10.1074/jbc.M111.253393	http://dx.doi.org/10.1074/jbc.M111.253393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576247	hybrid, Green Published			2022-12-25	WOS:000292294900065
J	Khashan, AS; Kenny, LC; Laursen, TM; Mahmood, U; Mortensen, PB; Henriksen, TB; O'Donoghue, K				Khashan, Ali S.; Kenny, Louise C.; Laursen, Thomas M.; Mahmood, Uzma; Mortensen, Preben B.; Henriksen, Tine B.; O'Donoghue, Keelin			Pregnancy and the Risk of Autoimmune Disease	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FETAL CELL MICROCHIMERISM; RHEUMATOID-ARTHRITIS; MATERNAL BLOOD; DENMARK; COHORT; PREECLAMPSIA; LEGACY; WOMEN	Autoimmune diseases (AID) predominantly affect women of reproductive age. While basic molecular studies have implicated persisting fetal cells in the mother in some AID, supportive epidemiological evidence is limited. We investigated the effect of vaginal delivery, caesarean section (CS) and induced abortion on the risk of subsequent maternal AID. Using the Danish Civil Registration System (CRS) we identified women who were born between 1960 and1992. We performed data linkage between the CRS other Danish national registers to identify women who had a pregnancy and those who developed AID. Women were categorised into 4 groups; nulligravida (control group), women who had 1st child by vaginal delivery, whose 1st delivery was by CS and who had abortions. Log-linear Poisson regression with person-years was used for data analysis adjusting for several potential confounders. There were 1,035,639 women aged >14 years and 25,570 developed AID: 43.4% nulligravida, 44.3% had their first pregnancy delivered vaginally, 7.6% CS and 4.1% abortions. The risk of AID was significantly higher in the 1st year after vaginal delivery (RR = 1.1[1.0, 1.2]) and CS (RR = 1.3[1.1, 1.5]) but significantly lower in the 1st year following abortion (RR = 0.7[0.6, 0.9]). These results suggest an association between pregnancy and the risk of subsequent maternal AID. Increased risks of AID after CS may be explained by amplified fetal cell traffic at delivery, while decreased risks after abortion may be due to the transfer of more primitive fetal stem cells. The increased risk of AID in the first year after delivery may also be related to greater testing during pregnancy.	[Khashan, Ali S.; Kenny, Louise C.; Mahmood, Uzma; O'Donoghue, Keelin] Cork Univ Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland; [Laursen, Thomas M.; Mortensen, Preben B.] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, Dept Paediat, DK-8000 Aarhus, Denmark	University College Cork; Aarhus University; Aarhus University	Khashan, AS (corresponding author), Cork Univ Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland.	k.odonoghue@ucc.ie	Laursen, Thomas Munk/AFQ-8066-2022; Kenny, Louise/X-6329-2019; Mortensen, Preben B/D-2358-2015; Kenny, Louise C/G-1112-2011	Kenny, Louise/0000-0002-9011-759X; Mortensen, Preben B/0000-0002-5230-9865; Kenny, Louise C/0000-0002-9011-759X; O'Donoghue, Keelin/0000-0002-4616-2887; Laursen, Thomas Munk/0000-0001-6934-1784	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The study was funded by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, J NEUROL SCI, V286, P73, DOI 10.1016/j.jns.2009.04.038; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Andersen TF, 1999, DAN MED BULL, V46, P263; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; Borchers AT, 2010, J AUTOIMMUN, V34, pJ287, DOI 10.1016/j.jaut.2009.11.015; Breslow NE, 1987, STAT METHODS CANC RE; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; HELIOVAARA M, 1995, BRIT J RHEUMATOL, V34, P625; Jansen MWJC, 2001, PRENATAL DIAG, V21, P1022, DOI 10.1002/pd.176; Jorgensen KT, 2010, ANN RHEUM DIS, V69, P358, DOI 10.1136/ard.2008.099945; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Klonisch T, 2009, TRENDS MOL MED, V15, P510, DOI 10.1016/j.molmed.2009.09.002; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0; Lissauer DM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001264; Miech RP, 2010, INT J CLIN EXP MED, V3, P164; Nelson J. Lee, 1998, Current Opinion in Rheumatology, V10, P564, DOI 10.1097/00002281-199811000-00010; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Nelson JL, 2002, ARTHRITIS RHEUM-US, V46, P291, DOI 10.1002/art.501; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K., 2006, REV GYNAECOL PERINAT, V6, P87, DOI DOI 10.1016/J.RIGAPP.2005.11.001; Ostensen M, 2007, SEMIN IMMUNOPATHOL, V29, P185, DOI 10.1007/s00281-007-0072-5; Pedersen CB, 2006, DAN MED BULL, V53, P441; RUNMARKER B, 1995, BRAIN, V118, P253, DOI 10.1093/brain/118.1.253; Ulff-Moller CJ, 2009, J RHEUMATOL, V36, P1903, DOI 10.3899/jrheum.090002; Waldorf KMA, 2008, IMMUNOL INVEST, V37, P631, DOI 10.1080/08820130802205886; *WHO, MAN INT CLASS DIS IC; World Health Organization, ICD 10 CLASS MENT BE	33	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19658	10.1371/journal.pone.0019658	http://dx.doi.org/10.1371/journal.pone.0019658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611120	Green Published, gold			2022-12-25	WOS:000290720200023
J	Wahl, M; Link, H; Alexandridis, N; Thomason, JC; Cifuentes, M; Costello, MJ; da Gama, BAP; Hillock, K; Hobday, AJ; Kaufmann, MJ; Keller, S; Kraufvelin, P; Kruger, I; Lauterbach, L; Antunes, BL; Molis, M; Nakaoka, M; Nystrom, J; bin Radzi, Z; Stockhausen, B; Thiel, M; Vance, T; Weseloh, A; Whittle, M; Wiesmann, L; Wunderer, L; Yamakita, T; Lenz, M				Wahl, Martin; Link, Heike; Alexandridis, Nicolaos; Thomason, Jeremy C.; Cifuentes, Mauricio; Costello, Mark J.; da Gama, Bernardo A. P.; Hillock, Kristina; Hobday, Alistair J.; Kaufmann, Manfred J.; Keller, Stefanie; Kraufvelin, Patrik; Kruger, Ina; Lauterbach, Lars; Antunes, Bruno L.; Molis, Markus; Nakaoka, Masahiro; Nystrom, Julia; bin Radzi, Zulkamal; Stockhausen, Bjoern; Thiel, Martin; Vance, Thomas; Weseloh, Annika; Whittle, Mark; Wiesmann, Lisa; Wunderer, Laura; Yamakita, Takehisa; Lenz, Mark			Re-Structuring of Marine Communities Exposed to Environmental Change: A Global Study on the Interactive Effects of Species and Functional Richness	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; CLIMATE-CHANGE; BIODIVERSITY; DIVERSITY; STABILITY; INVASION; COMPLEMENTARITY; COMPETITION; REDUNDANCY; IMPACTS	Species richness is the most commonly used but controversial biodiversity metric in studies on aspects of community stability such as structural composition or productivity. The apparent ambiguity of theoretical and experimental findings may in part be due to experimental shortcomings and/or heterogeneity of scales and methods in earlier studies. This has led to an urgent call for improved and more realistic experiments. In a series of experiments replicated at a global scale we translocated several hundred marine hard bottom communities to new environments simulating a rapid but moderate environmental change. Subsequently, we measured their rate of compositional change (re-structuring) which in the great majority of cases represented a compositional convergence towards local communities. Re-structuring is driven by mortality of community components (original species) and establishment of new species in the changed environmental context. The rate of this re-structuring was then related to various system properties. We show that availability of free substratum relates negatively while taxon richness relates positively to structural persistence (i.e., no or slow re-structuring). Thus, when faced with environmental change, taxon-rich communities retain their original composition longer than taxon-poor communities. The effect of taxon richness, however, interacts with another aspect of diversity, functional richness. Indeed, taxon richness relates positively to persistence in functionally depauperate communities, but not in functionally diverse communities. The interaction between taxonomic and functional diversity with regard to the behaviour of communities exposed to environmental stress may help understand some of the seemingly contrasting findings of past research.	[Wahl, Martin; Alexandridis, Nicolaos; Lenz, Mark] IFM GEOMAR, Dept Benth Ecol, Kiel, Germany; [Link, Heike] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Thomason, Jeremy C.] Marine Ecol Serv, Paris, France; [Cifuentes, Mauricio] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Costello, Mark J.] Univ Auckland, Leigh Marine Lab, Leigh, New Zealand; [da Gama, Bernardo A. P.; Antunes, Bruno L.] Univ Fed Fluminense, Dept Marine Biol, Rio De Janeiro, Brazil; [Hillock, Kristina] Waikato Conservancy, Dept Conservat, Hamilton, New Zealand; [Hobday, Alistair J.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Hobday, Alistair J.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Kaufmann, Manfred J.] Univ Madeira, Ctr Life Sci, Funchal, Portugal; [Kaufmann, Manfred J.] CIMAR CIIMAR Ctr Marine & Environm Res, Porto, Portugal; [Keller, Stefanie] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany; [Kraufvelin, Patrik] Abo Akad Univ, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Kraufvelin, Patrik] Novia Univ Appl Sci, Ekenas, Finland; [Lauterbach, Lars] Humboldt Univ, Dept Mikrobiol, Berlin, Germany; [Molis, Markus] Biol Anstalt Helgoland, AWI Marine Stn, Helgoland, Germany; [Nakaoka, Masahiro] Hokkaido Univ, Akkeshi Marine Stn, Field Sci Ctr No Biosphere, Akkeshi, Hokkaido, Japan; [bin Radzi, Zulkamal] Univ Malaysia Terengganu, Inst Oceanog, Terengganu, Malaysia; [Stockhausen, Bjoern] Commiss European Communities, Joint Res Ctr, Maritime Affairs Unit, I-21020 Ispra, Italy; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] CEAZA, Coquimbo, Chile; [Vance, Thomas] Plymouth Marine Lab, Dept Marine Ecol, Plymouth, Devon, England; [Weseloh, Annika] Ozeaneum Stralsund GmbH, Dept Educ, Stralsund, Germany; [Whittle, Mark] Univ Tasmania, Dept Zool, Hobart, Tas 7001, Australia; [Wunderer, Laura] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Yamakita, Takehisa] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Japan	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Quebec; Victoria University Wellington; University of Auckland; Universidade Federal Fluminense; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Universidade da Madeira; Universidade do Porto; Abo Akademi University; Novia University of Applied Sciences; Humboldt University of Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Hokkaido University; Universiti Malaysia Terengganu; European Commission Joint Research Centre; EC JRC ISPRA Site; Universidad Catolica del Norte; Plymouth Marine Laboratory; University of Tasmania; University of Munich; Japan Fisheries Research & Education Agency (FRA)	Wahl, M (corresponding author), IFM GEOMAR, Dept Benth Ecol, Kiel, Germany.	mwahl@ifm-geomar.de	Hobday, Alistair/A-1460-2012; Da Gama, Bernardo A. P./A-7861-2008; Lauterbach, Lars/L-6671-2014; Nakaoka, Masahiro/I-9237-2019; Lauterbach, Lars/P-6741-2019; Wahl, Martin/D-2038-2016; Cifuentes, Marie/J-5546-2014; Keller, Stefanie/K-7724-2019; Lenz, Mark/AAG-1734-2021; Kaufmann, Manfred/A-7561-2013; Costello, Mark/C-9267-2013	Hobday, Alistair/0000-0002-3194-8326; Da Gama, Bernardo A. P./0000-0003-2256-9313; Lauterbach, Lars/0000-0002-6601-6473; Nakaoka, Masahiro/0000-0002-5722-3585; Lauterbach, Lars/0000-0002-6601-6473; Wahl, Martin/0000-0001-8703-3857; Cifuentes, Marie/0000-0002-1011-6918; Keller, Stefanie/0000-0003-4826-9511; Kaufmann, Manfred/0000-0001-6213-3229; Costello, Mark/0000-0003-2362-0328; Kraufvelin, Patrik/0000-0003-3224-8388; Link, Heike/0000-0002-8484-845X; Alexandridis, Nikolaos/0000-0001-6031-1175	Mercator Stiftung (Essen, Germany); Grants-in-Aid for Scientific Research [21241055] Funding Source: KAKEN	Mercator Stiftung (Essen, Germany); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was run as part of the international research and training programme GAME (Global Approach by Modular Experiments) of IFM-GEOMAR which was generously funded by the Mercator Stiftung (Essen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Baez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002332; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Borrvall C, 2008, ECOL COMPLEX, V5, P99, DOI 10.1016/j.ecocom.2008.02.004; Bremner J, 2006, ECOL INDIC, V6, P609, DOI 10.1016/j.ecolind.2005.08.026; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Crawley M. J., 2009, R BOOK; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gili JM, 2009, ECOL STUD-ANAL SYNTH, V206, P191, DOI 10.1007/978-3-540-92704-4_13; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jenkins SR, 2009, ECOL STUD-ANAL SYNTH, V206, P177, DOI 10.1007/978-3-540-92704-4_12; Joseph S, 2009, CURR SCI INDIA, V97, P142; Kraufvelin P, 2010, MAR BIOL, V157, P29, DOI 10.1007/s00227-009-1293-z; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Maindonald J, 2010, DATA ANAL GRAPHICS U; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mooney HA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P12; Moorthi SI, 2008, ESTUAR COAST, V31, P152, DOI 10.1007/s12237-007-9015-6; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Naeem S, 2006, MAR ECOL PROG SER, V311, P273, DOI 10.3354/meps311273; Petchey OL, 2002, OIKOS, V99, P231, DOI 10.1034/j.1600-0706.2002.990203.x; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2010, R LANG STAT COMP; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Rohde K, 1997, OIKOS, V79, P169, DOI 10.2307/3546102; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Thompson R, 2007, BIODIVERS CONSERV, V16, P1359, DOI 10.1007/s10531-005-6232-9; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Wahl M, 2009, ECOL STUD-ANAL SYNTH, V206, P7, DOI 10.1007/978-3-540-92704-4_l; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2010, FRONT ECOL ENVIRON, V8, P10, DOI 10.1890/10.WB.002; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Wootton JT, 2009, ECOL STUD-ANAL SYNTH, V206, P201, DOI 10.1007/978-3-540-92704-4_14	57	21	21	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19514	10.1371/journal.pone.0019514	http://dx.doi.org/10.1371/journal.pone.0019514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611170	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000290720200011
J	Nummenmaa, L; Hietanen, JK; Calvo, MG; Hyona, J				Nummenmaa, Lauri; Hietanen, Jari K.; Calvo, Manuel G.; Hyona, Jukka			Food Catches the Eye but Not for Everyone: A BMI-Contingent Attentional Bias in Rapid Detection of Nutriments	PLOS ONE			English	Article							VISUAL-ATTENTION; APPETITIVE MOTIVATION; MOVEMENT ASSESSMENT; EMOTIONAL FACES; BRAIN; SEARCH; IMAGES; DOPAMINE; OBESITY; SYSTEM	An organism's survival depends crucially on its ability to detect and acquire nutriment. Attention circuits interact with cognitive and motivational systems to facilitate detection of salient sensory events in the environment. Here we show that the human attentional system is tuned to detect food targets among nonfood items. In two visual search experiments participants searched for discrepant food targets embedded in an array of nonfood distracters or vice versa. Detection times were faster when targets were food rather than nonfood items, and the detection advantage for food items showed a significant negative correlation with Body Mass Index (BMI). Also, eye tracking during searching within arrays of visually homogenous food and nonfood targets demonstrated that the BMI-contingent attentional bias was due to rapid capturing of the eyes by food items in individuals with low BMI. However, BMI was not associated with decision times after the discrepant food item was fixated. The results suggest that visual attention is biased towards foods, and that individual differences in energy consumption - as indexed by BMI - are associated with differential attentional effects related to foods. We speculate that such differences may constitute an important risk factor for gaining weight.	[Nummenmaa, Lauri] Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland; [Hietanen, Jari K.] Univ Tampere, Dept Psychol, FIN-33101 Tampere, Finland; [Calvo, Manuel G.] Univ La Laguna, Dept Cognit Psychol, E-38207 San Cristobal la Laguna, Spain; [Hyona, Jukka] Univ Turku, Dept Psychol, Turku, Finland	Aalto University; Aalto University; University of Turku; Tampere University; Universidad de la Laguna; University of Turku	Nummenmaa, L (corresponding author), Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland.	nummenmaa@neuro.hut.fi	Hyönä, Jukka/K-5280-2019; CALVO, MANUEL/N-3042-2019; Nummenmaa, Lauri/G-6910-2012; Calvo, Manuel/K-6381-2014	Hyönä, Jukka/0000-0002-5950-3361; CALVO, MANUEL/0000-0003-1083-9929; Nummenmaa, Lauri/0000-0002-2497-9757; Calvo, Manuel/0000-0003-1083-9929	Aalto University	Aalto University	This study was supported by the AivoAALTO grant from the Aalto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Calvo MG, 2008, EXP PSYCHOL, V55, P359, DOI 10.1027/1618-3169.55.6.359; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; CHRISTIE J, 1995, MEM COGNITION, V23, P547, DOI 10.3758/BF03197256; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kaurijoki S, 2008, CLIN PHYSIOL FUNCT I, V28, P270, DOI 10.1111/j.1475-097X.2008.00804.x; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; Mohanty A, 2008, CEREB CORTEX, V18, P2604, DOI 10.1093/cercor/bhn021; Nelson RA, 2007, PERCEPT PSYCHOPHYS, V69, P382, DOI 10.3758/BF03193759; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Nummenmaa L, 2010, J EXP PSYCHOL GEN, V139, P222, DOI 10.1037/a0018858; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Placanica JL, 2002, INT J EAT DISORDER, V32, P79, DOI 10.1002/eat.10066; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	47	58	59	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19215	10.1371/journal.pone.0019215	http://dx.doi.org/10.1371/journal.pone.0019215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603657	Green Published, gold, Green Submitted			2022-12-25	WOS:000290656300003
J	Brown, K; Fraser, G; Ramsay, M; Shanley, R; Cowley, N; van Wijgerden, J; Toff, P; Falconer, M; Hudson, M; Green, J; Kroll, JS; Vincent, C; Sevdalis, N				Brown, Katrina; Fraser, Graham; Ramsay, Mary; Shanley, Ruth; Cowley, Noel; van Wijgerden, Johan; Toff, Penelope; Falconer, Michelle; Hudson, Michael; Green, John; Kroll, J. Simon; Vincent, Charles; Sevdalis, Nick			Attitudinal and Demographic Predictors of Measles-Mumps-Rubella Vaccine (MMR) Uptake during the UK Catch-Up Campaign 2008-09: Cross-Sectional Survey	PLOS ONE			English	Article							IMMUNIZATION; VACCINATIONS; DECISIONS; CHILDREN; REASONS	Background and Objective: Continued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008-09 for children who missed MMR doses at scheduled age. Predictors of vaccine uptake during catch-ups are poorly understood, however evidence from routine schedule uptake suggests demographics and attitudes may be central. This work explored this hypothesis using a robust evidence-based measure. Design: Cross-sectional self-administered questionnaire with objective behavioural outcome. Setting and Participants: 365 UK parents, whose children were aged 5-18 years and had received < 2 MMR doses before the 2008-09 UK catch-up started. Main Outcome Measures: Parents' attitudes and demographics, parent-reported receipt of invitation to receive catch-up MMR dose(s), and catch-up MMR uptake according to child's medical record (receipt of MMR doses during year 1 of the catch-up). Results: Perceived social desirability/benefit of MMR uptake (OR = 1.76, 95% CI = 1.09-2.87) and younger child age (OR = 0.78, 95% CI = 0.68-0.89) were the only independent predictors of catch-up MMR uptake in the sample overall. Uptake predictors differed by whether the child had received 0 MMR doses or 1 MMR dose before the catch-up. Receipt of catch-up invitation predicted uptake only in the 0 dose group (OR = 3.45, 95% CI = 1.18-10.05), whilst perceived social desirability/benefit of MMR uptake predicted uptake only in the 1 dose group (OR = 9.61, 95% CI = 2.57-35.97). Attitudes and demographics explained only 28% of MMR uptake in the 0 dose group compared with 61% in the 1 dose group. Conclusions: Catch-up MMR invitations may effectively move children from 0 to 1 MMR doses (unimmunised to partially immunised), whilst attitudinal interventions highlighting social benefits of MMR may effectively move children from 1 to 2 MMR doses (partially to fully immunised). Older children may be best targeted through school-based programmes. A formal evaluation element should be incorporated into future catch-up campaigns to inform their continuing improvement.	[Brown, Katrina; Shanley, Ruth; Cowley, Noel; Vincent, Charles; Sevdalis, Nick] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Fraser, Graham] Hlth Protect Agcy, Reg Epidemiol Unit, London, England; [Ramsay, Mary] Hlth Protect Agcy, Ctr Infect, London, England; [van Wijgerden, Johan] NHS Ealing, London, England; [Toff, Penelope] NHS Brent, London, England; [Falconer, Michelle] NHS Halton & St Helens, Chester, Cheshire, England; [Green, John] Cent & NW London NHS Fdn Trust, London, England; [Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Imperial College London; Health Protection Agency; Health Protection Agency; Imperial College London	Brown, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	Katrina.Brown@imperial.ac.uk	SEVDALIS, NICK/A-8310-2008; Sevdalis, Nick/O-1419-2017; Sevdalis, Nick/AAJ-6280-2020; Vincent, Charles A/D-1134-2010; Ramsay, Mary Elizabeth/S-8281-2016	SEVDALIS, NICK/0000-0001-7560-8924; Sevdalis, Nick/0000-0001-7560-8924; Sevdalis, Nick/0000-0001-7560-8924; Vincent, Charles A/0000-0003-0270-0222; Ramsay, Mary Elizabeth/0000-0002-7156-7640	UK Health Protection Agency; Commissioning Support for London; National Institute for Health Research	UK Health Protection Agency; Commissioning Support for London; National Institute for Health Research(National Institute for Health Research (NIHR))	The research reported here was funded by the UK Health Protection Agency (http://www.hpa.org.uk/) and Commissioning Support for London (http://www.csl.nhs.uk/Pages/default.aspx). Brown, Sevdalis, Shanley, Cowley and Vincent are affiliated with the Imperial College Centre for Patient Safety and Service Quality, which is funded by the National Institute for Health Research (http://www.nihr.ac.uk/Pages/default.aspx). The researchers are independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; Brown KF, 2010, VACCINE; *CAP CATCH UP CAMP, 2007, CAPITAL CATCH UP MMR; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Department of Communities and Local Government, 2007, IND DEPR 2007; Department of Health, 2009, MMR CATCH UP CAMP VA; Department of Health, 2008, MMR CATCH UP PROGR; Dormandy E, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-2; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Elliman D, 2007, ARCH DIS CHILD, V92, P1055, DOI 10.1136/adc.2006.103531; Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692; Flynn M, 2004, BRIT J GEN PRACT, V54, P526; Gellatly J, 2005, FAM PRACT, V22, P658, DOI 10.1093/fampra/cmi066; Hadjikoumi I, 2006, ARCH DIS CHILD, V91, P621, DOI 10.1136/adc.2005.088898; Lashkari HP, 2010, EUROSURVEILLANCE, V15, P32; Lieu TA, 1997, PEDIATR INFECT DIS J, V16, P28, DOI 10.1097/00006454-199701000-00007; *LOND REG IMM STEE, 2009, CHILDH IMM PROGR LON; McCauley MM, 2008, J ADOLESCENT HEALTH, V43, P540, DOI 10.1016/j.jadohealth.2008.08.002; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Office for National Statistics, 2005, NATL STAT SOCIO EC C; Pearce A, 2008, BMJ-BRIT MED J, V336, P754, DOI 10.1136/bmj.39489.590671.25; Roberts KA, 2002, LANCET, V360, P1596, DOI 10.1016/S0140-6736(02)11560-1; ROBERTS RJ, 1995, BRIT MED J, V310, P1629, DOI 10.1136/bmj.310.6995.1629; Sevdalis N, 2007, PSYCHOL SCI, V18, P678, DOI 10.1111/j.1467-9280.2007.01958.x; Smith A, 2007, VACCINE, V25, P3996, DOI 10.1016/j.vaccine.2007.02.071	25	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19381	10.1371/journal.pone.0019381	http://dx.doi.org/10.1371/journal.pone.0019381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21602931	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500009
J	He, H; Nehete, PN; Nehete, B; Wieder, E; Yang, GJ; Buchl, S; Sastry, KJ				He, Hong; Nehete, Pramod N.; Nehete, Bharti; Wieder, Eric; Yang, Guojun; Buchl, Stephanie; Sastry, K. Jagannadha			Functional Impairment of Central Memory CD4 T Cells Is a Potential Early Prognostic Marker for Changing Viral Load in SHIV-Infected Rhesus Macaques	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; SIV; RESPONSES; DECLINE; VACCINE; AIDS; LYMPHOCYTES; GENERATION; PROTECTION	In HIV infection there is a paucity of literature about the degree of immune dysfunction to potentially correlate and/or predict disease progression relative to CD4(+) T cells count or viral load. We assessed functional characteristics of memory T cells subsets as potential prognostic markers for changing viral loads and/or disease progression using the SHIV-infected rhesus macaque model. Relative to long-term non-progressors with low/undetectable viral loads, those with chronic plasma viremia, but clinically healthy, exhibited significantly lower numbers and functional impairment of CD4(+) T cells, but not CD8(+) T cells, in terms of IL-2 production by central memory subset in response to PMA and ionomycine (PMA+I) stimulation. Highly viremic animals showed impaired cytokine-production by all T cells subsets. These results suggest that functional impairment of CD4(+) T cells in general, and of central memory subset in particular, may be a potential indicator/predictor of chronic infection with immune dysfunction, which could be assayed relatively easily using non-specific PMA+I stimulation.	[He, Hong; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Nehete, Pramod N.; Nehete, Bharti; Buchl, Stephanie; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Houston, TX 77030 USA; [Wieder, Eric] Univ Miami, Dept Med, Miami, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Miami	He, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jsastry@mdanderson.org		Sastry, Jagannadha/0000-0002-6987-4422; Nehete, Pramod/0000-0002-2815-2677	National Institute of Allergy and Infectious Diseases [AI 046969, AI 078898, AI 426969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046969, R21AI078898] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institute of Allergy and Infectious Diseases AI 046969, AI 078898, and AI 426969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno PM, 2006, J IMMUNOL, V176, P5338, DOI 10.4049/jimmunol.176.9.5338; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Cohen J, 2002, SCIENCE, V296, P2325, DOI 10.1126/science.296.5577.2325; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; Nehete PN, 2005, VACCINE, V23, P2154, DOI 10.1016/j.vaccine.2005.01.052; Nehete PN, 2008, VIROLOGY, V370, P130, DOI 10.1016/j.virol.2007.08.022; Nishimura Y, 2007, J VIROL, V81, P893, DOI 10.1128/JVI.01635-06; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Suryanarayana K, 1998, AIDS RES HUM RETROV, V14, P183, DOI 10.1089/aid.1998.14.183; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19607	10.1371/journal.pone.0019607	http://dx.doi.org/10.1371/journal.pone.0019607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602924	Green Submitted, Green Published, gold			2022-12-25	WOS:000290558500015
J	O'Donovan, A; Pantell, MS; Puterman, E; Dhabhar, FS; Blackburn, EH; Yaffe, K; Cawthon, RM; Opresko, PL; Hsueh, WC; Satterfield, S; Newman, AB; Ayonayon, HN; Rubin, SM; Harris, TB; Epel, ES				O'Donovan, Aoife; Pantell, Matthew S.; Puterman, Eli; Dhabhar, Firdaus S.; Blackburn, Elizabeth H.; Yaffe, Kristine; Cawthon, Richard M.; Opresko, Patricia L.; Hsueh, Wen-Chi; Satterfield, Suzanne; Newman, Anne B.; Ayonayon, Hilsa N.; Rubin, Susan M.; Harris, Tamara B.; Epel, Elissa S.		Hlth Aging Body Composition Study	Cumulative Inflammatory Load Is Associated with Short Leukocyte Telomere Length in the Health, Aging and Body Composition Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; CALORIE RESTRICTION; HUMAN HEPATOCYTES; DNA-DAMAGE; MORTALITY; RISK; INTERLEUKIN-6; CANCER; CELLS	Background: Leukocyte telomere length (LTL) is an emerging marker of biological age. Chronic inflammatory activity is commonly proposed as a promoter of biological aging in general, and of leukocyte telomere shortening in particular. In addition, senescent cells with critically short telomeres produce pro-inflammatory factors. However, in spite of the proposed causal links between inflammatory activity and LTL, there is little clinical evidence in support of their covariation and interaction. Methodology/Principal Findings: To address this issue, we examined if individuals with high levels of the systemic inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP) had increased odds for short LTL. Our sample included 1,962 high-functioning adults who participated in the Health, Aging and Body Composition Study (age range: 70-79 years). Logistic regression analyses indicated that individuals with high levels of either IL-6 or TNF-alpha had significantly higher odds for short LTL. Furthermore, individuals with high levels of both IL-6 and TNF-alpha had significantly higher odds for short LTL compared with those who had neither high (OR = 0.52, CI = 0.37-0.72), only IL-6 high (OR = 0.57, CI = 0.39-0.83) or only TNF-alpha high (OR = 0.67, CI = 0.46-0.99), adjusting for a wide variety of established risk factors and potential confounds. In contrast, CRP was not associated with LTL. Conclusions/Significance: Results suggest that cumulative inflammatory load, as indexed by the combination of high levels of IL-6 and TNF-alpha, is associated with increased odds for short LTL. In contrast, high levels of CRP were not accompanied by short LTL in this cohort of older adults. These data provide the first large-scale demonstration of links between inflammatory markers and LTL in an older population.	[O'Donovan, Aoife; Puterman, Eli; Yaffe, Kristine; Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [O'Donovan, Aoife; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, Berkeley, CA 94720 USA; [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, San Francisco, CA USA; [Dhabhar, Firdaus S.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine; Hsueh, Wen-Chi; Ayonayon, Hilsa N.; Rubin, Susan M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Opresko, Patricia L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Hsueh, Wen-Chi] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN 38163 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Harris, Tamara B.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA	O'Donovan, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	aoife.odonovan@ucsf.edu	Puterman, Eli/AAA-5237-2022; Newman, Anne B./C-6408-2013	Puterman, Eli/0000-0002-5898-2348; Newman, Anne B./0000-0002-0106-1150; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health (NIH) National Institute on Aging (NIA) [AG-6-2101, AG-6-2103, AG-6-2106, AG021918]; Society in Science: The Branco Weiss Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021918, N01AG062103, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Society in Science: The Branco Weiss Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was conducted on behalf of the Health, Aging and Body Composition (Health ABC) Study and was funded by National Institutes of Health (NIH) National Institute on Aging (NIA) grants AG-6-2101, AG-6-2103, AG-6-2106, and AG021918. This work was also supported by the Intramural Research Program of the NIH, NIA as well as by Society in Science: The Branco Weiss Fellowship (AOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Akiyama M, 2004, BIOCHEM BIOPH RES CO, V316, P528, DOI 10.1016/j.bbrc.2004.02.080; AVIV A, 2004, TELOMERES HUMAN AGIN, pPE43; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Calabro P, 2003, CIRCULATION, V108, P1930, DOI 10.1161/01.CIR.0000096055.62724.C5; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Jaiswal M, 2000, CANCER RES, V60, P184; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; MANGAN DF, 1991, J IMMUNOL, V147, P3408; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Nishida H, 2011, CYTOKINE, V53, P342, DOI 10.1016/j.cyto.2010.12.005; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Parish ST, 2009, J IMMUNOL, V182, P4237, DOI 10.4049/jimmunol.0803449; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Volpato S, 2001, CIRCULATION, V103, P947; Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318	52	219	223	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19687	10.1371/journal.pone.0019687	http://dx.doi.org/10.1371/journal.pone.0019687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602933	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000290558500023
J	Omori, Y; Katoh, K; Sato, S; Muranishi, Y; Chaya, T; Onishi, A; Minami, T; Fujikado, T; Furukawa, T				Omori, Yoshihiro; Katoh, Kimiko; Sato, Shigeru; Muranishi, Yuki; Chaya, Taro; Onishi, Akishi; Minami, Takashi; Fujikado, Takashi; Furukawa, Takahisa			Analysis of Transcriptional Regulatory Pathways of Photoreceptor Genes by Expression Profiling of the Otx2-Deficient Retina	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; HOMEOBOX GENE; SYNAPSE FORMATION; HORMONE-RECEPTOR; CELL FATE; MUTATIONS; CRX; DISEASE; PROTEIN; IDENTIFICATION	In the vertebrate retina, the Otx2 transcription factor plays a crucial role in the cell fate determination of both rod and cone photoreceptors. We previously reported that Otx2 conditional knockout (CKO) mice exhibited a total absence of rods and cones in the retina due to their cell fate conversion to amacrine-like cells. In order to investigate the entire transcriptome of the Otx2 CKO retina, we compared expression profile of Otx2 CKO and wild-type retinas at P1 and P12 using microarray. We observed that expression of 101- and 1049-probe sets significantly decreased in the Otx2 CKO retina at P1 and P12, respectively, whereas, expression of 3- and 4149-probe sets increased at P1 and P12, respectively. We found that expression of genes encoding transcription factors involved in photoreceptor development, including Crx, Nrl, Nr2e3, Esrrb, and NeuroD, was markedly down-regulated in the Otx2 CKO at both P1 and P12. Furthermore, we identified three human retinal disease loci mapped in close proximity to certain down-regulated genes in the Otx2 CKO retina including Ccdc126, Tnfsf13 and Pitpnm1, suggesting that these genes are possibly responsible for these diseases. These transcriptome data sets of the Otx2 CKO retina provide a resource on developing rods and cones to further understand the molecular mechanisms underlying photoreceptor development, function and disease.	[Omori, Yoshihiro; Katoh, Kimiko; Sato, Shigeru; Muranishi, Yuki; Chaya, Taro; Onishi, Akishi; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Omori, Yoshihiro; Chaya, Taro; Onishi, Akishi; Furukawa, Takahisa] CREST, JST, Osaka, Japan; [Sato, Shigeru; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Sato, Shigeru; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Visual Sci, Osaka, Japan; [Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; University of Tokyo	Omori, Y (corresponding author), Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan.	furukawa@obi.or.jp			Japan Science and Technology Agency [4118]; Ministry of Education, Culture, Sports, Science and Technology [20390087, 21790295]; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Novartis Foundation [20-10]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation [S-2144]; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness; Grants-in-Aid for Scientific Research [23790348] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness(Japan National Society for the Prevention of Blindness); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST and PRESTO (#4118) from Japan Science and Technology Agency (http://www.jst.go.jp/), and a Grant for Molecular Brain Science, a Grant-in-Aid for Scientific Research (B) (#20390087), Young Scientists (B) (#21790295), from Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/), The Takeda Science Foundation (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (http://www.ueharazaidan.com/), Naito Foundation (http://www.naito-f.or.jp/), Novartis Foundation (#20-10, http://novartisfound.or.jp/), Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/), Senri Life Science Foundation (#S-2144, http://www.senri-life.or.jp/), Kato Memorial Bioscience Foundation (http://www.katokinen.or.jp/), and Japan National Society for the Prevention of Blindness (http://www.nichigan.or.jp/link/situmei.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hughes AE, 1998, J MED GENET, V35, P770, DOI 10.1136/jmg.35.9.770; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; TOKUYASU K, 1959, J BIOPHYS BIOCHEM CY, V6, P225, DOI 10.1083/jcb.6.2.225; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wakabayashi T, 2008, NEUROSCI LETT, V442, P249, DOI 10.1016/j.neulet.2008.07.030; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	53	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19685	10.1371/journal.pone.0019685	http://dx.doi.org/10.1371/journal.pone.0019685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602925	Green Published, Green Submitted, gold			2022-12-25	WOS:000290558500022
J	Zhao, N; Pang, B; Shyu, CR; Korkin, D				Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry			Structural Similarity and Classification of Protein Interaction Interfaces	PLOS ONE			English	Article							INTERACTION PREDICTION; SEQUENCE; MIMICRY; CONSERVATION; VALIDATION; DATABASE; GROWTH; CAPRI; PRISM	Interactions between proteins play a key role in many cellular processes. Studying protein-protein interactions that share similar interaction interfaces may shed light on their evolution and could be helpful in elucidating the mechanisms behind stability and dynamics of the protein complexes. When two complexes share structurally similar subunits, the similarity of the interaction interfaces can be found through a structural superposition of the subunits. However, an accurate detection of similarity between the protein complexes containing subunits of unrelated structure remains an open problem. Here, we present an alignment-free machine learning approach to measure interface similarity. The approach relies on the feature-based representation of protein interfaces and does not depend on the superposition of the interacting subunit pairs. Specifically, we develop an SVM classifier of similar and dissimilar interfaces and derive a feature-based interface similarity measure. Next, the similarity measure is applied to a set of 2,80662,806 binary complex pairs to build a hierarchical classification of protein-protein interactions. Finally, we explore case studies of similar interfaces from each level of the hierarchy, considering cases when the subunits forming interactions are either homologous or structurally unrelated. The analysis has suggested that the positions of charged residues in the homologous interfaces are not necessarily conserved and may exhibit more complex conservation patterns.	[Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Korkin, Dmitry] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Zhao, N (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	korkin@korkinlab.org	Zhao, Nan/K-4015-2015	Zhao, Nan/0000-0002-7897-2374	National Science Foundation [DBI-0845196]; Direct For Biological Sciences [0845196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding from the National Science Foundation (DBI-0845196 to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/s004360050643; Alberts B., 1998, ESSENTIAL CELL BIOL; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Beckett D, 2004, BIOCHEMISTRY-US, V43, P7983, DOI 10.1021/bi049890b; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CIACCIA P, 1997, M TREE EFFICIENT ACC; Comaniciu D, 2000, PROC CVPR IEEE, P142, DOI 10.1109/CVPR.2000.854761; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HUBBARD S, 1994, PROTRUDER FORTRAN PR; Hubbard S.J., 1992, NACCESS COMPUTER PRO; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Prieto C, 2010, PROTEINS, V78, P109, DOI 10.1002/prot.22569; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shamim MTA, 2007, BIOINFORMATICS, V23, P3320, DOI 10.1093/bioinformatics/btm527; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Teyra J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-9; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19554	10.1371/journal.pone.0019554	http://dx.doi.org/10.1371/journal.pone.0019554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589874	Green Published, gold, Green Submitted			2022-12-25	WOS:000290531100018
J	Dejean, A				Dejean, Alain			Prey Capture Behavior in an Arboreal African Ponerine Ant	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; PREDATORY BEHAVIOR; MANDIBULAR GLAND; HYMENOPTERA; FORMICIDAE; DIVERSIFICATION; EVOLUTION; COCOA	I studied the predatory behavior of Platythyrea conradti, an arboreal ponerine ant, whereas most species in this subfamily are ground-dwelling. The workers, which hunt solitarily only around dusk, are able to capture a wide range of prey, including termites and agile, nocturnal insects as well as diurnal insects that are inactive at that moment of the Nyctemeron, resting on tree branches or under leaves. Prey are captured very rapidly, and the antennal palpation used by ground-dwelling ponerine species is reduced to a simple contact; stinging occurs immediately thereafter. The venom has an instant, violent effect as even large prey (up to 30 times the weight of a worker) never struggled after being stung. Only small prey are not stung. Workers retrieve their prey, even large items, singly. To capture termite workers and soldiers defending their nest entrances, ant workers crouch and fold their antennae backward. In their role as guards, the termites face the crouching ants and end up by rolling onto their backs, their legs batting the air. This is likely due to volatile secretions produced by the ants' mandibular gland. The same behavior is used against competing ants, including territorially-dominant arboreal species that retreat further and further away, so that the P. conradti finally drive them from large, sugary food sources.	[Dejean, Alain] CNRS, Ecol Forets Guyane UMR 8172, Kourou, France; [Dejean, Alain] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr		Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique [2ID]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGER M, 1993, B ENTOMOL RES, V83, P475, DOI 10.1017/S0007485300039912; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; CERDA X, 2011, PREDATION HYMENOPTER, pCH4; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DAVIDSON DW, 1996, PUBLICATION U CALIFO, V1, P127; Dejean A, 1997, NATURWISSENSCHAFTEN, V84, P76, DOI 10.1007/s001140050352; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; DEJEAN A, 1990, WESTV STUD, P472; DEJEAN A, 1994, SOCIOBIOLOGY, V23, P293; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011331; Djieto-Lordon C, 2001, INSECT SOC, V48, P324, DOI 10.1007/PL00001784; Djieto-Lordon C, 2001, SOCIOBIOLOGY, V38, P765; Djieto-Lordon C., 2006, Selbyana, V27, P79; Grimaldi David, 2005, pi; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; Hunt JH, 2003, SCIENCE, V300, P916, DOI 10.1126/science.1085065; Kenne M, 2009, MYRMECOL NEWS, V12, P109; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; MAJER JD, 1972, B ENTOMOL RES, V62, P151, DOI 10.1017/S0007485300047593; Majer Jonathan D., 1993, P115; Molet M, 2006, INSECT SOC, V53, P177, DOI 10.1007/s00040-005-0856-3; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morgan ED, 1999, J CHEM ECOL, V25, P1395, DOI 10.1023/A:1020987028163; Orivel J, 2000, SOCIOBIOLOGY, V35, P131; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Orivel J, 2001, TOXICON, V39, P195, DOI 10.1016/S0041-0101(00)00113-6; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Schmidt CA, 2009, MOL PHYLOGENETICS TA; Tobin John E., 1994, P279; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Wood WF, 2006, BIOCHEM SYST ECOL, V34, P536, DOI 10.1016/j.bse.2006.01.002; Yeo K, 2006, INSECT SOC, V53, P435, DOI 10.1007/s00040-005-0890-9	41	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19837	10.1371/journal.pone.0019837	http://dx.doi.org/10.1371/journal.pone.0019837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589941	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600033
J	Ng, KM; Lee, YK; Lai, WH; Chan, YC; Fung, ML; Tse, HF; Siu, CW				Ng, Kwong-Man; Lee, Yee-Ki; Lai, Wing-Hon; Chan, Yau-Chi; Fung, Man-Lung; Tse, Hung-Fat; Siu, Chung-Wah			Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; CARDIOMYOCYTE DIFFERENTIATION; SIGNAL-TRANSDUCTION; MOUSE; HEART; HDL; CARDIOMYOGENESIS; TRANSCRIPTION	The cardioprotective effects of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (apoA-I) are well documented, but their effects in the direction of the cardiac differentiation of embryonic stem cells are unknown. We evaluated the effects of exogenous apoA-I expression on cardiac differentiation of ESCs and maturation of ESC-derived cardiomyocytes. We stably over-expressed full-length human apoA-I cDNA with lentivirus (LV)-mediated gene transfer in undifferentiated mouse ESCs and human induced pluripotent stem cells. Upon cardiac differentiation, we observed a significantly higher percentage of beating embryoid bodies, an increased number of cardiomyocytes as determined by flow cytometry, and expression of cardiac markers including alpha-myosin heavy chain, beta-myosin heavy chain and myosin light chain 2 ventricular transcripts in LV-apoA-I transduced ESCs compared with control (LV-GFP). In the presence of noggin, a BMP4 antagonist, activation of BMP4-SMAD signaling cascade in apoA-I transduced ESCs completely abolished the apoA-I stimulated cardiac differentiation. Furthermore, co-application of recombinant apoA-I and BMP4 synergistically increased the percentage of beating EBs derived from untransduced D3 ESCs. These together suggests that that pro-cardiogenic apoA-I is mediated via the BMP4-SMAD signaling pathway. Functionally, cardiomyocytes derived from the apoA-I-transduced cells exhibited improved calcium handling properties in both non-caffeine and caffeine-induced calcium transient, suggesting that apoA-I plays a role in enhancing cardiac maturation. This increased cardiac differentiation and maturation has also been observed in human iPSCs, providing further evidence of the beneficial effects of apoA-I in promoting cardiac differentiation. In Conclusion, we present novel experimental evidence that apoA-I enhances cardiac differentiation of ESCs and iPSCs and promotes maturation of the calcium handling property of ESC-derived cardiomyocytes via the BMP4/SMAD signaling pathway.	[Ng, Kwong-Man; Fung, Man-Lung; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Ageing, Stem Cell & Regenerat Med Program, Hong Kong, Hong Kong, Peoples R China; [Ng, Kwong-Man; Fung, Man-Lung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Ng, Kwong-Man; Lee, Yee-Ki; Lai, Wing-Hon; Chan, Yau-Chi; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Ng, KM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Ageing, Stem Cell & Regenerat Med Program, Hong Kong, Hong Kong, Peoples R China.	hftse@hkucc.hku.hk; cwdsiu@hkucc.hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Chan, Yau Chi/C-4547-2009; Lee, Yee Ki/C-8692-2011	Tse, Hung-Fat/0000-0002-9578-7808; Chan, Yau Chi/0000-0003-0854-0506	HKU [201007176133]; Sun Chieh Yeh Heart Foundation	HKU(University of Hong Kong); Sun Chieh Yeh Heart Foundation	This work was supported by the HKU Small Project Funding (201007176133) to Kwong-Man Ng, Chung-Wah Siu and Hung-Fat Tse, and research funding from Sun Chieh Yeh Heart Foundation to Chung-Wah Siu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au KW, 2009, BIOCHEM BIOPH RES CO, V379, P898, DOI 10.1016/j.bbrc.2008.12.160; Baroukh N, 2004, FEBS LETT, V557, P39, DOI 10.1016/S0014-5793(03)01429-7; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bers Donald M, 2006, Biochem J, V396, pe1; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DeGeorge BR, 2008, CTS-CLIN TRANSL SCI, V1, P116, DOI 10.1111/j.1752-8062.2008.00034.x; Frias M.A., CARDIOVASC RES, V85, P118; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jamali M, 2001, FEBS LETT, V509, P126, DOI 10.1016/S0014-5793(01)03151-9; Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160; Lagostena L, 2005, CARDIOVASC RES, V66, P482, DOI 10.1016/j.cardiores.2005.01.018; Lane D M, 2001, Curr Opin Investig Drugs, V2, P1235; LEE YK, MOL ENDOCRINOL, V24, P1728; LIAO SY, HEART RHYTHM; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MALTSEV VA, 1994, IMMUNOL LETT, V42, P41, DOI 10.1016/0165-2478(94)90033-7; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mineo C, 2003, TRENDS CARDIOVAS MED, V13, P226, DOI 10.1016/S1050-1738(03)00098-7; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moore JC, 2005, REPROD TOXICOL, V20, P377, DOI 10.1016/j.reprotox.2005.04.012; Nakajima Y, 2002, DEV BIOL, V245, P291, DOI 10.1006/dbio.2002.0637; NG KM, J MOL CELL CARDIOL; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Siu Chung Wah, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P145; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Tahaa MF, 2008, INT J CARDIOL, V127, P78, DOI 10.1016/j.ijcard.2007.04.173; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; TAO R, AM J PHYSL HEART CIR, V298, P1022; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu JZ, 2010, STEM CELLS DEV, V19, P1723, DOI 10.1089/scd.2010.0066; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang X, 1999, DEVELOPMENT, V126, P1571; Yao YC, 2008, ARTERIOSCL THROM VAS, V28, P2266, DOI 10.1161/ATVBAHA.108.176958; YEH BK, 1968, J GEN PHYSIOL, V52, P666; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19787	10.1371/journal.pone.0019787	http://dx.doi.org/10.1371/journal.pone.0019787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589943	Green Published, gold, Green Submitted			2022-12-25	WOS:000290483600030
J	Watson, VG; Motsinger-Reif, A; Hardison, NE; Peters, EJ; Havener, TM; Everitt, L; Auman, JT; Comins, DL; McLeod, HL				Watson, Venita Gresham; Motsinger-Reif, Alison; Hardison, Nicholas E.; Peters, Eric J.; Havener, Tammy M.; Everitt, Lorraine; Auman, James Todd; Comins, Daniel L.; McLeod, Howard L.			Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees	PLOS ONE			English	Article							TOPOISOMERASE-I INHIBITORS; GENE-EXPRESSION PROFILES; CANCER-CELL LINES; HUMAN GENOME; DNA-DAMAGE; DISCOVERY; CISPLATIN; APOPTOSIS; SCREEN; SENSITIVITY	To date, the Centre d'Etude Polymorphism Humain (CEPH) cell line model has only been used as a pharmacogenomic tool to evaluate which genes are responsible for the disparity in response to a single drug. The purpose of this study was demonstrate the model's ability to establish a specific pattern of quantitative trait loci (QTL) related to a shared mechanism for multiple structurally related drugs, the camptothecins, which are Topoisomerase 1 inhibitors. A simultaneous screen of six camptothecin analogues for in vitro sensitivity in the CEPH cell lines resulted in cytotoxicity profiles and orders of potency which were in agreement with the literature. For all camptothecins studied, heritability estimates for cytotoxic response averaged 23.1 +/- 2.6%. Nonparametric linkage analysis was used to identify a relationship between genetic markers and response to the camptothecins. Ten QTLs on chromosomes 1, 3, 5, 6, 11, 12, 16 and 20 were identified as shared by all six camptothecin analogues. In a separate validation experiment, nine of the ten QTLs were replicated at the significant and suggestive levels using three additional camptothecin analogues. To further refine this list of QTLs, another validation study was undertaken and seven of the nine QTLs were independently replicated for all nine camptothecin analogues. This is the first study using the CEPH cell lines that demonstrates that a specific pattern of QTLs could be established for a class of drugs which share a mechanism of action. Moreover, it is the first study to report replication of linkage results for drug-induced cytotoxicity using this model. The QTLs, which have been identified as shared by all camptothecins and replicated across multiple datasets, are of considerable interest; they harbor genes related to the shared mechanism of action for the camptothecins, which are responsible for variation in response.	[Watson, Venita Gresham; Peters, Eric J.; Havener, Tammy M.; Everitt, Lorraine; Auman, James Todd; McLeod, Howard L.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [Motsinger-Reif, Alison; Hardison, Nicholas E.] N Carolina State Univ, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Comins, Daniel L.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Watson, VG (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA.	hmcleod@unc.edu	Motsinger-Reif, Alison/I-4167-2018; McLeod, Howard/ABD-8364-2021; Auman, James/AAY-7748-2020	Motsinger-Reif, Alison/0000-0003-1346-2493; McLeod, Howard/0000-0002-9004-9232; Havener, Tammy/0000-0002-4613-0498; Auman, James/0000-0002-9328-8829	Pharmacogenetics Research Network [U01 GM63340]; National Research Service Award [F31 CA1199385]; National Institute of Environmental Health Sciences [2 T32 ES007329]; Greensboro Golfers Against Cancer; NATIONAL CANCER INSTITUTE [F31CA119938, R01CA161608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Greensboro Golfers Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Pharmacogenetics Research Network (grant number U01 GM63340), a National Research Service Award Fellowship to VGW (grant number F31 CA1199385), and a National Institute of Environmental Health Sciences training grant to NEH (grant number 2 T32 ES007329). This work was also supported by the Greensboro Golfers Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Beretta GL, 2008, EXPERT OPIN THER TAR, V12, P1243, DOI [10.1517/14728222.12.10.1243, 10.1517/14728222.12.10.1243 ]; BERETTA GL, 2006, CURR MED CHEM ANTICA, P3291; Blower P. E., 2002, Pharmacogenomics Journal, V2, P259, DOI 10.1038/sj.tpj.6500116; Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; Daoud SS, 2003, CANCER RES, V63, P2782; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Duan SW, 2007, CANCER RES, V67, P5425, DOI 10.1158/0008-5472.CAN-06-4431; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gresham V, 2009, ADV DRUG DELIVER REV, V61, P369, DOI 10.1016/j.addr.2008.12.002; Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195; Hayward RL, 2003, CLIN CANCER RES, V9, P2856; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Nakatsu N, 2005, MOL CANCER THER, V4, P399; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Peters EJ, 2009, PHARMACOGENET GENOM, V19, P399, DOI 10.1097/FPC.0b013e328329fdec; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; RDC Team, 2005, R LANG ENV STAT COMP; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Takeba Y, 2007, J PHARMACOL SCI, V104, P232, DOI 10.1254/jphs.FP0070442; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Zembutsu H, 2002, CANCER RES, V62, P518; Zhou Y, 2002, CANCER RES, V62, P1688	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e17561	10.1371/journal.pone.0017561	http://dx.doi.org/10.1371/journal.pone.0017561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573211	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400001
J	Lazzari, C; Prodosmo, A; Siepi, F; Rinaldo, C; Galli, F; Gentileschi, M; Bartolazzi, A; Costanzo, A; Sacchi, A; Guerrini, L; Soddu, S				Lazzari, C.; Prodosmo, A.; Siepi, F.; Rinaldo, C.; Galli, F.; Gentileschi, M.; Bartolazzi, A.; Costanzo, A.; Sacchi, A.; Guerrini, L.; Soddu, S.			HIPK2 phosphorylates Delta Np63 alpha and promotes its degradation in response to DNA damage	ONCOGENE			English	Article						HIPK2; chemotherapy; Delta Np63; phosphorylation; degradation	SQUAMOUS-CELL CARCINOMA; INTERACTING PROTEIN KINASE-2; INDUCED APOPTOSIS; P53 FAMILY; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; CANCER-CELLS; P63	Homeodomain-interacting protein kinase 2 (HIPK2) is an emerging player in cell response to genotoxic agents that senses damage intensity and contributes to the cell's choice between cell cycle arrest and apoptosis. Phosphorylation of p53 at S46, an apoptosis-specific p53 posttranslational modification, is the most characterized HIPK2 function in response to lethal doses of ultraviolet (UV), ionizing radiation or different anticancer drugs, such as cisplatin, roscovitine and doxorubicin (DOX). Indeed, like p53, HIPK2 has been shown to contribute to the effectiveness of these treatments. Interestingly, p53-independent mechanisms of HIPK2-induced apoptosis were described for UV and tumor growth factor-beta treatments; however, it is unknown whether these mechanisms are relevant for the responses to anticancer drugs. Because of the importance of the so-called 'p53-independent apoptosis and drug response' in human cancer chemotherapy, we asked whether p53-independent factor(s) might be involved in HIPK2-mediated chemosensitivity. Here, we show that HIPK2 depletion by RNA interference induces resistance to different anticancer drugs even in p53-null cells, suggesting the involvement of HIPK2 targets other than p53 in response to chemotherapy. In particular, we found that HIPK2 phosphorylates and promotes proteasomal degradation of Delta Np63 alpha, a prosurvival Delta N isoform of the p53 family member, p63. Indeed, effective cell response to different genotoxic agents was shown to require phosphorylation-induced proteasomal degradation of Delta Np63 alpha. In DOX-treated cells, we show that HIPK2 depletion interferes with Delta Np63 alpha degradation, and expression of a HIPK2-resistant Delta Np63 alpha-Delta 390 mutant induces chemoresistance. We identify T397 as the Delta Np63 alpha residue phosphorylated by HIPK2, and show that the non-phosphorylatable Delta Np63 alpha-T397A mutant is not degraded in the face of either HIPK2 overexpression or DOX treatment. These results indicate Delta Np63 alpha as a novel target of HIPK2 in response to genotoxic drugs. Oncogene (2011) 30, 4802-4813; doi: 10.1038/onc.2011.182; published online 23 May 2011	[Lazzari, C.; Prodosmo, A.; Siepi, F.; Rinaldo, C.; Gentileschi, M.; Sacchi, A.; Soddu, S.] Regina Elena Inst Canc Res, Mol Oncogenesis Lab, Dept Expt Oncol, I-00158 Rome, Italy; [Galli, F.; Guerrini, L.] Univ Milan, Dept Biomol & Biotechnol Sci, Milan, Italy; [Bartolazzi, A.] Karolinska Hosp, Canc Ctr Karolinska, S-10401 Stockholm, Sweden; [Bartolazzi, A.] St Andrea Univ Hosp, Dept Pathol, Rome, Italy; [Costanzo, A.] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Milan; Karolinska Institutet; Karolinska University Hospital; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Rome Tor Vergata	Soddu, S (corresponding author), Regina Elena Inst Canc Res, Mol Oncogenesis Lab, Dept Expt Oncol, Via Messi dOro 156, I-00158 Rome, Italy.	soddu@ifo.it	Soddu, Silvia/ABH-6774-2020; Costanzo, Antonio/D-3896-2012; Costanzo, Antonio/GZG-2433-2022; prodosmo, andrea/AAA-7766-2020; Soddu, Silvia/K-2467-2018; Rinaldo, Cinzia/A-4252-2015; Bartolazzi, Armando/K-9708-2016	Soddu, Silvia/0000-0001-8526-0044; Costanzo, Antonio/0000-0001-9697-2557; Soddu, Silvia/0000-0001-8526-0044; Rinaldo, Cinzia/0000-0001-6124-762X; Bartolazzi, Armando/0000-0001-7820-5127; PRODOSMO, ANDREA/0000-0001-5828-8586	Ministero della Salute; Scientific Direction of the Regina Elena Cancer Institute; Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Ministero della Salute(Ministry of Health, Italy); Scientific Direction of the Regina Elena Cancer Institute; Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We are grateful to all people cited in the text for their kind gifts of cells and reagents and to Dr F Socciarelli for technical support. This work was supported by Ministero della Salute and 'New Idea Award' form the Scientific Direction of the Regina Elena Cancer Institute to SS. FS was a recipient of a fellowship from Fondazione Italiana per la Ricerca sul Cancro.	Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Bracaglia G, 2009, EMBO REP, V10, P1327, DOI 10.1038/embor.2009.217; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Calzado MA, 2009, CELL CYCLE, V8, P1659, DOI 10.4161/cc.8.11.8597; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cecchinelli B, 2006, CELL DEATH DIFFER, V13, P1994, DOI 10.1038/sj.cdd.4401933; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; CIARDIELLO F, 1990, CELL GROWTH DIFFER, V1, P407; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Du ZJ, 2010, CANCER SCI, V101, P2417, DOI 10.1111/j.1349-7006.2010.01700.x; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gresko E, 2009, ONCOGENE, V28, P698, DOI 10.1038/onc.2008.420; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang YP, 2008, CELL CYCLE, V7, P2846, DOI 10.4161/cc.7.18.6627; Huang YP, 2010, CELL CYCLE, V9, P328, DOI 10.4161/cc.9.2.10432; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Lanza M, 2006, CELL CYCLE, V5, P1996, DOI 10.4161/cc.5.17.3188; Lavra L, 2011, PLOS ONE IN PRESS; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Liefer KM, 2000, CANCER RES, V60, P4016; Lin ZH, 2006, J CANCER RES CLIN, V132, P811, DOI 10.1007/s00432-006-0130-8; MacPartlin M, 2008, J BIOL CHEM, V283, P15754, DOI 10.1074/jbc.M801394200; Moll UM, 2004, MOL CANCER RES, V2, P371; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Papoutsaki M, 2005, ONCOGENE, V24, P6970, DOI 10.1038/sj.onc.1208835; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Senoo M, 2001, BRIT J CANCER, V84, P1235, DOI 10.1054/bjoc.2000.1735; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Wang N, 2010, EMBO REP, V11, P633, DOI 10.1038/embor.2010.82; Wee HJ, 2008, BLOOD, V112, P3777, DOI 10.1182/blood-2008-01-134122; Wesierska-Gadek J, 2007, J CELL BIOCHEM, V100, P865, DOI 10.1002/jcb.21211; Westfall MD, 2005, CELL CYCLE, V4, P710, DOI 10.4161/cc.4.5.1685; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu GJ, 2005, CANCER RES, V65, P758; Yamada D, 2009, ONCOGENE, V28, P2535, DOI 10.1038/onc.2009.109; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	63	39	39	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	48					4802	4813		10.1038/onc.2011.182	http://dx.doi.org/10.1038/onc.2011.182			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21602882	Bronze			2022-12-25	WOS:000298134700004
J	Werbowetski-Ogilvie, TE; Schnerch, A; Rampalli, S; Mills, CE; Lee, JB; Hong, SH; Levadoux-Martin, M; Bhatia, M				Werbowetski-Ogilvie, T. E.; Schnerch, A.; Rampalli, S.; Mills, C. E.; Lee, J. B.; Hong, S-H; Levadoux-Martin, M.; Bhatia, M.			Evidence for the transmission of neoplastic properties from transformed to normal human stem cells	ONCOGENE			English	Article						transformation; human stem cells; self-renewal; differentiation	STROMAL FIBROBLASTS; HEMATOPOIETIC DEVELOPMENT; TUMOR-GROWTH; IN-VIVO; CANCER; LEUKEMIA; PROTEIN; DIFFERENTIATION; PROGENITORS; EXPRESSION	The in vivo relationship between human tumor cells and interacting normal cells in their local environment is poorly understood. Here, using a uniquely developed in vitro co-culture system for human embryonic stem cells (hESCs), we examined the interactions between transformed and normal human stem cells. Co-culture of transformed-hESCs (t-hESCs) with normal hESCs led to enhanced self-renewal and niche independence in normal hESCs. Global gene expression analysis of normal hESCs after timed exposure to t-hESCs indicated a transition of the molecular network controlling the hESC state, which included epigenetic changes, towards neoplastic features. These included enhanced pluripotent marker expression and a differentiation blockade as major hallmark changes. Functional studies revealed a loss in normal terminal differentiation programs for both hematopoiesis and neural lineages after normal stem cell co-culture with transformed variants. This transmission of neoplastic properties from t-hESCs to normal hESCs was dependent on direct cell-cell contact. Our study indicates that normal human stem cells can co-opt neoplastic cancer stem cell properties, raising the possibility that assimilation of healthy cells towards neoplastic behavior maybe a contributing feature of sustained tumorigenesis in vivo. Oncogene (2011) 30, 4632-4644; doi:10.1038/onc.2011.175; published online 30 May 2011	[Werbowetski-Ogilvie, T. E.; Schnerch, A.; Rampalli, S.; Lee, J. B.; Hong, S-H; Levadoux-Martin, M.; Bhatia, M.] McMaster Univ, Michael G Degroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Werbowetski-Ogilvie, T. E.; Schnerch, A.; Rampalli, S.; Lee, J. B.; Hong, S-H; Levadoux-Martin, M.; Bhatia, M.] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Mills, C. E.] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Bhatia, M (corresponding author), McMaster Univ, Fac Hlth Sci, McMaster Stem Cell & Canc Res Inst SCC RI, 1200 Main St W,MDCL 5029, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca		Rampalli, Shravanti/0000-0002-6391-6409; Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559	Canadian Institute of Health Research (CIHR); Canadian Cancer Society (CCS); Ontario Institute of Cancer Research (OICR); Canadian Cancer Society Research Institute (CCSRI); Canada Research Chair Program	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Ontario Institute of Cancer Research (OICR); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canada Research Chair Program(Canada Research Chairs)	We thank Dr Borhane Guezguez for critical review of this manuscript. This work was funded by the Canadian Institute of Health Research (CIHR), the Canadian Cancer Society (CCS) and the Ontario Institute of Cancer Research (OICR). A fellowship from the Canadian Cancer Society Research Institute (CCSRI) supports TEWO. MB is supported by the Canada Research Chair Program.	Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bedford L, 2005, DEV BIOL, V280, P386, DOI 10.1016/j.ydbio.2005.02.001; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Ji JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008065; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yenerel MN, 2005, EXP HEMATOL, V33, P758, DOI 10.1016/j.exphem.2005.03.015; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zangenberg M, 2009, EUR J HAEMATOL, V83, P439, DOI 10.1111/j.1600-0609.2009.01309.x; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	55	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	46					4632	4644		10.1038/onc.2011.175	http://dx.doi.org/10.1038/onc.2011.175			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	851EV	21625212				2022-12-25	WOS:000297252100003
J	Poncet-Montange, G; Martin, SJS; Bogatova, OV; Prusiner, SB; Shoichet, BK; Ghaemmaghami, S				Poncet-Montange, Guillaume; Martin, Susan J. St.; Bogatova, Olga V.; Prusiner, Stanley B.; Shoichet, Brian K.; Ghaemmaghami, Sina			A Survey of Antiprion Compounds Reveals the Prevalence of Non-PrP Molecular Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; SCRAPIE ISOFORM; NEUROBLASTOMA-CELLS; BRANCHED POLYAMINES; CRYSTAL-STRUCTURE; CULTURED-CELLS; N-TERMINUS; DISEASE; REPLICATION; INHIBITORS	Prion diseases are fatal neurodegenerative diseases caused by the accumulation of the misfolded isoform (PrPSc) of the prion protein (PrPC). Cell-based screens have identified several compounds that induce a reduction in PrPSc levels in infected cultured cells. However, the molecular targets of most antiprion compounds remain unknown. We undertook a large-scale, unbiased, cell-based screen for antiprion compounds and then investigated whether a representative subset of the active molecules had measurable affinity for PrP, increased the susceptibility of PrPSc to proteolysis, or altered the cellular localization or expression level of PrPC. None of the antiprion compounds showed in vitro affinity for PrP or had the ability to disaggregate PrPSc in infected brain homogenates. These observations suggest that most antiprion compounds identified in cell-based screens deploy their activity via non-PrP targets in the cell. Our findings indicate that in comparison to PrP conformers themselves, proteins that play auxiliary roles in prion propagation may be more effective targets for future drug discovery efforts.	[Prusiner, Stanley B.; Ghaemmaghami, Sina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Poncet-Montange, Guillaume; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Poncet-Montange, Guillaume; Martin, Susan J. St.; Bogatova, Olga V.; Prusiner, Stanley B.; Ghaemmaghami, Sina] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ghaemmaghami, S (corresponding author), 513 Parnassus Ave,HSE-744, San Francisco, CA 94143 USA.	sina@ind.ucsf.edu		Poncet-Montange, Guillaume/0000-0002-9884-7378; Ghaemmaghami, Sina/0000-0002-8696-2950	National Institutes of Health [AG02132, AG031220, AG021601]; Hillblom Foundation; Sherman Fairchild Foundation; NATIONAL INSTITUTE ON AGING [R37AG031220, P01AG002132, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; Sherman Fairchild Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG02132, AG031220, and AG021601, the Hillblom Foundation, and the Sherman Fairchild Foundation.	BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey WS, 2007, ANTIMICROB AGENTS CH, V51, P3887, DOI 10.1128/AAC.01599-06; Charveriat M, 2009, J GEN VIROL, V90, P1294, DOI 10.1099/vir.0.009084-0; Choi S, 2010, J AM CHEM SOC, V132, P1359, DOI 10.1021/ja908562q; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Mizoue LS, 2004, ANAL BIOCHEM, V326, P125, DOI 10.1016/j.ab.2003.10.048; MORTON A, 1995, BIOCHEMISTRY-US, V34, P8564, DOI 10.1021/bi00027a006; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1987, ANNU REV MED, V38, P381, DOI 10.1146/annurev.me.38.020187.002121; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27718	27728		10.1074/jbc.M111.234393	http://dx.doi.org/10.1074/jbc.M111.234393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21610081	Green Published, hybrid			2022-12-25	WOS:000293268700064
J	Carow, B; Ye, XQ; Gavier-Widen, D; Bhuju, S; Oehlmann, W; Singh, M; Skold, M; Ignatowicz, L; Yoshimura, A; Wigzell, H; Rottenberg, ME				Carow, Berit; Ye, Xiang Qun; Gavier-Widen, Dolores; Bhuju, Sabin; Oehlmann, Wulf; Singh, Mahavir; Skold, Markus; Ignatowicz, Lech; Yoshimura, Akihiko; Wigzell, Hans; Rottenberg, Martin E.			Silencing Suppressor of Cytokine Signaling-1 (SOCS1) in Macrophages Improves Mycobacterium tuberculosis Control in an Interferon-gamma (IFN-gamma)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; IFN-GAMMA; CHLAMYDIA-PNEUMONIAE; NEGATIVE REGULATION; IMMUNE-RESPONSE; INFECTION; GENE; EXPRESSION; MICE; INDUCTION	Protection against infection with Mycobacterium tuberculosis demands IFN-gamma. SOCS1 has been shown to inhibit responses to IFN-gamma and might thereby play a central role in the outcome of infection. We found that M. tuberculosis is a highly efficient stimulator of SOCS1 expression in murine and human macrophages and in tissues from infected mice. Surprisingly, SOCS1 reduced responses to IL-12, resulting in an impaired IFN-gamma secretion by macrophages that in turn accounted for a deteriorated intracellular mycobacterial control. Despite SOCS1 expression, mycobacteria-infected macrophages responded to exogenously added IFN-gamma. SOCS1 attenuated the expression of the majority of genes modulated by M. tuberculosis infection of macrophages. Using a conditional knockdown strategy in mice, we found that SOCS1 expression by macrophages hampered M. tuberculosis clearance early after infection in vivo in an IFN-gamma -dependent manner. On the other hand, at later time points, SOCS1 expression by non-macrophage cells protected the host from infection-induced detrimental inflammation.	[Carow, Berit; Ye, Xiang Qun; Skold, Markus; Ignatowicz, Lech; Wigzell, Hans; Rottenberg, Martin E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Gavier-Widen, Dolores] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, S-75007 Uppsala, Sweden; [Bhuju, Sabin; Oehlmann, Wulf; Singh, Mahavir] Lionex GmbH, D-38126 Braunschweig, Germany; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan	Karolinska Institutet; Swedish University of Agricultural Sciences; Keio University	Rottenberg, ME (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	Martin.Rottenberg@ki.se	Ignatowicz, Lech/F-2601-2013; Carow, Berit/AAE-3970-2020; Yoshimura, Akihiko/K-5515-2013	Rottenberg, Martin/0000-0003-0514-7434; Carow, Berit/0000-0002-8760-6253	European Community [200732 HOMITB]; Karolinska Institutet; Swedish Research Council	European Community(European Commission); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by European Community Grant 200732 HOMITB, the Karolinska Institutet, and the Swedish Research Council.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Ahmed CM, 2009, J VIROL, V83, P1402, DOI 10.1128/JVI.01138-08; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; Davies John Q, 2005, Methods Mol Biol, V290, P105; de Jong R, 1998, SCIENCE, V280, P1435; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Hanada T, 2005, J IMMUNOL, V174, P4325, DOI 10.4049/jimmunol.174.7.4325; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Hashimoto M, 2009, CANCER SCI, V100, P730, DOI 10.1111/j.1349-7006.2009.01098.x; Hmama Z, 1998, J IMMUNOL, V161, P4882; Hoshino K, 1999, J IMMUNOL, V162, P3749; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hussain S, 1999, J IMMUNOL, V163, P2041; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Puddu P, 1997, J IMMUNOL, V159, P3490; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Srivastava V, 2009, J BIOL CHEM, V284, P25532, DOI 10.1074/jbc.M109.006221; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; World Health Organization Occupational and Environmental Health Team, 2006, WORLD HEAL ORGAN FOO, DOI DOI 10.1016/0004-6981(88)90109-6; Yang TB, 2008, J IMMUNOL, V180, P4040, DOI 10.4049/jimmunol.180.6.4040; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	56	44	45	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26873	26887		10.1074/jbc.M111.238287	http://dx.doi.org/10.1074/jbc.M111.238287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21622562	Green Published, hybrid			2022-12-25	WOS:000293078200062
J	Hadian, K; Griesbach, RA; Dornauer, S; Wanger, TM; Nagel, D; Metlitzky, M; Beisker, W; Schmidt-Supprian, M; Krappmann, D				Hadian, Kamyar; Griesbach, Richard A.; Dornauer, Scarlett; Wanger, Tim M.; Nagel, Daniel; Metlitzky, Moritz; Beisker, Wolfgang; Schmidt-Supprian, Marc; Krappmann, Daniel			NF-kappa B Essential Modulator (NEMO) Interaction with Linear and Lys-63 Ubiquitin Chains Contributes to NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; ASSEMBLY COMPLEX; IKK COMPLEX; STEM-CELLS; TNF-ALPHA; BINDING; COMPONENT; DOMAIN; OLIGOMERIZATION; RECOGNITION	The I kappa B kinase (IKK) complex acts as a gatekeeper of canonical NF-kappa B signaling in response to upstream stimulation. IKK activation requires sensing of ubiquitin chains by the essential IKK regulatory subunit IKK gamma/NEMO. However, it has remained enigmatic whether NEMO binding to Lys-63-linked or linear ubiquitin chains is critical for triggering IKK activation. We show here that the NEMOC terminus, comprising the ubiquitin binding region and a zinc finger, has a high preference for binding to linear ubiquitin chains. However, immobilization of NEMO, which may be reminiscent of cellular oligomerization, facilitates the interaction with Lys-63 ubiquitin chains. Moreover, selective mutations in NEMO that abolish association with linear ubiquitin but do not affect binding to Lys-63 ubiquitin are only partially compromising NF-kappa B signaling in response to TNF alpha stimulation in fibroblasts and T cells. In line with this, TNF alpha-triggered expression of NF-kappa B target genes and induction of apoptosis was partially compromised by NEMO mutations that selectively impair the binding to linear ubiquitin chains. Thus, in vivo NEMO interaction with linear and Lys-63 ubiquitin chains is required for optimal IKK activation, suggesting that both type of chains are cooperating in triggering canonical NF-kappa B signaling.	[Hadian, Kamyar; Griesbach, Richard A.; Wanger, Tim M.; Nagel, Daniel; Metlitzky, Moritz; Beisker, Wolfgang; Krappmann, Daniel] Inst Toxicol, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Cellular Signal Integrat, D-85764 Neuherberg, Germany; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, Inst Mol Immunol & Signal Transduct, D-82152 Martinsried, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Krappmann, D (corresponding author), Inst Toxicol, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Cellular Signal Integrat, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	daniel.krappmann@helmholtz-muenchen.de	Krappmann, Daniel/AAT-4354-2021; Hadian, Kamyar/B-6314-2013; Krappmann, Daniel/ABF-4038-2021; Schmidt-Supprian, Marc/F-5893-2011	Krappmann, Daniel/0000-0001-7640-3234; Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Schmidt-Supprian, Marc/0000-0002-8543-6166	Deutsche Forschungsgemeinschaft [SPP1365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Priority Program SPP1365 (to D. K.).	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2000, Sci STKE, V2000, ppe1; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grubisha O, 2010, J MOL BIOL, V395, P89, DOI 10.1016/j.jmb.2009.10.018; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Smahi A, 2000, NATURE, V405, P466; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Yoshikawa A, 2009, FEBS LETT, V583, P3317, DOI 10.1016/j.febslet.2009.09.028	35	84	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26107	26117		10.1074/jbc.M111.233163	http://dx.doi.org/10.1074/jbc.M111.233163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622571	Green Published, hybrid			2022-12-25	WOS:000293073000068
J	Budry, L; Couture, C; Balsalobre, A; Drouin, J				Budry, Lionel; Couture, Catherine; Balsalobre, Aurelio; Drouin, Jacques			The Ets Factor Etv1 Interacts with Tpit Protein for Pituitary Pro-opiomelanocortin (POMC) Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX FACTOR; RIEGER-SYNDROME; FACTOR ER81; HOMEOBOX 1; CELL; PTX1; EXPRESSION; MUTATIONS; PITX2; RAS	Pro-opiomelanocortin (POMC) is expressed in two lineages of the pituitary, the anterior lobe corticotrophs and the intermediate lobe melanotrophs. POMC expression in these two lineages is highly dependent on the cell-restricted transcription factor Tpit. As Tpit intervenes relatively late in differentiation of those lineages, we have been searching for other transcription factors that may participate in their gene expression program. On the basis of similarity with the Tpit expression profile, we identified Ets variant gene 1 (Etv1/Er81) as a putative POMC transcription factor. Using Etv1-lacZ knockin mice, we describe preferential Etv1 expression in pituitary POMC cells and also in posterior lobe pituicytes. We further show that Etv1 enhances POMC transcription on its own and in synergy with Tpit. The Ets-binding site located within the Tpit/Pitx regulatory element is necessary for Etv1 activity in POMC-expressing AtT-20 cells but dispensable for synergy with Tpit. Etv1 and Tpit interact together in coimmunoprecipitation experiments. Furthermore, Etv1 is present at the POMC promoter, and siRNA-mediated knockdown of Etv1 in AtT-20 cells produces a significant decrease in POMC expression. Etv1 knockout pituitaries show normal POMC cell distribution and normal POMC mRNA abundance, suggesting compensation by other factors. The coordinate expression of Etv1 with POMC cell differentiation and its interaction with the highly cell-restricted Tpit factor indicate that Etv1 participates in a combinatorial code for pituitary cell-specific gene expression.	[Budry, Lionel; Couture, Catherine; Balsalobre, Aurelio; Drouin, Jacques] Inst Rech Clin Montreal, Mol Genet Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Drouin, J (corresponding author), Inst Rech Clin Montreal, Mol Genet Lab, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	jacques.drouin@ircm.qc.ca	Pillay, Nischalan/F-9536-2012	Drouin, Jacques/0000-0001-8226-5691	Canadian Institutes of Health Research [CIHR MT-86650, MOP-89716]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants CIHR MT-86650 from the Canadian Institutes of Health Research (to J.D.).; We thank Drs. T. Jessell and S. Arber for providing the Er81-nlslacZ mice. We also thank Brian Wilkes and Peter W. Schiller (CIHR Grant MOP-89716) for help in computer modeling of protein interactions with Tpit/PitxRE. We thank Dr. S. J. Rhodes for rabbit anti-Pit1, K. Moroashi for rabbit anti-SF1, S. Arber for anti-Etv1 antiserum, and X. Sun for anti-Etv5. We also thank E. Massicotte and M. Dupuis of the Institut de Recherches Cliniques de Montreal FACS Facility for FACS sorting of POMC-EGFP cells. We thank A. Vallee for expertly preparing histology sections at the Institut de Recherches Cliniques de Montreal Histology Facility. We also thank people at the McGill University and Genome Quebec Innovation Center for expression arrays hybridization and all members of the laboratory for unconditional support and thoughtful comments during the course of this work.	Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bradford AP, 1996, J BIOL CHEM, V271, P24639, DOI 10.1074/jbc.271.40.24639; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Drouin J., 2010, PITUITARY, P3; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; GOURDJI D, 1994, MOL CELL ENDOCRINOL, V100, P133, DOI 10.1016/0303-7207(94)90292-5; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamolet B, 2004, MOL ENDOCRINOL, V18, P995, DOI 10.1210/me.2003-0127; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Langlais D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000224; Lavoie PL, 2008, MOL ENDOCRINOL, V22, P1647, DOI 10.1210/me.2007-0567; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; Maniatis T., 1982, MOL CLONING LAB MANU; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Paez-Pereda Marcelo, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P259, DOI 10.2174/1568008054863817; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Pulichino AM, 2003, GENE DEV, V17, P711, DOI 10.1101/gad.1065603; Schweppe RE, 2003, J BIOL CHEM, V278, P16863, DOI 10.1074/jbc.M213063200; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Vallette-Kasic S, 2007, J CLIN ENDOCR METAB, V92, P3991, DOI 10.1210/jc.2007-0284; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Zhao LP, 2001, DEVELOPMENT, V128, P147	44	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25387	25396		10.1074/jbc.M110.202788	http://dx.doi.org/10.1074/jbc.M110.202788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622576	hybrid, Green Published			2022-12-25	WOS:000292547900084
J	Koch, D; Chan, ACK; Murphy, MEP; Lilie, H; Grass, G; Nies, DH				Koch, Doreen; Chan, Anson C. K.; Murphy, Michael E. P.; Lilie, Hauke; Grass, Gregor; Nies, Dietrich H.			Characterization of a Dipartite Iron Uptake System from Uropathogenic Escherichia coli Strain F11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COPPER TOLERANCE; OXIDASE; PROTEIN; TRANSPORTER; DETERMINANT; AFFINITY; BACTERIA; CUEO; HOMEOSTASIS	In the uropathogenic Escherichia coli strain F11, in silico genome analysis revealed the dicistronic iron uptake operon fetMP, which is under iron-regulated control mediated by the Fur regulator. The expression of fetMP in a mutant strain lacking known iron uptake systems improved growth under iron depletion and increased cellular iron accumulation. FetM is a member of the iron/lead transporter superfamily and is essential for iron uptake by the Fet system. FetP is a periplasmic protein that enhanced iron uptake by FetM. Recombinant FetP bound Cu(II) and the iron analog Mn(II) at distinct sites. The crystal structure of the FetP dimer reveals a copper site in each FetP subunit that adopts two conformations: CuA with a tetrahedral geometry composed of His(44), Met(90), His(97), and His(127), and CuB, a second degenerate octahedral geometry with the addition of Glu(46). The copper ions of each site occupy distinct positions and are separated by similar to 1.3 angstrom. Nearby, a putative additional Cu(I) binding site is proposed as an electron source that may function with CuA/CuB displacement to reduce Fe(III) for transport by FetM. Together, these data indicate that FetMP is an additional iron uptake system composed of a putative iron permease and an iron-scavenging and potentially iron-reducing periplasmic protein.	[Grass, Gregor] Univ Nebraska, Sch Biol Sci, Beadle Ctr, Lincoln, NE 68588 USA; [Lilie, Hauke] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Chan, Anson C. K.; Murphy, Michael E. P.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Grass, Gregor] Bundeswehr Inst Microbiol, D-80937 Munich, Germany	University of Nebraska System; University of Nebraska Lincoln; Martin Luther University Halle Wittenberg; University of British Columbia; Bundeswehr Institute of Microbiology (IMB)	Grass, G (corresponding author), Univ Nebraska, Sch Biol Sci, Beadle Ctr, Lincoln, NE 68588 USA.	gregorgrass@bundeswehr.org	Grass, Gregor/A-9981-2009; Murphy, Michael/R-6805-2017; Nies, Dietrich H/H-4143-2011	Grass, Gregor/0000-0002-8002-7718; Murphy, Michael/0000-0003-2589-0014; Chan, Anson/0000-0001-6625-8942	Deutsche Forschungsgemeinschaft [Ni262/8-2, GR2061/1-3]; Natural Sciences and Engineering Research Council of Canada (NSERC); Nebraska Tobacco Settlement Biomedical Research Development Funds; Department of Energy; Office of Biological and Environmental Research; NCRR; National Institutes of Health (NIH); Biomedical Technology Program; NIGMS, NIH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nebraska Tobacco Settlement Biomedical Research Development Funds; Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Program; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ni262/8-2 (to D.H.N. and G.G.) and GR2061/1-3 (to G.G.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to M.E.P.M.).; Supported in part by the Nebraska Tobacco Settlement Biomedical Research Development Funds. To whom correspondence should be addressed. Fax: 49-89-3168-3983; E-mail: gregorgrass@bundeswehr.org.; We thank Dr. Wolfgang Rabsch of the Robert Koch-Institut for allowing us to perform beta-galactosidase assays with E. coli strain F11 under S2 biosafety conditions in Wernigerode, Cecile Wandersman (Insitut Pasteur, Paris) for assaying heme-iron acquisition via Fet, and Dr. Angelika Schierhorn for the MALDI-TOF and the MALDI-In-Source-Decay-TOF-MS analysis. We thank Dr. Christian Lange for discussions and suggestions concerning ITC experiments. We thank Karola Otto for skillful technical assistance. Strain ECA458 was constructed by Nadine Taudte. We thank Herbert P. Schweizer (Colorado State University) for Tn7-bearing plasmids. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NCRR, National Institutes of Health (NIH), Biomedical Technology Program, and NIGMS, NIH.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHAKRABARTI P, 1989, BIOCHEMISTRY-US, V28, P6081, DOI 10.1021/bi00440a052; Chan ACK, 2010, J MOL BIOL, V401, P590, DOI 10.1016/j.jmb.2010.06.038; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Debut AJ, 2006, J MOL MICROB BIOTECH, V11, P1, DOI 10.1159/000092814; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; Dubbels BL, 2004, MICROBIOL-SGM, V150, P2931, DOI 10.1099/mic.0.27233-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman S, 2010, BIOMETALS, V23, P275, DOI 10.1007/s10534-009-9286-4; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Grosse C, 1999, J BACTERIOL, V181, P2385; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Haber F, 1932, NATURWISSENSCHAFTEN, V20, P948, DOI 10.1007/BF01504715; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Koch D, 2007, BIOMETALS, V20, P759, DOI 10.1007/s10534-006-9039-6; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Millero FJ, 1998, EARTH PLANET SC LETT, V154, P323, DOI 10.1016/S0012-821X(97)00179-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neilands J. B., 1980, ACS SYM SER, V140, P264; Nies D.H., 2009, ECOSAL ESCHERICHIA C; Nies DH, 2007, MOL MICROBIOLOGY HEA, V6, P118; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; STAPLETON A, 1991, J INFECT DIS, V163, P773, DOI 10.1093/infdis/163.4.773; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Thieme D, 2008, APPL ENVIRON MICROB, V74, P7463, DOI 10.1128/AEM.01370-08; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	59	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25317	25330		10.1074/jbc.M111.222745	http://dx.doi.org/10.1074/jbc.M111.222745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596746	hybrid, Green Published			2022-12-25	WOS:000292547900078
J	Warr, MR; Mills, JR; Nguyen, M; Lemaire-Ewing, S; Baardsnes, J; Sun, KLW; Malina, A; Young, JC; Jeyaraju, DV; O'Connor-McCourt, M; Pellegrini, L; Pelletier, J; Shore, GC				Warr, Matthew R.; Mills, John R.; Mai Nguyen; Lemaire-Ewing, Stephanie; Baardsnes, Jason; Sun, Karen L. W.; Malina, Abba; Young, Jason C.; Jeyaraju, Danny V.; O'Connor-McCourt, Maureen; Pellegrini, Luca; Pelletier, Jerry; Shore, Gordon C.			Mitochondrion-dependent N-terminal Processing of Outer Membrane Mcl-1 Protein Removes an Essential Mule/Lasu1 Protein-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; APOPTOSIS; EXPRESSION; BCL-2; SURVIVAL; DIFFERENTIATION; DESTRUCTION; DEGRADATION; CANCERS; FAMILY	Mcl-1, a pro-survival member of the Bcl-2 family located at the mitochondrial outer membrane, is subject to constitutive ubiquitylation by the Bcl-2 homology 3-only E3 ligase, Mule/Lasu1, resulting in rapid steady-state degradation via the proteasome. Insertion of newly synthesized Mcl-1 into the mitochondrial outer membrane is dependent on its C-terminal transmembrane segment, but once inserted, the N terminus of a portion of the Mcl-1 molecules can be subject to proteolytic processing. Remarkably, this processing requires an intact electrochemical potential across the inner membrane. Three lines of evidence directed at the endogenous protein, however, indicate that the resulting Mcl-1 Delta N isoform resides in the outer membrane: (i) full-length Mcl-1 and Mcl-1 Delta N resist extraction by alkali but are accessible to exogenous protease; (ii) almost the entire populations of Mcl-1 and Mcl-1 Delta N are accessible to the membrane-impermeant Cys-reactive agent 4-acetamido-4'-[(iodoacetyl)amino]stilbene-2,2'-disulfonic acid; and (iii) Mcl-1 and Mcl-1 Delta N exhibit equivalent chemical cross-linking to Bak in intact mitochondria, an Mcl-1 binding partner located in the outer membrane. In addition to the Mule Bcl-2 homology 3 domain, we show that interaction between Mcl-1 and Mule also requires the extreme N terminus of Mcl-1, which is lacking in Mcl-1 Delta N. Thus, Mcl-1 Delta N does not interact with Mule, exhibits reduced steady-state ubiquitylation, evades the hyper-rapid steady-state degradation that is observed for full-length Mcl-1 in response to treatments that limit global protein synthesis, and confers resistance to UV stress-induced cell death.	[Warr, Matthew R.; Mills, John R.; Mai Nguyen; Lemaire-Ewing, Stephanie; Sun, Karen L. W.; Malina, Abba; Young, Jason C.; Pelletier, Jerry; Shore, Gordon C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Baardsnes, Jason; O'Connor-McCourt, Maureen] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Jeyaraju, Danny V.; Pellegrini, Luca] Univ Laval, Ctr Rech, Quebec City, PQ G1J 2G3, Canada	McGill University; National Research Council Canada; Laval University	Shore, GC (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	gordon.shore@mcgill.ca		Malina, Abba/0000-0002-8511-9005; Jeyaraju, Danny/0000-0002-5562-3833; Pellegrini, Luca/0000-0002-4235-7708	Canadian Institutes of Health Research; National Cancer Institute of Canada; National Research Council, Canada; Cole Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); National Research Council, Canada; Cole Foundation	This work was supported in part by research grants from the Canadian Institutes of Health Research (to G. C. S., J. P., J. C. Y., and L. P.), the National Cancer Institute of Canada (to G. C. S. and J. P.), and the National Research Council, Canada (to M. O. M.).; Recipient of a fellowship from the Cole Foundation.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Chung TKH, 2002, CANCER LETT, V180, P63, DOI 10.1016/S0304-3835(01)00842-4; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Huang CR, 2010, FEBS LETT, V584, P3323, DOI 10.1016/j.febslet.2010.07.013; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Liu QA, 2010, J BIOL CHEM, V285, P41202, DOI 10.1074/jbc.M110.144857; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Miyamoto Y, 1999, ONCOLOGY-BASEL, V56, P73, DOI 10.1159/000011933; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Rinkenberger JL, 2000, GENE DEV, V14, P23; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Warr MR, 2008, CURR MOL MED, V8, P138; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	36	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25098	25107		10.1074/jbc.M111.218321	http://dx.doi.org/10.1074/jbc.M111.218321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613222	Green Published, hybrid			2022-12-25	WOS:000292547900058
J	Chou, CY; Tong, L				Chou, Chi-Yuan; Tong, Liang			Structural and Biochemical Studies on the Regulation of Biotin Carboxylase by Substrate Inhibition and Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; VELOCITY ANALYTICAL ULTRACENTRIFUGATION; AUREUS PYRUVATE-CARBOXYLASE; ACETYL-COA CARBOXYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CATALYTIC-ACTIVITY; INDUCED SYNERGISM; MAIN PROTEASE; ATP BINDING	Biotin carboxylase (BC) activity is shared among biotin-dependent carboxylases and catalyzes the Mg-ATP-dependent carboxylation of biotin using bicarbonate as the CO2 donor. BC has been studied extensively over the years by structural, kinetic, and mutagenesis analyses. Here we report three new crystal structures of Escherichia coli BC at up to 1.9 angstrom resolution, complexed with different ligands. Two structures are wild-type BC in complex with two ADP molecules and two Ca2+ ions or two ADP molecules and one Mg2+ ion. One ADP molecule is in the position normally taken by the ATP substrate, whereas the other ADP molecule occupies the binding sites of bicarbonate and biotin. One Ca2+ ion and the Mg2+ ion are associated with the ADP molecule in the active site, and the other Ca2+ ion is coordinated by Glu-87, Glu-288, and Asn-290. Our kinetic studies confirm that ATP shows substrate inhibition and that this inhibition is competitive against bicarbonate. The third structure is on the R16E mutant in complex with bicarbonate and Mg-ADP. Arg-16 is located near the dimer interface. The R16E mutant has only a 2-fold loss in catalytic activity compared with the wild-type enzyme. Analytical ultracentrifugation experiments showed that the mutation significantly destabilized the dimer, although the presence of substrates can induce dimer formation. The binding modes of bicarbonate and Mg-ADP are essentially the same as those to the wild-type enzyme. However, the mutation greatly disrupted the dimer interface and caused a large re-organization of the dimer. The structures of these new complexes have implications for the catalysis by BC.	[Chou, Chi-Yuan; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Columbia University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tong, Liang/0000-0002-0563-6468; Chou, Chi-Yuan/0000-0002-3400-171X	National Institutes of Health [DK067238]; National Science Council, Taiwan [98-2320-B-010-026-MY3]; National Health Research Institute, Taiwan [NHRI-EX99-9947SI]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067238 (to L. T.). This work was also supported by grants from the National Science Council, Taiwan (98-2320-B-010-026-MY3) and the National Health Research Institute, Taiwan (NHRI-EX99-9947SI, to C.-Y.C.)	Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho YS, 2008, PROTEINS, V70, P268, DOI 10.1002/prot.21611; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Chou CY, 2011, METHODS, V54, P76, DOI 10.1016/j.ymeth.2010.11.002; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6633; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hoschle B, 2005, MICROBIOL-SGM, V151, P3649, DOI 10.1099/mic.0.28260-0; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kondo S, 2004, ACTA CRYSTALLOGR D, V60, P486, DOI 10.1107/S0907444904000423; Kondo S, 2007, ACTA CRYSTALLOGR D, V63, P885, DOI 10.1107/S0907444907029423; KUKKO E, 1982, EUR J BIOCHEM, V127, P347, DOI 10.1111/j.1432-1033.1982.tb06878.x; Lin PY, 2008, ARCH BIOCHEM BIOPHYS, V472, P34, DOI 10.1016/j.abb.2008.01.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng B, 2008, ANAL BIOCHEM, V376, P131, DOI 10.1016/j.ab.2008.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; Sloane V, 2001, J BIOL CHEM, V276, P24991, DOI 10.1074/jbc.M101472200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; TIPTON PA, 1988, BIOCHEMISTRY-US, V27, P4317, DOI 10.1021/bi00412a019; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	42	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24417	24425		10.1074/jbc.M111.220517	http://dx.doi.org/10.1074/jbc.M111.220517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592965	Green Published, hybrid			2022-12-25	WOS:000292294900081
J	Ghayor, C; Correro, RM; Lange, K; Karfeld-Sulzer, LS; Gratz, KW; Weber, FE				Ghayor, Chafik; Correro, Rita M.; Lange, Katrin; Karfeld-Sulzer, Lindsay S.; Graetz, Klaus W.; Weber, Franz E.			Inhibition of Osteoclast Differentiation and Bone Resorption by N-Methylpyrrolidone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B LIGAND RANKL; KAPPA-B; C-FOS; RECEPTOR ACTIVATOR; IN-VITRO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; KINASE; OSTEOPOROSIS; CELLS	Regulation of RANKL (receptor activator of nuclear factor kappa B ligand)-induced osteoclast differentiation is of current interest in the development of antiresorptive agents. Osteoclasts are multinucleated cells that play a crucial role in bone resorption. In this study, we investigated the effects of N-methylpyrrolidone (NMP) on the regulation of RANKL-induced osteoclastogenesis. NMP inhibited RANKL-induced tartrate-resistant acid phosphatase activity and the formation of tartrate-resistant acid phosphatase-positive multinucleated cells. The RANKL-induced expression of NFATc1 (nuclear factor of activated T cells, cytoplasmic 1) and c-Fos, which are key transcription factors for osteoclastogenesis, was also reduced by treatment with NMP. Furthermore, NMP induced disruption of the actin rings and decreased the mRNAs of cathepsin K and MMP-9 (matrix metalloproteinase-9), both involved in bone resorption. Taken together, these results suggest that NMP inhibits osteoclast differentiation and attenuates bone resorption. Therefore, NMP could prove useful for the treatment of osteoporosis or other bone diseases associated with excessive bone resorption.	[Weber, Franz E.] Univ Zurich, Univ Spital Zurich, Dept Cranio Maxillofacial Surg, Klin Kiefer & Gesichtschirurg Oral Biotechnol & B, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Weber, FE (corresponding author), Univ Zurich, Univ Spital Zurich, Dept Cranio Maxillofacial Surg, Klin Kiefer & Gesichtschirurg Oral Biotechnol & B, Frauenklin Str 24,Nord2,B-843, CH-8091 Zurich, Switzerland.	franz.weber@zzm.uzh.ch	Weber, Franz E./I-7831-2019	Weber, Franz E./0000-0003-1670-2296; Ghayor, Chafik/0000-0002-3016-3412	Swiss National Science Foundation [310000-116240]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by Swiss National Science Foundation Grant 310000-116240.	BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; Body JJ, 2002, BONE, V30, p75S; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chambers TJ, 2000, J PATHOL, V192, P4; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghayor C, 2009, BIOCHEM BIOPH RES CO, V381, P247, DOI 10.1016/j.bbrc.2009.02.032; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Goldhahn J, 2010, BONE, V46, P267, DOI 10.1016/j.bone.2009.10.004; Ha H, 2011, BIOCHEM BIOPH RES CO, V406, P546, DOI 10.1016/j.bbrc.2011.02.085; Howard PA, 2010, AM J CARDIOVASC DRUG, V10, P359, DOI 10.2165/11584720-000000000-00000; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miguel BS, 2009, TISSUE ENG PT A, V15, P2955, DOI [10.1089/ten.tea.2009.0009, 10.1089/ten.TEA.2009.0009]; Mohamed SGK, 2007, BONE, V41, P592, DOI 10.1016/j.bone.2007.05.016; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; O'Regan RM, 2001, ONCOLOGY-NY, V15, P1177; Odvina CV, 2006, J INVEST MED, V54, P114, DOI 10.2310/6650.2006.05037; REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takahashi Naoyuki, 2007, V135, P285; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	39	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24458	24466		10.1074/jbc.M111.223297	http://dx.doi.org/10.1074/jbc.M111.223297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21613210	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000292294900086
J	Yin, J; Deng, ZX; Zhao, GP; Huang, X				Yin, Jun; Deng, Zixin; Zhao, Guoping; Huang, Xi			The N-terminal Nucleophile Serine of Cephalosporin Acylase Executes the Second Autoproteolytic Cleavage and Acylpeptide Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							7-AMINOCEPHALOSPORANIC ACID ACYLASE; HOMOSERINE LACTONE ACYLASE; ANGSTROM CRYSTAL-STRUCTURE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; PENICILLIN ACYLASE; INTRAMOLECULAR AUTOPROTEOLYSIS; ENZYMATIC CATALYSIS; PSEUDOMONAS STRAIN; SUBSTRATE-BINDING	Cephalosporin acylase (CA) precursor is translated as a single polypeptide chain and folds into a self-activating pre-protein. Activation requires two peptide bond cleavages that excise an internal spacer to form the mature alpha beta heterodimer. Using Q-TOF LC-MS, we located the second cleavage site between Glu(159) and Gly(160), and detected the corresponding 10-aa spacer (160)GDPPDLADQG(169) of CA mutants. The site of the second cleavage depended on Glu(159): moving Glu into the spacer or removing 5-10 residues from the spacer sequence resulted in shorter spacers with the cleavage at the carboxylic side of Glu. The mutant E159D was cleaved more slowly than the wild-type, as were mutants G160A and G160L. This allowed kinetic measurements showing that the second cleavage reaction was a first-order, intra-molecular process. Glutaryl-7-aminocephalosporanic acid is the classic substrate of CA, in which the N-terminal Ser(170) of the beta-subunit, is the nucleophile. Glu and Asp resemble glutaryl, suggesting that CA might also remove N-terminal Glu or Asp from peptides. This was indeed the case, suggesting that the N-terminal nucleophile also performed the second proteolytic cleavage. We also found that CA is an acylpeptide hydrolase rather than a previously expected acylamino acid acylase. It only exhibited exopeptidase activity for the hydrolysis of an externally added peptide, supporting the intra-molecular interaction. We propose that the final CA activation is an intramolecular process performed by an N-terminal nucleophile, during which large conformational changes in the alpha-subunit C-terminal region are required to bridge the gap between Glu(159) and Ser(170).	[Yin, Jun; Deng, Zixin; Huang, Xi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yin, Jun; Deng, Zixin; Huang, Xi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, X (corresponding author), 1954 Huashan Rd, Shanghai 200030, Peoples R China.	xhuang@sjtu.edu.cn		Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [30970064]; National High Technology Research and Development Program of China [863]; Major State Basic Research Development Program [973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 30970064, National High Technology Research and Development Program of China Grant 863, and Major State Basic Research Development Program Grant 973.	BALDWIN JE, 1988, NAT PROD REP, V5, P129, DOI 10.1039/np9880500129; Bokhove M, 2010, P NATL ACAD SCI USA, V107, P686, DOI 10.1073/pnas.0911839107; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Chilov GG, 2007, BIOCHEMISTRY-MOSCOW+, V72, P495, DOI 10.1134/S0006297907050057; Cho KJ, 2009, BIOCHEM BIOPH RES CO, V390, P342, DOI 10.1016/j.bbrc.2009.09.134; CHOI KS, 1992, J BACTERIOL, V174, P6270, DOI 10.1128/JB.174.19.6270-6276.1992; Dai MH, 1999, ACTA BIOCH BIOPH SIN, V31, P558; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fritz-Wolf K, 2002, PROTEIN SCI, V11, P92, DOI 10.1110/ps.ps.27502; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Huang X, 2002, J BIOL CHEM, V277, P10256, DOI 10.1074/jbc.M108683200; ISHII Y, 1994, J FERMENT BIOENG, V77, P591, DOI 10.1016/0922-338X(94)90138-4; Isupov MN, 1996, STRUCTURE, V4, P801, DOI 10.1016/S0969-2126(96)00087-1; JONES WM, 1991, P NATL ACAD SCI USA, V88, P2194, DOI 10.1073/pnas.88.6.2194; Kasche V, 1999, BBA-PROTEIN STRUCT M, V1433, P76, DOI 10.1016/S0167-4838(99)00155-7; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Kim JK, 2006, P NATL ACAD SCI USA, V103, P1732, DOI 10.1073/pnas.0507862103; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kim S, 2001, J BIOL CHEM, V276, P48376, DOI 10.1074/jbc.M109603200; Kim Y, 2002, J BIOL CHEM, V277, P2823, DOI 10.1074/jbc.M108888200; Kim Y, 2001, CHEM BIOL, V8, P1253, DOI 10.1016/S1074-5521(01)00092-8; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Lee YS, 1998, J BACTERIOL, V180, P4576, DOI 10.1128/JB.180.17.4576-4582.1998; Lee YS, 2000, J BIOL CHEM, V275, P39200, DOI 10.1074/jbc.M002504200; Li Y, 1998, PROTEIN EXPRES PURIF, V12, P233, DOI 10.1006/prep.1997.0823; Li Y, 1999, EUR J BIOCHEM, V262, P713, DOI 10.1046/j.1432-1327.1999.00417.x; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mao X, 2004, PROTEIN J, V23, P197, DOI 10.1023/B:JOPC.0000026415.96041.27; MATSUDA A, 1985, J BACTERIOL, V163, P1222, DOI 10.1128/JB.163.3.1222-1228.1985; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, J MOL BIOL, V360, P105, DOI 10.1016/j.jmb.2006.04.066; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Perrotta AT, 1999, NUCLEIC ACIDS RES, V27, P795, DOI 10.1093/nar/27.3.795; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SHIBUYA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1561, DOI 10.1080/00021369.1981.10864767; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; SYKES RB, 1981, NATURE, V291, P489, DOI 10.1038/291489a0; Thomas JM, 2009, J AM CHEM SOC, V131, P1135, DOI 10.1021/ja807790e; Wang YM, 2007, J MOL BIOL, V366, P82, DOI 10.1016/j.jmb.2006.09.051; Wang YM, 2010, J MOL BIOL, V403, P120, DOI 10.1016/j.jmb.2010.08.038; Williams K, 2009, BIOCHEMISTRY-US, V48, P2459, DOI 10.1021/bi8014955	49	11	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24476	24486		10.1074/jbc.M111.242313	http://dx.doi.org/10.1074/jbc.M111.242313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576250	Green Published, hybrid			2022-12-25	WOS:000292294900088
J	Delage, L; Leblanc, C; Collen, PN; Gschloessl, B; Oudot, MP; Sterck, L; Poulain, J; Aury, JM; Cock, JM				Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Oudot, Marie-Pierre; Sterck, Lieven; Poulain, Julie; Aury, Jean-Marc; Cock, J. Mark			In Silico Survey of the Mitochondrial Protein Uptake and Maturation Systems in the Brown Alga Ectocarpus siliculosus	PLOS ONE			English	Article							OUTER-MEMBRANE BIOGENESIS; DISULFIDE BOND FORMATION; AMINO-ACID-SEQUENCE; INNER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; PRECURSOR PROTEINS; SUBCELLULAR-LOCALIZATION; PROCESSING PEPTIDASE; YEAST MITOCHONDRIA	The acquisition of mitochondria was a key event in eukaryote evolution. The aim of this study was to identify homologues of the components of the mitochondrial protein import machinery in the brown alga Ectocarpus and to use this information to investigate the evolutionary history of this fundamental cellular process. Detailed searches were carried out both for components of the protein import system and for related peptidases. Comparative and phylogenetic analyses were used to investigate the evolution of mitochondrial proteins during eukaryote diversification. Key observations include phylogenetic evidence for very ancient origins for many protein import components (Tim21, Tim50, for example) and indications of differences between the outer membrane receptors that recognize the mitochondrial targeting signals, suggesting replacement, rearrangement and/or emergence of new components across the major eukaryotic lineages. Overall, the mitochondrial protein import components analysed in this study confirmed a high level of conservation during evolution, indicating that most are derived from very ancient, ancestral proteins. Several of the protein import components identified in Ectocarpus, such as Tim21, Tim50 and metaxin, have also been found in other stramenopiles and this study suggests an early origin during the evolution of the eukaryotes.	[Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Cock, J. Mark] Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Roscoff, France; [Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Cock, J. Mark] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marine Specie, Stn Biol Roscoff, Roscoff, France; [Oudot, Marie-Pierre] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Sterck, Lieven] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Poulain, Julie; Aury, Jean-Marc] Commissariat Energie Atom, Direct Sci Vivant, Inst Genom, Evry, France; [Poulain, Julie; Aury, Jean-Marc] CNRS, UMR 8030, Evry, France; [Poulain, Julie; Aury, Jean-Marc] Univ Evry, Evry, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; Flanders Institute for Biotechnology (VIB); Ghent University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Delage, L (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Roscoff, France.	cock@sb-roscoff.fr	Aury, Jean-Marc/N-1621-2019; Sterck, Lieven/A-9439-2016	Aury, Jean-Marc/0000-0003-1718-3010; Sterck, Lieven/0000-0001-7116-4000; Poulain, Julie/0000-0002-8744-3116; Cock, J. Mark/0000-0002-2650-0383	French GIS "Institut de la Genomique Marine"; Centre National de Recherche Scientifique; European Union network of excellence Marine Genomics Europe; GIS Europole Mer; University Pierre and Marie Curie	French GIS "Institut de la Genomique Marine"; Centre National de Recherche Scientifique; European Union network of excellence Marine Genomics Europe; GIS Europole Mer; University Pierre and Marie Curie	This work was supported by the French GIS "Institut de la Genomique Marine", the Centre National de Recherche Scientifique, the European Union network of excellence Marine Genomics Europe, the GIS Europole Mer, the University Pierre and Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; Burri L, 2006, FEBS J, V273, P1507, DOI 10.1111/j.1742-4658.2006.05171.x; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esser K, 2004, MOL GENET GENOMICS, V271, P616, DOI 10.1007/s00438-004-1011-y; Figueroa-Martinez F, 2008, GENETICS, V179, P149, DOI 10.1534/genetics.108.087965; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gaston D, 2009, METHOD ENZYMOL, V457, P21, DOI 10.1016/S0076-6879(09)05002-2; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Glaser E, 1998, PLANT MOL BIOL, V38, P311, DOI 10.1023/A:1006020208140; Glaser E, 1999, J BIOENERG BIOMEMBR, V31, P259, DOI 10.1023/A:1005475930477; Gray MW, 2001, GENOME BIOL, V2; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Hawkins John, 2006, Journal of Bioinformatics and Computational Biology, V4, P1, DOI 10.1142/S0219720006001771; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; ISAYA G, 1992, J BIOL CHEM, V267, P7904; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Juhola MK, 2000, FEBS LETT, V481, P91, DOI 10.1016/S0014-5793(00)01989-X; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitada S, 2007, J BACTERIOL, V189, P844, DOI 10.1128/JB.01261-06; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Li ZW, 2006, NUCLEIC ACIDS RES, V34, pD277, DOI 10.1093/nar/gkj124; Lionaki E, 2008, J BIOL CHEM, V283, P15747, DOI 10.1074/jbc.M800350200; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Luo WT, 2006, MOL GENET GENOMICS, V275, P431, DOI 10.1007/s00438-006-0099-7; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mirus O, 2009, J MOL MODEL, V15, P971, DOI 10.1007/s00894-008-0449-y; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nargang FE, 1998, MOL CELL BIOL, V18, P3173, DOI 10.1128/MCB.18.6.3173; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; PRATJE E, 1986, EMBO J, V5, P1313, DOI 10.1002/j.1460-2075.1986.tb04361.x; PRATJE E, 1983, EMBO J, V2, P1049, DOI 10.1002/j.1460-2075.1983.tb01544.x; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Settles AM, 1998, TRENDS CELL BIOL, V8, P494, DOI 10.1016/S0962-8924(98)01387-7; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; TSAOUSIS AD, 2010, MOL BIOL EVOL; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; van der Merwe JA, 2007, J PLANT PHYSIOL, V164, P1231, DOI 10.1016/j.jplph.2006.11.009; van Lis R, 2003, PLANT PHYSIOL, V132, P318, DOI 10.1104/pp.102.018325; VANLOON APGM, 1988, J CELL BIOCHEM, V36, P59, DOI 10.1002/jcb.240360107; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Weber ER, 1996, MOL BIOL CELL, V7, P307, DOI 10.1091/mbc.7.2.307; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Yano M, 2004, J BIOL CHEM, V279, P10808, DOI 10.1074/jbc.M311710200; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	133	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19540	10.1371/journal.pone.0019540	http://dx.doi.org/10.1371/journal.pone.0019540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611166	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200014
J	Hu, PS; Maiti, T				Hu, Pingsha; Maiti, Tapabrata			A Nonparametric Mean-Variance Smoothing Method to Assess Arabidopsis Cold Stress Transcriptional Regulator CBF2 Overexpression Microarray Data	PLOS ONE			English	Article							GENE-EXPRESSION; ACCLIMATION; NETWORK	Microarray is a powerful tool for genome-wide gene expression analysis. In microarray expression data, often mean and variance have certain relationships. We present a non-parametric mean-variance smoothing method (NPMVS) to analyze differentially expressed genes. In this method, a nonlinear smoothing curve is fitted to estimate the relationship between mean and variance. Inference is then made upon shrinkage estimation of posterior means assuming variances are known. Different methods have been applied to simulated datasets, in which a variety of mean and variance relationships were imposed. The simulation study showed that NPMVS outperformed the other two popular shrinkage estimation methods in some mean-variance relationships; and NPMVS was competitive with the two methods in other relationships. A real biological dataset, in which a cold stress transcription factor gene, CBF2, was overexpressed, has also been analyzed with the three methods. Gene ontology and cis-element analysis showed that NPMVS identified more cold and stress responsive genes than the other two methods did. The good performance of NPMVS is mainly due to its shrinkage estimation for both means and variances. In addition, NPMVS exploits a non-parametric regression between mean and variance, instead of assuming a specific parametric relationship between mean and variance. The source code written in R is available from the authors on request.	[Hu, Pingsha] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Maiti, Tapabrata] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hu, PS (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	phu@msu.edu			National Science Foundation (NSF)	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; CUI X, 2003, STAT APPL GENETICS M, V2; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Hu JH, 2007, BIOMETRICS, V63, P41, DOI 10.1111/j.1541-0420.2006.00675.x; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lonnstedt I, 2005, BIOSTATISTICS, V6, P279, DOI 10.1093/biostatistics/kxi009; Medina J, 2001, PLANT PHYSIOL, V125, P1655, DOI 10.1104/pp.125.4.1655; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; SMYTH GK, 2004, STAT APPL GENETICS M, V3; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Tong TJ, 2007, J AM STAT ASSOC, V102, P113, DOI 10.1198/016214506000001266; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; WEISER RL, 1990, PLANT PHYSIOL, V93, P1021, DOI 10.1104/pp.93.3.1021	20	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19640	10.1371/journal.pone.0019640	http://dx.doi.org/10.1371/journal.pone.0019640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611181	gold, Green Submitted, Green Published			2022-12-25	WOS:000290657500010
J	Everest, SJ; Ramsay, AM; Chaplin, MJ; Everitt, S; Stack, MJ; Neale, MH; Jeffrey, M; Moore, SJ; Bellworthy, SJ; Terry, LA				Everest, Sally J.; Ramsay, Andrew M.; Chaplin, Melanie J.; Everitt, Sharon; Stack, Michael J.; Neale, Michael H.; Jeffrey, Martin; Moore, S. Jo; Bellworthy, Susan J.; Terry, Linda A.			Detection and Localisation of PrPSc in the Liver of Sheep Infected with Scrapie and Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							RESISTANT PRION PROTEIN; TISSUE DISTRIBUTION; BLOOD-TRANSFUSION; NATURAL SCRAPIE; BRITISH SHEEP; BSE; FLOCK; TRANSMISSION; ACCUMULATION; DISEASES	Prions are largely contained within the nervous and lymphoid tissue of transmissible spongiform encephalopathy (TSE) infected animals. However, following advances in diagnostic sensitivity, PrPSc, a marker for prion disease, can now be located in a wide range of viscera and body fluids including muscle, saliva, blood, urine and milk, raising concerns that exposure to these materials could contribute to the spread of disease in humans and animals. Previously we demonstrated low levels of infectivity in the liver of sheep experimentally challenged with bovine spongiform encephalopathy. In this study we show that PrPSc accumulated in the liver of 89% of sheep naturally infected with scrapie and 100% of sheep challenged with BSE, at both clinical and preclinical stages of the disease. PrPSc was demonstrated in the absence of obvious inflammatory foci and was restricted to isolated resident cells, most likely Kupffer cells.	[Everest, Sally J.; Ramsay, Andrew M.; Chaplin, Melanie J.; Everitt, Sharon; Stack, Michael J.; Neale, Michael H.; Moore, S. Jo; Bellworthy, Susan J.; Terry, Linda A.] Vet Labs Agcy, Dept Pathol & Host Susceptibil, New Haw, Surrey, England; [Jeffrey, Martin] Vet Labs Agcy VLA Lasswade, Dept Pathol & Host Susceptibil, Penicuik, Midlothian, Scotland		Everest, SJ (corresponding author), Vet Labs Agcy, Dept Pathol & Host Susceptibil, New Haw, Surrey, England.	m.neale@vla.defra.gsi.gov.uk	Ramsay, Andrew/E-2148-2015; Jeffrey, Martin/D-2251-2009	Moore, S Jo/0000-0001-5276-1723	Food Standards Agency UK [MO3060]	Food Standards Agency UK	This work was supported by funding from the Food Standards Agency UK, project MO3060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Baylis M, 2002, TRENDS MICROBIOL, V10, P563, DOI 10.1016/S0966-842X(02)02477-0; Bellworthy SJ, 2005, VET REC, V156, P197, DOI 10.1136/vr.156.7.197; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Madec JY, 2000, MICROB PATHOGENESIS, V28, P353, DOI 10.1006/mpat.2000.0357; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199	21	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19737	10.1371/journal.pone.0019737	http://dx.doi.org/10.1371/journal.pone.0019737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589864	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100024
J	Roescher, N; Vosters, JL; Yin, HE; Illei, GG; Tak, PP; Chiorini, JA				Roescher, Nienke; Vosters, Jelle L.; Yin, Hongen; Illei, Gabor G.; Tak, Paul P.; Chiorini, John A.			Effect of Soluble ICAM-1 on a Sjogren's Syndrome-like Phenotype in NOD Mice Is Disease Stage Dependent	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SALIVARY-GLANDS; GENE-TRANSFER; CELLS; EXPRESSION; ACTIVATION; PATHWAYS; SELECTIN	Introduction: Intercellular adhesion molecule-1 (ICAM-1) is involved in migration and co-stimulation of T and B cells. Membrane bound ICAM-1 is over expressed in the salivary glands (SG) of Sjogren's syndrome (SS) patients and has therefore been proposed as a potential therapeutic target. To test the utility of ICAM-1 as a therapeutic target, we used local gene therapy in Non Obese Diabetic (NOD) mice to express soluble (s) ICAM-1 to compete with membrane bound ICAM-1 for binding with its receptor. Therapy was given prior to and just after the influx of immune cells into the SG. Methods: A recombinant serotype 2 adeno associated virus (rAAV2) encoding ICAM-1/Fc was constructed and its efficacy tested in the female NOD mice after retrograde instillation in SG at eight (early treatment) and ten (late treatment) weeks of age. SG inflammation was evaluated by focus score and immunohistochemical quantification of infiltrating cell types. Serum and SG tissue were analyzed for immunoglobulins (Ig). Results: Early treatment with ICAM-1/Fc resulted in decreased average number of inflammatory foci without changes in T and B cell composition. In contrast, late treated mice did not show any change in focus scores, but immunohistochemical staining showed an increase in the overall number of CD4+ and CD8+ T cells. Moreover, early treated mice showed decreased IgM within the SGs, whereas late treated mice had increased IgM levels, and on average higher IgG and IgA. Conclusions: Blocking the ICAM-1/LFA-1 interaction with sICAM-1/Fc may result in worsening of a SS like phenotype when infiltrates have already formed within the SG. As a treatment for human SS, caution should be taken targeting the ICAM-1 axis since most patients are diagnosed when inflammation is clearly present within the SG.	[Roescher, Nienke; Vosters, Jelle L.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Roescher, Nienke; Vosters, Jelle L.; Yin, Hongen; Illei, Gabor G.; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	University of Amsterdam; Academic Medical Center Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Roescher, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	jchiorini@dir.nidcr.nih.gov			Dutch Arthritis Association [NR 07-1-406]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000704, ZIADE000695] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by a Dutch Arthritis Association grant [NR 07-1-406] to JLV and an NIH, NIDCR intramural research grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4; Aziz K E, 1992, J Clin Lab Immunol, V37, P39; Bertry-Coussot L, 2002, J IMMUNOL, V168, P3641, DOI 10.4049/jimmunol.168.7.3641; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Chen WS, 2009, J RHEUMATOL, V36, P989, DOI 10.3899/jrheum.080733; Deeths MJ, 1999, EUR J IMMUNOL, V29, P45, DOI 10.1002/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO;2-I; DOERCK S, PLOS ONE, V5; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kapsogeorgou EK, 2001, CLIN EXP IMMUNOL, V124, P126, DOI 10.1046/j.1365-2249.2001.01500.x; Kok MR, 2003, HUM GENE THER, V14, P1605, DOI 10.1089/104303403322542257; Kok MR, 2003, ANN RHEUM DIS, V62, P1038, DOI 10.1136/ard.62.11.1038; Martin S, 1998, DIABETOLOGIA, V41, P1298, DOI 10.1007/s001250051068; Mikulowska-Mennis A, 2001, AM J PATHOL, V159, P671, DOI 10.1016/S0002-9440(10)61738-5; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; NIKOLOV NP, 2009, ARTHRITIS RHEUM, V60, P499; POUDRIER J, 1994, J EXP MED, V179, P1417, DOI 10.1084/jem.179.5.1417; Thanou-Stavraki A, 2008, SEMIN ARTHRITIS RHEU, V37, P273, DOI 10.1016/j.semarthrit.2007.06.002; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Turkcapar N, 2005, J RHEUMATOL, V32, P1063; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; WU AJ, 1994, J CELL PHYSIOL, V161, P217, DOI 10.1002/jcp.1041610205; Yamano S, 2002, HUM GENE THER, V13, P287, DOI 10.1089/10430340252769806	25	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19962	10.1371/journal.pone.0019962	http://dx.doi.org/10.1371/journal.pone.0019962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589878	Green Published, Green Submitted, gold			2022-12-25	WOS:000290531100035
J	Van Houtan, KS; Halley, JM				Van Houtan, Kyle S.; Halley, John M.			Long-Term Climate Forcing in Loggerhead Sea Turtle Nesting	PLOS ONE			English	Article							SURFACE-TEMPERATURE; OSCILLATION; PATTERNS	The long-term variability of marine turtle populations remains poorly understood, limiting science and management. Here we use basin-scale climate indices and regional surface temperatures to estimate loggerhead sea turtle (Caretta caretta) nesting at a variety of spatial and temporal scales. Borrowing from fisheries research, our models investigate how oceanographic processes influence juvenile recruitment and regulate population dynamics. This novel approach finds local populations in the North Pacific and Northwest Atlantic are regionally synchronized and strongly correlated to ocean conditions-such that climate models alone explain up to 88% of the observed changes over the past several decades. In addition to its performance, climate-based modeling also provides mechanistic forecasts of historical and future population changes. Hindcasts in both regions indicate climatic conditions may have been a factor in recent declines, but future forecasts are mixed. Available climatic data suggests the Pacific population will be significantly reduced by 2040, but indicates the Atlantic population may increase substantially. These results do not exonerate anthropogenic impacts, but highlight the significance of bottom-up oceanographic processes to marine organisms. Future studies should consider environmental baselines in assessments of marine turtle population variability and persistence.	[Van Houtan, Kyle S.] Pacific Isl Fisheries Sci Ctr, NOAA Fisheries Serv, Marine Turtle Assessment Program, Honolulu, HI USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA; [Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece	National Oceanic Atmospheric Admin (NOAA) - USA; Duke University; University of Ioannina	Van Houtan, KS (corresponding author), Pacific Isl Fisheries Sci Ctr, NOAA Fisheries Serv, Marine Turtle Assessment Program, Honolulu, HI USA.	kyle.vanhoutan@gmail.com	Halley, John M/AAP-3004-2020; Van Houtan, Kyle Schuyler/A-4695-2008; Van Houtan, Kyle S/GRY-0874-2022	Van Houtan, Kyle/0000-0001-5725-1773				BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; Bolten AB, 1998, ECOL APPL, V8, P1; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CARR AF, 1952, SCIENCE, V309, P1236; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clark J. S, 2007, MODELS ECOLOGICAL DA; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dawe EG, 2007, FISH OCEANOGR, V16, P303, DOI 10.1111/j.1365-2419.2007.00431.x; Drinkwater K.F., 2003, GEOPHYS MONOGR SER, V134, P211; Edwards M, 2010, TRENDS ECOL EVOL, V25, P602, DOI 10.1016/j.tree.2010.07.007; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Halley JM, 2009, PHYSICA A, V388, P2492, DOI 10.1016/j.physa.2009.02.027; Hatase H, 2004, MAR BIOL, V144, P807, DOI 10.1007/s00227-003-1232-3; Hjort J, 1914, RAPPORTS PROCES VERB, V20, P3; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KAMEZAKI N, 2002, CURRENT STATUS JAPAN; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Lasker R., 1981, P79; Lewison RL, 2009, ECOL APPL, V19, P920, DOI 10.1890/08-0623.1; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Matsuzawa Y, 2010, NESTING BEACH MANAGE; Natl Res Council, 2010, ASSESSMENT OF SEA-TURTLE STATUS AND TRENDS: INTEGRATING DEMOGRAPHY AND ABUNDANCE, P1; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Pearson A, 2009, NEW SCI, V201, P33; PHILANDER SGH, 1990, EL NINO LA NINA S OS; PIMM SL, 1982, FOOD WEBS; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; POLOVINA JJ, 2011, ICES J MAR SCI, DOI DOI 10.1093/ICESJMS/FSQ1198; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rivalan P, 2005, J WILDLIFE MANAGE, V69, P540, DOI 10.2193/0022-541X(2005)069[0540:MLEOTL]2.0.CO;2; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; SASSO CR, ANN SURVIVA IN PRESS; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Snover, 2002, GROWTH ONTOGENY SEA; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; TAKESHITA H, 2005, P 2 W PAC SEA TURTL, P27; THOMPSON N, 2009, NMFSSEFSC575 NOAA TU; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Van Houtan KS, 2007, CURR BIOL, V17, pR590, DOI 10.1016/j.cub.2007.06.021; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Van Houtan KS, 2009, CONSERV LETT, V2, P254, DOI 10.1111/j.1755-263X.2009.00081.x; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	56	54	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19043	10.1371/journal.pone.0019043	http://dx.doi.org/10.1371/journal.pone.0019043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21589639	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400023
J	Wang, D; Li, YP; Lee, SG; Wang, L; Fan, JH; Zhang, G; Wu, J; Ji, Y; Li, SL				Wang, Dong; Li, Yanping; Lee, Simin Gharib; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin			Ethnic Differences in Body Composition and Obesity Related Risk Factors: Study in Chinese and White Males Living in China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; MASS INDEX; WAIST CIRCUMFERENCE; METABOLIC-DISORDERS; INSULIN-RESISTANCE; FAT; PREVALENCE; ASIA; POPULATION	The purpose of this cross-sectional observational study was to identify ethnic differences in body composition and obesity-related risk factors between Chinese and white males living in China. 115 Chinese and 114 white male pilots aged 28-63 years were recruited. Fasting body weight, height and blood pressure were measured following standard procedures. Whole-body and segmental body composition were measured using an 8-contact electrode bioimpedance analysis (BIA) system. Fasting serum glucose, fasting plasma total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, and triglycerides (TG) were assessed using automatic biochemistry analyzer. After adjusting for age and body mass index (BMI), Chinese males had significantly higher percentage of body fat (PBF) both with respect to whole body (Chinese: 23.7% +/- 0.2% vs. Whites: 22.4% +/- 0.2%) and the trunk area (Chinese: 25.0% +/- 0.3% vs. Whites: 23.2% +/- 0.3%) compared to their white counterparts. At all BMIs, Chinese males had significantly higher fasting glucose levels (Chinese: 5.7 +/- 1.0 mmol/L vs. Whites: 5.2 +/- 1.0 mmol/L) but lower high-density lipoprotein levels (Chinese: 0.8 +/- 1.0 mmol/L vs. Whites: 1.0 +/- 1.0 mmol/L) than white males. In addition, a marginally significantly higher diastolic blood pressure was found among Chinese men than that among white men (Chinese: 80 +/- 1.0 mmHg vs. Whites: 77 +/- 1.0 mmHg). Chinese males had more body fat and a greater degree of central fat deposition pattern than that seen in white males in the present study. Furthermore, data on blood pressure, fasting glucose and blood lipids suggest that Chinese men may be more prone to obesity-related risk factors than white men.	[Wang, Dong; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin] Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China; [Wang, Dong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yanping] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Lee, Simin Gharib] Tsinghua Univ, Beijing 100084, Peoples R China	Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Tsinghua University	Wang, D (corresponding author), Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China.	wangdong621@live.cn; lsonglin@yahoo.com	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	Civil Aviation Administration of China [200 000 RMB]; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	Civil Aviation Administration of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Civil Aviation Administration of China, grant number 200 000 RMB; (http://www.caac.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; *AM HEART ASS, 2002, HEART DIS STROK STAT; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CJ, 2000, INT J OBESITY, V24, P1699, DOI 10.1038/sj.ijo.0801457; Cheng TO, 2009, INT J CARDIOL, V135, P385, DOI 10.1016/j.ijcard.2007.11.080; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; *CIV AV ADM CHIN, 2001, STAND MED CHECK CERT; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Deurenberg P, 2003, EUR J CLIN NUTR, V57, P405, DOI 10.1038/sj.ejcn.1601569; Deurenberg P, 1997, Asia Pac J Clin Nutr, V6, P102; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Du SM, 2010, BIOMED ENVIRON SCI, V23, P92, DOI 10.1016/S0895-3988(10)60037-2; ESTON R, 1994, BRIT J SPORT MED, V28, P9, DOI 10.1136/bjsm.28.1.9; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; James WPT, 2004, COMP QUANTIFICATION, P497; JIANG ZM, 1991, WORLD J SURG, V15, P95, DOI 10.1007/BF01658974; JIN J, 2008, ZHONG GUO YUN DONG Y, V27, P463; Lee CMY, 2007, ASIA PAC J CLIN NUTR, V16, P187; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rush EC, 2007, INT J OBESITY, V31, P1232, DOI 10.1038/sj.ijo.0803576; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; SLUYTER JD, 2009, OBESITY, V18, P183; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weng X, 2006, EUR J CLIN NUTR, V60, P931, DOI 10.1038/sj.ejcn.1602396; WHO, 2004, LANCET, V363, P902; World Economic Forum, 2010, GLOB RISKS 2010 GLOB; World Health Organization, 2021, OB OV FACT SHEETS; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhao D, 2007, AM J CARDIOL, V100, P835, DOI 10.1016/j.amjcard.2007.03.103	44	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19835	10.1371/journal.pone.0019835	http://dx.doi.org/10.1371/journal.pone.0019835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21602932	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200026
J	Zheng, BW; Zhang, QM; Gao, J; Han, HM; Li, M; Zhang, JR; Qi, JX; Yan, JH; Gao, GF				Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Zhang, Jingren; Qi, Jianxun; Yan, Jinghua; Gao, George F.			Insight into the Interaction of Metal Ions with TroA from Streptococcus suis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN ZNUA; ZINC-BINDING PROTEIN; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; IRON TRANSPORT; MANGANESE; VIRULENCE; REVEALS; PSAA	Background: The scavenging ability of sufficient divalent metal ions is pivotal for pathogenic bacteria to survive in the host. ATP-binding cassette (ABC)-type metal transporters provide a considerable amount of different transition metals for bacterial growth. TroA is a substrate binding protein for uptake of multiple metal ions. However, the function and structure of the TroA homologue from the epidemic Streptococcus suis isolates (SsTroA) have not been characterized. Methodology/Principal Findings: Here we determined the crystal structure of SsTroA from a highly pathogenic streptococcal toxic shock syndrome (STSS)-causing Streptococcus suis in complex with zinc. Inductively coupled plasma mass spectrometry (ICP-MS) analysis revealed that apo-SsTroA binds Zn2+ and Mn2+. Both metals bind to SsTroA with nanomolar affinity and stabilize the protein against thermal unfolding. Zn2+ and Mn2+ induce distinct conformational changes in SsTroA compared with the apo form as confirmed by both circular dichroism (CD) and nuclear magnetic resonance (NMR) spectra. NMR data also revealed that Zn2+/Mn2+ bind to SsTroA in either the same site or an adjacent region. Finally, we found that the folding of the metal-bound protein is more compact than the corresponding apoprotein. Conclusions/Significance: Our findings reveal a mechanism for uptake of metal ions in S. suis and this mechanism provides a reasonable explanation as to how SsTroA operates in metal transport.	[Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Qi, Jianxun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Zheng, Beiwen; Han, Huiming; Gao, George F.] Chinese Acad Sci, Coll Life Sci, Grad Univ, Beijing, Peoples R China; [Gao, Jia] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, Nanning, Guangxi, Peoples R China; [Zhang, Jingren] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Tsinghua University; Chinese Academy of Sciences	Zheng, BW (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021; Georgieva, Angelina/AAC-4823-2021	Georgieva, Angelina/0000-0003-0731-7775	Ministry of Science and Technology (MOST) [2011CB504003, 2006BAD06A04]; National Natural Science Fundation of China (NSFC) [30728014]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work was supported by grants from the Ministry of Science and Technology (MOST, Project 973 Grant No. 2011CB504003; National Key Technology R&D Program 2006BAD06A04); J.Z. and G. F. G. have a joint grant by National Natural Science Fundation of China (NSFC, Grant No. 30728014). G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2008, INFECT IMMUN, V76, P1590, DOI 10.1128/IAI.00987-07; Aranda J, 2009, MICROBIOL-SGM, V155, P1580, DOI 10.1099/mic.0.026278-0; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GARIEPY J, 1985, BIOCHEMISTRY-US, V24, P544, DOI 10.1021/bi00323a045; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Kamen DE, 2001, PROTEIN SCI, V10, P2123, DOI 10.1110/ps.19801; LANGFORD P, 1991, FEMS MICROBIOL LETT, V77, P347, DOI 10.1016/0378-1097(91)90578-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; McEwan AG, 2009, MOL MICROBIOL, V72, P812, DOI 10.1111/j.1365-2958.2009.06700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Sambrook J, 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	66	100	100	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19510	10.1371/journal.pone.0019510	http://dx.doi.org/10.1371/journal.pone.0019510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611125	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200010
J	Liu, CC; Guo, MS; Lin, FHY; Hsiao, KN; Chang, KHW; Chou, AH; Wang, YC; Chen, YC; Yang, CS; Chong, PCS				Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi; Chong, Pele Choi-Sing			Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71; PUBLIC-HEALTH; DISEASE VIRUS; PROTECTS MICE; POLIOVIRUS; INFECTION; VACCINE; STRAIN; VP1; IDENTIFICATION	Background: Enterovirus 71 (EV71) infections manifest most commonly as a childhood exanthema known as hand-foot-and-mouth disease (HFMD) and can cause neurological disease during acute infection. Principal Finding: In this study, we describe the production, purification and characterization of EV71 virus produced from Vero cells grown in a five-liter serum-free bioreactor system containing 5 g/L Cytodex 1 microcarrier. The viral titer was >10(6) TCID(50)/mL by 6 days post infection when a MOI of 10(-5) was used at the initial infection. Two EV71 virus fractions were separated and detected when the harvested EV71 virus concentrate was purified by sucrose gradient zonal ultracentrifugation. The EV71 viral particles detected in the 24-28% sucrose fractions had an icosahedral structure 30-31 nm in diameter and had low viral infectivity and RNA content. Three major viral proteins (VP0, VP1 and VP3) were observed by SDS-PAGE. The EV71 viral particles detected in the fractions containing 35-38% sucrose were 33-35 nm in size, had high viral infectivity and RNA content, and were composed of four viral proteins (VP1, VP2, VP3 and VP4), as shown by SDS-PAGE analyses. The two virus fractions were formalin-inactivated and induced high virus neutralizing antibody responses in mouse immunogenicity studies. Both mouse antisera recognized the immunodominant linear neutralization epitope of VP1 (residues 211-225). Conclusion: These results provide important information for cell-based EV71 vaccine development, particularly for the preparation of working standards for viral antigen quantification.	[Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Chong, Pele Choi-Sing] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan; [Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan Town, Miaoli County, Taiwan; [Chong, Pele Choi-Sing] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Liu, CC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Yang, Chung-Shi/E-3999-2010; Loos, Ruth/Q-2862-2016	Liu, Chia-Chyi/0000-0002-6257-0389; Loos, Ruth/0000-0002-8532-5087	Department of Health, the Taiwan CDC; National Science Council; National Health Research Institutes, Taiwan	Department of Health, the Taiwan CDC; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Department of Health, the Taiwan CDC, the National Science Council and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; FERGUSON M, 1990, J GEN VIROL, V71, P1271, DOI 10.1099/0022-1317-71-6-1271; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Guang DM, 2007, MICROBES INFECT, V9, P1299; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; HUMMELER K, 1962, VIROLOGY, V16, P84, DOI 10.1016/0042-6822(62)90205-2; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; MAYER MM, 1957, J IMMUNOL, V78, P435; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; MINOR PD, 1980, J GEN VIROL, V51, P147, DOI 10.1099/0022-1317-51-1-147; MINOR PD, 1991, J GEN VIROL, V72, P2475, DOI 10.1099/0022-1317-72-10-2475; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; VONSEEFRIED A, 1984, REV INFECT DIS, V6, pS345; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	35	139	164	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20005	10.1371/journal.pone.0020005	http://dx.doi.org/10.1371/journal.pone.0020005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603631	Green Submitted, Green Published, gold			2022-12-25	WOS:000290558500041
J	Wang, DY; Olman, MA; Stewart, J; Tipps, R; Huang, P; Sanders, PW; Toline, E; Prayson, RA; Lee, J; Weil, RJ; Palmer, CA; Gillespie, GY; Liu, WM; Pieper, RO; Guan, JL; Gladson, CL				Wang, Dongyan; Olman, Mitchell A.; Stewart, Jerry, Jr.; Tipps, Russell; Huang, Ping; Sanders, Paul W.; Toline, Eric; Prayson, Richard A.; Lee, Jeongwu; Weil, Robert J.; Palmer, Cheryl A.; Gillespie, G. Yancey; Liu, Wei Michael; Pieper, Russell O.; Guan, Jun-Lin; Gladson, Candece L.			Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HUMAN BREAST-CANCER; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; TYROSINE KINASE; CYCLE PROGRESSION; INTERACTING PROTEIN; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; SRC KINASE	The expression of focal adhesion kinase family interacting protein of 200-kDa (FIP200) in normal brain is limited to some neurons and glial cells. On immunohistochemical analysis of biopsies of glioblastoma tumors, we detected FIP200 in the tumor cells, tumor-associated endothelial cells, and occasional glial cells. Human glioblastoma tumor cell lines and immortalized human astrocytes cultured in complete media also expressed FIP200 as did primary human brain microvessel endothelial cells (MvEC), which proliferate in culture and resemble reactive endothelial cells. Downregulation of endogenous expression of FIP200 using small interfering RNA resulted in induction of apoptosis in the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC. It has been shown by other investigators using cells from other tissues that FIP200 can interact directly with, and inhibit, proline-rich tyrosine kinase 2 (Pyk2) and focal adhesion kinase (FAK). In the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC, we found that downregulation of FIP200 increased the activity of Pyk2 without increasing its expression, but did not affect the activity or expression of FAK. Coimmunoprecipitation and colocalization studies indicated that the endogenous FIP200 was largely associated with Pyk2, rather than FAK, in the glioblastoma tumor cells and brain MvEC. Moreover, the pro-apoptotic effect of FIP200 downregulation was inhibited significantly by a TAT-Pyk2-fusion protein containing the Pyk2 autophosphorylation site in these cells. In summary, downregulation of endogenous FIP200 protein in glioblastoma tumor cells, astrocytes, and brain MvECs promotes apoptosis, most likely due to the removal of a direct interaction of FIP200 with Pyk2 that inhibits Pyk2 activation, suggesting that FIP200 expression may be required for the survival of all three cell types found in glioblastoma tumors.	[Wang, Dongyan; Stewart, Jerry, Jr.; Toline, Eric; Palmer, Cheryl A.; Liu, Wei Michael; Gladson, Candece L.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA; [Olman, Mitchell A.] Univ Alabama Birmingham, Dept Med, Div Pulm Crit Care, Birmingham, AL 35294 USA; [Sanders, Paul W.] Univ Alabama Birmingham, Dept Nephrol, Birmingham, AL 35294 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Tipps, Russell; Huang, Ping; Liu, Wei Michael; Gladson, Candece L.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Lee, Jeongwu] Cleveland Clin, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Prayson, Richard A.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Weil, Robert J.; Gladson, Candece L.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA; [Pieper, Russell O.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Guan, Jun-Lin] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Wang, DY (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA.	gladsoc@ccf.org	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	National Institutes of Health [DK46199, HL58655, CA109748, CA127620]; Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK46199 to PWS, HL58655 to MAO, CA109748 and CA127620 to CLG, and the Melvin Burkhardt chair in Neurosurgical Oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic for support of RJW. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chano T, 2002, GENE, V291, P29, DOI 10.1016/S0378-1119(02)00585-1; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Dahiya R, 1998, INT J ONCOL, V12, P811; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gutenberg A, 2004, ACTA NEUROPATHOL, V108, P224, DOI 10.1007/s00401-004-0886-3; Han HS, 2003, J EXP MED, V197, P63, DOI 10.1084/jem.20021638; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Kuwabara K, 2004, ENDOCRINOLOGY, V145, P3324, DOI 10.1210/en.2003-1433; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lipinski CA, 2003, MOL CANCER RES, V1, P323; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Ramachandra M, 2002, CANCER RES, V62, P6045; Rege TA, 2009, J CELL PHYSIOL, V218, P94, DOI 10.1002/jcp.21570; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; The WHO, 2020, CLASSIFICATION TUMOU; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang DY, 2000, J CELL SCI, V113, P4221; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Ying WZ, 2008, AM J PHYSIOL-RENAL, V295, pF406, DOI 10.1152/ajprenal.90294.2008; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19629	10.1371/journal.pone.0019629	http://dx.doi.org/10.1371/journal.pone.0019629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602932	Green Published, gold			2022-12-25	WOS:000290558500017
J	He, S; Kato, K; Jiang, J; Wahl, DR; Mineishi, S; Fisher, EM; Murasko, DM; Glick, GD; Zhang, Y				He, Shan; Kato, Koji; Jiang, Jiu; Wahl, Daniel R.; Mineishi, Shin; Fisher, Erin M.; Murasko, Donna M.; Glick, Gary D.; Zhang, Yi			Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8(+) T Cells with Augmented Ability to Generate Long-Lasting Memory Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; HUMAN CEREBRAL GLIOMA; DONOR TH2 CELLS; ENERGY-METABOLISM; MAMMALIAN TARGET; VIRAL-INFECTION; IN-VIVO; RESISTANT PROLIFERATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS	Background: Cellular metabolism plays a critical role in regulating T cell responses and the development of memory T cells with long-term protections. However, the metabolic phenotype of antigen-activated T cells that are responsible for the generation of long-lived memory cells has not been characterized. Design and Methods: Using lymphocytic choriomeningitis virus (LCMV) peptide gp33-specific CD8(+) T cells derived from T cell receptor transgenic mice, we characterized the metabolic phenotype of proliferating T cells that were activated and expanded in vitro in the presence or absence of rapamycin, and determined the capability of these rapamycin-treated T cells to generate long-lived memory cells in vivo. Results: Antigen-activated CD8(+) T cells treated with rapamycin gave rise to 5-fold more long-lived memory T cells in vivo than untreated control T cells. In contrast to that control T cells only increased glycolysis, rapamycin-treated T cells upregulated both glycolysis and oxidative phosphorylation (OXPHOS). These rapamycin-treated T cells had greater ability than control T cells to survive withdrawal of either glucose or growth factors. Inhibition of OXPHOS by oligomycin significantly reduced the ability of rapamycin-treated T cells to survive growth factor withdrawal. This effect of OXPHOS inhibition was accompanied with mitochondrial hyperpolarization and elevation of reactive oxygen species that are known to be toxic to cells. Conclusions: Our findings indicate that these rapamycin-treated T cells may represent a unique cell model for identifying nutrients and signals critical to regulating metabolism in both effector and memory T cells, and for the development of new methods to improve the efficacy of adoptive T cell cancer therapy.	[He, Shan; Kato, Koji; Mineishi, Shin; Zhang, Yi] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Jiang, Jiu; Fisher, Erin M.; Murasko, Donna M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Wahl, Daniel R.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Glick, Gary D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	He, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	yizha@med.umich.edu	He, Shan/C-4989-2015; Ma, Zhonghua/J-6972-2014	Yin, Yanni/0000-0002-0798-3420; Ma, Zhonghua/0000-0002-5426-0997	Damon Runyon-Rachleff Innovation Award; American Cancer Society; NIH [R01 CA102464, R01 AI47450]; National Institutes of Health through the University of Michigan [P30CA46592]; NATIONAL CANCER INSTITUTE [R01CA102464, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047450] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Innovation Award; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Damon Runyon-Rachleff Innovation Award (YZ), American Cancer Society (YZ) and the NIH [R01 CA102464 (YZ) and R01 AI47450 (GDG)]. This research is supported in part by a grant from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; BENKE PJ, 1991, BIOCHEM MED METAB B, V45, P28, DOI 10.1016/0885-4505(91)90005-6; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DWARAKANATH BS, 1991, INDIAN J BIOCHEM BIO, V28, P203; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kuhnke A, 2003, ANN RHEUM DIS, V62, P133, DOI 10.1136/ard.62.2.133; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Slavik JM, 2004, J BIOL CHEM, V279, P910, DOI 10.1074/jbc.M209733200; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Sprent J, 2003, MICROBES INFECT, V5, P227, DOI 10.1016/S1286-4579(03)00015-7; Tejero-Taldo MI, 1999, J MOL CELL CARDIOL, V31, P1863, DOI 10.1006/jmcc.1999.1020; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; WAHL DR, LUPUS; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051; Zhang Y, 1998, BLOOD, V92, P118, DOI 10.1182/blood.V92.1.118.413a01_118_128; Zhang Y, 2004, BLOOD, V103, P3970, DOI 10.1182/blood-2003-09-3135; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	69	101	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20107	10.1371/journal.pone.0020107	http://dx.doi.org/10.1371/journal.pone.0020107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	22140571	gold, Green Submitted, Green Published			2022-12-25	WOS:000290657500043
J	Yang, D; Tao, J; Li, L; Kedei, N; Toth, ZE; Czap, A; Velasquez, JF; Mihova, D; Michalowski, AM; Yuspa, SH; Blumberg, PM				Yang, D.; Tao, J.; Li, L.; Kedei, N.; Toth, Z. E.; Czap, A.; Velasquez, J. F.; Mihova, D.; Michalowski, A. M.; Yuspa, S. H.; Blumberg, P. M.			RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma	ONCOGENE			English	Article						Ras activator; Akt; HGF; melanoma; cell transformation; guanine nucleotide exchange factor	POLYMERASE-CHAIN-REACTION; PHORBOL ESTERS; KINASE ACTIVATION; B-RAF; FUNCTIONAL-ANALYSIS; CELL PROLIFERATION; COLORECTAL TUMORS; REGULATED KINASE; BRAF MUTATIONS; PHOSPHORYLATION	RasGRP3, an activator for H-Ras, R-Ras and Ras-associated protein-1/2, has emerged as an important mediator of signaling downstream from receptor coupled phosphoinositide turnover in B and T cells. Here, we report that RasGRP3 showed a high level of expression in multiple human melanoma cell lines as well as in a subset of human melanoma tissue samples. Suppression of endogenous RasGRP3 expression in these melanoma cell lines reduced Ras-GTP formation as well as c-Met expression and Akt phosphorylation downstream from hepatocyte growth factor (HGF) or epidermal growth factor (EGF) stimulation. RasGRP3 suppression also inhibited cell proliferation and reduced both colony formation in soft agar and xenograft tumor growth in immunodeficient mice, demonstrating the importance of RasGRP3 for the transformed phenotype of the melanoma cells. Reciprocally, overexpression of RasGRP3 in human primary melanocytes altered cellular morphology, markedly enhanced cell proliferation and rendered the cells tumorigenic in a mouse xenograft model. Suppression of RasGRP3 expression in these cells inhibited downstream RasGRP3 responses and suppressed cell growth, confirming the functional role of RasGRP3 in the altered behavior of these cells. The identification of the role of RasGRP3 in melanoma highlights its importance, as a Ras activator, in the phosphoinositide signaling pathway in human melanoma and provides a new potential therapeutic target. Oncogene (2011) 30, 4590-4600; doi: 10.1038/onc.2011.166; published online 23 May 2011	[Yang, D.; Tao, J.; Li, L.; Kedei, N.; Czap, A.; Velasquez, J. F.; Mihova, D.; Michalowski, A. M.; Yuspa, S. H.; Blumberg, P. M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Toth, Z. E.] Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, Budapest, Hungary; [Toth, Z. E.] Hungarian Acad Sci, Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Semmelweis University; Hungarian Academy of Sciences	Blumberg, PM (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Room 4048,Bldg 37,37 Convent Dr MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018; Chan, Anthony Tak Cheung/R-3940-2018	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808; Chan, Anthony Tak Cheung/0000-0002-6912-8091	NIH, Center for Cancer Research, National Cancer Institute [Z1A BC 005270]; ETT [495/09]; Bolyai fellowship; NATIONAL CANCER INSTITUTE [ZIABC004504, ZIABC005445, ZIABC005270, Z01BC005270] Funding Source: NIH RePORTER	NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ETT; Bolyai fellowship(Hungarian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the intramural program of the NIH, Center for Cancer Research, National Cancer Institute (project number Z1A BC 005270) and in part by grant ETT 495/09. ZE Toth is supported by the Bolyai fellowship. We thank Glenn Merlino for helpful comments.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; BALL NJ, 1994, J INVEST DERMATOL, V102, P285, DOI 10.1111/1523-1747.ep12371783; Bastian BC, 2003, AM J PATHOL, V163, P1765, DOI 10.1016/S0002-9440(10)63536-5; Bauer J, 2006, DERMATOL THER, V19, P40, DOI 10.1111/j.1529-8019.2005.00055.x; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V271, P726, DOI 10.1006/bbrc.2000.2716; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Haluska Frank G, 2006, Curr Oncol Rep, V8, P400, DOI 10.1007/s11912-006-0065-x; Hingorani SR, 2003, CANCER RES, V63, P5198; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Huang HP, 2008, J AGR FOOD CHEM, V56, P9286, DOI 10.1021/jf8013102; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ikenoue T, 2003, CANCER RES, V63, P8132; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Powell MB, 1999, CARCINOGENESIS, V20, P1747, DOI 10.1093/carcin/20.9.1747; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Satyamoorthy K, 2003, CANCER RES, V63, P756; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Stope MB, 2004, MOL CELL BIOL, V24, P4664, DOI 10.1128/MCB.24.11.4664-4676.2004; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Sutlovic D, 2005, CROAT MED J, V46, P556; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Elsas A, 1995, Recent Results Cancer Res, V139, P57; Wang DZ, 2000, ONCOGENE, V19, P4647, DOI 10.1038/sj.onc.1203820; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	54	40	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2011	30	45					4590	4600		10.1038/onc.2011.166	http://dx.doi.org/10.1038/onc.2011.166			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	22139084	Green Accepted			2022-12-25	WOS:000296890700006
J	Zhou, JX; Brusch, L; Huang, S				Zhou, Joseph Xu; Brusch, Lutz; Huang, Sui			Predicting Pancreas Cell Fate Decisions and Reprogramming with a Hierarchical Multi-Attractor Model	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ROBUST DEVELOPMENT; NETWORK MODELS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; ALPHA; DIVERSIFICATION; PRECURSORS; PLASTICITY	Cell fate reprogramming, such as the generation of insulin-producing beta cells from other pancreas cells, can be achieved by external modulation of key transcription factors. However, the known gene regulatory interactions that form a complex network with multiple feedback loops make it increasingly difficult to design the cell reprogramming scheme because the linear regulatory pathways as schemes of causal influences upon cell lineages are inadequate for predicting the effect of transcriptional perturbation. However, sufficient information on regulatory networks is usually not available for detailed formal models. Here we demonstrate that by using the qualitatively described regulatory interactions as the basis for a coarse-grained dynamical ODE (ordinary differential equation) based model, it is possible to recapitulate the observed attractors of the exocrine and beta, delta, alpha endocrine cells and to predict which gene perturbation can result in desired lineage reprogramming. Our model indicates that the constraints imposed by the incompletely elucidated regulatory network architecture suffice to build a predictive model for making informed decisions in choosing the set of transcription factors that need to be modulated for fate reprogramming.	[Zhou, Joseph Xu; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Technische Universitat Dresden; University of Calgary; University of California System; University of California Santa Barbara	Zhou, JX (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	joseph.x.zhou@gmail.com	Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Mahara, Sylvia/0000-0001-7261-1423	German Ministry for Education and Research [0315259]; National Science Foundation [PHY05-51164]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by the German Ministry for Education and Research through grant no. 0315259. It was also supported in part by the National Science Foundation under Grant No. PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Furusawa C, 2003, J THEOR BIOL, V224, P413, DOI 10.1016/S0022-5193(03)00189-9; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2001, PHARMACOGENOMICS, V2, P203, DOI 10.1517/14622416.2.3.203; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mehta S, 2005, J HEPATO-BILIARY-PAN, V12, P208, DOI 10.1007/s00534-005-0981-4; Miyatsuka T, 2008, EXPERT OPIN THER TAR, V12, P1431, DOI [10.1517/14728222.12.11.1431, 10.1517/14728222.12.11.1431 ]; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZHOU Q, 2008, NATURE	57	110	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14752	10.1371/journal.pone.0014752	http://dx.doi.org/10.1371/journal.pone.0014752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21589872	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400002
